data_1bip_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1bip _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.456 ' O ' ' N ' ' A' ' 10' ' ' MET . 37.8 Cg_endo . . . . . 0 C--O 1.208 -0.975 0 N-CA-C 110.247 -0.713 . . . . 0.0 110.247 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -38.68 -21.69 0.01 OUTLIER Glycine 0 N--CA 1.509 3.55 0 O-C-N 121.64 -0.662 . . . . 0.0 113.279 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.456 ' N ' ' O ' ' A' ' 8' ' ' PRO . 6.3 mtt -112.11 116.64 30.83 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 178.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.447 ' CB ' ' O ' ' A' ' 10' ' ' MET . . . 84.35 -47.59 0.1 Allowed 'General case' 0 N--CA 1.509 2.476 0 CA-C-N 120.021 1.282 . . . . 0.0 110.081 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 85.2 mt -126.27 77.28 72.3 Favored Pre-proline 0 N--CA 1.508 2.438 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -72.47 171.82 16.3 Favored 'Trans proline' 0 N--CA 1.476 0.473 0 C-N-CA 120.751 0.967 . . . . 0.0 112.5 -174.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 29.4 m-70 -70.01 148.03 49.37 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.893 -178.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.439 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 29.0 t30 65.66 58.25 1.18 Allowed Pre-proline 0 N--CA 1.503 2.186 0 O-C-N 121.593 -0.692 . . . . 0.0 110.201 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.439 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 38.2 Cg_endo -78.85 158.4 27.68 Favored 'Trans proline' 0 N--CA 1.485 0.972 0 C-N-CA 122.376 2.051 . . . . 0.0 111.752 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.3 mt 53.74 44.25 29.89 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-O 121.074 0.464 . . . . 0.0 111.155 178.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -70.02 -40.51 75.15 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 121.584 -0.697 . . . . 0.0 109.283 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.51 -27.85 69.25 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 44.1 m -72.9 -36.33 67.29 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.413 ' CG ' ' N ' ' A' ' 22' ' ' TRP . 0.2 OUTLIER -63.07 -54.97 29.67 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.822 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.425 ' CE3' ' HA ' ' A' ' 22' ' ' TRP . 27.8 m95 -65.64 -27.85 68.68 Favored 'General case' 0 N--CA 1.501 2.084 0 C-N-CA 119.232 -0.987 . . . . 0.0 109.671 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -67.07 -30.03 69.97 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.403 HG21 ' CE1' ' A' ' 93' ' ' PHE . 62.4 t -71.96 -41.62 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 177.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 m -56.35 -42.78 78.31 Favored 'General case' 0 N--CA 1.501 2.112 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.672 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.5 m -77.37 -50.99 11.59 Favored 'General case' 0 N--CA 1.51 2.533 0 O-C-N 122.037 -0.415 . . . . 0.0 112.104 -178.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -62.95 -24.94 68.12 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.832 -0.543 . . . . 0.0 110.733 -178.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 34.7 p -97.05 -62.84 1.2 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 122.086 -0.384 . . . . 0.0 111.881 -177.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.8 m -100.97 12.93 36.73 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 121.36 -0.838 . . . . 0.0 111.581 -178.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 57.17 21.56 39.81 Favored Glycine 0 N--CA 1.505 3.289 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -178.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 45.2 t -109.49 164.24 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 O-C-N 121.87 -0.783 . . . . 0.0 109.396 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 136.14 -179.7 17.57 Favored Glycine 0 N--CA 1.5 2.928 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -63.66 173.37 4.62 Favored 'Trans proline' 0 N--CA 1.487 1.093 0 CA-C-N 119.319 1.559 . . . . 0.0 110.229 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 2.3 ptt180 -92.86 88.24 6.12 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 122.081 0.944 . . . . 0.0 110.197 -177.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.443 ' CD2' ' N ' ' A' ' 35' ' ' LEU . 2.1 pt? -145.53 -172.29 3.86 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 115.298 -0.865 . . . . 0.0 108.836 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -95.62 162.59 13.56 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.67 -57.33 3.62 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 122.127 -0.358 . . . . 0.0 110.182 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -51.38 -26.81 8.41 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 121.91 -0.494 . . . . 0.0 110.708 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -74.08 -44.48 53.9 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 2.5 ttm -63.5 -53.09 57.42 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.2 ttpp -54.24 -38.84 66.2 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.701 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.82 -38.54 91.16 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.12 -35.58 81.23 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 23.0 m -66.99 -35.57 80.26 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 120.396 -0.522 . . . . 0.0 109.616 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 18.2 m -71.76 -32.35 67.6 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.9 -35.07 74.32 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -78.07 -26.3 48.14 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.424 ' CD1' ' NH1' ' A' ' 56' ' ' ARG . 1.6 tm? -69.72 -45.93 67.1 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -178.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -78.22 -38.82 42.23 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.62 -36.85 57.23 Favored 'General case' 0 N--CA 1.506 2.358 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.407 ' O ' ' HD3' ' A' ' 56' ' ' ARG . 58.0 mt -85.58 105.54 7.22 Favored Pre-proline 0 N--CA 1.488 1.446 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 176.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -62.86 148.87 92.92 Favored 'Trans proline' 0 N--CA 1.482 0.818 0 C-N-CA 121.771 1.648 . . . . 0.0 111.412 -176.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -47.3 -27.43 1.57 Allowed 'General case' 0 N--CA 1.501 2.124 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.625 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -71.1 115.04 9.77 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 12.0 m 70.54 7.94 6.41 Favored 'General case' 0 N--CA 1.507 2.384 0 O-C-N 121.998 -0.439 . . . . 0.0 110.079 -179.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.424 ' NH1' ' CD1' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -50.22 -93.19 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.322 -0.861 . . . . 0.0 109.507 179.848 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 88.9 m -31.63 -36.29 0.02 OUTLIER 'General case' 0 N--CA 1.521 3.108 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -41.4 -51.99 3.64 Favored 'General case' 0 N--CA 1.512 2.626 0 CA-C-N 119.762 1.164 . . . . 0.0 111.559 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -44.16 -47.06 9.06 Favored 'General case' 0 N--CA 1.511 2.581 0 O-C-N 121.765 -0.584 . . . . 0.0 112.135 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.9 t -50.73 -46.27 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.733 0 CA-C-O 122.134 0.969 . . . . 0.0 108.401 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -58.93 -50.22 74.87 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 177.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.506 ' CG2' ' HB ' ' A' ' 67' ' ' VAL . 28.0 mm -51.45 -26.96 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 121.673 -0.642 . . . . 0.0 110.109 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.37 -40.41 36.31 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 120.019 -0.673 . . . . 0.0 109.48 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 17.7 ttp -77.02 -55.34 5.54 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.474 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -80.95 -23.84 38.53 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.748 -0.595 . . . . 0.0 111.651 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.68 148.62 12.81 Favored Glycine 0 N--CA 1.506 3.301 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.506 ' HB ' ' CG2' ' A' ' 62' ' ' ILE . 8.2 p -117.73 159.91 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.559 0 O-C-N 122.185 -0.597 . . . . 0.0 110.632 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.449 ' CG2' ' CE1' ' A' ' 74' ' ' HIS . 54.3 t -114.97 156.92 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 31.1 p -117.63 160.01 21.98 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.176 -177.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.2 t -62.02 -29.67 70.43 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.642 -178.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.2 p -71.78 -16.94 62.21 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 116.618 -0.264 . . . . 0.0 110.482 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.88 14.7 30.81 Favored Glycine 0 N--CA 1.498 2.779 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.6 mm100 -103.07 156.34 17.75 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-N 118.204 1.002 . . . . 0.0 109.195 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.449 ' CE1' ' CG2' ' A' ' 68' ' ' VAL . 9.2 m170 -115.2 155.54 26.99 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -145.83 -175.99 4.96 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 120.995 0.426 . . . . 0.0 109.869 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 59.78 -148.51 42.09 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 108.443 -1.863 . . . . 0.0 108.443 -178.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 57.27 21.5 6.74 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 122.077 -0.661 . . . . 0.0 110.326 179.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.8 mt -81.96 -14.75 55.62 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.777 -0.577 . . . . 0.0 110.673 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.0 tt -58.72 92.48 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -130.97 177.59 7.33 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.193 0.521 . . . . 0.0 109.811 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -77.02 103.36 6.9 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.524 0.678 . . . . 0.0 110.707 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.507 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 18.1 mt -78.25 170.11 17.76 Favored Pre-proline 0 N--CA 1.497 1.875 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 177.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.507 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 29.8 Cg_endo -70.92 98.43 0.8 Allowed 'Trans proline' 0 C--N 1.327 -0.561 0 C-N-CA 120.859 1.04 . . . . 0.0 109.463 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 102.57 1.43 49.97 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 3.5 m -139.42 91.61 10.87 Favored Pre-proline 0 N--CA 1.505 2.279 0 CA-C-N 119.087 1.444 . . . . 0.0 109.191 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -72.42 163.28 39.06 Favored 'Trans proline' 0 N--CA 1.482 0.828 0 C-N-CA 121.368 1.378 . . . . 0.0 111.576 -178.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.4 mtm-85 -48.5 -28.65 3.47 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.196 0.522 . . . . 0.0 109.769 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -59.57 -46.23 89.51 Favored 'General case' 0 N--CA 1.504 2.235 0 CA-C-N 116.189 -0.46 . . . . 0.0 112.005 -177.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 49.0 t -68.88 -40.58 81.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.585 -0.697 . . . . 0.0 109.823 -178.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -64.88 -27.39 68.83 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.35 -34.01 48.7 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 109.813 -0.439 . . . . 0.0 109.813 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.57 -45.67 68.17 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.893 -0.504 . . . . 0.0 109.808 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.403 ' CE1' HG21 ' A' ' 24' ' ' VAL . 44.3 t80 -78.57 -25.77 45.42 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 122.319 -0.238 . . . . 0.0 110.406 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.418 ' N ' ' HD2' ' A' ' 95' ' ' PRO . . . -42.85 -51.71 12.12 Favored Pre-proline 0 N--CA 1.503 2.212 0 CA-C-O 118.87 -0.586 . . . . 0.0 112.493 -177.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.418 ' HD2' ' N ' ' A' ' 94' ' ' ALA . 30.7 Cg_endo -72.98 -172.42 0.98 Allowed 'Trans proline' 0 N--CA 1.476 0.484 0 C-N-CA 121.697 1.598 . . . . 0.0 110.328 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.4 mttt 64.59 17.15 10.74 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -178.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.13 -75.89 0.15 Allowed 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 104' ' ' ASN . 8.4 m -64.56 1.18 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.334 0 O-C-N 121.612 -0.68 . . . . 0.0 112.487 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 22.3 p -87.8 174.5 8.34 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -61.04 -0.1 0.28 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.424 -0.797 . . . . 0.0 111.899 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.3 t -90.53 -4.04 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 CA-C-N 120.429 1.468 . . . . 0.0 111.188 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -140.25 -83.01 0.24 Allowed 'General case' 0 N--CA 1.51 2.557 0 C-N-CA 119.108 -1.037 . . . . 0.0 112.693 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 96.2 m -146.28 42.28 1.18 Allowed 'General case' 0 N--CA 1.504 2.256 0 CA-C-N 119.722 1.146 . . . . 0.0 109.258 -178.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.444 ' HA ' ' O ' ' A' ' 98' ' ' VAL . 11.2 p-10 -37.9 -60.66 0.71 Allowed 'General case' 0 N--CA 1.504 2.273 0 N-CA-C 113.553 0.945 . . . . 0.0 113.553 -178.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 79.2 mt 45.92 25.06 0.27 Allowed 'General case' 0 N--CA 1.51 2.564 0 CA-C-N 119.054 0.843 . . . . 0.0 111.396 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 64.02 141.73 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.321 -0.862 . . . . 0.0 109.674 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.2 p -112.5 -161.8 0.77 Allowed 'General case' 0 N--CA 1.506 2.348 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -66.13 -33.01 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -70.05 -1.25 9.35 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.189 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 57.74 30.36 62.64 Favored Glycine 0 N--CA 1.499 2.887 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -157.22 169.62 34.3 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -78.22 73.85 5.6 Favored 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 122.725 2.283 . . . . 0.0 112.134 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 49.2 p90 . . . . . 0 N--CA 1.507 2.407 0 O-C-N 121.827 -0.545 . . . . 0.0 110.462 177.951 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo . . . . . 0 N--CA 1.48 0.72 0 N-CA-C 110.564 -0.591 . . . . 0.0 110.564 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.6 2.12 74.07 Favored Glycine 0 N--CA 1.501 3.017 0 N-CA-C 110.634 -0.987 . . . . 0.0 110.634 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.45 ' O ' ' CB ' ' A' ' 11' ' ' ALA . 4.0 mmt -133.29 104.06 6.28 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.45 ' CB ' ' O ' ' A' ' 10' ' ' MET . . . 87.2 -57.11 0.04 OUTLIER 'General case' 0 N--CA 1.515 2.789 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -178.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 57.6 mt -100.53 102.36 18.61 Favored Pre-proline 0 N--CA 1.495 1.797 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 178.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -81.28 173.61 11.51 Favored 'Trans proline' 0 N--CA 1.477 0.501 0 C-N-CA 121.616 1.544 . . . . 0.0 111.879 -176.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 32.2 m-70 -76.0 146.88 39.2 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.469 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 19.2 t-20 68.11 56.87 0.71 Allowed Pre-proline 0 N--CA 1.508 2.473 0 O-C-N 121.393 -0.817 . . . . 0.0 111.721 179.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.469 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 41.2 Cg_endo -84.56 171.1 10.0 Favored 'Trans proline' 0 N--CA 1.481 0.774 0 C-N-CA 122.139 1.893 . . . . 0.0 111.066 178.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 27.6 mt 46.2 46.45 13.19 Favored 'General case' 0 N--CA 1.502 2.167 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.096 177.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -75.49 -43.04 51.31 Favored 'General case' 0 N--CA 1.505 2.311 0 O-C-N 121.482 -0.761 . . . . 0.0 109.002 178.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -63.57 -26.33 68.64 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 34.6 m -75.08 -34.54 61.78 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.32 -46.57 69.86 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 31.7 m95 -71.77 -29.41 64.45 Favored 'General case' 0 N--CA 1.506 2.326 0 C-N-CA 118.691 -1.203 . . . . 0.0 109.274 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -65.23 -32.41 74.07 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.9 t -71.35 -41.05 73.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 177.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.1 m -55.5 -39.15 70.1 Favored 'General case' 0 N--CA 1.502 2.159 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.161 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 94.5 m -77.62 -51.52 10.5 Favored 'General case' 0 N--CA 1.508 2.452 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -65.14 -25.01 67.57 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.432 -0.792 . . . . 0.0 110.672 -178.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 43.9 p -93.77 -61.09 1.61 Allowed 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -177.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.8 m -100.47 7.83 43.92 Favored 'General case' 0 N--CA 1.507 2.415 0 O-C-N 121.363 -0.836 . . . . 0.0 111.784 -178.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 58.29 24.81 56.4 Favored Glycine 0 N--CA 1.506 3.302 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -178.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 19.7 t -119.11 165.54 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 122.124 -0.633 . . . . 0.0 109.35 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 134.05 -178.89 18.01 Favored Glycine 0 N--CA 1.5 2.954 0 N-CA-C 108.394 -1.882 . . . . 0.0 108.394 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -64.62 171.67 7.96 Favored 'Trans proline' 0 N--CA 1.485 0.991 0 CA-C-N 119.63 1.715 . . . . 0.0 109.672 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.6 mtp180 -92.89 80.87 4.63 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 122.066 0.936 . . . . 0.0 110.115 -177.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -122.5 -175.67 3.2 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -99.61 140.76 33.34 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.96 -53.59 47.89 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.616 -0.677 . . . . 0.0 111.042 -179.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.6 tm0? -52.46 -46.64 66.59 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.95 -0.469 . . . . 0.0 110.888 -178.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -63.91 -32.07 73.47 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 33.1 tpp -66.94 -58.46 4.92 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 10.2 tptt -53.2 -36.99 61.57 Favored 'General case' 0 N--CA 1.501 2.076 0 CA-C-O 121.179 0.514 . . . . 0.0 109.656 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.49 -40.92 98.35 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.82 -38.74 89.27 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 20.1 m -66.5 -33.54 75.91 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 50.6 m -72.26 -31.16 65.54 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 15.3 ttt85 -73.05 -32.62 65.18 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -76.43 -32.1 58.27 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.1 tp -72.98 -35.94 66.98 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -72.7 -37.25 67.88 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 179.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.98 -38.51 82.77 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 45.4 mt -82.38 104.7 3.64 Favored Pre-proline 0 N--CA 1.495 1.789 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 177.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -58.32 140.72 95.49 Favored 'Trans proline' 0 N--CA 1.482 0.81 0 C-N-CA 121.775 1.65 . . . . 0.0 112.208 -175.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -48.99 -24.39 1.5 Allowed 'General case' 0 N--CA 1.5 2.075 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.201 -179.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -45.67 -71.9 0.07 Allowed 'General case' 0 N--CA 1.505 2.319 0 O-C-N 121.969 -0.457 . . . . 0.0 111.204 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 21.1 m -110.5 23.91 13.64 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.99 -0.444 . . . . 0.0 110.86 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.2 mtt180 -40.38 -83.44 0.01 OUTLIER 'General case' 0 N--CA 1.516 2.828 0 O-C-N 121.316 -0.865 . . . . 0.0 110.863 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 75.2 m -32.28 -35.88 0.02 OUTLIER 'General case' 0 N--CA 1.52 3.035 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -46.06 -58.07 3.91 Favored 'General case' 0 N--CA 1.511 2.607 0 CA-C-N 119.933 1.242 . . . . 0.0 110.931 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -42.61 -37.94 1.85 Allowed 'General case' 0 N--CA 1.513 2.715 0 O-C-N 121.675 -0.641 . . . . 0.0 112.346 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.8 t -55.08 -49.91 67.86 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 O-C-N 121.774 -0.579 . . . . 0.0 109.556 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -58.15 -28.99 65.23 Favored 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.442 ' CG2' ' HB ' ' A' ' 67' ' ' VAL . 2.0 mp -77.85 -27.58 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.269 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.1 tt -78.18 -40.9 36.29 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 120.117 -0.633 . . . . 0.0 109.813 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -78.85 -51.62 9.47 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.142 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -80.81 -23.91 38.89 Favored 'General case' 0 N--CA 1.502 2.135 0 C-N-CA 120.689 -0.404 . . . . 0.0 111.323 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.9 146.3 8.02 Favored Glycine 0 N--CA 1.498 2.788 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.442 ' HB ' ' CG2' ' A' ' 62' ' ' ILE . 14.2 p -117.45 160.12 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 O-C-N 122.347 -0.502 . . . . 0.0 109.781 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.451 ' CG2' ' CE1' ' A' ' 74' ' ' HIS . 55.5 t -114.2 157.54 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 53.3 p -117.28 159.28 22.95 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.838 -177.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 34.7 t -64.59 -28.04 69.36 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.385 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.5 p -71.4 -16.05 62.39 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.68 10.83 42.61 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -100.93 156.51 17.34 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 118.201 1.0 . . . . 0.0 109.197 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.451 ' CE1' ' CG2' ' A' ' 68' ' ' VAL . 11.2 m170 -115.86 155.49 27.81 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -144.44 -173.51 4.06 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.287 0.565 . . . . 0.0 110.26 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 61.01 -145.01 48.56 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.722 -1.751 . . . . 0.0 108.722 -178.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 56.44 21.61 5.71 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 122.229 -0.571 . . . . 0.0 109.486 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 10.1 mp -66.12 -21.6 66.35 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.484 -0.76 . . . . 0.0 109.983 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.0 tt -61.04 92.9 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -141.98 176.83 8.63 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.518 0.675 . . . . 0.0 110.662 -178.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -64.2 118.38 8.51 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.857 0.837 . . . . 0.0 111.367 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.461 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 22.0 mt -112.95 166.63 10.66 Favored Pre-proline 0 N--CA 1.497 1.89 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 177.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.461 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 29.4 Cg_endo -68.6 99.81 0.65 Allowed 'Trans proline' 0 C--N 1.326 -0.632 0 C-N-CA 121.063 1.175 . . . . 0.0 110.532 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.99 8.43 64.9 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.402 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 3.4 m -141.72 91.1 8.42 Favored Pre-proline 0 N--CA 1.511 2.615 0 CA-C-N 118.869 1.335 . . . . 0.0 109.504 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -72.95 166.4 30.15 Favored 'Trans proline' 0 N--CA 1.488 1.165 0 C-N-CA 121.895 1.73 . . . . 0.0 111.754 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 72.7 mtp180 -51.13 -27.55 8.78 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.173 0.511 . . . . 0.0 109.893 178.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -61.13 -45.92 92.69 Favored 'General case' 0 N--CA 1.502 2.169 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.239 -177.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 58.6 t -69.16 -43.61 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.665 -0.647 . . . . 0.0 110.602 -178.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -67.49 -27.71 67.23 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.9 tpt180 -78.65 -26.71 45.2 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.38 -48.45 17.24 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.923 -0.486 . . . . 0.0 110.065 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -78.31 -27.64 47.28 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 122.116 -0.365 . . . . 0.0 110.999 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.429 ' N ' ' HD2' ' A' ' 95' ' ' PRO . . . -53.09 -50.86 79.81 Favored Pre-proline 0 N--CA 1.502 2.14 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 94' ' ' ALA . 31.2 Cg_endo -71.3 82.43 1.09 Allowed 'Trans proline' 0 N--CA 1.482 0.823 0 C-N-CA 122.197 1.931 . . . . 0.0 111.978 -177.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 164.62 57.28 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.492 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.505 ' HG ' ' N ' ' A' ' 98' ' ' VAL . 2.3 pt? -86.94 -56.83 3.21 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -177.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.505 ' N ' ' HG ' ' A' ' 97' ' ' LEU . 13.1 m -92.48 25.14 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-N 120.833 1.651 . . . . 0.0 111.183 -178.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 30.8 p -90.74 170.47 10.1 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -62.98 -2.56 1.26 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.452 -0.78 . . . . 0.0 112.121 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.6 t -100.9 2.83 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 CA-C-N 120.416 1.462 . . . . 0.0 111.269 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -133.71 -90.5 0.37 Allowed 'General case' 0 N--CA 1.502 2.133 0 CA-C-N 118.822 0.737 . . . . 0.0 110.97 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 46.8 m -143.63 37.98 1.35 Allowed 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.559 -0.713 . . . . 0.0 109.491 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -33.89 -62.66 0.3 Allowed 'General case' 0 N--CA 1.509 2.516 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -178.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.4 mt 50.18 20.94 0.69 Allowed 'General case' 0 N--CA 1.506 2.341 0 CA-C-N 118.944 0.793 . . . . 0.0 110.946 -179.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 63.23 124.08 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.304 -0.872 . . . . 0.0 109.769 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.8 p -89.25 -160.2 0.65 Allowed 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.2 tt -66.58 -30.97 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -69.35 -0.97 7.08 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.007 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 58.67 27.74 61.84 Favored Glycine 0 N--CA 1.498 2.813 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -156.74 167.79 33.72 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -78.44 75.04 5.12 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 122.722 2.281 . . . . 0.0 111.764 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.41 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 19.5 p90 . . . . . 0 N--CA 1.508 2.471 0 O-C-N 121.617 -0.677 . . . . 0.0 110.956 178.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo . . . . . 0 CA--C 1.54 0.783 0 N-CA-C 110.503 -0.614 . . . . 0.0 110.503 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 79.49 -5.05 61.66 Favored Glycine 0 N--CA 1.499 2.852 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.442 ' O ' ' CB ' ' A' ' 11' ' ' ALA . 86.8 mmm -140.82 115.23 9.39 Favored 'General case' 0 N--CA 1.501 2.105 0 CA-C-N 118.665 1.232 . . . . 0.0 108.968 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.442 ' CB ' ' O ' ' A' ' 10' ' ' MET . . . 85.72 -56.94 0.08 Allowed 'General case' 0 N--CA 1.515 2.795 0 CA-C-N 119.939 1.245 . . . . 0.0 108.434 -179.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 80.7 mt -110.84 100.79 47.51 Favored Pre-proline 0 N--CA 1.489 1.507 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 178.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -80.48 172.94 12.91 Favored 'Trans proline' 0 C--O 1.22 -0.413 0 C-N-CA 121.41 1.407 . . . . 0.0 111.284 -176.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 50.8 m-70 -75.79 143.33 41.99 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.438 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 2.7 m120 63.36 61.94 1.76 Allowed Pre-proline 0 N--CA 1.502 2.152 0 O-C-N 121.769 -0.582 . . . . 0.0 109.742 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.438 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 40.3 Cg_endo -83.45 167.79 13.32 Favored 'Trans proline' 0 N--CA 1.483 0.859 0 C-N-CA 122.459 2.106 . . . . 0.0 111.693 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 42.2 mt 47.64 45.89 17.91 Favored 'General case' 0 N--CA 1.504 2.233 0 CA-C-O 121.105 0.478 . . . . 0.0 111.516 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -74.13 -39.67 63.16 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.538 -0.726 . . . . 0.0 109.447 179.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.3 t -66.58 -25.95 66.88 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 37.1 m -75.28 -41.75 56.48 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -43.75 97.03 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.412 ' CE3' ' HA ' ' A' ' 22' ' ' TRP . 38.7 m95 -74.19 -25.92 59.98 Favored 'General case' 0 N--CA 1.501 2.087 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.129 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -69.8 -28.47 65.76 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.424 HG21 ' CE1' ' A' ' 93' ' ' PHE . 52.1 t -75.61 -43.02 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 177.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -55.78 -41.77 74.56 Favored 'General case' 0 N--CA 1.503 2.19 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.349 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.1 m -77.67 -53.58 7.38 Favored 'General case' 0 N--CA 1.509 2.516 0 O-C-N 122.085 -0.385 . . . . 0.0 111.685 -178.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -60.5 -24.99 65.74 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.851 -0.53 . . . . 0.0 110.453 -178.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 31.8 p -97.23 -64.11 1.07 Allowed 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -177.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 19.6 m -101.2 14.55 31.59 Favored 'General case' 0 N--CA 1.508 2.45 0 O-C-N 121.386 -0.821 . . . . 0.0 112.0 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 57.05 21.16 37.33 Favored Glycine 0 N--CA 1.505 3.255 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.6 t -107.74 160.43 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.242 0 O-C-N 121.858 -0.79 . . . . 0.0 109.069 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 130.65 -179.39 16.97 Favored Glycine 0 N--CA 1.5 2.94 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -66.23 173.88 6.81 Favored 'Trans proline' 0 N--CA 1.486 1.076 0 CA-C-N 119.263 1.531 . . . . 0.0 109.736 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 2.9 ptt180 -92.81 82.66 4.72 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 122.086 0.945 . . . . 0.0 110.742 -177.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 24.5 mt -134.82 138.93 44.68 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.87 160.86 3.22 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -73.08 -56.49 5.05 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.963 -0.461 . . . . 0.0 111.209 -178.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -54.32 -35.65 62.9 Favored 'General case' 0 N--CA 1.506 2.364 0 O-C-N 121.913 -0.492 . . . . 0.0 110.47 -178.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -64.09 -57.65 8.98 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 5.0 ttm -53.08 -47.48 68.48 Favored 'General case' 0 N--CA 1.504 2.238 0 CA-C-O 121.6 0.714 . . . . 0.0 109.401 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 23.8 ttmt -55.95 -37.72 69.37 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.49 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.22 -35.21 79.83 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.61 -41.69 98.27 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 19.5 m -66.26 -38.65 88.32 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.552 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 84.9 m -69.76 -28.49 65.81 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -74.51 -32.23 62.43 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -74.54 -35.49 63.11 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.3 tt -75.68 -27.23 58.19 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -77.22 -52.16 9.71 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.57 -45.57 69.99 Favored 'General case' 0 N--CA 1.508 2.441 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 23.7 mm -67.57 106.47 1.26 Allowed Pre-proline 0 N--CA 1.49 1.528 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 175.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -58.51 151.2 63.64 Favored 'Trans proline' 0 N--CA 1.479 0.642 0 C-N-CA 121.479 1.453 . . . . 0.0 110.962 -176.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -40.72 -29.7 0.1 Allowed 'General case' 0 N--CA 1.507 2.377 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.686 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.423 ' CE2' HD12 ' A' ' 108' ' ' ILE . 0.2 OUTLIER -73.77 131.33 41.46 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.503 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 8.3 m 72.35 6.28 5.46 Favored 'General case' 0 N--CA 1.508 2.433 0 O-C-N 122.125 -0.36 . . . . 0.0 111.335 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.21 -85.23 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.715 0 CA-C-N 119.247 0.931 . . . . 0.0 110.038 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 85.5 m -38.09 -45.08 0.88 Allowed 'General case' 0 N--CA 1.518 2.97 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -39.86 -50.7 2.45 Favored 'General case' 0 N--CA 1.511 2.586 0 CA-C-N 119.819 1.19 . . . . 0.0 112.148 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -43.86 -47.02 8.2 Favored 'General case' 0 N--CA 1.518 2.939 0 O-C-N 121.573 -0.705 . . . . 0.0 111.609 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 45.2 t -53.71 -45.24 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.55 -32.15 72.21 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.85 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.451 ' CG2' ' HB ' ' A' ' 67' ' ' VAL . 1.2 mp -70.08 -28.19 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.95 -39.51 42.39 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.047 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 14.4 ttp -78.25 -54.8 5.83 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.927 -0.483 . . . . 0.0 110.374 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -80.95 -23.58 38.71 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 122.202 -0.311 . . . . 0.0 111.189 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.33 148.45 13.89 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 -178.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.451 ' HB ' ' CG2' ' A' ' 62' ' ' ILE . 7.7 p -118.01 159.52 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 O-C-N 122.206 -0.585 . . . . 0.0 109.661 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.455 ' CG2' ' CE1' ' A' ' 74' ' ' HIS . 76.2 t -115.21 157.56 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 CA-C-O 122.038 0.923 . . . . 0.0 110.368 -178.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.6 p -117.23 160.65 20.73 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.569 -177.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.6 t -63.5 -34.45 77.8 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.129 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.8 p -63.82 -17.74 63.42 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.73 9.1 47.24 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -97.49 156.88 16.29 Favored 'General case' 0 N--CA 1.503 2.207 0 CA-C-N 118.278 1.039 . . . . 0.0 109.892 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.455 ' CE1' ' CG2' ' A' ' 68' ' ' VAL . 9.9 m170 -116.04 155.06 28.79 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -141.76 -175.96 4.58 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.009 0.433 . . . . 0.0 109.908 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 59.45 -143.76 46.13 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.3 22.06 4.56 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 122.289 -0.536 . . . . 0.0 110.167 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 55.0 mt -81.43 -15.26 55.65 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.735 -0.603 . . . . 0.0 110.739 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.7 tt -57.26 91.99 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -128.38 179.77 5.46 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.26 0.552 . . . . 0.0 109.818 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.75 106.05 7.11 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.313 0.577 . . . . 0.0 110.696 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.535 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 23.0 mt -81.33 169.63 18.34 Favored Pre-proline 0 N--CA 1.495 1.798 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 177.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.535 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 28.3 Cg_endo -66.75 99.4 0.45 Allowed 'Trans proline' 0 C--N 1.329 -0.487 0 C-N-CA 120.978 1.119 . . . . 0.0 111.201 -178.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 103.07 -14.05 55.67 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 6.1 m -123.65 92.22 48.89 Favored Pre-proline 0 N--CA 1.504 2.253 0 CA-C-N 119.323 1.561 . . . . 0.0 110.352 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -72.12 166.11 30.61 Favored 'Trans proline' 0 N--CA 1.483 0.87 0 C-N-CA 121.598 1.532 . . . . 0.0 111.04 -179.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.5 mtm180 -46.9 -28.52 1.62 Allowed 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.152 0.501 . . . . 0.0 109.754 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.8 tm0? -58.65 -52.21 66.65 Favored 'General case' 0 N--CA 1.503 2.199 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.483 -178.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 60.1 t -64.23 -41.75 93.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.746 -0.596 . . . . 0.0 109.576 -178.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -25.94 68.47 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -79.0 -33.46 44.98 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.51 -47.68 63.01 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.424 ' CE1' HG21 ' A' ' 24' ' ' VAL . 42.5 t80 -78.27 -25.37 46.72 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.478 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.417 ' N ' ' HD2' ' A' ' 95' ' ' PRO . . . -42.69 -52.17 11.18 Favored Pre-proline 0 N--CA 1.504 2.227 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -177.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.417 ' HD2' ' N ' ' A' ' 94' ' ' ALA . 29.6 Cg_endo -70.98 -164.1 0.14 Allowed 'Trans proline' 0 C--N 1.328 -0.513 0 C-N-CA 121.689 1.593 . . . . 0.0 110.296 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 60.57 24.68 14.37 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -178.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.6 mt -73.42 -67.93 0.54 Allowed 'General case' 0 N--CA 1.505 2.276 0 O-C-N 122.034 -0.416 . . . . 0.0 111.42 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 14.7 m -85.52 22.11 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.35 -0.843 . . . . 0.0 111.085 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 30.8 p -99.44 173.31 6.81 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -59.06 -4.16 0.46 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.532 -0.73 . . . . 0.0 111.764 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 20.0 t -91.83 -0.27 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-N 120.545 1.52 . . . . 0.0 111.403 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -140.82 -89.39 0.16 Allowed 'General case' 0 N--CA 1.504 2.261 0 CA-C-N 118.974 0.807 . . . . 0.0 111.247 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 55.8 m -145.02 42.38 1.31 Allowed 'General case' 0 N--CA 1.508 2.471 0 O-C-N 121.432 -0.792 . . . . 0.0 109.518 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -36.2 -62.5 0.44 Allowed 'General case' 0 N--CA 1.512 2.67 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -178.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.9 mt 46.3 27.76 0.62 Allowed 'General case' 0 N--CA 1.513 2.722 0 CA-C-N 118.988 0.813 . . . . 0.0 111.268 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 70.34 150.34 0.09 Allowed 'General case' 0 N--CA 1.507 2.408 0 O-C-N 121.199 -0.938 . . . . 0.0 109.174 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.0 p -123.16 -163.78 1.14 Allowed 'General case' 0 N--CA 1.505 2.294 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.423 HD12 ' CE2' ' A' ' 54' ' ' TYR . 7.2 tp -66.12 -31.23 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.452 ' CB ' ' CE1' ' A' ' 113' ' ' PHE . 87.7 m-70 -75.68 5.55 6.0 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.974 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 57.96 32.29 66.28 Favored Glycine 0 N--CA 1.499 2.834 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -164.42 171.95 40.06 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 110.116 -1.193 . . . . 0.0 110.116 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -75.8 80.02 2.71 Favored 'Trans proline' 0 N--CA 1.48 0.708 0 C-N-CA 122.626 2.217 . . . . 0.0 110.855 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.461 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.163 0 CA-C-O 121.462 0.649 . . . . 0.0 111.213 179.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo . . . . . 0 CA--C 1.537 0.656 0 N-CA-C 109.904 -0.844 . . . . 0.0 109.904 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 58.32 24.18 55.07 Favored Glycine 0 N--CA 1.499 2.847 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.434 ' O ' ' CB ' ' A' ' 11' ' ' ALA . 38.7 mmm -138.07 95.08 2.96 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.98 -0.718 . . . . 0.0 109.1 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.434 ' CB ' ' O ' ' A' ' 10' ' ' MET . . . 86.77 -56.43 0.05 Allowed 'General case' 0 N--CA 1.515 2.803 0 CA-C-N 119.008 0.822 . . . . 0.0 108.796 -178.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.6 mt -104.59 101.11 26.16 Favored Pre-proline 0 N--CA 1.494 1.73 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 178.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -81.78 173.2 11.45 Favored 'Trans proline' 0 N--CA 1.476 0.457 0 C-N-CA 121.555 1.504 . . . . 0.0 111.764 -176.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 45.0 m-70 -74.52 146.15 42.9 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.486 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 0.9 OUTLIER 60.79 54.99 3.5 Favored Pre-proline 0 N--CA 1.501 2.094 0 O-C-N 121.56 -0.712 . . . . 0.0 109.955 -179.098 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.486 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 40.4 Cg_endo -81.17 166.96 18.19 Favored 'Trans proline' 0 N--CA 1.484 0.953 0 C-N-CA 122.239 1.959 . . . . 0.0 111.606 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 38.3 mt 51.09 45.08 28.3 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.921 177.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -68.09 -41.38 81.94 Favored 'General case' 0 N--CA 1.505 2.323 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.57 -26.27 68.62 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 178.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 60.7 m -75.52 -38.65 59.25 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.43 -50.68 70.55 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.434 ' CE3' ' HA ' ' A' ' 22' ' ' TRP . 32.1 m95 -69.86 -26.46 64.21 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 119.517 -0.873 . . . . 0.0 109.853 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.432 ' CD1' ' O ' ' A' ' 23' ' ' TYR . 7.7 t80 -67.59 -30.35 69.93 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.418 HG23 ' CD1' ' A' ' 93' ' ' PHE . 59.0 t -74.43 -44.43 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 108.301 -0.999 . . . . 0.0 108.301 178.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 p -56.7 -40.96 76.55 Favored 'General case' 0 N--CA 1.505 2.277 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.38 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.3 m -77.22 -53.19 8.04 Favored 'General case' 0 N--CA 1.509 2.497 0 O-C-N 122.01 -0.432 . . . . 0.0 111.872 -178.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -61.8 -24.88 67.14 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.798 -0.563 . . . . 0.0 110.6 -178.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 35.4 p -95.66 -63.86 1.11 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.966 -0.459 . . . . 0.0 111.956 -177.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.7 m -100.93 11.91 38.68 Favored 'General case' 0 N--CA 1.509 2.491 0 O-C-N 121.315 -0.866 . . . . 0.0 111.424 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 59.35 20.23 49.96 Favored Glycine 0 N--CA 1.502 3.056 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -178.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.1 t -106.37 158.72 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 O-C-N 121.888 -0.772 . . . . 0.0 109.079 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 135.04 179.06 16.14 Favored Glycine 0 N--CA 1.497 2.761 0 N-CA-C 108.74 -1.744 . . . . 0.0 108.74 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -65.8 172.39 8.37 Favored 'Trans proline' 0 N--CA 1.483 0.904 0 CA-C-N 119.289 1.545 . . . . 0.0 109.635 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 27.8 mtt180 -92.41 74.77 5.23 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 122.155 0.978 . . . . 0.0 109.705 -178.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.05 135.87 53.87 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.57 150.84 3.51 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.977 -0.452 . . . . 0.0 110.0 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.4 m -73.74 -28.68 61.81 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.736 -0.603 . . . . 0.0 111.185 -178.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -72.74 -31.4 64.92 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.867 -0.521 . . . . 0.0 109.656 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -75.72 -32.66 60.13 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.403 ' HB3' ' CD2' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -70.29 -53.59 16.19 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.575 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 21.7 tttp -56.73 -37.41 70.95 Favored 'General case' 0 N--CA 1.506 2.374 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.19 -38.48 90.62 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.3 mpt_? -65.08 -42.65 93.92 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 17.0 m -65.21 -34.72 79.05 Favored 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.883 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 82.3 m -74.44 -29.8 61.63 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.7 ttt180 -73.63 -32.58 64.11 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -78.75 -35.89 43.95 Favored 'General case' 0 N--CA 1.502 2.17 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.112 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.1 tt -69.63 -37.42 76.78 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -75.56 -41.23 55.38 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.85 -38.01 64.24 Favored 'General case' 0 N--CA 1.509 2.48 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 177.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 59.8 mt -78.92 105.69 3.39 Favored Pre-proline 0 N--CA 1.488 1.434 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 176.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -60.01 152.05 67.72 Favored 'Trans proline' 0 N--CA 1.481 0.745 0 C-N-CA 121.712 1.608 . . . . 0.0 111.278 -176.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -41.37 -29.17 0.14 Allowed 'General case' 0 N--CA 1.507 2.415 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.376 -178.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -67.12 121.85 16.51 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 66.2 m 60.79 15.55 6.0 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 122.195 -0.316 . . . . 0.0 110.537 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.402 ' NH1' ' HG2' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -49.58 -91.38 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.259 -0.901 . . . . 0.0 109.876 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 54.3 m -32.28 -33.95 0.01 OUTLIER 'General case' 0 N--CA 1.521 3.112 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -40.41 -51.64 2.82 Favored 'General case' 0 N--CA 1.509 2.501 0 CA-C-N 119.759 1.163 . . . . 0.0 111.893 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -40.42 -47.88 2.66 Favored 'General case' 0 N--CA 1.514 2.746 0 O-C-N 121.897 -0.502 . . . . 0.0 112.108 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.402 ' CG2' HD12 ' A' ' 97' ' ' LEU . 24.4 t -58.26 -49.22 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.57 -26.27 63.43 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.515 ' CG2' ' HB ' ' A' ' 67' ' ' VAL . 9.3 mt -78.81 -30.76 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.996 -0.44 . . . . 0.0 110.272 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.4 tt -78.03 -42.03 33.79 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 120.014 -0.675 . . . . 0.0 109.334 -178.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 6.8 tpt -78.27 -53.17 7.61 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.313 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -81.51 -21.87 38.33 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 122.147 -0.346 . . . . 0.0 111.429 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.13 149.9 14.35 Favored Glycine 0 N--CA 1.499 2.878 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -178.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.515 ' HB ' ' CG2' ' A' ' 62' ' ' ILE . 7.3 p -118.17 160.18 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.295 0 O-C-N 122.224 -0.574 . . . . 0.0 110.43 -179.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.448 HG21 ' CE1' ' A' ' 74' ' ' HIS . 42.3 t -114.72 157.35 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 28.2 p -117.43 160.27 21.45 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.544 0.688 . . . . 0.0 110.171 -177.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.3 t -61.65 -25.7 67.54 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.35 -178.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.2 p -80.19 -14.19 58.64 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 122.253 -0.279 . . . . 0.0 110.721 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.23 13.2 34.02 Favored Glycine 0 N--CA 1.498 2.804 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -99.15 156.92 16.71 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-N 118.103 0.951 . . . . 0.0 109.092 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.448 ' CE1' HG21 ' A' ' 68' ' ' VAL . 8.5 m170 -115.65 155.28 27.98 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -144.75 -177.14 5.36 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 120.949 0.404 . . . . 0.0 110.093 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 59.62 -141.03 47.67 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 108.876 -1.69 . . . . 0.0 108.876 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.6 ttp180 55.08 22.45 4.5 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 122.267 -0.549 . . . . 0.0 110.431 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -80.47 -15.26 57.18 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.609 -0.682 . . . . 0.0 110.657 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.1 tp -67.46 90.65 0.25 Allowed 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -126.03 177.26 6.46 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -60.81 100.69 0.12 Allowed 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 121.638 0.732 . . . . 0.0 110.535 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.528 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 19.7 mt -80.41 170.74 14.51 Favored Pre-proline 0 N--CA 1.498 1.946 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 177.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.528 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 29.2 Cg_endo -70.07 98.78 0.74 Allowed 'Trans proline' 0 C--O 1.219 -0.447 0 C-N-CA 120.709 0.939 . . . . 0.0 109.883 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 100.09 3.53 55.69 Favored Glycine 0 N--CA 1.495 2.625 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 3.5 m -138.76 91.13 12.09 Favored Pre-proline 0 N--CA 1.503 2.223 0 CA-C-N 119.114 1.457 . . . . 0.0 109.341 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -74.45 162.11 38.82 Favored 'Trans proline' 0 N--CA 1.481 0.786 0 C-N-CA 121.343 1.362 . . . . 0.0 111.2 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 3.8 mmm180 -47.92 -29.21 3.16 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -54.35 -50.46 67.41 Favored 'General case' 0 N--CA 1.508 2.432 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.809 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 63.4 t -64.63 -36.44 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 52.4 mm-40 -63.27 -26.7 68.9 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.73 -37.21 41.92 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.49 -48.76 71.51 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.418 ' CD1' HG23 ' A' ' 24' ' ' VAL . 41.3 t80 -78.51 -25.22 45.55 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 122.248 -0.282 . . . . 0.0 110.654 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.402 ' N ' ' HD2' ' A' ' 95' ' ' PRO . . . -40.88 -52.44 6.67 Favored Pre-proline 0 N--CA 1.505 2.315 0 CA-C-O 118.978 -0.534 . . . . 0.0 112.09 -177.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.402 ' HD2' ' N ' ' A' ' 94' ' ' ALA . 30.6 Cg_endo -74.44 -173.65 1.56 Allowed 'Trans proline' 0 C--N 1.328 -0.524 0 C-N-CA 121.708 1.606 . . . . 0.0 109.834 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 17.6 mttm 68.31 26.61 6.8 Favored 'General case' 0 N--CA 1.504 2.243 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -178.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.402 HD12 ' CG2' ' A' ' 60' ' ' VAL . 0.1 OUTLIER -73.53 -69.61 0.42 Allowed 'General case' 0 N--CA 1.516 2.848 0 O-C-N 121.837 -0.539 . . . . 0.0 110.791 -179.302 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 32.8 m -88.38 26.12 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 O-C-N 121.129 -0.982 . . . . 0.0 110.385 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 27.4 p -100.1 173.51 6.6 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.77 -1.62 0.43 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.565 -0.71 . . . . 0.0 112.019 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 20.9 t -96.77 1.29 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 CA-C-N 120.562 1.528 . . . . 0.0 111.222 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -141.09 -91.48 0.15 Allowed 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.488 -0.758 . . . . 0.0 111.318 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 60.5 m -142.74 45.46 1.59 Allowed 'General case' 0 N--CA 1.504 2.263 0 O-C-N 121.425 -0.797 . . . . 0.0 109.577 -178.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 58.1 t-20 -40.39 -68.84 0.15 Allowed 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.297 -0.877 . . . . 0.0 113.258 -178.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.1 mt 50.51 27.16 2.71 Favored 'General case' 0 N--CA 1.506 2.357 0 C-N-CA 120.329 -0.549 . . . . 0.0 110.348 -178.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 68.52 163.26 0.22 Allowed 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.332 -0.855 . . . . 0.0 109.364 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.503 ' OG1' ' CE1' ' A' ' 109' ' ' HIS . 16.6 p -135.92 -159.94 1.01 Allowed 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 120.869 0.366 . . . . 0.0 110.439 -176.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -93.13 -47.25 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 121.9 -0.5 . . . . 0.0 111.563 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.503 ' CE1' ' OG1' ' A' ' 107' ' ' THR . 0.0 OUTLIER -54.28 -22.64 12.38 Favored 'General case' 0 N--CA 1.529 3.479 0 O-C-N 121.673 -0.642 . . . . 0.0 109.88 -178.838 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.34 68.81 0.79 Allowed Glycine 0 N--CA 1.499 2.898 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.698 177.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 143.57 173.19 14.91 Favored Glycine 0 N--CA 1.5 2.91 0 CA-C-N 118.809 1.305 . . . . 0.0 111.4 178.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -73.67 85.47 1.3 Allowed 'Trans proline' 0 N--CA 1.482 0.814 0 C-N-CA 122.79 2.327 . . . . 0.0 110.375 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.5 ' O ' ' CE1' ' A' ' 109' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.515 2.78 0 C-N-CA 120.389 -0.524 . . . . 0.0 111.392 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo . . . . . 0 CA--C 1.541 0.847 0 N-CA-C 110.107 -0.766 . . . . 0.0 110.107 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 61.38 14.63 42.17 Favored Glycine 0 N--CA 1.501 2.969 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.45 ' O ' ' CB ' ' A' ' 11' ' ' ALA . 5.1 mmt -141.06 108.01 5.43 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.45 ' CB ' ' O ' ' A' ' 10' ' ' MET . . . 87.04 -59.93 0.04 OUTLIER 'General case' 0 N--CA 1.514 2.767 0 CA-C-N 119.94 1.246 . . . . 0.0 108.245 -178.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 21.9 mt -109.82 97.54 29.29 Favored Pre-proline 0 N--CA 1.492 1.667 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 178.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -83.62 174.75 8.52 Favored 'Trans proline' 0 N--CA 1.476 0.442 0 C-N-CA 121.814 1.676 . . . . 0.0 111.503 -177.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 45.2 m-70 -71.93 142.21 49.45 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.455 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 25.8 m120 59.1 59.02 5.36 Favored Pre-proline 0 N--CA 1.5 2.058 0 O-C-N 121.436 -0.79 . . . . 0.0 109.003 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.455 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 38.2 Cg_endo -78.97 151.5 24.13 Favored 'Trans proline' 0 N--CA 1.484 0.95 0 C-N-CA 122.345 2.03 . . . . 0.0 112.264 -178.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.7 mp 43.0 42.65 3.25 Favored 'General case' 0 N--CA 1.502 2.158 0 CA-C-O 121.163 0.506 . . . . 0.0 111.825 178.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -65.37 -32.4 74.02 Favored 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.23 -25.98 67.15 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 35.1 m -76.1 -38.46 56.92 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.6 -50.28 73.21 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.412 ' HA ' ' CE3' ' A' ' 22' ' ' TRP . 36.5 m95 -70.8 -27.37 63.85 Favored 'General case' 0 N--CA 1.501 2.122 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.786 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -68.12 -31.91 71.83 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.464 ' CG2' ' CD1' ' A' ' 93' ' ' PHE . 86.4 t -74.98 -40.58 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 177.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.01 -38.64 68.14 Favored 'General case' 0 N--CA 1.502 2.163 0 C-N-CA 120.095 -0.642 . . . . 0.0 109.561 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.7 m -77.07 -51.81 10.41 Favored 'General case' 0 N--CA 1.506 2.356 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.554 -178.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -62.22 -25.21 67.68 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.795 -0.565 . . . . 0.0 111.189 -178.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.4 ' CG2' HG11 ' A' ' 24' ' ' VAL . 79.6 p -97.3 -63.84 1.1 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 122.233 -0.292 . . . . 0.0 111.763 -177.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 55.8 m -101.72 14.72 31.13 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.358 -0.839 . . . . 0.0 112.129 -178.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 55.82 21.72 30.96 Favored Glycine 0 N--CA 1.505 3.254 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 56.3 t -106.89 162.78 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.821 -0.811 . . . . 0.0 109.011 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 130.16 178.24 15.31 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -66.55 174.88 5.77 Favored 'Trans proline' 0 N--CA 1.487 1.12 0 CA-C-N 119.165 1.482 . . . . 0.0 109.571 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.2 ptp85 -92.21 52.31 1.93 Allowed 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.98 0.895 . . . . 0.0 109.77 -178.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.48 127.83 41.84 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.47 148.78 4.78 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.807 -0.558 . . . . 0.0 110.171 -178.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 61.1 m -65.77 -40.34 91.93 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.67 -0.643 . . . . 0.0 111.947 -178.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -64.88 -44.29 90.15 Favored 'General case' 0 N--CA 1.504 2.264 0 CA-C-N 118.644 0.656 . . . . 0.0 109.72 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -66.87 -27.68 67.72 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -69.45 -59.03 3.25 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.31 -31.87 55.17 Favored 'General case' 0 N--CA 1.5 2.06 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.633 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.91 -40.79 78.93 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -64.24 -37.41 87.37 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 15.9 m -72.34 -33.45 67.31 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.922 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 21.8 m -73.69 -28.46 61.75 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 24.5 ttm180 -78.19 -35.56 48.5 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -78.03 -41.92 34.13 Favored 'General case' 0 N--CA 1.502 2.157 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.494 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.413 ' O ' ' NH1' ' A' ' 56' ' ' ARG . 5.6 tt -64.9 -45.22 86.82 Favored 'General case' 0 C--O 1.2 -1.552 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.416 ' HA ' ' NH2' ' A' ' 56' ' ' ARG . 0.2 OUTLIER -69.14 -28.66 66.64 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.403 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.2 -60.34 3.53 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.431 ' O ' ' NH2' ' A' ' 56' ' ' ARG . 2.8 mt -58.73 103.92 0.39 Allowed Pre-proline 0 N--CA 1.51 2.572 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 178.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -50.18 144.67 22.24 Favored 'Trans proline' 0 N--CA 1.488 1.166 0 C-N-CA 121.636 1.558 . . . . 0.0 113.094 -175.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.445 ' HA ' ' CG ' ' A' ' 56' ' ' ARG . . . -22.82 -46.19 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.767 0 C-N-CA 124.28 1.032 . . . . 0.0 113.693 -177.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -62.75 138.11 58.43 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 20.8 m 61.68 22.82 13.25 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 122.0 -0.438 . . . . 0.0 109.819 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.445 ' CG ' ' HA ' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -44.72 -93.08 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.892 0 O-C-N 121.063 -1.023 . . . . 0.0 110.72 -179.697 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 76.1 m -38.94 -22.35 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.555 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 -178.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -39.07 -48.02 1.61 Allowed 'General case' 0 N--CA 1.512 2.644 0 CA-C-N 120.984 1.72 . . . . 0.0 112.249 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -44.56 -57.95 3.31 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.62 -0.675 . . . . 0.0 111.42 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.4 t -48.51 -41.85 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.266 0 CA-C-O 121.125 0.488 . . . . 0.0 109.686 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 22.9 mtp85 -60.09 -64.15 1.05 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.498 ' CG2' ' HB ' ' A' ' 67' ' ' VAL . 36.9 mm -46.13 -26.95 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.787 -0.57 . . . . 0.0 111.365 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -77.82 -43.64 29.85 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.226 -0.989 . . . . 0.0 109.705 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -77.67 -53.38 7.62 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.6 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -79.93 -22.17 42.99 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 122.039 -0.413 . . . . 0.0 111.025 -179.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.96 154.06 15.03 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -178.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.498 ' HB ' ' CG2' ' A' ' 62' ' ' ILE . 2.5 p -117.46 158.94 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.341 0 CA-C-O 121.361 0.6 . . . . 0.0 109.548 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.467 ' CG2' ' CE1' ' A' ' 74' ' ' HIS . 54.7 t -115.69 157.05 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.6 p -117.48 159.53 22.67 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.522 -177.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.9 t -61.95 -32.73 73.19 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.23 0.538 . . . . 0.0 110.175 -178.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.2 p -65.69 -18.85 65.63 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.254 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.13 16.54 25.15 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -106.36 156.9 18.04 Favored 'General case' 0 N--CA 1.503 2.197 0 CA-C-N 118.284 1.042 . . . . 0.0 109.626 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.467 ' CE1' ' CG2' ' A' ' 68' ' ' VAL . 11.0 m170 -116.09 154.08 30.59 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.589 -0.695 . . . . 0.0 109.143 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -140.63 -174.99 4.12 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.044 0.449 . . . . 0.0 109.851 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 56.3 -141.29 41.33 Favored Glycine 0 N--CA 1.497 2.715 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.3 ttp180 54.39 24.8 5.44 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 122.228 -0.572 . . . . 0.0 110.54 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.4 mt -78.7 -19.03 53.39 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.698 -0.626 . . . . 0.0 110.38 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.5 tp -52.86 95.37 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.703 -0.623 . . . . 0.0 109.998 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -132.78 172.86 12.01 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -67.82 103.18 1.38 Allowed 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.497 0.665 . . . . 0.0 110.484 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.565 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 24.7 mt -78.45 171.33 12.79 Favored Pre-proline 0 N--CA 1.492 1.655 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 177.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.565 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 27.6 Cg_endo -66.61 99.21 0.43 Allowed 'Trans proline' 0 C--N 1.327 -0.579 0 C-N-CA 120.939 1.093 . . . . 0.0 110.715 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 98.18 -12.11 63.69 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 7.0 m -119.58 92.17 45.74 Favored Pre-proline 0 N--CA 1.5 2.063 0 CA-C-N 119.207 1.503 . . . . 0.0 110.101 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -73.16 164.46 35.33 Favored 'Trans proline' 0 N--CA 1.483 0.863 0 C-N-CA 121.514 1.476 . . . . 0.0 111.045 -179.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -46.32 -28.56 1.35 Allowed 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 177.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -54.47 -54.6 38.79 Favored 'General case' 0 N--CA 1.504 2.243 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.537 -178.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 64.5 t -60.84 -41.52 88.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.761 -0.587 . . . . 0.0 109.843 -178.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 7.1 mp0 -64.61 -26.59 68.47 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.49 -28.55 46.4 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.11 -48.68 17.11 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 122.014 -0.429 . . . . 0.0 109.876 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.464 ' CD1' ' CG2' ' A' ' 24' ' ' VAL . 36.1 t80 -77.72 -25.28 49.2 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 122.212 -0.305 . . . . 0.0 110.759 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.44 ' N ' ' HD2' ' A' ' 95' ' ' PRO . . . -53.15 -53.37 56.43 Favored Pre-proline 0 N--CA 1.5 2.049 0 CA-C-O 118.961 -0.542 . . . . 0.0 111.883 -177.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' A' ' 94' ' ' ALA . 30.2 Cg_endo -70.0 -11.16 29.99 Favored 'Trans proline' 0 N--CA 1.482 0.819 0 C-N-CA 121.918 1.745 . . . . 0.0 111.181 -179.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -89.47 17.19 6.53 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.89 -71.27 0.33 Allowed 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.671 -0.643 . . . . 0.0 109.966 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 104' ' ' ASN . 13.1 m -70.58 5.6 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.36 0 O-C-N 121.176 -0.953 . . . . 0.0 112.283 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 16.3 p -92.07 174.79 7.14 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.13 -3.98 0.45 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.526 -0.734 . . . . 0.0 112.389 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.0 t -89.06 -2.2 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 CA-C-N 120.069 1.304 . . . . 0.0 111.114 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.23 -86.97 0.2 Allowed 'General case' 0 N--CA 1.508 2.456 0 C-N-CA 119.486 -0.886 . . . . 0.0 111.978 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 95.6 m -146.7 43.83 1.18 Allowed 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.43 -0.794 . . . . 0.0 109.107 -178.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.434 ' HA ' ' O ' ' A' ' 98' ' ' VAL . 4.1 p30 -39.11 -55.4 1.62 Allowed 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.438 -0.789 . . . . 0.0 113.09 -178.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.2 mt 40.8 29.84 0.08 Allowed 'General case' 0 N--CA 1.511 2.623 0 CA-C-N 118.875 0.761 . . . . 0.0 111.071 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 65.5 155.41 0.08 Allowed 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.64 -0.662 . . . . 0.0 109.302 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.42 ' HA ' ' HD2' ' A' ' 56' ' ' ARG . 4.4 p -127.88 -160.22 1.0 Allowed 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -179.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.433 HG21 HD11 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -67.51 -34.11 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.41 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.425 ' HB3' ' CE1' ' A' ' 113' ' ' PHE . 93.1 m-70 -69.48 -2.55 11.53 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 116.234 -0.439 . . . . 0.0 112.049 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 60.25 29.92 69.78 Favored Glycine 0 N--CA 1.497 2.75 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -159.88 170.54 36.05 Favored Glycine 0 N--CA 1.496 2.653 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -78.02 76.24 4.45 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.537 2.158 . . . . 0.0 111.475 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.425 ' CE1' ' HB3' ' A' ' 109' ' ' HIS . 35.7 p90 . . . . . 0 N--CA 1.508 2.454 0 O-C-N 121.769 -0.582 . . . . 0.0 110.313 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo . . . . . 0 CA--C 1.538 0.692 0 N-CA-C 110.358 -0.67 . . . . 0.0 110.358 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.45 4.71 75.5 Favored Glycine 0 N--CA 1.5 2.964 0 N-CA-C 110.839 -0.905 . . . . 0.0 110.839 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.457 ' O ' ' CB ' ' A' ' 11' ' ' ALA . 1.5 mpt? -133.0 99.04 4.45 Favored 'General case' 0 N--CA 1.501 2.11 0 CA-C-N 118.103 0.951 . . . . 0.0 108.705 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.457 ' CB ' ' O ' ' A' ' 10' ' ' MET . . . 86.79 -56.01 0.05 Allowed 'General case' 0 N--CA 1.515 2.819 0 CA-C-N 119.355 0.98 . . . . 0.0 108.547 -178.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 9.2 mt -101.85 101.44 18.33 Favored Pre-proline 0 N--CA 1.493 1.695 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 178.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -80.58 173.37 12.35 Favored 'Trans proline' 0 N--CA 1.474 0.33 0 C-N-CA 121.536 1.491 . . . . 0.0 111.643 -176.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 46.0 m-70 -71.13 144.53 50.21 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.442 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 3.3 t-20 60.68 60.24 3.57 Favored Pre-proline 0 N--CA 1.499 1.99 0 O-C-N 121.597 -0.689 . . . . 0.0 109.198 -179.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.442 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 39.5 Cg_endo -81.43 151.28 17.45 Favored 'Trans proline' 0 N--CA 1.481 0.787 0 C-N-CA 122.318 2.012 . . . . 0.0 111.673 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.6 mp 51.57 41.26 28.52 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-O 121.048 0.451 . . . . 0.0 111.421 178.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -65.54 -40.62 93.08 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.67 -25.99 68.42 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 65.4 m -73.51 -42.83 61.29 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.414 ' CG ' ' N ' ' A' ' 22' ' ' TRP . 2.5 ptt-85 -60.59 -49.83 75.96 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.436 ' CE3' ' HA ' ' A' ' 22' ' ' TRP . 29.9 m95 -67.85 -26.94 66.29 Favored 'General case' 0 N--CA 1.5 2.052 0 C-N-CA 119.693 -0.803 . . . . 0.0 110.447 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.44 ' CD2' ' HB3' ' A' ' 40' ' ' MET . 5.4 t80 -66.91 -32.3 73.47 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 178.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.46 HG21 ' CE1' ' A' ' 93' ' ' PHE . 47.0 t -71.68 -43.81 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.3 m -53.91 -42.36 68.64 Favored 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.431 -179.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 16.7 m -76.96 -53.76 7.44 Favored 'General case' 0 N--CA 1.507 2.42 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -178.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.8 tpm_? -60.28 -25.53 65.79 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.78 -0.575 . . . . 0.0 110.878 -178.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 48.1 p -97.67 -63.32 1.14 Allowed 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -177.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 45.8 m -101.26 14.69 31.16 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.451 -0.78 . . . . 0.0 112.093 -178.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 55.64 21.06 27.2 Favored Glycine 0 N--CA 1.506 3.326 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 25.5 t -107.55 164.01 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 O-C-N 121.851 -0.794 . . . . 0.0 109.121 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 134.38 178.89 15.95 Favored Glycine 0 N--CA 1.498 2.817 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -66.12 175.25 4.96 Favored 'Trans proline' 0 N--CA 1.486 1.075 0 CA-C-N 119.14 1.47 . . . . 0.0 109.633 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.07 82.25 5.07 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.99 0.9 . . . . 0.0 109.941 -178.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -139.71 135.84 33.58 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.8 162.63 0.86 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 122.056 -0.402 . . . . 0.0 110.158 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.89 -54.0 8.05 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 122.051 -0.406 . . . . 0.0 110.595 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -51.48 -36.51 44.73 Favored 'General case' 0 N--CA 1.507 2.398 0 O-C-N 121.742 -0.599 . . . . 0.0 111.15 -178.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -70.75 -36.09 72.96 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 122.052 -0.405 . . . . 0.0 110.008 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.44 ' HB3' ' CD2' ' A' ' 23' ' ' TYR . 0.8 OUTLIER -66.18 -54.25 27.61 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.856 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.0 ttpt -54.63 -36.76 64.86 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.05 -39.72 95.57 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -63.6 -40.75 97.72 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 16.4 m -67.82 -33.5 74.91 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.054 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 17.9 m -74.44 -30.44 61.89 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.22 -35.29 71.43 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 178.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -79.07 -26.85 43.01 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 120.961 0.41 . . . . 0.0 109.947 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -71.52 -39.31 70.83 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.24 -40.45 37.2 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.23 -37.61 64.81 Favored 'General case' 0 N--CA 1.505 2.294 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 178.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 80.2 mt -79.04 105.15 2.73 Favored Pre-proline 0 N--CA 1.493 1.7 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 177.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -60.31 146.67 96.06 Favored 'Trans proline' 0 N--CA 1.479 0.631 0 C-N-CA 121.544 1.496 . . . . 0.0 110.997 -176.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -42.5 -27.99 0.19 Allowed 'General case' 0 N--CA 1.502 2.17 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.685 -178.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -67.37 119.83 12.86 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 20.8 m 62.02 17.38 8.99 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 122.383 -0.198 . . . . 0.0 110.647 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -44.93 -83.37 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.901 0 O-C-N 121.231 -0.918 . . . . 0.0 110.165 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 51.3 m -33.15 -43.62 0.11 Allowed 'General case' 0 N--CA 1.52 3.061 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -37.8 -48.07 1.07 Allowed 'General case' 0 N--CA 1.514 2.774 0 CA-C-N 119.741 1.155 . . . . 0.0 112.246 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -43.66 -53.23 5.9 Favored 'General case' 0 N--CA 1.513 2.722 0 O-C-N 121.542 -0.724 . . . . 0.0 111.582 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 38.5 t -48.69 -45.87 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.399 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.1 -54.61 45.06 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.475 ' CG2' ' HB ' ' A' ' 67' ' ' VAL . 34.4 mt -49.18 -27.39 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.337 0 O-C-N 121.344 -0.848 . . . . 0.0 109.965 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 27.5 tp -77.92 -41.85 35.11 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.491 -0.884 . . . . 0.0 109.994 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.26 -54.26 6.71 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.555 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -80.65 -22.86 40.13 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.931 -0.48 . . . . 0.0 111.224 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.65 150.49 17.07 Favored Glycine 0 N--CA 1.498 2.781 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -178.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.475 ' HB ' ' CG2' ' A' ' 62' ' ' ILE . 4.2 p -117.91 159.68 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.275 0 O-C-N 122.176 -0.603 . . . . 0.0 109.845 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.444 ' CG2' ' CE1' ' A' ' 74' ' ' HIS . 72.8 t -115.1 157.51 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 CA-C-O 121.767 0.794 . . . . 0.0 109.095 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.9 p -117.42 159.78 22.24 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.648 -177.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.3 t -62.07 -33.41 74.37 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.3 -178.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.8 p -66.2 -17.78 64.94 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.226 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.91 14.78 30.5 Favored Glycine 0 N--CA 1.498 2.798 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 67.8 mm-40 -102.58 157.06 17.2 Favored 'General case' 0 N--CA 1.503 2.221 0 CA-C-N 118.19 0.995 . . . . 0.0 109.321 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.444 ' CE1' ' CG2' ' A' ' 68' ' ' VAL . 9.5 m170 -115.83 155.3 28.13 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -143.48 -176.77 5.08 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.17 0.51 . . . . 0.0 110.278 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 60.09 -137.66 49.16 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 22.7 ttp180 51.42 26.07 2.96 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 122.317 -0.519 . . . . 0.0 110.301 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.4 mt -77.2 -20.47 55.29 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.719 -0.613 . . . . 0.0 110.636 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 95.8 mt -62.14 95.55 0.06 Allowed 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -143.23 177.01 8.7 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.368 0.604 . . . . 0.0 110.29 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -50.96 107.86 0.2 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.49 0.662 . . . . 0.0 111.775 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.517 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 18.3 mt -100.88 168.14 9.71 Favored Pre-proline 0 N--CA 1.495 1.797 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.517 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 26.6 Cg_endo -64.62 99.79 0.32 Allowed 'Trans proline' 0 N--CA 1.48 0.699 0 C-N-CA 121.277 1.318 . . . . 0.0 111.702 -178.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.84 -9.89 75.75 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 7.5 m -118.98 91.12 42.68 Favored Pre-proline 0 N--CA 1.503 2.217 0 CA-C-N 119.125 1.463 . . . . 0.0 110.538 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -72.02 165.44 32.59 Favored 'Trans proline' 0 N--CA 1.482 0.847 0 C-N-CA 121.712 1.608 . . . . 0.0 111.173 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.1 mmm-85 -47.59 -28.53 2.35 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -57.7 -53.42 58.36 Favored 'General case' 0 N--CA 1.502 2.159 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.048 -178.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.1 t -63.89 -38.72 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.19 -26.96 69.05 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.93 -35.95 42.56 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.22 -49.82 63.12 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.997 -0.439 . . . . 0.0 109.896 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.46 ' CE1' HG21 ' A' ' 24' ' ' VAL . 34.0 t80 -78.77 -25.11 44.35 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 122.12 -0.362 . . . . 0.0 110.554 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.417 ' N ' ' HD2' ' A' ' 95' ' ' PRO . . . -41.22 -51.06 8.22 Favored Pre-proline 0 N--CA 1.503 2.186 0 CA-C-O 118.773 -0.632 . . . . 0.0 112.29 -177.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.417 ' HD2' ' N ' ' A' ' 94' ' ' ALA . 30.3 Cg_endo -72.59 -167.24 0.32 Allowed 'Trans proline' 0 C--N 1.33 -0.43 0 C-N-CA 121.505 1.47 . . . . 0.0 109.62 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 77.0 mttt 62.48 20.44 11.92 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.92 -65.45 0.8 Allowed 'General case' 0 N--CA 1.509 2.486 0 O-C-N 121.875 -0.516 . . . . 0.0 110.786 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 27.1 m -84.6 20.63 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 120.963 -1.086 . . . . 0.0 111.279 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 25.2 p -98.91 174.71 6.23 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.04 -2.67 0.63 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.575 -0.703 . . . . 0.0 112.018 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 14.4 t -94.05 -0.64 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 CA-C-N 120.591 1.541 . . . . 0.0 111.062 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -138.12 -89.65 0.23 Allowed 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.383 -0.823 . . . . 0.0 111.185 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 54.0 m -144.92 39.5 1.23 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.374 -0.829 . . . . 0.0 109.432 -178.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -35.22 -60.84 0.46 Allowed 'General case' 0 N--CA 1.511 2.6 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -178.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.1 mt 43.23 31.45 0.38 Allowed 'General case' 0 N--CA 1.511 2.617 0 CA-C-N 118.657 0.662 . . . . 0.0 110.73 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 66.58 150.09 0.05 Allowed 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.7 p -119.58 -159.86 0.79 Allowed 'General case' 0 N--CA 1.504 2.226 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.8 tt -66.98 -32.35 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -72.92 1.73 8.21 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.9 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 57.91 33.18 67.79 Favored Glycine 0 N--CA 1.499 2.887 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -161.66 170.63 37.43 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -79.05 71.96 6.76 Favored 'Trans proline' 0 CA--C 1.545 1.047 0 C-N-CA 122.747 2.298 . . . . 0.0 111.55 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 44.8 p90 . . . . . 0 N--CA 1.505 2.311 0 O-C-N 121.816 -0.552 . . . . 0.0 110.171 178.53 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.452 ' O ' ' SD ' ' A' ' 10' ' ' MET . 36.1 Cg_endo . . . . . 0 C--O 1.215 -0.637 0 N-CA-C 110.133 -0.756 . . . . 0.0 110.133 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 60.15 12.52 23.89 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.589 ' O ' ' CB ' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -129.37 94.44 3.78 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.293 -1.122 . . . . 0.0 108.71 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.589 ' CB ' ' O ' ' A' ' 10' ' ' MET . . . 86.09 -58.14 0.07 Allowed 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -178.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 29.1 mt -95.69 103.25 12.29 Favored Pre-proline 0 N--CA 1.489 1.489 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.509 ' HD3' ' O ' ' A' ' 11' ' ' ALA . 34.1 Cg_endo -81.37 170.86 14.28 Favored 'Trans proline' 0 C--N 1.318 -1.038 0 C-N-CA 121.378 1.385 . . . . 0.0 111.864 -176.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 29.1 m-70 -69.82 149.2 48.16 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.466 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 1.1 t-20 67.2 63.95 0.74 Allowed Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 120.623 -1.298 . . . . 0.0 110.033 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.47 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 37.3 Cg_endo -79.7 166.35 21.71 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.808 2.339 . . . . 0.0 112.151 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.456 HD21 ' CB ' ' A' ' 20' ' ' CYS . 0.2 OUTLIER 33.13 47.03 0.11 Allowed 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.581 178.789 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -74.86 -34.85 62.33 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.99 -1.069 . . . . 0.0 108.982 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.455 ' OG ' ' SG ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -62.56 -43.36 99.01 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.171 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.456 ' CB ' HD21 ' A' ' 17' ' ' LEU . 36.2 m -59.88 -40.03 87.29 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 121.352 0.596 . . . . 0.0 109.706 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.565 ' HG3' ' N ' ' A' ' 22' ' ' TRP . 0.1 OUTLIER -58.08 -51.91 67.72 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.373 -0.83 . . . . 0.0 108.915 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.565 ' N ' ' HG3' ' A' ' 21' ' ' ARG . 27.6 m95 -68.75 -26.25 65.14 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 118.591 -1.244 . . . . 0.0 110.541 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.59 ' CG ' ' CE ' ' A' ' 40' ' ' MET . 19.0 t80 -66.97 -32.65 74.03 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.911 -1.118 . . . . 0.0 108.593 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.573 HG23 ' CE1' ' A' ' 93' ' ' PHE . 71.3 t -72.9 -42.25 60.51 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.274 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 178.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.471 ' OG ' ' HA ' ' A' ' 22' ' ' TRP . 0.5 OUTLIER -54.84 -40.0 69.14 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.059 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 3.7 m -77.28 -53.26 7.92 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.186 -0.946 . . . . 0.0 111.154 -178.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.1 ttm180 -59.56 -24.4 63.69 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.935 -1.103 . . . . 0.0 110.194 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.487 HG22 ' CG1' ' A' ' 24' ' ' VAL . 80.7 p -93.0 -67.53 0.85 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.186 -0.946 . . . . 0.0 111.419 -178.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.498 ' SG ' ' C ' ' A' ' 84' ' ' GLY . 93.2 m -99.51 18.07 18.79 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.496 -1.378 . . . . 0.0 110.104 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.456 ' HA2' ' O ' ' A' ' 26' ' ' THR . . . 57.63 15.55 18.8 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 26' ' ' THR . 75.6 t -101.87 154.48 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.13 -1.218 . . . . 0.0 109.283 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 142.66 179.23 19.3 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -66.37 177.15 3.42 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 CA-C-N 118.981 1.391 . . . . 0.0 109.875 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.47 ' HG2' ' O ' ' A' ' 34' ' ' ARG . 0.1 OUTLIER -91.28 81.68 5.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.726 -1.234 . . . . 0.0 110.162 -178.125 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.461 ' CD2' ' NH1' ' A' ' 43' ' ' ARG . 25.6 tp -138.13 127.98 25.38 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.94 161.58 0.76 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.059 -1.025 . . . . 0.0 109.662 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.435 ' O ' ' C ' ' A' ' 38' ' ' GLN . 1.2 p -67.96 -61.97 1.62 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.12 -0.987 . . . . 0.0 109.987 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 37' ' ' THR . 0.8 OUTLIER -43.95 -57.22 3.44 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.017 -1.052 . . . . 0.0 109.737 -179.361 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.466 ' O ' ' HB1' ' A' ' 42' ' ' ALA . 75.5 mm-40 -49.15 -43.38 41.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.252 -0.905 . . . . 0.0 109.699 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.59 ' CE ' ' CG ' ' A' ' 23' ' ' TYR . 1.8 tmm? -59.03 -62.97 1.48 Allowed 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.471 ' HG3' ' OE1' ' A' ' 102' ' ' GLU . 19.0 tttt -40.59 -31.68 0.17 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.466 ' HB1' ' O ' ' A' ' 39' ' ' GLU . . . -68.51 -50.93 48.46 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.593 -0.692 . . . . 0.0 109.688 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.541 ' CG ' ' O ' ' A' ' 40' ' ' MET . 0.0 OUTLIER -59.14 -41.24 87.83 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.193 -1.003 . . . . 0.0 109.768 -179.597 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.455 ' SG ' ' OG ' ' A' ' 19' ' ' SER . 8.8 m -65.03 -36.09 83.25 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.89 -1.132 . . . . 0.0 110.579 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 19.1 m -69.75 -32.02 70.31 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.737 -1.227 . . . . 0.0 108.937 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.86 -32.64 67.7 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.465 ' HG3' ' O ' ' A' ' 43' ' ' ARG . 0.1 OUTLIER -77.43 -29.14 52.79 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.703 -0.623 . . . . 0.0 109.638 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.504 ' CD1' HG11 ' A' ' 98' ' ' VAL . 0.6 OUTLIER -75.0 -38.42 61.61 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.115 -0.991 . . . . 0.0 108.544 179.59 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.425 ' O ' ' C ' ' A' ' 50' ' ' ALA . 2.9 tt0 -69.16 -53.04 22.13 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.478 ' O ' ' HD3' ' A' ' 52' ' ' PRO . . . -47.54 -52.98 15.74 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 178.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.553 ' CG2' ' HA ' ' A' ' 56' ' ' ARG . 26.8 mm -58.81 106.02 0.64 Allowed Pre-proline 0 C--N 1.304 -1.393 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 177.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 50' ' ' ALA . 28.0 Cg_endo -63.77 136.25 52.55 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 121.893 1.729 . . . . 0.0 111.528 -176.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.474 ' HA ' ' HG3' ' A' ' 56' ' ' ARG . . . -33.84 -36.15 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.792 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.474 ' O ' ' CB ' ' A' ' 55' ' ' CYS . 2.2 m-85 -67.63 117.14 9.16 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.01 -1.056 . . . . 0.0 108.794 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.474 ' CB ' ' O ' ' A' ' 54' ' ' TYR . 9.7 m 76.24 -2.46 2.73 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.461 -0.775 . . . . 0.0 109.784 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.553 ' HA ' ' CG2' ' A' ' 51' ' ' ILE . 0.4 OUTLIER -40.01 -87.44 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.199 -0.938 . . . . 0.0 109.188 -179.81 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.538 ' O ' ' C ' ' A' ' 58' ' ' GLU . 22.2 m -31.93 -58.34 0.29 Allowed 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.625 -0.672 . . . . 0.0 111.443 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.538 ' C ' ' O ' ' A' ' 57' ' ' CYS . 2.6 mm-40 -25.89 -53.5 0.05 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.55 -0.719 . . . . 0.0 111.249 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.47 ' HB3' ' HB2' ' A' ' 16' ' ' PRO . . . -37.81 -61.23 0.65 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.445 -0.785 . . . . 0.0 110.256 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.542 HG23 ' CD1' ' A' ' 97' ' ' LEU . 27.8 t -42.55 -51.35 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 CA-C-O 121.861 0.839 . . . . 0.0 108.904 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.485 ' O ' ' N ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -54.18 -63.66 1.08 Allowed 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.262 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.596 ' CG2' ' HB ' ' A' ' 67' ' ' VAL . 4.6 mm -40.06 -27.25 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.23 -0.919 . . . . 0.0 110.294 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.531 ' CD1' ' HB2' ' A' ' 79' ' ' LEU . 0.9 OUTLIER -77.59 -46.77 21.17 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 120.704 -1.248 . . . . 0.0 109.202 -179.973 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.489 ' SD ' ' NE ' ' A' ' 91' ' ' ARG . 0.1 OUTLIER -73.62 -53.65 9.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.23 -0.919 . . . . 0.0 110.152 -179.83 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -80.2 -21.43 42.95 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.82 -1.175 . . . . 0.0 110.315 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.489 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . 84.51 151.2 12.86 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -179.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.596 ' HB ' ' CG2' ' A' ' 62' ' ' ILE . 7.3 p -116.64 159.39 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.414 -1.051 . . . . 0.0 109.409 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.533 HG23 ' NE2' ' A' ' 74' ' ' HIS . 12.8 t -114.52 157.96 15.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-O 121.642 0.735 . . . . 0.0 109.185 -179.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.438 ' N ' ' CG1' ' A' ' 68' ' ' VAL . 27.5 p -116.83 158.94 23.12 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 121.615 0.722 . . . . 0.0 109.65 -178.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 32.1 t -62.25 -31.11 71.63 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.495 0.664 . . . . 0.0 110.13 -178.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.2 p -69.84 -14.01 62.54 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.499 -0.751 . . . . 0.0 109.6 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.3 9.24 48.29 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 108.881 -1.688 . . . . 0.0 108.881 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -91.84 157.25 16.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.088 -1.242 . . . . 0.0 109.877 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.533 ' NE2' HG23 ' A' ' 68' ' ' VAL . 10.1 m170 -115.83 156.32 26.31 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.022 -1.048 . . . . 0.0 108.739 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.423 ' HG2' ' C ' ' A' ' 74' ' ' HIS . 57.1 mm-40 -145.47 178.95 7.74 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.308 -0.87 . . . . 0.0 110.262 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 58.44 -147.13 39.8 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.43 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 2.9 ttp85 60.0 18.74 7.88 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.44 -1.035 . . . . 0.0 110.572 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.474 ' O ' ' NH2' ' A' ' 21' ' ' ARG . 1.8 mp -79.87 -19.53 48.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.837 -1.164 . . . . 0.0 109.812 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.531 ' HB2' ' CD1' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -64.46 89.26 0.06 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.972 -1.08 . . . . 0.0 108.691 179.484 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.42 ' O ' ' C ' ' A' ' 81' ' ' ASP . 8.3 mt-30 -136.39 178.32 7.16 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.295 -0.878 . . . . 0.0 110.201 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 80' ' ' GLN . 49.4 m-20 -39.33 129.35 1.79 Allowed 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.995 0.902 . . . . 0.0 110.93 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.582 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 22.0 mt -126.03 168.79 13.07 Favored Pre-proline 0 C--N 1.302 -1.484 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 178.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.582 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 27.4 Cg_endo -66.12 99.38 0.41 Allowed 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 121.008 1.138 . . . . 0.0 110.794 -179.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.498 ' C ' ' SG ' ' A' ' 29' ' ' CYS . . . 89.71 -7.97 80.76 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.458 ' SG ' ' OG1' ' A' ' 28' ' ' THR . 7.7 m -120.61 89.39 44.59 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 120.569 -1.547 . . . . 0.0 110.311 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.438 ' HD2' HG22 ' A' ' 89' ' ' VAL . 30.7 Cg_endo -76.44 159.01 36.4 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 C-N-CA 121.827 1.684 . . . . 0.0 111.197 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' A' ' 86' ' ' PRO . 4.3 mmt85 -44.63 -28.57 0.62 Allowed 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.41 ' N ' ' C ' ' A' ' 86' ' ' PRO . 4.5 tt0 -57.31 -60.5 3.54 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.668 -178.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.438 HG22 ' HD2' ' A' ' 86' ' ' PRO . 87.9 t -61.0 -42.59 93.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 O-C-N 120.793 -1.192 . . . . 0.0 110.364 -178.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.462 ' HG2' HD23 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -60.62 -27.53 67.83 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.182 -1.007 . . . . 0.0 108.514 179.841 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.489 ' NE ' ' SD ' ' A' ' 64' ' ' MET . 0.0 OUTLIER -78.05 -31.16 50.17 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.43 -0.794 . . . . 0.0 109.712 179.511 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.51 ' O ' ' HD2' ' A' ' 95' ' ' PRO . . . -71.08 -50.34 34.85 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.064 -1.023 . . . . 0.0 109.522 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.573 ' CE1' HG23 ' A' ' 24' ' ' VAL . 10.4 t80 -77.67 -25.72 49.76 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.424 -0.798 . . . . 0.0 109.915 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.562 ' N ' ' HD2' ' A' ' 95' ' ' PRO . . . -41.16 -52.46 7.22 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.308 -0.87 . . . . 0.0 111.885 -179.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 94' ' ' ALA . 29.6 Cg_endo -70.09 97.64 0.68 Allowed 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.227 1.951 . . . . 0.0 111.47 -178.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.507 ' CB ' ' O ' ' A' ' 95' ' ' PRO . 2.1 mttt 159.55 65.35 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.542 ' CD1' HG23 ' A' ' 60' ' ' VAL . 1.3 mt -109.91 -89.21 0.49 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.3 -0.875 . . . . 0.0 111.589 -178.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.508 ' C ' ' HA ' ' A' ' 104' ' ' ASN . 3.3 m -78.74 34.88 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 120.661 -1.275 . . . . 0.0 111.735 -178.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 12.9 p -106.83 173.32 6.37 Favored 'General case' 0 C--N 1.293 -1.882 0 O-C-N 120.706 -1.246 . . . . 0.0 108.463 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.488 ' HA ' ' OD1' ' A' ' 104' ' ' ASN . 15.3 mt-10 -60.59 1.74 0.13 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.746 -1.222 . . . . 0.0 111.874 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.7 t -99.13 0.82 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 119.888 -1.757 . . . . 0.0 110.829 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.521 ' HG3' ' N ' ' A' ' 103' ' ' CYS . 7.1 tp10 -149.93 -98.17 0.07 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.568 -1.333 . . . . 0.0 111.347 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.521 ' N ' ' HG3' ' A' ' 102' ' ' GLU . 78.4 m -117.39 43.65 2.3 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.93 -1.106 . . . . 0.0 109.794 -178.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.526 ' ND2' ' N ' ' A' ' 104' ' ' ASN . 0.1 OUTLIER -31.99 -92.17 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.308 -0.87 . . . . 0.0 111.806 -179.419 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.541 ' O ' ' CB ' ' A' ' 106' ' ' ALA . 1.3 mt 66.95 -1.76 1.31 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.005 -1.06 . . . . 0.0 111.822 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 105' ' ' LEU . . . 81.08 143.45 0.08 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.684 -1.26 . . . . 0.0 110.028 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.0 p -114.27 -162.09 0.8 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.29 -0.881 . . . . 0.0 108.723 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.431 HD13 ' CD1' ' A' ' 54' ' ' TYR . 19.3 tt -62.09 -22.65 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.902 -1.124 . . . . 0.0 108.753 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.432 ' HB3' ' CE1' ' A' ' 113' ' ' PHE . 90.6 m-70 -80.47 14.74 1.89 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.733 -0.604 . . . . 0.0 110.486 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 109' ' ' HIS . . . 44.15 25.61 0.75 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 109' ' ' HIS . . . -150.45 169.74 30.37 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.494 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 35.1 Cg_endo -78.96 72.87 6.28 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.876 2.384 . . . . 0.0 110.989 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.494 ' HB3' ' O ' ' A' ' 112' ' ' PRO . 17.7 p90 . . . . . 0 N--CA 1.494 1.752 0 O-C-N 121.37 -0.831 . . . . 0.0 109.529 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo . . . . . 0 N--CA 1.479 0.647 0 N-CA-C 111.103 -0.383 . . . . 0.0 111.103 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 62.84 16.32 56.48 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 -179.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.44 ' O ' ' CB ' ' A' ' 11' ' ' ALA . 16.6 mmm -140.91 84.62 1.94 Allowed 'General case' 0 N--CA 1.5 2.051 0 CA-C-N 117.749 0.774 . . . . 0.0 108.99 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.44 ' CB ' ' O ' ' A' ' 10' ' ' MET . . . 86.82 -57.65 0.05 OUTLIER 'General case' 0 N--CA 1.515 2.824 0 O-C-N 121.368 -0.833 . . . . 0.0 108.908 -178.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 61.2 mt -92.21 104.5 11.04 Favored Pre-proline 0 N--CA 1.498 1.935 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -75.21 169.6 22.18 Favored 'Trans proline' 0 C--O 1.22 -0.406 0 C-N-CA 121.348 1.365 . . . . 0.0 111.547 -175.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 35.1 m-70 -69.33 144.5 53.48 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.458 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 5.3 t-20 66.08 56.01 1.03 Allowed Pre-proline 0 N--CA 1.505 2.307 0 O-C-N 121.392 -0.817 . . . . 0.0 110.282 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.458 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 39.0 Cg_endo -80.54 166.86 19.54 Favored 'Trans proline' 0 N--CA 1.483 0.908 0 C-N-CA 122.317 2.011 . . . . 0.0 111.907 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.5 mp 42.92 43.81 3.69 Favored 'General case' 0 N--CA 1.504 2.238 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.192 177.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -69.07 -37.75 78.67 Favored 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.96 -26.13 68.69 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 56.9 m -74.61 -38.68 62.51 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.408 ' NH1' ' HB3' ' A' ' 78' ' ' LEU . 3.3 ttt180 -64.31 -48.88 73.96 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 33.5 m95 -68.74 -29.31 67.69 Favored 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 119.413 -0.915 . . . . 0.0 109.686 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.428 ' CD1' ' HB3' ' A' ' 40' ' ' MET . 57.7 t80 -66.38 -33.65 76.19 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 92.9 t -72.25 -38.97 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 177.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 m -56.27 -37.03 69.26 Favored 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 119.951 -0.7 . . . . 0.0 109.442 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 89.7 m -77.64 -50.09 13.2 Favored 'General case' 0 N--CA 1.506 2.347 0 N-CA-C 112.208 0.448 . . . . 0.0 112.208 -178.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.77 -25.31 67.87 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.512 -0.742 . . . . 0.0 110.622 -178.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 70.7 p -93.35 -63.38 1.22 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -177.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.6 m -100.32 9.29 42.91 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.438 -0.789 . . . . 0.0 111.636 -178.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 57.78 30.05 62.37 Favored Glycine 0 N--CA 1.507 3.37 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 37.9 t -121.24 164.09 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 122.192 -0.593 . . . . 0.0 109.672 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 136.19 177.82 15.29 Favored Glycine 0 N--CA 1.499 2.895 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -64.37 177.31 2.17 Favored 'Trans proline' 0 N--CA 1.489 1.254 0 CA-C-N 119.253 1.526 . . . . 0.0 110.047 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.28 87.25 5.99 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 122.17 0.986 . . . . 0.0 110.338 -177.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.5 mt -141.85 127.37 18.95 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 178.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.19 152.44 2.37 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.979 -0.45 . . . . 0.0 109.825 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.1 p -60.0 -59.66 5.07 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.789 -0.569 . . . . 0.0 110.655 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -52.56 -28.75 22.22 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.878 -0.514 . . . . 0.0 111.571 -178.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -71.97 -46.94 55.56 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.816 -0.553 . . . . 0.0 109.608 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.428 ' HB3' ' CD1' ' A' ' 23' ' ' TYR . 5.6 tpt -61.97 -54.57 39.84 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -53.61 -35.7 61.19 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.45 -42.81 99.74 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.3 -41.12 96.45 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 19.7 m -65.48 -33.22 75.43 Favored 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.244 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 18.6 m -73.47 -30.16 62.99 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.35 -32.38 62.76 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -77.02 -33.69 57.41 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.46 -33.53 64.91 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.49 -40.4 61.86 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.28 -39.13 85.77 Favored 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 71.7 mt -82.54 105.57 5.09 Favored Pre-proline 0 N--CA 1.493 1.684 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 177.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -58.2 139.87 92.14 Favored 'Trans proline' 0 N--CA 1.48 0.705 0 C-N-CA 121.52 1.48 . . . . 0.0 110.877 -177.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.42 ' CB ' ' NH1' ' A' ' 56' ' ' ARG . . . -39.48 -29.79 0.06 Allowed 'General case' 0 N--CA 1.507 2.387 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.356 -178.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -53.15 -70.47 0.09 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.922 -0.486 . . . . 0.0 110.623 -179.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 5.1 m -88.59 8.81 26.46 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.974 -0.454 . . . . 0.0 110.884 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.42 ' NH1' ' CB ' ' A' ' 53' ' ' ALA . 5.9 mtt180 -47.6 -85.35 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.666 0 O-C-N 121.445 -0.784 . . . . 0.0 110.282 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 73.3 m -32.79 -48.88 0.21 Allowed 'General case' 0 N--CA 1.521 3.083 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -41.74 -54.32 3.36 Favored 'General case' 0 N--CA 1.512 2.671 0 CA-C-N 119.319 0.963 . . . . 0.0 111.755 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -41.87 -44.63 3.43 Favored 'General case' 0 N--CA 1.513 2.706 0 O-C-N 121.787 -0.57 . . . . 0.0 112.065 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.7 t -57.17 -48.9 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.4 mtt180 -58.56 -26.74 63.89 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.466 ' CG2' ' HB ' ' A' ' 67' ' ' VAL . 34.5 mm -78.52 -30.74 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 O-C-N 121.945 -0.472 . . . . 0.0 110.362 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.9 tp -77.87 -43.37 30.43 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 120.079 -0.649 . . . . 0.0 109.79 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.79 -50.84 10.64 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.232 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -80.55 -22.74 40.52 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 122.087 -0.383 . . . . 0.0 110.88 -178.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.68 146.91 5.67 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.466 ' HB ' ' CG2' ' A' ' 62' ' ' ILE . 5.6 p -118.43 161.08 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.422 HG21 ' CE1' ' A' ' 74' ' ' HIS . 56.0 t -113.27 157.89 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 42.1 p -116.84 160.13 21.32 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.987 0.899 . . . . 0.0 110.969 -176.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 32.8 t -64.54 -17.53 64.01 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.431 -178.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.1 p -86.48 -14.61 42.64 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 122.05 -0.406 . . . . 0.0 110.034 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.25 13.53 33.09 Favored Glycine 0 N--CA 1.5 2.902 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -105.43 158.62 16.53 Favored 'General case' 0 N--CA 1.501 2.114 0 CA-C-N 118.142 0.971 . . . . 0.0 108.859 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.422 ' CE1' HG21 ' A' ' 68' ' ' VAL . 11.3 m170 -113.79 154.93 26.58 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -179.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -136.8 -179.02 5.45 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 55.3 -146.93 28.43 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 -178.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 54.84 22.28 4.13 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 122.253 -0.557 . . . . 0.0 109.988 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.408 ' HB3' ' NH1' ' A' ' 21' ' ' ARG . 2.1 mp -82.87 -14.61 53.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.765 -0.584 . . . . 0.0 110.388 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.5 mt -62.11 92.79 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -134.78 -177.02 4.43 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.758 0.79 . . . . 0.0 110.663 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -47.67 131.6 14.42 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.758 0.789 . . . . 0.0 111.544 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.455 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 20.6 mt -129.27 166.85 22.55 Favored Pre-proline 0 N--CA 1.497 1.918 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.455 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 29.6 Cg_endo -68.6 98.63 0.59 Allowed 'Trans proline' 0 C--N 1.327 -0.553 0 C-N-CA 120.936 1.091 . . . . 0.0 110.243 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.41 6.94 67.82 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.431 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 3.2 m -138.8 92.51 11.21 Favored Pre-proline 0 N--CA 1.508 2.425 0 CA-C-N 118.974 1.387 . . . . 0.0 110.062 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -74.79 165.45 31.45 Favored 'Trans proline' 0 N--CA 1.487 1.109 0 C-N-CA 121.924 1.749 . . . . 0.0 111.225 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 24.0 mtp180 -53.89 -25.96 22.66 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.042 0.448 . . . . 0.0 110.225 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.23 -45.86 89.65 Favored 'General case' 0 N--CA 1.503 2.213 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.008 -177.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 42.0 t -72.38 -43.37 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.596 -0.69 . . . . 0.0 111.023 -177.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -70.37 -27.02 64.0 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.8 ttt180 -78.76 -29.26 45.0 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.44 -47.09 20.61 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.945 -0.472 . . . . 0.0 110.28 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -79.03 -27.56 43.21 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 122.088 -0.383 . . . . 0.0 111.463 -178.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.449 ' N ' ' HD2' ' A' ' 95' ' ' PRO . . . -55.09 -46.45 99.67 Favored Pre-proline 0 N--CA 1.504 2.259 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -177.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' A' ' 94' ' ' ALA . 30.2 Cg_endo -70.06 -0.26 6.9 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 122.209 1.939 . . . . 0.0 114.017 -177.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.79 24.12 12.05 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.492 -0.755 . . . . 0.0 109.8 179.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.99 -24.22 59.57 Favored 'General case' 0 N--CA 1.51 2.526 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -178.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 33.7 m -93.4 25.63 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.322 0 CA-C-N 120.958 1.708 . . . . 0.0 111.182 -178.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 19.0 p -98.24 173.1 7.17 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -61.94 -1.52 0.68 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.656 -0.652 . . . . 0.0 112.25 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 36.3 t -100.04 4.4 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 CA-C-N 120.443 1.474 . . . . 0.0 110.96 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -141.07 -89.95 0.16 Allowed 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.38 -0.825 . . . . 0.0 111.488 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 19.8 m -143.62 43.0 1.49 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.502 -0.749 . . . . 0.0 109.927 -178.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.401 ' ND2' ' HB3' ' A' ' 112' ' ' PRO . 56.9 t-20 -42.97 -64.9 0.55 Allowed 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.224 -0.923 . . . . 0.0 112.329 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 6.1 mt 45.33 29.34 0.55 Allowed 'General case' 0 N--CA 1.51 2.569 0 CA-C-O 121.073 0.463 . . . . 0.0 109.995 -178.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 67.04 157.93 0.12 Allowed 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -178.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.8 p -128.82 -163.93 1.34 Allowed 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 18.1 tt -68.14 -33.15 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 177.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.427 ' HB3' ' CE2' ' A' ' 113' ' ' PHE . 96.9 m-70 -66.67 -4.9 9.89 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.729 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 61.55 41.39 99.55 Favored Glycine 0 N--CA 1.499 2.863 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -174.87 170.95 44.15 Favored Glycine 0 N--CA 1.501 3.024 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.401 ' HB3' ' ND2' ' A' ' 104' ' ' ASN . 32.3 Cg_endo -77.86 75.84 4.6 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.54 2.16 . . . . 0.0 111.376 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.427 ' CE2' ' HB3' ' A' ' 109' ' ' HIS . 36.8 p90 . . . . . 0 N--CA 1.502 2.145 0 O-C-N 121.65 -0.656 . . . . 0.0 110.468 178.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo . . . . . 0 C--O 1.215 -0.662 0 N-CA-C 110.67 -0.55 . . . . 0.0 110.67 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 62.46 10.85 31.61 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.595 ' O ' ' CB ' ' A' ' 11' ' ' ALA . 2.2 mtt -140.61 95.11 2.81 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.164 -1.198 . . . . 0.0 109.317 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.595 ' CB ' ' O ' ' A' ' 10' ' ' MET . . . 86.14 -60.58 0.06 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.925 -1.11 . . . . 0.0 108.314 -179.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.8 mp -96.83 103.31 14.32 Favored Pre-proline 0 N--CA 1.489 1.483 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.486 ' HD3' ' O ' ' A' ' 11' ' ' ALA . 31.6 Cg_endo -79.64 166.97 21.28 Favored 'Trans proline' 0 C--N 1.32 -0.959 0 C-N-CA 121.277 1.318 . . . . 0.0 112.163 -176.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 37.7 m-70 -68.65 149.0 49.62 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.486 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 0.5 OUTLIER 60.77 63.95 2.51 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 120.607 -1.308 . . . . 0.0 109.62 -179.857 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.486 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 37.2 Cg_endo -80.41 161.08 22.66 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.794 2.329 . . . . 0.0 111.372 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.458 HD11 ' N ' ' A' ' 17' ' ' LEU . 4.2 mp 42.07 45.61 3.45 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.526 -0.734 . . . . 0.0 110.858 178.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -76.91 -40.87 45.78 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.078 -1.014 . . . . 0.0 109.177 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.484 ' O ' ' HE1' ' A' ' 40' ' ' MET . 1.2 t -63.37 -25.96 68.53 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 58.1 m -72.26 -39.21 68.57 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.563 ' CG ' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -59.3 -53.48 57.78 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.472 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.563 ' N ' ' CG ' ' A' ' 21' ' ' ARG . 25.9 m95 -68.11 -29.48 68.41 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 118.984 -1.086 . . . . 0.0 110.429 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.53 ' CE1' HG21 ' A' ' 37' ' ' THR . 4.2 t80 -64.06 -30.62 71.68 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 120.998 -1.064 . . . . 0.0 108.346 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.606 HG23 ' CD2' ' A' ' 93' ' ' PHE . 74.6 t -74.93 -44.56 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 178.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.416 ' OG ' ' HA ' ' A' ' 22' ' ' TRP . 0.7 OUTLIER -52.65 -41.36 63.72 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.522 -0.871 . . . . 0.0 109.633 -179.679 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.495 ' CA ' ' O ' ' A' ' 31' ' ' VAL . 2.6 m -77.77 -56.68 4.31 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.212 -0.93 . . . . 0.0 111.689 -178.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.1 tpt85 -57.77 -24.76 58.67 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.755 -1.216 . . . . 0.0 111.0 -178.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.469 ' OG1' ' O ' ' A' ' 24' ' ' VAL . 78.3 p -97.15 -63.06 1.17 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.949 -1.094 . . . . 0.0 111.191 -178.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.492 ' SG ' ' C ' ' A' ' 84' ' ' GLY . 90.6 m -99.24 18.47 17.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.965 -1.084 . . . . 0.0 110.299 -178.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 26' ' ' THR . . . 52.76 19.41 6.69 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.548 HG11 ' N ' ' A' ' 32' ' ' GLY . 76.0 t -107.55 149.23 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.207 -1.173 . . . . 0.0 108.782 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.548 ' N ' HG11 ' A' ' 31' ' ' VAL . . . 141.96 177.34 16.99 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.449 -1.86 . . . . 0.0 108.449 -179.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -66.32 172.38 9.03 Favored 'Trans proline' 0 N--CA 1.479 0.654 0 CA-C-N 118.99 1.395 . . . . 0.0 109.988 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.23 64.43 4.47 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.876 -1.14 . . . . 0.0 110.074 -178.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.545 ' CD2' ' HB2' ' A' ' 39' ' ' GLU . 6.6 tt -106.33 120.41 41.8 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.463 ' C ' ' O ' ' A' ' 35' ' ' LEU . . . -41.56 135.32 2.15 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.345 -0.847 . . . . 0.0 109.363 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.53 HG21 ' CE1' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -52.19 -54.54 29.63 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.785 -1.197 . . . . 0.0 111.564 -178.738 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -51.93 -43.0 63.25 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.817 -1.177 . . . . 0.0 110.249 -178.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.545 ' HB2' ' CD2' ' A' ' 35' ' ' LEU . 27.4 mm-40 -67.12 -29.36 69.07 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.28 -0.888 . . . . 0.0 109.604 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.484 ' HE1' ' O ' ' A' ' 19' ' ' SER . 8.5 tpt -69.23 -60.78 2.11 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.123 -0.986 . . . . 0.0 108.361 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.54 -39.11 48.12 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.81 -41.42 97.74 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.347 -0.846 . . . . 0.0 109.154 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.528 ' CD ' HD12 ' A' ' 35' ' ' LEU . 21.3 mtt85 -60.08 -47.22 86.8 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.349 -0.845 . . . . 0.0 109.192 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 15.3 m -61.26 -37.05 81.72 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.19 -0.944 . . . . 0.0 110.577 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 96.9 m -71.14 -28.59 64.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.811 -1.18 . . . . 0.0 109.141 -179.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.1 tpp180 -74.35 -31.35 62.39 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.448 ' O ' HG12 ' A' ' 51' ' ' ILE . 0.7 OUTLIER -77.09 -37.13 55.02 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.952 -0.699 . . . . 0.0 109.389 179.951 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.442 HD13 HG11 ' A' ' 98' ' ' VAL . 6.2 tt -70.8 -36.57 73.06 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.297 -0.877 . . . . 0.0 108.666 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.446 ' O ' ' C ' ' A' ' 50' ' ' ALA . 13.3 tp10 -67.27 -51.4 53.35 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.519 ' O ' ' HD3' ' A' ' 52' ' ' PRO . . . -47.89 -49.68 28.97 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 178.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.448 HG12 ' O ' ' A' ' 47' ' ' GLN . 33.7 mm -62.04 106.09 0.76 Allowed Pre-proline 0 C--N 1.304 -1.411 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 176.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.523 ' O ' ' N ' ' A' ' 54' ' ' TYR . 26.6 Cg_endo -63.95 141.4 77.36 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 121.631 1.554 . . . . 0.0 110.81 -177.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.518 ' HA ' ' CD ' ' A' ' 56' ' ' ARG . . . -37.15 -28.67 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.908 -0.495 . . . . 0.0 110.079 -178.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.523 ' N ' ' O ' ' A' ' 52' ' ' PRO . 0.3 OUTLIER -65.41 119.85 11.75 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.095 -1.003 . . . . 0.0 108.578 178.998 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.523 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 63.6 m 64.91 8.98 5.0 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.355 -0.841 . . . . 0.0 110.256 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.518 ' CD ' ' HA ' ' A' ' 53' ' ' ALA . 8.6 mtt180 -42.42 -87.78 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.705 -1.247 . . . . 0.0 109.471 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.501 ' O ' ' C ' ' A' ' 58' ' ' GLU . 20.9 m -28.38 -50.71 0.08 Allowed 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.502 ' HB2' ' O ' ' A' ' 55' ' ' CYS . 0.1 OUTLIER -32.22 -51.23 0.25 Allowed 'General case' 0 N--CA 1.502 2.159 0 O-C-N 120.82 -1.175 . . . . 0.0 111.432 -178.74 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.479 ' C ' ' O ' ' A' ' 58' ' ' GLU . . . -36.5 -55.39 0.84 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.313 -0.867 . . . . 0.0 110.268 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.0 t -53.18 -49.89 49.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.474 -0.766 . . . . 0.0 109.252 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.468 ' O ' ' HB2' ' A' ' 65' ' ' ASP . 2.0 ttp180 -55.34 -29.35 58.19 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.294 -0.879 . . . . 0.0 109.508 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.569 ' CG2' ' HB ' ' A' ' 67' ' ' VAL . 30.2 mt -77.79 -28.53 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.331 -0.856 . . . . 0.0 109.938 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.519 ' O ' ' HA ' ' A' ' 77' ' ' ARG . 26.4 tp -77.56 -44.5 28.32 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.842 -1.161 . . . . 0.0 109.486 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 30.1 ttp -78.14 -50.69 11.5 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.869 -1.144 . . . . 0.0 109.72 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 61' ' ' ARG . 15.7 m-20 -80.37 -21.26 42.54 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.017 -1.052 . . . . 0.0 110.394 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . 86.65 152.28 21.11 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.569 ' HB ' ' CG2' ' A' ' 62' ' ' ILE . 1.4 p -117.02 159.97 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.539 -0.977 . . . . 0.0 109.248 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.634 ' CG2' ' CE1' ' A' ' 74' ' ' HIS . 12.9 t -113.58 158.16 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-O 121.87 0.843 . . . . 0.0 109.384 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.468 ' N ' ' CG1' ' A' ' 68' ' ' VAL . 69.8 p -117.57 158.76 24.04 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.683 0.754 . . . . 0.0 110.088 -178.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.1 t -65.0 -25.6 67.93 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.571 0.7 . . . . 0.0 109.791 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.1 p -71.13 -15.09 62.48 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.638 -0.664 . . . . 0.0 109.388 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 99.51 10.55 47.2 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.607 -1.797 . . . . 0.0 108.607 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -103.17 157.0 17.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.269 -1.136 . . . . 0.0 109.621 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.634 ' CE1' ' CG2' ' A' ' 68' ' ' VAL . 11.1 m170 -115.07 155.93 26.11 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.064 -1.022 . . . . 0.0 108.821 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -142.67 -174.87 4.27 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.271 -0.893 . . . . 0.0 110.465 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.4 ' HA2' HD13 ' A' ' 78' ' ' LEU . . . 60.62 -139.47 48.11 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.519 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER 52.39 33.19 12.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.215 -1.168 . . . . 0.0 109.368 -179.884 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.479 ' O ' ' N ' ' A' ' 80' ' ' GLN . 1.3 mt -79.06 -22.23 45.64 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.976 -1.078 . . . . 0.0 109.996 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.452 HD22 ' HB3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -45.85 98.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.798 -1.189 . . . . 0.0 108.855 179.513 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.479 ' N ' ' O ' ' A' ' 78' ' ' LEU . 40.1 mt-30 -145.12 174.21 11.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.124 -0.985 . . . . 0.0 110.428 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -56.78 140.75 46.76 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 122.045 0.926 . . . . 0.0 110.701 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.647 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 17.9 mt -133.06 171.17 9.63 Favored Pre-proline 0 C--N 1.301 -1.531 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 179.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.647 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 27.5 Cg_endo -65.91 98.88 0.38 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 120.856 1.038 . . . . 0.0 110.591 -179.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.492 ' C ' ' SG ' ' A' ' 29' ' ' CYS . . . 88.3 -6.73 83.21 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.464 ' SG ' ' OG1' ' A' ' 28' ' ' THR . 9.7 m -119.86 88.42 40.08 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 120.684 -1.48 . . . . 0.0 110.015 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 87' ' ' ARG . 30.5 Cg_endo -75.75 161.32 36.72 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 C-N-CA 122.085 1.857 . . . . 0.0 111.713 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.433 ' C ' ' O ' ' A' ' 86' ' ' PRO . 13.3 mtm-85 -43.57 -27.51 0.3 Allowed 'General case' 0 N--CA 1.482 1.136 0 CA-C-O 121.773 0.797 . . . . 0.0 108.913 178.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' A' ' 86' ' ' PRO . 32.9 tt0 -59.2 -59.84 4.81 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.753 -0.592 . . . . 0.0 111.317 -178.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.415 HG22 ' HD2' ' A' ' 86' ' ' PRO . 45.0 t -65.75 -40.7 88.52 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 O-C-N 120.871 -1.143 . . . . 0.0 110.531 -178.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.552 ' O ' ' CB ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -63.83 -28.07 69.6 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.249 -0.98 . . . . 0.0 108.574 179.843 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.09 -29.39 49.01 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.542 -0.723 . . . . 0.0 109.592 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.486 ' O ' ' HD2' ' A' ' 95' ' ' PRO . . . -74.58 -53.52 9.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -0.909 . . . . 0.0 109.965 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.606 ' CD2' HG23 ' A' ' 24' ' ' VAL . 6.0 t80 -78.25 -26.6 47.32 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.042 -1.036 . . . . 0.0 110.365 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.553 ' N ' ' HD2' ' A' ' 95' ' ' PRO . . . -40.91 -52.64 6.61 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.125 -0.985 . . . . 0.0 111.34 -178.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 94' ' ' ALA . 31.4 Cg_endo -72.27 -164.71 0.18 Allowed 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.143 1.895 . . . . 0.0 111.04 -178.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 95' ' ' PRO . 13.6 mmtm 63.73 30.41 14.71 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -178.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.477 ' O ' ' HB2' ' A' ' 102' ' ' GLU . 0.2 OUTLIER -73.77 -71.19 0.34 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.656 -0.653 . . . . 0.0 110.86 -179.157 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.534 ' O ' ' CB ' ' A' ' 104' ' ' ASN . 2.9 m -77.45 22.9 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.623 -1.298 . . . . 0.0 111.266 -179.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.428 ' C ' ' HB3' ' A' ' 104' ' ' ASN . 7.0 p -99.22 172.68 7.21 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 120.513 -1.367 . . . . 0.0 108.898 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.45 ' HA ' ' ND2' ' A' ' 104' ' ' ASN . 40.0 mt-10 -59.63 -0.31 0.17 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.804 -1.185 . . . . 0.0 111.891 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.481 ' O ' ' CG1' ' A' ' 101' ' ' VAL . 97.8 t -100.28 7.39 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 119.957 -1.714 . . . . 0.0 110.33 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 97' ' ' LEU . 2.0 mm-40 -145.75 -92.71 0.09 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.758 -1.214 . . . . 0.0 110.297 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.463 ' O ' ' C ' ' A' ' 104' ' ' ASN . 33.2 m -142.13 37.86 1.58 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.945 -1.097 . . . . 0.0 109.638 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 98' ' ' VAL . 5.1 p30 -35.12 -50.96 0.53 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.244 -0.91 . . . . 0.0 111.513 -179.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 106' ' ' ALA . 12.0 mt 42.23 31.61 0.27 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.916 -1.115 . . . . 0.0 110.226 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.468 ' O ' ' O ' ' A' ' 105' ' ' LEU . . . 60.28 121.33 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.857 -1.152 . . . . 0.0 109.521 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.8 p -91.58 -165.72 1.41 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.54 ' CD1' ' O ' ' A' ' 108' ' ' ILE . 0.0 OUTLIER -61.37 -25.77 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 120.931 -1.105 . . . . 0.0 108.49 179.261 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.46 ' HB3' ' CE1' ' A' ' 113' ' ' PHE . 86.9 m-70 -76.74 14.0 0.9 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.53 -0.731 . . . . 0.0 110.717 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 50.11 25.06 7.32 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.399 -1.481 . . . . 0.0 109.399 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -156.55 172.08 34.24 Favored Glycine 0 N--CA 1.49 2.246 0 C-N-CA 119.766 -1.207 . . . . 0.0 110.085 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.484 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 33.3 Cg_endo -78.5 74.25 5.5 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 123.001 2.467 . . . . 0.0 111.195 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.484 ' HB3' ' O ' ' A' ' 112' ' ' PRO . 32.6 p90 . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.177 -0.952 . . . . 0.0 109.947 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo . . . . . 0 CA--C 1.54 0.814 0 N-CA-C 110.298 -0.693 . . . . 0.0 110.298 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 58.1 17.89 32.15 Favored Glycine 0 N--CA 1.499 2.866 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.446 ' O ' ' CB ' ' A' ' 11' ' ' ALA . 84.3 mtp -140.84 108.09 5.51 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-N 117.935 0.868 . . . . 0.0 108.72 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.446 ' CB ' ' O ' ' A' ' 10' ' ' MET . . . 86.73 -58.4 0.05 OUTLIER 'General case' 0 N--CA 1.514 2.75 0 CA-C-N 119.75 1.159 . . . . 0.0 108.247 -178.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 44.8 mt -106.41 100.74 31.53 Favored Pre-proline 0 N--CA 1.492 1.648 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 178.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -81.01 173.47 11.89 Favored 'Trans proline' 0 N--CA 1.475 0.427 0 C-N-CA 121.471 1.447 . . . . 0.0 111.243 -177.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 59.6 m-70 -71.14 144.19 50.31 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.532 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 35.1 t-20 59.78 52.88 3.75 Favored Pre-proline 0 N--CA 1.498 1.972 0 O-C-N 121.725 -0.61 . . . . 0.0 110.05 -178.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.532 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 41.8 Cg_endo -83.05 170.27 12.39 Favored 'Trans proline' 0 N--CA 1.483 0.864 0 C-N-CA 122.043 1.829 . . . . 0.0 111.355 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 50.75 38.73 20.24 Favored 'General case' 0 N--CA 1.501 2.093 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.646 177.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -78.17 -43.31 28.98 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.542 -0.724 . . . . 0.0 109.484 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.18 -29.12 70.15 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 17.0 m -73.5 -40.1 64.32 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -61.23 -51.36 69.28 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.404 ' CE3' ' HA ' ' A' ' 22' ' ' TRP . 38.9 m95 -69.83 -28.15 65.46 Favored 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 119.581 -0.848 . . . . 0.0 109.743 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -67.47 -29.63 69.14 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.442 HG21 ' CE1' ' A' ' 93' ' ' PHE . 98.9 t -75.27 -42.89 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 85.0 p -54.73 -39.02 67.83 Favored 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.939 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 77.0 m -77.45 -48.77 16.32 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 122.296 -0.252 . . . . 0.0 111.661 -178.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.6 mmm180 -64.26 -24.88 67.82 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.626 -0.671 . . . . 0.0 111.054 -178.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.411 ' CG2' HG11 ' A' ' 24' ' ' VAL . 82.5 p -97.0 -61.97 1.33 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 122.162 -0.336 . . . . 0.0 111.872 -177.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.7 m -100.08 9.35 42.98 Favored 'General case' 0 N--CA 1.507 2.407 0 O-C-N 121.444 -0.785 . . . . 0.0 111.415 -178.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 57.43 25.93 55.8 Favored Glycine 0 N--CA 1.505 3.237 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 -178.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 41.0 t -115.38 164.49 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 122.105 -0.644 . . . . 0.0 109.556 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 132.61 178.28 15.43 Favored Glycine 0 N--CA 1.498 2.785 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -66.13 173.5 7.19 Favored 'Trans proline' 0 N--CA 1.486 1.058 0 CA-C-N 119.382 1.591 . . . . 0.0 109.833 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -92.24 79.99 5.04 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 122.02 0.914 . . . . 0.0 109.87 -178.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.71 129.52 50.66 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.25 132.59 28.76 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.925 -0.484 . . . . 0.0 109.747 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -52.58 -53.64 43.76 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.447 -0.783 . . . . 0.0 111.18 -179.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -50.12 -35.96 27.84 Favored 'General case' 0 N--CA 1.508 2.436 0 O-C-N 121.723 -0.61 . . . . 0.0 110.816 -178.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -70.93 -38.54 72.89 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 31.5 tpp -62.54 -57.55 10.74 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 41.2 tttt -55.77 -35.94 66.8 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.862 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.28 -37.09 86.25 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.74 -45.85 81.08 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 15.1 m -62.72 -35.57 80.2 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.094 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 17.7 m -75.3 -28.56 59.76 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.64 -34.95 70.22 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -78.43 -28.2 46.71 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -72.78 -35.47 67.42 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -178.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -77.92 -51.28 10.66 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.64 -33.39 54.99 Favored 'General case' 0 N--CA 1.505 2.303 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.0 mt -87.71 104.88 7.4 Favored Pre-proline 0 N--CA 1.492 1.651 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -60.56 149.22 88.08 Favored 'Trans proline' 0 N--CA 1.479 0.638 0 C-N-CA 121.826 1.684 . . . . 0.0 110.543 -177.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.1 -19.95 55.8 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.582 -177.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -49.56 -32.82 13.39 Favored 'General case' 0 N--CA 1.513 2.677 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 178.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 61.9 m -119.26 -69.89 0.82 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 115.336 -0.847 . . . . 0.0 108.955 178.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 35.7 mtt180 38.0 -92.96 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.696 0 C-N-CA 122.8 0.44 . . . . 0.0 111.273 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 86.4 m -37.96 -45.44 0.88 Allowed 'General case' 0 N--CA 1.515 2.815 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -40.21 -48.78 2.62 Favored 'General case' 0 N--CA 1.511 2.607 0 CA-C-N 119.843 1.202 . . . . 0.0 112.027 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -42.05 -49.22 4.74 Favored 'General case' 0 N--CA 1.513 2.685 0 CA-C-N 118.483 0.583 . . . . 0.0 111.905 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.6 t -57.94 -45.86 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -60.61 -26.83 67.29 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.47 ' CG2' ' HB ' ' A' ' 67' ' ' VAL . 50.6 mt -78.1 -29.31 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.881 -0.512 . . . . 0.0 109.71 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.2 tp -77.87 -41.51 36.55 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.853 -0.739 . . . . 0.0 109.954 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 39.4 tpp -78.56 -52.77 8.0 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.331 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -80.51 -22.94 40.43 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 122.048 -0.408 . . . . 0.0 110.981 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 85.15 147.47 9.21 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 109.196 -1.561 . . . . 0.0 109.196 -178.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.47 ' HB ' ' CG2' ' A' ' 62' ' ' ILE . 5.3 p -118.01 158.74 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.265 0 O-C-N 122.133 -0.628 . . . . 0.0 109.531 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.461 ' CG2' ' CE1' ' A' ' 74' ' ' HIS . 70.6 t -115.58 157.3 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-O 121.946 0.879 . . . . 0.0 109.463 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.6 p -117.35 159.99 21.86 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.03 -178.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 34.3 t -64.11 -33.62 76.18 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.932 -178.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.7 p -63.44 -17.8 63.07 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.69 8.13 49.52 Favored Glycine 0 N--CA 1.496 2.672 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 60.8 mt-30 -95.43 156.08 16.47 Favored 'General case' 0 N--CA 1.501 2.114 0 CA-C-N 118.158 0.979 . . . . 0.0 109.578 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.461 ' CE1' ' CG2' ' A' ' 68' ' ' VAL . 9.6 m170 -116.47 154.93 29.48 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -141.24 -175.49 4.36 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.106 0.479 . . . . 0.0 110.081 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 55.6 -146.1 31.03 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.9 ttp180 56.54 19.84 4.48 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 122.29 -0.535 . . . . 0.0 110.384 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.5 mt -84.03 -14.45 50.57 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.723 -0.611 . . . . 0.0 110.244 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.3 tt -61.93 92.88 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -135.31 172.8 12.49 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.255 0.55 . . . . 0.0 109.591 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -51.32 102.01 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.651 0.739 . . . . 0.0 111.384 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.525 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 21.5 mt -87.2 169.99 13.18 Favored Pre-proline 0 N--CA 1.495 1.803 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 177.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.525 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 28.9 Cg_endo -68.18 100.55 0.65 Allowed 'Trans proline' 0 C--N 1.327 -0.562 0 C-N-CA 120.942 1.095 . . . . 0.0 110.609 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.17 11.99 60.6 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 3.6 m -141.91 91.33 8.17 Favored Pre-proline 0 N--CA 1.506 2.353 0 CA-C-N 118.786 1.293 . . . . 0.0 109.11 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -74.19 161.45 40.68 Favored 'Trans proline' 0 N--CA 1.482 0.825 0 C-N-CA 121.538 1.492 . . . . 0.0 111.282 -178.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.82 -28.75 2.73 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.268 0.556 . . . . 0.0 109.599 177.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -55.38 -53.49 55.57 Favored 'General case' 0 N--CA 1.503 2.199 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.654 -178.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 54.2 t -62.83 -39.91 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.709 -0.62 . . . . 0.0 109.63 -178.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -64.11 -26.35 68.5 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.66 -33.99 46.68 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.29 -48.83 63.91 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.876 -0.515 . . . . 0.0 109.654 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.442 ' CE1' HG21 ' A' ' 24' ' ' VAL . 31.0 t80 -78.58 -26.25 45.49 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 122.262 -0.274 . . . . 0.0 110.55 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -41.25 -49.75 8.6 Favored Pre-proline 0 N--CA 1.506 2.336 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -177.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -77.84 33.15 0.45 Allowed 'Trans proline' 0 CA--C 1.55 1.308 0 C-N-CA 122.206 1.937 . . . . 0.0 112.964 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 49.8 mttm -123.99 30.97 5.96 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 178.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.414 ' O ' ' HB3' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -73.56 -71.31 0.32 Allowed 'General case' 0 N--CA 1.512 2.641 0 O-C-N 122.067 -0.396 . . . . 0.0 110.804 -179.196 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.0 m -94.95 28.32 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.388 -0.82 . . . . 0.0 109.855 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 27.9 p -96.96 170.05 9.42 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.85 -2.38 0.85 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.549 -0.72 . . . . 0.0 112.015 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 22.0 t -98.34 4.72 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 CA-C-N 120.36 1.436 . . . . 0.0 110.894 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.414 ' HB3' ' O ' ' A' ' 97' ' ' LEU . 4.8 tp10 -142.25 -91.55 0.13 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.559 -0.713 . . . . 0.0 111.039 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 93.6 m -143.61 42.06 1.47 Allowed 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.387 -0.821 . . . . 0.0 110.002 -178.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -39.85 -56.8 1.71 Allowed 'General case' 0 N--CA 1.508 2.456 0 N-CA-C 113.642 0.978 . . . . 0.0 113.642 -178.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.0 mt 45.87 23.9 0.2 Allowed 'General case' 0 N--CA 1.508 2.432 0 CA-C-N 118.995 0.816 . . . . 0.0 111.277 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 64.76 123.79 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.317 -0.865 . . . . 0.0 109.7 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.1 p -89.89 -159.0 0.56 Allowed 'General case' 0 N--CA 1.507 2.38 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.5 tp -66.63 -31.1 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -69.77 -0.87 7.8 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.893 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 58.54 28.78 62.89 Favored Glycine 0 N--CA 1.497 2.756 0 N-CA-C 109.299 -1.521 . . . . 0.0 109.299 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -157.01 168.72 34.04 Favored Glycine 0 N--CA 1.498 2.784 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -78.68 73.96 5.69 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 122.798 2.332 . . . . 0.0 111.933 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 30.2 p90 . . . . . 0 N--CA 1.505 2.305 0 O-C-N 121.583 -0.698 . . . . 0.0 110.431 178.282 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo . . . . . 0 CA--C 1.546 1.105 0 N-CA-C 111.038 -0.408 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 74.76 4.12 69.94 Favored Glycine 0 N--CA 1.502 3.048 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.453 ' O ' ' CB ' ' A' ' 11' ' ' ALA . 72.4 mmm -129.61 99.74 5.27 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.453 ' CB ' ' O ' ' A' ' 10' ' ' MET . . . 86.7 -54.59 0.06 Allowed 'General case' 0 N--CA 1.517 2.917 0 CA-C-N 119.448 1.022 . . . . 0.0 108.713 -178.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 36.8 mm -104.83 100.55 24.32 Favored Pre-proline 0 N--CA 1.495 1.783 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -84.27 175.04 7.63 Favored 'Trans proline' 0 N--CA 1.475 0.423 0 C-N-CA 121.749 1.632 . . . . 0.0 111.511 -177.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 -84.03 142.78 30.21 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.479 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 7.3 t-20 60.12 57.95 4.41 Favored Pre-proline 0 N--CA 1.501 2.094 0 O-C-N 121.605 -0.685 . . . . 0.0 109.676 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.479 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 39.7 Cg_endo -81.41 150.24 17.11 Favored 'Trans proline' 0 N--CA 1.481 0.747 0 C-N-CA 122.219 1.946 . . . . 0.0 112.069 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 76.9 mt 51.98 42.74 30.5 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.853 177.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -66.33 -34.24 77.54 Favored 'General case' 0 N--CA 1.506 2.353 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 178.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.3 t -63.49 -26.06 68.54 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 56.1 m -77.79 -34.76 52.05 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.436 ' CG ' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -65.94 -51.54 57.66 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.417 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.436 ' N ' ' CG ' ' A' ' 21' ' ' ARG . 27.7 m95 -66.83 -32.43 73.7 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 119.753 -0.779 . . . . 0.0 109.682 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -64.25 -32.33 73.88 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.2 t -70.51 -39.74 76.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 177.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 m -55.92 -40.39 73.01 Favored 'General case' 0 N--CA 1.501 2.088 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.361 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.1 m -77.19 -54.45 6.49 Favored 'General case' 0 N--CA 1.51 2.543 0 O-C-N 122.011 -0.431 . . . . 0.0 111.785 -178.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 14.3 ttm180 -60.05 -24.6 64.68 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.687 -0.633 . . . . 0.0 110.413 -178.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 44.3 p -95.21 -66.02 0.94 Allowed 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -177.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.8 m -100.35 13.27 34.96 Favored 'General case' 0 N--CA 1.51 2.556 0 O-C-N 121.247 -0.908 . . . . 0.0 111.413 -178.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 58.66 22.68 53.64 Favored Glycine 0 N--CA 1.505 3.269 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -178.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 29.0 t -110.01 165.53 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.363 0 O-C-N 121.899 -0.765 . . . . 0.0 109.376 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 131.06 178.63 15.56 Favored Glycine 0 N--CA 1.499 2.896 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -65.03 176.67 2.91 Favored 'Trans proline' 0 N--CA 1.489 1.249 0 CA-C-N 119.042 1.421 . . . . 0.0 109.905 179.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -91.59 79.58 5.46 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 122.196 0.998 . . . . 0.0 109.857 -178.099 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.4 mp -130.59 127.8 39.74 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 179.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.04 160.24 1.57 Allowed 'General case' 0 N--CA 1.501 2.121 0 O-C-N 122.041 -0.412 . . . . 0.0 110.12 -178.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.22 -37.93 72.02 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 122.02 -0.425 . . . . 0.0 111.206 -178.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.53 -42.77 77.99 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.881 -0.512 . . . . 0.0 110.081 -178.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -70.12 -28.17 65.17 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 2.7 tpt -70.06 -54.54 12.65 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.3 tttt -55.53 -33.9 64.22 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.505 179.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.73 -37.9 76.66 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.63 -37.83 88.81 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 13.1 m -72.23 -32.8 67.06 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.856 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 79.7 m -72.2 -29.71 64.24 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.63 -34.89 46.18 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -72.98 -38.15 66.79 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.409 ' CD1' HG13 ' A' ' 98' ' ' VAL . 1.2 tt -67.64 -59.78 3.07 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 179.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.448 ' HA ' ' NH1' ' A' ' 56' ' ' ARG . 1.1 tm-20 -52.57 -26.9 14.63 Favored 'General case' 0 N--CA 1.504 2.245 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.65 -61.31 2.61 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.504 ' O ' ' NH1' ' A' ' 56' ' ' ARG . 45.9 mm -57.12 102.98 0.33 Allowed Pre-proline 0 N--CA 1.509 2.501 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 177.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -54.82 149.8 39.85 Favored 'Trans proline' 0 N--CA 1.486 1.044 0 C-N-CA 121.895 1.73 . . . . 0.0 112.79 -175.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -37.19 -32.1 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.427 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.415 -178.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.419 ' CE1' HD12 ' A' ' 108' ' ' ILE . 58.9 m-85 -73.43 112.27 9.35 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 177.12 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 28.4 m 73.67 14.82 4.15 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 122.237 -0.289 . . . . 0.0 110.29 -178.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.504 ' NH1' ' O ' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -45.53 -86.52 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.919 0 O-C-N 121.083 -1.01 . . . . 0.0 109.813 -179.913 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 21.8 m -38.98 -38.55 0.45 Allowed 'General case' 0 N--CA 1.515 2.821 0 N-CA-C 113.801 1.038 . . . . 0.0 113.801 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -36.36 -43.91 0.4 Allowed 'General case' 0 N--CA 1.512 2.673 0 CA-C-N 120.294 1.406 . . . . 0.0 112.512 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -42.55 -54.53 3.89 Favored 'General case' 0 N--CA 1.514 2.755 0 O-C-N 121.851 -0.531 . . . . 0.0 111.765 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.417 ' CG2' ' CD1' ' A' ' 97' ' ' LEU . 95.2 t -57.58 -42.34 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.89 -30.41 67.76 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.469 ' CG2' ' HB ' ' A' ' 67' ' ' VAL . 1.6 mp -78.41 -30.43 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 O-C-N 121.954 -0.466 . . . . 0.0 110.469 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.8 tp -77.44 -41.72 38.71 Favored 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 119.314 -0.954 . . . . 0.0 110.282 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -78.72 -52.06 8.94 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.202 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -81.06 -22.99 38.84 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.936 -0.478 . . . . 0.0 111.267 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.58 147.38 10.93 Favored Glycine 0 N--CA 1.498 2.823 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 -178.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.469 ' HB ' ' CG2' ' A' ' 62' ' ' ILE . 7.6 p -118.29 159.65 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 122.052 -0.675 . . . . 0.0 109.644 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.451 ' CG2' ' CE1' ' A' ' 74' ' ' HIS . 69.3 t -114.9 157.77 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 CA-C-O 121.828 0.823 . . . . 0.0 109.602 -178.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 33.9 p -117.14 159.54 22.43 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.73 -177.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 42.6 t -63.28 -31.09 72.15 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.383 -178.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.5 p -68.32 -17.33 64.23 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.231 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.91 14.08 32.42 Favored Glycine 0 N--CA 1.498 2.795 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -102.37 156.21 17.74 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-N 118.085 0.942 . . . . 0.0 109.398 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.451 ' CE1' ' CG2' ' A' ' 68' ' ' VAL . 8.7 m170 -116.03 156.15 26.84 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -145.67 -174.1 4.31 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.034 0.445 . . . . 0.0 109.869 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 60.27 -148.68 43.4 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 56.11 28.32 12.8 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 122.122 -0.634 . . . . 0.0 109.679 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.4 mp -86.45 -14.37 43.43 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.716 -0.615 . . . . 0.0 111.202 -178.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.93 84.42 5.69 Favored 'General case' 0 N--CA 1.503 2.212 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 179.109 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -127.81 -173.13 2.84 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.464 0.649 . . . . 0.0 110.01 -178.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -50.43 102.31 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.695 0.76 . . . . 0.0 111.396 -179.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.508 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 22.2 mt -98.51 169.18 8.68 Favored Pre-proline 0 N--CA 1.497 1.916 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.508 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 28.7 Cg_endo -68.24 101.25 0.7 Allowed 'Trans proline' 0 N--CA 1.478 0.601 0 C-N-CA 121.189 1.259 . . . . 0.0 110.733 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.69 13.65 59.25 Favored Glycine 0 N--CA 1.497 2.71 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 3.7 m -143.6 91.03 6.9 Favored Pre-proline 0 N--CA 1.509 2.485 0 CA-C-N 118.637 1.219 . . . . 0.0 109.371 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -75.39 160.15 39.17 Favored 'Trans proline' 0 N--CA 1.483 0.856 0 C-N-CA 121.673 1.582 . . . . 0.0 111.464 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.0 mmt85 -49.55 -28.56 5.73 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 177.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 -57.13 -59.39 5.16 Favored 'General case' 0 N--CA 1.503 2.2 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.624 -178.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 53.6 t -61.07 -40.25 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.836 -0.54 . . . . 0.0 110.311 -178.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -65.42 -26.94 68.2 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.63 -31.68 47.05 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.42 -48.99 36.89 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 122.04 -0.413 . . . . 0.0 109.902 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -78.46 -25.34 45.82 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 122.326 -0.234 . . . . 0.0 111.132 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.414 ' N ' ' HD2' ' A' ' 95' ' ' PRO . . . -48.98 -48.83 71.43 Favored Pre-proline 0 N--CA 1.505 2.319 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -176.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.414 ' HD2' ' N ' ' A' ' 94' ' ' ALA . 29.3 Cg_endo -68.61 85.59 0.46 Allowed 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 121.841 1.694 . . . . 0.0 113.29 -176.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.414 ' C ' ' HD3' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -177.8 54.95 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.422 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.595 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.417 ' CD1' ' CG2' ' A' ' 60' ' ' VAL . 29.0 tp -86.27 -81.32 0.22 Allowed 'General case' 0 N--CA 1.507 2.388 0 O-C-N 121.218 -0.926 . . . . 0.0 111.753 -177.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.409 HG13 ' CD1' ' A' ' 48' ' ' LEU . 4.0 m -91.62 24.92 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.745 -0.597 . . . . 0.0 110.958 -176.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 29.9 p -93.47 168.71 10.87 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.16 -0.01 0.48 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.49 -0.756 . . . . 0.0 111.843 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 28.0 t -97.07 0.16 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 CA-C-N 120.518 1.508 . . . . 0.0 111.249 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 23.9 tp10 -140.71 -88.07 0.17 Allowed 'General case' 0 N--CA 1.504 2.245 0 CA-C-N 119.114 0.87 . . . . 0.0 111.433 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 57.3 m -143.74 45.56 1.48 Allowed 'General case' 0 N--CA 1.509 2.482 0 O-C-N 121.244 -0.91 . . . . 0.0 109.683 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -40.5 -57.59 1.78 Allowed 'General case' 0 N--CA 1.504 2.263 0 O-C-N 121.192 -0.942 . . . . 0.0 113.363 -178.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.6 mt 43.16 27.27 0.11 Allowed 'General case' 0 N--CA 1.515 2.777 0 CA-C-N 119.016 0.825 . . . . 0.0 111.112 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 63.57 153.66 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.451 -0.781 . . . . 0.0 109.801 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.3 p -123.82 -161.18 0.96 Allowed 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.419 HD12 ' CE1' ' A' ' 54' ' ' TYR . 4.3 tp -66.99 -33.8 65.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.072 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.427 ' HB3' ' CE1' ' A' ' 113' ' ' PHE . 74.4 m-70 -70.96 -0.72 9.9 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.907 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 56.28 43.41 89.44 Favored Glycine 0 N--CA 1.501 2.984 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -172.48 170.58 43.63 Favored Glycine 0 N--CA 1.501 2.993 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -77.17 77.1 3.92 Favored 'Trans proline' 0 CA--C 1.544 1.023 0 C-N-CA 122.36 2.04 . . . . 0.0 111.513 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.427 ' CE1' ' HB3' ' A' ' 109' ' ' HIS . 33.1 p90 . . . . . 0 N--CA 1.505 2.311 0 O-C-N 121.754 -0.591 . . . . 0.0 109.827 178.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo . . . . . 0 N--CA 1.48 0.698 0 N-CA-C 111.131 -0.373 . . . . 0.0 111.131 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 62.76 16.48 56.34 Favored Glycine 0 N--CA 1.497 2.733 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.439 ' O ' ' CB ' ' A' ' 11' ' ' ALA . 16.8 mmm -140.93 84.63 1.94 Allowed 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.882 -0.775 . . . . 0.0 109.011 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.439 ' CB ' ' O ' ' A' ' 10' ' ' MET . . . 86.73 -57.72 0.05 Allowed 'General case' 0 N--CA 1.516 2.864 0 O-C-N 121.379 -0.825 . . . . 0.0 108.84 -178.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 61.4 mt -92.14 104.4 10.71 Favored Pre-proline 0 N--CA 1.498 1.961 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -75.05 169.51 22.44 Favored 'Trans proline' 0 C--O 1.219 -0.433 0 C-N-CA 121.3 1.333 . . . . 0.0 111.649 -175.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 34.9 m-70 -69.28 144.62 53.54 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.456 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 5.3 t-20 65.98 55.98 1.05 Allowed Pre-proline 0 N--CA 1.506 2.357 0 O-C-N 121.358 -0.838 . . . . 0.0 110.303 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.456 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 38.6 Cg_endo -80.49 166.87 19.63 Favored 'Trans proline' 0 N--CA 1.484 0.932 0 C-N-CA 122.305 2.004 . . . . 0.0 111.923 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.6 mp 42.96 43.8 3.72 Favored 'General case' 0 N--CA 1.504 2.254 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.209 177.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -69.07 -37.68 78.63 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -63.01 -26.16 68.72 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 57.3 m -74.64 -38.78 62.42 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.406 ' NH1' ' HB3' ' A' ' 78' ' ' LEU . 3.4 ttt180 -64.13 -48.6 75.45 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 33.9 m95 -69.02 -29.07 67.17 Favored 'General case' 0 N--CA 1.502 2.149 0 C-N-CA 119.312 -0.955 . . . . 0.0 109.809 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.426 ' CD1' ' HB3' ' A' ' 40' ' ' MET . 57.1 t80 -66.5 -33.5 75.83 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 96.3 t -72.43 -38.96 61.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 177.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 m -56.18 -37.06 69.07 Favored 'General case' 0 N--CA 1.501 2.091 0 C-N-CA 119.946 -0.701 . . . . 0.0 109.529 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 90.9 m -77.8 -49.89 13.43 Favored 'General case' 0 N--CA 1.508 2.459 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.92 -25.29 67.82 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 121.519 -0.738 . . . . 0.0 110.544 -178.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 70.4 p -93.65 -62.9 1.27 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -177.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.6 m -100.43 9.23 42.92 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.384 -0.823 . . . . 0.0 111.617 -178.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 57.79 29.72 61.95 Favored Glycine 0 N--CA 1.507 3.382 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 -178.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 38.5 t -120.72 164.09 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 122.155 -0.615 . . . . 0.0 109.717 -179.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 136.16 177.72 15.21 Favored Glycine 0 N--CA 1.5 2.908 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -64.43 177.33 2.18 Favored 'Trans proline' 0 N--CA 1.489 1.231 0 CA-C-N 119.196 1.498 . . . . 0.0 110.028 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.21 87.19 6.0 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 122.197 0.999 . . . . 0.0 110.412 -177.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.6 mt -141.76 127.2 18.83 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.02 152.37 2.24 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.907 -0.496 . . . . 0.0 109.81 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.1 p -59.96 -59.64 5.1 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.813 -0.555 . . . . 0.0 110.604 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -52.49 -28.79 21.82 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.818 -0.551 . . . . 0.0 111.595 -178.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -72.0 -46.89 55.56 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.816 -0.553 . . . . 0.0 109.573 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.426 ' HB3' ' CD1' ' A' ' 23' ' ' TYR . 5.5 tpt -61.97 -54.61 39.27 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -53.59 -35.75 61.2 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.34 -42.83 99.71 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.23 -41.14 96.37 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 19.8 m -65.58 -33.17 75.28 Favored 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.233 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 18.9 m -73.43 -30.16 63.03 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -178.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.27 -32.46 62.94 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -77.15 -33.47 56.62 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.48 -33.52 64.87 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.52 -40.38 61.79 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.25 -39.13 85.67 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 70.8 mt -82.7 105.75 5.52 Favored Pre-proline 0 N--CA 1.493 1.684 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 177.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -58.29 139.87 92.2 Favored 'Trans proline' 0 N--CA 1.48 0.712 0 C-N-CA 121.42 1.413 . . . . 0.0 110.92 -177.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.42 ' CB ' ' NH1' ' A' ' 56' ' ' ARG . . . -39.47 -29.76 0.06 Allowed 'General case' 0 N--CA 1.508 2.432 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.359 -178.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -53.16 -70.41 0.09 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.919 -0.488 . . . . 0.0 110.698 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 5.0 m -88.55 8.76 26.64 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 122.062 -0.399 . . . . 0.0 110.89 -179.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.42 ' NH1' ' CB ' ' A' ' 53' ' ' ALA . 5.9 mtt180 -47.58 -85.2 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.67 0 O-C-N 121.491 -0.755 . . . . 0.0 110.33 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 72.6 m -32.95 -48.85 0.22 Allowed 'General case' 0 N--CA 1.521 3.113 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -41.67 -54.34 3.3 Favored 'General case' 0 N--CA 1.512 2.668 0 CA-C-N 119.325 0.966 . . . . 0.0 111.731 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -41.82 -44.75 3.41 Favored 'General case' 0 N--CA 1.514 2.731 0 O-C-N 121.776 -0.578 . . . . 0.0 112.04 -179.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.6 t -57.22 -48.83 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -58.57 -26.83 64.01 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.465 ' CG2' ' HB ' ' A' ' 67' ' ' VAL . 34.8 mm -78.42 -30.76 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 O-C-N 121.985 -0.447 . . . . 0.0 110.469 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.8 tp -77.77 -43.22 31.42 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 120.11 -0.636 . . . . 0.0 109.999 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.01 -50.76 10.58 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.18 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -80.6 -22.71 40.41 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 122.006 -0.434 . . . . 0.0 110.936 -178.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.73 146.89 5.7 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.465 ' HB ' ' CG2' ' A' ' 62' ' ' ILE . 5.5 p -118.42 161.18 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.424 HG21 ' CE1' ' A' ' 74' ' ' HIS . 56.0 t -113.34 157.85 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -179.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 42.2 p -116.67 160.07 21.28 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 121.95 0.881 . . . . 0.0 111.044 -176.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 32.9 t -64.61 -17.46 64.02 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.39 -178.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.1 p -86.49 -14.64 42.53 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 122.021 -0.424 . . . . 0.0 110.127 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.23 13.59 32.98 Favored Glycine 0 N--CA 1.499 2.892 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -105.48 158.56 16.58 Favored 'General case' 0 N--CA 1.502 2.125 0 CA-C-N 118.039 0.92 . . . . 0.0 108.834 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.424 ' CE1' HG21 ' A' ' 68' ' ' VAL . 11.3 m170 -113.72 154.95 26.46 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -179.138 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -136.89 -179.07 5.48 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 55.41 -146.94 28.82 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 108.622 -1.791 . . . . 0.0 108.622 -178.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 54.72 22.53 4.17 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 122.303 -0.528 . . . . 0.0 110.007 179.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.406 ' HB3' ' NH1' ' A' ' 21' ' ' ARG . 2.1 mp -83.1 -14.73 53.1 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.745 -0.597 . . . . 0.0 110.361 -179.247 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.5 mt -62.0 92.79 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -134.22 -177.21 4.48 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.719 0.771 . . . . 0.0 110.843 -178.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -48.68 130.14 17.2 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.506 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.436 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 20.6 mt -127.49 166.38 23.54 Favored Pre-proline 0 N--CA 1.496 1.87 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.436 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 29.6 Cg_endo -68.63 98.69 0.59 Allowed 'Trans proline' 0 C--N 1.328 -0.537 0 C-N-CA 120.88 1.054 . . . . 0.0 110.143 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.68 4.22 67.9 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.422 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 3.3 m -137.02 92.1 14.4 Favored Pre-proline 0 N--CA 1.508 2.47 0 CA-C-N 119.173 1.487 . . . . 0.0 110.02 -179.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -74.69 165.52 31.36 Favored 'Trans proline' 0 N--CA 1.485 1.028 0 C-N-CA 121.976 1.784 . . . . 0.0 111.328 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 23.9 mtp180 -54.09 -25.97 24.66 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.038 0.447 . . . . 0.0 110.133 178.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.58 -46.12 87.33 Favored 'General case' 0 N--CA 1.502 2.139 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.947 -177.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 42.2 t -72.46 -43.14 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.513 -0.742 . . . . 0.0 110.982 -177.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -70.49 -27.15 63.98 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.7 ttt180 -78.72 -29.15 45.17 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.34 -47.34 20.2 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.999 -0.438 . . . . 0.0 110.3 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -79.02 -27.48 43.25 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 122.021 -0.425 . . . . 0.0 111.47 -178.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.449 ' N ' ' HD2' ' A' ' 95' ' ' PRO . . . -54.81 -46.64 99.42 Favored Pre-proline 0 N--CA 1.505 2.281 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -177.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' A' ' 94' ' ' ALA . 30.1 Cg_endo -70.12 -0.22 6.89 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 122.239 1.959 . . . . 0.0 114.009 -177.125 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.71 23.92 12.25 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.496 -0.753 . . . . 0.0 109.838 179.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.93 -24.32 59.65 Favored 'General case' 0 N--CA 1.509 2.492 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -178.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 33.7 m -93.36 25.8 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 CA-C-N 121.0 1.727 . . . . 0.0 111.179 -178.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 19.1 p -98.28 173.2 7.11 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -62.07 -1.48 0.7 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.696 -0.628 . . . . 0.0 112.25 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 37.1 t -100.03 4.49 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 CA-C-N 120.407 1.458 . . . . 0.0 110.873 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -141.13 -89.97 0.15 Allowed 'General case' 0 N--CA 1.502 2.168 0 CA-C-N 118.99 0.814 . . . . 0.0 111.511 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 19.5 m -143.67 43.08 1.48 Allowed 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.572 -0.705 . . . . 0.0 109.886 -178.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.402 ' ND2' ' HB3' ' A' ' 112' ' ' PRO . 57.0 t-20 -43.02 -64.81 0.56 Allowed 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.299 -0.875 . . . . 0.0 112.287 -179.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 6.0 mt 45.34 29.39 0.56 Allowed 'General case' 0 N--CA 1.511 2.602 0 CA-C-O 121.066 0.46 . . . . 0.0 109.927 -178.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 67.09 157.98 0.13 Allowed 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -178.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.6 p -128.87 -163.92 1.34 Allowed 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -179.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 18.0 tt -68.17 -33.29 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.427 ' HB3' ' CE2' ' A' ' 113' ' ' PHE . 96.9 m-70 -66.68 -4.85 9.81 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.689 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 61.45 41.51 99.56 Favored Glycine 0 N--CA 1.499 2.874 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -174.82 170.94 44.14 Favored Glycine 0 N--CA 1.5 2.966 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.402 ' HB3' ' ND2' ' A' ' 104' ' ' ASN . 32.3 Cg_endo -77.9 75.85 4.6 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 122.553 2.168 . . . . 0.0 111.387 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.427 ' CE2' ' HB3' ' A' ' 109' ' ' HIS . 36.7 p90 . . . . . 0 N--CA 1.501 2.118 0 O-C-N 121.708 -0.62 . . . . 0.0 110.447 178.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo . . . . . 0 CA--C 1.542 0.92 0 N-CA-C 110.205 -0.729 . . . . 0.0 110.205 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 109.9 -10.55 32.07 Favored Glycine 0 N--CA 1.501 2.983 0 O-C-N 121.507 -0.746 . . . . 0.0 111.255 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.438 ' O ' ' CB ' ' A' ' 11' ' ' ALA . 6.1 mmt -128.03 111.77 13.89 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.438 ' CB ' ' O ' ' A' ' 10' ' ' MET . . . 86.17 -54.09 0.07 Allowed 'General case' 0 N--CA 1.514 2.741 0 CA-C-N 119.789 1.177 . . . . 0.0 108.708 -178.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 55.0 mt -113.38 100.74 52.44 Favored Pre-proline 0 N--CA 1.495 1.783 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 178.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -81.73 172.46 12.22 Favored 'Trans proline' 0 C--O 1.221 -0.366 0 C-N-CA 121.484 1.456 . . . . 0.0 111.524 -177.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 44.7 m-70 -77.61 150.1 34.69 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.471 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 10.8 t-20 66.99 53.92 0.75 Allowed Pre-proline 0 N--CA 1.503 2.21 0 O-C-N 121.459 -0.775 . . . . 0.0 110.049 -178.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.471 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 39.8 Cg_endo -78.45 163.07 27.45 Favored 'Trans proline' 0 N--CA 1.484 0.937 0 C-N-CA 122.282 1.988 . . . . 0.0 111.465 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 48.62 47.12 20.95 Favored 'General case' 0 N--CA 1.503 2.191 0 CA-C-O 121.246 0.546 . . . . 0.0 111.043 178.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -66.7 -35.43 80.1 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 121.493 -0.755 . . . . 0.0 109.078 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.18 -26.62 68.23 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 28.3 m -71.32 -45.2 63.58 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.38 -54.63 44.47 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.42 ' HA ' ' CE3' ' A' ' 22' ' ' TRP . 27.9 m95 -64.26 -27.18 68.87 Favored 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.676 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.444 ' CD2' ' HB3' ' A' ' 40' ' ' MET . 6.4 t80 -66.3 -32.5 73.95 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.414 HG21 ' CE1' ' A' ' 93' ' ' PHE . 61.1 t -70.61 -42.04 77.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 178.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 m -56.23 -44.37 79.52 Favored 'General case' 0 N--CA 1.502 2.158 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.656 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 20.9 m -76.05 -52.25 10.58 Favored 'General case' 0 N--CA 1.51 2.569 0 O-C-N 122.059 -0.401 . . . . 0.0 111.924 -178.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.7 tpm_? -61.89 -24.89 67.22 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.838 -0.539 . . . . 0.0 110.724 -178.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 35.6 p -96.23 -64.38 1.06 Allowed 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 120.689 -0.405 . . . . 0.0 112.058 -177.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.7 m -101.32 10.89 40.16 Favored 'General case' 0 N--CA 1.511 2.613 0 CA-C-N 119.183 0.901 . . . . 0.0 111.484 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.12 18.54 57.84 Favored Glycine 0 N--CA 1.501 2.972 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -178.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.2 t -102.77 164.04 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 O-C-N 121.696 -0.885 . . . . 0.0 109.112 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 130.3 179.46 16.06 Favored Glycine 0 N--CA 1.499 2.892 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 -179.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -64.84 173.06 6.17 Favored 'Trans proline' 0 N--CA 1.486 1.065 0 CA-C-N 119.201 1.5 . . . . 0.0 109.879 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -92.77 84.5 4.99 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 122.026 0.917 . . . . 0.0 110.178 -177.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 69.2 mt -140.79 145.1 35.88 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.29 163.11 3.16 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -179.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.23 -56.12 4.59 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.998 -0.439 . . . . 0.0 110.444 -179.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.28 -33.4 19.77 Favored 'General case' 0 N--CA 1.508 2.474 0 O-C-N 121.881 -0.512 . . . . 0.0 110.803 -178.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -71.35 -39.89 71.02 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 122.054 -0.404 . . . . 0.0 110.142 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.444 ' HB3' ' CD2' ' A' ' 23' ' ' TYR . 1.5 ttt -65.32 -52.79 51.6 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.426 ' HB2' ' CE2' ' A' ' 23' ' ' TYR . 6.4 tttm -53.58 -38.05 63.55 Favored 'General case' 0 N--CA 1.504 2.268 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.98 -40.92 97.27 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -60.36 -44.55 95.47 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 12.4 m -63.19 -35.95 82.0 Favored 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.635 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 69.0 m -70.52 -29.73 66.3 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.6 ttt-85 -73.8 -32.46 63.75 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -76.43 -29.48 57.02 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.49 -36.86 57.58 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -73.41 -36.21 65.95 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.65 -53.03 60.69 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 178.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.411 HD11 HG22 ' A' ' 51' ' ' ILE . 42.0 mm -63.59 105.81 0.76 Allowed Pre-proline 0 N--CA 1.496 1.871 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 176.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -59.27 149.82 78.32 Favored 'Trans proline' 0 N--CA 1.479 0.651 0 C-N-CA 121.593 1.529 . . . . 0.0 110.935 -176.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -40.46 -32.08 0.18 Allowed 'General case' 0 N--CA 1.505 2.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.53 -178.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -73.49 121.73 21.03 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 178.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 15.2 m 72.9 6.41 5.34 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 122.167 -0.333 . . . . 0.0 110.23 -178.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -49.11 -87.14 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.676 0 O-C-N 121.191 -0.943 . . . . 0.0 109.691 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 82.4 m -36.39 -43.51 0.38 Allowed 'General case' 0 N--CA 1.519 3.007 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -39.31 -48.36 1.84 Allowed 'General case' 0 N--CA 1.511 2.61 0 CA-C-N 119.549 1.068 . . . . 0.0 112.326 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -41.9 -50.37 4.48 Favored 'General case' 0 N--CA 1.517 2.922 0 CA-C-N 118.783 0.72 . . . . 0.0 111.522 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.9 t -58.23 -45.04 89.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.87 -27.66 65.4 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.475 ' CG2' ' HB ' ' A' ' 67' ' ' VAL . 1.4 mp -78.21 -30.85 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.898 -0.501 . . . . 0.0 109.852 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.3 tt -77.57 -40.73 41.38 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.469 -0.893 . . . . 0.0 110.139 -179.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 2.7 tmm? -78.4 -53.45 7.25 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.27 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -80.68 -22.83 40.07 Favored 'General case' 0 N--CA 1.502 2.154 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.157 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.97 147.63 11.79 Favored Glycine 0 N--CA 1.497 2.709 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 -178.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.475 ' HB ' ' CG2' ' A' ' 62' ' ' ILE . 7.6 p -118.48 160.58 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 O-C-N 122.196 -0.591 . . . . 0.0 109.782 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.459 HG21 ' CE1' ' A' ' 74' ' ' HIS . 54.7 t -114.38 157.81 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 CA-C-O 121.716 0.769 . . . . 0.0 109.292 -179.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 61.7 p -117.18 159.9 21.89 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.78 -177.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 35.4 t -63.3 -31.51 72.68 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.298 -178.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.2 p -69.14 -16.65 63.7 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.332 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.73 10.17 44.26 Favored Glycine 0 N--CA 1.498 2.783 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -100.18 157.56 16.49 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-N 118.04 0.92 . . . . 0.0 109.139 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.459 ' CE1' HG21 ' A' ' 68' ' ' VAL . 9.7 m170 -114.93 155.22 27.29 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -179.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -140.56 -176.44 4.64 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.122 0.487 . . . . 0.0 109.785 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 56.37 -144.5 36.63 Favored Glycine 0 N--CA 1.496 2.691 0 N-CA-C 108.592 -1.803 . . . . 0.0 108.592 -178.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 56.0 21.6 5.14 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 122.224 -0.574 . . . . 0.0 110.356 179.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.7 mp -76.21 -16.76 59.77 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.744 -0.597 . . . . 0.0 110.468 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.3 tp -59.34 91.64 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 41.0 mm-40 -130.81 -176.9 4.14 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.449 0.642 . . . . 0.0 109.821 -179.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.33 102.33 1.07 Allowed 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.657 0.742 . . . . 0.0 110.893 -179.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.513 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 20.5 mt -87.12 169.64 14.12 Favored Pre-proline 0 N--CA 1.496 1.856 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 177.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.513 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 29.5 Cg_endo -69.58 99.19 0.71 Allowed 'Trans proline' 0 C--N 1.328 -0.528 0 C-N-CA 121.028 1.152 . . . . 0.0 110.3 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 98.58 1.41 57.71 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 3.4 m -134.8 91.34 20.76 Favored Pre-proline 0 N--CA 1.504 2.242 0 CA-C-N 118.99 1.395 . . . . 0.0 109.274 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -72.09 161.18 45.44 Favored 'Trans proline' 0 N--CA 1.483 0.879 0 C-N-CA 121.3 1.333 . . . . 0.0 111.528 -179.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.6 mtp180 -48.15 -28.11 2.76 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.06 0.457 . . . . 0.0 109.907 178.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -60.8 -47.23 87.26 Favored 'General case' 0 N--CA 1.502 2.174 0 CA-C-N 116.325 -0.398 . . . . 0.0 112.006 -177.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 48.5 t -68.77 -39.52 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.585 -0.697 . . . . 0.0 109.837 -178.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -66.17 -26.76 67.56 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.3 tpt180 -78.89 -35.17 44.01 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 122.085 -0.385 . . . . 0.0 109.966 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.34 -45.99 68.11 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.414 ' CE1' HG21 ' A' ' 24' ' ' VAL . 37.3 t80 -78.34 -25.52 46.42 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.427 ' N ' ' HD2' ' A' ' 95' ' ' PRO . . . -41.56 -51.82 8.63 Favored Pre-proline 0 N--CA 1.503 2.191 0 CA-C-O 118.907 -0.568 . . . . 0.0 112.098 -177.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.427 ' HD2' ' N ' ' A' ' 94' ' ' ALA . 29.4 Cg_endo -72.32 -171.91 0.8 Allowed 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 121.532 1.488 . . . . 0.0 109.519 179.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 66.47 18.0 10.75 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.827 -0.546 . . . . 0.0 109.827 -178.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.3 -62.73 1.37 Allowed 'General case' 0 N--CA 1.516 2.849 0 O-C-N 121.687 -0.633 . . . . 0.0 112.134 -178.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 33.4 m -86.57 26.5 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.282 0 CA-C-N 119.621 1.101 . . . . 0.0 110.657 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 46.7 p -97.58 173.56 7.09 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -62.6 0.46 0.49 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.332 -0.855 . . . . 0.0 111.944 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.0 t -98.57 -0.83 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 CA-C-N 120.481 1.491 . . . . 0.0 111.211 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -138.46 -88.81 0.23 Allowed 'General case' 0 N--CA 1.507 2.39 0 CA-C-N 119.403 1.001 . . . . 0.0 111.918 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 92.0 m -141.44 42.03 1.75 Allowed 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.553 -0.717 . . . . 0.0 109.734 -178.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.447 ' ND2' ' HB3' ' A' ' 112' ' ' PRO . 46.5 t-20 -38.34 -69.91 0.11 Allowed 'General case' 0 N--CA 1.506 2.339 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -178.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.7 mt 48.18 26.99 1.16 Allowed 'General case' 0 N--CA 1.51 2.534 0 O-C-N 121.912 -0.492 . . . . 0.0 110.682 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 63.91 154.66 0.06 Allowed 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.561 ' OG1' ' CE1' ' A' ' 109' ' ' HIS . 1.7 p -124.51 -151.82 0.49 Allowed 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -178.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -57.96 -39.97 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 C-N-CA 123.08 0.552 . . . . 0.0 111.279 178.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.587 ' CE1' ' O ' ' A' ' 113' ' ' PHE . 3.8 p80 -92.53 23.15 4.15 Favored 'General case' 0 N--CA 1.514 2.775 0 O-C-N 122.219 -0.301 . . . . 0.0 110.875 -177.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 45.47 63.57 2.68 Favored Glycine 0 N--CA 1.504 3.2 0 O-C-N 121.723 -0.61 . . . . 0.0 111.986 177.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 173.31 171.32 37.82 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 110.499 -1.041 . . . . 0.0 110.499 179.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.455 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 36.3 Cg_endo -83.3 75.35 4.38 Favored 'Trans proline' 0 CA--C 1.545 1.043 0 C-N-CA 122.711 2.274 . . . . 0.0 111.057 -179.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.587 ' O ' ' CE1' ' A' ' 109' ' ' HIS . 20.2 p90 . . . . . 0 N--CA 1.531 3.597 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo . . . . . 0 CA--C 1.541 0.835 0 N-CA-C 110.356 -0.671 . . . . 0.0 110.356 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 57.66 14.59 15.41 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.588 ' O ' ' CB ' ' A' ' 11' ' ' ALA . 1.3 mtt -140.25 107.69 5.56 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.211 -1.17 . . . . 0.0 108.54 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.588 ' CB ' ' O ' ' A' ' 10' ' ' MET . . . 85.32 -62.22 0.07 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.843 -1.161 . . . . 0.0 108.057 -178.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.419 HG12 HD13 ' A' ' 51' ' ' ILE . 67.9 mt -104.05 101.17 24.22 Favored Pre-proline 0 C--N 1.304 -1.406 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 11' ' ' ALA . 33.2 Cg_endo -81.29 172.45 12.71 Favored 'Trans proline' 0 C--N 1.318 -1.073 0 C-N-CA 121.595 1.53 . . . . 0.0 111.674 -177.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.406 ' H ' ' CD2' ' A' ' 14' ' ' HIS . 29.4 m-70 -69.58 145.63 52.4 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.638 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 10.8 t-20 54.8 51.21 7.21 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 120.809 -1.182 . . . . 0.0 110.04 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.638 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 37.6 Cg_endo -78.72 166.07 24.04 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.398 2.066 . . . . 0.0 111.49 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.521 ' CD2' HD23 ' A' ' 97' ' ' LEU . 0.5 OUTLIER 48.45 48.32 19.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.741 -0.599 . . . . 0.0 111.091 178.879 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -75.08 -42.24 57.15 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.01 -1.056 . . . . 0.0 108.91 178.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.537 ' OG ' ' CE ' ' A' ' 40' ' ' MET . 0.3 OUTLIER -59.24 -25.61 64.19 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.191 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.418 ' N ' ' SG ' ' A' ' 44' ' ' CYS . 71.2 m -73.78 -38.77 64.54 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.597 -0.69 . . . . 0.0 109.286 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.455 ' O ' ' HD2' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -63.51 -48.05 79.18 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.263 -0.898 . . . . 0.0 108.848 179.498 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.46 ' HA ' ' OG ' ' A' ' 25' ' ' SER . 31.0 m95 -73.08 -26.77 61.38 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.642 -1.286 . . . . 0.0 109.82 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.516 ' HB2' ' HG2' ' A' ' 40' ' ' MET . 15.2 t80 -66.17 -31.28 72.02 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.08 -1.012 . . . . 0.0 108.422 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.465 ' O ' ' OG1' ' A' ' 28' ' ' THR . 93.4 t -75.42 -41.52 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.003 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.46 ' OG ' ' HA ' ' A' ' 22' ' ' TRP . 0.5 OUTLIER -56.2 -42.3 76.96 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.434 -0.906 . . . . 0.0 109.986 -179.863 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.492 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 2.4 m -77.59 -55.08 5.66 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.267 -0.896 . . . . 0.0 111.256 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.87 -24.56 62.34 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 120.743 -1.223 . . . . 0.0 110.3 -178.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.465 ' OG1' ' O ' ' A' ' 24' ' ' VAL . 72.4 p -92.87 -67.1 0.88 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.005 -1.059 . . . . 0.0 111.351 -178.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 84' ' ' GLY . 3.6 m -99.0 16.69 21.74 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.618 -1.301 . . . . 0.0 109.843 -179.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.474 ' HA2' ' O ' ' A' ' 26' ' ' THR . . . 56.48 21.48 34.63 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 26' ' ' THR . 73.6 t -105.79 161.11 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.141 -1.211 . . . . 0.0 109.615 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.406 ' N ' ' CG1' ' A' ' 31' ' ' VAL . . . 138.36 179.86 17.63 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 108.849 -1.7 . . . . 0.0 108.849 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -66.19 175.8 4.52 Favored 'Trans proline' 0 N--CA 1.482 0.803 0 CA-C-N 119.127 1.464 . . . . 0.0 110.051 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 7.4 mtt-85 -91.4 82.2 5.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.847 -1.158 . . . . 0.0 110.013 -178.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.97 131.2 28.26 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -45.95 158.28 0.1 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.086 -1.009 . . . . 0.0 109.326 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -75.79 -52.34 10.62 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.973 -1.079 . . . . 0.0 110.205 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -47.12 -34.03 5.67 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.971 -1.081 . . . . 0.0 109.643 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.472 ' O ' ' HD3' ' A' ' 43' ' ' ARG . 3.0 mt-10 -69.57 -41.65 75.57 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.15 -0.969 . . . . 0.0 108.906 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.537 ' CE ' ' OG ' ' A' ' 19' ' ' SER . 2.6 tpt -61.24 -60.41 3.79 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.6 ttpm? -50.35 -40.89 50.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.745 -0.597 . . . . 0.0 109.529 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.59 -45.59 88.78 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.282 -0.886 . . . . 0.0 109.486 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.519 ' HD2' ' N ' ' A' ' 43' ' ' ARG . 1.0 OUTLIER -59.82 -48.79 80.26 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.355 -0.841 . . . . 0.0 109.851 -179.695 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.418 ' SG ' ' N ' ' A' ' 20' ' ' CYS . 14.0 m -58.03 -34.42 70.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.992 -1.068 . . . . 0.0 110.439 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 20.8 m -70.95 -30.58 66.91 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.977 -1.077 . . . . 0.0 109.091 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.63 -35.61 75.39 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.471 ' O ' ' CG1' ' A' ' 51' ' ' ILE . 3.4 mt-30 -76.95 -26.48 54.06 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.457 HD23 ' HG2' ' A' ' 56' ' ' ARG . 1.7 tm? -71.65 -34.83 70.07 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.432 ' O ' ' C ' ' A' ' 50' ' ' ALA . 4.2 mm-40 -77.06 -58.43 3.29 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.481 ' O ' ' HD3' ' A' ' 52' ' ' PRO . . . -46.35 -35.17 5.17 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.519 ' CG2' ' HA ' ' A' ' 56' ' ' ARG . 21.9 mm -82.01 106.62 6.62 Favored Pre-proline 0 N--CA 1.488 1.449 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 50' ' ' ALA . 25.7 Cg_endo -61.84 148.35 93.28 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 121.883 1.722 . . . . 0.0 110.886 -177.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.486 ' HA ' ' HD2' ' A' ' 56' ' ' ARG . . . -59.77 -35.05 73.84 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.665 -0.647 . . . . 0.0 111.156 -178.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.45 ' C ' ' O ' ' A' ' 53' ' ' ALA . 6.0 t80 -45.58 -27.17 0.71 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.905 -1.122 . . . . 0.0 108.137 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.505 ' O ' ' C ' ' A' ' 56' ' ' ARG . 13.3 m -116.43 -73.34 0.65 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.519 ' HA ' ' CG2' ' A' ' 51' ' ' ILE . 22.4 mtt180 31.71 -98.89 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.828 -0.545 . . . . 0.0 110.176 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.497 ' C ' ' O ' ' A' ' 56' ' ' ARG . 66.2 m -33.46 -55.89 0.43 Allowed 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.277 -0.89 . . . . 0.0 111.208 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.482 ' O ' ' C ' ' A' ' 59' ' ' ALA . 1.1 tt0 -35.74 -53.63 0.72 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.766 -1.208 . . . . 0.0 111.05 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.482 ' C ' ' O ' ' A' ' 58' ' ' GLU . . . -35.85 -52.49 0.72 Allowed 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.214 -0.928 . . . . 0.0 110.287 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.489 HG23 ' CD1' ' A' ' 97' ' ' LEU . 7.4 t -53.52 -50.47 49.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 121.247 -0.908 . . . . 0.0 108.784 179.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.5 ' O ' ' HB2' ' A' ' 65' ' ' ASP . 6.8 mtp85 -53.55 -29.61 37.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.403 -0.81 . . . . 0.0 109.83 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.564 ' CG2' ' HB ' ' A' ' 67' ' ' VAL . 17.9 mt -77.6 -30.14 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 120.957 -1.089 . . . . 0.0 110.043 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' A' ' 77' ' ' ARG . 13.0 tp -77.26 -43.18 34.29 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.773 -1.205 . . . . 0.0 109.612 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 47.5 tpp -78.42 -50.96 10.76 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.18 -0.95 . . . . 0.0 109.945 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.5 ' HB2' ' O ' ' A' ' 61' ' ' ARG . 17.5 m-20 -79.68 -21.97 44.04 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.061 -1.024 . . . . 0.0 109.978 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.56 146.11 9.57 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.564 ' HB ' ' CG2' ' A' ' 62' ' ' ILE . 2.6 p -116.88 159.47 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.512 -0.993 . . . . 0.0 109.329 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.474 ' N ' HG23 ' A' ' 67' ' ' VAL . 7.9 t -114.3 157.99 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 CA-C-O 121.864 0.84 . . . . 0.0 109.892 -178.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.456 ' N ' ' CG1' ' A' ' 68' ' ' VAL . 21.7 p -116.87 159.27 22.64 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.604 0.716 . . . . 0.0 109.583 -178.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.0 t -62.27 -34.17 76.03 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.588 -0.695 . . . . 0.0 110.142 -179.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.8 p -65.63 -14.93 62.18 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.525 -0.734 . . . . 0.0 109.52 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 99.97 8.09 51.65 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.674 -1.77 . . . . 0.0 108.674 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -92.1 156.81 17.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.216 -1.167 . . . . 0.0 109.5 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.421 ' C ' ' HG2' ' A' ' 75' ' ' GLU . 12.5 m170 -115.8 155.88 27.06 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 120.812 -1.18 . . . . 0.0 108.675 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.421 ' HG2' ' C ' ' A' ' 74' ' ' HIS . 3.3 mt-10 -141.44 -172.89 3.62 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.088 -1.007 . . . . 0.0 110.585 -179.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 49.65 -146.07 7.73 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.478 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER 56.2 17.77 2.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -1.175 . . . . 0.0 110.1 179.64 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.421 ' O ' ' N ' ' A' ' 80' ' ' GLN . 0.1 OUTLIER -83.8 -11.96 56.33 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.983 -1.073 . . . . 0.0 110.127 -179.611 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.475 ' CD2' HD22 ' A' ' 63' ' ' LEU . 0.9 OUTLIER -47.71 99.32 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.869 -1.144 . . . . 0.0 109.34 179.718 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.421 ' N ' ' O ' ' A' ' 78' ' ' LEU . 2.2 mt-30 -134.39 170.99 14.91 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.238 -0.913 . . . . 0.0 109.698 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.438 ' OD1' ' HG3' ' A' ' 87' ' ' ARG . 2.2 m-20 -65.94 107.4 1.84 Allowed 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.595 0.712 . . . . 0.0 110.82 -179.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.663 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 18.0 mt -80.0 172.06 10.81 Favored Pre-proline 0 C--N 1.301 -1.506 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 177.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.663 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 28.3 Cg_endo -68.32 100.84 0.68 Allowed 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 120.872 1.048 . . . . 0.0 109.723 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.454 ' O ' ' SG ' ' A' ' 29' ' ' CYS . . . 92.27 15.44 53.56 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 -179.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.493 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 3.4 m -148.52 90.57 4.88 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 120.802 -1.411 . . . . 0.0 108.856 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.413 ' O ' ' C ' ' A' ' 87' ' ' ARG . 30.4 Cg_endo -74.77 160.48 40.77 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.367 1.378 . . . . 0.0 111.649 -178.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.438 ' HG3' ' OD1' ' A' ' 81' ' ' ASP . 53.4 mtp180 -44.7 -29.41 0.76 Allowed 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 122.152 0.977 . . . . 0.0 108.396 178.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -54.03 -52.39 60.99 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.58 -178.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 58.8 t -65.05 -41.61 92.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 O-C-N 120.94 -1.1 . . . . 0.0 110.207 -178.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.455 ' O ' ' HB1' ' A' ' 94' ' ' ALA . 3.6 mp0 -62.43 -27.4 69.08 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.262 -0.899 . . . . 0.0 108.705 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.464 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 0.0 OUTLIER -78.61 -33.06 47.74 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.444 -0.785 . . . . 0.0 109.957 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.502 ' O ' ' HD2' ' A' ' 95' ' ' PRO . . . -71.44 -45.6 62.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.933 -1.104 . . . . 0.0 109.499 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.574 ' O ' ' CD1' ' A' ' 93' ' ' PHE . 10.0 t80 -77.92 -25.71 48.53 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.383 -0.823 . . . . 0.0 110.102 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.564 ' N ' ' HD2' ' A' ' 95' ' ' PRO . . . -43.55 -50.89 16.63 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.395 -0.816 . . . . 0.0 112.094 -178.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 94' ' ' ALA . 32.9 Cg_endo -73.66 24.0 0.33 Allowed 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.64 2.227 . . . . 0.0 112.951 -178.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.411 ' O ' ' HG3' ' A' ' 102' ' ' GLU . 0.4 OUTLIER -126.8 28.69 5.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.688 -1.258 . . . . 0.0 108.898 178.612 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.521 HD23 ' CD2' ' A' ' 17' ' ' LEU . 0.6 OUTLIER -80.12 -77.77 0.18 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.403 -0.811 . . . . 0.0 110.403 -179.476 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.481 ' C ' ' HA ' ' A' ' 104' ' ' ASN . 2.5 m -79.81 27.89 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.906 -1.121 . . . . 0.0 110.873 -179.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.477 ' C ' ' HB2' ' A' ' 104' ' ' ASN . 5.1 p -101.27 170.98 7.88 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.909 -1.119 . . . . 0.0 108.196 179.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -60.39 1.33 0.13 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.571 -1.331 . . . . 0.0 112.179 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.7 t -101.02 1.69 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 119.822 -1.799 . . . . 0.0 110.972 -179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 97' ' ' LEU . 0.3 OUTLIER -140.17 -94.29 0.16 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.513 -1.367 . . . . 0.0 110.655 -179.714 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.468 ' O ' ' C ' ' A' ' 104' ' ' ASN . 72.8 m -131.99 38.68 3.5 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.928 -1.108 . . . . 0.0 109.004 -179.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.534 ' ND2' ' HB3' ' A' ' 112' ' ' PRO . 42.0 t-20 -29.52 -66.02 0.09 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.811 -0.556 . . . . 0.0 112.091 -179.107 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.474 ' O ' ' O ' ' A' ' 106' ' ' ALA . 11.3 mt 41.7 33.98 0.37 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.064 -1.023 . . . . 0.0 109.748 -179.2 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.474 ' O ' ' O ' ' A' ' 105' ' ' LEU . . . 55.23 165.6 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.032 -1.043 . . . . 0.0 108.993 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.73 ' OG1' ' CE1' ' A' ' 109' ' ' HIS . 1.7 p -133.79 -146.08 0.26 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.0 -1.063 . . . . 0.0 108.722 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.476 ' N ' ' OG1' ' A' ' 107' ' ' THR . 1.3 tt -69.05 -38.68 78.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.31 -0.869 . . . . 0.0 110.008 179.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.73 ' CE1' ' OG1' ' A' ' 107' ' ' THR . 0.6 OUTLIER -84.46 24.0 1.05 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.179 -0.951 . . . . 0.0 110.035 -179.75 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 109' ' ' HIS . . . 42.73 54.78 4.89 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -179.66 159.55 24.15 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.534 ' HB3' ' ND2' ' A' ' 104' ' ' ASN . 31.7 Cg_endo -77.04 79.58 3.09 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.722 2.281 . . . . 0.0 109.859 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.608 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.507 2.383 0 C-N-CA 118.826 -1.15 . . . . 0.0 113.073 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo . . . . . 0 CA--C 1.542 0.922 0 N-CA-C 110.999 -0.424 . . . . 0.0 110.999 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.55 -14.78 33.69 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.588 ' O ' ' CB ' ' A' ' 11' ' ' ALA . 0.7 OUTLIER -134.87 116.68 15.04 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.18 -1.188 . . . . 0.0 108.108 179.499 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.588 ' CB ' ' O ' ' A' ' 10' ' ' MET . . . 85.61 -59.05 0.07 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.796 -1.19 . . . . 0.0 107.811 -178.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.409 HD11 HG12 ' A' ' 51' ' ' ILE . 9.9 mm -107.2 101.36 38.01 Favored Pre-proline 0 C--N 1.303 -1.434 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 178.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -81.36 175.45 9.64 Favored 'Trans proline' 0 C--N 1.318 -1.064 0 C-N-CA 121.459 1.439 . . . . 0.0 111.955 -176.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 52.8 m-70 -76.76 147.84 37.06 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.673 -0.642 . . . . 0.0 109.553 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.567 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 0.1 OUTLIER 58.22 58.03 6.54 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 120.796 -1.19 . . . . 0.0 109.93 -179.758 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.567 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 37.1 Cg_endo -79.66 168.62 19.34 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.55 2.167 . . . . 0.0 111.03 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.533 ' N ' ' CD2' ' A' ' 17' ' ' LEU . 3.3 mm? 52.33 44.38 29.87 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.551 -0.718 . . . . 0.0 111.041 178.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.464 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 3.9 p30 -83.61 -47.29 11.43 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.867 -1.146 . . . . 0.0 109.412 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.59 -25.99 67.68 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.517 ' SG ' ' CD1' ' A' ' 17' ' ' LEU . 72.4 m -71.08 -50.02 38.24 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.624 -0.672 . . . . 0.0 109.62 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.561 ' CG ' ' N ' ' A' ' 22' ' ' TRP . 4.2 ptt180 -59.03 -52.09 67.24 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.132 -0.98 . . . . 0.0 109.632 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.561 ' N ' ' CG ' ' A' ' 21' ' ' ARG . 22.9 m95 -61.15 -34.32 74.83 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 118.584 -1.246 . . . . 0.0 108.943 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.547 ' HB2' ' CG ' ' A' ' 40' ' ' MET . 7.2 t80 -60.32 -30.45 69.52 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.471 ' CG1' HG22 ' A' ' 28' ' ' THR . 48.0 t -72.67 -41.88 62.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 C-N-CA 118.816 -1.154 . . . . 0.0 107.94 178.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.409 ' OG ' ' O ' ' A' ' 22' ' ' TRP . 64.8 p -55.67 -42.99 75.91 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.247 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 5.4 m -78.13 -52.98 7.9 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.158 -0.964 . . . . 0.0 111.708 -178.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.453 ' HG2' ' CE1' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -60.51 -25.76 66.35 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.703 -1.248 . . . . 0.0 110.792 -178.383 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.471 HG22 ' CG1' ' A' ' 24' ' ' VAL . 21.9 p -96.83 -60.84 1.51 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.019 -1.051 . . . . 0.0 111.095 -178.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.475 ' SG ' ' O ' ' A' ' 84' ' ' GLY . 3.5 m -99.39 15.78 25.23 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.875 -1.141 . . . . 0.0 110.13 -179.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.482 ' HA2' ' O ' ' A' ' 26' ' ' THR . . . 52.44 21.02 8.02 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 -179.001 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.496 ' CG1' ' N ' ' A' ' 32' ' ' GLY . 41.7 t -109.51 165.37 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.276 -1.132 . . . . 0.0 109.62 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.496 ' N ' ' CG1' ' A' ' 31' ' ' VAL . . . 130.3 178.32 15.36 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 108.58 -1.808 . . . . 0.0 108.58 -179.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -65.44 176.2 3.58 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 CA-C-N 119.188 1.494 . . . . 0.0 109.825 179.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 24.1 mtt180 -91.11 79.07 5.81 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.707 -1.246 . . . . 0.0 110.369 -177.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.465 ' O ' ' C ' ' A' ' 36' ' ' ALA . 52.1 mt -127.35 114.93 18.22 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 178.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.465 ' C ' ' O ' ' A' ' 35' ' ' LEU . . . -41.05 160.32 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.342 -0.849 . . . . 0.0 109.462 -179.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -68.38 -59.94 2.81 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.074 -1.017 . . . . 0.0 110.377 -179.107 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -48.48 -31.55 6.54 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.074 -1.016 . . . . 0.0 110.086 -179.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -68.7 -47.01 67.51 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.192 -0.942 . . . . 0.0 108.767 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.547 ' CG ' ' HB2' ' A' ' 23' ' ' TYR . 17.6 tpp -60.04 -60.54 3.66 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.1 tppt? -47.79 -35.4 10.0 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.561 -0.712 . . . . 0.0 109.152 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.16 -43.07 92.97 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.34 -0.85 . . . . 0.0 109.383 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -63.11 -43.79 97.45 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.328 -0.857 . . . . 0.0 109.905 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.426 ' SG ' ' N ' ' A' ' 20' ' ' CYS . 19.0 m -64.57 -36.39 84.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.08 -1.012 . . . . 0.0 110.063 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 63.9 m -70.21 -29.82 66.75 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.95 -1.094 . . . . 0.0 108.976 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.437 ' NH1' ' HB2' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -73.43 -32.4 64.38 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.077 -1.014 . . . . 0.0 108.296 179.459 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -77.34 -30.99 54.18 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.368 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.518 ' CD1' HG13 ' A' ' 98' ' ' VAL . 8.4 tt -74.11 -38.08 63.93 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.221 -0.924 . . . . 0.0 109.089 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.447 ' O ' ' C ' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -71.17 -53.59 13.95 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.256 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.483 ' O ' ' HD3' ' A' ' 52' ' ' PRO . . . -46.54 -46.39 19.28 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 178.107 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.409 HG12 HD11 ' A' ' 12' ' ' ILE . 73.8 mt -67.61 106.97 1.44 Allowed Pre-proline 0 C--N 1.304 -1.387 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 176.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.529 ' O ' ' N ' ' A' ' 54' ' ' TYR . 24.5 Cg_endo -60.61 138.94 83.21 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 121.581 1.521 . . . . 0.0 111.097 -176.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.569 ' HA ' ' CG ' ' A' ' 56' ' ' ARG . . . -32.54 -33.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.198 0.523 . . . . 0.0 110.669 -178.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.529 ' N ' ' O ' ' A' ' 52' ' ' PRO . 2.0 m-85 -66.82 122.68 18.22 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.298 -0.876 . . . . 0.0 109.481 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.498 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 34.1 m 73.43 13.47 4.56 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.588 -0.695 . . . . 0.0 111.126 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.569 ' CG ' ' HA ' ' A' ' 53' ' ' ALA . 9.0 mmt85 -41.41 -87.28 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.606 -1.309 . . . . 0.0 109.362 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.521 ' C ' ' O ' ' A' ' 56' ' ' ARG . 6.5 m -24.9 -49.51 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.447 0 O-C-N 121.786 -0.571 . . . . 0.0 112.161 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.509 ' C ' ' O ' ' A' ' 57' ' ' CYS . 12.8 tt0 -25.73 -49.9 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.365 -0.834 . . . . 0.0 111.775 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.516 ' HB3' ' CD2' ' A' ' 17' ' ' LEU . . . -40.9 -60.41 1.19 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.135 -0.978 . . . . 0.0 110.013 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.581 ' CG2' ' CD1' ' A' ' 97' ' ' LEU . 39.8 t -52.31 -39.77 29.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 O-C-N 121.395 -0.816 . . . . 0.0 109.403 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.498 ' O ' ' HB2' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -62.01 -33.11 73.74 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.416 -0.803 . . . . 0.0 110.116 -179.677 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.55 ' CG2' ' HB ' ' A' ' 67' ' ' VAL . 48.5 mt -77.38 -28.47 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.926 -1.109 . . . . 0.0 110.09 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.405 HD22 HD21 ' A' ' 79' ' ' LEU . 2.3 tt -77.01 -46.72 22.83 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.779 -1.2 . . . . 0.0 109.61 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 10.2 tpt -77.19 -50.42 12.99 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.082 -1.011 . . . . 0.0 109.914 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.498 ' HB2' ' O ' ' A' ' 61' ' ' ARG . 19.9 m-20 -80.21 -21.47 42.89 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.97 -1.081 . . . . 0.0 110.076 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . 85.29 151.69 15.97 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.55 ' HB ' ' CG2' ' A' ' 62' ' ' ILE . 1.6 p -117.09 157.82 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.368 -1.077 . . . . 0.0 109.276 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.508 HG23 ' NE2' ' A' ' 74' ' ' HIS . 14.7 t -116.27 158.32 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.32 -0.863 . . . . 0.0 110.075 -178.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.467 ' N ' ' CG1' ' A' ' 68' ' ' VAL . 29.7 p -117.17 158.71 23.8 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.046 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.6 t -64.38 -32.98 74.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.515 -0.74 . . . . 0.0 109.791 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.2 p -64.75 -14.25 58.08 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.574 -0.704 . . . . 0.0 109.362 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 99.67 8.07 52.54 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -91.25 156.21 17.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.964 -1.315 . . . . 0.0 109.836 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.508 ' NE2' HG23 ' A' ' 68' ' ' VAL . 11.0 m170 -116.4 156.19 27.2 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.002 -1.061 . . . . 0.0 108.616 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 74' ' ' HIS . 5.2 mt-10 -142.83 -179.04 6.1 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.213 -0.93 . . . . 0.0 110.237 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 51.85 -143.11 19.87 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.419 ' HD2' ' O ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER 56.7 15.9 2.39 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.491 -1.005 . . . . 0.0 110.242 179.544 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 80' ' ' GLN . 2.4 mp -84.9 -11.04 56.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.956 -1.09 . . . . 0.0 110.244 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.469 HD22 ' HG2' ' A' ' 90' ' ' GLN . 1.1 tm? -43.03 96.22 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.008 -1.058 . . . . 0.0 109.046 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.518 ' N ' ' O ' ' A' ' 78' ' ' LEU . 83.7 mt-30 -143.53 179.39 7.15 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.198 -0.939 . . . . 0.0 110.501 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.84 112.05 4.06 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.818 0.818 . . . . 0.0 111.633 -178.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.656 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 23.2 mt -91.76 172.14 6.9 Favored Pre-proline 0 N--CA 1.488 1.463 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 177.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.656 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 28.4 Cg_endo -67.45 100.58 0.57 Allowed 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 121.1 1.2 . . . . 0.0 110.907 -179.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.475 ' O ' ' SG ' ' A' ' 29' ' ' CYS . . . 90.86 12.68 60.23 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.463 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 3.3 m -142.98 91.9 7.03 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 120.916 -1.343 . . . . 0.0 109.255 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.406 ' O ' ' C ' ' A' ' 87' ' ' ARG . 29.2 Cg_endo -73.39 159.53 46.47 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 121.272 1.315 . . . . 0.0 111.451 -179.016 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.406 ' C ' ' O ' ' A' ' 86' ' ' PRO . 6.3 mtm-85 -44.91 -27.87 0.59 Allowed 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 121.903 0.859 . . . . 0.0 108.889 178.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.95 -46.47 82.09 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.906 -0.496 . . . . 0.0 112.058 -177.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 40.5 t -69.99 -41.66 79.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 120.689 -1.257 . . . . 0.0 110.929 -178.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.469 ' HG2' HD22 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -64.64 -30.11 71.13 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.048 -1.032 . . . . 0.0 108.807 -179.909 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.457 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 0.0 OUTLIER -78.17 -27.81 48.12 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.504 179.609 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.504 ' O ' ' HD2' ' A' ' 95' ' ' PRO . . . -73.17 -51.2 18.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.103 -0.998 . . . . 0.0 109.68 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.443 ' C ' ' HD2' ' A' ' 95' ' ' PRO . 40.9 t80 -77.78 -26.53 49.8 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.19 -0.944 . . . . 0.0 110.022 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.568 ' N ' ' HD2' ' A' ' 95' ' ' PRO . . . -42.28 -51.96 10.38 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.383 -0.823 . . . . 0.0 111.593 -178.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 94' ' ' ALA . 31.2 Cg_endo -72.06 80.63 1.52 Allowed 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.203 1.935 . . . . 0.0 111.628 -178.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.446 ' O ' ' HG3' ' A' ' 102' ' ' GLU . 0.0 OUTLIER 176.44 56.51 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.628 -0.67 . . . . 0.0 109.22 179.234 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.581 ' CD1' ' CG2' ' A' ' 60' ' ' VAL . 0.1 OUTLIER -96.27 -82.17 0.4 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.212 -0.93 . . . . 0.0 111.271 -179.075 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.518 HG13 ' CD1' ' A' ' 48' ' ' LEU . 3.6 m -81.91 28.77 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.735 -1.228 . . . . 0.0 111.197 -178.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.449 ' C ' ' HB3' ' A' ' 104' ' ' ASN . 5.3 p -97.53 170.88 8.73 Favored 'General case' 0 C--N 1.294 -1.834 0 O-C-N 120.644 -1.285 . . . . 0.0 108.449 179.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.79 -2.05 0.2 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.679 -1.263 . . . . 0.0 111.892 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.437 ' O ' ' CG1' ' A' ' 101' ' ' VAL . 57.4 t -100.86 6.4 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 119.844 -1.785 . . . . 0.0 110.73 -179.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.446 ' HG3' ' O ' ' A' ' 96' ' ' LYS . 0.3 OUTLIER -141.52 -91.17 0.14 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.684 -1.26 . . . . 0.0 110.386 -179.899 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.455 ' O ' ' C ' ' A' ' 104' ' ' ASN . 3.6 m -142.89 38.58 1.46 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.951 -1.093 . . . . 0.0 108.861 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.499 ' HA ' ' O ' ' A' ' 98' ' ' VAL . 8.3 p30 -34.87 -51.86 0.52 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.21 -0.931 . . . . 0.0 112.158 -178.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.455 HD11 ' O ' ' A' ' 103' ' ' CYS . 0.6 OUTLIER 40.55 26.94 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.953 -1.092 . . . . 0.0 109.825 -179.396 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' A' ' 104' ' ' ASN . . . 62.25 153.85 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.778 -1.202 . . . . 0.0 108.693 -178.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.4 p -128.56 -178.48 4.6 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.099 -1.001 . . . . 0.0 108.629 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.1 tp -64.17 -33.1 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.921 -1.112 . . . . 0.0 108.83 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -62.68 -2.31 1.09 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.771 -0.581 . . . . 0.0 111.084 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 63.31 31.73 81.72 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -162.79 172.51 38.85 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.941 -1.263 . . . . 0.0 109.941 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.524 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 30.2 Cg_endo -76.87 69.46 6.91 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 123.049 2.499 . . . . 0.0 111.6 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.524 ' HB3' ' O ' ' A' ' 112' ' ' PRO . 34.9 p90 . . . . . 0 N--CA 1.497 1.904 0 O-C-N 121.397 -0.814 . . . . 0.0 110.481 178.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo . . . . . 0 N--CA 1.485 0.979 0 N-CA-C 111.203 -0.345 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 83.33 -5.69 76.02 Favored Glycine 0 N--CA 1.5 2.913 0 N-CA-C 110.696 -0.961 . . . . 0.0 110.696 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.449 ' O ' ' CB ' ' A' ' 11' ' ' ALA . 1.6 mtp -136.81 112.24 9.25 Favored 'General case' 0 N--CA 1.501 2.121 0 CA-C-N 118.287 1.043 . . . . 0.0 108.292 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.449 ' CB ' ' O ' ' A' ' 10' ' ' MET . . . 86.39 -57.22 0.06 Allowed 'General case' 0 N--CA 1.514 2.752 0 CA-C-N 119.834 1.197 . . . . 0.0 108.171 -178.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 36.0 mt -106.86 100.36 31.12 Favored Pre-proline 0 N--CA 1.492 1.672 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 178.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -82.11 172.74 11.55 Favored 'Trans proline' 0 C--O 1.22 -0.388 0 C-N-CA 121.397 1.398 . . . . 0.0 111.593 -177.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 45.2 m-70 -72.44 145.19 47.79 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.402 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 4.4 t-20 65.04 64.14 1.07 Allowed Pre-proline 0 N--CA 1.505 2.285 0 O-C-N 121.521 -0.737 . . . . 0.0 109.506 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.402 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 38.2 Cg_endo -82.1 151.95 16.21 Favored 'Trans proline' 0 N--CA 1.482 0.845 0 C-N-CA 122.344 2.029 . . . . 0.0 112.047 -179.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.9 mp 46.88 35.0 2.92 Favored 'General case' 0 N--CA 1.502 2.166 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.177 177.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -66.52 -32.55 73.97 Favored 'General case' 0 N--CA 1.505 2.296 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.0 -32.32 73.98 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 33.8 m -71.25 -33.83 70.19 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.419 ' CG ' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -60.98 -54.89 39.35 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.11 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.453 ' CE3' ' HA ' ' A' ' 22' ' ' TRP . 30.6 m95 -67.26 -27.0 66.84 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.55 -179.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -68.4 -29.68 68.42 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.444 ' CG2' ' CD1' ' A' ' 93' ' ' PHE . 80.7 t -73.29 -42.61 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 177.018 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -53.24 -40.64 64.71 Favored 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 120.594 -0.442 . . . . 0.0 109.968 -179.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 31.1 m -77.19 -52.79 8.65 Favored 'General case' 0 N--CA 1.508 2.472 0 O-C-N 122.204 -0.31 . . . . 0.0 111.669 -178.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -59.96 -25.06 64.9 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.859 -0.526 . . . . 0.0 110.678 -178.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 59.7 p -97.74 -65.83 0.94 Allowed 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -177.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 57.4 m -100.88 16.04 26.5 Favored 'General case' 0 N--CA 1.51 2.546 0 O-C-N 121.298 -0.876 . . . . 0.0 111.924 -178.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 56.83 20.87 34.63 Favored Glycine 0 N--CA 1.505 3.263 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.9 t -106.94 160.63 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 O-C-N 121.759 -0.847 . . . . 0.0 109.01 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 134.68 177.89 15.27 Favored Glycine 0 N--CA 1.499 2.851 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -66.46 172.74 8.68 Favored 'Trans proline' 0 N--CA 1.486 1.082 0 CA-C-N 119.098 1.449 . . . . 0.0 109.938 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 8.8 ttt-85 -93.27 86.33 5.29 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 122.027 0.918 . . . . 0.0 110.363 -178.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 76.4 mt -139.65 130.93 26.7 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.01 145.94 6.79 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.868 -0.52 . . . . 0.0 109.928 -178.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -56.93 -57.87 10.62 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.705 -0.622 . . . . 0.0 111.217 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -49.2 -36.98 21.24 Favored 'General case' 0 N--CA 1.509 2.506 0 O-C-N 121.676 -0.64 . . . . 0.0 111.246 -178.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -70.38 -38.22 74.67 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 122.042 -0.411 . . . . 0.0 110.087 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.61 -54.69 28.04 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 -179.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -52.71 -36.05 56.68 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.24 -43.78 97.07 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.61 -48.45 81.71 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 14.6 m -61.25 -34.0 74.43 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 122.04 -0.412 . . . . 0.0 111.338 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 17.9 m -73.8 -28.69 61.76 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 7.8 tpt85 -75.11 -34.31 61.7 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -79.08 -36.96 40.0 Favored 'General case' 0 N--CA 1.5 2.055 0 CA-C-O 121.184 0.516 . . . . 0.0 110.207 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.427 ' HG ' ' HD2' ' A' ' 56' ' ' ARG . 3.5 tt -70.32 -38.58 74.96 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.207 -178.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -77.72 -42.72 33.36 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.99 -37.43 63.99 Favored 'General case' 0 N--CA 1.507 2.397 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 178.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.409 ' O ' ' HD3' ' A' ' 56' ' ' ARG . 51.1 mt -86.46 105.65 8.27 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 177.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -62.87 141.59 85.2 Favored 'Trans proline' 0 N--CA 1.481 0.753 0 C-N-CA 121.517 1.478 . . . . 0.0 110.856 -177.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -43.27 -29.83 0.44 Allowed 'General case' 0 N--CA 1.503 2.189 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.286 -178.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.07 110.01 5.49 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 25.1 m 86.39 -15.36 0.47 Allowed 'General case' 0 N--CA 1.513 2.706 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -177.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.427 ' HD2' ' HG ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -45.75 -81.94 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.357 0 O-C-N 121.737 -0.602 . . . . 0.0 110.865 -179.855 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 94.0 m -24.5 -42.88 0.01 OUTLIER 'General case' 0 N--CA 1.519 3.001 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -179.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -41.5 -57.08 2.34 Favored 'General case' 0 N--CA 1.511 2.588 0 CA-C-N 119.055 0.843 . . . . 0.0 111.429 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -39.43 -44.63 1.39 Allowed 'General case' 0 N--CA 1.514 2.748 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 38.7 t -58.92 -50.21 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.347 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.67 -25.05 66.07 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.477 ' CG2' ' HB ' ' A' ' 67' ' ' VAL . 43.1 mm -77.88 -29.13 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.906 -0.496 . . . . 0.0 109.938 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.1 tt -78.35 -41.12 34.36 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.449 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -78.08 -53.33 7.51 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.207 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -80.49 -23.56 40.06 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 122.065 -0.397 . . . . 0.0 111.591 -178.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.62 145.93 6.69 Favored Glycine 0 N--CA 1.503 3.15 0 N-CA-C 109.964 -1.255 . . . . 0.0 109.964 -179.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.477 ' HB ' ' CG2' ' A' ' 62' ' ' ILE . 7.2 p -118.7 159.5 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.492 0 O-C-N 122.151 -0.617 . . . . 0.0 110.209 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.435 ' CG2' ' CE1' ' A' ' 74' ' ' HIS . 65.7 t -115.49 157.35 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 32.0 p -117.77 159.63 22.71 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.359 -178.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.6 t -63.02 -33.91 76.43 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.076 -178.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.5 p -63.38 -18.78 64.05 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.988 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.45 13.91 34.16 Favored Glycine 0 N--CA 1.497 2.713 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -103.35 157.23 17.17 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 118.226 1.013 . . . . 0.0 109.225 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.435 ' CE1' ' CG2' ' A' ' 68' ' ' VAL . 8.9 m170 -115.01 155.36 27.11 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -179.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -140.32 -179.35 5.95 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 120.849 0.357 . . . . 0.0 110.122 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 51.54 -149.32 8.34 Favored Glycine 0 N--CA 1.497 2.752 0 N-CA-C 109.101 -1.6 . . . . 0.0 109.101 -179.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.8 ttp85 59.17 17.6 5.78 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 122.298 -0.531 . . . . 0.0 110.616 179.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 59.8 mt -78.34 -17.45 56.51 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.719 -0.613 . . . . 0.0 109.84 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -51.93 98.56 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -140.1 172.56 12.58 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.106 0.479 . . . . 0.0 110.01 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -64.26 102.36 0.51 Allowed 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.672 0.749 . . . . 0.0 111.088 -179.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.597 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 23.7 mt -81.58 172.98 8.39 Favored Pre-proline 0 N--CA 1.495 1.799 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 177.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.597 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 26.3 Cg_endo -65.3 99.97 0.37 Allowed 'Trans proline' 0 N--CA 1.477 0.534 0 C-N-CA 120.971 1.114 . . . . 0.0 111.034 -179.107 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.68 -7.86 80.67 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 7.2 m -117.12 92.08 38.44 Favored Pre-proline 0 N--CA 1.502 2.142 0 CA-C-N 119.279 1.539 . . . . 0.0 110.3 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -71.39 164.05 37.03 Favored 'Trans proline' 0 N--CA 1.481 0.754 0 C-N-CA 121.36 1.373 . . . . 0.0 111.205 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.5 mmm-85 -48.24 -29.22 3.59 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.212 0.53 . . . . 0.0 109.571 178.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -55.69 -48.74 74.57 Favored 'General case' 0 N--CA 1.505 2.284 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.377 -178.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 80.2 t -62.55 -37.27 78.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 42.0 mm-40 -64.35 -30.11 71.16 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.95 -27.97 49.41 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -74.91 -46.73 33.95 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.967 -0.458 . . . . 0.0 109.874 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.444 ' CD1' ' CG2' ' A' ' 24' ' ' VAL . 29.3 t80 -78.17 -25.13 47.06 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 122.207 -0.308 . . . . 0.0 110.579 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.444 ' N ' ' HD2' ' A' ' 95' ' ' PRO . . . -50.89 -52.87 53.46 Favored Pre-proline 0 N--CA 1.499 2.006 0 CA-C-O 118.842 -0.599 . . . . 0.0 111.938 -177.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 94' ' ' ALA . 30.4 Cg_endo -71.19 -16.59 31.68 Favored 'Trans proline' 0 N--CA 1.484 0.966 0 C-N-CA 122.062 1.841 . . . . 0.0 111.159 -179.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.8 mmpt? -86.99 11.4 13.69 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.934 -0.479 . . . . 0.0 110.193 178.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.455 ' O ' ' HB3' ' A' ' 102' ' ' GLU . 0.2 OUTLIER -72.43 -60.47 2.22 Favored 'General case' 0 N--CA 1.508 2.447 0 O-C-N 121.668 -0.645 . . . . 0.0 111.33 -178.913 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 104' ' ' ASN . 13.2 m -89.38 25.34 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 120.819 -1.176 . . . . 0.0 110.517 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 29.7 p -99.35 173.14 6.91 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.52 -0.54 0.27 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.534 -0.729 . . . . 0.0 112.07 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.8 t -93.82 -0.52 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-N 120.537 1.517 . . . . 0.0 111.028 -179.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.455 ' HB3' ' O ' ' A' ' 97' ' ' LEU . 8.3 tt0 -146.95 -90.79 0.09 Allowed 'General case' 0 N--CA 1.505 2.277 0 C-N-CA 119.499 -0.88 . . . . 0.0 112.11 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 83.8 m -137.0 45.57 2.24 Favored 'General case' 0 N--CA 1.511 2.609 0 CA-C-N 119.13 0.877 . . . . 0.0 110.609 -177.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.4 ' HA ' ' O ' ' A' ' 98' ' ' VAL . 60.0 t-20 -43.6 -72.68 0.06 Allowed 'General case' 0 N--CA 1.508 2.469 0 O-C-N 120.924 -1.11 . . . . 0.0 112.96 -179.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.6 mp 51.25 34.48 11.54 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.966 -0.459 . . . . 0.0 110.628 -178.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 63.55 148.22 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.27 -0.894 . . . . 0.0 109.73 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.8 p -121.16 -164.41 1.12 Allowed 'General case' 0 N--CA 1.505 2.316 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -179.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.0 tt -68.26 -30.72 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.439 ' HB3' ' CE1' ' A' ' 113' ' ' PHE . 95.5 m-70 -71.48 0.66 7.87 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.644 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 60.9 36.54 92.27 Favored Glycine 0 N--CA 1.497 2.74 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -169.8 173.94 43.99 Favored Glycine 0 N--CA 1.498 2.823 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -77.88 78.53 3.53 Favored 'Trans proline' 0 N--CA 1.481 0.747 0 C-N-CA 122.65 2.234 . . . . 0.0 110.487 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.444 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.504 2.27 0 CA-C-O 121.34 0.59 . . . . 0.0 111.399 179.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo . . . . . 0 CA--C 1.543 0.932 0 N-CA-C 110.734 -0.525 . . . . 0.0 110.734 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 69.78 6.11 54.34 Favored Glycine 0 N--CA 1.502 3.066 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.456 ' O ' ' CB ' ' A' ' 11' ' ' ALA . 0.1 OUTLIER -140.52 107.21 5.35 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.788 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 10' ' ' MET . . . 87.04 -58.69 0.04 OUTLIER 'General case' 0 N--CA 1.516 2.829 0 CA-C-N 119.865 1.211 . . . . 0.0 108.399 -178.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 41.1 mt -103.57 101.38 23.48 Favored Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 178.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -81.82 172.45 12.14 Favored 'Trans proline' 0 N--CA 1.477 0.549 0 C-N-CA 121.701 1.601 . . . . 0.0 111.97 -176.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 30.6 m-70 -74.68 145.4 43.2 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 68.14 64.48 0.63 Allowed Pre-proline 0 N--CA 1.508 2.45 0 O-C-N 121.404 -0.81 . . . . 0.0 110.593 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -84.34 171.42 10.06 Favored 'Trans proline' 0 N--CA 1.484 0.959 0 C-N-CA 122.51 2.14 . . . . 0.0 111.908 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 66.1 mt 43.43 46.29 5.64 Favored 'General case' 0 N--CA 1.503 2.223 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.435 177.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -73.47 -41.1 63.59 Favored 'General case' 0 N--CA 1.505 2.28 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.2 t -63.42 -25.74 68.42 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 32.5 m -77.73 -35.38 51.98 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 110.251 -0.278 . . . . 0.0 110.251 -179.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 11.2 ttp180 -69.92 -42.96 72.63 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 31.1 m95 -73.38 -30.97 63.64 Favored 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 118.762 -1.175 . . . . 0.0 108.99 178.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.447 ' CD1' ' HG2' ' A' ' 40' ' ' MET . 8.2 t80 -63.96 -33.85 76.66 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.42 HG23 ' CD1' ' A' ' 93' ' ' PHE . 43.6 t -70.51 -38.86 75.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 177.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.1 m -55.18 -39.18 69.27 Favored 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.887 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.9 m -77.49 -54.48 6.38 Favored 'General case' 0 N--CA 1.511 2.607 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -178.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -60.83 -24.72 66.09 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.508 -0.745 . . . . 0.0 110.6 -178.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 44.2 p -95.93 -63.21 1.17 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 122.003 -0.435 . . . . 0.0 112.153 -177.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.7 m -100.23 12.11 37.82 Favored 'General case' 0 N--CA 1.509 2.507 0 O-C-N 121.249 -0.907 . . . . 0.0 111.484 -178.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 57.26 24.13 50.35 Favored Glycine 0 N--CA 1.507 3.395 0 N-CA-C 109.434 -1.467 . . . . 0.0 109.434 -178.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.7 t -116.48 164.83 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 O-C-N 122.053 -0.675 . . . . 0.0 109.469 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 132.09 -177.32 18.79 Favored Glycine 0 N--CA 1.499 2.871 0 N-CA-C 108.675 -1.77 . . . . 0.0 108.675 -178.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -64.01 172.22 6.4 Favored 'Trans proline' 0 N--CA 1.483 0.888 0 CA-C-N 119.485 1.643 . . . . 0.0 109.808 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -92.99 84.64 4.93 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.918 0.866 . . . . 0.0 110.518 -177.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.0 tp -140.26 132.9 28.84 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.88 159.38 0.41 Allowed 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.937 -0.477 . . . . 0.0 109.994 -179.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 34.5 m -74.21 -27.89 61.01 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.934 -0.479 . . . . 0.0 111.255 -178.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -74.17 -38.32 63.72 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.869 -0.519 . . . . 0.0 110.524 -178.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -72.8 -30.65 64.25 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.447 ' HG2' ' CD1' ' A' ' 23' ' ' TYR . 0.5 OUTLIER -70.86 -56.09 7.04 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.665 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.74 -33.65 70.49 Favored 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.88 -34.14 74.95 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.885 -0.784 . . . . 0.0 108.885 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -66.32 -48.93 68.71 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 16.4 m -62.4 -37.71 86.82 Favored 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.332 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 89.5 m -73.88 -28.25 61.47 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -178.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -72.76 -32.27 65.52 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -77.79 -37.02 49.77 Favored 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 120.571 -0.451 . . . . 0.0 109.799 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.401 ' CD2' ' CZ ' ' A' ' 56' ' ' ARG . 2.1 tt -68.65 -36.64 78.86 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -77.09 -41.64 41.35 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.74 -35.11 68.22 Favored 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 58.2 mt -87.0 104.73 6.51 Favored Pre-proline 0 N--CA 1.489 1.5 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 177.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -59.15 145.37 97.94 Favored 'Trans proline' 0 N--CA 1.477 0.557 0 C-N-CA 121.383 1.389 . . . . 0.0 110.305 -177.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -36.49 -32.69 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.444 0 C-N-CA 122.767 0.427 . . . . 0.0 112.049 -178.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -71.04 123.36 21.92 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 23.3 m 77.23 -1.04 2.82 Favored 'General case' 0 N--CA 1.509 2.497 0 C-N-CA 122.266 0.226 . . . . 0.0 110.739 -179.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.401 ' CZ ' ' CD2' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -57.84 -91.56 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.438 -0.789 . . . . 0.0 109.762 -179.918 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 64.6 m -27.51 -42.36 0.02 OUTLIER 'General case' 0 N--CA 1.523 3.178 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -40.02 -54.24 2.26 Favored 'General case' 0 N--CA 1.513 2.703 0 CA-C-N 119.493 1.042 . . . . 0.0 111.801 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -40.4 -46.58 2.42 Favored 'General case' 0 N--CA 1.511 2.581 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 39.4 t -56.56 -49.94 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -59.32 -26.47 65.04 Favored 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.237 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.449 ' CG2' ' HB ' ' A' ' 67' ' ' VAL . 42.4 mm -78.42 -29.84 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 O-C-N 121.926 -0.484 . . . . 0.0 110.341 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.0 -38.64 36.16 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.848 -0.741 . . . . 0.0 109.9 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 2.6 ttm -78.63 -52.78 7.95 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.028 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -80.7 -24.03 39.12 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 122.007 -0.433 . . . . 0.0 111.051 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.41 144.58 5.07 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 108.839 -1.704 . . . . 0.0 108.839 -179.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.449 ' HB ' ' CG2' ' A' ' 62' ' ' ILE . 7.1 p -117.66 159.35 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 122.254 -0.556 . . . . 0.0 109.594 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.409 HG21 ' CD2' ' A' ' 74' ' ' HIS . 51.0 t -114.33 157.23 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.3 p -116.99 159.57 22.29 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.99 -177.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 48.3 t -62.78 -30.47 71.48 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.326 -178.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.8 p -70.1 -16.9 63.19 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.447 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.59 11.46 41.04 Favored Glycine 0 N--CA 1.498 2.8 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -98.64 157.78 16.04 Favored 'General case' 0 N--CA 1.501 2.113 0 CA-C-N 118.103 0.951 . . . . 0.0 109.227 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.409 ' CD2' HG21 ' A' ' 68' ' ' VAL . 10.8 m170 -114.93 155.68 26.44 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -140.29 -178.02 5.29 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.11 0.481 . . . . 0.0 110.194 -179.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 51.79 -144.08 17.56 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.814 -1.315 . . . . 0.0 109.814 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 55.32 22.4 4.82 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 122.394 -0.474 . . . . 0.0 110.071 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.6 mt -86.27 -13.83 45.56 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.719 -0.613 . . . . 0.0 110.93 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.4 tp -61.23 93.24 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -142.9 -177.44 5.33 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.545 0.688 . . . . 0.0 110.216 -178.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -54.3 138.59 38.76 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.842 0.83 . . . . 0.0 111.353 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.496 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 21.3 mt -130.61 168.26 17.74 Favored Pre-proline 0 N--CA 1.497 1.916 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 178.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.496 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 29.4 Cg_endo -68.74 99.75 0.66 Allowed 'Trans proline' 0 N--CA 1.478 0.564 0 C-N-CA 121.044 1.163 . . . . 0.0 110.386 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.8 9.91 63.65 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.431 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 3.4 m -141.95 90.88 8.3 Favored Pre-proline 0 N--CA 1.509 2.515 0 CA-C-N 118.761 1.28 . . . . 0.0 109.756 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -74.25 164.88 33.19 Favored 'Trans proline' 0 N--CA 1.487 1.097 0 C-N-CA 121.885 1.724 . . . . 0.0 111.475 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -48.94 -28.06 3.58 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.063 0.459 . . . . 0.0 110.087 178.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -60.31 -47.49 85.81 Favored 'General case' 0 N--CA 1.502 2.164 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -177.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 44.6 t -69.58 -40.94 80.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.775 -0.578 . . . . 0.0 111.518 -177.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -73.3 -25.44 60.66 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.784 -179.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.7 tpt180 -78.93 -34.36 44.62 Favored 'General case' 0 N--CA 1.503 2.197 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.231 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.39 -43.69 31.83 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.869 -0.519 . . . . 0.0 110.003 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.42 ' CD1' HG23 ' A' ' 24' ' ' VAL . 28.4 t80 -78.53 -25.91 45.63 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 122.274 -0.267 . . . . 0.0 110.415 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.438 ' N ' ' HD2' ' A' ' 95' ' ' PRO . . . -43.41 -51.53 14.78 Favored Pre-proline 0 N--CA 1.502 2.164 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -178.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' A' ' 94' ' ' ALA . 29.2 Cg_endo -70.6 -170.24 0.43 Allowed 'Trans proline' 0 N--CA 1.481 0.784 0 C-N-CA 121.73 1.62 . . . . 0.0 111.058 -179.01 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 61.34 20.36 11.02 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 -178.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.71 -60.96 2.01 Favored 'General case' 0 N--CA 1.508 2.434 0 O-C-N 121.969 -0.457 . . . . 0.0 112.232 -178.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 104' ' ' ASN . 19.8 m -82.94 35.06 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 O-C-N 121.112 -0.993 . . . . 0.0 111.921 -178.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 24.6 p -109.1 174.99 5.62 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 178.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -59.66 -2.46 0.36 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.467 -0.771 . . . . 0.0 111.926 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.9 t -95.61 1.5 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 CA-C-N 120.479 1.49 . . . . 0.0 111.321 -179.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -148.02 -91.96 0.08 Allowed 'General case' 0 N--CA 1.504 2.252 0 CA-C-N 119.011 0.823 . . . . 0.0 111.771 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 7.3 m -132.89 49.35 2.32 Favored 'General case' 0 N--CA 1.509 2.503 0 O-C-N 121.365 -0.834 . . . . 0.0 110.1 -178.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' A' ' 98' ' ' VAL . 38.2 t30 -42.23 -82.29 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.559 0 O-C-N 120.779 -1.201 . . . . 0.0 112.533 -179.014 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 8.1 mt 51.58 24.64 2.39 Favored 'General case' 0 N--CA 1.506 2.343 0 O-C-N 121.836 -0.54 . . . . 0.0 111.922 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 71.07 152.27 0.11 Allowed 'General case' 0 N--CA 1.513 2.722 0 O-C-N 121.001 -1.062 . . . . 0.0 110.669 178.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.9 p -127.85 -163.84 1.31 Allowed 'General case' 0 N--CA 1.51 2.536 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.418 ' CG2' ' CD2' ' A' ' 109' ' ' HIS . 10.9 tt -67.3 -37.28 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.244 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.033 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.418 ' CD2' ' CG2' ' A' ' 108' ' ' ILE . 68.3 m-70 -67.43 -2.03 5.72 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.784 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 58.57 28.6 62.74 Favored Glycine 0 N--CA 1.498 2.778 0 N-CA-C 108.744 -1.742 . . . . 0.0 108.744 -178.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -141.19 178.64 20.1 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -179.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.418 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 32.7 Cg_endo -87.87 55.36 2.63 Favored 'Trans proline' 0 N--CA 1.481 0.772 0 C-N-CA 123.358 2.705 . . . . 0.0 110.655 -179.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.418 ' HB3' ' O ' ' A' ' 112' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.498 1.966 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -178.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo . . . . . 0 N--CA 1.479 0.651 0 N-CA-C 110.262 -0.707 . . . . 0.0 110.262 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 71.38 4.71 57.68 Favored Glycine 0 N--CA 1.502 3.076 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.439 ' O ' ' CB ' ' A' ' 11' ' ' ALA . 2.0 mpt? -139.91 99.85 3.79 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 118.153 0.977 . . . . 0.0 108.59 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.439 ' CB ' ' O ' ' A' ' 10' ' ' MET . . . 86.87 -57.46 0.05 OUTLIER 'General case' 0 N--CA 1.516 2.836 0 CA-C-N 119.392 0.997 . . . . 0.0 108.504 -178.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 17.5 mt -100.1 102.66 18.7 Favored Pre-proline 0 N--CA 1.499 1.992 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 178.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -79.76 176.37 9.56 Favored 'Trans proline' 0 C--O 1.22 -0.402 0 C-N-CA 121.458 1.439 . . . . 0.0 111.034 -177.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.422 ' CE1' HG23 ' A' ' 69' ' ' THR . 41.0 m-70 -86.0 142.61 28.65 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 120.721 0.296 . . . . 0.0 111.017 -177.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.55 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 9.2 t-20 70.46 48.12 0.3 Allowed Pre-proline 0 N--CA 1.508 2.451 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 178.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.55 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 42.7 Cg_endo -86.65 175.51 5.21 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 121.79 1.66 . . . . 0.0 111.345 178.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 49.36 45.18 23.81 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 177.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -77.57 -43.16 32.71 Favored 'General case' 0 N--CA 1.509 2.482 0 O-C-N 121.219 -0.925 . . . . 0.0 108.954 178.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.94 -24.77 66.3 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 57.1 m -74.21 -34.25 63.66 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -179.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.96 -43.57 67.85 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.213 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 32.7 m95 -71.53 -26.5 62.67 Favored 'General case' 0 N--CA 1.504 2.263 0 C-N-CA 118.771 -1.172 . . . . 0.0 109.426 178.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.53 ' HB2' ' HG2' ' A' ' 40' ' ' MET . 10.9 t80 -70.24 -35.36 73.77 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 64.7 t -70.12 -38.59 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 177.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 m -57.42 -38.57 74.56 Favored 'General case' 0 N--CA 1.502 2.147 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.149 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 99.8 m -77.05 -51.75 10.53 Favored 'General case' 0 N--CA 1.511 2.578 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.2 tpt180 -62.99 -24.72 68.05 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.425 -0.797 . . . . 0.0 110.335 -178.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 56.3 p -92.75 -66.58 0.91 Allowed 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -177.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.7 m -100.87 11.49 39.48 Favored 'General case' 0 N--CA 1.511 2.606 0 CA-C-N 119.452 1.024 . . . . 0.0 111.467 -179.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 60.49 25.58 63.25 Favored Glycine 0 N--CA 1.503 3.16 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -178.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 47.8 t -108.32 163.73 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.317 0 O-C-N 121.911 -0.758 . . . . 0.0 109.437 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 126.04 -179.31 16.32 Favored Glycine 0 N--CA 1.499 2.849 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -64.84 171.61 8.34 Favored 'Trans proline' 0 N--CA 1.486 1.033 0 CA-C-N 119.266 1.533 . . . . 0.0 109.911 179.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 10.3 mmt-85 -93.23 84.36 4.78 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.917 0.865 . . . . 0.0 109.992 -178.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -131.98 143.89 50.41 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.76 142.2 58.51 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -49.98 -58.7 4.93 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.506 -0.746 . . . . 0.0 111.004 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -46.82 -40.59 14.04 Favored 'General case' 0 N--CA 1.508 2.462 0 O-C-N 121.892 -0.505 . . . . 0.0 111.482 -178.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -62.78 -46.97 85.52 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.53 ' HG2' ' HB2' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -59.41 -57.69 11.89 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -179.585 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 39.8 tttt -51.82 -29.94 21.39 Favored 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.94 -46.29 78.74 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.9 mmt-85 -58.06 -60.42 3.77 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 16.5 m -54.29 -32.82 57.27 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -178.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 21.5 m -75.43 -30.55 60.07 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -178.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.32 -34.11 70.27 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -79.05 -31.15 44.43 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.122 0.487 . . . . 0.0 109.817 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -67.76 -44.71 76.85 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -178.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -78.12 -28.12 48.43 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.81 -44.28 77.69 Favored 'General case' 0 N--CA 1.504 2.258 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.403 HG22 HD11 ' A' ' 51' ' ' ILE . 39.5 mm -79.83 106.19 4.52 Favored Pre-proline 0 N--CA 1.49 1.568 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 176.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -54.51 144.62 62.0 Favored 'Trans proline' 0 N--CA 1.481 0.766 0 C-N-CA 121.564 1.51 . . . . 0.0 111.572 -175.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.424 ' HA ' ' CG ' ' A' ' 56' ' ' ARG . . . -32.63 -32.42 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.342 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -177.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -63.19 125.27 23.53 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 14.1 m 77.56 17.15 1.47 Allowed 'General case' 0 N--CA 1.514 2.772 0 CA-C-O 119.358 -0.353 . . . . 0.0 111.898 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.424 ' CG ' ' HA ' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -48.68 -89.06 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.862 0 CA-C-N 119.851 1.205 . . . . 0.0 110.175 179.688 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 82.8 m -37.2 -44.2 0.56 Allowed 'General case' 0 N--CA 1.518 2.928 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -42.58 -51.02 5.3 Favored 'General case' 0 N--CA 1.512 2.642 0 CA-C-N 119.931 1.242 . . . . 0.0 111.735 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -41.88 -45.48 3.71 Favored 'General case' 0 N--CA 1.513 2.71 0 O-C-N 121.701 -0.625 . . . . 0.0 112.007 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 20.4 t -55.34 -48.58 76.63 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 10.1 ttp180 -58.81 -29.42 66.84 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.826 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.43 ' CG2' ' HB ' ' A' ' 67' ' ' VAL . 11.2 mt -77.57 -27.32 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.286 0 O-C-N 121.899 -0.501 . . . . 0.0 109.955 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.4 tp -77.63 -43.95 29.81 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 120.073 -0.651 . . . . 0.0 110.082 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.54 -50.42 11.61 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.284 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -81.09 -23.31 38.54 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.965 -0.459 . . . . 0.0 111.48 -179.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.87 149.31 8.24 Favored Glycine 0 N--CA 1.499 2.838 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -178.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.43 ' HB ' ' CG2' ' A' ' 62' ' ' ILE . 5.8 p -117.93 159.37 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.428 ' CG2' ' CE1' ' A' ' 74' ' ' HIS . 79.1 t -114.7 158.07 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-O 121.756 0.789 . . . . 0.0 109.389 -178.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.422 HG23 ' CE1' ' A' ' 14' ' ' HIS . 27.0 p -117.0 158.61 23.83 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 115.339 -0.846 . . . . 0.0 108.96 -178.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.7 t -64.26 -33.14 75.13 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.883 -178.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.6 p -62.91 -17.6 61.94 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.935 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.58 13.5 34.96 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -103.85 156.9 17.46 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-N 118.198 0.999 . . . . 0.0 109.524 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.428 ' CE1' ' CG2' ' A' ' 68' ' ' VAL . 9.3 m170 -115.44 155.86 26.67 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -142.79 -177.49 5.34 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 120.236 -0.586 . . . . 0.0 110.612 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.413 ' O ' ' CG ' ' A' ' 77' ' ' ARG . . . 59.95 -132.42 50.86 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 108.374 -1.89 . . . . 0.0 108.374 -178.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.413 ' CG ' ' O ' ' A' ' 76' ' ' GLY . 2.1 ptm180 44.18 28.61 0.29 Allowed 'General case' 0 N--CA 1.507 2.383 0 CA-C-O 120.978 0.418 . . . . 0.0 110.189 179.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.7 mt -72.81 -19.45 61.33 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 122.037 -0.415 . . . . 0.0 110.58 -178.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.5 tp -49.21 105.27 0.08 Allowed 'General case' 0 N--CA 1.503 2.183 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -139.95 170.51 15.74 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.371 0.605 . . . . 0.0 109.89 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -80.45 105.49 11.74 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 121.379 0.609 . . . . 0.0 110.342 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.559 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 15.5 mt -86.7 171.87 9.34 Favored Pre-proline 0 N--CA 1.5 2.03 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 177.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.559 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 28.9 Cg_endo -68.73 103.28 0.97 Allowed 'Trans proline' 0 C--N 1.328 -0.5 0 C-N-CA 120.865 1.043 . . . . 0.0 109.878 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.36 11.76 60.63 Favored Glycine 0 N--CA 1.498 2.813 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 3.5 m -143.07 90.37 7.46 Favored Pre-proline 0 N--CA 1.507 2.376 0 CA-C-N 118.705 1.252 . . . . 0.0 108.563 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -74.38 159.93 42.66 Favored 'Trans proline' 0 C--N 1.325 -0.673 0 C-N-CA 121.16 1.24 . . . . 0.0 111.0 -178.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 32.0 mtp180 -49.23 -28.64 4.79 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.389 0.614 . . . . 0.0 109.738 178.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -56.15 -49.0 75.21 Favored 'General case' 0 N--CA 1.503 2.176 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.971 -178.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.5 t -65.14 -39.43 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.667 -0.646 . . . . 0.0 109.667 -178.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 23.4 mm-40 -64.26 -29.4 70.49 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -78.46 -26.78 46.22 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.9 -50.14 25.5 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.869 -0.519 . . . . 0.0 109.656 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -78.88 -26.04 43.92 Favored 'General case' 0 N--CA 1.508 2.456 0 O-C-N 122.057 -0.402 . . . . 0.0 111.042 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.41 ' N ' ' CD ' ' A' ' 95' ' ' PRO . . . -48.74 -47.43 72.12 Favored Pre-proline 0 N--CA 1.505 2.278 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -177.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' A' ' 94' ' ' ALA . 33.0 Cg_endo -73.77 25.46 0.33 Allowed 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 122.371 2.047 . . . . 0.0 114.258 -178.148 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.1 mttp -135.61 37.81 2.88 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.48 ' O ' ' HB3' ' A' ' 102' ' ' GLU . 0.3 OUTLIER -74.58 -75.27 0.17 Allowed 'General case' 0 N--CA 1.503 2.208 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.992 -178.978 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 8.7 m -76.0 10.11 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 O-C-N 121.067 -1.021 . . . . 0.0 111.637 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 11.9 p -87.04 176.6 7.54 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -65.09 5.35 0.36 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.452 -0.78 . . . . 0.0 111.873 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 56.3 t -96.23 -5.24 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 CA-C-N 120.265 1.393 . . . . 0.0 111.009 -179.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.48 ' HB3' ' O ' ' A' ' 97' ' ' LEU . 4.1 tp10 -142.07 -85.46 0.17 Allowed 'General case' 0 N--CA 1.513 2.71 0 C-N-CA 118.626 -1.23 . . . . 0.0 112.869 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 20.8 m -136.57 40.56 2.59 Favored 'General case' 0 N--CA 1.507 2.387 0 CA-C-N 119.601 1.091 . . . . 0.0 110.616 -177.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.408 ' O ' ' CB ' ' A' ' 105' ' ' LEU . 25.6 t30 -44.95 -95.76 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.385 -0.822 . . . . 0.0 111.946 -179.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.408 ' CB ' ' O ' ' A' ' 104' ' ' ASN . 1.4 mt 87.19 -58.41 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.462 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -177.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 160.95 127.68 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.503 ' OG1' ' CE1' ' A' ' 109' ' ' HIS . 2.3 p -91.59 -146.62 0.21 Allowed 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -178.445 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.5 tp -57.41 -39.34 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.825 -0.547 . . . . 0.0 111.059 178.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.51 ' CE1' ' O ' ' A' ' 113' ' ' PHE . 2.2 p80 -90.78 21.93 3.84 Favored 'General case' 0 N--CA 1.515 2.786 0 O-C-N 122.047 -0.408 . . . . 0.0 111.255 -177.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 53.18 64.89 3.77 Favored Glycine 0 N--CA 1.497 2.733 0 O-C-N 121.598 -0.688 . . . . 0.0 111.609 177.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 159.49 172.97 27.35 Favored Glycine 0 N--CA 1.498 2.822 0 CA-C-N 118.419 1.11 . . . . 0.0 111.096 178.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.46 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 36.2 Cg_endo -85.17 80.38 2.09 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.059 2.506 . . . . 0.0 111.642 -178.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.51 ' O ' ' CE1' ' A' ' 109' ' ' HIS . 8.3 p90 . . . . . 0 N--CA 1.535 3.783 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo . . . . . 0 C--O 1.215 -0.661 0 N-CA-C 110.707 -0.536 . . . . 0.0 110.707 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.72 10.2 36.62 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.596 ' O ' ' CB ' ' A' ' 11' ' ' ALA . 0.3 OUTLIER -137.01 104.55 5.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.338 -1.095 . . . . 0.0 108.768 179.803 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.596 ' CB ' ' O ' ' A' ' 10' ' ' MET . . . 86.01 -59.68 0.06 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.749 -1.219 . . . . 0.0 108.181 -178.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 5.6 mt -102.2 101.6 20.13 Favored Pre-proline 0 C--N 1.303 -1.42 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 11' ' ' ALA . 34.3 Cg_endo -82.11 173.39 10.97 Favored 'Trans proline' 0 C--N 1.319 -0.981 0 C-N-CA 121.602 1.534 . . . . 0.0 111.945 -176.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 51.3 m-70 -74.85 149.38 39.59 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -179.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.646 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 6.4 t30 55.3 50.94 6.47 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 120.831 -1.168 . . . . 0.0 110.039 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.646 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 37.7 Cg_endo -78.99 -174.64 2.37 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 122.478 2.119 . . . . 0.0 111.122 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.521 ' HB3' ' CD1' ' A' ' 63' ' ' LEU . 4.3 mm? 47.12 41.79 12.02 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.716 -0.615 . . . . 0.0 111.046 178.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.444 ' CG ' ' N ' ' A' ' 19' ' ' SER . 1.9 p30 -81.91 -47.21 13.03 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.034 -1.041 . . . . 0.0 109.128 179.1 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.444 ' N ' ' CG ' ' A' ' 18' ' ' ASP . 0.2 OUTLIER -60.74 -26.46 67.21 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.276 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.459 ' SG ' ' CD1' ' A' ' 17' ' ' LEU . 75.4 m -74.77 -34.73 62.52 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.535 ' HG3' ' N ' ' A' ' 22' ' ' TRP . 0.1 OUTLIER -66.95 -49.94 63.89 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.399 -0.813 . . . . 0.0 108.877 179.503 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.535 ' N ' ' HG3' ' A' ' 21' ' ' ARG . 31.6 m95 -71.44 -27.51 63.33 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.86 -1.15 . . . . 0.0 109.456 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.543 ' HB2' ' CG ' ' A' ' 40' ' ' MET . 26.4 t80 -67.03 -34.61 78.09 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.248 -0.907 . . . . 0.0 109.227 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.576 HG23 ' CD1' ' A' ' 93' ' ' PHE . 78.3 t -74.86 -40.15 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 118.59 -1.244 . . . . 0.0 108.087 178.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.467 ' OG ' ' O ' ' A' ' 22' ' ' TRP . 61.1 p -55.44 -37.66 67.99 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.114 -1.035 . . . . 0.0 109.262 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.466 ' OG1' ' O ' ' A' ' 31' ' ' VAL . 3.5 m -78.31 -55.09 5.52 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.337 -0.852 . . . . 0.0 111.476 -178.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 8.3 mmm180 -58.47 -25.1 61.91 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.792 -1.192 . . . . 0.0 110.388 -178.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 24' ' ' VAL . 69.5 p -95.61 -64.44 1.06 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.175 -0.953 . . . . 0.0 111.57 -177.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.473 ' SG ' ' O ' ' A' ' 84' ' ' GLY . 3.4 m -98.89 16.15 23.3 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.816 -1.178 . . . . 0.0 109.806 -178.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.45 ' HA2' ' O ' ' A' ' 26' ' ' THR . . . 51.78 21.94 7.97 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 -179.006 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.516 ' CG1' ' N ' ' A' ' 32' ' ' GLY . 40.7 t -102.47 165.63 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.386 -1.067 . . . . 0.0 109.335 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.516 ' N ' ' CG1' ' A' ' 31' ' ' VAL . . . 129.69 176.87 14.6 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.438 -1.865 . . . . 0.0 108.438 -179.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -65.3 173.5 6.2 Favored 'Trans proline' 0 C--O 1.214 -0.693 0 CA-C-N 119.143 1.472 . . . . 0.0 109.897 179.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -92.26 82.87 4.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.872 -1.143 . . . . 0.0 110.3 -178.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.43 HD13 ' HA ' ' A' ' 35' ' ' LEU . 9.1 tp -137.29 135.5 37.19 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.015 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 35' ' ' LEU . . . -46.55 155.4 0.24 Allowed 'General case' 0 N--CA 1.487 1.375 0 O-C-N 120.923 -1.111 . . . . 0.0 109.051 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.431 ' O ' ' C ' ' A' ' 38' ' ' GLN . 0.6 OUTLIER -74.34 -55.27 6.2 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.042 -1.036 . . . . 0.0 110.002 -179.562 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.431 ' C ' ' O ' ' A' ' 37' ' ' THR . 2.2 mp0 -43.31 -34.6 1.25 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.228 -0.92 . . . . 0.0 109.691 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.43 ' O ' ' HB1' ' A' ' 42' ' ' ALA . 10.1 mm-40 -64.87 -52.1 58.41 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.109 -0.994 . . . . 0.0 108.593 179.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.543 ' CG ' ' HB2' ' A' ' 23' ' ' TYR . 0.4 OUTLIER -54.43 -60.78 2.89 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.232 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.435 ' C ' ' O ' ' A' ' 40' ' ' MET . 20.9 ttpt -44.3 -35.34 2.29 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.43 ' HB1' ' O ' ' A' ' 39' ' ' GLU . . . -63.2 -48.93 76.23 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.486 -0.759 . . . . 0.0 109.029 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.443 ' HD3' ' OG ' ' A' ' 19' ' ' SER . 7.7 mtt-85 -55.1 -52.39 63.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.373 -0.83 . . . . 0.0 109.539 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 20.9 m -55.89 -35.77 66.91 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 0.0 109.904 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 81.7 m -68.97 -28.62 66.78 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.038 -1.039 . . . . 0.0 109.148 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.72 -31.34 64.91 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.326 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.42 ' O ' HG13 ' A' ' 51' ' ' ILE . 3.4 mm-40 -76.79 -36.41 57.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.465 -0.772 . . . . 0.0 109.506 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.511 ' CD2' HD11 ' A' ' 105' ' ' LEU . 7.4 tt -72.21 -36.63 69.22 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.265 -0.897 . . . . 0.0 109.299 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.458 ' O ' ' C ' ' A' ' 50' ' ' ALA . 1.2 tt0 -71.64 -55.73 7.19 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.49 ' O ' ' HD3' ' A' ' 52' ' ' PRO . . . -45.92 -47.92 16.29 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 178.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.452 HG23 ' HD3' ' A' ' 56' ' ' ARG . 88.9 mt -62.12 106.43 0.84 Allowed Pre-proline 0 C--N 1.303 -1.452 0 N-CA-C 107.059 -1.459 . . . . 0.0 107.059 176.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.535 ' O ' ' N ' ' A' ' 54' ' ' TYR . 25.1 Cg_endo -61.38 141.03 91.11 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 121.607 1.538 . . . . 0.0 110.925 -177.082 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.522 ' HA ' ' HG3' ' A' ' 56' ' ' ARG . . . -31.29 -35.18 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.156 0.503 . . . . 0.0 110.811 -178.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.54 ' O ' ' CB ' ' A' ' 55' ' ' CYS . 9.4 m-85 -75.0 129.14 37.14 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.138 -0.976 . . . . 0.0 109.153 179.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.54 ' CB ' ' O ' ' A' ' 54' ' ' TYR . 4.3 m 79.23 0.45 2.33 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.338 -0.851 . . . . 0.0 110.924 179.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.529 ' O ' ' C ' ' A' ' 57' ' ' CYS . 3.7 mmt85 -43.19 -90.24 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.704 -1.248 . . . . 0.0 109.706 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.529 ' C ' ' O ' ' A' ' 56' ' ' ARG . 3.3 m -21.47 -55.13 0.02 OUTLIER 'General case' 0 N--CA 1.514 2.755 0 O-C-N 122.069 -0.394 . . . . 0.0 111.706 -179.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.503 ' C ' ' O ' ' A' ' 57' ' ' CYS . 1.3 mm-40 -31.13 -59.41 0.22 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.596 -0.69 . . . . 0.0 110.82 -179.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.503 ' C ' ' O ' ' A' ' 58' ' ' GLU . . . -29.05 -56.38 0.14 Allowed 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 121.223 0.535 . . . . 0.0 111.07 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.524 ' CG2' ' CD2' ' A' ' 97' ' ' LEU . 32.0 t -55.17 -53.09 38.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 O-C-N 121.282 -0.886 . . . . 0.0 109.498 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.518 ' O ' ' HB2' ' A' ' 65' ' ' ASP . 17.9 mmt85 -56.49 -26.85 55.56 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.389 -0.819 . . . . 0.0 109.989 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.645 ' CG2' ' CB ' ' A' ' 67' ' ' VAL . 16.1 mm -79.09 -28.9 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.914 -1.116 . . . . 0.0 110.494 -179.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.521 ' CD1' ' HB3' ' A' ' 17' ' ' LEU . 9.1 tt -77.48 -50.03 13.52 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.91 -1.119 . . . . 0.0 108.848 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -78.12 -47.81 17.4 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.198 -0.939 . . . . 0.0 109.743 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.518 ' HB2' ' O ' ' A' ' 61' ' ' ARG . 0.7 OUTLIER -80.21 -20.02 45.64 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.117 -0.989 . . . . 0.0 109.799 -179.98 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 62' ' ' ILE . . . 102.05 162.21 26.61 Favored Glycine 0 N--CA 1.485 1.944 0 C-N-CA 119.31 -1.424 . . . . 0.0 110.749 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.645 ' CB ' ' CG2' ' A' ' 62' ' ' ILE . 3.6 p -113.85 155.54 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.461 HG21 ' CD2' ' A' ' 74' ' ' HIS . 22.3 t -120.52 156.25 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 120.893 -1.13 . . . . 0.0 110.185 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.435 ' N ' ' CG1' ' A' ' 68' ' ' VAL . 46.3 p -118.19 158.49 25.01 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.3 t -65.31 -27.9 68.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.415 -0.803 . . . . 0.0 109.681 -179.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.1 p -68.47 -14.23 62.86 Favored 'General case' 0 C--N 1.294 -1.815 0 O-C-N 121.586 -0.696 . . . . 0.0 109.238 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 99.28 8.76 52.71 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 108.827 -1.709 . . . . 0.0 108.827 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -93.02 156.41 16.91 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.106 -1.232 . . . . 0.0 109.648 -179.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.461 ' CD2' HG21 ' A' ' 68' ' ' VAL . 9.0 m170 -116.53 155.2 29.08 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 120.963 -1.086 . . . . 0.0 109.043 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.515 ' HB2' ' CG1' ' A' ' 67' ' ' VAL . 19.5 mm-40 -147.78 -169.92 3.45 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 121.563 0.696 . . . . 0.0 109.352 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 58.78 -145.61 42.92 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.93 16.9 4.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.286 -1.126 . . . . 0.0 110.069 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.521 ' O ' ' N ' ' A' ' 80' ' ' GLN . 1.0 OUTLIER -76.18 -18.51 59.05 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.985 -1.072 . . . . 0.0 109.669 -179.645 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.471 ' HG ' ' HG2' ' A' ' 90' ' ' GLN . 7.7 tt -47.41 94.91 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.101 -0.999 . . . . 0.0 108.706 179.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.521 ' N ' ' O ' ' A' ' 78' ' ' LEU . 23.2 mm100 -127.71 179.24 5.63 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.075 -1.016 . . . . 0.0 110.197 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.14 104.82 3.74 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.808 0.813 . . . . 0.0 110.863 -179.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.672 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 13.7 mt -82.88 173.41 7.59 Favored Pre-proline 0 C--N 1.298 -1.643 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 177.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.672 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 28.5 Cg_endo -69.15 104.86 1.29 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 120.873 1.048 . . . . 0.0 109.695 179.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.473 ' O ' ' SG ' ' A' ' 29' ' ' CYS . . . 92.04 4.75 66.63 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 -179.298 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.445 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 3.3 m -139.1 88.03 13.54 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 120.753 -1.44 . . . . 0.0 108.758 179.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.425 ' O ' ' C ' ' A' ' 87' ' ' ARG . 30.9 Cg_endo -76.21 159.13 37.2 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 121.638 1.558 . . . . 0.0 111.884 -178.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.425 ' C ' ' O ' ' A' ' 86' ' ' PRO . 7.1 mmm-85 -45.2 -28.24 0.74 Allowed 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.413 ' N ' ' C ' ' A' ' 86' ' ' PRO . 49.8 tt0 -54.34 -61.74 2.11 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.262 -178.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 58.8 t -59.06 -40.64 81.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.084 -1.01 . . . . 0.0 109.952 -178.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.471 ' HG2' ' HG ' ' A' ' 79' ' ' LEU . 0.4 OUTLIER -62.77 -26.82 68.9 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 119.537 -0.865 . . . . 0.0 108.737 179.685 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.53 -31.22 47.41 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.434 -0.791 . . . . 0.0 109.77 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.503 ' O ' ' HD2' ' A' ' 95' ' ' PRO . . . -73.37 -42.97 61.54 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.087 -1.008 . . . . 0.0 109.47 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.576 ' CD1' HG23 ' A' ' 24' ' ' VAL . 21.5 t80 -78.03 -25.75 48.01 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.35 -0.844 . . . . 0.0 110.143 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.546 ' N ' ' HD2' ' A' ' 95' ' ' PRO . . . -37.24 -53.36 2.16 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.597 -0.69 . . . . 0.0 110.94 -179.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 94' ' ' ALA . 31.5 Cg_endo -73.75 -178.74 3.97 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.175 1.917 . . . . 0.0 110.305 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 95' ' ' PRO . 0.1 OUTLIER 71.36 24.66 3.66 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.248 -0.908 . . . . 0.0 108.839 -179.201 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.524 ' CD2' ' CG2' ' A' ' 60' ' ' VAL . 17.6 tp -73.01 -69.87 0.39 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.464 -0.772 . . . . 0.0 110.64 -179.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 104' ' ' ASN . 2.4 m -79.35 26.57 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.571 -1.331 . . . . 0.0 110.906 -179.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.462 HG22 ' HA ' ' A' ' 96' ' ' LYS . 5.2 p -103.87 174.22 5.96 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 120.617 -1.302 . . . . 0.0 108.902 179.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -58.81 -0.93 0.12 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.848 -1.157 . . . . 0.0 112.006 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.1 t -98.78 6.16 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 119.945 -1.722 . . . . 0.0 110.459 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.428 ' CB ' ' O ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -145.57 -90.49 0.1 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.741 -1.225 . . . . 0.0 110.391 -179.949 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.51 ' O ' ' CD1' ' A' ' 105' ' ' LEU . 56.0 m -145.22 40.85 1.24 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.953 -1.092 . . . . 0.0 109.195 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.555 ' O ' ' CB ' ' A' ' 105' ' ' LEU . 24.0 t30 -33.28 -89.47 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.412 -0.805 . . . . 0.0 111.983 -178.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.569 ' O ' ' CB ' ' A' ' 106' ' ' ALA . 3.3 mt 85.3 -66.87 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -177.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.569 ' CB ' ' O ' ' A' ' 105' ' ' LEU . . . 155.97 115.1 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.8 p -85.55 -162.26 0.7 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.4 tp -73.38 -16.97 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 120.87 -1.144 . . . . 0.0 109.424 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.466 ' CB ' ' CE1' ' A' ' 113' ' ' PHE . 84.1 m-70 -80.06 16.27 1.27 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.432 -0.792 . . . . 0.0 110.377 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 109' ' ' HIS . . . 43.97 26.44 0.83 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 109' ' ' HIS . . . -153.6 172.72 32.4 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.463 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 33.7 Cg_endo -78.29 81.91 2.6 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 123.021 2.481 . . . . 0.0 110.938 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.589 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.064 -1.022 . . . . 0.0 110.552 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo . . . . . 0 CA--C 1.539 0.743 0 N-CA-C 110.568 -0.589 . . . . 0.0 110.568 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 54.44 17.32 8.17 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.876 -1.289 . . . . 0.0 109.876 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.584 ' O ' ' CB ' ' A' ' 11' ' ' ALA . 1.4 mtt -139.38 108.2 5.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.29 -1.123 . . . . 0.0 108.669 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.584 ' CB ' ' O ' ' A' ' 10' ' ' MET . . . 85.35 -60.89 0.07 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.815 -1.178 . . . . 0.0 108.288 -178.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.451 HD13 ' CB ' ' A' ' 55' ' ' CYS . 1.7 mt -103.1 101.56 22.55 Favored Pre-proline 0 N--CA 1.485 1.315 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.458 ' HD3' ' O ' ' A' ' 11' ' ' ALA . 31.7 Cg_endo -80.61 174.14 11.47 Favored 'Trans proline' 0 C--N 1.317 -1.089 0 C-N-CA 121.281 1.321 . . . . 0.0 111.355 -177.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.463 ' O ' ' CG ' ' A' ' 15' ' ' ASN . 53.8 m-70 -73.75 148.27 42.74 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.769 -0.582 . . . . 0.0 109.761 -179.023 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.569 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 3.1 p-10 43.25 58.63 11.96 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.065 -1.022 . . . . 0.0 110.503 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.569 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 37.2 Cg_endo -81.09 166.16 18.85 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.676 2.251 . . . . 0.0 110.91 179.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.445 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 14.5 mt 55.08 45.82 25.38 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.471 -0.768 . . . . 0.0 111.179 178.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -69.74 -45.38 68.25 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.815 -1.178 . . . . 0.0 108.589 178.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.474 ' O ' ' HB2' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -62.4 -25.2 67.81 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.886 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.445 ' SG ' ' HB3' ' A' ' 17' ' ' LEU . 73.9 m -69.55 -44.79 70.2 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.376 0.608 . . . . 0.0 109.483 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.61 -48.71 76.24 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.179 -0.951 . . . . 0.0 109.389 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.448 ' HA ' ' CE3' ' A' ' 22' ' ' TRP . 26.5 m95 -69.59 -26.25 64.37 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.443 -1.411 . . . . 0.0 109.382 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.587 ' CG ' ' HG2' ' A' ' 40' ' ' MET . 1.5 t80 -67.44 -30.11 69.75 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.546 HG21 ' CE2' ' A' ' 93' ' ' PHE . 59.1 t -75.18 -42.95 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 C-N-CA 118.758 -1.177 . . . . 0.0 107.859 178.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.7 p -56.03 -41.75 75.46 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.076 -1.05 . . . . 0.0 109.965 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.504 ' CA ' ' O ' ' A' ' 31' ' ' VAL . 3.4 m -77.83 -54.48 6.28 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.253 -0.904 . . . . 0.0 111.308 -178.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -58.7 -24.83 62.13 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 120.847 -1.158 . . . . 0.0 110.437 -178.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.504 ' CG2' HG11 ' A' ' 24' ' ' VAL . 59.1 p -94.62 -65.68 0.97 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.135 -0.978 . . . . 0.0 111.232 -178.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.476 ' SG ' ' O ' ' A' ' 84' ' ' GLY . 3.5 m -99.3 16.95 21.32 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.737 -1.227 . . . . 0.0 109.914 -178.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 26' ' ' THR . . . 55.93 18.88 20.03 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 -178.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.504 ' O ' ' CA ' ' A' ' 26' ' ' THR . 30.2 t -101.6 157.3 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.312 -1.11 . . . . 0.0 109.525 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.405 ' N ' ' CG1' ' A' ' 31' ' ' VAL . . . 131.29 177.61 14.99 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.494 -1.842 . . . . 0.0 108.494 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -66.59 171.99 9.94 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 CA-C-N 119.15 1.475 . . . . 0.0 110.066 179.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -92.67 70.58 4.88 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.935 -1.103 . . . . 0.0 110.364 -178.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.451 ' O ' ' C ' ' A' ' 36' ' ' ALA . 0.8 OUTLIER -109.8 122.8 48.33 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 178.803 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.451 ' C ' ' O ' ' A' ' 35' ' ' LEU . . . -41.27 128.71 2.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.324 -0.86 . . . . 0.0 109.154 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.8 m -51.16 -38.8 54.24 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.829 -1.169 . . . . 0.0 111.377 -178.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -61.04 -36.95 80.94 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.751 -1.218 . . . . 0.0 110.194 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -72.43 -26.76 61.96 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.135 -0.978 . . . . 0.0 109.196 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.587 ' HG2' ' CG ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -72.48 -60.89 2.01 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.898 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -54.56 -36.16 64.03 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.84 -43.5 95.98 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.328 -0.857 . . . . 0.0 109.095 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.405 ' NH1' ' CG ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -60.23 -52.66 64.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.311 -0.868 . . . . 0.0 109.579 179.929 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.428 ' SG ' ' N ' ' A' ' 20' ' ' CYS . 14.7 m -56.68 -35.97 69.05 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.262 -0.899 . . . . 0.0 110.633 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 32.8 m -70.45 -30.72 67.63 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.754 -1.216 . . . . 0.0 109.043 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -68.41 -34.74 76.56 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 179.098 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.466 ' O ' HG13 ' A' ' 51' ' ' ILE . 3.1 mt-30 -77.83 -27.41 49.96 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.542 -0.724 . . . . 0.0 109.138 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.424 ' HG ' ' HB2' ' A' ' 103' ' ' CYS . 1.6 tm? -69.55 -39.02 77.69 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.465 -0.772 . . . . 0.0 108.942 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.429 ' HG3' HD13 ' A' ' 105' ' ' LEU . 3.6 tt0 -77.41 -47.23 20.31 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.489 ' O ' ' HD3' ' A' ' 52' ' ' PRO . . . -45.53 -43.76 12.12 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 178.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.469 ' O ' ' HD2' ' A' ' 56' ' ' ARG . 49.4 mt -73.42 107.44 3.36 Favored Pre-proline 0 C--N 1.301 -1.519 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 177.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.535 ' O ' ' N ' ' A' ' 54' ' ' TYR . 25.4 Cg_endo -61.15 149.43 89.25 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 121.702 1.601 . . . . 0.0 111.224 -176.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.637 ' HA ' ' HD3' ' A' ' 56' ' ' ARG . . . -34.99 -29.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.037 0.446 . . . . 0.0 111.083 -178.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.54 ' O ' ' CB ' ' A' ' 55' ' ' CYS . 1.5 m-85 -79.88 125.87 30.28 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 120.999 -1.063 . . . . 0.0 110.017 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.54 ' CB ' ' O ' ' A' ' 54' ' ' TYR . 4.5 m 81.63 -0.22 1.58 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.489 -0.757 . . . . 0.0 111.727 178.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.637 ' HD3' ' HA ' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -46.98 -89.9 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.316 -1.49 . . . . 0.0 109.328 -179.916 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.493 ' O ' ' C ' ' A' ' 58' ' ' GLU . 53.5 m -33.36 -56.81 0.42 Allowed 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.325 -0.86 . . . . 0.0 111.904 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.493 ' C ' ' O ' ' A' ' 57' ' ' CYS . 27.3 tt0 -32.34 -51.35 0.26 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.029 -1.045 . . . . 0.0 111.416 -179.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.458 ' C ' ' O ' ' A' ' 58' ' ' GLU . . . -36.17 -54.82 0.8 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.282 -0.886 . . . . 0.0 110.643 -179.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 44.0 t -54.63 -47.98 71.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 121.327 -0.858 . . . . 0.0 109.17 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.59 -27.03 62.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.217 -0.927 . . . . 0.0 109.442 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.589 ' CG2' ' HB ' ' A' ' 67' ' ' VAL . 3.7 mm -77.74 -30.14 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.254 -0.904 . . . . 0.0 109.747 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.512 ' O ' ' HA ' ' A' ' 77' ' ' ARG . 8.1 tt -77.88 -40.43 40.06 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.81 -1.181 . . . . 0.0 109.283 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.453 ' SD ' ' HG ' ' A' ' 79' ' ' LEU . 10.4 tpt -77.81 -53.72 7.17 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.239 -0.913 . . . . 0.0 109.985 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -79.61 -22.28 43.87 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.194 -0.941 . . . . 0.0 110.307 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.425 ' CA ' ' HB2' ' A' ' 77' ' ' ARG . . . 88.76 146.71 13.19 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.589 ' HB ' ' CG2' ' A' ' 62' ' ' ILE . 4.0 p -116.88 160.18 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.61 -0.935 . . . . 0.0 109.337 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.635 ' CG2' ' CE1' ' A' ' 74' ' ' HIS . 9.5 t -114.17 158.46 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 CA-C-O 121.9 0.857 . . . . 0.0 109.854 -178.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.459 ' N ' ' CG1' ' A' ' 68' ' ' VAL . 69.1 p -116.78 158.51 23.77 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.636 0.731 . . . . 0.0 109.728 -178.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 38.8 t -65.55 -25.63 67.51 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.418 0.628 . . . . 0.0 110.11 -178.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.2 p -71.82 -14.15 61.89 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.484 -0.76 . . . . 0.0 109.226 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.25 8.4 50.25 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 108.789 -1.725 . . . . 0.0 108.789 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.433 ' O ' ' OG1' ' A' ' 69' ' ' THR . 1.1 mt-30 -100.86 156.15 17.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.075 -1.25 . . . . 0.0 109.18 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.635 ' CE1' ' CG2' ' A' ' 68' ' ' VAL . 13.4 m170 -115.25 155.66 26.84 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.968 -1.083 . . . . 0.0 108.958 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.422 ' CD ' ' O ' ' A' ' 74' ' ' HIS . 22.4 mm-40 -139.51 -171.45 3.14 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.549 -0.86 . . . . 0.0 109.999 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 53.77 -147.1 20.6 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 108.366 -1.894 . . . . 0.0 108.366 -178.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.512 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 14.4 ttt85 52.94 23.13 2.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.118 -1.225 . . . . 0.0 109.577 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.18 -10.82 45.68 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.087 -1.008 . . . . 0.0 110.654 -179.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.613 HD11 ' N ' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -57.08 123.18 14.34 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.461 -1.4 . . . . 0.0 108.68 179.514 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.457 ' CG ' ' O ' ' A' ' 79' ' ' LEU . 49.6 mt-30 -156.5 -179.2 7.95 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.758 -1.214 . . . . 0.0 110.234 -178.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.19 105.57 1.12 Allowed 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.869 0.843 . . . . 0.0 110.754 -179.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.65 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 22.2 mt -89.7 171.77 8.24 Favored Pre-proline 0 C--N 1.298 -1.632 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.018 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.65 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 28.3 Cg_endo -67.29 100.39 0.55 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 121.136 1.224 . . . . 0.0 110.422 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.476 ' O ' ' SG ' ' A' ' 29' ' ' CYS . . . 91.27 14.26 57.59 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.464 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 3.3 m -144.55 91.58 6.19 Favored Pre-proline 0 N--CA 1.498 1.926 0 O-C-N 120.904 -1.35 . . . . 0.0 109.224 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.414 ' O ' ' C ' ' A' ' 87' ' ' ARG . 29.9 Cg_endo -75.2 157.09 42.11 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 121.459 1.439 . . . . 0.0 112.028 -178.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.414 ' C ' ' O ' ' A' ' 86' ' ' PRO . 8.1 mtm-85 -45.25 -28.54 0.82 Allowed 'General case' 0 N--CA 1.483 1.201 0 O-C-N 121.306 -0.872 . . . . 0.0 108.821 178.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -57.78 -62.27 1.92 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.907 -0.496 . . . . 0.0 111.456 -177.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.8 t -61.34 -39.4 82.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 120.958 -1.089 . . . . 0.0 110.137 -178.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.433 ' O ' ' HB1' ' A' ' 94' ' ' ALA . 2.2 mp0 -63.62 -27.41 69.22 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.684 -0.806 . . . . 0.0 108.856 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.43 -33.38 48.63 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.469 -0.77 . . . . 0.0 109.52 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.482 ' O ' ' HD2' ' A' ' 95' ' ' PRO . . . -69.98 -50.94 36.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.154 -0.966 . . . . 0.0 109.513 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.574 ' O ' ' CD1' ' A' ' 93' ' ' PHE . 5.6 t80 -78.14 -25.72 47.49 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.241 -0.912 . . . . 0.0 110.239 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.561 ' N ' ' HD2' ' A' ' 95' ' ' PRO . . . -38.55 -53.02 3.34 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.331 -0.856 . . . . 0.0 111.365 -178.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 94' ' ' ALA . 30.0 Cg_endo -71.38 -174.68 1.29 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.025 1.817 . . . . 0.0 110.854 -179.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.496 ' CB ' ' O ' ' A' ' 95' ' ' PRO . 1.2 ttmm 74.31 32.71 0.95 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.273 -0.892 . . . . 0.0 108.857 -178.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.61 -73.08 0.25 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.475 -0.766 . . . . 0.0 111.469 -178.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.528 ' O ' ' CB ' ' A' ' 104' ' ' ASN . 2.0 m -77.62 24.69 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.737 -1.227 . . . . 0.0 111.678 -178.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.46 HG22 ' HA ' ' A' ' 96' ' ' LYS . 24.7 p -95.81 169.54 9.93 Favored 'General case' 0 C--N 1.294 -1.815 0 O-C-N 120.547 -1.345 . . . . 0.0 108.671 179.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.468 ' HA ' ' ND2' ' A' ' 104' ' ' ASN . 0.6 OUTLIER -59.74 -1.0 0.22 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.658 -1.276 . . . . 0.0 111.774 -179.665 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.0 t -98.92 5.87 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 119.855 -1.778 . . . . 0.0 110.336 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -142.17 -91.29 0.13 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.808 -1.182 . . . . 0.0 110.117 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.487 ' O ' HD22 ' A' ' 105' ' ' LEU . 74.2 m -145.15 39.56 1.21 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.938 -1.101 . . . . 0.0 109.451 -179.177 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.528 ' CB ' ' O ' ' A' ' 98' ' ' VAL . 4.5 p30 -34.58 -47.9 0.34 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.355 -0.841 . . . . 0.0 111.719 -179.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.487 HD22 ' O ' ' A' ' 103' ' ' CYS . 1.3 mm? 44.44 24.75 0.1 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.695 -1.253 . . . . 0.0 110.109 -179.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.476 ' O ' ' O ' ' A' ' 105' ' ' LEU . . . 60.93 122.78 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.771 -1.205 . . . . 0.0 109.125 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.437 HG23 HG22 ' A' ' 98' ' ' VAL . 2.4 p -95.28 -172.7 2.73 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.078 -1.013 . . . . 0.0 108.624 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.511 HG21 ' N ' ' A' ' 109' ' ' HIS . 8.2 tp -58.74 -21.43 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 120.935 -1.103 . . . . 0.0 109.21 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.511 ' N ' HG21 ' A' ' 108' ' ' ILE . 79.2 m-70 -80.11 16.66 1.17 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.654 -0.654 . . . . 0.0 110.373 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 109' ' ' HIS . . . 43.93 26.89 0.9 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 109' ' ' HIS . . . -154.4 171.08 32.89 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.473 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 32.2 Cg_endo -78.67 73.57 5.86 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 123.066 2.511 . . . . 0.0 111.603 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.48 ' CE1' ' HB3' ' A' ' 109' ' ' HIS . 25.0 p90 . . . . . 0 N--CA 1.492 1.648 0 O-C-N 121.223 -0.923 . . . . 0.0 109.889 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 42.4 t . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.38 -90.85 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -103.14 69.22 0.3 Allowed Glycine 0 N--CA 1.498 2.772 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.1 t -105.8 21.76 16.72 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 122.24 -0.565 . . . . 0.0 110.182 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 12.7 p -56.06 171.64 0.24 Allowed 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 24.3 m 64.39 118.79 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -76.82 142.05 69.17 Favored Pre-proline 0 N--CA 1.504 2.253 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.456 ' O ' ' N ' ' A' ' 10' ' ' MET . 37.8 Cg_endo -77.84 -96.03 0.01 OUTLIER 'Trans proline' 0 C--O 1.208 -0.975 0 C-N-CA 121.686 1.591 . . . . 0.0 110.247 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -38.68 -21.69 0.01 OUTLIER Glycine 0 N--CA 1.509 3.55 0 O-C-N 121.64 -0.662 . . . . 0.0 113.279 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.456 ' N ' ' O ' ' A' ' 8' ' ' PRO . 6.3 mtt -112.11 116.64 30.83 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 178.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.447 ' CB ' ' O ' ' A' ' 10' ' ' MET . . . 84.35 -47.59 0.1 Allowed 'General case' 0 N--CA 1.509 2.476 0 CA-C-N 120.021 1.282 . . . . 0.0 110.081 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 85.2 mt -126.27 77.28 72.3 Favored Pre-proline 0 N--CA 1.508 2.438 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -72.47 171.82 16.3 Favored 'Trans proline' 0 N--CA 1.476 0.473 0 C-N-CA 120.751 0.967 . . . . 0.0 112.5 -174.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 29.4 m-70 -70.01 148.03 49.37 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.893 -178.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.439 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 29.0 t30 65.66 58.25 1.18 Allowed Pre-proline 0 N--CA 1.503 2.186 0 O-C-N 121.593 -0.692 . . . . 0.0 110.201 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.439 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 38.2 Cg_endo -78.85 158.4 27.68 Favored 'Trans proline' 0 N--CA 1.485 0.972 0 C-N-CA 122.376 2.051 . . . . 0.0 111.752 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.3 mt 53.74 44.25 29.89 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-O 121.074 0.464 . . . . 0.0 111.155 178.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -70.02 -40.51 75.15 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 121.584 -0.697 . . . . 0.0 109.283 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.51 -27.85 69.25 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 44.1 m -72.9 -36.33 67.29 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.413 ' CG ' ' N ' ' A' ' 22' ' ' TRP . 0.2 OUTLIER -63.07 -54.97 29.67 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.822 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.425 ' CE3' ' HA ' ' A' ' 22' ' ' TRP . 27.8 m95 -65.64 -27.85 68.68 Favored 'General case' 0 N--CA 1.501 2.084 0 C-N-CA 119.232 -0.987 . . . . 0.0 109.671 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -67.07 -30.03 69.97 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.403 HG21 ' CE1' ' A' ' 93' ' ' PHE . 62.4 t -71.96 -41.62 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 177.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 m -56.35 -42.78 78.31 Favored 'General case' 0 N--CA 1.501 2.112 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.672 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.5 m -77.37 -50.99 11.59 Favored 'General case' 0 N--CA 1.51 2.533 0 O-C-N 122.037 -0.415 . . . . 0.0 112.104 -178.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -62.95 -24.94 68.12 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.832 -0.543 . . . . 0.0 110.733 -178.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 34.7 p -97.05 -62.84 1.2 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 122.086 -0.384 . . . . 0.0 111.881 -177.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.8 m -100.97 12.93 36.73 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 121.36 -0.838 . . . . 0.0 111.581 -178.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 57.17 21.56 39.81 Favored Glycine 0 N--CA 1.505 3.289 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -178.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 45.2 t -109.49 164.24 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 O-C-N 121.87 -0.783 . . . . 0.0 109.396 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 136.14 -179.7 17.57 Favored Glycine 0 N--CA 1.5 2.928 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -63.66 173.37 4.62 Favored 'Trans proline' 0 N--CA 1.487 1.093 0 CA-C-N 119.319 1.559 . . . . 0.0 110.229 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 2.3 ptt180 -92.86 88.24 6.12 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 122.081 0.944 . . . . 0.0 110.197 -177.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.443 ' CD2' ' N ' ' A' ' 35' ' ' LEU . 2.1 pt? -145.53 -172.29 3.86 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 115.298 -0.865 . . . . 0.0 108.836 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -95.62 162.59 13.56 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.67 -57.33 3.62 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 122.127 -0.358 . . . . 0.0 110.182 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -51.38 -26.81 8.41 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 121.91 -0.494 . . . . 0.0 110.708 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -74.08 -44.48 53.9 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 2.5 ttm -63.5 -53.09 57.42 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.2 ttpp -54.24 -38.84 66.2 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.701 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.82 -38.54 91.16 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.12 -35.58 81.23 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 23.0 m -66.99 -35.57 80.26 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 120.396 -0.522 . . . . 0.0 109.616 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 18.2 m -71.76 -32.35 67.6 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.9 -35.07 74.32 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -78.07 -26.3 48.14 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.424 ' CD1' ' NH1' ' A' ' 56' ' ' ARG . 1.6 tm? -69.72 -45.93 67.1 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -178.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -78.22 -38.82 42.23 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.62 -36.85 57.23 Favored 'General case' 0 N--CA 1.506 2.358 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.407 ' O ' ' HD3' ' A' ' 56' ' ' ARG . 58.0 mt -85.58 105.54 7.22 Favored Pre-proline 0 N--CA 1.488 1.446 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 176.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -62.86 148.87 92.92 Favored 'Trans proline' 0 N--CA 1.482 0.818 0 C-N-CA 121.771 1.648 . . . . 0.0 111.412 -176.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -47.3 -27.43 1.57 Allowed 'General case' 0 N--CA 1.501 2.124 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.625 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -71.1 115.04 9.77 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 12.0 m 70.54 7.94 6.41 Favored 'General case' 0 N--CA 1.507 2.384 0 O-C-N 121.998 -0.439 . . . . 0.0 110.079 -179.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.424 ' NH1' ' CD1' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -50.22 -93.19 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.322 -0.861 . . . . 0.0 109.507 179.848 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 88.9 m -31.63 -36.29 0.02 OUTLIER 'General case' 0 N--CA 1.521 3.108 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -41.4 -51.99 3.64 Favored 'General case' 0 N--CA 1.512 2.626 0 CA-C-N 119.762 1.164 . . . . 0.0 111.559 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -44.16 -47.06 9.06 Favored 'General case' 0 N--CA 1.511 2.581 0 O-C-N 121.765 -0.584 . . . . 0.0 112.135 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.9 t -50.73 -46.27 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.733 0 CA-C-O 122.134 0.969 . . . . 0.0 108.401 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -58.93 -50.22 74.87 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 177.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.506 ' CG2' ' HB ' ' A' ' 67' ' ' VAL . 28.0 mm -51.45 -26.96 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 121.673 -0.642 . . . . 0.0 110.109 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.37 -40.41 36.31 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 120.019 -0.673 . . . . 0.0 109.48 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 17.7 ttp -77.02 -55.34 5.54 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.474 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -80.95 -23.84 38.53 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.748 -0.595 . . . . 0.0 111.651 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.68 148.62 12.81 Favored Glycine 0 N--CA 1.506 3.301 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.506 ' HB ' ' CG2' ' A' ' 62' ' ' ILE . 8.2 p -117.73 159.91 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.559 0 O-C-N 122.185 -0.597 . . . . 0.0 110.632 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.449 ' CG2' ' CE1' ' A' ' 74' ' ' HIS . 54.3 t -114.97 156.92 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 31.1 p -117.63 160.01 21.98 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.176 -177.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.2 t -62.02 -29.67 70.43 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.642 -178.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.2 p -71.78 -16.94 62.21 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 116.618 -0.264 . . . . 0.0 110.482 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.88 14.7 30.81 Favored Glycine 0 N--CA 1.498 2.779 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.6 mm100 -103.07 156.34 17.75 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-N 118.204 1.002 . . . . 0.0 109.195 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.449 ' CE1' ' CG2' ' A' ' 68' ' ' VAL . 9.2 m170 -115.2 155.54 26.99 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -145.83 -175.99 4.96 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 120.995 0.426 . . . . 0.0 109.869 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 59.78 -148.51 42.09 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 108.443 -1.863 . . . . 0.0 108.443 -178.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 57.27 21.5 6.74 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 122.077 -0.661 . . . . 0.0 110.326 179.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.8 mt -81.96 -14.75 55.62 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.777 -0.577 . . . . 0.0 110.673 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.0 tt -58.72 92.48 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -130.97 177.59 7.33 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.193 0.521 . . . . 0.0 109.811 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -77.02 103.36 6.9 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.524 0.678 . . . . 0.0 110.707 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.507 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 18.1 mt -78.25 170.11 17.76 Favored Pre-proline 0 N--CA 1.497 1.875 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 177.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.507 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 29.8 Cg_endo -70.92 98.43 0.8 Allowed 'Trans proline' 0 C--N 1.327 -0.561 0 C-N-CA 120.859 1.04 . . . . 0.0 109.463 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 102.57 1.43 49.97 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 3.5 m -139.42 91.61 10.87 Favored Pre-proline 0 N--CA 1.505 2.279 0 CA-C-N 119.087 1.444 . . . . 0.0 109.191 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -72.42 163.28 39.06 Favored 'Trans proline' 0 N--CA 1.482 0.828 0 C-N-CA 121.368 1.378 . . . . 0.0 111.576 -178.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.4 mtm-85 -48.5 -28.65 3.47 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.196 0.522 . . . . 0.0 109.769 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -59.57 -46.23 89.51 Favored 'General case' 0 N--CA 1.504 2.235 0 CA-C-N 116.189 -0.46 . . . . 0.0 112.005 -177.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 49.0 t -68.88 -40.58 81.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.585 -0.697 . . . . 0.0 109.823 -178.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -64.88 -27.39 68.83 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.35 -34.01 48.7 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 109.813 -0.439 . . . . 0.0 109.813 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.57 -45.67 68.17 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.893 -0.504 . . . . 0.0 109.808 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.403 ' CE1' HG21 ' A' ' 24' ' ' VAL . 44.3 t80 -78.57 -25.77 45.42 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 122.319 -0.238 . . . . 0.0 110.406 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.418 ' N ' ' HD2' ' A' ' 95' ' ' PRO . . . -42.85 -51.71 12.12 Favored Pre-proline 0 N--CA 1.503 2.212 0 CA-C-O 118.87 -0.586 . . . . 0.0 112.493 -177.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.418 ' HD2' ' N ' ' A' ' 94' ' ' ALA . 30.7 Cg_endo -72.98 -172.42 0.98 Allowed 'Trans proline' 0 N--CA 1.476 0.484 0 C-N-CA 121.697 1.598 . . . . 0.0 110.328 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.4 mttt 64.59 17.15 10.74 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -178.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.13 -75.89 0.15 Allowed 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 104' ' ' ASN . 8.4 m -64.56 1.18 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.334 0 O-C-N 121.612 -0.68 . . . . 0.0 112.487 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 22.3 p -87.8 174.5 8.34 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -61.04 -0.1 0.28 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.424 -0.797 . . . . 0.0 111.899 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.3 t -90.53 -4.04 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 CA-C-N 120.429 1.468 . . . . 0.0 111.188 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -140.25 -83.01 0.24 Allowed 'General case' 0 N--CA 1.51 2.557 0 C-N-CA 119.108 -1.037 . . . . 0.0 112.693 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 96.2 m -146.28 42.28 1.18 Allowed 'General case' 0 N--CA 1.504 2.256 0 CA-C-N 119.722 1.146 . . . . 0.0 109.258 -178.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.444 ' HA ' ' O ' ' A' ' 98' ' ' VAL . 11.2 p-10 -37.9 -60.66 0.71 Allowed 'General case' 0 N--CA 1.504 2.273 0 N-CA-C 113.553 0.945 . . . . 0.0 113.553 -178.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 79.2 mt 45.92 25.06 0.27 Allowed 'General case' 0 N--CA 1.51 2.564 0 CA-C-N 119.054 0.843 . . . . 0.0 111.396 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 64.02 141.73 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.321 -0.862 . . . . 0.0 109.674 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.2 p -112.5 -161.8 0.77 Allowed 'General case' 0 N--CA 1.506 2.348 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -66.13 -33.01 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -70.05 -1.25 9.35 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.189 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 57.74 30.36 62.64 Favored Glycine 0 N--CA 1.499 2.887 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -157.22 169.62 34.3 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -78.22 73.85 5.6 Favored 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 122.725 2.283 . . . . 0.0 112.134 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 49.2 p90 174.05 161.29 0.17 Allowed 'General case' 0 N--CA 1.507 2.407 0 O-C-N 121.827 -0.545 . . . . 0.0 110.462 177.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 16.9 p -159.1 158.65 33.36 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.9 mt 52.11 -176.88 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.678 -0.639 . . . . 0.0 109.921 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 9.0 p 46.79 24.87 0.38 Allowed 'General case' 0 N--CA 1.507 2.398 0 O-C-N 122.084 -0.385 . . . . 0.0 110.87 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -63.59 -155.56 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 21.8 mt -45.7 -20.46 0.08 Allowed 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.189 -0.944 . . . . 0.0 113.065 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 104.85 69.73 0.77 Allowed Glycine 0 N--CA 1.499 2.845 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 58.83 69.99 0.68 Allowed 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.765 0.793 . . . . 0.0 109.926 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -102.71 26.15 25.07 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 . . . . . 0 N--CA 1.497 1.916 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.325 -179.806 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 3.1 t . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 26.8 m -45.87 -44.49 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.392 0 O-C-N 122.2 -0.313 . . . . 0.0 111.031 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 151.61 -175.46 30.42 Favored Glycine 0 N--CA 1.5 2.907 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.1 t -151.32 52.27 0.84 Allowed 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.6 0.714 . . . . 0.0 109.296 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 84.5 p -58.38 -170.39 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.772 -0.58 . . . . 0.0 109.809 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 34.2 m -84.38 119.21 24.84 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.2 tp -121.62 138.95 29.09 Favored Pre-proline 0 N--CA 1.494 1.754 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -76.2 160.22 36.35 Favored 'Trans proline' 0 N--CA 1.48 0.72 0 C-N-CA 121.65 1.567 . . . . 0.0 110.564 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.6 2.12 74.07 Favored Glycine 0 N--CA 1.501 3.017 0 N-CA-C 110.634 -0.987 . . . . 0.0 110.634 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.45 ' O ' ' CB ' ' A' ' 11' ' ' ALA . 4.0 mmt -133.29 104.06 6.28 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.45 ' CB ' ' O ' ' A' ' 10' ' ' MET . . . 87.2 -57.11 0.04 OUTLIER 'General case' 0 N--CA 1.515 2.789 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -178.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 57.6 mt -100.53 102.36 18.61 Favored Pre-proline 0 N--CA 1.495 1.797 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 178.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -81.28 173.61 11.51 Favored 'Trans proline' 0 N--CA 1.477 0.501 0 C-N-CA 121.616 1.544 . . . . 0.0 111.879 -176.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 32.2 m-70 -76.0 146.88 39.2 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.469 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 19.2 t-20 68.11 56.87 0.71 Allowed Pre-proline 0 N--CA 1.508 2.473 0 O-C-N 121.393 -0.817 . . . . 0.0 111.721 179.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.469 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 41.2 Cg_endo -84.56 171.1 10.0 Favored 'Trans proline' 0 N--CA 1.481 0.774 0 C-N-CA 122.139 1.893 . . . . 0.0 111.066 178.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 27.6 mt 46.2 46.45 13.19 Favored 'General case' 0 N--CA 1.502 2.167 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.096 177.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -75.49 -43.04 51.31 Favored 'General case' 0 N--CA 1.505 2.311 0 O-C-N 121.482 -0.761 . . . . 0.0 109.002 178.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -63.57 -26.33 68.64 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 34.6 m -75.08 -34.54 61.78 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.32 -46.57 69.86 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 31.7 m95 -71.77 -29.41 64.45 Favored 'General case' 0 N--CA 1.506 2.326 0 C-N-CA 118.691 -1.203 . . . . 0.0 109.274 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -65.23 -32.41 74.07 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.9 t -71.35 -41.05 73.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 177.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.1 m -55.5 -39.15 70.1 Favored 'General case' 0 N--CA 1.502 2.159 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.161 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 94.5 m -77.62 -51.52 10.5 Favored 'General case' 0 N--CA 1.508 2.452 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -65.14 -25.01 67.57 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.432 -0.792 . . . . 0.0 110.672 -178.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 43.9 p -93.77 -61.09 1.61 Allowed 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -177.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.8 m -100.47 7.83 43.92 Favored 'General case' 0 N--CA 1.507 2.415 0 O-C-N 121.363 -0.836 . . . . 0.0 111.784 -178.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 58.29 24.81 56.4 Favored Glycine 0 N--CA 1.506 3.302 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -178.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 19.7 t -119.11 165.54 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 122.124 -0.633 . . . . 0.0 109.35 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 134.05 -178.89 18.01 Favored Glycine 0 N--CA 1.5 2.954 0 N-CA-C 108.394 -1.882 . . . . 0.0 108.394 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -64.62 171.67 7.96 Favored 'Trans proline' 0 N--CA 1.485 0.991 0 CA-C-N 119.63 1.715 . . . . 0.0 109.672 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.6 mtp180 -92.89 80.87 4.63 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 122.066 0.936 . . . . 0.0 110.115 -177.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -122.5 -175.67 3.2 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -99.61 140.76 33.34 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.96 -53.59 47.89 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.616 -0.677 . . . . 0.0 111.042 -179.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.6 tm0? -52.46 -46.64 66.59 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.95 -0.469 . . . . 0.0 110.888 -178.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -63.91 -32.07 73.47 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 33.1 tpp -66.94 -58.46 4.92 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 10.2 tptt -53.2 -36.99 61.57 Favored 'General case' 0 N--CA 1.501 2.076 0 CA-C-O 121.179 0.514 . . . . 0.0 109.656 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.49 -40.92 98.35 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.82 -38.74 89.27 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 20.1 m -66.5 -33.54 75.91 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 50.6 m -72.26 -31.16 65.54 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 15.3 ttt85 -73.05 -32.62 65.18 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -76.43 -32.1 58.27 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.1 tp -72.98 -35.94 66.98 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -72.7 -37.25 67.88 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 179.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.98 -38.51 82.77 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 45.4 mt -82.38 104.7 3.64 Favored Pre-proline 0 N--CA 1.495 1.789 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 177.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -58.32 140.72 95.49 Favored 'Trans proline' 0 N--CA 1.482 0.81 0 C-N-CA 121.775 1.65 . . . . 0.0 112.208 -175.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -48.99 -24.39 1.5 Allowed 'General case' 0 N--CA 1.5 2.075 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.201 -179.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -45.67 -71.9 0.07 Allowed 'General case' 0 N--CA 1.505 2.319 0 O-C-N 121.969 -0.457 . . . . 0.0 111.204 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 21.1 m -110.5 23.91 13.64 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.99 -0.444 . . . . 0.0 110.86 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.2 mtt180 -40.38 -83.44 0.01 OUTLIER 'General case' 0 N--CA 1.516 2.828 0 O-C-N 121.316 -0.865 . . . . 0.0 110.863 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 75.2 m -32.28 -35.88 0.02 OUTLIER 'General case' 0 N--CA 1.52 3.035 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -46.06 -58.07 3.91 Favored 'General case' 0 N--CA 1.511 2.607 0 CA-C-N 119.933 1.242 . . . . 0.0 110.931 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -42.61 -37.94 1.85 Allowed 'General case' 0 N--CA 1.513 2.715 0 O-C-N 121.675 -0.641 . . . . 0.0 112.346 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.8 t -55.08 -49.91 67.86 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 O-C-N 121.774 -0.579 . . . . 0.0 109.556 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -58.15 -28.99 65.23 Favored 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.442 ' CG2' ' HB ' ' A' ' 67' ' ' VAL . 2.0 mp -77.85 -27.58 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.269 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.1 tt -78.18 -40.9 36.29 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 120.117 -0.633 . . . . 0.0 109.813 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -78.85 -51.62 9.47 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.142 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -80.81 -23.91 38.89 Favored 'General case' 0 N--CA 1.502 2.135 0 C-N-CA 120.689 -0.404 . . . . 0.0 111.323 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.9 146.3 8.02 Favored Glycine 0 N--CA 1.498 2.788 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.442 ' HB ' ' CG2' ' A' ' 62' ' ' ILE . 14.2 p -117.45 160.12 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 O-C-N 122.347 -0.502 . . . . 0.0 109.781 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.451 ' CG2' ' CE1' ' A' ' 74' ' ' HIS . 55.5 t -114.2 157.54 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 53.3 p -117.28 159.28 22.95 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.838 -177.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 34.7 t -64.59 -28.04 69.36 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.385 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.5 p -71.4 -16.05 62.39 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.68 10.83 42.61 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -100.93 156.51 17.34 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 118.201 1.0 . . . . 0.0 109.197 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.451 ' CE1' ' CG2' ' A' ' 68' ' ' VAL . 11.2 m170 -115.86 155.49 27.81 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -144.44 -173.51 4.06 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.287 0.565 . . . . 0.0 110.26 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 61.01 -145.01 48.56 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.722 -1.751 . . . . 0.0 108.722 -178.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 56.44 21.61 5.71 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 122.229 -0.571 . . . . 0.0 109.486 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 10.1 mp -66.12 -21.6 66.35 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.484 -0.76 . . . . 0.0 109.983 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.0 tt -61.04 92.9 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -141.98 176.83 8.63 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.518 0.675 . . . . 0.0 110.662 -178.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -64.2 118.38 8.51 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.857 0.837 . . . . 0.0 111.367 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.461 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 22.0 mt -112.95 166.63 10.66 Favored Pre-proline 0 N--CA 1.497 1.89 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 177.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.461 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 29.4 Cg_endo -68.6 99.81 0.65 Allowed 'Trans proline' 0 C--N 1.326 -0.632 0 C-N-CA 121.063 1.175 . . . . 0.0 110.532 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.99 8.43 64.9 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.402 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 3.4 m -141.72 91.1 8.42 Favored Pre-proline 0 N--CA 1.511 2.615 0 CA-C-N 118.869 1.335 . . . . 0.0 109.504 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -72.95 166.4 30.15 Favored 'Trans proline' 0 N--CA 1.488 1.165 0 C-N-CA 121.895 1.73 . . . . 0.0 111.754 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 72.7 mtp180 -51.13 -27.55 8.78 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.173 0.511 . . . . 0.0 109.893 178.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -61.13 -45.92 92.69 Favored 'General case' 0 N--CA 1.502 2.169 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.239 -177.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 58.6 t -69.16 -43.61 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.665 -0.647 . . . . 0.0 110.602 -178.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -67.49 -27.71 67.23 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.9 tpt180 -78.65 -26.71 45.2 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.38 -48.45 17.24 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.923 -0.486 . . . . 0.0 110.065 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -78.31 -27.64 47.28 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 122.116 -0.365 . . . . 0.0 110.999 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.429 ' N ' ' HD2' ' A' ' 95' ' ' PRO . . . -53.09 -50.86 79.81 Favored Pre-proline 0 N--CA 1.502 2.14 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 94' ' ' ALA . 31.2 Cg_endo -71.3 82.43 1.09 Allowed 'Trans proline' 0 N--CA 1.482 0.823 0 C-N-CA 122.197 1.931 . . . . 0.0 111.978 -177.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 164.62 57.28 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.492 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.505 ' HG ' ' N ' ' A' ' 98' ' ' VAL . 2.3 pt? -86.94 -56.83 3.21 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -177.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.505 ' N ' ' HG ' ' A' ' 97' ' ' LEU . 13.1 m -92.48 25.14 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-N 120.833 1.651 . . . . 0.0 111.183 -178.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 30.8 p -90.74 170.47 10.1 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -62.98 -2.56 1.26 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.452 -0.78 . . . . 0.0 112.121 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.6 t -100.9 2.83 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 CA-C-N 120.416 1.462 . . . . 0.0 111.269 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -133.71 -90.5 0.37 Allowed 'General case' 0 N--CA 1.502 2.133 0 CA-C-N 118.822 0.737 . . . . 0.0 110.97 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 46.8 m -143.63 37.98 1.35 Allowed 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.559 -0.713 . . . . 0.0 109.491 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -33.89 -62.66 0.3 Allowed 'General case' 0 N--CA 1.509 2.516 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -178.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.4 mt 50.18 20.94 0.69 Allowed 'General case' 0 N--CA 1.506 2.341 0 CA-C-N 118.944 0.793 . . . . 0.0 110.946 -179.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 63.23 124.08 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.304 -0.872 . . . . 0.0 109.769 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.8 p -89.25 -160.2 0.65 Allowed 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.2 tt -66.58 -30.97 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -69.35 -0.97 7.08 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.007 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 58.67 27.74 61.84 Favored Glycine 0 N--CA 1.498 2.813 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -156.74 167.79 33.72 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -78.44 75.04 5.12 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 122.722 2.281 . . . . 0.0 111.764 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.425 ' CE1' HD22 ' A' ' 117' ' ' LEU . 19.5 p90 173.99 149.75 0.08 Allowed 'General case' 0 N--CA 1.508 2.471 0 O-C-N 121.617 -0.677 . . . . 0.0 110.956 178.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 15.2 p -137.27 129.64 29.68 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 177.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.4 mm? 53.32 178.84 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.263 0 O-C-N 121.196 -0.94 . . . . 0.0 110.415 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 7.0 t 58.68 19.09 6.45 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 122.153 -0.342 . . . . 0.0 110.819 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.425 HD22 ' CE1' ' A' ' 113' ' ' PHE . 5.2 mp -62.26 -97.81 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.651 -0.655 . . . . 0.0 109.76 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -60.76 -14.62 22.45 Favored 'General case' 0 N--CA 1.504 2.248 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -178.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 59.33 101.54 0.01 OUTLIER Glycine 0 N--CA 1.499 2.852 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -87.02 69.27 10.22 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.724 0.773 . . . . 0.0 109.466 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -89.44 2.33 82.9 Favored Glycine 0 N--CA 1.498 2.771 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 . . . . . 0 N--CA 1.498 1.936 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.436 179.971 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 48.8 m . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.5 m -54.95 -59.91 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 122.213 -0.304 . . . . 0.0 110.858 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 95.35 124.03 4.24 Favored Glycine 0 N--CA 1.498 2.794 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.1 t -99.66 24.29 8.47 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 122.293 -0.534 . . . . 0.0 109.775 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.6 m -93.83 174.13 7.33 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 58.8 m -103.77 99.77 9.56 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.7 pt -89.24 155.72 49.02 Favored Pre-proline 0 N--CA 1.499 2.021 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -78.91 150.36 23.54 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.254 1.97 . . . . 0.0 110.503 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 79.49 -5.05 61.66 Favored Glycine 0 N--CA 1.499 2.852 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.442 ' O ' ' CB ' ' A' ' 11' ' ' ALA . 86.8 mmm -140.82 115.23 9.39 Favored 'General case' 0 N--CA 1.501 2.105 0 CA-C-N 118.665 1.232 . . . . 0.0 108.968 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.442 ' CB ' ' O ' ' A' ' 10' ' ' MET . . . 85.72 -56.94 0.08 Allowed 'General case' 0 N--CA 1.515 2.795 0 CA-C-N 119.939 1.245 . . . . 0.0 108.434 -179.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 80.7 mt -110.84 100.79 47.51 Favored Pre-proline 0 N--CA 1.489 1.507 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 178.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -80.48 172.94 12.91 Favored 'Trans proline' 0 C--O 1.22 -0.413 0 C-N-CA 121.41 1.407 . . . . 0.0 111.284 -176.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 50.8 m-70 -75.79 143.33 41.99 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.438 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 2.7 m120 63.36 61.94 1.76 Allowed Pre-proline 0 N--CA 1.502 2.152 0 O-C-N 121.769 -0.582 . . . . 0.0 109.742 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.438 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 40.3 Cg_endo -83.45 167.79 13.32 Favored 'Trans proline' 0 N--CA 1.483 0.859 0 C-N-CA 122.459 2.106 . . . . 0.0 111.693 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 42.2 mt 47.64 45.89 17.91 Favored 'General case' 0 N--CA 1.504 2.233 0 CA-C-O 121.105 0.478 . . . . 0.0 111.516 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -74.13 -39.67 63.16 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.538 -0.726 . . . . 0.0 109.447 179.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.3 t -66.58 -25.95 66.88 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 37.1 m -75.28 -41.75 56.48 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -43.75 97.03 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.412 ' CE3' ' HA ' ' A' ' 22' ' ' TRP . 38.7 m95 -74.19 -25.92 59.98 Favored 'General case' 0 N--CA 1.501 2.087 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.129 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -69.8 -28.47 65.76 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.424 HG21 ' CE1' ' A' ' 93' ' ' PHE . 52.1 t -75.61 -43.02 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 177.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -55.78 -41.77 74.56 Favored 'General case' 0 N--CA 1.503 2.19 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.349 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.1 m -77.67 -53.58 7.38 Favored 'General case' 0 N--CA 1.509 2.516 0 O-C-N 122.085 -0.385 . . . . 0.0 111.685 -178.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -60.5 -24.99 65.74 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.851 -0.53 . . . . 0.0 110.453 -178.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 31.8 p -97.23 -64.11 1.07 Allowed 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -177.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 19.6 m -101.2 14.55 31.59 Favored 'General case' 0 N--CA 1.508 2.45 0 O-C-N 121.386 -0.821 . . . . 0.0 112.0 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 57.05 21.16 37.33 Favored Glycine 0 N--CA 1.505 3.255 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.6 t -107.74 160.43 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.242 0 O-C-N 121.858 -0.79 . . . . 0.0 109.069 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 130.65 -179.39 16.97 Favored Glycine 0 N--CA 1.5 2.94 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -66.23 173.88 6.81 Favored 'Trans proline' 0 N--CA 1.486 1.076 0 CA-C-N 119.263 1.531 . . . . 0.0 109.736 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 2.9 ptt180 -92.81 82.66 4.72 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 122.086 0.945 . . . . 0.0 110.742 -177.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 24.5 mt -134.82 138.93 44.68 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.87 160.86 3.22 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -73.08 -56.49 5.05 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.963 -0.461 . . . . 0.0 111.209 -178.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -54.32 -35.65 62.9 Favored 'General case' 0 N--CA 1.506 2.364 0 O-C-N 121.913 -0.492 . . . . 0.0 110.47 -178.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -64.09 -57.65 8.98 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 5.0 ttm -53.08 -47.48 68.48 Favored 'General case' 0 N--CA 1.504 2.238 0 CA-C-O 121.6 0.714 . . . . 0.0 109.401 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 23.8 ttmt -55.95 -37.72 69.37 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.49 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.22 -35.21 79.83 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.61 -41.69 98.27 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 19.5 m -66.26 -38.65 88.32 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.552 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 84.9 m -69.76 -28.49 65.81 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -74.51 -32.23 62.43 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -74.54 -35.49 63.11 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.3 tt -75.68 -27.23 58.19 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -77.22 -52.16 9.71 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.57 -45.57 69.99 Favored 'General case' 0 N--CA 1.508 2.441 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 23.7 mm -67.57 106.47 1.26 Allowed Pre-proline 0 N--CA 1.49 1.528 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 175.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -58.51 151.2 63.64 Favored 'Trans proline' 0 N--CA 1.479 0.642 0 C-N-CA 121.479 1.453 . . . . 0.0 110.962 -176.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -40.72 -29.7 0.1 Allowed 'General case' 0 N--CA 1.507 2.377 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.686 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.423 ' CE2' HD12 ' A' ' 108' ' ' ILE . 0.2 OUTLIER -73.77 131.33 41.46 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.503 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 8.3 m 72.35 6.28 5.46 Favored 'General case' 0 N--CA 1.508 2.433 0 O-C-N 122.125 -0.36 . . . . 0.0 111.335 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.21 -85.23 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.715 0 CA-C-N 119.247 0.931 . . . . 0.0 110.038 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 85.5 m -38.09 -45.08 0.88 Allowed 'General case' 0 N--CA 1.518 2.97 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -39.86 -50.7 2.45 Favored 'General case' 0 N--CA 1.511 2.586 0 CA-C-N 119.819 1.19 . . . . 0.0 112.148 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -43.86 -47.02 8.2 Favored 'General case' 0 N--CA 1.518 2.939 0 O-C-N 121.573 -0.705 . . . . 0.0 111.609 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 45.2 t -53.71 -45.24 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.55 -32.15 72.21 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.85 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.451 ' CG2' ' HB ' ' A' ' 67' ' ' VAL . 1.2 mp -70.08 -28.19 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.95 -39.51 42.39 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.047 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 14.4 ttp -78.25 -54.8 5.83 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.927 -0.483 . . . . 0.0 110.374 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -80.95 -23.58 38.71 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 122.202 -0.311 . . . . 0.0 111.189 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.33 148.45 13.89 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 -178.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.451 ' HB ' ' CG2' ' A' ' 62' ' ' ILE . 7.7 p -118.01 159.52 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 O-C-N 122.206 -0.585 . . . . 0.0 109.661 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.455 ' CG2' ' CE1' ' A' ' 74' ' ' HIS . 76.2 t -115.21 157.56 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 CA-C-O 122.038 0.923 . . . . 0.0 110.368 -178.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.6 p -117.23 160.65 20.73 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.569 -177.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.6 t -63.5 -34.45 77.8 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.129 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.8 p -63.82 -17.74 63.42 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.73 9.1 47.24 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -97.49 156.88 16.29 Favored 'General case' 0 N--CA 1.503 2.207 0 CA-C-N 118.278 1.039 . . . . 0.0 109.892 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.455 ' CE1' ' CG2' ' A' ' 68' ' ' VAL . 9.9 m170 -116.04 155.06 28.79 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -141.76 -175.96 4.58 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.009 0.433 . . . . 0.0 109.908 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 59.45 -143.76 46.13 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.3 22.06 4.56 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 122.289 -0.536 . . . . 0.0 110.167 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 55.0 mt -81.43 -15.26 55.65 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.735 -0.603 . . . . 0.0 110.739 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.7 tt -57.26 91.99 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -128.38 179.77 5.46 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.26 0.552 . . . . 0.0 109.818 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.75 106.05 7.11 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.313 0.577 . . . . 0.0 110.696 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.535 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 23.0 mt -81.33 169.63 18.34 Favored Pre-proline 0 N--CA 1.495 1.798 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 177.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.535 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 28.3 Cg_endo -66.75 99.4 0.45 Allowed 'Trans proline' 0 C--N 1.329 -0.487 0 C-N-CA 120.978 1.119 . . . . 0.0 111.201 -178.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 103.07 -14.05 55.67 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 6.1 m -123.65 92.22 48.89 Favored Pre-proline 0 N--CA 1.504 2.253 0 CA-C-N 119.323 1.561 . . . . 0.0 110.352 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -72.12 166.11 30.61 Favored 'Trans proline' 0 N--CA 1.483 0.87 0 C-N-CA 121.598 1.532 . . . . 0.0 111.04 -179.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.5 mtm180 -46.9 -28.52 1.62 Allowed 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.152 0.501 . . . . 0.0 109.754 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.8 tm0? -58.65 -52.21 66.65 Favored 'General case' 0 N--CA 1.503 2.199 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.483 -178.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 60.1 t -64.23 -41.75 93.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.746 -0.596 . . . . 0.0 109.576 -178.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -25.94 68.47 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -79.0 -33.46 44.98 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.51 -47.68 63.01 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.424 ' CE1' HG21 ' A' ' 24' ' ' VAL . 42.5 t80 -78.27 -25.37 46.72 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.478 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.417 ' N ' ' HD2' ' A' ' 95' ' ' PRO . . . -42.69 -52.17 11.18 Favored Pre-proline 0 N--CA 1.504 2.227 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -177.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.417 ' HD2' ' N ' ' A' ' 94' ' ' ALA . 29.6 Cg_endo -70.98 -164.1 0.14 Allowed 'Trans proline' 0 C--N 1.328 -0.513 0 C-N-CA 121.689 1.593 . . . . 0.0 110.296 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 60.57 24.68 14.37 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -178.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.6 mt -73.42 -67.93 0.54 Allowed 'General case' 0 N--CA 1.505 2.276 0 O-C-N 122.034 -0.416 . . . . 0.0 111.42 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 14.7 m -85.52 22.11 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.35 -0.843 . . . . 0.0 111.085 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 30.8 p -99.44 173.31 6.81 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -59.06 -4.16 0.46 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.532 -0.73 . . . . 0.0 111.764 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 20.0 t -91.83 -0.27 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-N 120.545 1.52 . . . . 0.0 111.403 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -140.82 -89.39 0.16 Allowed 'General case' 0 N--CA 1.504 2.261 0 CA-C-N 118.974 0.807 . . . . 0.0 111.247 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 55.8 m -145.02 42.38 1.31 Allowed 'General case' 0 N--CA 1.508 2.471 0 O-C-N 121.432 -0.792 . . . . 0.0 109.518 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -36.2 -62.5 0.44 Allowed 'General case' 0 N--CA 1.512 2.67 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -178.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.9 mt 46.3 27.76 0.62 Allowed 'General case' 0 N--CA 1.513 2.722 0 CA-C-N 118.988 0.813 . . . . 0.0 111.268 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 70.34 150.34 0.09 Allowed 'General case' 0 N--CA 1.507 2.408 0 O-C-N 121.199 -0.938 . . . . 0.0 109.174 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.0 p -123.16 -163.78 1.14 Allowed 'General case' 0 N--CA 1.505 2.294 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.423 HD12 ' CE2' ' A' ' 54' ' ' TYR . 7.2 tp -66.12 -31.23 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.452 ' CB ' ' CE1' ' A' ' 113' ' ' PHE . 87.7 m-70 -75.68 5.55 6.0 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.974 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 57.96 32.29 66.28 Favored Glycine 0 N--CA 1.499 2.834 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -164.42 171.95 40.06 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 110.116 -1.193 . . . . 0.0 110.116 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -75.8 80.02 2.71 Favored 'Trans proline' 0 N--CA 1.48 0.708 0 C-N-CA 122.626 2.217 . . . . 0.0 110.855 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.461 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER 174.04 169.16 0.21 Allowed 'General case' 0 N--CA 1.502 2.163 0 CA-C-O 121.462 0.649 . . . . 0.0 111.213 179.176 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 10.3 p -178.19 137.08 0.17 Allowed 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.8 mm? 51.24 25.58 2.54 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.362 -0.836 . . . . 0.0 110.252 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 70.1 m -110.07 -65.76 1.13 Allowed 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -49.63 -80.17 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.523 0 O-C-N 122.042 -0.411 . . . . 0.0 110.188 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 15.7 mt -53.45 -16.47 1.46 Allowed 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -101.52 82.58 0.47 Allowed Glycine 0 N--CA 1.502 3.035 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -153.13 70.8 0.88 Allowed 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.687 0.756 . . . . 0.0 109.159 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -68.75 -16.99 70.73 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.098 0 CA-C-O 118.236 -0.887 . . . . 0.0 110.034 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 26.3 t . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.5 p -90.9 31.86 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 122.256 -0.278 . . . . 0.0 110.354 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 135.29 -86.08 0.25 Allowed Glycine 0 N--CA 1.499 2.873 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.5 t 41.28 30.72 0.13 Allowed 'General case' 0 N--CA 1.507 2.391 0 CA-C-O 121.157 0.504 . . . . 0.0 111.729 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.3 m 59.12 -159.28 0.3 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.79 -0.569 . . . . 0.0 110.028 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 34.3 m 67.64 130.6 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.164 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.422 ' N ' ' CD1' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -108.12 161.9 21.77 Favored Pre-proline 0 N--CA 1.503 2.197 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.488 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -78.5 153.59 27.11 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 122.126 1.884 . . . . 0.0 109.904 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 58.32 24.18 55.07 Favored Glycine 0 N--CA 1.499 2.847 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.434 ' O ' ' CB ' ' A' ' 11' ' ' ALA . 38.7 mmm -138.07 95.08 2.96 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.98 -0.718 . . . . 0.0 109.1 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.434 ' CB ' ' O ' ' A' ' 10' ' ' MET . . . 86.77 -56.43 0.05 Allowed 'General case' 0 N--CA 1.515 2.803 0 CA-C-N 119.008 0.822 . . . . 0.0 108.796 -178.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.6 mt -104.59 101.11 26.16 Favored Pre-proline 0 N--CA 1.494 1.73 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 178.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -81.78 173.2 11.45 Favored 'Trans proline' 0 N--CA 1.476 0.457 0 C-N-CA 121.555 1.504 . . . . 0.0 111.764 -176.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 45.0 m-70 -74.52 146.15 42.9 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.486 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 0.9 OUTLIER 60.79 54.99 3.5 Favored Pre-proline 0 N--CA 1.501 2.094 0 O-C-N 121.56 -0.712 . . . . 0.0 109.955 -179.098 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.486 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 40.4 Cg_endo -81.17 166.96 18.19 Favored 'Trans proline' 0 N--CA 1.484 0.953 0 C-N-CA 122.239 1.959 . . . . 0.0 111.606 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 38.3 mt 51.09 45.08 28.3 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.921 177.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -68.09 -41.38 81.94 Favored 'General case' 0 N--CA 1.505 2.323 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.57 -26.27 68.62 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 178.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 60.7 m -75.52 -38.65 59.25 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.43 -50.68 70.55 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.434 ' HA ' ' CE3' ' A' ' 22' ' ' TRP . 32.1 m95 -69.86 -26.46 64.21 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 119.517 -0.873 . . . . 0.0 109.853 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.432 ' O ' ' CD1' ' A' ' 23' ' ' TYR . 7.7 t80 -67.59 -30.35 69.93 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.418 HG23 ' CD1' ' A' ' 93' ' ' PHE . 59.0 t -74.43 -44.43 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 108.301 -0.999 . . . . 0.0 108.301 178.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 p -56.7 -40.96 76.55 Favored 'General case' 0 N--CA 1.505 2.277 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.38 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.3 m -77.22 -53.19 8.04 Favored 'General case' 0 N--CA 1.509 2.497 0 O-C-N 122.01 -0.432 . . . . 0.0 111.872 -178.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -61.8 -24.88 67.14 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.798 -0.563 . . . . 0.0 110.6 -178.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 35.4 p -95.66 -63.86 1.11 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.966 -0.459 . . . . 0.0 111.956 -177.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.7 m -100.93 11.91 38.68 Favored 'General case' 0 N--CA 1.509 2.491 0 O-C-N 121.315 -0.866 . . . . 0.0 111.424 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 59.35 20.23 49.96 Favored Glycine 0 N--CA 1.502 3.056 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -178.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.1 t -106.37 158.72 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 O-C-N 121.888 -0.772 . . . . 0.0 109.079 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 135.04 179.06 16.14 Favored Glycine 0 N--CA 1.497 2.761 0 N-CA-C 108.74 -1.744 . . . . 0.0 108.74 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -65.8 172.39 8.37 Favored 'Trans proline' 0 N--CA 1.483 0.904 0 CA-C-N 119.289 1.545 . . . . 0.0 109.635 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 27.8 mtt180 -92.41 74.77 5.23 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 122.155 0.978 . . . . 0.0 109.705 -178.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.05 135.87 53.87 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.57 150.84 3.51 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.977 -0.452 . . . . 0.0 110.0 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.4 m -73.74 -28.68 61.81 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.736 -0.603 . . . . 0.0 111.185 -178.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -72.74 -31.4 64.92 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.867 -0.521 . . . . 0.0 109.656 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -75.72 -32.66 60.13 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.403 ' HB3' ' CD2' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -70.29 -53.59 16.19 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.575 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 21.7 tttp -56.73 -37.41 70.95 Favored 'General case' 0 N--CA 1.506 2.374 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.19 -38.48 90.62 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.3 mpt_? -65.08 -42.65 93.92 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 17.0 m -65.21 -34.72 79.05 Favored 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.883 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 82.3 m -74.44 -29.8 61.63 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.7 ttt180 -73.63 -32.58 64.11 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -78.75 -35.89 43.95 Favored 'General case' 0 N--CA 1.502 2.17 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.112 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.1 tt -69.63 -37.42 76.78 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -75.56 -41.23 55.38 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.85 -38.01 64.24 Favored 'General case' 0 N--CA 1.509 2.48 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 177.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 59.8 mt -78.92 105.69 3.39 Favored Pre-proline 0 N--CA 1.488 1.434 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 176.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -60.01 152.05 67.72 Favored 'Trans proline' 0 N--CA 1.481 0.745 0 C-N-CA 121.712 1.608 . . . . 0.0 111.278 -176.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -41.37 -29.17 0.14 Allowed 'General case' 0 N--CA 1.507 2.415 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.376 -178.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -67.12 121.85 16.51 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 66.2 m 60.79 15.55 6.0 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 122.195 -0.316 . . . . 0.0 110.537 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.402 ' NH1' ' HG2' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -49.58 -91.38 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.259 -0.901 . . . . 0.0 109.876 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 54.3 m -32.28 -33.95 0.01 OUTLIER 'General case' 0 N--CA 1.521 3.112 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -40.41 -51.64 2.82 Favored 'General case' 0 N--CA 1.509 2.501 0 CA-C-N 119.759 1.163 . . . . 0.0 111.893 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -40.42 -47.88 2.66 Favored 'General case' 0 N--CA 1.514 2.746 0 O-C-N 121.897 -0.502 . . . . 0.0 112.108 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.402 ' CG2' HD12 ' A' ' 97' ' ' LEU . 24.4 t -58.26 -49.22 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.57 -26.27 63.43 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.515 ' CG2' ' HB ' ' A' ' 67' ' ' VAL . 9.3 mt -78.81 -30.76 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.996 -0.44 . . . . 0.0 110.272 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.4 tt -78.03 -42.03 33.79 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 120.014 -0.675 . . . . 0.0 109.334 -178.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 6.8 tpt -78.27 -53.17 7.61 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.313 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -81.51 -21.87 38.33 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 122.147 -0.346 . . . . 0.0 111.429 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.13 149.9 14.35 Favored Glycine 0 N--CA 1.499 2.878 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -178.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.515 ' HB ' ' CG2' ' A' ' 62' ' ' ILE . 7.3 p -118.17 160.18 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.295 0 O-C-N 122.224 -0.574 . . . . 0.0 110.43 -179.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.448 HG21 ' CE1' ' A' ' 74' ' ' HIS . 42.3 t -114.72 157.35 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 28.2 p -117.43 160.27 21.45 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.544 0.688 . . . . 0.0 110.171 -177.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.3 t -61.65 -25.7 67.54 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.35 -178.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.2 p -80.19 -14.19 58.64 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 122.253 -0.279 . . . . 0.0 110.721 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.23 13.2 34.02 Favored Glycine 0 N--CA 1.498 2.804 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -99.15 156.92 16.71 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-N 118.103 0.951 . . . . 0.0 109.092 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.448 ' CE1' HG21 ' A' ' 68' ' ' VAL . 8.5 m170 -115.65 155.28 27.98 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -144.75 -177.14 5.36 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 120.949 0.404 . . . . 0.0 110.093 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 59.62 -141.03 47.67 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 108.876 -1.69 . . . . 0.0 108.876 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.6 ttp180 55.08 22.45 4.5 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 122.267 -0.549 . . . . 0.0 110.431 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -80.47 -15.26 57.18 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.609 -0.682 . . . . 0.0 110.657 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.1 tp -67.46 90.65 0.25 Allowed 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -126.03 177.26 6.46 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -60.81 100.69 0.12 Allowed 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 121.638 0.732 . . . . 0.0 110.535 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.528 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 19.7 mt -80.41 170.74 14.51 Favored Pre-proline 0 N--CA 1.498 1.946 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 177.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.528 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 29.2 Cg_endo -70.07 98.78 0.74 Allowed 'Trans proline' 0 C--O 1.219 -0.447 0 C-N-CA 120.709 0.939 . . . . 0.0 109.883 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 100.09 3.53 55.69 Favored Glycine 0 N--CA 1.495 2.625 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 3.5 m -138.76 91.13 12.09 Favored Pre-proline 0 N--CA 1.503 2.223 0 CA-C-N 119.114 1.457 . . . . 0.0 109.341 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -74.45 162.11 38.82 Favored 'Trans proline' 0 N--CA 1.481 0.786 0 C-N-CA 121.343 1.362 . . . . 0.0 111.2 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 3.8 mmm180 -47.92 -29.21 3.16 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -54.35 -50.46 67.41 Favored 'General case' 0 N--CA 1.508 2.432 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.809 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 63.4 t -64.63 -36.44 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 52.4 mm-40 -63.27 -26.7 68.9 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.73 -37.21 41.92 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.49 -48.76 71.51 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.418 ' CD1' HG23 ' A' ' 24' ' ' VAL . 41.3 t80 -78.51 -25.22 45.55 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 122.248 -0.282 . . . . 0.0 110.654 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.402 ' N ' ' HD2' ' A' ' 95' ' ' PRO . . . -40.88 -52.44 6.67 Favored Pre-proline 0 N--CA 1.505 2.315 0 CA-C-O 118.978 -0.534 . . . . 0.0 112.09 -177.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.402 ' HD2' ' N ' ' A' ' 94' ' ' ALA . 30.6 Cg_endo -74.44 -173.65 1.56 Allowed 'Trans proline' 0 C--N 1.328 -0.524 0 C-N-CA 121.708 1.606 . . . . 0.0 109.834 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 17.6 mttm 68.31 26.61 6.8 Favored 'General case' 0 N--CA 1.504 2.243 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -178.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.402 HD12 ' CG2' ' A' ' 60' ' ' VAL . 0.1 OUTLIER -73.53 -69.61 0.42 Allowed 'General case' 0 N--CA 1.516 2.848 0 O-C-N 121.837 -0.539 . . . . 0.0 110.791 -179.302 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 32.8 m -88.38 26.12 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 O-C-N 121.129 -0.982 . . . . 0.0 110.385 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 27.4 p -100.1 173.51 6.6 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.77 -1.62 0.43 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.565 -0.71 . . . . 0.0 112.019 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 20.9 t -96.77 1.29 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 CA-C-N 120.562 1.528 . . . . 0.0 111.222 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -141.09 -91.48 0.15 Allowed 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.488 -0.758 . . . . 0.0 111.318 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 60.5 m -142.74 45.46 1.59 Allowed 'General case' 0 N--CA 1.504 2.263 0 O-C-N 121.425 -0.797 . . . . 0.0 109.577 -178.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 58.1 t-20 -40.39 -68.84 0.15 Allowed 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.297 -0.877 . . . . 0.0 113.258 -178.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.1 mt 50.51 27.16 2.71 Favored 'General case' 0 N--CA 1.506 2.357 0 C-N-CA 120.329 -0.549 . . . . 0.0 110.348 -178.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 68.52 163.26 0.22 Allowed 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.332 -0.855 . . . . 0.0 109.364 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.503 ' OG1' ' CE1' ' A' ' 109' ' ' HIS . 16.6 p -135.92 -159.94 1.01 Allowed 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 120.869 0.366 . . . . 0.0 110.439 -176.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -93.13 -47.25 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 121.9 -0.5 . . . . 0.0 111.563 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.512 ' NE2' ' CB ' ' A' ' 114' ' ' CYS . 0.0 OUTLIER -54.28 -22.64 12.38 Favored 'General case' 0 N--CA 1.529 3.479 0 O-C-N 121.673 -0.642 . . . . 0.0 109.88 -178.838 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.34 68.81 0.79 Allowed Glycine 0 N--CA 1.499 2.898 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.698 177.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 143.57 173.19 14.91 Favored Glycine 0 N--CA 1.5 2.91 0 CA-C-N 118.809 1.305 . . . . 0.0 111.4 178.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -73.67 85.47 1.3 Allowed 'Trans proline' 0 N--CA 1.482 0.814 0 C-N-CA 122.79 2.327 . . . . 0.0 110.375 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.5 ' O ' ' CE1' ' A' ' 109' ' ' HIS . 0.0 OUTLIER 176.62 -173.01 0.09 Allowed 'General case' 0 N--CA 1.515 2.78 0 C-N-CA 120.389 -0.524 . . . . 0.0 111.392 -179.823 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.512 ' CB ' ' NE2' ' A' ' 109' ' ' HIS . 28.7 p 160.6 -174.91 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.681 0 C-N-CA 123.534 0.734 . . . . 0.0 109.307 178.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 70.48 -83.73 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 O-C-N 122.223 -0.298 . . . . 0.0 110.611 178.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 15.1 m -87.59 -69.76 0.67 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.896 -0.502 . . . . 0.0 110.526 -178.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.426 HD22 ' CZ ' ' A' ' 113' ' ' PHE . 0.4 OUTLIER 66.05 -87.4 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -179.415 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.8 mp -56.53 -15.84 4.99 Favored 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.04 136.18 0.35 Allowed Glycine 0 N--CA 1.5 2.918 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 60.46 72.85 0.5 Allowed 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.577 0.703 . . . . 0.0 109.909 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.55 21.4 44.77 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 . . . . . 0 N--CA 1.498 1.93 0 CA-C-O 118.061 -0.971 . . . . 0.0 109.559 180.0 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.8 m . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 48.6 t -72.16 -77.08 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 95.45 134.06 7.62 Favored Glycine 0 N--CA 1.5 2.919 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.5 t -96.13 20.92 9.51 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 122.219 -0.577 . . . . 0.0 110.105 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 60.1 p -168.77 157.4 8.32 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 34.7 m 60.3 161.87 0.05 Allowed 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.412 HG22 HD11 ' A' ' 7' ' ' ILE . 0.2 OUTLIER -154.24 166.53 15.66 Favored Pre-proline 0 N--CA 1.507 2.416 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -179.094 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -76.68 143.87 24.36 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.301 2.001 . . . . 0.0 110.107 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 61.38 14.63 42.17 Favored Glycine 0 N--CA 1.501 2.969 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.45 ' O ' ' CB ' ' A' ' 11' ' ' ALA . 5.1 mmt -141.06 108.01 5.43 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.45 ' CB ' ' O ' ' A' ' 10' ' ' MET . . . 87.04 -59.93 0.04 OUTLIER 'General case' 0 N--CA 1.514 2.767 0 CA-C-N 119.94 1.246 . . . . 0.0 108.245 -178.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 21.9 mt -109.82 97.54 29.29 Favored Pre-proline 0 N--CA 1.492 1.667 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 178.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -83.62 174.75 8.52 Favored 'Trans proline' 0 N--CA 1.476 0.442 0 C-N-CA 121.814 1.676 . . . . 0.0 111.503 -177.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 45.2 m-70 -71.93 142.21 49.45 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.455 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 25.8 m120 59.1 59.02 5.36 Favored Pre-proline 0 N--CA 1.5 2.058 0 O-C-N 121.436 -0.79 . . . . 0.0 109.003 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.455 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 38.2 Cg_endo -78.97 151.5 24.13 Favored 'Trans proline' 0 N--CA 1.484 0.95 0 C-N-CA 122.345 2.03 . . . . 0.0 112.264 -178.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.7 mp 43.0 42.65 3.25 Favored 'General case' 0 N--CA 1.502 2.158 0 CA-C-O 121.163 0.506 . . . . 0.0 111.825 178.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -65.37 -32.4 74.02 Favored 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.23 -25.98 67.15 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 35.1 m -76.1 -38.46 56.92 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.6 -50.28 73.21 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.412 ' HA ' ' CE3' ' A' ' 22' ' ' TRP . 36.5 m95 -70.8 -27.37 63.85 Favored 'General case' 0 N--CA 1.501 2.122 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.786 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -68.12 -31.91 71.83 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.464 ' CG2' ' CD1' ' A' ' 93' ' ' PHE . 86.4 t -74.98 -40.58 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 177.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.01 -38.64 68.14 Favored 'General case' 0 N--CA 1.502 2.163 0 C-N-CA 120.095 -0.642 . . . . 0.0 109.561 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.7 m -77.07 -51.81 10.41 Favored 'General case' 0 N--CA 1.506 2.356 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.554 -178.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -62.22 -25.21 67.68 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.795 -0.565 . . . . 0.0 111.189 -178.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.4 ' CG2' HG11 ' A' ' 24' ' ' VAL . 79.6 p -97.3 -63.84 1.1 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 122.233 -0.292 . . . . 0.0 111.763 -177.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 55.8 m -101.72 14.72 31.13 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.358 -0.839 . . . . 0.0 112.129 -178.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 55.82 21.72 30.96 Favored Glycine 0 N--CA 1.505 3.254 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 56.3 t -106.89 162.78 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.821 -0.811 . . . . 0.0 109.011 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 130.16 178.24 15.31 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -66.55 174.88 5.77 Favored 'Trans proline' 0 N--CA 1.487 1.12 0 CA-C-N 119.165 1.482 . . . . 0.0 109.571 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.2 ptp85 -92.21 52.31 1.93 Allowed 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.98 0.895 . . . . 0.0 109.77 -178.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.48 127.83 41.84 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.47 148.78 4.78 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.807 -0.558 . . . . 0.0 110.171 -178.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 61.1 m -65.77 -40.34 91.93 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.67 -0.643 . . . . 0.0 111.947 -178.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -64.88 -44.29 90.15 Favored 'General case' 0 N--CA 1.504 2.264 0 CA-C-N 118.644 0.656 . . . . 0.0 109.72 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -66.87 -27.68 67.72 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -69.45 -59.03 3.25 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.31 -31.87 55.17 Favored 'General case' 0 N--CA 1.5 2.06 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.633 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.91 -40.79 78.93 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -64.24 -37.41 87.37 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 15.9 m -72.34 -33.45 67.31 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.922 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 21.8 m -73.69 -28.46 61.75 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 24.5 ttm180 -78.19 -35.56 48.5 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -78.03 -41.92 34.13 Favored 'General case' 0 N--CA 1.502 2.157 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.494 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.413 ' O ' ' NH1' ' A' ' 56' ' ' ARG . 5.6 tt -64.9 -45.22 86.82 Favored 'General case' 0 C--O 1.2 -1.552 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.416 ' HA ' ' NH2' ' A' ' 56' ' ' ARG . 0.2 OUTLIER -69.14 -28.66 66.64 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.403 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.2 -60.34 3.53 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.431 ' O ' ' NH2' ' A' ' 56' ' ' ARG . 2.8 mt -58.73 103.92 0.39 Allowed Pre-proline 0 N--CA 1.51 2.572 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 178.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -50.18 144.67 22.24 Favored 'Trans proline' 0 N--CA 1.488 1.166 0 C-N-CA 121.636 1.558 . . . . 0.0 113.094 -175.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.445 ' HA ' ' CG ' ' A' ' 56' ' ' ARG . . . -22.82 -46.19 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.767 0 C-N-CA 124.28 1.032 . . . . 0.0 113.693 -177.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -62.75 138.11 58.43 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 20.8 m 61.68 22.82 13.25 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 122.0 -0.438 . . . . 0.0 109.819 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.445 ' CG ' ' HA ' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -44.72 -93.08 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.892 0 O-C-N 121.063 -1.023 . . . . 0.0 110.72 -179.697 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 76.1 m -38.94 -22.35 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.555 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 -178.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -39.07 -48.02 1.61 Allowed 'General case' 0 N--CA 1.512 2.644 0 CA-C-N 120.984 1.72 . . . . 0.0 112.249 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -44.56 -57.95 3.31 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.62 -0.675 . . . . 0.0 111.42 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.4 t -48.51 -41.85 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.266 0 CA-C-O 121.125 0.488 . . . . 0.0 109.686 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 22.9 mtp85 -60.09 -64.15 1.05 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.498 ' CG2' ' HB ' ' A' ' 67' ' ' VAL . 36.9 mm -46.13 -26.95 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.787 -0.57 . . . . 0.0 111.365 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -77.82 -43.64 29.85 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.226 -0.989 . . . . 0.0 109.705 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -77.67 -53.38 7.62 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.6 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -79.93 -22.17 42.99 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 122.039 -0.413 . . . . 0.0 111.025 -179.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.96 154.06 15.03 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -178.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.498 ' HB ' ' CG2' ' A' ' 62' ' ' ILE . 2.5 p -117.46 158.94 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.341 0 CA-C-O 121.361 0.6 . . . . 0.0 109.548 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.467 ' CG2' ' CE1' ' A' ' 74' ' ' HIS . 54.7 t -115.69 157.05 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.6 p -117.48 159.53 22.67 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.522 -177.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.9 t -61.95 -32.73 73.19 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.23 0.538 . . . . 0.0 110.175 -178.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.2 p -65.69 -18.85 65.63 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.254 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.13 16.54 25.15 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -106.36 156.9 18.04 Favored 'General case' 0 N--CA 1.503 2.197 0 CA-C-N 118.284 1.042 . . . . 0.0 109.626 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.467 ' CE1' ' CG2' ' A' ' 68' ' ' VAL . 11.0 m170 -116.09 154.08 30.59 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.589 -0.695 . . . . 0.0 109.143 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -140.63 -174.99 4.12 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.044 0.449 . . . . 0.0 109.851 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 56.3 -141.29 41.33 Favored Glycine 0 N--CA 1.497 2.715 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.3 ttp180 54.39 24.8 5.44 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 122.228 -0.572 . . . . 0.0 110.54 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.4 mt -78.7 -19.03 53.39 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.698 -0.626 . . . . 0.0 110.38 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.5 tp -52.86 95.37 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.703 -0.623 . . . . 0.0 109.998 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -132.78 172.86 12.01 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -67.82 103.18 1.38 Allowed 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.497 0.665 . . . . 0.0 110.484 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.565 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 24.7 mt -78.45 171.33 12.79 Favored Pre-proline 0 N--CA 1.492 1.655 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 177.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.565 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 27.6 Cg_endo -66.61 99.21 0.43 Allowed 'Trans proline' 0 C--N 1.327 -0.579 0 C-N-CA 120.939 1.093 . . . . 0.0 110.715 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 98.18 -12.11 63.69 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 7.0 m -119.58 92.17 45.74 Favored Pre-proline 0 N--CA 1.5 2.063 0 CA-C-N 119.207 1.503 . . . . 0.0 110.101 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -73.16 164.46 35.33 Favored 'Trans proline' 0 N--CA 1.483 0.863 0 C-N-CA 121.514 1.476 . . . . 0.0 111.045 -179.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -46.32 -28.56 1.35 Allowed 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 177.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -54.47 -54.6 38.79 Favored 'General case' 0 N--CA 1.504 2.243 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.537 -178.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 64.5 t -60.84 -41.52 88.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.761 -0.587 . . . . 0.0 109.843 -178.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 7.1 mp0 -64.61 -26.59 68.47 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.49 -28.55 46.4 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.11 -48.68 17.11 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 122.014 -0.429 . . . . 0.0 109.876 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.464 ' CD1' ' CG2' ' A' ' 24' ' ' VAL . 36.1 t80 -77.72 -25.28 49.2 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 122.212 -0.305 . . . . 0.0 110.759 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.44 ' N ' ' HD2' ' A' ' 95' ' ' PRO . . . -53.15 -53.37 56.43 Favored Pre-proline 0 N--CA 1.5 2.049 0 CA-C-O 118.961 -0.542 . . . . 0.0 111.883 -177.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' A' ' 94' ' ' ALA . 30.2 Cg_endo -70.0 -11.16 29.99 Favored 'Trans proline' 0 N--CA 1.482 0.819 0 C-N-CA 121.918 1.745 . . . . 0.0 111.181 -179.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -89.47 17.19 6.53 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.89 -71.27 0.33 Allowed 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.671 -0.643 . . . . 0.0 109.966 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 104' ' ' ASN . 13.1 m -70.58 5.6 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.36 0 O-C-N 121.176 -0.953 . . . . 0.0 112.283 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 16.3 p -92.07 174.79 7.14 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.13 -3.98 0.45 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.526 -0.734 . . . . 0.0 112.389 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.0 t -89.06 -2.2 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 CA-C-N 120.069 1.304 . . . . 0.0 111.114 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.23 -86.97 0.2 Allowed 'General case' 0 N--CA 1.508 2.456 0 C-N-CA 119.486 -0.886 . . . . 0.0 111.978 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 95.6 m -146.7 43.83 1.18 Allowed 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.43 -0.794 . . . . 0.0 109.107 -178.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.434 ' HA ' ' O ' ' A' ' 98' ' ' VAL . 4.1 p30 -39.11 -55.4 1.62 Allowed 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.438 -0.789 . . . . 0.0 113.09 -178.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.2 mt 40.8 29.84 0.08 Allowed 'General case' 0 N--CA 1.511 2.623 0 CA-C-N 118.875 0.761 . . . . 0.0 111.071 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 65.5 155.41 0.08 Allowed 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.64 -0.662 . . . . 0.0 109.302 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.42 ' HA ' ' HD2' ' A' ' 56' ' ' ARG . 4.4 p -127.88 -160.22 1.0 Allowed 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -179.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.433 HG21 HD11 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -67.51 -34.11 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.41 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.425 ' HB3' ' CE1' ' A' ' 113' ' ' PHE . 93.1 m-70 -69.48 -2.55 11.53 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 116.234 -0.439 . . . . 0.0 112.049 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 60.25 29.92 69.78 Favored Glycine 0 N--CA 1.497 2.75 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -159.88 170.54 36.05 Favored Glycine 0 N--CA 1.496 2.653 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -78.02 76.24 4.45 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.537 2.158 . . . . 0.0 111.475 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.425 ' CE1' ' HB3' ' A' ' 109' ' ' HIS . 35.7 p90 173.96 163.71 0.19 Allowed 'General case' 0 N--CA 1.508 2.454 0 O-C-N 121.769 -0.582 . . . . 0.0 110.313 178.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 29.7 p -173.01 160.13 4.13 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 122.11 -0.369 . . . . 0.0 110.179 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 67.19 -82.91 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.261 0 O-C-N 122.133 -0.354 . . . . 0.0 111.344 178.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 40.2 t -46.08 -86.48 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.825 -0.547 . . . . 0.0 111.475 -178.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 56.13 -95.2 0.05 Allowed 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -178.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -61.43 -11.65 11.33 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.41 -0.806 . . . . 0.0 112.794 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -54.27 114.69 4.45 Favored Glycine 0 N--CA 1.5 2.904 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -108.61 66.15 0.64 Allowed 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.935 0.874 . . . . 0.0 108.777 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -57.96 -21.68 45.92 Favored Glycine 0 N--CA 1.498 2.808 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 . . . . . 0 N--CA 1.499 2.013 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.528 -179.921 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 10.4 p . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.0 t -64.83 -71.86 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 95.7 -136.58 12.95 Favored Glycine 0 N--CA 1.497 2.749 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.8 t -172.64 77.29 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 61.88 171.73 0.12 Allowed 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.644 -0.66 . . . . 0.0 109.711 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 67.2 m 58.88 104.01 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 44.6 pt -94.46 156.27 38.78 Favored Pre-proline 0 N--CA 1.499 1.986 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.11 159.45 30.24 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.241 1.96 . . . . 0.0 110.358 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.45 4.71 75.5 Favored Glycine 0 N--CA 1.5 2.964 0 N-CA-C 110.839 -0.905 . . . . 0.0 110.839 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.457 ' O ' ' CB ' ' A' ' 11' ' ' ALA . 1.5 mpt? -133.0 99.04 4.45 Favored 'General case' 0 N--CA 1.501 2.11 0 CA-C-N 118.103 0.951 . . . . 0.0 108.705 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.457 ' CB ' ' O ' ' A' ' 10' ' ' MET . . . 86.79 -56.01 0.05 Allowed 'General case' 0 N--CA 1.515 2.819 0 CA-C-N 119.355 0.98 . . . . 0.0 108.547 -178.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 9.2 mt -101.85 101.44 18.33 Favored Pre-proline 0 N--CA 1.493 1.695 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 178.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -80.58 173.37 12.35 Favored 'Trans proline' 0 N--CA 1.474 0.33 0 C-N-CA 121.536 1.491 . . . . 0.0 111.643 -176.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 46.0 m-70 -71.13 144.53 50.21 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.442 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 3.3 t-20 60.68 60.24 3.57 Favored Pre-proline 0 N--CA 1.499 1.99 0 O-C-N 121.597 -0.689 . . . . 0.0 109.198 -179.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.442 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 39.5 Cg_endo -81.43 151.28 17.45 Favored 'Trans proline' 0 N--CA 1.481 0.787 0 C-N-CA 122.318 2.012 . . . . 0.0 111.673 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.6 mp 51.57 41.26 28.52 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-O 121.048 0.451 . . . . 0.0 111.421 178.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -65.54 -40.62 93.08 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.67 -25.99 68.42 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 65.4 m -73.51 -42.83 61.29 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.414 ' CG ' ' N ' ' A' ' 22' ' ' TRP . 2.5 ptt-85 -60.59 -49.83 75.96 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.436 ' CE3' ' HA ' ' A' ' 22' ' ' TRP . 29.9 m95 -67.85 -26.94 66.29 Favored 'General case' 0 N--CA 1.5 2.052 0 C-N-CA 119.693 -0.803 . . . . 0.0 110.447 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.44 ' CD2' ' HB3' ' A' ' 40' ' ' MET . 5.4 t80 -66.91 -32.3 73.47 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 178.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.46 HG21 ' CE1' ' A' ' 93' ' ' PHE . 47.0 t -71.68 -43.81 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.3 m -53.91 -42.36 68.64 Favored 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.431 -179.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 16.7 m -76.96 -53.76 7.44 Favored 'General case' 0 N--CA 1.507 2.42 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -178.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.8 tpm_? -60.28 -25.53 65.79 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.78 -0.575 . . . . 0.0 110.878 -178.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 48.1 p -97.67 -63.32 1.14 Allowed 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -177.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 45.8 m -101.26 14.69 31.16 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.451 -0.78 . . . . 0.0 112.093 -178.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 55.64 21.06 27.2 Favored Glycine 0 N--CA 1.506 3.326 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 25.5 t -107.55 164.01 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 O-C-N 121.851 -0.794 . . . . 0.0 109.121 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 134.38 178.89 15.95 Favored Glycine 0 N--CA 1.498 2.817 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -66.12 175.25 4.96 Favored 'Trans proline' 0 N--CA 1.486 1.075 0 CA-C-N 119.14 1.47 . . . . 0.0 109.633 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.07 82.25 5.07 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.99 0.9 . . . . 0.0 109.941 -178.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -139.71 135.84 33.58 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.8 162.63 0.86 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 122.056 -0.402 . . . . 0.0 110.158 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.89 -54.0 8.05 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 122.051 -0.406 . . . . 0.0 110.595 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -51.48 -36.51 44.73 Favored 'General case' 0 N--CA 1.507 2.398 0 O-C-N 121.742 -0.599 . . . . 0.0 111.15 -178.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -70.75 -36.09 72.96 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 122.052 -0.405 . . . . 0.0 110.008 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.44 ' HB3' ' CD2' ' A' ' 23' ' ' TYR . 0.8 OUTLIER -66.18 -54.25 27.61 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.856 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.0 ttpt -54.63 -36.76 64.86 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.05 -39.72 95.57 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -63.6 -40.75 97.72 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 16.4 m -67.82 -33.5 74.91 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.054 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 17.9 m -74.44 -30.44 61.89 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.22 -35.29 71.43 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 178.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -79.07 -26.85 43.01 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 120.961 0.41 . . . . 0.0 109.947 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -71.52 -39.31 70.83 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.24 -40.45 37.2 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.23 -37.61 64.81 Favored 'General case' 0 N--CA 1.505 2.294 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 178.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 80.2 mt -79.04 105.15 2.73 Favored Pre-proline 0 N--CA 1.493 1.7 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 177.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -60.31 146.67 96.06 Favored 'Trans proline' 0 N--CA 1.479 0.631 0 C-N-CA 121.544 1.496 . . . . 0.0 110.997 -176.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -42.5 -27.99 0.19 Allowed 'General case' 0 N--CA 1.502 2.17 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.685 -178.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -67.37 119.83 12.86 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 20.8 m 62.02 17.38 8.99 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 122.383 -0.198 . . . . 0.0 110.647 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -44.93 -83.37 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.901 0 O-C-N 121.231 -0.918 . . . . 0.0 110.165 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 51.3 m -33.15 -43.62 0.11 Allowed 'General case' 0 N--CA 1.52 3.061 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -37.8 -48.07 1.07 Allowed 'General case' 0 N--CA 1.514 2.774 0 CA-C-N 119.741 1.155 . . . . 0.0 112.246 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -43.66 -53.23 5.9 Favored 'General case' 0 N--CA 1.513 2.722 0 O-C-N 121.542 -0.724 . . . . 0.0 111.582 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 38.5 t -48.69 -45.87 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.399 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.1 -54.61 45.06 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.475 ' CG2' ' HB ' ' A' ' 67' ' ' VAL . 34.4 mt -49.18 -27.39 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.337 0 O-C-N 121.344 -0.848 . . . . 0.0 109.965 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 27.5 tp -77.92 -41.85 35.11 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.491 -0.884 . . . . 0.0 109.994 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.26 -54.26 6.71 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.555 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -80.65 -22.86 40.13 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.931 -0.48 . . . . 0.0 111.224 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.65 150.49 17.07 Favored Glycine 0 N--CA 1.498 2.781 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -178.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.475 ' HB ' ' CG2' ' A' ' 62' ' ' ILE . 4.2 p -117.91 159.68 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.275 0 O-C-N 122.176 -0.603 . . . . 0.0 109.845 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.444 ' CG2' ' CE1' ' A' ' 74' ' ' HIS . 72.8 t -115.1 157.51 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 CA-C-O 121.767 0.794 . . . . 0.0 109.095 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.9 p -117.42 159.78 22.24 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.648 -177.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.3 t -62.07 -33.41 74.37 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.3 -178.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.8 p -66.2 -17.78 64.94 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.226 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.91 14.78 30.5 Favored Glycine 0 N--CA 1.498 2.798 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 67.8 mm-40 -102.58 157.06 17.2 Favored 'General case' 0 N--CA 1.503 2.221 0 CA-C-N 118.19 0.995 . . . . 0.0 109.321 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.444 ' CE1' ' CG2' ' A' ' 68' ' ' VAL . 9.5 m170 -115.83 155.3 28.13 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -143.48 -176.77 5.08 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.17 0.51 . . . . 0.0 110.278 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 60.09 -137.66 49.16 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 22.7 ttp180 51.42 26.07 2.96 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 122.317 -0.519 . . . . 0.0 110.301 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.4 mt -77.2 -20.47 55.29 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.719 -0.613 . . . . 0.0 110.636 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 95.8 mt -62.14 95.55 0.06 Allowed 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -143.23 177.01 8.7 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.368 0.604 . . . . 0.0 110.29 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -50.96 107.86 0.2 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.49 0.662 . . . . 0.0 111.775 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.517 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 18.3 mt -100.88 168.14 9.71 Favored Pre-proline 0 N--CA 1.495 1.797 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.517 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 26.6 Cg_endo -64.62 99.79 0.32 Allowed 'Trans proline' 0 N--CA 1.48 0.699 0 C-N-CA 121.277 1.318 . . . . 0.0 111.702 -178.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.84 -9.89 75.75 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 7.5 m -118.98 91.12 42.68 Favored Pre-proline 0 N--CA 1.503 2.217 0 CA-C-N 119.125 1.463 . . . . 0.0 110.538 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -72.02 165.44 32.59 Favored 'Trans proline' 0 N--CA 1.482 0.847 0 C-N-CA 121.712 1.608 . . . . 0.0 111.173 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.1 mmm-85 -47.59 -28.53 2.35 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -57.7 -53.42 58.36 Favored 'General case' 0 N--CA 1.502 2.159 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.048 -178.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.1 t -63.89 -38.72 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.19 -26.96 69.05 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.93 -35.95 42.56 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.22 -49.82 63.12 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.997 -0.439 . . . . 0.0 109.896 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.46 ' CE1' HG21 ' A' ' 24' ' ' VAL . 34.0 t80 -78.77 -25.11 44.35 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 122.12 -0.362 . . . . 0.0 110.554 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.417 ' N ' ' HD2' ' A' ' 95' ' ' PRO . . . -41.22 -51.06 8.22 Favored Pre-proline 0 N--CA 1.503 2.186 0 CA-C-O 118.773 -0.632 . . . . 0.0 112.29 -177.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.417 ' HD2' ' N ' ' A' ' 94' ' ' ALA . 30.3 Cg_endo -72.59 -167.24 0.32 Allowed 'Trans proline' 0 C--N 1.33 -0.43 0 C-N-CA 121.505 1.47 . . . . 0.0 109.62 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 77.0 mttt 62.48 20.44 11.92 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.92 -65.45 0.8 Allowed 'General case' 0 N--CA 1.509 2.486 0 O-C-N 121.875 -0.516 . . . . 0.0 110.786 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 27.1 m -84.6 20.63 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 120.963 -1.086 . . . . 0.0 111.279 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 25.2 p -98.91 174.71 6.23 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.04 -2.67 0.63 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.575 -0.703 . . . . 0.0 112.018 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 14.4 t -94.05 -0.64 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 CA-C-N 120.591 1.541 . . . . 0.0 111.062 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -138.12 -89.65 0.23 Allowed 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.383 -0.823 . . . . 0.0 111.185 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 54.0 m -144.92 39.5 1.23 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.374 -0.829 . . . . 0.0 109.432 -178.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -35.22 -60.84 0.46 Allowed 'General case' 0 N--CA 1.511 2.6 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -178.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.1 mt 43.23 31.45 0.38 Allowed 'General case' 0 N--CA 1.511 2.617 0 CA-C-N 118.657 0.662 . . . . 0.0 110.73 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 66.58 150.09 0.05 Allowed 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.7 p -119.58 -159.86 0.79 Allowed 'General case' 0 N--CA 1.504 2.226 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.8 tt -66.98 -32.35 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -72.92 1.73 8.21 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.9 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 57.91 33.18 67.79 Favored Glycine 0 N--CA 1.499 2.887 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -161.66 170.63 37.43 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -79.05 71.96 6.76 Favored 'Trans proline' 0 CA--C 1.545 1.047 0 C-N-CA 122.747 2.298 . . . . 0.0 111.55 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 44.8 p90 175.39 155.38 0.17 Allowed 'General case' 0 N--CA 1.505 2.311 0 O-C-N 121.816 -0.552 . . . . 0.0 110.171 178.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 20.6 p -156.31 150.33 25.19 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 56.36 -177.47 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.717 -0.614 . . . . 0.0 110.069 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 57.19 -89.97 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 55.37 -88.8 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.838 -0.539 . . . . 0.0 110.105 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 16.5 mt -50.53 -18.4 0.66 Allowed 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.6 -0.687 . . . . 0.0 112.812 -179.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -107.51 40.96 2.33 Favored Glycine 0 N--CA 1.499 2.839 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -96.16 53.5 1.36 Allowed 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.911 0.862 . . . . 0.0 109.289 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -57.34 -24.57 52.3 Favored Glycine 0 N--CA 1.499 2.876 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 . . . . . 0 N--CA 1.5 2.07 0 CA-C-O 117.85 -1.072 . . . . 0.0 110.225 179.773 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.206 0.527 . . . . 0.0 109.583 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -54.48 -99.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.353 -0.842 . . . . 0.0 109.726 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 165.47 -139.06 5.58 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.46 ' O ' ' O ' ' A' ' 5' ' ' SER . 8.5 t -116.19 20.53 14.27 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.24 -1.153 . . . . 0.0 110.092 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 4' ' ' THR . 23.2 m 42.91 -166.13 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.144 -0.973 . . . . 0.0 109.741 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.481 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 34.0 m -99.99 120.71 40.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.221 -0.924 . . . . 0.0 109.13 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.451 ' HB ' ' SD ' ' A' ' 10' ' ' MET . 1.0 OUTLIER -42.64 101.96 0.26 Allowed Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.328 -0.858 . . . . 0.0 109.81 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 6' ' ' CYS . 36.1 Cg_endo -77.86 159.0 31.25 Favored 'Trans proline' 0 C--N 1.315 -1.217 0 C-N-CA 121.87 1.713 . . . . 0.0 110.133 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 60.15 12.52 23.89 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.589 ' O ' ' CB ' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -129.37 94.44 3.78 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.293 -1.122 . . . . 0.0 108.71 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.589 ' CB ' ' O ' ' A' ' 10' ' ' MET . . . 86.09 -58.14 0.07 Allowed 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -178.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 29.1 mt -95.69 103.25 12.29 Favored Pre-proline 0 N--CA 1.489 1.489 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.509 ' HD3' ' O ' ' A' ' 11' ' ' ALA . 34.1 Cg_endo -81.37 170.86 14.28 Favored 'Trans proline' 0 C--N 1.318 -1.038 0 C-N-CA 121.378 1.385 . . . . 0.0 111.864 -176.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 29.1 m-70 -69.82 149.2 48.16 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.466 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 1.1 t-20 67.2 63.95 0.74 Allowed Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 120.623 -1.298 . . . . 0.0 110.033 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.47 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 37.3 Cg_endo -79.7 166.35 21.71 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.808 2.339 . . . . 0.0 112.151 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.456 HD21 ' CB ' ' A' ' 20' ' ' CYS . 0.2 OUTLIER 33.13 47.03 0.11 Allowed 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.581 178.789 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -74.86 -34.85 62.33 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.99 -1.069 . . . . 0.0 108.982 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.455 ' OG ' ' SG ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -62.56 -43.36 99.01 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.171 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.456 ' CB ' HD21 ' A' ' 17' ' ' LEU . 36.2 m -59.88 -40.03 87.29 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 121.352 0.596 . . . . 0.0 109.706 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.565 ' HG3' ' N ' ' A' ' 22' ' ' TRP . 0.1 OUTLIER -58.08 -51.91 67.72 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.373 -0.83 . . . . 0.0 108.915 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.565 ' N ' ' HG3' ' A' ' 21' ' ' ARG . 27.6 m95 -68.75 -26.25 65.14 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 118.591 -1.244 . . . . 0.0 110.541 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.59 ' CG ' ' CE ' ' A' ' 40' ' ' MET . 19.0 t80 -66.97 -32.65 74.03 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.911 -1.118 . . . . 0.0 108.593 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.573 HG23 ' CE1' ' A' ' 93' ' ' PHE . 71.3 t -72.9 -42.25 60.51 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.274 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 178.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.471 ' OG ' ' HA ' ' A' ' 22' ' ' TRP . 0.5 OUTLIER -54.84 -40.0 69.14 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.059 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 3.7 m -77.28 -53.26 7.92 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.186 -0.946 . . . . 0.0 111.154 -178.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.1 ttm180 -59.56 -24.4 63.69 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.935 -1.103 . . . . 0.0 110.194 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.487 HG22 ' CG1' ' A' ' 24' ' ' VAL . 80.7 p -93.0 -67.53 0.85 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.186 -0.946 . . . . 0.0 111.419 -178.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.498 ' SG ' ' C ' ' A' ' 84' ' ' GLY . 93.2 m -99.51 18.07 18.79 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.496 -1.378 . . . . 0.0 110.104 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.456 ' HA2' ' O ' ' A' ' 26' ' ' THR . . . 57.63 15.55 18.8 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 26' ' ' THR . 75.6 t -101.87 154.48 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.13 -1.218 . . . . 0.0 109.283 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 142.66 179.23 19.3 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -66.37 177.15 3.42 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 CA-C-N 118.981 1.391 . . . . 0.0 109.875 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.47 ' HG2' ' O ' ' A' ' 34' ' ' ARG . 0.1 OUTLIER -91.28 81.68 5.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.726 -1.234 . . . . 0.0 110.162 -178.125 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.461 ' CD2' ' NH1' ' A' ' 43' ' ' ARG . 25.6 tp -138.13 127.98 25.38 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.94 161.58 0.76 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.059 -1.025 . . . . 0.0 109.662 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.435 ' O ' ' C ' ' A' ' 38' ' ' GLN . 1.2 p -67.96 -61.97 1.62 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.12 -0.987 . . . . 0.0 109.987 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 37' ' ' THR . 0.8 OUTLIER -43.95 -57.22 3.44 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.017 -1.052 . . . . 0.0 109.737 -179.361 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.466 ' O ' ' HB1' ' A' ' 42' ' ' ALA . 75.5 mm-40 -49.15 -43.38 41.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.252 -0.905 . . . . 0.0 109.699 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.59 ' CE ' ' CG ' ' A' ' 23' ' ' TYR . 1.8 tmm? -59.03 -62.97 1.48 Allowed 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.471 ' HG3' ' OE1' ' A' ' 102' ' ' GLU . 19.0 tttt -40.59 -31.68 0.17 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.466 ' HB1' ' O ' ' A' ' 39' ' ' GLU . . . -68.51 -50.93 48.46 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.593 -0.692 . . . . 0.0 109.688 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.541 ' CG ' ' O ' ' A' ' 40' ' ' MET . 0.0 OUTLIER -59.14 -41.24 87.83 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.193 -1.003 . . . . 0.0 109.768 -179.597 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.455 ' SG ' ' OG ' ' A' ' 19' ' ' SER . 8.8 m -65.03 -36.09 83.25 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.89 -1.132 . . . . 0.0 110.579 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 19.1 m -69.75 -32.02 70.31 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.737 -1.227 . . . . 0.0 108.937 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.86 -32.64 67.7 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.465 ' HG3' ' O ' ' A' ' 43' ' ' ARG . 0.1 OUTLIER -77.43 -29.14 52.79 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.703 -0.623 . . . . 0.0 109.638 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.504 ' CD1' HG11 ' A' ' 98' ' ' VAL . 0.6 OUTLIER -75.0 -38.42 61.61 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.115 -0.991 . . . . 0.0 108.544 179.59 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.425 ' O ' ' C ' ' A' ' 50' ' ' ALA . 2.9 tt0 -69.16 -53.04 22.13 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.478 ' O ' ' HD3' ' A' ' 52' ' ' PRO . . . -47.54 -52.98 15.74 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 178.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.553 ' CG2' ' HA ' ' A' ' 56' ' ' ARG . 26.8 mm -58.81 106.02 0.64 Allowed Pre-proline 0 C--N 1.304 -1.393 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 177.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 50' ' ' ALA . 28.0 Cg_endo -63.77 136.25 52.55 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 121.893 1.729 . . . . 0.0 111.528 -176.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.474 ' HA ' ' HG3' ' A' ' 56' ' ' ARG . . . -33.84 -36.15 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.792 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.474 ' O ' ' CB ' ' A' ' 55' ' ' CYS . 2.2 m-85 -67.63 117.14 9.16 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.01 -1.056 . . . . 0.0 108.794 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.474 ' CB ' ' O ' ' A' ' 54' ' ' TYR . 9.7 m 76.24 -2.46 2.73 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.461 -0.775 . . . . 0.0 109.784 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.553 ' HA ' ' CG2' ' A' ' 51' ' ' ILE . 0.4 OUTLIER -40.01 -87.44 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.199 -0.938 . . . . 0.0 109.188 -179.81 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.538 ' O ' ' C ' ' A' ' 58' ' ' GLU . 22.2 m -31.93 -58.34 0.29 Allowed 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.625 -0.672 . . . . 0.0 111.443 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.538 ' C ' ' O ' ' A' ' 57' ' ' CYS . 2.6 mm-40 -25.89 -53.5 0.05 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.55 -0.719 . . . . 0.0 111.249 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.47 ' HB3' ' HB2' ' A' ' 16' ' ' PRO . . . -37.81 -61.23 0.65 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.445 -0.785 . . . . 0.0 110.256 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.542 HG23 ' CD1' ' A' ' 97' ' ' LEU . 27.8 t -42.55 -51.35 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 CA-C-O 121.861 0.839 . . . . 0.0 108.904 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.485 ' O ' ' N ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -54.18 -63.66 1.08 Allowed 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.262 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.596 ' CG2' ' HB ' ' A' ' 67' ' ' VAL . 4.6 mm -40.06 -27.25 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.23 -0.919 . . . . 0.0 110.294 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.531 ' CD1' ' HB2' ' A' ' 79' ' ' LEU . 0.9 OUTLIER -77.59 -46.77 21.17 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 120.704 -1.248 . . . . 0.0 109.202 -179.973 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.489 ' SD ' ' NE ' ' A' ' 91' ' ' ARG . 0.1 OUTLIER -73.62 -53.65 9.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.23 -0.919 . . . . 0.0 110.152 -179.83 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -80.2 -21.43 42.95 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.82 -1.175 . . . . 0.0 110.315 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.489 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . 84.51 151.2 12.86 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -179.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.596 ' HB ' ' CG2' ' A' ' 62' ' ' ILE . 7.3 p -116.64 159.39 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.414 -1.051 . . . . 0.0 109.409 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.533 HG23 ' NE2' ' A' ' 74' ' ' HIS . 12.8 t -114.52 157.96 15.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-O 121.642 0.735 . . . . 0.0 109.185 -179.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.438 ' N ' ' CG1' ' A' ' 68' ' ' VAL . 27.5 p -116.83 158.94 23.12 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 121.615 0.722 . . . . 0.0 109.65 -178.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 32.1 t -62.25 -31.11 71.63 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.495 0.664 . . . . 0.0 110.13 -178.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.2 p -69.84 -14.01 62.54 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.499 -0.751 . . . . 0.0 109.6 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.3 9.24 48.29 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 108.881 -1.688 . . . . 0.0 108.881 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -91.84 157.25 16.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.088 -1.242 . . . . 0.0 109.877 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.533 ' NE2' HG23 ' A' ' 68' ' ' VAL . 10.1 m170 -115.83 156.32 26.31 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.022 -1.048 . . . . 0.0 108.739 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.423 ' HG2' ' C ' ' A' ' 74' ' ' HIS . 57.1 mm-40 -145.47 178.95 7.74 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.308 -0.87 . . . . 0.0 110.262 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 58.44 -147.13 39.8 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.43 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 2.9 ttp85 60.0 18.74 7.88 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.44 -1.035 . . . . 0.0 110.572 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.474 ' O ' ' NH2' ' A' ' 21' ' ' ARG . 1.8 mp -79.87 -19.53 48.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.837 -1.164 . . . . 0.0 109.812 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.531 ' HB2' ' CD1' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -64.46 89.26 0.06 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.972 -1.08 . . . . 0.0 108.691 179.484 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.42 ' O ' ' C ' ' A' ' 81' ' ' ASP . 8.3 mt-30 -136.39 178.32 7.16 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.295 -0.878 . . . . 0.0 110.201 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 80' ' ' GLN . 49.4 m-20 -39.33 129.35 1.79 Allowed 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.995 0.902 . . . . 0.0 110.93 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.582 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 22.0 mt -126.03 168.79 13.07 Favored Pre-proline 0 C--N 1.302 -1.484 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 178.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.582 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 27.4 Cg_endo -66.12 99.38 0.41 Allowed 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 121.008 1.138 . . . . 0.0 110.794 -179.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.498 ' C ' ' SG ' ' A' ' 29' ' ' CYS . . . 89.71 -7.97 80.76 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.458 ' SG ' ' OG1' ' A' ' 28' ' ' THR . 7.7 m -120.61 89.39 44.59 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 120.569 -1.547 . . . . 0.0 110.311 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.438 ' HD2' HG22 ' A' ' 89' ' ' VAL . 30.7 Cg_endo -76.44 159.01 36.4 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 C-N-CA 121.827 1.684 . . . . 0.0 111.197 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' A' ' 86' ' ' PRO . 4.3 mmt85 -44.63 -28.57 0.62 Allowed 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.41 ' N ' ' C ' ' A' ' 86' ' ' PRO . 4.5 tt0 -57.31 -60.5 3.54 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.668 -178.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.438 HG22 ' HD2' ' A' ' 86' ' ' PRO . 87.9 t -61.0 -42.59 93.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 O-C-N 120.793 -1.192 . . . . 0.0 110.364 -178.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.462 ' HG2' HD23 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -60.62 -27.53 67.83 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.182 -1.007 . . . . 0.0 108.514 179.841 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.489 ' NE ' ' SD ' ' A' ' 64' ' ' MET . 0.0 OUTLIER -78.05 -31.16 50.17 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.43 -0.794 . . . . 0.0 109.712 179.511 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.51 ' O ' ' HD2' ' A' ' 95' ' ' PRO . . . -71.08 -50.34 34.85 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.064 -1.023 . . . . 0.0 109.522 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.573 ' CE1' HG23 ' A' ' 24' ' ' VAL . 10.4 t80 -77.67 -25.72 49.76 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.424 -0.798 . . . . 0.0 109.915 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.562 ' N ' ' HD2' ' A' ' 95' ' ' PRO . . . -41.16 -52.46 7.22 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.308 -0.87 . . . . 0.0 111.885 -179.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 94' ' ' ALA . 29.6 Cg_endo -70.09 97.64 0.68 Allowed 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.227 1.951 . . . . 0.0 111.47 -178.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.507 ' CB ' ' O ' ' A' ' 95' ' ' PRO . 2.1 mttt 159.55 65.35 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.542 ' CD1' HG23 ' A' ' 60' ' ' VAL . 1.3 mt -109.91 -89.21 0.49 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.3 -0.875 . . . . 0.0 111.589 -178.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.508 ' C ' ' HA ' ' A' ' 104' ' ' ASN . 3.3 m -78.74 34.88 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 120.661 -1.275 . . . . 0.0 111.735 -178.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 12.9 p -106.83 173.32 6.37 Favored 'General case' 0 C--N 1.293 -1.882 0 O-C-N 120.706 -1.246 . . . . 0.0 108.463 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.488 ' HA ' ' OD1' ' A' ' 104' ' ' ASN . 15.3 mt-10 -60.59 1.74 0.13 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.746 -1.222 . . . . 0.0 111.874 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.7 t -99.13 0.82 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 119.888 -1.757 . . . . 0.0 110.829 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.521 ' HG3' ' N ' ' A' ' 103' ' ' CYS . 7.1 tp10 -149.93 -98.17 0.07 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.568 -1.333 . . . . 0.0 111.347 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.521 ' N ' ' HG3' ' A' ' 102' ' ' GLU . 78.4 m -117.39 43.65 2.3 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.93 -1.106 . . . . 0.0 109.794 -178.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.526 ' ND2' ' N ' ' A' ' 104' ' ' ASN . 0.1 OUTLIER -31.99 -92.17 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.308 -0.87 . . . . 0.0 111.806 -179.419 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.541 ' O ' ' CB ' ' A' ' 106' ' ' ALA . 1.3 mt 66.95 -1.76 1.31 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.005 -1.06 . . . . 0.0 111.822 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 105' ' ' LEU . . . 81.08 143.45 0.08 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.684 -1.26 . . . . 0.0 110.028 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.0 p -114.27 -162.09 0.8 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.29 -0.881 . . . . 0.0 108.723 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.431 HD13 ' CD1' ' A' ' 54' ' ' TYR . 19.3 tt -62.09 -22.65 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.902 -1.124 . . . . 0.0 108.753 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.454 ' CE1' ' HB3' ' A' ' 117' ' ' LEU . 90.6 m-70 -80.47 14.74 1.89 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.733 -0.604 . . . . 0.0 110.486 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 109' ' ' HIS . . . 44.15 25.61 0.75 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 109' ' ' HIS . . . -150.45 169.74 30.37 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.494 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 35.1 Cg_endo -78.96 72.87 6.28 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.876 2.384 . . . . 0.0 110.989 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.494 ' HB3' ' O ' ' A' ' 112' ' ' PRO . 17.7 p90 171.77 160.99 0.1 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.37 -0.831 . . . . 0.0 109.529 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.54 ' O ' ' CB ' ' A' ' 115' ' ' LEU . 16.5 p -155.73 -155.09 0.53 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.029 -1.044 . . . . 0.0 110.021 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.54 ' CB ' ' O ' ' A' ' 114' ' ' CYS . 0.1 OUTLIER 81.58 -152.23 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.684 -0.635 . . . . 0.0 109.447 -179.685 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 115' ' ' LEU . 2.5 p -42.47 -85.52 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.213 -0.929 . . . . 0.0 109.929 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.462 ' HG ' ' CE1' ' A' ' 113' ' ' PHE . 0.3 OUTLIER 53.08 -157.04 0.16 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.226 -0.921 . . . . 0.0 109.368 -179.776 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.64 -13.2 0.61 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.829 -1.17 . . . . 0.0 112.082 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -89.57 34.13 4.13 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -172.92 78.68 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.228 -1.16 . . . . 0.0 109.573 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.09 -6.79 65.31 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.234 -1.156 . . . . 0.0 109.507 179.942 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 79.1 p . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.3 m -119.56 -111.35 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 94.73 -87.07 1.06 Allowed Glycine 0 N--CA 1.498 2.818 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.8 t 41.44 46.8 3.03 Favored 'General case' 0 N--CA 1.51 2.539 0 CA-C-O 121.355 0.598 . . . . 0.0 111.362 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 60.6 p -120.99 -160.03 0.83 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.721 -0.612 . . . . 0.0 109.464 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 64.4 m 61.58 -160.96 0.3 Allowed 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.438 ' CG2' ' HD2' ' A' ' 8' ' ' PRO . 34.0 mt 71.76 139.79 0.07 OUTLIER Pre-proline 0 N--CA 1.506 2.355 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 -178.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.438 ' HD2' ' CG2' ' A' ' 7' ' ' ILE . 30.6 Cg_endo -71.67 165.81 31.37 Favored 'Trans proline' 0 N--CA 1.479 0.647 0 C-N-CA 121.661 1.574 . . . . 0.0 111.103 -178.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 62.84 16.32 56.48 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 -179.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.44 ' O ' ' CB ' ' A' ' 11' ' ' ALA . 16.6 mmm -140.91 84.62 1.94 Allowed 'General case' 0 N--CA 1.5 2.051 0 CA-C-N 117.749 0.774 . . . . 0.0 108.99 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.44 ' CB ' ' O ' ' A' ' 10' ' ' MET . . . 86.82 -57.65 0.05 OUTLIER 'General case' 0 N--CA 1.515 2.824 0 O-C-N 121.368 -0.833 . . . . 0.0 108.908 -178.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 61.2 mt -92.21 104.5 11.04 Favored Pre-proline 0 N--CA 1.498 1.935 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -75.21 169.6 22.18 Favored 'Trans proline' 0 C--O 1.22 -0.406 0 C-N-CA 121.348 1.365 . . . . 0.0 111.547 -175.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 35.1 m-70 -69.33 144.5 53.48 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.458 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 5.3 t-20 66.08 56.01 1.03 Allowed Pre-proline 0 N--CA 1.505 2.307 0 O-C-N 121.392 -0.817 . . . . 0.0 110.282 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.458 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 39.0 Cg_endo -80.54 166.86 19.54 Favored 'Trans proline' 0 N--CA 1.483 0.908 0 C-N-CA 122.317 2.011 . . . . 0.0 111.907 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.5 mp 42.92 43.81 3.69 Favored 'General case' 0 N--CA 1.504 2.238 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.192 177.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -69.07 -37.75 78.67 Favored 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.96 -26.13 68.69 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 56.9 m -74.61 -38.68 62.51 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.408 ' NH1' ' HB3' ' A' ' 78' ' ' LEU . 3.3 ttt180 -64.31 -48.88 73.96 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 33.5 m95 -68.74 -29.31 67.69 Favored 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 119.413 -0.915 . . . . 0.0 109.686 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.428 ' CD1' ' HB3' ' A' ' 40' ' ' MET . 57.7 t80 -66.38 -33.65 76.19 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 92.9 t -72.25 -38.97 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 177.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 m -56.27 -37.03 69.26 Favored 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 119.951 -0.7 . . . . 0.0 109.442 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 89.7 m -77.64 -50.09 13.2 Favored 'General case' 0 N--CA 1.506 2.347 0 N-CA-C 112.208 0.448 . . . . 0.0 112.208 -178.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.77 -25.31 67.87 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.512 -0.742 . . . . 0.0 110.622 -178.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 70.7 p -93.35 -63.38 1.22 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -177.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.6 m -100.32 9.29 42.91 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.438 -0.789 . . . . 0.0 111.636 -178.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 57.78 30.05 62.37 Favored Glycine 0 N--CA 1.507 3.37 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 37.9 t -121.24 164.09 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 122.192 -0.593 . . . . 0.0 109.672 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 136.19 177.82 15.29 Favored Glycine 0 N--CA 1.499 2.895 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -64.37 177.31 2.17 Favored 'Trans proline' 0 N--CA 1.489 1.254 0 CA-C-N 119.253 1.526 . . . . 0.0 110.047 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.28 87.25 5.99 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 122.17 0.986 . . . . 0.0 110.338 -177.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.5 mt -141.85 127.37 18.95 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 178.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.19 152.44 2.37 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.979 -0.45 . . . . 0.0 109.825 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.1 p -60.0 -59.66 5.07 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.789 -0.569 . . . . 0.0 110.655 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -52.56 -28.75 22.22 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.878 -0.514 . . . . 0.0 111.571 -178.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -71.97 -46.94 55.56 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.816 -0.553 . . . . 0.0 109.608 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.428 ' HB3' ' CD1' ' A' ' 23' ' ' TYR . 5.6 tpt -61.97 -54.57 39.84 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -53.61 -35.7 61.19 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.45 -42.81 99.74 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.3 -41.12 96.45 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 19.7 m -65.48 -33.22 75.43 Favored 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.244 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 18.6 m -73.47 -30.16 62.99 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.35 -32.38 62.76 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -77.02 -33.69 57.41 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.46 -33.53 64.91 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.49 -40.4 61.86 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.28 -39.13 85.77 Favored 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 71.7 mt -82.54 105.57 5.09 Favored Pre-proline 0 N--CA 1.493 1.684 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 177.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -58.2 139.87 92.14 Favored 'Trans proline' 0 N--CA 1.48 0.705 0 C-N-CA 121.52 1.48 . . . . 0.0 110.877 -177.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.42 ' CB ' ' NH1' ' A' ' 56' ' ' ARG . . . -39.48 -29.79 0.06 Allowed 'General case' 0 N--CA 1.507 2.387 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.356 -178.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -53.15 -70.47 0.09 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.922 -0.486 . . . . 0.0 110.623 -179.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 5.1 m -88.59 8.81 26.46 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.974 -0.454 . . . . 0.0 110.884 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.42 ' NH1' ' CB ' ' A' ' 53' ' ' ALA . 5.9 mtt180 -47.6 -85.35 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.666 0 O-C-N 121.445 -0.784 . . . . 0.0 110.282 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 73.3 m -32.79 -48.88 0.21 Allowed 'General case' 0 N--CA 1.521 3.083 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -41.74 -54.32 3.36 Favored 'General case' 0 N--CA 1.512 2.671 0 CA-C-N 119.319 0.963 . . . . 0.0 111.755 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -41.87 -44.63 3.43 Favored 'General case' 0 N--CA 1.513 2.706 0 O-C-N 121.787 -0.57 . . . . 0.0 112.065 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.7 t -57.17 -48.9 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.4 mtt180 -58.56 -26.74 63.89 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.466 ' CG2' ' HB ' ' A' ' 67' ' ' VAL . 34.5 mm -78.52 -30.74 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 O-C-N 121.945 -0.472 . . . . 0.0 110.362 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.9 tp -77.87 -43.37 30.43 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 120.079 -0.649 . . . . 0.0 109.79 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.79 -50.84 10.64 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.232 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -80.55 -22.74 40.52 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 122.087 -0.383 . . . . 0.0 110.88 -178.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.68 146.91 5.67 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.466 ' HB ' ' CG2' ' A' ' 62' ' ' ILE . 5.6 p -118.43 161.08 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.422 HG21 ' CE1' ' A' ' 74' ' ' HIS . 56.0 t -113.27 157.89 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 42.1 p -116.84 160.13 21.32 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.987 0.899 . . . . 0.0 110.969 -176.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 32.8 t -64.54 -17.53 64.01 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.431 -178.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.1 p -86.48 -14.61 42.64 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 122.05 -0.406 . . . . 0.0 110.034 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.25 13.53 33.09 Favored Glycine 0 N--CA 1.5 2.902 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -105.43 158.62 16.53 Favored 'General case' 0 N--CA 1.501 2.114 0 CA-C-N 118.142 0.971 . . . . 0.0 108.859 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.422 ' CE1' HG21 ' A' ' 68' ' ' VAL . 11.3 m170 -113.79 154.93 26.58 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -179.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -136.8 -179.02 5.45 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 55.3 -146.93 28.43 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 -178.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 54.84 22.28 4.13 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 122.253 -0.557 . . . . 0.0 109.988 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.408 ' HB3' ' NH1' ' A' ' 21' ' ' ARG . 2.1 mp -82.87 -14.61 53.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.765 -0.584 . . . . 0.0 110.388 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.5 mt -62.11 92.79 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -134.78 -177.02 4.43 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.758 0.79 . . . . 0.0 110.663 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -47.67 131.6 14.42 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.758 0.789 . . . . 0.0 111.544 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.455 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 20.6 mt -129.27 166.85 22.55 Favored Pre-proline 0 N--CA 1.497 1.918 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.455 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 29.6 Cg_endo -68.6 98.63 0.59 Allowed 'Trans proline' 0 C--N 1.327 -0.553 0 C-N-CA 120.936 1.091 . . . . 0.0 110.243 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.41 6.94 67.82 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.431 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 3.2 m -138.8 92.51 11.21 Favored Pre-proline 0 N--CA 1.508 2.425 0 CA-C-N 118.974 1.387 . . . . 0.0 110.062 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -74.79 165.45 31.45 Favored 'Trans proline' 0 N--CA 1.487 1.109 0 C-N-CA 121.924 1.749 . . . . 0.0 111.225 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 24.0 mtp180 -53.89 -25.96 22.66 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.042 0.448 . . . . 0.0 110.225 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.23 -45.86 89.65 Favored 'General case' 0 N--CA 1.503 2.213 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.008 -177.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 42.0 t -72.38 -43.37 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.596 -0.69 . . . . 0.0 111.023 -177.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -70.37 -27.02 64.0 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.8 ttt180 -78.76 -29.26 45.0 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.44 -47.09 20.61 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.945 -0.472 . . . . 0.0 110.28 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -79.03 -27.56 43.21 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 122.088 -0.383 . . . . 0.0 111.463 -178.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.449 ' N ' ' HD2' ' A' ' 95' ' ' PRO . . . -55.09 -46.45 99.67 Favored Pre-proline 0 N--CA 1.504 2.259 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -177.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' A' ' 94' ' ' ALA . 30.2 Cg_endo -70.06 -0.26 6.9 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 122.209 1.939 . . . . 0.0 114.017 -177.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.79 24.12 12.05 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.492 -0.755 . . . . 0.0 109.8 179.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.99 -24.22 59.57 Favored 'General case' 0 N--CA 1.51 2.526 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -178.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 33.7 m -93.4 25.63 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.322 0 CA-C-N 120.958 1.708 . . . . 0.0 111.182 -178.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 19.0 p -98.24 173.1 7.17 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -61.94 -1.52 0.68 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.656 -0.652 . . . . 0.0 112.25 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 36.3 t -100.04 4.4 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 CA-C-N 120.443 1.474 . . . . 0.0 110.96 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -141.07 -89.95 0.16 Allowed 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.38 -0.825 . . . . 0.0 111.488 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 19.8 m -143.62 43.0 1.49 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.502 -0.749 . . . . 0.0 109.927 -178.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.401 ' ND2' ' HB3' ' A' ' 112' ' ' PRO . 56.9 t-20 -42.97 -64.9 0.55 Allowed 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.224 -0.923 . . . . 0.0 112.329 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 6.1 mt 45.33 29.34 0.55 Allowed 'General case' 0 N--CA 1.51 2.569 0 CA-C-O 121.073 0.463 . . . . 0.0 109.995 -178.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 67.04 157.93 0.12 Allowed 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -178.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.8 p -128.82 -163.93 1.34 Allowed 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 18.1 tt -68.14 -33.15 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 177.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.427 ' HB3' ' CE2' ' A' ' 113' ' ' PHE . 96.9 m-70 -66.67 -4.9 9.89 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.729 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 61.55 41.39 99.55 Favored Glycine 0 N--CA 1.499 2.863 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -174.87 170.95 44.15 Favored Glycine 0 N--CA 1.501 3.024 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.401 ' HB3' ' ND2' ' A' ' 104' ' ' ASN . 32.3 Cg_endo -77.86 75.84 4.6 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.54 2.16 . . . . 0.0 111.376 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.427 ' CE2' ' HB3' ' A' ' 109' ' ' HIS . 36.8 p90 178.67 156.32 0.45 Allowed 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.65 -0.656 . . . . 0.0 110.468 178.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 4.7 t 178.62 158.55 0.52 Allowed 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 55.83 22.18 5.38 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.69 -0.631 . . . . 0.0 109.879 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.74 -69.5 0.07 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.83 -0.544 . . . . 0.0 109.654 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.492 ' O ' ' HB2' ' A' ' 118' ' ' LEU . 0.4 OUTLIER 59.88 29.74 19.3 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -179.764 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.492 ' HB2' ' O ' ' A' ' 117' ' ' LEU . 20.6 mt 76.38 -18.69 0.46 Allowed 'General case' 0 N--CA 1.508 2.467 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 130.61 176.88 14.6 Favored Glycine 0 N--CA 1.5 2.91 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -97.9 43.98 1.05 Allowed 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 121.722 0.772 . . . . 0.0 109.413 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -94.3 25.29 23.19 Favored Glycine 0 N--CA 1.498 2.77 0 N-CA-C 109.886 -1.285 . . . . 0.0 109.886 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 . . . . . 0 N--CA 1.499 1.977 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.463 179.889 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 7.4 t . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.9 p -44.21 -56.3 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.197 -0.939 . . . . 0.0 109.759 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 102.33 149.76 22.27 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.3 t -150.62 58.65 0.94 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.262 -1.14 . . . . 0.0 109.47 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.458 ' O ' ' O ' ' A' ' 6' ' ' CYS . 0.4 OUTLIER -89.69 65.44 6.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.258 -0.901 . . . . 0.0 109.65 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.458 ' O ' ' O ' ' A' ' 5' ' ' SER . 65.3 m 60.71 139.18 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.294 -0.879 . . . . 0.0 109.774 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.494 ' HB ' ' HD2' ' A' ' 8' ' ' PRO . 0.2 OUTLIER -133.96 160.92 66.69 Favored Pre-proline 0 N--CA 1.491 1.602 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.363 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.494 ' HD2' ' HB ' ' A' ' 7' ' ' ILE . 34.5 Cg_endo -77.25 166.11 26.79 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.309 2.006 . . . . 0.0 110.67 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 62.46 10.85 31.61 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.595 ' O ' ' CB ' ' A' ' 11' ' ' ALA . 2.2 mtt -140.61 95.11 2.81 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.164 -1.198 . . . . 0.0 109.317 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.595 ' CB ' ' O ' ' A' ' 10' ' ' MET . . . 86.14 -60.58 0.06 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.925 -1.11 . . . . 0.0 108.314 -179.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.8 mp -96.83 103.31 14.32 Favored Pre-proline 0 N--CA 1.489 1.483 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.486 ' HD3' ' O ' ' A' ' 11' ' ' ALA . 31.6 Cg_endo -79.64 166.97 21.28 Favored 'Trans proline' 0 C--N 1.32 -0.959 0 C-N-CA 121.277 1.318 . . . . 0.0 112.163 -176.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 37.7 m-70 -68.65 149.0 49.62 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.486 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 0.5 OUTLIER 60.77 63.95 2.51 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 120.607 -1.308 . . . . 0.0 109.62 -179.857 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.486 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 37.2 Cg_endo -80.41 161.08 22.66 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.794 2.329 . . . . 0.0 111.372 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.458 HD11 ' N ' ' A' ' 17' ' ' LEU . 4.2 mp 42.07 45.61 3.45 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.526 -0.734 . . . . 0.0 110.858 178.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -76.91 -40.87 45.78 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.078 -1.014 . . . . 0.0 109.177 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.484 ' O ' ' HE1' ' A' ' 40' ' ' MET . 1.2 t -63.37 -25.96 68.53 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 58.1 m -72.26 -39.21 68.57 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.563 ' CG ' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -59.3 -53.48 57.78 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.472 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.563 ' N ' ' CG ' ' A' ' 21' ' ' ARG . 25.9 m95 -68.11 -29.48 68.41 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 118.984 -1.086 . . . . 0.0 110.429 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.53 ' CE1' HG21 ' A' ' 37' ' ' THR . 4.2 t80 -64.06 -30.62 71.68 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 120.998 -1.064 . . . . 0.0 108.346 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.606 HG23 ' CD2' ' A' ' 93' ' ' PHE . 74.6 t -74.93 -44.56 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 178.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.416 ' OG ' ' HA ' ' A' ' 22' ' ' TRP . 0.7 OUTLIER -52.65 -41.36 63.72 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.522 -0.871 . . . . 0.0 109.633 -179.679 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.495 ' CA ' ' O ' ' A' ' 31' ' ' VAL . 2.6 m -77.77 -56.68 4.31 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.212 -0.93 . . . . 0.0 111.689 -178.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.1 tpt85 -57.77 -24.76 58.67 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.755 -1.216 . . . . 0.0 111.0 -178.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.469 ' OG1' ' O ' ' A' ' 24' ' ' VAL . 78.3 p -97.15 -63.06 1.17 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.949 -1.094 . . . . 0.0 111.191 -178.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.492 ' SG ' ' C ' ' A' ' 84' ' ' GLY . 90.6 m -99.24 18.47 17.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.965 -1.084 . . . . 0.0 110.299 -178.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 26' ' ' THR . . . 52.76 19.41 6.69 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.548 HG11 ' N ' ' A' ' 32' ' ' GLY . 76.0 t -107.55 149.23 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.207 -1.173 . . . . 0.0 108.782 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.548 ' N ' HG11 ' A' ' 31' ' ' VAL . . . 141.96 177.34 16.99 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.449 -1.86 . . . . 0.0 108.449 -179.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -66.32 172.38 9.03 Favored 'Trans proline' 0 N--CA 1.479 0.654 0 CA-C-N 118.99 1.395 . . . . 0.0 109.988 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.23 64.43 4.47 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.876 -1.14 . . . . 0.0 110.074 -178.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.545 ' CD2' ' HB2' ' A' ' 39' ' ' GLU . 6.6 tt -106.33 120.41 41.8 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.463 ' C ' ' O ' ' A' ' 35' ' ' LEU . . . -41.56 135.32 2.15 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.345 -0.847 . . . . 0.0 109.363 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.53 HG21 ' CE1' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -52.19 -54.54 29.63 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.785 -1.197 . . . . 0.0 111.564 -178.738 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -51.93 -43.0 63.25 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.817 -1.177 . . . . 0.0 110.249 -178.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.545 ' HB2' ' CD2' ' A' ' 35' ' ' LEU . 27.4 mm-40 -67.12 -29.36 69.07 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.28 -0.888 . . . . 0.0 109.604 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.484 ' HE1' ' O ' ' A' ' 19' ' ' SER . 8.5 tpt -69.23 -60.78 2.11 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.123 -0.986 . . . . 0.0 108.361 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.54 -39.11 48.12 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.81 -41.42 97.74 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.347 -0.846 . . . . 0.0 109.154 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.528 ' CD ' HD12 ' A' ' 35' ' ' LEU . 21.3 mtt85 -60.08 -47.22 86.8 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.349 -0.845 . . . . 0.0 109.192 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 15.3 m -61.26 -37.05 81.72 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.19 -0.944 . . . . 0.0 110.577 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 96.9 m -71.14 -28.59 64.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.811 -1.18 . . . . 0.0 109.141 -179.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.1 tpp180 -74.35 -31.35 62.39 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.448 ' O ' HG12 ' A' ' 51' ' ' ILE . 0.7 OUTLIER -77.09 -37.13 55.02 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.952 -0.699 . . . . 0.0 109.389 179.951 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.442 HD13 HG11 ' A' ' 98' ' ' VAL . 6.2 tt -70.8 -36.57 73.06 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.297 -0.877 . . . . 0.0 108.666 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.446 ' O ' ' C ' ' A' ' 50' ' ' ALA . 13.3 tp10 -67.27 -51.4 53.35 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.519 ' O ' ' HD3' ' A' ' 52' ' ' PRO . . . -47.89 -49.68 28.97 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 178.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.448 HG12 ' O ' ' A' ' 47' ' ' GLN . 33.7 mm -62.04 106.09 0.76 Allowed Pre-proline 0 C--N 1.304 -1.411 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 176.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.523 ' O ' ' N ' ' A' ' 54' ' ' TYR . 26.6 Cg_endo -63.95 141.4 77.36 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 121.631 1.554 . . . . 0.0 110.81 -177.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.518 ' HA ' ' CD ' ' A' ' 56' ' ' ARG . . . -37.15 -28.67 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.908 -0.495 . . . . 0.0 110.079 -178.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.523 ' N ' ' O ' ' A' ' 52' ' ' PRO . 0.3 OUTLIER -65.41 119.85 11.75 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.095 -1.003 . . . . 0.0 108.578 178.998 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.523 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 63.6 m 64.91 8.98 5.0 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.355 -0.841 . . . . 0.0 110.256 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.518 ' CD ' ' HA ' ' A' ' 53' ' ' ALA . 8.6 mtt180 -42.42 -87.78 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.705 -1.247 . . . . 0.0 109.471 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.501 ' O ' ' C ' ' A' ' 58' ' ' GLU . 20.9 m -28.38 -50.71 0.08 Allowed 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.502 ' HB2' ' O ' ' A' ' 55' ' ' CYS . 0.1 OUTLIER -32.22 -51.23 0.25 Allowed 'General case' 0 N--CA 1.502 2.159 0 O-C-N 120.82 -1.175 . . . . 0.0 111.432 -178.74 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.479 ' C ' ' O ' ' A' ' 58' ' ' GLU . . . -36.5 -55.39 0.84 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.313 -0.867 . . . . 0.0 110.268 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.0 t -53.18 -49.89 49.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.474 -0.766 . . . . 0.0 109.252 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.468 ' O ' ' HB2' ' A' ' 65' ' ' ASP . 2.0 ttp180 -55.34 -29.35 58.19 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.294 -0.879 . . . . 0.0 109.508 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.569 ' CG2' ' HB ' ' A' ' 67' ' ' VAL . 30.2 mt -77.79 -28.53 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.331 -0.856 . . . . 0.0 109.938 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.519 ' O ' ' HA ' ' A' ' 77' ' ' ARG . 26.4 tp -77.56 -44.5 28.32 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.842 -1.161 . . . . 0.0 109.486 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 30.1 ttp -78.14 -50.69 11.5 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.869 -1.144 . . . . 0.0 109.72 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 61' ' ' ARG . 15.7 m-20 -80.37 -21.26 42.54 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.017 -1.052 . . . . 0.0 110.394 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . 86.65 152.28 21.11 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.569 ' HB ' ' CG2' ' A' ' 62' ' ' ILE . 1.4 p -117.02 159.97 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.539 -0.977 . . . . 0.0 109.248 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.634 ' CG2' ' CE1' ' A' ' 74' ' ' HIS . 12.9 t -113.58 158.16 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-O 121.87 0.843 . . . . 0.0 109.384 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.468 ' N ' ' CG1' ' A' ' 68' ' ' VAL . 69.8 p -117.57 158.76 24.04 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.683 0.754 . . . . 0.0 110.088 -178.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.1 t -65.0 -25.6 67.93 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.571 0.7 . . . . 0.0 109.791 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.1 p -71.13 -15.09 62.48 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.638 -0.664 . . . . 0.0 109.388 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 99.51 10.55 47.2 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.607 -1.797 . . . . 0.0 108.607 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -103.17 157.0 17.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.269 -1.136 . . . . 0.0 109.621 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.634 ' CE1' ' CG2' ' A' ' 68' ' ' VAL . 11.1 m170 -115.07 155.93 26.11 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.064 -1.022 . . . . 0.0 108.821 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -142.67 -174.87 4.27 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.271 -0.893 . . . . 0.0 110.465 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.4 ' HA2' HD13 ' A' ' 78' ' ' LEU . . . 60.62 -139.47 48.11 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.519 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER 52.39 33.19 12.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.215 -1.168 . . . . 0.0 109.368 -179.884 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.479 ' O ' ' N ' ' A' ' 80' ' ' GLN . 1.3 mt -79.06 -22.23 45.64 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.976 -1.078 . . . . 0.0 109.996 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.452 HD22 ' HB3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -45.85 98.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.798 -1.189 . . . . 0.0 108.855 179.513 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.479 ' N ' ' O ' ' A' ' 78' ' ' LEU . 40.1 mt-30 -145.12 174.21 11.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.124 -0.985 . . . . 0.0 110.428 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -56.78 140.75 46.76 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 122.045 0.926 . . . . 0.0 110.701 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.647 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 17.9 mt -133.06 171.17 9.63 Favored Pre-proline 0 C--N 1.301 -1.531 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 179.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.647 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 27.5 Cg_endo -65.91 98.88 0.38 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 120.856 1.038 . . . . 0.0 110.591 -179.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.492 ' C ' ' SG ' ' A' ' 29' ' ' CYS . . . 88.3 -6.73 83.21 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.464 ' SG ' ' OG1' ' A' ' 28' ' ' THR . 9.7 m -119.86 88.42 40.08 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 120.684 -1.48 . . . . 0.0 110.015 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 87' ' ' ARG . 30.5 Cg_endo -75.75 161.32 36.72 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 C-N-CA 122.085 1.857 . . . . 0.0 111.713 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.433 ' C ' ' O ' ' A' ' 86' ' ' PRO . 13.3 mtm-85 -43.57 -27.51 0.3 Allowed 'General case' 0 N--CA 1.482 1.136 0 CA-C-O 121.773 0.797 . . . . 0.0 108.913 178.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' A' ' 86' ' ' PRO . 32.9 tt0 -59.2 -59.84 4.81 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.753 -0.592 . . . . 0.0 111.317 -178.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.415 HG22 ' HD2' ' A' ' 86' ' ' PRO . 45.0 t -65.75 -40.7 88.52 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 O-C-N 120.871 -1.143 . . . . 0.0 110.531 -178.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.552 ' O ' ' CB ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -63.83 -28.07 69.6 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.249 -0.98 . . . . 0.0 108.574 179.843 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.09 -29.39 49.01 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.542 -0.723 . . . . 0.0 109.592 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.486 ' O ' ' HD2' ' A' ' 95' ' ' PRO . . . -74.58 -53.52 9.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -0.909 . . . . 0.0 109.965 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.606 ' CD2' HG23 ' A' ' 24' ' ' VAL . 6.0 t80 -78.25 -26.6 47.32 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.042 -1.036 . . . . 0.0 110.365 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.553 ' N ' ' HD2' ' A' ' 95' ' ' PRO . . . -40.91 -52.64 6.61 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.125 -0.985 . . . . 0.0 111.34 -178.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 94' ' ' ALA . 31.4 Cg_endo -72.27 -164.71 0.18 Allowed 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.143 1.895 . . . . 0.0 111.04 -178.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 95' ' ' PRO . 13.6 mmtm 63.73 30.41 14.71 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -178.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.477 ' O ' ' HB2' ' A' ' 102' ' ' GLU . 0.2 OUTLIER -73.77 -71.19 0.34 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.656 -0.653 . . . . 0.0 110.86 -179.157 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.534 ' O ' ' CB ' ' A' ' 104' ' ' ASN . 2.9 m -77.45 22.9 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.623 -1.298 . . . . 0.0 111.266 -179.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.428 ' C ' ' HB3' ' A' ' 104' ' ' ASN . 7.0 p -99.22 172.68 7.21 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 120.513 -1.367 . . . . 0.0 108.898 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.45 ' HA ' ' ND2' ' A' ' 104' ' ' ASN . 40.0 mt-10 -59.63 -0.31 0.17 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.804 -1.185 . . . . 0.0 111.891 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.481 ' O ' ' CG1' ' A' ' 101' ' ' VAL . 97.8 t -100.28 7.39 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 119.957 -1.714 . . . . 0.0 110.33 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 97' ' ' LEU . 2.0 mm-40 -145.75 -92.71 0.09 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.758 -1.214 . . . . 0.0 110.297 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.463 ' O ' ' C ' ' A' ' 104' ' ' ASN . 33.2 m -142.13 37.86 1.58 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.945 -1.097 . . . . 0.0 109.638 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 98' ' ' VAL . 5.1 p30 -35.12 -50.96 0.53 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.244 -0.91 . . . . 0.0 111.513 -179.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 106' ' ' ALA . 12.0 mt 42.23 31.61 0.27 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.916 -1.115 . . . . 0.0 110.226 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.468 ' O ' ' O ' ' A' ' 105' ' ' LEU . . . 60.28 121.33 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.857 -1.152 . . . . 0.0 109.521 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.8 p -91.58 -165.72 1.41 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.54 ' CD1' ' O ' ' A' ' 108' ' ' ILE . 0.0 OUTLIER -61.37 -25.77 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 120.931 -1.105 . . . . 0.0 108.49 179.261 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.46 ' HB3' ' CE1' ' A' ' 113' ' ' PHE . 86.9 m-70 -76.74 14.0 0.9 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.53 -0.731 . . . . 0.0 110.717 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 50.11 25.06 7.32 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.399 -1.481 . . . . 0.0 109.399 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -156.55 172.08 34.24 Favored Glycine 0 N--CA 1.49 2.246 0 C-N-CA 119.766 -1.207 . . . . 0.0 110.085 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.484 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 33.3 Cg_endo -78.5 74.25 5.5 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 123.001 2.467 . . . . 0.0 111.195 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.484 ' HB3' ' O ' ' A' ' 112' ' ' PRO . 32.6 p90 171.77 143.53 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.177 -0.952 . . . . 0.0 109.947 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 16.6 p -142.02 151.07 42.11 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.773 -1.204 . . . . 0.0 109.184 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.489 ' O ' ' HB2' ' A' ' 116' ' ' SER . 0.9 OUTLIER 50.88 -174.89 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.944 -1.098 . . . . 0.0 109.625 -179.903 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.489 ' HB2' ' O ' ' A' ' 115' ' ' LEU . 16.1 m 64.12 -103.46 0.11 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.497 -0.752 . . . . 0.0 110.168 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 19.6 mt 55.22 -149.9 0.44 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.022 -1.048 . . . . 0.0 109.061 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.7 mt -50.12 -15.7 0.24 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.014 -1.054 . . . . 0.0 111.738 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -63.46 -85.21 0.06 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -135.0 69.53 1.45 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.238 -1.154 . . . . 0.0 109.415 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -89.58 18.78 44.39 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.246 -1.149 . . . . 0.0 109.551 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.418 ' O ' ' CB ' ' A' ' 2' ' ' VAL . 79.5 p . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.418 ' CB ' ' O ' ' A' ' 1' ' ' SER . 5.2 t 85.29 -50.27 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.673 0 C-N-CA 122.907 0.483 . . . . 0.0 109.995 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 81.06 -116.55 4.24 Favored Glycine 0 N--CA 1.496 2.645 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.8 t 41.43 31.28 0.17 Allowed 'General case' 0 N--CA 1.509 2.502 0 CA-C-O 121.224 0.535 . . . . 0.0 111.042 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -110.49 175.04 5.58 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.948 -0.47 . . . . 0.0 109.795 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 94.9 m -122.43 168.46 12.07 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.6 mt -87.34 138.23 32.27 Favored Pre-proline 0 N--CA 1.5 2.026 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -81.24 148.73 16.84 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 121.872 1.714 . . . . 0.0 110.298 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 58.1 17.89 32.15 Favored Glycine 0 N--CA 1.499 2.866 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.446 ' O ' ' CB ' ' A' ' 11' ' ' ALA . 84.3 mtp -140.84 108.09 5.51 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-N 117.935 0.868 . . . . 0.0 108.72 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.446 ' CB ' ' O ' ' A' ' 10' ' ' MET . . . 86.73 -58.4 0.05 OUTLIER 'General case' 0 N--CA 1.514 2.75 0 CA-C-N 119.75 1.159 . . . . 0.0 108.247 -178.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 44.8 mt -106.41 100.74 31.53 Favored Pre-proline 0 N--CA 1.492 1.648 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 178.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -81.01 173.47 11.89 Favored 'Trans proline' 0 N--CA 1.475 0.427 0 C-N-CA 121.471 1.447 . . . . 0.0 111.243 -177.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 59.6 m-70 -71.14 144.19 50.31 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.532 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 35.1 t-20 59.78 52.88 3.75 Favored Pre-proline 0 N--CA 1.498 1.972 0 O-C-N 121.725 -0.61 . . . . 0.0 110.05 -178.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.532 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 41.8 Cg_endo -83.05 170.27 12.39 Favored 'Trans proline' 0 N--CA 1.483 0.864 0 C-N-CA 122.043 1.829 . . . . 0.0 111.355 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 50.75 38.73 20.24 Favored 'General case' 0 N--CA 1.501 2.093 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.646 177.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -78.17 -43.31 28.98 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.542 -0.724 . . . . 0.0 109.484 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.18 -29.12 70.15 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 17.0 m -73.5 -40.1 64.32 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -61.23 -51.36 69.28 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.404 ' CE3' ' HA ' ' A' ' 22' ' ' TRP . 38.9 m95 -69.83 -28.15 65.46 Favored 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 119.581 -0.848 . . . . 0.0 109.743 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -67.47 -29.63 69.14 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.442 HG21 ' CE1' ' A' ' 93' ' ' PHE . 98.9 t -75.27 -42.89 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 85.0 p -54.73 -39.02 67.83 Favored 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.939 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 77.0 m -77.45 -48.77 16.32 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 122.296 -0.252 . . . . 0.0 111.661 -178.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.6 mmm180 -64.26 -24.88 67.82 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.626 -0.671 . . . . 0.0 111.054 -178.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.411 ' CG2' HG11 ' A' ' 24' ' ' VAL . 82.5 p -97.0 -61.97 1.33 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 122.162 -0.336 . . . . 0.0 111.872 -177.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.7 m -100.08 9.35 42.98 Favored 'General case' 0 N--CA 1.507 2.407 0 O-C-N 121.444 -0.785 . . . . 0.0 111.415 -178.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 57.43 25.93 55.8 Favored Glycine 0 N--CA 1.505 3.237 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 -178.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 41.0 t -115.38 164.49 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 122.105 -0.644 . . . . 0.0 109.556 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 132.61 178.28 15.43 Favored Glycine 0 N--CA 1.498 2.785 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -66.13 173.5 7.19 Favored 'Trans proline' 0 N--CA 1.486 1.058 0 CA-C-N 119.382 1.591 . . . . 0.0 109.833 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -92.24 79.99 5.04 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 122.02 0.914 . . . . 0.0 109.87 -178.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.71 129.52 50.66 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.25 132.59 28.76 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.925 -0.484 . . . . 0.0 109.747 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -52.58 -53.64 43.76 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.447 -0.783 . . . . 0.0 111.18 -179.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -50.12 -35.96 27.84 Favored 'General case' 0 N--CA 1.508 2.436 0 O-C-N 121.723 -0.61 . . . . 0.0 110.816 -178.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -70.93 -38.54 72.89 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 31.5 tpp -62.54 -57.55 10.74 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 41.2 tttt -55.77 -35.94 66.8 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.862 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.28 -37.09 86.25 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.74 -45.85 81.08 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 15.1 m -62.72 -35.57 80.2 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.094 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 17.7 m -75.3 -28.56 59.76 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.64 -34.95 70.22 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -78.43 -28.2 46.71 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -72.78 -35.47 67.42 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -178.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -77.92 -51.28 10.66 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.64 -33.39 54.99 Favored 'General case' 0 N--CA 1.505 2.303 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.0 mt -87.71 104.88 7.4 Favored Pre-proline 0 N--CA 1.492 1.651 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -60.56 149.22 88.08 Favored 'Trans proline' 0 N--CA 1.479 0.638 0 C-N-CA 121.826 1.684 . . . . 0.0 110.543 -177.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.1 -19.95 55.8 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.582 -177.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -49.56 -32.82 13.39 Favored 'General case' 0 N--CA 1.513 2.677 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 178.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 61.9 m -119.26 -69.89 0.82 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 115.336 -0.847 . . . . 0.0 108.955 178.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 35.7 mtt180 38.0 -92.96 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.696 0 C-N-CA 122.8 0.44 . . . . 0.0 111.273 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 86.4 m -37.96 -45.44 0.88 Allowed 'General case' 0 N--CA 1.515 2.815 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -40.21 -48.78 2.62 Favored 'General case' 0 N--CA 1.511 2.607 0 CA-C-N 119.843 1.202 . . . . 0.0 112.027 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -42.05 -49.22 4.74 Favored 'General case' 0 N--CA 1.513 2.685 0 CA-C-N 118.483 0.583 . . . . 0.0 111.905 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.6 t -57.94 -45.86 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -60.61 -26.83 67.29 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.47 ' CG2' ' HB ' ' A' ' 67' ' ' VAL . 50.6 mt -78.1 -29.31 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.881 -0.512 . . . . 0.0 109.71 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.2 tp -77.87 -41.51 36.55 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.853 -0.739 . . . . 0.0 109.954 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 39.4 tpp -78.56 -52.77 8.0 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.331 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -80.51 -22.94 40.43 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 122.048 -0.408 . . . . 0.0 110.981 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 85.15 147.47 9.21 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 109.196 -1.561 . . . . 0.0 109.196 -178.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.47 ' HB ' ' CG2' ' A' ' 62' ' ' ILE . 5.3 p -118.01 158.74 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.265 0 O-C-N 122.133 -0.628 . . . . 0.0 109.531 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.461 ' CG2' ' CE1' ' A' ' 74' ' ' HIS . 70.6 t -115.58 157.3 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-O 121.946 0.879 . . . . 0.0 109.463 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.6 p -117.35 159.99 21.86 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.03 -178.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 34.3 t -64.11 -33.62 76.18 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.932 -178.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.7 p -63.44 -17.8 63.07 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.69 8.13 49.52 Favored Glycine 0 N--CA 1.496 2.672 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 60.8 mt-30 -95.43 156.08 16.47 Favored 'General case' 0 N--CA 1.501 2.114 0 CA-C-N 118.158 0.979 . . . . 0.0 109.578 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.461 ' CE1' ' CG2' ' A' ' 68' ' ' VAL . 9.6 m170 -116.47 154.93 29.48 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -141.24 -175.49 4.36 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.106 0.479 . . . . 0.0 110.081 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 55.6 -146.1 31.03 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.9 ttp180 56.54 19.84 4.48 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 122.29 -0.535 . . . . 0.0 110.384 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.5 mt -84.03 -14.45 50.57 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.723 -0.611 . . . . 0.0 110.244 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.3 tt -61.93 92.88 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -135.31 172.8 12.49 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.255 0.55 . . . . 0.0 109.591 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -51.32 102.01 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.651 0.739 . . . . 0.0 111.384 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.525 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 21.5 mt -87.2 169.99 13.18 Favored Pre-proline 0 N--CA 1.495 1.803 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 177.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.525 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 28.9 Cg_endo -68.18 100.55 0.65 Allowed 'Trans proline' 0 C--N 1.327 -0.562 0 C-N-CA 120.942 1.095 . . . . 0.0 110.609 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.17 11.99 60.6 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 3.6 m -141.91 91.33 8.17 Favored Pre-proline 0 N--CA 1.506 2.353 0 CA-C-N 118.786 1.293 . . . . 0.0 109.11 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -74.19 161.45 40.68 Favored 'Trans proline' 0 N--CA 1.482 0.825 0 C-N-CA 121.538 1.492 . . . . 0.0 111.282 -178.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.82 -28.75 2.73 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.268 0.556 . . . . 0.0 109.599 177.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -55.38 -53.49 55.57 Favored 'General case' 0 N--CA 1.503 2.199 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.654 -178.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 54.2 t -62.83 -39.91 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.709 -0.62 . . . . 0.0 109.63 -178.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -64.11 -26.35 68.5 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.66 -33.99 46.68 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.29 -48.83 63.91 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.876 -0.515 . . . . 0.0 109.654 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.442 ' CE1' HG21 ' A' ' 24' ' ' VAL . 31.0 t80 -78.58 -26.25 45.49 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 122.262 -0.274 . . . . 0.0 110.55 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -41.25 -49.75 8.6 Favored Pre-proline 0 N--CA 1.506 2.336 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -177.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -77.84 33.15 0.45 Allowed 'Trans proline' 0 CA--C 1.55 1.308 0 C-N-CA 122.206 1.937 . . . . 0.0 112.964 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 49.8 mttm -123.99 30.97 5.96 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 178.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.414 ' O ' ' HB3' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -73.56 -71.31 0.32 Allowed 'General case' 0 N--CA 1.512 2.641 0 O-C-N 122.067 -0.396 . . . . 0.0 110.804 -179.196 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.0 m -94.95 28.32 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.388 -0.82 . . . . 0.0 109.855 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 27.9 p -96.96 170.05 9.42 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.85 -2.38 0.85 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.549 -0.72 . . . . 0.0 112.015 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 22.0 t -98.34 4.72 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 CA-C-N 120.36 1.436 . . . . 0.0 110.894 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.414 ' HB3' ' O ' ' A' ' 97' ' ' LEU . 4.8 tp10 -142.25 -91.55 0.13 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.559 -0.713 . . . . 0.0 111.039 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 93.6 m -143.61 42.06 1.47 Allowed 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.387 -0.821 . . . . 0.0 110.002 -178.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -39.85 -56.8 1.71 Allowed 'General case' 0 N--CA 1.508 2.456 0 N-CA-C 113.642 0.978 . . . . 0.0 113.642 -178.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.0 mt 45.87 23.9 0.2 Allowed 'General case' 0 N--CA 1.508 2.432 0 CA-C-N 118.995 0.816 . . . . 0.0 111.277 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 64.76 123.79 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.317 -0.865 . . . . 0.0 109.7 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.1 p -89.89 -159.0 0.56 Allowed 'General case' 0 N--CA 1.507 2.38 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.5 tp -66.63 -31.1 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -69.77 -0.87 7.8 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.893 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 58.54 28.78 62.89 Favored Glycine 0 N--CA 1.497 2.756 0 N-CA-C 109.299 -1.521 . . . . 0.0 109.299 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -157.01 168.72 34.04 Favored Glycine 0 N--CA 1.498 2.784 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -78.68 73.96 5.69 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 122.798 2.332 . . . . 0.0 111.933 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 30.2 p90 176.29 154.01 0.2 Allowed 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.583 -0.698 . . . . 0.0 110.431 178.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 20.6 p -165.08 144.16 6.66 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 51.02 24.89 2.02 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.579 -0.7 . . . . 0.0 110.613 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 28.1 t -130.2 -89.59 0.48 Allowed 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 53.06 -88.53 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.949 -0.47 . . . . 0.0 110.412 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -51.26 -16.25 0.49 Allowed 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.11 -99.74 0.01 OUTLIER Glycine 0 N--CA 1.502 3.078 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 57.27 72.42 0.52 Allowed 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 121.648 0.737 . . . . 0.0 109.558 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -65.51 -14.5 60.19 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 . . . . . 0 N--CA 1.5 2.052 0 CA-C-O 118.113 -0.946 . . . . 0.0 109.422 -179.89 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 77.5 p . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.4 m -42.2 -37.28 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.56 0 O-C-N 122.117 -0.365 . . . . 0.0 111.629 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -67.07 96.95 0.34 Allowed Glycine 0 N--CA 1.498 2.832 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.6 t -132.55 52.5 2.07 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 121.613 0.72 . . . . 0.0 109.276 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.1 t -88.7 68.57 8.63 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 121.554 0.692 . . . . 0.0 109.574 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.1 m -140.3 -163.94 1.62 Allowed 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.681 -0.637 . . . . 0.0 109.289 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -162.53 153.56 14.74 Favored Pre-proline 0 N--CA 1.506 2.363 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -79.41 126.1 6.66 Favored 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 122.364 2.043 . . . . 0.0 111.038 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 74.76 4.12 69.94 Favored Glycine 0 N--CA 1.502 3.048 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.453 ' O ' ' CB ' ' A' ' 11' ' ' ALA . 72.4 mmm -129.61 99.74 5.27 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.453 ' CB ' ' O ' ' A' ' 10' ' ' MET . . . 86.7 -54.59 0.06 Allowed 'General case' 0 N--CA 1.517 2.917 0 CA-C-N 119.448 1.022 . . . . 0.0 108.713 -178.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 36.8 mm -104.83 100.55 24.32 Favored Pre-proline 0 N--CA 1.495 1.783 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -84.27 175.04 7.63 Favored 'Trans proline' 0 N--CA 1.475 0.423 0 C-N-CA 121.749 1.632 . . . . 0.0 111.511 -177.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 -84.03 142.78 30.21 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.479 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 7.3 t-20 60.12 57.95 4.41 Favored Pre-proline 0 N--CA 1.501 2.094 0 O-C-N 121.605 -0.685 . . . . 0.0 109.676 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.479 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 39.7 Cg_endo -81.41 150.24 17.11 Favored 'Trans proline' 0 N--CA 1.481 0.747 0 C-N-CA 122.219 1.946 . . . . 0.0 112.069 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 76.9 mt 51.98 42.74 30.5 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.853 177.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -66.33 -34.24 77.54 Favored 'General case' 0 N--CA 1.506 2.353 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 178.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.3 t -63.49 -26.06 68.54 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 56.1 m -77.79 -34.76 52.05 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.436 ' CG ' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -65.94 -51.54 57.66 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.417 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.436 ' N ' ' CG ' ' A' ' 21' ' ' ARG . 27.7 m95 -66.83 -32.43 73.7 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 119.753 -0.779 . . . . 0.0 109.682 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -64.25 -32.33 73.88 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.2 t -70.51 -39.74 76.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 177.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 m -55.92 -40.39 73.01 Favored 'General case' 0 N--CA 1.501 2.088 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.361 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.1 m -77.19 -54.45 6.49 Favored 'General case' 0 N--CA 1.51 2.543 0 O-C-N 122.011 -0.431 . . . . 0.0 111.785 -178.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 14.3 ttm180 -60.05 -24.6 64.68 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.687 -0.633 . . . . 0.0 110.413 -178.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 44.3 p -95.21 -66.02 0.94 Allowed 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -177.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.8 m -100.35 13.27 34.96 Favored 'General case' 0 N--CA 1.51 2.556 0 O-C-N 121.247 -0.908 . . . . 0.0 111.413 -178.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 58.66 22.68 53.64 Favored Glycine 0 N--CA 1.505 3.269 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -178.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 29.0 t -110.01 165.53 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.363 0 O-C-N 121.899 -0.765 . . . . 0.0 109.376 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 131.06 178.63 15.56 Favored Glycine 0 N--CA 1.499 2.896 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -65.03 176.67 2.91 Favored 'Trans proline' 0 N--CA 1.489 1.249 0 CA-C-N 119.042 1.421 . . . . 0.0 109.905 179.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -91.59 79.58 5.46 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 122.196 0.998 . . . . 0.0 109.857 -178.099 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.4 mp -130.59 127.8 39.74 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 179.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.04 160.24 1.57 Allowed 'General case' 0 N--CA 1.501 2.121 0 O-C-N 122.041 -0.412 . . . . 0.0 110.12 -178.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.22 -37.93 72.02 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 122.02 -0.425 . . . . 0.0 111.206 -178.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.53 -42.77 77.99 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.881 -0.512 . . . . 0.0 110.081 -178.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -70.12 -28.17 65.17 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 2.7 tpt -70.06 -54.54 12.65 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.3 tttt -55.53 -33.9 64.22 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.505 179.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.73 -37.9 76.66 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.63 -37.83 88.81 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 13.1 m -72.23 -32.8 67.06 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.856 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 79.7 m -72.2 -29.71 64.24 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.63 -34.89 46.18 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -72.98 -38.15 66.79 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.409 ' CD1' HG13 ' A' ' 98' ' ' VAL . 1.2 tt -67.64 -59.78 3.07 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 179.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.448 ' HA ' ' NH1' ' A' ' 56' ' ' ARG . 1.1 tm-20 -52.57 -26.9 14.63 Favored 'General case' 0 N--CA 1.504 2.245 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.65 -61.31 2.61 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.504 ' O ' ' NH1' ' A' ' 56' ' ' ARG . 45.9 mm -57.12 102.98 0.33 Allowed Pre-proline 0 N--CA 1.509 2.501 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 177.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -54.82 149.8 39.85 Favored 'Trans proline' 0 N--CA 1.486 1.044 0 C-N-CA 121.895 1.73 . . . . 0.0 112.79 -175.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -37.19 -32.1 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.427 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.415 -178.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.419 ' CE1' HD12 ' A' ' 108' ' ' ILE . 58.9 m-85 -73.43 112.27 9.35 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 177.12 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 28.4 m 73.67 14.82 4.15 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 122.237 -0.289 . . . . 0.0 110.29 -178.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.504 ' NH1' ' O ' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -45.53 -86.52 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.919 0 O-C-N 121.083 -1.01 . . . . 0.0 109.813 -179.913 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 21.8 m -38.98 -38.55 0.45 Allowed 'General case' 0 N--CA 1.515 2.821 0 N-CA-C 113.801 1.038 . . . . 0.0 113.801 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -36.36 -43.91 0.4 Allowed 'General case' 0 N--CA 1.512 2.673 0 CA-C-N 120.294 1.406 . . . . 0.0 112.512 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -42.55 -54.53 3.89 Favored 'General case' 0 N--CA 1.514 2.755 0 O-C-N 121.851 -0.531 . . . . 0.0 111.765 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.417 ' CG2' ' CD1' ' A' ' 97' ' ' LEU . 95.2 t -57.58 -42.34 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.89 -30.41 67.76 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.469 ' CG2' ' HB ' ' A' ' 67' ' ' VAL . 1.6 mp -78.41 -30.43 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 O-C-N 121.954 -0.466 . . . . 0.0 110.469 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.8 tp -77.44 -41.72 38.71 Favored 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 119.314 -0.954 . . . . 0.0 110.282 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -78.72 -52.06 8.94 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.202 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -81.06 -22.99 38.84 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.936 -0.478 . . . . 0.0 111.267 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.58 147.38 10.93 Favored Glycine 0 N--CA 1.498 2.823 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 -178.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.469 ' HB ' ' CG2' ' A' ' 62' ' ' ILE . 7.6 p -118.29 159.65 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 122.052 -0.675 . . . . 0.0 109.644 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.451 ' CG2' ' CE1' ' A' ' 74' ' ' HIS . 69.3 t -114.9 157.77 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 CA-C-O 121.828 0.823 . . . . 0.0 109.602 -178.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 33.9 p -117.14 159.54 22.43 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.73 -177.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 42.6 t -63.28 -31.09 72.15 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.383 -178.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.5 p -68.32 -17.33 64.23 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.231 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.91 14.08 32.42 Favored Glycine 0 N--CA 1.498 2.795 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -102.37 156.21 17.74 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-N 118.085 0.942 . . . . 0.0 109.398 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.451 ' CE1' ' CG2' ' A' ' 68' ' ' VAL . 8.7 m170 -116.03 156.15 26.84 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -145.67 -174.1 4.31 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.034 0.445 . . . . 0.0 109.869 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 60.27 -148.68 43.4 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 56.11 28.32 12.8 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 122.122 -0.634 . . . . 0.0 109.679 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.4 mp -86.45 -14.37 43.43 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.716 -0.615 . . . . 0.0 111.202 -178.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.93 84.42 5.69 Favored 'General case' 0 N--CA 1.503 2.212 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 179.109 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -127.81 -173.13 2.84 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.464 0.649 . . . . 0.0 110.01 -178.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -50.43 102.31 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.695 0.76 . . . . 0.0 111.396 -179.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.508 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 22.2 mt -98.51 169.18 8.68 Favored Pre-proline 0 N--CA 1.497 1.916 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.508 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 28.7 Cg_endo -68.24 101.25 0.7 Allowed 'Trans proline' 0 N--CA 1.478 0.601 0 C-N-CA 121.189 1.259 . . . . 0.0 110.733 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.69 13.65 59.25 Favored Glycine 0 N--CA 1.497 2.71 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 3.7 m -143.6 91.03 6.9 Favored Pre-proline 0 N--CA 1.509 2.485 0 CA-C-N 118.637 1.219 . . . . 0.0 109.371 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -75.39 160.15 39.17 Favored 'Trans proline' 0 N--CA 1.483 0.856 0 C-N-CA 121.673 1.582 . . . . 0.0 111.464 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.0 mmt85 -49.55 -28.56 5.73 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 177.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 -57.13 -59.39 5.16 Favored 'General case' 0 N--CA 1.503 2.2 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.624 -178.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 53.6 t -61.07 -40.25 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.836 -0.54 . . . . 0.0 110.311 -178.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -65.42 -26.94 68.2 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.63 -31.68 47.05 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.42 -48.99 36.89 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 122.04 -0.413 . . . . 0.0 109.902 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -78.46 -25.34 45.82 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 122.326 -0.234 . . . . 0.0 111.132 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.414 ' N ' ' HD2' ' A' ' 95' ' ' PRO . . . -48.98 -48.83 71.43 Favored Pre-proline 0 N--CA 1.505 2.319 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -176.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.414 ' HD2' ' N ' ' A' ' 94' ' ' ALA . 29.3 Cg_endo -68.61 85.59 0.46 Allowed 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 121.841 1.694 . . . . 0.0 113.29 -176.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.414 ' C ' ' HD3' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -177.8 54.95 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.422 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.595 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.417 ' CD1' ' CG2' ' A' ' 60' ' ' VAL . 29.0 tp -86.27 -81.32 0.22 Allowed 'General case' 0 N--CA 1.507 2.388 0 O-C-N 121.218 -0.926 . . . . 0.0 111.753 -177.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.409 HG13 ' CD1' ' A' ' 48' ' ' LEU . 4.0 m -91.62 24.92 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.745 -0.597 . . . . 0.0 110.958 -176.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 29.9 p -93.47 168.71 10.87 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.16 -0.01 0.48 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.49 -0.756 . . . . 0.0 111.843 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 28.0 t -97.07 0.16 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 CA-C-N 120.518 1.508 . . . . 0.0 111.249 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 23.9 tp10 -140.71 -88.07 0.17 Allowed 'General case' 0 N--CA 1.504 2.245 0 CA-C-N 119.114 0.87 . . . . 0.0 111.433 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 57.3 m -143.74 45.56 1.48 Allowed 'General case' 0 N--CA 1.509 2.482 0 O-C-N 121.244 -0.91 . . . . 0.0 109.683 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -40.5 -57.59 1.78 Allowed 'General case' 0 N--CA 1.504 2.263 0 O-C-N 121.192 -0.942 . . . . 0.0 113.363 -178.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.6 mt 43.16 27.27 0.11 Allowed 'General case' 0 N--CA 1.515 2.777 0 CA-C-N 119.016 0.825 . . . . 0.0 111.112 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 63.57 153.66 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.451 -0.781 . . . . 0.0 109.801 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.3 p -123.82 -161.18 0.96 Allowed 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.419 HD12 ' CE1' ' A' ' 54' ' ' TYR . 4.3 tp -66.99 -33.8 65.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.072 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.427 ' HB3' ' CE1' ' A' ' 113' ' ' PHE . 74.4 m-70 -70.96 -0.72 9.9 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.907 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 56.28 43.41 89.44 Favored Glycine 0 N--CA 1.501 2.984 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -172.48 170.58 43.63 Favored Glycine 0 N--CA 1.501 2.993 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -77.17 77.1 3.92 Favored 'Trans proline' 0 CA--C 1.544 1.023 0 C-N-CA 122.36 2.04 . . . . 0.0 111.513 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.427 ' CE1' ' HB3' ' A' ' 109' ' ' HIS . 33.1 p90 173.51 150.8 0.08 Allowed 'General case' 0 N--CA 1.505 2.311 0 O-C-N 121.754 -0.591 . . . . 0.0 109.827 178.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 20.6 p -145.49 86.62 1.76 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.756 -0.59 . . . . 0.0 110.168 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -153.58 -174.7 5.05 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.246 -0.909 . . . . 0.0 109.601 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 71.7 m -55.12 -54.76 39.06 Favored 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.474 ' O ' ' HB2' ' A' ' 118' ' ' LEU . 0.1 OUTLIER 81.1 -69.04 0.09 Allowed 'General case' 0 N--CA 1.51 2.555 0 C-N-CA 122.677 0.391 . . . . 0.0 110.707 179.223 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' A' ' 117' ' ' LEU . 2.0 mp 74.09 -17.81 0.44 Allowed 'General case' 0 N--CA 1.512 2.633 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -179.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -99.05 30.07 10.55 Favored Glycine 0 N--CA 1.499 2.854 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -104.93 47.72 0.86 Allowed 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.857 0.836 . . . . 0.0 109.301 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.21 10.62 68.13 Favored Glycine 0 N--CA 1.499 2.899 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 . . . . . 0 N--CA 1.497 1.914 0 CA-C-N 118.091 0.945 . . . . 0.0 109.299 179.853 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 79.1 p . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.2 m -119.62 -111.09 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 94.53 -87.25 1.08 Allowed Glycine 0 N--CA 1.499 2.856 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.8 t 41.54 46.6 3.1 Favored 'General case' 0 N--CA 1.509 2.522 0 CA-C-O 121.436 0.636 . . . . 0.0 111.452 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 59.9 p -120.85 -160.01 0.82 Allowed 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.728 -0.608 . . . . 0.0 109.505 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 64.0 m 61.42 -160.97 0.3 Allowed 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.438 ' CG2' ' HD2' ' A' ' 8' ' ' PRO . 33.7 mt 71.91 139.74 0.07 OUTLIER Pre-proline 0 N--CA 1.506 2.356 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 -178.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.438 ' HD2' ' CG2' ' A' ' 7' ' ' ILE . 30.6 Cg_endo -71.7 165.82 31.37 Favored 'Trans proline' 0 N--CA 1.48 0.698 0 C-N-CA 121.624 1.549 . . . . 0.0 111.131 -178.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 62.76 16.48 56.34 Favored Glycine 0 N--CA 1.497 2.733 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.439 ' O ' ' CB ' ' A' ' 11' ' ' ALA . 16.8 mmm -140.93 84.63 1.94 Allowed 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.882 -0.775 . . . . 0.0 109.011 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.439 ' CB ' ' O ' ' A' ' 10' ' ' MET . . . 86.73 -57.72 0.05 Allowed 'General case' 0 N--CA 1.516 2.864 0 O-C-N 121.379 -0.825 . . . . 0.0 108.84 -178.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 61.4 mt -92.14 104.4 10.71 Favored Pre-proline 0 N--CA 1.498 1.961 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -75.05 169.51 22.44 Favored 'Trans proline' 0 C--O 1.219 -0.433 0 C-N-CA 121.3 1.333 . . . . 0.0 111.649 -175.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 34.9 m-70 -69.28 144.62 53.54 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.456 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 5.3 t-20 65.98 55.98 1.05 Allowed Pre-proline 0 N--CA 1.506 2.357 0 O-C-N 121.358 -0.838 . . . . 0.0 110.303 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.456 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 38.6 Cg_endo -80.49 166.87 19.63 Favored 'Trans proline' 0 N--CA 1.484 0.932 0 C-N-CA 122.305 2.004 . . . . 0.0 111.923 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.6 mp 42.96 43.8 3.72 Favored 'General case' 0 N--CA 1.504 2.254 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.209 177.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -69.07 -37.68 78.63 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -63.01 -26.16 68.72 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 57.3 m -74.64 -38.78 62.42 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.406 ' NH1' ' HB3' ' A' ' 78' ' ' LEU . 3.4 ttt180 -64.13 -48.6 75.45 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 33.9 m95 -69.02 -29.07 67.17 Favored 'General case' 0 N--CA 1.502 2.149 0 C-N-CA 119.312 -0.955 . . . . 0.0 109.809 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.426 ' CD1' ' HB3' ' A' ' 40' ' ' MET . 57.1 t80 -66.5 -33.5 75.83 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 96.3 t -72.43 -38.96 61.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 177.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 m -56.18 -37.06 69.07 Favored 'General case' 0 N--CA 1.501 2.091 0 C-N-CA 119.946 -0.701 . . . . 0.0 109.529 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 90.9 m -77.8 -49.89 13.43 Favored 'General case' 0 N--CA 1.508 2.459 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.92 -25.29 67.82 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 121.519 -0.738 . . . . 0.0 110.544 -178.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 70.4 p -93.65 -62.9 1.27 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -177.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.6 m -100.43 9.23 42.92 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.384 -0.823 . . . . 0.0 111.617 -178.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 57.79 29.72 61.95 Favored Glycine 0 N--CA 1.507 3.382 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 -178.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 38.5 t -120.72 164.09 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 122.155 -0.615 . . . . 0.0 109.717 -179.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 136.16 177.72 15.21 Favored Glycine 0 N--CA 1.5 2.908 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -64.43 177.33 2.18 Favored 'Trans proline' 0 N--CA 1.489 1.231 0 CA-C-N 119.196 1.498 . . . . 0.0 110.028 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.21 87.19 6.0 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 122.197 0.999 . . . . 0.0 110.412 -177.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.6 mt -141.76 127.2 18.83 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.02 152.37 2.24 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.907 -0.496 . . . . 0.0 109.81 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.1 p -59.96 -59.64 5.1 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.813 -0.555 . . . . 0.0 110.604 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -52.49 -28.79 21.82 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.818 -0.551 . . . . 0.0 111.595 -178.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -72.0 -46.89 55.56 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.816 -0.553 . . . . 0.0 109.573 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.426 ' HB3' ' CD1' ' A' ' 23' ' ' TYR . 5.5 tpt -61.97 -54.61 39.27 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -53.59 -35.75 61.2 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.34 -42.83 99.71 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.23 -41.14 96.37 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 19.8 m -65.58 -33.17 75.28 Favored 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.233 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 18.9 m -73.43 -30.16 63.03 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -178.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.27 -32.46 62.94 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -77.15 -33.47 56.62 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.48 -33.52 64.87 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.52 -40.38 61.79 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.25 -39.13 85.67 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 70.8 mt -82.7 105.75 5.52 Favored Pre-proline 0 N--CA 1.493 1.684 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 177.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -58.29 139.87 92.2 Favored 'Trans proline' 0 N--CA 1.48 0.712 0 C-N-CA 121.42 1.413 . . . . 0.0 110.92 -177.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.42 ' CB ' ' NH1' ' A' ' 56' ' ' ARG . . . -39.47 -29.76 0.06 Allowed 'General case' 0 N--CA 1.508 2.432 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.359 -178.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -53.16 -70.41 0.09 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.919 -0.488 . . . . 0.0 110.698 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 5.0 m -88.55 8.76 26.64 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 122.062 -0.399 . . . . 0.0 110.89 -179.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.42 ' NH1' ' CB ' ' A' ' 53' ' ' ALA . 5.9 mtt180 -47.58 -85.2 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.67 0 O-C-N 121.491 -0.755 . . . . 0.0 110.33 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 72.6 m -32.95 -48.85 0.22 Allowed 'General case' 0 N--CA 1.521 3.113 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -41.67 -54.34 3.3 Favored 'General case' 0 N--CA 1.512 2.668 0 CA-C-N 119.325 0.966 . . . . 0.0 111.731 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -41.82 -44.75 3.41 Favored 'General case' 0 N--CA 1.514 2.731 0 O-C-N 121.776 -0.578 . . . . 0.0 112.04 -179.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.6 t -57.22 -48.83 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -58.57 -26.83 64.01 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.465 ' CG2' ' HB ' ' A' ' 67' ' ' VAL . 34.8 mm -78.42 -30.76 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 O-C-N 121.985 -0.447 . . . . 0.0 110.469 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.8 tp -77.77 -43.22 31.42 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 120.11 -0.636 . . . . 0.0 109.999 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.01 -50.76 10.58 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.18 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -80.6 -22.71 40.41 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 122.006 -0.434 . . . . 0.0 110.936 -178.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.73 146.89 5.7 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.465 ' HB ' ' CG2' ' A' ' 62' ' ' ILE . 5.5 p -118.42 161.18 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.424 HG21 ' CE1' ' A' ' 74' ' ' HIS . 56.0 t -113.34 157.85 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -179.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 42.2 p -116.67 160.07 21.28 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 121.95 0.881 . . . . 0.0 111.044 -176.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 32.9 t -64.61 -17.46 64.02 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.39 -178.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.1 p -86.49 -14.64 42.53 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 122.021 -0.424 . . . . 0.0 110.127 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.23 13.59 32.98 Favored Glycine 0 N--CA 1.499 2.892 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -105.48 158.56 16.58 Favored 'General case' 0 N--CA 1.502 2.125 0 CA-C-N 118.039 0.92 . . . . 0.0 108.834 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.424 ' CE1' HG21 ' A' ' 68' ' ' VAL . 11.3 m170 -113.72 154.95 26.46 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -179.138 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -136.89 -179.07 5.48 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 55.41 -146.94 28.82 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 108.622 -1.791 . . . . 0.0 108.622 -178.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 54.72 22.53 4.17 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 122.303 -0.528 . . . . 0.0 110.007 179.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.406 ' HB3' ' NH1' ' A' ' 21' ' ' ARG . 2.1 mp -83.1 -14.73 53.1 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.745 -0.597 . . . . 0.0 110.361 -179.247 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.5 mt -62.0 92.79 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -134.22 -177.21 4.48 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.719 0.771 . . . . 0.0 110.843 -178.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -48.68 130.14 17.2 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.506 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.436 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 20.6 mt -127.49 166.38 23.54 Favored Pre-proline 0 N--CA 1.496 1.87 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.436 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 29.6 Cg_endo -68.63 98.69 0.59 Allowed 'Trans proline' 0 C--N 1.328 -0.537 0 C-N-CA 120.88 1.054 . . . . 0.0 110.143 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.68 4.22 67.9 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.422 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 3.3 m -137.02 92.1 14.4 Favored Pre-proline 0 N--CA 1.508 2.47 0 CA-C-N 119.173 1.487 . . . . 0.0 110.02 -179.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -74.69 165.52 31.36 Favored 'Trans proline' 0 N--CA 1.485 1.028 0 C-N-CA 121.976 1.784 . . . . 0.0 111.328 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 23.9 mtp180 -54.09 -25.97 24.66 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.038 0.447 . . . . 0.0 110.133 178.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.58 -46.12 87.33 Favored 'General case' 0 N--CA 1.502 2.139 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.947 -177.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 42.2 t -72.46 -43.14 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.513 -0.742 . . . . 0.0 110.982 -177.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -70.49 -27.15 63.98 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.7 ttt180 -78.72 -29.15 45.17 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.34 -47.34 20.2 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.999 -0.438 . . . . 0.0 110.3 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -79.02 -27.48 43.25 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 122.021 -0.425 . . . . 0.0 111.47 -178.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.449 ' N ' ' HD2' ' A' ' 95' ' ' PRO . . . -54.81 -46.64 99.42 Favored Pre-proline 0 N--CA 1.505 2.281 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -177.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' A' ' 94' ' ' ALA . 30.1 Cg_endo -70.12 -0.22 6.89 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 122.239 1.959 . . . . 0.0 114.009 -177.125 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.71 23.92 12.25 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.496 -0.753 . . . . 0.0 109.838 179.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.93 -24.32 59.65 Favored 'General case' 0 N--CA 1.509 2.492 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -178.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 33.7 m -93.36 25.8 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 CA-C-N 121.0 1.727 . . . . 0.0 111.179 -178.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 19.1 p -98.28 173.2 7.11 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -62.07 -1.48 0.7 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.696 -0.628 . . . . 0.0 112.25 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 37.1 t -100.03 4.49 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 CA-C-N 120.407 1.458 . . . . 0.0 110.873 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -141.13 -89.97 0.15 Allowed 'General case' 0 N--CA 1.502 2.168 0 CA-C-N 118.99 0.814 . . . . 0.0 111.511 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 19.5 m -143.67 43.08 1.48 Allowed 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.572 -0.705 . . . . 0.0 109.886 -178.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.402 ' ND2' ' HB3' ' A' ' 112' ' ' PRO . 57.0 t-20 -43.02 -64.81 0.56 Allowed 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.299 -0.875 . . . . 0.0 112.287 -179.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 6.0 mt 45.34 29.39 0.56 Allowed 'General case' 0 N--CA 1.511 2.602 0 CA-C-O 121.066 0.46 . . . . 0.0 109.927 -178.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 67.09 157.98 0.13 Allowed 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -178.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.6 p -128.87 -163.92 1.34 Allowed 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -179.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 18.0 tt -68.17 -33.29 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.427 ' HB3' ' CE2' ' A' ' 113' ' ' PHE . 96.9 m-70 -66.68 -4.85 9.81 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.689 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 61.45 41.51 99.56 Favored Glycine 0 N--CA 1.499 2.874 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -174.82 170.94 44.14 Favored Glycine 0 N--CA 1.5 2.966 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.402 ' HB3' ' ND2' ' A' ' 104' ' ' ASN . 32.3 Cg_endo -77.9 75.85 4.6 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 122.553 2.168 . . . . 0.0 111.387 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.427 ' CE2' ' HB3' ' A' ' 109' ' ' HIS . 36.7 p90 178.72 156.3 0.45 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.708 -0.62 . . . . 0.0 110.447 178.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 4.8 t 178.61 158.61 0.52 Allowed 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 55.68 22.26 5.23 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.699 -0.626 . . . . 0.0 109.932 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.66 -69.31 0.07 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.82 -0.55 . . . . 0.0 109.694 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.492 ' O ' ' HB2' ' A' ' 118' ' ' LEU . 0.4 OUTLIER 59.68 29.73 19.31 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.718 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.492 ' HB2' ' O ' ' A' ' 117' ' ' LEU . 20.4 mt 76.31 -18.73 0.45 Allowed 'General case' 0 N--CA 1.509 2.513 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 130.69 176.92 14.61 Favored Glycine 0 N--CA 1.499 2.891 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -97.94 43.88 1.05 Allowed 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.677 0.751 . . . . 0.0 109.379 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -94.32 25.28 23.29 Favored Glycine 0 N--CA 1.498 2.814 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 . . . . . 0 N--CA 1.498 1.974 0 CA-C-O 118.003 -0.999 . . . . 0.0 109.449 179.859 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.2 m . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.056 0.455 . . . . 0.0 109.976 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.4 ' CG2' ' N ' ' A' ' 3' ' ' GLY . 1.2 p -108.13 -95.31 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.4 ' N ' ' CG2' ' A' ' 2' ' ' VAL . . . -66.92 -105.1 0.02 OUTLIER Glycine 0 N--CA 1.499 2.84 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.3 t 42.87 62.99 1.6 Allowed 'General case' 0 N--CA 1.509 2.508 0 CA-C-O 121.813 0.816 . . . . 0.0 110.535 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.57 83.77 1.54 Allowed 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.668 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 39.3 m 56.52 102.98 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.549 -0.719 . . . . 0.0 110.233 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 94.7 mt -133.36 142.66 45.02 Favored Pre-proline 0 N--CA 1.499 2.02 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.92 99.66 1.31 Allowed 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 121.849 1.699 . . . . 0.0 110.205 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 109.9 -10.55 32.07 Favored Glycine 0 N--CA 1.501 2.983 0 O-C-N 121.507 -0.746 . . . . 0.0 111.255 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.438 ' O ' ' CB ' ' A' ' 11' ' ' ALA . 6.1 mmt -128.03 111.77 13.89 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.438 ' CB ' ' O ' ' A' ' 10' ' ' MET . . . 86.17 -54.09 0.07 Allowed 'General case' 0 N--CA 1.514 2.741 0 CA-C-N 119.789 1.177 . . . . 0.0 108.708 -178.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 55.0 mt -113.38 100.74 52.44 Favored Pre-proline 0 N--CA 1.495 1.783 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 178.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -81.73 172.46 12.22 Favored 'Trans proline' 0 C--O 1.221 -0.366 0 C-N-CA 121.484 1.456 . . . . 0.0 111.524 -177.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 44.7 m-70 -77.61 150.1 34.69 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.471 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 10.8 t-20 66.99 53.92 0.75 Allowed Pre-proline 0 N--CA 1.503 2.21 0 O-C-N 121.459 -0.775 . . . . 0.0 110.049 -178.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.471 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 39.8 Cg_endo -78.45 163.07 27.45 Favored 'Trans proline' 0 N--CA 1.484 0.937 0 C-N-CA 122.282 1.988 . . . . 0.0 111.465 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 48.62 47.12 20.95 Favored 'General case' 0 N--CA 1.503 2.191 0 CA-C-O 121.246 0.546 . . . . 0.0 111.043 178.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -66.7 -35.43 80.1 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 121.493 -0.755 . . . . 0.0 109.078 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.18 -26.62 68.23 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 28.3 m -71.32 -45.2 63.58 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.38 -54.63 44.47 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.42 ' HA ' ' CE3' ' A' ' 22' ' ' TRP . 27.9 m95 -64.26 -27.18 68.87 Favored 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.676 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.444 ' CD2' ' HB3' ' A' ' 40' ' ' MET . 6.4 t80 -66.3 -32.5 73.95 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.414 HG21 ' CE1' ' A' ' 93' ' ' PHE . 61.1 t -70.61 -42.04 77.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 178.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 m -56.23 -44.37 79.52 Favored 'General case' 0 N--CA 1.502 2.158 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.656 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 20.9 m -76.05 -52.25 10.58 Favored 'General case' 0 N--CA 1.51 2.569 0 O-C-N 122.059 -0.401 . . . . 0.0 111.924 -178.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.7 tpm_? -61.89 -24.89 67.22 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.838 -0.539 . . . . 0.0 110.724 -178.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 35.6 p -96.23 -64.38 1.06 Allowed 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 120.689 -0.405 . . . . 0.0 112.058 -177.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.7 m -101.32 10.89 40.16 Favored 'General case' 0 N--CA 1.511 2.613 0 CA-C-N 119.183 0.901 . . . . 0.0 111.484 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.12 18.54 57.84 Favored Glycine 0 N--CA 1.501 2.972 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -178.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.2 t -102.77 164.04 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 O-C-N 121.696 -0.885 . . . . 0.0 109.112 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 130.3 179.46 16.06 Favored Glycine 0 N--CA 1.499 2.892 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 -179.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -64.84 173.06 6.17 Favored 'Trans proline' 0 N--CA 1.486 1.065 0 CA-C-N 119.201 1.5 . . . . 0.0 109.879 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -92.77 84.5 4.99 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 122.026 0.917 . . . . 0.0 110.178 -177.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 69.2 mt -140.79 145.1 35.88 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.29 163.11 3.16 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -179.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.23 -56.12 4.59 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.998 -0.439 . . . . 0.0 110.444 -179.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.28 -33.4 19.77 Favored 'General case' 0 N--CA 1.508 2.474 0 O-C-N 121.881 -0.512 . . . . 0.0 110.803 -178.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -71.35 -39.89 71.02 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 122.054 -0.404 . . . . 0.0 110.142 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.444 ' HB3' ' CD2' ' A' ' 23' ' ' TYR . 1.5 ttt -65.32 -52.79 51.6 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.426 ' HB2' ' CE2' ' A' ' 23' ' ' TYR . 6.4 tttm -53.58 -38.05 63.55 Favored 'General case' 0 N--CA 1.504 2.268 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.98 -40.92 97.27 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -60.36 -44.55 95.47 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 12.4 m -63.19 -35.95 82.0 Favored 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.635 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 69.0 m -70.52 -29.73 66.3 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.6 ttt-85 -73.8 -32.46 63.75 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -76.43 -29.48 57.02 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.49 -36.86 57.58 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -73.41 -36.21 65.95 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.65 -53.03 60.69 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 178.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.411 HD11 HG22 ' A' ' 51' ' ' ILE . 42.0 mm -63.59 105.81 0.76 Allowed Pre-proline 0 N--CA 1.496 1.871 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 176.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -59.27 149.82 78.32 Favored 'Trans proline' 0 N--CA 1.479 0.651 0 C-N-CA 121.593 1.529 . . . . 0.0 110.935 -176.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -40.46 -32.08 0.18 Allowed 'General case' 0 N--CA 1.505 2.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.53 -178.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -73.49 121.73 21.03 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 178.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 15.2 m 72.9 6.41 5.34 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 122.167 -0.333 . . . . 0.0 110.23 -178.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -49.11 -87.14 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.676 0 O-C-N 121.191 -0.943 . . . . 0.0 109.691 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 82.4 m -36.39 -43.51 0.38 Allowed 'General case' 0 N--CA 1.519 3.007 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -39.31 -48.36 1.84 Allowed 'General case' 0 N--CA 1.511 2.61 0 CA-C-N 119.549 1.068 . . . . 0.0 112.326 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -41.9 -50.37 4.48 Favored 'General case' 0 N--CA 1.517 2.922 0 CA-C-N 118.783 0.72 . . . . 0.0 111.522 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.9 t -58.23 -45.04 89.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.87 -27.66 65.4 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.475 ' CG2' ' HB ' ' A' ' 67' ' ' VAL . 1.4 mp -78.21 -30.85 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.898 -0.501 . . . . 0.0 109.852 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.3 tt -77.57 -40.73 41.38 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.469 -0.893 . . . . 0.0 110.139 -179.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 2.7 tmm? -78.4 -53.45 7.25 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.27 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -80.68 -22.83 40.07 Favored 'General case' 0 N--CA 1.502 2.154 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.157 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.97 147.63 11.79 Favored Glycine 0 N--CA 1.497 2.709 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 -178.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.475 ' HB ' ' CG2' ' A' ' 62' ' ' ILE . 7.6 p -118.48 160.58 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 O-C-N 122.196 -0.591 . . . . 0.0 109.782 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.459 HG21 ' CE1' ' A' ' 74' ' ' HIS . 54.7 t -114.38 157.81 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 CA-C-O 121.716 0.769 . . . . 0.0 109.292 -179.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 61.7 p -117.18 159.9 21.89 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.78 -177.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 35.4 t -63.3 -31.51 72.68 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.298 -178.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.2 p -69.14 -16.65 63.7 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.332 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.73 10.17 44.26 Favored Glycine 0 N--CA 1.498 2.783 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -100.18 157.56 16.49 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-N 118.04 0.92 . . . . 0.0 109.139 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.459 ' CE1' HG21 ' A' ' 68' ' ' VAL . 9.7 m170 -114.93 155.22 27.29 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -179.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -140.56 -176.44 4.64 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.122 0.487 . . . . 0.0 109.785 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 56.37 -144.5 36.63 Favored Glycine 0 N--CA 1.496 2.691 0 N-CA-C 108.592 -1.803 . . . . 0.0 108.592 -178.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 56.0 21.6 5.14 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 122.224 -0.574 . . . . 0.0 110.356 179.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.7 mp -76.21 -16.76 59.77 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.744 -0.597 . . . . 0.0 110.468 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.3 tp -59.34 91.64 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 41.0 mm-40 -130.81 -176.9 4.14 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.449 0.642 . . . . 0.0 109.821 -179.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.33 102.33 1.07 Allowed 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.657 0.742 . . . . 0.0 110.893 -179.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.513 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 20.5 mt -87.12 169.64 14.12 Favored Pre-proline 0 N--CA 1.496 1.856 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 177.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.513 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 29.5 Cg_endo -69.58 99.19 0.71 Allowed 'Trans proline' 0 C--N 1.328 -0.528 0 C-N-CA 121.028 1.152 . . . . 0.0 110.3 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 98.58 1.41 57.71 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 3.4 m -134.8 91.34 20.76 Favored Pre-proline 0 N--CA 1.504 2.242 0 CA-C-N 118.99 1.395 . . . . 0.0 109.274 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -72.09 161.18 45.44 Favored 'Trans proline' 0 N--CA 1.483 0.879 0 C-N-CA 121.3 1.333 . . . . 0.0 111.528 -179.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.6 mtp180 -48.15 -28.11 2.76 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.06 0.457 . . . . 0.0 109.907 178.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -60.8 -47.23 87.26 Favored 'General case' 0 N--CA 1.502 2.174 0 CA-C-N 116.325 -0.398 . . . . 0.0 112.006 -177.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 48.5 t -68.77 -39.52 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.585 -0.697 . . . . 0.0 109.837 -178.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -66.17 -26.76 67.56 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.3 tpt180 -78.89 -35.17 44.01 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 122.085 -0.385 . . . . 0.0 109.966 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.34 -45.99 68.11 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.414 ' CE1' HG21 ' A' ' 24' ' ' VAL . 37.3 t80 -78.34 -25.52 46.42 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.427 ' N ' ' HD2' ' A' ' 95' ' ' PRO . . . -41.56 -51.82 8.63 Favored Pre-proline 0 N--CA 1.503 2.191 0 CA-C-O 118.907 -0.568 . . . . 0.0 112.098 -177.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.427 ' HD2' ' N ' ' A' ' 94' ' ' ALA . 29.4 Cg_endo -72.32 -171.91 0.8 Allowed 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 121.532 1.488 . . . . 0.0 109.519 179.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 66.47 18.0 10.75 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.827 -0.546 . . . . 0.0 109.827 -178.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.3 -62.73 1.37 Allowed 'General case' 0 N--CA 1.516 2.849 0 O-C-N 121.687 -0.633 . . . . 0.0 112.134 -178.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 33.4 m -86.57 26.5 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.282 0 CA-C-N 119.621 1.101 . . . . 0.0 110.657 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 46.7 p -97.58 173.56 7.09 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -62.6 0.46 0.49 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.332 -0.855 . . . . 0.0 111.944 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.0 t -98.57 -0.83 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 CA-C-N 120.481 1.491 . . . . 0.0 111.211 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -138.46 -88.81 0.23 Allowed 'General case' 0 N--CA 1.507 2.39 0 CA-C-N 119.403 1.001 . . . . 0.0 111.918 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 92.0 m -141.44 42.03 1.75 Allowed 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.553 -0.717 . . . . 0.0 109.734 -178.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.447 ' ND2' ' HB3' ' A' ' 112' ' ' PRO . 46.5 t-20 -38.34 -69.91 0.11 Allowed 'General case' 0 N--CA 1.506 2.339 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -178.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.7 mt 48.18 26.99 1.16 Allowed 'General case' 0 N--CA 1.51 2.534 0 O-C-N 121.912 -0.492 . . . . 0.0 110.682 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 63.91 154.66 0.06 Allowed 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.561 ' OG1' ' CE1' ' A' ' 109' ' ' HIS . 1.7 p -124.51 -151.82 0.49 Allowed 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -178.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -57.96 -39.97 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 C-N-CA 123.08 0.552 . . . . 0.0 111.279 178.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.587 ' CE1' ' O ' ' A' ' 113' ' ' PHE . 3.8 p80 -92.53 23.15 4.15 Favored 'General case' 0 N--CA 1.514 2.775 0 O-C-N 122.219 -0.301 . . . . 0.0 110.875 -177.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 45.47 63.57 2.68 Favored Glycine 0 N--CA 1.504 3.2 0 O-C-N 121.723 -0.61 . . . . 0.0 111.986 177.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 173.31 171.32 37.82 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 110.499 -1.041 . . . . 0.0 110.499 179.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.455 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 36.3 Cg_endo -83.3 75.35 4.38 Favored 'Trans proline' 0 CA--C 1.545 1.043 0 C-N-CA 122.711 2.274 . . . . 0.0 111.057 -179.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.587 ' O ' ' CE1' ' A' ' 109' ' ' HIS . 20.2 p90 176.96 88.94 0.01 OUTLIER 'General case' 0 N--CA 1.531 3.597 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.428 ' HA ' ' NE2' ' A' ' 109' ' ' HIS . 21.9 p -118.15 170.01 9.22 Favored 'General case' 0 N--CA 1.513 2.705 0 O-C-N 119.799 -1.813 . . . . 0.0 110.702 178.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.408 ' O ' ' CB ' ' A' ' 116' ' ' SER . 0.6 OUTLIER 74.25 109.64 0.07 Allowed 'General case' 0 N--CA 1.504 2.275 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.135 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.408 ' CB ' ' O ' ' A' ' 115' ' ' LEU . 1.1 t 82.56 -69.49 0.06 Allowed 'General case' 0 N--CA 1.513 2.678 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.438 ' CD1' ' O ' ' A' ' 113' ' ' PHE . 1.5 mp 68.52 -156.81 0.18 Allowed 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.2 mp -46.9 -20.32 0.14 Allowed 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.453 -0.779 . . . . 0.0 113.037 -178.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 63.06 115.54 0.01 OUTLIER Glycine 0 N--CA 1.5 2.952 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -108.93 66.68 0.64 Allowed 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.843 0.83 . . . . 0.0 109.125 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -61.2 -21.88 60.08 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 . . . . . 0 N--CA 1.499 2.012 0 CA-C-O 118.412 -0.804 . . . . 0.0 110.194 -179.769 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 86.6 p . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.314 0.578 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.538 ' CG2' ' N ' ' A' ' 3' ' ' GLY . 0.2 OUTLIER 173.09 -84.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.281 -0.887 . . . . 0.0 109.207 179.892 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.538 ' N ' ' CG2' ' A' ' 2' ' ' VAL . . . -152.48 153.2 24.73 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.3 t -175.23 64.08 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.15 -1.206 . . . . 0.0 109.506 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.38 -152.74 0.49 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.305 -0.872 . . . . 0.0 109.316 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 79.6 m -78.23 106.86 10.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.149 -0.969 . . . . 0.0 109.469 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.467 ' HB ' ' HB2' ' A' ' 10' ' ' MET . 0.0 OUTLIER -125.66 158.85 63.57 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.344 -0.848 . . . . 0.0 109.005 179.747 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.425 ' HD2' ' CG2' ' A' ' 7' ' ' ILE . 35.5 Cg_endo -78.75 143.9 19.01 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.469 2.112 . . . . 0.0 110.356 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 57.66 14.59 15.41 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.588 ' O ' ' CB ' ' A' ' 11' ' ' ALA . 1.3 mtt -140.25 107.69 5.56 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.211 -1.17 . . . . 0.0 108.54 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.588 ' CB ' ' O ' ' A' ' 10' ' ' MET . . . 85.32 -62.22 0.07 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.843 -1.161 . . . . 0.0 108.057 -178.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.419 HG12 HD13 ' A' ' 51' ' ' ILE . 67.9 mt -104.05 101.17 24.22 Favored Pre-proline 0 C--N 1.304 -1.406 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 11' ' ' ALA . 33.2 Cg_endo -81.29 172.45 12.71 Favored 'Trans proline' 0 C--N 1.318 -1.073 0 C-N-CA 121.595 1.53 . . . . 0.0 111.674 -177.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.406 ' H ' ' CD2' ' A' ' 14' ' ' HIS . 29.4 m-70 -69.58 145.63 52.4 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.638 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 10.8 t-20 54.8 51.21 7.21 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 120.809 -1.182 . . . . 0.0 110.04 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.638 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 37.6 Cg_endo -78.72 166.07 24.04 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.398 2.066 . . . . 0.0 111.49 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.521 ' CD2' HD23 ' A' ' 97' ' ' LEU . 0.5 OUTLIER 48.45 48.32 19.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.741 -0.599 . . . . 0.0 111.091 178.879 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -75.08 -42.24 57.15 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.01 -1.056 . . . . 0.0 108.91 178.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.537 ' OG ' ' CE ' ' A' ' 40' ' ' MET . 0.3 OUTLIER -59.24 -25.61 64.19 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.191 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.418 ' N ' ' SG ' ' A' ' 44' ' ' CYS . 71.2 m -73.78 -38.77 64.54 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.597 -0.69 . . . . 0.0 109.286 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.455 ' O ' ' HD2' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -63.51 -48.05 79.18 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.263 -0.898 . . . . 0.0 108.848 179.498 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.46 ' HA ' ' OG ' ' A' ' 25' ' ' SER . 31.0 m95 -73.08 -26.77 61.38 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.642 -1.286 . . . . 0.0 109.82 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.516 ' HB2' ' HG2' ' A' ' 40' ' ' MET . 15.2 t80 -66.17 -31.28 72.02 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.08 -1.012 . . . . 0.0 108.422 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.465 ' O ' ' OG1' ' A' ' 28' ' ' THR . 93.4 t -75.42 -41.52 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.003 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.46 ' OG ' ' HA ' ' A' ' 22' ' ' TRP . 0.5 OUTLIER -56.2 -42.3 76.96 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.434 -0.906 . . . . 0.0 109.986 -179.863 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.492 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 2.4 m -77.59 -55.08 5.66 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.267 -0.896 . . . . 0.0 111.256 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.87 -24.56 62.34 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 120.743 -1.223 . . . . 0.0 110.3 -178.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.465 ' OG1' ' O ' ' A' ' 24' ' ' VAL . 72.4 p -92.87 -67.1 0.88 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.005 -1.059 . . . . 0.0 111.351 -178.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 84' ' ' GLY . 3.6 m -99.0 16.69 21.74 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.618 -1.301 . . . . 0.0 109.843 -179.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.474 ' HA2' ' O ' ' A' ' 26' ' ' THR . . . 56.48 21.48 34.63 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 26' ' ' THR . 73.6 t -105.79 161.11 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.141 -1.211 . . . . 0.0 109.615 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.406 ' N ' ' CG1' ' A' ' 31' ' ' VAL . . . 138.36 179.86 17.63 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 108.849 -1.7 . . . . 0.0 108.849 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -66.19 175.8 4.52 Favored 'Trans proline' 0 N--CA 1.482 0.803 0 CA-C-N 119.127 1.464 . . . . 0.0 110.051 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 7.4 mtt-85 -91.4 82.2 5.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.847 -1.158 . . . . 0.0 110.013 -178.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.97 131.2 28.26 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -45.95 158.28 0.1 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.086 -1.009 . . . . 0.0 109.326 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -75.79 -52.34 10.62 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.973 -1.079 . . . . 0.0 110.205 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -47.12 -34.03 5.67 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.971 -1.081 . . . . 0.0 109.643 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.472 ' O ' ' HD3' ' A' ' 43' ' ' ARG . 3.0 mt-10 -69.57 -41.65 75.57 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.15 -0.969 . . . . 0.0 108.906 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.537 ' CE ' ' OG ' ' A' ' 19' ' ' SER . 2.6 tpt -61.24 -60.41 3.79 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.6 ttpm? -50.35 -40.89 50.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.745 -0.597 . . . . 0.0 109.529 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.59 -45.59 88.78 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.282 -0.886 . . . . 0.0 109.486 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.519 ' HD2' ' N ' ' A' ' 43' ' ' ARG . 1.0 OUTLIER -59.82 -48.79 80.26 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.355 -0.841 . . . . 0.0 109.851 -179.695 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.418 ' SG ' ' N ' ' A' ' 20' ' ' CYS . 14.0 m -58.03 -34.42 70.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.992 -1.068 . . . . 0.0 110.439 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 20.8 m -70.95 -30.58 66.91 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.977 -1.077 . . . . 0.0 109.091 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.63 -35.61 75.39 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.471 ' O ' ' CG1' ' A' ' 51' ' ' ILE . 3.4 mt-30 -76.95 -26.48 54.06 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.457 HD23 ' HG2' ' A' ' 56' ' ' ARG . 1.7 tm? -71.65 -34.83 70.07 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.432 ' O ' ' C ' ' A' ' 50' ' ' ALA . 4.2 mm-40 -77.06 -58.43 3.29 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.481 ' O ' ' HD3' ' A' ' 52' ' ' PRO . . . -46.35 -35.17 5.17 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.519 ' CG2' ' HA ' ' A' ' 56' ' ' ARG . 21.9 mm -82.01 106.62 6.62 Favored Pre-proline 0 N--CA 1.488 1.449 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 50' ' ' ALA . 25.7 Cg_endo -61.84 148.35 93.28 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 121.883 1.722 . . . . 0.0 110.886 -177.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.486 ' HA ' ' HD2' ' A' ' 56' ' ' ARG . . . -59.77 -35.05 73.84 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.665 -0.647 . . . . 0.0 111.156 -178.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.45 ' C ' ' O ' ' A' ' 53' ' ' ALA . 6.0 t80 -45.58 -27.17 0.71 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.905 -1.122 . . . . 0.0 108.137 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.505 ' O ' ' C ' ' A' ' 56' ' ' ARG . 13.3 m -116.43 -73.34 0.65 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.519 ' HA ' ' CG2' ' A' ' 51' ' ' ILE . 22.4 mtt180 31.71 -98.89 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.828 -0.545 . . . . 0.0 110.176 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.497 ' C ' ' O ' ' A' ' 56' ' ' ARG . 66.2 m -33.46 -55.89 0.43 Allowed 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.277 -0.89 . . . . 0.0 111.208 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.482 ' O ' ' C ' ' A' ' 59' ' ' ALA . 1.1 tt0 -35.74 -53.63 0.72 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.766 -1.208 . . . . 0.0 111.05 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.482 ' C ' ' O ' ' A' ' 58' ' ' GLU . . . -35.85 -52.49 0.72 Allowed 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.214 -0.928 . . . . 0.0 110.287 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.489 HG23 ' CD1' ' A' ' 97' ' ' LEU . 7.4 t -53.52 -50.47 49.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 121.247 -0.908 . . . . 0.0 108.784 179.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.5 ' O ' ' HB2' ' A' ' 65' ' ' ASP . 6.8 mtp85 -53.55 -29.61 37.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.403 -0.81 . . . . 0.0 109.83 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.564 ' CG2' ' HB ' ' A' ' 67' ' ' VAL . 17.9 mt -77.6 -30.14 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 120.957 -1.089 . . . . 0.0 110.043 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' A' ' 77' ' ' ARG . 13.0 tp -77.26 -43.18 34.29 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.773 -1.205 . . . . 0.0 109.612 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 47.5 tpp -78.42 -50.96 10.76 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.18 -0.95 . . . . 0.0 109.945 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.5 ' HB2' ' O ' ' A' ' 61' ' ' ARG . 17.5 m-20 -79.68 -21.97 44.04 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.061 -1.024 . . . . 0.0 109.978 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.56 146.11 9.57 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.564 ' HB ' ' CG2' ' A' ' 62' ' ' ILE . 2.6 p -116.88 159.47 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.512 -0.993 . . . . 0.0 109.329 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.474 ' N ' HG23 ' A' ' 67' ' ' VAL . 7.9 t -114.3 157.99 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 CA-C-O 121.864 0.84 . . . . 0.0 109.892 -178.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.456 ' N ' ' CG1' ' A' ' 68' ' ' VAL . 21.7 p -116.87 159.27 22.64 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.604 0.716 . . . . 0.0 109.583 -178.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.0 t -62.27 -34.17 76.03 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.588 -0.695 . . . . 0.0 110.142 -179.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.8 p -65.63 -14.93 62.18 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.525 -0.734 . . . . 0.0 109.52 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 99.97 8.09 51.65 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.674 -1.77 . . . . 0.0 108.674 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -92.1 156.81 17.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.216 -1.167 . . . . 0.0 109.5 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.421 ' C ' ' HG2' ' A' ' 75' ' ' GLU . 12.5 m170 -115.8 155.88 27.06 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 120.812 -1.18 . . . . 0.0 108.675 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.421 ' HG2' ' C ' ' A' ' 74' ' ' HIS . 3.3 mt-10 -141.44 -172.89 3.62 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.088 -1.007 . . . . 0.0 110.585 -179.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 49.65 -146.07 7.73 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.478 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER 56.2 17.77 2.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -1.175 . . . . 0.0 110.1 179.64 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.421 ' O ' ' N ' ' A' ' 80' ' ' GLN . 0.1 OUTLIER -83.8 -11.96 56.33 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.983 -1.073 . . . . 0.0 110.127 -179.611 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.475 ' CD2' HD22 ' A' ' 63' ' ' LEU . 0.9 OUTLIER -47.71 99.32 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.869 -1.144 . . . . 0.0 109.34 179.718 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.421 ' N ' ' O ' ' A' ' 78' ' ' LEU . 2.2 mt-30 -134.39 170.99 14.91 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.238 -0.913 . . . . 0.0 109.698 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.438 ' OD1' ' HG3' ' A' ' 87' ' ' ARG . 2.2 m-20 -65.94 107.4 1.84 Allowed 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.595 0.712 . . . . 0.0 110.82 -179.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.663 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 18.0 mt -80.0 172.06 10.81 Favored Pre-proline 0 C--N 1.301 -1.506 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 177.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.663 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 28.3 Cg_endo -68.32 100.84 0.68 Allowed 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 120.872 1.048 . . . . 0.0 109.723 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.454 ' O ' ' SG ' ' A' ' 29' ' ' CYS . . . 92.27 15.44 53.56 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 -179.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.493 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 3.4 m -148.52 90.57 4.88 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 120.802 -1.411 . . . . 0.0 108.856 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.413 ' O ' ' C ' ' A' ' 87' ' ' ARG . 30.4 Cg_endo -74.77 160.48 40.77 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.367 1.378 . . . . 0.0 111.649 -178.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.438 ' HG3' ' OD1' ' A' ' 81' ' ' ASP . 53.4 mtp180 -44.7 -29.41 0.76 Allowed 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 122.152 0.977 . . . . 0.0 108.396 178.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -54.03 -52.39 60.99 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.58 -178.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 58.8 t -65.05 -41.61 92.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 O-C-N 120.94 -1.1 . . . . 0.0 110.207 -178.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.455 ' O ' ' HB1' ' A' ' 94' ' ' ALA . 3.6 mp0 -62.43 -27.4 69.08 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.262 -0.899 . . . . 0.0 108.705 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.464 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 0.0 OUTLIER -78.61 -33.06 47.74 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.444 -0.785 . . . . 0.0 109.957 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.502 ' O ' ' HD2' ' A' ' 95' ' ' PRO . . . -71.44 -45.6 62.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.933 -1.104 . . . . 0.0 109.499 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.574 ' O ' ' CD1' ' A' ' 93' ' ' PHE . 10.0 t80 -77.92 -25.71 48.53 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.383 -0.823 . . . . 0.0 110.102 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.564 ' N ' ' HD2' ' A' ' 95' ' ' PRO . . . -43.55 -50.89 16.63 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.395 -0.816 . . . . 0.0 112.094 -178.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 94' ' ' ALA . 32.9 Cg_endo -73.66 24.0 0.33 Allowed 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.64 2.227 . . . . 0.0 112.951 -178.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.411 ' O ' ' HG3' ' A' ' 102' ' ' GLU . 0.4 OUTLIER -126.8 28.69 5.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.688 -1.258 . . . . 0.0 108.898 178.612 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.521 HD23 ' CD2' ' A' ' 17' ' ' LEU . 0.6 OUTLIER -80.12 -77.77 0.18 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.403 -0.811 . . . . 0.0 110.403 -179.476 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.481 ' C ' ' HA ' ' A' ' 104' ' ' ASN . 2.5 m -79.81 27.89 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.906 -1.121 . . . . 0.0 110.873 -179.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.477 ' C ' ' HB2' ' A' ' 104' ' ' ASN . 5.1 p -101.27 170.98 7.88 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.909 -1.119 . . . . 0.0 108.196 179.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -60.39 1.33 0.13 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.571 -1.331 . . . . 0.0 112.179 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.7 t -101.02 1.69 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 119.822 -1.799 . . . . 0.0 110.972 -179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 97' ' ' LEU . 0.3 OUTLIER -140.17 -94.29 0.16 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.513 -1.367 . . . . 0.0 110.655 -179.714 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.468 ' O ' ' C ' ' A' ' 104' ' ' ASN . 72.8 m -131.99 38.68 3.5 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.928 -1.108 . . . . 0.0 109.004 -179.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.534 ' ND2' ' HB3' ' A' ' 112' ' ' PRO . 42.0 t-20 -29.52 -66.02 0.09 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.811 -0.556 . . . . 0.0 112.091 -179.107 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.474 ' O ' ' O ' ' A' ' 106' ' ' ALA . 11.3 mt 41.7 33.98 0.37 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.064 -1.023 . . . . 0.0 109.748 -179.2 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.474 ' O ' ' O ' ' A' ' 105' ' ' LEU . . . 55.23 165.6 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.032 -1.043 . . . . 0.0 108.993 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.73 ' OG1' ' CE1' ' A' ' 109' ' ' HIS . 1.7 p -133.79 -146.08 0.26 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.0 -1.063 . . . . 0.0 108.722 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.476 ' N ' ' OG1' ' A' ' 107' ' ' THR . 1.3 tt -69.05 -38.68 78.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.31 -0.869 . . . . 0.0 110.008 179.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.73 ' CE1' ' OG1' ' A' ' 107' ' ' THR . 0.6 OUTLIER -84.46 24.0 1.05 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.179 -0.951 . . . . 0.0 110.035 -179.75 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 109' ' ' HIS . . . 42.73 54.78 4.89 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -179.66 159.55 24.15 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.534 ' HB3' ' ND2' ' A' ' 104' ' ' ASN . 31.7 Cg_endo -77.04 79.58 3.09 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.722 2.281 . . . . 0.0 109.859 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.608 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER 173.01 96.8 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.383 0 C-N-CA 118.826 -1.15 . . . . 0.0 113.073 -179.765 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.612 ' HB3' ' NE2' ' A' ' 109' ' ' HIS . 17.3 p -124.47 173.81 8.2 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.284 -1.51 . . . . 0.0 109.561 177.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.569 ' CB ' ' O ' ' A' ' 114' ' ' CYS . 0.0 OUTLIER 84.95 -46.35 0.08 Allowed 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -179.157 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 20.0 m -72.77 -31.1 64.65 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.262 -0.899 . . . . 0.0 108.937 179.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.55 HD11 ' CD2' ' A' ' 109' ' ' HIS . 5.5 mp -59.74 -15.79 22.59 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.23 -0.919 . . . . 0.0 109.441 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.518 ' HB2' ' O ' ' A' ' 117' ' ' LEU . 20.3 mt 69.52 -15.4 0.3 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.604 -0.685 . . . . 0.0 112.466 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.26 -148.48 35.96 Favored Glycine 0 N--CA 1.491 2.327 0 O-C-N 120.342 -1.474 . . . . 0.0 109.706 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -105.08 71.4 0.95 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.335 -1.097 . . . . 0.0 109.608 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.2 -11.86 59.67 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.281 -1.129 . . . . 0.0 109.452 -179.909 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.446 ' O ' ' C ' ' A' ' 2' ' ' VAL . 76.6 p . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.446 ' C ' ' O ' ' A' ' 1' ' ' SER . 6.1 m -39.48 -45.58 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.571 -0.706 . . . . 0.0 110.144 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.536 ' O ' ' CG2' ' A' ' 4' ' ' THR . . . 146.19 -88.65 0.16 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.536 ' CG2' ' O ' ' A' ' 3' ' ' GLY . 8.5 t 40.73 29.42 0.07 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.545 -0.973 . . . . 0.0 109.826 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 3' ' ' GLY . 0.4 OUTLIER 49.66 -176.03 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.336 -0.853 . . . . 0.0 109.684 179.9 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.4 m 59.17 99.62 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.246 -0.909 . . . . 0.0 109.715 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.558 ' CG1' ' HD2' ' A' ' 8' ' ' PRO . 3.4 tt -138.88 143.41 37.25 Favored Pre-proline 0 N--CA 1.491 1.576 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.558 ' HD2' ' CG1' ' A' ' 7' ' ' ILE . 34.7 Cg_endo -77.0 140.88 20.56 Favored 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 121.739 1.626 . . . . 0.0 110.999 -179.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.55 -14.78 33.69 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.588 ' O ' ' CB ' ' A' ' 11' ' ' ALA . 0.7 OUTLIER -134.87 116.68 15.04 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.18 -1.188 . . . . 0.0 108.108 179.499 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.588 ' CB ' ' O ' ' A' ' 10' ' ' MET . . . 85.61 -59.05 0.07 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.796 -1.19 . . . . 0.0 107.811 -178.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.409 HD11 HG12 ' A' ' 51' ' ' ILE . 9.9 mm -107.2 101.36 38.01 Favored Pre-proline 0 C--N 1.303 -1.434 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 178.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -81.36 175.45 9.64 Favored 'Trans proline' 0 C--N 1.318 -1.064 0 C-N-CA 121.459 1.439 . . . . 0.0 111.955 -176.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 52.8 m-70 -76.76 147.84 37.06 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.673 -0.642 . . . . 0.0 109.553 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.567 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 0.1 OUTLIER 58.22 58.03 6.54 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 120.796 -1.19 . . . . 0.0 109.93 -179.758 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.567 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 37.1 Cg_endo -79.66 168.62 19.34 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.55 2.167 . . . . 0.0 111.03 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.533 ' N ' ' CD2' ' A' ' 17' ' ' LEU . 3.3 mm? 52.33 44.38 29.87 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.551 -0.718 . . . . 0.0 111.041 178.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.464 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 3.9 p30 -83.61 -47.29 11.43 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.867 -1.146 . . . . 0.0 109.412 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.59 -25.99 67.68 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.517 ' SG ' ' CD1' ' A' ' 17' ' ' LEU . 72.4 m -71.08 -50.02 38.24 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.624 -0.672 . . . . 0.0 109.62 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.561 ' CG ' ' N ' ' A' ' 22' ' ' TRP . 4.2 ptt180 -59.03 -52.09 67.24 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.132 -0.98 . . . . 0.0 109.632 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.561 ' N ' ' CG ' ' A' ' 21' ' ' ARG . 22.9 m95 -61.15 -34.32 74.83 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 118.584 -1.246 . . . . 0.0 108.943 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.547 ' HB2' ' CG ' ' A' ' 40' ' ' MET . 7.2 t80 -60.32 -30.45 69.52 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.471 ' CG1' HG22 ' A' ' 28' ' ' THR . 48.0 t -72.67 -41.88 62.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 C-N-CA 118.816 -1.154 . . . . 0.0 107.94 178.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.409 ' OG ' ' O ' ' A' ' 22' ' ' TRP . 64.8 p -55.67 -42.99 75.91 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.247 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 5.4 m -78.13 -52.98 7.9 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.158 -0.964 . . . . 0.0 111.708 -178.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.453 ' HG2' ' CE1' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -60.51 -25.76 66.35 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.703 -1.248 . . . . 0.0 110.792 -178.383 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.471 HG22 ' CG1' ' A' ' 24' ' ' VAL . 21.9 p -96.83 -60.84 1.51 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.019 -1.051 . . . . 0.0 111.095 -178.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.475 ' SG ' ' O ' ' A' ' 84' ' ' GLY . 3.5 m -99.39 15.78 25.23 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.875 -1.141 . . . . 0.0 110.13 -179.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.482 ' HA2' ' O ' ' A' ' 26' ' ' THR . . . 52.44 21.02 8.02 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 -179.001 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.496 ' CG1' ' N ' ' A' ' 32' ' ' GLY . 41.7 t -109.51 165.37 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.276 -1.132 . . . . 0.0 109.62 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.496 ' N ' ' CG1' ' A' ' 31' ' ' VAL . . . 130.3 178.32 15.36 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 108.58 -1.808 . . . . 0.0 108.58 -179.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -65.44 176.2 3.58 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 CA-C-N 119.188 1.494 . . . . 0.0 109.825 179.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 24.1 mtt180 -91.11 79.07 5.81 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.707 -1.246 . . . . 0.0 110.369 -177.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.465 ' O ' ' C ' ' A' ' 36' ' ' ALA . 52.1 mt -127.35 114.93 18.22 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 178.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.465 ' C ' ' O ' ' A' ' 35' ' ' LEU . . . -41.05 160.32 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.342 -0.849 . . . . 0.0 109.462 -179.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -68.38 -59.94 2.81 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.074 -1.017 . . . . 0.0 110.377 -179.107 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -48.48 -31.55 6.54 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.074 -1.016 . . . . 0.0 110.086 -179.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -68.7 -47.01 67.51 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.192 -0.942 . . . . 0.0 108.767 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.547 ' CG ' ' HB2' ' A' ' 23' ' ' TYR . 17.6 tpp -60.04 -60.54 3.66 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.1 tppt? -47.79 -35.4 10.0 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.561 -0.712 . . . . 0.0 109.152 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.16 -43.07 92.97 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.34 -0.85 . . . . 0.0 109.383 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -63.11 -43.79 97.45 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.328 -0.857 . . . . 0.0 109.905 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.426 ' SG ' ' N ' ' A' ' 20' ' ' CYS . 19.0 m -64.57 -36.39 84.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.08 -1.012 . . . . 0.0 110.063 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 63.9 m -70.21 -29.82 66.75 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.95 -1.094 . . . . 0.0 108.976 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.437 ' NH1' ' HB2' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -73.43 -32.4 64.38 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.077 -1.014 . . . . 0.0 108.296 179.459 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -77.34 -30.99 54.18 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.368 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.518 ' CD1' HG13 ' A' ' 98' ' ' VAL . 8.4 tt -74.11 -38.08 63.93 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.221 -0.924 . . . . 0.0 109.089 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.447 ' O ' ' C ' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -71.17 -53.59 13.95 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.256 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.483 ' O ' ' HD3' ' A' ' 52' ' ' PRO . . . -46.54 -46.39 19.28 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 178.107 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.409 HG12 HD11 ' A' ' 12' ' ' ILE . 73.8 mt -67.61 106.97 1.44 Allowed Pre-proline 0 C--N 1.304 -1.387 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 176.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.529 ' O ' ' N ' ' A' ' 54' ' ' TYR . 24.5 Cg_endo -60.61 138.94 83.21 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 121.581 1.521 . . . . 0.0 111.097 -176.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.569 ' HA ' ' CG ' ' A' ' 56' ' ' ARG . . . -32.54 -33.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.198 0.523 . . . . 0.0 110.669 -178.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.529 ' N ' ' O ' ' A' ' 52' ' ' PRO . 2.0 m-85 -66.82 122.68 18.22 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.298 -0.876 . . . . 0.0 109.481 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.498 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 34.1 m 73.43 13.47 4.56 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.588 -0.695 . . . . 0.0 111.126 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.569 ' CG ' ' HA ' ' A' ' 53' ' ' ALA . 9.0 mmt85 -41.41 -87.28 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.606 -1.309 . . . . 0.0 109.362 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.521 ' C ' ' O ' ' A' ' 56' ' ' ARG . 6.5 m -24.9 -49.51 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.447 0 O-C-N 121.786 -0.571 . . . . 0.0 112.161 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.509 ' C ' ' O ' ' A' ' 57' ' ' CYS . 12.8 tt0 -25.73 -49.9 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.365 -0.834 . . . . 0.0 111.775 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.516 ' HB3' ' CD2' ' A' ' 17' ' ' LEU . . . -40.9 -60.41 1.19 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.135 -0.978 . . . . 0.0 110.013 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.581 ' CG2' ' CD1' ' A' ' 97' ' ' LEU . 39.8 t -52.31 -39.77 29.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 O-C-N 121.395 -0.816 . . . . 0.0 109.403 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.498 ' O ' ' HB2' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -62.01 -33.11 73.74 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.416 -0.803 . . . . 0.0 110.116 -179.677 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.55 ' CG2' ' HB ' ' A' ' 67' ' ' VAL . 48.5 mt -77.38 -28.47 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.926 -1.109 . . . . 0.0 110.09 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.405 HD22 HD21 ' A' ' 79' ' ' LEU . 2.3 tt -77.01 -46.72 22.83 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.779 -1.2 . . . . 0.0 109.61 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 10.2 tpt -77.19 -50.42 12.99 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.082 -1.011 . . . . 0.0 109.914 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.498 ' HB2' ' O ' ' A' ' 61' ' ' ARG . 19.9 m-20 -80.21 -21.47 42.89 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.97 -1.081 . . . . 0.0 110.076 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . 85.29 151.69 15.97 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.55 ' HB ' ' CG2' ' A' ' 62' ' ' ILE . 1.6 p -117.09 157.82 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.368 -1.077 . . . . 0.0 109.276 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.508 HG23 ' NE2' ' A' ' 74' ' ' HIS . 14.7 t -116.27 158.32 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.32 -0.863 . . . . 0.0 110.075 -178.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.467 ' N ' ' CG1' ' A' ' 68' ' ' VAL . 29.7 p -117.17 158.71 23.8 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.046 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.6 t -64.38 -32.98 74.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.515 -0.74 . . . . 0.0 109.791 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.2 p -64.75 -14.25 58.08 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.574 -0.704 . . . . 0.0 109.362 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 99.67 8.07 52.54 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -91.25 156.21 17.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.964 -1.315 . . . . 0.0 109.836 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.508 ' NE2' HG23 ' A' ' 68' ' ' VAL . 11.0 m170 -116.4 156.19 27.2 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.002 -1.061 . . . . 0.0 108.616 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 74' ' ' HIS . 5.2 mt-10 -142.83 -179.04 6.1 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.213 -0.93 . . . . 0.0 110.237 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 51.85 -143.11 19.87 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.419 ' HD2' ' O ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER 56.7 15.9 2.39 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.491 -1.005 . . . . 0.0 110.242 179.544 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 80' ' ' GLN . 2.4 mp -84.9 -11.04 56.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.956 -1.09 . . . . 0.0 110.244 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.469 HD22 ' HG2' ' A' ' 90' ' ' GLN . 1.1 tm? -43.03 96.22 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.008 -1.058 . . . . 0.0 109.046 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.518 ' N ' ' O ' ' A' ' 78' ' ' LEU . 83.7 mt-30 -143.53 179.39 7.15 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.198 -0.939 . . . . 0.0 110.501 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.84 112.05 4.06 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.818 0.818 . . . . 0.0 111.633 -178.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.656 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 23.2 mt -91.76 172.14 6.9 Favored Pre-proline 0 N--CA 1.488 1.463 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 177.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.656 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 28.4 Cg_endo -67.45 100.58 0.57 Allowed 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 121.1 1.2 . . . . 0.0 110.907 -179.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.475 ' O ' ' SG ' ' A' ' 29' ' ' CYS . . . 90.86 12.68 60.23 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.463 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 3.3 m -142.98 91.9 7.03 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 120.916 -1.343 . . . . 0.0 109.255 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.406 ' O ' ' C ' ' A' ' 87' ' ' ARG . 29.2 Cg_endo -73.39 159.53 46.47 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 121.272 1.315 . . . . 0.0 111.451 -179.016 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.406 ' C ' ' O ' ' A' ' 86' ' ' PRO . 6.3 mtm-85 -44.91 -27.87 0.59 Allowed 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 121.903 0.859 . . . . 0.0 108.889 178.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.95 -46.47 82.09 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.906 -0.496 . . . . 0.0 112.058 -177.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 40.5 t -69.99 -41.66 79.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 120.689 -1.257 . . . . 0.0 110.929 -178.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.469 ' HG2' HD22 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -64.64 -30.11 71.13 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.048 -1.032 . . . . 0.0 108.807 -179.909 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.457 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 0.0 OUTLIER -78.17 -27.81 48.12 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.504 179.609 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.504 ' O ' ' HD2' ' A' ' 95' ' ' PRO . . . -73.17 -51.2 18.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.103 -0.998 . . . . 0.0 109.68 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.443 ' C ' ' HD2' ' A' ' 95' ' ' PRO . 40.9 t80 -77.78 -26.53 49.8 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.19 -0.944 . . . . 0.0 110.022 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.568 ' N ' ' HD2' ' A' ' 95' ' ' PRO . . . -42.28 -51.96 10.38 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.383 -0.823 . . . . 0.0 111.593 -178.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 94' ' ' ALA . 31.2 Cg_endo -72.06 80.63 1.52 Allowed 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.203 1.935 . . . . 0.0 111.628 -178.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.446 ' O ' ' HG3' ' A' ' 102' ' ' GLU . 0.0 OUTLIER 176.44 56.51 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.628 -0.67 . . . . 0.0 109.22 179.234 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.581 ' CD1' ' CG2' ' A' ' 60' ' ' VAL . 0.1 OUTLIER -96.27 -82.17 0.4 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.212 -0.93 . . . . 0.0 111.271 -179.075 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.518 HG13 ' CD1' ' A' ' 48' ' ' LEU . 3.6 m -81.91 28.77 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.735 -1.228 . . . . 0.0 111.197 -178.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.449 ' C ' ' HB3' ' A' ' 104' ' ' ASN . 5.3 p -97.53 170.88 8.73 Favored 'General case' 0 C--N 1.294 -1.834 0 O-C-N 120.644 -1.285 . . . . 0.0 108.449 179.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.79 -2.05 0.2 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.679 -1.263 . . . . 0.0 111.892 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.437 ' O ' ' CG1' ' A' ' 101' ' ' VAL . 57.4 t -100.86 6.4 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 119.844 -1.785 . . . . 0.0 110.73 -179.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.446 ' HG3' ' O ' ' A' ' 96' ' ' LYS . 0.3 OUTLIER -141.52 -91.17 0.14 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.684 -1.26 . . . . 0.0 110.386 -179.899 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.455 ' O ' ' C ' ' A' ' 104' ' ' ASN . 3.6 m -142.89 38.58 1.46 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.951 -1.093 . . . . 0.0 108.861 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.499 ' HA ' ' O ' ' A' ' 98' ' ' VAL . 8.3 p30 -34.87 -51.86 0.52 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.21 -0.931 . . . . 0.0 112.158 -178.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.455 HD11 ' O ' ' A' ' 103' ' ' CYS . 0.6 OUTLIER 40.55 26.94 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.953 -1.092 . . . . 0.0 109.825 -179.396 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' A' ' 104' ' ' ASN . . . 62.25 153.85 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.778 -1.202 . . . . 0.0 108.693 -178.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.4 p -128.56 -178.48 4.6 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.099 -1.001 . . . . 0.0 108.629 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.1 tp -64.17 -33.1 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.921 -1.112 . . . . 0.0 108.83 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.456 ' CE1' HD11 ' A' ' 117' ' ' LEU . 84.9 m-70 -62.68 -2.31 1.09 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.771 -0.581 . . . . 0.0 111.084 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 63.31 31.73 81.72 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -162.79 172.51 38.85 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.941 -1.263 . . . . 0.0 109.941 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.524 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 30.2 Cg_endo -76.87 69.46 6.91 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 123.049 2.499 . . . . 0.0 111.6 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.524 ' HB3' ' O ' ' A' ' 112' ' ' PRO . 34.9 p90 173.0 159.96 0.12 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.397 -0.814 . . . . 0.0 110.481 178.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.51 ' O ' ' HB2' ' A' ' 115' ' ' LEU . 1.8 p -144.69 160.46 41.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.396 -0.815 . . . . 0.0 108.859 179.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.51 ' HB2' ' O ' ' A' ' 114' ' ' CYS . 5.5 tp 173.56 -69.73 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.131 -0.981 . . . . 0.0 109.296 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -170.91 -79.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.368 -0.833 . . . . 0.0 109.173 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.502 ' O ' ' HB2' ' A' ' 118' ' ' LEU . 5.3 mp 49.81 20.37 0.54 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.311 -0.868 . . . . 0.0 109.889 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.502 ' HB2' ' O ' ' A' ' 117' ' ' LEU . 10.4 mp 66.51 -11.77 0.22 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.251 -0.906 . . . . 0.0 112.846 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.432 ' O ' ' C ' ' A' ' 120' ' ' ALA . . . 78.12 35.84 33.22 Favored Glycine 0 N--CA 1.489 2.231 0 O-C-N 120.253 -1.529 . . . . 0.0 109.682 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 119' ' ' GLY . . . 43.22 73.01 0.15 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -1.138 . . . . 0.0 109.609 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.455 ' O ' ' CB ' ' A' ' 122' ' ' GLU . . . -63.2 -18.74 60.89 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.455 ' CB ' ' O ' ' A' ' 121' ' ' GLY . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 O-C-N 121.242 -1.152 . . . . 0.0 109.453 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 8.3 p . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.55 -88.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -109.67 89.11 0.54 Allowed Glycine 0 N--CA 1.497 2.753 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.3 t -177.47 69.39 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.494 0.664 . . . . 0.0 109.392 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.5 t -126.65 163.9 22.45 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.699 -0.625 . . . . 0.0 109.364 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 3.9 m 52.38 -168.97 0.04 OUTLIER 'General case' 0 N--CA 1.505 2.296 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.454 HD11 HG22 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -142.48 126.91 9.94 Favored Pre-proline 0 N--CA 1.499 2.006 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.928 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -76.27 156.42 37.39 Favored 'Trans proline' 0 N--CA 1.485 0.979 0 C-N-CA 121.859 1.706 . . . . 0.0 111.203 -178.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 83.33 -5.69 76.02 Favored Glycine 0 N--CA 1.5 2.913 0 N-CA-C 110.696 -0.961 . . . . 0.0 110.696 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.449 ' O ' ' CB ' ' A' ' 11' ' ' ALA . 1.6 mtp -136.81 112.24 9.25 Favored 'General case' 0 N--CA 1.501 2.121 0 CA-C-N 118.287 1.043 . . . . 0.0 108.292 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.449 ' CB ' ' O ' ' A' ' 10' ' ' MET . . . 86.39 -57.22 0.06 Allowed 'General case' 0 N--CA 1.514 2.752 0 CA-C-N 119.834 1.197 . . . . 0.0 108.171 -178.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 36.0 mt -106.86 100.36 31.12 Favored Pre-proline 0 N--CA 1.492 1.672 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 178.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -82.11 172.74 11.55 Favored 'Trans proline' 0 C--O 1.22 -0.388 0 C-N-CA 121.397 1.398 . . . . 0.0 111.593 -177.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 45.2 m-70 -72.44 145.19 47.79 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.402 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 4.4 t-20 65.04 64.14 1.07 Allowed Pre-proline 0 N--CA 1.505 2.285 0 O-C-N 121.521 -0.737 . . . . 0.0 109.506 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.402 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 38.2 Cg_endo -82.1 151.95 16.21 Favored 'Trans proline' 0 N--CA 1.482 0.845 0 C-N-CA 122.344 2.029 . . . . 0.0 112.047 -179.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.9 mp 46.88 35.0 2.92 Favored 'General case' 0 N--CA 1.502 2.166 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.177 177.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -66.52 -32.55 73.97 Favored 'General case' 0 N--CA 1.505 2.296 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.0 -32.32 73.98 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 33.8 m -71.25 -33.83 70.19 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.419 ' CG ' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -60.98 -54.89 39.35 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.11 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.453 ' HA ' ' CE3' ' A' ' 22' ' ' TRP . 30.6 m95 -67.26 -27.0 66.84 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.55 -179.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -68.4 -29.68 68.42 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.444 HG23 ' CD1' ' A' ' 93' ' ' PHE . 80.7 t -73.29 -42.61 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 177.018 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -53.24 -40.64 64.71 Favored 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 120.594 -0.442 . . . . 0.0 109.968 -179.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 31.1 m -77.19 -52.79 8.65 Favored 'General case' 0 N--CA 1.508 2.472 0 O-C-N 122.204 -0.31 . . . . 0.0 111.669 -178.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -59.96 -25.06 64.9 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.859 -0.526 . . . . 0.0 110.678 -178.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 59.7 p -97.74 -65.83 0.94 Allowed 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -177.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 57.4 m -100.88 16.04 26.5 Favored 'General case' 0 N--CA 1.51 2.546 0 O-C-N 121.298 -0.876 . . . . 0.0 111.924 -178.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 56.83 20.87 34.63 Favored Glycine 0 N--CA 1.505 3.263 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.9 t -106.94 160.63 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 O-C-N 121.759 -0.847 . . . . 0.0 109.01 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 134.68 177.89 15.27 Favored Glycine 0 N--CA 1.499 2.851 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -66.46 172.74 8.68 Favored 'Trans proline' 0 N--CA 1.486 1.082 0 CA-C-N 119.098 1.449 . . . . 0.0 109.938 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 8.8 ttt-85 -93.27 86.33 5.29 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 122.027 0.918 . . . . 0.0 110.363 -178.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 76.4 mt -139.65 130.93 26.7 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.01 145.94 6.79 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.868 -0.52 . . . . 0.0 109.928 -178.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -56.93 -57.87 10.62 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.705 -0.622 . . . . 0.0 111.217 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -49.2 -36.98 21.24 Favored 'General case' 0 N--CA 1.509 2.506 0 O-C-N 121.676 -0.64 . . . . 0.0 111.246 -178.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -70.38 -38.22 74.67 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 122.042 -0.411 . . . . 0.0 110.087 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.61 -54.69 28.04 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 -179.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -52.71 -36.05 56.68 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.24 -43.78 97.07 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.61 -48.45 81.71 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 14.6 m -61.25 -34.0 74.43 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 122.04 -0.412 . . . . 0.0 111.338 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 17.9 m -73.8 -28.69 61.76 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 7.8 tpt85 -75.11 -34.31 61.7 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -79.08 -36.96 40.0 Favored 'General case' 0 N--CA 1.5 2.055 0 CA-C-O 121.184 0.516 . . . . 0.0 110.207 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.427 ' HG ' ' HD2' ' A' ' 56' ' ' ARG . 3.5 tt -70.32 -38.58 74.96 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.207 -178.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -77.72 -42.72 33.36 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.99 -37.43 63.99 Favored 'General case' 0 N--CA 1.507 2.397 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 178.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.409 ' O ' ' HD3' ' A' ' 56' ' ' ARG . 51.1 mt -86.46 105.65 8.27 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 177.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -62.87 141.59 85.2 Favored 'Trans proline' 0 N--CA 1.481 0.753 0 C-N-CA 121.517 1.478 . . . . 0.0 110.856 -177.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -43.27 -29.83 0.44 Allowed 'General case' 0 N--CA 1.503 2.189 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.286 -178.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.07 110.01 5.49 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 25.1 m 86.39 -15.36 0.47 Allowed 'General case' 0 N--CA 1.513 2.706 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -177.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.427 ' HD2' ' HG ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -45.75 -81.94 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.357 0 O-C-N 121.737 -0.602 . . . . 0.0 110.865 -179.855 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 94.0 m -24.5 -42.88 0.01 OUTLIER 'General case' 0 N--CA 1.519 3.001 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -179.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -41.5 -57.08 2.34 Favored 'General case' 0 N--CA 1.511 2.588 0 CA-C-N 119.055 0.843 . . . . 0.0 111.429 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -39.43 -44.63 1.39 Allowed 'General case' 0 N--CA 1.514 2.748 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 38.7 t -58.92 -50.21 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.347 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.67 -25.05 66.07 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.477 ' CG2' ' HB ' ' A' ' 67' ' ' VAL . 43.1 mm -77.88 -29.13 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.906 -0.496 . . . . 0.0 109.938 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.1 tt -78.35 -41.12 34.36 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.449 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -78.08 -53.33 7.51 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.207 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -80.49 -23.56 40.06 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 122.065 -0.397 . . . . 0.0 111.591 -178.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.62 145.93 6.69 Favored Glycine 0 N--CA 1.503 3.15 0 N-CA-C 109.964 -1.255 . . . . 0.0 109.964 -179.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.477 ' HB ' ' CG2' ' A' ' 62' ' ' ILE . 7.2 p -118.7 159.5 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.492 0 O-C-N 122.151 -0.617 . . . . 0.0 110.209 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.435 ' CG2' ' CE1' ' A' ' 74' ' ' HIS . 65.7 t -115.49 157.35 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 32.0 p -117.77 159.63 22.71 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.359 -178.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.6 t -63.02 -33.91 76.43 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.076 -178.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.5 p -63.38 -18.78 64.05 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.988 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.45 13.91 34.16 Favored Glycine 0 N--CA 1.497 2.713 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -103.35 157.23 17.17 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 118.226 1.013 . . . . 0.0 109.225 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.435 ' CE1' ' CG2' ' A' ' 68' ' ' VAL . 8.9 m170 -115.01 155.36 27.11 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -179.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -140.32 -179.35 5.95 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 120.849 0.357 . . . . 0.0 110.122 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 51.54 -149.32 8.34 Favored Glycine 0 N--CA 1.497 2.752 0 N-CA-C 109.101 -1.6 . . . . 0.0 109.101 -179.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.8 ttp85 59.17 17.6 5.78 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 122.298 -0.531 . . . . 0.0 110.616 179.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 59.8 mt -78.34 -17.45 56.51 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.719 -0.613 . . . . 0.0 109.84 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -51.93 98.56 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -140.1 172.56 12.58 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.106 0.479 . . . . 0.0 110.01 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -64.26 102.36 0.51 Allowed 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.672 0.749 . . . . 0.0 111.088 -179.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.597 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 23.7 mt -81.58 172.98 8.39 Favored Pre-proline 0 N--CA 1.495 1.799 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 177.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.597 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 26.3 Cg_endo -65.3 99.97 0.37 Allowed 'Trans proline' 0 N--CA 1.477 0.534 0 C-N-CA 120.971 1.114 . . . . 0.0 111.034 -179.107 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.68 -7.86 80.67 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 7.2 m -117.12 92.08 38.44 Favored Pre-proline 0 N--CA 1.502 2.142 0 CA-C-N 119.279 1.539 . . . . 0.0 110.3 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -71.39 164.05 37.03 Favored 'Trans proline' 0 N--CA 1.481 0.754 0 C-N-CA 121.36 1.373 . . . . 0.0 111.205 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.5 mmm-85 -48.24 -29.22 3.59 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.212 0.53 . . . . 0.0 109.571 178.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -55.69 -48.74 74.57 Favored 'General case' 0 N--CA 1.505 2.284 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.377 -178.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 80.2 t -62.55 -37.27 78.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 42.0 mm-40 -64.35 -30.11 71.16 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.95 -27.97 49.41 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -74.91 -46.73 33.95 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.967 -0.458 . . . . 0.0 109.874 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.444 ' CD1' HG23 ' A' ' 24' ' ' VAL . 29.3 t80 -78.17 -25.13 47.06 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 122.207 -0.308 . . . . 0.0 110.579 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.444 ' N ' ' HD2' ' A' ' 95' ' ' PRO . . . -50.89 -52.87 53.46 Favored Pre-proline 0 N--CA 1.499 2.006 0 CA-C-O 118.842 -0.599 . . . . 0.0 111.938 -177.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 94' ' ' ALA . 30.4 Cg_endo -71.19 -16.59 31.68 Favored 'Trans proline' 0 N--CA 1.484 0.966 0 C-N-CA 122.062 1.841 . . . . 0.0 111.159 -179.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.8 mmpt? -86.99 11.4 13.69 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.934 -0.479 . . . . 0.0 110.193 178.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.455 ' O ' ' HB3' ' A' ' 102' ' ' GLU . 0.2 OUTLIER -72.43 -60.47 2.22 Favored 'General case' 0 N--CA 1.508 2.447 0 O-C-N 121.668 -0.645 . . . . 0.0 111.33 -178.913 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 104' ' ' ASN . 13.2 m -89.38 25.34 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 120.819 -1.176 . . . . 0.0 110.517 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 29.7 p -99.35 173.14 6.91 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.52 -0.54 0.27 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.534 -0.729 . . . . 0.0 112.07 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.8 t -93.82 -0.52 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-N 120.537 1.517 . . . . 0.0 111.028 -179.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.455 ' HB3' ' O ' ' A' ' 97' ' ' LEU . 8.3 tt0 -146.95 -90.79 0.09 Allowed 'General case' 0 N--CA 1.505 2.277 0 C-N-CA 119.499 -0.88 . . . . 0.0 112.11 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 83.8 m -137.0 45.57 2.24 Favored 'General case' 0 N--CA 1.511 2.609 0 CA-C-N 119.13 0.877 . . . . 0.0 110.609 -177.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.4 ' HA ' ' O ' ' A' ' 98' ' ' VAL . 60.0 t-20 -43.6 -72.68 0.06 Allowed 'General case' 0 N--CA 1.508 2.469 0 O-C-N 120.924 -1.11 . . . . 0.0 112.96 -179.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.6 mp 51.25 34.48 11.54 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.966 -0.459 . . . . 0.0 110.628 -178.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 63.55 148.22 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.27 -0.894 . . . . 0.0 109.73 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.8 p -121.16 -164.41 1.12 Allowed 'General case' 0 N--CA 1.505 2.316 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -179.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.0 tt -68.26 -30.72 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.439 ' HB3' ' CE1' ' A' ' 113' ' ' PHE . 95.5 m-70 -71.48 0.66 7.87 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.644 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 60.9 36.54 92.27 Favored Glycine 0 N--CA 1.497 2.74 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -169.8 173.94 43.99 Favored Glycine 0 N--CA 1.498 2.823 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -77.88 78.53 3.53 Favored 'Trans proline' 0 N--CA 1.481 0.747 0 C-N-CA 122.65 2.234 . . . . 0.0 110.487 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.444 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER 174.53 165.29 0.24 Allowed 'General case' 0 N--CA 1.504 2.27 0 CA-C-O 121.34 0.59 . . . . 0.0 111.399 179.353 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 3.0 t 176.03 165.55 0.4 Allowed 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 75.61 -78.36 0.04 OUTLIER 'General case' 0 N--CA 1.507 2.417 0 O-C-N 122.073 -0.392 . . . . 0.0 110.362 179.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.6 p -54.2 -89.44 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.716 -0.615 . . . . 0.0 109.764 -179.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.432 ' HG ' ' CE1' ' A' ' 109' ' ' HIS . 1.9 mm? 51.61 -88.57 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.298 0 CA-C-N 118.304 0.502 . . . . 0.0 110.585 179.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 11.1 mp -51.84 -17.92 1.12 Allowed 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.576 -0.703 . . . . 0.0 112.654 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -109.76 153.89 16.76 Favored Glycine 0 N--CA 1.498 2.774 0 N-CA-C 109.249 -1.541 . . . . 0.0 109.249 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 56.36 68.19 0.89 Allowed 'General case' 0 N--CA 1.501 2.092 0 CA-C-O 121.769 0.795 . . . . 0.0 109.819 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -62.08 -22.13 62.36 Favored Glycine 0 N--CA 1.497 2.709 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 . . . . . 0 N--CA 1.497 1.903 0 CA-C-O 118.022 -0.99 . . . . 0.0 109.55 -179.916 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.41 ' O ' ' CB ' ' A' ' 2' ' ' VAL . 1.1 m . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.41 ' CB ' ' O ' ' A' ' 1' ' ' SER . 5.0 t 85.07 -35.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.765 0 C-N-CA 122.892 0.477 . . . . 0.0 110.948 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 97.96 152.63 28.34 Favored Glycine 0 N--CA 1.497 2.732 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.0 t -117.49 24.84 10.84 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 122.195 -0.591 . . . . 0.0 109.997 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.86 -169.03 1.55 Allowed 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 84.3 m -133.93 164.85 26.35 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 50.7 mt -141.83 115.4 6.68 Favored Pre-proline 0 N--CA 1.5 2.049 0 CA-C-O 118.698 -0.668 . . . . 0.0 109.362 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -78.31 147.43 23.04 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 121.78 1.653 . . . . 0.0 110.734 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 69.78 6.11 54.34 Favored Glycine 0 N--CA 1.502 3.066 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.456 ' O ' ' CB ' ' A' ' 11' ' ' ALA . 0.1 OUTLIER -140.52 107.21 5.35 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.788 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 10' ' ' MET . . . 87.04 -58.69 0.04 OUTLIER 'General case' 0 N--CA 1.516 2.829 0 CA-C-N 119.865 1.211 . . . . 0.0 108.399 -178.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 41.1 mt -103.57 101.38 23.48 Favored Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 178.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -81.82 172.45 12.14 Favored 'Trans proline' 0 N--CA 1.477 0.549 0 C-N-CA 121.701 1.601 . . . . 0.0 111.97 -176.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 30.6 m-70 -74.68 145.4 43.2 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 68.14 64.48 0.63 Allowed Pre-proline 0 N--CA 1.508 2.45 0 O-C-N 121.404 -0.81 . . . . 0.0 110.593 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -84.34 171.42 10.06 Favored 'Trans proline' 0 N--CA 1.484 0.959 0 C-N-CA 122.51 2.14 . . . . 0.0 111.908 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 66.1 mt 43.43 46.29 5.64 Favored 'General case' 0 N--CA 1.503 2.223 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.435 177.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -73.47 -41.1 63.59 Favored 'General case' 0 N--CA 1.505 2.28 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.2 t -63.42 -25.74 68.42 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 32.5 m -77.73 -35.38 51.98 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 110.251 -0.278 . . . . 0.0 110.251 -179.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 11.2 ttp180 -69.92 -42.96 72.63 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 31.1 m95 -73.38 -30.97 63.64 Favored 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 118.762 -1.175 . . . . 0.0 108.99 178.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.447 ' CD1' ' HG2' ' A' ' 40' ' ' MET . 8.2 t80 -63.96 -33.85 76.66 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.42 HG23 ' CD1' ' A' ' 93' ' ' PHE . 43.6 t -70.51 -38.86 75.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 177.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.1 m -55.18 -39.18 69.27 Favored 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.887 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.9 m -77.49 -54.48 6.38 Favored 'General case' 0 N--CA 1.511 2.607 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -178.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -60.83 -24.72 66.09 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.508 -0.745 . . . . 0.0 110.6 -178.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 44.2 p -95.93 -63.21 1.17 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 122.003 -0.435 . . . . 0.0 112.153 -177.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.7 m -100.23 12.11 37.82 Favored 'General case' 0 N--CA 1.509 2.507 0 O-C-N 121.249 -0.907 . . . . 0.0 111.484 -178.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 57.26 24.13 50.35 Favored Glycine 0 N--CA 1.507 3.395 0 N-CA-C 109.434 -1.467 . . . . 0.0 109.434 -178.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.7 t -116.48 164.83 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 O-C-N 122.053 -0.675 . . . . 0.0 109.469 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 132.09 -177.32 18.79 Favored Glycine 0 N--CA 1.499 2.871 0 N-CA-C 108.675 -1.77 . . . . 0.0 108.675 -178.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -64.01 172.22 6.4 Favored 'Trans proline' 0 N--CA 1.483 0.888 0 CA-C-N 119.485 1.643 . . . . 0.0 109.808 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -92.99 84.64 4.93 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.918 0.866 . . . . 0.0 110.518 -177.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.0 tp -140.26 132.9 28.84 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.88 159.38 0.41 Allowed 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.937 -0.477 . . . . 0.0 109.994 -179.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 34.5 m -74.21 -27.89 61.01 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.934 -0.479 . . . . 0.0 111.255 -178.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -74.17 -38.32 63.72 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.869 -0.519 . . . . 0.0 110.524 -178.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -72.8 -30.65 64.25 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.447 ' HG2' ' CD1' ' A' ' 23' ' ' TYR . 0.5 OUTLIER -70.86 -56.09 7.04 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.665 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.74 -33.65 70.49 Favored 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.88 -34.14 74.95 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.885 -0.784 . . . . 0.0 108.885 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -66.32 -48.93 68.71 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 16.4 m -62.4 -37.71 86.82 Favored 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.332 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 89.5 m -73.88 -28.25 61.47 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -178.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -72.76 -32.27 65.52 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -77.79 -37.02 49.77 Favored 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 120.571 -0.451 . . . . 0.0 109.799 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.401 ' CD2' ' CZ ' ' A' ' 56' ' ' ARG . 2.1 tt -68.65 -36.64 78.86 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -77.09 -41.64 41.35 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.74 -35.11 68.22 Favored 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 58.2 mt -87.0 104.73 6.51 Favored Pre-proline 0 N--CA 1.489 1.5 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 177.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -59.15 145.37 97.94 Favored 'Trans proline' 0 N--CA 1.477 0.557 0 C-N-CA 121.383 1.389 . . . . 0.0 110.305 -177.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -36.49 -32.69 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.444 0 C-N-CA 122.767 0.427 . . . . 0.0 112.049 -178.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -71.04 123.36 21.92 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 23.3 m 77.23 -1.04 2.82 Favored 'General case' 0 N--CA 1.509 2.497 0 C-N-CA 122.266 0.226 . . . . 0.0 110.739 -179.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.401 ' CZ ' ' CD2' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -57.84 -91.56 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.438 -0.789 . . . . 0.0 109.762 -179.918 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 64.6 m -27.51 -42.36 0.02 OUTLIER 'General case' 0 N--CA 1.523 3.178 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -40.02 -54.24 2.26 Favored 'General case' 0 N--CA 1.513 2.703 0 CA-C-N 119.493 1.042 . . . . 0.0 111.801 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -40.4 -46.58 2.42 Favored 'General case' 0 N--CA 1.511 2.581 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 39.4 t -56.56 -49.94 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -59.32 -26.47 65.04 Favored 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.237 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.449 ' CG2' ' HB ' ' A' ' 67' ' ' VAL . 42.4 mm -78.42 -29.84 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 O-C-N 121.926 -0.484 . . . . 0.0 110.341 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.0 -38.64 36.16 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.848 -0.741 . . . . 0.0 109.9 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 2.6 ttm -78.63 -52.78 7.95 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.028 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -80.7 -24.03 39.12 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 122.007 -0.433 . . . . 0.0 111.051 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.41 144.58 5.07 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 108.839 -1.704 . . . . 0.0 108.839 -179.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.449 ' HB ' ' CG2' ' A' ' 62' ' ' ILE . 7.1 p -117.66 159.35 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 122.254 -0.556 . . . . 0.0 109.594 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.409 HG21 ' CD2' ' A' ' 74' ' ' HIS . 51.0 t -114.33 157.23 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.3 p -116.99 159.57 22.29 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.99 -177.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 48.3 t -62.78 -30.47 71.48 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.326 -178.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.8 p -70.1 -16.9 63.19 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.447 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.59 11.46 41.04 Favored Glycine 0 N--CA 1.498 2.8 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -98.64 157.78 16.04 Favored 'General case' 0 N--CA 1.501 2.113 0 CA-C-N 118.103 0.951 . . . . 0.0 109.227 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.409 ' CD2' HG21 ' A' ' 68' ' ' VAL . 10.8 m170 -114.93 155.68 26.44 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -140.29 -178.02 5.29 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.11 0.481 . . . . 0.0 110.194 -179.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 51.79 -144.08 17.56 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.814 -1.315 . . . . 0.0 109.814 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 55.32 22.4 4.82 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 122.394 -0.474 . . . . 0.0 110.071 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.6 mt -86.27 -13.83 45.56 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.719 -0.613 . . . . 0.0 110.93 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.4 tp -61.23 93.24 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -142.9 -177.44 5.33 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.545 0.688 . . . . 0.0 110.216 -178.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -54.3 138.59 38.76 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.842 0.83 . . . . 0.0 111.353 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.496 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 21.3 mt -130.61 168.26 17.74 Favored Pre-proline 0 N--CA 1.497 1.916 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 178.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.496 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 29.4 Cg_endo -68.74 99.75 0.66 Allowed 'Trans proline' 0 N--CA 1.478 0.564 0 C-N-CA 121.044 1.163 . . . . 0.0 110.386 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.8 9.91 63.65 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.431 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 3.4 m -141.95 90.88 8.3 Favored Pre-proline 0 N--CA 1.509 2.515 0 CA-C-N 118.761 1.28 . . . . 0.0 109.756 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -74.25 164.88 33.19 Favored 'Trans proline' 0 N--CA 1.487 1.097 0 C-N-CA 121.885 1.724 . . . . 0.0 111.475 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -48.94 -28.06 3.58 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.063 0.459 . . . . 0.0 110.087 178.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -60.31 -47.49 85.81 Favored 'General case' 0 N--CA 1.502 2.164 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -177.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 44.6 t -69.58 -40.94 80.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.775 -0.578 . . . . 0.0 111.518 -177.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -73.3 -25.44 60.66 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.784 -179.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.7 tpt180 -78.93 -34.36 44.62 Favored 'General case' 0 N--CA 1.503 2.197 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.231 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.39 -43.69 31.83 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.869 -0.519 . . . . 0.0 110.003 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.42 ' CD1' HG23 ' A' ' 24' ' ' VAL . 28.4 t80 -78.53 -25.91 45.63 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 122.274 -0.267 . . . . 0.0 110.415 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.438 ' N ' ' HD2' ' A' ' 95' ' ' PRO . . . -43.41 -51.53 14.78 Favored Pre-proline 0 N--CA 1.502 2.164 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -178.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' A' ' 94' ' ' ALA . 29.2 Cg_endo -70.6 -170.24 0.43 Allowed 'Trans proline' 0 N--CA 1.481 0.784 0 C-N-CA 121.73 1.62 . . . . 0.0 111.058 -179.01 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 61.34 20.36 11.02 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 -178.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.71 -60.96 2.01 Favored 'General case' 0 N--CA 1.508 2.434 0 O-C-N 121.969 -0.457 . . . . 0.0 112.232 -178.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 104' ' ' ASN . 19.8 m -82.94 35.06 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 O-C-N 121.112 -0.993 . . . . 0.0 111.921 -178.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 24.6 p -109.1 174.99 5.62 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 178.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -59.66 -2.46 0.36 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.467 -0.771 . . . . 0.0 111.926 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.9 t -95.61 1.5 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 CA-C-N 120.479 1.49 . . . . 0.0 111.321 -179.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -148.02 -91.96 0.08 Allowed 'General case' 0 N--CA 1.504 2.252 0 CA-C-N 119.011 0.823 . . . . 0.0 111.771 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 7.3 m -132.89 49.35 2.32 Favored 'General case' 0 N--CA 1.509 2.503 0 O-C-N 121.365 -0.834 . . . . 0.0 110.1 -178.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' A' ' 98' ' ' VAL . 38.2 t30 -42.23 -82.29 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.559 0 O-C-N 120.779 -1.201 . . . . 0.0 112.533 -179.014 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 8.1 mt 51.58 24.64 2.39 Favored 'General case' 0 N--CA 1.506 2.343 0 O-C-N 121.836 -0.54 . . . . 0.0 111.922 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 71.07 152.27 0.11 Allowed 'General case' 0 N--CA 1.513 2.722 0 O-C-N 121.001 -1.062 . . . . 0.0 110.669 178.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.9 p -127.85 -163.84 1.31 Allowed 'General case' 0 N--CA 1.51 2.536 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.418 ' CG2' ' CD2' ' A' ' 109' ' ' HIS . 10.9 tt -67.3 -37.28 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.244 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.033 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.63 ' CD2' ' HA ' ' A' ' 114' ' ' CYS . 68.3 m-70 -67.43 -2.03 5.72 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.784 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 58.57 28.6 62.74 Favored Glycine 0 N--CA 1.498 2.778 0 N-CA-C 108.744 -1.742 . . . . 0.0 108.744 -178.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -141.19 178.64 20.1 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -179.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.418 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 32.7 Cg_endo -87.87 55.36 2.63 Favored 'Trans proline' 0 N--CA 1.481 0.772 0 C-N-CA 123.358 2.705 . . . . 0.0 110.655 -179.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.452 ' CG ' ' N ' ' A' ' 114' ' ' CYS . 0.2 OUTLIER 175.68 -160.03 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -178.297 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.63 ' HA ' ' CD2' ' A' ' 109' ' ' HIS . 0.1 OUTLIER -145.71 83.11 1.64 Allowed 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 120.143 -0.623 . . . . 0.0 109.881 176.12 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.562 ' N ' ' CE1' ' A' ' 109' ' ' HIS . 0.2 OUTLIER -37.77 179.38 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.183 0 C-N-CA 124.348 1.059 . . . . 0.0 113.702 -179.405 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.409 ' CB ' ' O ' ' A' ' 115' ' ' LEU . 2.8 t 77.72 41.83 0.13 Allowed 'General case' 0 N--CA 1.507 2.386 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 -176.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.554 ' N ' HD11 ' A' ' 117' ' ' LEU . 0.0 OUTLIER -96.98 19.34 12.94 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.466 -0.771 . . . . 0.0 109.816 -177.548 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.8 mp -46.1 -25.26 0.55 Allowed 'General case' 0 N--CA 1.509 2.496 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -177.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 51.56 60.05 7.8 Favored Glycine 0 N--CA 1.504 3.231 0 CA-C-N 119.662 1.119 . . . . 0.0 110.531 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 59.85 71.61 0.57 Allowed 'General case' 0 N--CA 1.499 2.002 0 CA-C-O 121.771 0.796 . . . . 0.0 109.509 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -57.5 -23.29 48.51 Favored Glycine 0 N--CA 1.497 2.746 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 . . . . . 0 N--CA 1.497 1.896 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.151 179.952 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.1 m -91.4 31.91 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 122.173 -0.329 . . . . 0.0 110.491 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -88.99 87.6 1.49 Allowed Glycine 0 N--CA 1.497 2.759 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.3 t -176.12 78.37 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 61.3 176.81 0.11 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.526 -0.734 . . . . 0.0 109.55 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 17.5 m -115.35 162.01 17.71 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 23.5 pt -121.96 136.39 26.19 Favored Pre-proline 0 N--CA 1.499 1.983 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -179.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -81.66 160.77 19.2 Favored 'Trans proline' 0 N--CA 1.479 0.651 0 C-N-CA 122.004 1.802 . . . . 0.0 110.262 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 71.38 4.71 57.68 Favored Glycine 0 N--CA 1.502 3.076 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.439 ' O ' ' CB ' ' A' ' 11' ' ' ALA . 2.0 mpt? -139.91 99.85 3.79 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 118.153 0.977 . . . . 0.0 108.59 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.439 ' CB ' ' O ' ' A' ' 10' ' ' MET . . . 86.87 -57.46 0.05 OUTLIER 'General case' 0 N--CA 1.516 2.836 0 CA-C-N 119.392 0.997 . . . . 0.0 108.504 -178.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 17.5 mt -100.1 102.66 18.7 Favored Pre-proline 0 N--CA 1.499 1.992 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 178.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -79.76 176.37 9.56 Favored 'Trans proline' 0 C--O 1.22 -0.402 0 C-N-CA 121.458 1.439 . . . . 0.0 111.034 -177.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.422 ' CE1' HG23 ' A' ' 69' ' ' THR . 41.0 m-70 -86.0 142.61 28.65 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 120.721 0.296 . . . . 0.0 111.017 -177.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.55 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 9.2 t-20 70.46 48.12 0.3 Allowed Pre-proline 0 N--CA 1.508 2.451 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 178.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.55 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 42.7 Cg_endo -86.65 175.51 5.21 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 121.79 1.66 . . . . 0.0 111.345 178.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 49.36 45.18 23.81 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 177.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -77.57 -43.16 32.71 Favored 'General case' 0 N--CA 1.509 2.482 0 O-C-N 121.219 -0.925 . . . . 0.0 108.954 178.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.94 -24.77 66.3 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 57.1 m -74.21 -34.25 63.66 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -179.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.96 -43.57 67.85 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.213 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 32.7 m95 -71.53 -26.5 62.67 Favored 'General case' 0 N--CA 1.504 2.263 0 C-N-CA 118.771 -1.172 . . . . 0.0 109.426 178.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.53 ' HB2' ' HG2' ' A' ' 40' ' ' MET . 10.9 t80 -70.24 -35.36 73.77 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 64.7 t -70.12 -38.59 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 177.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 m -57.42 -38.57 74.56 Favored 'General case' 0 N--CA 1.502 2.147 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.149 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 99.8 m -77.05 -51.75 10.53 Favored 'General case' 0 N--CA 1.511 2.578 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.2 tpt180 -62.99 -24.72 68.05 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.425 -0.797 . . . . 0.0 110.335 -178.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 56.3 p -92.75 -66.58 0.91 Allowed 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -177.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.7 m -100.87 11.49 39.48 Favored 'General case' 0 N--CA 1.511 2.606 0 CA-C-N 119.452 1.024 . . . . 0.0 111.467 -179.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 60.49 25.58 63.25 Favored Glycine 0 N--CA 1.503 3.16 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -178.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 47.8 t -108.32 163.73 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.317 0 O-C-N 121.911 -0.758 . . . . 0.0 109.437 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 126.04 -179.31 16.32 Favored Glycine 0 N--CA 1.499 2.849 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -64.84 171.61 8.34 Favored 'Trans proline' 0 N--CA 1.486 1.033 0 CA-C-N 119.266 1.533 . . . . 0.0 109.911 179.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 10.3 mmt-85 -93.23 84.36 4.78 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.917 0.865 . . . . 0.0 109.992 -178.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -131.98 143.89 50.41 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.76 142.2 58.51 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -49.98 -58.7 4.93 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.506 -0.746 . . . . 0.0 111.004 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -46.82 -40.59 14.04 Favored 'General case' 0 N--CA 1.508 2.462 0 O-C-N 121.892 -0.505 . . . . 0.0 111.482 -178.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -62.78 -46.97 85.52 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.53 ' HG2' ' HB2' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -59.41 -57.69 11.89 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -179.585 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 39.8 tttt -51.82 -29.94 21.39 Favored 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.94 -46.29 78.74 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.9 mmt-85 -58.06 -60.42 3.77 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 16.5 m -54.29 -32.82 57.27 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -178.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 21.5 m -75.43 -30.55 60.07 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -178.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.32 -34.11 70.27 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -79.05 -31.15 44.43 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.122 0.487 . . . . 0.0 109.817 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -67.76 -44.71 76.85 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -178.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -78.12 -28.12 48.43 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.81 -44.28 77.69 Favored 'General case' 0 N--CA 1.504 2.258 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.403 HG22 HD11 ' A' ' 51' ' ' ILE . 39.5 mm -79.83 106.19 4.52 Favored Pre-proline 0 N--CA 1.49 1.568 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 176.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -54.51 144.62 62.0 Favored 'Trans proline' 0 N--CA 1.481 0.766 0 C-N-CA 121.564 1.51 . . . . 0.0 111.572 -175.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.424 ' HA ' ' CG ' ' A' ' 56' ' ' ARG . . . -32.63 -32.42 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.342 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -177.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -63.19 125.27 23.53 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 14.1 m 77.56 17.15 1.47 Allowed 'General case' 0 N--CA 1.514 2.772 0 CA-C-O 119.358 -0.353 . . . . 0.0 111.898 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.424 ' CG ' ' HA ' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -48.68 -89.06 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.862 0 CA-C-N 119.851 1.205 . . . . 0.0 110.175 179.688 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 82.8 m -37.2 -44.2 0.56 Allowed 'General case' 0 N--CA 1.518 2.928 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -42.58 -51.02 5.3 Favored 'General case' 0 N--CA 1.512 2.642 0 CA-C-N 119.931 1.242 . . . . 0.0 111.735 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -41.88 -45.48 3.71 Favored 'General case' 0 N--CA 1.513 2.71 0 O-C-N 121.701 -0.625 . . . . 0.0 112.007 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 20.4 t -55.34 -48.58 76.63 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 10.1 ttp180 -58.81 -29.42 66.84 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.826 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.43 ' CG2' ' HB ' ' A' ' 67' ' ' VAL . 11.2 mt -77.57 -27.32 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.286 0 O-C-N 121.899 -0.501 . . . . 0.0 109.955 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.4 tp -77.63 -43.95 29.81 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 120.073 -0.651 . . . . 0.0 110.082 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.54 -50.42 11.61 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.284 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -81.09 -23.31 38.54 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.965 -0.459 . . . . 0.0 111.48 -179.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.87 149.31 8.24 Favored Glycine 0 N--CA 1.499 2.838 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -178.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.43 ' HB ' ' CG2' ' A' ' 62' ' ' ILE . 5.8 p -117.93 159.37 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.428 ' CG2' ' CE1' ' A' ' 74' ' ' HIS . 79.1 t -114.7 158.07 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-O 121.756 0.789 . . . . 0.0 109.389 -178.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.422 HG23 ' CE1' ' A' ' 14' ' ' HIS . 27.0 p -117.0 158.61 23.83 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 115.339 -0.846 . . . . 0.0 108.96 -178.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.7 t -64.26 -33.14 75.13 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.883 -178.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.6 p -62.91 -17.6 61.94 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.935 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.58 13.5 34.96 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -103.85 156.9 17.46 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-N 118.198 0.999 . . . . 0.0 109.524 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.428 ' CE1' ' CG2' ' A' ' 68' ' ' VAL . 9.3 m170 -115.44 155.86 26.67 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -142.79 -177.49 5.34 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 120.236 -0.586 . . . . 0.0 110.612 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.413 ' O ' ' CG ' ' A' ' 77' ' ' ARG . . . 59.95 -132.42 50.86 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 108.374 -1.89 . . . . 0.0 108.374 -178.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.413 ' CG ' ' O ' ' A' ' 76' ' ' GLY . 2.1 ptm180 44.18 28.61 0.29 Allowed 'General case' 0 N--CA 1.507 2.383 0 CA-C-O 120.978 0.418 . . . . 0.0 110.189 179.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.7 mt -72.81 -19.45 61.33 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 122.037 -0.415 . . . . 0.0 110.58 -178.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.5 tp -49.21 105.27 0.08 Allowed 'General case' 0 N--CA 1.503 2.183 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -139.95 170.51 15.74 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.371 0.605 . . . . 0.0 109.89 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -80.45 105.49 11.74 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 121.379 0.609 . . . . 0.0 110.342 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.559 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 15.5 mt -86.7 171.87 9.34 Favored Pre-proline 0 N--CA 1.5 2.03 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 177.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.559 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 28.9 Cg_endo -68.73 103.28 0.97 Allowed 'Trans proline' 0 C--N 1.328 -0.5 0 C-N-CA 120.865 1.043 . . . . 0.0 109.878 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.36 11.76 60.63 Favored Glycine 0 N--CA 1.498 2.813 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 3.5 m -143.07 90.37 7.46 Favored Pre-proline 0 N--CA 1.507 2.376 0 CA-C-N 118.705 1.252 . . . . 0.0 108.563 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -74.38 159.93 42.66 Favored 'Trans proline' 0 C--N 1.325 -0.673 0 C-N-CA 121.16 1.24 . . . . 0.0 111.0 -178.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 32.0 mtp180 -49.23 -28.64 4.79 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.389 0.614 . . . . 0.0 109.738 178.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -56.15 -49.0 75.21 Favored 'General case' 0 N--CA 1.503 2.176 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.971 -178.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.5 t -65.14 -39.43 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.667 -0.646 . . . . 0.0 109.667 -178.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 23.4 mm-40 -64.26 -29.4 70.49 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -78.46 -26.78 46.22 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.9 -50.14 25.5 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.869 -0.519 . . . . 0.0 109.656 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -78.88 -26.04 43.92 Favored 'General case' 0 N--CA 1.508 2.456 0 O-C-N 122.057 -0.402 . . . . 0.0 111.042 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.41 ' N ' ' CD ' ' A' ' 95' ' ' PRO . . . -48.74 -47.43 72.12 Favored Pre-proline 0 N--CA 1.505 2.278 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -177.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' A' ' 94' ' ' ALA . 33.0 Cg_endo -73.77 25.46 0.33 Allowed 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 122.371 2.047 . . . . 0.0 114.258 -178.148 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.1 mttp -135.61 37.81 2.88 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.48 ' O ' ' HB3' ' A' ' 102' ' ' GLU . 0.3 OUTLIER -74.58 -75.27 0.17 Allowed 'General case' 0 N--CA 1.503 2.208 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.992 -178.978 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 8.7 m -76.0 10.11 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 O-C-N 121.067 -1.021 . . . . 0.0 111.637 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 11.9 p -87.04 176.6 7.54 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -65.09 5.35 0.36 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.452 -0.78 . . . . 0.0 111.873 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 56.3 t -96.23 -5.24 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 CA-C-N 120.265 1.393 . . . . 0.0 111.009 -179.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.48 ' HB3' ' O ' ' A' ' 97' ' ' LEU . 4.1 tp10 -142.07 -85.46 0.17 Allowed 'General case' 0 N--CA 1.513 2.71 0 C-N-CA 118.626 -1.23 . . . . 0.0 112.869 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 20.8 m -136.57 40.56 2.59 Favored 'General case' 0 N--CA 1.507 2.387 0 CA-C-N 119.601 1.091 . . . . 0.0 110.616 -177.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.408 ' O ' ' CB ' ' A' ' 105' ' ' LEU . 25.6 t30 -44.95 -95.76 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.385 -0.822 . . . . 0.0 111.946 -179.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.408 ' CB ' ' O ' ' A' ' 104' ' ' ASN . 1.4 mt 87.19 -58.41 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.462 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -177.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 160.95 127.68 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.503 ' OG1' ' CE1' ' A' ' 109' ' ' HIS . 2.3 p -91.59 -146.62 0.21 Allowed 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -178.445 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.5 tp -57.41 -39.34 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.825 -0.547 . . . . 0.0 111.059 178.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.51 ' CE1' ' O ' ' A' ' 113' ' ' PHE . 2.2 p80 -90.78 21.93 3.84 Favored 'General case' 0 N--CA 1.515 2.786 0 O-C-N 122.047 -0.408 . . . . 0.0 111.255 -177.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 53.18 64.89 3.77 Favored Glycine 0 N--CA 1.497 2.733 0 O-C-N 121.598 -0.688 . . . . 0.0 111.609 177.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 159.49 172.97 27.35 Favored Glycine 0 N--CA 1.498 2.822 0 CA-C-N 118.419 1.11 . . . . 0.0 111.096 178.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.46 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 36.2 Cg_endo -85.17 80.38 2.09 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.059 2.506 . . . . 0.0 111.642 -178.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.51 ' O ' ' CE1' ' A' ' 109' ' ' HIS . 8.3 p90 175.66 89.71 0.01 OUTLIER 'General case' 0 N--CA 1.535 3.783 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.441 ' HA ' ' NE2' ' A' ' 109' ' ' HIS . 16.9 p -113.82 -178.22 3.32 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 120.185 -1.572 . . . . 0.0 110.397 178.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 67.56 33.22 5.2 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -178.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.421 ' O ' ' HB2' ' A' ' 117' ' ' LEU . 89.2 p -163.84 -135.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.475 HD23 ' CE2' ' A' ' 113' ' ' PHE . 2.4 mp 67.35 -119.52 0.23 Allowed 'General case' 0 N--CA 1.501 2.104 0 CA-C-N 119.254 0.934 . . . . 0.0 109.199 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.408 ' HB2' ' O ' ' A' ' 117' ' ' LEU . 7.0 mp 70.26 -17.02 0.28 Allowed 'General case' 0 N--CA 1.519 2.98 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -165.15 -110.26 0.23 Allowed Glycine 0 N--CA 1.499 2.879 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -129.57 -139.18 0.23 Allowed 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 52.76 22.83 12.73 Favored Glycine 0 N--CA 1.501 3.0 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 . . . . . 0 N--CA 1.499 2.016 0 CA-C-O 118.137 -0.935 . . . . 0.0 109.629 -179.774 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.546 ' O ' ' CB ' ' A' ' 2' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.546 ' CB ' ' O ' ' A' ' 1' ' ' SER . 2.8 t 83.59 -60.77 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.734 -0.604 . . . . 0.0 109.561 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 121.54 -81.18 0.34 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.5 t -89.25 38.6 0.9 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.253 -1.145 . . . . 0.0 109.492 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.5 m -46.5 164.63 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.246 -0.909 . . . . 0.0 109.438 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 84.8 m 59.19 109.82 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.125 -0.985 . . . . 0.0 109.915 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.561 ' CG2' ' HD2' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -98.41 157.81 33.71 Favored Pre-proline 0 N--CA 1.492 1.668 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.26 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.561 ' HD2' ' CG2' ' A' ' 7' ' ' ILE . 35.3 Cg_endo -78.11 156.26 29.94 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.26 1.973 . . . . 0.0 110.707 -179.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.72 10.2 36.62 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.596 ' O ' ' CB ' ' A' ' 11' ' ' ALA . 0.3 OUTLIER -137.01 104.55 5.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.338 -1.095 . . . . 0.0 108.768 179.803 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.596 ' CB ' ' O ' ' A' ' 10' ' ' MET . . . 86.01 -59.68 0.06 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.749 -1.219 . . . . 0.0 108.181 -178.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 5.6 mt -102.2 101.6 20.13 Favored Pre-proline 0 C--N 1.303 -1.42 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 11' ' ' ALA . 34.3 Cg_endo -82.11 173.39 10.97 Favored 'Trans proline' 0 C--N 1.319 -0.981 0 C-N-CA 121.602 1.534 . . . . 0.0 111.945 -176.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 51.3 m-70 -74.85 149.38 39.59 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -179.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.646 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 6.4 t30 55.3 50.94 6.47 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 120.831 -1.168 . . . . 0.0 110.039 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.646 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 37.7 Cg_endo -78.99 -174.64 2.37 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 122.478 2.119 . . . . 0.0 111.122 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.521 ' HB3' ' CD1' ' A' ' 63' ' ' LEU . 4.3 mm? 47.12 41.79 12.02 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.716 -0.615 . . . . 0.0 111.046 178.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.444 ' CG ' ' N ' ' A' ' 19' ' ' SER . 1.9 p30 -81.91 -47.21 13.03 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.034 -1.041 . . . . 0.0 109.128 179.1 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.444 ' N ' ' CG ' ' A' ' 18' ' ' ASP . 0.2 OUTLIER -60.74 -26.46 67.21 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.276 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.459 ' SG ' ' CD1' ' A' ' 17' ' ' LEU . 75.4 m -74.77 -34.73 62.52 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.535 ' HG3' ' N ' ' A' ' 22' ' ' TRP . 0.1 OUTLIER -66.95 -49.94 63.89 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.399 -0.813 . . . . 0.0 108.877 179.503 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.535 ' N ' ' HG3' ' A' ' 21' ' ' ARG . 31.6 m95 -71.44 -27.51 63.33 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.86 -1.15 . . . . 0.0 109.456 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.543 ' HB2' ' CG ' ' A' ' 40' ' ' MET . 26.4 t80 -67.03 -34.61 78.09 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.248 -0.907 . . . . 0.0 109.227 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.576 HG23 ' CD1' ' A' ' 93' ' ' PHE . 78.3 t -74.86 -40.15 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 118.59 -1.244 . . . . 0.0 108.087 178.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.467 ' OG ' ' O ' ' A' ' 22' ' ' TRP . 61.1 p -55.44 -37.66 67.99 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.114 -1.035 . . . . 0.0 109.262 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.466 ' OG1' ' O ' ' A' ' 31' ' ' VAL . 3.5 m -78.31 -55.09 5.52 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.337 -0.852 . . . . 0.0 111.476 -178.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 8.3 mmm180 -58.47 -25.1 61.91 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.792 -1.192 . . . . 0.0 110.388 -178.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 24' ' ' VAL . 69.5 p -95.61 -64.44 1.06 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.175 -0.953 . . . . 0.0 111.57 -177.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.473 ' SG ' ' O ' ' A' ' 84' ' ' GLY . 3.4 m -98.89 16.15 23.3 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.816 -1.178 . . . . 0.0 109.806 -178.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.45 ' HA2' ' O ' ' A' ' 26' ' ' THR . . . 51.78 21.94 7.97 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 -179.006 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.516 ' CG1' ' N ' ' A' ' 32' ' ' GLY . 40.7 t -102.47 165.63 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.386 -1.067 . . . . 0.0 109.335 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.516 ' N ' ' CG1' ' A' ' 31' ' ' VAL . . . 129.69 176.87 14.6 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.438 -1.865 . . . . 0.0 108.438 -179.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -65.3 173.5 6.2 Favored 'Trans proline' 0 C--O 1.214 -0.693 0 CA-C-N 119.143 1.472 . . . . 0.0 109.897 179.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -92.26 82.87 4.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.872 -1.143 . . . . 0.0 110.3 -178.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.43 HD13 ' HA ' ' A' ' 35' ' ' LEU . 9.1 tp -137.29 135.5 37.19 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.015 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 35' ' ' LEU . . . -46.55 155.4 0.24 Allowed 'General case' 0 N--CA 1.487 1.375 0 O-C-N 120.923 -1.111 . . . . 0.0 109.051 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.431 ' O ' ' C ' ' A' ' 38' ' ' GLN . 0.6 OUTLIER -74.34 -55.27 6.2 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.042 -1.036 . . . . 0.0 110.002 -179.562 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.431 ' C ' ' O ' ' A' ' 37' ' ' THR . 2.2 mp0 -43.31 -34.6 1.25 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.228 -0.92 . . . . 0.0 109.691 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.43 ' O ' ' HB1' ' A' ' 42' ' ' ALA . 10.1 mm-40 -64.87 -52.1 58.41 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.109 -0.994 . . . . 0.0 108.593 179.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.543 ' CG ' ' HB2' ' A' ' 23' ' ' TYR . 0.4 OUTLIER -54.43 -60.78 2.89 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.232 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.435 ' C ' ' O ' ' A' ' 40' ' ' MET . 20.9 ttpt -44.3 -35.34 2.29 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.43 ' HB1' ' O ' ' A' ' 39' ' ' GLU . . . -63.2 -48.93 76.23 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.486 -0.759 . . . . 0.0 109.029 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.443 ' HD3' ' OG ' ' A' ' 19' ' ' SER . 7.7 mtt-85 -55.1 -52.39 63.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.373 -0.83 . . . . 0.0 109.539 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 20.9 m -55.89 -35.77 66.91 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 0.0 109.904 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 81.7 m -68.97 -28.62 66.78 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.038 -1.039 . . . . 0.0 109.148 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.72 -31.34 64.91 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.326 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.42 ' O ' HG13 ' A' ' 51' ' ' ILE . 3.4 mm-40 -76.79 -36.41 57.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.465 -0.772 . . . . 0.0 109.506 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.511 ' CD2' HD11 ' A' ' 105' ' ' LEU . 7.4 tt -72.21 -36.63 69.22 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.265 -0.897 . . . . 0.0 109.299 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.458 ' O ' ' C ' ' A' ' 50' ' ' ALA . 1.2 tt0 -71.64 -55.73 7.19 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.49 ' O ' ' HD3' ' A' ' 52' ' ' PRO . . . -45.92 -47.92 16.29 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 178.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.452 HG23 ' HD3' ' A' ' 56' ' ' ARG . 88.9 mt -62.12 106.43 0.84 Allowed Pre-proline 0 C--N 1.303 -1.452 0 N-CA-C 107.059 -1.459 . . . . 0.0 107.059 176.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.535 ' O ' ' N ' ' A' ' 54' ' ' TYR . 25.1 Cg_endo -61.38 141.03 91.11 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 121.607 1.538 . . . . 0.0 110.925 -177.082 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.522 ' HA ' ' HG3' ' A' ' 56' ' ' ARG . . . -31.29 -35.18 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.156 0.503 . . . . 0.0 110.811 -178.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.54 ' O ' ' CB ' ' A' ' 55' ' ' CYS . 9.4 m-85 -75.0 129.14 37.14 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.138 -0.976 . . . . 0.0 109.153 179.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.54 ' CB ' ' O ' ' A' ' 54' ' ' TYR . 4.3 m 79.23 0.45 2.33 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.338 -0.851 . . . . 0.0 110.924 179.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.529 ' O ' ' C ' ' A' ' 57' ' ' CYS . 3.7 mmt85 -43.19 -90.24 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.704 -1.248 . . . . 0.0 109.706 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.529 ' C ' ' O ' ' A' ' 56' ' ' ARG . 3.3 m -21.47 -55.13 0.02 OUTLIER 'General case' 0 N--CA 1.514 2.755 0 O-C-N 122.069 -0.394 . . . . 0.0 111.706 -179.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.503 ' C ' ' O ' ' A' ' 57' ' ' CYS . 1.3 mm-40 -31.13 -59.41 0.22 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.596 -0.69 . . . . 0.0 110.82 -179.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.503 ' C ' ' O ' ' A' ' 58' ' ' GLU . . . -29.05 -56.38 0.14 Allowed 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 121.223 0.535 . . . . 0.0 111.07 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.524 ' CG2' ' CD2' ' A' ' 97' ' ' LEU . 32.0 t -55.17 -53.09 38.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 O-C-N 121.282 -0.886 . . . . 0.0 109.498 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.518 ' O ' ' HB2' ' A' ' 65' ' ' ASP . 17.9 mmt85 -56.49 -26.85 55.56 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.389 -0.819 . . . . 0.0 109.989 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.645 ' CG2' ' CB ' ' A' ' 67' ' ' VAL . 16.1 mm -79.09 -28.9 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.914 -1.116 . . . . 0.0 110.494 -179.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.521 ' CD1' ' HB3' ' A' ' 17' ' ' LEU . 9.1 tt -77.48 -50.03 13.52 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.91 -1.119 . . . . 0.0 108.848 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -78.12 -47.81 17.4 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.198 -0.939 . . . . 0.0 109.743 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.518 ' HB2' ' O ' ' A' ' 61' ' ' ARG . 0.7 OUTLIER -80.21 -20.02 45.64 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.117 -0.989 . . . . 0.0 109.799 -179.98 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 62' ' ' ILE . . . 102.05 162.21 26.61 Favored Glycine 0 N--CA 1.485 1.944 0 C-N-CA 119.31 -1.424 . . . . 0.0 110.749 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.645 ' CB ' ' CG2' ' A' ' 62' ' ' ILE . 3.6 p -113.85 155.54 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.461 HG21 ' CD2' ' A' ' 74' ' ' HIS . 22.3 t -120.52 156.25 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 120.893 -1.13 . . . . 0.0 110.185 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.435 ' N ' ' CG1' ' A' ' 68' ' ' VAL . 46.3 p -118.19 158.49 25.01 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.3 t -65.31 -27.9 68.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.415 -0.803 . . . . 0.0 109.681 -179.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.1 p -68.47 -14.23 62.86 Favored 'General case' 0 C--N 1.294 -1.815 0 O-C-N 121.586 -0.696 . . . . 0.0 109.238 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 99.28 8.76 52.71 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 108.827 -1.709 . . . . 0.0 108.827 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -93.02 156.41 16.91 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.106 -1.232 . . . . 0.0 109.648 -179.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.461 ' CD2' HG21 ' A' ' 68' ' ' VAL . 9.0 m170 -116.53 155.2 29.08 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 120.963 -1.086 . . . . 0.0 109.043 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.515 ' HB2' ' CG1' ' A' ' 67' ' ' VAL . 19.5 mm-40 -147.78 -169.92 3.45 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 121.563 0.696 . . . . 0.0 109.352 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 58.78 -145.61 42.92 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.93 16.9 4.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.286 -1.126 . . . . 0.0 110.069 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.521 ' O ' ' N ' ' A' ' 80' ' ' GLN . 1.0 OUTLIER -76.18 -18.51 59.05 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.985 -1.072 . . . . 0.0 109.669 -179.645 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.471 ' HG ' ' HG2' ' A' ' 90' ' ' GLN . 7.7 tt -47.41 94.91 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.101 -0.999 . . . . 0.0 108.706 179.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.521 ' N ' ' O ' ' A' ' 78' ' ' LEU . 23.2 mm100 -127.71 179.24 5.63 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.075 -1.016 . . . . 0.0 110.197 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.14 104.82 3.74 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.808 0.813 . . . . 0.0 110.863 -179.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.672 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 13.7 mt -82.88 173.41 7.59 Favored Pre-proline 0 C--N 1.298 -1.643 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 177.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.672 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 28.5 Cg_endo -69.15 104.86 1.29 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 120.873 1.048 . . . . 0.0 109.695 179.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.473 ' O ' ' SG ' ' A' ' 29' ' ' CYS . . . 92.04 4.75 66.63 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 -179.298 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.445 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 3.3 m -139.1 88.03 13.54 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 120.753 -1.44 . . . . 0.0 108.758 179.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.425 ' O ' ' C ' ' A' ' 87' ' ' ARG . 30.9 Cg_endo -76.21 159.13 37.2 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 121.638 1.558 . . . . 0.0 111.884 -178.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.425 ' C ' ' O ' ' A' ' 86' ' ' PRO . 7.1 mmm-85 -45.2 -28.24 0.74 Allowed 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.413 ' N ' ' C ' ' A' ' 86' ' ' PRO . 49.8 tt0 -54.34 -61.74 2.11 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.262 -178.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 58.8 t -59.06 -40.64 81.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.084 -1.01 . . . . 0.0 109.952 -178.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.471 ' HG2' ' HG ' ' A' ' 79' ' ' LEU . 0.4 OUTLIER -62.77 -26.82 68.9 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 119.537 -0.865 . . . . 0.0 108.737 179.685 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.53 -31.22 47.41 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.434 -0.791 . . . . 0.0 109.77 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.503 ' O ' ' HD2' ' A' ' 95' ' ' PRO . . . -73.37 -42.97 61.54 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.087 -1.008 . . . . 0.0 109.47 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.576 ' CD1' HG23 ' A' ' 24' ' ' VAL . 21.5 t80 -78.03 -25.75 48.01 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.35 -0.844 . . . . 0.0 110.143 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.546 ' N ' ' HD2' ' A' ' 95' ' ' PRO . . . -37.24 -53.36 2.16 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.597 -0.69 . . . . 0.0 110.94 -179.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 94' ' ' ALA . 31.5 Cg_endo -73.75 -178.74 3.97 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.175 1.917 . . . . 0.0 110.305 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 95' ' ' PRO . 0.1 OUTLIER 71.36 24.66 3.66 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.248 -0.908 . . . . 0.0 108.839 -179.201 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.524 ' CD2' ' CG2' ' A' ' 60' ' ' VAL . 17.6 tp -73.01 -69.87 0.39 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.464 -0.772 . . . . 0.0 110.64 -179.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 104' ' ' ASN . 2.4 m -79.35 26.57 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.571 -1.331 . . . . 0.0 110.906 -179.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.462 HG22 ' HA ' ' A' ' 96' ' ' LYS . 5.2 p -103.87 174.22 5.96 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 120.617 -1.302 . . . . 0.0 108.902 179.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -58.81 -0.93 0.12 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.848 -1.157 . . . . 0.0 112.006 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.1 t -98.78 6.16 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 119.945 -1.722 . . . . 0.0 110.459 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.428 ' CB ' ' O ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -145.57 -90.49 0.1 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.741 -1.225 . . . . 0.0 110.391 -179.949 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.51 ' O ' ' CD1' ' A' ' 105' ' ' LEU . 56.0 m -145.22 40.85 1.24 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.953 -1.092 . . . . 0.0 109.195 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.555 ' O ' ' CB ' ' A' ' 105' ' ' LEU . 24.0 t30 -33.28 -89.47 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.412 -0.805 . . . . 0.0 111.983 -178.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.569 ' O ' ' CB ' ' A' ' 106' ' ' ALA . 3.3 mt 85.3 -66.87 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -177.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.569 ' CB ' ' O ' ' A' ' 105' ' ' LEU . . . 155.97 115.1 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.8 p -85.55 -162.26 0.7 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.4 tp -73.38 -16.97 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 120.87 -1.144 . . . . 0.0 109.424 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.486 ' ND1' HD12 ' A' ' 117' ' ' LEU . 84.1 m-70 -80.06 16.27 1.27 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.432 -0.792 . . . . 0.0 110.377 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 109' ' ' HIS . . . 43.97 26.44 0.83 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 109' ' ' HIS . . . -153.6 172.72 32.4 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.463 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 33.7 Cg_endo -78.29 81.91 2.6 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 123.021 2.481 . . . . 0.0 110.938 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.589 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER 168.38 171.43 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.064 -1.022 . . . . 0.0 110.552 179.356 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.443 ' O ' ' C ' ' A' ' 115' ' ' LEU . 0.5 OUTLIER -174.54 144.66 0.89 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.234 -0.916 . . . . 0.0 109.176 179.503 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.443 ' C ' ' O ' ' A' ' 114' ' ' CYS . 71.5 mt 42.27 55.07 4.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.987 -1.07 . . . . 0.0 109.527 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.42 ' HB2' ' O ' ' A' ' 115' ' ' LEU . 13.8 t 172.34 -67.33 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.36 -0.837 . . . . 0.0 109.208 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.53 ' O ' ' HB2' ' A' ' 118' ' ' LEU . 0.2 OUTLIER 57.46 24.28 10.04 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.265 -0.897 . . . . 0.0 109.522 179.844 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.53 ' HB2' ' O ' ' A' ' 117' ' ' LEU . 1.0 OUTLIER 69.37 -14.11 0.34 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.455 -0.778 . . . . 0.0 112.269 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -174.83 176.73 47.04 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -137.0 65.69 1.49 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.092 -1.24 . . . . 0.0 109.569 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.74 -14.29 54.62 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.302 -1.117 . . . . 0.0 109.53 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 16.1 p . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.276 0.56 . . . . 0.0 109.524 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.413 ' CG1' ' N ' ' A' ' 3' ' ' GLY . 49.3 t -80.74 -88.82 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.17 -0.957 . . . . 0.0 109.5 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.413 ' N ' ' CG1' ' A' ' 2' ' ' VAL . . . 143.26 -94.14 0.18 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.2 t -89.26 39.45 0.94 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.218 -1.166 . . . . 0.0 109.258 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.82 178.35 1.37 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.321 -0.862 . . . . 0.0 109.555 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 68.2 m -135.79 178.3 7.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.336 -0.852 . . . . 0.0 109.319 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.485 ' CG2' ' HD2' ' A' ' 8' ' ' PRO . 35.2 mm -116.18 140.22 26.15 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.187 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.485 ' HD2' ' CG2' ' A' ' 7' ' ' ILE . 36.4 Cg_endo -80.35 151.07 20.06 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 122.188 1.925 . . . . 0.0 110.568 -179.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 54.44 17.32 8.17 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.876 -1.289 . . . . 0.0 109.876 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.584 ' O ' ' CB ' ' A' ' 11' ' ' ALA . 1.4 mtt -139.38 108.2 5.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.29 -1.123 . . . . 0.0 108.669 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.584 ' CB ' ' O ' ' A' ' 10' ' ' MET . . . 85.35 -60.89 0.07 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.815 -1.178 . . . . 0.0 108.288 -178.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.451 HD13 ' CB ' ' A' ' 55' ' ' CYS . 1.7 mt -103.1 101.56 22.55 Favored Pre-proline 0 N--CA 1.485 1.315 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.458 ' HD3' ' O ' ' A' ' 11' ' ' ALA . 31.7 Cg_endo -80.61 174.14 11.47 Favored 'Trans proline' 0 C--N 1.317 -1.089 0 C-N-CA 121.281 1.321 . . . . 0.0 111.355 -177.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.463 ' O ' ' CG ' ' A' ' 15' ' ' ASN . 53.8 m-70 -73.75 148.27 42.74 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.769 -0.582 . . . . 0.0 109.761 -179.023 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.569 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 3.1 p-10 43.25 58.63 11.96 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.065 -1.022 . . . . 0.0 110.503 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.569 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 37.2 Cg_endo -81.09 166.16 18.85 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.676 2.251 . . . . 0.0 110.91 179.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.445 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 14.5 mt 55.08 45.82 25.38 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.471 -0.768 . . . . 0.0 111.179 178.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -69.74 -45.38 68.25 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.815 -1.178 . . . . 0.0 108.589 178.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.474 ' O ' ' HB2' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -62.4 -25.2 67.81 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.886 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.445 ' SG ' ' HB3' ' A' ' 17' ' ' LEU . 73.9 m -69.55 -44.79 70.2 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.376 0.608 . . . . 0.0 109.483 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.61 -48.71 76.24 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.179 -0.951 . . . . 0.0 109.389 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.448 ' HA ' ' CE3' ' A' ' 22' ' ' TRP . 26.5 m95 -69.59 -26.25 64.37 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.443 -1.411 . . . . 0.0 109.382 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.587 ' CG ' ' HG2' ' A' ' 40' ' ' MET . 1.5 t80 -67.44 -30.11 69.75 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.546 HG21 ' CE2' ' A' ' 93' ' ' PHE . 59.1 t -75.18 -42.95 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 C-N-CA 118.758 -1.177 . . . . 0.0 107.859 178.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.7 p -56.03 -41.75 75.46 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.076 -1.05 . . . . 0.0 109.965 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.504 ' CA ' ' O ' ' A' ' 31' ' ' VAL . 3.4 m -77.83 -54.48 6.28 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.253 -0.904 . . . . 0.0 111.308 -178.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -58.7 -24.83 62.13 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 120.847 -1.158 . . . . 0.0 110.437 -178.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.504 ' CG2' HG11 ' A' ' 24' ' ' VAL . 59.1 p -94.62 -65.68 0.97 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.135 -0.978 . . . . 0.0 111.232 -178.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.476 ' SG ' ' O ' ' A' ' 84' ' ' GLY . 3.5 m -99.3 16.95 21.32 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.737 -1.227 . . . . 0.0 109.914 -178.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 26' ' ' THR . . . 55.93 18.88 20.03 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 -178.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.504 ' O ' ' CA ' ' A' ' 26' ' ' THR . 30.2 t -101.6 157.3 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.312 -1.11 . . . . 0.0 109.525 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.405 ' N ' ' CG1' ' A' ' 31' ' ' VAL . . . 131.29 177.61 14.99 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.494 -1.842 . . . . 0.0 108.494 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -66.59 171.99 9.94 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 CA-C-N 119.15 1.475 . . . . 0.0 110.066 179.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -92.67 70.58 4.88 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.935 -1.103 . . . . 0.0 110.364 -178.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.451 ' O ' ' C ' ' A' ' 36' ' ' ALA . 0.8 OUTLIER -109.8 122.8 48.33 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 178.803 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.451 ' C ' ' O ' ' A' ' 35' ' ' LEU . . . -41.27 128.71 2.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.324 -0.86 . . . . 0.0 109.154 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.8 m -51.16 -38.8 54.24 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.829 -1.169 . . . . 0.0 111.377 -178.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -61.04 -36.95 80.94 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.751 -1.218 . . . . 0.0 110.194 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -72.43 -26.76 61.96 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.135 -0.978 . . . . 0.0 109.196 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.587 ' HG2' ' CG ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -72.48 -60.89 2.01 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.898 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -54.56 -36.16 64.03 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.84 -43.5 95.98 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.328 -0.857 . . . . 0.0 109.095 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.405 ' NH1' ' CG ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -60.23 -52.66 64.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.311 -0.868 . . . . 0.0 109.579 179.929 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.428 ' SG ' ' N ' ' A' ' 20' ' ' CYS . 14.7 m -56.68 -35.97 69.05 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.262 -0.899 . . . . 0.0 110.633 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 32.8 m -70.45 -30.72 67.63 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.754 -1.216 . . . . 0.0 109.043 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -68.41 -34.74 76.56 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 179.098 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.466 ' O ' HG13 ' A' ' 51' ' ' ILE . 3.1 mt-30 -77.83 -27.41 49.96 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.542 -0.724 . . . . 0.0 109.138 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.424 ' HG ' ' HB2' ' A' ' 103' ' ' CYS . 1.6 tm? -69.55 -39.02 77.69 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.465 -0.772 . . . . 0.0 108.942 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.429 ' HG3' HD13 ' A' ' 105' ' ' LEU . 3.6 tt0 -77.41 -47.23 20.31 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.489 ' O ' ' HD3' ' A' ' 52' ' ' PRO . . . -45.53 -43.76 12.12 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 178.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.469 ' O ' ' HD2' ' A' ' 56' ' ' ARG . 49.4 mt -73.42 107.44 3.36 Favored Pre-proline 0 C--N 1.301 -1.519 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 177.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.535 ' O ' ' N ' ' A' ' 54' ' ' TYR . 25.4 Cg_endo -61.15 149.43 89.25 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 121.702 1.601 . . . . 0.0 111.224 -176.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.637 ' HA ' ' HD3' ' A' ' 56' ' ' ARG . . . -34.99 -29.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.037 0.446 . . . . 0.0 111.083 -178.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.54 ' O ' ' CB ' ' A' ' 55' ' ' CYS . 1.5 m-85 -79.88 125.87 30.28 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 120.999 -1.063 . . . . 0.0 110.017 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.54 ' CB ' ' O ' ' A' ' 54' ' ' TYR . 4.5 m 81.63 -0.22 1.58 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.489 -0.757 . . . . 0.0 111.727 178.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.637 ' HD3' ' HA ' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -46.98 -89.9 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.316 -1.49 . . . . 0.0 109.328 -179.916 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.493 ' O ' ' C ' ' A' ' 58' ' ' GLU . 53.5 m -33.36 -56.81 0.42 Allowed 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.325 -0.86 . . . . 0.0 111.904 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.493 ' C ' ' O ' ' A' ' 57' ' ' CYS . 27.3 tt0 -32.34 -51.35 0.26 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.029 -1.045 . . . . 0.0 111.416 -179.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.458 ' C ' ' O ' ' A' ' 58' ' ' GLU . . . -36.17 -54.82 0.8 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.282 -0.886 . . . . 0.0 110.643 -179.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 44.0 t -54.63 -47.98 71.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 121.327 -0.858 . . . . 0.0 109.17 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.59 -27.03 62.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.217 -0.927 . . . . 0.0 109.442 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.589 ' CG2' ' HB ' ' A' ' 67' ' ' VAL . 3.7 mm -77.74 -30.14 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.254 -0.904 . . . . 0.0 109.747 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.512 ' O ' ' HA ' ' A' ' 77' ' ' ARG . 8.1 tt -77.88 -40.43 40.06 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.81 -1.181 . . . . 0.0 109.283 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.453 ' SD ' ' HG ' ' A' ' 79' ' ' LEU . 10.4 tpt -77.81 -53.72 7.17 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.239 -0.913 . . . . 0.0 109.985 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -79.61 -22.28 43.87 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.194 -0.941 . . . . 0.0 110.307 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.425 ' CA ' ' HB2' ' A' ' 77' ' ' ARG . . . 88.76 146.71 13.19 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.589 ' HB ' ' CG2' ' A' ' 62' ' ' ILE . 4.0 p -116.88 160.18 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.61 -0.935 . . . . 0.0 109.337 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.635 ' CG2' ' CE1' ' A' ' 74' ' ' HIS . 9.5 t -114.17 158.46 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 CA-C-O 121.9 0.857 . . . . 0.0 109.854 -178.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.459 ' N ' ' CG1' ' A' ' 68' ' ' VAL . 69.1 p -116.78 158.51 23.77 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.636 0.731 . . . . 0.0 109.728 -178.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 38.8 t -65.55 -25.63 67.51 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.418 0.628 . . . . 0.0 110.11 -178.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.2 p -71.82 -14.15 61.89 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.484 -0.76 . . . . 0.0 109.226 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.25 8.4 50.25 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 108.789 -1.725 . . . . 0.0 108.789 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.433 ' O ' ' OG1' ' A' ' 69' ' ' THR . 1.1 mt-30 -100.86 156.15 17.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.075 -1.25 . . . . 0.0 109.18 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.635 ' CE1' ' CG2' ' A' ' 68' ' ' VAL . 13.4 m170 -115.25 155.66 26.84 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.968 -1.083 . . . . 0.0 108.958 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.422 ' CD ' ' O ' ' A' ' 74' ' ' HIS . 22.4 mm-40 -139.51 -171.45 3.14 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.549 -0.86 . . . . 0.0 109.999 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 53.77 -147.1 20.6 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 108.366 -1.894 . . . . 0.0 108.366 -178.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.512 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 14.4 ttt85 52.94 23.13 2.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.118 -1.225 . . . . 0.0 109.577 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.18 -10.82 45.68 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.087 -1.008 . . . . 0.0 110.654 -179.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.613 HD11 ' N ' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -57.08 123.18 14.34 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.461 -1.4 . . . . 0.0 108.68 179.514 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.457 ' CG ' ' O ' ' A' ' 79' ' ' LEU . 49.6 mt-30 -156.5 -179.2 7.95 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.758 -1.214 . . . . 0.0 110.234 -178.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.19 105.57 1.12 Allowed 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.869 0.843 . . . . 0.0 110.754 -179.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.65 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 22.2 mt -89.7 171.77 8.24 Favored Pre-proline 0 C--N 1.298 -1.632 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.018 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.65 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 28.3 Cg_endo -67.29 100.39 0.55 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 121.136 1.224 . . . . 0.0 110.422 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.476 ' O ' ' SG ' ' A' ' 29' ' ' CYS . . . 91.27 14.26 57.59 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.464 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 3.3 m -144.55 91.58 6.19 Favored Pre-proline 0 N--CA 1.498 1.926 0 O-C-N 120.904 -1.35 . . . . 0.0 109.224 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.414 ' O ' ' C ' ' A' ' 87' ' ' ARG . 29.9 Cg_endo -75.2 157.09 42.11 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 121.459 1.439 . . . . 0.0 112.028 -178.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.414 ' C ' ' O ' ' A' ' 86' ' ' PRO . 8.1 mtm-85 -45.25 -28.54 0.82 Allowed 'General case' 0 N--CA 1.483 1.201 0 O-C-N 121.306 -0.872 . . . . 0.0 108.821 178.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -57.78 -62.27 1.92 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.907 -0.496 . . . . 0.0 111.456 -177.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.8 t -61.34 -39.4 82.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 120.958 -1.089 . . . . 0.0 110.137 -178.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.433 ' O ' ' HB1' ' A' ' 94' ' ' ALA . 2.2 mp0 -63.62 -27.41 69.22 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.684 -0.806 . . . . 0.0 108.856 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.43 -33.38 48.63 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.469 -0.77 . . . . 0.0 109.52 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.482 ' O ' ' HD2' ' A' ' 95' ' ' PRO . . . -69.98 -50.94 36.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.154 -0.966 . . . . 0.0 109.513 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.574 ' O ' ' CD1' ' A' ' 93' ' ' PHE . 5.6 t80 -78.14 -25.72 47.49 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.241 -0.912 . . . . 0.0 110.239 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.561 ' N ' ' HD2' ' A' ' 95' ' ' PRO . . . -38.55 -53.02 3.34 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.331 -0.856 . . . . 0.0 111.365 -178.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 94' ' ' ALA . 30.0 Cg_endo -71.38 -174.68 1.29 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.025 1.817 . . . . 0.0 110.854 -179.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.496 ' CB ' ' O ' ' A' ' 95' ' ' PRO . 1.2 ttmm 74.31 32.71 0.95 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.273 -0.892 . . . . 0.0 108.857 -178.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.61 -73.08 0.25 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.475 -0.766 . . . . 0.0 111.469 -178.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.528 ' O ' ' CB ' ' A' ' 104' ' ' ASN . 2.0 m -77.62 24.69 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.737 -1.227 . . . . 0.0 111.678 -178.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.46 HG22 ' HA ' ' A' ' 96' ' ' LYS . 24.7 p -95.81 169.54 9.93 Favored 'General case' 0 C--N 1.294 -1.815 0 O-C-N 120.547 -1.345 . . . . 0.0 108.671 179.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.468 ' HA ' ' ND2' ' A' ' 104' ' ' ASN . 0.6 OUTLIER -59.74 -1.0 0.22 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.658 -1.276 . . . . 0.0 111.774 -179.665 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.0 t -98.92 5.87 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 119.855 -1.778 . . . . 0.0 110.336 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -142.17 -91.29 0.13 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.808 -1.182 . . . . 0.0 110.117 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.487 ' O ' HD22 ' A' ' 105' ' ' LEU . 74.2 m -145.15 39.56 1.21 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.938 -1.101 . . . . 0.0 109.451 -179.177 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.528 ' CB ' ' O ' ' A' ' 98' ' ' VAL . 4.5 p30 -34.58 -47.9 0.34 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.355 -0.841 . . . . 0.0 111.719 -179.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.487 HD22 ' O ' ' A' ' 103' ' ' CYS . 1.3 mm? 44.44 24.75 0.1 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.695 -1.253 . . . . 0.0 110.109 -179.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.476 ' O ' ' O ' ' A' ' 105' ' ' LEU . . . 60.93 122.78 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.771 -1.205 . . . . 0.0 109.125 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.437 HG23 HG22 ' A' ' 98' ' ' VAL . 2.4 p -95.28 -172.7 2.73 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.078 -1.013 . . . . 0.0 108.624 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.511 HG21 ' N ' ' A' ' 109' ' ' HIS . 8.2 tp -58.74 -21.43 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 120.935 -1.103 . . . . 0.0 109.21 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.511 ' N ' HG21 ' A' ' 108' ' ' ILE . 79.2 m-70 -80.11 16.66 1.17 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.654 -0.654 . . . . 0.0 110.373 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 109' ' ' HIS . . . 43.93 26.89 0.9 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 109' ' ' HIS . . . -154.4 171.08 32.89 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.473 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 32.2 Cg_endo -78.67 73.57 5.86 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 123.066 2.511 . . . . 0.0 111.603 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.48 ' CE1' ' HB3' ' A' ' 109' ' ' HIS . 25.0 p90 172.1 149.73 0.05 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.223 -0.923 . . . . 0.0 109.889 178.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.512 ' O ' ' CB ' ' A' ' 115' ' ' LEU . 12.5 p -139.67 127.41 21.89 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.865 -1.147 . . . . 0.0 109.464 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.512 ' CB ' ' O ' ' A' ' 114' ' ' CYS . 1.3 mt 162.18 -169.14 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.705 -1.247 . . . . 0.0 109.725 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.72 21.69 3.93 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.423 -0.798 . . . . 0.0 109.089 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.532 ' N ' ' CD1' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -63.54 -4.22 2.71 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.201 -0.937 . . . . 0.0 110.807 -179.555 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.532 ' N ' HD11 ' A' ' 117' ' ' LEU . 0.5 OUTLIER -49.61 -22.25 1.25 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.774 -1.204 . . . . 0.0 112.691 -178.805 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -70.68 -91.12 0.08 OUTLIER Glycine 0 N--CA 1.489 2.232 0 O-C-N 120.056 -1.652 . . . . 0.0 109.479 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -131.46 -130.92 0.19 Allowed 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.236 -1.156 . . . . 0.0 108.37 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 63.44 11.29 40.29 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 . . . . . 0 N--CA 1.489 1.506 0 O-C-N 121.225 -1.162 . . . . 0.0 109.406 -179.922 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.456 ' O ' ' N ' ' A' ' 10' ' ' MET . 37.8 Cg_endo . . . . . 0 C--O 1.208 -0.975 0 N-CA-C 110.247 -0.713 . . . . 0.0 110.247 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -38.68 -21.69 0.01 OUTLIER Glycine 0 N--CA 1.509 3.55 0 O-C-N 121.64 -0.662 . . . . 0.0 113.279 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.588 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 6.3 mtt -112.11 116.64 30.83 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 178.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.588 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 84.35 -47.59 0.1 Allowed 'General case' 0 N--CA 1.509 2.476 0 CA-C-N 120.021 1.282 . . . . 0.0 110.081 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 85.2 mt -126.27 77.28 72.3 Favored Pre-proline 0 N--CA 1.508 2.438 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -72.47 171.82 16.3 Favored 'Trans proline' 0 N--CA 1.476 0.473 0 C-N-CA 120.751 0.967 . . . . 0.0 112.5 -174.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 18.7 m80 -70.01 148.03 49.37 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.893 -178.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.467 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 29.0 t30 65.66 58.25 1.18 Allowed Pre-proline 0 N--CA 1.503 2.186 0 O-C-N 121.593 -0.692 . . . . 0.0 110.201 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.467 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 38.2 Cg_endo -78.85 158.4 27.68 Favored 'Trans proline' 0 N--CA 1.485 0.972 0 C-N-CA 122.376 2.051 . . . . 0.0 111.752 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.3 mt 53.74 44.25 29.89 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-O 121.074 0.464 . . . . 0.0 111.155 178.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -70.02 -40.51 75.15 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 121.584 -0.697 . . . . 0.0 109.283 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.51 -27.85 69.25 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.536 ' O ' HG23 ' A' ' 24' ' ' VAL . 44.1 m -72.9 -36.33 67.29 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.413 ' CG ' ' N ' ' A' ' 22' ' ' TRP . 0.2 OUTLIER -63.07 -54.97 29.67 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.822 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.441 ' HA ' ' CE3' ' A' ' 22' ' ' TRP . 27.8 m95 -65.64 -27.85 68.68 Favored 'General case' 0 N--CA 1.501 2.084 0 C-N-CA 119.232 -0.987 . . . . 0.0 109.671 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -67.07 -30.03 69.97 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.728 HG22 ' CD1' ' A' ' 93' ' ' PHE . 62.4 t -71.96 -41.62 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 177.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 m -56.35 -42.78 78.31 Favored 'General case' 0 N--CA 1.501 2.112 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.672 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.5 m -77.37 -50.99 11.59 Favored 'General case' 0 N--CA 1.51 2.533 0 O-C-N 122.037 -0.415 . . . . 0.0 112.104 -178.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -62.95 -24.94 68.12 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.832 -0.543 . . . . 0.0 110.733 -178.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.519 HG23 ' O ' ' A' ' 24' ' ' VAL . 34.7 p -97.05 -62.84 1.2 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 122.086 -0.384 . . . . 0.0 111.881 -177.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.6 ' O ' HG23 ' A' ' 31' ' ' VAL . 3.8 m -100.97 12.93 36.73 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 121.36 -0.838 . . . . 0.0 111.581 -178.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 57.17 21.56 39.81 Favored Glycine 0 N--CA 1.505 3.289 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -178.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 29' ' ' CYS . 45.2 t -109.49 164.24 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 O-C-N 121.87 -0.783 . . . . 0.0 109.396 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.497 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 136.14 -179.7 17.57 Favored Glycine 0 N--CA 1.5 2.928 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -63.66 173.37 4.62 Favored 'Trans proline' 0 N--CA 1.487 1.093 0 CA-C-N 119.319 1.559 . . . . 0.0 110.229 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 2.3 ptt180 -92.86 88.24 6.12 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 122.081 0.944 . . . . 0.0 110.197 -177.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.694 HD23 ' H ' ' A' ' 35' ' ' LEU . 2.1 pt? -145.53 -172.29 3.86 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 115.298 -0.865 . . . . 0.0 108.836 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -95.62 162.59 13.56 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.67 -57.33 3.62 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 122.127 -0.358 . . . . 0.0 110.182 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -51.38 -26.81 8.41 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 121.91 -0.494 . . . . 0.0 110.708 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -74.08 -44.48 53.9 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.609 ' HE3' HD11 ' A' ' 35' ' ' LEU . 2.5 ttm -63.5 -53.09 57.42 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.2 ttpp -54.24 -38.84 66.2 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.701 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.82 -38.54 91.16 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.12 -35.58 81.23 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 23.0 m -66.99 -35.57 80.26 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 120.396 -0.522 . . . . 0.0 109.616 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 18.2 m -71.76 -32.35 67.6 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.9 -35.07 74.32 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.47 ' O ' HD12 ' A' ' 51' ' ' ILE . 4.1 mt-30 -78.07 -26.3 48.14 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.804 HD11 ' NH1' ' A' ' 56' ' ' ARG . 1.6 tm? -69.72 -45.93 67.1 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -178.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -78.22 -38.82 42.23 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.62 -36.85 57.23 Favored 'General case' 0 N--CA 1.506 2.358 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.47 HD12 ' O ' ' A' ' 47' ' ' GLN . 58.0 mt -85.58 105.54 7.22 Favored Pre-proline 0 N--CA 1.488 1.446 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 176.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -62.86 148.87 92.92 Favored 'Trans proline' 0 N--CA 1.482 0.818 0 C-N-CA 121.771 1.648 . . . . 0.0 111.412 -176.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.67 ' HB1' ' N ' ' A' ' 108' ' ' ILE . . . -47.3 -27.43 1.57 Allowed 'General case' 0 N--CA 1.501 2.124 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.625 -179.083 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -71.1 115.04 9.77 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 12.0 m 70.54 7.94 6.41 Favored 'General case' 0 N--CA 1.507 2.384 0 O-C-N 121.998 -0.439 . . . . 0.0 110.079 -179.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.804 ' NH1' HD11 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -50.22 -93.19 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.322 -0.861 . . . . 0.0 109.507 179.848 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 88.9 m -31.63 -36.29 0.02 OUTLIER 'General case' 0 N--CA 1.521 3.108 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -41.4 -51.99 3.64 Favored 'General case' 0 N--CA 1.512 2.626 0 CA-C-N 119.762 1.164 . . . . 0.0 111.559 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -44.16 -47.06 9.06 Favored 'General case' 0 N--CA 1.511 2.581 0 O-C-N 121.765 -0.584 . . . . 0.0 112.135 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.9 t -50.73 -46.27 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.733 0 CA-C-O 122.134 0.969 . . . . 0.0 108.401 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -58.93 -50.22 74.87 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 177.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.921 HG23 ' HB ' ' A' ' 67' ' ' VAL . 28.0 mm -51.45 -26.96 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 121.673 -0.642 . . . . 0.0 110.109 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.37 -40.41 36.31 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 120.019 -0.673 . . . . 0.0 109.48 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 17.7 ttp -77.02 -55.34 5.54 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.474 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -80.95 -23.84 38.53 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.748 -0.595 . . . . 0.0 111.651 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.68 148.62 12.81 Favored Glycine 0 N--CA 1.506 3.301 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.921 ' HB ' HG23 ' A' ' 62' ' ' ILE . 8.2 p -117.73 159.91 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.559 0 O-C-N 122.185 -0.597 . . . . 0.0 110.632 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.699 HG22 ' NE2' ' A' ' 74' ' ' HIS . 54.3 t -114.97 156.92 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.12 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 31.1 p -117.63 160.01 21.98 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.176 -177.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.2 t -62.02 -29.67 70.43 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.642 -178.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.2 p -71.78 -16.94 62.21 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 116.618 -0.264 . . . . 0.0 110.482 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.88 14.7 30.81 Favored Glycine 0 N--CA 1.498 2.779 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.6 mm100 -103.07 156.34 17.75 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-N 118.204 1.002 . . . . 0.0 109.195 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.699 ' NE2' HG22 ' A' ' 68' ' ' VAL . 9.2 m170 -115.2 155.54 26.99 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -145.83 -175.99 4.96 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 120.995 0.426 . . . . 0.0 109.869 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 59.78 -148.51 42.09 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 108.443 -1.863 . . . . 0.0 108.443 -178.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 57.27 21.5 6.74 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 122.077 -0.661 . . . . 0.0 110.326 179.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.8 mt -81.96 -14.75 55.62 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.777 -0.577 . . . . 0.0 110.673 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.0 tt -58.72 92.48 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -130.97 177.59 7.33 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.193 0.521 . . . . 0.0 109.811 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -77.02 103.36 6.9 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.524 0.678 . . . . 0.0 110.707 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.528 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 18.1 mt -78.25 170.11 17.76 Favored Pre-proline 0 N--CA 1.497 1.875 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 177.495 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.528 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 29.8 Cg_endo -70.92 98.43 0.8 Allowed 'Trans proline' 0 C--N 1.327 -0.561 0 C-N-CA 120.859 1.04 . . . . 0.0 109.463 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 102.57 1.43 49.97 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 3.5 m -139.42 91.61 10.87 Favored Pre-proline 0 N--CA 1.505 2.279 0 CA-C-N 119.087 1.444 . . . . 0.0 109.191 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -72.42 163.28 39.06 Favored 'Trans proline' 0 N--CA 1.482 0.828 0 C-N-CA 121.368 1.378 . . . . 0.0 111.576 -178.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.4 mtm-85 -48.5 -28.65 3.47 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.196 0.522 . . . . 0.0 109.769 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -59.57 -46.23 89.51 Favored 'General case' 0 N--CA 1.504 2.235 0 CA-C-N 116.189 -0.46 . . . . 0.0 112.005 -177.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 49.0 t -68.88 -40.58 81.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.585 -0.697 . . . . 0.0 109.823 -178.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.489 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 1.9 mp0 -64.88 -27.39 68.83 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.35 -34.01 48.7 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 109.813 -0.439 . . . . 0.0 109.813 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.57 -45.67 68.17 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.893 -0.504 . . . . 0.0 109.808 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.728 ' CD1' HG22 ' A' ' 24' ' ' VAL . 44.3 t80 -78.57 -25.77 45.42 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 122.319 -0.238 . . . . 0.0 110.406 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.663 ' HB3' ' HD3' ' A' ' 95' ' ' PRO . . . -42.85 -51.71 12.12 Favored Pre-proline 0 N--CA 1.503 2.212 0 CA-C-O 118.87 -0.586 . . . . 0.0 112.493 -177.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.663 ' HD3' ' HB3' ' A' ' 94' ' ' ALA . 30.7 Cg_endo -72.98 -172.42 0.98 Allowed 'Trans proline' 0 N--CA 1.476 0.484 0 C-N-CA 121.697 1.598 . . . . 0.0 110.328 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.4 mttt 64.59 17.15 10.74 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -178.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.613 HD12 ' O ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -74.13 -75.89 0.15 Allowed 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.484 HG12 ' NH1' ' A' ' 56' ' ' ARG . 8.4 m -64.56 1.18 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.334 0 O-C-N 121.612 -0.68 . . . . 0.0 112.487 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 22.3 p -87.8 174.5 8.34 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -61.04 -0.1 0.28 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.424 -0.797 . . . . 0.0 111.899 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.475 ' O ' HG12 ' A' ' 101' ' ' VAL . 21.3 t -90.53 -4.04 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 CA-C-N 120.429 1.468 . . . . 0.0 111.188 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -140.25 -83.01 0.24 Allowed 'General case' 0 N--CA 1.51 2.557 0 C-N-CA 119.108 -1.037 . . . . 0.0 112.693 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 96.2 m -146.28 42.28 1.18 Allowed 'General case' 0 N--CA 1.504 2.256 0 CA-C-N 119.722 1.146 . . . . 0.0 109.258 -178.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.42 ' HA ' ' O ' ' A' ' 98' ' ' VAL . 11.2 p-10 -37.9 -60.66 0.71 Allowed 'General case' 0 N--CA 1.504 2.273 0 N-CA-C 113.553 0.945 . . . . 0.0 113.553 -178.22 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.402 ' O ' ' HB3' ' A' ' 106' ' ' ALA . 79.2 mt 45.92 25.06 0.27 Allowed 'General case' 0 N--CA 1.51 2.564 0 CA-C-N 119.054 0.843 . . . . 0.0 111.396 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 105' ' ' LEU . . . 64.02 141.73 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.321 -0.862 . . . . 0.0 109.674 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.2 p -112.5 -161.8 0.77 Allowed 'General case' 0 N--CA 1.506 2.348 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.67 ' N ' ' HB1' ' A' ' 53' ' ' ALA . 1.0 OUTLIER -66.13 -33.01 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.278 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -70.05 -1.25 9.35 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.189 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 57.74 30.36 62.64 Favored Glycine 0 N--CA 1.499 2.887 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -157.22 169.62 34.3 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.4 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 31.8 Cg_endo -78.22 73.85 5.6 Favored 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 122.725 2.283 . . . . 0.0 112.134 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.4 ' HB3' ' O ' ' A' ' 112' ' ' PRO . 49.2 p90 . . . . . 0 N--CA 1.507 2.407 0 O-C-N 121.827 -0.545 . . . . 0.0 110.462 177.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo . . . . . 0 N--CA 1.48 0.72 0 N-CA-C 110.564 -0.591 . . . . 0.0 110.564 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.6 2.12 74.07 Favored Glycine 0 N--CA 1.501 3.017 0 N-CA-C 110.634 -0.987 . . . . 0.0 110.634 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.573 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 4.0 mmt -133.29 104.06 6.28 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 87.2 -57.11 0.04 OUTLIER 'General case' 0 N--CA 1.515 2.789 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -178.178 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 57.6 mt -100.53 102.36 18.61 Favored Pre-proline 0 N--CA 1.495 1.797 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 178.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -81.28 173.61 11.51 Favored 'Trans proline' 0 N--CA 1.477 0.501 0 C-N-CA 121.616 1.544 . . . . 0.0 111.879 -176.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 43.3 m80 -76.0 146.88 39.2 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.488 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 19.2 t-20 68.11 56.87 0.71 Allowed Pre-proline 0 N--CA 1.508 2.473 0 O-C-N 121.393 -0.817 . . . . 0.0 111.721 179.205 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.488 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 41.2 Cg_endo -84.56 171.1 10.0 Favored 'Trans proline' 0 N--CA 1.481 0.774 0 C-N-CA 122.139 1.893 . . . . 0.0 111.066 178.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 27.6 mt 46.2 46.45 13.19 Favored 'General case' 0 N--CA 1.502 2.167 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.096 177.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -75.49 -43.04 51.31 Favored 'General case' 0 N--CA 1.505 2.311 0 O-C-N 121.482 -0.761 . . . . 0.0 109.002 178.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -63.57 -26.33 68.64 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.715 ' O ' HG23 ' A' ' 24' ' ' VAL . 34.6 m -75.08 -34.54 61.78 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.6 ' NH1' HD23 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -68.32 -46.57 69.86 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.793 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 31.7 m95 -71.77 -29.41 64.45 Favored 'General case' 0 N--CA 1.506 2.326 0 C-N-CA 118.691 -1.203 . . . . 0.0 109.274 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -65.23 -32.41 74.07 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 20' ' ' CYS . 47.9 t -71.35 -41.05 73.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 177.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.1 m -55.5 -39.15 70.1 Favored 'General case' 0 N--CA 1.502 2.159 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.161 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 94.5 m -77.62 -51.52 10.5 Favored 'General case' 0 N--CA 1.508 2.452 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -65.14 -25.01 67.57 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.432 -0.792 . . . . 0.0 110.672 -178.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.46 HG23 ' O ' ' A' ' 24' ' ' VAL . 43.9 p -93.77 -61.09 1.61 Allowed 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -177.501 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.694 ' O ' HG23 ' A' ' 31' ' ' VAL . 3.8 m -100.47 7.83 43.92 Favored 'General case' 0 N--CA 1.507 2.415 0 O-C-N 121.363 -0.836 . . . . 0.0 111.784 -178.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 58.29 24.81 56.4 Favored Glycine 0 N--CA 1.506 3.302 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -178.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.694 HG23 ' O ' ' A' ' 29' ' ' CYS . 19.7 t -119.11 165.54 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 122.124 -0.633 . . . . 0.0 109.35 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.48 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 134.05 -178.89 18.01 Favored Glycine 0 N--CA 1.5 2.954 0 N-CA-C 108.394 -1.882 . . . . 0.0 108.394 -178.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.414 ' HB2' HD23 ' A' ' 35' ' ' LEU . 26.7 Cg_endo -64.62 171.67 7.96 Favored 'Trans proline' 0 N--CA 1.485 0.991 0 CA-C-N 119.63 1.715 . . . . 0.0 109.672 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.748 ' C ' HD22 ' A' ' 35' ' ' LEU . 9.6 mtp180 -92.89 80.87 4.63 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 122.066 0.936 . . . . 0.0 110.115 -177.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.748 HD22 ' C ' ' A' ' 34' ' ' ARG . 4.3 mm? -122.5 -175.67 3.2 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.085 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -99.61 140.76 33.34 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.96 -53.59 47.89 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.616 -0.677 . . . . 0.0 111.042 -179.105 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.6 tm0? -52.46 -46.64 66.59 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.95 -0.469 . . . . 0.0 110.888 -178.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -63.91 -32.07 73.47 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 33.1 tpp -66.94 -58.46 4.92 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 10.2 tptt -53.2 -36.99 61.57 Favored 'General case' 0 N--CA 1.501 2.076 0 CA-C-O 121.179 0.514 . . . . 0.0 109.656 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.49 -40.92 98.35 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.82 -38.74 89.27 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 20.1 m -66.5 -33.54 75.91 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 50.6 m -72.26 -31.16 65.54 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 15.3 ttt85 -73.05 -32.62 65.18 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -76.43 -32.1 58.27 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.76 HD21 HG12 ' A' ' 98' ' ' VAL . 1.1 tp -72.98 -35.94 66.98 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.486 ' OE1' HD22 ' A' ' 105' ' ' LEU . 6.0 tp10 -72.7 -37.25 67.88 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 179.017 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.98 -38.51 82.77 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.021 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 45.4 mt -82.38 104.7 3.64 Favored Pre-proline 0 N--CA 1.495 1.789 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 177.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -58.32 140.72 95.49 Favored 'Trans proline' 0 N--CA 1.482 0.81 0 C-N-CA 121.775 1.65 . . . . 0.0 112.208 -175.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.586 ' HB1' ' N ' ' A' ' 108' ' ' ILE . . . -48.99 -24.39 1.5 Allowed 'General case' 0 N--CA 1.5 2.075 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.201 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -45.67 -71.9 0.07 Allowed 'General case' 0 N--CA 1.505 2.319 0 O-C-N 121.969 -0.457 . . . . 0.0 111.204 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 21.1 m -110.5 23.91 13.64 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.99 -0.444 . . . . 0.0 110.86 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.2 mtt180 -40.38 -83.44 0.01 OUTLIER 'General case' 0 N--CA 1.516 2.828 0 O-C-N 121.316 -0.865 . . . . 0.0 110.863 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 75.2 m -32.28 -35.88 0.02 OUTLIER 'General case' 0 N--CA 1.52 3.035 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -46.06 -58.07 3.91 Favored 'General case' 0 N--CA 1.511 2.607 0 CA-C-N 119.933 1.242 . . . . 0.0 110.931 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -42.61 -37.94 1.85 Allowed 'General case' 0 N--CA 1.513 2.715 0 O-C-N 121.675 -0.641 . . . . 0.0 112.346 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.709 ' CG2' HD13 ' A' ' 97' ' ' LEU . 25.8 t -55.08 -49.91 67.86 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 O-C-N 121.774 -0.579 . . . . 0.0 109.556 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -58.15 -28.99 65.23 Favored 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.794 HG23 ' HB ' ' A' ' 67' ' ' VAL . 2.0 mp -77.85 -27.58 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.269 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.46 HD23 ' C ' ' A' ' 63' ' ' LEU . 10.1 tt -78.18 -40.9 36.29 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 120.117 -0.633 . . . . 0.0 109.813 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -78.85 -51.62 9.47 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.142 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -80.81 -23.91 38.89 Favored 'General case' 0 N--CA 1.502 2.135 0 C-N-CA 120.689 -0.404 . . . . 0.0 111.323 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.9 146.3 8.02 Favored Glycine 0 N--CA 1.498 2.788 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.794 ' HB ' HG23 ' A' ' 62' ' ' ILE . 14.2 p -117.45 160.12 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 O-C-N 122.347 -0.502 . . . . 0.0 109.781 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.645 HG22 ' NE2' ' A' ' 74' ' ' HIS . 55.5 t -114.2 157.54 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 53.3 p -117.28 159.28 22.95 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.838 -177.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 34.7 t -64.59 -28.04 69.36 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.385 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.5 p -71.4 -16.05 62.39 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.68 10.83 42.61 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -100.93 156.51 17.34 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 118.201 1.0 . . . . 0.0 109.197 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.645 ' NE2' HG22 ' A' ' 68' ' ' VAL . 11.2 m170 -115.86 155.49 27.81 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -144.44 -173.51 4.06 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.287 0.565 . . . . 0.0 110.26 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.534 ' O ' HD12 ' A' ' 78' ' ' LEU . . . 61.01 -145.01 48.56 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.722 -1.751 . . . . 0.0 108.722 -178.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.411 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 2.7 tpt180 56.44 21.61 5.71 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 122.229 -0.571 . . . . 0.0 109.486 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.6 HD23 ' NH1' ' A' ' 21' ' ' ARG . 10.1 mp -66.12 -21.6 66.35 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.484 -0.76 . . . . 0.0 109.983 -179.098 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.527 HD12 ' HB3' ' A' ' 90' ' ' GLN . 3.0 tt -61.04 92.9 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.485 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -141.98 176.83 8.63 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.518 0.675 . . . . 0.0 110.662 -178.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -64.2 118.38 8.51 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.857 0.837 . . . . 0.0 111.367 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.484 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 22.0 mt -112.95 166.63 10.66 Favored Pre-proline 0 N--CA 1.497 1.89 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 177.167 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.484 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 29.4 Cg_endo -68.6 99.81 0.65 Allowed 'Trans proline' 0 C--N 1.326 -0.632 0 C-N-CA 121.063 1.175 . . . . 0.0 110.532 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.99 8.43 64.9 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.431 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 3.4 m -141.72 91.1 8.42 Favored Pre-proline 0 N--CA 1.511 2.615 0 CA-C-N 118.869 1.335 . . . . 0.0 109.504 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -72.95 166.4 30.15 Favored 'Trans proline' 0 N--CA 1.488 1.165 0 C-N-CA 121.895 1.73 . . . . 0.0 111.754 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 72.7 mtp180 -51.13 -27.55 8.78 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.173 0.511 . . . . 0.0 109.893 178.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -61.13 -45.92 92.69 Favored 'General case' 0 N--CA 1.502 2.169 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.239 -177.209 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 58.6 t -69.16 -43.61 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.665 -0.647 . . . . 0.0 110.602 -178.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.65 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 31.2 mt-30 -67.49 -27.71 67.23 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.421 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 5.9 tpt180 -78.65 -26.71 45.2 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.38 -48.45 17.24 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.923 -0.486 . . . . 0.0 110.065 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -78.31 -27.64 47.28 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 122.116 -0.365 . . . . 0.0 110.999 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.65 ' HB2' ' O ' ' A' ' 90' ' ' GLN . . . -53.09 -50.86 79.81 Favored Pre-proline 0 N--CA 1.502 2.14 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.637 ' HD3' ' HB3' ' A' ' 94' ' ' ALA . 31.2 Cg_endo -71.3 82.43 1.09 Allowed 'Trans proline' 0 N--CA 1.482 0.823 0 C-N-CA 122.197 1.931 . . . . 0.0 111.978 -177.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 164.62 57.28 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.492 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.196 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.8 ' HG ' HG13 ' A' ' 98' ' ' VAL . 2.3 pt? -86.94 -56.83 3.21 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -177.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.8 HG13 ' HG ' ' A' ' 97' ' ' LEU . 13.1 m -92.48 25.14 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-N 120.833 1.651 . . . . 0.0 111.183 -178.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 30.8 p -90.74 170.47 10.1 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -62.98 -2.56 1.26 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.452 -0.78 . . . . 0.0 112.121 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.57 ' O ' HG12 ' A' ' 101' ' ' VAL . 21.6 t -100.9 2.83 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 CA-C-N 120.416 1.462 . . . . 0.0 111.269 -179.297 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -133.71 -90.5 0.37 Allowed 'General case' 0 N--CA 1.502 2.133 0 CA-C-N 118.822 0.737 . . . . 0.0 110.97 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.712 ' O ' HD12 ' A' ' 105' ' ' LEU . 46.8 m -143.63 37.98 1.35 Allowed 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.559 -0.713 . . . . 0.0 109.491 -178.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -33.89 -62.66 0.3 Allowed 'General case' 0 N--CA 1.509 2.516 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -178.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.712 HD12 ' O ' ' A' ' 103' ' ' CYS . 3.4 mt 50.18 20.94 0.69 Allowed 'General case' 0 N--CA 1.506 2.341 0 CA-C-N 118.944 0.793 . . . . 0.0 110.946 -179.144 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 63.23 124.08 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.304 -0.872 . . . . 0.0 109.769 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.8 p -89.25 -160.2 0.65 Allowed 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.586 ' N ' ' HB1' ' A' ' 53' ' ' ALA . 6.2 tt -66.58 -30.97 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.371 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.414 ' HB3' ' CE1' ' A' ' 113' ' ' PHE . 96.2 m-70 -69.35 -0.97 7.08 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.007 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 58.67 27.74 61.84 Favored Glycine 0 N--CA 1.498 2.813 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -156.74 167.79 33.72 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -78.44 75.04 5.12 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 122.722 2.281 . . . . 0.0 111.764 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.414 ' CE1' ' HB3' ' A' ' 109' ' ' HIS . 19.5 p90 . . . . . 0 N--CA 1.508 2.471 0 O-C-N 121.617 -0.677 . . . . 0.0 110.956 178.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo . . . . . 0 CA--C 1.54 0.783 0 N-CA-C 110.503 -0.614 . . . . 0.0 110.503 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 79.49 -5.05 61.66 Favored Glycine 0 N--CA 1.499 2.852 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.562 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 86.8 mmm -140.82 115.23 9.39 Favored 'General case' 0 N--CA 1.501 2.105 0 CA-C-N 118.665 1.232 . . . . 0.0 108.968 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 85.72 -56.94 0.08 Allowed 'General case' 0 N--CA 1.515 2.795 0 CA-C-N 119.939 1.245 . . . . 0.0 108.434 -179.082 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.441 HG12 HD12 ' A' ' 51' ' ' ILE . 80.7 mt -110.84 100.79 47.51 Favored Pre-proline 0 N--CA 1.489 1.507 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 178.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -80.48 172.94 12.91 Favored 'Trans proline' 0 C--O 1.22 -0.413 0 C-N-CA 121.41 1.407 . . . . 0.0 111.284 -176.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 50.8 m-70 -75.79 143.33 41.99 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.454 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 2.7 m120 63.36 61.94 1.76 Allowed Pre-proline 0 N--CA 1.502 2.152 0 O-C-N 121.769 -0.582 . . . . 0.0 109.742 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.454 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 40.3 Cg_endo -83.45 167.79 13.32 Favored 'Trans proline' 0 N--CA 1.483 0.859 0 C-N-CA 122.459 2.106 . . . . 0.0 111.693 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 42.2 mt 47.64 45.89 17.91 Favored 'General case' 0 N--CA 1.504 2.233 0 CA-C-O 121.105 0.478 . . . . 0.0 111.516 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -74.13 -39.67 63.16 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.538 -0.726 . . . . 0.0 109.447 179.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.3 t -66.58 -25.95 66.88 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.533 ' O ' HG23 ' A' ' 24' ' ' VAL . 37.1 m -75.28 -41.75 56.48 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -43.75 97.03 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.434 ' HA ' ' CE3' ' A' ' 22' ' ' TRP . 38.7 m95 -74.19 -25.92 59.98 Favored 'General case' 0 N--CA 1.501 2.087 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.129 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -69.8 -28.47 65.76 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.737 HG22 ' CE1' ' A' ' 93' ' ' PHE . 52.1 t -75.61 -43.02 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 177.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.447 ' HB3' HD13 ' A' ' 82' ' ' LEU . 0.8 OUTLIER -55.78 -41.77 74.56 Favored 'General case' 0 N--CA 1.503 2.19 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.349 -179.403 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.1 m -77.67 -53.58 7.38 Favored 'General case' 0 N--CA 1.509 2.516 0 O-C-N 122.085 -0.385 . . . . 0.0 111.685 -178.148 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -60.5 -24.99 65.74 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.851 -0.53 . . . . 0.0 110.453 -178.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.554 HG23 ' O ' ' A' ' 24' ' ' VAL . 31.8 p -97.23 -64.11 1.07 Allowed 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -177.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.558 ' O ' HG23 ' A' ' 31' ' ' VAL . 19.6 m -101.2 14.55 31.59 Favored 'General case' 0 N--CA 1.508 2.45 0 O-C-N 121.386 -0.821 . . . . 0.0 112.0 -178.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 57.05 21.16 37.33 Favored Glycine 0 N--CA 1.505 3.255 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 29' ' ' CYS . 23.6 t -107.74 160.43 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.242 0 O-C-N 121.858 -0.79 . . . . 0.0 109.069 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.436 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 130.65 -179.39 16.97 Favored Glycine 0 N--CA 1.5 2.94 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -66.23 173.88 6.81 Favored 'Trans proline' 0 N--CA 1.486 1.076 0 CA-C-N 119.263 1.531 . . . . 0.0 109.736 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 2.9 ptt180 -92.81 82.66 4.72 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 122.086 0.945 . . . . 0.0 110.742 -177.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 24.5 mt -134.82 138.93 44.68 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.87 160.86 3.22 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -73.08 -56.49 5.05 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.963 -0.461 . . . . 0.0 111.209 -178.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -54.32 -35.65 62.9 Favored 'General case' 0 N--CA 1.506 2.364 0 O-C-N 121.913 -0.492 . . . . 0.0 110.47 -178.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -64.09 -57.65 8.98 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 5.0 ttm -53.08 -47.48 68.48 Favored 'General case' 0 N--CA 1.504 2.238 0 CA-C-O 121.6 0.714 . . . . 0.0 109.401 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 23.8 ttmt -55.95 -37.72 69.37 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.49 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.22 -35.21 79.83 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.61 -41.69 98.27 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 19.5 m -66.26 -38.65 88.32 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.552 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 84.9 m -69.76 -28.49 65.81 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -74.51 -32.23 62.43 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -74.54 -35.49 63.11 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.442 HD11 HG12 ' A' ' 98' ' ' VAL . 2.3 tt -75.68 -27.23 58.19 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.487 ' HG2' HD13 ' A' ' 105' ' ' LEU . 1.6 mm-40 -77.22 -52.16 9.71 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.57 -45.57 69.99 Favored 'General case' 0 N--CA 1.508 2.441 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.441 HD12 HG12 ' A' ' 12' ' ' ILE . 23.7 mm -67.57 106.47 1.26 Allowed Pre-proline 0 N--CA 1.49 1.528 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 175.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -58.51 151.2 63.64 Favored 'Trans proline' 0 N--CA 1.479 0.642 0 C-N-CA 121.479 1.453 . . . . 0.0 110.962 -176.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.423 ' HA ' ' HD3' ' A' ' 56' ' ' ARG . . . -40.72 -29.7 0.1 Allowed 'General case' 0 N--CA 1.507 2.377 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.686 -178.549 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -73.77 131.33 41.46 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 8.3 m 72.35 6.28 5.46 Favored 'General case' 0 N--CA 1.508 2.433 0 O-C-N 122.125 -0.36 . . . . 0.0 111.335 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.423 ' HD3' ' HA ' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -49.21 -85.23 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.715 0 CA-C-N 119.247 0.931 . . . . 0.0 110.038 -179.765 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 85.5 m -38.09 -45.08 0.88 Allowed 'General case' 0 N--CA 1.518 2.97 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.411 ' O ' HD12 ' A' ' 62' ' ' ILE . 25.5 tt0 -39.86 -50.7 2.45 Favored 'General case' 0 N--CA 1.511 2.586 0 CA-C-N 119.819 1.19 . . . . 0.0 112.148 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -43.86 -47.02 8.2 Favored 'General case' 0 N--CA 1.518 2.939 0 O-C-N 121.573 -0.705 . . . . 0.0 111.609 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 1.008 HG21 HD13 ' A' ' 97' ' ' LEU . 45.2 t -53.71 -45.24 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.55 -32.15 72.21 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.85 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.693 HG23 ' HB ' ' A' ' 67' ' ' VAL . 1.2 mp -70.08 -28.19 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.795 HD13 ' O ' ' A' ' 63' ' ' LEU . 0.9 OUTLIER -77.95 -39.51 42.39 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.047 -179.349 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 14.4 ttp -78.25 -54.8 5.83 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.927 -0.483 . . . . 0.0 110.374 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -80.95 -23.58 38.71 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 122.202 -0.311 . . . . 0.0 111.189 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.33 148.45 13.89 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 -178.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.693 ' HB ' HG23 ' A' ' 62' ' ' ILE . 7.7 p -118.01 159.52 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 O-C-N 122.206 -0.585 . . . . 0.0 109.661 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.647 HG22 ' NE2' ' A' ' 74' ' ' HIS . 76.2 t -115.21 157.56 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 CA-C-O 122.038 0.923 . . . . 0.0 110.368 -178.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.404 ' N ' HG12 ' A' ' 68' ' ' VAL . 23.6 p -117.23 160.65 20.73 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.569 -177.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.6 t -63.5 -34.45 77.8 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.129 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.8 p -63.82 -17.74 63.42 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.73 9.1 47.24 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -97.49 156.88 16.29 Favored 'General case' 0 N--CA 1.503 2.207 0 CA-C-N 118.278 1.039 . . . . 0.0 109.892 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.647 ' NE2' HG22 ' A' ' 68' ' ' VAL . 9.9 m170 -116.04 155.06 28.79 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -141.76 -175.96 4.58 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.009 0.433 . . . . 0.0 109.908 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 59.45 -143.76 46.13 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.3 22.06 4.56 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 122.289 -0.536 . . . . 0.0 110.167 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 55.0 mt -81.43 -15.26 55.65 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.735 -0.603 . . . . 0.0 110.739 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.707 HD21 ' HB3' ' A' ' 90' ' ' GLN . 4.7 tt -57.26 91.99 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -128.38 179.77 5.46 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.26 0.552 . . . . 0.0 109.818 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.75 106.05 7.11 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.313 0.577 . . . . 0.0 110.696 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.564 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 23.0 mt -81.33 169.63 18.34 Favored Pre-proline 0 N--CA 1.495 1.798 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 177.249 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.564 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 28.3 Cg_endo -66.75 99.4 0.45 Allowed 'Trans proline' 0 C--N 1.329 -0.487 0 C-N-CA 120.978 1.119 . . . . 0.0 111.201 -178.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 103.07 -14.05 55.67 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 6.1 m -123.65 92.22 48.89 Favored Pre-proline 0 N--CA 1.504 2.253 0 CA-C-N 119.323 1.561 . . . . 0.0 110.352 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -72.12 166.11 30.61 Favored 'Trans proline' 0 N--CA 1.483 0.87 0 C-N-CA 121.598 1.532 . . . . 0.0 111.04 -179.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.5 mtm180 -46.9 -28.52 1.62 Allowed 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.152 0.501 . . . . 0.0 109.754 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.8 tm0? -58.65 -52.21 66.65 Favored 'General case' 0 N--CA 1.503 2.199 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.483 -178.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 60.1 t -64.23 -41.75 93.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.746 -0.596 . . . . 0.0 109.576 -178.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.707 ' HB3' HD21 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -63.57 -25.94 68.47 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.29 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -79.0 -33.46 44.98 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.51 -47.68 63.01 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.737 ' CE1' HG22 ' A' ' 24' ' ' VAL . 42.5 t80 -78.27 -25.37 46.72 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.478 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.67 ' HB3' ' HD3' ' A' ' 95' ' ' PRO . . . -42.69 -52.17 11.18 Favored Pre-proline 0 N--CA 1.504 2.227 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -177.428 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.67 ' HD3' ' HB3' ' A' ' 94' ' ' ALA . 29.6 Cg_endo -70.98 -164.1 0.14 Allowed 'Trans proline' 0 C--N 1.328 -0.513 0 C-N-CA 121.689 1.593 . . . . 0.0 110.296 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 60.57 24.68 14.37 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -178.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 1.008 HD13 HG21 ' A' ' 60' ' ' VAL . 6.6 mt -73.42 -67.93 0.54 Allowed 'General case' 0 N--CA 1.505 2.276 0 O-C-N 122.034 -0.416 . . . . 0.0 111.42 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.442 HG12 HD11 ' A' ' 48' ' ' LEU . 14.7 m -85.52 22.11 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.35 -0.843 . . . . 0.0 111.085 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 30.8 p -99.44 173.31 6.81 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -59.06 -4.16 0.46 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.532 -0.73 . . . . 0.0 111.764 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.53 ' O ' HG12 ' A' ' 101' ' ' VAL . 20.0 t -91.83 -0.27 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-N 120.545 1.52 . . . . 0.0 111.403 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -140.82 -89.39 0.16 Allowed 'General case' 0 N--CA 1.504 2.261 0 CA-C-N 118.974 0.807 . . . . 0.0 111.247 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.443 ' O ' HD12 ' A' ' 105' ' ' LEU . 55.8 m -145.02 42.38 1.31 Allowed 'General case' 0 N--CA 1.508 2.471 0 O-C-N 121.432 -0.792 . . . . 0.0 109.518 -178.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -36.2 -62.5 0.44 Allowed 'General case' 0 N--CA 1.512 2.67 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -178.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.487 HD13 ' HG2' ' A' ' 49' ' ' GLU . 1.9 mt 46.3 27.76 0.62 Allowed 'General case' 0 N--CA 1.513 2.722 0 CA-C-N 118.988 0.813 . . . . 0.0 111.268 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 105' ' ' LEU . . . 70.34 150.34 0.09 Allowed 'General case' 0 N--CA 1.507 2.408 0 O-C-N 121.199 -0.938 . . . . 0.0 109.174 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.0 p -123.16 -163.78 1.14 Allowed 'General case' 0 N--CA 1.505 2.294 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.2 tp -66.12 -31.23 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.452 ' CB ' ' CE1' ' A' ' 113' ' ' PHE . 80.2 m80 -75.68 5.55 6.0 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.974 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 57.96 32.29 66.28 Favored Glycine 0 N--CA 1.499 2.834 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -164.42 171.95 40.06 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 110.116 -1.193 . . . . 0.0 110.116 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -75.8 80.02 2.71 Favored 'Trans proline' 0 N--CA 1.48 0.708 0 C-N-CA 122.626 2.217 . . . . 0.0 110.855 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.461 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.163 0 CA-C-O 121.462 0.649 . . . . 0.0 111.213 179.176 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo . . . . . 0 CA--C 1.537 0.656 0 N-CA-C 109.904 -0.844 . . . . 0.0 109.904 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 58.32 24.18 55.07 Favored Glycine 0 N--CA 1.499 2.847 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.577 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 38.7 mmm -138.07 95.08 2.96 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.98 -0.718 . . . . 0.0 109.1 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.577 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 86.77 -56.43 0.05 Allowed 'General case' 0 N--CA 1.515 2.803 0 CA-C-N 119.008 0.822 . . . . 0.0 108.796 -178.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.6 mt -104.59 101.11 26.16 Favored Pre-proline 0 N--CA 1.494 1.73 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 178.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -81.78 173.2 11.45 Favored 'Trans proline' 0 N--CA 1.476 0.457 0 C-N-CA 121.555 1.504 . . . . 0.0 111.764 -176.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 45.0 m-70 -74.52 146.15 42.9 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.519 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 0.9 OUTLIER 60.79 54.99 3.5 Favored Pre-proline 0 N--CA 1.501 2.094 0 O-C-N 121.56 -0.712 . . . . 0.0 109.955 -179.098 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.519 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 40.4 Cg_endo -81.17 166.96 18.19 Favored 'Trans proline' 0 N--CA 1.484 0.953 0 C-N-CA 122.239 1.959 . . . . 0.0 111.606 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 38.3 mt 51.09 45.08 28.3 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.921 177.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -68.09 -41.38 81.94 Favored 'General case' 0 N--CA 1.505 2.323 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.57 -26.27 68.62 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 178.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.477 ' O ' HG23 ' A' ' 24' ' ' VAL . 60.7 m -75.52 -38.65 59.25 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.717 ' HD3' HD12 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -62.43 -50.68 70.55 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.004 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.457 ' HA ' ' CE3' ' A' ' 22' ' ' TRP . 32.1 m95 -69.86 -26.46 64.21 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 119.517 -0.873 . . . . 0.0 109.853 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.432 ' O ' ' CD1' ' A' ' 23' ' ' TYR . 7.7 t80 -67.59 -30.35 69.93 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.685 HG22 ' CD1' ' A' ' 93' ' ' PHE . 59.0 t -74.43 -44.43 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 108.301 -0.999 . . . . 0.0 108.301 178.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 p -56.7 -40.96 76.55 Favored 'General case' 0 N--CA 1.505 2.277 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.38 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.3 m -77.22 -53.19 8.04 Favored 'General case' 0 N--CA 1.509 2.497 0 O-C-N 122.01 -0.432 . . . . 0.0 111.872 -178.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -61.8 -24.88 67.14 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.798 -0.563 . . . . 0.0 110.6 -178.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.542 HG23 ' O ' ' A' ' 24' ' ' VAL . 35.4 p -95.66 -63.86 1.11 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.966 -0.459 . . . . 0.0 111.956 -177.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.46 ' O ' HG23 ' A' ' 31' ' ' VAL . 3.7 m -100.93 11.91 38.68 Favored 'General case' 0 N--CA 1.509 2.491 0 O-C-N 121.315 -0.866 . . . . 0.0 111.424 -178.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 59.35 20.23 49.96 Favored Glycine 0 N--CA 1.502 3.056 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -178.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 29' ' ' CYS . 61.1 t -106.37 158.72 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 O-C-N 121.888 -0.772 . . . . 0.0 109.079 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.434 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 135.04 179.06 16.14 Favored Glycine 0 N--CA 1.497 2.761 0 N-CA-C 108.74 -1.744 . . . . 0.0 108.74 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -65.8 172.39 8.37 Favored 'Trans proline' 0 N--CA 1.483 0.904 0 CA-C-N 119.289 1.545 . . . . 0.0 109.635 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 27.8 mtt180 -92.41 74.77 5.23 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 122.155 0.978 . . . . 0.0 109.705 -178.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 35' ' ' LEU . 0.2 OUTLIER -124.05 135.87 53.87 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.084 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.57 150.84 3.51 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.977 -0.452 . . . . 0.0 110.0 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.4 m -73.74 -28.68 61.81 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.736 -0.603 . . . . 0.0 111.185 -178.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -72.74 -31.4 64.92 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.867 -0.521 . . . . 0.0 109.656 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -75.72 -32.66 60.13 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.41 ' HB3' ' CD2' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -70.29 -53.59 16.19 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.575 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 21.7 tttp -56.73 -37.41 70.95 Favored 'General case' 0 N--CA 1.506 2.374 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.19 -38.48 90.62 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.3 mpt_? -65.08 -42.65 93.92 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 17.0 m -65.21 -34.72 79.05 Favored 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.883 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 82.3 m -74.44 -29.8 61.63 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.7 ttt180 -73.63 -32.58 64.11 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -78.75 -35.89 43.95 Favored 'General case' 0 N--CA 1.502 2.17 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.112 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.1 tt -69.63 -37.42 76.78 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -75.56 -41.23 55.38 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.85 -38.01 64.24 Favored 'General case' 0 N--CA 1.509 2.48 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 177.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 59.8 mt -78.92 105.69 3.39 Favored Pre-proline 0 N--CA 1.488 1.434 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 176.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -60.01 152.05 67.72 Favored 'Trans proline' 0 N--CA 1.481 0.745 0 C-N-CA 121.712 1.608 . . . . 0.0 111.278 -176.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -41.37 -29.17 0.14 Allowed 'General case' 0 N--CA 1.507 2.415 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.376 -178.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -67.12 121.85 16.51 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 66.2 m 60.79 15.55 6.0 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 122.195 -0.316 . . . . 0.0 110.537 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.58 -91.38 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.259 -0.901 . . . . 0.0 109.876 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 54.3 m -32.28 -33.95 0.01 OUTLIER 'General case' 0 N--CA 1.521 3.112 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -40.41 -51.64 2.82 Favored 'General case' 0 N--CA 1.509 2.501 0 CA-C-N 119.759 1.163 . . . . 0.0 111.893 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.592 ' HA ' HD12 ' A' ' 62' ' ' ILE . . . -40.42 -47.88 2.66 Favored 'General case' 0 N--CA 1.514 2.746 0 O-C-N 121.897 -0.502 . . . . 0.0 112.108 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.725 HG21 HD13 ' A' ' 97' ' ' LEU . 24.4 t -58.26 -49.22 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.57 -26.27 63.43 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.13 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.871 HG23 ' HB ' ' A' ' 67' ' ' VAL . 9.3 mt -78.81 -30.76 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.996 -0.44 . . . . 0.0 110.272 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.71 ' O ' HD23 ' A' ' 63' ' ' LEU . 4.4 tt -78.03 -42.03 33.79 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 120.014 -0.675 . . . . 0.0 109.334 -178.47 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 6.8 tpt -78.27 -53.17 7.61 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.313 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -81.51 -21.87 38.33 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 122.147 -0.346 . . . . 0.0 111.429 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.13 149.9 14.35 Favored Glycine 0 N--CA 1.499 2.878 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -178.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.871 ' HB ' HG23 ' A' ' 62' ' ' ILE . 7.3 p -118.17 160.18 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.295 0 O-C-N 122.224 -0.574 . . . . 0.0 110.43 -179.146 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.735 HG22 ' NE2' ' A' ' 74' ' ' HIS . 42.3 t -114.72 157.35 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 28.2 p -117.43 160.27 21.45 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.544 0.688 . . . . 0.0 110.171 -177.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.3 t -61.65 -25.7 67.54 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.35 -178.019 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.2 p -80.19 -14.19 58.64 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 122.253 -0.279 . . . . 0.0 110.721 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.23 13.2 34.02 Favored Glycine 0 N--CA 1.498 2.804 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -99.15 156.92 16.71 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-N 118.103 0.951 . . . . 0.0 109.092 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.735 ' NE2' HG22 ' A' ' 68' ' ' VAL . 8.5 m170 -115.65 155.28 27.98 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -144.75 -177.14 5.36 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 120.949 0.404 . . . . 0.0 110.093 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 59.62 -141.03 47.67 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 108.876 -1.69 . . . . 0.0 108.876 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.6 ttp180 55.08 22.45 4.5 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 122.267 -0.549 . . . . 0.0 110.431 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -80.47 -15.26 57.18 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.609 -0.682 . . . . 0.0 110.657 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.717 HD12 ' HD3' ' A' ' 21' ' ' ARG . 2.1 tp -67.46 90.65 0.25 Allowed 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -126.03 177.26 6.46 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -60.81 100.69 0.12 Allowed 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 121.638 0.732 . . . . 0.0 110.535 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.559 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 19.7 mt -80.41 170.74 14.51 Favored Pre-proline 0 N--CA 1.498 1.946 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 177.324 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.559 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 29.2 Cg_endo -70.07 98.78 0.74 Allowed 'Trans proline' 0 C--O 1.219 -0.447 0 C-N-CA 120.709 0.939 . . . . 0.0 109.883 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 100.09 3.53 55.69 Favored Glycine 0 N--CA 1.495 2.625 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 3.5 m -138.76 91.13 12.09 Favored Pre-proline 0 N--CA 1.503 2.223 0 CA-C-N 119.114 1.457 . . . . 0.0 109.341 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -74.45 162.11 38.82 Favored 'Trans proline' 0 N--CA 1.481 0.786 0 C-N-CA 121.343 1.362 . . . . 0.0 111.2 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 3.8 mmm180 -47.92 -29.21 3.16 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -54.35 -50.46 67.41 Favored 'General case' 0 N--CA 1.508 2.432 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.809 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 63.4 t -64.63 -36.44 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.655 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 52.4 mm-40 -63.27 -26.7 68.9 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.73 -37.21 41.92 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.49 -48.76 71.51 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.685 ' CD1' HG22 ' A' ' 24' ' ' VAL . 41.3 t80 -78.51 -25.22 45.55 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 122.248 -0.282 . . . . 0.0 110.654 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.755 ' HB3' ' HD3' ' A' ' 95' ' ' PRO . . . -40.88 -52.44 6.67 Favored Pre-proline 0 N--CA 1.505 2.315 0 CA-C-O 118.978 -0.534 . . . . 0.0 112.09 -177.237 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.755 ' HD3' ' HB3' ' A' ' 94' ' ' ALA . 30.6 Cg_endo -74.44 -173.65 1.56 Allowed 'Trans proline' 0 C--N 1.328 -0.524 0 C-N-CA 121.708 1.606 . . . . 0.0 109.834 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 17.6 mttm 68.31 26.61 6.8 Favored 'General case' 0 N--CA 1.504 2.243 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -178.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.725 HD13 HG21 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -73.53 -69.61 0.42 Allowed 'General case' 0 N--CA 1.516 2.848 0 O-C-N 121.837 -0.539 . . . . 0.0 110.791 -179.302 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 32.8 m -88.38 26.12 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 O-C-N 121.129 -0.982 . . . . 0.0 110.385 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 27.4 p -100.1 173.51 6.6 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.77 -1.62 0.43 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.565 -0.71 . . . . 0.0 112.019 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.539 ' O ' HG12 ' A' ' 101' ' ' VAL . 20.9 t -96.77 1.29 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 CA-C-N 120.562 1.528 . . . . 0.0 111.222 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -141.09 -91.48 0.15 Allowed 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.488 -0.758 . . . . 0.0 111.318 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.536 ' O ' HD12 ' A' ' 105' ' ' LEU . 60.5 m -142.74 45.46 1.59 Allowed 'General case' 0 N--CA 1.504 2.263 0 O-C-N 121.425 -0.797 . . . . 0.0 109.577 -178.455 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 58.1 t-20 -40.39 -68.84 0.15 Allowed 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.297 -0.877 . . . . 0.0 113.258 -178.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.536 HD12 ' O ' ' A' ' 103' ' ' CYS . 2.1 mt 50.51 27.16 2.71 Favored 'General case' 0 N--CA 1.506 2.357 0 C-N-CA 120.329 -0.549 . . . . 0.0 110.348 -178.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 105' ' ' LEU . . . 68.52 163.26 0.22 Allowed 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.332 -0.855 . . . . 0.0 109.364 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.503 ' OG1' ' CE1' ' A' ' 109' ' ' HIS . 16.6 p -135.92 -159.94 1.01 Allowed 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 120.869 0.366 . . . . 0.0 110.439 -176.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.504 HG23 ' N ' ' A' ' 109' ' ' HIS . 0.7 OUTLIER -93.13 -47.25 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 121.9 -0.5 . . . . 0.0 111.563 -179.439 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.504 ' N ' HG23 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -54.28 -22.64 12.38 Favored 'General case' 0 N--CA 1.529 3.479 0 O-C-N 121.673 -0.642 . . . . 0.0 109.88 -178.838 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.34 68.81 0.79 Allowed Glycine 0 N--CA 1.499 2.898 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.698 177.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 143.57 173.19 14.91 Favored Glycine 0 N--CA 1.5 2.91 0 CA-C-N 118.809 1.305 . . . . 0.0 111.4 178.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -73.67 85.47 1.3 Allowed 'Trans proline' 0 N--CA 1.482 0.814 0 C-N-CA 122.79 2.327 . . . . 0.0 110.375 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.5 ' O ' ' CE1' ' A' ' 109' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.515 2.78 0 C-N-CA 120.389 -0.524 . . . . 0.0 111.392 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo . . . . . 0 CA--C 1.541 0.847 0 N-CA-C 110.107 -0.766 . . . . 0.0 110.107 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 61.38 14.63 42.17 Favored Glycine 0 N--CA 1.501 2.969 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.573 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 5.1 mmt -141.06 108.01 5.43 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 87.04 -59.93 0.04 OUTLIER 'General case' 0 N--CA 1.514 2.767 0 CA-C-N 119.94 1.246 . . . . 0.0 108.245 -178.395 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.799 HD11 ' HB3' ' A' ' 55' ' ' CYS . 21.9 mt -109.82 97.54 29.29 Favored Pre-proline 0 N--CA 1.492 1.667 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 178.034 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -83.62 174.75 8.52 Favored 'Trans proline' 0 N--CA 1.476 0.442 0 C-N-CA 121.814 1.676 . . . . 0.0 111.503 -177.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 31.4 m80 -71.93 142.21 49.45 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.472 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 25.8 m120 59.1 59.02 5.36 Favored Pre-proline 0 N--CA 1.5 2.058 0 O-C-N 121.436 -0.79 . . . . 0.0 109.003 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.472 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 38.2 Cg_endo -78.97 151.5 24.13 Favored 'Trans proline' 0 N--CA 1.484 0.95 0 C-N-CA 122.345 2.03 . . . . 0.0 112.264 -178.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.928 HD13 ' HB1' ' A' ' 59' ' ' ALA . 6.7 mp 43.0 42.65 3.25 Favored 'General case' 0 N--CA 1.502 2.158 0 CA-C-O 121.163 0.506 . . . . 0.0 111.825 178.229 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -65.37 -32.4 74.02 Favored 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.23 -25.98 67.15 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.155 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 35.1 m -76.1 -38.46 56.92 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.6 -50.28 73.21 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.42 ' HA ' ' CE3' ' A' ' 22' ' ' TRP . 36.5 m95 -70.8 -27.37 63.85 Favored 'General case' 0 N--CA 1.501 2.122 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.786 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.744 ' HE1' HG23 ' A' ' 37' ' ' THR . 7.9 t80 -68.12 -31.91 71.83 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.583 HG22 ' CD1' ' A' ' 93' ' ' PHE . 86.4 t -74.98 -40.58 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 177.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.507 ' HB3' HD13 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -55.01 -38.64 68.14 Favored 'General case' 0 N--CA 1.502 2.163 0 C-N-CA 120.095 -0.642 . . . . 0.0 109.561 -179.626 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.7 m -77.07 -51.81 10.41 Favored 'General case' 0 N--CA 1.506 2.356 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.554 -178.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -62.22 -25.21 67.68 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.795 -0.565 . . . . 0.0 111.189 -178.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 79.6 p -97.3 -63.84 1.1 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 122.233 -0.292 . . . . 0.0 111.763 -177.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.551 ' O ' HG23 ' A' ' 31' ' ' VAL . 55.8 m -101.72 14.72 31.13 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.358 -0.839 . . . . 0.0 112.129 -178.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 55.82 21.72 30.96 Favored Glycine 0 N--CA 1.505 3.254 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 29' ' ' CYS . 56.3 t -106.89 162.78 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.821 -0.811 . . . . 0.0 109.011 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.489 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 130.16 178.24 15.31 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 -179.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -66.55 174.88 5.77 Favored 'Trans proline' 0 N--CA 1.487 1.12 0 CA-C-N 119.165 1.482 . . . . 0.0 109.571 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.2 ptp85 -92.21 52.31 1.93 Allowed 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.98 0.895 . . . . 0.0 109.77 -178.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.48 127.83 41.84 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.231 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.47 148.78 4.78 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.807 -0.558 . . . . 0.0 110.171 -178.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.744 HG23 ' HE1' ' A' ' 23' ' ' TYR . 61.1 m -65.77 -40.34 91.93 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.67 -0.643 . . . . 0.0 111.947 -178.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -64.88 -44.29 90.15 Favored 'General case' 0 N--CA 1.504 2.264 0 CA-C-N 118.644 0.656 . . . . 0.0 109.72 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -66.87 -27.68 67.72 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -69.45 -59.03 3.25 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.31 -31.87 55.17 Favored 'General case' 0 N--CA 1.5 2.06 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.633 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.91 -40.79 78.93 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -64.24 -37.41 87.37 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 15.9 m -72.34 -33.45 67.31 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.922 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 21.8 m -73.69 -28.46 61.75 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 24.5 ttm180 -78.19 -35.56 48.5 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.543 ' O ' HD12 ' A' ' 51' ' ' ILE . 8.3 mt-30 -78.03 -41.92 34.13 Favored 'General case' 0 N--CA 1.502 2.157 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.494 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.549 HD22 ' O ' ' A' ' 103' ' ' CYS . 5.6 tt -64.9 -45.22 86.82 Favored 'General case' 0 C--O 1.2 -1.552 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.14 -28.66 66.64 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.403 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.497 ' HB3' ' O ' ' A' ' 47' ' ' GLN . . . -55.2 -60.34 3.53 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.543 HD12 ' O ' ' A' ' 47' ' ' GLN . 2.8 mt -58.73 103.92 0.39 Allowed Pre-proline 0 N--CA 1.51 2.572 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 178.332 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -50.18 144.67 22.24 Favored 'Trans proline' 0 N--CA 1.488 1.166 0 C-N-CA 121.636 1.558 . . . . 0.0 113.094 -175.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.488 ' HA ' ' CG ' ' A' ' 56' ' ' ARG . . . -22.82 -46.19 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.767 0 C-N-CA 124.28 1.032 . . . . 0.0 113.693 -177.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -62.75 138.11 58.43 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.799 ' HB3' HD11 ' A' ' 12' ' ' ILE . 20.8 m 61.68 22.82 13.25 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 122.0 -0.438 . . . . 0.0 109.819 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.488 ' CG ' ' HA ' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -44.72 -93.08 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.892 0 O-C-N 121.063 -1.023 . . . . 0.0 110.72 -179.697 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.691 ' SG ' HG21 ' A' ' 98' ' ' VAL . 76.1 m -38.94 -22.35 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.555 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 -178.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -39.07 -48.02 1.61 Allowed 'General case' 0 N--CA 1.512 2.644 0 CA-C-N 120.984 1.72 . . . . 0.0 112.249 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.928 ' HB1' HD13 ' A' ' 17' ' ' LEU . . . -44.56 -57.95 3.31 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.62 -0.675 . . . . 0.0 111.42 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.517 HG22 HD13 ' A' ' 97' ' ' LEU . 41.4 t -48.51 -41.85 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.266 0 CA-C-O 121.125 0.488 . . . . 0.0 109.686 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 22.9 mtp85 -60.09 -64.15 1.05 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.905 HD12 ' HB ' ' A' ' 67' ' ' VAL . 36.9 mm -46.13 -26.95 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.787 -0.57 . . . . 0.0 111.365 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.58 ' C ' HD13 ' A' ' 63' ' ' LEU . 3.5 tm? -77.82 -43.64 29.85 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.226 -0.989 . . . . 0.0 109.705 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -77.67 -53.38 7.62 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.6 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -79.93 -22.17 42.99 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 122.039 -0.413 . . . . 0.0 111.025 -179.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.96 154.06 15.03 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -178.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.905 ' HB ' HD12 ' A' ' 62' ' ' ILE . 2.5 p -117.46 158.94 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.341 0 CA-C-O 121.361 0.6 . . . . 0.0 109.548 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.665 HG22 ' NE2' ' A' ' 74' ' ' HIS . 54.7 t -115.69 157.05 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.6 p -117.48 159.53 22.67 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.522 -177.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.9 t -61.95 -32.73 73.19 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.23 0.538 . . . . 0.0 110.175 -178.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.2 p -65.69 -18.85 65.63 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.254 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.13 16.54 25.15 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -106.36 156.9 18.04 Favored 'General case' 0 N--CA 1.503 2.197 0 CA-C-N 118.284 1.042 . . . . 0.0 109.626 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.665 ' NE2' HG22 ' A' ' 68' ' ' VAL . 11.0 m170 -116.09 154.08 30.59 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.589 -0.695 . . . . 0.0 109.143 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -140.63 -174.99 4.12 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.044 0.449 . . . . 0.0 109.851 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 56.3 -141.29 41.33 Favored Glycine 0 N--CA 1.497 2.715 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.3 ttp180 54.39 24.8 5.44 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 122.228 -0.572 . . . . 0.0 110.54 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.4 mt -78.7 -19.03 53.39 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.698 -0.626 . . . . 0.0 110.38 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.763 HD21 ' HB3' ' A' ' 90' ' ' GLN . 6.5 tp -52.86 95.37 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.703 -0.623 . . . . 0.0 109.998 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -132.78 172.86 12.01 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -67.82 103.18 1.38 Allowed 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.497 0.665 . . . . 0.0 110.484 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.603 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 24.7 mt -78.45 171.33 12.79 Favored Pre-proline 0 N--CA 1.492 1.655 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 177.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.603 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 27.6 Cg_endo -66.61 99.21 0.43 Allowed 'Trans proline' 0 C--N 1.327 -0.579 0 C-N-CA 120.939 1.093 . . . . 0.0 110.715 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 98.18 -12.11 63.69 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 7.0 m -119.58 92.17 45.74 Favored Pre-proline 0 N--CA 1.5 2.063 0 CA-C-N 119.207 1.503 . . . . 0.0 110.101 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -73.16 164.46 35.33 Favored 'Trans proline' 0 N--CA 1.483 0.863 0 C-N-CA 121.514 1.476 . . . . 0.0 111.045 -179.01 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -46.32 -28.56 1.35 Allowed 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 177.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -54.47 -54.6 38.79 Favored 'General case' 0 N--CA 1.504 2.243 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.537 -178.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 64.5 t -60.84 -41.52 88.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.761 -0.587 . . . . 0.0 109.843 -178.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.763 ' HB3' HD21 ' A' ' 79' ' ' LEU . 7.1 mp0 -64.61 -26.59 68.47 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.49 -28.55 46.4 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.11 -48.68 17.11 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 122.014 -0.429 . . . . 0.0 109.876 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.583 ' CD1' HG22 ' A' ' 24' ' ' VAL . 36.1 t80 -77.72 -25.28 49.2 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 122.212 -0.305 . . . . 0.0 110.759 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.684 ' HB2' ' O ' ' A' ' 90' ' ' GLN . . . -53.15 -53.37 56.43 Favored Pre-proline 0 N--CA 1.5 2.049 0 CA-C-O 118.961 -0.542 . . . . 0.0 111.883 -177.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.682 ' HD3' ' HB3' ' A' ' 94' ' ' ALA . 30.2 Cg_endo -70.0 -11.16 29.99 Favored 'Trans proline' 0 N--CA 1.482 0.819 0 C-N-CA 121.918 1.745 . . . . 0.0 111.181 -179.222 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -89.47 17.19 6.53 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.133 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.727 HD21 HD23 ' A' ' 17' ' ' LEU . 0.1 OUTLIER -73.89 -71.27 0.33 Allowed 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.671 -0.643 . . . . 0.0 109.966 -179.734 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.691 HG21 ' SG ' ' A' ' 57' ' ' CYS . 13.1 m -70.58 5.6 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.36 0 O-C-N 121.176 -0.953 . . . . 0.0 112.283 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 16.3 p -92.07 174.79 7.14 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.13 -3.98 0.45 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.526 -0.734 . . . . 0.0 112.389 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.0 t -89.06 -2.2 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 CA-C-N 120.069 1.304 . . . . 0.0 111.114 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.23 -86.97 0.2 Allowed 'General case' 0 N--CA 1.508 2.456 0 C-N-CA 119.486 -0.886 . . . . 0.0 111.978 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.717 ' O ' HD12 ' A' ' 105' ' ' LEU . 95.6 m -146.7 43.83 1.18 Allowed 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.43 -0.794 . . . . 0.0 109.107 -178.391 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.414 ' HA ' ' O ' ' A' ' 98' ' ' VAL . 7.3 p-10 -39.11 -55.4 1.62 Allowed 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.438 -0.789 . . . . 0.0 113.09 -178.225 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.717 HD12 ' O ' ' A' ' 103' ' ' CYS . 2.2 mt 40.8 29.84 0.08 Allowed 'General case' 0 N--CA 1.511 2.623 0 CA-C-N 118.875 0.761 . . . . 0.0 111.071 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 105' ' ' LEU . . . 65.5 155.41 0.08 Allowed 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.64 -0.662 . . . . 0.0 109.302 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.438 ' HA ' ' HD2' ' A' ' 56' ' ' ARG . 4.4 p -127.88 -160.22 1.0 Allowed 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -179.346 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.848 HD13 ' O ' ' A' ' 108' ' ' ILE . 0.0 OUTLIER -67.51 -34.11 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.41 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.447 ' HB3' ' CE1' ' A' ' 113' ' ' PHE . 93.1 m-70 -69.48 -2.55 11.53 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 116.234 -0.439 . . . . 0.0 112.049 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 60.25 29.92 69.78 Favored Glycine 0 N--CA 1.497 2.75 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -159.88 170.54 36.05 Favored Glycine 0 N--CA 1.496 2.653 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -78.02 76.24 4.45 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.537 2.158 . . . . 0.0 111.475 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.447 ' CE1' ' HB3' ' A' ' 109' ' ' HIS . 35.7 p90 . . . . . 0 N--CA 1.508 2.454 0 O-C-N 121.769 -0.582 . . . . 0.0 110.313 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo . . . . . 0 CA--C 1.538 0.692 0 N-CA-C 110.358 -0.67 . . . . 0.0 110.358 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.45 4.71 75.5 Favored Glycine 0 N--CA 1.5 2.964 0 N-CA-C 110.839 -0.905 . . . . 0.0 110.839 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.59 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 1.5 mpt? -133.0 99.04 4.45 Favored 'General case' 0 N--CA 1.501 2.11 0 CA-C-N 118.103 0.951 . . . . 0.0 108.705 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.59 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 86.79 -56.01 0.05 Allowed 'General case' 0 N--CA 1.515 2.819 0 CA-C-N 119.355 0.98 . . . . 0.0 108.547 -178.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 9.2 mt -101.85 101.44 18.33 Favored Pre-proline 0 N--CA 1.493 1.695 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 178.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -80.58 173.37 12.35 Favored 'Trans proline' 0 N--CA 1.474 0.33 0 C-N-CA 121.536 1.491 . . . . 0.0 111.643 -176.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 49.9 m80 -71.13 144.53 50.21 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.46 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 3.3 t-20 60.68 60.24 3.57 Favored Pre-proline 0 N--CA 1.499 1.99 0 O-C-N 121.597 -0.689 . . . . 0.0 109.198 -179.119 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.46 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 39.5 Cg_endo -81.43 151.28 17.45 Favored 'Trans proline' 0 N--CA 1.481 0.787 0 C-N-CA 122.318 2.012 . . . . 0.0 111.673 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.556 HD23 ' SG ' ' A' ' 20' ' ' CYS . 3.6 mp 51.57 41.26 28.52 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-O 121.048 0.451 . . . . 0.0 111.421 178.163 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.408 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 7.2 p-10 -65.54 -40.62 93.08 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.67 -25.99 68.42 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.089 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.556 ' SG ' HD23 ' A' ' 17' ' ' LEU . 65.4 m -73.51 -42.83 61.29 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.667 ' NH2' HD22 ' A' ' 78' ' ' LEU . 2.5 ptt-85 -60.59 -49.83 75.96 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.451 ' HA ' ' CE3' ' A' ' 22' ' ' TRP . 29.9 m95 -67.85 -26.94 66.29 Favored 'General case' 0 N--CA 1.5 2.052 0 C-N-CA 119.693 -0.803 . . . . 0.0 110.447 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.451 ' CD2' ' HB3' ' A' ' 40' ' ' MET . 5.4 t80 -66.91 -32.3 73.47 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 178.628 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.727 HG22 ' CE1' ' A' ' 93' ' ' PHE . 47.0 t -71.68 -43.81 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.305 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.3 m -53.91 -42.36 68.64 Favored 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.431 -179.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 16.7 m -76.96 -53.76 7.44 Favored 'General case' 0 N--CA 1.507 2.42 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -178.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.8 tpm_? -60.28 -25.53 65.79 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.78 -0.575 . . . . 0.0 110.878 -178.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 48.1 p -97.67 -63.32 1.14 Allowed 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -177.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.61 ' O ' HG23 ' A' ' 31' ' ' VAL . 45.8 m -101.26 14.69 31.16 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.451 -0.78 . . . . 0.0 112.093 -178.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 55.64 21.06 27.2 Favored Glycine 0 N--CA 1.506 3.326 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 29' ' ' CYS . 25.5 t -107.55 164.01 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 O-C-N 121.851 -0.794 . . . . 0.0 109.121 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.492 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 134.38 178.89 15.95 Favored Glycine 0 N--CA 1.498 2.817 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -66.12 175.25 4.96 Favored 'Trans proline' 0 N--CA 1.486 1.075 0 CA-C-N 119.14 1.47 . . . . 0.0 109.633 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.07 82.25 5.07 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.99 0.9 . . . . 0.0 109.941 -178.178 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -139.71 135.84 33.58 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.511 ' HB3' ' OE2' ' A' ' 39' ' ' GLU . . . -53.8 162.63 0.86 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 122.056 -0.402 . . . . 0.0 110.158 -179.176 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.89 -54.0 8.05 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 122.051 -0.406 . . . . 0.0 110.595 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -51.48 -36.51 44.73 Favored 'General case' 0 N--CA 1.507 2.398 0 O-C-N 121.742 -0.599 . . . . 0.0 111.15 -178.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.511 ' OE2' ' HB3' ' A' ' 36' ' ' ALA . 43.4 mt-10 -70.75 -36.09 72.96 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 122.052 -0.405 . . . . 0.0 110.008 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.451 ' HB3' ' CD2' ' A' ' 23' ' ' TYR . 0.8 OUTLIER -66.18 -54.25 27.61 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.856 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.0 ttpt -54.63 -36.76 64.86 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.05 -39.72 95.57 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -63.6 -40.75 97.72 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 16.4 m -67.82 -33.5 74.91 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.054 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 17.9 m -74.44 -30.44 61.89 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.22 -35.29 71.43 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 178.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -79.07 -26.85 43.01 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 120.961 0.41 . . . . 0.0 109.947 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.631 ' O ' HD13 ' A' ' 48' ' ' LEU . 1.4 tm? -71.52 -39.31 70.83 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -178.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.51 ' HG3' HD22 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -78.24 -40.45 37.2 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.454 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.41 ' O ' ' HD3' ' A' ' 52' ' ' PRO . . . -54.23 -37.61 64.81 Favored 'General case' 0 N--CA 1.505 2.294 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 178.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 80.2 mt -79.04 105.15 2.73 Favored Pre-proline 0 N--CA 1.493 1.7 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 177.067 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' A' ' 50' ' ' ALA . 26.7 Cg_endo -60.31 146.67 96.06 Favored 'Trans proline' 0 N--CA 1.479 0.631 0 C-N-CA 121.544 1.496 . . . . 0.0 110.997 -176.242 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.436 ' HB2' ' NH1' ' A' ' 56' ' ' ARG . . . -42.5 -27.99 0.19 Allowed 'General case' 0 N--CA 1.502 2.17 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.685 -178.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -67.37 119.83 12.86 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 20.8 m 62.02 17.38 8.99 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 122.383 -0.198 . . . . 0.0 110.647 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.436 ' NH1' ' HB2' ' A' ' 53' ' ' ALA . 4.6 mtt180 -44.93 -83.37 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.901 0 O-C-N 121.231 -0.918 . . . . 0.0 110.165 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.536 ' SG ' HG21 ' A' ' 98' ' ' VAL . 51.3 m -33.15 -43.62 0.11 Allowed 'General case' 0 N--CA 1.52 3.061 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -37.8 -48.07 1.07 Allowed 'General case' 0 N--CA 1.514 2.774 0 CA-C-N 119.741 1.155 . . . . 0.0 112.246 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -43.66 -53.23 5.9 Favored 'General case' 0 N--CA 1.513 2.722 0 O-C-N 121.542 -0.724 . . . . 0.0 111.582 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 38.5 t -48.69 -45.87 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.399 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.1 -54.61 45.06 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.75 HG23 ' HB ' ' A' ' 67' ' ' VAL . 34.4 mt -49.18 -27.39 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.337 0 O-C-N 121.344 -0.848 . . . . 0.0 109.965 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.431 HD12 ' HA ' ' A' ' 63' ' ' LEU . 27.5 tp -77.92 -41.85 35.11 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.491 -0.884 . . . . 0.0 109.994 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.26 -54.26 6.71 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.555 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -80.65 -22.86 40.13 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.931 -0.48 . . . . 0.0 111.224 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.65 150.49 17.07 Favored Glycine 0 N--CA 1.498 2.781 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -178.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.75 ' HB ' HG23 ' A' ' 62' ' ' ILE . 4.2 p -117.91 159.68 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.275 0 O-C-N 122.176 -0.603 . . . . 0.0 109.845 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.688 HG22 ' NE2' ' A' ' 74' ' ' HIS . 72.8 t -115.1 157.51 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 CA-C-O 121.767 0.794 . . . . 0.0 109.095 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.9 p -117.42 159.78 22.24 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.648 -177.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.3 t -62.07 -33.41 74.37 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.3 -178.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.8 p -66.2 -17.78 64.94 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.226 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.91 14.78 30.5 Favored Glycine 0 N--CA 1.498 2.798 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 67.8 mm-40 -102.58 157.06 17.2 Favored 'General case' 0 N--CA 1.503 2.221 0 CA-C-N 118.19 0.995 . . . . 0.0 109.321 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.688 ' NE2' HG22 ' A' ' 68' ' ' VAL . 9.5 m170 -115.83 155.3 28.13 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -143.48 -176.77 5.08 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.17 0.51 . . . . 0.0 110.278 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 60.09 -137.66 49.16 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 22.7 ttp180 51.42 26.07 2.96 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 122.317 -0.519 . . . . 0.0 110.301 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.667 HD22 ' NH2' ' A' ' 21' ' ' ARG . 3.4 mt -77.2 -20.47 55.29 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.719 -0.613 . . . . 0.0 110.636 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.421 HD11 HD23 ' A' ' 63' ' ' LEU . 95.8 mt -62.14 95.55 0.06 Allowed 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -143.23 177.01 8.7 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.368 0.604 . . . . 0.0 110.29 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -50.96 107.86 0.2 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.49 0.662 . . . . 0.0 111.775 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.545 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 18.3 mt -100.88 168.14 9.71 Favored Pre-proline 0 N--CA 1.495 1.797 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.336 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.545 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 26.6 Cg_endo -64.62 99.79 0.32 Allowed 'Trans proline' 0 N--CA 1.48 0.699 0 C-N-CA 121.277 1.318 . . . . 0.0 111.702 -178.367 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.84 -9.89 75.75 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 7.5 m -118.98 91.12 42.68 Favored Pre-proline 0 N--CA 1.503 2.217 0 CA-C-N 119.125 1.463 . . . . 0.0 110.538 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -72.02 165.44 32.59 Favored 'Trans proline' 0 N--CA 1.482 0.847 0 C-N-CA 121.712 1.608 . . . . 0.0 111.173 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.1 mmm-85 -47.59 -28.53 2.35 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -57.7 -53.42 58.36 Favored 'General case' 0 N--CA 1.502 2.159 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.048 -178.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.1 t -63.89 -38.72 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.754 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -63.19 -26.96 69.05 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.42 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.93 -35.95 42.56 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.22 -49.82 63.12 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.997 -0.439 . . . . 0.0 109.896 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.727 ' CE1' HG22 ' A' ' 24' ' ' VAL . 34.0 t80 -78.77 -25.11 44.35 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 122.12 -0.362 . . . . 0.0 110.554 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.754 ' HB2' ' O ' ' A' ' 90' ' ' GLN . . . -41.22 -51.06 8.22 Favored Pre-proline 0 N--CA 1.503 2.186 0 CA-C-O 118.773 -0.632 . . . . 0.0 112.29 -177.337 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.657 ' HD3' ' HB3' ' A' ' 94' ' ' ALA . 30.3 Cg_endo -72.59 -167.24 0.32 Allowed 'Trans proline' 0 C--N 1.33 -0.43 0 C-N-CA 121.505 1.47 . . . . 0.0 109.62 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 77.0 mttt 62.48 20.44 11.92 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.433 ' HA ' HD22 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -72.92 -65.45 0.8 Allowed 'General case' 0 N--CA 1.509 2.486 0 O-C-N 121.875 -0.516 . . . . 0.0 110.786 -179.132 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.536 HG21 ' SG ' ' A' ' 57' ' ' CYS . 27.1 m -84.6 20.63 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 120.963 -1.086 . . . . 0.0 111.279 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 25.2 p -98.91 174.71 6.23 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.04 -2.67 0.63 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.575 -0.703 . . . . 0.0 112.018 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.5 ' O ' HG12 ' A' ' 101' ' ' VAL . 14.4 t -94.05 -0.64 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 CA-C-N 120.591 1.541 . . . . 0.0 111.062 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -138.12 -89.65 0.23 Allowed 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.383 -0.823 . . . . 0.0 111.185 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.552 ' O ' HD12 ' A' ' 105' ' ' LEU . 54.0 m -144.92 39.5 1.23 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.374 -0.829 . . . . 0.0 109.432 -178.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -35.22 -60.84 0.46 Allowed 'General case' 0 N--CA 1.511 2.6 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -178.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.552 HD12 ' O ' ' A' ' 103' ' ' CYS . 1.1 mt 43.23 31.45 0.38 Allowed 'General case' 0 N--CA 1.511 2.617 0 CA-C-N 118.657 0.662 . . . . 0.0 110.73 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 105' ' ' LEU . . . 66.58 150.09 0.05 Allowed 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -178.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.7 p -119.58 -159.86 0.79 Allowed 'General case' 0 N--CA 1.504 2.226 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.8 tt -66.98 -32.35 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -72.92 1.73 8.21 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.9 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 57.91 33.18 67.79 Favored Glycine 0 N--CA 1.499 2.887 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -161.66 170.63 37.43 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -79.05 71.96 6.76 Favored 'Trans proline' 0 CA--C 1.545 1.047 0 C-N-CA 122.747 2.298 . . . . 0.0 111.55 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 44.8 p90 . . . . . 0 N--CA 1.505 2.311 0 O-C-N 121.816 -0.552 . . . . 0.0 110.171 178.53 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.452 ' O ' ' SD ' ' A' ' 10' ' ' MET . 36.1 Cg_endo . . . . . 0 C--O 1.215 -0.637 0 N-CA-C 110.133 -0.756 . . . . 0.0 110.133 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 60.15 12.52 23.89 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.726 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -129.37 94.44 3.78 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.293 -1.122 . . . . 0.0 108.71 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.726 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 86.09 -58.14 0.07 Allowed 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -178.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 29.1 mt -95.69 103.25 12.29 Favored Pre-proline 0 N--CA 1.489 1.489 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.516 ' HD3' ' O ' ' A' ' 11' ' ' ALA . 34.1 Cg_endo -81.37 170.86 14.28 Favored 'Trans proline' 0 C--N 1.318 -1.038 0 C-N-CA 121.378 1.385 . . . . 0.0 111.864 -176.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 32.3 m80 -69.82 149.2 48.16 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.48 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 1.1 t-20 67.2 63.95 0.74 Allowed Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 120.623 -1.298 . . . . 0.0 110.033 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.807 ' HB2' ' HB1' ' A' ' 59' ' ' ALA . 37.3 Cg_endo -79.7 166.35 21.71 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.808 2.339 . . . . 0.0 112.151 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.53 HD23 ' SG ' ' A' ' 20' ' ' CYS . 0.2 OUTLIER 33.13 47.03 0.11 Allowed 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.581 178.789 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -74.86 -34.85 62.33 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.99 -1.069 . . . . 0.0 108.982 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.448 ' OG ' ' SG ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -62.56 -43.36 99.01 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.171 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.53 ' SG ' HD23 ' A' ' 17' ' ' LEU . 36.2 m -59.88 -40.03 87.29 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 121.352 0.596 . . . . 0.0 109.706 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.557 ' HG3' ' N ' ' A' ' 22' ' ' TRP . 0.1 OUTLIER -58.08 -51.91 67.72 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.373 -0.83 . . . . 0.0 108.915 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.557 ' N ' ' HG3' ' A' ' 21' ' ' ARG . 27.6 m95 -68.75 -26.25 65.14 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 118.591 -1.244 . . . . 0.0 110.541 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.651 ' HE1' HG22 ' A' ' 37' ' ' THR . 19.0 t80 -66.97 -32.65 74.03 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.911 -1.118 . . . . 0.0 108.593 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.558 HG22 ' CE1' ' A' ' 93' ' ' PHE . 71.3 t -72.9 -42.25 60.51 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.274 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 178.04 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.476 ' OG ' ' HA ' ' A' ' 22' ' ' TRP . 0.5 OUTLIER -54.84 -40.0 69.14 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.059 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.488 ' CA ' ' O ' ' A' ' 31' ' ' VAL . 3.7 m -77.28 -53.26 7.92 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.186 -0.946 . . . . 0.0 111.154 -178.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.1 ttm180 -59.56 -24.4 63.69 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.935 -1.103 . . . . 0.0 110.194 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.456 ' OG1' ' SG ' ' A' ' 85' ' ' CYS . 80.7 p -93.0 -67.53 0.85 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.186 -0.946 . . . . 0.0 111.419 -178.271 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.498 ' SG ' ' C ' ' A' ' 84' ' ' GLY . 93.2 m -99.51 18.07 18.79 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.496 -1.378 . . . . 0.0 110.104 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' A' ' 26' ' ' THR . . . 57.63 15.55 18.8 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.488 ' O ' ' CA ' ' A' ' 26' ' ' THR . 75.6 t -101.87 154.48 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.13 -1.218 . . . . 0.0 109.283 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.435 ' HA3' ' HG1' ' A' ' 26' ' ' THR . . . 142.66 179.23 19.3 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -66.37 177.15 3.42 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 CA-C-N 118.981 1.391 . . . . 0.0 109.875 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' ' 34' ' ' ARG . 0.1 OUTLIER -91.28 81.68 5.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.726 -1.234 . . . . 0.0 110.162 -178.125 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.461 ' CD2' ' NH1' ' A' ' 43' ' ' ARG . 25.6 tp -138.13 127.98 25.38 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.108 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.94 161.58 0.76 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.059 -1.025 . . . . 0.0 109.662 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.651 HG22 ' HE1' ' A' ' 23' ' ' TYR . 1.2 p -67.96 -61.97 1.62 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.12 -0.987 . . . . 0.0 109.987 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 37' ' ' THR . 0.8 OUTLIER -43.95 -57.22 3.44 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.017 -1.052 . . . . 0.0 109.737 -179.361 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.577 ' O ' ' HB3' ' A' ' 42' ' ' ALA . 75.5 mm-40 -49.15 -43.38 41.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.252 -0.905 . . . . 0.0 109.699 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.59 ' CE ' ' CG ' ' A' ' 23' ' ' TYR . 1.8 tmm? -59.03 -62.97 1.48 Allowed 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.493 ' HG3' ' OE1' ' A' ' 102' ' ' GLU . 19.0 tttt -40.59 -31.68 0.17 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.577 ' HB3' ' O ' ' A' ' 39' ' ' GLU . . . -68.51 -50.93 48.46 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.593 -0.692 . . . . 0.0 109.688 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.541 ' CG ' ' O ' ' A' ' 40' ' ' MET . 0.0 OUTLIER -59.14 -41.24 87.83 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.193 -1.003 . . . . 0.0 109.768 -179.597 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.448 ' SG ' ' OG ' ' A' ' 19' ' ' SER . 8.8 m -65.03 -36.09 83.25 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.89 -1.132 . . . . 0.0 110.579 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 19.1 m -69.75 -32.02 70.31 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.737 -1.227 . . . . 0.0 108.937 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.86 -32.64 67.7 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.493 ' HG3' ' O ' ' A' ' 43' ' ' ARG . 0.1 OUTLIER -77.43 -29.14 52.79 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.703 -0.623 . . . . 0.0 109.638 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.095 HD11 HG12 ' A' ' 98' ' ' VAL . 0.6 OUTLIER -75.0 -38.42 61.61 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.115 -0.991 . . . . 0.0 108.544 179.59 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.425 ' O ' ' C ' ' A' ' 50' ' ' ALA . 2.9 tt0 -69.16 -53.04 22.13 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.473 ' O ' ' HD3' ' A' ' 52' ' ' PRO . . . -47.54 -52.98 15.74 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 178.21 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.764 HG22 ' HG2' ' A' ' 56' ' ' ARG . 26.8 mm -58.81 106.02 0.64 Allowed Pre-proline 0 C--N 1.304 -1.393 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 177.065 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 50' ' ' ALA . 28.0 Cg_endo -63.77 136.25 52.55 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 121.893 1.729 . . . . 0.0 111.528 -176.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.626 ' HB1' ' N ' ' A' ' 108' ' ' ILE . . . -33.84 -36.15 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.792 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.71 ' CZ ' HD11 ' A' ' 108' ' ' ILE . 2.2 m-85 -67.63 117.14 9.16 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.01 -1.056 . . . . 0.0 108.794 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.474 ' CB ' ' O ' ' A' ' 54' ' ' TYR . 9.7 m 76.24 -2.46 2.73 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.461 -0.775 . . . . 0.0 109.784 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.764 ' HG2' HG22 ' A' ' 51' ' ' ILE . 0.4 OUTLIER -40.01 -87.44 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.199 -0.938 . . . . 0.0 109.188 -179.81 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.538 ' O ' ' C ' ' A' ' 58' ' ' GLU . 22.2 m -31.93 -58.34 0.29 Allowed 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.625 -0.672 . . . . 0.0 111.443 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.538 ' C ' ' O ' ' A' ' 57' ' ' CYS . 2.6 mm-40 -25.89 -53.5 0.05 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.55 -0.719 . . . . 0.0 111.249 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.807 ' HB1' ' HB2' ' A' ' 16' ' ' PRO . . . -37.81 -61.23 0.65 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.445 -0.785 . . . . 0.0 110.256 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.842 HG21 HD13 ' A' ' 97' ' ' LEU . 27.8 t -42.55 -51.35 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 CA-C-O 121.861 0.839 . . . . 0.0 108.904 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.485 ' O ' ' N ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -54.18 -63.66 1.08 Allowed 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.262 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.917 HD12 ' HB ' ' A' ' 67' ' ' VAL . 4.6 mm -40.06 -27.25 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.23 -0.919 . . . . 0.0 110.294 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.819 HD13 ' O ' ' A' ' 63' ' ' LEU . 0.9 OUTLIER -77.59 -46.77 21.17 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 120.704 -1.248 . . . . 0.0 109.202 -179.973 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.489 ' SD ' ' NE ' ' A' ' 91' ' ' ARG . 0.1 OUTLIER -73.62 -53.65 9.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.23 -0.919 . . . . 0.0 110.152 -179.83 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -80.2 -21.43 42.95 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.82 -1.175 . . . . 0.0 110.315 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.474 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . 84.51 151.2 12.86 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -179.066 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.917 ' HB ' HD12 ' A' ' 62' ' ' ILE . 7.3 p -116.64 159.39 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.414 -1.051 . . . . 0.0 109.409 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.544 ' N ' HG22 ' A' ' 67' ' ' VAL . 12.8 t -114.52 157.96 15.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-O 121.642 0.735 . . . . 0.0 109.185 -179.316 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.438 ' N ' ' CG1' ' A' ' 68' ' ' VAL . 27.5 p -116.83 158.94 23.12 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 121.615 0.722 . . . . 0.0 109.65 -178.174 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 32.1 t -62.25 -31.11 71.63 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.495 0.664 . . . . 0.0 110.13 -178.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.2 p -69.84 -14.01 62.54 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.499 -0.751 . . . . 0.0 109.6 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.3 9.24 48.29 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 108.881 -1.688 . . . . 0.0 108.881 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -91.84 157.25 16.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.088 -1.242 . . . . 0.0 109.877 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.527 ' CD2' HG22 ' A' ' 68' ' ' VAL . 10.1 m170 -115.83 156.32 26.31 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.022 -1.048 . . . . 0.0 108.739 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.406 ' HG2' ' C ' ' A' ' 74' ' ' HIS . 57.1 mm-40 -145.47 178.95 7.74 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.308 -0.87 . . . . 0.0 110.262 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 58.44 -147.13 39.8 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 2.9 ttp85 60.0 18.74 7.88 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.44 -1.035 . . . . 0.0 110.572 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.474 ' O ' ' NH2' ' A' ' 21' ' ' ARG . 1.8 mp -79.87 -19.53 48.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.837 -1.164 . . . . 0.0 109.812 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.699 HD21 ' HG2' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -64.46 89.26 0.06 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.972 -1.08 . . . . 0.0 108.691 179.484 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.42 ' O ' ' C ' ' A' ' 81' ' ' ASP . 34.4 mt-30 -136.39 178.32 7.16 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.295 -0.878 . . . . 0.0 110.201 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 80' ' ' GLN . 49.4 m-20 -39.33 129.35 1.79 Allowed 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.995 0.902 . . . . 0.0 110.93 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.609 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 22.0 mt -126.03 168.79 13.07 Favored Pre-proline 0 C--N 1.302 -1.484 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 178.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.609 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 27.4 Cg_endo -66.12 99.38 0.41 Allowed 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 121.008 1.138 . . . . 0.0 110.794 -179.236 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.498 ' C ' ' SG ' ' A' ' 29' ' ' CYS . . . 89.71 -7.97 80.76 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.456 ' SG ' ' OG1' ' A' ' 28' ' ' THR . 7.7 m -120.61 89.39 44.59 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 120.569 -1.547 . . . . 0.0 110.311 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.41 ' C ' ' N ' ' A' ' 88' ' ' GLN . 30.7 Cg_endo -76.44 159.01 36.4 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 C-N-CA 121.827 1.684 . . . . 0.0 111.197 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' A' ' 86' ' ' PRO . 4.3 mmt85 -44.63 -28.57 0.62 Allowed 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.41 ' N ' ' C ' ' A' ' 86' ' ' PRO . 4.5 tt0 -57.31 -60.5 3.54 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.668 -178.235 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 87.9 t -61.0 -42.59 93.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 O-C-N 120.793 -1.192 . . . . 0.0 110.364 -178.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.749 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -60.62 -27.53 67.83 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.182 -1.007 . . . . 0.0 108.514 179.841 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.509 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 0.0 OUTLIER -78.05 -31.16 50.17 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.43 -0.794 . . . . 0.0 109.712 179.511 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.506 ' O ' ' HD2' ' A' ' 95' ' ' PRO . . . -71.08 -50.34 34.85 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.064 -1.023 . . . . 0.0 109.522 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.558 ' CE1' HG22 ' A' ' 24' ' ' VAL . 10.4 t80 -77.67 -25.72 49.76 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.424 -0.798 . . . . 0.0 109.915 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.79 ' HB3' ' HD3' ' A' ' 95' ' ' PRO . . . -41.16 -52.46 7.22 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.308 -0.87 . . . . 0.0 111.885 -179.187 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.79 ' HD3' ' HB3' ' A' ' 94' ' ' ALA . 29.6 Cg_endo -70.09 97.64 0.68 Allowed 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.227 1.951 . . . . 0.0 111.47 -178.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.507 ' CB ' ' O ' ' A' ' 95' ' ' PRO . 2.1 mttt 159.55 65.35 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.842 HD13 HG21 ' A' ' 60' ' ' VAL . 1.3 mt -109.91 -89.21 0.49 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.3 -0.875 . . . . 0.0 111.589 -178.108 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 1.095 HG12 HD11 ' A' ' 48' ' ' LEU . 3.3 m -78.74 34.88 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 120.661 -1.275 . . . . 0.0 111.735 -178.206 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 12.9 p -106.83 173.32 6.37 Favored 'General case' 0 C--N 1.293 -1.882 0 O-C-N 120.706 -1.246 . . . . 0.0 108.463 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.737 ' HA ' HD21 ' A' ' 104' ' ' ASN . 15.3 mt-10 -60.59 1.74 0.13 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.746 -1.222 . . . . 0.0 111.874 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.7 t -99.13 0.82 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 119.888 -1.757 . . . . 0.0 110.829 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.521 ' HB3' ' O ' ' A' ' 97' ' ' LEU . 7.1 tp10 -149.93 -98.17 0.07 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.568 -1.333 . . . . 0.0 111.347 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.541 ' O ' HD22 ' A' ' 48' ' ' LEU . 78.4 m -117.39 43.65 2.3 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.93 -1.106 . . . . 0.0 109.794 -178.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.737 HD21 ' HA ' ' A' ' 100' ' ' GLU . 1.4 p30 -31.99 -92.17 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.308 -0.87 . . . . 0.0 111.806 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.728 ' O ' ' HB3' ' A' ' 106' ' ' ALA . 1.3 mt 66.95 -1.76 1.31 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.005 -1.06 . . . . 0.0 111.822 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.728 ' HB3' ' O ' ' A' ' 105' ' ' LEU . . . 81.08 143.45 0.08 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.684 -1.26 . . . . 0.0 110.028 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.667 HG21 HG21 ' A' ' 98' ' ' VAL . 3.0 p -114.27 -162.09 0.8 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.29 -0.881 . . . . 0.0 108.723 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.71 HD11 ' CZ ' ' A' ' 54' ' ' TYR . 19.3 tt -62.09 -22.65 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.902 -1.124 . . . . 0.0 108.753 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.451 ' HB3' ' CE1' ' A' ' 113' ' ' PHE . 90.6 m-70 -80.47 14.74 1.89 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.733 -0.604 . . . . 0.0 110.486 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 109' ' ' HIS . . . 44.15 25.61 0.75 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 109' ' ' HIS . . . -150.45 169.74 30.37 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.488 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 35.1 Cg_endo -78.96 72.87 6.28 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.876 2.384 . . . . 0.0 110.989 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.488 ' HB3' ' O ' ' A' ' 112' ' ' PRO . 17.7 p90 . . . . . 0 N--CA 1.494 1.752 0 O-C-N 121.37 -0.831 . . . . 0.0 109.529 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.406 ' HG3' HG21 ' A' ' 67' ' ' VAL . 30.6 Cg_endo . . . . . 0 N--CA 1.479 0.647 0 N-CA-C 111.103 -0.383 . . . . 0.0 111.103 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 62.84 16.32 56.48 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 -179.064 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.573 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 16.6 mmm -140.91 84.62 1.94 Allowed 'General case' 0 N--CA 1.5 2.051 0 CA-C-N 117.749 0.774 . . . . 0.0 108.99 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 86.82 -57.65 0.05 OUTLIER 'General case' 0 N--CA 1.515 2.824 0 O-C-N 121.368 -0.833 . . . . 0.0 108.908 -178.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.717 HD11 ' HB2' ' A' ' 55' ' ' CYS . 61.2 mt -92.21 104.5 11.04 Favored Pre-proline 0 N--CA 1.498 1.935 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.398 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -75.21 169.6 22.18 Favored 'Trans proline' 0 C--O 1.22 -0.406 0 C-N-CA 121.348 1.365 . . . . 0.0 111.547 -175.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 47.1 m80 -69.33 144.5 53.48 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.491 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 5.3 t-20 66.08 56.01 1.03 Allowed Pre-proline 0 N--CA 1.505 2.307 0 O-C-N 121.392 -0.817 . . . . 0.0 110.282 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.491 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 39.0 Cg_endo -80.54 166.86 19.54 Favored 'Trans proline' 0 N--CA 1.483 0.908 0 C-N-CA 122.317 2.011 . . . . 0.0 111.907 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.5 mp 42.92 43.81 3.69 Favored 'General case' 0 N--CA 1.504 2.238 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.192 177.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -69.07 -37.75 78.67 Favored 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.96 -26.13 68.69 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 56.9 m -74.61 -38.68 62.51 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.585 HH22 HD23 ' A' ' 78' ' ' LEU . 3.3 ttt180 -64.31 -48.88 73.96 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 33.5 m95 -68.74 -29.31 67.69 Favored 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 119.413 -0.915 . . . . 0.0 109.686 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.44 ' CD1' ' HB3' ' A' ' 40' ' ' MET . 57.7 t80 -66.38 -33.65 76.19 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.428 HG22 ' CD2' ' A' ' 93' ' ' PHE . 92.9 t -72.25 -38.97 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 177.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 m -56.27 -37.03 69.26 Favored 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 119.951 -0.7 . . . . 0.0 109.442 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 89.7 m -77.64 -50.09 13.2 Favored 'General case' 0 N--CA 1.506 2.347 0 N-CA-C 112.208 0.448 . . . . 0.0 112.208 -178.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.77 -25.31 67.87 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.512 -0.742 . . . . 0.0 110.622 -178.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.425 HG23 ' O ' ' A' ' 24' ' ' VAL . 70.7 p -93.35 -63.38 1.22 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -177.27 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.65 ' O ' HG23 ' A' ' 31' ' ' VAL . 3.6 m -100.32 9.29 42.91 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.438 -0.789 . . . . 0.0 111.636 -178.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 57.78 30.05 62.37 Favored Glycine 0 N--CA 1.507 3.37 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 29' ' ' CYS . 37.9 t -121.24 164.09 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 122.192 -0.593 . . . . 0.0 109.672 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.496 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 136.19 177.82 15.29 Favored Glycine 0 N--CA 1.499 2.895 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -64.37 177.31 2.17 Favored 'Trans proline' 0 N--CA 1.489 1.254 0 CA-C-N 119.253 1.526 . . . . 0.0 110.047 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.28 87.25 5.99 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 122.17 0.986 . . . . 0.0 110.338 -177.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.5 mt -141.85 127.37 18.95 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 178.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.19 152.44 2.37 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.979 -0.45 . . . . 0.0 109.825 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.1 p -60.0 -59.66 5.07 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.789 -0.569 . . . . 0.0 110.655 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -52.56 -28.75 22.22 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.878 -0.514 . . . . 0.0 111.571 -178.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -71.97 -46.94 55.56 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.816 -0.553 . . . . 0.0 109.608 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.44 ' HB3' ' CD1' ' A' ' 23' ' ' TYR . 5.6 tpt -61.97 -54.57 39.84 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -53.61 -35.7 61.19 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.45 -42.81 99.74 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.3 -41.12 96.45 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 19.7 m -65.48 -33.22 75.43 Favored 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.244 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 18.6 m -73.47 -30.16 62.99 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.35 -32.38 62.76 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -77.02 -33.69 57.41 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.782 HD22 ' O ' ' A' ' 103' ' ' CYS . 0.6 OUTLIER -73.46 -33.53 64.91 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.49 -40.4 61.86 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.28 -39.13 85.77 Favored 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.49 HG23 HG12 ' A' ' 12' ' ' ILE . 71.7 mt -82.54 105.57 5.09 Favored Pre-proline 0 N--CA 1.493 1.684 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 177.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -58.2 139.87 92.14 Favored 'Trans proline' 0 N--CA 1.48 0.705 0 C-N-CA 121.52 1.48 . . . . 0.0 110.877 -177.161 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.698 ' HB2' ' NH1' ' A' ' 56' ' ' ARG . . . -39.48 -29.79 0.06 Allowed 'General case' 0 N--CA 1.507 2.387 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.356 -178.136 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -53.15 -70.47 0.09 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.922 -0.486 . . . . 0.0 110.623 -179.132 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.717 ' HB2' HD11 ' A' ' 12' ' ' ILE . 5.1 m -88.59 8.81 26.46 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.974 -0.454 . . . . 0.0 110.884 -179.115 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.698 ' NH1' ' HB2' ' A' ' 53' ' ' ALA . 5.9 mtt180 -47.6 -85.35 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.666 0 O-C-N 121.445 -0.784 . . . . 0.0 110.282 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 73.3 m -32.79 -48.88 0.21 Allowed 'General case' 0 N--CA 1.521 3.083 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -41.74 -54.32 3.36 Favored 'General case' 0 N--CA 1.512 2.671 0 CA-C-N 119.319 0.963 . . . . 0.0 111.755 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -41.87 -44.63 3.43 Favored 'General case' 0 N--CA 1.513 2.706 0 O-C-N 121.787 -0.57 . . . . 0.0 112.065 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.7 t -57.17 -48.9 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.4 mtt180 -58.56 -26.74 63.89 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.959 HG23 ' HB ' ' A' ' 67' ' ' VAL . 34.5 mm -78.52 -30.74 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 O-C-N 121.945 -0.472 . . . . 0.0 110.362 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.489 HD12 ' HA ' ' A' ' 63' ' ' LEU . 14.9 tp -77.87 -43.37 30.43 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 120.079 -0.649 . . . . 0.0 109.79 -179.119 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.79 -50.84 10.64 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.232 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -80.55 -22.74 40.52 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 122.087 -0.383 . . . . 0.0 110.88 -178.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.68 146.91 5.67 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.959 ' HB ' HG23 ' A' ' 62' ' ' ILE . 5.6 p -118.43 161.08 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.668 HG22 ' NE2' ' A' ' 74' ' ' HIS . 56.0 t -113.27 157.89 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 42.1 p -116.84 160.13 21.32 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.987 0.899 . . . . 0.0 110.969 -176.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 32.8 t -64.54 -17.53 64.01 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.431 -178.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.1 p -86.48 -14.61 42.64 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 122.05 -0.406 . . . . 0.0 110.034 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.25 13.53 33.09 Favored Glycine 0 N--CA 1.5 2.902 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -105.43 158.62 16.53 Favored 'General case' 0 N--CA 1.501 2.114 0 CA-C-N 118.142 0.971 . . . . 0.0 108.859 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.668 ' NE2' HG22 ' A' ' 68' ' ' VAL . 11.3 m170 -113.79 154.93 26.58 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -179.082 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -136.8 -179.02 5.45 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.051 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 55.3 -146.93 28.43 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 -178.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 54.84 22.28 4.13 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 122.253 -0.557 . . . . 0.0 109.988 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.585 HD23 HH22 ' A' ' 21' ' ' ARG . 2.1 mp -82.87 -14.61 53.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.765 -0.584 . . . . 0.0 110.388 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.5 mt -62.11 92.79 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -134.78 -177.02 4.43 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.758 0.79 . . . . 0.0 110.663 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -47.67 131.6 14.42 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.758 0.789 . . . . 0.0 111.544 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.472 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 20.6 mt -129.27 166.85 22.55 Favored Pre-proline 0 N--CA 1.497 1.918 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.158 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.472 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 29.6 Cg_endo -68.6 98.63 0.59 Allowed 'Trans proline' 0 C--N 1.327 -0.553 0 C-N-CA 120.936 1.091 . . . . 0.0 110.243 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.41 6.94 67.82 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.47 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 3.2 m -138.8 92.51 11.21 Favored Pre-proline 0 N--CA 1.508 2.425 0 CA-C-N 118.974 1.387 . . . . 0.0 110.062 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -74.79 165.45 31.45 Favored 'Trans proline' 0 N--CA 1.487 1.109 0 C-N-CA 121.924 1.749 . . . . 0.0 111.225 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 24.0 mtp180 -53.89 -25.96 22.66 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.042 0.448 . . . . 0.0 110.225 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.23 -45.86 89.65 Favored 'General case' 0 N--CA 1.503 2.213 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.008 -177.156 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 42.0 t -72.38 -43.37 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.596 -0.69 . . . . 0.0 111.023 -177.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.616 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 2.1 pt20 -70.37 -27.02 64.0 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.414 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 8.8 ttt180 -78.76 -29.26 45.0 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.44 -47.09 20.61 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.945 -0.472 . . . . 0.0 110.28 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.428 ' CD2' HG22 ' A' ' 24' ' ' VAL . 90.3 t80 -79.03 -27.56 43.21 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 122.088 -0.383 . . . . 0.0 111.463 -178.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.616 ' HB2' ' O ' ' A' ' 90' ' ' GLN . . . -55.09 -46.45 99.67 Favored Pre-proline 0 N--CA 1.504 2.259 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -177.443 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 94' ' ' ALA . 30.2 Cg_endo -70.06 -0.26 6.9 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 122.209 1.939 . . . . 0.0 114.017 -177.189 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.79 24.12 12.05 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.492 -0.755 . . . . 0.0 109.8 179.008 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.99 -24.22 59.57 Favored 'General case' 0 N--CA 1.51 2.526 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -178.146 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 33.7 m -93.4 25.63 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.322 0 CA-C-N 120.958 1.708 . . . . 0.0 111.182 -178.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.406 ' C ' ' HB2' ' A' ' 104' ' ' ASN . 19.0 p -98.24 173.1 7.17 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -61.94 -1.52 0.68 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.656 -0.652 . . . . 0.0 112.25 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.582 ' O ' HG12 ' A' ' 101' ' ' VAL . 36.3 t -100.04 4.4 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 CA-C-N 120.443 1.474 . . . . 0.0 110.96 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -141.07 -89.95 0.16 Allowed 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.38 -0.825 . . . . 0.0 111.488 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.782 ' O ' HD22 ' A' ' 48' ' ' LEU . 19.8 m -143.62 43.0 1.49 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.502 -0.749 . . . . 0.0 109.927 -178.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.409 ' ND2' ' HB3' ' A' ' 112' ' ' PRO . 56.9 t-20 -42.97 -64.9 0.55 Allowed 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.224 -0.923 . . . . 0.0 112.329 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.429 ' O ' ' HB3' ' A' ' 106' ' ' ALA . 6.1 mt 45.33 29.34 0.55 Allowed 'General case' 0 N--CA 1.51 2.569 0 CA-C-O 121.073 0.463 . . . . 0.0 109.995 -178.506 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 105' ' ' LEU . . . 67.04 157.93 0.12 Allowed 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -178.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.8 p -128.82 -163.93 1.34 Allowed 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 18.1 tt -68.14 -33.15 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 177.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.447 ' HB3' ' CE2' ' A' ' 113' ' ' PHE . 96.9 m-70 -66.67 -4.9 9.89 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.729 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 61.55 41.39 99.55 Favored Glycine 0 N--CA 1.499 2.863 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -174.87 170.95 44.15 Favored Glycine 0 N--CA 1.501 3.024 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.409 ' HB3' ' ND2' ' A' ' 104' ' ' ASN . 32.3 Cg_endo -77.86 75.84 4.6 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.54 2.16 . . . . 0.0 111.376 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.447 ' CE2' ' HB3' ' A' ' 109' ' ' HIS . 36.8 p90 . . . . . 0 N--CA 1.502 2.145 0 O-C-N 121.65 -0.656 . . . . 0.0 110.468 178.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo . . . . . 0 C--O 1.215 -0.662 0 N-CA-C 110.67 -0.55 . . . . 0.0 110.67 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 62.46 10.85 31.61 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.727 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 2.2 mtt -140.61 95.11 2.81 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.164 -1.198 . . . . 0.0 109.317 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.727 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 86.14 -60.58 0.06 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.925 -1.11 . . . . 0.0 108.314 -179.158 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.484 HG13 HD12 ' A' ' 51' ' ' ILE . 1.8 mp -96.83 103.31 14.32 Favored Pre-proline 0 N--CA 1.489 1.483 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.494 ' HD3' ' O ' ' A' ' 11' ' ' ALA . 31.6 Cg_endo -79.64 166.97 21.28 Favored 'Trans proline' 0 C--N 1.32 -0.959 0 C-N-CA 121.277 1.318 . . . . 0.0 112.163 -176.674 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -68.65 149.0 49.62 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.496 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 0.5 OUTLIER 60.77 63.95 2.51 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 120.607 -1.308 . . . . 0.0 109.62 -179.857 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.496 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 37.2 Cg_endo -80.41 161.08 22.66 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.794 2.329 . . . . 0.0 111.372 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.449 ' CD1' ' N ' ' A' ' 17' ' ' LEU . 4.2 mp 42.07 45.61 3.45 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.526 -0.734 . . . . 0.0 110.858 178.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -76.91 -40.87 45.78 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.078 -1.014 . . . . 0.0 109.177 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.481 ' O ' ' HE3' ' A' ' 40' ' ' MET . 1.2 t -63.37 -25.96 68.53 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 58.1 m -72.26 -39.21 68.57 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.563 ' CG ' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -59.3 -53.48 57.78 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.472 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.563 ' N ' ' CG ' ' A' ' 21' ' ' ARG . 25.9 m95 -68.11 -29.48 68.41 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 118.984 -1.086 . . . . 0.0 110.429 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.459 ' HE1' HG23 ' A' ' 37' ' ' THR . 4.2 t80 -64.06 -30.62 71.68 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 120.998 -1.064 . . . . 0.0 108.346 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 1.102 HG22 ' CD2' ' A' ' 93' ' ' PHE . 74.6 t -74.93 -44.56 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 178.147 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.503 ' HB3' HD13 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -52.65 -41.36 63.72 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.522 -0.871 . . . . 0.0 109.633 -179.679 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.514 ' HG1' ' HA3' ' A' ' 32' ' ' GLY . 2.6 m -77.77 -56.68 4.31 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.212 -0.93 . . . . 0.0 111.689 -178.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.1 tpt85 -57.77 -24.76 58.67 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.755 -1.216 . . . . 0.0 111.0 -178.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.469 ' OG1' ' O ' ' A' ' 24' ' ' VAL . 78.3 p -97.15 -63.06 1.17 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.949 -1.094 . . . . 0.0 111.191 -178.205 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.565 ' O ' HG23 ' A' ' 31' ' ' VAL . 90.6 m -99.24 18.47 17.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.965 -1.084 . . . . 0.0 110.299 -178.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' A' ' 26' ' ' THR . . . 52.76 19.41 6.69 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 29' ' ' CYS . 76.0 t -107.55 149.23 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.207 -1.173 . . . . 0.0 108.782 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.514 ' HA3' ' HG1' ' A' ' 26' ' ' THR . . . 141.96 177.34 16.99 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.449 -1.86 . . . . 0.0 108.449 -179.141 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -66.32 172.38 9.03 Favored 'Trans proline' 0 N--CA 1.479 0.654 0 CA-C-N 118.99 1.395 . . . . 0.0 109.988 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.23 64.43 4.47 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.876 -1.14 . . . . 0.0 110.074 -178.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.679 HD11 ' NE ' ' A' ' 43' ' ' ARG . 6.6 tt -106.33 120.41 41.8 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.509 ' N ' HD23 ' A' ' 35' ' ' LEU . . . -41.56 135.32 2.15 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.345 -0.847 . . . . 0.0 109.363 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.459 HG23 ' HE1' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -52.19 -54.54 29.63 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.785 -1.197 . . . . 0.0 111.564 -178.738 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -51.93 -43.0 63.25 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.817 -1.177 . . . . 0.0 110.249 -178.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.579 ' CB ' HD21 ' A' ' 35' ' ' LEU . 27.4 mm-40 -67.12 -29.36 69.07 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.28 -0.888 . . . . 0.0 109.604 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.503 ' SD ' HD13 ' A' ' 35' ' ' LEU . 8.5 tpt -69.23 -60.78 2.11 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.123 -0.986 . . . . 0.0 108.361 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.54 -39.11 48.12 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.81 -41.42 97.74 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.347 -0.846 . . . . 0.0 109.154 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.679 ' NE ' HD11 ' A' ' 35' ' ' LEU . 21.3 mtt85 -60.08 -47.22 86.8 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.349 -0.845 . . . . 0.0 109.192 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 15.3 m -61.26 -37.05 81.72 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.19 -0.944 . . . . 0.0 110.577 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 96.9 m -71.14 -28.59 64.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.811 -1.18 . . . . 0.0 109.141 -179.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.1 tpp180 -74.35 -31.35 62.39 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.462 ' O ' HG12 ' A' ' 51' ' ' ILE . 0.7 OUTLIER -77.09 -37.13 55.02 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.952 -0.699 . . . . 0.0 109.389 179.951 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.94 HD11 HG12 ' A' ' 98' ' ' VAL . 6.2 tt -70.8 -36.57 73.06 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.297 -0.877 . . . . 0.0 108.666 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.446 ' O ' ' C ' ' A' ' 50' ' ' ALA . 13.3 tp10 -67.27 -51.4 53.35 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.514 ' O ' ' HD3' ' A' ' 52' ' ' PRO . . . -47.89 -49.68 28.97 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 178.098 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.484 HD12 HG13 ' A' ' 12' ' ' ILE . 33.7 mm -62.04 106.09 0.76 Allowed Pre-proline 0 C--N 1.304 -1.411 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 176.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.523 ' O ' ' N ' ' A' ' 54' ' ' TYR . 26.6 Cg_endo -63.95 141.4 77.36 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 121.631 1.554 . . . . 0.0 110.81 -177.104 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.535 ' HB2' ' NH2' ' A' ' 56' ' ' ARG . . . -37.15 -28.67 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.908 -0.495 . . . . 0.0 110.079 -178.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.523 ' N ' ' O ' ' A' ' 52' ' ' PRO . 0.3 OUTLIER -65.41 119.85 11.75 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.095 -1.003 . . . . 0.0 108.578 178.998 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.523 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 63.6 m 64.91 8.98 5.0 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.355 -0.841 . . . . 0.0 110.256 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.535 ' NH2' ' HB2' ' A' ' 53' ' ' ALA . 8.6 mtt180 -42.42 -87.78 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.705 -1.247 . . . . 0.0 109.471 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.501 ' O ' ' C ' ' A' ' 58' ' ' GLU . 20.9 m -28.38 -50.71 0.08 Allowed 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.512 ' HB2' ' O ' ' A' ' 55' ' ' CYS . 0.1 OUTLIER -32.22 -51.23 0.25 Allowed 'General case' 0 N--CA 1.502 2.159 0 O-C-N 120.82 -1.175 . . . . 0.0 111.432 -178.74 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.479 ' C ' ' O ' ' A' ' 58' ' ' GLU . . . -36.5 -55.39 0.84 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.313 -0.867 . . . . 0.0 110.268 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.0 t -53.18 -49.89 49.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.474 -0.766 . . . . 0.0 109.252 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.482 ' O ' ' HB2' ' A' ' 65' ' ' ASP . 2.0 ttp180 -55.34 -29.35 58.19 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.294 -0.879 . . . . 0.0 109.508 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.744 HG23 ' HB ' ' A' ' 67' ' ' VAL . 30.2 mt -77.79 -28.53 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.331 -0.856 . . . . 0.0 109.938 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.527 ' O ' ' HA ' ' A' ' 77' ' ' ARG . 26.4 tp -77.56 -44.5 28.32 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.842 -1.161 . . . . 0.0 109.486 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 30.1 ttp -78.14 -50.69 11.5 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.869 -1.144 . . . . 0.0 109.72 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.482 ' HB2' ' O ' ' A' ' 61' ' ' ARG . 15.7 m-20 -80.37 -21.26 42.54 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.017 -1.052 . . . . 0.0 110.394 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.435 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . 86.65 152.28 21.11 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.744 ' HB ' HG23 ' A' ' 62' ' ' ILE . 1.4 p -117.02 159.97 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.539 -0.977 . . . . 0.0 109.248 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.998 HG22 ' CE1' ' A' ' 74' ' ' HIS . 12.9 t -113.58 158.16 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-O 121.87 0.843 . . . . 0.0 109.384 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.468 ' N ' ' CG1' ' A' ' 68' ' ' VAL . 69.8 p -117.57 158.76 24.04 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.683 0.754 . . . . 0.0 110.088 -178.008 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.1 t -65.0 -25.6 67.93 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.571 0.7 . . . . 0.0 109.791 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.1 p -71.13 -15.09 62.48 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.638 -0.664 . . . . 0.0 109.388 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 99.51 10.55 47.2 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.607 -1.797 . . . . 0.0 108.607 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -103.17 157.0 17.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.269 -1.136 . . . . 0.0 109.621 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.998 ' CE1' HG22 ' A' ' 68' ' ' VAL . 1.7 m80 -115.07 155.93 26.11 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.064 -1.022 . . . . 0.0 108.821 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -142.67 -174.87 4.27 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.271 -0.893 . . . . 0.0 110.465 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 60.62 -139.47 48.11 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.527 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER 52.39 33.19 12.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.215 -1.168 . . . . 0.0 109.368 -179.884 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.479 ' O ' ' N ' ' A' ' 80' ' ' GLN . 1.3 mt -79.06 -22.23 45.64 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.976 -1.078 . . . . 0.0 109.996 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.423 ' C ' ' O ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -45.85 98.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.798 -1.189 . . . . 0.0 108.855 179.513 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.479 ' N ' ' O ' ' A' ' 78' ' ' LEU . 40.1 mt-30 -145.12 174.21 11.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.124 -0.985 . . . . 0.0 110.428 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -56.78 140.75 46.76 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 122.045 0.926 . . . . 0.0 110.701 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.663 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 17.9 mt -133.06 171.17 9.63 Favored Pre-proline 0 C--N 1.301 -1.531 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 179.133 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.663 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 27.5 Cg_endo -65.91 98.88 0.38 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 120.856 1.038 . . . . 0.0 110.591 -179.201 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.492 ' C ' ' SG ' ' A' ' 29' ' ' CYS . . . 88.3 -6.73 83.21 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.464 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 9.7 m -119.86 88.42 40.08 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 120.684 -1.48 . . . . 0.0 110.015 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 87' ' ' ARG . 30.5 Cg_endo -75.75 161.32 36.72 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 C-N-CA 122.085 1.857 . . . . 0.0 111.713 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.433 ' C ' ' O ' ' A' ' 86' ' ' PRO . 13.3 mtm-85 -43.57 -27.51 0.3 Allowed 'General case' 0 N--CA 1.482 1.136 0 CA-C-O 121.773 0.797 . . . . 0.0 108.913 178.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' A' ' 86' ' ' PRO . 32.9 tt0 -59.2 -59.84 4.81 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.753 -0.592 . . . . 0.0 111.317 -178.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 45.0 t -65.75 -40.7 88.52 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 O-C-N 120.871 -1.143 . . . . 0.0 110.531 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.909 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -63.83 -28.07 69.6 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.249 -0.98 . . . . 0.0 108.574 179.843 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.407 ' HB2' ' O ' ' A' ' 87' ' ' ARG . 0.1 OUTLIER -78.09 -29.39 49.01 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.542 -0.723 . . . . 0.0 109.592 179.556 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.479 ' O ' ' HD2' ' A' ' 95' ' ' PRO . . . -74.58 -53.52 9.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -0.909 . . . . 0.0 109.965 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 1.102 ' CD2' HG22 ' A' ' 24' ' ' VAL . 6.0 t80 -78.25 -26.6 47.32 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.042 -1.036 . . . . 0.0 110.365 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.909 ' HB2' ' O ' ' A' ' 90' ' ' GLN . . . -40.91 -52.64 6.61 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.125 -0.985 . . . . 0.0 111.34 -178.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.827 ' HD3' ' HB3' ' A' ' 94' ' ' ALA . 31.4 Cg_endo -72.27 -164.71 0.18 Allowed 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.143 1.895 . . . . 0.0 111.04 -178.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 95' ' ' PRO . 13.6 mmtm 63.73 30.41 14.71 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -178.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.507 ' HA ' HD22 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -73.77 -71.19 0.34 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.656 -0.653 . . . . 0.0 110.86 -179.157 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.94 HG12 HD11 ' A' ' 48' ' ' LEU . 2.9 m -77.45 22.9 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.623 -1.298 . . . . 0.0 111.266 -179.306 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.435 ' C ' ' HB3' ' A' ' 104' ' ' ASN . 7.0 p -99.22 172.68 7.21 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 120.513 -1.367 . . . . 0.0 108.898 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.465 ' HA ' ' ND2' ' A' ' 104' ' ' ASN . 40.0 mt-10 -59.63 -0.31 0.17 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.804 -1.185 . . . . 0.0 111.891 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.702 ' O ' HG12 ' A' ' 101' ' ' VAL . 97.8 t -100.28 7.39 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 119.957 -1.714 . . . . 0.0 110.33 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.506 ' HB2' ' O ' ' A' ' 97' ' ' LEU . 2.0 mm-40 -145.75 -92.71 0.09 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.758 -1.214 . . . . 0.0 110.297 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.463 ' O ' ' C ' ' A' ' 104' ' ' ASN . 33.2 m -142.13 37.86 1.58 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.945 -1.097 . . . . 0.0 109.638 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 98' ' ' VAL . 5.1 p30 -35.12 -50.96 0.53 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.244 -0.91 . . . . 0.0 111.513 -179.044 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 106' ' ' ALA . 12.0 mt 42.23 31.61 0.27 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.916 -1.115 . . . . 0.0 110.226 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.468 ' O ' ' O ' ' A' ' 105' ' ' LEU . . . 60.28 121.33 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.857 -1.152 . . . . 0.0 109.521 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.8 p -91.58 -165.72 1.41 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 1.035 HD13 ' O ' ' A' ' 108' ' ' ILE . 0.0 OUTLIER -61.37 -25.77 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 120.931 -1.105 . . . . 0.0 108.49 179.261 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.48 ' HB3' ' CE1' ' A' ' 113' ' ' PHE . 86.9 m-70 -76.74 14.0 0.9 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.53 -0.731 . . . . 0.0 110.717 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 50.11 25.06 7.32 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.399 -1.481 . . . . 0.0 109.399 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -156.55 172.08 34.24 Favored Glycine 0 N--CA 1.49 2.246 0 C-N-CA 119.766 -1.207 . . . . 0.0 110.085 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.474 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 33.3 Cg_endo -78.5 74.25 5.5 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 123.001 2.467 . . . . 0.0 111.195 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.48 ' CE1' ' HB3' ' A' ' 109' ' ' HIS . 32.6 p90 . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.177 -0.952 . . . . 0.0 109.947 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo . . . . . 0 CA--C 1.54 0.814 0 N-CA-C 110.298 -0.693 . . . . 0.0 110.298 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 58.1 17.89 32.15 Favored Glycine 0 N--CA 1.499 2.866 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.583 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 84.3 mtp -140.84 108.09 5.51 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-N 117.935 0.868 . . . . 0.0 108.72 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.583 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 86.73 -58.4 0.05 OUTLIER 'General case' 0 N--CA 1.514 2.75 0 CA-C-N 119.75 1.159 . . . . 0.0 108.247 -178.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.843 HD11 ' HB3' ' A' ' 55' ' ' CYS . 44.8 mt -106.41 100.74 31.53 Favored Pre-proline 0 N--CA 1.492 1.648 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 178.238 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -81.01 173.47 11.89 Favored 'Trans proline' 0 N--CA 1.475 0.427 0 C-N-CA 121.471 1.447 . . . . 0.0 111.243 -177.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 57.7 m80 -71.14 144.19 50.31 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.563 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 35.1 t-20 59.78 52.88 3.75 Favored Pre-proline 0 N--CA 1.498 1.972 0 O-C-N 121.725 -0.61 . . . . 0.0 110.05 -178.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.563 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 41.8 Cg_endo -83.05 170.27 12.39 Favored 'Trans proline' 0 N--CA 1.483 0.864 0 C-N-CA 122.043 1.829 . . . . 0.0 111.355 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.668 HD23 ' HB1' ' A' ' 59' ' ' ALA . 4.3 mm? 50.75 38.73 20.24 Favored 'General case' 0 N--CA 1.501 2.093 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.646 177.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -78.17 -43.31 28.98 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.542 -0.724 . . . . 0.0 109.484 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.18 -29.12 70.15 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 17.0 m -73.5 -40.1 64.32 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.569 ' CZ ' HD11 ' A' ' 82' ' ' LEU . 0.6 OUTLIER -61.23 -51.36 69.28 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -179.722 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.42 ' CE3' ' HA ' ' A' ' 22' ' ' TRP . 38.9 m95 -69.83 -28.15 65.46 Favored 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 119.581 -0.848 . . . . 0.0 109.743 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.589 ' HE1' HG22 ' A' ' 37' ' ' THR . 18.4 t80 -67.47 -29.63 69.14 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.547 HG22 ' CE1' ' A' ' 93' ' ' PHE . 98.9 t -75.27 -42.89 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 85.0 p -54.73 -39.02 67.83 Favored 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.939 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 77.0 m -77.45 -48.77 16.32 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 122.296 -0.252 . . . . 0.0 111.661 -178.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.6 mmm180 -64.26 -24.88 67.82 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.626 -0.671 . . . . 0.0 111.054 -178.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 82.5 p -97.0 -61.97 1.33 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 122.162 -0.336 . . . . 0.0 111.872 -177.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.654 ' O ' HG23 ' A' ' 31' ' ' VAL . 3.7 m -100.08 9.35 42.98 Favored 'General case' 0 N--CA 1.507 2.407 0 O-C-N 121.444 -0.785 . . . . 0.0 111.415 -178.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 57.43 25.93 55.8 Favored Glycine 0 N--CA 1.505 3.237 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 -178.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' ' 29' ' ' CYS . 41.0 t -115.38 164.49 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 122.105 -0.644 . . . . 0.0 109.556 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.498 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 132.61 178.28 15.43 Favored Glycine 0 N--CA 1.498 2.785 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -66.13 173.5 7.19 Favored 'Trans proline' 0 N--CA 1.486 1.058 0 CA-C-N 119.382 1.591 . . . . 0.0 109.833 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -92.24 79.99 5.04 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 122.02 0.914 . . . . 0.0 109.87 -178.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.401 ' HA ' HD22 ' A' ' 35' ' ' LEU . 0.2 OUTLIER -124.71 129.52 50.66 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.037 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.25 132.59 28.76 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.925 -0.484 . . . . 0.0 109.747 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.589 HG22 ' HE1' ' A' ' 23' ' ' TYR . 0.6 OUTLIER -52.58 -53.64 43.76 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.447 -0.783 . . . . 0.0 111.18 -179.108 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -50.12 -35.96 27.84 Favored 'General case' 0 N--CA 1.508 2.436 0 O-C-N 121.723 -0.61 . . . . 0.0 110.816 -178.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -70.93 -38.54 72.89 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 31.5 tpp -62.54 -57.55 10.74 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 41.2 tttt -55.77 -35.94 66.8 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.862 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.28 -37.09 86.25 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.74 -45.85 81.08 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 15.1 m -62.72 -35.57 80.2 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.094 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 17.7 m -75.3 -28.56 59.76 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.64 -34.95 70.22 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -78.43 -28.2 46.71 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.689 ' O ' HD13 ' A' ' 48' ' ' LEU . 1.4 tm? -72.78 -35.47 67.42 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -178.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -77.92 -51.28 10.66 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.64 -33.39 54.99 Favored 'General case' 0 N--CA 1.505 2.303 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.0 mt -87.71 104.88 7.4 Favored Pre-proline 0 N--CA 1.492 1.651 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.559 ' HD2' ' HB1' ' A' ' 11' ' ' ALA . 25.7 Cg_endo -60.56 149.22 88.08 Favored 'Trans proline' 0 N--CA 1.479 0.638 0 C-N-CA 121.826 1.684 . . . . 0.0 110.543 -177.501 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.1 -19.95 55.8 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.582 -177.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -49.56 -32.82 13.39 Favored 'General case' 0 N--CA 1.513 2.677 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 178.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.843 ' HB3' HD11 ' A' ' 12' ' ' ILE . 61.9 m -119.26 -69.89 0.82 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 115.336 -0.847 . . . . 0.0 108.955 178.161 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 35.7 mtt180 38.0 -92.96 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.696 0 C-N-CA 122.8 0.44 . . . . 0.0 111.273 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.403 ' HA ' HD13 ' A' ' 97' ' ' LEU . 86.4 m -37.96 -45.44 0.88 Allowed 'General case' 0 N--CA 1.515 2.815 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -40.21 -48.78 2.62 Favored 'General case' 0 N--CA 1.511 2.607 0 CA-C-N 119.843 1.202 . . . . 0.0 112.027 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.668 ' HB1' HD23 ' A' ' 17' ' ' LEU . . . -42.05 -49.22 4.74 Favored 'General case' 0 N--CA 1.513 2.685 0 CA-C-N 118.483 0.583 . . . . 0.0 111.905 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.921 HG21 HD22 ' A' ' 97' ' ' LEU . 57.6 t -57.94 -45.86 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -60.61 -26.83 67.29 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.795 HG23 ' HB ' ' A' ' 67' ' ' VAL . 50.6 mt -78.1 -29.31 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.881 -0.512 . . . . 0.0 109.71 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.2 tp -77.87 -41.51 36.55 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.853 -0.739 . . . . 0.0 109.954 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.707 ' SD ' HD22 ' A' ' 79' ' ' LEU . 39.4 tpp -78.56 -52.77 8.0 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.331 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -80.51 -22.94 40.43 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 122.048 -0.408 . . . . 0.0 110.981 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 85.15 147.47 9.21 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 109.196 -1.561 . . . . 0.0 109.196 -178.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.795 ' HB ' HG23 ' A' ' 62' ' ' ILE . 5.3 p -118.01 158.74 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.265 0 O-C-N 122.133 -0.628 . . . . 0.0 109.531 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.662 HG22 ' NE2' ' A' ' 74' ' ' HIS . 70.6 t -115.58 157.3 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-O 121.946 0.879 . . . . 0.0 109.463 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.6 p -117.35 159.99 21.86 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.03 -178.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 34.3 t -64.11 -33.62 76.18 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.932 -178.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.7 p -63.44 -17.8 63.07 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.69 8.13 49.52 Favored Glycine 0 N--CA 1.496 2.672 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 60.8 mt-30 -95.43 156.08 16.47 Favored 'General case' 0 N--CA 1.501 2.114 0 CA-C-N 118.158 0.979 . . . . 0.0 109.578 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.662 ' NE2' HG22 ' A' ' 68' ' ' VAL . 9.6 m170 -116.47 154.93 29.48 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -141.24 -175.49 4.36 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.106 0.479 . . . . 0.0 110.081 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 55.6 -146.1 31.03 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.9 ttp180 56.54 19.84 4.48 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 122.29 -0.535 . . . . 0.0 110.384 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.5 mt -84.03 -14.45 50.57 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.723 -0.611 . . . . 0.0 110.244 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.873 HD21 ' CB ' ' A' ' 90' ' ' GLN . 5.3 tt -61.93 92.88 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -135.31 172.8 12.49 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.255 0.55 . . . . 0.0 109.591 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -51.32 102.01 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.651 0.739 . . . . 0.0 111.384 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.569 HD11 ' CZ ' ' A' ' 21' ' ' ARG . 21.5 mt -87.2 169.99 13.18 Favored Pre-proline 0 N--CA 1.495 1.803 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 177.255 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.557 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 28.9 Cg_endo -68.18 100.55 0.65 Allowed 'Trans proline' 0 C--N 1.327 -0.562 0 C-N-CA 120.942 1.095 . . . . 0.0 110.609 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.17 11.99 60.6 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.416 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 3.6 m -141.91 91.33 8.17 Favored Pre-proline 0 N--CA 1.506 2.353 0 CA-C-N 118.786 1.293 . . . . 0.0 109.11 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -74.19 161.45 40.68 Favored 'Trans proline' 0 N--CA 1.482 0.825 0 C-N-CA 121.538 1.492 . . . . 0.0 111.282 -178.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.82 -28.75 2.73 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.268 0.556 . . . . 0.0 109.599 177.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -55.38 -53.49 55.57 Favored 'General case' 0 N--CA 1.503 2.199 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.654 -178.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 54.2 t -62.83 -39.91 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.709 -0.62 . . . . 0.0 109.63 -178.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.873 ' CB ' HD21 ' A' ' 79' ' ' LEU . 1.9 mp0 -64.11 -26.35 68.5 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.66 -33.99 46.68 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.29 -48.83 63.91 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.876 -0.515 . . . . 0.0 109.654 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.547 ' CE1' HG22 ' A' ' 24' ' ' VAL . 31.0 t80 -78.58 -26.25 45.49 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 122.262 -0.274 . . . . 0.0 110.55 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.695 ' HB3' ' HD3' ' A' ' 95' ' ' PRO . . . -41.25 -49.75 8.6 Favored Pre-proline 0 N--CA 1.506 2.336 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -177.121 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.695 ' HD3' ' HB3' ' A' ' 94' ' ' ALA . 34.5 Cg_endo -77.84 33.15 0.45 Allowed 'Trans proline' 0 CA--C 1.55 1.308 0 C-N-CA 122.206 1.937 . . . . 0.0 112.964 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 49.8 mttm -123.99 30.97 5.96 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 178.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.921 HD22 HG21 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -73.56 -71.31 0.32 Allowed 'General case' 0 N--CA 1.512 2.641 0 O-C-N 122.067 -0.396 . . . . 0.0 110.804 -179.196 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.853 HG13 HD12 ' A' ' 97' ' ' LEU . 11.0 m -94.95 28.32 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.388 -0.82 . . . . 0.0 109.855 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 27.9 p -96.96 170.05 9.42 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.85 -2.38 0.85 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.549 -0.72 . . . . 0.0 112.015 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.573 ' O ' HG12 ' A' ' 101' ' ' VAL . 22.0 t -98.34 4.72 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 CA-C-N 120.36 1.436 . . . . 0.0 110.894 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.429 ' HB3' ' O ' ' A' ' 97' ' ' LEU . 4.8 tp10 -142.25 -91.55 0.13 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.559 -0.713 . . . . 0.0 111.039 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.483 ' O ' HD12 ' A' ' 105' ' ' LEU . 93.6 m -143.61 42.06 1.47 Allowed 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.387 -0.821 . . . . 0.0 110.002 -178.385 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -39.85 -56.8 1.71 Allowed 'General case' 0 N--CA 1.508 2.456 0 N-CA-C 113.642 0.978 . . . . 0.0 113.642 -178.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.483 HD12 ' O ' ' A' ' 103' ' ' CYS . 2.0 mt 45.87 23.9 0.2 Allowed 'General case' 0 N--CA 1.508 2.432 0 CA-C-N 118.995 0.816 . . . . 0.0 111.277 -179.119 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 105' ' ' LEU . . . 64.76 123.79 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.317 -0.865 . . . . 0.0 109.7 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.1 p -89.89 -159.0 0.56 Allowed 'General case' 0 N--CA 1.507 2.38 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.5 tp -66.63 -31.1 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.115 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -69.77 -0.87 7.8 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.893 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 58.54 28.78 62.89 Favored Glycine 0 N--CA 1.497 2.756 0 N-CA-C 109.299 -1.521 . . . . 0.0 109.299 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -157.01 168.72 34.04 Favored Glycine 0 N--CA 1.498 2.784 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -78.68 73.96 5.69 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 122.798 2.332 . . . . 0.0 111.933 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 30.2 p90 . . . . . 0 N--CA 1.505 2.305 0 O-C-N 121.583 -0.698 . . . . 0.0 110.431 178.282 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo . . . . . 0 CA--C 1.546 1.105 0 N-CA-C 111.038 -0.408 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 74.76 4.12 69.94 Favored Glycine 0 N--CA 1.502 3.048 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.577 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 72.4 mmm -129.61 99.74 5.27 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.577 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 86.7 -54.59 0.06 Allowed 'General case' 0 N--CA 1.517 2.917 0 CA-C-N 119.448 1.022 . . . . 0.0 108.713 -178.321 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.691 HD11 ' HB2' ' A' ' 55' ' ' CYS . 36.8 mm -104.83 100.55 24.32 Favored Pre-proline 0 N--CA 1.495 1.783 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.581 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.404 ' HD3' ' CD1' ' A' ' 51' ' ' ILE . 35.6 Cg_endo -84.27 175.04 7.63 Favored 'Trans proline' 0 N--CA 1.475 0.423 0 C-N-CA 121.749 1.632 . . . . 0.0 111.511 -177.44 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 -84.03 142.78 30.21 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.499 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 7.3 t-20 60.12 57.95 4.41 Favored Pre-proline 0 N--CA 1.501 2.094 0 O-C-N 121.605 -0.685 . . . . 0.0 109.676 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.499 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 39.7 Cg_endo -81.41 150.24 17.11 Favored 'Trans proline' 0 N--CA 1.481 0.747 0 C-N-CA 122.219 1.946 . . . . 0.0 112.069 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 76.9 mt 51.98 42.74 30.5 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.853 177.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -66.33 -34.24 77.54 Favored 'General case' 0 N--CA 1.506 2.353 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 178.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.3 t -63.49 -26.06 68.54 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.037 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.696 ' O ' HG23 ' A' ' 24' ' ' VAL . 56.1 m -77.79 -34.76 52.05 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.678 ' HB3' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -65.94 -51.54 57.66 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.417 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.45 ' HA ' ' CE3' ' A' ' 22' ' ' TRP . 27.7 m95 -66.83 -32.43 73.7 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 119.753 -0.779 . . . . 0.0 109.682 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -64.25 -32.33 73.88 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 20' ' ' CYS . 48.2 t -70.51 -39.74 76.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 177.367 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 m -55.92 -40.39 73.01 Favored 'General case' 0 N--CA 1.501 2.088 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.361 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.1 m -77.19 -54.45 6.49 Favored 'General case' 0 N--CA 1.51 2.543 0 O-C-N 122.011 -0.431 . . . . 0.0 111.785 -178.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 14.3 ttm180 -60.05 -24.6 64.68 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.687 -0.633 . . . . 0.0 110.413 -178.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.531 HG23 ' O ' ' A' ' 24' ' ' VAL . 44.3 p -95.21 -66.02 0.94 Allowed 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -177.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.539 ' O ' HG23 ' A' ' 31' ' ' VAL . 3.8 m -100.35 13.27 34.96 Favored 'General case' 0 N--CA 1.51 2.556 0 O-C-N 121.247 -0.908 . . . . 0.0 111.413 -178.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 58.66 22.68 53.64 Favored Glycine 0 N--CA 1.505 3.269 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -178.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 29' ' ' CYS . 29.0 t -110.01 165.53 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.363 0 O-C-N 121.899 -0.765 . . . . 0.0 109.376 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.496 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 131.06 178.63 15.56 Favored Glycine 0 N--CA 1.499 2.896 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -65.03 176.67 2.91 Favored 'Trans proline' 0 N--CA 1.489 1.249 0 CA-C-N 119.042 1.421 . . . . 0.0 109.905 179.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.774 ' C ' HD12 ' A' ' 35' ' ' LEU . 0.3 OUTLIER -91.59 79.58 5.46 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 122.196 0.998 . . . . 0.0 109.857 -178.099 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.774 HD12 ' C ' ' A' ' 34' ' ' ARG . 9.4 mp -130.59 127.8 39.74 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.04 160.24 1.57 Allowed 'General case' 0 N--CA 1.501 2.121 0 O-C-N 122.041 -0.412 . . . . 0.0 110.12 -178.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.22 -37.93 72.02 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 122.02 -0.425 . . . . 0.0 111.206 -178.278 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.53 -42.77 77.99 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.881 -0.512 . . . . 0.0 110.081 -178.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -70.12 -28.17 65.17 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 2.7 tpt -70.06 -54.54 12.65 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.3 tttt -55.53 -33.9 64.22 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.505 179.293 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.73 -37.9 76.66 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.63 -37.83 88.81 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 13.1 m -72.23 -32.8 67.06 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.856 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.406 ' HA ' ' CB ' ' A' ' 103' ' ' CYS . 79.7 m -72.2 -29.71 64.24 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.63 -34.89 46.18 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.528 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 4.4 mm-40 -72.98 -38.15 66.79 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.911 HD11 HG12 ' A' ' 98' ' ' VAL . 1.2 tt -67.64 -59.78 3.07 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 179.459 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.817 ' N ' HD23 ' A' ' 48' ' ' LEU . 1.1 tm-20 -52.57 -26.9 14.63 Favored 'General case' 0 N--CA 1.504 2.245 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.276 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 47' ' ' GLN . . . -61.65 -61.31 2.61 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.207 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.561 HG23 HD13 ' A' ' 12' ' ' ILE . 45.9 mm -57.12 102.98 0.33 Allowed Pre-proline 0 N--CA 1.509 2.501 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 177.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -54.82 149.8 39.85 Favored 'Trans proline' 0 N--CA 1.486 1.044 0 C-N-CA 121.895 1.73 . . . . 0.0 112.79 -175.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -37.19 -32.1 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.427 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.415 -178.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -73.43 112.27 9.35 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 177.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.691 ' HB2' HD11 ' A' ' 12' ' ' ILE . 28.4 m 73.67 14.82 4.15 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 122.237 -0.289 . . . . 0.0 110.29 -178.33 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.504 ' NH1' ' O ' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -45.53 -86.52 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.919 0 O-C-N 121.083 -1.01 . . . . 0.0 109.813 -179.913 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 21.8 m -38.98 -38.55 0.45 Allowed 'General case' 0 N--CA 1.515 2.821 0 N-CA-C 113.801 1.038 . . . . 0.0 113.801 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.725 ' O ' HD12 ' A' ' 62' ' ' ILE . 0.5 OUTLIER -36.36 -43.91 0.4 Allowed 'General case' 0 N--CA 1.512 2.673 0 CA-C-N 120.294 1.406 . . . . 0.0 112.512 -179.697 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -42.55 -54.53 3.89 Favored 'General case' 0 N--CA 1.514 2.755 0 O-C-N 121.851 -0.531 . . . . 0.0 111.765 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.818 ' CG2' HD13 ' A' ' 97' ' ' LEU . 95.2 t -57.58 -42.34 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.89 -30.41 67.76 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.725 HD12 ' O ' ' A' ' 58' ' ' GLU . 1.6 mp -78.41 -30.43 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 O-C-N 121.954 -0.466 . . . . 0.0 110.469 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.678 HD21 ' HB3' ' A' ' 21' ' ' ARG . 3.8 tp -77.44 -41.72 38.71 Favored 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 119.314 -0.954 . . . . 0.0 110.282 -178.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.69 ' HA ' HD21 ' A' ' 79' ' ' LEU . 0.7 OUTLIER -78.72 -52.06 8.94 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.202 -179.821 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -81.06 -22.99 38.84 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.936 -0.478 . . . . 0.0 111.267 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.58 147.38 10.93 Favored Glycine 0 N--CA 1.498 2.823 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 -178.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.704 ' HB ' HG23 ' A' ' 62' ' ' ILE . 7.6 p -118.29 159.65 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 122.052 -0.675 . . . . 0.0 109.644 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.667 HG22 ' NE2' ' A' ' 74' ' ' HIS . 69.3 t -114.9 157.77 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 CA-C-O 121.828 0.823 . . . . 0.0 109.602 -178.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.409 ' N ' HG12 ' A' ' 68' ' ' VAL . 33.9 p -117.14 159.54 22.43 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.73 -177.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 42.6 t -63.28 -31.09 72.15 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.383 -178.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.5 p -68.32 -17.33 64.23 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.231 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.91 14.08 32.42 Favored Glycine 0 N--CA 1.498 2.795 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.271 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -102.37 156.21 17.74 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-N 118.085 0.942 . . . . 0.0 109.398 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.667 ' NE2' HG22 ' A' ' 68' ' ' VAL . 8.7 m170 -116.03 156.15 26.84 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -145.67 -174.1 4.31 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.034 0.445 . . . . 0.0 109.869 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 60.27 -148.68 43.4 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 56.11 28.32 12.8 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 122.122 -0.634 . . . . 0.0 109.679 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.452 HD23 ' NH2' ' A' ' 21' ' ' ARG . 6.4 mp -86.45 -14.37 43.43 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.716 -0.615 . . . . 0.0 111.202 -178.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.69 HD21 ' HA ' ' A' ' 64' ' ' MET . 1.0 OUTLIER -79.93 84.42 5.69 Favored 'General case' 0 N--CA 1.503 2.212 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 179.109 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -127.81 -173.13 2.84 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.464 0.649 . . . . 0.0 110.01 -178.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -50.43 102.31 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.695 0.76 . . . . 0.0 111.396 -179.079 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.53 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 22.2 mt -98.51 169.18 8.68 Favored Pre-proline 0 N--CA 1.497 1.916 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.53 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 28.7 Cg_endo -68.24 101.25 0.7 Allowed 'Trans proline' 0 N--CA 1.478 0.601 0 C-N-CA 121.189 1.259 . . . . 0.0 110.733 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.69 13.65 59.25 Favored Glycine 0 N--CA 1.497 2.71 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 3.7 m -143.6 91.03 6.9 Favored Pre-proline 0 N--CA 1.509 2.485 0 CA-C-N 118.637 1.219 . . . . 0.0 109.371 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -75.39 160.15 39.17 Favored 'Trans proline' 0 N--CA 1.483 0.856 0 C-N-CA 121.673 1.582 . . . . 0.0 111.464 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.0 mmt85 -49.55 -28.56 5.73 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 177.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 -57.13 -59.39 5.16 Favored 'General case' 0 N--CA 1.503 2.2 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.624 -178.281 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 53.6 t -61.07 -40.25 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.836 -0.54 . . . . 0.0 110.311 -178.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.734 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 0.3 OUTLIER -65.42 -26.94 68.2 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.638 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.63 -31.68 47.05 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.42 -48.99 36.89 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 122.04 -0.413 . . . . 0.0 109.902 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.464 ' HD2' HG13 ' A' ' 24' ' ' VAL . 67.2 t80 -78.46 -25.34 45.82 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 122.326 -0.234 . . . . 0.0 111.132 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.734 ' HB2' ' O ' ' A' ' 90' ' ' GLN . . . -48.98 -48.83 71.43 Favored Pre-proline 0 N--CA 1.505 2.319 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -176.537 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.477 ' HD3' ' HB3' ' A' ' 94' ' ' ALA . 29.3 Cg_endo -68.61 85.59 0.46 Allowed 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 121.841 1.694 . . . . 0.0 113.29 -176.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.424 ' C ' ' HD3' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -177.8 54.95 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.422 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.595 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.818 HD13 ' CG2' ' A' ' 60' ' ' VAL . 29.0 tp -86.27 -81.32 0.22 Allowed 'General case' 0 N--CA 1.507 2.388 0 O-C-N 121.218 -0.926 . . . . 0.0 111.753 -177.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.911 HG12 HD11 ' A' ' 48' ' ' LEU . 4.0 m -91.62 24.92 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.745 -0.597 . . . . 0.0 110.958 -176.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 29.9 p -93.47 168.71 10.87 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.16 -0.01 0.48 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.49 -0.756 . . . . 0.0 111.843 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.551 ' O ' HG12 ' A' ' 101' ' ' VAL . 28.0 t -97.07 0.16 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 CA-C-N 120.518 1.508 . . . . 0.0 111.249 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.409 ' HB3' ' O ' ' A' ' 97' ' ' LEU . 23.9 tp10 -140.71 -88.07 0.17 Allowed 'General case' 0 N--CA 1.504 2.245 0 CA-C-N 119.114 0.87 . . . . 0.0 111.433 -179.326 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.517 ' O ' HD12 ' A' ' 105' ' ' LEU . 57.3 m -143.74 45.56 1.48 Allowed 'General case' 0 N--CA 1.509 2.482 0 O-C-N 121.244 -0.91 . . . . 0.0 109.683 -179.155 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.9 p-10 -40.5 -57.59 1.78 Allowed 'General case' 0 N--CA 1.504 2.263 0 O-C-N 121.192 -0.942 . . . . 0.0 113.363 -178.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.517 HD12 ' O ' ' A' ' 103' ' ' CYS . 3.6 mt 43.16 27.27 0.11 Allowed 'General case' 0 N--CA 1.515 2.777 0 CA-C-N 119.016 0.825 . . . . 0.0 111.112 -179.413 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 63.57 153.66 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.451 -0.781 . . . . 0.0 109.801 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.3 p -123.82 -161.18 0.96 Allowed 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.3 tp -66.99 -33.8 65.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.072 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.451 ' HB3' ' CE1' ' A' ' 113' ' ' PHE . 66.0 m80 -70.96 -0.72 9.9 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.907 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 56.28 43.41 89.44 Favored Glycine 0 N--CA 1.501 2.984 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -172.48 170.58 43.63 Favored Glycine 0 N--CA 1.501 2.993 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -77.17 77.1 3.92 Favored 'Trans proline' 0 CA--C 1.544 1.023 0 C-N-CA 122.36 2.04 . . . . 0.0 111.513 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.451 ' CE1' ' HB3' ' A' ' 109' ' ' HIS . 33.1 p90 . . . . . 0 N--CA 1.505 2.311 0 O-C-N 121.754 -0.591 . . . . 0.0 109.827 178.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.405 ' HG3' HG21 ' A' ' 67' ' ' VAL . 30.6 Cg_endo . . . . . 0 N--CA 1.48 0.698 0 N-CA-C 111.131 -0.373 . . . . 0.0 111.131 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 62.76 16.48 56.34 Favored Glycine 0 N--CA 1.497 2.733 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.062 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.574 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 16.8 mmm -140.93 84.63 1.94 Allowed 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.882 -0.775 . . . . 0.0 109.011 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.574 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 86.73 -57.72 0.05 Allowed 'General case' 0 N--CA 1.516 2.864 0 O-C-N 121.379 -0.825 . . . . 0.0 108.84 -178.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.715 HD11 ' HB2' ' A' ' 55' ' ' CYS . 61.4 mt -92.14 104.4 10.71 Favored Pre-proline 0 N--CA 1.498 1.961 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 178.459 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -75.05 169.51 22.44 Favored 'Trans proline' 0 C--O 1.219 -0.433 0 C-N-CA 121.3 1.333 . . . . 0.0 111.649 -175.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 47.0 m80 -69.28 144.62 53.54 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.489 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 5.3 t-20 65.98 55.98 1.05 Allowed Pre-proline 0 N--CA 1.506 2.357 0 O-C-N 121.358 -0.838 . . . . 0.0 110.303 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.489 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 38.6 Cg_endo -80.49 166.87 19.63 Favored 'Trans proline' 0 N--CA 1.484 0.932 0 C-N-CA 122.305 2.004 . . . . 0.0 111.923 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.6 mp 42.96 43.8 3.72 Favored 'General case' 0 N--CA 1.504 2.254 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.209 177.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -69.07 -37.68 78.63 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -63.01 -26.16 68.72 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.681 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 57.3 m -74.64 -38.78 62.42 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.584 HH22 HD23 ' A' ' 78' ' ' LEU . 3.4 ttt180 -64.13 -48.6 75.45 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 33.9 m95 -69.02 -29.07 67.17 Favored 'General case' 0 N--CA 1.502 2.149 0 C-N-CA 119.312 -0.955 . . . . 0.0 109.809 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.439 ' CD1' ' HB3' ' A' ' 40' ' ' MET . 57.1 t80 -66.5 -33.5 75.83 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.424 HG22 ' CD2' ' A' ' 93' ' ' PHE . 96.3 t -72.43 -38.96 61.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 177.604 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 m -56.18 -37.06 69.07 Favored 'General case' 0 N--CA 1.501 2.091 0 C-N-CA 119.946 -0.701 . . . . 0.0 109.529 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 90.9 m -77.8 -49.89 13.43 Favored 'General case' 0 N--CA 1.508 2.459 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.92 -25.29 67.82 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 121.519 -0.738 . . . . 0.0 110.544 -178.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 24' ' ' VAL . 70.4 p -93.65 -62.9 1.27 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -177.181 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.655 ' O ' HG23 ' A' ' 31' ' ' VAL . 3.6 m -100.43 9.23 42.92 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.384 -0.823 . . . . 0.0 111.617 -178.562 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 57.79 29.72 61.95 Favored Glycine 0 N--CA 1.507 3.382 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 -178.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 29' ' ' CYS . 38.5 t -120.72 164.09 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 122.155 -0.615 . . . . 0.0 109.717 -179.251 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.495 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 136.16 177.72 15.21 Favored Glycine 0 N--CA 1.5 2.908 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -64.43 177.33 2.18 Favored 'Trans proline' 0 N--CA 1.489 1.231 0 CA-C-N 119.196 1.498 . . . . 0.0 110.028 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.21 87.19 6.0 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 122.197 0.999 . . . . 0.0 110.412 -177.644 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.6 mt -141.76 127.2 18.83 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.02 152.37 2.24 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.907 -0.496 . . . . 0.0 109.81 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.1 p -59.96 -59.64 5.1 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.813 -0.555 . . . . 0.0 110.604 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -52.49 -28.79 21.82 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.818 -0.551 . . . . 0.0 111.595 -178.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -72.0 -46.89 55.56 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.816 -0.553 . . . . 0.0 109.573 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.439 ' HB3' ' CD1' ' A' ' 23' ' ' TYR . 5.5 tpt -61.97 -54.61 39.27 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -53.59 -35.75 61.2 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.34 -42.83 99.71 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.23 -41.14 96.37 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 19.8 m -65.58 -33.17 75.28 Favored 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.233 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 18.9 m -73.43 -30.16 63.03 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -178.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.27 -32.46 62.94 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -77.15 -33.47 56.62 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.785 HD22 ' O ' ' A' ' 103' ' ' CYS . 0.6 OUTLIER -73.48 -33.52 64.87 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.841 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.52 -40.38 61.79 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.25 -39.13 85.67 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.486 HG23 HG12 ' A' ' 12' ' ' ILE . 70.8 mt -82.7 105.75 5.52 Favored Pre-proline 0 N--CA 1.493 1.684 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 177.636 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -58.29 139.87 92.2 Favored 'Trans proline' 0 N--CA 1.48 0.712 0 C-N-CA 121.42 1.413 . . . . 0.0 110.92 -177.205 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.7 ' HB2' ' NH1' ' A' ' 56' ' ' ARG . . . -39.47 -29.76 0.06 Allowed 'General case' 0 N--CA 1.508 2.432 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.359 -178.131 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -53.16 -70.41 0.09 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.919 -0.488 . . . . 0.0 110.698 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.715 ' HB2' HD11 ' A' ' 12' ' ' ILE . 5.0 m -88.55 8.76 26.64 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 122.062 -0.399 . . . . 0.0 110.89 -179.181 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.7 ' NH1' ' HB2' ' A' ' 53' ' ' ALA . 5.9 mtt180 -47.58 -85.2 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.67 0 O-C-N 121.491 -0.755 . . . . 0.0 110.33 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 72.6 m -32.95 -48.85 0.22 Allowed 'General case' 0 N--CA 1.521 3.113 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -41.67 -54.34 3.3 Favored 'General case' 0 N--CA 1.512 2.668 0 CA-C-N 119.325 0.966 . . . . 0.0 111.731 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -41.82 -44.75 3.41 Favored 'General case' 0 N--CA 1.514 2.731 0 O-C-N 121.776 -0.578 . . . . 0.0 112.04 -179.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.6 t -57.22 -48.83 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -58.57 -26.83 64.01 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.957 HG23 ' HB ' ' A' ' 67' ' ' VAL . 34.8 mm -78.42 -30.76 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 O-C-N 121.985 -0.447 . . . . 0.0 110.469 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.486 HD12 ' HA ' ' A' ' 63' ' ' LEU . 14.8 tp -77.77 -43.22 31.42 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 120.11 -0.636 . . . . 0.0 109.999 -179.22 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.01 -50.76 10.58 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.18 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -80.6 -22.71 40.41 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 122.006 -0.434 . . . . 0.0 110.936 -178.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.73 146.89 5.7 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.957 ' HB ' HG23 ' A' ' 62' ' ' ILE . 5.5 p -118.42 161.18 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.667 HG22 ' NE2' ' A' ' 74' ' ' HIS . 56.0 t -113.34 157.85 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -179.383 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 42.2 p -116.67 160.07 21.28 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 121.95 0.881 . . . . 0.0 111.044 -176.385 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 32.9 t -64.61 -17.46 64.02 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.39 -178.182 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.1 p -86.49 -14.64 42.53 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 122.021 -0.424 . . . . 0.0 110.127 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.23 13.59 32.98 Favored Glycine 0 N--CA 1.499 2.892 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -105.48 158.56 16.58 Favored 'General case' 0 N--CA 1.502 2.125 0 CA-C-N 118.039 0.92 . . . . 0.0 108.834 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.667 ' NE2' HG22 ' A' ' 68' ' ' VAL . 11.3 m170 -113.72 154.95 26.46 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -179.138 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -136.89 -179.07 5.48 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.048 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 55.41 -146.94 28.82 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 108.622 -1.791 . . . . 0.0 108.622 -178.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 54.72 22.53 4.17 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 122.303 -0.528 . . . . 0.0 110.007 179.156 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.584 HD23 HH22 ' A' ' 21' ' ' ARG . 2.1 mp -83.1 -14.73 53.1 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.745 -0.597 . . . . 0.0 110.361 -179.247 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.5 mt -62.0 92.79 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -134.22 -177.21 4.48 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.719 0.771 . . . . 0.0 110.843 -178.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -48.68 130.14 17.2 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.506 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.466 ' HB2' ' HB2' ' A' ' 85' ' ' CYS . 20.6 mt -127.49 166.38 23.54 Favored Pre-proline 0 N--CA 1.496 1.87 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.097 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 29.6 Cg_endo -68.63 98.69 0.59 Allowed 'Trans proline' 0 C--N 1.328 -0.537 0 C-N-CA 120.88 1.054 . . . . 0.0 110.143 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.68 4.22 67.9 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.466 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 3.3 m -137.02 92.1 14.4 Favored Pre-proline 0 N--CA 1.508 2.47 0 CA-C-N 119.173 1.487 . . . . 0.0 110.02 -179.31 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -74.69 165.52 31.36 Favored 'Trans proline' 0 N--CA 1.485 1.028 0 C-N-CA 121.976 1.784 . . . . 0.0 111.328 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 23.9 mtp180 -54.09 -25.97 24.66 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.038 0.447 . . . . 0.0 110.133 178.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.58 -46.12 87.33 Favored 'General case' 0 N--CA 1.502 2.139 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.947 -177.185 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 42.2 t -72.46 -43.14 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.513 -0.742 . . . . 0.0 110.982 -177.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.619 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 2.2 pt20 -70.49 -27.15 63.98 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.411 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 8.7 ttt180 -78.72 -29.15 45.17 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.34 -47.34 20.2 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.999 -0.438 . . . . 0.0 110.3 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.424 ' CD2' HG22 ' A' ' 24' ' ' VAL . 90.6 t80 -79.02 -27.48 43.25 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 122.021 -0.425 . . . . 0.0 111.47 -178.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.619 ' HB2' ' O ' ' A' ' 90' ' ' GLN . . . -54.81 -46.64 99.42 Favored Pre-proline 0 N--CA 1.505 2.281 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -177.512 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 94' ' ' ALA . 30.1 Cg_endo -70.12 -0.22 6.89 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 122.239 1.959 . . . . 0.0 114.009 -177.125 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.71 23.92 12.25 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.496 -0.753 . . . . 0.0 109.838 179.064 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.93 -24.32 59.65 Favored 'General case' 0 N--CA 1.509 2.492 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -178.113 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 33.7 m -93.36 25.8 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 CA-C-N 121.0 1.727 . . . . 0.0 111.179 -178.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.406 ' C ' ' HB2' ' A' ' 104' ' ' ASN . 19.1 p -98.28 173.2 7.11 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -62.07 -1.48 0.7 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.696 -0.628 . . . . 0.0 112.25 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.584 ' O ' HG12 ' A' ' 101' ' ' VAL . 37.1 t -100.03 4.49 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 CA-C-N 120.407 1.458 . . . . 0.0 110.873 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -141.13 -89.97 0.15 Allowed 'General case' 0 N--CA 1.502 2.168 0 CA-C-N 118.99 0.814 . . . . 0.0 111.511 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.785 ' O ' HD22 ' A' ' 48' ' ' LEU . 19.5 m -143.67 43.08 1.48 Allowed 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.572 -0.705 . . . . 0.0 109.886 -178.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.409 ' ND2' ' HB3' ' A' ' 112' ' ' PRO . 57.0 t-20 -43.02 -64.81 0.56 Allowed 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.299 -0.875 . . . . 0.0 112.287 -179.287 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.426 ' O ' ' HB3' ' A' ' 106' ' ' ALA . 6.0 mt 45.34 29.39 0.56 Allowed 'General case' 0 N--CA 1.511 2.602 0 CA-C-O 121.066 0.46 . . . . 0.0 109.927 -178.482 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 105' ' ' LEU . . . 67.09 157.98 0.13 Allowed 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -178.616 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.6 p -128.87 -163.92 1.34 Allowed 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -179.307 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 18.0 tt -68.17 -33.29 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.447 ' HB3' ' CE2' ' A' ' 113' ' ' PHE . 96.9 m-70 -66.68 -4.85 9.81 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.689 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 61.45 41.51 99.56 Favored Glycine 0 N--CA 1.499 2.874 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -174.82 170.94 44.14 Favored Glycine 0 N--CA 1.5 2.966 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.409 ' HB3' ' ND2' ' A' ' 104' ' ' ASN . 32.3 Cg_endo -77.9 75.85 4.6 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 122.553 2.168 . . . . 0.0 111.387 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.447 ' CE2' ' HB3' ' A' ' 109' ' ' HIS . 36.7 p90 . . . . . 0 N--CA 1.501 2.118 0 O-C-N 121.708 -0.62 . . . . 0.0 110.447 178.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo . . . . . 0 CA--C 1.542 0.92 0 N-CA-C 110.205 -0.729 . . . . 0.0 110.205 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 109.9 -10.55 32.07 Favored Glycine 0 N--CA 1.501 2.983 0 O-C-N 121.507 -0.746 . . . . 0.0 111.255 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.571 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 6.1 mmt -128.03 111.77 13.89 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 86.17 -54.09 0.07 Allowed 'General case' 0 N--CA 1.514 2.741 0 CA-C-N 119.789 1.177 . . . . 0.0 108.708 -178.515 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 55.0 mt -113.38 100.74 52.44 Favored Pre-proline 0 N--CA 1.495 1.783 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 178.439 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -81.73 172.46 12.22 Favored 'Trans proline' 0 C--O 1.221 -0.366 0 C-N-CA 121.484 1.456 . . . . 0.0 111.524 -177.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.436 ' NE2' HG22 ' A' ' 69' ' ' THR . 33.7 m80 -77.61 150.1 34.69 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -179.347 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.508 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 0.9 OUTLIER 66.99 53.92 0.75 Allowed Pre-proline 0 N--CA 1.503 2.21 0 O-C-N 121.459 -0.775 . . . . 0.0 110.049 -178.525 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.508 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 39.8 Cg_endo -78.45 163.07 27.45 Favored 'Trans proline' 0 N--CA 1.484 0.937 0 C-N-CA 122.282 1.988 . . . . 0.0 111.465 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.575 ' N ' HD22 ' A' ' 17' ' ' LEU . 3.4 mm? 48.62 47.12 20.95 Favored 'General case' 0 N--CA 1.503 2.191 0 CA-C-O 121.246 0.546 . . . . 0.0 111.043 178.648 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -66.7 -35.43 80.1 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 121.493 -0.755 . . . . 0.0 109.078 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.18 -26.62 68.23 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 28.3 m -71.32 -45.2 63.58 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.681 ' NH2' HD23 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -59.38 -54.63 44.47 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.863 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.436 ' HA ' ' CE3' ' A' ' 22' ' ' TRP . 27.9 m95 -64.26 -27.18 68.87 Favored 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.676 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.457 ' CD2' ' HB3' ' A' ' 40' ' ' MET . 6.4 t80 -66.3 -32.5 73.95 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.121 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.692 HG22 ' CD1' ' A' ' 93' ' ' PHE . 61.1 t -70.61 -42.04 77.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 178.276 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 m -56.23 -44.37 79.52 Favored 'General case' 0 N--CA 1.502 2.158 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.656 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 20.9 m -76.05 -52.25 10.58 Favored 'General case' 0 N--CA 1.51 2.569 0 O-C-N 122.059 -0.401 . . . . 0.0 111.924 -178.127 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.7 tpm_? -61.89 -24.89 67.22 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.838 -0.539 . . . . 0.0 110.724 -178.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.531 HG23 ' O ' ' A' ' 24' ' ' VAL . 35.6 p -96.23 -64.38 1.06 Allowed 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 120.689 -0.405 . . . . 0.0 112.058 -177.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.7 m -101.32 10.89 40.16 Favored 'General case' 0 N--CA 1.511 2.613 0 CA-C-N 119.183 0.901 . . . . 0.0 111.484 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.12 18.54 57.84 Favored Glycine 0 N--CA 1.501 2.972 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -178.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.51 HG12 ' N ' ' A' ' 32' ' ' GLY . 46.2 t -102.77 164.04 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 O-C-N 121.696 -0.885 . . . . 0.0 109.112 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.51 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 130.3 179.46 16.06 Favored Glycine 0 N--CA 1.499 2.892 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -64.84 173.06 6.17 Favored 'Trans proline' 0 N--CA 1.486 1.065 0 CA-C-N 119.201 1.5 . . . . 0.0 109.879 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.432 ' O ' HD23 ' A' ' 35' ' ' LEU . 0.2 OUTLIER -92.77 84.5 4.99 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 122.026 0.917 . . . . 0.0 110.178 -177.836 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.432 HD23 ' O ' ' A' ' 34' ' ' ARG . 69.2 mt -140.79 145.1 35.88 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.582 ' HB3' ' HG3' ' A' ' 39' ' ' GLU . . . -58.29 163.11 3.16 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -179.245 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.23 -56.12 4.59 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.998 -0.439 . . . . 0.0 110.444 -179.405 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.28 -33.4 19.77 Favored 'General case' 0 N--CA 1.508 2.474 0 O-C-N 121.881 -0.512 . . . . 0.0 110.803 -178.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.582 ' HG3' ' HB3' ' A' ' 36' ' ' ALA . 3.6 mm-40 -71.35 -39.89 71.02 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 122.054 -0.404 . . . . 0.0 110.142 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.457 ' HB3' ' CD2' ' A' ' 23' ' ' TYR . 1.5 ttt -65.32 -52.79 51.6 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.432 ' HB2' ' CE2' ' A' ' 23' ' ' TYR . 6.4 tttm -53.58 -38.05 63.55 Favored 'General case' 0 N--CA 1.504 2.268 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.98 -40.92 97.27 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -60.36 -44.55 95.47 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 12.4 m -63.19 -35.95 82.0 Favored 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.635 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 69.0 m -70.52 -29.73 66.3 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.6 ttt-85 -73.8 -32.46 63.75 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -76.43 -29.48 57.02 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.844 HD11 HG12 ' A' ' 98' ' ' VAL . 0.6 OUTLIER -76.49 -36.86 57.58 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -73.41 -36.21 65.95 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.65 -53.03 60.69 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 178.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.458 HG22 ' HA ' ' A' ' 56' ' ' ARG . 42.0 mm -63.59 105.81 0.76 Allowed Pre-proline 0 N--CA 1.496 1.871 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 176.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -59.27 149.82 78.32 Favored 'Trans proline' 0 N--CA 1.479 0.651 0 C-N-CA 121.593 1.529 . . . . 0.0 110.935 -176.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -40.46 -32.08 0.18 Allowed 'General case' 0 N--CA 1.505 2.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.53 -178.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -73.49 121.73 21.03 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 178.288 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 15.2 m 72.9 6.41 5.34 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 122.167 -0.333 . . . . 0.0 110.23 -178.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.458 ' HA ' HG22 ' A' ' 51' ' ' ILE . 1.5 mtt180 -49.11 -87.14 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.676 0 O-C-N 121.191 -0.943 . . . . 0.0 109.691 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 82.4 m -36.39 -43.51 0.38 Allowed 'General case' 0 N--CA 1.519 3.007 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.677 ' O ' HD12 ' A' ' 62' ' ' ILE . 8.7 mt-10 -39.31 -48.36 1.84 Allowed 'General case' 0 N--CA 1.511 2.61 0 CA-C-N 119.549 1.068 . . . . 0.0 112.326 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.416 ' HB1' HD23 ' A' ' 17' ' ' LEU . . . -41.9 -50.37 4.48 Favored 'General case' 0 N--CA 1.517 2.922 0 CA-C-N 118.783 0.72 . . . . 0.0 111.522 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 1.005 HG11 HD22 ' A' ' 97' ' ' LEU . 34.9 t -58.23 -45.04 89.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.87 -27.66 65.4 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.728 HG23 ' HB ' ' A' ' 67' ' ' VAL . 1.4 mp -78.21 -30.85 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.898 -0.501 . . . . 0.0 109.852 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.514 ' CD2' HD13 ' A' ' 79' ' ' LEU . 7.3 tt -77.57 -40.73 41.38 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.469 -0.893 . . . . 0.0 110.139 -179.189 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 2.7 tmm? -78.4 -53.45 7.25 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.27 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -80.68 -22.83 40.07 Favored 'General case' 0 N--CA 1.502 2.154 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.157 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.97 147.63 11.79 Favored Glycine 0 N--CA 1.497 2.709 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 -178.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.728 ' HB ' HG23 ' A' ' 62' ' ' ILE . 7.6 p -118.48 160.58 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 O-C-N 122.196 -0.591 . . . . 0.0 109.782 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.692 HG22 ' NE2' ' A' ' 74' ' ' HIS . 54.7 t -114.38 157.81 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 CA-C-O 121.716 0.769 . . . . 0.0 109.292 -179.111 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.436 HG22 ' NE2' ' A' ' 14' ' ' HIS . 61.7 p -117.18 159.9 21.89 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.78 -177.552 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 35.4 t -63.3 -31.51 72.68 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.298 -178.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.2 p -69.14 -16.65 63.7 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.332 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.73 10.17 44.26 Favored Glycine 0 N--CA 1.498 2.783 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.156 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -100.18 157.56 16.49 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-N 118.04 0.92 . . . . 0.0 109.139 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.692 ' NE2' HG22 ' A' ' 68' ' ' VAL . 9.7 m170 -114.93 155.22 27.29 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -179.479 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -140.56 -176.44 4.64 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.122 0.487 . . . . 0.0 109.785 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.676 ' O ' HD12 ' A' ' 78' ' ' LEU . . . 56.37 -144.5 36.63 Favored Glycine 0 N--CA 1.496 2.691 0 N-CA-C 108.592 -1.803 . . . . 0.0 108.592 -178.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 56.0 21.6 5.14 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 122.224 -0.574 . . . . 0.0 110.356 179.006 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.681 HD23 ' NH2' ' A' ' 21' ' ' ARG . 6.7 mp -76.21 -16.76 59.77 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.744 -0.597 . . . . 0.0 110.468 -179.364 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.514 HD13 ' CD2' ' A' ' 63' ' ' LEU . 2.3 tp -59.34 91.64 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.271 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 41.0 mm-40 -130.81 -176.9 4.14 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.449 0.642 . . . . 0.0 109.821 -179.115 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.33 102.33 1.07 Allowed 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.657 0.742 . . . . 0.0 110.893 -179.204 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.542 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 20.5 mt -87.12 169.64 14.12 Favored Pre-proline 0 N--CA 1.496 1.856 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 177.277 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.542 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 29.5 Cg_endo -69.58 99.19 0.71 Allowed 'Trans proline' 0 C--N 1.328 -0.528 0 C-N-CA 121.028 1.152 . . . . 0.0 110.3 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 98.58 1.41 57.71 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.4 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 3.4 m -134.8 91.34 20.76 Favored Pre-proline 0 N--CA 1.504 2.242 0 CA-C-N 118.99 1.395 . . . . 0.0 109.274 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -72.09 161.18 45.44 Favored 'Trans proline' 0 N--CA 1.483 0.879 0 C-N-CA 121.3 1.333 . . . . 0.0 111.528 -179.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.6 mtp180 -48.15 -28.11 2.76 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.06 0.457 . . . . 0.0 109.907 178.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -60.8 -47.23 87.26 Favored 'General case' 0 N--CA 1.502 2.174 0 CA-C-N 116.325 -0.398 . . . . 0.0 112.006 -177.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 48.5 t -68.77 -39.52 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.585 -0.697 . . . . 0.0 109.837 -178.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.565 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 2.2 mp0 -66.17 -26.76 67.56 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.3 tpt180 -78.89 -35.17 44.01 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 122.085 -0.385 . . . . 0.0 109.966 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.34 -45.99 68.11 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.692 ' CD1' HG22 ' A' ' 24' ' ' VAL . 37.3 t80 -78.34 -25.52 46.42 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.7 ' HB3' ' HD3' ' A' ' 95' ' ' PRO . . . -41.56 -51.82 8.63 Favored Pre-proline 0 N--CA 1.503 2.191 0 CA-C-O 118.907 -0.568 . . . . 0.0 112.098 -177.611 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.7 ' HD3' ' HB3' ' A' ' 94' ' ' ALA . 29.4 Cg_endo -72.32 -171.91 0.8 Allowed 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 121.532 1.488 . . . . 0.0 109.519 179.324 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.46 ' HA ' HG21 ' A' ' 99' ' ' THR . 0.1 OUTLIER 66.47 18.0 10.75 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.827 -0.546 . . . . 0.0 109.827 -178.943 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 1.056 HD12 HG13 ' A' ' 98' ' ' VAL . 0.3 OUTLIER -73.3 -62.73 1.37 Allowed 'General case' 0 N--CA 1.516 2.849 0 O-C-N 121.687 -0.633 . . . . 0.0 112.134 -178.718 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 1.056 HG13 HD12 ' A' ' 97' ' ' LEU . 33.4 m -86.57 26.5 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.282 0 CA-C-N 119.621 1.101 . . . . 0.0 110.657 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.46 HG21 ' HA ' ' A' ' 96' ' ' LYS . 46.7 p -97.58 173.56 7.09 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -62.6 0.46 0.49 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.332 -0.855 . . . . 0.0 111.944 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.412 ' O ' HG12 ' A' ' 101' ' ' VAL . 5.0 t -98.57 -0.83 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 CA-C-N 120.481 1.491 . . . . 0.0 111.211 -179.39 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -138.46 -88.81 0.23 Allowed 'General case' 0 N--CA 1.507 2.39 0 CA-C-N 119.403 1.001 . . . . 0.0 111.918 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.757 ' O ' HD22 ' A' ' 48' ' ' LEU . 92.0 m -141.44 42.03 1.75 Allowed 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.553 -0.717 . . . . 0.0 109.734 -178.139 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.454 ' ND2' ' HB3' ' A' ' 112' ' ' PRO . 46.5 t-20 -38.34 -69.91 0.11 Allowed 'General case' 0 N--CA 1.506 2.339 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -178.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.7 mt 48.18 26.99 1.16 Allowed 'General case' 0 N--CA 1.51 2.534 0 O-C-N 121.912 -0.492 . . . . 0.0 110.682 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 63.91 154.66 0.06 Allowed 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.505 ' OG1' ' CE1' ' A' ' 109' ' ' HIS . 1.7 p -124.51 -151.82 0.49 Allowed 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -178.476 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.527 HG23 ' N ' ' A' ' 109' ' ' HIS . 0.5 OUTLIER -57.96 -39.97 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 C-N-CA 123.08 0.552 . . . . 0.0 111.279 178.509 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.617 ' CE1' ' O ' ' A' ' 113' ' ' PHE . 2.9 p-80 -92.53 23.15 4.15 Favored 'General case' 0 N--CA 1.514 2.775 0 O-C-N 122.219 -0.301 . . . . 0.0 110.875 -177.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 45.47 63.57 2.68 Favored Glycine 0 N--CA 1.504 3.2 0 O-C-N 121.723 -0.61 . . . . 0.0 111.986 177.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 173.31 171.32 37.82 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 110.499 -1.041 . . . . 0.0 110.499 179.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.468 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 36.3 Cg_endo -83.3 75.35 4.38 Favored 'Trans proline' 0 CA--C 1.545 1.043 0 C-N-CA 122.711 2.274 . . . . 0.0 111.057 -179.189 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.617 ' O ' ' CE1' ' A' ' 109' ' ' HIS . 20.2 p90 . . . . . 0 N--CA 1.531 3.597 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo . . . . . 0 CA--C 1.541 0.835 0 N-CA-C 110.356 -0.671 . . . . 0.0 110.356 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 57.66 14.59 15.41 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.75 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 1.3 mtt -140.25 107.69 5.56 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.211 -1.17 . . . . 0.0 108.54 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.75 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 85.32 -62.22 0.07 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.843 -1.161 . . . . 0.0 108.057 -178.571 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.802 HD11 ' CB ' ' A' ' 55' ' ' CYS . 67.9 mt -104.05 101.17 24.22 Favored Pre-proline 0 C--N 1.304 -1.406 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.341 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 11' ' ' ALA . 33.2 Cg_endo -81.29 172.45 12.71 Favored 'Trans proline' 0 C--N 1.318 -1.073 0 C-N-CA 121.595 1.53 . . . . 0.0 111.674 -177.241 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.466 ' H ' ' CD2' ' A' ' 14' ' ' HIS . 29.4 m-70 -69.58 145.63 52.4 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.667 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 2.8 t30 54.8 51.21 7.21 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 120.809 -1.182 . . . . 0.0 110.04 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.667 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 37.6 Cg_endo -78.72 166.07 24.04 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.398 2.066 . . . . 0.0 111.49 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.737 HD23 ' SG ' ' A' ' 20' ' ' CYS . 0.5 OUTLIER 48.45 48.32 19.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.741 -0.599 . . . . 0.0 111.091 178.879 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -75.08 -42.24 57.15 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.01 -1.056 . . . . 0.0 108.91 178.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.556 ' OG ' ' HE2' ' A' ' 40' ' ' MET . 0.3 OUTLIER -59.24 -25.61 64.19 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.191 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.737 ' SG ' HD23 ' A' ' 17' ' ' LEU . 71.2 m -73.78 -38.77 64.54 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.597 -0.69 . . . . 0.0 109.286 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.47 ' O ' ' HD2' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -63.51 -48.05 79.18 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.263 -0.898 . . . . 0.0 108.848 179.498 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.466 ' HA ' ' OG ' ' A' ' 25' ' ' SER . 31.0 m95 -73.08 -26.77 61.38 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.642 -1.286 . . . . 0.0 109.82 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.519 ' HB2' ' HG2' ' A' ' 40' ' ' MET . 15.2 t80 -66.17 -31.28 72.02 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.08 -1.012 . . . . 0.0 108.422 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.546 ' O ' HG23 ' A' ' 28' ' ' THR . 93.4 t -75.42 -41.52 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.003 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.466 ' OG ' ' HA ' ' A' ' 22' ' ' TRP . 0.5 OUTLIER -56.2 -42.3 76.96 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.434 -0.906 . . . . 0.0 109.986 -179.863 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 2.4 m -77.59 -55.08 5.66 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.267 -0.896 . . . . 0.0 111.256 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.87 -24.56 62.34 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 120.743 -1.223 . . . . 0.0 110.3 -178.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.546 HG23 ' O ' ' A' ' 24' ' ' VAL . 72.4 p -92.87 -67.1 0.88 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.005 -1.059 . . . . 0.0 111.351 -178.568 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 84' ' ' GLY . 3.6 m -99.0 16.69 21.74 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.618 -1.301 . . . . 0.0 109.843 -179.159 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 26' ' ' THR . . . 56.48 21.48 34.63 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.358 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.515 HG12 ' N ' ' A' ' 32' ' ' GLY . 73.6 t -105.79 161.11 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.141 -1.211 . . . . 0.0 109.615 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.515 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 138.36 179.86 17.63 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 108.849 -1.7 . . . . 0.0 108.849 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -66.19 175.8 4.52 Favored 'Trans proline' 0 N--CA 1.482 0.803 0 CA-C-N 119.127 1.464 . . . . 0.0 110.051 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 7.4 mtt-85 -91.4 82.2 5.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.847 -1.158 . . . . 0.0 110.013 -178.408 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.97 131.2 28.26 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -45.95 158.28 0.1 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.086 -1.009 . . . . 0.0 109.326 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -75.79 -52.34 10.62 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.973 -1.079 . . . . 0.0 110.205 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -47.12 -34.03 5.67 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.971 -1.081 . . . . 0.0 109.643 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.497 ' O ' ' HD3' ' A' ' 43' ' ' ARG . 3.0 mt-10 -69.57 -41.65 75.57 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.15 -0.969 . . . . 0.0 108.906 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.556 ' HE2' ' OG ' ' A' ' 19' ' ' SER . 2.6 tpt -61.24 -60.41 3.79 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.6 ttpm? -50.35 -40.89 50.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.745 -0.597 . . . . 0.0 109.529 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.59 -45.59 88.78 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.282 -0.886 . . . . 0.0 109.486 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.534 ' HD2' ' N ' ' A' ' 43' ' ' ARG . 1.0 OUTLIER -59.82 -48.79 80.26 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.355 -0.841 . . . . 0.0 109.851 -179.695 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.418 ' SG ' ' N ' ' A' ' 20' ' ' CYS . 14.0 m -58.03 -34.42 70.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.992 -1.068 . . . . 0.0 110.439 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 20.8 m -70.95 -30.58 66.91 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.977 -1.077 . . . . 0.0 109.091 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.63 -35.61 75.39 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.471 ' O ' ' CG1' ' A' ' 51' ' ' ILE . 3.4 mt-30 -76.95 -26.48 54.06 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.617 HD12 HD12 ' A' ' 105' ' ' LEU . 1.7 tm? -71.65 -34.83 70.07 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.491 ' HG2' HD13 ' A' ' 105' ' ' LEU . 4.2 mm-40 -77.06 -58.43 3.29 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.487 ' O ' ' HD3' ' A' ' 52' ' ' PRO . . . -46.35 -35.17 5.17 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.534 HD12 HG12 ' A' ' 12' ' ' ILE . 21.9 mm -82.01 106.62 6.62 Favored Pre-proline 0 N--CA 1.488 1.449 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.296 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.487 ' HD3' ' O ' ' A' ' 50' ' ' ALA . 25.7 Cg_endo -61.84 148.35 93.28 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 121.883 1.722 . . . . 0.0 110.886 -177.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.836 ' HB2' ' NH1' ' A' ' 56' ' ' ARG . . . -59.77 -35.05 73.84 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.665 -0.647 . . . . 0.0 111.156 -178.101 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.745 ' HA ' HD12 ' A' ' 108' ' ' ILE . 6.0 t80 -45.58 -27.17 0.71 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.905 -1.122 . . . . 0.0 108.137 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.802 ' CB ' HD11 ' A' ' 12' ' ' ILE . 13.3 m -116.43 -73.34 0.65 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.012 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.836 ' NH1' ' HB2' ' A' ' 53' ' ' ALA . 22.4 mtt180 31.71 -98.89 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.828 -0.545 . . . . 0.0 110.176 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.497 ' C ' ' O ' ' A' ' 56' ' ' ARG . 66.2 m -33.46 -55.89 0.43 Allowed 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.277 -0.89 . . . . 0.0 111.208 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.482 ' O ' ' C ' ' A' ' 59' ' ' ALA . 1.1 tt0 -35.74 -53.63 0.72 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.766 -1.208 . . . . 0.0 111.05 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.482 ' C ' ' O ' ' A' ' 58' ' ' GLU . . . -35.85 -52.49 0.72 Allowed 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.214 -0.928 . . . . 0.0 110.287 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.749 HG22 HD13 ' A' ' 97' ' ' LEU . 7.4 t -53.52 -50.47 49.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 121.247 -0.908 . . . . 0.0 108.784 179.517 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.516 ' O ' ' HB2' ' A' ' 65' ' ' ASP . 6.8 mtp85 -53.55 -29.61 37.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.403 -0.81 . . . . 0.0 109.83 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.818 HG23 ' HB ' ' A' ' 67' ' ' VAL . 17.9 mt -77.6 -30.14 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 120.957 -1.089 . . . . 0.0 110.043 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.494 ' O ' ' HA ' ' A' ' 77' ' ' ARG . 13.0 tp -77.26 -43.18 34.29 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.773 -1.205 . . . . 0.0 109.612 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 47.5 tpp -78.42 -50.96 10.76 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.18 -0.95 . . . . 0.0 109.945 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.516 ' HB2' ' O ' ' A' ' 61' ' ' ARG . 17.5 m-20 -79.68 -21.97 44.04 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.061 -1.024 . . . . 0.0 109.978 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.56 146.11 9.57 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.818 ' HB ' HG23 ' A' ' 62' ' ' ILE . 2.6 p -116.88 159.47 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.512 -0.993 . . . . 0.0 109.329 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.759 HG22 ' CE1' ' A' ' 74' ' ' HIS . 7.9 t -114.3 157.99 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 CA-C-O 121.864 0.84 . . . . 0.0 109.892 -178.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.456 ' N ' ' CG1' ' A' ' 68' ' ' VAL . 21.7 p -116.87 159.27 22.64 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.604 0.716 . . . . 0.0 109.583 -178.32 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.0 t -62.27 -34.17 76.03 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.588 -0.695 . . . . 0.0 110.142 -179.12 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.8 p -65.63 -14.93 62.18 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.525 -0.734 . . . . 0.0 109.52 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 99.97 8.09 51.65 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.674 -1.77 . . . . 0.0 108.674 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -92.1 156.81 17.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.216 -1.167 . . . . 0.0 109.5 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.759 ' CE1' HG22 ' A' ' 68' ' ' VAL . 0.9 OUTLIER -115.8 155.88 27.06 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 120.812 -1.18 . . . . 0.0 108.675 179.99 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.436 ' HG2' ' C ' ' A' ' 74' ' ' HIS . 3.3 mt-10 -141.44 -172.89 3.62 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.088 -1.007 . . . . 0.0 110.585 -179.265 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 49.65 -146.07 7.73 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.494 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER 56.2 17.77 2.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -1.175 . . . . 0.0 110.1 179.64 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.421 ' O ' ' N ' ' A' ' 80' ' ' GLN . 0.1 OUTLIER -83.8 -11.96 56.33 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.983 -1.073 . . . . 0.0 110.127 -179.611 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -47.71 99.32 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.869 -1.144 . . . . 0.0 109.34 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.421 ' N ' ' O ' ' A' ' 78' ' ' LEU . 2.2 mt-30 -134.39 170.99 14.91 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.238 -0.913 . . . . 0.0 109.698 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.45 ' OD1' ' HG3' ' A' ' 87' ' ' ARG . 2.2 m-20 -65.94 107.4 1.84 Allowed 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.595 0.712 . . . . 0.0 110.82 -179.165 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.682 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 18.0 mt -80.0 172.06 10.81 Favored Pre-proline 0 C--N 1.301 -1.506 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 177.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.682 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 28.3 Cg_endo -68.32 100.84 0.68 Allowed 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 120.872 1.048 . . . . 0.0 109.723 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.454 ' O ' ' SG ' ' A' ' 29' ' ' CYS . . . 92.27 15.44 53.56 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 -179.353 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.511 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 3.4 m -148.52 90.57 4.88 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 120.802 -1.411 . . . . 0.0 108.856 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.413 ' O ' ' C ' ' A' ' 87' ' ' ARG . 30.4 Cg_endo -74.77 160.48 40.77 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.367 1.378 . . . . 0.0 111.649 -178.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.45 ' HG3' ' OD1' ' A' ' 81' ' ' ASP . 53.4 mtp180 -44.7 -29.41 0.76 Allowed 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 122.152 0.977 . . . . 0.0 108.396 178.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -54.03 -52.39 60.99 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.58 -178.12 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 58.8 t -65.05 -41.61 92.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 O-C-N 120.94 -1.1 . . . . 0.0 110.207 -178.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.564 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 3.6 mp0 -62.43 -27.4 69.08 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.262 -0.899 . . . . 0.0 108.705 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.498 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 0.0 OUTLIER -78.61 -33.06 47.74 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.444 -0.785 . . . . 0.0 109.957 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.502 ' O ' ' HD2' ' A' ' 95' ' ' PRO . . . -71.44 -45.6 62.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.933 -1.104 . . . . 0.0 109.499 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.574 ' O ' ' CD1' ' A' ' 93' ' ' PHE . 10.0 t80 -77.92 -25.71 48.53 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.383 -0.823 . . . . 0.0 110.102 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.782 ' HB3' ' HD3' ' A' ' 95' ' ' PRO . . . -43.55 -50.89 16.63 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.395 -0.816 . . . . 0.0 112.094 -178.661 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.782 ' HD3' ' HB3' ' A' ' 94' ' ' ALA . 32.9 Cg_endo -73.66 24.0 0.33 Allowed 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.64 2.227 . . . . 0.0 112.951 -178.571 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.411 ' O ' ' HG3' ' A' ' 102' ' ' GLU . 0.4 OUTLIER -126.8 28.69 5.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.688 -1.258 . . . . 0.0 108.898 178.612 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.749 HD13 HG22 ' A' ' 60' ' ' VAL . 0.6 OUTLIER -80.12 -77.77 0.18 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.403 -0.811 . . . . 0.0 110.403 -179.476 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 98' ' ' VAL . 2.5 m -79.81 27.89 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.906 -1.121 . . . . 0.0 110.873 -179.374 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.483 ' C ' ' HB2' ' A' ' 104' ' ' ASN . 5.1 p -101.27 170.98 7.88 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.909 -1.119 . . . . 0.0 108.196 179.089 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -60.39 1.33 0.13 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.571 -1.331 . . . . 0.0 112.179 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.404 ' HB ' ' HG2' ' A' ' 96' ' ' LYS . 2.7 t -101.02 1.69 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 119.822 -1.799 . . . . 0.0 110.972 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.508 ' HB2' ' O ' ' A' ' 97' ' ' LEU . 0.3 OUTLIER -140.17 -94.29 0.16 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.513 -1.367 . . . . 0.0 110.655 -179.714 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.468 ' O ' ' C ' ' A' ' 104' ' ' ASN . 72.8 m -131.99 38.68 3.5 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.928 -1.108 . . . . 0.0 109.004 -179.159 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.538 ' ND2' ' HB3' ' A' ' 112' ' ' PRO . 42.0 t-20 -29.52 -66.02 0.09 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.811 -0.556 . . . . 0.0 112.091 -179.107 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.617 HD12 HD12 ' A' ' 48' ' ' LEU . 11.3 mt 41.7 33.98 0.37 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.064 -1.023 . . . . 0.0 109.748 -179.2 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.474 ' O ' ' O ' ' A' ' 105' ' ' LEU . . . 55.23 165.6 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.032 -1.043 . . . . 0.0 108.993 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.693 ' C ' ' HB1' ' A' ' 53' ' ' ALA . 1.7 p -133.79 -146.08 0.26 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.0 -1.063 . . . . 0.0 108.722 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.745 HD12 ' HA ' ' A' ' 54' ' ' TYR . 1.3 tt -69.05 -38.68 78.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.31 -0.869 . . . . 0.0 110.008 179.315 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.739 ' CE1' ' O ' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -84.46 24.0 1.05 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.179 -0.951 . . . . 0.0 110.035 -179.75 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 109' ' ' HIS . . . 42.73 54.78 4.89 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.199 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -179.66 159.55 24.15 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.538 ' HB3' ' ND2' ' A' ' 104' ' ' ASN . 31.7 Cg_endo -77.04 79.58 3.09 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.722 2.281 . . . . 0.0 109.859 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.739 ' O ' ' CE1' ' A' ' 109' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.507 2.383 0 C-N-CA 118.826 -1.15 . . . . 0.0 113.073 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo . . . . . 0 CA--C 1.542 0.922 0 N-CA-C 110.999 -0.424 . . . . 0.0 110.999 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.55 -14.78 33.69 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.73 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 0.7 OUTLIER -134.87 116.68 15.04 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.18 -1.188 . . . . 0.0 108.108 179.499 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 85.61 -59.05 0.07 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.796 -1.19 . . . . 0.0 107.811 -178.45 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.402 HG23 HD12 ' A' ' 12' ' ' ILE . 9.9 mm -107.2 101.36 38.01 Favored Pre-proline 0 C--N 1.303 -1.434 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 178.027 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -81.36 175.45 9.64 Favored 'Trans proline' 0 C--N 1.318 -1.064 0 C-N-CA 121.459 1.439 . . . . 0.0 111.955 -176.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 52.8 m-70 -76.76 147.84 37.06 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.673 -0.642 . . . . 0.0 109.553 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.586 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 4.0 t-20 58.22 58.03 6.54 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 120.796 -1.19 . . . . 0.0 109.93 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.586 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 37.1 Cg_endo -79.66 168.62 19.34 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.55 2.167 . . . . 0.0 111.03 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.855 ' CD2' ' HB1' ' A' ' 59' ' ' ALA . 3.3 mm? 52.33 44.38 29.87 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.551 -0.718 . . . . 0.0 111.041 178.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.472 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 3.9 p30 -83.61 -47.29 11.43 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.867 -1.146 . . . . 0.0 109.412 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.59 -25.99 67.68 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.393 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.691 ' SG ' HD13 ' A' ' 17' ' ' LEU . 72.4 m -71.08 -50.02 38.24 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.624 -0.672 . . . . 0.0 109.62 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.561 ' CG ' ' N ' ' A' ' 22' ' ' TRP . 4.2 ptt180 -59.03 -52.09 67.24 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.132 -0.98 . . . . 0.0 109.632 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.561 ' N ' ' CG ' ' A' ' 21' ' ' ARG . 22.9 m95 -61.15 -34.32 74.83 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 118.584 -1.246 . . . . 0.0 108.943 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.538 ' HB2' ' CG ' ' A' ' 40' ' ' MET . 7.2 t80 -60.32 -30.45 69.52 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.613 ' O ' HG23 ' A' ' 28' ' ' THR . 48.0 t -72.67 -41.88 62.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 C-N-CA 118.816 -1.154 . . . . 0.0 107.94 178.231 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 64.8 p -55.67 -42.99 75.91 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.247 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 5.4 m -78.13 -52.98 7.9 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.158 -0.964 . . . . 0.0 111.708 -178.407 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.473 ' HG2' ' CE1' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -60.51 -25.76 66.35 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.703 -1.248 . . . . 0.0 110.792 -178.383 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.613 HG23 ' O ' ' A' ' 24' ' ' VAL . 21.9 p -96.83 -60.84 1.51 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.019 -1.051 . . . . 0.0 111.095 -178.237 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.475 ' SG ' ' O ' ' A' ' 84' ' ' GLY . 3.5 m -99.39 15.78 25.23 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.875 -1.141 . . . . 0.0 110.13 -179.106 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 26' ' ' THR . . . 52.44 21.02 8.02 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 -179.001 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.557 HG12 ' N ' ' A' ' 32' ' ' GLY . 41.7 t -109.51 165.37 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.276 -1.132 . . . . 0.0 109.62 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.557 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 130.3 178.32 15.36 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 108.58 -1.808 . . . . 0.0 108.58 -179.453 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -65.44 176.2 3.58 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 CA-C-N 119.188 1.494 . . . . 0.0 109.825 179.166 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 24.1 mtt180 -91.11 79.07 5.81 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.707 -1.246 . . . . 0.0 110.369 -177.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.465 ' O ' ' C ' ' A' ' 36' ' ' ALA . 52.1 mt -127.35 114.93 18.22 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 178.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.465 ' C ' ' O ' ' A' ' 35' ' ' LEU . . . -41.05 160.32 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.342 -0.849 . . . . 0.0 109.462 -179.14 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.467 HG22 ' HE1' ' A' ' 23' ' ' TYR . 0.7 OUTLIER -68.38 -59.94 2.81 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.074 -1.017 . . . . 0.0 110.377 -179.107 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -48.48 -31.55 6.54 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.074 -1.016 . . . . 0.0 110.086 -179.119 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -68.7 -47.01 67.51 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.192 -0.942 . . . . 0.0 108.767 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.538 ' CG ' ' HB2' ' A' ' 23' ' ' TYR . 17.6 tpp -60.04 -60.54 3.66 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.1 tppt? -47.79 -35.4 10.0 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.561 -0.712 . . . . 0.0 109.152 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.16 -43.07 92.97 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.34 -0.85 . . . . 0.0 109.383 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -63.11 -43.79 97.45 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.328 -0.857 . . . . 0.0 109.905 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.426 ' SG ' ' N ' ' A' ' 20' ' ' CYS . 19.0 m -64.57 -36.39 84.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.08 -1.012 . . . . 0.0 110.063 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 63.9 m -70.21 -29.82 66.75 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.95 -1.094 . . . . 0.0 108.976 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.448 ' NH1' ' HB2' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -73.43 -32.4 64.38 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.077 -1.014 . . . . 0.0 108.296 179.459 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -77.34 -30.99 54.18 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.368 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.039 HD11 HG12 ' A' ' 98' ' ' VAL . 8.4 tt -74.11 -38.08 63.93 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.221 -0.924 . . . . 0.0 109.089 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.447 ' O ' ' C ' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -71.17 -53.59 13.95 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.256 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.481 ' O ' ' HD3' ' A' ' 52' ' ' PRO . . . -46.54 -46.39 19.28 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 178.107 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 73.8 mt -67.61 106.97 1.44 Allowed Pre-proline 0 C--N 1.304 -1.387 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 176.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.529 ' O ' ' N ' ' A' ' 54' ' ' TYR . 24.5 Cg_endo -60.61 138.94 83.21 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 121.581 1.521 . . . . 0.0 111.097 -176.712 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.593 ' HA ' ' CG ' ' A' ' 56' ' ' ARG . . . -32.54 -33.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.198 0.523 . . . . 0.0 110.669 -178.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.529 ' N ' ' O ' ' A' ' 52' ' ' PRO . 2.0 m-85 -66.82 122.68 18.22 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.298 -0.876 . . . . 0.0 109.481 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 34.1 m 73.43 13.47 4.56 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.588 -0.695 . . . . 0.0 111.126 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.593 ' CG ' ' HA ' ' A' ' 53' ' ' ALA . 9.0 mmt85 -41.41 -87.28 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.606 -1.309 . . . . 0.0 109.362 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.521 ' C ' ' O ' ' A' ' 56' ' ' ARG . 6.5 m -24.9 -49.51 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.447 0 O-C-N 121.786 -0.571 . . . . 0.0 112.161 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.509 ' C ' ' O ' ' A' ' 57' ' ' CYS . 12.8 tt0 -25.73 -49.9 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.365 -0.834 . . . . 0.0 111.775 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.855 ' HB1' ' CD2' ' A' ' 17' ' ' LEU . . . -40.9 -60.41 1.19 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.135 -0.978 . . . . 0.0 110.013 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.981 ' CG2' HD13 ' A' ' 97' ' ' LEU . 39.8 t -52.31 -39.77 29.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 O-C-N 121.395 -0.816 . . . . 0.0 109.403 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.515 ' O ' ' HB2' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -62.01 -33.11 73.74 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.416 -0.803 . . . . 0.0 110.116 -179.677 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.771 HG23 ' HB ' ' A' ' 67' ' ' VAL . 48.5 mt -77.38 -28.47 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.926 -1.109 . . . . 0.0 110.09 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.667 HD21 HD23 ' A' ' 79' ' ' LEU . 2.3 tt -77.01 -46.72 22.83 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.779 -1.2 . . . . 0.0 109.61 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 10.2 tpt -77.19 -50.42 12.99 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.082 -1.011 . . . . 0.0 109.914 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.515 ' HB2' ' O ' ' A' ' 61' ' ' ARG . 19.9 m-20 -80.21 -21.47 42.89 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.97 -1.081 . . . . 0.0 110.076 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.429 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . 85.29 151.69 15.97 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.771 ' HB ' HG23 ' A' ' 62' ' ' ILE . 1.6 p -117.09 157.82 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.368 -1.077 . . . . 0.0 109.276 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.684 HG22 ' CE1' ' A' ' 74' ' ' HIS . 14.7 t -116.27 158.32 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.32 -0.863 . . . . 0.0 110.075 -178.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.467 ' N ' ' CG1' ' A' ' 68' ' ' VAL . 29.7 p -117.17 158.71 23.8 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.046 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.6 t -64.38 -32.98 74.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.515 -0.74 . . . . 0.0 109.791 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.2 p -64.75 -14.25 58.08 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.574 -0.704 . . . . 0.0 109.362 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 99.67 8.07 52.54 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -91.25 156.21 17.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.964 -1.315 . . . . 0.0 109.836 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.684 ' CE1' HG22 ' A' ' 68' ' ' VAL . 0.9 OUTLIER -116.4 156.19 27.2 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.002 -1.061 . . . . 0.0 108.616 179.929 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 74' ' ' HIS . 5.2 mt-10 -142.83 -179.04 6.1 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.213 -0.93 . . . . 0.0 110.237 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 51.85 -143.11 19.87 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.438 ' HD2' ' O ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER 56.7 15.9 2.39 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.491 -1.005 . . . . 0.0 110.242 179.544 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 80' ' ' GLN . 2.4 mp -84.9 -11.04 56.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.956 -1.09 . . . . 0.0 110.244 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.788 HD21 ' HG2' ' A' ' 90' ' ' GLN . 1.1 tm? -43.03 96.22 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.008 -1.058 . . . . 0.0 109.046 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.518 ' N ' ' O ' ' A' ' 78' ' ' LEU . 83.7 mt-30 -143.53 179.39 7.15 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.198 -0.939 . . . . 0.0 110.501 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.84 112.05 4.06 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.818 0.818 . . . . 0.0 111.633 -178.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.675 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 23.2 mt -91.76 172.14 6.9 Favored Pre-proline 0 N--CA 1.488 1.463 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 177.527 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.675 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 28.4 Cg_endo -67.45 100.58 0.57 Allowed 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 121.1 1.2 . . . . 0.0 110.907 -179.559 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.475 ' O ' ' SG ' ' A' ' 29' ' ' CYS . . . 90.86 12.68 60.23 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.492 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 3.3 m -142.98 91.9 7.03 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 120.916 -1.343 . . . . 0.0 109.255 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.406 ' O ' ' C ' ' A' ' 87' ' ' ARG . 29.2 Cg_endo -73.39 159.53 46.47 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 121.272 1.315 . . . . 0.0 111.451 -179.016 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.406 ' C ' ' O ' ' A' ' 86' ' ' PRO . 6.3 mtm-85 -44.91 -27.87 0.59 Allowed 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 121.903 0.859 . . . . 0.0 108.889 178.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.95 -46.47 82.09 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.906 -0.496 . . . . 0.0 112.058 -177.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.48 HG11 ' HB ' ' A' ' 28' ' ' THR . 40.5 t -69.99 -41.66 79.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 120.689 -1.257 . . . . 0.0 110.929 -178.158 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.788 ' HG2' HD21 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -64.64 -30.11 71.13 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.048 -1.032 . . . . 0.0 108.807 -179.909 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.488 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 0.0 OUTLIER -78.17 -27.81 48.12 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.504 179.609 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.501 ' O ' ' HD2' ' A' ' 95' ' ' PRO . . . -73.17 -51.2 18.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.103 -0.998 . . . . 0.0 109.68 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.452 ' C ' ' HD2' ' A' ' 95' ' ' PRO . 40.9 t80 -77.78 -26.53 49.8 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.19 -0.944 . . . . 0.0 110.022 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.805 ' HB3' ' HD3' ' A' ' 95' ' ' PRO . . . -42.28 -51.96 10.38 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.383 -0.823 . . . . 0.0 111.593 -178.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.805 ' HD3' ' HB3' ' A' ' 94' ' ' ALA . 31.2 Cg_endo -72.06 80.63 1.52 Allowed 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.203 1.935 . . . . 0.0 111.628 -178.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.432 ' O ' ' HG3' ' A' ' 102' ' ' GLU . 0.0 OUTLIER 176.44 56.51 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.628 -0.67 . . . . 0.0 109.22 179.234 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.997 HD23 HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -96.27 -82.17 0.4 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.212 -0.93 . . . . 0.0 111.271 -179.075 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 1.039 HG12 HD11 ' A' ' 48' ' ' LEU . 3.6 m -81.91 28.77 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.735 -1.228 . . . . 0.0 111.197 -178.713 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.465 ' C ' ' HB3' ' A' ' 104' ' ' ASN . 5.3 p -97.53 170.88 8.73 Favored 'General case' 0 C--N 1.294 -1.834 0 O-C-N 120.644 -1.285 . . . . 0.0 108.449 179.048 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.79 -2.05 0.2 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.679 -1.263 . . . . 0.0 111.892 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.672 ' O ' HG12 ' A' ' 101' ' ' VAL . 57.4 t -100.86 6.4 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 119.844 -1.785 . . . . 0.0 110.73 -179.126 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.436 ' CB ' ' O ' ' A' ' 97' ' ' LEU . 0.3 OUTLIER -141.52 -91.17 0.14 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.684 -1.26 . . . . 0.0 110.386 -179.899 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.802 ' O ' HD12 ' A' ' 105' ' ' LEU . 3.6 m -142.89 38.58 1.46 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.951 -1.093 . . . . 0.0 108.861 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.493 ' O ' ' N ' ' A' ' 106' ' ' ALA . 8.3 p30 -34.87 -51.86 0.52 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.21 -0.931 . . . . 0.0 112.158 -178.254 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.802 HD12 ' O ' ' A' ' 103' ' ' CYS . 0.6 OUTLIER 40.55 26.94 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.953 -1.092 . . . . 0.0 109.825 -179.396 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' A' ' 104' ' ' ASN . . . 62.25 153.85 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.778 -1.202 . . . . 0.0 108.693 -178.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.4 p -128.56 -178.48 4.6 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.099 -1.001 . . . . 0.0 108.629 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.579 ' N ' ' HB1' ' A' ' 53' ' ' ALA . 7.1 tp -64.17 -33.1 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.921 -1.112 . . . . 0.0 108.83 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -62.68 -2.31 1.09 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.771 -0.581 . . . . 0.0 111.084 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 63.31 31.73 81.72 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -162.79 172.51 38.85 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.941 -1.263 . . . . 0.0 109.941 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.523 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 30.2 Cg_endo -76.87 69.46 6.91 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 123.049 2.499 . . . . 0.0 111.6 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.523 ' HB3' ' O ' ' A' ' 112' ' ' PRO . 34.9 p90 . . . . . 0 N--CA 1.497 1.904 0 O-C-N 121.397 -0.814 . . . . 0.0 110.481 178.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo . . . . . 0 N--CA 1.485 0.979 0 N-CA-C 111.203 -0.345 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 83.33 -5.69 76.02 Favored Glycine 0 N--CA 1.5 2.913 0 N-CA-C 110.696 -0.961 . . . . 0.0 110.696 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.562 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 1.6 mtp -136.81 112.24 9.25 Favored 'General case' 0 N--CA 1.501 2.121 0 CA-C-N 118.287 1.043 . . . . 0.0 108.292 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 86.39 -57.22 0.06 Allowed 'General case' 0 N--CA 1.514 2.752 0 CA-C-N 119.834 1.197 . . . . 0.0 108.171 -178.388 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.702 HD11 ' CB ' ' A' ' 55' ' ' CYS . 36.0 mt -106.86 100.36 31.12 Favored Pre-proline 0 N--CA 1.492 1.672 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 178.123 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -82.11 172.74 11.55 Favored 'Trans proline' 0 C--O 1.22 -0.388 0 C-N-CA 121.397 1.398 . . . . 0.0 111.593 -177.123 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 55.4 m80 -72.44 145.19 47.79 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.412 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 4.4 t-20 65.04 64.14 1.07 Allowed Pre-proline 0 N--CA 1.505 2.285 0 O-C-N 121.521 -0.737 . . . . 0.0 109.506 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.722 ' HB2' ' HB1' ' A' ' 59' ' ' ALA . 38.2 Cg_endo -82.1 151.95 16.21 Favored 'Trans proline' 0 N--CA 1.482 0.845 0 C-N-CA 122.344 2.029 . . . . 0.0 112.047 -179.354 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.62 HD12 ' HB2' ' A' ' 16' ' ' PRO . 2.9 mp 46.88 35.0 2.92 Favored 'General case' 0 N--CA 1.502 2.166 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.177 177.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -66.52 -32.55 73.97 Favored 'General case' 0 N--CA 1.505 2.296 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.0 -32.32 73.98 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.476 ' O ' HG23 ' A' ' 24' ' ' VAL . 33.8 m -71.25 -33.83 70.19 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.419 ' CG ' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -60.98 -54.89 39.35 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.11 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.469 ' HA ' ' CE3' ' A' ' 22' ' ' TRP . 30.6 m95 -67.26 -27.0 66.84 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.55 -179.134 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.558 ' HE1' HG22 ' A' ' 37' ' ' THR . 14.5 t80 -68.4 -29.68 68.42 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.193 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.601 HG22 ' CD1' ' A' ' 93' ' ' PHE . 80.7 t -73.29 -42.61 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 177.018 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -53.24 -40.64 64.71 Favored 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 120.594 -0.442 . . . . 0.0 109.968 -179.467 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 31.1 m -77.19 -52.79 8.65 Favored 'General case' 0 N--CA 1.508 2.472 0 O-C-N 122.204 -0.31 . . . . 0.0 111.669 -178.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.587 ' NH1' HG21 ' A' ' 37' ' ' THR . 2.3 mmp_? -59.96 -25.06 64.9 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.859 -0.526 . . . . 0.0 110.678 -178.779 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 59.7 p -97.74 -65.83 0.94 Allowed 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -177.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.512 ' O ' HG23 ' A' ' 31' ' ' VAL . 57.4 m -100.88 16.04 26.5 Favored 'General case' 0 N--CA 1.51 2.546 0 O-C-N 121.298 -0.876 . . . . 0.0 111.924 -178.625 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 56.83 20.87 34.63 Favored Glycine 0 N--CA 1.505 3.263 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 29' ' ' CYS . 54.9 t -106.94 160.63 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 O-C-N 121.759 -0.847 . . . . 0.0 109.01 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.453 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 134.68 177.89 15.27 Favored Glycine 0 N--CA 1.499 2.851 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -66.46 172.74 8.68 Favored 'Trans proline' 0 N--CA 1.486 1.082 0 CA-C-N 119.098 1.449 . . . . 0.0 109.938 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 8.8 ttt-85 -93.27 86.33 5.29 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 122.027 0.918 . . . . 0.0 110.363 -178.162 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 76.4 mt -139.65 130.93 26.7 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.045 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.01 145.94 6.79 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.868 -0.52 . . . . 0.0 109.928 -178.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.587 HG21 ' NH1' ' A' ' 27' ' ' ARG . 0.8 OUTLIER -56.93 -57.87 10.62 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.705 -0.622 . . . . 0.0 111.217 -179.369 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -49.2 -36.98 21.24 Favored 'General case' 0 N--CA 1.509 2.506 0 O-C-N 121.676 -0.64 . . . . 0.0 111.246 -178.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -70.38 -38.22 74.67 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 122.042 -0.411 . . . . 0.0 110.087 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.403 ' CE ' ' HA ' ' A' ' 40' ' ' MET . 0.0 OUTLIER -64.61 -54.69 28.04 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 -179.64 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -52.71 -36.05 56.68 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.24 -43.78 97.07 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.61 -48.45 81.71 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 14.6 m -61.25 -34.0 74.43 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 122.04 -0.412 . . . . 0.0 111.338 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 17.9 m -73.8 -28.69 61.76 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 7.8 tpt85 -75.11 -34.31 61.7 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -79.08 -36.96 40.0 Favored 'General case' 0 N--CA 1.5 2.055 0 CA-C-O 121.184 0.516 . . . . 0.0 110.207 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.7 HD21 ' NH1' ' A' ' 56' ' ' ARG . 3.5 tt -70.32 -38.58 74.96 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.207 -178.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -77.72 -42.72 33.36 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.99 -37.43 63.99 Favored 'General case' 0 N--CA 1.507 2.397 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 178.313 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.421 ' O ' ' HD3' ' A' ' 56' ' ' ARG . 51.1 mt -86.46 105.65 8.27 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 177.287 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -62.87 141.59 85.2 Favored 'Trans proline' 0 N--CA 1.481 0.753 0 C-N-CA 121.517 1.478 . . . . 0.0 110.856 -177.042 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -43.27 -29.83 0.44 Allowed 'General case' 0 N--CA 1.503 2.189 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.286 -178.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.07 110.01 5.49 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.559 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.702 ' CB ' HD11 ' A' ' 12' ' ' ILE . 25.1 m 86.39 -15.36 0.47 Allowed 'General case' 0 N--CA 1.513 2.706 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -177.368 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.7 ' NH1' HD21 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -45.75 -81.94 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.357 0 O-C-N 121.737 -0.602 . . . . 0.0 110.865 -179.855 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 94.0 m -24.5 -42.88 0.01 OUTLIER 'General case' 0 N--CA 1.519 3.001 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -179.037 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -41.5 -57.08 2.34 Favored 'General case' 0 N--CA 1.511 2.588 0 CA-C-N 119.055 0.843 . . . . 0.0 111.429 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.722 ' HB1' ' HB2' ' A' ' 16' ' ' PRO . . . -39.43 -44.63 1.39 Allowed 'General case' 0 N--CA 1.514 2.748 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 38.7 t -58.92 -50.21 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.347 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.67 -25.05 66.07 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.526 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.917 HG23 ' HB ' ' A' ' 67' ' ' VAL . 43.1 mm -77.88 -29.13 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.906 -0.496 . . . . 0.0 109.938 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.1 tt -78.35 -41.12 34.36 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.449 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -78.08 -53.33 7.51 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.207 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -80.49 -23.56 40.06 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 122.065 -0.397 . . . . 0.0 111.591 -178.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.62 145.93 6.69 Favored Glycine 0 N--CA 1.503 3.15 0 N-CA-C 109.964 -1.255 . . . . 0.0 109.964 -179.151 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.917 ' HB ' HG23 ' A' ' 62' ' ' ILE . 7.2 p -118.7 159.5 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.492 0 O-C-N 122.151 -0.617 . . . . 0.0 110.209 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.704 HG22 ' NE2' ' A' ' 74' ' ' HIS . 65.7 t -115.49 157.35 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 32.0 p -117.77 159.63 22.71 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.359 -178.136 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.6 t -63.02 -33.91 76.43 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.076 -178.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.5 p -63.38 -18.78 64.05 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.988 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.45 13.91 34.16 Favored Glycine 0 N--CA 1.497 2.713 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -103.35 157.23 17.17 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 118.226 1.013 . . . . 0.0 109.225 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.704 ' NE2' HG22 ' A' ' 68' ' ' VAL . 8.9 m170 -115.01 155.36 27.11 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -179.41 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -140.32 -179.35 5.95 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 120.849 0.357 . . . . 0.0 110.122 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 51.54 -149.32 8.34 Favored Glycine 0 N--CA 1.497 2.752 0 N-CA-C 109.101 -1.6 . . . . 0.0 109.101 -179.147 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.8 ttp85 59.17 17.6 5.78 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 122.298 -0.531 . . . . 0.0 110.616 179.04 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 59.8 mt -78.34 -17.45 56.51 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.719 -0.613 . . . . 0.0 109.84 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.677 HD23 ' O ' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -51.93 98.56 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.024 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -140.1 172.56 12.58 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.106 0.479 . . . . 0.0 110.01 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -64.26 102.36 0.51 Allowed 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.672 0.749 . . . . 0.0 111.088 -179.079 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.647 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 23.7 mt -81.58 172.98 8.39 Favored Pre-proline 0 N--CA 1.495 1.799 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 177.296 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.647 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 26.3 Cg_endo -65.3 99.97 0.37 Allowed 'Trans proline' 0 N--CA 1.477 0.534 0 C-N-CA 120.971 1.114 . . . . 0.0 111.034 -179.107 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.68 -7.86 80.67 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 7.2 m -117.12 92.08 38.44 Favored Pre-proline 0 N--CA 1.502 2.142 0 CA-C-N 119.279 1.539 . . . . 0.0 110.3 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -71.39 164.05 37.03 Favored 'Trans proline' 0 N--CA 1.481 0.754 0 C-N-CA 121.36 1.373 . . . . 0.0 111.205 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.5 mmm-85 -48.24 -29.22 3.59 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.212 0.53 . . . . 0.0 109.571 178.235 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -55.69 -48.74 74.57 Favored 'General case' 0 N--CA 1.505 2.284 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.377 -178.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 80.2 t -62.55 -37.27 78.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.542 ' HB3' HD12 ' A' ' 79' ' ' LEU . 42.0 mm-40 -64.35 -30.11 71.16 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.053 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.95 -27.97 49.41 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -74.91 -46.73 33.95 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.967 -0.458 . . . . 0.0 109.874 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.601 ' CD1' HG22 ' A' ' 24' ' ' VAL . 29.3 t80 -78.17 -25.13 47.06 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 122.207 -0.308 . . . . 0.0 110.579 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.689 ' HB3' ' HD3' ' A' ' 95' ' ' PRO . . . -50.89 -52.87 53.46 Favored Pre-proline 0 N--CA 1.499 2.006 0 CA-C-O 118.842 -0.599 . . . . 0.0 111.938 -177.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.689 ' HD3' ' HB3' ' A' ' 94' ' ' ALA . 30.4 Cg_endo -71.19 -16.59 31.68 Favored 'Trans proline' 0 N--CA 1.484 0.966 0 C-N-CA 122.062 1.841 . . . . 0.0 111.159 -179.501 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.8 mmpt? -86.99 11.4 13.69 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.934 -0.479 . . . . 0.0 110.193 178.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.471 ' O ' ' HB3' ' A' ' 102' ' ' GLU . 0.2 OUTLIER -72.43 -60.47 2.22 Favored 'General case' 0 N--CA 1.508 2.447 0 O-C-N 121.668 -0.645 . . . . 0.0 111.33 -178.913 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.664 HG12 HD11 ' A' ' 48' ' ' LEU . 13.2 m -89.38 25.34 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 120.819 -1.176 . . . . 0.0 110.517 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 29.7 p -99.35 173.14 6.91 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.52 -0.54 0.27 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.534 -0.729 . . . . 0.0 112.07 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.535 ' O ' HG12 ' A' ' 101' ' ' VAL . 21.8 t -93.82 -0.52 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-N 120.537 1.517 . . . . 0.0 111.028 -179.398 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.471 ' HB3' ' O ' ' A' ' 97' ' ' LEU . 8.3 tt0 -146.95 -90.79 0.09 Allowed 'General case' 0 N--CA 1.505 2.277 0 C-N-CA 119.499 -0.88 . . . . 0.0 112.11 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.687 ' O ' HD22 ' A' ' 48' ' ' LEU . 83.8 m -137.0 45.57 2.24 Favored 'General case' 0 N--CA 1.511 2.609 0 CA-C-N 119.13 0.877 . . . . 0.0 110.609 -177.76 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 -43.6 -72.68 0.06 Allowed 'General case' 0 N--CA 1.508 2.469 0 O-C-N 120.924 -1.11 . . . . 0.0 112.96 -179.02 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.6 mp 51.25 34.48 11.54 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.966 -0.459 . . . . 0.0 110.628 -178.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 63.55 148.22 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.27 -0.894 . . . . 0.0 109.73 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.8 p -121.16 -164.41 1.12 Allowed 'General case' 0 N--CA 1.505 2.316 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -179.412 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.0 tt -68.26 -30.72 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.468 ' HB3' ' CE1' ' A' ' 113' ' ' PHE . 95.5 m-70 -71.48 0.66 7.87 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.644 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 60.9 36.54 92.27 Favored Glycine 0 N--CA 1.497 2.74 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -169.8 173.94 43.99 Favored Glycine 0 N--CA 1.498 2.823 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -77.88 78.53 3.53 Favored 'Trans proline' 0 N--CA 1.481 0.747 0 C-N-CA 122.65 2.234 . . . . 0.0 110.487 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.468 ' CE1' ' HB3' ' A' ' 109' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.504 2.27 0 CA-C-O 121.34 0.59 . . . . 0.0 111.399 179.353 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo . . . . . 0 CA--C 1.543 0.932 0 N-CA-C 110.734 -0.525 . . . . 0.0 110.734 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 69.78 6.11 54.34 Favored Glycine 0 N--CA 1.502 3.066 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.57 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 0.1 OUTLIER -140.52 107.21 5.35 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.788 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.57 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 87.04 -58.69 0.04 OUTLIER 'General case' 0 N--CA 1.516 2.829 0 CA-C-N 119.865 1.211 . . . . 0.0 108.399 -178.578 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.659 HD11 ' HB2' ' A' ' 55' ' ' CYS . 41.1 mt -103.57 101.38 23.48 Favored Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 178.369 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -81.82 172.45 12.14 Favored 'Trans proline' 0 N--CA 1.477 0.549 0 C-N-CA 121.701 1.601 . . . . 0.0 111.97 -176.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -74.68 145.4 43.2 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.401 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 10.4 t-20 68.14 64.48 0.63 Allowed Pre-proline 0 N--CA 1.508 2.45 0 O-C-N 121.404 -0.81 . . . . 0.0 110.593 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.401 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 41.0 Cg_endo -84.34 171.42 10.06 Favored 'Trans proline' 0 N--CA 1.484 0.959 0 C-N-CA 122.51 2.14 . . . . 0.0 111.908 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 66.1 mt 43.43 46.29 5.64 Favored 'General case' 0 N--CA 1.503 2.223 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.435 177.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -73.47 -41.1 63.59 Favored 'General case' 0 N--CA 1.505 2.28 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.2 t -63.42 -25.74 68.42 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.717 ' O ' HG23 ' A' ' 24' ' ' VAL . 32.5 m -77.73 -35.38 51.98 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 110.251 -0.278 . . . . 0.0 110.251 -179.11 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 11.2 ttp180 -69.92 -42.96 72.63 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.418 ' HA ' ' CE3' ' A' ' 22' ' ' TRP . 31.1 m95 -73.38 -30.97 63.64 Favored 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 118.762 -1.175 . . . . 0.0 108.99 178.54 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.753 ' HE1' HG23 ' A' ' 37' ' ' THR . 8.2 t80 -63.96 -33.85 76.66 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.717 HG23 ' O ' ' A' ' 20' ' ' CYS . 43.6 t -70.51 -38.86 75.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 177.594 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.1 m -55.18 -39.18 69.27 Favored 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.887 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.9 m -77.49 -54.48 6.38 Favored 'General case' 0 N--CA 1.511 2.607 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -178.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -60.83 -24.72 66.09 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.508 -0.745 . . . . 0.0 110.6 -178.472 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.414 HG23 ' O ' ' A' ' 24' ' ' VAL . 44.2 p -95.93 -63.21 1.17 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 122.003 -0.435 . . . . 0.0 112.153 -177.539 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.683 ' O ' HG23 ' A' ' 31' ' ' VAL . 3.7 m -100.23 12.11 37.82 Favored 'General case' 0 N--CA 1.509 2.507 0 O-C-N 121.249 -0.907 . . . . 0.0 111.484 -178.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 57.26 24.13 50.35 Favored Glycine 0 N--CA 1.507 3.395 0 N-CA-C 109.434 -1.467 . . . . 0.0 109.434 -178.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 29' ' ' CYS . 27.7 t -116.48 164.83 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 O-C-N 122.053 -0.675 . . . . 0.0 109.469 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.495 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 132.09 -177.32 18.79 Favored Glycine 0 N--CA 1.499 2.871 0 N-CA-C 108.675 -1.77 . . . . 0.0 108.675 -178.803 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -64.01 172.22 6.4 Favored 'Trans proline' 0 N--CA 1.483 0.888 0 CA-C-N 119.485 1.643 . . . . 0.0 109.808 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -92.99 84.64 4.93 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.918 0.866 . . . . 0.0 110.518 -177.603 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.0 tp -140.26 132.9 28.84 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.88 159.38 0.41 Allowed 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.937 -0.477 . . . . 0.0 109.994 -179.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.753 HG23 ' HE1' ' A' ' 23' ' ' TYR . 34.5 m -74.21 -27.89 61.01 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.934 -0.479 . . . . 0.0 111.255 -178.564 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -74.17 -38.32 63.72 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.869 -0.519 . . . . 0.0 110.524 -178.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -72.8 -30.65 64.25 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.469 ' HA ' ' HE3' ' A' ' 40' ' ' MET . 0.5 OUTLIER -70.86 -56.09 7.04 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.665 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.74 -33.65 70.49 Favored 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.88 -34.14 74.95 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.885 -0.784 . . . . 0.0 108.885 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -66.32 -48.93 68.71 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 16.4 m -62.4 -37.71 86.82 Favored 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.332 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 89.5 m -73.88 -28.25 61.47 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -178.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -72.76 -32.27 65.52 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.432 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -77.79 -37.02 49.77 Favored 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 120.571 -0.451 . . . . 0.0 109.799 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.56 HD11 HG12 ' A' ' 98' ' ' VAL . 2.1 tt -68.65 -36.64 78.86 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -77.09 -41.64 41.35 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.74 -35.11 68.22 Favored 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.141 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.563 HG22 ' HG2' ' A' ' 56' ' ' ARG . 58.2 mt -87.0 104.73 6.51 Favored Pre-proline 0 N--CA 1.489 1.5 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 177.247 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -59.15 145.37 97.94 Favored 'Trans proline' 0 N--CA 1.477 0.557 0 C-N-CA 121.383 1.389 . . . . 0.0 110.305 -177.4 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -36.49 -32.69 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.444 0 C-N-CA 122.767 0.427 . . . . 0.0 112.049 -178.16 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -71.04 123.36 21.92 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.659 ' HB2' HD11 ' A' ' 12' ' ' ILE . 23.3 m 77.23 -1.04 2.82 Favored 'General case' 0 N--CA 1.509 2.497 0 C-N-CA 122.266 0.226 . . . . 0.0 110.739 -179.007 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.563 ' HG2' HG22 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -57.84 -91.56 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.438 -0.789 . . . . 0.0 109.762 -179.918 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 64.6 m -27.51 -42.36 0.02 OUTLIER 'General case' 0 N--CA 1.523 3.178 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -40.02 -54.24 2.26 Favored 'General case' 0 N--CA 1.513 2.703 0 CA-C-N 119.493 1.042 . . . . 0.0 111.801 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -40.4 -46.58 2.42 Favored 'General case' 0 N--CA 1.511 2.581 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 39.4 t -56.56 -49.94 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -59.32 -26.47 65.04 Favored 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.237 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.942 HG23 ' HB ' ' A' ' 67' ' ' VAL . 42.4 mm -78.42 -29.84 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 O-C-N 121.926 -0.484 . . . . 0.0 110.341 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.468 HD23 HD13 ' A' ' 79' ' ' LEU . 0.7 OUTLIER -79.0 -38.64 36.16 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.848 -0.741 . . . . 0.0 109.9 -179.48 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 2.6 ttm -78.63 -52.78 7.95 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.028 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -80.7 -24.03 39.12 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 122.007 -0.433 . . . . 0.0 111.051 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.41 144.58 5.07 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 108.839 -1.704 . . . . 0.0 108.839 -179.067 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.942 ' HB ' HG23 ' A' ' 62' ' ' ILE . 7.1 p -117.66 159.35 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 122.254 -0.556 . . . . 0.0 109.594 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.526 HG22 ' CD2' ' A' ' 74' ' ' HIS . 51.0 t -114.33 157.23 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.3 p -116.99 159.57 22.29 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.99 -177.29 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 48.3 t -62.78 -30.47 71.48 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.326 -178.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.8 p -70.1 -16.9 63.19 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.447 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.59 11.46 41.04 Favored Glycine 0 N--CA 1.498 2.8 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -98.64 157.78 16.04 Favored 'General case' 0 N--CA 1.501 2.113 0 CA-C-N 118.103 0.951 . . . . 0.0 109.227 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.526 ' CD2' HG22 ' A' ' 68' ' ' VAL . 10.8 m170 -114.93 155.68 26.44 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -140.29 -178.02 5.29 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.11 0.481 . . . . 0.0 110.194 -179.294 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 51.79 -144.08 17.56 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.814 -1.315 . . . . 0.0 109.814 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 55.32 22.4 4.82 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 122.394 -0.474 . . . . 0.0 110.071 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.6 mt -86.27 -13.83 45.56 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.719 -0.613 . . . . 0.0 110.93 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.468 HD13 HD23 ' A' ' 63' ' ' LEU . 1.4 tp -61.23 93.24 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -142.9 -177.44 5.33 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.545 0.688 . . . . 0.0 110.216 -178.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -54.3 138.59 38.76 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.842 0.83 . . . . 0.0 111.353 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.528 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 21.3 mt -130.61 168.26 17.74 Favored Pre-proline 0 N--CA 1.497 1.916 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 178.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.528 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 29.4 Cg_endo -68.74 99.75 0.66 Allowed 'Trans proline' 0 N--CA 1.478 0.564 0 C-N-CA 121.044 1.163 . . . . 0.0 110.386 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.8 9.91 63.65 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.466 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 3.4 m -141.95 90.88 8.3 Favored Pre-proline 0 N--CA 1.509 2.515 0 CA-C-N 118.761 1.28 . . . . 0.0 109.756 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -74.25 164.88 33.19 Favored 'Trans proline' 0 N--CA 1.487 1.097 0 C-N-CA 121.885 1.724 . . . . 0.0 111.475 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -48.94 -28.06 3.58 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.063 0.459 . . . . 0.0 110.087 178.442 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -60.31 -47.49 85.81 Favored 'General case' 0 N--CA 1.502 2.164 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -177.428 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 44.6 t -69.58 -40.94 80.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.775 -0.578 . . . . 0.0 111.518 -177.394 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.751 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 0.4 OUTLIER -73.3 -25.44 60.66 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.784 -179.549 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.7 tpt180 -78.93 -34.36 44.62 Favored 'General case' 0 N--CA 1.503 2.197 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.231 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.39 -43.69 31.83 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.869 -0.519 . . . . 0.0 110.003 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.548 ' CE1' HG22 ' A' ' 24' ' ' VAL . 28.4 t80 -78.53 -25.91 45.63 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 122.274 -0.267 . . . . 0.0 110.415 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.751 ' HB2' ' O ' ' A' ' 90' ' ' GLN . . . -43.41 -51.53 14.78 Favored Pre-proline 0 N--CA 1.502 2.164 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -178.084 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.66 ' HD3' ' HB3' ' A' ' 94' ' ' ALA . 29.2 Cg_endo -70.6 -170.24 0.43 Allowed 'Trans proline' 0 N--CA 1.481 0.784 0 C-N-CA 121.73 1.62 . . . . 0.0 111.058 -179.01 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 61.34 20.36 11.02 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 -178.213 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.71 -60.96 2.01 Favored 'General case' 0 N--CA 1.508 2.434 0 O-C-N 121.969 -0.457 . . . . 0.0 112.232 -178.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.56 HG12 HD11 ' A' ' 48' ' ' LEU . 19.8 m -82.94 35.06 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 O-C-N 121.112 -0.993 . . . . 0.0 111.921 -178.448 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.411 ' C ' ' HB2' ' A' ' 104' ' ' ASN . 24.6 p -109.1 174.99 5.62 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 178.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -59.66 -2.46 0.36 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.467 -0.771 . . . . 0.0 111.926 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.564 ' O ' HG12 ' A' ' 101' ' ' VAL . 21.9 t -95.61 1.5 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 CA-C-N 120.479 1.49 . . . . 0.0 111.321 -179.321 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -148.02 -91.96 0.08 Allowed 'General case' 0 N--CA 1.504 2.252 0 CA-C-N 119.011 0.823 . . . . 0.0 111.771 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 7.3 m -132.89 49.35 2.32 Favored 'General case' 0 N--CA 1.509 2.503 0 O-C-N 121.365 -0.834 . . . . 0.0 110.1 -178.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.411 ' HB2' ' C ' ' A' ' 99' ' ' THR . 38.2 t30 -42.23 -82.29 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.559 0 O-C-N 120.779 -1.201 . . . . 0.0 112.533 -179.014 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.5 ' O ' ' HB3' ' A' ' 106' ' ' ALA . 8.1 mt 51.58 24.64 2.39 Favored 'General case' 0 N--CA 1.506 2.343 0 O-C-N 121.836 -0.54 . . . . 0.0 111.922 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' A' ' 105' ' ' LEU . . . 71.07 152.27 0.11 Allowed 'General case' 0 N--CA 1.513 2.722 0 O-C-N 121.001 -1.062 . . . . 0.0 110.669 178.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.485 HG21 ' O ' ' A' ' 113' ' ' PHE . 3.9 p -127.85 -163.84 1.31 Allowed 'General case' 0 N--CA 1.51 2.536 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.409 HG23 ' N ' ' A' ' 109' ' ' HIS . 10.9 tt -67.3 -37.28 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.244 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.033 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.409 ' N ' HG23 ' A' ' 108' ' ' ILE . 76.5 m80 -67.43 -2.03 5.72 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.784 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 58.57 28.6 62.74 Favored Glycine 0 N--CA 1.498 2.778 0 N-CA-C 108.744 -1.742 . . . . 0.0 108.744 -178.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -141.19 178.64 20.1 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -179.259 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.426 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 32.7 Cg_endo -87.87 55.36 2.63 Favored 'Trans proline' 0 N--CA 1.481 0.772 0 C-N-CA 123.358 2.705 . . . . 0.0 110.655 -179.343 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.485 ' O ' HG21 ' A' ' 107' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.498 1.966 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -178.297 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo . . . . . 0 N--CA 1.479 0.651 0 N-CA-C 110.262 -0.707 . . . . 0.0 110.262 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 71.38 4.71 57.68 Favored Glycine 0 N--CA 1.502 3.076 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.574 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 2.0 mpt? -139.91 99.85 3.79 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 118.153 0.977 . . . . 0.0 108.59 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.574 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 86.87 -57.46 0.05 OUTLIER 'General case' 0 N--CA 1.516 2.836 0 CA-C-N 119.392 0.997 . . . . 0.0 108.504 -178.556 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.442 ' HA ' HD12 ' A' ' 51' ' ' ILE . 17.5 mt -100.1 102.66 18.7 Favored Pre-proline 0 N--CA 1.499 1.992 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 178.485 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -79.76 176.37 9.56 Favored 'Trans proline' 0 C--O 1.22 -0.402 0 C-N-CA 121.458 1.439 . . . . 0.0 111.034 -177.19 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 46.2 m80 -86.0 142.61 28.65 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 120.721 0.296 . . . . 0.0 111.017 -177.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.584 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 9.2 t-20 70.46 48.12 0.3 Allowed Pre-proline 0 N--CA 1.508 2.451 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 178.489 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.584 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 42.7 Cg_endo -86.65 175.51 5.21 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 121.79 1.66 . . . . 0.0 111.345 178.387 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 49.36 45.18 23.81 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 177.427 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -77.57 -43.16 32.71 Favored 'General case' 0 N--CA 1.509 2.482 0 O-C-N 121.219 -0.925 . . . . 0.0 108.954 178.023 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.94 -24.77 66.3 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.554 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 57.1 m -74.21 -34.25 63.66 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -179.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.96 -43.57 67.85 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.213 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 32.7 m95 -71.53 -26.5 62.67 Favored 'General case' 0 N--CA 1.504 2.263 0 C-N-CA 118.771 -1.172 . . . . 0.0 109.426 178.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.547 ' HB2' ' HG2' ' A' ' 40' ' ' MET . 10.9 t80 -70.24 -35.36 73.77 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.522 ' O ' HG23 ' A' ' 28' ' ' THR . 64.7 t -70.12 -38.59 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 177.319 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 m -57.42 -38.57 74.56 Favored 'General case' 0 N--CA 1.502 2.147 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.149 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 99.8 m -77.05 -51.75 10.53 Favored 'General case' 0 N--CA 1.511 2.578 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.259 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.2 tpt180 -62.99 -24.72 68.05 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.425 -0.797 . . . . 0.0 110.335 -178.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.522 HG23 ' O ' ' A' ' 24' ' ' VAL . 56.3 p -92.75 -66.58 0.91 Allowed 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -177.569 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.7 m -100.87 11.49 39.48 Favored 'General case' 0 N--CA 1.511 2.606 0 CA-C-N 119.452 1.024 . . . . 0.0 111.467 -179.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 60.49 25.58 63.25 Favored Glycine 0 N--CA 1.503 3.16 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -178.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.504 HG12 ' N ' ' A' ' 32' ' ' GLY . 47.8 t -108.32 163.73 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.317 0 O-C-N 121.911 -0.758 . . . . 0.0 109.437 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.504 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 126.04 -179.31 16.32 Favored Glycine 0 N--CA 1.499 2.849 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 -179.063 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -64.84 171.61 8.34 Favored 'Trans proline' 0 N--CA 1.486 1.033 0 CA-C-N 119.266 1.533 . . . . 0.0 109.911 179.195 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.759 ' O ' HD22 ' A' ' 35' ' ' LEU . 10.3 mmt-85 -93.23 84.36 4.78 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.917 0.865 . . . . 0.0 109.992 -178.147 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.759 HD22 ' O ' ' A' ' 34' ' ' ARG . 2.4 mm? -131.98 143.89 50.41 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.284 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.568 ' HB3' ' HG3' ' A' ' 39' ' ' GLU . . . -64.76 142.2 58.51 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -49.98 -58.7 4.93 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.506 -0.746 . . . . 0.0 111.004 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -46.82 -40.59 14.04 Favored 'General case' 0 N--CA 1.508 2.462 0 O-C-N 121.892 -0.505 . . . . 0.0 111.482 -178.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.568 ' HG3' ' HB3' ' A' ' 36' ' ' ALA . 13.5 mt-10 -62.78 -46.97 85.52 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.547 ' HG2' ' HB2' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -59.41 -57.69 11.89 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -179.585 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 39.8 tttt -51.82 -29.94 21.39 Favored 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 39' ' ' GLU . . . -65.94 -46.29 78.74 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.129 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.9 mmt-85 -58.06 -60.42 3.77 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 16.5 m -54.29 -32.82 57.27 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -178.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 21.5 m -75.43 -30.55 60.07 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -178.474 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.32 -34.11 70.27 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -79.05 -31.15 44.43 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.122 0.487 . . . . 0.0 109.817 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.475 ' HA ' HD22 ' A' ' 48' ' ' LEU . 1.2 tm? -67.76 -44.71 76.85 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -178.637 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -78.12 -28.12 48.43 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.17 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.81 -44.28 77.69 Favored 'General case' 0 N--CA 1.504 2.258 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.442 HD12 ' HA ' ' A' ' 12' ' ' ILE . 39.5 mm -79.83 106.19 4.52 Favored Pre-proline 0 N--CA 1.49 1.568 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 176.475 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -54.51 144.62 62.0 Favored 'Trans proline' 0 N--CA 1.481 0.766 0 C-N-CA 121.564 1.51 . . . . 0.0 111.572 -175.413 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.455 ' HA ' ' CG ' ' A' ' 56' ' ' ARG . . . -32.63 -32.42 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.342 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -177.308 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -63.19 125.27 23.53 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 14.1 m 77.56 17.15 1.47 Allowed 'General case' 0 N--CA 1.514 2.772 0 CA-C-O 119.358 -0.353 . . . . 0.0 111.898 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.455 ' CG ' ' HA ' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -48.68 -89.06 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.862 0 CA-C-N 119.851 1.205 . . . . 0.0 110.175 179.688 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 82.8 m -37.2 -44.2 0.56 Allowed 'General case' 0 N--CA 1.518 2.928 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -42.58 -51.02 5.3 Favored 'General case' 0 N--CA 1.512 2.642 0 CA-C-N 119.931 1.242 . . . . 0.0 111.735 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.616 ' HA ' HD12 ' A' ' 62' ' ' ILE . . . -41.88 -45.48 3.71 Favored 'General case' 0 N--CA 1.513 2.71 0 O-C-N 121.701 -0.625 . . . . 0.0 112.007 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.711 HG22 HD13 ' A' ' 97' ' ' LEU . 20.4 t -55.34 -48.58 76.63 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 10.1 ttp180 -58.81 -29.42 66.84 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.826 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.766 HG23 ' HB ' ' A' ' 67' ' ' VAL . 11.2 mt -77.57 -27.32 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.286 0 O-C-N 121.899 -0.501 . . . . 0.0 109.955 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.4 tp -77.63 -43.95 29.81 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 120.073 -0.651 . . . . 0.0 110.082 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.54 -50.42 11.61 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.284 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -81.09 -23.31 38.54 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.965 -0.459 . . . . 0.0 111.48 -179.093 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.87 149.31 8.24 Favored Glycine 0 N--CA 1.499 2.838 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -178.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.766 ' HB ' HG23 ' A' ' 62' ' ' ILE . 5.8 p -117.93 159.37 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.63 HG22 ' CE1' ' A' ' 74' ' ' HIS . 79.1 t -114.7 158.07 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-O 121.756 0.789 . . . . 0.0 109.389 -178.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.655 HG23 ' OE2' ' A' ' 75' ' ' GLU . 27.0 p -117.0 158.61 23.83 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 115.339 -0.846 . . . . 0.0 108.96 -178.427 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.7 t -64.26 -33.14 75.13 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.883 -178.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.6 p -62.91 -17.6 61.94 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.935 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.58 13.5 34.96 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -103.85 156.9 17.46 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-N 118.198 0.999 . . . . 0.0 109.524 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.63 ' CE1' HG22 ' A' ' 68' ' ' VAL . 9.3 m170 -115.44 155.86 26.67 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.655 ' OE2' HG23 ' A' ' 69' ' ' THR . 3.3 mp0 -142.79 -177.49 5.34 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 120.236 -0.586 . . . . 0.0 110.612 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.413 ' O ' ' CG ' ' A' ' 77' ' ' ARG . . . 59.95 -132.42 50.86 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 108.374 -1.89 . . . . 0.0 108.374 -178.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.413 ' CG ' ' O ' ' A' ' 76' ' ' GLY . 2.1 ptm180 44.18 28.61 0.29 Allowed 'General case' 0 N--CA 1.507 2.383 0 CA-C-O 120.978 0.418 . . . . 0.0 110.189 179.648 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.7 mt -72.81 -19.45 61.33 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 122.037 -0.415 . . . . 0.0 110.58 -178.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.644 HD13 ' CB ' ' A' ' 90' ' ' GLN . 2.5 tp -49.21 105.27 0.08 Allowed 'General case' 0 N--CA 1.503 2.183 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.096 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -139.95 170.51 15.74 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.371 0.605 . . . . 0.0 109.89 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -80.45 105.49 11.74 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 121.379 0.609 . . . . 0.0 110.342 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.598 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 15.5 mt -86.7 171.87 9.34 Favored Pre-proline 0 N--CA 1.5 2.03 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 177.409 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.598 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 28.9 Cg_endo -68.73 103.28 0.97 Allowed 'Trans proline' 0 C--N 1.328 -0.5 0 C-N-CA 120.865 1.043 . . . . 0.0 109.878 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.36 11.76 60.63 Favored Glycine 0 N--CA 1.498 2.813 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 3.5 m -143.07 90.37 7.46 Favored Pre-proline 0 N--CA 1.507 2.376 0 CA-C-N 118.705 1.252 . . . . 0.0 108.563 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -74.38 159.93 42.66 Favored 'Trans proline' 0 C--N 1.325 -0.673 0 C-N-CA 121.16 1.24 . . . . 0.0 111.0 -178.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.564 ' HA ' HD11 ' A' ' 79' ' ' LEU . 32.0 mtp180 -49.23 -28.64 4.79 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.389 0.614 . . . . 0.0 109.738 178.309 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -56.15 -49.0 75.21 Favored 'General case' 0 N--CA 1.503 2.176 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.971 -178.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.5 t -65.14 -39.43 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.667 -0.646 . . . . 0.0 109.667 -178.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.71 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 23.4 mm-40 -64.26 -29.4 70.49 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.234 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.429 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 1.7 tpt180 -78.46 -26.78 46.22 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.9 -50.14 25.5 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.869 -0.519 . . . . 0.0 109.656 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -78.88 -26.04 43.92 Favored 'General case' 0 N--CA 1.508 2.456 0 O-C-N 122.057 -0.402 . . . . 0.0 111.042 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.71 ' HB2' ' O ' ' A' ' 90' ' ' GLN . . . -48.74 -47.43 72.12 Favored Pre-proline 0 N--CA 1.505 2.278 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -177.118 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.519 ' HD3' ' HB3' ' A' ' 94' ' ' ALA . 33.0 Cg_endo -73.77 25.46 0.33 Allowed 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 122.371 2.047 . . . . 0.0 114.258 -178.148 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.501 ' HE3' HG21 ' A' ' 101' ' ' VAL . 5.1 mttp -135.61 37.81 2.88 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.1 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.711 HD13 HG22 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -74.58 -75.27 0.17 Allowed 'General case' 0 N--CA 1.503 2.208 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.992 -178.978 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 8.7 m -76.0 10.11 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 O-C-N 121.067 -1.021 . . . . 0.0 111.637 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 11.9 p -87.04 176.6 7.54 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.243 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -65.09 5.35 0.36 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.452 -0.78 . . . . 0.0 111.873 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.501 HG21 ' HE3' ' A' ' 96' ' ' LYS . 56.3 t -96.23 -5.24 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 CA-C-N 120.265 1.393 . . . . 0.0 111.009 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.509 ' HB3' ' O ' ' A' ' 97' ' ' LEU . 4.1 tp10 -142.07 -85.46 0.17 Allowed 'General case' 0 N--CA 1.513 2.71 0 C-N-CA 118.626 -1.23 . . . . 0.0 112.869 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 20.8 m -136.57 40.56 2.59 Favored 'General case' 0 N--CA 1.507 2.387 0 CA-C-N 119.601 1.091 . . . . 0.0 110.616 -177.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.433 ' ND2' ' HA ' ' A' ' 112' ' ' PRO . 10.6 t-20 -44.95 -95.76 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.385 -0.822 . . . . 0.0 111.946 -179.381 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.512 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 1.4 mt 87.19 -58.41 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.462 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -177.178 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.713 ' HB1' ' HA2' ' A' ' 110' ' ' GLY . . . 160.95 127.68 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.836 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.3 p -91.59 -146.62 0.21 Allowed 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -178.445 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.503 HG23 ' N ' ' A' ' 109' ' ' HIS . 6.5 tp -57.41 -39.34 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.825 -0.547 . . . . 0.0 111.059 178.617 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.58 ' CE1' ' O ' ' A' ' 113' ' ' PHE . 1.2 p-80 -90.78 21.93 3.84 Favored 'General case' 0 N--CA 1.515 2.786 0 O-C-N 122.047 -0.408 . . . . 0.0 111.255 -177.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.713 ' HA2' ' HB1' ' A' ' 106' ' ' ALA . . . 53.18 64.89 3.77 Favored Glycine 0 N--CA 1.497 2.733 0 O-C-N 121.598 -0.688 . . . . 0.0 111.609 177.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 159.49 172.97 27.35 Favored Glycine 0 N--CA 1.498 2.822 0 CA-C-N 118.419 1.11 . . . . 0.0 111.096 178.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.476 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 36.2 Cg_endo -85.17 80.38 2.09 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.059 2.506 . . . . 0.0 111.642 -178.625 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.58 ' O ' ' CE1' ' A' ' 109' ' ' HIS . 8.3 p90 . . . . . 0 N--CA 1.535 3.783 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo . . . . . 0 C--O 1.215 -0.661 0 N-CA-C 110.707 -0.536 . . . . 0.0 110.707 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.72 10.2 36.62 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.744 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 0.3 OUTLIER -137.01 104.55 5.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.338 -1.095 . . . . 0.0 108.768 179.803 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.744 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 86.01 -59.68 0.06 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.749 -1.219 . . . . 0.0 108.181 -178.683 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 5.6 mt -102.2 101.6 20.13 Favored Pre-proline 0 C--N 1.303 -1.42 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.289 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 11' ' ' ALA . 34.3 Cg_endo -82.11 173.39 10.97 Favored 'Trans proline' 0 C--N 1.319 -0.981 0 C-N-CA 121.602 1.534 . . . . 0.0 111.945 -176.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 51.4 m80 -74.85 149.38 39.59 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -179.464 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.677 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 6.4 t30 55.3 50.94 6.47 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 120.831 -1.168 . . . . 0.0 110.039 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.677 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 37.7 Cg_endo -78.99 -174.64 2.37 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 122.478 2.119 . . . . 0.0 111.122 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.611 HD21 ' HB1' ' A' ' 59' ' ' ALA . 4.3 mm? 47.12 41.79 12.02 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.716 -0.615 . . . . 0.0 111.046 178.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.444 ' CG ' ' N ' ' A' ' 19' ' ' SER . 1.9 p30 -81.91 -47.21 13.03 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.034 -1.041 . . . . 0.0 109.128 179.1 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.454 ' OG ' ' HD3' ' A' ' 43' ' ' ARG . 0.2 OUTLIER -60.74 -26.46 67.21 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.276 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.459 ' SG ' ' CD1' ' A' ' 17' ' ' LEU . 75.4 m -74.77 -34.73 62.52 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.526 ' HG3' ' N ' ' A' ' 22' ' ' TRP . 0.1 OUTLIER -66.95 -49.94 63.89 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.399 -0.813 . . . . 0.0 108.877 179.503 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.536 ' HB2' ' CE ' ' A' ' 40' ' ' MET . 31.6 m95 -71.44 -27.51 63.33 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.86 -1.15 . . . . 0.0 109.456 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.529 ' HB2' ' CG ' ' A' ' 40' ' ' MET . 26.4 t80 -67.03 -34.61 78.09 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.248 -0.907 . . . . 0.0 109.227 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.574 HG22 ' CD1' ' A' ' 93' ' ' PHE . 78.3 t -74.86 -40.15 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 118.59 -1.244 . . . . 0.0 108.087 178.383 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.467 ' OG ' ' O ' ' A' ' 22' ' ' TRP . 61.1 p -55.44 -37.66 67.99 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.114 -1.035 . . . . 0.0 109.262 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.44 ' O ' ' HA2' ' A' ' 30' ' ' GLY . 3.5 m -78.31 -55.09 5.52 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.337 -0.852 . . . . 0.0 111.476 -178.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 8.3 mmm180 -58.47 -25.1 61.91 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.792 -1.192 . . . . 0.0 110.388 -178.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.43 ' HB ' HG11 ' A' ' 89' ' ' VAL . 69.5 p -95.61 -64.44 1.06 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.175 -0.953 . . . . 0.0 111.57 -177.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.473 ' SG ' ' O ' ' A' ' 84' ' ' GLY . 3.4 m -98.89 16.15 23.3 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.816 -1.178 . . . . 0.0 109.806 -178.723 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' A' ' 26' ' ' THR . . . 51.78 21.94 7.97 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 -179.006 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.557 HG12 ' N ' ' A' ' 32' ' ' GLY . 40.7 t -102.47 165.63 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.386 -1.067 . . . . 0.0 109.335 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.557 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 129.69 176.87 14.6 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.438 -1.865 . . . . 0.0 108.438 -179.458 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -65.3 173.5 6.2 Favored 'Trans proline' 0 C--O 1.214 -0.693 0 CA-C-N 119.143 1.472 . . . . 0.0 109.897 179.047 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -92.26 82.87 4.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.872 -1.143 . . . . 0.0 110.3 -178.175 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.474 HD12 ' HA ' ' A' ' 35' ' ' LEU . 9.1 tp -137.29 135.5 37.19 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.015 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 35' ' ' LEU . . . -46.55 155.4 0.24 Allowed 'General case' 0 N--CA 1.487 1.375 0 O-C-N 120.923 -1.111 . . . . 0.0 109.051 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.431 ' O ' ' C ' ' A' ' 38' ' ' GLN . 0.6 OUTLIER -74.34 -55.27 6.2 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.042 -1.036 . . . . 0.0 110.002 -179.562 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.431 ' C ' ' O ' ' A' ' 37' ' ' THR . 2.2 mp0 -43.31 -34.6 1.25 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.228 -0.92 . . . . 0.0 109.691 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.607 ' O ' ' HB3' ' A' ' 42' ' ' ALA . 10.1 mm-40 -64.87 -52.1 58.41 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.109 -0.994 . . . . 0.0 108.593 179.404 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.536 ' CE ' ' HB2' ' A' ' 22' ' ' TRP . 0.4 OUTLIER -54.43 -60.78 2.89 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.232 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.435 ' C ' ' O ' ' A' ' 40' ' ' MET . 20.9 ttpt -44.3 -35.34 2.29 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.607 ' HB3' ' O ' ' A' ' 39' ' ' GLU . . . -63.2 -48.93 76.23 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.486 -0.759 . . . . 0.0 109.029 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.454 ' HD3' ' OG ' ' A' ' 19' ' ' SER . 7.7 mtt-85 -55.1 -52.39 63.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.373 -0.83 . . . . 0.0 109.539 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 20.9 m -55.89 -35.77 66.91 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 0.0 109.904 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 81.7 m -68.97 -28.62 66.78 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.038 -1.039 . . . . 0.0 109.148 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.72 -31.34 64.91 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.326 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.404 ' O ' HG13 ' A' ' 51' ' ' ILE . 3.4 mm-40 -76.79 -36.41 57.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.465 -0.772 . . . . 0.0 109.506 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.844 HD11 HG12 ' A' ' 98' ' ' VAL . 7.4 tt -72.21 -36.63 69.22 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.265 -0.897 . . . . 0.0 109.299 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.458 ' O ' ' C ' ' A' ' 50' ' ' ALA . 1.2 tt0 -71.64 -55.73 7.19 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.485 ' O ' ' HD3' ' A' ' 52' ' ' PRO . . . -45.92 -47.92 16.29 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 178.31 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.404 HG13 ' O ' ' A' ' 47' ' ' GLN . 88.9 mt -62.12 106.43 0.84 Allowed Pre-proline 0 C--N 1.303 -1.452 0 N-CA-C 107.059 -1.459 . . . . 0.0 107.059 176.538 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.535 ' O ' ' N ' ' A' ' 54' ' ' TYR . 25.1 Cg_endo -61.38 141.03 91.11 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 121.607 1.538 . . . . 0.0 110.925 -177.082 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.569 ' HA ' ' HG3' ' A' ' 56' ' ' ARG . . . -31.29 -35.18 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.156 0.503 . . . . 0.0 110.811 -178.514 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.54 ' O ' ' CB ' ' A' ' 55' ' ' CYS . 9.4 m-85 -75.0 129.14 37.14 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.138 -0.976 . . . . 0.0 109.153 179.384 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.54 ' CB ' ' O ' ' A' ' 54' ' ' TYR . 4.3 m 79.23 0.45 2.33 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.338 -0.851 . . . . 0.0 110.924 179.405 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.569 ' HG3' ' HA ' ' A' ' 53' ' ' ALA . 3.7 mmt85 -43.19 -90.24 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.704 -1.248 . . . . 0.0 109.706 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.529 ' C ' ' O ' ' A' ' 56' ' ' ARG . 3.3 m -21.47 -55.13 0.02 OUTLIER 'General case' 0 N--CA 1.514 2.755 0 O-C-N 122.069 -0.394 . . . . 0.0 111.706 -179.24 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.503 ' C ' ' O ' ' A' ' 57' ' ' CYS . 1.3 mm-40 -31.13 -59.41 0.22 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.596 -0.69 . . . . 0.0 110.82 -179.333 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.611 ' HB1' HD21 ' A' ' 17' ' ' LEU . . . -29.05 -56.38 0.14 Allowed 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 121.223 0.535 . . . . 0.0 111.07 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 1.013 ' CG2' HD22 ' A' ' 97' ' ' LEU . 32.0 t -55.17 -53.09 38.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 O-C-N 121.282 -0.886 . . . . 0.0 109.498 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.529 ' O ' ' HB2' ' A' ' 65' ' ' ASP . 17.9 mmt85 -56.49 -26.85 55.56 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.389 -0.819 . . . . 0.0 109.989 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.792 HG21 HG23 ' A' ' 67' ' ' VAL . 16.1 mm -79.09 -28.9 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.914 -1.116 . . . . 0.0 110.494 -179.518 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.549 ' CD1' ' HB3' ' A' ' 17' ' ' LEU . 9.1 tt -77.48 -50.03 13.52 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.91 -1.119 . . . . 0.0 108.848 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -78.12 -47.81 17.4 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.198 -0.939 . . . . 0.0 109.743 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.529 ' HB2' ' O ' ' A' ' 61' ' ' ARG . 0.7 OUTLIER -80.21 -20.02 45.64 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.117 -0.989 . . . . 0.0 109.799 -179.98 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 62' ' ' ILE . . . 102.05 162.21 26.61 Favored Glycine 0 N--CA 1.485 1.944 0 C-N-CA 119.31 -1.424 . . . . 0.0 110.749 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.792 HG23 HG21 ' A' ' 62' ' ' ILE . 3.6 p -113.85 155.54 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.527 HG22 ' NE2' ' A' ' 74' ' ' HIS . 22.3 t -120.52 156.25 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 120.893 -1.13 . . . . 0.0 110.185 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.435 ' N ' ' CG1' ' A' ' 68' ' ' VAL . 46.3 p -118.19 158.49 25.01 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.3 t -65.31 -27.9 68.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.415 -0.803 . . . . 0.0 109.681 -179.049 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.1 p -68.47 -14.23 62.86 Favored 'General case' 0 C--N 1.294 -1.815 0 O-C-N 121.586 -0.696 . . . . 0.0 109.238 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 99.28 8.76 52.71 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 108.827 -1.709 . . . . 0.0 108.827 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -93.02 156.41 16.91 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.106 -1.232 . . . . 0.0 109.648 -179.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.527 ' NE2' HG22 ' A' ' 68' ' ' VAL . 9.0 m170 -116.53 155.2 29.08 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 120.963 -1.086 . . . . 0.0 109.043 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.512 ' HB2' ' CG1' ' A' ' 67' ' ' VAL . 19.5 mm-40 -147.78 -169.92 3.45 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 121.563 0.696 . . . . 0.0 109.352 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 58.78 -145.61 42.92 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.93 16.9 4.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.286 -1.126 . . . . 0.0 110.069 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.521 ' O ' ' N ' ' A' ' 80' ' ' GLN . 1.0 OUTLIER -76.18 -18.51 59.05 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.985 -1.072 . . . . 0.0 109.669 -179.645 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.675 HD21 ' HB3' ' A' ' 90' ' ' GLN . 7.7 tt -47.41 94.91 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.101 -0.999 . . . . 0.0 108.706 179.232 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.521 ' N ' ' O ' ' A' ' 78' ' ' LEU . 23.2 mm100 -127.71 179.24 5.63 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.075 -1.016 . . . . 0.0 110.197 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.14 104.82 3.74 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.808 0.813 . . . . 0.0 110.863 -179.128 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.705 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 13.7 mt -82.88 173.41 7.59 Favored Pre-proline 0 C--N 1.298 -1.643 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 177.721 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.705 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 28.5 Cg_endo -69.15 104.86 1.29 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 120.873 1.048 . . . . 0.0 109.695 179.374 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.473 ' O ' ' SG ' ' A' ' 29' ' ' CYS . . . 92.04 4.75 66.63 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 -179.298 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.456 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 3.3 m -139.1 88.03 13.54 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 120.753 -1.44 . . . . 0.0 108.758 179.503 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.425 ' O ' ' C ' ' A' ' 87' ' ' ARG . 30.9 Cg_endo -76.21 159.13 37.2 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 121.638 1.558 . . . . 0.0 111.884 -178.669 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.425 ' C ' ' O ' ' A' ' 86' ' ' PRO . 7.1 mmm-85 -45.2 -28.24 0.74 Allowed 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.656 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.413 ' N ' ' C ' ' A' ' 86' ' ' PRO . 49.8 tt0 -54.34 -61.74 2.11 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.262 -178.435 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.43 HG11 ' HB ' ' A' ' 28' ' ' THR . 58.8 t -59.06 -40.64 81.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.084 -1.01 . . . . 0.0 109.952 -178.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.675 ' HB3' HD21 ' A' ' 79' ' ' LEU . 0.4 OUTLIER -62.77 -26.82 68.9 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 119.537 -0.865 . . . . 0.0 108.737 179.685 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.53 -31.22 47.41 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.434 -0.791 . . . . 0.0 109.77 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.5 ' O ' ' HD2' ' A' ' 95' ' ' PRO . . . -73.37 -42.97 61.54 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.087 -1.008 . . . . 0.0 109.47 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.574 ' CD1' HG22 ' A' ' 24' ' ' VAL . 21.5 t80 -78.03 -25.75 48.01 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.35 -0.844 . . . . 0.0 110.143 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.867 ' HB3' ' HD3' ' A' ' 95' ' ' PRO . . . -37.24 -53.36 2.16 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.597 -0.69 . . . . 0.0 110.94 -179.136 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.867 ' HD3' ' HB3' ' A' ' 94' ' ' ALA . 31.5 Cg_endo -73.75 -178.74 3.97 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.175 1.917 . . . . 0.0 110.305 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.447 ' HB2' ' O ' ' A' ' 95' ' ' PRO . 0.1 OUTLIER 71.36 24.66 3.66 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.248 -0.908 . . . . 0.0 108.839 -179.201 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 1.013 HD22 ' CG2' ' A' ' 60' ' ' VAL . 17.6 tp -73.01 -69.87 0.39 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.464 -0.772 . . . . 0.0 110.64 -179.209 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.844 HG12 HD11 ' A' ' 48' ' ' LEU . 2.4 m -79.35 26.57 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.571 -1.331 . . . . 0.0 110.906 -179.449 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.422 ' C ' ' HB2' ' A' ' 104' ' ' ASN . 5.2 p -103.87 174.22 5.96 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 120.617 -1.302 . . . . 0.0 108.902 179.285 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -58.81 -0.93 0.12 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.848 -1.157 . . . . 0.0 112.006 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.1 t -98.78 6.16 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 119.945 -1.722 . . . . 0.0 110.459 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.443 ' HB2' ' O ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -145.57 -90.49 0.1 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.741 -1.225 . . . . 0.0 110.391 -179.949 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.51 ' O ' ' CD1' ' A' ' 105' ' ' LEU . 56.0 m -145.22 40.85 1.24 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.953 -1.092 . . . . 0.0 109.195 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.555 ' O ' ' CB ' ' A' ' 105' ' ' LEU . 24.0 t30 -33.28 -89.47 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.412 -0.805 . . . . 0.0 111.983 -178.774 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.772 HD12 HD22 ' A' ' 48' ' ' LEU . 3.3 mt 85.3 -66.87 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -177.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.724 ' HB2' ' O ' ' A' ' 105' ' ' LEU . . . 155.97 115.1 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.639 HG21 HG21 ' A' ' 98' ' ' VAL . 2.8 p -85.55 -162.26 0.7 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.4 tp -73.38 -16.97 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 120.87 -1.144 . . . . 0.0 109.424 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.466 ' CB ' ' CE1' ' A' ' 113' ' ' PHE . 84.1 m-70 -80.06 16.27 1.27 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.432 -0.792 . . . . 0.0 110.377 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 109' ' ' HIS . . . 43.97 26.44 0.83 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 109' ' ' HIS . . . -153.6 172.72 32.4 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.45 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 33.7 Cg_endo -78.29 81.91 2.6 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 123.021 2.481 . . . . 0.0 110.938 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.589 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.064 -1.022 . . . . 0.0 110.552 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo . . . . . 0 CA--C 1.539 0.743 0 N-CA-C 110.568 -0.589 . . . . 0.0 110.568 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.4 ' C ' ' HG2' ' A' ' 10' ' ' MET . . . 54.44 17.32 8.17 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.876 -1.289 . . . . 0.0 109.876 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.747 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 1.4 mtt -139.38 108.2 5.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.29 -1.123 . . . . 0.0 108.669 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.747 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 85.35 -60.89 0.07 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.815 -1.178 . . . . 0.0 108.288 -178.767 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.747 HD11 ' CB ' ' A' ' 55' ' ' CYS . 1.7 mt -103.1 101.56 22.55 Favored Pre-proline 0 N--CA 1.485 1.315 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.454 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.466 ' HD3' ' O ' ' A' ' 11' ' ' ALA . 31.7 Cg_endo -80.61 174.14 11.47 Favored 'Trans proline' 0 C--N 1.317 -1.089 0 C-N-CA 121.281 1.321 . . . . 0.0 111.355 -177.38 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.463 ' O ' ' CG ' ' A' ' 15' ' ' ASN . 55.9 m80 -73.75 148.27 42.74 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.769 -0.582 . . . . 0.0 109.761 -179.023 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.581 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 3.1 p-10 43.25 58.63 11.96 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.065 -1.022 . . . . 0.0 110.503 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.581 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 37.2 Cg_endo -81.09 166.16 18.85 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.676 2.251 . . . . 0.0 110.91 179.389 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.451 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 14.5 mt 55.08 45.82 25.38 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.471 -0.768 . . . . 0.0 111.179 178.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -69.74 -45.38 68.25 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.815 -1.178 . . . . 0.0 108.589 178.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.501 ' O ' ' HB2' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -62.4 -25.2 67.81 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.886 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.458 ' O ' HG23 ' A' ' 24' ' ' VAL . 73.9 m -69.55 -44.79 70.2 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.376 0.608 . . . . 0.0 109.483 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.61 -48.71 76.24 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.179 -0.951 . . . . 0.0 109.389 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.442 ' HA ' ' CE3' ' A' ' 22' ' ' TRP . 26.5 m95 -69.59 -26.25 64.37 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.443 -1.411 . . . . 0.0 109.382 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.601 ' CG ' ' HG2' ' A' ' 40' ' ' MET . 1.5 t80 -67.44 -30.11 69.75 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.865 HG13 ' HD2' ' A' ' 93' ' ' PHE . 59.1 t -75.18 -42.95 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 C-N-CA 118.758 -1.177 . . . . 0.0 107.859 178.207 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.7 p -56.03 -41.75 75.46 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.076 -1.05 . . . . 0.0 109.965 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.504 ' CA ' ' O ' ' A' ' 31' ' ' VAL . 3.4 m -77.83 -54.48 6.28 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.253 -0.904 . . . . 0.0 111.308 -178.73 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -58.7 -24.83 62.13 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 120.847 -1.158 . . . . 0.0 110.437 -178.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.421 HG23 ' O ' ' A' ' 24' ' ' VAL . 59.1 p -94.62 -65.68 0.97 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.135 -0.978 . . . . 0.0 111.232 -178.235 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.476 ' SG ' ' O ' ' A' ' 84' ' ' GLY . 3.5 m -99.3 16.95 21.32 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.737 -1.227 . . . . 0.0 109.914 -178.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.454 ' HA2' ' O ' ' A' ' 26' ' ' THR . . . 55.93 18.88 20.03 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 -178.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.504 ' O ' ' CA ' ' A' ' 26' ' ' THR . 30.2 t -101.6 157.3 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.312 -1.11 . . . . 0.0 109.525 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.405 ' N ' ' CG1' ' A' ' 31' ' ' VAL . . . 131.29 177.61 14.99 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.494 -1.842 . . . . 0.0 108.494 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -66.59 171.99 9.94 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 CA-C-N 119.15 1.475 . . . . 0.0 110.066 179.253 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -92.67 70.58 4.88 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.935 -1.103 . . . . 0.0 110.364 -178.194 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.451 ' O ' ' C ' ' A' ' 36' ' ' ALA . 0.8 OUTLIER -109.8 122.8 48.33 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 178.803 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.451 ' C ' ' O ' ' A' ' 35' ' ' LEU . . . -41.27 128.71 2.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.324 -0.86 . . . . 0.0 109.154 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.448 HG23 ' CE1' ' A' ' 23' ' ' TYR . 15.8 m -51.16 -38.8 54.24 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.829 -1.169 . . . . 0.0 111.377 -178.491 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -61.04 -36.95 80.94 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.751 -1.218 . . . . 0.0 110.194 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -72.43 -26.76 61.96 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.135 -0.978 . . . . 0.0 109.196 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.601 ' HG2' ' CG ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -72.48 -60.89 2.01 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.898 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -54.56 -36.16 64.03 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.84 -43.5 95.98 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.328 -0.857 . . . . 0.0 109.095 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.405 ' NH1' ' CG ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -60.23 -52.66 64.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.311 -0.868 . . . . 0.0 109.579 179.929 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.428 ' SG ' ' N ' ' A' ' 20' ' ' CYS . 14.7 m -56.68 -35.97 69.05 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.262 -0.899 . . . . 0.0 110.633 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 32.8 m -70.45 -30.72 67.63 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.754 -1.216 . . . . 0.0 109.043 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -68.41 -34.74 76.56 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 179.098 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.454 ' O ' HG13 ' A' ' 51' ' ' ILE . 3.1 mt-30 -77.83 -27.41 49.96 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.542 -0.724 . . . . 0.0 109.138 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.715 ' O ' HD13 ' A' ' 48' ' ' LEU . 1.6 tm? -69.55 -39.02 77.69 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.465 -0.772 . . . . 0.0 108.942 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.425 ' O ' ' C ' ' A' ' 50' ' ' ALA . 3.6 tt0 -77.41 -47.23 20.31 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.489 ' O ' ' HD3' ' A' ' 52' ' ' PRO . . . -45.53 -43.76 12.12 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 178.442 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.462 ' O ' ' HD2' ' A' ' 56' ' ' ARG . 49.4 mt -73.42 107.44 3.36 Favored Pre-proline 0 C--N 1.301 -1.519 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 177.319 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.535 ' O ' ' N ' ' A' ' 54' ' ' TYR . 25.4 Cg_endo -61.15 149.43 89.25 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 121.702 1.601 . . . . 0.0 111.224 -176.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.676 ' HA ' ' HD3' ' A' ' 56' ' ' ARG . . . -34.99 -29.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.037 0.446 . . . . 0.0 111.083 -178.715 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.54 ' O ' ' CB ' ' A' ' 55' ' ' CYS . 1.5 m-85 -79.88 125.87 30.28 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 120.999 -1.063 . . . . 0.0 110.017 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.747 ' CB ' HD11 ' A' ' 12' ' ' ILE . 4.5 m 81.63 -0.22 1.58 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.489 -0.757 . . . . 0.0 111.727 178.349 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.676 ' HD3' ' HA ' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -46.98 -89.9 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.316 -1.49 . . . . 0.0 109.328 -179.916 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.493 ' O ' ' C ' ' A' ' 58' ' ' GLU . 53.5 m -33.36 -56.81 0.42 Allowed 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.325 -0.86 . . . . 0.0 111.904 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.493 ' C ' ' O ' ' A' ' 57' ' ' CYS . 27.3 tt0 -32.34 -51.35 0.26 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.029 -1.045 . . . . 0.0 111.416 -179.361 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.458 ' C ' ' O ' ' A' ' 58' ' ' GLU . . . -36.17 -54.82 0.8 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.282 -0.886 . . . . 0.0 110.643 -179.563 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 44.0 t -54.63 -47.98 71.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 121.327 -0.858 . . . . 0.0 109.17 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.59 -27.03 62.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.217 -0.927 . . . . 0.0 109.442 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.95 HD12 ' HB ' ' A' ' 67' ' ' VAL . 3.7 mm -77.74 -30.14 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.254 -0.904 . . . . 0.0 109.747 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.527 ' O ' ' HA ' ' A' ' 77' ' ' ARG . 8.1 tt -77.88 -40.43 40.06 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.81 -1.181 . . . . 0.0 109.283 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.453 ' SD ' ' HG ' ' A' ' 79' ' ' LEU . 10.4 tpt -77.81 -53.72 7.17 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.239 -0.913 . . . . 0.0 109.985 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -79.61 -22.28 43.87 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.194 -0.941 . . . . 0.0 110.307 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.423 ' CA ' ' HB2' ' A' ' 77' ' ' ARG . . . 88.76 146.71 13.19 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.95 ' HB ' HD12 ' A' ' 62' ' ' ILE . 4.0 p -116.88 160.18 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.61 -0.935 . . . . 0.0 109.337 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.943 HG22 ' CE1' ' A' ' 74' ' ' HIS . 9.5 t -114.17 158.46 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 CA-C-O 121.9 0.857 . . . . 0.0 109.854 -178.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.459 ' N ' ' CG1' ' A' ' 68' ' ' VAL . 69.1 p -116.78 158.51 23.77 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.636 0.731 . . . . 0.0 109.728 -178.363 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 38.8 t -65.55 -25.63 67.51 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.418 0.628 . . . . 0.0 110.11 -178.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.2 p -71.82 -14.15 61.89 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.484 -0.76 . . . . 0.0 109.226 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.25 8.4 50.25 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 108.789 -1.725 . . . . 0.0 108.789 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -100.86 156.15 17.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.075 -1.25 . . . . 0.0 109.18 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.943 ' CE1' HG22 ' A' ' 68' ' ' VAL . 1.0 OUTLIER -115.25 155.66 26.84 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.968 -1.083 . . . . 0.0 108.958 -179.559 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.422 ' CD ' ' O ' ' A' ' 74' ' ' HIS . 22.4 mm-40 -139.51 -171.45 3.14 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.549 -0.86 . . . . 0.0 109.999 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 53.77 -147.1 20.6 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 108.366 -1.894 . . . . 0.0 108.366 -178.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.527 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 14.4 ttt85 52.94 23.13 2.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.118 -1.225 . . . . 0.0 109.577 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.18 -10.82 45.68 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.087 -1.008 . . . . 0.0 110.654 -179.211 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.866 HD22 ' O ' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -57.08 123.18 14.34 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.461 -1.4 . . . . 0.0 108.68 179.514 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.457 ' CG ' ' O ' ' A' ' 79' ' ' LEU . 49.6 mt-30 -156.5 -179.2 7.95 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.758 -1.214 . . . . 0.0 110.234 -178.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.19 105.57 1.12 Allowed 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.869 0.843 . . . . 0.0 110.754 -179.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.674 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 22.2 mt -89.7 171.77 8.24 Favored Pre-proline 0 C--N 1.298 -1.632 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.018 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.674 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 28.3 Cg_endo -67.29 100.39 0.55 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 121.136 1.224 . . . . 0.0 110.422 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.476 ' O ' ' SG ' ' A' ' 29' ' ' CYS . . . 91.27 14.26 57.59 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.481 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 3.3 m -144.55 91.58 6.19 Favored Pre-proline 0 N--CA 1.498 1.926 0 O-C-N 120.904 -1.35 . . . . 0.0 109.224 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.414 ' O ' ' C ' ' A' ' 87' ' ' ARG . 29.9 Cg_endo -75.2 157.09 42.11 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 121.459 1.439 . . . . 0.0 112.028 -178.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.414 ' C ' ' O ' ' A' ' 86' ' ' PRO . 8.1 mtm-85 -45.25 -28.54 0.82 Allowed 'General case' 0 N--CA 1.483 1.201 0 O-C-N 121.306 -0.872 . . . . 0.0 108.821 178.796 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -57.78 -62.27 1.92 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.907 -0.496 . . . . 0.0 111.456 -177.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.8 t -61.34 -39.4 82.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 120.958 -1.089 . . . . 0.0 110.137 -178.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.784 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 2.2 mp0 -63.62 -27.41 69.22 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.684 -0.806 . . . . 0.0 108.856 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.422 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 0.0 OUTLIER -78.43 -33.38 48.63 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.469 -0.77 . . . . 0.0 109.52 179.679 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.482 ' O ' ' HD2' ' A' ' 95' ' ' PRO . . . -69.98 -50.94 36.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.154 -0.966 . . . . 0.0 109.513 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.865 ' HD2' HG13 ' A' ' 24' ' ' VAL . 5.6 t80 -78.14 -25.72 47.49 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.241 -0.912 . . . . 0.0 110.239 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.843 ' HB3' ' HD3' ' A' ' 95' ' ' PRO . . . -38.55 -53.02 3.34 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.331 -0.856 . . . . 0.0 111.365 -178.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.843 ' HD3' ' HB3' ' A' ' 94' ' ' ALA . 30.0 Cg_endo -71.38 -174.68 1.29 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.025 1.817 . . . . 0.0 110.854 -179.319 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.496 ' CB ' ' O ' ' A' ' 95' ' ' PRO . 1.2 ttmm 74.31 32.71 0.95 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.273 -0.892 . . . . 0.0 108.857 -178.813 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.61 -73.08 0.25 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.475 -0.766 . . . . 0.0 111.469 -178.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.528 ' O ' ' CB ' ' A' ' 104' ' ' ASN . 2.0 m -77.62 24.69 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.737 -1.227 . . . . 0.0 111.678 -178.489 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 24.7 p -95.81 169.54 9.93 Favored 'General case' 0 C--N 1.294 -1.815 0 O-C-N 120.547 -1.345 . . . . 0.0 108.671 179.14 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.483 ' HA ' ' ND2' ' A' ' 104' ' ' ASN . 0.6 OUTLIER -59.74 -1.0 0.22 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.658 -1.276 . . . . 0.0 111.774 -179.665 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.453 ' O ' HG12 ' A' ' 101' ' ' VAL . 11.0 t -98.92 5.87 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 119.855 -1.778 . . . . 0.0 110.336 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -142.17 -91.29 0.13 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.808 -1.182 . . . . 0.0 110.117 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.535 ' O ' HD23 ' A' ' 105' ' ' LEU . 74.2 m -145.15 39.56 1.21 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.938 -1.101 . . . . 0.0 109.451 -179.177 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.528 ' CB ' ' O ' ' A' ' 98' ' ' VAL . 4.5 p30 -34.58 -47.9 0.34 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.355 -0.841 . . . . 0.0 111.719 -179.209 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.535 HD23 ' O ' ' A' ' 103' ' ' CYS . 1.3 mm? 44.44 24.75 0.1 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.695 -1.253 . . . . 0.0 110.109 -179.558 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.476 ' O ' ' O ' ' A' ' 105' ' ' LEU . . . 60.93 122.78 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.771 -1.205 . . . . 0.0 109.125 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.42 HG21 HG21 ' A' ' 98' ' ' VAL . 2.4 p -95.28 -172.7 2.73 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.078 -1.013 . . . . 0.0 108.624 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.2 tp -58.74 -21.43 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 120.935 -1.103 . . . . 0.0 109.21 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.498 ' HB3' ' CE1' ' A' ' 113' ' ' PHE . 79.2 m-70 -80.11 16.66 1.17 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.654 -0.654 . . . . 0.0 110.373 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 109' ' ' HIS . . . 43.93 26.89 0.9 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 109' ' ' HIS . . . -154.4 171.08 32.89 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.715 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.459 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 32.2 Cg_endo -78.67 73.57 5.86 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 123.066 2.511 . . . . 0.0 111.603 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.498 ' CE1' ' HB3' ' A' ' 109' ' ' HIS . 25.0 p90 . . . . . 0 N--CA 1.492 1.648 0 O-C-N 121.223 -0.923 . . . . 0.0 109.889 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 42.4 t . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.423 HG23 ' H ' ' A' ' 3' ' ' GLY . 0.2 OUTLIER -133.38 -90.85 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.423 ' H ' HG23 ' A' ' 2' ' ' VAL . . . -103.14 69.22 0.3 Allowed Glycine 0 N--CA 1.498 2.772 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.1 t -105.8 21.76 16.72 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 122.24 -0.565 . . . . 0.0 110.182 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 12.7 p -56.06 171.64 0.24 Allowed 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 24.3 m 64.39 118.79 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.637 HG22 ' HD2' ' A' ' 8' ' ' PRO . 0.9 OUTLIER -76.82 142.05 69.17 Favored Pre-proline 0 N--CA 1.504 2.253 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -179.911 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.637 ' HD2' HG22 ' A' ' 7' ' ' ILE . 37.8 Cg_endo -77.84 -96.03 0.01 OUTLIER 'Trans proline' 0 C--O 1.208 -0.975 0 C-N-CA 121.686 1.591 . . . . 0.0 110.247 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -38.68 -21.69 0.01 OUTLIER Glycine 0 N--CA 1.509 3.55 0 O-C-N 121.64 -0.662 . . . . 0.0 113.279 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.588 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 6.3 mtt -112.11 116.64 30.83 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 178.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.588 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 84.35 -47.59 0.1 Allowed 'General case' 0 N--CA 1.509 2.476 0 CA-C-N 120.021 1.282 . . . . 0.0 110.081 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 85.2 mt -126.27 77.28 72.3 Favored Pre-proline 0 N--CA 1.508 2.438 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -72.47 171.82 16.3 Favored 'Trans proline' 0 N--CA 1.476 0.473 0 C-N-CA 120.751 0.967 . . . . 0.0 112.5 -174.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 18.7 m80 -70.01 148.03 49.37 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.893 -178.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.467 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 29.0 t30 65.66 58.25 1.18 Allowed Pre-proline 0 N--CA 1.503 2.186 0 O-C-N 121.593 -0.692 . . . . 0.0 110.201 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.467 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 38.2 Cg_endo -78.85 158.4 27.68 Favored 'Trans proline' 0 N--CA 1.485 0.972 0 C-N-CA 122.376 2.051 . . . . 0.0 111.752 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.3 mt 53.74 44.25 29.89 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-O 121.074 0.464 . . . . 0.0 111.155 178.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -70.02 -40.51 75.15 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 121.584 -0.697 . . . . 0.0 109.283 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.51 -27.85 69.25 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.536 ' O ' HG23 ' A' ' 24' ' ' VAL . 44.1 m -72.9 -36.33 67.29 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.413 ' CG ' ' N ' ' A' ' 22' ' ' TRP . 0.2 OUTLIER -63.07 -54.97 29.67 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.822 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.441 ' HA ' ' CE3' ' A' ' 22' ' ' TRP . 27.8 m95 -65.64 -27.85 68.68 Favored 'General case' 0 N--CA 1.501 2.084 0 C-N-CA 119.232 -0.987 . . . . 0.0 109.671 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -67.07 -30.03 69.97 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.728 HG22 ' CD1' ' A' ' 93' ' ' PHE . 62.4 t -71.96 -41.62 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 177.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 m -56.35 -42.78 78.31 Favored 'General case' 0 N--CA 1.501 2.112 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.672 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.5 m -77.37 -50.99 11.59 Favored 'General case' 0 N--CA 1.51 2.533 0 O-C-N 122.037 -0.415 . . . . 0.0 112.104 -178.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -62.95 -24.94 68.12 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.832 -0.543 . . . . 0.0 110.733 -178.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.519 HG23 ' O ' ' A' ' 24' ' ' VAL . 34.7 p -97.05 -62.84 1.2 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 122.086 -0.384 . . . . 0.0 111.881 -177.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.6 ' O ' HG23 ' A' ' 31' ' ' VAL . 3.8 m -100.97 12.93 36.73 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 121.36 -0.838 . . . . 0.0 111.581 -178.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 57.17 21.56 39.81 Favored Glycine 0 N--CA 1.505 3.289 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -178.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 29' ' ' CYS . 45.2 t -109.49 164.24 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 O-C-N 121.87 -0.783 . . . . 0.0 109.396 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.497 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 136.14 -179.7 17.57 Favored Glycine 0 N--CA 1.5 2.928 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -63.66 173.37 4.62 Favored 'Trans proline' 0 N--CA 1.487 1.093 0 CA-C-N 119.319 1.559 . . . . 0.0 110.229 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 2.3 ptt180 -92.86 88.24 6.12 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 122.081 0.944 . . . . 0.0 110.197 -177.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.694 HD23 ' H ' ' A' ' 35' ' ' LEU . 2.1 pt? -145.53 -172.29 3.86 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 115.298 -0.865 . . . . 0.0 108.836 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -95.62 162.59 13.56 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.67 -57.33 3.62 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 122.127 -0.358 . . . . 0.0 110.182 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -51.38 -26.81 8.41 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 121.91 -0.494 . . . . 0.0 110.708 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -74.08 -44.48 53.9 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.609 ' HE3' HD11 ' A' ' 35' ' ' LEU . 2.5 ttm -63.5 -53.09 57.42 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.2 ttpp -54.24 -38.84 66.2 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.701 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.82 -38.54 91.16 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.12 -35.58 81.23 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 23.0 m -66.99 -35.57 80.26 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 120.396 -0.522 . . . . 0.0 109.616 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 18.2 m -71.76 -32.35 67.6 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.9 -35.07 74.32 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.47 ' O ' HD12 ' A' ' 51' ' ' ILE . 4.1 mt-30 -78.07 -26.3 48.14 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.804 HD11 ' NH1' ' A' ' 56' ' ' ARG . 1.6 tm? -69.72 -45.93 67.1 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -178.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -78.22 -38.82 42.23 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.62 -36.85 57.23 Favored 'General case' 0 N--CA 1.506 2.358 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.47 HD12 ' O ' ' A' ' 47' ' ' GLN . 58.0 mt -85.58 105.54 7.22 Favored Pre-proline 0 N--CA 1.488 1.446 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 176.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -62.86 148.87 92.92 Favored 'Trans proline' 0 N--CA 1.482 0.818 0 C-N-CA 121.771 1.648 . . . . 0.0 111.412 -176.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.67 ' HB1' ' N ' ' A' ' 108' ' ' ILE . . . -47.3 -27.43 1.57 Allowed 'General case' 0 N--CA 1.501 2.124 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.625 -179.083 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -71.1 115.04 9.77 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 12.0 m 70.54 7.94 6.41 Favored 'General case' 0 N--CA 1.507 2.384 0 O-C-N 121.998 -0.439 . . . . 0.0 110.079 -179.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.804 ' NH1' HD11 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -50.22 -93.19 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.322 -0.861 . . . . 0.0 109.507 179.848 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 88.9 m -31.63 -36.29 0.02 OUTLIER 'General case' 0 N--CA 1.521 3.108 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -41.4 -51.99 3.64 Favored 'General case' 0 N--CA 1.512 2.626 0 CA-C-N 119.762 1.164 . . . . 0.0 111.559 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -44.16 -47.06 9.06 Favored 'General case' 0 N--CA 1.511 2.581 0 O-C-N 121.765 -0.584 . . . . 0.0 112.135 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.9 t -50.73 -46.27 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.733 0 CA-C-O 122.134 0.969 . . . . 0.0 108.401 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -58.93 -50.22 74.87 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 177.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.921 HG23 ' HB ' ' A' ' 67' ' ' VAL . 28.0 mm -51.45 -26.96 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 121.673 -0.642 . . . . 0.0 110.109 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.37 -40.41 36.31 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 120.019 -0.673 . . . . 0.0 109.48 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 17.7 ttp -77.02 -55.34 5.54 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.474 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -80.95 -23.84 38.53 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.748 -0.595 . . . . 0.0 111.651 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.68 148.62 12.81 Favored Glycine 0 N--CA 1.506 3.301 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.921 ' HB ' HG23 ' A' ' 62' ' ' ILE . 8.2 p -117.73 159.91 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.559 0 O-C-N 122.185 -0.597 . . . . 0.0 110.632 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.699 HG22 ' NE2' ' A' ' 74' ' ' HIS . 54.3 t -114.97 156.92 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.12 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 31.1 p -117.63 160.01 21.98 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.176 -177.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.2 t -62.02 -29.67 70.43 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.642 -178.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.2 p -71.78 -16.94 62.21 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 116.618 -0.264 . . . . 0.0 110.482 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.88 14.7 30.81 Favored Glycine 0 N--CA 1.498 2.779 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.6 mm100 -103.07 156.34 17.75 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-N 118.204 1.002 . . . . 0.0 109.195 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.699 ' NE2' HG22 ' A' ' 68' ' ' VAL . 9.2 m170 -115.2 155.54 26.99 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -145.83 -175.99 4.96 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 120.995 0.426 . . . . 0.0 109.869 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 59.78 -148.51 42.09 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 108.443 -1.863 . . . . 0.0 108.443 -178.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 57.27 21.5 6.74 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 122.077 -0.661 . . . . 0.0 110.326 179.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.8 mt -81.96 -14.75 55.62 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.777 -0.577 . . . . 0.0 110.673 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.0 tt -58.72 92.48 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -130.97 177.59 7.33 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.193 0.521 . . . . 0.0 109.811 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -77.02 103.36 6.9 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.524 0.678 . . . . 0.0 110.707 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.528 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 18.1 mt -78.25 170.11 17.76 Favored Pre-proline 0 N--CA 1.497 1.875 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 177.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.528 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 29.8 Cg_endo -70.92 98.43 0.8 Allowed 'Trans proline' 0 C--N 1.327 -0.561 0 C-N-CA 120.859 1.04 . . . . 0.0 109.463 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 102.57 1.43 49.97 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 3.5 m -139.42 91.61 10.87 Favored Pre-proline 0 N--CA 1.505 2.279 0 CA-C-N 119.087 1.444 . . . . 0.0 109.191 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -72.42 163.28 39.06 Favored 'Trans proline' 0 N--CA 1.482 0.828 0 C-N-CA 121.368 1.378 . . . . 0.0 111.576 -178.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.4 mtm-85 -48.5 -28.65 3.47 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.196 0.522 . . . . 0.0 109.769 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -59.57 -46.23 89.51 Favored 'General case' 0 N--CA 1.504 2.235 0 CA-C-N 116.189 -0.46 . . . . 0.0 112.005 -177.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 49.0 t -68.88 -40.58 81.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.585 -0.697 . . . . 0.0 109.823 -178.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.489 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 1.9 mp0 -64.88 -27.39 68.83 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.35 -34.01 48.7 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 109.813 -0.439 . . . . 0.0 109.813 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.57 -45.67 68.17 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.893 -0.504 . . . . 0.0 109.808 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.728 ' CD1' HG22 ' A' ' 24' ' ' VAL . 44.3 t80 -78.57 -25.77 45.42 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 122.319 -0.238 . . . . 0.0 110.406 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.663 ' HB3' ' HD3' ' A' ' 95' ' ' PRO . . . -42.85 -51.71 12.12 Favored Pre-proline 0 N--CA 1.503 2.212 0 CA-C-O 118.87 -0.586 . . . . 0.0 112.493 -177.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.663 ' HD3' ' HB3' ' A' ' 94' ' ' ALA . 30.7 Cg_endo -72.98 -172.42 0.98 Allowed 'Trans proline' 0 N--CA 1.476 0.484 0 C-N-CA 121.697 1.598 . . . . 0.0 110.328 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.4 mttt 64.59 17.15 10.74 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -178.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.613 HD12 ' O ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -74.13 -75.89 0.15 Allowed 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.484 HG12 ' NH1' ' A' ' 56' ' ' ARG . 8.4 m -64.56 1.18 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.334 0 O-C-N 121.612 -0.68 . . . . 0.0 112.487 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 22.3 p -87.8 174.5 8.34 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -61.04 -0.1 0.28 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.424 -0.797 . . . . 0.0 111.899 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.475 ' O ' HG12 ' A' ' 101' ' ' VAL . 21.3 t -90.53 -4.04 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 CA-C-N 120.429 1.468 . . . . 0.0 111.188 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -140.25 -83.01 0.24 Allowed 'General case' 0 N--CA 1.51 2.557 0 C-N-CA 119.108 -1.037 . . . . 0.0 112.693 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 96.2 m -146.28 42.28 1.18 Allowed 'General case' 0 N--CA 1.504 2.256 0 CA-C-N 119.722 1.146 . . . . 0.0 109.258 -178.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.42 ' HA ' ' O ' ' A' ' 98' ' ' VAL . 11.2 p-10 -37.9 -60.66 0.71 Allowed 'General case' 0 N--CA 1.504 2.273 0 N-CA-C 113.553 0.945 . . . . 0.0 113.553 -178.22 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.402 ' O ' ' HB3' ' A' ' 106' ' ' ALA . 79.2 mt 45.92 25.06 0.27 Allowed 'General case' 0 N--CA 1.51 2.564 0 CA-C-N 119.054 0.843 . . . . 0.0 111.396 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 105' ' ' LEU . . . 64.02 141.73 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.321 -0.862 . . . . 0.0 109.674 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.2 p -112.5 -161.8 0.77 Allowed 'General case' 0 N--CA 1.506 2.348 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.67 ' N ' ' HB1' ' A' ' 53' ' ' ALA . 1.0 OUTLIER -66.13 -33.01 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.278 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 72.2 m80 -70.05 -1.25 9.35 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.189 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 57.74 30.36 62.64 Favored Glycine 0 N--CA 1.499 2.887 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -157.22 169.62 34.3 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.4 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 31.8 Cg_endo -78.22 73.85 5.6 Favored 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 122.725 2.283 . . . . 0.0 112.134 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.4 ' HB3' ' O ' ' A' ' 112' ' ' PRO . 49.2 p90 174.05 161.29 0.17 Allowed 'General case' 0 N--CA 1.507 2.407 0 O-C-N 121.827 -0.545 . . . . 0.0 110.462 177.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 16.9 p -159.1 158.65 33.36 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.9 mt 52.11 -176.88 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.678 -0.639 . . . . 0.0 109.921 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 9.0 p 46.79 24.87 0.38 Allowed 'General case' 0 N--CA 1.507 2.398 0 O-C-N 122.084 -0.385 . . . . 0.0 110.87 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.484 HD13 ' HA ' ' A' ' 117' ' ' LEU . 2.2 mm? -63.59 -155.56 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 21.8 mt -45.7 -20.46 0.08 Allowed 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.189 -0.944 . . . . 0.0 113.065 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 104.85 69.73 0.77 Allowed Glycine 0 N--CA 1.499 2.845 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 58.83 69.99 0.68 Allowed 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.765 0.793 . . . . 0.0 109.926 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -102.71 26.15 25.07 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 . . . . . 0 N--CA 1.497 1.916 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.325 -179.806 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 3.1 t . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.487 HG23 ' N ' ' A' ' 3' ' ' GLY . 26.8 m -45.87 -44.49 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.392 0 O-C-N 122.2 -0.313 . . . . 0.0 111.031 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.487 ' N ' HG23 ' A' ' 2' ' ' VAL . . . 151.61 -175.46 30.42 Favored Glycine 0 N--CA 1.5 2.907 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.1 t -151.32 52.27 0.84 Allowed 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.6 0.714 . . . . 0.0 109.296 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 84.5 p -58.38 -170.39 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.772 -0.58 . . . . 0.0 109.809 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 34.2 m -84.38 119.21 24.84 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.536 HG23 ' HB2' ' A' ' 10' ' ' MET . 3.2 tp -121.62 138.95 29.09 Favored Pre-proline 0 N--CA 1.494 1.754 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -76.2 160.22 36.35 Favored 'Trans proline' 0 N--CA 1.48 0.72 0 C-N-CA 121.65 1.567 . . . . 0.0 110.564 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.6 2.12 74.07 Favored Glycine 0 N--CA 1.501 3.017 0 N-CA-C 110.634 -0.987 . . . . 0.0 110.634 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.573 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 4.0 mmt -133.29 104.06 6.28 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 87.2 -57.11 0.04 OUTLIER 'General case' 0 N--CA 1.515 2.789 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -178.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 57.6 mt -100.53 102.36 18.61 Favored Pre-proline 0 N--CA 1.495 1.797 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 178.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -81.28 173.61 11.51 Favored 'Trans proline' 0 N--CA 1.477 0.501 0 C-N-CA 121.616 1.544 . . . . 0.0 111.879 -176.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 43.3 m80 -76.0 146.88 39.2 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.488 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 19.2 t-20 68.11 56.87 0.71 Allowed Pre-proline 0 N--CA 1.508 2.473 0 O-C-N 121.393 -0.817 . . . . 0.0 111.721 179.205 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.488 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 41.2 Cg_endo -84.56 171.1 10.0 Favored 'Trans proline' 0 N--CA 1.481 0.774 0 C-N-CA 122.139 1.893 . . . . 0.0 111.066 178.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 27.6 mt 46.2 46.45 13.19 Favored 'General case' 0 N--CA 1.502 2.167 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.096 177.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -75.49 -43.04 51.31 Favored 'General case' 0 N--CA 1.505 2.311 0 O-C-N 121.482 -0.761 . . . . 0.0 109.002 178.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -63.57 -26.33 68.64 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.715 ' O ' HG23 ' A' ' 24' ' ' VAL . 34.6 m -75.08 -34.54 61.78 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.6 ' NH1' HD23 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -68.32 -46.57 69.86 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.793 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 31.7 m95 -71.77 -29.41 64.45 Favored 'General case' 0 N--CA 1.506 2.326 0 C-N-CA 118.691 -1.203 . . . . 0.0 109.274 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -65.23 -32.41 74.07 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 20' ' ' CYS . 47.9 t -71.35 -41.05 73.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 177.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.1 m -55.5 -39.15 70.1 Favored 'General case' 0 N--CA 1.502 2.159 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.161 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 94.5 m -77.62 -51.52 10.5 Favored 'General case' 0 N--CA 1.508 2.452 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -65.14 -25.01 67.57 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.432 -0.792 . . . . 0.0 110.672 -178.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.46 HG23 ' O ' ' A' ' 24' ' ' VAL . 43.9 p -93.77 -61.09 1.61 Allowed 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -177.501 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.694 ' O ' HG23 ' A' ' 31' ' ' VAL . 3.8 m -100.47 7.83 43.92 Favored 'General case' 0 N--CA 1.507 2.415 0 O-C-N 121.363 -0.836 . . . . 0.0 111.784 -178.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 58.29 24.81 56.4 Favored Glycine 0 N--CA 1.506 3.302 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -178.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.694 HG23 ' O ' ' A' ' 29' ' ' CYS . 19.7 t -119.11 165.54 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 122.124 -0.633 . . . . 0.0 109.35 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.48 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 134.05 -178.89 18.01 Favored Glycine 0 N--CA 1.5 2.954 0 N-CA-C 108.394 -1.882 . . . . 0.0 108.394 -178.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.414 ' HB2' HD23 ' A' ' 35' ' ' LEU . 26.7 Cg_endo -64.62 171.67 7.96 Favored 'Trans proline' 0 N--CA 1.485 0.991 0 CA-C-N 119.63 1.715 . . . . 0.0 109.672 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.748 ' C ' HD22 ' A' ' 35' ' ' LEU . 9.6 mtp180 -92.89 80.87 4.63 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 122.066 0.936 . . . . 0.0 110.115 -177.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.748 HD22 ' C ' ' A' ' 34' ' ' ARG . 4.3 mm? -122.5 -175.67 3.2 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.085 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -99.61 140.76 33.34 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.96 -53.59 47.89 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.616 -0.677 . . . . 0.0 111.042 -179.105 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.6 tm0? -52.46 -46.64 66.59 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.95 -0.469 . . . . 0.0 110.888 -178.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -63.91 -32.07 73.47 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 33.1 tpp -66.94 -58.46 4.92 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 10.2 tptt -53.2 -36.99 61.57 Favored 'General case' 0 N--CA 1.501 2.076 0 CA-C-O 121.179 0.514 . . . . 0.0 109.656 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.49 -40.92 98.35 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.82 -38.74 89.27 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 20.1 m -66.5 -33.54 75.91 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 50.6 m -72.26 -31.16 65.54 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 15.3 ttt85 -73.05 -32.62 65.18 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -76.43 -32.1 58.27 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.76 HD21 HG12 ' A' ' 98' ' ' VAL . 1.1 tp -72.98 -35.94 66.98 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.486 ' OE1' HD22 ' A' ' 105' ' ' LEU . 6.0 tp10 -72.7 -37.25 67.88 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 179.017 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.98 -38.51 82.77 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 45.4 mt -82.38 104.7 3.64 Favored Pre-proline 0 N--CA 1.495 1.789 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 177.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -58.32 140.72 95.49 Favored 'Trans proline' 0 N--CA 1.482 0.81 0 C-N-CA 121.775 1.65 . . . . 0.0 112.208 -175.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.586 ' HB1' ' N ' ' A' ' 108' ' ' ILE . . . -48.99 -24.39 1.5 Allowed 'General case' 0 N--CA 1.5 2.075 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.201 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -45.67 -71.9 0.07 Allowed 'General case' 0 N--CA 1.505 2.319 0 O-C-N 121.969 -0.457 . . . . 0.0 111.204 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 21.1 m -110.5 23.91 13.64 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.99 -0.444 . . . . 0.0 110.86 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.2 mtt180 -40.38 -83.44 0.01 OUTLIER 'General case' 0 N--CA 1.516 2.828 0 O-C-N 121.316 -0.865 . . . . 0.0 110.863 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 75.2 m -32.28 -35.88 0.02 OUTLIER 'General case' 0 N--CA 1.52 3.035 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -46.06 -58.07 3.91 Favored 'General case' 0 N--CA 1.511 2.607 0 CA-C-N 119.933 1.242 . . . . 0.0 110.931 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -42.61 -37.94 1.85 Allowed 'General case' 0 N--CA 1.513 2.715 0 O-C-N 121.675 -0.641 . . . . 0.0 112.346 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.709 ' CG2' HD13 ' A' ' 97' ' ' LEU . 25.8 t -55.08 -49.91 67.86 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 O-C-N 121.774 -0.579 . . . . 0.0 109.556 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -58.15 -28.99 65.23 Favored 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.794 HG23 ' HB ' ' A' ' 67' ' ' VAL . 2.0 mp -77.85 -27.58 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.269 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.46 HD23 ' C ' ' A' ' 63' ' ' LEU . 10.1 tt -78.18 -40.9 36.29 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 120.117 -0.633 . . . . 0.0 109.813 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -78.85 -51.62 9.47 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.142 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -80.81 -23.91 38.89 Favored 'General case' 0 N--CA 1.502 2.135 0 C-N-CA 120.689 -0.404 . . . . 0.0 111.323 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.9 146.3 8.02 Favored Glycine 0 N--CA 1.498 2.788 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.794 ' HB ' HG23 ' A' ' 62' ' ' ILE . 14.2 p -117.45 160.12 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 O-C-N 122.347 -0.502 . . . . 0.0 109.781 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.645 HG22 ' NE2' ' A' ' 74' ' ' HIS . 55.5 t -114.2 157.54 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 53.3 p -117.28 159.28 22.95 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.838 -177.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 34.7 t -64.59 -28.04 69.36 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.385 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.5 p -71.4 -16.05 62.39 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.68 10.83 42.61 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -100.93 156.51 17.34 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 118.201 1.0 . . . . 0.0 109.197 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.645 ' NE2' HG22 ' A' ' 68' ' ' VAL . 11.2 m170 -115.86 155.49 27.81 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -144.44 -173.51 4.06 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.287 0.565 . . . . 0.0 110.26 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.534 ' O ' HD12 ' A' ' 78' ' ' LEU . . . 61.01 -145.01 48.56 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.722 -1.751 . . . . 0.0 108.722 -178.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.411 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 2.7 tpt180 56.44 21.61 5.71 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 122.229 -0.571 . . . . 0.0 109.486 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.6 HD23 ' NH1' ' A' ' 21' ' ' ARG . 10.1 mp -66.12 -21.6 66.35 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.484 -0.76 . . . . 0.0 109.983 -179.098 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.527 HD12 ' HB3' ' A' ' 90' ' ' GLN . 3.0 tt -61.04 92.9 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -141.98 176.83 8.63 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.518 0.675 . . . . 0.0 110.662 -178.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -64.2 118.38 8.51 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.857 0.837 . . . . 0.0 111.367 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.484 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 22.0 mt -112.95 166.63 10.66 Favored Pre-proline 0 N--CA 1.497 1.89 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 177.167 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.484 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 29.4 Cg_endo -68.6 99.81 0.65 Allowed 'Trans proline' 0 C--N 1.326 -0.632 0 C-N-CA 121.063 1.175 . . . . 0.0 110.532 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.99 8.43 64.9 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.431 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 3.4 m -141.72 91.1 8.42 Favored Pre-proline 0 N--CA 1.511 2.615 0 CA-C-N 118.869 1.335 . . . . 0.0 109.504 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -72.95 166.4 30.15 Favored 'Trans proline' 0 N--CA 1.488 1.165 0 C-N-CA 121.895 1.73 . . . . 0.0 111.754 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 72.7 mtp180 -51.13 -27.55 8.78 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.173 0.511 . . . . 0.0 109.893 178.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -61.13 -45.92 92.69 Favored 'General case' 0 N--CA 1.502 2.169 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.239 -177.209 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 58.6 t -69.16 -43.61 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.665 -0.647 . . . . 0.0 110.602 -178.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.65 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 31.2 mt-30 -67.49 -27.71 67.23 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.421 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 5.9 tpt180 -78.65 -26.71 45.2 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.38 -48.45 17.24 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.923 -0.486 . . . . 0.0 110.065 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -78.31 -27.64 47.28 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 122.116 -0.365 . . . . 0.0 110.999 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.65 ' HB2' ' O ' ' A' ' 90' ' ' GLN . . . -53.09 -50.86 79.81 Favored Pre-proline 0 N--CA 1.502 2.14 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.637 ' HD3' ' HB3' ' A' ' 94' ' ' ALA . 31.2 Cg_endo -71.3 82.43 1.09 Allowed 'Trans proline' 0 N--CA 1.482 0.823 0 C-N-CA 122.197 1.931 . . . . 0.0 111.978 -177.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 164.62 57.28 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.492 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.196 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.8 ' HG ' HG13 ' A' ' 98' ' ' VAL . 2.3 pt? -86.94 -56.83 3.21 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -177.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.8 HG13 ' HG ' ' A' ' 97' ' ' LEU . 13.1 m -92.48 25.14 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-N 120.833 1.651 . . . . 0.0 111.183 -178.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 30.8 p -90.74 170.47 10.1 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -62.98 -2.56 1.26 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.452 -0.78 . . . . 0.0 112.121 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.57 ' O ' HG12 ' A' ' 101' ' ' VAL . 21.6 t -100.9 2.83 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 CA-C-N 120.416 1.462 . . . . 0.0 111.269 -179.297 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -133.71 -90.5 0.37 Allowed 'General case' 0 N--CA 1.502 2.133 0 CA-C-N 118.822 0.737 . . . . 0.0 110.97 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.712 ' O ' HD12 ' A' ' 105' ' ' LEU . 46.8 m -143.63 37.98 1.35 Allowed 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.559 -0.713 . . . . 0.0 109.491 -178.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -33.89 -62.66 0.3 Allowed 'General case' 0 N--CA 1.509 2.516 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -178.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.712 HD12 ' O ' ' A' ' 103' ' ' CYS . 3.4 mt 50.18 20.94 0.69 Allowed 'General case' 0 N--CA 1.506 2.341 0 CA-C-N 118.944 0.793 . . . . 0.0 110.946 -179.144 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 63.23 124.08 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.304 -0.872 . . . . 0.0 109.769 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.8 p -89.25 -160.2 0.65 Allowed 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.586 ' N ' ' HB1' ' A' ' 53' ' ' ALA . 6.2 tt -66.58 -30.97 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.414 ' HB3' ' CE1' ' A' ' 113' ' ' PHE . 96.2 m-70 -69.35 -0.97 7.08 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.007 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 58.67 27.74 61.84 Favored Glycine 0 N--CA 1.498 2.813 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -156.74 167.79 33.72 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -78.44 75.04 5.12 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 122.722 2.281 . . . . 0.0 111.764 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.487 ' CD1' HD11 ' A' ' 117' ' ' LEU . 19.5 p90 173.99 149.75 0.08 Allowed 'General case' 0 N--CA 1.508 2.471 0 O-C-N 121.617 -0.677 . . . . 0.0 110.956 178.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 15.2 p -137.27 129.64 29.68 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 177.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.434 HD13 ' HA ' ' A' ' 115' ' ' LEU . 2.4 mm? 53.32 178.84 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.263 0 O-C-N 121.196 -0.94 . . . . 0.0 110.415 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 7.0 t 58.68 19.09 6.45 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 122.153 -0.342 . . . . 0.0 110.819 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.487 HD11 ' CD1' ' A' ' 113' ' ' PHE . 5.2 mp -62.26 -97.81 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.651 -0.655 . . . . 0.0 109.76 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.464 ' HA ' HD13 ' A' ' 118' ' ' LEU . 4.6 mm? -60.76 -14.62 22.45 Favored 'General case' 0 N--CA 1.504 2.248 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -178.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 59.33 101.54 0.01 OUTLIER Glycine 0 N--CA 1.499 2.852 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -87.02 69.27 10.22 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.724 0.773 . . . . 0.0 109.466 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -89.44 2.33 82.9 Favored Glycine 0 N--CA 1.498 2.771 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 . . . . . 0 N--CA 1.498 1.936 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.436 179.971 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 48.8 m . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.53 HG23 ' H ' ' A' ' 3' ' ' GLY . 2.5 m -54.95 -59.91 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 122.213 -0.304 . . . . 0.0 110.858 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.53 ' H ' HG23 ' A' ' 2' ' ' VAL . . . 95.35 124.03 4.24 Favored Glycine 0 N--CA 1.498 2.794 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.1 t -99.66 24.29 8.47 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 122.293 -0.534 . . . . 0.0 109.775 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.6 m -93.83 174.13 7.33 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.639 ' HB3' HD12 ' A' ' 12' ' ' ILE . 58.8 m -103.77 99.77 9.56 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.7 pt -89.24 155.72 49.02 Favored Pre-proline 0 N--CA 1.499 2.021 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -78.91 150.36 23.54 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.254 1.97 . . . . 0.0 110.503 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 79.49 -5.05 61.66 Favored Glycine 0 N--CA 1.499 2.852 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.562 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 86.8 mmm -140.82 115.23 9.39 Favored 'General case' 0 N--CA 1.501 2.105 0 CA-C-N 118.665 1.232 . . . . 0.0 108.968 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 85.72 -56.94 0.08 Allowed 'General case' 0 N--CA 1.515 2.795 0 CA-C-N 119.939 1.245 . . . . 0.0 108.434 -179.082 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.639 HD12 ' HB3' ' A' ' 6' ' ' CYS . 80.7 mt -110.84 100.79 47.51 Favored Pre-proline 0 N--CA 1.489 1.507 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 178.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -80.48 172.94 12.91 Favored 'Trans proline' 0 C--O 1.22 -0.413 0 C-N-CA 121.41 1.407 . . . . 0.0 111.284 -176.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 50.8 m-70 -75.79 143.33 41.99 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.454 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 2.7 m120 63.36 61.94 1.76 Allowed Pre-proline 0 N--CA 1.502 2.152 0 O-C-N 121.769 -0.582 . . . . 0.0 109.742 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.454 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 40.3 Cg_endo -83.45 167.79 13.32 Favored 'Trans proline' 0 N--CA 1.483 0.859 0 C-N-CA 122.459 2.106 . . . . 0.0 111.693 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 42.2 mt 47.64 45.89 17.91 Favored 'General case' 0 N--CA 1.504 2.233 0 CA-C-O 121.105 0.478 . . . . 0.0 111.516 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -74.13 -39.67 63.16 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.538 -0.726 . . . . 0.0 109.447 179.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.3 t -66.58 -25.95 66.88 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.533 ' O ' HG23 ' A' ' 24' ' ' VAL . 37.1 m -75.28 -41.75 56.48 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -43.75 97.03 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.434 ' HA ' ' CE3' ' A' ' 22' ' ' TRP . 38.7 m95 -74.19 -25.92 59.98 Favored 'General case' 0 N--CA 1.501 2.087 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.129 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -69.8 -28.47 65.76 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.737 HG22 ' CE1' ' A' ' 93' ' ' PHE . 52.1 t -75.61 -43.02 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 177.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.447 ' HB3' HD13 ' A' ' 82' ' ' LEU . 0.8 OUTLIER -55.78 -41.77 74.56 Favored 'General case' 0 N--CA 1.503 2.19 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.349 -179.403 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.1 m -77.67 -53.58 7.38 Favored 'General case' 0 N--CA 1.509 2.516 0 O-C-N 122.085 -0.385 . . . . 0.0 111.685 -178.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -60.5 -24.99 65.74 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.851 -0.53 . . . . 0.0 110.453 -178.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.554 HG23 ' O ' ' A' ' 24' ' ' VAL . 31.8 p -97.23 -64.11 1.07 Allowed 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -177.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.558 ' O ' HG23 ' A' ' 31' ' ' VAL . 19.6 m -101.2 14.55 31.59 Favored 'General case' 0 N--CA 1.508 2.45 0 O-C-N 121.386 -0.821 . . . . 0.0 112.0 -178.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 57.05 21.16 37.33 Favored Glycine 0 N--CA 1.505 3.255 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 29' ' ' CYS . 23.6 t -107.74 160.43 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.242 0 O-C-N 121.858 -0.79 . . . . 0.0 109.069 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.436 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 130.65 -179.39 16.97 Favored Glycine 0 N--CA 1.5 2.94 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -66.23 173.88 6.81 Favored 'Trans proline' 0 N--CA 1.486 1.076 0 CA-C-N 119.263 1.531 . . . . 0.0 109.736 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 2.9 ptt180 -92.81 82.66 4.72 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 122.086 0.945 . . . . 0.0 110.742 -177.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 24.5 mt -134.82 138.93 44.68 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.87 160.86 3.22 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -73.08 -56.49 5.05 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.963 -0.461 . . . . 0.0 111.209 -178.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -54.32 -35.65 62.9 Favored 'General case' 0 N--CA 1.506 2.364 0 O-C-N 121.913 -0.492 . . . . 0.0 110.47 -178.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -64.09 -57.65 8.98 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 5.0 ttm -53.08 -47.48 68.48 Favored 'General case' 0 N--CA 1.504 2.238 0 CA-C-O 121.6 0.714 . . . . 0.0 109.401 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 23.8 ttmt -55.95 -37.72 69.37 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.49 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.22 -35.21 79.83 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.61 -41.69 98.27 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 19.5 m -66.26 -38.65 88.32 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.552 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 84.9 m -69.76 -28.49 65.81 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -74.51 -32.23 62.43 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -74.54 -35.49 63.11 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.442 HD11 HG12 ' A' ' 98' ' ' VAL . 2.3 tt -75.68 -27.23 58.19 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.487 ' HG2' HD13 ' A' ' 105' ' ' LEU . 1.6 mm-40 -77.22 -52.16 9.71 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.57 -45.57 69.99 Favored 'General case' 0 N--CA 1.508 2.441 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.441 HD12 HG12 ' A' ' 12' ' ' ILE . 23.7 mm -67.57 106.47 1.26 Allowed Pre-proline 0 N--CA 1.49 1.528 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 175.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -58.51 151.2 63.64 Favored 'Trans proline' 0 N--CA 1.479 0.642 0 C-N-CA 121.479 1.453 . . . . 0.0 110.962 -176.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.423 ' HA ' ' HD3' ' A' ' 56' ' ' ARG . . . -40.72 -29.7 0.1 Allowed 'General case' 0 N--CA 1.507 2.377 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.686 -178.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -73.77 131.33 41.46 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 8.3 m 72.35 6.28 5.46 Favored 'General case' 0 N--CA 1.508 2.433 0 O-C-N 122.125 -0.36 . . . . 0.0 111.335 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.423 ' HD3' ' HA ' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -49.21 -85.23 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.715 0 CA-C-N 119.247 0.931 . . . . 0.0 110.038 -179.765 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 85.5 m -38.09 -45.08 0.88 Allowed 'General case' 0 N--CA 1.518 2.97 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.411 ' O ' HD12 ' A' ' 62' ' ' ILE . 25.5 tt0 -39.86 -50.7 2.45 Favored 'General case' 0 N--CA 1.511 2.586 0 CA-C-N 119.819 1.19 . . . . 0.0 112.148 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -43.86 -47.02 8.2 Favored 'General case' 0 N--CA 1.518 2.939 0 O-C-N 121.573 -0.705 . . . . 0.0 111.609 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 1.008 HG21 HD13 ' A' ' 97' ' ' LEU . 45.2 t -53.71 -45.24 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.55 -32.15 72.21 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.85 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.693 HG23 ' HB ' ' A' ' 67' ' ' VAL . 1.2 mp -70.08 -28.19 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.795 HD13 ' O ' ' A' ' 63' ' ' LEU . 0.9 OUTLIER -77.95 -39.51 42.39 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.047 -179.349 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 14.4 ttp -78.25 -54.8 5.83 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.927 -0.483 . . . . 0.0 110.374 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -80.95 -23.58 38.71 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 122.202 -0.311 . . . . 0.0 111.189 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.33 148.45 13.89 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 -178.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.693 ' HB ' HG23 ' A' ' 62' ' ' ILE . 7.7 p -118.01 159.52 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 O-C-N 122.206 -0.585 . . . . 0.0 109.661 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.647 HG22 ' NE2' ' A' ' 74' ' ' HIS . 76.2 t -115.21 157.56 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 CA-C-O 122.038 0.923 . . . . 0.0 110.368 -178.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.404 ' N ' HG12 ' A' ' 68' ' ' VAL . 23.6 p -117.23 160.65 20.73 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.569 -177.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.6 t -63.5 -34.45 77.8 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.129 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.8 p -63.82 -17.74 63.42 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.73 9.1 47.24 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -97.49 156.88 16.29 Favored 'General case' 0 N--CA 1.503 2.207 0 CA-C-N 118.278 1.039 . . . . 0.0 109.892 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.647 ' NE2' HG22 ' A' ' 68' ' ' VAL . 9.9 m170 -116.04 155.06 28.79 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -141.76 -175.96 4.58 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.009 0.433 . . . . 0.0 109.908 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 59.45 -143.76 46.13 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.3 22.06 4.56 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 122.289 -0.536 . . . . 0.0 110.167 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 55.0 mt -81.43 -15.26 55.65 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.735 -0.603 . . . . 0.0 110.739 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.707 HD21 ' HB3' ' A' ' 90' ' ' GLN . 4.7 tt -57.26 91.99 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -128.38 179.77 5.46 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.26 0.552 . . . . 0.0 109.818 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.75 106.05 7.11 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.313 0.577 . . . . 0.0 110.696 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.564 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 23.0 mt -81.33 169.63 18.34 Favored Pre-proline 0 N--CA 1.495 1.798 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 177.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.564 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 28.3 Cg_endo -66.75 99.4 0.45 Allowed 'Trans proline' 0 C--N 1.329 -0.487 0 C-N-CA 120.978 1.119 . . . . 0.0 111.201 -178.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 103.07 -14.05 55.67 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 6.1 m -123.65 92.22 48.89 Favored Pre-proline 0 N--CA 1.504 2.253 0 CA-C-N 119.323 1.561 . . . . 0.0 110.352 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -72.12 166.11 30.61 Favored 'Trans proline' 0 N--CA 1.483 0.87 0 C-N-CA 121.598 1.532 . . . . 0.0 111.04 -179.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.5 mtm180 -46.9 -28.52 1.62 Allowed 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.152 0.501 . . . . 0.0 109.754 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.8 tm0? -58.65 -52.21 66.65 Favored 'General case' 0 N--CA 1.503 2.199 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.483 -178.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 60.1 t -64.23 -41.75 93.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.746 -0.596 . . . . 0.0 109.576 -178.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.707 ' HB3' HD21 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -63.57 -25.94 68.47 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.29 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -79.0 -33.46 44.98 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.51 -47.68 63.01 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.737 ' CE1' HG22 ' A' ' 24' ' ' VAL . 42.5 t80 -78.27 -25.37 46.72 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.478 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.67 ' HB3' ' HD3' ' A' ' 95' ' ' PRO . . . -42.69 -52.17 11.18 Favored Pre-proline 0 N--CA 1.504 2.227 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -177.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.67 ' HD3' ' HB3' ' A' ' 94' ' ' ALA . 29.6 Cg_endo -70.98 -164.1 0.14 Allowed 'Trans proline' 0 C--N 1.328 -0.513 0 C-N-CA 121.689 1.593 . . . . 0.0 110.296 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 60.57 24.68 14.37 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -178.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 1.008 HD13 HG21 ' A' ' 60' ' ' VAL . 6.6 mt -73.42 -67.93 0.54 Allowed 'General case' 0 N--CA 1.505 2.276 0 O-C-N 122.034 -0.416 . . . . 0.0 111.42 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.442 HG12 HD11 ' A' ' 48' ' ' LEU . 14.7 m -85.52 22.11 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.35 -0.843 . . . . 0.0 111.085 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 30.8 p -99.44 173.31 6.81 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -59.06 -4.16 0.46 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.532 -0.73 . . . . 0.0 111.764 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.53 ' O ' HG12 ' A' ' 101' ' ' VAL . 20.0 t -91.83 -0.27 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-N 120.545 1.52 . . . . 0.0 111.403 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -140.82 -89.39 0.16 Allowed 'General case' 0 N--CA 1.504 2.261 0 CA-C-N 118.974 0.807 . . . . 0.0 111.247 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.443 ' O ' HD12 ' A' ' 105' ' ' LEU . 55.8 m -145.02 42.38 1.31 Allowed 'General case' 0 N--CA 1.508 2.471 0 O-C-N 121.432 -0.792 . . . . 0.0 109.518 -178.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -36.2 -62.5 0.44 Allowed 'General case' 0 N--CA 1.512 2.67 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -178.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.487 HD13 ' HG2' ' A' ' 49' ' ' GLU . 1.9 mt 46.3 27.76 0.62 Allowed 'General case' 0 N--CA 1.513 2.722 0 CA-C-N 118.988 0.813 . . . . 0.0 111.268 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 105' ' ' LEU . . . 70.34 150.34 0.09 Allowed 'General case' 0 N--CA 1.507 2.408 0 O-C-N 121.199 -0.938 . . . . 0.0 109.174 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.0 p -123.16 -163.78 1.14 Allowed 'General case' 0 N--CA 1.505 2.294 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.2 tp -66.12 -31.23 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.452 ' CB ' ' CE1' ' A' ' 113' ' ' PHE . 80.2 m80 -75.68 5.55 6.0 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.974 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 57.96 32.29 66.28 Favored Glycine 0 N--CA 1.499 2.834 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -164.42 171.95 40.06 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 110.116 -1.193 . . . . 0.0 110.116 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -75.8 80.02 2.71 Favored 'Trans proline' 0 N--CA 1.48 0.708 0 C-N-CA 122.626 2.217 . . . . 0.0 110.855 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.461 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER 174.04 169.16 0.21 Allowed 'General case' 0 N--CA 1.502 2.163 0 CA-C-O 121.462 0.649 . . . . 0.0 111.213 179.176 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 10.3 p -178.19 137.08 0.17 Allowed 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.8 mm? 51.24 25.58 2.54 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.362 -0.836 . . . . 0.0 110.252 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 70.1 m -110.07 -65.76 1.13 Allowed 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.407 HD23 ' H ' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -49.63 -80.17 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.523 0 O-C-N 122.042 -0.411 . . . . 0.0 110.188 -179.949 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 15.7 mt -53.45 -16.47 1.46 Allowed 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -101.52 82.58 0.47 Allowed Glycine 0 N--CA 1.502 3.035 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -153.13 70.8 0.88 Allowed 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.687 0.756 . . . . 0.0 109.159 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -68.75 -16.99 70.73 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.098 0 CA-C-O 118.236 -0.887 . . . . 0.0 110.034 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 26.3 t . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.627 ' O ' HG22 ' A' ' 2' ' ' VAL . 14.5 p -90.9 31.86 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 122.256 -0.278 . . . . 0.0 110.354 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.419 ' C ' HG22 ' A' ' 4' ' ' THR . . . 135.29 -86.08 0.25 Allowed Glycine 0 N--CA 1.499 2.873 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.419 HG22 ' C ' ' A' ' 3' ' ' GLY . 9.5 t 41.28 30.72 0.13 Allowed 'General case' 0 N--CA 1.507 2.391 0 CA-C-O 121.157 0.504 . . . . 0.0 111.729 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.3 m 59.12 -159.28 0.3 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.79 -0.569 . . . . 0.0 110.028 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 34.3 m 67.64 130.6 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.164 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.653 ' N ' HD13 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -108.12 161.9 21.77 Favored Pre-proline 0 N--CA 1.503 2.197 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.488 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -78.5 153.59 27.11 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 122.126 1.884 . . . . 0.0 109.904 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 58.32 24.18 55.07 Favored Glycine 0 N--CA 1.499 2.847 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.577 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 38.7 mmm -138.07 95.08 2.96 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.98 -0.718 . . . . 0.0 109.1 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.577 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 86.77 -56.43 0.05 Allowed 'General case' 0 N--CA 1.515 2.803 0 CA-C-N 119.008 0.822 . . . . 0.0 108.796 -178.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.6 mt -104.59 101.11 26.16 Favored Pre-proline 0 N--CA 1.494 1.73 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 178.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -81.78 173.2 11.45 Favored 'Trans proline' 0 N--CA 1.476 0.457 0 C-N-CA 121.555 1.504 . . . . 0.0 111.764 -176.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 45.0 m-70 -74.52 146.15 42.9 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.519 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 0.9 OUTLIER 60.79 54.99 3.5 Favored Pre-proline 0 N--CA 1.501 2.094 0 O-C-N 121.56 -0.712 . . . . 0.0 109.955 -179.098 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.519 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 40.4 Cg_endo -81.17 166.96 18.19 Favored 'Trans proline' 0 N--CA 1.484 0.953 0 C-N-CA 122.239 1.959 . . . . 0.0 111.606 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 38.3 mt 51.09 45.08 28.3 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.921 177.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -68.09 -41.38 81.94 Favored 'General case' 0 N--CA 1.505 2.323 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.57 -26.27 68.62 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 178.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.477 ' O ' HG23 ' A' ' 24' ' ' VAL . 60.7 m -75.52 -38.65 59.25 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.717 ' HD3' HD12 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -62.43 -50.68 70.55 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.004 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.457 ' HA ' ' CE3' ' A' ' 22' ' ' TRP . 32.1 m95 -69.86 -26.46 64.21 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 119.517 -0.873 . . . . 0.0 109.853 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.432 ' O ' ' CD1' ' A' ' 23' ' ' TYR . 7.7 t80 -67.59 -30.35 69.93 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.685 HG22 ' CD1' ' A' ' 93' ' ' PHE . 59.0 t -74.43 -44.43 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 108.301 -0.999 . . . . 0.0 108.301 178.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 p -56.7 -40.96 76.55 Favored 'General case' 0 N--CA 1.505 2.277 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.38 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.3 m -77.22 -53.19 8.04 Favored 'General case' 0 N--CA 1.509 2.497 0 O-C-N 122.01 -0.432 . . . . 0.0 111.872 -178.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -61.8 -24.88 67.14 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.798 -0.563 . . . . 0.0 110.6 -178.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.542 HG23 ' O ' ' A' ' 24' ' ' VAL . 35.4 p -95.66 -63.86 1.11 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.966 -0.459 . . . . 0.0 111.956 -177.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.46 ' O ' HG23 ' A' ' 31' ' ' VAL . 3.7 m -100.93 11.91 38.68 Favored 'General case' 0 N--CA 1.509 2.491 0 O-C-N 121.315 -0.866 . . . . 0.0 111.424 -178.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 59.35 20.23 49.96 Favored Glycine 0 N--CA 1.502 3.056 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -178.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 29' ' ' CYS . 61.1 t -106.37 158.72 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 O-C-N 121.888 -0.772 . . . . 0.0 109.079 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.434 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 135.04 179.06 16.14 Favored Glycine 0 N--CA 1.497 2.761 0 N-CA-C 108.74 -1.744 . . . . 0.0 108.74 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -65.8 172.39 8.37 Favored 'Trans proline' 0 N--CA 1.483 0.904 0 CA-C-N 119.289 1.545 . . . . 0.0 109.635 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 27.8 mtt180 -92.41 74.77 5.23 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 122.155 0.978 . . . . 0.0 109.705 -178.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 35' ' ' LEU . 0.2 OUTLIER -124.05 135.87 53.87 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.084 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.57 150.84 3.51 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.977 -0.452 . . . . 0.0 110.0 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.4 m -73.74 -28.68 61.81 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.736 -0.603 . . . . 0.0 111.185 -178.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -72.74 -31.4 64.92 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.867 -0.521 . . . . 0.0 109.656 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -75.72 -32.66 60.13 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.41 ' HB3' ' CD2' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -70.29 -53.59 16.19 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.575 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 21.7 tttp -56.73 -37.41 70.95 Favored 'General case' 0 N--CA 1.506 2.374 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.19 -38.48 90.62 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.3 mpt_? -65.08 -42.65 93.92 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 17.0 m -65.21 -34.72 79.05 Favored 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.883 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 82.3 m -74.44 -29.8 61.63 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.7 ttt180 -73.63 -32.58 64.11 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -78.75 -35.89 43.95 Favored 'General case' 0 N--CA 1.502 2.17 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.112 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.1 tt -69.63 -37.42 76.78 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -75.56 -41.23 55.38 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.85 -38.01 64.24 Favored 'General case' 0 N--CA 1.509 2.48 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 177.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 59.8 mt -78.92 105.69 3.39 Favored Pre-proline 0 N--CA 1.488 1.434 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 176.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -60.01 152.05 67.72 Favored 'Trans proline' 0 N--CA 1.481 0.745 0 C-N-CA 121.712 1.608 . . . . 0.0 111.278 -176.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -41.37 -29.17 0.14 Allowed 'General case' 0 N--CA 1.507 2.415 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.376 -178.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -67.12 121.85 16.51 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 66.2 m 60.79 15.55 6.0 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 122.195 -0.316 . . . . 0.0 110.537 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.58 -91.38 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.259 -0.901 . . . . 0.0 109.876 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 54.3 m -32.28 -33.95 0.01 OUTLIER 'General case' 0 N--CA 1.521 3.112 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -40.41 -51.64 2.82 Favored 'General case' 0 N--CA 1.509 2.501 0 CA-C-N 119.759 1.163 . . . . 0.0 111.893 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.592 ' HA ' HD12 ' A' ' 62' ' ' ILE . . . -40.42 -47.88 2.66 Favored 'General case' 0 N--CA 1.514 2.746 0 O-C-N 121.897 -0.502 . . . . 0.0 112.108 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.725 HG21 HD13 ' A' ' 97' ' ' LEU . 24.4 t -58.26 -49.22 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.57 -26.27 63.43 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.13 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.871 HG23 ' HB ' ' A' ' 67' ' ' VAL . 9.3 mt -78.81 -30.76 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.996 -0.44 . . . . 0.0 110.272 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.71 ' O ' HD23 ' A' ' 63' ' ' LEU . 4.4 tt -78.03 -42.03 33.79 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 120.014 -0.675 . . . . 0.0 109.334 -178.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 6.8 tpt -78.27 -53.17 7.61 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.313 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -81.51 -21.87 38.33 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 122.147 -0.346 . . . . 0.0 111.429 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.13 149.9 14.35 Favored Glycine 0 N--CA 1.499 2.878 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -178.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.871 ' HB ' HG23 ' A' ' 62' ' ' ILE . 7.3 p -118.17 160.18 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.295 0 O-C-N 122.224 -0.574 . . . . 0.0 110.43 -179.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.735 HG22 ' NE2' ' A' ' 74' ' ' HIS . 42.3 t -114.72 157.35 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 28.2 p -117.43 160.27 21.45 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.544 0.688 . . . . 0.0 110.171 -177.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.3 t -61.65 -25.7 67.54 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.35 -178.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.2 p -80.19 -14.19 58.64 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 122.253 -0.279 . . . . 0.0 110.721 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.23 13.2 34.02 Favored Glycine 0 N--CA 1.498 2.804 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -99.15 156.92 16.71 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-N 118.103 0.951 . . . . 0.0 109.092 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.735 ' NE2' HG22 ' A' ' 68' ' ' VAL . 8.5 m170 -115.65 155.28 27.98 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -144.75 -177.14 5.36 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 120.949 0.404 . . . . 0.0 110.093 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 59.62 -141.03 47.67 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 108.876 -1.69 . . . . 0.0 108.876 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.6 ttp180 55.08 22.45 4.5 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 122.267 -0.549 . . . . 0.0 110.431 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -80.47 -15.26 57.18 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.609 -0.682 . . . . 0.0 110.657 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.717 HD12 ' HD3' ' A' ' 21' ' ' ARG . 2.1 tp -67.46 90.65 0.25 Allowed 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -126.03 177.26 6.46 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -60.81 100.69 0.12 Allowed 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 121.638 0.732 . . . . 0.0 110.535 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.559 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 19.7 mt -80.41 170.74 14.51 Favored Pre-proline 0 N--CA 1.498 1.946 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 177.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.559 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 29.2 Cg_endo -70.07 98.78 0.74 Allowed 'Trans proline' 0 C--O 1.219 -0.447 0 C-N-CA 120.709 0.939 . . . . 0.0 109.883 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 100.09 3.53 55.69 Favored Glycine 0 N--CA 1.495 2.625 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 3.5 m -138.76 91.13 12.09 Favored Pre-proline 0 N--CA 1.503 2.223 0 CA-C-N 119.114 1.457 . . . . 0.0 109.341 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -74.45 162.11 38.82 Favored 'Trans proline' 0 N--CA 1.481 0.786 0 C-N-CA 121.343 1.362 . . . . 0.0 111.2 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 3.8 mmm180 -47.92 -29.21 3.16 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -54.35 -50.46 67.41 Favored 'General case' 0 N--CA 1.508 2.432 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.809 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 63.4 t -64.63 -36.44 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.655 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 52.4 mm-40 -63.27 -26.7 68.9 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.73 -37.21 41.92 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.49 -48.76 71.51 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.685 ' CD1' HG22 ' A' ' 24' ' ' VAL . 41.3 t80 -78.51 -25.22 45.55 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 122.248 -0.282 . . . . 0.0 110.654 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.755 ' HB3' ' HD3' ' A' ' 95' ' ' PRO . . . -40.88 -52.44 6.67 Favored Pre-proline 0 N--CA 1.505 2.315 0 CA-C-O 118.978 -0.534 . . . . 0.0 112.09 -177.237 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.755 ' HD3' ' HB3' ' A' ' 94' ' ' ALA . 30.6 Cg_endo -74.44 -173.65 1.56 Allowed 'Trans proline' 0 C--N 1.328 -0.524 0 C-N-CA 121.708 1.606 . . . . 0.0 109.834 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 17.6 mttm 68.31 26.61 6.8 Favored 'General case' 0 N--CA 1.504 2.243 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -178.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.725 HD13 HG21 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -73.53 -69.61 0.42 Allowed 'General case' 0 N--CA 1.516 2.848 0 O-C-N 121.837 -0.539 . . . . 0.0 110.791 -179.302 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 32.8 m -88.38 26.12 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 O-C-N 121.129 -0.982 . . . . 0.0 110.385 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 27.4 p -100.1 173.51 6.6 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.77 -1.62 0.43 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.565 -0.71 . . . . 0.0 112.019 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.539 ' O ' HG12 ' A' ' 101' ' ' VAL . 20.9 t -96.77 1.29 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 CA-C-N 120.562 1.528 . . . . 0.0 111.222 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -141.09 -91.48 0.15 Allowed 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.488 -0.758 . . . . 0.0 111.318 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.536 ' O ' HD12 ' A' ' 105' ' ' LEU . 60.5 m -142.74 45.46 1.59 Allowed 'General case' 0 N--CA 1.504 2.263 0 O-C-N 121.425 -0.797 . . . . 0.0 109.577 -178.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 58.1 t-20 -40.39 -68.84 0.15 Allowed 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.297 -0.877 . . . . 0.0 113.258 -178.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.536 HD12 ' O ' ' A' ' 103' ' ' CYS . 2.1 mt 50.51 27.16 2.71 Favored 'General case' 0 N--CA 1.506 2.357 0 C-N-CA 120.329 -0.549 . . . . 0.0 110.348 -178.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 105' ' ' LEU . . . 68.52 163.26 0.22 Allowed 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.332 -0.855 . . . . 0.0 109.364 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.503 ' OG1' ' CE1' ' A' ' 109' ' ' HIS . 16.6 p -135.92 -159.94 1.01 Allowed 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 120.869 0.366 . . . . 0.0 110.439 -176.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.504 HG23 ' N ' ' A' ' 109' ' ' HIS . 0.7 OUTLIER -93.13 -47.25 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 121.9 -0.5 . . . . 0.0 111.563 -179.439 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.512 ' NE2' ' CB ' ' A' ' 114' ' ' CYS . 0.0 OUTLIER -54.28 -22.64 12.38 Favored 'General case' 0 N--CA 1.529 3.479 0 O-C-N 121.673 -0.642 . . . . 0.0 109.88 -178.838 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.34 68.81 0.79 Allowed Glycine 0 N--CA 1.499 2.898 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.698 177.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 143.57 173.19 14.91 Favored Glycine 0 N--CA 1.5 2.91 0 CA-C-N 118.809 1.305 . . . . 0.0 111.4 178.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -73.67 85.47 1.3 Allowed 'Trans proline' 0 N--CA 1.482 0.814 0 C-N-CA 122.79 2.327 . . . . 0.0 110.375 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.573 ' CG ' HD11 ' A' ' 117' ' ' LEU . 0.0 OUTLIER 176.62 -173.01 0.09 Allowed 'General case' 0 N--CA 1.515 2.78 0 C-N-CA 120.389 -0.524 . . . . 0.0 111.392 -179.823 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.512 ' CB ' ' NE2' ' A' ' 109' ' ' HIS . 28.7 p 160.6 -174.91 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.681 0 C-N-CA 123.534 0.734 . . . . 0.0 109.307 178.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 70.48 -83.73 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 O-C-N 122.223 -0.298 . . . . 0.0 110.611 178.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 15.1 m -87.59 -69.76 0.67 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.896 -0.502 . . . . 0.0 110.526 -178.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.573 HD11 ' CG ' ' A' ' 113' ' ' PHE . 0.4 OUTLIER 66.05 -87.4 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -179.415 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.8 mp -56.53 -15.84 4.99 Favored 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.04 136.18 0.35 Allowed Glycine 0 N--CA 1.5 2.918 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 60.46 72.85 0.5 Allowed 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.577 0.703 . . . . 0.0 109.909 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.55 21.4 44.77 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 . . . . . 0 N--CA 1.498 1.93 0 CA-C-O 118.061 -0.971 . . . . 0.0 109.559 180.0 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.8 m . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 48.6 t -72.16 -77.08 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 95.45 134.06 7.62 Favored Glycine 0 N--CA 1.5 2.919 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.5 t -96.13 20.92 9.51 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 122.219 -0.577 . . . . 0.0 110.105 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 60.1 p -168.77 157.4 8.32 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 34.7 m 60.3 161.87 0.05 Allowed 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -154.24 166.53 15.66 Favored Pre-proline 0 N--CA 1.507 2.416 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -76.68 143.87 24.36 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.301 2.001 . . . . 0.0 110.107 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 61.38 14.63 42.17 Favored Glycine 0 N--CA 1.501 2.969 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.573 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 5.1 mmt -141.06 108.01 5.43 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 87.04 -59.93 0.04 OUTLIER 'General case' 0 N--CA 1.514 2.767 0 CA-C-N 119.94 1.246 . . . . 0.0 108.245 -178.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.799 HD11 ' HB3' ' A' ' 55' ' ' CYS . 21.9 mt -109.82 97.54 29.29 Favored Pre-proline 0 N--CA 1.492 1.667 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 178.034 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -83.62 174.75 8.52 Favored 'Trans proline' 0 N--CA 1.476 0.442 0 C-N-CA 121.814 1.676 . . . . 0.0 111.503 -177.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 31.4 m80 -71.93 142.21 49.45 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.472 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 25.8 m120 59.1 59.02 5.36 Favored Pre-proline 0 N--CA 1.5 2.058 0 O-C-N 121.436 -0.79 . . . . 0.0 109.003 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.472 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 38.2 Cg_endo -78.97 151.5 24.13 Favored 'Trans proline' 0 N--CA 1.484 0.95 0 C-N-CA 122.345 2.03 . . . . 0.0 112.264 -178.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.928 HD13 ' HB1' ' A' ' 59' ' ' ALA . 6.7 mp 43.0 42.65 3.25 Favored 'General case' 0 N--CA 1.502 2.158 0 CA-C-O 121.163 0.506 . . . . 0.0 111.825 178.229 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -65.37 -32.4 74.02 Favored 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.23 -25.98 67.15 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 35.1 m -76.1 -38.46 56.92 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.6 -50.28 73.21 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.42 ' HA ' ' CE3' ' A' ' 22' ' ' TRP . 36.5 m95 -70.8 -27.37 63.85 Favored 'General case' 0 N--CA 1.501 2.122 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.786 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.744 ' HE1' HG23 ' A' ' 37' ' ' THR . 7.9 t80 -68.12 -31.91 71.83 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.583 HG22 ' CD1' ' A' ' 93' ' ' PHE . 86.4 t -74.98 -40.58 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 177.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.507 ' HB3' HD13 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -55.01 -38.64 68.14 Favored 'General case' 0 N--CA 1.502 2.163 0 C-N-CA 120.095 -0.642 . . . . 0.0 109.561 -179.626 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.7 m -77.07 -51.81 10.41 Favored 'General case' 0 N--CA 1.506 2.356 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.554 -178.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -62.22 -25.21 67.68 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.795 -0.565 . . . . 0.0 111.189 -178.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 79.6 p -97.3 -63.84 1.1 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 122.233 -0.292 . . . . 0.0 111.763 -177.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.551 ' O ' HG23 ' A' ' 31' ' ' VAL . 55.8 m -101.72 14.72 31.13 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.358 -0.839 . . . . 0.0 112.129 -178.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 55.82 21.72 30.96 Favored Glycine 0 N--CA 1.505 3.254 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 29' ' ' CYS . 56.3 t -106.89 162.78 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.821 -0.811 . . . . 0.0 109.011 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.489 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 130.16 178.24 15.31 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 -179.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -66.55 174.88 5.77 Favored 'Trans proline' 0 N--CA 1.487 1.12 0 CA-C-N 119.165 1.482 . . . . 0.0 109.571 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.2 ptp85 -92.21 52.31 1.93 Allowed 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.98 0.895 . . . . 0.0 109.77 -178.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.48 127.83 41.84 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.231 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.47 148.78 4.78 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.807 -0.558 . . . . 0.0 110.171 -178.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.744 HG23 ' HE1' ' A' ' 23' ' ' TYR . 61.1 m -65.77 -40.34 91.93 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.67 -0.643 . . . . 0.0 111.947 -178.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -64.88 -44.29 90.15 Favored 'General case' 0 N--CA 1.504 2.264 0 CA-C-N 118.644 0.656 . . . . 0.0 109.72 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -66.87 -27.68 67.72 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -69.45 -59.03 3.25 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.31 -31.87 55.17 Favored 'General case' 0 N--CA 1.5 2.06 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.633 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.91 -40.79 78.93 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -64.24 -37.41 87.37 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 15.9 m -72.34 -33.45 67.31 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.922 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 21.8 m -73.69 -28.46 61.75 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 24.5 ttm180 -78.19 -35.56 48.5 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.543 ' O ' HD12 ' A' ' 51' ' ' ILE . 8.3 mt-30 -78.03 -41.92 34.13 Favored 'General case' 0 N--CA 1.502 2.157 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.494 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.549 HD22 ' O ' ' A' ' 103' ' ' CYS . 5.6 tt -64.9 -45.22 86.82 Favored 'General case' 0 C--O 1.2 -1.552 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.14 -28.66 66.64 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.497 ' HB3' ' O ' ' A' ' 47' ' ' GLN . . . -55.2 -60.34 3.53 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.543 HD12 ' O ' ' A' ' 47' ' ' GLN . 2.8 mt -58.73 103.92 0.39 Allowed Pre-proline 0 N--CA 1.51 2.572 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 178.332 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -50.18 144.67 22.24 Favored 'Trans proline' 0 N--CA 1.488 1.166 0 C-N-CA 121.636 1.558 . . . . 0.0 113.094 -175.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.488 ' HA ' ' CG ' ' A' ' 56' ' ' ARG . . . -22.82 -46.19 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.767 0 C-N-CA 124.28 1.032 . . . . 0.0 113.693 -177.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -62.75 138.11 58.43 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.799 ' HB3' HD11 ' A' ' 12' ' ' ILE . 20.8 m 61.68 22.82 13.25 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 122.0 -0.438 . . . . 0.0 109.819 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.488 ' CG ' ' HA ' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -44.72 -93.08 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.892 0 O-C-N 121.063 -1.023 . . . . 0.0 110.72 -179.697 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.691 ' SG ' HG21 ' A' ' 98' ' ' VAL . 76.1 m -38.94 -22.35 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.555 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 -178.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -39.07 -48.02 1.61 Allowed 'General case' 0 N--CA 1.512 2.644 0 CA-C-N 120.984 1.72 . . . . 0.0 112.249 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.928 ' HB1' HD13 ' A' ' 17' ' ' LEU . . . -44.56 -57.95 3.31 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.62 -0.675 . . . . 0.0 111.42 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.517 HG22 HD13 ' A' ' 97' ' ' LEU . 41.4 t -48.51 -41.85 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.266 0 CA-C-O 121.125 0.488 . . . . 0.0 109.686 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 22.9 mtp85 -60.09 -64.15 1.05 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.905 HD12 ' HB ' ' A' ' 67' ' ' VAL . 36.9 mm -46.13 -26.95 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.787 -0.57 . . . . 0.0 111.365 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.58 ' C ' HD13 ' A' ' 63' ' ' LEU . 3.5 tm? -77.82 -43.64 29.85 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.226 -0.989 . . . . 0.0 109.705 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -77.67 -53.38 7.62 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.6 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -79.93 -22.17 42.99 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 122.039 -0.413 . . . . 0.0 111.025 -179.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.96 154.06 15.03 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -178.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.905 ' HB ' HD12 ' A' ' 62' ' ' ILE . 2.5 p -117.46 158.94 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.341 0 CA-C-O 121.361 0.6 . . . . 0.0 109.548 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.665 HG22 ' NE2' ' A' ' 74' ' ' HIS . 54.7 t -115.69 157.05 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.6 p -117.48 159.53 22.67 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.522 -177.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.9 t -61.95 -32.73 73.19 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.23 0.538 . . . . 0.0 110.175 -178.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.2 p -65.69 -18.85 65.63 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.254 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.13 16.54 25.15 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -106.36 156.9 18.04 Favored 'General case' 0 N--CA 1.503 2.197 0 CA-C-N 118.284 1.042 . . . . 0.0 109.626 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.665 ' NE2' HG22 ' A' ' 68' ' ' VAL . 11.0 m170 -116.09 154.08 30.59 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.589 -0.695 . . . . 0.0 109.143 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -140.63 -174.99 4.12 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.044 0.449 . . . . 0.0 109.851 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 56.3 -141.29 41.33 Favored Glycine 0 N--CA 1.497 2.715 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.3 ttp180 54.39 24.8 5.44 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 122.228 -0.572 . . . . 0.0 110.54 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.4 mt -78.7 -19.03 53.39 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.698 -0.626 . . . . 0.0 110.38 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.763 HD21 ' HB3' ' A' ' 90' ' ' GLN . 6.5 tp -52.86 95.37 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.703 -0.623 . . . . 0.0 109.998 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -132.78 172.86 12.01 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -67.82 103.18 1.38 Allowed 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.497 0.665 . . . . 0.0 110.484 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.603 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 24.7 mt -78.45 171.33 12.79 Favored Pre-proline 0 N--CA 1.492 1.655 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 177.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.603 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 27.6 Cg_endo -66.61 99.21 0.43 Allowed 'Trans proline' 0 C--N 1.327 -0.579 0 C-N-CA 120.939 1.093 . . . . 0.0 110.715 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 98.18 -12.11 63.69 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 7.0 m -119.58 92.17 45.74 Favored Pre-proline 0 N--CA 1.5 2.063 0 CA-C-N 119.207 1.503 . . . . 0.0 110.101 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -73.16 164.46 35.33 Favored 'Trans proline' 0 N--CA 1.483 0.863 0 C-N-CA 121.514 1.476 . . . . 0.0 111.045 -179.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -46.32 -28.56 1.35 Allowed 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 177.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -54.47 -54.6 38.79 Favored 'General case' 0 N--CA 1.504 2.243 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.537 -178.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 64.5 t -60.84 -41.52 88.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.761 -0.587 . . . . 0.0 109.843 -178.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.763 ' HB3' HD21 ' A' ' 79' ' ' LEU . 7.1 mp0 -64.61 -26.59 68.47 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.49 -28.55 46.4 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.11 -48.68 17.11 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 122.014 -0.429 . . . . 0.0 109.876 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.583 ' CD1' HG22 ' A' ' 24' ' ' VAL . 36.1 t80 -77.72 -25.28 49.2 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 122.212 -0.305 . . . . 0.0 110.759 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.684 ' HB2' ' O ' ' A' ' 90' ' ' GLN . . . -53.15 -53.37 56.43 Favored Pre-proline 0 N--CA 1.5 2.049 0 CA-C-O 118.961 -0.542 . . . . 0.0 111.883 -177.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.682 ' HD3' ' HB3' ' A' ' 94' ' ' ALA . 30.2 Cg_endo -70.0 -11.16 29.99 Favored 'Trans proline' 0 N--CA 1.482 0.819 0 C-N-CA 121.918 1.745 . . . . 0.0 111.181 -179.222 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -89.47 17.19 6.53 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.133 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.727 HD21 HD23 ' A' ' 17' ' ' LEU . 0.1 OUTLIER -73.89 -71.27 0.33 Allowed 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.671 -0.643 . . . . 0.0 109.966 -179.734 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.691 HG21 ' SG ' ' A' ' 57' ' ' CYS . 13.1 m -70.58 5.6 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.36 0 O-C-N 121.176 -0.953 . . . . 0.0 112.283 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 16.3 p -92.07 174.79 7.14 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.13 -3.98 0.45 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.526 -0.734 . . . . 0.0 112.389 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.0 t -89.06 -2.2 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 CA-C-N 120.069 1.304 . . . . 0.0 111.114 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.23 -86.97 0.2 Allowed 'General case' 0 N--CA 1.508 2.456 0 C-N-CA 119.486 -0.886 . . . . 0.0 111.978 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.717 ' O ' HD12 ' A' ' 105' ' ' LEU . 95.6 m -146.7 43.83 1.18 Allowed 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.43 -0.794 . . . . 0.0 109.107 -178.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.414 ' HA ' ' O ' ' A' ' 98' ' ' VAL . 7.3 p-10 -39.11 -55.4 1.62 Allowed 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.438 -0.789 . . . . 0.0 113.09 -178.225 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.717 HD12 ' O ' ' A' ' 103' ' ' CYS . 2.2 mt 40.8 29.84 0.08 Allowed 'General case' 0 N--CA 1.511 2.623 0 CA-C-N 118.875 0.761 . . . . 0.0 111.071 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 105' ' ' LEU . . . 65.5 155.41 0.08 Allowed 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.64 -0.662 . . . . 0.0 109.302 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.438 ' HA ' ' HD2' ' A' ' 56' ' ' ARG . 4.4 p -127.88 -160.22 1.0 Allowed 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -179.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.848 HD13 ' O ' ' A' ' 108' ' ' ILE . 0.0 OUTLIER -67.51 -34.11 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.41 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.447 ' HB3' ' CE1' ' A' ' 113' ' ' PHE . 93.1 m-70 -69.48 -2.55 11.53 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 116.234 -0.439 . . . . 0.0 112.049 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 60.25 29.92 69.78 Favored Glycine 0 N--CA 1.497 2.75 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -159.88 170.54 36.05 Favored Glycine 0 N--CA 1.496 2.653 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -78.02 76.24 4.45 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.537 2.158 . . . . 0.0 111.475 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.476 ' HD1' HD11 ' A' ' 117' ' ' LEU . 35.7 p90 173.96 163.71 0.19 Allowed 'General case' 0 N--CA 1.508 2.454 0 O-C-N 121.769 -0.582 . . . . 0.0 110.313 178.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.472 ' SG ' HG21 ' A' ' 98' ' ' VAL . 29.7 p -173.01 160.13 4.13 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 122.11 -0.369 . . . . 0.0 110.179 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 67.19 -82.91 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.261 0 O-C-N 122.133 -0.354 . . . . 0.0 111.344 178.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 40.2 t -46.08 -86.48 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.825 -0.547 . . . . 0.0 111.475 -178.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.476 HD11 ' HD1' ' A' ' 113' ' ' PHE . 0.3 OUTLIER 56.13 -95.2 0.05 Allowed 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -178.876 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.428 HD13 ' HA ' ' A' ' 118' ' ' LEU . 4.6 mm? -61.43 -11.65 11.33 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.41 -0.806 . . . . 0.0 112.794 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -54.27 114.69 4.45 Favored Glycine 0 N--CA 1.5 2.904 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -108.61 66.15 0.64 Allowed 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.935 0.874 . . . . 0.0 108.777 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -57.96 -21.68 45.92 Favored Glycine 0 N--CA 1.498 2.808 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 . . . . . 0 N--CA 1.499 2.013 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.528 -179.921 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 10.4 p . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.0 t -64.83 -71.86 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 95.7 -136.58 12.95 Favored Glycine 0 N--CA 1.497 2.749 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.593 HG23 ' O ' ' A' ' 4' ' ' THR . 5.8 t -172.64 77.29 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 61.88 171.73 0.12 Allowed 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.644 -0.66 . . . . 0.0 109.711 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 67.2 m 58.88 104.01 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 44.6 pt -94.46 156.27 38.78 Favored Pre-proline 0 N--CA 1.499 1.986 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.11 159.45 30.24 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.241 1.96 . . . . 0.0 110.358 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.45 4.71 75.5 Favored Glycine 0 N--CA 1.5 2.964 0 N-CA-C 110.839 -0.905 . . . . 0.0 110.839 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.59 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 1.5 mpt? -133.0 99.04 4.45 Favored 'General case' 0 N--CA 1.501 2.11 0 CA-C-N 118.103 0.951 . . . . 0.0 108.705 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.59 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 86.79 -56.01 0.05 Allowed 'General case' 0 N--CA 1.515 2.819 0 CA-C-N 119.355 0.98 . . . . 0.0 108.547 -178.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 9.2 mt -101.85 101.44 18.33 Favored Pre-proline 0 N--CA 1.493 1.695 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 178.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -80.58 173.37 12.35 Favored 'Trans proline' 0 N--CA 1.474 0.33 0 C-N-CA 121.536 1.491 . . . . 0.0 111.643 -176.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 49.9 m80 -71.13 144.53 50.21 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.46 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 3.3 t-20 60.68 60.24 3.57 Favored Pre-proline 0 N--CA 1.499 1.99 0 O-C-N 121.597 -0.689 . . . . 0.0 109.198 -179.119 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.46 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 39.5 Cg_endo -81.43 151.28 17.45 Favored 'Trans proline' 0 N--CA 1.481 0.787 0 C-N-CA 122.318 2.012 . . . . 0.0 111.673 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.556 HD23 ' SG ' ' A' ' 20' ' ' CYS . 3.6 mp 51.57 41.26 28.52 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-O 121.048 0.451 . . . . 0.0 111.421 178.163 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.408 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 7.2 p-10 -65.54 -40.62 93.08 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.67 -25.99 68.42 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.089 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.556 ' SG ' HD23 ' A' ' 17' ' ' LEU . 65.4 m -73.51 -42.83 61.29 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.667 ' NH2' HD22 ' A' ' 78' ' ' LEU . 2.5 ptt-85 -60.59 -49.83 75.96 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.451 ' HA ' ' CE3' ' A' ' 22' ' ' TRP . 29.9 m95 -67.85 -26.94 66.29 Favored 'General case' 0 N--CA 1.5 2.052 0 C-N-CA 119.693 -0.803 . . . . 0.0 110.447 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.451 ' CD2' ' HB3' ' A' ' 40' ' ' MET . 5.4 t80 -66.91 -32.3 73.47 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 178.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.727 HG22 ' CE1' ' A' ' 93' ' ' PHE . 47.0 t -71.68 -43.81 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.305 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.3 m -53.91 -42.36 68.64 Favored 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.431 -179.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 16.7 m -76.96 -53.76 7.44 Favored 'General case' 0 N--CA 1.507 2.42 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -178.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.8 tpm_? -60.28 -25.53 65.79 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.78 -0.575 . . . . 0.0 110.878 -178.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 48.1 p -97.67 -63.32 1.14 Allowed 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -177.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.61 ' O ' HG23 ' A' ' 31' ' ' VAL . 45.8 m -101.26 14.69 31.16 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.451 -0.78 . . . . 0.0 112.093 -178.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 55.64 21.06 27.2 Favored Glycine 0 N--CA 1.506 3.326 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 29' ' ' CYS . 25.5 t -107.55 164.01 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 O-C-N 121.851 -0.794 . . . . 0.0 109.121 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.492 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 134.38 178.89 15.95 Favored Glycine 0 N--CA 1.498 2.817 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -66.12 175.25 4.96 Favored 'Trans proline' 0 N--CA 1.486 1.075 0 CA-C-N 119.14 1.47 . . . . 0.0 109.633 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.07 82.25 5.07 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.99 0.9 . . . . 0.0 109.941 -178.178 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -139.71 135.84 33.58 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.511 ' HB3' ' OE2' ' A' ' 39' ' ' GLU . . . -53.8 162.63 0.86 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 122.056 -0.402 . . . . 0.0 110.158 -179.176 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.89 -54.0 8.05 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 122.051 -0.406 . . . . 0.0 110.595 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -51.48 -36.51 44.73 Favored 'General case' 0 N--CA 1.507 2.398 0 O-C-N 121.742 -0.599 . . . . 0.0 111.15 -178.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.511 ' OE2' ' HB3' ' A' ' 36' ' ' ALA . 43.4 mt-10 -70.75 -36.09 72.96 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 122.052 -0.405 . . . . 0.0 110.008 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.451 ' HB3' ' CD2' ' A' ' 23' ' ' TYR . 0.8 OUTLIER -66.18 -54.25 27.61 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.856 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.0 ttpt -54.63 -36.76 64.86 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.05 -39.72 95.57 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -63.6 -40.75 97.72 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 16.4 m -67.82 -33.5 74.91 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.054 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 17.9 m -74.44 -30.44 61.89 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.22 -35.29 71.43 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 178.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -79.07 -26.85 43.01 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 120.961 0.41 . . . . 0.0 109.947 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.631 ' O ' HD13 ' A' ' 48' ' ' LEU . 1.4 tm? -71.52 -39.31 70.83 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -178.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.51 ' HG3' HD22 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -78.24 -40.45 37.2 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.454 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.41 ' O ' ' HD3' ' A' ' 52' ' ' PRO . . . -54.23 -37.61 64.81 Favored 'General case' 0 N--CA 1.505 2.294 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 178.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 80.2 mt -79.04 105.15 2.73 Favored Pre-proline 0 N--CA 1.493 1.7 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 177.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' A' ' 50' ' ' ALA . 26.7 Cg_endo -60.31 146.67 96.06 Favored 'Trans proline' 0 N--CA 1.479 0.631 0 C-N-CA 121.544 1.496 . . . . 0.0 110.997 -176.242 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.436 ' HB2' ' NH1' ' A' ' 56' ' ' ARG . . . -42.5 -27.99 0.19 Allowed 'General case' 0 N--CA 1.502 2.17 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.685 -178.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -67.37 119.83 12.86 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 20.8 m 62.02 17.38 8.99 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 122.383 -0.198 . . . . 0.0 110.647 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.436 ' NH1' ' HB2' ' A' ' 53' ' ' ALA . 4.6 mtt180 -44.93 -83.37 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.901 0 O-C-N 121.231 -0.918 . . . . 0.0 110.165 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.536 ' SG ' HG21 ' A' ' 98' ' ' VAL . 51.3 m -33.15 -43.62 0.11 Allowed 'General case' 0 N--CA 1.52 3.061 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -37.8 -48.07 1.07 Allowed 'General case' 0 N--CA 1.514 2.774 0 CA-C-N 119.741 1.155 . . . . 0.0 112.246 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -43.66 -53.23 5.9 Favored 'General case' 0 N--CA 1.513 2.722 0 O-C-N 121.542 -0.724 . . . . 0.0 111.582 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 38.5 t -48.69 -45.87 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.399 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.1 -54.61 45.06 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.75 HG23 ' HB ' ' A' ' 67' ' ' VAL . 34.4 mt -49.18 -27.39 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.337 0 O-C-N 121.344 -0.848 . . . . 0.0 109.965 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.431 HD12 ' HA ' ' A' ' 63' ' ' LEU . 27.5 tp -77.92 -41.85 35.11 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.491 -0.884 . . . . 0.0 109.994 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.26 -54.26 6.71 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.555 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -80.65 -22.86 40.13 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.931 -0.48 . . . . 0.0 111.224 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.65 150.49 17.07 Favored Glycine 0 N--CA 1.498 2.781 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -178.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.75 ' HB ' HG23 ' A' ' 62' ' ' ILE . 4.2 p -117.91 159.68 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.275 0 O-C-N 122.176 -0.603 . . . . 0.0 109.845 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.688 HG22 ' NE2' ' A' ' 74' ' ' HIS . 72.8 t -115.1 157.51 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 CA-C-O 121.767 0.794 . . . . 0.0 109.095 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.9 p -117.42 159.78 22.24 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.648 -177.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.3 t -62.07 -33.41 74.37 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.3 -178.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.8 p -66.2 -17.78 64.94 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.226 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.91 14.78 30.5 Favored Glycine 0 N--CA 1.498 2.798 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 67.8 mm-40 -102.58 157.06 17.2 Favored 'General case' 0 N--CA 1.503 2.221 0 CA-C-N 118.19 0.995 . . . . 0.0 109.321 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.688 ' NE2' HG22 ' A' ' 68' ' ' VAL . 9.5 m170 -115.83 155.3 28.13 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -143.48 -176.77 5.08 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.17 0.51 . . . . 0.0 110.278 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 60.09 -137.66 49.16 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 22.7 ttp180 51.42 26.07 2.96 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 122.317 -0.519 . . . . 0.0 110.301 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.667 HD22 ' NH2' ' A' ' 21' ' ' ARG . 3.4 mt -77.2 -20.47 55.29 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.719 -0.613 . . . . 0.0 110.636 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.421 HD11 HD23 ' A' ' 63' ' ' LEU . 95.8 mt -62.14 95.55 0.06 Allowed 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -143.23 177.01 8.7 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.368 0.604 . . . . 0.0 110.29 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -50.96 107.86 0.2 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.49 0.662 . . . . 0.0 111.775 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.545 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 18.3 mt -100.88 168.14 9.71 Favored Pre-proline 0 N--CA 1.495 1.797 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.545 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 26.6 Cg_endo -64.62 99.79 0.32 Allowed 'Trans proline' 0 N--CA 1.48 0.699 0 C-N-CA 121.277 1.318 . . . . 0.0 111.702 -178.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.84 -9.89 75.75 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 7.5 m -118.98 91.12 42.68 Favored Pre-proline 0 N--CA 1.503 2.217 0 CA-C-N 119.125 1.463 . . . . 0.0 110.538 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -72.02 165.44 32.59 Favored 'Trans proline' 0 N--CA 1.482 0.847 0 C-N-CA 121.712 1.608 . . . . 0.0 111.173 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.1 mmm-85 -47.59 -28.53 2.35 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -57.7 -53.42 58.36 Favored 'General case' 0 N--CA 1.502 2.159 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.048 -178.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.1 t -63.89 -38.72 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.754 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -63.19 -26.96 69.05 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.42 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.93 -35.95 42.56 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.22 -49.82 63.12 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.997 -0.439 . . . . 0.0 109.896 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.727 ' CE1' HG22 ' A' ' 24' ' ' VAL . 34.0 t80 -78.77 -25.11 44.35 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 122.12 -0.362 . . . . 0.0 110.554 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.754 ' HB2' ' O ' ' A' ' 90' ' ' GLN . . . -41.22 -51.06 8.22 Favored Pre-proline 0 N--CA 1.503 2.186 0 CA-C-O 118.773 -0.632 . . . . 0.0 112.29 -177.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.657 ' HD3' ' HB3' ' A' ' 94' ' ' ALA . 30.3 Cg_endo -72.59 -167.24 0.32 Allowed 'Trans proline' 0 C--N 1.33 -0.43 0 C-N-CA 121.505 1.47 . . . . 0.0 109.62 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 77.0 mttt 62.48 20.44 11.92 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.433 ' HA ' HD22 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -72.92 -65.45 0.8 Allowed 'General case' 0 N--CA 1.509 2.486 0 O-C-N 121.875 -0.516 . . . . 0.0 110.786 -179.132 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.536 HG21 ' SG ' ' A' ' 57' ' ' CYS . 27.1 m -84.6 20.63 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 120.963 -1.086 . . . . 0.0 111.279 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 25.2 p -98.91 174.71 6.23 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.04 -2.67 0.63 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.575 -0.703 . . . . 0.0 112.018 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.5 ' O ' HG12 ' A' ' 101' ' ' VAL . 14.4 t -94.05 -0.64 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 CA-C-N 120.591 1.541 . . . . 0.0 111.062 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -138.12 -89.65 0.23 Allowed 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.383 -0.823 . . . . 0.0 111.185 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.552 ' O ' HD12 ' A' ' 105' ' ' LEU . 54.0 m -144.92 39.5 1.23 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.374 -0.829 . . . . 0.0 109.432 -178.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -35.22 -60.84 0.46 Allowed 'General case' 0 N--CA 1.511 2.6 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -178.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.552 HD12 ' O ' ' A' ' 103' ' ' CYS . 1.1 mt 43.23 31.45 0.38 Allowed 'General case' 0 N--CA 1.511 2.617 0 CA-C-N 118.657 0.662 . . . . 0.0 110.73 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 105' ' ' LEU . . . 66.58 150.09 0.05 Allowed 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -178.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.7 p -119.58 -159.86 0.79 Allowed 'General case' 0 N--CA 1.504 2.226 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.8 tt -66.98 -32.35 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -72.92 1.73 8.21 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.9 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 57.91 33.18 67.79 Favored Glycine 0 N--CA 1.499 2.887 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -161.66 170.63 37.43 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -79.05 71.96 6.76 Favored 'Trans proline' 0 CA--C 1.545 1.047 0 C-N-CA 122.747 2.298 . . . . 0.0 111.55 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 44.8 p90 175.39 155.38 0.17 Allowed 'General case' 0 N--CA 1.505 2.311 0 O-C-N 121.816 -0.552 . . . . 0.0 110.171 178.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 20.6 p -156.31 150.33 25.19 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 56.36 -177.47 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.717 -0.614 . . . . 0.0 110.069 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 57.19 -89.97 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 55.37 -88.8 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.838 -0.539 . . . . 0.0 110.105 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 16.5 mt -50.53 -18.4 0.66 Allowed 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.6 -0.687 . . . . 0.0 112.812 -179.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -107.51 40.96 2.33 Favored Glycine 0 N--CA 1.499 2.839 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -96.16 53.5 1.36 Allowed 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.911 0.862 . . . . 0.0 109.289 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -57.34 -24.57 52.3 Favored Glycine 0 N--CA 1.499 2.876 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 . . . . . 0 N--CA 1.5 2.07 0 CA-C-O 117.85 -1.072 . . . . 0.0 110.225 179.773 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.206 0.527 . . . . 0.0 109.583 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.462 HG23 ' H ' ' A' ' 3' ' ' GLY . 0.7 OUTLIER -54.48 -99.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.353 -0.842 . . . . 0.0 109.726 -179.895 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.462 ' H ' HG23 ' A' ' 2' ' ' VAL . . . 165.47 -139.06 5.58 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.46 ' O ' ' O ' ' A' ' 5' ' ' SER . 8.5 t -116.19 20.53 14.27 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.24 -1.153 . . . . 0.0 110.092 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 4' ' ' THR . 23.2 m 42.91 -166.13 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.144 -0.973 . . . . 0.0 109.741 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.463 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 34.0 m -99.99 120.71 40.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.221 -0.924 . . . . 0.0 109.13 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.457 ' HB ' ' SD ' ' A' ' 10' ' ' MET . 1.0 OUTLIER -42.64 101.96 0.26 Allowed Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.328 -0.858 . . . . 0.0 109.81 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 6' ' ' CYS . 36.1 Cg_endo -77.86 159.0 31.25 Favored 'Trans proline' 0 C--N 1.315 -1.217 0 C-N-CA 121.87 1.713 . . . . 0.0 110.133 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 60.15 12.52 23.89 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.726 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -129.37 94.44 3.78 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.293 -1.122 . . . . 0.0 108.71 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.726 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 86.09 -58.14 0.07 Allowed 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -178.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 29.1 mt -95.69 103.25 12.29 Favored Pre-proline 0 N--CA 1.489 1.489 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.516 ' HD3' ' O ' ' A' ' 11' ' ' ALA . 34.1 Cg_endo -81.37 170.86 14.28 Favored 'Trans proline' 0 C--N 1.318 -1.038 0 C-N-CA 121.378 1.385 . . . . 0.0 111.864 -176.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 32.3 m80 -69.82 149.2 48.16 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.48 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 1.1 t-20 67.2 63.95 0.74 Allowed Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 120.623 -1.298 . . . . 0.0 110.033 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.807 ' HB2' ' HB1' ' A' ' 59' ' ' ALA . 37.3 Cg_endo -79.7 166.35 21.71 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.808 2.339 . . . . 0.0 112.151 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.53 HD23 ' SG ' ' A' ' 20' ' ' CYS . 0.2 OUTLIER 33.13 47.03 0.11 Allowed 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.581 178.789 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -74.86 -34.85 62.33 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.99 -1.069 . . . . 0.0 108.982 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.448 ' OG ' ' SG ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -62.56 -43.36 99.01 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.171 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.53 ' SG ' HD23 ' A' ' 17' ' ' LEU . 36.2 m -59.88 -40.03 87.29 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 121.352 0.596 . . . . 0.0 109.706 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.557 ' HG3' ' N ' ' A' ' 22' ' ' TRP . 0.1 OUTLIER -58.08 -51.91 67.72 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.373 -0.83 . . . . 0.0 108.915 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.557 ' N ' ' HG3' ' A' ' 21' ' ' ARG . 27.6 m95 -68.75 -26.25 65.14 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 118.591 -1.244 . . . . 0.0 110.541 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.651 ' HE1' HG22 ' A' ' 37' ' ' THR . 19.0 t80 -66.97 -32.65 74.03 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.911 -1.118 . . . . 0.0 108.593 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.558 HG22 ' CE1' ' A' ' 93' ' ' PHE . 71.3 t -72.9 -42.25 60.51 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.274 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 178.04 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.476 ' OG ' ' HA ' ' A' ' 22' ' ' TRP . 0.5 OUTLIER -54.84 -40.0 69.14 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.059 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.488 ' CA ' ' O ' ' A' ' 31' ' ' VAL . 3.7 m -77.28 -53.26 7.92 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.186 -0.946 . . . . 0.0 111.154 -178.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.1 ttm180 -59.56 -24.4 63.69 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.935 -1.103 . . . . 0.0 110.194 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.456 ' OG1' ' SG ' ' A' ' 85' ' ' CYS . 80.7 p -93.0 -67.53 0.85 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.186 -0.946 . . . . 0.0 111.419 -178.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.498 ' SG ' ' C ' ' A' ' 84' ' ' GLY . 93.2 m -99.51 18.07 18.79 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.496 -1.378 . . . . 0.0 110.104 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' A' ' 26' ' ' THR . . . 57.63 15.55 18.8 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.488 ' O ' ' CA ' ' A' ' 26' ' ' THR . 75.6 t -101.87 154.48 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.13 -1.218 . . . . 0.0 109.283 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.435 ' HA3' ' HG1' ' A' ' 26' ' ' THR . . . 142.66 179.23 19.3 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -66.37 177.15 3.42 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 CA-C-N 118.981 1.391 . . . . 0.0 109.875 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' ' 34' ' ' ARG . 0.1 OUTLIER -91.28 81.68 5.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.726 -1.234 . . . . 0.0 110.162 -178.125 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.461 ' CD2' ' NH1' ' A' ' 43' ' ' ARG . 25.6 tp -138.13 127.98 25.38 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.108 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.94 161.58 0.76 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.059 -1.025 . . . . 0.0 109.662 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.651 HG22 ' HE1' ' A' ' 23' ' ' TYR . 1.2 p -67.96 -61.97 1.62 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.12 -0.987 . . . . 0.0 109.987 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 37' ' ' THR . 0.8 OUTLIER -43.95 -57.22 3.44 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.017 -1.052 . . . . 0.0 109.737 -179.361 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.577 ' O ' ' HB3' ' A' ' 42' ' ' ALA . 75.5 mm-40 -49.15 -43.38 41.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.252 -0.905 . . . . 0.0 109.699 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.59 ' CE ' ' CG ' ' A' ' 23' ' ' TYR . 1.8 tmm? -59.03 -62.97 1.48 Allowed 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.493 ' HG3' ' OE1' ' A' ' 102' ' ' GLU . 19.0 tttt -40.59 -31.68 0.17 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.577 ' HB3' ' O ' ' A' ' 39' ' ' GLU . . . -68.51 -50.93 48.46 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.593 -0.692 . . . . 0.0 109.688 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.541 ' CG ' ' O ' ' A' ' 40' ' ' MET . 0.0 OUTLIER -59.14 -41.24 87.83 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.193 -1.003 . . . . 0.0 109.768 -179.597 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.448 ' SG ' ' OG ' ' A' ' 19' ' ' SER . 8.8 m -65.03 -36.09 83.25 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.89 -1.132 . . . . 0.0 110.579 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 19.1 m -69.75 -32.02 70.31 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.737 -1.227 . . . . 0.0 108.937 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.86 -32.64 67.7 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.493 ' HG3' ' O ' ' A' ' 43' ' ' ARG . 0.1 OUTLIER -77.43 -29.14 52.79 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.703 -0.623 . . . . 0.0 109.638 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.095 HD11 HG12 ' A' ' 98' ' ' VAL . 0.6 OUTLIER -75.0 -38.42 61.61 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.115 -0.991 . . . . 0.0 108.544 179.59 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.425 ' O ' ' C ' ' A' ' 50' ' ' ALA . 2.9 tt0 -69.16 -53.04 22.13 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.473 ' O ' ' HD3' ' A' ' 52' ' ' PRO . . . -47.54 -52.98 15.74 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 178.21 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.764 HG22 ' HG2' ' A' ' 56' ' ' ARG . 26.8 mm -58.81 106.02 0.64 Allowed Pre-proline 0 C--N 1.304 -1.393 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 177.065 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 50' ' ' ALA . 28.0 Cg_endo -63.77 136.25 52.55 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 121.893 1.729 . . . . 0.0 111.528 -176.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.626 ' HB1' ' N ' ' A' ' 108' ' ' ILE . . . -33.84 -36.15 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.792 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.71 ' CZ ' HD11 ' A' ' 108' ' ' ILE . 2.2 m-85 -67.63 117.14 9.16 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.01 -1.056 . . . . 0.0 108.794 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.474 ' CB ' ' O ' ' A' ' 54' ' ' TYR . 9.7 m 76.24 -2.46 2.73 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.461 -0.775 . . . . 0.0 109.784 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.764 ' HG2' HG22 ' A' ' 51' ' ' ILE . 0.4 OUTLIER -40.01 -87.44 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.199 -0.938 . . . . 0.0 109.188 -179.81 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.538 ' O ' ' C ' ' A' ' 58' ' ' GLU . 22.2 m -31.93 -58.34 0.29 Allowed 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.625 -0.672 . . . . 0.0 111.443 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.538 ' C ' ' O ' ' A' ' 57' ' ' CYS . 2.6 mm-40 -25.89 -53.5 0.05 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.55 -0.719 . . . . 0.0 111.249 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.807 ' HB1' ' HB2' ' A' ' 16' ' ' PRO . . . -37.81 -61.23 0.65 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.445 -0.785 . . . . 0.0 110.256 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.842 HG21 HD13 ' A' ' 97' ' ' LEU . 27.8 t -42.55 -51.35 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 CA-C-O 121.861 0.839 . . . . 0.0 108.904 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.485 ' O ' ' N ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -54.18 -63.66 1.08 Allowed 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.262 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.917 HD12 ' HB ' ' A' ' 67' ' ' VAL . 4.6 mm -40.06 -27.25 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.23 -0.919 . . . . 0.0 110.294 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.819 HD13 ' O ' ' A' ' 63' ' ' LEU . 0.9 OUTLIER -77.59 -46.77 21.17 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 120.704 -1.248 . . . . 0.0 109.202 -179.973 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.489 ' SD ' ' NE ' ' A' ' 91' ' ' ARG . 0.1 OUTLIER -73.62 -53.65 9.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.23 -0.919 . . . . 0.0 110.152 -179.83 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -80.2 -21.43 42.95 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.82 -1.175 . . . . 0.0 110.315 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.474 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . 84.51 151.2 12.86 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -179.066 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.917 ' HB ' HD12 ' A' ' 62' ' ' ILE . 7.3 p -116.64 159.39 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.414 -1.051 . . . . 0.0 109.409 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.544 ' N ' HG22 ' A' ' 67' ' ' VAL . 12.8 t -114.52 157.96 15.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-O 121.642 0.735 . . . . 0.0 109.185 -179.316 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.438 ' N ' ' CG1' ' A' ' 68' ' ' VAL . 27.5 p -116.83 158.94 23.12 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 121.615 0.722 . . . . 0.0 109.65 -178.174 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 32.1 t -62.25 -31.11 71.63 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.495 0.664 . . . . 0.0 110.13 -178.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.2 p -69.84 -14.01 62.54 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.499 -0.751 . . . . 0.0 109.6 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.3 9.24 48.29 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 108.881 -1.688 . . . . 0.0 108.881 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -91.84 157.25 16.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.088 -1.242 . . . . 0.0 109.877 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.527 ' CD2' HG22 ' A' ' 68' ' ' VAL . 10.1 m170 -115.83 156.32 26.31 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.022 -1.048 . . . . 0.0 108.739 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.406 ' HG2' ' C ' ' A' ' 74' ' ' HIS . 57.1 mm-40 -145.47 178.95 7.74 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.308 -0.87 . . . . 0.0 110.262 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 58.44 -147.13 39.8 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 2.9 ttp85 60.0 18.74 7.88 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.44 -1.035 . . . . 0.0 110.572 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.474 ' O ' ' NH2' ' A' ' 21' ' ' ARG . 1.8 mp -79.87 -19.53 48.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.837 -1.164 . . . . 0.0 109.812 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.699 HD21 ' HG2' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -64.46 89.26 0.06 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.972 -1.08 . . . . 0.0 108.691 179.484 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.42 ' O ' ' C ' ' A' ' 81' ' ' ASP . 34.4 mt-30 -136.39 178.32 7.16 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.295 -0.878 . . . . 0.0 110.201 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 80' ' ' GLN . 49.4 m-20 -39.33 129.35 1.79 Allowed 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.995 0.902 . . . . 0.0 110.93 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.609 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 22.0 mt -126.03 168.79 13.07 Favored Pre-proline 0 C--N 1.302 -1.484 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 178.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.609 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 27.4 Cg_endo -66.12 99.38 0.41 Allowed 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 121.008 1.138 . . . . 0.0 110.794 -179.236 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.498 ' C ' ' SG ' ' A' ' 29' ' ' CYS . . . 89.71 -7.97 80.76 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.456 ' SG ' ' OG1' ' A' ' 28' ' ' THR . 7.7 m -120.61 89.39 44.59 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 120.569 -1.547 . . . . 0.0 110.311 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.41 ' C ' ' N ' ' A' ' 88' ' ' GLN . 30.7 Cg_endo -76.44 159.01 36.4 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 C-N-CA 121.827 1.684 . . . . 0.0 111.197 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' A' ' 86' ' ' PRO . 4.3 mmt85 -44.63 -28.57 0.62 Allowed 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.41 ' N ' ' C ' ' A' ' 86' ' ' PRO . 4.5 tt0 -57.31 -60.5 3.54 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.668 -178.235 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 87.9 t -61.0 -42.59 93.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 O-C-N 120.793 -1.192 . . . . 0.0 110.364 -178.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.749 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -60.62 -27.53 67.83 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.182 -1.007 . . . . 0.0 108.514 179.841 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.509 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 0.0 OUTLIER -78.05 -31.16 50.17 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.43 -0.794 . . . . 0.0 109.712 179.511 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.506 ' O ' ' HD2' ' A' ' 95' ' ' PRO . . . -71.08 -50.34 34.85 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.064 -1.023 . . . . 0.0 109.522 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.558 ' CE1' HG22 ' A' ' 24' ' ' VAL . 10.4 t80 -77.67 -25.72 49.76 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.424 -0.798 . . . . 0.0 109.915 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.79 ' HB3' ' HD3' ' A' ' 95' ' ' PRO . . . -41.16 -52.46 7.22 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.308 -0.87 . . . . 0.0 111.885 -179.187 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.79 ' HD3' ' HB3' ' A' ' 94' ' ' ALA . 29.6 Cg_endo -70.09 97.64 0.68 Allowed 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.227 1.951 . . . . 0.0 111.47 -178.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.507 ' CB ' ' O ' ' A' ' 95' ' ' PRO . 2.1 mttt 159.55 65.35 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.842 HD13 HG21 ' A' ' 60' ' ' VAL . 1.3 mt -109.91 -89.21 0.49 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.3 -0.875 . . . . 0.0 111.589 -178.108 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 1.095 HG12 HD11 ' A' ' 48' ' ' LEU . 3.3 m -78.74 34.88 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 120.661 -1.275 . . . . 0.0 111.735 -178.206 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 12.9 p -106.83 173.32 6.37 Favored 'General case' 0 C--N 1.293 -1.882 0 O-C-N 120.706 -1.246 . . . . 0.0 108.463 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.737 ' HA ' HD21 ' A' ' 104' ' ' ASN . 15.3 mt-10 -60.59 1.74 0.13 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.746 -1.222 . . . . 0.0 111.874 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.7 t -99.13 0.82 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 119.888 -1.757 . . . . 0.0 110.829 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.521 ' HB3' ' O ' ' A' ' 97' ' ' LEU . 7.1 tp10 -149.93 -98.17 0.07 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.568 -1.333 . . . . 0.0 111.347 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.541 ' O ' HD22 ' A' ' 48' ' ' LEU . 78.4 m -117.39 43.65 2.3 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.93 -1.106 . . . . 0.0 109.794 -178.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.737 HD21 ' HA ' ' A' ' 100' ' ' GLU . 1.4 p30 -31.99 -92.17 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.308 -0.87 . . . . 0.0 111.806 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.728 ' O ' ' HB3' ' A' ' 106' ' ' ALA . 1.3 mt 66.95 -1.76 1.31 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.005 -1.06 . . . . 0.0 111.822 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.728 ' HB3' ' O ' ' A' ' 105' ' ' LEU . . . 81.08 143.45 0.08 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.684 -1.26 . . . . 0.0 110.028 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.667 HG21 HG21 ' A' ' 98' ' ' VAL . 3.0 p -114.27 -162.09 0.8 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.29 -0.881 . . . . 0.0 108.723 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.71 HD11 ' CZ ' ' A' ' 54' ' ' TYR . 19.3 tt -62.09 -22.65 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.902 -1.124 . . . . 0.0 108.753 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.451 ' HB3' ' CE1' ' A' ' 113' ' ' PHE . 77.0 m80 -80.47 14.74 1.89 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.733 -0.604 . . . . 0.0 110.486 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 109' ' ' HIS . . . 44.15 25.61 0.75 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 109' ' ' HIS . . . -150.45 169.74 30.37 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.488 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 35.1 Cg_endo -78.96 72.87 6.28 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.876 2.384 . . . . 0.0 110.989 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.488 ' HB3' ' O ' ' A' ' 112' ' ' PRO . 17.7 p90 171.77 160.99 0.1 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.37 -0.831 . . . . 0.0 109.529 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.54 ' O ' ' CB ' ' A' ' 115' ' ' LEU . 16.5 p -155.73 -155.09 0.53 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.029 -1.044 . . . . 0.0 110.021 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.54 ' CB ' ' O ' ' A' ' 114' ' ' CYS . 0.1 OUTLIER 81.58 -152.23 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.684 -0.635 . . . . 0.0 109.447 -179.685 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 115' ' ' LEU . 2.5 p -42.47 -85.52 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.213 -0.929 . . . . 0.0 109.929 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.468 ' HG ' ' CE1' ' A' ' 113' ' ' PHE . 0.3 OUTLIER 53.08 -157.04 0.16 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.226 -0.921 . . . . 0.0 109.368 -179.776 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.64 -13.2 0.61 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.829 -1.17 . . . . 0.0 112.082 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -89.57 34.13 4.13 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -172.92 78.68 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.228 -1.16 . . . . 0.0 109.573 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.09 -6.79 65.31 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.234 -1.156 . . . . 0.0 109.507 179.942 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 79.1 p . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.3 m -119.56 -111.35 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.408 ' O ' HG22 ' A' ' 4' ' ' THR . . . 94.73 -87.07 1.06 Allowed Glycine 0 N--CA 1.498 2.818 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.408 HG22 ' O ' ' A' ' 3' ' ' GLY . 8.8 t 41.44 46.8 3.03 Favored 'General case' 0 N--CA 1.51 2.539 0 CA-C-O 121.355 0.598 . . . . 0.0 111.362 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 60.6 p -120.99 -160.03 0.83 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.721 -0.612 . . . . 0.0 109.464 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 64.4 m 61.58 -160.96 0.3 Allowed 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.456 ' CG2' ' HD2' ' A' ' 8' ' ' PRO . 34.0 mt 71.76 139.79 0.07 OUTLIER Pre-proline 0 N--CA 1.506 2.355 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 -178.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.456 ' HD2' ' CG2' ' A' ' 7' ' ' ILE . 30.6 Cg_endo -71.67 165.81 31.37 Favored 'Trans proline' 0 N--CA 1.479 0.647 0 C-N-CA 121.661 1.574 . . . . 0.0 111.103 -178.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 62.84 16.32 56.48 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 -179.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.573 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 16.6 mmm -140.91 84.62 1.94 Allowed 'General case' 0 N--CA 1.5 2.051 0 CA-C-N 117.749 0.774 . . . . 0.0 108.99 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 86.82 -57.65 0.05 OUTLIER 'General case' 0 N--CA 1.515 2.824 0 O-C-N 121.368 -0.833 . . . . 0.0 108.908 -178.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.717 HD11 ' HB2' ' A' ' 55' ' ' CYS . 61.2 mt -92.21 104.5 11.04 Favored Pre-proline 0 N--CA 1.498 1.935 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -75.21 169.6 22.18 Favored 'Trans proline' 0 C--O 1.22 -0.406 0 C-N-CA 121.348 1.365 . . . . 0.0 111.547 -175.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 47.1 m80 -69.33 144.5 53.48 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.491 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 5.3 t-20 66.08 56.01 1.03 Allowed Pre-proline 0 N--CA 1.505 2.307 0 O-C-N 121.392 -0.817 . . . . 0.0 110.282 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.491 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 39.0 Cg_endo -80.54 166.86 19.54 Favored 'Trans proline' 0 N--CA 1.483 0.908 0 C-N-CA 122.317 2.011 . . . . 0.0 111.907 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.5 mp 42.92 43.81 3.69 Favored 'General case' 0 N--CA 1.504 2.238 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.192 177.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -69.07 -37.75 78.67 Favored 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.96 -26.13 68.69 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 56.9 m -74.61 -38.68 62.51 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.585 HH22 HD23 ' A' ' 78' ' ' LEU . 3.3 ttt180 -64.31 -48.88 73.96 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 33.5 m95 -68.74 -29.31 67.69 Favored 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 119.413 -0.915 . . . . 0.0 109.686 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.44 ' CD1' ' HB3' ' A' ' 40' ' ' MET . 57.7 t80 -66.38 -33.65 76.19 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.428 HG22 ' CD2' ' A' ' 93' ' ' PHE . 92.9 t -72.25 -38.97 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 177.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 m -56.27 -37.03 69.26 Favored 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 119.951 -0.7 . . . . 0.0 109.442 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 89.7 m -77.64 -50.09 13.2 Favored 'General case' 0 N--CA 1.506 2.347 0 N-CA-C 112.208 0.448 . . . . 0.0 112.208 -178.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.77 -25.31 67.87 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.512 -0.742 . . . . 0.0 110.622 -178.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.425 HG23 ' O ' ' A' ' 24' ' ' VAL . 70.7 p -93.35 -63.38 1.22 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -177.27 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.65 ' O ' HG23 ' A' ' 31' ' ' VAL . 3.6 m -100.32 9.29 42.91 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.438 -0.789 . . . . 0.0 111.636 -178.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 57.78 30.05 62.37 Favored Glycine 0 N--CA 1.507 3.37 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 29' ' ' CYS . 37.9 t -121.24 164.09 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 122.192 -0.593 . . . . 0.0 109.672 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.496 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 136.19 177.82 15.29 Favored Glycine 0 N--CA 1.499 2.895 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -64.37 177.31 2.17 Favored 'Trans proline' 0 N--CA 1.489 1.254 0 CA-C-N 119.253 1.526 . . . . 0.0 110.047 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.28 87.25 5.99 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 122.17 0.986 . . . . 0.0 110.338 -177.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.5 mt -141.85 127.37 18.95 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 178.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.19 152.44 2.37 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.979 -0.45 . . . . 0.0 109.825 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.1 p -60.0 -59.66 5.07 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.789 -0.569 . . . . 0.0 110.655 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -52.56 -28.75 22.22 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.878 -0.514 . . . . 0.0 111.571 -178.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -71.97 -46.94 55.56 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.816 -0.553 . . . . 0.0 109.608 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.44 ' HB3' ' CD1' ' A' ' 23' ' ' TYR . 5.6 tpt -61.97 -54.57 39.84 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -53.61 -35.7 61.19 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.45 -42.81 99.74 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.3 -41.12 96.45 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 19.7 m -65.48 -33.22 75.43 Favored 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.244 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 18.6 m -73.47 -30.16 62.99 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.35 -32.38 62.76 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -77.02 -33.69 57.41 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.782 HD22 ' O ' ' A' ' 103' ' ' CYS . 0.6 OUTLIER -73.46 -33.53 64.91 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.49 -40.4 61.86 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.28 -39.13 85.77 Favored 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.49 HG23 HG12 ' A' ' 12' ' ' ILE . 71.7 mt -82.54 105.57 5.09 Favored Pre-proline 0 N--CA 1.493 1.684 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 177.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -58.2 139.87 92.14 Favored 'Trans proline' 0 N--CA 1.48 0.705 0 C-N-CA 121.52 1.48 . . . . 0.0 110.877 -177.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.698 ' HB2' ' NH1' ' A' ' 56' ' ' ARG . . . -39.48 -29.79 0.06 Allowed 'General case' 0 N--CA 1.507 2.387 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.356 -178.136 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -53.15 -70.47 0.09 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.922 -0.486 . . . . 0.0 110.623 -179.132 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.717 ' HB2' HD11 ' A' ' 12' ' ' ILE . 5.1 m -88.59 8.81 26.46 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.974 -0.454 . . . . 0.0 110.884 -179.115 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.698 ' NH1' ' HB2' ' A' ' 53' ' ' ALA . 5.9 mtt180 -47.6 -85.35 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.666 0 O-C-N 121.445 -0.784 . . . . 0.0 110.282 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 73.3 m -32.79 -48.88 0.21 Allowed 'General case' 0 N--CA 1.521 3.083 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -41.74 -54.32 3.36 Favored 'General case' 0 N--CA 1.512 2.671 0 CA-C-N 119.319 0.963 . . . . 0.0 111.755 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -41.87 -44.63 3.43 Favored 'General case' 0 N--CA 1.513 2.706 0 O-C-N 121.787 -0.57 . . . . 0.0 112.065 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.7 t -57.17 -48.9 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.4 mtt180 -58.56 -26.74 63.89 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.959 HG23 ' HB ' ' A' ' 67' ' ' VAL . 34.5 mm -78.52 -30.74 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 O-C-N 121.945 -0.472 . . . . 0.0 110.362 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.489 HD12 ' HA ' ' A' ' 63' ' ' LEU . 14.9 tp -77.87 -43.37 30.43 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 120.079 -0.649 . . . . 0.0 109.79 -179.119 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.79 -50.84 10.64 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.232 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -80.55 -22.74 40.52 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 122.087 -0.383 . . . . 0.0 110.88 -178.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.68 146.91 5.67 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.959 ' HB ' HG23 ' A' ' 62' ' ' ILE . 5.6 p -118.43 161.08 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.668 HG22 ' NE2' ' A' ' 74' ' ' HIS . 56.0 t -113.27 157.89 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 42.1 p -116.84 160.13 21.32 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.987 0.899 . . . . 0.0 110.969 -176.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 32.8 t -64.54 -17.53 64.01 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.431 -178.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.1 p -86.48 -14.61 42.64 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 122.05 -0.406 . . . . 0.0 110.034 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.25 13.53 33.09 Favored Glycine 0 N--CA 1.5 2.902 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -105.43 158.62 16.53 Favored 'General case' 0 N--CA 1.501 2.114 0 CA-C-N 118.142 0.971 . . . . 0.0 108.859 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.668 ' NE2' HG22 ' A' ' 68' ' ' VAL . 11.3 m170 -113.79 154.93 26.58 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -179.082 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -136.8 -179.02 5.45 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 55.3 -146.93 28.43 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 -178.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 54.84 22.28 4.13 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 122.253 -0.557 . . . . 0.0 109.988 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.585 HD23 HH22 ' A' ' 21' ' ' ARG . 2.1 mp -82.87 -14.61 53.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.765 -0.584 . . . . 0.0 110.388 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.5 mt -62.11 92.79 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -134.78 -177.02 4.43 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.758 0.79 . . . . 0.0 110.663 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -47.67 131.6 14.42 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.758 0.789 . . . . 0.0 111.544 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.472 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 20.6 mt -129.27 166.85 22.55 Favored Pre-proline 0 N--CA 1.497 1.918 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.158 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.472 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 29.6 Cg_endo -68.6 98.63 0.59 Allowed 'Trans proline' 0 C--N 1.327 -0.553 0 C-N-CA 120.936 1.091 . . . . 0.0 110.243 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.41 6.94 67.82 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.47 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 3.2 m -138.8 92.51 11.21 Favored Pre-proline 0 N--CA 1.508 2.425 0 CA-C-N 118.974 1.387 . . . . 0.0 110.062 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -74.79 165.45 31.45 Favored 'Trans proline' 0 N--CA 1.487 1.109 0 C-N-CA 121.924 1.749 . . . . 0.0 111.225 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 24.0 mtp180 -53.89 -25.96 22.66 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.042 0.448 . . . . 0.0 110.225 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.23 -45.86 89.65 Favored 'General case' 0 N--CA 1.503 2.213 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.008 -177.156 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 42.0 t -72.38 -43.37 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.596 -0.69 . . . . 0.0 111.023 -177.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.616 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 2.1 pt20 -70.37 -27.02 64.0 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.414 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 8.8 ttt180 -78.76 -29.26 45.0 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.44 -47.09 20.61 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.945 -0.472 . . . . 0.0 110.28 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.428 ' CD2' HG22 ' A' ' 24' ' ' VAL . 90.3 t80 -79.03 -27.56 43.21 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 122.088 -0.383 . . . . 0.0 111.463 -178.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.616 ' HB2' ' O ' ' A' ' 90' ' ' GLN . . . -55.09 -46.45 99.67 Favored Pre-proline 0 N--CA 1.504 2.259 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -177.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 94' ' ' ALA . 30.2 Cg_endo -70.06 -0.26 6.9 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 122.209 1.939 . . . . 0.0 114.017 -177.189 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.79 24.12 12.05 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.492 -0.755 . . . . 0.0 109.8 179.008 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.99 -24.22 59.57 Favored 'General case' 0 N--CA 1.51 2.526 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -178.146 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 33.7 m -93.4 25.63 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.322 0 CA-C-N 120.958 1.708 . . . . 0.0 111.182 -178.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.406 ' C ' ' HB2' ' A' ' 104' ' ' ASN . 19.0 p -98.24 173.1 7.17 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -61.94 -1.52 0.68 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.656 -0.652 . . . . 0.0 112.25 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.582 ' O ' HG12 ' A' ' 101' ' ' VAL . 36.3 t -100.04 4.4 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 CA-C-N 120.443 1.474 . . . . 0.0 110.96 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -141.07 -89.95 0.16 Allowed 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.38 -0.825 . . . . 0.0 111.488 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.782 ' O ' HD22 ' A' ' 48' ' ' LEU . 19.8 m -143.62 43.0 1.49 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.502 -0.749 . . . . 0.0 109.927 -178.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.409 ' ND2' ' HB3' ' A' ' 112' ' ' PRO . 56.9 t-20 -42.97 -64.9 0.55 Allowed 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.224 -0.923 . . . . 0.0 112.329 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.429 ' O ' ' HB3' ' A' ' 106' ' ' ALA . 6.1 mt 45.33 29.34 0.55 Allowed 'General case' 0 N--CA 1.51 2.569 0 CA-C-O 121.073 0.463 . . . . 0.0 109.995 -178.506 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 105' ' ' LEU . . . 67.04 157.93 0.12 Allowed 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -178.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.8 p -128.82 -163.93 1.34 Allowed 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 18.1 tt -68.14 -33.15 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 177.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.447 ' HB3' ' CE2' ' A' ' 113' ' ' PHE . 56.0 m80 -66.67 -4.9 9.89 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.729 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 61.55 41.39 99.55 Favored Glycine 0 N--CA 1.499 2.863 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -174.87 170.95 44.15 Favored Glycine 0 N--CA 1.501 3.024 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.409 ' HB3' ' ND2' ' A' ' 104' ' ' ASN . 32.3 Cg_endo -77.86 75.84 4.6 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.54 2.16 . . . . 0.0 111.376 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.447 ' CE2' ' HB3' ' A' ' 109' ' ' HIS . 36.8 p90 178.67 156.32 0.45 Allowed 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.65 -0.656 . . . . 0.0 110.468 178.362 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 4.7 t 178.62 158.55 0.52 Allowed 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 55.83 22.18 5.38 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.69 -0.631 . . . . 0.0 109.879 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.74 -69.5 0.07 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.83 -0.544 . . . . 0.0 109.654 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.515 ' O ' ' HB2' ' A' ' 118' ' ' LEU . 0.4 OUTLIER 59.88 29.74 19.3 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -179.764 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.515 ' HB2' ' O ' ' A' ' 117' ' ' LEU . 20.6 mt 76.38 -18.69 0.46 Allowed 'General case' 0 N--CA 1.508 2.467 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 130.61 176.88 14.6 Favored Glycine 0 N--CA 1.5 2.91 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -97.9 43.98 1.05 Allowed 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 121.722 0.772 . . . . 0.0 109.413 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -94.3 25.29 23.19 Favored Glycine 0 N--CA 1.498 2.77 0 N-CA-C 109.886 -1.285 . . . . 0.0 109.886 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 . . . . . 0 N--CA 1.499 1.977 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.463 179.889 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 7.4 t . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.65 HG13 ' H ' ' A' ' 3' ' ' GLY . 1.9 p -44.21 -56.3 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.197 -0.939 . . . . 0.0 109.759 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.65 ' H ' HG13 ' A' ' 2' ' ' VAL . . . 102.33 149.76 22.27 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.3 t -150.62 58.65 0.94 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.262 -1.14 . . . . 0.0 109.47 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.458 ' O ' ' O ' ' A' ' 6' ' ' CYS . 0.4 OUTLIER -89.69 65.44 6.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.258 -0.901 . . . . 0.0 109.65 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.458 ' O ' ' O ' ' A' ' 5' ' ' SER . 65.3 m 60.71 139.18 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.294 -0.879 . . . . 0.0 109.774 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.876 HD13 ' H ' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -133.96 160.92 66.69 Favored Pre-proline 0 N--CA 1.491 1.602 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.363 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.524 ' HD2' ' HB ' ' A' ' 7' ' ' ILE . 34.5 Cg_endo -77.25 166.11 26.79 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.309 2.006 . . . . 0.0 110.67 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 62.46 10.85 31.61 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.727 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 2.2 mtt -140.61 95.11 2.81 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.164 -1.198 . . . . 0.0 109.317 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.727 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 86.14 -60.58 0.06 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.925 -1.11 . . . . 0.0 108.314 -179.158 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.484 HG13 HD12 ' A' ' 51' ' ' ILE . 1.8 mp -96.83 103.31 14.32 Favored Pre-proline 0 N--CA 1.489 1.483 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.494 ' HD3' ' O ' ' A' ' 11' ' ' ALA . 31.6 Cg_endo -79.64 166.97 21.28 Favored 'Trans proline' 0 C--N 1.32 -0.959 0 C-N-CA 121.277 1.318 . . . . 0.0 112.163 -176.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -68.65 149.0 49.62 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.496 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 0.5 OUTLIER 60.77 63.95 2.51 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 120.607 -1.308 . . . . 0.0 109.62 -179.857 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.496 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 37.2 Cg_endo -80.41 161.08 22.66 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.794 2.329 . . . . 0.0 111.372 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.449 ' CD1' ' N ' ' A' ' 17' ' ' LEU . 4.2 mp 42.07 45.61 3.45 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.526 -0.734 . . . . 0.0 110.858 178.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -76.91 -40.87 45.78 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.078 -1.014 . . . . 0.0 109.177 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.481 ' O ' ' HE3' ' A' ' 40' ' ' MET . 1.2 t -63.37 -25.96 68.53 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 58.1 m -72.26 -39.21 68.57 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.563 ' CG ' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -59.3 -53.48 57.78 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.472 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.563 ' N ' ' CG ' ' A' ' 21' ' ' ARG . 25.9 m95 -68.11 -29.48 68.41 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 118.984 -1.086 . . . . 0.0 110.429 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.459 ' HE1' HG23 ' A' ' 37' ' ' THR . 4.2 t80 -64.06 -30.62 71.68 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 120.998 -1.064 . . . . 0.0 108.346 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 1.102 HG22 ' CD2' ' A' ' 93' ' ' PHE . 74.6 t -74.93 -44.56 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 178.147 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.503 ' HB3' HD13 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -52.65 -41.36 63.72 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.522 -0.871 . . . . 0.0 109.633 -179.679 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.514 ' HG1' ' HA3' ' A' ' 32' ' ' GLY . 2.6 m -77.77 -56.68 4.31 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.212 -0.93 . . . . 0.0 111.689 -178.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.1 tpt85 -57.77 -24.76 58.67 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.755 -1.216 . . . . 0.0 111.0 -178.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.469 ' OG1' ' O ' ' A' ' 24' ' ' VAL . 78.3 p -97.15 -63.06 1.17 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.949 -1.094 . . . . 0.0 111.191 -178.205 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.565 ' O ' HG23 ' A' ' 31' ' ' VAL . 90.6 m -99.24 18.47 17.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.965 -1.084 . . . . 0.0 110.299 -178.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' A' ' 26' ' ' THR . . . 52.76 19.41 6.69 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 29' ' ' CYS . 76.0 t -107.55 149.23 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.207 -1.173 . . . . 0.0 108.782 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.514 ' HA3' ' HG1' ' A' ' 26' ' ' THR . . . 141.96 177.34 16.99 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.449 -1.86 . . . . 0.0 108.449 -179.141 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -66.32 172.38 9.03 Favored 'Trans proline' 0 N--CA 1.479 0.654 0 CA-C-N 118.99 1.395 . . . . 0.0 109.988 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.23 64.43 4.47 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.876 -1.14 . . . . 0.0 110.074 -178.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.679 HD11 ' NE ' ' A' ' 43' ' ' ARG . 6.6 tt -106.33 120.41 41.8 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.509 ' N ' HD23 ' A' ' 35' ' ' LEU . . . -41.56 135.32 2.15 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.345 -0.847 . . . . 0.0 109.363 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.459 HG23 ' HE1' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -52.19 -54.54 29.63 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.785 -1.197 . . . . 0.0 111.564 -178.738 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -51.93 -43.0 63.25 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.817 -1.177 . . . . 0.0 110.249 -178.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.579 ' CB ' HD21 ' A' ' 35' ' ' LEU . 27.4 mm-40 -67.12 -29.36 69.07 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.28 -0.888 . . . . 0.0 109.604 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.503 ' SD ' HD13 ' A' ' 35' ' ' LEU . 8.5 tpt -69.23 -60.78 2.11 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.123 -0.986 . . . . 0.0 108.361 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.54 -39.11 48.12 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.81 -41.42 97.74 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.347 -0.846 . . . . 0.0 109.154 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.679 ' NE ' HD11 ' A' ' 35' ' ' LEU . 21.3 mtt85 -60.08 -47.22 86.8 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.349 -0.845 . . . . 0.0 109.192 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 15.3 m -61.26 -37.05 81.72 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.19 -0.944 . . . . 0.0 110.577 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 96.9 m -71.14 -28.59 64.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.811 -1.18 . . . . 0.0 109.141 -179.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.1 tpp180 -74.35 -31.35 62.39 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.462 ' O ' HG12 ' A' ' 51' ' ' ILE . 0.7 OUTLIER -77.09 -37.13 55.02 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.952 -0.699 . . . . 0.0 109.389 179.951 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.94 HD11 HG12 ' A' ' 98' ' ' VAL . 6.2 tt -70.8 -36.57 73.06 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.297 -0.877 . . . . 0.0 108.666 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.446 ' O ' ' C ' ' A' ' 50' ' ' ALA . 13.3 tp10 -67.27 -51.4 53.35 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.514 ' O ' ' HD3' ' A' ' 52' ' ' PRO . . . -47.89 -49.68 28.97 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 178.098 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.484 HD12 HG13 ' A' ' 12' ' ' ILE . 33.7 mm -62.04 106.09 0.76 Allowed Pre-proline 0 C--N 1.304 -1.411 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 176.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.523 ' O ' ' N ' ' A' ' 54' ' ' TYR . 26.6 Cg_endo -63.95 141.4 77.36 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 121.631 1.554 . . . . 0.0 110.81 -177.104 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.535 ' HB2' ' NH2' ' A' ' 56' ' ' ARG . . . -37.15 -28.67 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.908 -0.495 . . . . 0.0 110.079 -178.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.523 ' N ' ' O ' ' A' ' 52' ' ' PRO . 0.3 OUTLIER -65.41 119.85 11.75 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.095 -1.003 . . . . 0.0 108.578 178.998 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.523 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 63.6 m 64.91 8.98 5.0 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.355 -0.841 . . . . 0.0 110.256 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.535 ' NH2' ' HB2' ' A' ' 53' ' ' ALA . 8.6 mtt180 -42.42 -87.78 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.705 -1.247 . . . . 0.0 109.471 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.501 ' O ' ' C ' ' A' ' 58' ' ' GLU . 20.9 m -28.38 -50.71 0.08 Allowed 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.512 ' HB2' ' O ' ' A' ' 55' ' ' CYS . 0.1 OUTLIER -32.22 -51.23 0.25 Allowed 'General case' 0 N--CA 1.502 2.159 0 O-C-N 120.82 -1.175 . . . . 0.0 111.432 -178.74 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.479 ' C ' ' O ' ' A' ' 58' ' ' GLU . . . -36.5 -55.39 0.84 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.313 -0.867 . . . . 0.0 110.268 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.0 t -53.18 -49.89 49.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.474 -0.766 . . . . 0.0 109.252 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.482 ' O ' ' HB2' ' A' ' 65' ' ' ASP . 2.0 ttp180 -55.34 -29.35 58.19 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.294 -0.879 . . . . 0.0 109.508 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.744 HG23 ' HB ' ' A' ' 67' ' ' VAL . 30.2 mt -77.79 -28.53 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.331 -0.856 . . . . 0.0 109.938 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.527 ' O ' ' HA ' ' A' ' 77' ' ' ARG . 26.4 tp -77.56 -44.5 28.32 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.842 -1.161 . . . . 0.0 109.486 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 30.1 ttp -78.14 -50.69 11.5 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.869 -1.144 . . . . 0.0 109.72 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.482 ' HB2' ' O ' ' A' ' 61' ' ' ARG . 15.7 m-20 -80.37 -21.26 42.54 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.017 -1.052 . . . . 0.0 110.394 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.435 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . 86.65 152.28 21.11 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.744 ' HB ' HG23 ' A' ' 62' ' ' ILE . 1.4 p -117.02 159.97 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.539 -0.977 . . . . 0.0 109.248 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.998 HG22 ' CE1' ' A' ' 74' ' ' HIS . 12.9 t -113.58 158.16 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-O 121.87 0.843 . . . . 0.0 109.384 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.468 ' N ' ' CG1' ' A' ' 68' ' ' VAL . 69.8 p -117.57 158.76 24.04 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.683 0.754 . . . . 0.0 110.088 -178.008 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.1 t -65.0 -25.6 67.93 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.571 0.7 . . . . 0.0 109.791 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.1 p -71.13 -15.09 62.48 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.638 -0.664 . . . . 0.0 109.388 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 99.51 10.55 47.2 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.607 -1.797 . . . . 0.0 108.607 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -103.17 157.0 17.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.269 -1.136 . . . . 0.0 109.621 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.998 ' CE1' HG22 ' A' ' 68' ' ' VAL . 1.7 m80 -115.07 155.93 26.11 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.064 -1.022 . . . . 0.0 108.821 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -142.67 -174.87 4.27 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.271 -0.893 . . . . 0.0 110.465 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 60.62 -139.47 48.11 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.527 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER 52.39 33.19 12.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.215 -1.168 . . . . 0.0 109.368 -179.884 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.479 ' O ' ' N ' ' A' ' 80' ' ' GLN . 1.3 mt -79.06 -22.23 45.64 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.976 -1.078 . . . . 0.0 109.996 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.423 ' C ' ' O ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -45.85 98.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.798 -1.189 . . . . 0.0 108.855 179.513 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.479 ' N ' ' O ' ' A' ' 78' ' ' LEU . 40.1 mt-30 -145.12 174.21 11.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.124 -0.985 . . . . 0.0 110.428 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -56.78 140.75 46.76 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 122.045 0.926 . . . . 0.0 110.701 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.663 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 17.9 mt -133.06 171.17 9.63 Favored Pre-proline 0 C--N 1.301 -1.531 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 179.133 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.663 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 27.5 Cg_endo -65.91 98.88 0.38 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 120.856 1.038 . . . . 0.0 110.591 -179.201 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.492 ' C ' ' SG ' ' A' ' 29' ' ' CYS . . . 88.3 -6.73 83.21 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.464 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 9.7 m -119.86 88.42 40.08 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 120.684 -1.48 . . . . 0.0 110.015 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 87' ' ' ARG . 30.5 Cg_endo -75.75 161.32 36.72 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 C-N-CA 122.085 1.857 . . . . 0.0 111.713 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.433 ' C ' ' O ' ' A' ' 86' ' ' PRO . 13.3 mtm-85 -43.57 -27.51 0.3 Allowed 'General case' 0 N--CA 1.482 1.136 0 CA-C-O 121.773 0.797 . . . . 0.0 108.913 178.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' A' ' 86' ' ' PRO . 32.9 tt0 -59.2 -59.84 4.81 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.753 -0.592 . . . . 0.0 111.317 -178.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 45.0 t -65.75 -40.7 88.52 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 O-C-N 120.871 -1.143 . . . . 0.0 110.531 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.909 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -63.83 -28.07 69.6 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.249 -0.98 . . . . 0.0 108.574 179.843 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.407 ' HB2' ' O ' ' A' ' 87' ' ' ARG . 0.1 OUTLIER -78.09 -29.39 49.01 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.542 -0.723 . . . . 0.0 109.592 179.556 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.479 ' O ' ' HD2' ' A' ' 95' ' ' PRO . . . -74.58 -53.52 9.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -0.909 . . . . 0.0 109.965 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 1.102 ' CD2' HG22 ' A' ' 24' ' ' VAL . 6.0 t80 -78.25 -26.6 47.32 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.042 -1.036 . . . . 0.0 110.365 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.909 ' HB2' ' O ' ' A' ' 90' ' ' GLN . . . -40.91 -52.64 6.61 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.125 -0.985 . . . . 0.0 111.34 -178.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.827 ' HD3' ' HB3' ' A' ' 94' ' ' ALA . 31.4 Cg_endo -72.27 -164.71 0.18 Allowed 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.143 1.895 . . . . 0.0 111.04 -178.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 95' ' ' PRO . 13.6 mmtm 63.73 30.41 14.71 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -178.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.507 ' HA ' HD22 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -73.77 -71.19 0.34 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.656 -0.653 . . . . 0.0 110.86 -179.157 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.94 HG12 HD11 ' A' ' 48' ' ' LEU . 2.9 m -77.45 22.9 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.623 -1.298 . . . . 0.0 111.266 -179.306 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.435 ' C ' ' HB3' ' A' ' 104' ' ' ASN . 7.0 p -99.22 172.68 7.21 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 120.513 -1.367 . . . . 0.0 108.898 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.465 ' HA ' ' ND2' ' A' ' 104' ' ' ASN . 40.0 mt-10 -59.63 -0.31 0.17 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.804 -1.185 . . . . 0.0 111.891 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.702 ' O ' HG12 ' A' ' 101' ' ' VAL . 97.8 t -100.28 7.39 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 119.957 -1.714 . . . . 0.0 110.33 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.506 ' HB2' ' O ' ' A' ' 97' ' ' LEU . 2.0 mm-40 -145.75 -92.71 0.09 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.758 -1.214 . . . . 0.0 110.297 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.463 ' O ' ' C ' ' A' ' 104' ' ' ASN . 33.2 m -142.13 37.86 1.58 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.945 -1.097 . . . . 0.0 109.638 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 98' ' ' VAL . 5.1 p30 -35.12 -50.96 0.53 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.244 -0.91 . . . . 0.0 111.513 -179.044 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 106' ' ' ALA . 12.0 mt 42.23 31.61 0.27 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.916 -1.115 . . . . 0.0 110.226 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.468 ' O ' ' O ' ' A' ' 105' ' ' LEU . . . 60.28 121.33 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.857 -1.152 . . . . 0.0 109.521 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.8 p -91.58 -165.72 1.41 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 1.035 HD13 ' O ' ' A' ' 108' ' ' ILE . 0.0 OUTLIER -61.37 -25.77 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 120.931 -1.105 . . . . 0.0 108.49 179.261 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.48 ' HB3' ' CE1' ' A' ' 113' ' ' PHE . 80.4 m80 -76.74 14.0 0.9 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.53 -0.731 . . . . 0.0 110.717 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 50.11 25.06 7.32 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.399 -1.481 . . . . 0.0 109.399 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -156.55 172.08 34.24 Favored Glycine 0 N--CA 1.49 2.246 0 C-N-CA 119.766 -1.207 . . . . 0.0 110.085 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.474 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 33.3 Cg_endo -78.5 74.25 5.5 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 123.001 2.467 . . . . 0.0 111.195 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.48 ' CE1' ' HB3' ' A' ' 109' ' ' HIS . 32.6 p90 171.77 143.53 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.177 -0.952 . . . . 0.0 109.947 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 16.6 p -142.02 151.07 42.11 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.773 -1.204 . . . . 0.0 109.184 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.488 ' O ' ' HB2' ' A' ' 116' ' ' SER . 0.9 OUTLIER 50.88 -174.89 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.944 -1.098 . . . . 0.0 109.625 -179.903 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.488 ' HB2' ' O ' ' A' ' 115' ' ' LEU . 16.1 m 64.12 -103.46 0.11 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.497 -0.752 . . . . 0.0 110.168 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 19.6 mt 55.22 -149.9 0.44 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.022 -1.048 . . . . 0.0 109.061 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.7 mt -50.12 -15.7 0.24 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.014 -1.054 . . . . 0.0 111.738 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -63.46 -85.21 0.06 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -135.0 69.53 1.45 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.238 -1.154 . . . . 0.0 109.415 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -89.58 18.78 44.39 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.246 -1.149 . . . . 0.0 109.551 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.503 ' C ' HG23 ' A' ' 2' ' ' VAL . 79.5 p . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.503 HG23 ' C ' ' A' ' 1' ' ' SER . 5.2 t 85.29 -50.27 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.673 0 C-N-CA 122.907 0.483 . . . . 0.0 109.995 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.423 ' C ' HG22 ' A' ' 4' ' ' THR . . . 81.06 -116.55 4.24 Favored Glycine 0 N--CA 1.496 2.645 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.423 HG22 ' C ' ' A' ' 3' ' ' GLY . 9.8 t 41.43 31.28 0.17 Allowed 'General case' 0 N--CA 1.509 2.502 0 CA-C-O 121.224 0.535 . . . . 0.0 111.042 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -110.49 175.04 5.58 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.948 -0.47 . . . . 0.0 109.795 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 94.9 m -122.43 168.46 12.07 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.569 HG21 ' SD ' ' A' ' 10' ' ' MET . 17.6 mt -87.34 138.23 32.27 Favored Pre-proline 0 N--CA 1.5 2.026 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -81.24 148.73 16.84 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 121.872 1.714 . . . . 0.0 110.298 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 58.1 17.89 32.15 Favored Glycine 0 N--CA 1.499 2.866 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.583 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 84.3 mtp -140.84 108.09 5.51 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-N 117.935 0.868 . . . . 0.0 108.72 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.583 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 86.73 -58.4 0.05 OUTLIER 'General case' 0 N--CA 1.514 2.75 0 CA-C-N 119.75 1.159 . . . . 0.0 108.247 -178.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.843 HD11 ' HB3' ' A' ' 55' ' ' CYS . 44.8 mt -106.41 100.74 31.53 Favored Pre-proline 0 N--CA 1.492 1.648 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 178.238 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -81.01 173.47 11.89 Favored 'Trans proline' 0 N--CA 1.475 0.427 0 C-N-CA 121.471 1.447 . . . . 0.0 111.243 -177.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 57.7 m80 -71.14 144.19 50.31 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.563 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 35.1 t-20 59.78 52.88 3.75 Favored Pre-proline 0 N--CA 1.498 1.972 0 O-C-N 121.725 -0.61 . . . . 0.0 110.05 -178.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.563 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 41.8 Cg_endo -83.05 170.27 12.39 Favored 'Trans proline' 0 N--CA 1.483 0.864 0 C-N-CA 122.043 1.829 . . . . 0.0 111.355 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.668 HD23 ' HB1' ' A' ' 59' ' ' ALA . 4.3 mm? 50.75 38.73 20.24 Favored 'General case' 0 N--CA 1.501 2.093 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.646 177.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -78.17 -43.31 28.98 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.542 -0.724 . . . . 0.0 109.484 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.18 -29.12 70.15 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 17.0 m -73.5 -40.1 64.32 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.569 ' CZ ' HD11 ' A' ' 82' ' ' LEU . 0.6 OUTLIER -61.23 -51.36 69.28 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -179.722 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.42 ' CE3' ' HA ' ' A' ' 22' ' ' TRP . 38.9 m95 -69.83 -28.15 65.46 Favored 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 119.581 -0.848 . . . . 0.0 109.743 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.589 ' HE1' HG22 ' A' ' 37' ' ' THR . 18.4 t80 -67.47 -29.63 69.14 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.547 HG22 ' CE1' ' A' ' 93' ' ' PHE . 98.9 t -75.27 -42.89 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 85.0 p -54.73 -39.02 67.83 Favored 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.939 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 77.0 m -77.45 -48.77 16.32 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 122.296 -0.252 . . . . 0.0 111.661 -178.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.6 mmm180 -64.26 -24.88 67.82 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.626 -0.671 . . . . 0.0 111.054 -178.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 82.5 p -97.0 -61.97 1.33 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 122.162 -0.336 . . . . 0.0 111.872 -177.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.654 ' O ' HG23 ' A' ' 31' ' ' VAL . 3.7 m -100.08 9.35 42.98 Favored 'General case' 0 N--CA 1.507 2.407 0 O-C-N 121.444 -0.785 . . . . 0.0 111.415 -178.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 57.43 25.93 55.8 Favored Glycine 0 N--CA 1.505 3.237 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 -178.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' ' 29' ' ' CYS . 41.0 t -115.38 164.49 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 122.105 -0.644 . . . . 0.0 109.556 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.498 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 132.61 178.28 15.43 Favored Glycine 0 N--CA 1.498 2.785 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -66.13 173.5 7.19 Favored 'Trans proline' 0 N--CA 1.486 1.058 0 CA-C-N 119.382 1.591 . . . . 0.0 109.833 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -92.24 79.99 5.04 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 122.02 0.914 . . . . 0.0 109.87 -178.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.401 ' HA ' HD22 ' A' ' 35' ' ' LEU . 0.2 OUTLIER -124.71 129.52 50.66 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.037 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.25 132.59 28.76 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.925 -0.484 . . . . 0.0 109.747 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.589 HG22 ' HE1' ' A' ' 23' ' ' TYR . 0.6 OUTLIER -52.58 -53.64 43.76 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.447 -0.783 . . . . 0.0 111.18 -179.108 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -50.12 -35.96 27.84 Favored 'General case' 0 N--CA 1.508 2.436 0 O-C-N 121.723 -0.61 . . . . 0.0 110.816 -178.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -70.93 -38.54 72.89 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 31.5 tpp -62.54 -57.55 10.74 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 41.2 tttt -55.77 -35.94 66.8 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.862 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.28 -37.09 86.25 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.74 -45.85 81.08 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 15.1 m -62.72 -35.57 80.2 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.094 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 17.7 m -75.3 -28.56 59.76 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.64 -34.95 70.22 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -78.43 -28.2 46.71 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.689 ' O ' HD13 ' A' ' 48' ' ' LEU . 1.4 tm? -72.78 -35.47 67.42 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -178.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -77.92 -51.28 10.66 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.64 -33.39 54.99 Favored 'General case' 0 N--CA 1.505 2.303 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.0 mt -87.71 104.88 7.4 Favored Pre-proline 0 N--CA 1.492 1.651 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.559 ' HD2' ' HB1' ' A' ' 11' ' ' ALA . 25.7 Cg_endo -60.56 149.22 88.08 Favored 'Trans proline' 0 N--CA 1.479 0.638 0 C-N-CA 121.826 1.684 . . . . 0.0 110.543 -177.501 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.1 -19.95 55.8 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.582 -177.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -49.56 -32.82 13.39 Favored 'General case' 0 N--CA 1.513 2.677 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 178.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.843 ' HB3' HD11 ' A' ' 12' ' ' ILE . 61.9 m -119.26 -69.89 0.82 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 115.336 -0.847 . . . . 0.0 108.955 178.161 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 35.7 mtt180 38.0 -92.96 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.696 0 C-N-CA 122.8 0.44 . . . . 0.0 111.273 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.403 ' HA ' HD13 ' A' ' 97' ' ' LEU . 86.4 m -37.96 -45.44 0.88 Allowed 'General case' 0 N--CA 1.515 2.815 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -40.21 -48.78 2.62 Favored 'General case' 0 N--CA 1.511 2.607 0 CA-C-N 119.843 1.202 . . . . 0.0 112.027 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.668 ' HB1' HD23 ' A' ' 17' ' ' LEU . . . -42.05 -49.22 4.74 Favored 'General case' 0 N--CA 1.513 2.685 0 CA-C-N 118.483 0.583 . . . . 0.0 111.905 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.921 HG21 HD22 ' A' ' 97' ' ' LEU . 57.6 t -57.94 -45.86 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -60.61 -26.83 67.29 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.795 HG23 ' HB ' ' A' ' 67' ' ' VAL . 50.6 mt -78.1 -29.31 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.881 -0.512 . . . . 0.0 109.71 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.2 tp -77.87 -41.51 36.55 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.853 -0.739 . . . . 0.0 109.954 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.707 ' SD ' HD22 ' A' ' 79' ' ' LEU . 39.4 tpp -78.56 -52.77 8.0 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.331 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -80.51 -22.94 40.43 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 122.048 -0.408 . . . . 0.0 110.981 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 85.15 147.47 9.21 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 109.196 -1.561 . . . . 0.0 109.196 -178.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.795 ' HB ' HG23 ' A' ' 62' ' ' ILE . 5.3 p -118.01 158.74 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.265 0 O-C-N 122.133 -0.628 . . . . 0.0 109.531 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.662 HG22 ' NE2' ' A' ' 74' ' ' HIS . 70.6 t -115.58 157.3 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-O 121.946 0.879 . . . . 0.0 109.463 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.6 p -117.35 159.99 21.86 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.03 -178.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 34.3 t -64.11 -33.62 76.18 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.932 -178.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.7 p -63.44 -17.8 63.07 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.69 8.13 49.52 Favored Glycine 0 N--CA 1.496 2.672 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 60.8 mt-30 -95.43 156.08 16.47 Favored 'General case' 0 N--CA 1.501 2.114 0 CA-C-N 118.158 0.979 . . . . 0.0 109.578 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.662 ' NE2' HG22 ' A' ' 68' ' ' VAL . 9.6 m170 -116.47 154.93 29.48 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -141.24 -175.49 4.36 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.106 0.479 . . . . 0.0 110.081 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 55.6 -146.1 31.03 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.9 ttp180 56.54 19.84 4.48 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 122.29 -0.535 . . . . 0.0 110.384 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.5 mt -84.03 -14.45 50.57 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.723 -0.611 . . . . 0.0 110.244 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.873 HD21 ' CB ' ' A' ' 90' ' ' GLN . 5.3 tt -61.93 92.88 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -135.31 172.8 12.49 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.255 0.55 . . . . 0.0 109.591 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -51.32 102.01 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.651 0.739 . . . . 0.0 111.384 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.569 HD11 ' CZ ' ' A' ' 21' ' ' ARG . 21.5 mt -87.2 169.99 13.18 Favored Pre-proline 0 N--CA 1.495 1.803 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 177.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.557 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 28.9 Cg_endo -68.18 100.55 0.65 Allowed 'Trans proline' 0 C--N 1.327 -0.562 0 C-N-CA 120.942 1.095 . . . . 0.0 110.609 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.17 11.99 60.6 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.416 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 3.6 m -141.91 91.33 8.17 Favored Pre-proline 0 N--CA 1.506 2.353 0 CA-C-N 118.786 1.293 . . . . 0.0 109.11 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -74.19 161.45 40.68 Favored 'Trans proline' 0 N--CA 1.482 0.825 0 C-N-CA 121.538 1.492 . . . . 0.0 111.282 -178.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.82 -28.75 2.73 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.268 0.556 . . . . 0.0 109.599 177.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -55.38 -53.49 55.57 Favored 'General case' 0 N--CA 1.503 2.199 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.654 -178.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 54.2 t -62.83 -39.91 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.709 -0.62 . . . . 0.0 109.63 -178.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.873 ' CB ' HD21 ' A' ' 79' ' ' LEU . 1.9 mp0 -64.11 -26.35 68.5 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.66 -33.99 46.68 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.29 -48.83 63.91 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.876 -0.515 . . . . 0.0 109.654 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.547 ' CE1' HG22 ' A' ' 24' ' ' VAL . 31.0 t80 -78.58 -26.25 45.49 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 122.262 -0.274 . . . . 0.0 110.55 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.695 ' HB3' ' HD3' ' A' ' 95' ' ' PRO . . . -41.25 -49.75 8.6 Favored Pre-proline 0 N--CA 1.506 2.336 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -177.121 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.695 ' HD3' ' HB3' ' A' ' 94' ' ' ALA . 34.5 Cg_endo -77.84 33.15 0.45 Allowed 'Trans proline' 0 CA--C 1.55 1.308 0 C-N-CA 122.206 1.937 . . . . 0.0 112.964 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 49.8 mttm -123.99 30.97 5.96 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 178.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.921 HD22 HG21 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -73.56 -71.31 0.32 Allowed 'General case' 0 N--CA 1.512 2.641 0 O-C-N 122.067 -0.396 . . . . 0.0 110.804 -179.196 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.853 HG13 HD12 ' A' ' 97' ' ' LEU . 11.0 m -94.95 28.32 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.388 -0.82 . . . . 0.0 109.855 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 27.9 p -96.96 170.05 9.42 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.85 -2.38 0.85 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.549 -0.72 . . . . 0.0 112.015 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.573 ' O ' HG12 ' A' ' 101' ' ' VAL . 22.0 t -98.34 4.72 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 CA-C-N 120.36 1.436 . . . . 0.0 110.894 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.429 ' HB3' ' O ' ' A' ' 97' ' ' LEU . 4.8 tp10 -142.25 -91.55 0.13 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.559 -0.713 . . . . 0.0 111.039 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.483 ' O ' HD12 ' A' ' 105' ' ' LEU . 93.6 m -143.61 42.06 1.47 Allowed 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.387 -0.821 . . . . 0.0 110.002 -178.385 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -39.85 -56.8 1.71 Allowed 'General case' 0 N--CA 1.508 2.456 0 N-CA-C 113.642 0.978 . . . . 0.0 113.642 -178.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.483 HD12 ' O ' ' A' ' 103' ' ' CYS . 2.0 mt 45.87 23.9 0.2 Allowed 'General case' 0 N--CA 1.508 2.432 0 CA-C-N 118.995 0.816 . . . . 0.0 111.277 -179.119 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 105' ' ' LEU . . . 64.76 123.79 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.317 -0.865 . . . . 0.0 109.7 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.1 p -89.89 -159.0 0.56 Allowed 'General case' 0 N--CA 1.507 2.38 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.5 tp -66.63 -31.1 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -69.77 -0.87 7.8 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.893 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 58.54 28.78 62.89 Favored Glycine 0 N--CA 1.497 2.756 0 N-CA-C 109.299 -1.521 . . . . 0.0 109.299 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -157.01 168.72 34.04 Favored Glycine 0 N--CA 1.498 2.784 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -78.68 73.96 5.69 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 122.798 2.332 . . . . 0.0 111.933 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 30.2 p90 176.29 154.01 0.2 Allowed 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.583 -0.698 . . . . 0.0 110.431 178.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 20.6 p -165.08 144.16 6.66 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 51.02 24.89 2.02 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.579 -0.7 . . . . 0.0 110.613 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 28.1 t -130.2 -89.59 0.48 Allowed 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 53.06 -88.53 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.949 -0.47 . . . . 0.0 110.412 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -51.26 -16.25 0.49 Allowed 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.11 -99.74 0.01 OUTLIER Glycine 0 N--CA 1.502 3.078 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 57.27 72.42 0.52 Allowed 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 121.648 0.737 . . . . 0.0 109.558 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -65.51 -14.5 60.19 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 . . . . . 0 N--CA 1.5 2.052 0 CA-C-O 118.113 -0.946 . . . . 0.0 109.422 -179.89 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 77.5 p . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.4 m -42.2 -37.28 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.56 0 O-C-N 122.117 -0.365 . . . . 0.0 111.629 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -67.07 96.95 0.34 Allowed Glycine 0 N--CA 1.498 2.832 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.6 t -132.55 52.5 2.07 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 121.613 0.72 . . . . 0.0 109.276 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.1 t -88.7 68.57 8.63 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 121.554 0.692 . . . . 0.0 109.574 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.1 m -140.3 -163.94 1.62 Allowed 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.681 -0.637 . . . . 0.0 109.289 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.759 HD12 ' CB ' ' A' ' 10' ' ' MET . 0.2 OUTLIER -162.53 153.56 14.74 Favored Pre-proline 0 N--CA 1.506 2.363 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -79.41 126.1 6.66 Favored 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 122.364 2.043 . . . . 0.0 111.038 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 74.76 4.12 69.94 Favored Glycine 0 N--CA 1.502 3.048 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.759 ' CB ' HD12 ' A' ' 7' ' ' ILE . 72.4 mmm -129.61 99.74 5.27 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.577 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 86.7 -54.59 0.06 Allowed 'General case' 0 N--CA 1.517 2.917 0 CA-C-N 119.448 1.022 . . . . 0.0 108.713 -178.321 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.691 HD11 ' HB2' ' A' ' 55' ' ' CYS . 36.8 mm -104.83 100.55 24.32 Favored Pre-proline 0 N--CA 1.495 1.783 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.581 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.404 ' HD3' ' CD1' ' A' ' 51' ' ' ILE . 35.6 Cg_endo -84.27 175.04 7.63 Favored 'Trans proline' 0 N--CA 1.475 0.423 0 C-N-CA 121.749 1.632 . . . . 0.0 111.511 -177.44 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 -84.03 142.78 30.21 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.499 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 7.3 t-20 60.12 57.95 4.41 Favored Pre-proline 0 N--CA 1.501 2.094 0 O-C-N 121.605 -0.685 . . . . 0.0 109.676 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.499 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 39.7 Cg_endo -81.41 150.24 17.11 Favored 'Trans proline' 0 N--CA 1.481 0.747 0 C-N-CA 122.219 1.946 . . . . 0.0 112.069 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 76.9 mt 51.98 42.74 30.5 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.853 177.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -66.33 -34.24 77.54 Favored 'General case' 0 N--CA 1.506 2.353 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 178.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.3 t -63.49 -26.06 68.54 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.696 ' O ' HG23 ' A' ' 24' ' ' VAL . 56.1 m -77.79 -34.76 52.05 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.678 ' HB3' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -65.94 -51.54 57.66 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.417 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.45 ' HA ' ' CE3' ' A' ' 22' ' ' TRP . 27.7 m95 -66.83 -32.43 73.7 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 119.753 -0.779 . . . . 0.0 109.682 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -64.25 -32.33 73.88 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 20' ' ' CYS . 48.2 t -70.51 -39.74 76.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 177.367 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 m -55.92 -40.39 73.01 Favored 'General case' 0 N--CA 1.501 2.088 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.361 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.1 m -77.19 -54.45 6.49 Favored 'General case' 0 N--CA 1.51 2.543 0 O-C-N 122.011 -0.431 . . . . 0.0 111.785 -178.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 14.3 ttm180 -60.05 -24.6 64.68 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.687 -0.633 . . . . 0.0 110.413 -178.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.531 HG23 ' O ' ' A' ' 24' ' ' VAL . 44.3 p -95.21 -66.02 0.94 Allowed 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -177.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.539 ' O ' HG23 ' A' ' 31' ' ' VAL . 3.8 m -100.35 13.27 34.96 Favored 'General case' 0 N--CA 1.51 2.556 0 O-C-N 121.247 -0.908 . . . . 0.0 111.413 -178.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 58.66 22.68 53.64 Favored Glycine 0 N--CA 1.505 3.269 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -178.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 29' ' ' CYS . 29.0 t -110.01 165.53 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.363 0 O-C-N 121.899 -0.765 . . . . 0.0 109.376 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.496 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 131.06 178.63 15.56 Favored Glycine 0 N--CA 1.499 2.896 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -65.03 176.67 2.91 Favored 'Trans proline' 0 N--CA 1.489 1.249 0 CA-C-N 119.042 1.421 . . . . 0.0 109.905 179.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.774 ' C ' HD12 ' A' ' 35' ' ' LEU . 0.3 OUTLIER -91.59 79.58 5.46 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 122.196 0.998 . . . . 0.0 109.857 -178.099 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.774 HD12 ' C ' ' A' ' 34' ' ' ARG . 9.4 mp -130.59 127.8 39.74 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.04 160.24 1.57 Allowed 'General case' 0 N--CA 1.501 2.121 0 O-C-N 122.041 -0.412 . . . . 0.0 110.12 -178.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.22 -37.93 72.02 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 122.02 -0.425 . . . . 0.0 111.206 -178.278 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.53 -42.77 77.99 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.881 -0.512 . . . . 0.0 110.081 -178.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -70.12 -28.17 65.17 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 2.7 tpt -70.06 -54.54 12.65 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.3 tttt -55.53 -33.9 64.22 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.505 179.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.73 -37.9 76.66 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.63 -37.83 88.81 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 13.1 m -72.23 -32.8 67.06 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.856 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.406 ' HA ' ' CB ' ' A' ' 103' ' ' CYS . 79.7 m -72.2 -29.71 64.24 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.63 -34.89 46.18 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.528 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 4.4 mm-40 -72.98 -38.15 66.79 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.911 HD11 HG12 ' A' ' 98' ' ' VAL . 1.2 tt -67.64 -59.78 3.07 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 179.459 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.817 ' N ' HD23 ' A' ' 48' ' ' LEU . 1.1 tm-20 -52.57 -26.9 14.63 Favored 'General case' 0 N--CA 1.504 2.245 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.276 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 47' ' ' GLN . . . -61.65 -61.31 2.61 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.207 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.561 HG23 HD13 ' A' ' 12' ' ' ILE . 45.9 mm -57.12 102.98 0.33 Allowed Pre-proline 0 N--CA 1.509 2.501 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 177.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -54.82 149.8 39.85 Favored 'Trans proline' 0 N--CA 1.486 1.044 0 C-N-CA 121.895 1.73 . . . . 0.0 112.79 -175.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -37.19 -32.1 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.427 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.415 -178.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -73.43 112.27 9.35 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 177.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.691 ' HB2' HD11 ' A' ' 12' ' ' ILE . 28.4 m 73.67 14.82 4.15 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 122.237 -0.289 . . . . 0.0 110.29 -178.33 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.504 ' NH1' ' O ' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -45.53 -86.52 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.919 0 O-C-N 121.083 -1.01 . . . . 0.0 109.813 -179.913 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 21.8 m -38.98 -38.55 0.45 Allowed 'General case' 0 N--CA 1.515 2.821 0 N-CA-C 113.801 1.038 . . . . 0.0 113.801 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.725 ' O ' HD12 ' A' ' 62' ' ' ILE . 0.5 OUTLIER -36.36 -43.91 0.4 Allowed 'General case' 0 N--CA 1.512 2.673 0 CA-C-N 120.294 1.406 . . . . 0.0 112.512 -179.697 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -42.55 -54.53 3.89 Favored 'General case' 0 N--CA 1.514 2.755 0 O-C-N 121.851 -0.531 . . . . 0.0 111.765 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.818 ' CG2' HD13 ' A' ' 97' ' ' LEU . 95.2 t -57.58 -42.34 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.89 -30.41 67.76 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.725 HD12 ' O ' ' A' ' 58' ' ' GLU . 1.6 mp -78.41 -30.43 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 O-C-N 121.954 -0.466 . . . . 0.0 110.469 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.678 HD21 ' HB3' ' A' ' 21' ' ' ARG . 3.8 tp -77.44 -41.72 38.71 Favored 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 119.314 -0.954 . . . . 0.0 110.282 -178.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.69 ' HA ' HD21 ' A' ' 79' ' ' LEU . 0.7 OUTLIER -78.72 -52.06 8.94 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.202 -179.821 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -81.06 -22.99 38.84 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.936 -0.478 . . . . 0.0 111.267 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.58 147.38 10.93 Favored Glycine 0 N--CA 1.498 2.823 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 -178.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.704 ' HB ' HG23 ' A' ' 62' ' ' ILE . 7.6 p -118.29 159.65 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 122.052 -0.675 . . . . 0.0 109.644 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.667 HG22 ' NE2' ' A' ' 74' ' ' HIS . 69.3 t -114.9 157.77 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 CA-C-O 121.828 0.823 . . . . 0.0 109.602 -178.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.409 ' N ' HG12 ' A' ' 68' ' ' VAL . 33.9 p -117.14 159.54 22.43 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.73 -177.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 42.6 t -63.28 -31.09 72.15 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.383 -178.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.5 p -68.32 -17.33 64.23 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.231 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.91 14.08 32.42 Favored Glycine 0 N--CA 1.498 2.795 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.271 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -102.37 156.21 17.74 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-N 118.085 0.942 . . . . 0.0 109.398 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.667 ' NE2' HG22 ' A' ' 68' ' ' VAL . 8.7 m170 -116.03 156.15 26.84 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -145.67 -174.1 4.31 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.034 0.445 . . . . 0.0 109.869 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 60.27 -148.68 43.4 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 56.11 28.32 12.8 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 122.122 -0.634 . . . . 0.0 109.679 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.452 HD23 ' NH2' ' A' ' 21' ' ' ARG . 6.4 mp -86.45 -14.37 43.43 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.716 -0.615 . . . . 0.0 111.202 -178.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.69 HD21 ' HA ' ' A' ' 64' ' ' MET . 1.0 OUTLIER -79.93 84.42 5.69 Favored 'General case' 0 N--CA 1.503 2.212 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 179.109 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -127.81 -173.13 2.84 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.464 0.649 . . . . 0.0 110.01 -178.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -50.43 102.31 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.695 0.76 . . . . 0.0 111.396 -179.079 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.53 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 22.2 mt -98.51 169.18 8.68 Favored Pre-proline 0 N--CA 1.497 1.916 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.53 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 28.7 Cg_endo -68.24 101.25 0.7 Allowed 'Trans proline' 0 N--CA 1.478 0.601 0 C-N-CA 121.189 1.259 . . . . 0.0 110.733 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.69 13.65 59.25 Favored Glycine 0 N--CA 1.497 2.71 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 3.7 m -143.6 91.03 6.9 Favored Pre-proline 0 N--CA 1.509 2.485 0 CA-C-N 118.637 1.219 . . . . 0.0 109.371 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -75.39 160.15 39.17 Favored 'Trans proline' 0 N--CA 1.483 0.856 0 C-N-CA 121.673 1.582 . . . . 0.0 111.464 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.0 mmt85 -49.55 -28.56 5.73 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 177.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 -57.13 -59.39 5.16 Favored 'General case' 0 N--CA 1.503 2.2 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.624 -178.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 53.6 t -61.07 -40.25 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.836 -0.54 . . . . 0.0 110.311 -178.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.734 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 0.3 OUTLIER -65.42 -26.94 68.2 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.638 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.63 -31.68 47.05 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.42 -48.99 36.89 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 122.04 -0.413 . . . . 0.0 109.902 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.464 ' HD2' HG13 ' A' ' 24' ' ' VAL . 67.2 t80 -78.46 -25.34 45.82 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 122.326 -0.234 . . . . 0.0 111.132 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.734 ' HB2' ' O ' ' A' ' 90' ' ' GLN . . . -48.98 -48.83 71.43 Favored Pre-proline 0 N--CA 1.505 2.319 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -176.537 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.477 ' HD3' ' HB3' ' A' ' 94' ' ' ALA . 29.3 Cg_endo -68.61 85.59 0.46 Allowed 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 121.841 1.694 . . . . 0.0 113.29 -176.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.424 ' C ' ' HD3' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -177.8 54.95 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.422 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.595 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.818 HD13 ' CG2' ' A' ' 60' ' ' VAL . 29.0 tp -86.27 -81.32 0.22 Allowed 'General case' 0 N--CA 1.507 2.388 0 O-C-N 121.218 -0.926 . . . . 0.0 111.753 -177.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.911 HG12 HD11 ' A' ' 48' ' ' LEU . 4.0 m -91.62 24.92 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.745 -0.597 . . . . 0.0 110.958 -176.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 29.9 p -93.47 168.71 10.87 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.16 -0.01 0.48 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.49 -0.756 . . . . 0.0 111.843 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.551 ' O ' HG12 ' A' ' 101' ' ' VAL . 28.0 t -97.07 0.16 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 CA-C-N 120.518 1.508 . . . . 0.0 111.249 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.409 ' HB3' ' O ' ' A' ' 97' ' ' LEU . 23.9 tp10 -140.71 -88.07 0.17 Allowed 'General case' 0 N--CA 1.504 2.245 0 CA-C-N 119.114 0.87 . . . . 0.0 111.433 -179.326 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.517 ' O ' HD12 ' A' ' 105' ' ' LEU . 57.3 m -143.74 45.56 1.48 Allowed 'General case' 0 N--CA 1.509 2.482 0 O-C-N 121.244 -0.91 . . . . 0.0 109.683 -179.155 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.9 p-10 -40.5 -57.59 1.78 Allowed 'General case' 0 N--CA 1.504 2.263 0 O-C-N 121.192 -0.942 . . . . 0.0 113.363 -178.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.517 HD12 ' O ' ' A' ' 103' ' ' CYS . 3.6 mt 43.16 27.27 0.11 Allowed 'General case' 0 N--CA 1.515 2.777 0 CA-C-N 119.016 0.825 . . . . 0.0 111.112 -179.413 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 63.57 153.66 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.451 -0.781 . . . . 0.0 109.801 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.3 p -123.82 -161.18 0.96 Allowed 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.3 tp -66.99 -33.8 65.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.451 ' HB3' ' CE1' ' A' ' 113' ' ' PHE . 66.0 m80 -70.96 -0.72 9.9 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.907 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 56.28 43.41 89.44 Favored Glycine 0 N--CA 1.501 2.984 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -172.48 170.58 43.63 Favored Glycine 0 N--CA 1.501 2.993 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -77.17 77.1 3.92 Favored 'Trans proline' 0 CA--C 1.544 1.023 0 C-N-CA 122.36 2.04 . . . . 0.0 111.513 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.451 ' CE1' ' HB3' ' A' ' 109' ' ' HIS . 33.1 p90 173.51 150.8 0.08 Allowed 'General case' 0 N--CA 1.505 2.311 0 O-C-N 121.754 -0.591 . . . . 0.0 109.827 178.517 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 20.6 p -145.49 86.62 1.76 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.756 -0.59 . . . . 0.0 110.168 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -153.58 -174.7 5.05 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.246 -0.909 . . . . 0.0 109.601 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 71.7 m -55.12 -54.76 39.06 Favored 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.495 ' O ' ' HB2' ' A' ' 118' ' ' LEU . 0.1 OUTLIER 81.1 -69.04 0.09 Allowed 'General case' 0 N--CA 1.51 2.555 0 C-N-CA 122.677 0.391 . . . . 0.0 110.707 179.223 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.495 ' HB2' ' O ' ' A' ' 117' ' ' LEU . 2.0 mp 74.09 -17.81 0.44 Allowed 'General case' 0 N--CA 1.512 2.633 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -179.463 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -99.05 30.07 10.55 Favored Glycine 0 N--CA 1.499 2.854 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -104.93 47.72 0.86 Allowed 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.857 0.836 . . . . 0.0 109.301 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.21 10.62 68.13 Favored Glycine 0 N--CA 1.499 2.899 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 . . . . . 0 N--CA 1.497 1.914 0 CA-C-N 118.091 0.945 . . . . 0.0 109.299 179.853 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 79.1 p . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.2 m -119.62 -111.09 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.41 ' O ' HG22 ' A' ' 4' ' ' THR . . . 94.53 -87.25 1.08 Allowed Glycine 0 N--CA 1.499 2.856 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.41 HG22 ' O ' ' A' ' 3' ' ' GLY . 8.8 t 41.54 46.6 3.1 Favored 'General case' 0 N--CA 1.509 2.522 0 CA-C-O 121.436 0.636 . . . . 0.0 111.452 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 59.9 p -120.85 -160.01 0.82 Allowed 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.728 -0.608 . . . . 0.0 109.505 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 64.0 m 61.42 -160.97 0.3 Allowed 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.456 ' CG2' ' HD2' ' A' ' 8' ' ' PRO . 33.7 mt 71.91 139.74 0.07 OUTLIER Pre-proline 0 N--CA 1.506 2.356 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 -178.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.456 ' HD2' ' CG2' ' A' ' 7' ' ' ILE . 30.6 Cg_endo -71.7 165.82 31.37 Favored 'Trans proline' 0 N--CA 1.48 0.698 0 C-N-CA 121.624 1.549 . . . . 0.0 111.131 -178.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 62.76 16.48 56.34 Favored Glycine 0 N--CA 1.497 2.733 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.574 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 16.8 mmm -140.93 84.63 1.94 Allowed 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.882 -0.775 . . . . 0.0 109.011 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.574 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 86.73 -57.72 0.05 Allowed 'General case' 0 N--CA 1.516 2.864 0 O-C-N 121.379 -0.825 . . . . 0.0 108.84 -178.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.715 HD11 ' HB2' ' A' ' 55' ' ' CYS . 61.4 mt -92.14 104.4 10.71 Favored Pre-proline 0 N--CA 1.498 1.961 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 178.459 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -75.05 169.51 22.44 Favored 'Trans proline' 0 C--O 1.219 -0.433 0 C-N-CA 121.3 1.333 . . . . 0.0 111.649 -175.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 47.0 m80 -69.28 144.62 53.54 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.489 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 5.3 t-20 65.98 55.98 1.05 Allowed Pre-proline 0 N--CA 1.506 2.357 0 O-C-N 121.358 -0.838 . . . . 0.0 110.303 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.489 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 38.6 Cg_endo -80.49 166.87 19.63 Favored 'Trans proline' 0 N--CA 1.484 0.932 0 C-N-CA 122.305 2.004 . . . . 0.0 111.923 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.6 mp 42.96 43.8 3.72 Favored 'General case' 0 N--CA 1.504 2.254 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.209 177.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -69.07 -37.68 78.63 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -63.01 -26.16 68.72 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 57.3 m -74.64 -38.78 62.42 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.584 HH22 HD23 ' A' ' 78' ' ' LEU . 3.4 ttt180 -64.13 -48.6 75.45 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 33.9 m95 -69.02 -29.07 67.17 Favored 'General case' 0 N--CA 1.502 2.149 0 C-N-CA 119.312 -0.955 . . . . 0.0 109.809 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.439 ' CD1' ' HB3' ' A' ' 40' ' ' MET . 57.1 t80 -66.5 -33.5 75.83 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.424 HG22 ' CD2' ' A' ' 93' ' ' PHE . 96.3 t -72.43 -38.96 61.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 177.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 m -56.18 -37.06 69.07 Favored 'General case' 0 N--CA 1.501 2.091 0 C-N-CA 119.946 -0.701 . . . . 0.0 109.529 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 90.9 m -77.8 -49.89 13.43 Favored 'General case' 0 N--CA 1.508 2.459 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.92 -25.29 67.82 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 121.519 -0.738 . . . . 0.0 110.544 -178.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 24' ' ' VAL . 70.4 p -93.65 -62.9 1.27 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -177.181 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.655 ' O ' HG23 ' A' ' 31' ' ' VAL . 3.6 m -100.43 9.23 42.92 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.384 -0.823 . . . . 0.0 111.617 -178.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 57.79 29.72 61.95 Favored Glycine 0 N--CA 1.507 3.382 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 -178.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 29' ' ' CYS . 38.5 t -120.72 164.09 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 122.155 -0.615 . . . . 0.0 109.717 -179.251 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.495 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 136.16 177.72 15.21 Favored Glycine 0 N--CA 1.5 2.908 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -64.43 177.33 2.18 Favored 'Trans proline' 0 N--CA 1.489 1.231 0 CA-C-N 119.196 1.498 . . . . 0.0 110.028 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.21 87.19 6.0 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 122.197 0.999 . . . . 0.0 110.412 -177.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.6 mt -141.76 127.2 18.83 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.02 152.37 2.24 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.907 -0.496 . . . . 0.0 109.81 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.1 p -59.96 -59.64 5.1 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.813 -0.555 . . . . 0.0 110.604 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -52.49 -28.79 21.82 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.818 -0.551 . . . . 0.0 111.595 -178.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -72.0 -46.89 55.56 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.816 -0.553 . . . . 0.0 109.573 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.439 ' HB3' ' CD1' ' A' ' 23' ' ' TYR . 5.5 tpt -61.97 -54.61 39.27 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -53.59 -35.75 61.2 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.34 -42.83 99.71 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.23 -41.14 96.37 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 19.8 m -65.58 -33.17 75.28 Favored 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.233 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 18.9 m -73.43 -30.16 63.03 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -178.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.27 -32.46 62.94 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -77.15 -33.47 56.62 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.785 HD22 ' O ' ' A' ' 103' ' ' CYS . 0.6 OUTLIER -73.48 -33.52 64.87 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.841 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.52 -40.38 61.79 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.25 -39.13 85.67 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.486 HG23 HG12 ' A' ' 12' ' ' ILE . 70.8 mt -82.7 105.75 5.52 Favored Pre-proline 0 N--CA 1.493 1.684 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 177.636 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -58.29 139.87 92.2 Favored 'Trans proline' 0 N--CA 1.48 0.712 0 C-N-CA 121.42 1.413 . . . . 0.0 110.92 -177.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.7 ' HB2' ' NH1' ' A' ' 56' ' ' ARG . . . -39.47 -29.76 0.06 Allowed 'General case' 0 N--CA 1.508 2.432 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.359 -178.131 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -53.16 -70.41 0.09 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.919 -0.488 . . . . 0.0 110.698 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.715 ' HB2' HD11 ' A' ' 12' ' ' ILE . 5.0 m -88.55 8.76 26.64 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 122.062 -0.399 . . . . 0.0 110.89 -179.181 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.7 ' NH1' ' HB2' ' A' ' 53' ' ' ALA . 5.9 mtt180 -47.58 -85.2 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.67 0 O-C-N 121.491 -0.755 . . . . 0.0 110.33 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 72.6 m -32.95 -48.85 0.22 Allowed 'General case' 0 N--CA 1.521 3.113 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -41.67 -54.34 3.3 Favored 'General case' 0 N--CA 1.512 2.668 0 CA-C-N 119.325 0.966 . . . . 0.0 111.731 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -41.82 -44.75 3.41 Favored 'General case' 0 N--CA 1.514 2.731 0 O-C-N 121.776 -0.578 . . . . 0.0 112.04 -179.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.6 t -57.22 -48.83 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -58.57 -26.83 64.01 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.957 HG23 ' HB ' ' A' ' 67' ' ' VAL . 34.8 mm -78.42 -30.76 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 O-C-N 121.985 -0.447 . . . . 0.0 110.469 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.486 HD12 ' HA ' ' A' ' 63' ' ' LEU . 14.8 tp -77.77 -43.22 31.42 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 120.11 -0.636 . . . . 0.0 109.999 -179.22 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.01 -50.76 10.58 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.18 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -80.6 -22.71 40.41 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 122.006 -0.434 . . . . 0.0 110.936 -178.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.73 146.89 5.7 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.957 ' HB ' HG23 ' A' ' 62' ' ' ILE . 5.5 p -118.42 161.18 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.667 HG22 ' NE2' ' A' ' 74' ' ' HIS . 56.0 t -113.34 157.85 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -179.383 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 42.2 p -116.67 160.07 21.28 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 121.95 0.881 . . . . 0.0 111.044 -176.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 32.9 t -64.61 -17.46 64.02 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.39 -178.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.1 p -86.49 -14.64 42.53 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 122.021 -0.424 . . . . 0.0 110.127 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.23 13.59 32.98 Favored Glycine 0 N--CA 1.499 2.892 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -105.48 158.56 16.58 Favored 'General case' 0 N--CA 1.502 2.125 0 CA-C-N 118.039 0.92 . . . . 0.0 108.834 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.667 ' NE2' HG22 ' A' ' 68' ' ' VAL . 11.3 m170 -113.72 154.95 26.46 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -179.138 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -136.89 -179.07 5.48 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 55.41 -146.94 28.82 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 108.622 -1.791 . . . . 0.0 108.622 -178.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 54.72 22.53 4.17 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 122.303 -0.528 . . . . 0.0 110.007 179.156 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.584 HD23 HH22 ' A' ' 21' ' ' ARG . 2.1 mp -83.1 -14.73 53.1 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.745 -0.597 . . . . 0.0 110.361 -179.247 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.5 mt -62.0 92.79 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -134.22 -177.21 4.48 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.719 0.771 . . . . 0.0 110.843 -178.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -48.68 130.14 17.2 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.506 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.466 ' HB2' ' HB2' ' A' ' 85' ' ' CYS . 20.6 mt -127.49 166.38 23.54 Favored Pre-proline 0 N--CA 1.496 1.87 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.097 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 29.6 Cg_endo -68.63 98.69 0.59 Allowed 'Trans proline' 0 C--N 1.328 -0.537 0 C-N-CA 120.88 1.054 . . . . 0.0 110.143 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.68 4.22 67.9 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.466 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 3.3 m -137.02 92.1 14.4 Favored Pre-proline 0 N--CA 1.508 2.47 0 CA-C-N 119.173 1.487 . . . . 0.0 110.02 -179.31 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -74.69 165.52 31.36 Favored 'Trans proline' 0 N--CA 1.485 1.028 0 C-N-CA 121.976 1.784 . . . . 0.0 111.328 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 23.9 mtp180 -54.09 -25.97 24.66 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.038 0.447 . . . . 0.0 110.133 178.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.58 -46.12 87.33 Favored 'General case' 0 N--CA 1.502 2.139 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.947 -177.185 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 42.2 t -72.46 -43.14 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.513 -0.742 . . . . 0.0 110.982 -177.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.619 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 2.2 pt20 -70.49 -27.15 63.98 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.411 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 8.7 ttt180 -78.72 -29.15 45.17 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.34 -47.34 20.2 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.999 -0.438 . . . . 0.0 110.3 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.424 ' CD2' HG22 ' A' ' 24' ' ' VAL . 90.6 t80 -79.02 -27.48 43.25 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 122.021 -0.425 . . . . 0.0 111.47 -178.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.619 ' HB2' ' O ' ' A' ' 90' ' ' GLN . . . -54.81 -46.64 99.42 Favored Pre-proline 0 N--CA 1.505 2.281 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -177.512 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 94' ' ' ALA . 30.1 Cg_endo -70.12 -0.22 6.89 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 122.239 1.959 . . . . 0.0 114.009 -177.125 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.71 23.92 12.25 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.496 -0.753 . . . . 0.0 109.838 179.064 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.93 -24.32 59.65 Favored 'General case' 0 N--CA 1.509 2.492 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -178.113 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 33.7 m -93.36 25.8 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 CA-C-N 121.0 1.727 . . . . 0.0 111.179 -178.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.406 ' C ' ' HB2' ' A' ' 104' ' ' ASN . 19.1 p -98.28 173.2 7.11 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -62.07 -1.48 0.7 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.696 -0.628 . . . . 0.0 112.25 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.584 ' O ' HG12 ' A' ' 101' ' ' VAL . 37.1 t -100.03 4.49 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 CA-C-N 120.407 1.458 . . . . 0.0 110.873 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -141.13 -89.97 0.15 Allowed 'General case' 0 N--CA 1.502 2.168 0 CA-C-N 118.99 0.814 . . . . 0.0 111.511 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.785 ' O ' HD22 ' A' ' 48' ' ' LEU . 19.5 m -143.67 43.08 1.48 Allowed 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.572 -0.705 . . . . 0.0 109.886 -178.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.409 ' ND2' ' HB3' ' A' ' 112' ' ' PRO . 57.0 t-20 -43.02 -64.81 0.56 Allowed 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.299 -0.875 . . . . 0.0 112.287 -179.287 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.426 ' O ' ' HB3' ' A' ' 106' ' ' ALA . 6.0 mt 45.34 29.39 0.56 Allowed 'General case' 0 N--CA 1.511 2.602 0 CA-C-O 121.066 0.46 . . . . 0.0 109.927 -178.482 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 105' ' ' LEU . . . 67.09 157.98 0.13 Allowed 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -178.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.6 p -128.87 -163.92 1.34 Allowed 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -179.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 18.0 tt -68.17 -33.29 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.447 ' HB3' ' CE2' ' A' ' 113' ' ' PHE . 56.2 m80 -66.68 -4.85 9.81 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.689 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 61.45 41.51 99.56 Favored Glycine 0 N--CA 1.499 2.874 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -174.82 170.94 44.14 Favored Glycine 0 N--CA 1.5 2.966 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.409 ' HB3' ' ND2' ' A' ' 104' ' ' ASN . 32.3 Cg_endo -77.9 75.85 4.6 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 122.553 2.168 . . . . 0.0 111.387 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.447 ' CE2' ' HB3' ' A' ' 109' ' ' HIS . 36.7 p90 178.72 156.3 0.45 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.708 -0.62 . . . . 0.0 110.447 178.386 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 4.8 t 178.61 158.61 0.52 Allowed 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 55.68 22.26 5.23 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.699 -0.626 . . . . 0.0 109.932 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.66 -69.31 0.07 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.82 -0.55 . . . . 0.0 109.694 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.516 ' O ' ' HB2' ' A' ' 118' ' ' LEU . 0.4 OUTLIER 59.68 29.73 19.31 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.718 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.516 ' HB2' ' O ' ' A' ' 117' ' ' LEU . 20.4 mt 76.31 -18.73 0.45 Allowed 'General case' 0 N--CA 1.509 2.513 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 130.69 176.92 14.61 Favored Glycine 0 N--CA 1.499 2.891 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -97.94 43.88 1.05 Allowed 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.677 0.751 . . . . 0.0 109.379 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -94.32 25.28 23.29 Favored Glycine 0 N--CA 1.498 2.814 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 . . . . . 0 N--CA 1.498 1.974 0 CA-C-O 118.003 -0.999 . . . . 0.0 109.449 179.859 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.2 m . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.056 0.455 . . . . 0.0 109.976 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.631 HG22 ' N ' ' A' ' 3' ' ' GLY . 1.2 p -108.13 -95.31 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.631 ' N ' HG22 ' A' ' 2' ' ' VAL . . . -66.92 -105.1 0.02 OUTLIER Glycine 0 N--CA 1.499 2.84 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.422 HG22 ' C ' ' A' ' 3' ' ' GLY . 4.3 t 42.87 62.99 1.6 Allowed 'General case' 0 N--CA 1.509 2.508 0 CA-C-O 121.813 0.816 . . . . 0.0 110.535 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.57 83.77 1.54 Allowed 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.668 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 39.3 m 56.52 102.98 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.549 -0.719 . . . . 0.0 110.233 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.503 HG23 ' HD2' ' A' ' 8' ' ' PRO . 94.7 mt -133.36 142.66 45.02 Favored Pre-proline 0 N--CA 1.499 2.02 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.503 ' HD2' HG23 ' A' ' 7' ' ' ILE . 35.1 Cg_endo -77.92 99.66 1.31 Allowed 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 121.849 1.699 . . . . 0.0 110.205 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 109.9 -10.55 32.07 Favored Glycine 0 N--CA 1.501 2.983 0 O-C-N 121.507 -0.746 . . . . 0.0 111.255 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.571 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 6.1 mmt -128.03 111.77 13.89 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 86.17 -54.09 0.07 Allowed 'General case' 0 N--CA 1.514 2.741 0 CA-C-N 119.789 1.177 . . . . 0.0 108.708 -178.515 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 55.0 mt -113.38 100.74 52.44 Favored Pre-proline 0 N--CA 1.495 1.783 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 178.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -81.73 172.46 12.22 Favored 'Trans proline' 0 C--O 1.221 -0.366 0 C-N-CA 121.484 1.456 . . . . 0.0 111.524 -177.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.436 ' NE2' HG22 ' A' ' 69' ' ' THR . 33.7 m80 -77.61 150.1 34.69 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -179.347 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.508 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 0.9 OUTLIER 66.99 53.92 0.75 Allowed Pre-proline 0 N--CA 1.503 2.21 0 O-C-N 121.459 -0.775 . . . . 0.0 110.049 -178.525 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.508 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 39.8 Cg_endo -78.45 163.07 27.45 Favored 'Trans proline' 0 N--CA 1.484 0.937 0 C-N-CA 122.282 1.988 . . . . 0.0 111.465 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.575 ' N ' HD22 ' A' ' 17' ' ' LEU . 3.4 mm? 48.62 47.12 20.95 Favored 'General case' 0 N--CA 1.503 2.191 0 CA-C-O 121.246 0.546 . . . . 0.0 111.043 178.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -66.7 -35.43 80.1 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 121.493 -0.755 . . . . 0.0 109.078 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.18 -26.62 68.23 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 28.3 m -71.32 -45.2 63.58 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.681 ' NH2' HD23 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -59.38 -54.63 44.47 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.863 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.436 ' HA ' ' CE3' ' A' ' 22' ' ' TRP . 27.9 m95 -64.26 -27.18 68.87 Favored 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.676 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.457 ' CD2' ' HB3' ' A' ' 40' ' ' MET . 6.4 t80 -66.3 -32.5 73.95 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.121 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.692 HG22 ' CD1' ' A' ' 93' ' ' PHE . 61.1 t -70.61 -42.04 77.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 178.276 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 m -56.23 -44.37 79.52 Favored 'General case' 0 N--CA 1.502 2.158 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.656 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 20.9 m -76.05 -52.25 10.58 Favored 'General case' 0 N--CA 1.51 2.569 0 O-C-N 122.059 -0.401 . . . . 0.0 111.924 -178.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.7 tpm_? -61.89 -24.89 67.22 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.838 -0.539 . . . . 0.0 110.724 -178.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.531 HG23 ' O ' ' A' ' 24' ' ' VAL . 35.6 p -96.23 -64.38 1.06 Allowed 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 120.689 -0.405 . . . . 0.0 112.058 -177.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.7 m -101.32 10.89 40.16 Favored 'General case' 0 N--CA 1.511 2.613 0 CA-C-N 119.183 0.901 . . . . 0.0 111.484 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.12 18.54 57.84 Favored Glycine 0 N--CA 1.501 2.972 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -178.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.51 HG12 ' N ' ' A' ' 32' ' ' GLY . 46.2 t -102.77 164.04 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 O-C-N 121.696 -0.885 . . . . 0.0 109.112 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.51 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 130.3 179.46 16.06 Favored Glycine 0 N--CA 1.499 2.892 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -64.84 173.06 6.17 Favored 'Trans proline' 0 N--CA 1.486 1.065 0 CA-C-N 119.201 1.5 . . . . 0.0 109.879 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.432 ' O ' HD23 ' A' ' 35' ' ' LEU . 0.2 OUTLIER -92.77 84.5 4.99 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 122.026 0.917 . . . . 0.0 110.178 -177.836 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.432 HD23 ' O ' ' A' ' 34' ' ' ARG . 69.2 mt -140.79 145.1 35.88 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.582 ' HB3' ' HG3' ' A' ' 39' ' ' GLU . . . -58.29 163.11 3.16 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -179.245 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.23 -56.12 4.59 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.998 -0.439 . . . . 0.0 110.444 -179.405 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.28 -33.4 19.77 Favored 'General case' 0 N--CA 1.508 2.474 0 O-C-N 121.881 -0.512 . . . . 0.0 110.803 -178.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.582 ' HG3' ' HB3' ' A' ' 36' ' ' ALA . 3.6 mm-40 -71.35 -39.89 71.02 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 122.054 -0.404 . . . . 0.0 110.142 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.457 ' HB3' ' CD2' ' A' ' 23' ' ' TYR . 1.5 ttt -65.32 -52.79 51.6 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.432 ' HB2' ' CE2' ' A' ' 23' ' ' TYR . 6.4 tttm -53.58 -38.05 63.55 Favored 'General case' 0 N--CA 1.504 2.268 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.98 -40.92 97.27 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -60.36 -44.55 95.47 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 12.4 m -63.19 -35.95 82.0 Favored 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.635 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 69.0 m -70.52 -29.73 66.3 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.6 ttt-85 -73.8 -32.46 63.75 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -76.43 -29.48 57.02 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.844 HD11 HG12 ' A' ' 98' ' ' VAL . 0.6 OUTLIER -76.49 -36.86 57.58 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -73.41 -36.21 65.95 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.65 -53.03 60.69 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 178.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.458 HG22 ' HA ' ' A' ' 56' ' ' ARG . 42.0 mm -63.59 105.81 0.76 Allowed Pre-proline 0 N--CA 1.496 1.871 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 176.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -59.27 149.82 78.32 Favored 'Trans proline' 0 N--CA 1.479 0.651 0 C-N-CA 121.593 1.529 . . . . 0.0 110.935 -176.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -40.46 -32.08 0.18 Allowed 'General case' 0 N--CA 1.505 2.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.53 -178.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -73.49 121.73 21.03 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 178.288 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 15.2 m 72.9 6.41 5.34 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 122.167 -0.333 . . . . 0.0 110.23 -178.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.458 ' HA ' HG22 ' A' ' 51' ' ' ILE . 1.5 mtt180 -49.11 -87.14 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.676 0 O-C-N 121.191 -0.943 . . . . 0.0 109.691 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 82.4 m -36.39 -43.51 0.38 Allowed 'General case' 0 N--CA 1.519 3.007 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.677 ' O ' HD12 ' A' ' 62' ' ' ILE . 8.7 mt-10 -39.31 -48.36 1.84 Allowed 'General case' 0 N--CA 1.511 2.61 0 CA-C-N 119.549 1.068 . . . . 0.0 112.326 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.416 ' HB1' HD23 ' A' ' 17' ' ' LEU . . . -41.9 -50.37 4.48 Favored 'General case' 0 N--CA 1.517 2.922 0 CA-C-N 118.783 0.72 . . . . 0.0 111.522 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 1.005 HG11 HD22 ' A' ' 97' ' ' LEU . 34.9 t -58.23 -45.04 89.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.87 -27.66 65.4 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.728 HG23 ' HB ' ' A' ' 67' ' ' VAL . 1.4 mp -78.21 -30.85 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.898 -0.501 . . . . 0.0 109.852 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.514 ' CD2' HD13 ' A' ' 79' ' ' LEU . 7.3 tt -77.57 -40.73 41.38 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.469 -0.893 . . . . 0.0 110.139 -179.189 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 2.7 tmm? -78.4 -53.45 7.25 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.27 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -80.68 -22.83 40.07 Favored 'General case' 0 N--CA 1.502 2.154 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.157 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.97 147.63 11.79 Favored Glycine 0 N--CA 1.497 2.709 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 -178.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.728 ' HB ' HG23 ' A' ' 62' ' ' ILE . 7.6 p -118.48 160.58 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 O-C-N 122.196 -0.591 . . . . 0.0 109.782 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.692 HG22 ' NE2' ' A' ' 74' ' ' HIS . 54.7 t -114.38 157.81 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 CA-C-O 121.716 0.769 . . . . 0.0 109.292 -179.111 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.436 HG22 ' NE2' ' A' ' 14' ' ' HIS . 61.7 p -117.18 159.9 21.89 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.78 -177.552 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 35.4 t -63.3 -31.51 72.68 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.298 -178.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.2 p -69.14 -16.65 63.7 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.332 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.73 10.17 44.26 Favored Glycine 0 N--CA 1.498 2.783 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -100.18 157.56 16.49 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-N 118.04 0.92 . . . . 0.0 109.139 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.692 ' NE2' HG22 ' A' ' 68' ' ' VAL . 9.7 m170 -114.93 155.22 27.29 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -179.479 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -140.56 -176.44 4.64 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.122 0.487 . . . . 0.0 109.785 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.676 ' O ' HD12 ' A' ' 78' ' ' LEU . . . 56.37 -144.5 36.63 Favored Glycine 0 N--CA 1.496 2.691 0 N-CA-C 108.592 -1.803 . . . . 0.0 108.592 -178.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 56.0 21.6 5.14 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 122.224 -0.574 . . . . 0.0 110.356 179.006 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.681 HD23 ' NH2' ' A' ' 21' ' ' ARG . 6.7 mp -76.21 -16.76 59.77 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.744 -0.597 . . . . 0.0 110.468 -179.364 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.514 HD13 ' CD2' ' A' ' 63' ' ' LEU . 2.3 tp -59.34 91.64 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.271 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 41.0 mm-40 -130.81 -176.9 4.14 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.449 0.642 . . . . 0.0 109.821 -179.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.33 102.33 1.07 Allowed 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.657 0.742 . . . . 0.0 110.893 -179.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.542 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 20.5 mt -87.12 169.64 14.12 Favored Pre-proline 0 N--CA 1.496 1.856 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 177.277 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.542 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 29.5 Cg_endo -69.58 99.19 0.71 Allowed 'Trans proline' 0 C--N 1.328 -0.528 0 C-N-CA 121.028 1.152 . . . . 0.0 110.3 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 98.58 1.41 57.71 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.4 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 3.4 m -134.8 91.34 20.76 Favored Pre-proline 0 N--CA 1.504 2.242 0 CA-C-N 118.99 1.395 . . . . 0.0 109.274 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -72.09 161.18 45.44 Favored 'Trans proline' 0 N--CA 1.483 0.879 0 C-N-CA 121.3 1.333 . . . . 0.0 111.528 -179.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.6 mtp180 -48.15 -28.11 2.76 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.06 0.457 . . . . 0.0 109.907 178.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -60.8 -47.23 87.26 Favored 'General case' 0 N--CA 1.502 2.174 0 CA-C-N 116.325 -0.398 . . . . 0.0 112.006 -177.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 48.5 t -68.77 -39.52 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.585 -0.697 . . . . 0.0 109.837 -178.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.565 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 2.2 mp0 -66.17 -26.76 67.56 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.3 tpt180 -78.89 -35.17 44.01 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 122.085 -0.385 . . . . 0.0 109.966 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.34 -45.99 68.11 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.692 ' CD1' HG22 ' A' ' 24' ' ' VAL . 37.3 t80 -78.34 -25.52 46.42 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.7 ' HB3' ' HD3' ' A' ' 95' ' ' PRO . . . -41.56 -51.82 8.63 Favored Pre-proline 0 N--CA 1.503 2.191 0 CA-C-O 118.907 -0.568 . . . . 0.0 112.098 -177.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.7 ' HD3' ' HB3' ' A' ' 94' ' ' ALA . 29.4 Cg_endo -72.32 -171.91 0.8 Allowed 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 121.532 1.488 . . . . 0.0 109.519 179.324 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.46 ' HA ' HG21 ' A' ' 99' ' ' THR . 0.1 OUTLIER 66.47 18.0 10.75 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.827 -0.546 . . . . 0.0 109.827 -178.943 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 1.056 HD12 HG13 ' A' ' 98' ' ' VAL . 0.3 OUTLIER -73.3 -62.73 1.37 Allowed 'General case' 0 N--CA 1.516 2.849 0 O-C-N 121.687 -0.633 . . . . 0.0 112.134 -178.718 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 1.056 HG13 HD12 ' A' ' 97' ' ' LEU . 33.4 m -86.57 26.5 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.282 0 CA-C-N 119.621 1.101 . . . . 0.0 110.657 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.46 HG21 ' HA ' ' A' ' 96' ' ' LYS . 46.7 p -97.58 173.56 7.09 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -62.6 0.46 0.49 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.332 -0.855 . . . . 0.0 111.944 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.412 ' O ' HG12 ' A' ' 101' ' ' VAL . 5.0 t -98.57 -0.83 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 CA-C-N 120.481 1.491 . . . . 0.0 111.211 -179.39 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -138.46 -88.81 0.23 Allowed 'General case' 0 N--CA 1.507 2.39 0 CA-C-N 119.403 1.001 . . . . 0.0 111.918 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.757 ' O ' HD22 ' A' ' 48' ' ' LEU . 92.0 m -141.44 42.03 1.75 Allowed 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.553 -0.717 . . . . 0.0 109.734 -178.139 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.454 ' ND2' ' HB3' ' A' ' 112' ' ' PRO . 46.5 t-20 -38.34 -69.91 0.11 Allowed 'General case' 0 N--CA 1.506 2.339 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -178.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.7 mt 48.18 26.99 1.16 Allowed 'General case' 0 N--CA 1.51 2.534 0 O-C-N 121.912 -0.492 . . . . 0.0 110.682 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 63.91 154.66 0.06 Allowed 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.561 ' OG1' ' CE1' ' A' ' 109' ' ' HIS . 1.7 p -124.51 -151.82 0.49 Allowed 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -178.476 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.527 HG23 ' N ' ' A' ' 109' ' ' HIS . 0.5 OUTLIER -57.96 -39.97 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 C-N-CA 123.08 0.552 . . . . 0.0 111.279 178.509 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.587 ' CE1' ' O ' ' A' ' 113' ' ' PHE . 3.8 p80 -92.53 23.15 4.15 Favored 'General case' 0 N--CA 1.514 2.775 0 O-C-N 122.219 -0.301 . . . . 0.0 110.875 -177.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 45.47 63.57 2.68 Favored Glycine 0 N--CA 1.504 3.2 0 O-C-N 121.723 -0.61 . . . . 0.0 111.986 177.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 173.31 171.32 37.82 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 110.499 -1.041 . . . . 0.0 110.499 179.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.468 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 36.3 Cg_endo -83.3 75.35 4.38 Favored 'Trans proline' 0 CA--C 1.545 1.043 0 C-N-CA 122.711 2.274 . . . . 0.0 111.057 -179.189 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.712 ' O ' HD11 ' A' ' 117' ' ' LEU . 20.2 p90 176.96 88.94 0.01 OUTLIER 'General case' 0 N--CA 1.531 3.597 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.445 ' HA ' ' NE2' ' A' ' 109' ' ' HIS . 21.9 p -118.15 170.01 9.22 Favored 'General case' 0 N--CA 1.513 2.705 0 O-C-N 119.799 -1.813 . . . . 0.0 110.702 178.257 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.408 ' O ' ' CB ' ' A' ' 116' ' ' SER . 0.6 OUTLIER 74.25 109.64 0.07 Allowed 'General case' 0 N--CA 1.504 2.275 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.135 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.408 ' CB ' ' O ' ' A' ' 115' ' ' LEU . 1.1 t 82.56 -69.49 0.06 Allowed 'General case' 0 N--CA 1.513 2.678 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.712 HD11 ' O ' ' A' ' 113' ' ' PHE . 1.5 mp 68.52 -156.81 0.18 Allowed 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.2 mp -46.9 -20.32 0.14 Allowed 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.453 -0.779 . . . . 0.0 113.037 -178.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 63.06 115.54 0.01 OUTLIER Glycine 0 N--CA 1.5 2.952 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -108.93 66.68 0.64 Allowed 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.843 0.83 . . . . 0.0 109.125 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -61.2 -21.88 60.08 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 . . . . . 0 N--CA 1.499 2.012 0 CA-C-O 118.412 -0.804 . . . . 0.0 110.194 -179.769 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.626 ' C ' HG12 ' A' ' 2' ' ' VAL . 86.6 p . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.314 0.578 . . . . 0.0 109.477 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.787 HG22 ' N ' ' A' ' 3' ' ' GLY . 0.2 OUTLIER 173.09 -84.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.281 -0.887 . . . . 0.0 109.207 179.892 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.787 ' N ' HG22 ' A' ' 2' ' ' VAL . . . -152.48 153.2 24.73 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 4' ' ' THR . 4.3 t -175.23 64.08 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.15 -1.206 . . . . 0.0 109.506 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.38 -152.74 0.49 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.305 -0.872 . . . . 0.0 109.316 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 79.6 m -78.23 106.86 10.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.149 -0.969 . . . . 0.0 109.469 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.794 HG22 ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -125.66 158.85 63.57 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.344 -0.848 . . . . 0.0 109.005 179.747 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.794 ' HD2' HG22 ' A' ' 7' ' ' ILE . 35.5 Cg_endo -78.75 143.9 19.01 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.469 2.112 . . . . 0.0 110.356 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 57.66 14.59 15.41 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.75 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 1.3 mtt -140.25 107.69 5.56 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.211 -1.17 . . . . 0.0 108.54 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.75 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 85.32 -62.22 0.07 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.843 -1.161 . . . . 0.0 108.057 -178.571 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.802 HD11 ' CB ' ' A' ' 55' ' ' CYS . 67.9 mt -104.05 101.17 24.22 Favored Pre-proline 0 C--N 1.304 -1.406 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 11' ' ' ALA . 33.2 Cg_endo -81.29 172.45 12.71 Favored 'Trans proline' 0 C--N 1.318 -1.073 0 C-N-CA 121.595 1.53 . . . . 0.0 111.674 -177.241 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.466 ' H ' ' CD2' ' A' ' 14' ' ' HIS . 29.4 m-70 -69.58 145.63 52.4 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.667 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 2.8 t30 54.8 51.21 7.21 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 120.809 -1.182 . . . . 0.0 110.04 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.667 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 37.6 Cg_endo -78.72 166.07 24.04 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.398 2.066 . . . . 0.0 111.49 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.737 HD23 ' SG ' ' A' ' 20' ' ' CYS . 0.5 OUTLIER 48.45 48.32 19.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.741 -0.599 . . . . 0.0 111.091 178.879 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -75.08 -42.24 57.15 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.01 -1.056 . . . . 0.0 108.91 178.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.556 ' OG ' ' HE2' ' A' ' 40' ' ' MET . 0.3 OUTLIER -59.24 -25.61 64.19 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.191 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.737 ' SG ' HD23 ' A' ' 17' ' ' LEU . 71.2 m -73.78 -38.77 64.54 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.597 -0.69 . . . . 0.0 109.286 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.47 ' O ' ' HD2' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -63.51 -48.05 79.18 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.263 -0.898 . . . . 0.0 108.848 179.498 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.466 ' HA ' ' OG ' ' A' ' 25' ' ' SER . 31.0 m95 -73.08 -26.77 61.38 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.642 -1.286 . . . . 0.0 109.82 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.519 ' HB2' ' HG2' ' A' ' 40' ' ' MET . 15.2 t80 -66.17 -31.28 72.02 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.08 -1.012 . . . . 0.0 108.422 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.546 ' O ' HG23 ' A' ' 28' ' ' THR . 93.4 t -75.42 -41.52 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.003 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.466 ' OG ' ' HA ' ' A' ' 22' ' ' TRP . 0.5 OUTLIER -56.2 -42.3 76.96 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.434 -0.906 . . . . 0.0 109.986 -179.863 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 2.4 m -77.59 -55.08 5.66 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.267 -0.896 . . . . 0.0 111.256 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.87 -24.56 62.34 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 120.743 -1.223 . . . . 0.0 110.3 -178.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.546 HG23 ' O ' ' A' ' 24' ' ' VAL . 72.4 p -92.87 -67.1 0.88 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.005 -1.059 . . . . 0.0 111.351 -178.568 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 84' ' ' GLY . 3.6 m -99.0 16.69 21.74 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.618 -1.301 . . . . 0.0 109.843 -179.159 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 26' ' ' THR . . . 56.48 21.48 34.63 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.358 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.515 HG12 ' N ' ' A' ' 32' ' ' GLY . 73.6 t -105.79 161.11 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.141 -1.211 . . . . 0.0 109.615 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.515 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 138.36 179.86 17.63 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 108.849 -1.7 . . . . 0.0 108.849 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -66.19 175.8 4.52 Favored 'Trans proline' 0 N--CA 1.482 0.803 0 CA-C-N 119.127 1.464 . . . . 0.0 110.051 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 7.4 mtt-85 -91.4 82.2 5.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.847 -1.158 . . . . 0.0 110.013 -178.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.97 131.2 28.26 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -45.95 158.28 0.1 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.086 -1.009 . . . . 0.0 109.326 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -75.79 -52.34 10.62 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.973 -1.079 . . . . 0.0 110.205 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -47.12 -34.03 5.67 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.971 -1.081 . . . . 0.0 109.643 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.497 ' O ' ' HD3' ' A' ' 43' ' ' ARG . 3.0 mt-10 -69.57 -41.65 75.57 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.15 -0.969 . . . . 0.0 108.906 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.556 ' HE2' ' OG ' ' A' ' 19' ' ' SER . 2.6 tpt -61.24 -60.41 3.79 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.6 ttpm? -50.35 -40.89 50.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.745 -0.597 . . . . 0.0 109.529 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.59 -45.59 88.78 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.282 -0.886 . . . . 0.0 109.486 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.534 ' HD2' ' N ' ' A' ' 43' ' ' ARG . 1.0 OUTLIER -59.82 -48.79 80.26 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.355 -0.841 . . . . 0.0 109.851 -179.695 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.418 ' SG ' ' N ' ' A' ' 20' ' ' CYS . 14.0 m -58.03 -34.42 70.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.992 -1.068 . . . . 0.0 110.439 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 20.8 m -70.95 -30.58 66.91 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.977 -1.077 . . . . 0.0 109.091 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.63 -35.61 75.39 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.471 ' O ' ' CG1' ' A' ' 51' ' ' ILE . 3.4 mt-30 -76.95 -26.48 54.06 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.617 HD12 HD12 ' A' ' 105' ' ' LEU . 1.7 tm? -71.65 -34.83 70.07 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.491 ' HG2' HD13 ' A' ' 105' ' ' LEU . 4.2 mm-40 -77.06 -58.43 3.29 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.487 ' O ' ' HD3' ' A' ' 52' ' ' PRO . . . -46.35 -35.17 5.17 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.534 HD12 HG12 ' A' ' 12' ' ' ILE . 21.9 mm -82.01 106.62 6.62 Favored Pre-proline 0 N--CA 1.488 1.449 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.296 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.487 ' HD3' ' O ' ' A' ' 50' ' ' ALA . 25.7 Cg_endo -61.84 148.35 93.28 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 121.883 1.722 . . . . 0.0 110.886 -177.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.836 ' HB2' ' NH1' ' A' ' 56' ' ' ARG . . . -59.77 -35.05 73.84 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.665 -0.647 . . . . 0.0 111.156 -178.101 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.745 ' HA ' HD12 ' A' ' 108' ' ' ILE . 6.0 t80 -45.58 -27.17 0.71 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.905 -1.122 . . . . 0.0 108.137 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.802 ' CB ' HD11 ' A' ' 12' ' ' ILE . 13.3 m -116.43 -73.34 0.65 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.012 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.836 ' NH1' ' HB2' ' A' ' 53' ' ' ALA . 22.4 mtt180 31.71 -98.89 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.828 -0.545 . . . . 0.0 110.176 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.497 ' C ' ' O ' ' A' ' 56' ' ' ARG . 66.2 m -33.46 -55.89 0.43 Allowed 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.277 -0.89 . . . . 0.0 111.208 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.482 ' O ' ' C ' ' A' ' 59' ' ' ALA . 1.1 tt0 -35.74 -53.63 0.72 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.766 -1.208 . . . . 0.0 111.05 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.482 ' C ' ' O ' ' A' ' 58' ' ' GLU . . . -35.85 -52.49 0.72 Allowed 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.214 -0.928 . . . . 0.0 110.287 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.749 HG22 HD13 ' A' ' 97' ' ' LEU . 7.4 t -53.52 -50.47 49.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 121.247 -0.908 . . . . 0.0 108.784 179.517 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.516 ' O ' ' HB2' ' A' ' 65' ' ' ASP . 6.8 mtp85 -53.55 -29.61 37.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.403 -0.81 . . . . 0.0 109.83 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.818 HG23 ' HB ' ' A' ' 67' ' ' VAL . 17.9 mt -77.6 -30.14 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 120.957 -1.089 . . . . 0.0 110.043 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.494 ' O ' ' HA ' ' A' ' 77' ' ' ARG . 13.0 tp -77.26 -43.18 34.29 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.773 -1.205 . . . . 0.0 109.612 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 47.5 tpp -78.42 -50.96 10.76 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.18 -0.95 . . . . 0.0 109.945 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.516 ' HB2' ' O ' ' A' ' 61' ' ' ARG . 17.5 m-20 -79.68 -21.97 44.04 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.061 -1.024 . . . . 0.0 109.978 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.56 146.11 9.57 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.818 ' HB ' HG23 ' A' ' 62' ' ' ILE . 2.6 p -116.88 159.47 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.512 -0.993 . . . . 0.0 109.329 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.759 HG22 ' CE1' ' A' ' 74' ' ' HIS . 7.9 t -114.3 157.99 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 CA-C-O 121.864 0.84 . . . . 0.0 109.892 -178.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.456 ' N ' ' CG1' ' A' ' 68' ' ' VAL . 21.7 p -116.87 159.27 22.64 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.604 0.716 . . . . 0.0 109.583 -178.32 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.0 t -62.27 -34.17 76.03 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.588 -0.695 . . . . 0.0 110.142 -179.12 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.8 p -65.63 -14.93 62.18 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.525 -0.734 . . . . 0.0 109.52 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 99.97 8.09 51.65 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.674 -1.77 . . . . 0.0 108.674 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -92.1 156.81 17.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.216 -1.167 . . . . 0.0 109.5 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.759 ' CE1' HG22 ' A' ' 68' ' ' VAL . 0.9 OUTLIER -115.8 155.88 27.06 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 120.812 -1.18 . . . . 0.0 108.675 179.99 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.436 ' HG2' ' C ' ' A' ' 74' ' ' HIS . 3.3 mt-10 -141.44 -172.89 3.62 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.088 -1.007 . . . . 0.0 110.585 -179.265 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 49.65 -146.07 7.73 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.494 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER 56.2 17.77 2.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -1.175 . . . . 0.0 110.1 179.64 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.421 ' O ' ' N ' ' A' ' 80' ' ' GLN . 0.1 OUTLIER -83.8 -11.96 56.33 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.983 -1.073 . . . . 0.0 110.127 -179.611 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -47.71 99.32 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.869 -1.144 . . . . 0.0 109.34 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.421 ' N ' ' O ' ' A' ' 78' ' ' LEU . 2.2 mt-30 -134.39 170.99 14.91 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.238 -0.913 . . . . 0.0 109.698 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.45 ' OD1' ' HG3' ' A' ' 87' ' ' ARG . 2.2 m-20 -65.94 107.4 1.84 Allowed 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.595 0.712 . . . . 0.0 110.82 -179.165 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.682 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 18.0 mt -80.0 172.06 10.81 Favored Pre-proline 0 C--N 1.301 -1.506 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 177.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.682 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 28.3 Cg_endo -68.32 100.84 0.68 Allowed 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 120.872 1.048 . . . . 0.0 109.723 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.454 ' O ' ' SG ' ' A' ' 29' ' ' CYS . . . 92.27 15.44 53.56 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 -179.353 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.511 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 3.4 m -148.52 90.57 4.88 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 120.802 -1.411 . . . . 0.0 108.856 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.413 ' O ' ' C ' ' A' ' 87' ' ' ARG . 30.4 Cg_endo -74.77 160.48 40.77 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.367 1.378 . . . . 0.0 111.649 -178.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.45 ' HG3' ' OD1' ' A' ' 81' ' ' ASP . 53.4 mtp180 -44.7 -29.41 0.76 Allowed 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 122.152 0.977 . . . . 0.0 108.396 178.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -54.03 -52.39 60.99 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.58 -178.12 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 58.8 t -65.05 -41.61 92.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 O-C-N 120.94 -1.1 . . . . 0.0 110.207 -178.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.564 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 3.6 mp0 -62.43 -27.4 69.08 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.262 -0.899 . . . . 0.0 108.705 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.498 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 0.0 OUTLIER -78.61 -33.06 47.74 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.444 -0.785 . . . . 0.0 109.957 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.502 ' O ' ' HD2' ' A' ' 95' ' ' PRO . . . -71.44 -45.6 62.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.933 -1.104 . . . . 0.0 109.499 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.574 ' O ' ' CD1' ' A' ' 93' ' ' PHE . 10.0 t80 -77.92 -25.71 48.53 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.383 -0.823 . . . . 0.0 110.102 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.782 ' HB3' ' HD3' ' A' ' 95' ' ' PRO . . . -43.55 -50.89 16.63 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.395 -0.816 . . . . 0.0 112.094 -178.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.782 ' HD3' ' HB3' ' A' ' 94' ' ' ALA . 32.9 Cg_endo -73.66 24.0 0.33 Allowed 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.64 2.227 . . . . 0.0 112.951 -178.571 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.411 ' O ' ' HG3' ' A' ' 102' ' ' GLU . 0.4 OUTLIER -126.8 28.69 5.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.688 -1.258 . . . . 0.0 108.898 178.612 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.749 HD13 HG22 ' A' ' 60' ' ' VAL . 0.6 OUTLIER -80.12 -77.77 0.18 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.403 -0.811 . . . . 0.0 110.403 -179.476 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 98' ' ' VAL . 2.5 m -79.81 27.89 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.906 -1.121 . . . . 0.0 110.873 -179.374 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.483 ' C ' ' HB2' ' A' ' 104' ' ' ASN . 5.1 p -101.27 170.98 7.88 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.909 -1.119 . . . . 0.0 108.196 179.089 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -60.39 1.33 0.13 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.571 -1.331 . . . . 0.0 112.179 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.404 ' HB ' ' HG2' ' A' ' 96' ' ' LYS . 2.7 t -101.02 1.69 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 119.822 -1.799 . . . . 0.0 110.972 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.508 ' HB2' ' O ' ' A' ' 97' ' ' LEU . 0.3 OUTLIER -140.17 -94.29 0.16 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.513 -1.367 . . . . 0.0 110.655 -179.714 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.468 ' O ' ' C ' ' A' ' 104' ' ' ASN . 72.8 m -131.99 38.68 3.5 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.928 -1.108 . . . . 0.0 109.004 -179.159 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.538 ' ND2' ' HB3' ' A' ' 112' ' ' PRO . 42.0 t-20 -29.52 -66.02 0.09 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.811 -0.556 . . . . 0.0 112.091 -179.107 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.617 HD12 HD12 ' A' ' 48' ' ' LEU . 11.3 mt 41.7 33.98 0.37 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.064 -1.023 . . . . 0.0 109.748 -179.2 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.474 ' O ' ' O ' ' A' ' 105' ' ' LEU . . . 55.23 165.6 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.032 -1.043 . . . . 0.0 108.993 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.73 ' OG1' ' CE1' ' A' ' 109' ' ' HIS . 1.7 p -133.79 -146.08 0.26 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.0 -1.063 . . . . 0.0 108.722 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.745 HD12 ' HA ' ' A' ' 54' ' ' TYR . 1.3 tt -69.05 -38.68 78.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.31 -0.869 . . . . 0.0 110.008 179.315 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.73 ' CE1' ' OG1' ' A' ' 107' ' ' THR . 0.6 OUTLIER -84.46 24.0 1.05 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.179 -0.951 . . . . 0.0 110.035 -179.75 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 109' ' ' HIS . . . 42.73 54.78 4.89 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.199 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -179.66 159.55 24.15 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.538 ' HB3' ' ND2' ' A' ' 104' ' ' ASN . 31.7 Cg_endo -77.04 79.58 3.09 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.722 2.281 . . . . 0.0 109.859 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.608 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER 173.01 96.8 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.383 0 C-N-CA 118.826 -1.15 . . . . 0.0 113.073 -179.765 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.619 ' HB3' ' NE2' ' A' ' 109' ' ' HIS . 17.3 p -124.47 173.81 8.2 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.284 -1.51 . . . . 0.0 109.561 177.302 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.569 ' CB ' ' O ' ' A' ' 114' ' ' CYS . 0.0 OUTLIER 84.95 -46.35 0.08 Allowed 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -179.157 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 20.0 m -72.77 -31.1 64.65 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.262 -0.899 . . . . 0.0 108.937 179.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.676 HD13 ' CD2' ' A' ' 109' ' ' HIS . 5.5 mp -59.74 -15.79 22.59 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.23 -0.919 . . . . 0.0 109.441 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.532 ' HB2' ' O ' ' A' ' 117' ' ' LEU . 20.3 mt 69.52 -15.4 0.3 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.604 -0.685 . . . . 0.0 112.466 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.26 -148.48 35.96 Favored Glycine 0 N--CA 1.491 2.327 0 O-C-N 120.342 -1.474 . . . . 0.0 109.706 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -105.08 71.4 0.95 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.335 -1.097 . . . . 0.0 109.608 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.2 -11.86 59.67 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.281 -1.129 . . . . 0.0 109.452 -179.909 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.446 ' O ' ' C ' ' A' ' 2' ' ' VAL . 76.6 p . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.446 ' C ' ' O ' ' A' ' 1' ' ' SER . 6.1 m -39.48 -45.58 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.571 -0.706 . . . . 0.0 110.144 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.536 ' O ' ' CG2' ' A' ' 4' ' ' THR . . . 146.19 -88.65 0.16 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.536 ' CG2' ' O ' ' A' ' 3' ' ' GLY . 8.5 t 40.73 29.42 0.07 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.545 -0.973 . . . . 0.0 109.826 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 3' ' ' GLY . 0.4 OUTLIER 49.66 -176.03 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.336 -0.853 . . . . 0.0 109.684 179.9 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.4 m 59.17 99.62 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.246 -0.909 . . . . 0.0 109.715 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.569 ' CG1' ' HD2' ' A' ' 8' ' ' PRO . 3.4 tt -138.88 143.41 37.25 Favored Pre-proline 0 N--CA 1.491 1.576 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.569 ' HD2' ' CG1' ' A' ' 7' ' ' ILE . 34.7 Cg_endo -77.0 140.88 20.56 Favored 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 121.739 1.626 . . . . 0.0 110.999 -179.049 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.55 -14.78 33.69 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.73 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 0.7 OUTLIER -134.87 116.68 15.04 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.18 -1.188 . . . . 0.0 108.108 179.499 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 85.61 -59.05 0.07 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.796 -1.19 . . . . 0.0 107.811 -178.45 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.402 HG23 HD12 ' A' ' 12' ' ' ILE . 9.9 mm -107.2 101.36 38.01 Favored Pre-proline 0 C--N 1.303 -1.434 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 178.027 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -81.36 175.45 9.64 Favored 'Trans proline' 0 C--N 1.318 -1.064 0 C-N-CA 121.459 1.439 . . . . 0.0 111.955 -176.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 52.8 m-70 -76.76 147.84 37.06 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.673 -0.642 . . . . 0.0 109.553 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.586 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 4.0 t-20 58.22 58.03 6.54 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 120.796 -1.19 . . . . 0.0 109.93 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.586 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 37.1 Cg_endo -79.66 168.62 19.34 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.55 2.167 . . . . 0.0 111.03 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.855 ' CD2' ' HB1' ' A' ' 59' ' ' ALA . 3.3 mm? 52.33 44.38 29.87 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.551 -0.718 . . . . 0.0 111.041 178.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.472 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 3.9 p30 -83.61 -47.29 11.43 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.867 -1.146 . . . . 0.0 109.412 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.59 -25.99 67.68 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.393 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.691 ' SG ' HD13 ' A' ' 17' ' ' LEU . 72.4 m -71.08 -50.02 38.24 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.624 -0.672 . . . . 0.0 109.62 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.561 ' CG ' ' N ' ' A' ' 22' ' ' TRP . 4.2 ptt180 -59.03 -52.09 67.24 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.132 -0.98 . . . . 0.0 109.632 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.561 ' N ' ' CG ' ' A' ' 21' ' ' ARG . 22.9 m95 -61.15 -34.32 74.83 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 118.584 -1.246 . . . . 0.0 108.943 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.538 ' HB2' ' CG ' ' A' ' 40' ' ' MET . 7.2 t80 -60.32 -30.45 69.52 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.613 ' O ' HG23 ' A' ' 28' ' ' THR . 48.0 t -72.67 -41.88 62.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 C-N-CA 118.816 -1.154 . . . . 0.0 107.94 178.231 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 64.8 p -55.67 -42.99 75.91 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.247 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 5.4 m -78.13 -52.98 7.9 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.158 -0.964 . . . . 0.0 111.708 -178.407 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.473 ' HG2' ' CE1' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -60.51 -25.76 66.35 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.703 -1.248 . . . . 0.0 110.792 -178.383 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.613 HG23 ' O ' ' A' ' 24' ' ' VAL . 21.9 p -96.83 -60.84 1.51 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.019 -1.051 . . . . 0.0 111.095 -178.237 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.475 ' SG ' ' O ' ' A' ' 84' ' ' GLY . 3.5 m -99.39 15.78 25.23 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.875 -1.141 . . . . 0.0 110.13 -179.106 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 26' ' ' THR . . . 52.44 21.02 8.02 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 -179.001 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.557 HG12 ' N ' ' A' ' 32' ' ' GLY . 41.7 t -109.51 165.37 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.276 -1.132 . . . . 0.0 109.62 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.557 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 130.3 178.32 15.36 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 108.58 -1.808 . . . . 0.0 108.58 -179.453 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -65.44 176.2 3.58 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 CA-C-N 119.188 1.494 . . . . 0.0 109.825 179.166 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 24.1 mtt180 -91.11 79.07 5.81 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.707 -1.246 . . . . 0.0 110.369 -177.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.465 ' O ' ' C ' ' A' ' 36' ' ' ALA . 52.1 mt -127.35 114.93 18.22 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 178.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.465 ' C ' ' O ' ' A' ' 35' ' ' LEU . . . -41.05 160.32 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.342 -0.849 . . . . 0.0 109.462 -179.14 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.467 HG22 ' HE1' ' A' ' 23' ' ' TYR . 0.7 OUTLIER -68.38 -59.94 2.81 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.074 -1.017 . . . . 0.0 110.377 -179.107 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -48.48 -31.55 6.54 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.074 -1.016 . . . . 0.0 110.086 -179.119 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -68.7 -47.01 67.51 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.192 -0.942 . . . . 0.0 108.767 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.538 ' CG ' ' HB2' ' A' ' 23' ' ' TYR . 17.6 tpp -60.04 -60.54 3.66 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.1 tppt? -47.79 -35.4 10.0 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.561 -0.712 . . . . 0.0 109.152 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.16 -43.07 92.97 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.34 -0.85 . . . . 0.0 109.383 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -63.11 -43.79 97.45 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.328 -0.857 . . . . 0.0 109.905 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.426 ' SG ' ' N ' ' A' ' 20' ' ' CYS . 19.0 m -64.57 -36.39 84.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.08 -1.012 . . . . 0.0 110.063 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 63.9 m -70.21 -29.82 66.75 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.95 -1.094 . . . . 0.0 108.976 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.448 ' NH1' ' HB2' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -73.43 -32.4 64.38 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.077 -1.014 . . . . 0.0 108.296 179.459 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -77.34 -30.99 54.18 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.368 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.039 HD11 HG12 ' A' ' 98' ' ' VAL . 8.4 tt -74.11 -38.08 63.93 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.221 -0.924 . . . . 0.0 109.089 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.447 ' O ' ' C ' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -71.17 -53.59 13.95 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.256 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.481 ' O ' ' HD3' ' A' ' 52' ' ' PRO . . . -46.54 -46.39 19.28 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 178.107 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 73.8 mt -67.61 106.97 1.44 Allowed Pre-proline 0 C--N 1.304 -1.387 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 176.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.529 ' O ' ' N ' ' A' ' 54' ' ' TYR . 24.5 Cg_endo -60.61 138.94 83.21 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 121.581 1.521 . . . . 0.0 111.097 -176.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.593 ' HA ' ' CG ' ' A' ' 56' ' ' ARG . . . -32.54 -33.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.198 0.523 . . . . 0.0 110.669 -178.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.529 ' N ' ' O ' ' A' ' 52' ' ' PRO . 2.0 m-85 -66.82 122.68 18.22 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.298 -0.876 . . . . 0.0 109.481 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 34.1 m 73.43 13.47 4.56 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.588 -0.695 . . . . 0.0 111.126 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.593 ' CG ' ' HA ' ' A' ' 53' ' ' ALA . 9.0 mmt85 -41.41 -87.28 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.606 -1.309 . . . . 0.0 109.362 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.521 ' C ' ' O ' ' A' ' 56' ' ' ARG . 6.5 m -24.9 -49.51 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.447 0 O-C-N 121.786 -0.571 . . . . 0.0 112.161 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.509 ' C ' ' O ' ' A' ' 57' ' ' CYS . 12.8 tt0 -25.73 -49.9 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.365 -0.834 . . . . 0.0 111.775 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.855 ' HB1' ' CD2' ' A' ' 17' ' ' LEU . . . -40.9 -60.41 1.19 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.135 -0.978 . . . . 0.0 110.013 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.981 ' CG2' HD13 ' A' ' 97' ' ' LEU . 39.8 t -52.31 -39.77 29.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 O-C-N 121.395 -0.816 . . . . 0.0 109.403 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.515 ' O ' ' HB2' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -62.01 -33.11 73.74 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.416 -0.803 . . . . 0.0 110.116 -179.677 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.771 HG23 ' HB ' ' A' ' 67' ' ' VAL . 48.5 mt -77.38 -28.47 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.926 -1.109 . . . . 0.0 110.09 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.667 HD21 HD23 ' A' ' 79' ' ' LEU . 2.3 tt -77.01 -46.72 22.83 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.779 -1.2 . . . . 0.0 109.61 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 10.2 tpt -77.19 -50.42 12.99 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.082 -1.011 . . . . 0.0 109.914 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.515 ' HB2' ' O ' ' A' ' 61' ' ' ARG . 19.9 m-20 -80.21 -21.47 42.89 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.97 -1.081 . . . . 0.0 110.076 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.429 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . 85.29 151.69 15.97 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.771 ' HB ' HG23 ' A' ' 62' ' ' ILE . 1.6 p -117.09 157.82 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.368 -1.077 . . . . 0.0 109.276 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.684 HG22 ' CE1' ' A' ' 74' ' ' HIS . 14.7 t -116.27 158.32 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.32 -0.863 . . . . 0.0 110.075 -178.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.467 ' N ' ' CG1' ' A' ' 68' ' ' VAL . 29.7 p -117.17 158.71 23.8 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.046 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.6 t -64.38 -32.98 74.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.515 -0.74 . . . . 0.0 109.791 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.2 p -64.75 -14.25 58.08 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.574 -0.704 . . . . 0.0 109.362 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 99.67 8.07 52.54 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -91.25 156.21 17.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.964 -1.315 . . . . 0.0 109.836 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.684 ' CE1' HG22 ' A' ' 68' ' ' VAL . 0.9 OUTLIER -116.4 156.19 27.2 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.002 -1.061 . . . . 0.0 108.616 179.929 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 74' ' ' HIS . 5.2 mt-10 -142.83 -179.04 6.1 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.213 -0.93 . . . . 0.0 110.237 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 51.85 -143.11 19.87 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.438 ' HD2' ' O ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER 56.7 15.9 2.39 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.491 -1.005 . . . . 0.0 110.242 179.544 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 80' ' ' GLN . 2.4 mp -84.9 -11.04 56.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.956 -1.09 . . . . 0.0 110.244 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.788 HD21 ' HG2' ' A' ' 90' ' ' GLN . 1.1 tm? -43.03 96.22 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.008 -1.058 . . . . 0.0 109.046 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.518 ' N ' ' O ' ' A' ' 78' ' ' LEU . 83.7 mt-30 -143.53 179.39 7.15 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.198 -0.939 . . . . 0.0 110.501 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.84 112.05 4.06 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.818 0.818 . . . . 0.0 111.633 -178.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.675 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 23.2 mt -91.76 172.14 6.9 Favored Pre-proline 0 N--CA 1.488 1.463 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 177.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.675 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 28.4 Cg_endo -67.45 100.58 0.57 Allowed 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 121.1 1.2 . . . . 0.0 110.907 -179.559 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.475 ' O ' ' SG ' ' A' ' 29' ' ' CYS . . . 90.86 12.68 60.23 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.492 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 3.3 m -142.98 91.9 7.03 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 120.916 -1.343 . . . . 0.0 109.255 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.406 ' O ' ' C ' ' A' ' 87' ' ' ARG . 29.2 Cg_endo -73.39 159.53 46.47 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 121.272 1.315 . . . . 0.0 111.451 -179.016 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.406 ' C ' ' O ' ' A' ' 86' ' ' PRO . 6.3 mtm-85 -44.91 -27.87 0.59 Allowed 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 121.903 0.859 . . . . 0.0 108.889 178.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.95 -46.47 82.09 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.906 -0.496 . . . . 0.0 112.058 -177.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.48 HG11 ' HB ' ' A' ' 28' ' ' THR . 40.5 t -69.99 -41.66 79.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 120.689 -1.257 . . . . 0.0 110.929 -178.158 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.788 ' HG2' HD21 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -64.64 -30.11 71.13 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.048 -1.032 . . . . 0.0 108.807 -179.909 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.488 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 0.0 OUTLIER -78.17 -27.81 48.12 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.504 179.609 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.501 ' O ' ' HD2' ' A' ' 95' ' ' PRO . . . -73.17 -51.2 18.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.103 -0.998 . . . . 0.0 109.68 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.452 ' C ' ' HD2' ' A' ' 95' ' ' PRO . 40.9 t80 -77.78 -26.53 49.8 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.19 -0.944 . . . . 0.0 110.022 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.805 ' HB3' ' HD3' ' A' ' 95' ' ' PRO . . . -42.28 -51.96 10.38 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.383 -0.823 . . . . 0.0 111.593 -178.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.805 ' HD3' ' HB3' ' A' ' 94' ' ' ALA . 31.2 Cg_endo -72.06 80.63 1.52 Allowed 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.203 1.935 . . . . 0.0 111.628 -178.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.432 ' O ' ' HG3' ' A' ' 102' ' ' GLU . 0.0 OUTLIER 176.44 56.51 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.628 -0.67 . . . . 0.0 109.22 179.234 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.997 HD23 HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -96.27 -82.17 0.4 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.212 -0.93 . . . . 0.0 111.271 -179.075 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 1.039 HG12 HD11 ' A' ' 48' ' ' LEU . 3.6 m -81.91 28.77 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.735 -1.228 . . . . 0.0 111.197 -178.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.465 ' C ' ' HB3' ' A' ' 104' ' ' ASN . 5.3 p -97.53 170.88 8.73 Favored 'General case' 0 C--N 1.294 -1.834 0 O-C-N 120.644 -1.285 . . . . 0.0 108.449 179.048 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.79 -2.05 0.2 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.679 -1.263 . . . . 0.0 111.892 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.672 ' O ' HG12 ' A' ' 101' ' ' VAL . 57.4 t -100.86 6.4 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 119.844 -1.785 . . . . 0.0 110.73 -179.126 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.436 ' CB ' ' O ' ' A' ' 97' ' ' LEU . 0.3 OUTLIER -141.52 -91.17 0.14 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.684 -1.26 . . . . 0.0 110.386 -179.899 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.802 ' O ' HD12 ' A' ' 105' ' ' LEU . 3.6 m -142.89 38.58 1.46 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.951 -1.093 . . . . 0.0 108.861 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.493 ' O ' ' N ' ' A' ' 106' ' ' ALA . 8.3 p30 -34.87 -51.86 0.52 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.21 -0.931 . . . . 0.0 112.158 -178.254 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.802 HD12 ' O ' ' A' ' 103' ' ' CYS . 0.6 OUTLIER 40.55 26.94 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.953 -1.092 . . . . 0.0 109.825 -179.396 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' A' ' 104' ' ' ASN . . . 62.25 153.85 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.778 -1.202 . . . . 0.0 108.693 -178.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.4 p -128.56 -178.48 4.6 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.099 -1.001 . . . . 0.0 108.629 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.579 ' N ' ' HB1' ' A' ' 53' ' ' ALA . 7.1 tp -64.17 -33.1 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.921 -1.112 . . . . 0.0 108.83 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -62.68 -2.31 1.09 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.771 -0.581 . . . . 0.0 111.084 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 63.31 31.73 81.72 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -162.79 172.51 38.85 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.941 -1.263 . . . . 0.0 109.941 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.523 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 30.2 Cg_endo -76.87 69.46 6.91 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 123.049 2.499 . . . . 0.0 111.6 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.523 ' HB3' ' O ' ' A' ' 112' ' ' PRO . 34.9 p90 173.0 159.96 0.12 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.397 -0.814 . . . . 0.0 110.481 178.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.513 ' O ' ' HB2' ' A' ' 115' ' ' LEU . 1.8 p -144.69 160.46 41.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.396 -0.815 . . . . 0.0 108.859 179.09 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.513 ' HB2' ' O ' ' A' ' 114' ' ' CYS . 5.5 tp 173.56 -69.73 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.131 -0.981 . . . . 0.0 109.296 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -170.91 -79.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.368 -0.833 . . . . 0.0 109.173 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.51 ' O ' ' HB2' ' A' ' 118' ' ' LEU . 5.3 mp 49.81 20.37 0.54 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.311 -0.868 . . . . 0.0 109.889 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.51 ' HB2' ' O ' ' A' ' 117' ' ' LEU . 10.4 mp 66.51 -11.77 0.22 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.251 -0.906 . . . . 0.0 112.846 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.432 ' O ' ' C ' ' A' ' 120' ' ' ALA . . . 78.12 35.84 33.22 Favored Glycine 0 N--CA 1.489 2.231 0 O-C-N 120.253 -1.529 . . . . 0.0 109.682 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 119' ' ' GLY . . . 43.22 73.01 0.15 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -1.138 . . . . 0.0 109.609 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.455 ' O ' ' CB ' ' A' ' 122' ' ' GLU . . . -63.2 -18.74 60.89 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.455 ' CB ' ' O ' ' A' ' 121' ' ' GLY . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 O-C-N 121.242 -1.152 . . . . 0.0 109.453 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 8.3 p . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.55 -88.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -109.67 89.11 0.54 Allowed Glycine 0 N--CA 1.497 2.753 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.551 HG23 ' O ' ' A' ' 4' ' ' THR . 7.3 t -177.47 69.39 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.494 0.664 . . . . 0.0 109.392 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.5 t -126.65 163.9 22.45 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.699 -0.625 . . . . 0.0 109.364 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 3.9 m 52.38 -168.97 0.04 OUTLIER 'General case' 0 N--CA 1.505 2.296 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.572 HD13 ' N ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -142.48 126.91 9.94 Favored Pre-proline 0 N--CA 1.499 2.006 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.928 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.572 ' N ' HD13 ' A' ' 7' ' ' ILE . 35.8 Cg_endo -76.27 156.42 37.39 Favored 'Trans proline' 0 N--CA 1.485 0.979 0 C-N-CA 121.859 1.706 . . . . 0.0 111.203 -178.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 83.33 -5.69 76.02 Favored Glycine 0 N--CA 1.5 2.913 0 N-CA-C 110.696 -0.961 . . . . 0.0 110.696 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.562 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 1.6 mtp -136.81 112.24 9.25 Favored 'General case' 0 N--CA 1.501 2.121 0 CA-C-N 118.287 1.043 . . . . 0.0 108.292 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 86.39 -57.22 0.06 Allowed 'General case' 0 N--CA 1.514 2.752 0 CA-C-N 119.834 1.197 . . . . 0.0 108.171 -178.388 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.702 HD11 ' CB ' ' A' ' 55' ' ' CYS . 36.0 mt -106.86 100.36 31.12 Favored Pre-proline 0 N--CA 1.492 1.672 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 178.123 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -82.11 172.74 11.55 Favored 'Trans proline' 0 C--O 1.22 -0.388 0 C-N-CA 121.397 1.398 . . . . 0.0 111.593 -177.123 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 55.4 m80 -72.44 145.19 47.79 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.412 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 4.4 t-20 65.04 64.14 1.07 Allowed Pre-proline 0 N--CA 1.505 2.285 0 O-C-N 121.521 -0.737 . . . . 0.0 109.506 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.722 ' HB2' ' HB1' ' A' ' 59' ' ' ALA . 38.2 Cg_endo -82.1 151.95 16.21 Favored 'Trans proline' 0 N--CA 1.482 0.845 0 C-N-CA 122.344 2.029 . . . . 0.0 112.047 -179.354 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.62 HD12 ' HB2' ' A' ' 16' ' ' PRO . 2.9 mp 46.88 35.0 2.92 Favored 'General case' 0 N--CA 1.502 2.166 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.177 177.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -66.52 -32.55 73.97 Favored 'General case' 0 N--CA 1.505 2.296 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.0 -32.32 73.98 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.476 ' O ' HG23 ' A' ' 24' ' ' VAL . 33.8 m -71.25 -33.83 70.19 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.419 ' CG ' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -60.98 -54.89 39.35 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.11 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.469 ' HA ' ' CE3' ' A' ' 22' ' ' TRP . 30.6 m95 -67.26 -27.0 66.84 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.55 -179.134 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.558 ' HE1' HG22 ' A' ' 37' ' ' THR . 14.5 t80 -68.4 -29.68 68.42 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.193 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.601 HG22 ' CD1' ' A' ' 93' ' ' PHE . 80.7 t -73.29 -42.61 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 177.018 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -53.24 -40.64 64.71 Favored 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 120.594 -0.442 . . . . 0.0 109.968 -179.467 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 31.1 m -77.19 -52.79 8.65 Favored 'General case' 0 N--CA 1.508 2.472 0 O-C-N 122.204 -0.31 . . . . 0.0 111.669 -178.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.587 ' NH1' HG21 ' A' ' 37' ' ' THR . 2.3 mmp_? -59.96 -25.06 64.9 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.859 -0.526 . . . . 0.0 110.678 -178.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 59.7 p -97.74 -65.83 0.94 Allowed 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -177.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.512 ' O ' HG23 ' A' ' 31' ' ' VAL . 57.4 m -100.88 16.04 26.5 Favored 'General case' 0 N--CA 1.51 2.546 0 O-C-N 121.298 -0.876 . . . . 0.0 111.924 -178.625 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 56.83 20.87 34.63 Favored Glycine 0 N--CA 1.505 3.263 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 29' ' ' CYS . 54.9 t -106.94 160.63 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 O-C-N 121.759 -0.847 . . . . 0.0 109.01 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.453 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 134.68 177.89 15.27 Favored Glycine 0 N--CA 1.499 2.851 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -66.46 172.74 8.68 Favored 'Trans proline' 0 N--CA 1.486 1.082 0 CA-C-N 119.098 1.449 . . . . 0.0 109.938 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 8.8 ttt-85 -93.27 86.33 5.29 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 122.027 0.918 . . . . 0.0 110.363 -178.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 76.4 mt -139.65 130.93 26.7 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.01 145.94 6.79 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.868 -0.52 . . . . 0.0 109.928 -178.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.587 HG21 ' NH1' ' A' ' 27' ' ' ARG . 0.8 OUTLIER -56.93 -57.87 10.62 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.705 -0.622 . . . . 0.0 111.217 -179.369 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -49.2 -36.98 21.24 Favored 'General case' 0 N--CA 1.509 2.506 0 O-C-N 121.676 -0.64 . . . . 0.0 111.246 -178.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -70.38 -38.22 74.67 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 122.042 -0.411 . . . . 0.0 110.087 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.403 ' CE ' ' HA ' ' A' ' 40' ' ' MET . 0.0 OUTLIER -64.61 -54.69 28.04 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 -179.64 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -52.71 -36.05 56.68 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.24 -43.78 97.07 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.61 -48.45 81.71 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 14.6 m -61.25 -34.0 74.43 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 122.04 -0.412 . . . . 0.0 111.338 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 17.9 m -73.8 -28.69 61.76 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 7.8 tpt85 -75.11 -34.31 61.7 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -79.08 -36.96 40.0 Favored 'General case' 0 N--CA 1.5 2.055 0 CA-C-O 121.184 0.516 . . . . 0.0 110.207 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.7 HD21 ' NH1' ' A' ' 56' ' ' ARG . 3.5 tt -70.32 -38.58 74.96 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.207 -178.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -77.72 -42.72 33.36 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.99 -37.43 63.99 Favored 'General case' 0 N--CA 1.507 2.397 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 178.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.421 ' O ' ' HD3' ' A' ' 56' ' ' ARG . 51.1 mt -86.46 105.65 8.27 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 177.287 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -62.87 141.59 85.2 Favored 'Trans proline' 0 N--CA 1.481 0.753 0 C-N-CA 121.517 1.478 . . . . 0.0 110.856 -177.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -43.27 -29.83 0.44 Allowed 'General case' 0 N--CA 1.503 2.189 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.286 -178.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.07 110.01 5.49 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.559 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.702 ' CB ' HD11 ' A' ' 12' ' ' ILE . 25.1 m 86.39 -15.36 0.47 Allowed 'General case' 0 N--CA 1.513 2.706 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -177.368 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.7 ' NH1' HD21 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -45.75 -81.94 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.357 0 O-C-N 121.737 -0.602 . . . . 0.0 110.865 -179.855 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 94.0 m -24.5 -42.88 0.01 OUTLIER 'General case' 0 N--CA 1.519 3.001 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -179.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -41.5 -57.08 2.34 Favored 'General case' 0 N--CA 1.511 2.588 0 CA-C-N 119.055 0.843 . . . . 0.0 111.429 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.722 ' HB1' ' HB2' ' A' ' 16' ' ' PRO . . . -39.43 -44.63 1.39 Allowed 'General case' 0 N--CA 1.514 2.748 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 38.7 t -58.92 -50.21 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.347 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.67 -25.05 66.07 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.917 HG23 ' HB ' ' A' ' 67' ' ' VAL . 43.1 mm -77.88 -29.13 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.906 -0.496 . . . . 0.0 109.938 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.1 tt -78.35 -41.12 34.36 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.449 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -78.08 -53.33 7.51 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.207 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -80.49 -23.56 40.06 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 122.065 -0.397 . . . . 0.0 111.591 -178.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.62 145.93 6.69 Favored Glycine 0 N--CA 1.503 3.15 0 N-CA-C 109.964 -1.255 . . . . 0.0 109.964 -179.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.917 ' HB ' HG23 ' A' ' 62' ' ' ILE . 7.2 p -118.7 159.5 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.492 0 O-C-N 122.151 -0.617 . . . . 0.0 110.209 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.704 HG22 ' NE2' ' A' ' 74' ' ' HIS . 65.7 t -115.49 157.35 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 32.0 p -117.77 159.63 22.71 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.359 -178.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.6 t -63.02 -33.91 76.43 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.076 -178.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.5 p -63.38 -18.78 64.05 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.988 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.45 13.91 34.16 Favored Glycine 0 N--CA 1.497 2.713 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -103.35 157.23 17.17 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 118.226 1.013 . . . . 0.0 109.225 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.704 ' NE2' HG22 ' A' ' 68' ' ' VAL . 8.9 m170 -115.01 155.36 27.11 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -179.41 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -140.32 -179.35 5.95 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 120.849 0.357 . . . . 0.0 110.122 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 51.54 -149.32 8.34 Favored Glycine 0 N--CA 1.497 2.752 0 N-CA-C 109.101 -1.6 . . . . 0.0 109.101 -179.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.8 ttp85 59.17 17.6 5.78 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 122.298 -0.531 . . . . 0.0 110.616 179.04 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 59.8 mt -78.34 -17.45 56.51 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.719 -0.613 . . . . 0.0 109.84 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.677 HD23 ' O ' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -51.93 98.56 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.024 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -140.1 172.56 12.58 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.106 0.479 . . . . 0.0 110.01 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -64.26 102.36 0.51 Allowed 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.672 0.749 . . . . 0.0 111.088 -179.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.647 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 23.7 mt -81.58 172.98 8.39 Favored Pre-proline 0 N--CA 1.495 1.799 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 177.296 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.647 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 26.3 Cg_endo -65.3 99.97 0.37 Allowed 'Trans proline' 0 N--CA 1.477 0.534 0 C-N-CA 120.971 1.114 . . . . 0.0 111.034 -179.107 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.68 -7.86 80.67 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 7.2 m -117.12 92.08 38.44 Favored Pre-proline 0 N--CA 1.502 2.142 0 CA-C-N 119.279 1.539 . . . . 0.0 110.3 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -71.39 164.05 37.03 Favored 'Trans proline' 0 N--CA 1.481 0.754 0 C-N-CA 121.36 1.373 . . . . 0.0 111.205 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.5 mmm-85 -48.24 -29.22 3.59 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.212 0.53 . . . . 0.0 109.571 178.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -55.69 -48.74 74.57 Favored 'General case' 0 N--CA 1.505 2.284 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.377 -178.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 80.2 t -62.55 -37.27 78.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.542 ' HB3' HD12 ' A' ' 79' ' ' LEU . 42.0 mm-40 -64.35 -30.11 71.16 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.053 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.95 -27.97 49.41 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -74.91 -46.73 33.95 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.967 -0.458 . . . . 0.0 109.874 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.601 ' CD1' HG22 ' A' ' 24' ' ' VAL . 29.3 t80 -78.17 -25.13 47.06 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 122.207 -0.308 . . . . 0.0 110.579 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.689 ' HB3' ' HD3' ' A' ' 95' ' ' PRO . . . -50.89 -52.87 53.46 Favored Pre-proline 0 N--CA 1.499 2.006 0 CA-C-O 118.842 -0.599 . . . . 0.0 111.938 -177.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.689 ' HD3' ' HB3' ' A' ' 94' ' ' ALA . 30.4 Cg_endo -71.19 -16.59 31.68 Favored 'Trans proline' 0 N--CA 1.484 0.966 0 C-N-CA 122.062 1.841 . . . . 0.0 111.159 -179.501 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.8 mmpt? -86.99 11.4 13.69 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.934 -0.479 . . . . 0.0 110.193 178.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.471 ' O ' ' HB3' ' A' ' 102' ' ' GLU . 0.2 OUTLIER -72.43 -60.47 2.22 Favored 'General case' 0 N--CA 1.508 2.447 0 O-C-N 121.668 -0.645 . . . . 0.0 111.33 -178.913 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.664 HG12 HD11 ' A' ' 48' ' ' LEU . 13.2 m -89.38 25.34 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 120.819 -1.176 . . . . 0.0 110.517 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 29.7 p -99.35 173.14 6.91 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.52 -0.54 0.27 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.534 -0.729 . . . . 0.0 112.07 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.535 ' O ' HG12 ' A' ' 101' ' ' VAL . 21.8 t -93.82 -0.52 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-N 120.537 1.517 . . . . 0.0 111.028 -179.398 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.471 ' HB3' ' O ' ' A' ' 97' ' ' LEU . 8.3 tt0 -146.95 -90.79 0.09 Allowed 'General case' 0 N--CA 1.505 2.277 0 C-N-CA 119.499 -0.88 . . . . 0.0 112.11 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.687 ' O ' HD22 ' A' ' 48' ' ' LEU . 83.8 m -137.0 45.57 2.24 Favored 'General case' 0 N--CA 1.511 2.609 0 CA-C-N 119.13 0.877 . . . . 0.0 110.609 -177.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 -43.6 -72.68 0.06 Allowed 'General case' 0 N--CA 1.508 2.469 0 O-C-N 120.924 -1.11 . . . . 0.0 112.96 -179.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.6 mp 51.25 34.48 11.54 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.966 -0.459 . . . . 0.0 110.628 -178.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 63.55 148.22 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.27 -0.894 . . . . 0.0 109.73 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.8 p -121.16 -164.41 1.12 Allowed 'General case' 0 N--CA 1.505 2.316 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -179.412 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.0 tt -68.26 -30.72 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.468 ' HB3' ' CE1' ' A' ' 113' ' ' PHE . 73.0 m80 -71.48 0.66 7.87 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.644 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 60.9 36.54 92.27 Favored Glycine 0 N--CA 1.497 2.74 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -169.8 173.94 43.99 Favored Glycine 0 N--CA 1.498 2.823 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -77.88 78.53 3.53 Favored 'Trans proline' 0 N--CA 1.481 0.747 0 C-N-CA 122.65 2.234 . . . . 0.0 110.487 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.468 ' CE1' ' HB3' ' A' ' 109' ' ' HIS . 0.0 OUTLIER 174.53 165.29 0.24 Allowed 'General case' 0 N--CA 1.504 2.27 0 CA-C-O 121.34 0.59 . . . . 0.0 111.399 179.353 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 3.0 t 176.03 165.55 0.4 Allowed 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 75.61 -78.36 0.04 OUTLIER 'General case' 0 N--CA 1.507 2.417 0 O-C-N 122.073 -0.392 . . . . 0.0 110.362 179.553 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.6 p -54.2 -89.44 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.716 -0.615 . . . . 0.0 109.764 -179.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.43 ' HA ' HD13 ' A' ' 117' ' ' LEU . 1.9 mm? 51.61 -88.57 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.298 0 CA-C-N 118.304 0.502 . . . . 0.0 110.585 179.442 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.476 ' N ' HD12 ' A' ' 118' ' ' LEU . 11.1 mp -51.84 -17.92 1.12 Allowed 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.576 -0.703 . . . . 0.0 112.654 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -109.76 153.89 16.76 Favored Glycine 0 N--CA 1.498 2.774 0 N-CA-C 109.249 -1.541 . . . . 0.0 109.249 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 56.36 68.19 0.89 Allowed 'General case' 0 N--CA 1.501 2.092 0 CA-C-O 121.769 0.795 . . . . 0.0 109.819 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -62.08 -22.13 62.36 Favored Glycine 0 N--CA 1.497 2.709 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 . . . . . 0 N--CA 1.497 1.903 0 CA-C-O 118.022 -0.99 . . . . 0.0 109.55 -179.916 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.493 ' C ' HG23 ' A' ' 2' ' ' VAL . 1.1 m . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.493 HG23 ' C ' ' A' ' 1' ' ' SER . 5.0 t 85.07 -35.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.765 0 C-N-CA 122.892 0.477 . . . . 0.0 110.948 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 97.96 152.63 28.34 Favored Glycine 0 N--CA 1.497 2.732 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.0 t -117.49 24.84 10.84 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 122.195 -0.591 . . . . 0.0 109.997 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.86 -169.03 1.55 Allowed 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 84.3 m -133.93 164.85 26.35 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.512 HG22 ' HB2' ' A' ' 10' ' ' MET . 50.7 mt -141.83 115.4 6.68 Favored Pre-proline 0 N--CA 1.5 2.049 0 CA-C-O 118.698 -0.668 . . . . 0.0 109.362 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -78.31 147.43 23.04 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 121.78 1.653 . . . . 0.0 110.734 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 69.78 6.11 54.34 Favored Glycine 0 N--CA 1.502 3.066 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.57 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 0.1 OUTLIER -140.52 107.21 5.35 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.788 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.57 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 87.04 -58.69 0.04 OUTLIER 'General case' 0 N--CA 1.516 2.829 0 CA-C-N 119.865 1.211 . . . . 0.0 108.399 -178.578 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.659 HD11 ' HB2' ' A' ' 55' ' ' CYS . 41.1 mt -103.57 101.38 23.48 Favored Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 178.369 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -81.82 172.45 12.14 Favored 'Trans proline' 0 N--CA 1.477 0.549 0 C-N-CA 121.701 1.601 . . . . 0.0 111.97 -176.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -74.68 145.4 43.2 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.401 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 10.4 t-20 68.14 64.48 0.63 Allowed Pre-proline 0 N--CA 1.508 2.45 0 O-C-N 121.404 -0.81 . . . . 0.0 110.593 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.401 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 41.0 Cg_endo -84.34 171.42 10.06 Favored 'Trans proline' 0 N--CA 1.484 0.959 0 C-N-CA 122.51 2.14 . . . . 0.0 111.908 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 66.1 mt 43.43 46.29 5.64 Favored 'General case' 0 N--CA 1.503 2.223 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.435 177.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -73.47 -41.1 63.59 Favored 'General case' 0 N--CA 1.505 2.28 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.2 t -63.42 -25.74 68.42 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.717 ' O ' HG23 ' A' ' 24' ' ' VAL . 32.5 m -77.73 -35.38 51.98 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 110.251 -0.278 . . . . 0.0 110.251 -179.11 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 11.2 ttp180 -69.92 -42.96 72.63 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.418 ' HA ' ' CE3' ' A' ' 22' ' ' TRP . 31.1 m95 -73.38 -30.97 63.64 Favored 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 118.762 -1.175 . . . . 0.0 108.99 178.54 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.753 ' HE1' HG23 ' A' ' 37' ' ' THR . 8.2 t80 -63.96 -33.85 76.66 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.717 HG23 ' O ' ' A' ' 20' ' ' CYS . 43.6 t -70.51 -38.86 75.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 177.594 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.1 m -55.18 -39.18 69.27 Favored 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.887 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.9 m -77.49 -54.48 6.38 Favored 'General case' 0 N--CA 1.511 2.607 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -178.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -60.83 -24.72 66.09 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.508 -0.745 . . . . 0.0 110.6 -178.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.414 HG23 ' O ' ' A' ' 24' ' ' VAL . 44.2 p -95.93 -63.21 1.17 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 122.003 -0.435 . . . . 0.0 112.153 -177.539 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.683 ' O ' HG23 ' A' ' 31' ' ' VAL . 3.7 m -100.23 12.11 37.82 Favored 'General case' 0 N--CA 1.509 2.507 0 O-C-N 121.249 -0.907 . . . . 0.0 111.484 -178.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 57.26 24.13 50.35 Favored Glycine 0 N--CA 1.507 3.395 0 N-CA-C 109.434 -1.467 . . . . 0.0 109.434 -178.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 29' ' ' CYS . 27.7 t -116.48 164.83 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 O-C-N 122.053 -0.675 . . . . 0.0 109.469 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.495 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 132.09 -177.32 18.79 Favored Glycine 0 N--CA 1.499 2.871 0 N-CA-C 108.675 -1.77 . . . . 0.0 108.675 -178.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -64.01 172.22 6.4 Favored 'Trans proline' 0 N--CA 1.483 0.888 0 CA-C-N 119.485 1.643 . . . . 0.0 109.808 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -92.99 84.64 4.93 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.918 0.866 . . . . 0.0 110.518 -177.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.0 tp -140.26 132.9 28.84 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.88 159.38 0.41 Allowed 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.937 -0.477 . . . . 0.0 109.994 -179.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.753 HG23 ' HE1' ' A' ' 23' ' ' TYR . 34.5 m -74.21 -27.89 61.01 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.934 -0.479 . . . . 0.0 111.255 -178.564 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -74.17 -38.32 63.72 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.869 -0.519 . . . . 0.0 110.524 -178.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -72.8 -30.65 64.25 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.469 ' HA ' ' HE3' ' A' ' 40' ' ' MET . 0.5 OUTLIER -70.86 -56.09 7.04 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.665 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.74 -33.65 70.49 Favored 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.88 -34.14 74.95 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.885 -0.784 . . . . 0.0 108.885 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -66.32 -48.93 68.71 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 16.4 m -62.4 -37.71 86.82 Favored 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.332 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 89.5 m -73.88 -28.25 61.47 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -178.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -72.76 -32.27 65.52 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.432 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -77.79 -37.02 49.77 Favored 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 120.571 -0.451 . . . . 0.0 109.799 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.56 HD11 HG12 ' A' ' 98' ' ' VAL . 2.1 tt -68.65 -36.64 78.86 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -77.09 -41.64 41.35 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.74 -35.11 68.22 Favored 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.563 HG22 ' HG2' ' A' ' 56' ' ' ARG . 58.2 mt -87.0 104.73 6.51 Favored Pre-proline 0 N--CA 1.489 1.5 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 177.247 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -59.15 145.37 97.94 Favored 'Trans proline' 0 N--CA 1.477 0.557 0 C-N-CA 121.383 1.389 . . . . 0.0 110.305 -177.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -36.49 -32.69 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.444 0 C-N-CA 122.767 0.427 . . . . 0.0 112.049 -178.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -71.04 123.36 21.92 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.659 ' HB2' HD11 ' A' ' 12' ' ' ILE . 23.3 m 77.23 -1.04 2.82 Favored 'General case' 0 N--CA 1.509 2.497 0 C-N-CA 122.266 0.226 . . . . 0.0 110.739 -179.007 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.563 ' HG2' HG22 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -57.84 -91.56 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.438 -0.789 . . . . 0.0 109.762 -179.918 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 64.6 m -27.51 -42.36 0.02 OUTLIER 'General case' 0 N--CA 1.523 3.178 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -40.02 -54.24 2.26 Favored 'General case' 0 N--CA 1.513 2.703 0 CA-C-N 119.493 1.042 . . . . 0.0 111.801 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -40.4 -46.58 2.42 Favored 'General case' 0 N--CA 1.511 2.581 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 39.4 t -56.56 -49.94 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -59.32 -26.47 65.04 Favored 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.237 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.942 HG23 ' HB ' ' A' ' 67' ' ' VAL . 42.4 mm -78.42 -29.84 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 O-C-N 121.926 -0.484 . . . . 0.0 110.341 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.468 HD23 HD13 ' A' ' 79' ' ' LEU . 0.7 OUTLIER -79.0 -38.64 36.16 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.848 -0.741 . . . . 0.0 109.9 -179.48 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 2.6 ttm -78.63 -52.78 7.95 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.028 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -80.7 -24.03 39.12 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 122.007 -0.433 . . . . 0.0 111.051 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.41 144.58 5.07 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 108.839 -1.704 . . . . 0.0 108.839 -179.067 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.942 ' HB ' HG23 ' A' ' 62' ' ' ILE . 7.1 p -117.66 159.35 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 122.254 -0.556 . . . . 0.0 109.594 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.526 HG22 ' CD2' ' A' ' 74' ' ' HIS . 51.0 t -114.33 157.23 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.3 p -116.99 159.57 22.29 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.99 -177.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 48.3 t -62.78 -30.47 71.48 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.326 -178.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.8 p -70.1 -16.9 63.19 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.447 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.59 11.46 41.04 Favored Glycine 0 N--CA 1.498 2.8 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -98.64 157.78 16.04 Favored 'General case' 0 N--CA 1.501 2.113 0 CA-C-N 118.103 0.951 . . . . 0.0 109.227 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.526 ' CD2' HG22 ' A' ' 68' ' ' VAL . 10.8 m170 -114.93 155.68 26.44 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -140.29 -178.02 5.29 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.11 0.481 . . . . 0.0 110.194 -179.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 51.79 -144.08 17.56 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.814 -1.315 . . . . 0.0 109.814 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 55.32 22.4 4.82 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 122.394 -0.474 . . . . 0.0 110.071 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.6 mt -86.27 -13.83 45.56 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.719 -0.613 . . . . 0.0 110.93 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.468 HD13 HD23 ' A' ' 63' ' ' LEU . 1.4 tp -61.23 93.24 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -142.9 -177.44 5.33 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.545 0.688 . . . . 0.0 110.216 -178.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -54.3 138.59 38.76 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.842 0.83 . . . . 0.0 111.353 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.528 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 21.3 mt -130.61 168.26 17.74 Favored Pre-proline 0 N--CA 1.497 1.916 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 178.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.528 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 29.4 Cg_endo -68.74 99.75 0.66 Allowed 'Trans proline' 0 N--CA 1.478 0.564 0 C-N-CA 121.044 1.163 . . . . 0.0 110.386 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.8 9.91 63.65 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.466 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 3.4 m -141.95 90.88 8.3 Favored Pre-proline 0 N--CA 1.509 2.515 0 CA-C-N 118.761 1.28 . . . . 0.0 109.756 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -74.25 164.88 33.19 Favored 'Trans proline' 0 N--CA 1.487 1.097 0 C-N-CA 121.885 1.724 . . . . 0.0 111.475 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -48.94 -28.06 3.58 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.063 0.459 . . . . 0.0 110.087 178.442 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -60.31 -47.49 85.81 Favored 'General case' 0 N--CA 1.502 2.164 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -177.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 44.6 t -69.58 -40.94 80.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.775 -0.578 . . . . 0.0 111.518 -177.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.751 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 0.4 OUTLIER -73.3 -25.44 60.66 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.784 -179.549 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.7 tpt180 -78.93 -34.36 44.62 Favored 'General case' 0 N--CA 1.503 2.197 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.231 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.39 -43.69 31.83 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.869 -0.519 . . . . 0.0 110.003 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.548 ' CE1' HG22 ' A' ' 24' ' ' VAL . 28.4 t80 -78.53 -25.91 45.63 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 122.274 -0.267 . . . . 0.0 110.415 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.751 ' HB2' ' O ' ' A' ' 90' ' ' GLN . . . -43.41 -51.53 14.78 Favored Pre-proline 0 N--CA 1.502 2.164 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -178.084 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.66 ' HD3' ' HB3' ' A' ' 94' ' ' ALA . 29.2 Cg_endo -70.6 -170.24 0.43 Allowed 'Trans proline' 0 N--CA 1.481 0.784 0 C-N-CA 121.73 1.62 . . . . 0.0 111.058 -179.01 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 61.34 20.36 11.02 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 -178.213 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.71 -60.96 2.01 Favored 'General case' 0 N--CA 1.508 2.434 0 O-C-N 121.969 -0.457 . . . . 0.0 112.232 -178.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.56 HG12 HD11 ' A' ' 48' ' ' LEU . 19.8 m -82.94 35.06 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 O-C-N 121.112 -0.993 . . . . 0.0 111.921 -178.448 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.411 ' C ' ' HB2' ' A' ' 104' ' ' ASN . 24.6 p -109.1 174.99 5.62 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 178.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -59.66 -2.46 0.36 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.467 -0.771 . . . . 0.0 111.926 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.564 ' O ' HG12 ' A' ' 101' ' ' VAL . 21.9 t -95.61 1.5 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 CA-C-N 120.479 1.49 . . . . 0.0 111.321 -179.321 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -148.02 -91.96 0.08 Allowed 'General case' 0 N--CA 1.504 2.252 0 CA-C-N 119.011 0.823 . . . . 0.0 111.771 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 7.3 m -132.89 49.35 2.32 Favored 'General case' 0 N--CA 1.509 2.503 0 O-C-N 121.365 -0.834 . . . . 0.0 110.1 -178.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.411 ' HB2' ' C ' ' A' ' 99' ' ' THR . 38.2 t30 -42.23 -82.29 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.559 0 O-C-N 120.779 -1.201 . . . . 0.0 112.533 -179.014 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.5 ' O ' ' HB3' ' A' ' 106' ' ' ALA . 8.1 mt 51.58 24.64 2.39 Favored 'General case' 0 N--CA 1.506 2.343 0 O-C-N 121.836 -0.54 . . . . 0.0 111.922 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' A' ' 105' ' ' LEU . . . 71.07 152.27 0.11 Allowed 'General case' 0 N--CA 1.513 2.722 0 O-C-N 121.001 -1.062 . . . . 0.0 110.669 178.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.485 HG21 ' O ' ' A' ' 113' ' ' PHE . 3.9 p -127.85 -163.84 1.31 Allowed 'General case' 0 N--CA 1.51 2.536 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.409 HG23 ' N ' ' A' ' 109' ' ' HIS . 10.9 tt -67.3 -37.28 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.244 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.033 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.607 ' CD2' ' CB ' ' A' ' 115' ' ' LEU . 76.5 m80 -67.43 -2.03 5.72 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.784 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 58.57 28.6 62.74 Favored Glycine 0 N--CA 1.498 2.778 0 N-CA-C 108.744 -1.742 . . . . 0.0 108.744 -178.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -141.19 178.64 20.1 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -179.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.426 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 32.7 Cg_endo -87.87 55.36 2.63 Favored 'Trans proline' 0 N--CA 1.481 0.772 0 C-N-CA 123.358 2.705 . . . . 0.0 110.655 -179.343 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.567 ' CZ ' HD12 ' A' ' 115' ' ' LEU . 0.2 OUTLIER 175.68 -160.03 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -178.297 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.516 ' O ' ' O ' ' A' ' 115' ' ' LEU . 0.1 OUTLIER -145.71 83.11 1.64 Allowed 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 120.143 -0.623 . . . . 0.0 109.881 176.12 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.607 ' CB ' ' CD2' ' A' ' 109' ' ' HIS . 0.2 OUTLIER -37.77 179.38 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.183 0 C-N-CA 124.348 1.059 . . . . 0.0 113.702 -179.405 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.409 ' CB ' ' O ' ' A' ' 115' ' ' LEU . 2.8 t 77.72 41.83 0.13 Allowed 'General case' 0 N--CA 1.507 2.386 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 -176.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.835 HD22 ' H ' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -96.98 19.34 12.94 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.466 -0.771 . . . . 0.0 109.816 -177.548 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.8 mp -46.1 -25.26 0.55 Allowed 'General case' 0 N--CA 1.509 2.496 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -177.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 51.56 60.05 7.8 Favored Glycine 0 N--CA 1.504 3.231 0 CA-C-N 119.662 1.119 . . . . 0.0 110.531 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 59.85 71.61 0.57 Allowed 'General case' 0 N--CA 1.499 2.002 0 CA-C-O 121.771 0.796 . . . . 0.0 109.509 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -57.5 -23.29 48.51 Favored Glycine 0 N--CA 1.497 2.746 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 . . . . . 0 N--CA 1.497 1.896 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.151 179.952 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.1 m -91.4 31.91 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 122.173 -0.329 . . . . 0.0 110.491 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -88.99 87.6 1.49 Allowed Glycine 0 N--CA 1.497 2.759 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.527 HG23 ' O ' ' A' ' 4' ' ' THR . 4.3 t -176.12 78.37 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 61.3 176.81 0.11 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.526 -0.734 . . . . 0.0 109.55 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 17.5 m -115.35 162.01 17.71 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 23.5 pt -121.96 136.39 26.19 Favored Pre-proline 0 N--CA 1.499 1.983 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -179.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -81.66 160.77 19.2 Favored 'Trans proline' 0 N--CA 1.479 0.651 0 C-N-CA 122.004 1.802 . . . . 0.0 110.262 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 71.38 4.71 57.68 Favored Glycine 0 N--CA 1.502 3.076 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.574 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 2.0 mpt? -139.91 99.85 3.79 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 118.153 0.977 . . . . 0.0 108.59 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.574 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 86.87 -57.46 0.05 OUTLIER 'General case' 0 N--CA 1.516 2.836 0 CA-C-N 119.392 0.997 . . . . 0.0 108.504 -178.556 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.442 ' HA ' HD12 ' A' ' 51' ' ' ILE . 17.5 mt -100.1 102.66 18.7 Favored Pre-proline 0 N--CA 1.499 1.992 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 178.485 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -79.76 176.37 9.56 Favored 'Trans proline' 0 C--O 1.22 -0.402 0 C-N-CA 121.458 1.439 . . . . 0.0 111.034 -177.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 46.2 m80 -86.0 142.61 28.65 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 120.721 0.296 . . . . 0.0 111.017 -177.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.584 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 9.2 t-20 70.46 48.12 0.3 Allowed Pre-proline 0 N--CA 1.508 2.451 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 178.489 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.584 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 42.7 Cg_endo -86.65 175.51 5.21 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 121.79 1.66 . . . . 0.0 111.345 178.387 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 49.36 45.18 23.81 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 177.427 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -77.57 -43.16 32.71 Favored 'General case' 0 N--CA 1.509 2.482 0 O-C-N 121.219 -0.925 . . . . 0.0 108.954 178.023 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.94 -24.77 66.3 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.554 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 57.1 m -74.21 -34.25 63.66 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -179.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.96 -43.57 67.85 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.213 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 32.7 m95 -71.53 -26.5 62.67 Favored 'General case' 0 N--CA 1.504 2.263 0 C-N-CA 118.771 -1.172 . . . . 0.0 109.426 178.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.547 ' HB2' ' HG2' ' A' ' 40' ' ' MET . 10.9 t80 -70.24 -35.36 73.77 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.522 ' O ' HG23 ' A' ' 28' ' ' THR . 64.7 t -70.12 -38.59 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 177.319 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 m -57.42 -38.57 74.56 Favored 'General case' 0 N--CA 1.502 2.147 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.149 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 99.8 m -77.05 -51.75 10.53 Favored 'General case' 0 N--CA 1.511 2.578 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.2 tpt180 -62.99 -24.72 68.05 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.425 -0.797 . . . . 0.0 110.335 -178.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.522 HG23 ' O ' ' A' ' 24' ' ' VAL . 56.3 p -92.75 -66.58 0.91 Allowed 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -177.569 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.7 m -100.87 11.49 39.48 Favored 'General case' 0 N--CA 1.511 2.606 0 CA-C-N 119.452 1.024 . . . . 0.0 111.467 -179.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 60.49 25.58 63.25 Favored Glycine 0 N--CA 1.503 3.16 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -178.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.504 HG12 ' N ' ' A' ' 32' ' ' GLY . 47.8 t -108.32 163.73 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.317 0 O-C-N 121.911 -0.758 . . . . 0.0 109.437 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.504 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 126.04 -179.31 16.32 Favored Glycine 0 N--CA 1.499 2.849 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 -179.063 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -64.84 171.61 8.34 Favored 'Trans proline' 0 N--CA 1.486 1.033 0 CA-C-N 119.266 1.533 . . . . 0.0 109.911 179.195 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.759 ' O ' HD22 ' A' ' 35' ' ' LEU . 10.3 mmt-85 -93.23 84.36 4.78 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.917 0.865 . . . . 0.0 109.992 -178.147 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.759 HD22 ' O ' ' A' ' 34' ' ' ARG . 2.4 mm? -131.98 143.89 50.41 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.284 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.568 ' HB3' ' HG3' ' A' ' 39' ' ' GLU . . . -64.76 142.2 58.51 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -49.98 -58.7 4.93 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.506 -0.746 . . . . 0.0 111.004 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -46.82 -40.59 14.04 Favored 'General case' 0 N--CA 1.508 2.462 0 O-C-N 121.892 -0.505 . . . . 0.0 111.482 -178.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.568 ' HG3' ' HB3' ' A' ' 36' ' ' ALA . 13.5 mt-10 -62.78 -46.97 85.52 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.547 ' HG2' ' HB2' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -59.41 -57.69 11.89 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -179.585 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 39.8 tttt -51.82 -29.94 21.39 Favored 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 39' ' ' GLU . . . -65.94 -46.29 78.74 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.129 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.9 mmt-85 -58.06 -60.42 3.77 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 16.5 m -54.29 -32.82 57.27 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -178.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 21.5 m -75.43 -30.55 60.07 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -178.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.32 -34.11 70.27 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -79.05 -31.15 44.43 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.122 0.487 . . . . 0.0 109.817 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.475 ' HA ' HD22 ' A' ' 48' ' ' LEU . 1.2 tm? -67.76 -44.71 76.85 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -178.637 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -78.12 -28.12 48.43 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.81 -44.28 77.69 Favored 'General case' 0 N--CA 1.504 2.258 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.442 HD12 ' HA ' ' A' ' 12' ' ' ILE . 39.5 mm -79.83 106.19 4.52 Favored Pre-proline 0 N--CA 1.49 1.568 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 176.475 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -54.51 144.62 62.0 Favored 'Trans proline' 0 N--CA 1.481 0.766 0 C-N-CA 121.564 1.51 . . . . 0.0 111.572 -175.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.455 ' HA ' ' CG ' ' A' ' 56' ' ' ARG . . . -32.63 -32.42 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.342 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -177.308 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -63.19 125.27 23.53 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 14.1 m 77.56 17.15 1.47 Allowed 'General case' 0 N--CA 1.514 2.772 0 CA-C-O 119.358 -0.353 . . . . 0.0 111.898 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.455 ' CG ' ' HA ' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -48.68 -89.06 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.862 0 CA-C-N 119.851 1.205 . . . . 0.0 110.175 179.688 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 82.8 m -37.2 -44.2 0.56 Allowed 'General case' 0 N--CA 1.518 2.928 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -42.58 -51.02 5.3 Favored 'General case' 0 N--CA 1.512 2.642 0 CA-C-N 119.931 1.242 . . . . 0.0 111.735 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.616 ' HA ' HD12 ' A' ' 62' ' ' ILE . . . -41.88 -45.48 3.71 Favored 'General case' 0 N--CA 1.513 2.71 0 O-C-N 121.701 -0.625 . . . . 0.0 112.007 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.711 HG22 HD13 ' A' ' 97' ' ' LEU . 20.4 t -55.34 -48.58 76.63 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 10.1 ttp180 -58.81 -29.42 66.84 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.826 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.766 HG23 ' HB ' ' A' ' 67' ' ' VAL . 11.2 mt -77.57 -27.32 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.286 0 O-C-N 121.899 -0.501 . . . . 0.0 109.955 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.4 tp -77.63 -43.95 29.81 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 120.073 -0.651 . . . . 0.0 110.082 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.54 -50.42 11.61 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.284 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -81.09 -23.31 38.54 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.965 -0.459 . . . . 0.0 111.48 -179.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.87 149.31 8.24 Favored Glycine 0 N--CA 1.499 2.838 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -178.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.766 ' HB ' HG23 ' A' ' 62' ' ' ILE . 5.8 p -117.93 159.37 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.63 HG22 ' CE1' ' A' ' 74' ' ' HIS . 79.1 t -114.7 158.07 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-O 121.756 0.789 . . . . 0.0 109.389 -178.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.655 HG23 ' OE2' ' A' ' 75' ' ' GLU . 27.0 p -117.0 158.61 23.83 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 115.339 -0.846 . . . . 0.0 108.96 -178.427 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.7 t -64.26 -33.14 75.13 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.883 -178.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.6 p -62.91 -17.6 61.94 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.935 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.58 13.5 34.96 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -103.85 156.9 17.46 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-N 118.198 0.999 . . . . 0.0 109.524 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.63 ' CE1' HG22 ' A' ' 68' ' ' VAL . 9.3 m170 -115.44 155.86 26.67 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.655 ' OE2' HG23 ' A' ' 69' ' ' THR . 3.3 mp0 -142.79 -177.49 5.34 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 120.236 -0.586 . . . . 0.0 110.612 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.413 ' O ' ' CG ' ' A' ' 77' ' ' ARG . . . 59.95 -132.42 50.86 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 108.374 -1.89 . . . . 0.0 108.374 -178.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.413 ' CG ' ' O ' ' A' ' 76' ' ' GLY . 2.1 ptm180 44.18 28.61 0.29 Allowed 'General case' 0 N--CA 1.507 2.383 0 CA-C-O 120.978 0.418 . . . . 0.0 110.189 179.648 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.7 mt -72.81 -19.45 61.33 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 122.037 -0.415 . . . . 0.0 110.58 -178.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.644 HD13 ' CB ' ' A' ' 90' ' ' GLN . 2.5 tp -49.21 105.27 0.08 Allowed 'General case' 0 N--CA 1.503 2.183 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.096 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -139.95 170.51 15.74 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.371 0.605 . . . . 0.0 109.89 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -80.45 105.49 11.74 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 121.379 0.609 . . . . 0.0 110.342 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.598 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 15.5 mt -86.7 171.87 9.34 Favored Pre-proline 0 N--CA 1.5 2.03 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 177.409 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.598 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 28.9 Cg_endo -68.73 103.28 0.97 Allowed 'Trans proline' 0 C--N 1.328 -0.5 0 C-N-CA 120.865 1.043 . . . . 0.0 109.878 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.36 11.76 60.63 Favored Glycine 0 N--CA 1.498 2.813 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 3.5 m -143.07 90.37 7.46 Favored Pre-proline 0 N--CA 1.507 2.376 0 CA-C-N 118.705 1.252 . . . . 0.0 108.563 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -74.38 159.93 42.66 Favored 'Trans proline' 0 C--N 1.325 -0.673 0 C-N-CA 121.16 1.24 . . . . 0.0 111.0 -178.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.564 ' HA ' HD11 ' A' ' 79' ' ' LEU . 32.0 mtp180 -49.23 -28.64 4.79 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.389 0.614 . . . . 0.0 109.738 178.309 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -56.15 -49.0 75.21 Favored 'General case' 0 N--CA 1.503 2.176 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.971 -178.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.5 t -65.14 -39.43 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.667 -0.646 . . . . 0.0 109.667 -178.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.71 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 23.4 mm-40 -64.26 -29.4 70.49 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.234 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.429 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 1.7 tpt180 -78.46 -26.78 46.22 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.9 -50.14 25.5 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.869 -0.519 . . . . 0.0 109.656 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -78.88 -26.04 43.92 Favored 'General case' 0 N--CA 1.508 2.456 0 O-C-N 122.057 -0.402 . . . . 0.0 111.042 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.71 ' HB2' ' O ' ' A' ' 90' ' ' GLN . . . -48.74 -47.43 72.12 Favored Pre-proline 0 N--CA 1.505 2.278 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -177.118 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.519 ' HD3' ' HB3' ' A' ' 94' ' ' ALA . 33.0 Cg_endo -73.77 25.46 0.33 Allowed 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 122.371 2.047 . . . . 0.0 114.258 -178.148 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.501 ' HE3' HG21 ' A' ' 101' ' ' VAL . 5.1 mttp -135.61 37.81 2.88 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.1 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.711 HD13 HG22 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -74.58 -75.27 0.17 Allowed 'General case' 0 N--CA 1.503 2.208 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.992 -178.978 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 8.7 m -76.0 10.11 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 O-C-N 121.067 -1.021 . . . . 0.0 111.637 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 11.9 p -87.04 176.6 7.54 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -65.09 5.35 0.36 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.452 -0.78 . . . . 0.0 111.873 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.501 HG21 ' HE3' ' A' ' 96' ' ' LYS . 56.3 t -96.23 -5.24 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 CA-C-N 120.265 1.393 . . . . 0.0 111.009 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.509 ' HB3' ' O ' ' A' ' 97' ' ' LEU . 4.1 tp10 -142.07 -85.46 0.17 Allowed 'General case' 0 N--CA 1.513 2.71 0 C-N-CA 118.626 -1.23 . . . . 0.0 112.869 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 20.8 m -136.57 40.56 2.59 Favored 'General case' 0 N--CA 1.507 2.387 0 CA-C-N 119.601 1.091 . . . . 0.0 110.616 -177.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.433 ' ND2' ' HA ' ' A' ' 112' ' ' PRO . 10.6 t-20 -44.95 -95.76 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.385 -0.822 . . . . 0.0 111.946 -179.381 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.512 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 1.4 mt 87.19 -58.41 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.462 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -177.178 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.713 ' HB1' ' HA2' ' A' ' 110' ' ' GLY . . . 160.95 127.68 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.503 ' OG1' ' CE1' ' A' ' 109' ' ' HIS . 2.3 p -91.59 -146.62 0.21 Allowed 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -178.445 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.503 HG23 ' N ' ' A' ' 109' ' ' HIS . 6.5 tp -57.41 -39.34 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.825 -0.547 . . . . 0.0 111.059 178.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.51 ' CE1' ' O ' ' A' ' 113' ' ' PHE . 2.2 p80 -90.78 21.93 3.84 Favored 'General case' 0 N--CA 1.515 2.786 0 O-C-N 122.047 -0.408 . . . . 0.0 111.255 -177.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.713 ' HA2' ' HB1' ' A' ' 106' ' ' ALA . . . 53.18 64.89 3.77 Favored Glycine 0 N--CA 1.497 2.733 0 O-C-N 121.598 -0.688 . . . . 0.0 111.609 177.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 159.49 172.97 27.35 Favored Glycine 0 N--CA 1.498 2.822 0 CA-C-N 118.419 1.11 . . . . 0.0 111.096 178.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.476 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 36.2 Cg_endo -85.17 80.38 2.09 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.059 2.506 . . . . 0.0 111.642 -178.625 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.597 ' CE2' HD21 ' A' ' 117' ' ' LEU . 8.3 p90 175.66 89.71 0.01 OUTLIER 'General case' 0 N--CA 1.535 3.783 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.465 ' HA ' ' NE2' ' A' ' 109' ' ' HIS . 16.9 p -113.82 -178.22 3.32 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 120.185 -1.572 . . . . 0.0 110.397 178.123 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.434 HD13 ' HA ' ' A' ' 115' ' ' LEU . 0.6 OUTLIER 67.56 33.22 5.2 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -178.912 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.427 ' O ' ' HB2' ' A' ' 117' ' ' LEU . 89.2 p -163.84 -135.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.597 HD21 ' CE2' ' A' ' 113' ' ' PHE . 2.4 mp 67.35 -119.52 0.23 Allowed 'General case' 0 N--CA 1.501 2.104 0 CA-C-N 119.254 0.934 . . . . 0.0 109.199 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.419 ' HB2' ' O ' ' A' ' 117' ' ' LEU . 7.0 mp 70.26 -17.02 0.28 Allowed 'General case' 0 N--CA 1.519 2.98 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -165.15 -110.26 0.23 Allowed Glycine 0 N--CA 1.499 2.879 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -129.57 -139.18 0.23 Allowed 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 52.76 22.83 12.73 Favored Glycine 0 N--CA 1.501 3.0 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 . . . . . 0 N--CA 1.499 2.016 0 CA-C-O 118.137 -0.935 . . . . 0.0 109.629 -179.774 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.691 ' C ' HG23 ' A' ' 2' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.691 HG23 ' C ' ' A' ' 1' ' ' SER . 2.8 t 83.59 -60.77 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.734 -0.604 . . . . 0.0 109.561 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 121.54 -81.18 0.34 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.5 t -89.25 38.6 0.9 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.253 -1.145 . . . . 0.0 109.492 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.5 m -46.5 164.63 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.246 -0.909 . . . . 0.0 109.438 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 84.8 m 59.19 109.82 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.125 -0.985 . . . . 0.0 109.915 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 1.005 HG22 ' HD2' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -98.41 157.81 33.71 Favored Pre-proline 0 N--CA 1.492 1.668 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.26 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 1.005 ' HD2' HG22 ' A' ' 7' ' ' ILE . 35.3 Cg_endo -78.11 156.26 29.94 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.26 1.973 . . . . 0.0 110.707 -179.224 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.72 10.2 36.62 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.744 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 0.3 OUTLIER -137.01 104.55 5.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.338 -1.095 . . . . 0.0 108.768 179.803 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.744 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 86.01 -59.68 0.06 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.749 -1.219 . . . . 0.0 108.181 -178.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 5.6 mt -102.2 101.6 20.13 Favored Pre-proline 0 C--N 1.303 -1.42 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 11' ' ' ALA . 34.3 Cg_endo -82.11 173.39 10.97 Favored 'Trans proline' 0 C--N 1.319 -0.981 0 C-N-CA 121.602 1.534 . . . . 0.0 111.945 -176.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 51.4 m80 -74.85 149.38 39.59 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -179.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.677 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 6.4 t30 55.3 50.94 6.47 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 120.831 -1.168 . . . . 0.0 110.039 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.677 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 37.7 Cg_endo -78.99 -174.64 2.37 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 122.478 2.119 . . . . 0.0 111.122 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.611 HD21 ' HB1' ' A' ' 59' ' ' ALA . 4.3 mm? 47.12 41.79 12.02 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.716 -0.615 . . . . 0.0 111.046 178.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.444 ' CG ' ' N ' ' A' ' 19' ' ' SER . 1.9 p30 -81.91 -47.21 13.03 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.034 -1.041 . . . . 0.0 109.128 179.1 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.454 ' OG ' ' HD3' ' A' ' 43' ' ' ARG . 0.2 OUTLIER -60.74 -26.46 67.21 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.276 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.459 ' SG ' ' CD1' ' A' ' 17' ' ' LEU . 75.4 m -74.77 -34.73 62.52 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.526 ' HG3' ' N ' ' A' ' 22' ' ' TRP . 0.1 OUTLIER -66.95 -49.94 63.89 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.399 -0.813 . . . . 0.0 108.877 179.503 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.536 ' HB2' ' CE ' ' A' ' 40' ' ' MET . 31.6 m95 -71.44 -27.51 63.33 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.86 -1.15 . . . . 0.0 109.456 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.529 ' HB2' ' CG ' ' A' ' 40' ' ' MET . 26.4 t80 -67.03 -34.61 78.09 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.248 -0.907 . . . . 0.0 109.227 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.574 HG22 ' CD1' ' A' ' 93' ' ' PHE . 78.3 t -74.86 -40.15 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 118.59 -1.244 . . . . 0.0 108.087 178.383 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.467 ' OG ' ' O ' ' A' ' 22' ' ' TRP . 61.1 p -55.44 -37.66 67.99 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.114 -1.035 . . . . 0.0 109.262 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.44 ' O ' ' HA2' ' A' ' 30' ' ' GLY . 3.5 m -78.31 -55.09 5.52 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.337 -0.852 . . . . 0.0 111.476 -178.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 8.3 mmm180 -58.47 -25.1 61.91 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.792 -1.192 . . . . 0.0 110.388 -178.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.43 ' HB ' HG11 ' A' ' 89' ' ' VAL . 69.5 p -95.61 -64.44 1.06 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.175 -0.953 . . . . 0.0 111.57 -177.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.473 ' SG ' ' O ' ' A' ' 84' ' ' GLY . 3.4 m -98.89 16.15 23.3 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.816 -1.178 . . . . 0.0 109.806 -178.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' A' ' 26' ' ' THR . . . 51.78 21.94 7.97 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 -179.006 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.557 HG12 ' N ' ' A' ' 32' ' ' GLY . 40.7 t -102.47 165.63 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.386 -1.067 . . . . 0.0 109.335 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.557 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 129.69 176.87 14.6 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.438 -1.865 . . . . 0.0 108.438 -179.458 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -65.3 173.5 6.2 Favored 'Trans proline' 0 C--O 1.214 -0.693 0 CA-C-N 119.143 1.472 . . . . 0.0 109.897 179.047 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -92.26 82.87 4.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.872 -1.143 . . . . 0.0 110.3 -178.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.474 HD12 ' HA ' ' A' ' 35' ' ' LEU . 9.1 tp -137.29 135.5 37.19 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.015 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 35' ' ' LEU . . . -46.55 155.4 0.24 Allowed 'General case' 0 N--CA 1.487 1.375 0 O-C-N 120.923 -1.111 . . . . 0.0 109.051 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.431 ' O ' ' C ' ' A' ' 38' ' ' GLN . 0.6 OUTLIER -74.34 -55.27 6.2 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.042 -1.036 . . . . 0.0 110.002 -179.562 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.431 ' C ' ' O ' ' A' ' 37' ' ' THR . 2.2 mp0 -43.31 -34.6 1.25 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.228 -0.92 . . . . 0.0 109.691 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.607 ' O ' ' HB3' ' A' ' 42' ' ' ALA . 10.1 mm-40 -64.87 -52.1 58.41 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.109 -0.994 . . . . 0.0 108.593 179.404 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.536 ' CE ' ' HB2' ' A' ' 22' ' ' TRP . 0.4 OUTLIER -54.43 -60.78 2.89 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.232 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.435 ' C ' ' O ' ' A' ' 40' ' ' MET . 20.9 ttpt -44.3 -35.34 2.29 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.607 ' HB3' ' O ' ' A' ' 39' ' ' GLU . . . -63.2 -48.93 76.23 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.486 -0.759 . . . . 0.0 109.029 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.454 ' HD3' ' OG ' ' A' ' 19' ' ' SER . 7.7 mtt-85 -55.1 -52.39 63.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.373 -0.83 . . . . 0.0 109.539 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 20.9 m -55.89 -35.77 66.91 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 0.0 109.904 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 81.7 m -68.97 -28.62 66.78 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.038 -1.039 . . . . 0.0 109.148 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.72 -31.34 64.91 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.326 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.404 ' O ' HG13 ' A' ' 51' ' ' ILE . 3.4 mm-40 -76.79 -36.41 57.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.465 -0.772 . . . . 0.0 109.506 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.844 HD11 HG12 ' A' ' 98' ' ' VAL . 7.4 tt -72.21 -36.63 69.22 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.265 -0.897 . . . . 0.0 109.299 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.458 ' O ' ' C ' ' A' ' 50' ' ' ALA . 1.2 tt0 -71.64 -55.73 7.19 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.485 ' O ' ' HD3' ' A' ' 52' ' ' PRO . . . -45.92 -47.92 16.29 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 178.31 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.404 HG13 ' O ' ' A' ' 47' ' ' GLN . 88.9 mt -62.12 106.43 0.84 Allowed Pre-proline 0 C--N 1.303 -1.452 0 N-CA-C 107.059 -1.459 . . . . 0.0 107.059 176.538 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.535 ' O ' ' N ' ' A' ' 54' ' ' TYR . 25.1 Cg_endo -61.38 141.03 91.11 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 121.607 1.538 . . . . 0.0 110.925 -177.082 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.569 ' HA ' ' HG3' ' A' ' 56' ' ' ARG . . . -31.29 -35.18 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.156 0.503 . . . . 0.0 110.811 -178.514 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.54 ' O ' ' CB ' ' A' ' 55' ' ' CYS . 9.4 m-85 -75.0 129.14 37.14 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.138 -0.976 . . . . 0.0 109.153 179.384 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.54 ' CB ' ' O ' ' A' ' 54' ' ' TYR . 4.3 m 79.23 0.45 2.33 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.338 -0.851 . . . . 0.0 110.924 179.405 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.569 ' HG3' ' HA ' ' A' ' 53' ' ' ALA . 3.7 mmt85 -43.19 -90.24 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.704 -1.248 . . . . 0.0 109.706 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.529 ' C ' ' O ' ' A' ' 56' ' ' ARG . 3.3 m -21.47 -55.13 0.02 OUTLIER 'General case' 0 N--CA 1.514 2.755 0 O-C-N 122.069 -0.394 . . . . 0.0 111.706 -179.24 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.503 ' C ' ' O ' ' A' ' 57' ' ' CYS . 1.3 mm-40 -31.13 -59.41 0.22 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.596 -0.69 . . . . 0.0 110.82 -179.333 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.611 ' HB1' HD21 ' A' ' 17' ' ' LEU . . . -29.05 -56.38 0.14 Allowed 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 121.223 0.535 . . . . 0.0 111.07 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 1.013 ' CG2' HD22 ' A' ' 97' ' ' LEU . 32.0 t -55.17 -53.09 38.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 O-C-N 121.282 -0.886 . . . . 0.0 109.498 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.529 ' O ' ' HB2' ' A' ' 65' ' ' ASP . 17.9 mmt85 -56.49 -26.85 55.56 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.389 -0.819 . . . . 0.0 109.989 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.792 HG21 HG23 ' A' ' 67' ' ' VAL . 16.1 mm -79.09 -28.9 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.914 -1.116 . . . . 0.0 110.494 -179.518 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.549 ' CD1' ' HB3' ' A' ' 17' ' ' LEU . 9.1 tt -77.48 -50.03 13.52 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.91 -1.119 . . . . 0.0 108.848 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -78.12 -47.81 17.4 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.198 -0.939 . . . . 0.0 109.743 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.529 ' HB2' ' O ' ' A' ' 61' ' ' ARG . 0.7 OUTLIER -80.21 -20.02 45.64 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.117 -0.989 . . . . 0.0 109.799 -179.98 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 62' ' ' ILE . . . 102.05 162.21 26.61 Favored Glycine 0 N--CA 1.485 1.944 0 C-N-CA 119.31 -1.424 . . . . 0.0 110.749 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.792 HG23 HG21 ' A' ' 62' ' ' ILE . 3.6 p -113.85 155.54 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.527 HG22 ' NE2' ' A' ' 74' ' ' HIS . 22.3 t -120.52 156.25 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 120.893 -1.13 . . . . 0.0 110.185 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.435 ' N ' ' CG1' ' A' ' 68' ' ' VAL . 46.3 p -118.19 158.49 25.01 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.3 t -65.31 -27.9 68.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.415 -0.803 . . . . 0.0 109.681 -179.049 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.1 p -68.47 -14.23 62.86 Favored 'General case' 0 C--N 1.294 -1.815 0 O-C-N 121.586 -0.696 . . . . 0.0 109.238 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 99.28 8.76 52.71 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 108.827 -1.709 . . . . 0.0 108.827 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -93.02 156.41 16.91 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.106 -1.232 . . . . 0.0 109.648 -179.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.527 ' NE2' HG22 ' A' ' 68' ' ' VAL . 9.0 m170 -116.53 155.2 29.08 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 120.963 -1.086 . . . . 0.0 109.043 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.512 ' HB2' ' CG1' ' A' ' 67' ' ' VAL . 19.5 mm-40 -147.78 -169.92 3.45 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 121.563 0.696 . . . . 0.0 109.352 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 58.78 -145.61 42.92 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.93 16.9 4.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.286 -1.126 . . . . 0.0 110.069 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.521 ' O ' ' N ' ' A' ' 80' ' ' GLN . 1.0 OUTLIER -76.18 -18.51 59.05 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.985 -1.072 . . . . 0.0 109.669 -179.645 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.675 HD21 ' HB3' ' A' ' 90' ' ' GLN . 7.7 tt -47.41 94.91 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.101 -0.999 . . . . 0.0 108.706 179.232 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.521 ' N ' ' O ' ' A' ' 78' ' ' LEU . 23.2 mm100 -127.71 179.24 5.63 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.075 -1.016 . . . . 0.0 110.197 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.14 104.82 3.74 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.808 0.813 . . . . 0.0 110.863 -179.128 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.705 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 13.7 mt -82.88 173.41 7.59 Favored Pre-proline 0 C--N 1.298 -1.643 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 177.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.705 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 28.5 Cg_endo -69.15 104.86 1.29 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 120.873 1.048 . . . . 0.0 109.695 179.374 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.473 ' O ' ' SG ' ' A' ' 29' ' ' CYS . . . 92.04 4.75 66.63 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 -179.298 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.456 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 3.3 m -139.1 88.03 13.54 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 120.753 -1.44 . . . . 0.0 108.758 179.503 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.425 ' O ' ' C ' ' A' ' 87' ' ' ARG . 30.9 Cg_endo -76.21 159.13 37.2 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 121.638 1.558 . . . . 0.0 111.884 -178.669 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.425 ' C ' ' O ' ' A' ' 86' ' ' PRO . 7.1 mmm-85 -45.2 -28.24 0.74 Allowed 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.413 ' N ' ' C ' ' A' ' 86' ' ' PRO . 49.8 tt0 -54.34 -61.74 2.11 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.262 -178.435 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.43 HG11 ' HB ' ' A' ' 28' ' ' THR . 58.8 t -59.06 -40.64 81.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.084 -1.01 . . . . 0.0 109.952 -178.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.675 ' HB3' HD21 ' A' ' 79' ' ' LEU . 0.4 OUTLIER -62.77 -26.82 68.9 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 119.537 -0.865 . . . . 0.0 108.737 179.685 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.53 -31.22 47.41 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.434 -0.791 . . . . 0.0 109.77 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.5 ' O ' ' HD2' ' A' ' 95' ' ' PRO . . . -73.37 -42.97 61.54 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.087 -1.008 . . . . 0.0 109.47 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.574 ' CD1' HG22 ' A' ' 24' ' ' VAL . 21.5 t80 -78.03 -25.75 48.01 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.35 -0.844 . . . . 0.0 110.143 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.867 ' HB3' ' HD3' ' A' ' 95' ' ' PRO . . . -37.24 -53.36 2.16 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.597 -0.69 . . . . 0.0 110.94 -179.136 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.867 ' HD3' ' HB3' ' A' ' 94' ' ' ALA . 31.5 Cg_endo -73.75 -178.74 3.97 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.175 1.917 . . . . 0.0 110.305 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.447 ' HB2' ' O ' ' A' ' 95' ' ' PRO . 0.1 OUTLIER 71.36 24.66 3.66 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.248 -0.908 . . . . 0.0 108.839 -179.201 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 1.013 HD22 ' CG2' ' A' ' 60' ' ' VAL . 17.6 tp -73.01 -69.87 0.39 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.464 -0.772 . . . . 0.0 110.64 -179.209 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.844 HG12 HD11 ' A' ' 48' ' ' LEU . 2.4 m -79.35 26.57 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.571 -1.331 . . . . 0.0 110.906 -179.449 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.422 ' C ' ' HB2' ' A' ' 104' ' ' ASN . 5.2 p -103.87 174.22 5.96 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 120.617 -1.302 . . . . 0.0 108.902 179.285 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -58.81 -0.93 0.12 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.848 -1.157 . . . . 0.0 112.006 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.1 t -98.78 6.16 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 119.945 -1.722 . . . . 0.0 110.459 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.443 ' HB2' ' O ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -145.57 -90.49 0.1 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.741 -1.225 . . . . 0.0 110.391 -179.949 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.51 ' O ' ' CD1' ' A' ' 105' ' ' LEU . 56.0 m -145.22 40.85 1.24 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.953 -1.092 . . . . 0.0 109.195 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.555 ' O ' ' CB ' ' A' ' 105' ' ' LEU . 24.0 t30 -33.28 -89.47 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.412 -0.805 . . . . 0.0 111.983 -178.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.772 HD12 HD22 ' A' ' 48' ' ' LEU . 3.3 mt 85.3 -66.87 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -177.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.724 ' HB2' ' O ' ' A' ' 105' ' ' LEU . . . 155.97 115.1 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.639 HG21 HG21 ' A' ' 98' ' ' VAL . 2.8 p -85.55 -162.26 0.7 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.4 tp -73.38 -16.97 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 120.87 -1.144 . . . . 0.0 109.424 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.503 ' ND1' HD11 ' A' ' 117' ' ' LEU . 84.1 m-70 -80.06 16.27 1.27 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.432 -0.792 . . . . 0.0 110.377 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 109' ' ' HIS . . . 43.97 26.44 0.83 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 109' ' ' HIS . . . -153.6 172.72 32.4 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.45 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 33.7 Cg_endo -78.29 81.91 2.6 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 123.021 2.481 . . . . 0.0 110.938 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.589 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER 168.38 171.43 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.064 -1.022 . . . . 0.0 110.552 179.356 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.443 ' O ' ' C ' ' A' ' 115' ' ' LEU . 0.5 OUTLIER -174.54 144.66 0.89 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.234 -0.916 . . . . 0.0 109.176 179.503 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.443 ' C ' ' O ' ' A' ' 114' ' ' CYS . 71.5 mt 42.27 55.07 4.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.987 -1.07 . . . . 0.0 109.527 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.434 ' HB2' ' O ' ' A' ' 115' ' ' LEU . 13.8 t 172.34 -67.33 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.36 -0.837 . . . . 0.0 109.208 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.542 ' O ' ' HB2' ' A' ' 118' ' ' LEU . 0.2 OUTLIER 57.46 24.28 10.04 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.265 -0.897 . . . . 0.0 109.522 179.844 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.542 ' HB2' ' O ' ' A' ' 117' ' ' LEU . 1.0 OUTLIER 69.37 -14.11 0.34 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.455 -0.778 . . . . 0.0 112.269 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -174.83 176.73 47.04 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -137.0 65.69 1.49 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.092 -1.24 . . . . 0.0 109.569 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.74 -14.29 54.62 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.302 -1.117 . . . . 0.0 109.53 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 16.1 p . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.276 0.56 . . . . 0.0 109.524 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.643 HG11 ' OG ' ' A' ' 5' ' ' SER . 49.3 t -80.74 -88.82 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.17 -0.957 . . . . 0.0 109.5 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.613 ' N ' HG12 ' A' ' 2' ' ' VAL . . . 143.26 -94.14 0.18 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.2 t -89.26 39.45 0.94 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.218 -1.166 . . . . 0.0 109.258 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.643 ' OG ' HG11 ' A' ' 2' ' ' VAL . 0.1 OUTLIER -66.82 178.35 1.37 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.321 -0.862 . . . . 0.0 109.555 -179.864 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 68.2 m -135.79 178.3 7.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.336 -0.852 . . . . 0.0 109.319 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.498 ' CG2' ' HD2' ' A' ' 8' ' ' PRO . 35.2 mm -116.18 140.22 26.15 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.187 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.498 ' HD2' ' CG2' ' A' ' 7' ' ' ILE . 36.4 Cg_endo -80.35 151.07 20.06 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 122.188 1.925 . . . . 0.0 110.568 -179.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.4 ' C ' ' HG2' ' A' ' 10' ' ' MET . . . 54.44 17.32 8.17 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.876 -1.289 . . . . 0.0 109.876 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.747 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 1.4 mtt -139.38 108.2 5.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.29 -1.123 . . . . 0.0 108.669 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.747 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 85.35 -60.89 0.07 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.815 -1.178 . . . . 0.0 108.288 -178.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.747 HD11 ' CB ' ' A' ' 55' ' ' CYS . 1.7 mt -103.1 101.56 22.55 Favored Pre-proline 0 N--CA 1.485 1.315 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.454 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.466 ' HD3' ' O ' ' A' ' 11' ' ' ALA . 31.7 Cg_endo -80.61 174.14 11.47 Favored 'Trans proline' 0 C--N 1.317 -1.089 0 C-N-CA 121.281 1.321 . . . . 0.0 111.355 -177.38 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.463 ' O ' ' CG ' ' A' ' 15' ' ' ASN . 55.9 m80 -73.75 148.27 42.74 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.769 -0.582 . . . . 0.0 109.761 -179.023 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.581 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 3.1 p-10 43.25 58.63 11.96 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.065 -1.022 . . . . 0.0 110.503 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.581 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 37.2 Cg_endo -81.09 166.16 18.85 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.676 2.251 . . . . 0.0 110.91 179.389 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.451 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 14.5 mt 55.08 45.82 25.38 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.471 -0.768 . . . . 0.0 111.179 178.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -69.74 -45.38 68.25 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.815 -1.178 . . . . 0.0 108.589 178.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.501 ' O ' ' HB2' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -62.4 -25.2 67.81 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.886 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.458 ' O ' HG23 ' A' ' 24' ' ' VAL . 73.9 m -69.55 -44.79 70.2 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.376 0.608 . . . . 0.0 109.483 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.61 -48.71 76.24 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.179 -0.951 . . . . 0.0 109.389 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.442 ' HA ' ' CE3' ' A' ' 22' ' ' TRP . 26.5 m95 -69.59 -26.25 64.37 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.443 -1.411 . . . . 0.0 109.382 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.601 ' CG ' ' HG2' ' A' ' 40' ' ' MET . 1.5 t80 -67.44 -30.11 69.75 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.865 HG13 ' HD2' ' A' ' 93' ' ' PHE . 59.1 t -75.18 -42.95 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 C-N-CA 118.758 -1.177 . . . . 0.0 107.859 178.207 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.7 p -56.03 -41.75 75.46 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.076 -1.05 . . . . 0.0 109.965 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.504 ' CA ' ' O ' ' A' ' 31' ' ' VAL . 3.4 m -77.83 -54.48 6.28 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.253 -0.904 . . . . 0.0 111.308 -178.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -58.7 -24.83 62.13 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 120.847 -1.158 . . . . 0.0 110.437 -178.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.421 HG23 ' O ' ' A' ' 24' ' ' VAL . 59.1 p -94.62 -65.68 0.97 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.135 -0.978 . . . . 0.0 111.232 -178.235 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.476 ' SG ' ' O ' ' A' ' 84' ' ' GLY . 3.5 m -99.3 16.95 21.32 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.737 -1.227 . . . . 0.0 109.914 -178.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.454 ' HA2' ' O ' ' A' ' 26' ' ' THR . . . 55.93 18.88 20.03 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 -178.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.504 ' O ' ' CA ' ' A' ' 26' ' ' THR . 30.2 t -101.6 157.3 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.312 -1.11 . . . . 0.0 109.525 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.405 ' N ' ' CG1' ' A' ' 31' ' ' VAL . . . 131.29 177.61 14.99 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.494 -1.842 . . . . 0.0 108.494 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -66.59 171.99 9.94 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 CA-C-N 119.15 1.475 . . . . 0.0 110.066 179.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -92.67 70.58 4.88 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.935 -1.103 . . . . 0.0 110.364 -178.194 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.451 ' O ' ' C ' ' A' ' 36' ' ' ALA . 0.8 OUTLIER -109.8 122.8 48.33 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 178.803 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.451 ' C ' ' O ' ' A' ' 35' ' ' LEU . . . -41.27 128.71 2.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.324 -0.86 . . . . 0.0 109.154 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.448 HG23 ' CE1' ' A' ' 23' ' ' TYR . 15.8 m -51.16 -38.8 54.24 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.829 -1.169 . . . . 0.0 111.377 -178.491 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -61.04 -36.95 80.94 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.751 -1.218 . . . . 0.0 110.194 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -72.43 -26.76 61.96 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.135 -0.978 . . . . 0.0 109.196 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.601 ' HG2' ' CG ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -72.48 -60.89 2.01 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.898 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -54.56 -36.16 64.03 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.84 -43.5 95.98 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.328 -0.857 . . . . 0.0 109.095 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.405 ' NH1' ' CG ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -60.23 -52.66 64.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.311 -0.868 . . . . 0.0 109.579 179.929 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.428 ' SG ' ' N ' ' A' ' 20' ' ' CYS . 14.7 m -56.68 -35.97 69.05 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.262 -0.899 . . . . 0.0 110.633 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 32.8 m -70.45 -30.72 67.63 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.754 -1.216 . . . . 0.0 109.043 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -68.41 -34.74 76.56 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 179.098 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.454 ' O ' HG13 ' A' ' 51' ' ' ILE . 3.1 mt-30 -77.83 -27.41 49.96 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.542 -0.724 . . . . 0.0 109.138 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.715 ' O ' HD13 ' A' ' 48' ' ' LEU . 1.6 tm? -69.55 -39.02 77.69 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.465 -0.772 . . . . 0.0 108.942 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.425 ' O ' ' C ' ' A' ' 50' ' ' ALA . 3.6 tt0 -77.41 -47.23 20.31 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.489 ' O ' ' HD3' ' A' ' 52' ' ' PRO . . . -45.53 -43.76 12.12 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 178.442 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.462 ' O ' ' HD2' ' A' ' 56' ' ' ARG . 49.4 mt -73.42 107.44 3.36 Favored Pre-proline 0 C--N 1.301 -1.519 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 177.319 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.535 ' O ' ' N ' ' A' ' 54' ' ' TYR . 25.4 Cg_endo -61.15 149.43 89.25 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 121.702 1.601 . . . . 0.0 111.224 -176.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.676 ' HA ' ' HD3' ' A' ' 56' ' ' ARG . . . -34.99 -29.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.037 0.446 . . . . 0.0 111.083 -178.715 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.54 ' O ' ' CB ' ' A' ' 55' ' ' CYS . 1.5 m-85 -79.88 125.87 30.28 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 120.999 -1.063 . . . . 0.0 110.017 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.747 ' CB ' HD11 ' A' ' 12' ' ' ILE . 4.5 m 81.63 -0.22 1.58 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.489 -0.757 . . . . 0.0 111.727 178.349 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.676 ' HD3' ' HA ' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -46.98 -89.9 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.316 -1.49 . . . . 0.0 109.328 -179.916 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.493 ' O ' ' C ' ' A' ' 58' ' ' GLU . 53.5 m -33.36 -56.81 0.42 Allowed 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.325 -0.86 . . . . 0.0 111.904 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.493 ' C ' ' O ' ' A' ' 57' ' ' CYS . 27.3 tt0 -32.34 -51.35 0.26 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.029 -1.045 . . . . 0.0 111.416 -179.361 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.458 ' C ' ' O ' ' A' ' 58' ' ' GLU . . . -36.17 -54.82 0.8 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.282 -0.886 . . . . 0.0 110.643 -179.563 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 44.0 t -54.63 -47.98 71.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 121.327 -0.858 . . . . 0.0 109.17 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.59 -27.03 62.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.217 -0.927 . . . . 0.0 109.442 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.95 HD12 ' HB ' ' A' ' 67' ' ' VAL . 3.7 mm -77.74 -30.14 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.254 -0.904 . . . . 0.0 109.747 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.527 ' O ' ' HA ' ' A' ' 77' ' ' ARG . 8.1 tt -77.88 -40.43 40.06 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.81 -1.181 . . . . 0.0 109.283 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.453 ' SD ' ' HG ' ' A' ' 79' ' ' LEU . 10.4 tpt -77.81 -53.72 7.17 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.239 -0.913 . . . . 0.0 109.985 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -79.61 -22.28 43.87 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.194 -0.941 . . . . 0.0 110.307 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.423 ' CA ' ' HB2' ' A' ' 77' ' ' ARG . . . 88.76 146.71 13.19 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.95 ' HB ' HD12 ' A' ' 62' ' ' ILE . 4.0 p -116.88 160.18 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.61 -0.935 . . . . 0.0 109.337 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.943 HG22 ' CE1' ' A' ' 74' ' ' HIS . 9.5 t -114.17 158.46 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 CA-C-O 121.9 0.857 . . . . 0.0 109.854 -178.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.459 ' N ' ' CG1' ' A' ' 68' ' ' VAL . 69.1 p -116.78 158.51 23.77 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.636 0.731 . . . . 0.0 109.728 -178.363 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 38.8 t -65.55 -25.63 67.51 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.418 0.628 . . . . 0.0 110.11 -178.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.2 p -71.82 -14.15 61.89 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.484 -0.76 . . . . 0.0 109.226 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.25 8.4 50.25 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 108.789 -1.725 . . . . 0.0 108.789 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -100.86 156.15 17.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.075 -1.25 . . . . 0.0 109.18 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.943 ' CE1' HG22 ' A' ' 68' ' ' VAL . 1.0 OUTLIER -115.25 155.66 26.84 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.968 -1.083 . . . . 0.0 108.958 -179.559 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.422 ' CD ' ' O ' ' A' ' 74' ' ' HIS . 22.4 mm-40 -139.51 -171.45 3.14 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.549 -0.86 . . . . 0.0 109.999 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 53.77 -147.1 20.6 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 108.366 -1.894 . . . . 0.0 108.366 -178.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.527 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 14.4 ttt85 52.94 23.13 2.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.118 -1.225 . . . . 0.0 109.577 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.18 -10.82 45.68 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.087 -1.008 . . . . 0.0 110.654 -179.211 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.866 HD22 ' O ' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -57.08 123.18 14.34 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.461 -1.4 . . . . 0.0 108.68 179.514 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.457 ' CG ' ' O ' ' A' ' 79' ' ' LEU . 49.6 mt-30 -156.5 -179.2 7.95 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.758 -1.214 . . . . 0.0 110.234 -178.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.19 105.57 1.12 Allowed 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.869 0.843 . . . . 0.0 110.754 -179.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.674 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 22.2 mt -89.7 171.77 8.24 Favored Pre-proline 0 C--N 1.298 -1.632 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.018 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.674 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 28.3 Cg_endo -67.29 100.39 0.55 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 121.136 1.224 . . . . 0.0 110.422 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.476 ' O ' ' SG ' ' A' ' 29' ' ' CYS . . . 91.27 14.26 57.59 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.481 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 3.3 m -144.55 91.58 6.19 Favored Pre-proline 0 N--CA 1.498 1.926 0 O-C-N 120.904 -1.35 . . . . 0.0 109.224 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.414 ' O ' ' C ' ' A' ' 87' ' ' ARG . 29.9 Cg_endo -75.2 157.09 42.11 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 121.459 1.439 . . . . 0.0 112.028 -178.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.414 ' C ' ' O ' ' A' ' 86' ' ' PRO . 8.1 mtm-85 -45.25 -28.54 0.82 Allowed 'General case' 0 N--CA 1.483 1.201 0 O-C-N 121.306 -0.872 . . . . 0.0 108.821 178.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -57.78 -62.27 1.92 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.907 -0.496 . . . . 0.0 111.456 -177.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.8 t -61.34 -39.4 82.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 120.958 -1.089 . . . . 0.0 110.137 -178.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.784 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 2.2 mp0 -63.62 -27.41 69.22 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.684 -0.806 . . . . 0.0 108.856 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.422 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 0.0 OUTLIER -78.43 -33.38 48.63 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.469 -0.77 . . . . 0.0 109.52 179.679 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.482 ' O ' ' HD2' ' A' ' 95' ' ' PRO . . . -69.98 -50.94 36.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.154 -0.966 . . . . 0.0 109.513 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.865 ' HD2' HG13 ' A' ' 24' ' ' VAL . 5.6 t80 -78.14 -25.72 47.49 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.241 -0.912 . . . . 0.0 110.239 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.843 ' HB3' ' HD3' ' A' ' 95' ' ' PRO . . . -38.55 -53.02 3.34 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.331 -0.856 . . . . 0.0 111.365 -178.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.843 ' HD3' ' HB3' ' A' ' 94' ' ' ALA . 30.0 Cg_endo -71.38 -174.68 1.29 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.025 1.817 . . . . 0.0 110.854 -179.319 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.496 ' CB ' ' O ' ' A' ' 95' ' ' PRO . 1.2 ttmm 74.31 32.71 0.95 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.273 -0.892 . . . . 0.0 108.857 -178.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.61 -73.08 0.25 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.475 -0.766 . . . . 0.0 111.469 -178.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.528 ' O ' ' CB ' ' A' ' 104' ' ' ASN . 2.0 m -77.62 24.69 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.737 -1.227 . . . . 0.0 111.678 -178.489 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 24.7 p -95.81 169.54 9.93 Favored 'General case' 0 C--N 1.294 -1.815 0 O-C-N 120.547 -1.345 . . . . 0.0 108.671 179.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.483 ' HA ' ' ND2' ' A' ' 104' ' ' ASN . 0.6 OUTLIER -59.74 -1.0 0.22 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.658 -1.276 . . . . 0.0 111.774 -179.665 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.453 ' O ' HG12 ' A' ' 101' ' ' VAL . 11.0 t -98.92 5.87 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 119.855 -1.778 . . . . 0.0 110.336 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -142.17 -91.29 0.13 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.808 -1.182 . . . . 0.0 110.117 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.535 ' O ' HD23 ' A' ' 105' ' ' LEU . 74.2 m -145.15 39.56 1.21 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.938 -1.101 . . . . 0.0 109.451 -179.177 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.528 ' CB ' ' O ' ' A' ' 98' ' ' VAL . 4.5 p30 -34.58 -47.9 0.34 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.355 -0.841 . . . . 0.0 111.719 -179.209 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.535 HD23 ' O ' ' A' ' 103' ' ' CYS . 1.3 mm? 44.44 24.75 0.1 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.695 -1.253 . . . . 0.0 110.109 -179.558 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.476 ' O ' ' O ' ' A' ' 105' ' ' LEU . . . 60.93 122.78 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.771 -1.205 . . . . 0.0 109.125 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.42 HG21 HG21 ' A' ' 98' ' ' VAL . 2.4 p -95.28 -172.7 2.73 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.078 -1.013 . . . . 0.0 108.624 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.2 tp -58.74 -21.43 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 120.935 -1.103 . . . . 0.0 109.21 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.498 ' HB3' ' CE1' ' A' ' 113' ' ' PHE . 74.1 m80 -80.11 16.66 1.17 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.654 -0.654 . . . . 0.0 110.373 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 109' ' ' HIS . . . 43.93 26.89 0.9 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 109' ' ' HIS . . . -154.4 171.08 32.89 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.715 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.459 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 32.2 Cg_endo -78.67 73.57 5.86 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 123.066 2.511 . . . . 0.0 111.603 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.498 ' CE1' ' HB3' ' A' ' 109' ' ' HIS . 25.0 p90 172.1 149.73 0.05 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.223 -0.923 . . . . 0.0 109.889 178.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.512 ' O ' ' CB ' ' A' ' 115' ' ' LEU . 12.5 p -139.67 127.41 21.89 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.865 -1.147 . . . . 0.0 109.464 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.512 ' CB ' ' O ' ' A' ' 114' ' ' CYS . 1.3 mt 162.18 -169.14 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.705 -1.247 . . . . 0.0 109.725 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.72 21.69 3.93 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.423 -0.798 . . . . 0.0 109.089 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.828 HD22 ' C ' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -63.54 -4.22 2.71 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.201 -0.937 . . . . 0.0 110.807 -179.555 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.545 ' N ' HD13 ' A' ' 117' ' ' LEU . 0.5 OUTLIER -49.61 -22.25 1.25 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.774 -1.204 . . . . 0.0 112.691 -178.805 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -70.68 -91.12 0.08 OUTLIER Glycine 0 N--CA 1.489 2.232 0 O-C-N 120.056 -1.652 . . . . 0.0 109.479 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -131.46 -130.92 0.19 Allowed 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.236 -1.156 . . . . 0.0 108.37 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 63.44 11.29 40.29 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 . . . . . 0 N--CA 1.489 1.506 0 O-C-N 121.225 -1.162 . . . . 0.0 109.406 -179.922 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.456 ' O ' ' N ' ' A' ' 10' ' ' MET . 37.8 Cg_endo . . . . . 0 C--O 1.208 -0.975 0 N-CA-C 110.247 -0.713 . . . . 0.0 110.247 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -38.68 -21.69 0.01 OUTLIER Glycine 0 N--CA 1.509 3.55 0 O-C-N 121.64 -0.662 . . . . 0.0 113.279 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.588 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 6.3 mtt -112.11 116.64 30.83 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 178.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.588 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 84.35 -47.59 0.1 Allowed 'General case' 0 N--CA 1.509 2.476 0 CA-C-N 120.021 1.282 . . . . 0.0 110.081 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 85.2 mt -126.27 77.28 72.3 Favored Pre-proline 0 N--CA 1.508 2.438 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -72.47 171.82 16.3 Favored 'Trans proline' 0 N--CA 1.476 0.473 0 C-N-CA 120.751 0.967 . . . . 0.0 112.5 -174.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.53 ' CE1' HG22 ' A' ' 69' ' ' THR . 29.4 m-70 -70.01 148.03 49.37 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.893 -178.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.467 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 29.0 t30 65.66 58.25 1.18 Allowed Pre-proline 0 N--CA 1.503 2.186 0 O-C-N 121.593 -0.692 . . . . 0.0 110.201 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.467 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 38.2 Cg_endo -78.85 158.4 27.68 Favored 'Trans proline' 0 N--CA 1.485 0.972 0 C-N-CA 122.376 2.051 . . . . 0.0 111.752 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.3 mt 53.74 44.25 29.89 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-O 121.074 0.464 . . . . 0.0 111.155 178.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -70.02 -40.51 75.15 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 121.584 -0.697 . . . . 0.0 109.283 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.51 -27.85 69.25 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.536 ' O ' HG23 ' A' ' 24' ' ' VAL . 44.1 m -72.9 -36.33 67.29 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.413 ' CG ' ' N ' ' A' ' 22' ' ' TRP . 0.2 OUTLIER -63.07 -54.97 29.67 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.822 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.441 ' HA ' ' CE3' ' A' ' 22' ' ' TRP . 27.8 m95 -65.64 -27.85 68.68 Favored 'General case' 0 N--CA 1.501 2.084 0 C-N-CA 119.232 -0.987 . . . . 0.0 109.671 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -67.07 -30.03 69.97 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.728 HG22 ' CD1' ' A' ' 93' ' ' PHE . 62.4 t -71.96 -41.62 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 177.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 m -56.35 -42.78 78.31 Favored 'General case' 0 N--CA 1.501 2.112 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.672 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.5 m -77.37 -50.99 11.59 Favored 'General case' 0 N--CA 1.51 2.533 0 O-C-N 122.037 -0.415 . . . . 0.0 112.104 -178.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -62.95 -24.94 68.12 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.832 -0.543 . . . . 0.0 110.733 -178.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.519 HG23 ' O ' ' A' ' 24' ' ' VAL . 34.7 p -97.05 -62.84 1.2 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 122.086 -0.384 . . . . 0.0 111.881 -177.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.6 ' O ' HG23 ' A' ' 31' ' ' VAL . 3.8 m -100.97 12.93 36.73 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 121.36 -0.838 . . . . 0.0 111.581 -178.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 57.17 21.56 39.81 Favored Glycine 0 N--CA 1.505 3.289 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -178.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 29' ' ' CYS . 45.2 t -109.49 164.24 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 O-C-N 121.87 -0.783 . . . . 0.0 109.396 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.497 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 136.14 -179.7 17.57 Favored Glycine 0 N--CA 1.5 2.928 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -63.66 173.37 4.62 Favored 'Trans proline' 0 N--CA 1.487 1.093 0 CA-C-N 119.319 1.559 . . . . 0.0 110.229 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 2.3 ptt180 -92.86 88.24 6.12 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 122.081 0.944 . . . . 0.0 110.197 -177.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.694 HD23 ' H ' ' A' ' 35' ' ' LEU . 2.1 pt? -145.53 -172.29 3.86 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 115.298 -0.865 . . . . 0.0 108.836 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -95.62 162.59 13.56 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.67 -57.33 3.62 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 122.127 -0.358 . . . . 0.0 110.182 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -51.38 -26.81 8.41 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 121.91 -0.494 . . . . 0.0 110.708 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -74.08 -44.48 53.9 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.609 ' HE3' HD11 ' A' ' 35' ' ' LEU . 2.5 ttm -63.5 -53.09 57.42 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.2 ttpp -54.24 -38.84 66.2 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.701 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.82 -38.54 91.16 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.12 -35.58 81.23 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 23.0 m -66.99 -35.57 80.26 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 120.396 -0.522 . . . . 0.0 109.616 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 18.2 m -71.76 -32.35 67.6 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.9 -35.07 74.32 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.47 ' O ' HD12 ' A' ' 51' ' ' ILE . 4.1 mt-30 -78.07 -26.3 48.14 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.804 HD11 ' NH1' ' A' ' 56' ' ' ARG . 1.6 tm? -69.72 -45.93 67.1 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -178.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -78.22 -38.82 42.23 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.62 -36.85 57.23 Favored 'General case' 0 N--CA 1.506 2.358 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.47 HD12 ' O ' ' A' ' 47' ' ' GLN . 58.0 mt -85.58 105.54 7.22 Favored Pre-proline 0 N--CA 1.488 1.446 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 176.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -62.86 148.87 92.92 Favored 'Trans proline' 0 N--CA 1.482 0.818 0 C-N-CA 121.771 1.648 . . . . 0.0 111.412 -176.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.67 ' HB1' ' N ' ' A' ' 108' ' ' ILE . . . -47.3 -27.43 1.57 Allowed 'General case' 0 N--CA 1.501 2.124 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.625 -179.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -71.1 115.04 9.77 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 12.0 m 70.54 7.94 6.41 Favored 'General case' 0 N--CA 1.507 2.384 0 O-C-N 121.998 -0.439 . . . . 0.0 110.079 -179.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.804 ' NH1' HD11 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -50.22 -93.19 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.322 -0.861 . . . . 0.0 109.507 179.848 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 88.9 m -31.63 -36.29 0.02 OUTLIER 'General case' 0 N--CA 1.521 3.108 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -41.4 -51.99 3.64 Favored 'General case' 0 N--CA 1.512 2.626 0 CA-C-N 119.762 1.164 . . . . 0.0 111.559 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -44.16 -47.06 9.06 Favored 'General case' 0 N--CA 1.511 2.581 0 O-C-N 121.765 -0.584 . . . . 0.0 112.135 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.9 t -50.73 -46.27 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.733 0 CA-C-O 122.134 0.969 . . . . 0.0 108.401 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -58.93 -50.22 74.87 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 177.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.921 HG23 ' HB ' ' A' ' 67' ' ' VAL . 28.0 mm -51.45 -26.96 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 121.673 -0.642 . . . . 0.0 110.109 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.37 -40.41 36.31 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 120.019 -0.673 . . . . 0.0 109.48 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 17.7 ttp -77.02 -55.34 5.54 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.474 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -80.95 -23.84 38.53 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.748 -0.595 . . . . 0.0 111.651 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.68 148.62 12.81 Favored Glycine 0 N--CA 1.506 3.301 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.921 ' HB ' HG23 ' A' ' 62' ' ' ILE . 8.2 p -117.73 159.91 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.559 0 O-C-N 122.185 -0.597 . . . . 0.0 110.632 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.699 HG22 ' NE2' ' A' ' 74' ' ' HIS . 54.3 t -114.97 156.92 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.53 HG22 ' CE1' ' A' ' 14' ' ' HIS . 31.1 p -117.63 160.01 21.98 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.176 -177.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.2 t -62.02 -29.67 70.43 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.642 -178.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.2 p -71.78 -16.94 62.21 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 116.618 -0.264 . . . . 0.0 110.482 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.88 14.7 30.81 Favored Glycine 0 N--CA 1.498 2.779 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.6 mm100 -103.07 156.34 17.75 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-N 118.204 1.002 . . . . 0.0 109.195 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.699 ' NE2' HG22 ' A' ' 68' ' ' VAL . 9.2 m170 -115.2 155.54 26.99 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -145.83 -175.99 4.96 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 120.995 0.426 . . . . 0.0 109.869 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 59.78 -148.51 42.09 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 108.443 -1.863 . . . . 0.0 108.443 -178.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 57.27 21.5 6.74 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 122.077 -0.661 . . . . 0.0 110.326 179.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.8 mt -81.96 -14.75 55.62 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.777 -0.577 . . . . 0.0 110.673 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.0 tt -58.72 92.48 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -130.97 177.59 7.33 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.193 0.521 . . . . 0.0 109.811 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -77.02 103.36 6.9 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.524 0.678 . . . . 0.0 110.707 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.528 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 18.1 mt -78.25 170.11 17.76 Favored Pre-proline 0 N--CA 1.497 1.875 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 177.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.528 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 29.8 Cg_endo -70.92 98.43 0.8 Allowed 'Trans proline' 0 C--N 1.327 -0.561 0 C-N-CA 120.859 1.04 . . . . 0.0 109.463 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 102.57 1.43 49.97 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 3.5 m -139.42 91.61 10.87 Favored Pre-proline 0 N--CA 1.505 2.279 0 CA-C-N 119.087 1.444 . . . . 0.0 109.191 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -72.42 163.28 39.06 Favored 'Trans proline' 0 N--CA 1.482 0.828 0 C-N-CA 121.368 1.378 . . . . 0.0 111.576 -178.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.4 mtm-85 -48.5 -28.65 3.47 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.196 0.522 . . . . 0.0 109.769 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -59.57 -46.23 89.51 Favored 'General case' 0 N--CA 1.504 2.235 0 CA-C-N 116.189 -0.46 . . . . 0.0 112.005 -177.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 49.0 t -68.88 -40.58 81.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.585 -0.697 . . . . 0.0 109.823 -178.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.489 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 1.9 mp0 -64.88 -27.39 68.83 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.35 -34.01 48.7 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 109.813 -0.439 . . . . 0.0 109.813 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.57 -45.67 68.17 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.893 -0.504 . . . . 0.0 109.808 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.728 ' CD1' HG22 ' A' ' 24' ' ' VAL . 44.3 t80 -78.57 -25.77 45.42 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 122.319 -0.238 . . . . 0.0 110.406 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.663 ' HB3' ' HD3' ' A' ' 95' ' ' PRO . . . -42.85 -51.71 12.12 Favored Pre-proline 0 N--CA 1.503 2.212 0 CA-C-O 118.87 -0.586 . . . . 0.0 112.493 -177.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.663 ' HD3' ' HB3' ' A' ' 94' ' ' ALA . 30.7 Cg_endo -72.98 -172.42 0.98 Allowed 'Trans proline' 0 N--CA 1.476 0.484 0 C-N-CA 121.697 1.598 . . . . 0.0 110.328 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.4 mttt 64.59 17.15 10.74 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -178.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.613 HD12 ' O ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -74.13 -75.89 0.15 Allowed 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.484 HG12 ' NH1' ' A' ' 56' ' ' ARG . 8.4 m -64.56 1.18 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.334 0 O-C-N 121.612 -0.68 . . . . 0.0 112.487 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 22.3 p -87.8 174.5 8.34 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -61.04 -0.1 0.28 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.424 -0.797 . . . . 0.0 111.899 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.475 ' O ' HG12 ' A' ' 101' ' ' VAL . 21.3 t -90.53 -4.04 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 CA-C-N 120.429 1.468 . . . . 0.0 111.188 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -140.25 -83.01 0.24 Allowed 'General case' 0 N--CA 1.51 2.557 0 C-N-CA 119.108 -1.037 . . . . 0.0 112.693 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 96.2 m -146.28 42.28 1.18 Allowed 'General case' 0 N--CA 1.504 2.256 0 CA-C-N 119.722 1.146 . . . . 0.0 109.258 -178.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.42 ' HA ' ' O ' ' A' ' 98' ' ' VAL . 11.2 p-10 -37.9 -60.66 0.71 Allowed 'General case' 0 N--CA 1.504 2.273 0 N-CA-C 113.553 0.945 . . . . 0.0 113.553 -178.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.402 ' O ' ' HB3' ' A' ' 106' ' ' ALA . 79.2 mt 45.92 25.06 0.27 Allowed 'General case' 0 N--CA 1.51 2.564 0 CA-C-N 119.054 0.843 . . . . 0.0 111.396 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 105' ' ' LEU . . . 64.02 141.73 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.321 -0.862 . . . . 0.0 109.674 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.2 p -112.5 -161.8 0.77 Allowed 'General case' 0 N--CA 1.506 2.348 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.67 ' N ' ' HB1' ' A' ' 53' ' ' ALA . 1.0 OUTLIER -66.13 -33.01 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.278 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -70.05 -1.25 9.35 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.189 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 57.74 30.36 62.64 Favored Glycine 0 N--CA 1.499 2.887 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -157.22 169.62 34.3 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.4 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 31.8 Cg_endo -78.22 73.85 5.6 Favored 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 122.725 2.283 . . . . 0.0 112.134 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.4 ' HB3' ' O ' ' A' ' 112' ' ' PRO . 49.2 p90 . . . . . 0 N--CA 1.507 2.407 0 O-C-N 121.827 -0.545 . . . . 0.0 110.462 177.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo . . . . . 0 N--CA 1.48 0.72 0 N-CA-C 110.564 -0.591 . . . . 0.0 110.564 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.6 2.12 74.07 Favored Glycine 0 N--CA 1.501 3.017 0 N-CA-C 110.634 -0.987 . . . . 0.0 110.634 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.573 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 4.0 mmt -133.29 104.06 6.28 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 87.2 -57.11 0.04 OUTLIER 'General case' 0 N--CA 1.515 2.789 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -178.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 57.6 mt -100.53 102.36 18.61 Favored Pre-proline 0 N--CA 1.495 1.797 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 178.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -81.28 173.61 11.51 Favored 'Trans proline' 0 N--CA 1.477 0.501 0 C-N-CA 121.616 1.544 . . . . 0.0 111.879 -176.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.44 ' CE1' HG22 ' A' ' 69' ' ' THR . 32.2 m-70 -76.0 146.88 39.2 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.488 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 19.2 t-20 68.11 56.87 0.71 Allowed Pre-proline 0 N--CA 1.508 2.473 0 O-C-N 121.393 -0.817 . . . . 0.0 111.721 179.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.488 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 41.2 Cg_endo -84.56 171.1 10.0 Favored 'Trans proline' 0 N--CA 1.481 0.774 0 C-N-CA 122.139 1.893 . . . . 0.0 111.066 178.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 27.6 mt 46.2 46.45 13.19 Favored 'General case' 0 N--CA 1.502 2.167 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.096 177.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -75.49 -43.04 51.31 Favored 'General case' 0 N--CA 1.505 2.311 0 O-C-N 121.482 -0.761 . . . . 0.0 109.002 178.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -63.57 -26.33 68.64 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.715 ' O ' HG23 ' A' ' 24' ' ' VAL . 34.6 m -75.08 -34.54 61.78 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.6 ' NH1' HD23 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -68.32 -46.57 69.86 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.793 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 31.7 m95 -71.77 -29.41 64.45 Favored 'General case' 0 N--CA 1.506 2.326 0 C-N-CA 118.691 -1.203 . . . . 0.0 109.274 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -65.23 -32.41 74.07 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 20' ' ' CYS . 47.9 t -71.35 -41.05 73.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 177.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.1 m -55.5 -39.15 70.1 Favored 'General case' 0 N--CA 1.502 2.159 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.161 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 94.5 m -77.62 -51.52 10.5 Favored 'General case' 0 N--CA 1.508 2.452 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -65.14 -25.01 67.57 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.432 -0.792 . . . . 0.0 110.672 -178.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.46 HG23 ' O ' ' A' ' 24' ' ' VAL . 43.9 p -93.77 -61.09 1.61 Allowed 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -177.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.694 ' O ' HG23 ' A' ' 31' ' ' VAL . 3.8 m -100.47 7.83 43.92 Favored 'General case' 0 N--CA 1.507 2.415 0 O-C-N 121.363 -0.836 . . . . 0.0 111.784 -178.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 58.29 24.81 56.4 Favored Glycine 0 N--CA 1.506 3.302 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -178.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.694 HG23 ' O ' ' A' ' 29' ' ' CYS . 19.7 t -119.11 165.54 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 122.124 -0.633 . . . . 0.0 109.35 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.48 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 134.05 -178.89 18.01 Favored Glycine 0 N--CA 1.5 2.954 0 N-CA-C 108.394 -1.882 . . . . 0.0 108.394 -178.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.414 ' HB2' HD23 ' A' ' 35' ' ' LEU . 26.7 Cg_endo -64.62 171.67 7.96 Favored 'Trans proline' 0 N--CA 1.485 0.991 0 CA-C-N 119.63 1.715 . . . . 0.0 109.672 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.748 ' C ' HD22 ' A' ' 35' ' ' LEU . 9.6 mtp180 -92.89 80.87 4.63 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 122.066 0.936 . . . . 0.0 110.115 -177.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.748 HD22 ' C ' ' A' ' 34' ' ' ARG . 4.3 mm? -122.5 -175.67 3.2 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -99.61 140.76 33.34 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.96 -53.59 47.89 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.616 -0.677 . . . . 0.0 111.042 -179.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.6 tm0? -52.46 -46.64 66.59 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.95 -0.469 . . . . 0.0 110.888 -178.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -63.91 -32.07 73.47 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 33.1 tpp -66.94 -58.46 4.92 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 10.2 tptt -53.2 -36.99 61.57 Favored 'General case' 0 N--CA 1.501 2.076 0 CA-C-O 121.179 0.514 . . . . 0.0 109.656 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.49 -40.92 98.35 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.82 -38.74 89.27 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 20.1 m -66.5 -33.54 75.91 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 50.6 m -72.26 -31.16 65.54 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 15.3 ttt85 -73.05 -32.62 65.18 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -76.43 -32.1 58.27 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.76 HD21 HG12 ' A' ' 98' ' ' VAL . 1.1 tp -72.98 -35.94 66.98 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.486 ' OE1' HD22 ' A' ' 105' ' ' LEU . 6.0 tp10 -72.7 -37.25 67.88 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 179.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.98 -38.51 82.77 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 45.4 mt -82.38 104.7 3.64 Favored Pre-proline 0 N--CA 1.495 1.789 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 177.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -58.32 140.72 95.49 Favored 'Trans proline' 0 N--CA 1.482 0.81 0 C-N-CA 121.775 1.65 . . . . 0.0 112.208 -175.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.586 ' HB1' ' N ' ' A' ' 108' ' ' ILE . . . -48.99 -24.39 1.5 Allowed 'General case' 0 N--CA 1.5 2.075 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.201 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -45.67 -71.9 0.07 Allowed 'General case' 0 N--CA 1.505 2.319 0 O-C-N 121.969 -0.457 . . . . 0.0 111.204 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 21.1 m -110.5 23.91 13.64 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.99 -0.444 . . . . 0.0 110.86 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.2 mtt180 -40.38 -83.44 0.01 OUTLIER 'General case' 0 N--CA 1.516 2.828 0 O-C-N 121.316 -0.865 . . . . 0.0 110.863 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 75.2 m -32.28 -35.88 0.02 OUTLIER 'General case' 0 N--CA 1.52 3.035 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -46.06 -58.07 3.91 Favored 'General case' 0 N--CA 1.511 2.607 0 CA-C-N 119.933 1.242 . . . . 0.0 110.931 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -42.61 -37.94 1.85 Allowed 'General case' 0 N--CA 1.513 2.715 0 O-C-N 121.675 -0.641 . . . . 0.0 112.346 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.709 ' CG2' HD13 ' A' ' 97' ' ' LEU . 25.8 t -55.08 -49.91 67.86 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 O-C-N 121.774 -0.579 . . . . 0.0 109.556 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -58.15 -28.99 65.23 Favored 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.794 HG23 ' HB ' ' A' ' 67' ' ' VAL . 2.0 mp -77.85 -27.58 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.269 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.46 HD23 ' C ' ' A' ' 63' ' ' LEU . 10.1 tt -78.18 -40.9 36.29 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 120.117 -0.633 . . . . 0.0 109.813 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -78.85 -51.62 9.47 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.142 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -80.81 -23.91 38.89 Favored 'General case' 0 N--CA 1.502 2.135 0 C-N-CA 120.689 -0.404 . . . . 0.0 111.323 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.9 146.3 8.02 Favored Glycine 0 N--CA 1.498 2.788 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.794 ' HB ' HG23 ' A' ' 62' ' ' ILE . 14.2 p -117.45 160.12 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 O-C-N 122.347 -0.502 . . . . 0.0 109.781 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.645 HG22 ' NE2' ' A' ' 74' ' ' HIS . 55.5 t -114.2 157.54 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.44 HG22 ' CE1' ' A' ' 14' ' ' HIS . 53.3 p -117.28 159.28 22.95 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.838 -177.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 34.7 t -64.59 -28.04 69.36 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.385 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.5 p -71.4 -16.05 62.39 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.68 10.83 42.61 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -100.93 156.51 17.34 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 118.201 1.0 . . . . 0.0 109.197 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.645 ' NE2' HG22 ' A' ' 68' ' ' VAL . 11.2 m170 -115.86 155.49 27.81 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -144.44 -173.51 4.06 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.287 0.565 . . . . 0.0 110.26 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.534 ' O ' HD12 ' A' ' 78' ' ' LEU . . . 61.01 -145.01 48.56 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.722 -1.751 . . . . 0.0 108.722 -178.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.411 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 2.7 tpt180 56.44 21.61 5.71 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 122.229 -0.571 . . . . 0.0 109.486 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.6 HD23 ' NH1' ' A' ' 21' ' ' ARG . 10.1 mp -66.12 -21.6 66.35 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.484 -0.76 . . . . 0.0 109.983 -179.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.527 HD12 ' HB3' ' A' ' 90' ' ' GLN . 3.0 tt -61.04 92.9 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -141.98 176.83 8.63 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.518 0.675 . . . . 0.0 110.662 -178.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -64.2 118.38 8.51 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.857 0.837 . . . . 0.0 111.367 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.484 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 22.0 mt -112.95 166.63 10.66 Favored Pre-proline 0 N--CA 1.497 1.89 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 177.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.484 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 29.4 Cg_endo -68.6 99.81 0.65 Allowed 'Trans proline' 0 C--N 1.326 -0.632 0 C-N-CA 121.063 1.175 . . . . 0.0 110.532 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.99 8.43 64.9 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.431 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 3.4 m -141.72 91.1 8.42 Favored Pre-proline 0 N--CA 1.511 2.615 0 CA-C-N 118.869 1.335 . . . . 0.0 109.504 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -72.95 166.4 30.15 Favored 'Trans proline' 0 N--CA 1.488 1.165 0 C-N-CA 121.895 1.73 . . . . 0.0 111.754 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 72.7 mtp180 -51.13 -27.55 8.78 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.173 0.511 . . . . 0.0 109.893 178.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -61.13 -45.92 92.69 Favored 'General case' 0 N--CA 1.502 2.169 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.239 -177.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 58.6 t -69.16 -43.61 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.665 -0.647 . . . . 0.0 110.602 -178.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.65 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 31.2 mt-30 -67.49 -27.71 67.23 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.421 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 5.9 tpt180 -78.65 -26.71 45.2 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.38 -48.45 17.24 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.923 -0.486 . . . . 0.0 110.065 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -78.31 -27.64 47.28 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 122.116 -0.365 . . . . 0.0 110.999 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.65 ' HB2' ' O ' ' A' ' 90' ' ' GLN . . . -53.09 -50.86 79.81 Favored Pre-proline 0 N--CA 1.502 2.14 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.637 ' HD3' ' HB3' ' A' ' 94' ' ' ALA . 31.2 Cg_endo -71.3 82.43 1.09 Allowed 'Trans proline' 0 N--CA 1.482 0.823 0 C-N-CA 122.197 1.931 . . . . 0.0 111.978 -177.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 164.62 57.28 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.492 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.8 ' HG ' HG13 ' A' ' 98' ' ' VAL . 2.3 pt? -86.94 -56.83 3.21 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -177.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.8 HG13 ' HG ' ' A' ' 97' ' ' LEU . 13.1 m -92.48 25.14 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-N 120.833 1.651 . . . . 0.0 111.183 -178.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 30.8 p -90.74 170.47 10.1 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -62.98 -2.56 1.26 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.452 -0.78 . . . . 0.0 112.121 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.57 ' O ' HG12 ' A' ' 101' ' ' VAL . 21.6 t -100.9 2.83 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 CA-C-N 120.416 1.462 . . . . 0.0 111.269 -179.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -133.71 -90.5 0.37 Allowed 'General case' 0 N--CA 1.502 2.133 0 CA-C-N 118.822 0.737 . . . . 0.0 110.97 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.712 ' O ' HD12 ' A' ' 105' ' ' LEU . 46.8 m -143.63 37.98 1.35 Allowed 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.559 -0.713 . . . . 0.0 109.491 -178.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -33.89 -62.66 0.3 Allowed 'General case' 0 N--CA 1.509 2.516 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -178.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.712 HD12 ' O ' ' A' ' 103' ' ' CYS . 3.4 mt 50.18 20.94 0.69 Allowed 'General case' 0 N--CA 1.506 2.341 0 CA-C-N 118.944 0.793 . . . . 0.0 110.946 -179.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 63.23 124.08 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.304 -0.872 . . . . 0.0 109.769 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.8 p -89.25 -160.2 0.65 Allowed 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.586 ' N ' ' HB1' ' A' ' 53' ' ' ALA . 6.2 tt -66.58 -30.97 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.414 ' HB3' ' CE1' ' A' ' 113' ' ' PHE . 96.2 m-70 -69.35 -0.97 7.08 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.007 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 58.67 27.74 61.84 Favored Glycine 0 N--CA 1.498 2.813 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -156.74 167.79 33.72 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -78.44 75.04 5.12 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 122.722 2.281 . . . . 0.0 111.764 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.414 ' CE1' ' HB3' ' A' ' 109' ' ' HIS . 19.5 p90 . . . . . 0 N--CA 1.508 2.471 0 O-C-N 121.617 -0.677 . . . . 0.0 110.956 178.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo . . . . . 0 CA--C 1.54 0.783 0 N-CA-C 110.503 -0.614 . . . . 0.0 110.503 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 79.49 -5.05 61.66 Favored Glycine 0 N--CA 1.499 2.852 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.562 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 86.8 mmm -140.82 115.23 9.39 Favored 'General case' 0 N--CA 1.501 2.105 0 CA-C-N 118.665 1.232 . . . . 0.0 108.968 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 85.72 -56.94 0.08 Allowed 'General case' 0 N--CA 1.515 2.795 0 CA-C-N 119.939 1.245 . . . . 0.0 108.434 -179.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.441 HG12 HD12 ' A' ' 51' ' ' ILE . 80.7 mt -110.84 100.79 47.51 Favored Pre-proline 0 N--CA 1.489 1.507 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 178.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -80.48 172.94 12.91 Favored 'Trans proline' 0 C--O 1.22 -0.413 0 C-N-CA 121.41 1.407 . . . . 0.0 111.284 -176.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 50.8 m-70 -75.79 143.33 41.99 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.454 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 2.7 m120 63.36 61.94 1.76 Allowed Pre-proline 0 N--CA 1.502 2.152 0 O-C-N 121.769 -0.582 . . . . 0.0 109.742 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.454 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 40.3 Cg_endo -83.45 167.79 13.32 Favored 'Trans proline' 0 N--CA 1.483 0.859 0 C-N-CA 122.459 2.106 . . . . 0.0 111.693 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 42.2 mt 47.64 45.89 17.91 Favored 'General case' 0 N--CA 1.504 2.233 0 CA-C-O 121.105 0.478 . . . . 0.0 111.516 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -74.13 -39.67 63.16 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.538 -0.726 . . . . 0.0 109.447 179.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.3 t -66.58 -25.95 66.88 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.533 ' O ' HG23 ' A' ' 24' ' ' VAL . 37.1 m -75.28 -41.75 56.48 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -43.75 97.03 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.434 ' HA ' ' CE3' ' A' ' 22' ' ' TRP . 38.7 m95 -74.19 -25.92 59.98 Favored 'General case' 0 N--CA 1.501 2.087 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.129 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -69.8 -28.47 65.76 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.737 HG22 ' CE1' ' A' ' 93' ' ' PHE . 52.1 t -75.61 -43.02 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 177.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.447 ' HB3' HD13 ' A' ' 82' ' ' LEU . 0.8 OUTLIER -55.78 -41.77 74.56 Favored 'General case' 0 N--CA 1.503 2.19 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.349 -179.403 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.1 m -77.67 -53.58 7.38 Favored 'General case' 0 N--CA 1.509 2.516 0 O-C-N 122.085 -0.385 . . . . 0.0 111.685 -178.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -60.5 -24.99 65.74 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.851 -0.53 . . . . 0.0 110.453 -178.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.554 HG23 ' O ' ' A' ' 24' ' ' VAL . 31.8 p -97.23 -64.11 1.07 Allowed 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -177.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.558 ' O ' HG23 ' A' ' 31' ' ' VAL . 19.6 m -101.2 14.55 31.59 Favored 'General case' 0 N--CA 1.508 2.45 0 O-C-N 121.386 -0.821 . . . . 0.0 112.0 -178.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 57.05 21.16 37.33 Favored Glycine 0 N--CA 1.505 3.255 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 29' ' ' CYS . 23.6 t -107.74 160.43 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.242 0 O-C-N 121.858 -0.79 . . . . 0.0 109.069 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.436 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 130.65 -179.39 16.97 Favored Glycine 0 N--CA 1.5 2.94 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -66.23 173.88 6.81 Favored 'Trans proline' 0 N--CA 1.486 1.076 0 CA-C-N 119.263 1.531 . . . . 0.0 109.736 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 2.9 ptt180 -92.81 82.66 4.72 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 122.086 0.945 . . . . 0.0 110.742 -177.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 24.5 mt -134.82 138.93 44.68 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.87 160.86 3.22 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -73.08 -56.49 5.05 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.963 -0.461 . . . . 0.0 111.209 -178.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -54.32 -35.65 62.9 Favored 'General case' 0 N--CA 1.506 2.364 0 O-C-N 121.913 -0.492 . . . . 0.0 110.47 -178.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -64.09 -57.65 8.98 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 5.0 ttm -53.08 -47.48 68.48 Favored 'General case' 0 N--CA 1.504 2.238 0 CA-C-O 121.6 0.714 . . . . 0.0 109.401 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 23.8 ttmt -55.95 -37.72 69.37 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.49 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.22 -35.21 79.83 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.61 -41.69 98.27 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 19.5 m -66.26 -38.65 88.32 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.552 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 84.9 m -69.76 -28.49 65.81 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -74.51 -32.23 62.43 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -74.54 -35.49 63.11 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.442 HD11 HG12 ' A' ' 98' ' ' VAL . 2.3 tt -75.68 -27.23 58.19 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.487 ' HG2' HD13 ' A' ' 105' ' ' LEU . 1.6 mm-40 -77.22 -52.16 9.71 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.57 -45.57 69.99 Favored 'General case' 0 N--CA 1.508 2.441 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.441 HD12 HG12 ' A' ' 12' ' ' ILE . 23.7 mm -67.57 106.47 1.26 Allowed Pre-proline 0 N--CA 1.49 1.528 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 175.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -58.51 151.2 63.64 Favored 'Trans proline' 0 N--CA 1.479 0.642 0 C-N-CA 121.479 1.453 . . . . 0.0 110.962 -176.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.423 ' HA ' ' HD3' ' A' ' 56' ' ' ARG . . . -40.72 -29.7 0.1 Allowed 'General case' 0 N--CA 1.507 2.377 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.686 -178.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -73.77 131.33 41.46 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 8.3 m 72.35 6.28 5.46 Favored 'General case' 0 N--CA 1.508 2.433 0 O-C-N 122.125 -0.36 . . . . 0.0 111.335 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.423 ' HD3' ' HA ' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -49.21 -85.23 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.715 0 CA-C-N 119.247 0.931 . . . . 0.0 110.038 -179.765 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 85.5 m -38.09 -45.08 0.88 Allowed 'General case' 0 N--CA 1.518 2.97 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.411 ' O ' HD12 ' A' ' 62' ' ' ILE . 25.5 tt0 -39.86 -50.7 2.45 Favored 'General case' 0 N--CA 1.511 2.586 0 CA-C-N 119.819 1.19 . . . . 0.0 112.148 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -43.86 -47.02 8.2 Favored 'General case' 0 N--CA 1.518 2.939 0 O-C-N 121.573 -0.705 . . . . 0.0 111.609 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 1.008 HG21 HD13 ' A' ' 97' ' ' LEU . 45.2 t -53.71 -45.24 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.55 -32.15 72.21 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.85 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.693 HG23 ' HB ' ' A' ' 67' ' ' VAL . 1.2 mp -70.08 -28.19 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.795 HD13 ' O ' ' A' ' 63' ' ' LEU . 0.9 OUTLIER -77.95 -39.51 42.39 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.047 -179.349 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 14.4 ttp -78.25 -54.8 5.83 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.927 -0.483 . . . . 0.0 110.374 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -80.95 -23.58 38.71 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 122.202 -0.311 . . . . 0.0 111.189 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.33 148.45 13.89 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 -178.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.693 ' HB ' HG23 ' A' ' 62' ' ' ILE . 7.7 p -118.01 159.52 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 O-C-N 122.206 -0.585 . . . . 0.0 109.661 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.647 HG22 ' NE2' ' A' ' 74' ' ' HIS . 76.2 t -115.21 157.56 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 CA-C-O 122.038 0.923 . . . . 0.0 110.368 -178.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.404 ' N ' HG12 ' A' ' 68' ' ' VAL . 23.6 p -117.23 160.65 20.73 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.569 -177.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.6 t -63.5 -34.45 77.8 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.129 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.8 p -63.82 -17.74 63.42 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.73 9.1 47.24 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -97.49 156.88 16.29 Favored 'General case' 0 N--CA 1.503 2.207 0 CA-C-N 118.278 1.039 . . . . 0.0 109.892 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.647 ' NE2' HG22 ' A' ' 68' ' ' VAL . 9.9 m170 -116.04 155.06 28.79 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -141.76 -175.96 4.58 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.009 0.433 . . . . 0.0 109.908 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 59.45 -143.76 46.13 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.3 22.06 4.56 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 122.289 -0.536 . . . . 0.0 110.167 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 55.0 mt -81.43 -15.26 55.65 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.735 -0.603 . . . . 0.0 110.739 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.707 HD21 ' HB3' ' A' ' 90' ' ' GLN . 4.7 tt -57.26 91.99 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -128.38 179.77 5.46 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.26 0.552 . . . . 0.0 109.818 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.75 106.05 7.11 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.313 0.577 . . . . 0.0 110.696 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.564 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 23.0 mt -81.33 169.63 18.34 Favored Pre-proline 0 N--CA 1.495 1.798 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 177.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.564 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 28.3 Cg_endo -66.75 99.4 0.45 Allowed 'Trans proline' 0 C--N 1.329 -0.487 0 C-N-CA 120.978 1.119 . . . . 0.0 111.201 -178.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 103.07 -14.05 55.67 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 6.1 m -123.65 92.22 48.89 Favored Pre-proline 0 N--CA 1.504 2.253 0 CA-C-N 119.323 1.561 . . . . 0.0 110.352 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -72.12 166.11 30.61 Favored 'Trans proline' 0 N--CA 1.483 0.87 0 C-N-CA 121.598 1.532 . . . . 0.0 111.04 -179.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.5 mtm180 -46.9 -28.52 1.62 Allowed 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.152 0.501 . . . . 0.0 109.754 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.8 tm0? -58.65 -52.21 66.65 Favored 'General case' 0 N--CA 1.503 2.199 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.483 -178.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 60.1 t -64.23 -41.75 93.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.746 -0.596 . . . . 0.0 109.576 -178.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.707 ' HB3' HD21 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -63.57 -25.94 68.47 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.29 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -79.0 -33.46 44.98 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.51 -47.68 63.01 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.737 ' CE1' HG22 ' A' ' 24' ' ' VAL . 42.5 t80 -78.27 -25.37 46.72 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.478 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.67 ' HB3' ' HD3' ' A' ' 95' ' ' PRO . . . -42.69 -52.17 11.18 Favored Pre-proline 0 N--CA 1.504 2.227 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -177.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.67 ' HD3' ' HB3' ' A' ' 94' ' ' ALA . 29.6 Cg_endo -70.98 -164.1 0.14 Allowed 'Trans proline' 0 C--N 1.328 -0.513 0 C-N-CA 121.689 1.593 . . . . 0.0 110.296 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 60.57 24.68 14.37 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -178.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 1.008 HD13 HG21 ' A' ' 60' ' ' VAL . 6.6 mt -73.42 -67.93 0.54 Allowed 'General case' 0 N--CA 1.505 2.276 0 O-C-N 122.034 -0.416 . . . . 0.0 111.42 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.442 HG12 HD11 ' A' ' 48' ' ' LEU . 14.7 m -85.52 22.11 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.35 -0.843 . . . . 0.0 111.085 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 30.8 p -99.44 173.31 6.81 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -59.06 -4.16 0.46 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.532 -0.73 . . . . 0.0 111.764 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.53 ' O ' HG12 ' A' ' 101' ' ' VAL . 20.0 t -91.83 -0.27 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-N 120.545 1.52 . . . . 0.0 111.403 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -140.82 -89.39 0.16 Allowed 'General case' 0 N--CA 1.504 2.261 0 CA-C-N 118.974 0.807 . . . . 0.0 111.247 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.443 ' O ' HD12 ' A' ' 105' ' ' LEU . 55.8 m -145.02 42.38 1.31 Allowed 'General case' 0 N--CA 1.508 2.471 0 O-C-N 121.432 -0.792 . . . . 0.0 109.518 -178.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -36.2 -62.5 0.44 Allowed 'General case' 0 N--CA 1.512 2.67 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -178.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.487 HD13 ' HG2' ' A' ' 49' ' ' GLU . 1.9 mt 46.3 27.76 0.62 Allowed 'General case' 0 N--CA 1.513 2.722 0 CA-C-N 118.988 0.813 . . . . 0.0 111.268 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 105' ' ' LEU . . . 70.34 150.34 0.09 Allowed 'General case' 0 N--CA 1.507 2.408 0 O-C-N 121.199 -0.938 . . . . 0.0 109.174 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.0 p -123.16 -163.78 1.14 Allowed 'General case' 0 N--CA 1.505 2.294 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.479 HG23 ' CD2' ' A' ' 109' ' ' HIS . 7.2 tp -66.12 -31.23 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.479 ' CD2' HG23 ' A' ' 108' ' ' ILE . 87.7 m-70 -75.68 5.55 6.0 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.974 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 57.96 32.29 66.28 Favored Glycine 0 N--CA 1.499 2.834 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -164.42 171.95 40.06 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 110.116 -1.193 . . . . 0.0 110.116 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -75.8 80.02 2.71 Favored 'Trans proline' 0 N--CA 1.48 0.708 0 C-N-CA 122.626 2.217 . . . . 0.0 110.855 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.461 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.163 0 CA-C-O 121.462 0.649 . . . . 0.0 111.213 179.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo . . . . . 0 CA--C 1.537 0.656 0 N-CA-C 109.904 -0.844 . . . . 0.0 109.904 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 58.32 24.18 55.07 Favored Glycine 0 N--CA 1.499 2.847 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.577 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 38.7 mmm -138.07 95.08 2.96 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.98 -0.718 . . . . 0.0 109.1 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.577 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 86.77 -56.43 0.05 Allowed 'General case' 0 N--CA 1.515 2.803 0 CA-C-N 119.008 0.822 . . . . 0.0 108.796 -178.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.6 mt -104.59 101.11 26.16 Favored Pre-proline 0 N--CA 1.494 1.73 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 178.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -81.78 173.2 11.45 Favored 'Trans proline' 0 N--CA 1.476 0.457 0 C-N-CA 121.555 1.504 . . . . 0.0 111.764 -176.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 45.0 m-70 -74.52 146.15 42.9 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.519 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 0.9 OUTLIER 60.79 54.99 3.5 Favored Pre-proline 0 N--CA 1.501 2.094 0 O-C-N 121.56 -0.712 . . . . 0.0 109.955 -179.098 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.519 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 40.4 Cg_endo -81.17 166.96 18.19 Favored 'Trans proline' 0 N--CA 1.484 0.953 0 C-N-CA 122.239 1.959 . . . . 0.0 111.606 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 38.3 mt 51.09 45.08 28.3 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.921 177.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -68.09 -41.38 81.94 Favored 'General case' 0 N--CA 1.505 2.323 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.57 -26.27 68.62 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 178.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.477 ' O ' HG23 ' A' ' 24' ' ' VAL . 60.7 m -75.52 -38.65 59.25 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.717 ' HD3' HD12 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -62.43 -50.68 70.55 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.004 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.457 ' HA ' ' CE3' ' A' ' 22' ' ' TRP . 32.1 m95 -69.86 -26.46 64.21 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 119.517 -0.873 . . . . 0.0 109.853 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.432 ' O ' ' CD1' ' A' ' 23' ' ' TYR . 7.7 t80 -67.59 -30.35 69.93 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.685 HG22 ' CD1' ' A' ' 93' ' ' PHE . 59.0 t -74.43 -44.43 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 108.301 -0.999 . . . . 0.0 108.301 178.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 p -56.7 -40.96 76.55 Favored 'General case' 0 N--CA 1.505 2.277 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.38 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.3 m -77.22 -53.19 8.04 Favored 'General case' 0 N--CA 1.509 2.497 0 O-C-N 122.01 -0.432 . . . . 0.0 111.872 -178.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -61.8 -24.88 67.14 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.798 -0.563 . . . . 0.0 110.6 -178.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.542 HG23 ' O ' ' A' ' 24' ' ' VAL . 35.4 p -95.66 -63.86 1.11 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.966 -0.459 . . . . 0.0 111.956 -177.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.46 ' O ' HG23 ' A' ' 31' ' ' VAL . 3.7 m -100.93 11.91 38.68 Favored 'General case' 0 N--CA 1.509 2.491 0 O-C-N 121.315 -0.866 . . . . 0.0 111.424 -178.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 59.35 20.23 49.96 Favored Glycine 0 N--CA 1.502 3.056 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -178.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 29' ' ' CYS . 61.1 t -106.37 158.72 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 O-C-N 121.888 -0.772 . . . . 0.0 109.079 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.434 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 135.04 179.06 16.14 Favored Glycine 0 N--CA 1.497 2.761 0 N-CA-C 108.74 -1.744 . . . . 0.0 108.74 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -65.8 172.39 8.37 Favored 'Trans proline' 0 N--CA 1.483 0.904 0 CA-C-N 119.289 1.545 . . . . 0.0 109.635 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 27.8 mtt180 -92.41 74.77 5.23 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 122.155 0.978 . . . . 0.0 109.705 -178.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 35' ' ' LEU . 0.2 OUTLIER -124.05 135.87 53.87 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.084 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.57 150.84 3.51 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.977 -0.452 . . . . 0.0 110.0 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.4 m -73.74 -28.68 61.81 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.736 -0.603 . . . . 0.0 111.185 -178.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -72.74 -31.4 64.92 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.867 -0.521 . . . . 0.0 109.656 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -75.72 -32.66 60.13 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.41 ' HB3' ' CD2' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -70.29 -53.59 16.19 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.575 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 21.7 tttp -56.73 -37.41 70.95 Favored 'General case' 0 N--CA 1.506 2.374 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.19 -38.48 90.62 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.3 mpt_? -65.08 -42.65 93.92 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 17.0 m -65.21 -34.72 79.05 Favored 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.883 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 82.3 m -74.44 -29.8 61.63 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.7 ttt180 -73.63 -32.58 64.11 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -78.75 -35.89 43.95 Favored 'General case' 0 N--CA 1.502 2.17 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.112 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.1 tt -69.63 -37.42 76.78 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -75.56 -41.23 55.38 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.85 -38.01 64.24 Favored 'General case' 0 N--CA 1.509 2.48 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 177.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 59.8 mt -78.92 105.69 3.39 Favored Pre-proline 0 N--CA 1.488 1.434 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 176.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -60.01 152.05 67.72 Favored 'Trans proline' 0 N--CA 1.481 0.745 0 C-N-CA 121.712 1.608 . . . . 0.0 111.278 -176.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -41.37 -29.17 0.14 Allowed 'General case' 0 N--CA 1.507 2.415 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.376 -178.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -67.12 121.85 16.51 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 66.2 m 60.79 15.55 6.0 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 122.195 -0.316 . . . . 0.0 110.537 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.58 -91.38 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.259 -0.901 . . . . 0.0 109.876 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 54.3 m -32.28 -33.95 0.01 OUTLIER 'General case' 0 N--CA 1.521 3.112 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -40.41 -51.64 2.82 Favored 'General case' 0 N--CA 1.509 2.501 0 CA-C-N 119.759 1.163 . . . . 0.0 111.893 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.592 ' HA ' HD12 ' A' ' 62' ' ' ILE . . . -40.42 -47.88 2.66 Favored 'General case' 0 N--CA 1.514 2.746 0 O-C-N 121.897 -0.502 . . . . 0.0 112.108 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.725 HG21 HD13 ' A' ' 97' ' ' LEU . 24.4 t -58.26 -49.22 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.57 -26.27 63.43 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.871 HG23 ' HB ' ' A' ' 67' ' ' VAL . 9.3 mt -78.81 -30.76 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.996 -0.44 . . . . 0.0 110.272 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.71 ' O ' HD23 ' A' ' 63' ' ' LEU . 4.4 tt -78.03 -42.03 33.79 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 120.014 -0.675 . . . . 0.0 109.334 -178.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 6.8 tpt -78.27 -53.17 7.61 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.313 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -81.51 -21.87 38.33 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 122.147 -0.346 . . . . 0.0 111.429 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.13 149.9 14.35 Favored Glycine 0 N--CA 1.499 2.878 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -178.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.871 ' HB ' HG23 ' A' ' 62' ' ' ILE . 7.3 p -118.17 160.18 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.295 0 O-C-N 122.224 -0.574 . . . . 0.0 110.43 -179.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.735 HG22 ' NE2' ' A' ' 74' ' ' HIS . 42.3 t -114.72 157.35 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 28.2 p -117.43 160.27 21.45 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.544 0.688 . . . . 0.0 110.171 -177.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.3 t -61.65 -25.7 67.54 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.35 -178.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.2 p -80.19 -14.19 58.64 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 122.253 -0.279 . . . . 0.0 110.721 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.23 13.2 34.02 Favored Glycine 0 N--CA 1.498 2.804 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -99.15 156.92 16.71 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-N 118.103 0.951 . . . . 0.0 109.092 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.735 ' NE2' HG22 ' A' ' 68' ' ' VAL . 8.5 m170 -115.65 155.28 27.98 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -144.75 -177.14 5.36 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 120.949 0.404 . . . . 0.0 110.093 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 59.62 -141.03 47.67 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 108.876 -1.69 . . . . 0.0 108.876 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.6 ttp180 55.08 22.45 4.5 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 122.267 -0.549 . . . . 0.0 110.431 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -80.47 -15.26 57.18 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.609 -0.682 . . . . 0.0 110.657 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.717 HD12 ' HD3' ' A' ' 21' ' ' ARG . 2.1 tp -67.46 90.65 0.25 Allowed 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -126.03 177.26 6.46 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -60.81 100.69 0.12 Allowed 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 121.638 0.732 . . . . 0.0 110.535 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.559 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 19.7 mt -80.41 170.74 14.51 Favored Pre-proline 0 N--CA 1.498 1.946 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 177.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.559 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 29.2 Cg_endo -70.07 98.78 0.74 Allowed 'Trans proline' 0 C--O 1.219 -0.447 0 C-N-CA 120.709 0.939 . . . . 0.0 109.883 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 100.09 3.53 55.69 Favored Glycine 0 N--CA 1.495 2.625 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 3.5 m -138.76 91.13 12.09 Favored Pre-proline 0 N--CA 1.503 2.223 0 CA-C-N 119.114 1.457 . . . . 0.0 109.341 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -74.45 162.11 38.82 Favored 'Trans proline' 0 N--CA 1.481 0.786 0 C-N-CA 121.343 1.362 . . . . 0.0 111.2 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 3.8 mmm180 -47.92 -29.21 3.16 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -54.35 -50.46 67.41 Favored 'General case' 0 N--CA 1.508 2.432 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.809 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 63.4 t -64.63 -36.44 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.655 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 52.4 mm-40 -63.27 -26.7 68.9 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.73 -37.21 41.92 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.49 -48.76 71.51 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.685 ' CD1' HG22 ' A' ' 24' ' ' VAL . 41.3 t80 -78.51 -25.22 45.55 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 122.248 -0.282 . . . . 0.0 110.654 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.755 ' HB3' ' HD3' ' A' ' 95' ' ' PRO . . . -40.88 -52.44 6.67 Favored Pre-proline 0 N--CA 1.505 2.315 0 CA-C-O 118.978 -0.534 . . . . 0.0 112.09 -177.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.755 ' HD3' ' HB3' ' A' ' 94' ' ' ALA . 30.6 Cg_endo -74.44 -173.65 1.56 Allowed 'Trans proline' 0 C--N 1.328 -0.524 0 C-N-CA 121.708 1.606 . . . . 0.0 109.834 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 17.6 mttm 68.31 26.61 6.8 Favored 'General case' 0 N--CA 1.504 2.243 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -178.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.725 HD13 HG21 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -73.53 -69.61 0.42 Allowed 'General case' 0 N--CA 1.516 2.848 0 O-C-N 121.837 -0.539 . . . . 0.0 110.791 -179.302 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 32.8 m -88.38 26.12 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 O-C-N 121.129 -0.982 . . . . 0.0 110.385 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 27.4 p -100.1 173.51 6.6 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.77 -1.62 0.43 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.565 -0.71 . . . . 0.0 112.019 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.539 ' O ' HG12 ' A' ' 101' ' ' VAL . 20.9 t -96.77 1.29 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 CA-C-N 120.562 1.528 . . . . 0.0 111.222 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -141.09 -91.48 0.15 Allowed 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.488 -0.758 . . . . 0.0 111.318 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.536 ' O ' HD12 ' A' ' 105' ' ' LEU . 60.5 m -142.74 45.46 1.59 Allowed 'General case' 0 N--CA 1.504 2.263 0 O-C-N 121.425 -0.797 . . . . 0.0 109.577 -178.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 58.1 t-20 -40.39 -68.84 0.15 Allowed 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.297 -0.877 . . . . 0.0 113.258 -178.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.536 HD12 ' O ' ' A' ' 103' ' ' CYS . 2.1 mt 50.51 27.16 2.71 Favored 'General case' 0 N--CA 1.506 2.357 0 C-N-CA 120.329 -0.549 . . . . 0.0 110.348 -178.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 105' ' ' LEU . . . 68.52 163.26 0.22 Allowed 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.332 -0.855 . . . . 0.0 109.364 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.503 ' OG1' ' CE1' ' A' ' 109' ' ' HIS . 16.6 p -135.92 -159.94 1.01 Allowed 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 120.869 0.366 . . . . 0.0 110.439 -176.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.504 HG23 ' N ' ' A' ' 109' ' ' HIS . 0.7 OUTLIER -93.13 -47.25 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 121.9 -0.5 . . . . 0.0 111.563 -179.439 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.504 ' N ' HG23 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -54.28 -22.64 12.38 Favored 'General case' 0 N--CA 1.529 3.479 0 O-C-N 121.673 -0.642 . . . . 0.0 109.88 -178.838 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.34 68.81 0.79 Allowed Glycine 0 N--CA 1.499 2.898 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.698 177.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 143.57 173.19 14.91 Favored Glycine 0 N--CA 1.5 2.91 0 CA-C-N 118.809 1.305 . . . . 0.0 111.4 178.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -73.67 85.47 1.3 Allowed 'Trans proline' 0 N--CA 1.482 0.814 0 C-N-CA 122.79 2.327 . . . . 0.0 110.375 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.5 ' O ' ' CE1' ' A' ' 109' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.515 2.78 0 C-N-CA 120.389 -0.524 . . . . 0.0 111.392 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo . . . . . 0 CA--C 1.541 0.847 0 N-CA-C 110.107 -0.766 . . . . 0.0 110.107 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 61.38 14.63 42.17 Favored Glycine 0 N--CA 1.501 2.969 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.573 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 5.1 mmt -141.06 108.01 5.43 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 87.04 -59.93 0.04 OUTLIER 'General case' 0 N--CA 1.514 2.767 0 CA-C-N 119.94 1.246 . . . . 0.0 108.245 -178.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.799 HD11 ' HB3' ' A' ' 55' ' ' CYS . 21.9 mt -109.82 97.54 29.29 Favored Pre-proline 0 N--CA 1.492 1.667 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 178.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -83.62 174.75 8.52 Favored 'Trans proline' 0 N--CA 1.476 0.442 0 C-N-CA 121.814 1.676 . . . . 0.0 111.503 -177.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 45.2 m-70 -71.93 142.21 49.45 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.472 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 25.8 m120 59.1 59.02 5.36 Favored Pre-proline 0 N--CA 1.5 2.058 0 O-C-N 121.436 -0.79 . . . . 0.0 109.003 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.472 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 38.2 Cg_endo -78.97 151.5 24.13 Favored 'Trans proline' 0 N--CA 1.484 0.95 0 C-N-CA 122.345 2.03 . . . . 0.0 112.264 -178.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.928 HD13 ' HB1' ' A' ' 59' ' ' ALA . 6.7 mp 43.0 42.65 3.25 Favored 'General case' 0 N--CA 1.502 2.158 0 CA-C-O 121.163 0.506 . . . . 0.0 111.825 178.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -65.37 -32.4 74.02 Favored 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.23 -25.98 67.15 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 35.1 m -76.1 -38.46 56.92 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.6 -50.28 73.21 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.42 ' HA ' ' CE3' ' A' ' 22' ' ' TRP . 36.5 m95 -70.8 -27.37 63.85 Favored 'General case' 0 N--CA 1.501 2.122 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.786 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.744 ' HE1' HG23 ' A' ' 37' ' ' THR . 7.9 t80 -68.12 -31.91 71.83 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.583 HG22 ' CD1' ' A' ' 93' ' ' PHE . 86.4 t -74.98 -40.58 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 177.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.507 ' HB3' HD13 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -55.01 -38.64 68.14 Favored 'General case' 0 N--CA 1.502 2.163 0 C-N-CA 120.095 -0.642 . . . . 0.0 109.561 -179.626 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.7 m -77.07 -51.81 10.41 Favored 'General case' 0 N--CA 1.506 2.356 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.554 -178.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -62.22 -25.21 67.68 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.795 -0.565 . . . . 0.0 111.189 -178.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 79.6 p -97.3 -63.84 1.1 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 122.233 -0.292 . . . . 0.0 111.763 -177.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.551 ' O ' HG23 ' A' ' 31' ' ' VAL . 55.8 m -101.72 14.72 31.13 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.358 -0.839 . . . . 0.0 112.129 -178.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 55.82 21.72 30.96 Favored Glycine 0 N--CA 1.505 3.254 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 29' ' ' CYS . 56.3 t -106.89 162.78 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.821 -0.811 . . . . 0.0 109.011 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.489 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 130.16 178.24 15.31 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 -179.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -66.55 174.88 5.77 Favored 'Trans proline' 0 N--CA 1.487 1.12 0 CA-C-N 119.165 1.482 . . . . 0.0 109.571 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.2 ptp85 -92.21 52.31 1.93 Allowed 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.98 0.895 . . . . 0.0 109.77 -178.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.48 127.83 41.84 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.47 148.78 4.78 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.807 -0.558 . . . . 0.0 110.171 -178.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.744 HG23 ' HE1' ' A' ' 23' ' ' TYR . 61.1 m -65.77 -40.34 91.93 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.67 -0.643 . . . . 0.0 111.947 -178.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -64.88 -44.29 90.15 Favored 'General case' 0 N--CA 1.504 2.264 0 CA-C-N 118.644 0.656 . . . . 0.0 109.72 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -66.87 -27.68 67.72 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -69.45 -59.03 3.25 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.31 -31.87 55.17 Favored 'General case' 0 N--CA 1.5 2.06 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.633 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.91 -40.79 78.93 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -64.24 -37.41 87.37 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 15.9 m -72.34 -33.45 67.31 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.922 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 21.8 m -73.69 -28.46 61.75 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 24.5 ttm180 -78.19 -35.56 48.5 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.543 ' O ' HD12 ' A' ' 51' ' ' ILE . 8.3 mt-30 -78.03 -41.92 34.13 Favored 'General case' 0 N--CA 1.502 2.157 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.494 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.549 HD22 ' O ' ' A' ' 103' ' ' CYS . 5.6 tt -64.9 -45.22 86.82 Favored 'General case' 0 C--O 1.2 -1.552 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.14 -28.66 66.64 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.497 ' HB3' ' O ' ' A' ' 47' ' ' GLN . . . -55.2 -60.34 3.53 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.543 HD12 ' O ' ' A' ' 47' ' ' GLN . 2.8 mt -58.73 103.92 0.39 Allowed Pre-proline 0 N--CA 1.51 2.572 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 178.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -50.18 144.67 22.24 Favored 'Trans proline' 0 N--CA 1.488 1.166 0 C-N-CA 121.636 1.558 . . . . 0.0 113.094 -175.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.488 ' HA ' ' CG ' ' A' ' 56' ' ' ARG . . . -22.82 -46.19 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.767 0 C-N-CA 124.28 1.032 . . . . 0.0 113.693 -177.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -62.75 138.11 58.43 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.799 ' HB3' HD11 ' A' ' 12' ' ' ILE . 20.8 m 61.68 22.82 13.25 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 122.0 -0.438 . . . . 0.0 109.819 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.488 ' CG ' ' HA ' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -44.72 -93.08 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.892 0 O-C-N 121.063 -1.023 . . . . 0.0 110.72 -179.697 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.691 ' SG ' HG21 ' A' ' 98' ' ' VAL . 76.1 m -38.94 -22.35 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.555 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 -178.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -39.07 -48.02 1.61 Allowed 'General case' 0 N--CA 1.512 2.644 0 CA-C-N 120.984 1.72 . . . . 0.0 112.249 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.928 ' HB1' HD13 ' A' ' 17' ' ' LEU . . . -44.56 -57.95 3.31 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.62 -0.675 . . . . 0.0 111.42 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.517 HG22 HD13 ' A' ' 97' ' ' LEU . 41.4 t -48.51 -41.85 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.266 0 CA-C-O 121.125 0.488 . . . . 0.0 109.686 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 22.9 mtp85 -60.09 -64.15 1.05 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.905 HD12 ' HB ' ' A' ' 67' ' ' VAL . 36.9 mm -46.13 -26.95 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.787 -0.57 . . . . 0.0 111.365 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.58 ' C ' HD13 ' A' ' 63' ' ' LEU . 3.5 tm? -77.82 -43.64 29.85 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.226 -0.989 . . . . 0.0 109.705 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -77.67 -53.38 7.62 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.6 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -79.93 -22.17 42.99 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 122.039 -0.413 . . . . 0.0 111.025 -179.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.96 154.06 15.03 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -178.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.905 ' HB ' HD12 ' A' ' 62' ' ' ILE . 2.5 p -117.46 158.94 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.341 0 CA-C-O 121.361 0.6 . . . . 0.0 109.548 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.665 HG22 ' NE2' ' A' ' 74' ' ' HIS . 54.7 t -115.69 157.05 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.6 p -117.48 159.53 22.67 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.522 -177.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.9 t -61.95 -32.73 73.19 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.23 0.538 . . . . 0.0 110.175 -178.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.2 p -65.69 -18.85 65.63 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.254 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.13 16.54 25.15 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -106.36 156.9 18.04 Favored 'General case' 0 N--CA 1.503 2.197 0 CA-C-N 118.284 1.042 . . . . 0.0 109.626 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.665 ' NE2' HG22 ' A' ' 68' ' ' VAL . 11.0 m170 -116.09 154.08 30.59 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.589 -0.695 . . . . 0.0 109.143 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -140.63 -174.99 4.12 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.044 0.449 . . . . 0.0 109.851 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 56.3 -141.29 41.33 Favored Glycine 0 N--CA 1.497 2.715 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.3 ttp180 54.39 24.8 5.44 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 122.228 -0.572 . . . . 0.0 110.54 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.4 mt -78.7 -19.03 53.39 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.698 -0.626 . . . . 0.0 110.38 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.763 HD21 ' HB3' ' A' ' 90' ' ' GLN . 6.5 tp -52.86 95.37 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.703 -0.623 . . . . 0.0 109.998 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -132.78 172.86 12.01 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -67.82 103.18 1.38 Allowed 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.497 0.665 . . . . 0.0 110.484 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.603 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 24.7 mt -78.45 171.33 12.79 Favored Pre-proline 0 N--CA 1.492 1.655 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 177.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.603 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 27.6 Cg_endo -66.61 99.21 0.43 Allowed 'Trans proline' 0 C--N 1.327 -0.579 0 C-N-CA 120.939 1.093 . . . . 0.0 110.715 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 98.18 -12.11 63.69 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 7.0 m -119.58 92.17 45.74 Favored Pre-proline 0 N--CA 1.5 2.063 0 CA-C-N 119.207 1.503 . . . . 0.0 110.101 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -73.16 164.46 35.33 Favored 'Trans proline' 0 N--CA 1.483 0.863 0 C-N-CA 121.514 1.476 . . . . 0.0 111.045 -179.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -46.32 -28.56 1.35 Allowed 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 177.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -54.47 -54.6 38.79 Favored 'General case' 0 N--CA 1.504 2.243 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.537 -178.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 64.5 t -60.84 -41.52 88.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.761 -0.587 . . . . 0.0 109.843 -178.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.763 ' HB3' HD21 ' A' ' 79' ' ' LEU . 7.1 mp0 -64.61 -26.59 68.47 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.49 -28.55 46.4 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.11 -48.68 17.11 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 122.014 -0.429 . . . . 0.0 109.876 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.583 ' CD1' HG22 ' A' ' 24' ' ' VAL . 36.1 t80 -77.72 -25.28 49.2 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 122.212 -0.305 . . . . 0.0 110.759 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.684 ' HB2' ' O ' ' A' ' 90' ' ' GLN . . . -53.15 -53.37 56.43 Favored Pre-proline 0 N--CA 1.5 2.049 0 CA-C-O 118.961 -0.542 . . . . 0.0 111.883 -177.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.682 ' HD3' ' HB3' ' A' ' 94' ' ' ALA . 30.2 Cg_endo -70.0 -11.16 29.99 Favored 'Trans proline' 0 N--CA 1.482 0.819 0 C-N-CA 121.918 1.745 . . . . 0.0 111.181 -179.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -89.47 17.19 6.53 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.727 HD21 HD23 ' A' ' 17' ' ' LEU . 0.1 OUTLIER -73.89 -71.27 0.33 Allowed 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.671 -0.643 . . . . 0.0 109.966 -179.734 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.691 HG21 ' SG ' ' A' ' 57' ' ' CYS . 13.1 m -70.58 5.6 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.36 0 O-C-N 121.176 -0.953 . . . . 0.0 112.283 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 16.3 p -92.07 174.79 7.14 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.13 -3.98 0.45 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.526 -0.734 . . . . 0.0 112.389 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.0 t -89.06 -2.2 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 CA-C-N 120.069 1.304 . . . . 0.0 111.114 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.23 -86.97 0.2 Allowed 'General case' 0 N--CA 1.508 2.456 0 C-N-CA 119.486 -0.886 . . . . 0.0 111.978 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.717 ' O ' HD12 ' A' ' 105' ' ' LEU . 95.6 m -146.7 43.83 1.18 Allowed 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.43 -0.794 . . . . 0.0 109.107 -178.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.414 ' HA ' ' O ' ' A' ' 98' ' ' VAL . 4.1 p30 -39.11 -55.4 1.62 Allowed 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.438 -0.789 . . . . 0.0 113.09 -178.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.717 HD12 ' O ' ' A' ' 103' ' ' CYS . 2.2 mt 40.8 29.84 0.08 Allowed 'General case' 0 N--CA 1.511 2.623 0 CA-C-N 118.875 0.761 . . . . 0.0 111.071 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 105' ' ' LEU . . . 65.5 155.41 0.08 Allowed 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.64 -0.662 . . . . 0.0 109.302 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.438 ' HA ' ' HD2' ' A' ' 56' ' ' ARG . 4.4 p -127.88 -160.22 1.0 Allowed 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -179.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.848 HD13 ' O ' ' A' ' 108' ' ' ILE . 0.0 OUTLIER -67.51 -34.11 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.41 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.447 ' HB3' ' CE1' ' A' ' 113' ' ' PHE . 93.1 m-70 -69.48 -2.55 11.53 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 116.234 -0.439 . . . . 0.0 112.049 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 60.25 29.92 69.78 Favored Glycine 0 N--CA 1.497 2.75 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -159.88 170.54 36.05 Favored Glycine 0 N--CA 1.496 2.653 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -78.02 76.24 4.45 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.537 2.158 . . . . 0.0 111.475 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.447 ' CE1' ' HB3' ' A' ' 109' ' ' HIS . 35.7 p90 . . . . . 0 N--CA 1.508 2.454 0 O-C-N 121.769 -0.582 . . . . 0.0 110.313 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo . . . . . 0 CA--C 1.538 0.692 0 N-CA-C 110.358 -0.67 . . . . 0.0 110.358 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.45 4.71 75.5 Favored Glycine 0 N--CA 1.5 2.964 0 N-CA-C 110.839 -0.905 . . . . 0.0 110.839 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.59 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 1.5 mpt? -133.0 99.04 4.45 Favored 'General case' 0 N--CA 1.501 2.11 0 CA-C-N 118.103 0.951 . . . . 0.0 108.705 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.59 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 86.79 -56.01 0.05 Allowed 'General case' 0 N--CA 1.515 2.819 0 CA-C-N 119.355 0.98 . . . . 0.0 108.547 -178.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 9.2 mt -101.85 101.44 18.33 Favored Pre-proline 0 N--CA 1.493 1.695 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 178.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -80.58 173.37 12.35 Favored 'Trans proline' 0 N--CA 1.474 0.33 0 C-N-CA 121.536 1.491 . . . . 0.0 111.643 -176.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 46.0 m-70 -71.13 144.53 50.21 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.46 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 3.3 t-20 60.68 60.24 3.57 Favored Pre-proline 0 N--CA 1.499 1.99 0 O-C-N 121.597 -0.689 . . . . 0.0 109.198 -179.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.46 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 39.5 Cg_endo -81.43 151.28 17.45 Favored 'Trans proline' 0 N--CA 1.481 0.787 0 C-N-CA 122.318 2.012 . . . . 0.0 111.673 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.556 HD23 ' SG ' ' A' ' 20' ' ' CYS . 3.6 mp 51.57 41.26 28.52 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-O 121.048 0.451 . . . . 0.0 111.421 178.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.408 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 7.2 p-10 -65.54 -40.62 93.08 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.67 -25.99 68.42 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.556 ' SG ' HD23 ' A' ' 17' ' ' LEU . 65.4 m -73.51 -42.83 61.29 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.667 ' NH2' HD22 ' A' ' 78' ' ' LEU . 2.5 ptt-85 -60.59 -49.83 75.96 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.451 ' HA ' ' CE3' ' A' ' 22' ' ' TRP . 29.9 m95 -67.85 -26.94 66.29 Favored 'General case' 0 N--CA 1.5 2.052 0 C-N-CA 119.693 -0.803 . . . . 0.0 110.447 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.451 ' CD2' ' HB3' ' A' ' 40' ' ' MET . 5.4 t80 -66.91 -32.3 73.47 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 178.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.727 HG22 ' CE1' ' A' ' 93' ' ' PHE . 47.0 t -71.68 -43.81 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.3 m -53.91 -42.36 68.64 Favored 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.431 -179.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 16.7 m -76.96 -53.76 7.44 Favored 'General case' 0 N--CA 1.507 2.42 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -178.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.8 tpm_? -60.28 -25.53 65.79 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.78 -0.575 . . . . 0.0 110.878 -178.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 48.1 p -97.67 -63.32 1.14 Allowed 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -177.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.61 ' O ' HG23 ' A' ' 31' ' ' VAL . 45.8 m -101.26 14.69 31.16 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.451 -0.78 . . . . 0.0 112.093 -178.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 55.64 21.06 27.2 Favored Glycine 0 N--CA 1.506 3.326 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 29' ' ' CYS . 25.5 t -107.55 164.01 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 O-C-N 121.851 -0.794 . . . . 0.0 109.121 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.492 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 134.38 178.89 15.95 Favored Glycine 0 N--CA 1.498 2.817 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -66.12 175.25 4.96 Favored 'Trans proline' 0 N--CA 1.486 1.075 0 CA-C-N 119.14 1.47 . . . . 0.0 109.633 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.07 82.25 5.07 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.99 0.9 . . . . 0.0 109.941 -178.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -139.71 135.84 33.58 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.511 ' HB3' ' OE2' ' A' ' 39' ' ' GLU . . . -53.8 162.63 0.86 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 122.056 -0.402 . . . . 0.0 110.158 -179.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.89 -54.0 8.05 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 122.051 -0.406 . . . . 0.0 110.595 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -51.48 -36.51 44.73 Favored 'General case' 0 N--CA 1.507 2.398 0 O-C-N 121.742 -0.599 . . . . 0.0 111.15 -178.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.511 ' OE2' ' HB3' ' A' ' 36' ' ' ALA . 43.4 mt-10 -70.75 -36.09 72.96 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 122.052 -0.405 . . . . 0.0 110.008 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.451 ' HB3' ' CD2' ' A' ' 23' ' ' TYR . 0.8 OUTLIER -66.18 -54.25 27.61 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.856 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.0 ttpt -54.63 -36.76 64.86 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.05 -39.72 95.57 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -63.6 -40.75 97.72 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 16.4 m -67.82 -33.5 74.91 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.054 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 17.9 m -74.44 -30.44 61.89 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.22 -35.29 71.43 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 178.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -79.07 -26.85 43.01 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 120.961 0.41 . . . . 0.0 109.947 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.631 ' O ' HD13 ' A' ' 48' ' ' LEU . 1.4 tm? -71.52 -39.31 70.83 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -178.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.51 ' HG3' HD22 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -78.24 -40.45 37.2 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.454 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.41 ' O ' ' HD3' ' A' ' 52' ' ' PRO . . . -54.23 -37.61 64.81 Favored 'General case' 0 N--CA 1.505 2.294 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 178.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 80.2 mt -79.04 105.15 2.73 Favored Pre-proline 0 N--CA 1.493 1.7 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 177.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' A' ' 50' ' ' ALA . 26.7 Cg_endo -60.31 146.67 96.06 Favored 'Trans proline' 0 N--CA 1.479 0.631 0 C-N-CA 121.544 1.496 . . . . 0.0 110.997 -176.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.436 ' HB2' ' NH1' ' A' ' 56' ' ' ARG . . . -42.5 -27.99 0.19 Allowed 'General case' 0 N--CA 1.502 2.17 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.685 -178.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -67.37 119.83 12.86 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 20.8 m 62.02 17.38 8.99 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 122.383 -0.198 . . . . 0.0 110.647 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.436 ' NH1' ' HB2' ' A' ' 53' ' ' ALA . 4.6 mtt180 -44.93 -83.37 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.901 0 O-C-N 121.231 -0.918 . . . . 0.0 110.165 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.536 ' SG ' HG21 ' A' ' 98' ' ' VAL . 51.3 m -33.15 -43.62 0.11 Allowed 'General case' 0 N--CA 1.52 3.061 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -37.8 -48.07 1.07 Allowed 'General case' 0 N--CA 1.514 2.774 0 CA-C-N 119.741 1.155 . . . . 0.0 112.246 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -43.66 -53.23 5.9 Favored 'General case' 0 N--CA 1.513 2.722 0 O-C-N 121.542 -0.724 . . . . 0.0 111.582 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 38.5 t -48.69 -45.87 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.399 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.1 -54.61 45.06 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.75 HG23 ' HB ' ' A' ' 67' ' ' VAL . 34.4 mt -49.18 -27.39 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.337 0 O-C-N 121.344 -0.848 . . . . 0.0 109.965 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.431 HD12 ' HA ' ' A' ' 63' ' ' LEU . 27.5 tp -77.92 -41.85 35.11 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.491 -0.884 . . . . 0.0 109.994 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.26 -54.26 6.71 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.555 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -80.65 -22.86 40.13 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.931 -0.48 . . . . 0.0 111.224 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.65 150.49 17.07 Favored Glycine 0 N--CA 1.498 2.781 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -178.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.75 ' HB ' HG23 ' A' ' 62' ' ' ILE . 4.2 p -117.91 159.68 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.275 0 O-C-N 122.176 -0.603 . . . . 0.0 109.845 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.688 HG22 ' NE2' ' A' ' 74' ' ' HIS . 72.8 t -115.1 157.51 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 CA-C-O 121.767 0.794 . . . . 0.0 109.095 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.9 p -117.42 159.78 22.24 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.648 -177.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.3 t -62.07 -33.41 74.37 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.3 -178.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.8 p -66.2 -17.78 64.94 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.226 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.91 14.78 30.5 Favored Glycine 0 N--CA 1.498 2.798 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 67.8 mm-40 -102.58 157.06 17.2 Favored 'General case' 0 N--CA 1.503 2.221 0 CA-C-N 118.19 0.995 . . . . 0.0 109.321 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.688 ' NE2' HG22 ' A' ' 68' ' ' VAL . 9.5 m170 -115.83 155.3 28.13 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -143.48 -176.77 5.08 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.17 0.51 . . . . 0.0 110.278 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 60.09 -137.66 49.16 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 22.7 ttp180 51.42 26.07 2.96 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 122.317 -0.519 . . . . 0.0 110.301 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.667 HD22 ' NH2' ' A' ' 21' ' ' ARG . 3.4 mt -77.2 -20.47 55.29 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.719 -0.613 . . . . 0.0 110.636 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.421 HD11 HD23 ' A' ' 63' ' ' LEU . 95.8 mt -62.14 95.55 0.06 Allowed 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -143.23 177.01 8.7 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.368 0.604 . . . . 0.0 110.29 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -50.96 107.86 0.2 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.49 0.662 . . . . 0.0 111.775 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.545 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 18.3 mt -100.88 168.14 9.71 Favored Pre-proline 0 N--CA 1.495 1.797 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.545 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 26.6 Cg_endo -64.62 99.79 0.32 Allowed 'Trans proline' 0 N--CA 1.48 0.699 0 C-N-CA 121.277 1.318 . . . . 0.0 111.702 -178.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.84 -9.89 75.75 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 7.5 m -118.98 91.12 42.68 Favored Pre-proline 0 N--CA 1.503 2.217 0 CA-C-N 119.125 1.463 . . . . 0.0 110.538 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -72.02 165.44 32.59 Favored 'Trans proline' 0 N--CA 1.482 0.847 0 C-N-CA 121.712 1.608 . . . . 0.0 111.173 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.1 mmm-85 -47.59 -28.53 2.35 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -57.7 -53.42 58.36 Favored 'General case' 0 N--CA 1.502 2.159 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.048 -178.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.1 t -63.89 -38.72 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.754 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -63.19 -26.96 69.05 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.42 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.93 -35.95 42.56 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.22 -49.82 63.12 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.997 -0.439 . . . . 0.0 109.896 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.727 ' CE1' HG22 ' A' ' 24' ' ' VAL . 34.0 t80 -78.77 -25.11 44.35 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 122.12 -0.362 . . . . 0.0 110.554 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.754 ' HB2' ' O ' ' A' ' 90' ' ' GLN . . . -41.22 -51.06 8.22 Favored Pre-proline 0 N--CA 1.503 2.186 0 CA-C-O 118.773 -0.632 . . . . 0.0 112.29 -177.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.657 ' HD3' ' HB3' ' A' ' 94' ' ' ALA . 30.3 Cg_endo -72.59 -167.24 0.32 Allowed 'Trans proline' 0 C--N 1.33 -0.43 0 C-N-CA 121.505 1.47 . . . . 0.0 109.62 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 77.0 mttt 62.48 20.44 11.92 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.433 ' HA ' HD22 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -72.92 -65.45 0.8 Allowed 'General case' 0 N--CA 1.509 2.486 0 O-C-N 121.875 -0.516 . . . . 0.0 110.786 -179.132 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.536 HG21 ' SG ' ' A' ' 57' ' ' CYS . 27.1 m -84.6 20.63 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 120.963 -1.086 . . . . 0.0 111.279 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 25.2 p -98.91 174.71 6.23 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.04 -2.67 0.63 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.575 -0.703 . . . . 0.0 112.018 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.5 ' O ' HG12 ' A' ' 101' ' ' VAL . 14.4 t -94.05 -0.64 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 CA-C-N 120.591 1.541 . . . . 0.0 111.062 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -138.12 -89.65 0.23 Allowed 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.383 -0.823 . . . . 0.0 111.185 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.552 ' O ' HD12 ' A' ' 105' ' ' LEU . 54.0 m -144.92 39.5 1.23 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.374 -0.829 . . . . 0.0 109.432 -178.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -35.22 -60.84 0.46 Allowed 'General case' 0 N--CA 1.511 2.6 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -178.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.552 HD12 ' O ' ' A' ' 103' ' ' CYS . 1.1 mt 43.23 31.45 0.38 Allowed 'General case' 0 N--CA 1.511 2.617 0 CA-C-N 118.657 0.662 . . . . 0.0 110.73 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 105' ' ' LEU . . . 66.58 150.09 0.05 Allowed 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -178.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.7 p -119.58 -159.86 0.79 Allowed 'General case' 0 N--CA 1.504 2.226 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.8 tt -66.98 -32.35 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -72.92 1.73 8.21 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.9 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 57.91 33.18 67.79 Favored Glycine 0 N--CA 1.499 2.887 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -161.66 170.63 37.43 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -79.05 71.96 6.76 Favored 'Trans proline' 0 CA--C 1.545 1.047 0 C-N-CA 122.747 2.298 . . . . 0.0 111.55 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 44.8 p90 . . . . . 0 N--CA 1.505 2.311 0 O-C-N 121.816 -0.552 . . . . 0.0 110.171 178.53 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.452 ' O ' ' SD ' ' A' ' 10' ' ' MET . 36.1 Cg_endo . . . . . 0 C--O 1.215 -0.637 0 N-CA-C 110.133 -0.756 . . . . 0.0 110.133 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 60.15 12.52 23.89 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.726 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -129.37 94.44 3.78 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.293 -1.122 . . . . 0.0 108.71 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.726 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 86.09 -58.14 0.07 Allowed 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -178.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 29.1 mt -95.69 103.25 12.29 Favored Pre-proline 0 N--CA 1.489 1.489 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.516 ' HD3' ' O ' ' A' ' 11' ' ' ALA . 34.1 Cg_endo -81.37 170.86 14.28 Favored 'Trans proline' 0 C--N 1.318 -1.038 0 C-N-CA 121.378 1.385 . . . . 0.0 111.864 -176.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.419 ' H ' ' CD2' ' A' ' 14' ' ' HIS . 29.1 m-70 -69.82 149.2 48.16 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.48 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 1.1 t-20 67.2 63.95 0.74 Allowed Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 120.623 -1.298 . . . . 0.0 110.033 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.807 ' HB2' ' HB1' ' A' ' 59' ' ' ALA . 37.3 Cg_endo -79.7 166.35 21.71 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.808 2.339 . . . . 0.0 112.151 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.53 HD23 ' SG ' ' A' ' 20' ' ' CYS . 0.2 OUTLIER 33.13 47.03 0.11 Allowed 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.581 178.789 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -74.86 -34.85 62.33 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.99 -1.069 . . . . 0.0 108.982 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.448 ' OG ' ' SG ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -62.56 -43.36 99.01 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.171 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.53 ' SG ' HD23 ' A' ' 17' ' ' LEU . 36.2 m -59.88 -40.03 87.29 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 121.352 0.596 . . . . 0.0 109.706 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.557 ' HG3' ' N ' ' A' ' 22' ' ' TRP . 0.1 OUTLIER -58.08 -51.91 67.72 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.373 -0.83 . . . . 0.0 108.915 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.557 ' N ' ' HG3' ' A' ' 21' ' ' ARG . 27.6 m95 -68.75 -26.25 65.14 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 118.591 -1.244 . . . . 0.0 110.541 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.651 ' HE1' HG22 ' A' ' 37' ' ' THR . 19.0 t80 -66.97 -32.65 74.03 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.911 -1.118 . . . . 0.0 108.593 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.558 HG22 ' CE1' ' A' ' 93' ' ' PHE . 71.3 t -72.9 -42.25 60.51 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.274 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 178.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.476 ' OG ' ' HA ' ' A' ' 22' ' ' TRP . 0.5 OUTLIER -54.84 -40.0 69.14 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.059 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.488 ' CA ' ' O ' ' A' ' 31' ' ' VAL . 3.7 m -77.28 -53.26 7.92 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.186 -0.946 . . . . 0.0 111.154 -178.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.1 ttm180 -59.56 -24.4 63.69 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.935 -1.103 . . . . 0.0 110.194 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.456 ' OG1' ' SG ' ' A' ' 85' ' ' CYS . 80.7 p -93.0 -67.53 0.85 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.186 -0.946 . . . . 0.0 111.419 -178.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.498 ' SG ' ' C ' ' A' ' 84' ' ' GLY . 93.2 m -99.51 18.07 18.79 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.496 -1.378 . . . . 0.0 110.104 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' A' ' 26' ' ' THR . . . 57.63 15.55 18.8 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.488 ' O ' ' CA ' ' A' ' 26' ' ' THR . 75.6 t -101.87 154.48 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.13 -1.218 . . . . 0.0 109.283 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.435 ' HA3' ' HG1' ' A' ' 26' ' ' THR . . . 142.66 179.23 19.3 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -66.37 177.15 3.42 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 CA-C-N 118.981 1.391 . . . . 0.0 109.875 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' ' 34' ' ' ARG . 0.1 OUTLIER -91.28 81.68 5.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.726 -1.234 . . . . 0.0 110.162 -178.125 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.461 ' CD2' ' NH1' ' A' ' 43' ' ' ARG . 25.6 tp -138.13 127.98 25.38 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.94 161.58 0.76 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.059 -1.025 . . . . 0.0 109.662 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.651 HG22 ' HE1' ' A' ' 23' ' ' TYR . 1.2 p -67.96 -61.97 1.62 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.12 -0.987 . . . . 0.0 109.987 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 37' ' ' THR . 0.8 OUTLIER -43.95 -57.22 3.44 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.017 -1.052 . . . . 0.0 109.737 -179.361 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.577 ' O ' ' HB3' ' A' ' 42' ' ' ALA . 75.5 mm-40 -49.15 -43.38 41.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.252 -0.905 . . . . 0.0 109.699 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.59 ' CE ' ' CG ' ' A' ' 23' ' ' TYR . 1.8 tmm? -59.03 -62.97 1.48 Allowed 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.493 ' HG3' ' OE1' ' A' ' 102' ' ' GLU . 19.0 tttt -40.59 -31.68 0.17 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.577 ' HB3' ' O ' ' A' ' 39' ' ' GLU . . . -68.51 -50.93 48.46 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.593 -0.692 . . . . 0.0 109.688 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.541 ' CG ' ' O ' ' A' ' 40' ' ' MET . 0.0 OUTLIER -59.14 -41.24 87.83 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.193 -1.003 . . . . 0.0 109.768 -179.597 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.448 ' SG ' ' OG ' ' A' ' 19' ' ' SER . 8.8 m -65.03 -36.09 83.25 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.89 -1.132 . . . . 0.0 110.579 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 19.1 m -69.75 -32.02 70.31 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.737 -1.227 . . . . 0.0 108.937 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.86 -32.64 67.7 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.493 ' HG3' ' O ' ' A' ' 43' ' ' ARG . 0.1 OUTLIER -77.43 -29.14 52.79 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.703 -0.623 . . . . 0.0 109.638 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.095 HD11 HG12 ' A' ' 98' ' ' VAL . 0.6 OUTLIER -75.0 -38.42 61.61 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.115 -0.991 . . . . 0.0 108.544 179.59 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.425 ' O ' ' C ' ' A' ' 50' ' ' ALA . 2.9 tt0 -69.16 -53.04 22.13 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.473 ' O ' ' HD3' ' A' ' 52' ' ' PRO . . . -47.54 -52.98 15.74 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 178.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.764 HG22 ' HG2' ' A' ' 56' ' ' ARG . 26.8 mm -58.81 106.02 0.64 Allowed Pre-proline 0 C--N 1.304 -1.393 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 177.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 50' ' ' ALA . 28.0 Cg_endo -63.77 136.25 52.55 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 121.893 1.729 . . . . 0.0 111.528 -176.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.626 ' HB1' ' N ' ' A' ' 108' ' ' ILE . . . -33.84 -36.15 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.792 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.71 ' CZ ' HD11 ' A' ' 108' ' ' ILE . 2.2 m-85 -67.63 117.14 9.16 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.01 -1.056 . . . . 0.0 108.794 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.474 ' CB ' ' O ' ' A' ' 54' ' ' TYR . 9.7 m 76.24 -2.46 2.73 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.461 -0.775 . . . . 0.0 109.784 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.764 ' HG2' HG22 ' A' ' 51' ' ' ILE . 0.4 OUTLIER -40.01 -87.44 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.199 -0.938 . . . . 0.0 109.188 -179.81 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.538 ' O ' ' C ' ' A' ' 58' ' ' GLU . 22.2 m -31.93 -58.34 0.29 Allowed 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.625 -0.672 . . . . 0.0 111.443 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.538 ' C ' ' O ' ' A' ' 57' ' ' CYS . 2.6 mm-40 -25.89 -53.5 0.05 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.55 -0.719 . . . . 0.0 111.249 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.807 ' HB1' ' HB2' ' A' ' 16' ' ' PRO . . . -37.81 -61.23 0.65 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.445 -0.785 . . . . 0.0 110.256 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.842 HG21 HD13 ' A' ' 97' ' ' LEU . 27.8 t -42.55 -51.35 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 CA-C-O 121.861 0.839 . . . . 0.0 108.904 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.485 ' O ' ' N ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -54.18 -63.66 1.08 Allowed 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.262 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.917 HD12 ' HB ' ' A' ' 67' ' ' VAL . 4.6 mm -40.06 -27.25 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.23 -0.919 . . . . 0.0 110.294 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.819 HD13 ' O ' ' A' ' 63' ' ' LEU . 0.9 OUTLIER -77.59 -46.77 21.17 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 120.704 -1.248 . . . . 0.0 109.202 -179.973 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.489 ' SD ' ' NE ' ' A' ' 91' ' ' ARG . 0.1 OUTLIER -73.62 -53.65 9.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.23 -0.919 . . . . 0.0 110.152 -179.83 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -80.2 -21.43 42.95 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.82 -1.175 . . . . 0.0 110.315 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.474 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . 84.51 151.2 12.86 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -179.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.917 ' HB ' HD12 ' A' ' 62' ' ' ILE . 7.3 p -116.64 159.39 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.414 -1.051 . . . . 0.0 109.409 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.544 ' N ' HG22 ' A' ' 67' ' ' VAL . 12.8 t -114.52 157.96 15.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-O 121.642 0.735 . . . . 0.0 109.185 -179.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.438 ' N ' ' CG1' ' A' ' 68' ' ' VAL . 27.5 p -116.83 158.94 23.12 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 121.615 0.722 . . . . 0.0 109.65 -178.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 32.1 t -62.25 -31.11 71.63 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.495 0.664 . . . . 0.0 110.13 -178.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.2 p -69.84 -14.01 62.54 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.499 -0.751 . . . . 0.0 109.6 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.3 9.24 48.29 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 108.881 -1.688 . . . . 0.0 108.881 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -91.84 157.25 16.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.088 -1.242 . . . . 0.0 109.877 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.527 ' CD2' HG22 ' A' ' 68' ' ' VAL . 10.1 m170 -115.83 156.32 26.31 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.022 -1.048 . . . . 0.0 108.739 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.406 ' HG2' ' C ' ' A' ' 74' ' ' HIS . 57.1 mm-40 -145.47 178.95 7.74 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.308 -0.87 . . . . 0.0 110.262 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 58.44 -147.13 39.8 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 2.9 ttp85 60.0 18.74 7.88 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.44 -1.035 . . . . 0.0 110.572 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.474 ' O ' ' NH2' ' A' ' 21' ' ' ARG . 1.8 mp -79.87 -19.53 48.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.837 -1.164 . . . . 0.0 109.812 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.699 HD21 ' HG2' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -64.46 89.26 0.06 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.972 -1.08 . . . . 0.0 108.691 179.484 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.42 ' O ' ' C ' ' A' ' 81' ' ' ASP . 8.3 mt-30 -136.39 178.32 7.16 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.295 -0.878 . . . . 0.0 110.201 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 80' ' ' GLN . 49.4 m-20 -39.33 129.35 1.79 Allowed 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.995 0.902 . . . . 0.0 110.93 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.609 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 22.0 mt -126.03 168.79 13.07 Favored Pre-proline 0 C--N 1.302 -1.484 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 178.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.609 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 27.4 Cg_endo -66.12 99.38 0.41 Allowed 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 121.008 1.138 . . . . 0.0 110.794 -179.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.498 ' C ' ' SG ' ' A' ' 29' ' ' CYS . . . 89.71 -7.97 80.76 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.456 ' SG ' ' OG1' ' A' ' 28' ' ' THR . 7.7 m -120.61 89.39 44.59 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 120.569 -1.547 . . . . 0.0 110.311 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.41 ' C ' ' N ' ' A' ' 88' ' ' GLN . 30.7 Cg_endo -76.44 159.01 36.4 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 C-N-CA 121.827 1.684 . . . . 0.0 111.197 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' A' ' 86' ' ' PRO . 4.3 mmt85 -44.63 -28.57 0.62 Allowed 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.41 ' N ' ' C ' ' A' ' 86' ' ' PRO . 4.5 tt0 -57.31 -60.5 3.54 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.668 -178.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 87.9 t -61.0 -42.59 93.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 O-C-N 120.793 -1.192 . . . . 0.0 110.364 -178.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.749 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -60.62 -27.53 67.83 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.182 -1.007 . . . . 0.0 108.514 179.841 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.509 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 0.0 OUTLIER -78.05 -31.16 50.17 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.43 -0.794 . . . . 0.0 109.712 179.511 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.506 ' O ' ' HD2' ' A' ' 95' ' ' PRO . . . -71.08 -50.34 34.85 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.064 -1.023 . . . . 0.0 109.522 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.558 ' CE1' HG22 ' A' ' 24' ' ' VAL . 10.4 t80 -77.67 -25.72 49.76 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.424 -0.798 . . . . 0.0 109.915 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.79 ' HB3' ' HD3' ' A' ' 95' ' ' PRO . . . -41.16 -52.46 7.22 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.308 -0.87 . . . . 0.0 111.885 -179.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.79 ' HD3' ' HB3' ' A' ' 94' ' ' ALA . 29.6 Cg_endo -70.09 97.64 0.68 Allowed 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.227 1.951 . . . . 0.0 111.47 -178.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.507 ' CB ' ' O ' ' A' ' 95' ' ' PRO . 2.1 mttt 159.55 65.35 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.842 HD13 HG21 ' A' ' 60' ' ' VAL . 1.3 mt -109.91 -89.21 0.49 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.3 -0.875 . . . . 0.0 111.589 -178.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 1.095 HG12 HD11 ' A' ' 48' ' ' LEU . 3.3 m -78.74 34.88 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 120.661 -1.275 . . . . 0.0 111.735 -178.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 12.9 p -106.83 173.32 6.37 Favored 'General case' 0 C--N 1.293 -1.882 0 O-C-N 120.706 -1.246 . . . . 0.0 108.463 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.495 ' HA ' ' OD1' ' A' ' 104' ' ' ASN . 15.3 mt-10 -60.59 1.74 0.13 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.746 -1.222 . . . . 0.0 111.874 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.7 t -99.13 0.82 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 119.888 -1.757 . . . . 0.0 110.829 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.521 ' HB3' ' O ' ' A' ' 97' ' ' LEU . 7.1 tp10 -149.93 -98.17 0.07 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.568 -1.333 . . . . 0.0 111.347 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.541 ' O ' HD22 ' A' ' 48' ' ' LEU . 78.4 m -117.39 43.65 2.3 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.93 -1.106 . . . . 0.0 109.794 -178.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.526 ' ND2' ' N ' ' A' ' 104' ' ' ASN . 0.1 OUTLIER -31.99 -92.17 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.308 -0.87 . . . . 0.0 111.806 -179.419 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.728 ' O ' ' HB3' ' A' ' 106' ' ' ALA . 1.3 mt 66.95 -1.76 1.31 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.005 -1.06 . . . . 0.0 111.822 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.728 ' HB3' ' O ' ' A' ' 105' ' ' LEU . . . 81.08 143.45 0.08 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.684 -1.26 . . . . 0.0 110.028 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.667 HG21 HG21 ' A' ' 98' ' ' VAL . 3.0 p -114.27 -162.09 0.8 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.29 -0.881 . . . . 0.0 108.723 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.71 HD11 ' CZ ' ' A' ' 54' ' ' TYR . 19.3 tt -62.09 -22.65 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.902 -1.124 . . . . 0.0 108.753 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.451 ' HB3' ' CE1' ' A' ' 113' ' ' PHE . 90.6 m-70 -80.47 14.74 1.89 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.733 -0.604 . . . . 0.0 110.486 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 109' ' ' HIS . . . 44.15 25.61 0.75 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 109' ' ' HIS . . . -150.45 169.74 30.37 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.488 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 35.1 Cg_endo -78.96 72.87 6.28 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.876 2.384 . . . . 0.0 110.989 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.488 ' HB3' ' O ' ' A' ' 112' ' ' PRO . 17.7 p90 . . . . . 0 N--CA 1.494 1.752 0 O-C-N 121.37 -0.831 . . . . 0.0 109.529 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.406 ' HG3' HG21 ' A' ' 67' ' ' VAL . 30.6 Cg_endo . . . . . 0 N--CA 1.479 0.647 0 N-CA-C 111.103 -0.383 . . . . 0.0 111.103 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 62.84 16.32 56.48 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 -179.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.573 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 16.6 mmm -140.91 84.62 1.94 Allowed 'General case' 0 N--CA 1.5 2.051 0 CA-C-N 117.749 0.774 . . . . 0.0 108.99 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 86.82 -57.65 0.05 OUTLIER 'General case' 0 N--CA 1.515 2.824 0 O-C-N 121.368 -0.833 . . . . 0.0 108.908 -178.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.717 HD11 ' HB2' ' A' ' 55' ' ' CYS . 61.2 mt -92.21 104.5 11.04 Favored Pre-proline 0 N--CA 1.498 1.935 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -75.21 169.6 22.18 Favored 'Trans proline' 0 C--O 1.22 -0.406 0 C-N-CA 121.348 1.365 . . . . 0.0 111.547 -175.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 35.1 m-70 -69.33 144.5 53.48 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.491 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 5.3 t-20 66.08 56.01 1.03 Allowed Pre-proline 0 N--CA 1.505 2.307 0 O-C-N 121.392 -0.817 . . . . 0.0 110.282 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.491 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 39.0 Cg_endo -80.54 166.86 19.54 Favored 'Trans proline' 0 N--CA 1.483 0.908 0 C-N-CA 122.317 2.011 . . . . 0.0 111.907 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.5 mp 42.92 43.81 3.69 Favored 'General case' 0 N--CA 1.504 2.238 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.192 177.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -69.07 -37.75 78.67 Favored 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.96 -26.13 68.69 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 56.9 m -74.61 -38.68 62.51 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.585 HH22 HD23 ' A' ' 78' ' ' LEU . 3.3 ttt180 -64.31 -48.88 73.96 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 33.5 m95 -68.74 -29.31 67.69 Favored 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 119.413 -0.915 . . . . 0.0 109.686 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.44 ' CD1' ' HB3' ' A' ' 40' ' ' MET . 57.7 t80 -66.38 -33.65 76.19 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.428 HG22 ' CD2' ' A' ' 93' ' ' PHE . 92.9 t -72.25 -38.97 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 177.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 m -56.27 -37.03 69.26 Favored 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 119.951 -0.7 . . . . 0.0 109.442 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 89.7 m -77.64 -50.09 13.2 Favored 'General case' 0 N--CA 1.506 2.347 0 N-CA-C 112.208 0.448 . . . . 0.0 112.208 -178.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.77 -25.31 67.87 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.512 -0.742 . . . . 0.0 110.622 -178.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.425 HG23 ' O ' ' A' ' 24' ' ' VAL . 70.7 p -93.35 -63.38 1.22 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -177.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.65 ' O ' HG23 ' A' ' 31' ' ' VAL . 3.6 m -100.32 9.29 42.91 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.438 -0.789 . . . . 0.0 111.636 -178.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 57.78 30.05 62.37 Favored Glycine 0 N--CA 1.507 3.37 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 29' ' ' CYS . 37.9 t -121.24 164.09 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 122.192 -0.593 . . . . 0.0 109.672 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.496 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 136.19 177.82 15.29 Favored Glycine 0 N--CA 1.499 2.895 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -64.37 177.31 2.17 Favored 'Trans proline' 0 N--CA 1.489 1.254 0 CA-C-N 119.253 1.526 . . . . 0.0 110.047 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.28 87.25 5.99 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 122.17 0.986 . . . . 0.0 110.338 -177.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.5 mt -141.85 127.37 18.95 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 178.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.19 152.44 2.37 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.979 -0.45 . . . . 0.0 109.825 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.1 p -60.0 -59.66 5.07 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.789 -0.569 . . . . 0.0 110.655 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -52.56 -28.75 22.22 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.878 -0.514 . . . . 0.0 111.571 -178.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -71.97 -46.94 55.56 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.816 -0.553 . . . . 0.0 109.608 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.44 ' HB3' ' CD1' ' A' ' 23' ' ' TYR . 5.6 tpt -61.97 -54.57 39.84 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -53.61 -35.7 61.19 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.45 -42.81 99.74 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.3 -41.12 96.45 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 19.7 m -65.48 -33.22 75.43 Favored 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.244 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 18.6 m -73.47 -30.16 62.99 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.35 -32.38 62.76 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -77.02 -33.69 57.41 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.782 HD22 ' O ' ' A' ' 103' ' ' CYS . 0.6 OUTLIER -73.46 -33.53 64.91 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.49 -40.4 61.86 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.28 -39.13 85.77 Favored 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.49 HG23 HG12 ' A' ' 12' ' ' ILE . 71.7 mt -82.54 105.57 5.09 Favored Pre-proline 0 N--CA 1.493 1.684 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 177.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -58.2 139.87 92.14 Favored 'Trans proline' 0 N--CA 1.48 0.705 0 C-N-CA 121.52 1.48 . . . . 0.0 110.877 -177.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.698 ' HB2' ' NH1' ' A' ' 56' ' ' ARG . . . -39.48 -29.79 0.06 Allowed 'General case' 0 N--CA 1.507 2.387 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.356 -178.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -53.15 -70.47 0.09 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.922 -0.486 . . . . 0.0 110.623 -179.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.717 ' HB2' HD11 ' A' ' 12' ' ' ILE . 5.1 m -88.59 8.81 26.46 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.974 -0.454 . . . . 0.0 110.884 -179.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.698 ' NH1' ' HB2' ' A' ' 53' ' ' ALA . 5.9 mtt180 -47.6 -85.35 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.666 0 O-C-N 121.445 -0.784 . . . . 0.0 110.282 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 73.3 m -32.79 -48.88 0.21 Allowed 'General case' 0 N--CA 1.521 3.083 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -41.74 -54.32 3.36 Favored 'General case' 0 N--CA 1.512 2.671 0 CA-C-N 119.319 0.963 . . . . 0.0 111.755 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -41.87 -44.63 3.43 Favored 'General case' 0 N--CA 1.513 2.706 0 O-C-N 121.787 -0.57 . . . . 0.0 112.065 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.7 t -57.17 -48.9 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.4 mtt180 -58.56 -26.74 63.89 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.959 HG23 ' HB ' ' A' ' 67' ' ' VAL . 34.5 mm -78.52 -30.74 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 O-C-N 121.945 -0.472 . . . . 0.0 110.362 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.489 HD12 ' HA ' ' A' ' 63' ' ' LEU . 14.9 tp -77.87 -43.37 30.43 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 120.079 -0.649 . . . . 0.0 109.79 -179.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.79 -50.84 10.64 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.232 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -80.55 -22.74 40.52 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 122.087 -0.383 . . . . 0.0 110.88 -178.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.68 146.91 5.67 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.959 ' HB ' HG23 ' A' ' 62' ' ' ILE . 5.6 p -118.43 161.08 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.668 HG22 ' NE2' ' A' ' 74' ' ' HIS . 56.0 t -113.27 157.89 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 42.1 p -116.84 160.13 21.32 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.987 0.899 . . . . 0.0 110.969 -176.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 32.8 t -64.54 -17.53 64.01 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.431 -178.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.1 p -86.48 -14.61 42.64 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 122.05 -0.406 . . . . 0.0 110.034 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.25 13.53 33.09 Favored Glycine 0 N--CA 1.5 2.902 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -105.43 158.62 16.53 Favored 'General case' 0 N--CA 1.501 2.114 0 CA-C-N 118.142 0.971 . . . . 0.0 108.859 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.668 ' NE2' HG22 ' A' ' 68' ' ' VAL . 11.3 m170 -113.79 154.93 26.58 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -179.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -136.8 -179.02 5.45 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 55.3 -146.93 28.43 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 -178.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 54.84 22.28 4.13 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 122.253 -0.557 . . . . 0.0 109.988 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.585 HD23 HH22 ' A' ' 21' ' ' ARG . 2.1 mp -82.87 -14.61 53.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.765 -0.584 . . . . 0.0 110.388 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.5 mt -62.11 92.79 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -134.78 -177.02 4.43 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.758 0.79 . . . . 0.0 110.663 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -47.67 131.6 14.42 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.758 0.789 . . . . 0.0 111.544 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.472 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 20.6 mt -129.27 166.85 22.55 Favored Pre-proline 0 N--CA 1.497 1.918 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.472 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 29.6 Cg_endo -68.6 98.63 0.59 Allowed 'Trans proline' 0 C--N 1.327 -0.553 0 C-N-CA 120.936 1.091 . . . . 0.0 110.243 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.41 6.94 67.82 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.47 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 3.2 m -138.8 92.51 11.21 Favored Pre-proline 0 N--CA 1.508 2.425 0 CA-C-N 118.974 1.387 . . . . 0.0 110.062 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -74.79 165.45 31.45 Favored 'Trans proline' 0 N--CA 1.487 1.109 0 C-N-CA 121.924 1.749 . . . . 0.0 111.225 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 24.0 mtp180 -53.89 -25.96 22.66 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.042 0.448 . . . . 0.0 110.225 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.23 -45.86 89.65 Favored 'General case' 0 N--CA 1.503 2.213 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.008 -177.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 42.0 t -72.38 -43.37 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.596 -0.69 . . . . 0.0 111.023 -177.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.616 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 2.1 pt20 -70.37 -27.02 64.0 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.414 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 8.8 ttt180 -78.76 -29.26 45.0 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.44 -47.09 20.61 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.945 -0.472 . . . . 0.0 110.28 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.428 ' CD2' HG22 ' A' ' 24' ' ' VAL . 90.3 t80 -79.03 -27.56 43.21 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 122.088 -0.383 . . . . 0.0 111.463 -178.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.616 ' HB2' ' O ' ' A' ' 90' ' ' GLN . . . -55.09 -46.45 99.67 Favored Pre-proline 0 N--CA 1.504 2.259 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -177.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 94' ' ' ALA . 30.2 Cg_endo -70.06 -0.26 6.9 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 122.209 1.939 . . . . 0.0 114.017 -177.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.79 24.12 12.05 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.492 -0.755 . . . . 0.0 109.8 179.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.99 -24.22 59.57 Favored 'General case' 0 N--CA 1.51 2.526 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -178.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 33.7 m -93.4 25.63 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.322 0 CA-C-N 120.958 1.708 . . . . 0.0 111.182 -178.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.406 ' C ' ' HB2' ' A' ' 104' ' ' ASN . 19.0 p -98.24 173.1 7.17 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -61.94 -1.52 0.68 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.656 -0.652 . . . . 0.0 112.25 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.582 ' O ' HG12 ' A' ' 101' ' ' VAL . 36.3 t -100.04 4.4 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 CA-C-N 120.443 1.474 . . . . 0.0 110.96 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -141.07 -89.95 0.16 Allowed 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.38 -0.825 . . . . 0.0 111.488 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.782 ' O ' HD22 ' A' ' 48' ' ' LEU . 19.8 m -143.62 43.0 1.49 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.502 -0.749 . . . . 0.0 109.927 -178.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.409 ' ND2' ' HB3' ' A' ' 112' ' ' PRO . 56.9 t-20 -42.97 -64.9 0.55 Allowed 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.224 -0.923 . . . . 0.0 112.329 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.429 ' O ' ' HB3' ' A' ' 106' ' ' ALA . 6.1 mt 45.33 29.34 0.55 Allowed 'General case' 0 N--CA 1.51 2.569 0 CA-C-O 121.073 0.463 . . . . 0.0 109.995 -178.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 105' ' ' LEU . . . 67.04 157.93 0.12 Allowed 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -178.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.8 p -128.82 -163.93 1.34 Allowed 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 18.1 tt -68.14 -33.15 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 177.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.447 ' HB3' ' CE2' ' A' ' 113' ' ' PHE . 96.9 m-70 -66.67 -4.9 9.89 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.729 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 61.55 41.39 99.55 Favored Glycine 0 N--CA 1.499 2.863 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -174.87 170.95 44.15 Favored Glycine 0 N--CA 1.501 3.024 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.409 ' HB3' ' ND2' ' A' ' 104' ' ' ASN . 32.3 Cg_endo -77.86 75.84 4.6 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.54 2.16 . . . . 0.0 111.376 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.447 ' CE2' ' HB3' ' A' ' 109' ' ' HIS . 36.8 p90 . . . . . 0 N--CA 1.502 2.145 0 O-C-N 121.65 -0.656 . . . . 0.0 110.468 178.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo . . . . . 0 C--O 1.215 -0.662 0 N-CA-C 110.67 -0.55 . . . . 0.0 110.67 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 62.46 10.85 31.61 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.727 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 2.2 mtt -140.61 95.11 2.81 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.164 -1.198 . . . . 0.0 109.317 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.727 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 86.14 -60.58 0.06 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.925 -1.11 . . . . 0.0 108.314 -179.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.484 HG13 HD12 ' A' ' 51' ' ' ILE . 1.8 mp -96.83 103.31 14.32 Favored Pre-proline 0 N--CA 1.489 1.483 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.494 ' HD3' ' O ' ' A' ' 11' ' ' ALA . 31.6 Cg_endo -79.64 166.97 21.28 Favored 'Trans proline' 0 C--N 1.32 -0.959 0 C-N-CA 121.277 1.318 . . . . 0.0 112.163 -176.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.426 ' H ' ' CD2' ' A' ' 14' ' ' HIS . 37.7 m-70 -68.65 149.0 49.62 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.496 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 0.5 OUTLIER 60.77 63.95 2.51 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 120.607 -1.308 . . . . 0.0 109.62 -179.857 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.496 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 37.2 Cg_endo -80.41 161.08 22.66 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.794 2.329 . . . . 0.0 111.372 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.449 ' CD1' ' N ' ' A' ' 17' ' ' LEU . 4.2 mp 42.07 45.61 3.45 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.526 -0.734 . . . . 0.0 110.858 178.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -76.91 -40.87 45.78 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.078 -1.014 . . . . 0.0 109.177 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.481 ' O ' ' HE3' ' A' ' 40' ' ' MET . 1.2 t -63.37 -25.96 68.53 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 58.1 m -72.26 -39.21 68.57 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.563 ' CG ' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -59.3 -53.48 57.78 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.472 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.563 ' N ' ' CG ' ' A' ' 21' ' ' ARG . 25.9 m95 -68.11 -29.48 68.41 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 118.984 -1.086 . . . . 0.0 110.429 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.459 ' HE1' HG23 ' A' ' 37' ' ' THR . 4.2 t80 -64.06 -30.62 71.68 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 120.998 -1.064 . . . . 0.0 108.346 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 1.102 HG22 ' CD2' ' A' ' 93' ' ' PHE . 74.6 t -74.93 -44.56 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 178.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.503 ' HB3' HD13 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -52.65 -41.36 63.72 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.522 -0.871 . . . . 0.0 109.633 -179.679 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.514 ' HG1' ' HA3' ' A' ' 32' ' ' GLY . 2.6 m -77.77 -56.68 4.31 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.212 -0.93 . . . . 0.0 111.689 -178.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.1 tpt85 -57.77 -24.76 58.67 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.755 -1.216 . . . . 0.0 111.0 -178.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.469 ' OG1' ' O ' ' A' ' 24' ' ' VAL . 78.3 p -97.15 -63.06 1.17 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.949 -1.094 . . . . 0.0 111.191 -178.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.565 ' O ' HG23 ' A' ' 31' ' ' VAL . 90.6 m -99.24 18.47 17.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.965 -1.084 . . . . 0.0 110.299 -178.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' A' ' 26' ' ' THR . . . 52.76 19.41 6.69 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 29' ' ' CYS . 76.0 t -107.55 149.23 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.207 -1.173 . . . . 0.0 108.782 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.514 ' HA3' ' HG1' ' A' ' 26' ' ' THR . . . 141.96 177.34 16.99 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.449 -1.86 . . . . 0.0 108.449 -179.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -66.32 172.38 9.03 Favored 'Trans proline' 0 N--CA 1.479 0.654 0 CA-C-N 118.99 1.395 . . . . 0.0 109.988 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.23 64.43 4.47 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.876 -1.14 . . . . 0.0 110.074 -178.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.679 HD11 ' NE ' ' A' ' 43' ' ' ARG . 6.6 tt -106.33 120.41 41.8 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.509 ' N ' HD23 ' A' ' 35' ' ' LEU . . . -41.56 135.32 2.15 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.345 -0.847 . . . . 0.0 109.363 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.459 HG23 ' HE1' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -52.19 -54.54 29.63 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.785 -1.197 . . . . 0.0 111.564 -178.738 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -51.93 -43.0 63.25 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.817 -1.177 . . . . 0.0 110.249 -178.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.579 ' CB ' HD21 ' A' ' 35' ' ' LEU . 27.4 mm-40 -67.12 -29.36 69.07 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.28 -0.888 . . . . 0.0 109.604 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.503 ' SD ' HD13 ' A' ' 35' ' ' LEU . 8.5 tpt -69.23 -60.78 2.11 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.123 -0.986 . . . . 0.0 108.361 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.54 -39.11 48.12 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.81 -41.42 97.74 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.347 -0.846 . . . . 0.0 109.154 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.679 ' NE ' HD11 ' A' ' 35' ' ' LEU . 21.3 mtt85 -60.08 -47.22 86.8 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.349 -0.845 . . . . 0.0 109.192 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 15.3 m -61.26 -37.05 81.72 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.19 -0.944 . . . . 0.0 110.577 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 96.9 m -71.14 -28.59 64.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.811 -1.18 . . . . 0.0 109.141 -179.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.1 tpp180 -74.35 -31.35 62.39 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.462 ' O ' HG12 ' A' ' 51' ' ' ILE . 0.7 OUTLIER -77.09 -37.13 55.02 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.952 -0.699 . . . . 0.0 109.389 179.951 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.94 HD11 HG12 ' A' ' 98' ' ' VAL . 6.2 tt -70.8 -36.57 73.06 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.297 -0.877 . . . . 0.0 108.666 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.446 ' O ' ' C ' ' A' ' 50' ' ' ALA . 13.3 tp10 -67.27 -51.4 53.35 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.514 ' O ' ' HD3' ' A' ' 52' ' ' PRO . . . -47.89 -49.68 28.97 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 178.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.484 HD12 HG13 ' A' ' 12' ' ' ILE . 33.7 mm -62.04 106.09 0.76 Allowed Pre-proline 0 C--N 1.304 -1.411 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 176.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.523 ' O ' ' N ' ' A' ' 54' ' ' TYR . 26.6 Cg_endo -63.95 141.4 77.36 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 121.631 1.554 . . . . 0.0 110.81 -177.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.535 ' HB2' ' NH2' ' A' ' 56' ' ' ARG . . . -37.15 -28.67 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.908 -0.495 . . . . 0.0 110.079 -178.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.523 ' N ' ' O ' ' A' ' 52' ' ' PRO . 0.3 OUTLIER -65.41 119.85 11.75 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.095 -1.003 . . . . 0.0 108.578 178.998 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.523 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 63.6 m 64.91 8.98 5.0 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.355 -0.841 . . . . 0.0 110.256 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.535 ' NH2' ' HB2' ' A' ' 53' ' ' ALA . 8.6 mtt180 -42.42 -87.78 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.705 -1.247 . . . . 0.0 109.471 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.501 ' O ' ' C ' ' A' ' 58' ' ' GLU . 20.9 m -28.38 -50.71 0.08 Allowed 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.512 ' HB2' ' O ' ' A' ' 55' ' ' CYS . 0.1 OUTLIER -32.22 -51.23 0.25 Allowed 'General case' 0 N--CA 1.502 2.159 0 O-C-N 120.82 -1.175 . . . . 0.0 111.432 -178.74 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.479 ' C ' ' O ' ' A' ' 58' ' ' GLU . . . -36.5 -55.39 0.84 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.313 -0.867 . . . . 0.0 110.268 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.0 t -53.18 -49.89 49.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.474 -0.766 . . . . 0.0 109.252 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.482 ' O ' ' HB2' ' A' ' 65' ' ' ASP . 2.0 ttp180 -55.34 -29.35 58.19 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.294 -0.879 . . . . 0.0 109.508 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.744 HG23 ' HB ' ' A' ' 67' ' ' VAL . 30.2 mt -77.79 -28.53 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.331 -0.856 . . . . 0.0 109.938 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.527 ' O ' ' HA ' ' A' ' 77' ' ' ARG . 26.4 tp -77.56 -44.5 28.32 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.842 -1.161 . . . . 0.0 109.486 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 30.1 ttp -78.14 -50.69 11.5 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.869 -1.144 . . . . 0.0 109.72 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.482 ' HB2' ' O ' ' A' ' 61' ' ' ARG . 15.7 m-20 -80.37 -21.26 42.54 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.017 -1.052 . . . . 0.0 110.394 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.435 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . 86.65 152.28 21.11 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.744 ' HB ' HG23 ' A' ' 62' ' ' ILE . 1.4 p -117.02 159.97 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.539 -0.977 . . . . 0.0 109.248 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.798 HG22 ' NE2' ' A' ' 74' ' ' HIS . 12.9 t -113.58 158.16 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-O 121.87 0.843 . . . . 0.0 109.384 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.468 ' N ' ' CG1' ' A' ' 68' ' ' VAL . 69.8 p -117.57 158.76 24.04 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.683 0.754 . . . . 0.0 110.088 -178.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.1 t -65.0 -25.6 67.93 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.571 0.7 . . . . 0.0 109.791 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.1 p -71.13 -15.09 62.48 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.638 -0.664 . . . . 0.0 109.388 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 99.51 10.55 47.2 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.607 -1.797 . . . . 0.0 108.607 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -103.17 157.0 17.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.269 -1.136 . . . . 0.0 109.621 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.798 ' NE2' HG22 ' A' ' 68' ' ' VAL . 11.1 m170 -115.07 155.93 26.11 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.064 -1.022 . . . . 0.0 108.821 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -142.67 -174.87 4.27 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.271 -0.893 . . . . 0.0 110.465 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 60.62 -139.47 48.11 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.527 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER 52.39 33.19 12.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.215 -1.168 . . . . 0.0 109.368 -179.884 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.479 ' O ' ' N ' ' A' ' 80' ' ' GLN . 1.3 mt -79.06 -22.23 45.64 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.976 -1.078 . . . . 0.0 109.996 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.423 ' C ' ' O ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -45.85 98.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.798 -1.189 . . . . 0.0 108.855 179.513 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.479 ' N ' ' O ' ' A' ' 78' ' ' LEU . 40.1 mt-30 -145.12 174.21 11.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.124 -0.985 . . . . 0.0 110.428 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -56.78 140.75 46.76 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 122.045 0.926 . . . . 0.0 110.701 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.663 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 17.9 mt -133.06 171.17 9.63 Favored Pre-proline 0 C--N 1.301 -1.531 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 179.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.663 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 27.5 Cg_endo -65.91 98.88 0.38 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 120.856 1.038 . . . . 0.0 110.591 -179.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.492 ' C ' ' SG ' ' A' ' 29' ' ' CYS . . . 88.3 -6.73 83.21 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.464 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 9.7 m -119.86 88.42 40.08 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 120.684 -1.48 . . . . 0.0 110.015 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 87' ' ' ARG . 30.5 Cg_endo -75.75 161.32 36.72 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 C-N-CA 122.085 1.857 . . . . 0.0 111.713 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.433 ' C ' ' O ' ' A' ' 86' ' ' PRO . 13.3 mtm-85 -43.57 -27.51 0.3 Allowed 'General case' 0 N--CA 1.482 1.136 0 CA-C-O 121.773 0.797 . . . . 0.0 108.913 178.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' A' ' 86' ' ' PRO . 32.9 tt0 -59.2 -59.84 4.81 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.753 -0.592 . . . . 0.0 111.317 -178.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 45.0 t -65.75 -40.7 88.52 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 O-C-N 120.871 -1.143 . . . . 0.0 110.531 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.909 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -63.83 -28.07 69.6 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.249 -0.98 . . . . 0.0 108.574 179.843 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.407 ' HB2' ' O ' ' A' ' 87' ' ' ARG . 0.1 OUTLIER -78.09 -29.39 49.01 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.542 -0.723 . . . . 0.0 109.592 179.556 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.479 ' O ' ' HD2' ' A' ' 95' ' ' PRO . . . -74.58 -53.52 9.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -0.909 . . . . 0.0 109.965 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 1.102 ' CD2' HG22 ' A' ' 24' ' ' VAL . 6.0 t80 -78.25 -26.6 47.32 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.042 -1.036 . . . . 0.0 110.365 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.909 ' HB2' ' O ' ' A' ' 90' ' ' GLN . . . -40.91 -52.64 6.61 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.125 -0.985 . . . . 0.0 111.34 -178.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.827 ' HD3' ' HB3' ' A' ' 94' ' ' ALA . 31.4 Cg_endo -72.27 -164.71 0.18 Allowed 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.143 1.895 . . . . 0.0 111.04 -178.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 95' ' ' PRO . 13.6 mmtm 63.73 30.41 14.71 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -178.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.507 ' HA ' HD22 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -73.77 -71.19 0.34 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.656 -0.653 . . . . 0.0 110.86 -179.157 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.94 HG12 HD11 ' A' ' 48' ' ' LEU . 2.9 m -77.45 22.9 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.623 -1.298 . . . . 0.0 111.266 -179.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.435 ' C ' ' HB3' ' A' ' 104' ' ' ASN . 7.0 p -99.22 172.68 7.21 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 120.513 -1.367 . . . . 0.0 108.898 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.465 ' HA ' ' ND2' ' A' ' 104' ' ' ASN . 40.0 mt-10 -59.63 -0.31 0.17 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.804 -1.185 . . . . 0.0 111.891 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.702 ' O ' HG12 ' A' ' 101' ' ' VAL . 97.8 t -100.28 7.39 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 119.957 -1.714 . . . . 0.0 110.33 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.506 ' HB2' ' O ' ' A' ' 97' ' ' LEU . 2.0 mm-40 -145.75 -92.71 0.09 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.758 -1.214 . . . . 0.0 110.297 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.463 ' O ' ' C ' ' A' ' 104' ' ' ASN . 33.2 m -142.13 37.86 1.58 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.945 -1.097 . . . . 0.0 109.638 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 98' ' ' VAL . 5.1 p30 -35.12 -50.96 0.53 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.244 -0.91 . . . . 0.0 111.513 -179.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 106' ' ' ALA . 12.0 mt 42.23 31.61 0.27 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.916 -1.115 . . . . 0.0 110.226 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.468 ' O ' ' O ' ' A' ' 105' ' ' LEU . . . 60.28 121.33 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.857 -1.152 . . . . 0.0 109.521 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.8 p -91.58 -165.72 1.41 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 1.035 HD13 ' O ' ' A' ' 108' ' ' ILE . 0.0 OUTLIER -61.37 -25.77 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 120.931 -1.105 . . . . 0.0 108.49 179.261 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.48 ' HB3' ' CE1' ' A' ' 113' ' ' PHE . 86.9 m-70 -76.74 14.0 0.9 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.53 -0.731 . . . . 0.0 110.717 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 50.11 25.06 7.32 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.399 -1.481 . . . . 0.0 109.399 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -156.55 172.08 34.24 Favored Glycine 0 N--CA 1.49 2.246 0 C-N-CA 119.766 -1.207 . . . . 0.0 110.085 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.474 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 33.3 Cg_endo -78.5 74.25 5.5 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 123.001 2.467 . . . . 0.0 111.195 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.48 ' CE1' ' HB3' ' A' ' 109' ' ' HIS . 32.6 p90 . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.177 -0.952 . . . . 0.0 109.947 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo . . . . . 0 CA--C 1.54 0.814 0 N-CA-C 110.298 -0.693 . . . . 0.0 110.298 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 58.1 17.89 32.15 Favored Glycine 0 N--CA 1.499 2.866 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.583 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 84.3 mtp -140.84 108.09 5.51 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-N 117.935 0.868 . . . . 0.0 108.72 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.583 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 86.73 -58.4 0.05 OUTLIER 'General case' 0 N--CA 1.514 2.75 0 CA-C-N 119.75 1.159 . . . . 0.0 108.247 -178.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.843 HD11 ' HB3' ' A' ' 55' ' ' CYS . 44.8 mt -106.41 100.74 31.53 Favored Pre-proline 0 N--CA 1.492 1.648 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 178.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -81.01 173.47 11.89 Favored 'Trans proline' 0 N--CA 1.475 0.427 0 C-N-CA 121.471 1.447 . . . . 0.0 111.243 -177.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 59.6 m-70 -71.14 144.19 50.31 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.563 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 35.1 t-20 59.78 52.88 3.75 Favored Pre-proline 0 N--CA 1.498 1.972 0 O-C-N 121.725 -0.61 . . . . 0.0 110.05 -178.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.563 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 41.8 Cg_endo -83.05 170.27 12.39 Favored 'Trans proline' 0 N--CA 1.483 0.864 0 C-N-CA 122.043 1.829 . . . . 0.0 111.355 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.668 HD23 ' HB1' ' A' ' 59' ' ' ALA . 4.3 mm? 50.75 38.73 20.24 Favored 'General case' 0 N--CA 1.501 2.093 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.646 177.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -78.17 -43.31 28.98 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.542 -0.724 . . . . 0.0 109.484 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.18 -29.12 70.15 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 17.0 m -73.5 -40.1 64.32 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.569 ' CZ ' HD11 ' A' ' 82' ' ' LEU . 0.6 OUTLIER -61.23 -51.36 69.28 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -179.722 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.42 ' CE3' ' HA ' ' A' ' 22' ' ' TRP . 38.9 m95 -69.83 -28.15 65.46 Favored 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 119.581 -0.848 . . . . 0.0 109.743 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.589 ' HE1' HG22 ' A' ' 37' ' ' THR . 18.4 t80 -67.47 -29.63 69.14 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.547 HG22 ' CE1' ' A' ' 93' ' ' PHE . 98.9 t -75.27 -42.89 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 85.0 p -54.73 -39.02 67.83 Favored 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.939 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 77.0 m -77.45 -48.77 16.32 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 122.296 -0.252 . . . . 0.0 111.661 -178.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.6 mmm180 -64.26 -24.88 67.82 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.626 -0.671 . . . . 0.0 111.054 -178.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 82.5 p -97.0 -61.97 1.33 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 122.162 -0.336 . . . . 0.0 111.872 -177.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.654 ' O ' HG23 ' A' ' 31' ' ' VAL . 3.7 m -100.08 9.35 42.98 Favored 'General case' 0 N--CA 1.507 2.407 0 O-C-N 121.444 -0.785 . . . . 0.0 111.415 -178.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 57.43 25.93 55.8 Favored Glycine 0 N--CA 1.505 3.237 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 -178.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' ' 29' ' ' CYS . 41.0 t -115.38 164.49 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 122.105 -0.644 . . . . 0.0 109.556 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.498 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 132.61 178.28 15.43 Favored Glycine 0 N--CA 1.498 2.785 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -66.13 173.5 7.19 Favored 'Trans proline' 0 N--CA 1.486 1.058 0 CA-C-N 119.382 1.591 . . . . 0.0 109.833 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -92.24 79.99 5.04 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 122.02 0.914 . . . . 0.0 109.87 -178.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.401 ' HA ' HD22 ' A' ' 35' ' ' LEU . 0.2 OUTLIER -124.71 129.52 50.66 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.037 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.25 132.59 28.76 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.925 -0.484 . . . . 0.0 109.747 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.589 HG22 ' HE1' ' A' ' 23' ' ' TYR . 0.6 OUTLIER -52.58 -53.64 43.76 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.447 -0.783 . . . . 0.0 111.18 -179.108 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -50.12 -35.96 27.84 Favored 'General case' 0 N--CA 1.508 2.436 0 O-C-N 121.723 -0.61 . . . . 0.0 110.816 -178.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -70.93 -38.54 72.89 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 31.5 tpp -62.54 -57.55 10.74 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 41.2 tttt -55.77 -35.94 66.8 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.862 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.28 -37.09 86.25 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.74 -45.85 81.08 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 15.1 m -62.72 -35.57 80.2 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.094 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 17.7 m -75.3 -28.56 59.76 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.64 -34.95 70.22 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -78.43 -28.2 46.71 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.689 ' O ' HD13 ' A' ' 48' ' ' LEU . 1.4 tm? -72.78 -35.47 67.42 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -178.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -77.92 -51.28 10.66 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.64 -33.39 54.99 Favored 'General case' 0 N--CA 1.505 2.303 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.0 mt -87.71 104.88 7.4 Favored Pre-proline 0 N--CA 1.492 1.651 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.559 ' HD2' ' HB1' ' A' ' 11' ' ' ALA . 25.7 Cg_endo -60.56 149.22 88.08 Favored 'Trans proline' 0 N--CA 1.479 0.638 0 C-N-CA 121.826 1.684 . . . . 0.0 110.543 -177.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.1 -19.95 55.8 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.582 -177.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -49.56 -32.82 13.39 Favored 'General case' 0 N--CA 1.513 2.677 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 178.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.843 ' HB3' HD11 ' A' ' 12' ' ' ILE . 61.9 m -119.26 -69.89 0.82 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 115.336 -0.847 . . . . 0.0 108.955 178.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 35.7 mtt180 38.0 -92.96 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.696 0 C-N-CA 122.8 0.44 . . . . 0.0 111.273 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.403 ' HA ' HD13 ' A' ' 97' ' ' LEU . 86.4 m -37.96 -45.44 0.88 Allowed 'General case' 0 N--CA 1.515 2.815 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -40.21 -48.78 2.62 Favored 'General case' 0 N--CA 1.511 2.607 0 CA-C-N 119.843 1.202 . . . . 0.0 112.027 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.668 ' HB1' HD23 ' A' ' 17' ' ' LEU . . . -42.05 -49.22 4.74 Favored 'General case' 0 N--CA 1.513 2.685 0 CA-C-N 118.483 0.583 . . . . 0.0 111.905 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.921 HG21 HD22 ' A' ' 97' ' ' LEU . 57.6 t -57.94 -45.86 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -60.61 -26.83 67.29 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.795 HG23 ' HB ' ' A' ' 67' ' ' VAL . 50.6 mt -78.1 -29.31 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.881 -0.512 . . . . 0.0 109.71 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.2 tp -77.87 -41.51 36.55 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.853 -0.739 . . . . 0.0 109.954 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.707 ' SD ' HD22 ' A' ' 79' ' ' LEU . 39.4 tpp -78.56 -52.77 8.0 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.331 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -80.51 -22.94 40.43 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 122.048 -0.408 . . . . 0.0 110.981 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 85.15 147.47 9.21 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 109.196 -1.561 . . . . 0.0 109.196 -178.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.795 ' HB ' HG23 ' A' ' 62' ' ' ILE . 5.3 p -118.01 158.74 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.265 0 O-C-N 122.133 -0.628 . . . . 0.0 109.531 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.662 HG22 ' NE2' ' A' ' 74' ' ' HIS . 70.6 t -115.58 157.3 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-O 121.946 0.879 . . . . 0.0 109.463 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.6 p -117.35 159.99 21.86 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.03 -178.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 34.3 t -64.11 -33.62 76.18 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.932 -178.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.7 p -63.44 -17.8 63.07 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.69 8.13 49.52 Favored Glycine 0 N--CA 1.496 2.672 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 60.8 mt-30 -95.43 156.08 16.47 Favored 'General case' 0 N--CA 1.501 2.114 0 CA-C-N 118.158 0.979 . . . . 0.0 109.578 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.662 ' NE2' HG22 ' A' ' 68' ' ' VAL . 9.6 m170 -116.47 154.93 29.48 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -141.24 -175.49 4.36 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.106 0.479 . . . . 0.0 110.081 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 55.6 -146.1 31.03 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.9 ttp180 56.54 19.84 4.48 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 122.29 -0.535 . . . . 0.0 110.384 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.5 mt -84.03 -14.45 50.57 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.723 -0.611 . . . . 0.0 110.244 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.873 HD21 ' CB ' ' A' ' 90' ' ' GLN . 5.3 tt -61.93 92.88 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -135.31 172.8 12.49 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.255 0.55 . . . . 0.0 109.591 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -51.32 102.01 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.651 0.739 . . . . 0.0 111.384 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.569 HD11 ' CZ ' ' A' ' 21' ' ' ARG . 21.5 mt -87.2 169.99 13.18 Favored Pre-proline 0 N--CA 1.495 1.803 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 177.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.557 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 28.9 Cg_endo -68.18 100.55 0.65 Allowed 'Trans proline' 0 C--N 1.327 -0.562 0 C-N-CA 120.942 1.095 . . . . 0.0 110.609 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.17 11.99 60.6 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.416 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 3.6 m -141.91 91.33 8.17 Favored Pre-proline 0 N--CA 1.506 2.353 0 CA-C-N 118.786 1.293 . . . . 0.0 109.11 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -74.19 161.45 40.68 Favored 'Trans proline' 0 N--CA 1.482 0.825 0 C-N-CA 121.538 1.492 . . . . 0.0 111.282 -178.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.82 -28.75 2.73 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.268 0.556 . . . . 0.0 109.599 177.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -55.38 -53.49 55.57 Favored 'General case' 0 N--CA 1.503 2.199 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.654 -178.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 54.2 t -62.83 -39.91 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.709 -0.62 . . . . 0.0 109.63 -178.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.873 ' CB ' HD21 ' A' ' 79' ' ' LEU . 1.9 mp0 -64.11 -26.35 68.5 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.66 -33.99 46.68 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.29 -48.83 63.91 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.876 -0.515 . . . . 0.0 109.654 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.547 ' CE1' HG22 ' A' ' 24' ' ' VAL . 31.0 t80 -78.58 -26.25 45.49 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 122.262 -0.274 . . . . 0.0 110.55 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.695 ' HB3' ' HD3' ' A' ' 95' ' ' PRO . . . -41.25 -49.75 8.6 Favored Pre-proline 0 N--CA 1.506 2.336 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -177.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.695 ' HD3' ' HB3' ' A' ' 94' ' ' ALA . 34.5 Cg_endo -77.84 33.15 0.45 Allowed 'Trans proline' 0 CA--C 1.55 1.308 0 C-N-CA 122.206 1.937 . . . . 0.0 112.964 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 49.8 mttm -123.99 30.97 5.96 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 178.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.921 HD22 HG21 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -73.56 -71.31 0.32 Allowed 'General case' 0 N--CA 1.512 2.641 0 O-C-N 122.067 -0.396 . . . . 0.0 110.804 -179.196 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.853 HG13 HD12 ' A' ' 97' ' ' LEU . 11.0 m -94.95 28.32 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.388 -0.82 . . . . 0.0 109.855 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 27.9 p -96.96 170.05 9.42 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.414 ' HA ' ' ND2' ' A' ' 104' ' ' ASN . 0.2 OUTLIER -61.85 -2.38 0.85 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.549 -0.72 . . . . 0.0 112.015 -179.65 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.573 ' O ' HG12 ' A' ' 101' ' ' VAL . 22.0 t -98.34 4.72 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 CA-C-N 120.36 1.436 . . . . 0.0 110.894 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.429 ' HB3' ' O ' ' A' ' 97' ' ' LEU . 4.8 tp10 -142.25 -91.55 0.13 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.559 -0.713 . . . . 0.0 111.039 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.483 ' O ' HD12 ' A' ' 105' ' ' LEU . 93.6 m -143.61 42.06 1.47 Allowed 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.387 -0.821 . . . . 0.0 110.002 -178.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.414 ' ND2' ' HA ' ' A' ' 100' ' ' GLU . 3.9 p30 -39.85 -56.8 1.71 Allowed 'General case' 0 N--CA 1.508 2.456 0 N-CA-C 113.642 0.978 . . . . 0.0 113.642 -178.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.483 HD12 ' O ' ' A' ' 103' ' ' CYS . 2.0 mt 45.87 23.9 0.2 Allowed 'General case' 0 N--CA 1.508 2.432 0 CA-C-N 118.995 0.816 . . . . 0.0 111.277 -179.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 105' ' ' LEU . . . 64.76 123.79 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.317 -0.865 . . . . 0.0 109.7 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.1 p -89.89 -159.0 0.56 Allowed 'General case' 0 N--CA 1.507 2.38 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.5 tp -66.63 -31.1 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -69.77 -0.87 7.8 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.893 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 58.54 28.78 62.89 Favored Glycine 0 N--CA 1.497 2.756 0 N-CA-C 109.299 -1.521 . . . . 0.0 109.299 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -157.01 168.72 34.04 Favored Glycine 0 N--CA 1.498 2.784 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -78.68 73.96 5.69 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 122.798 2.332 . . . . 0.0 111.933 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 30.2 p90 . . . . . 0 N--CA 1.505 2.305 0 O-C-N 121.583 -0.698 . . . . 0.0 110.431 178.282 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo . . . . . 0 CA--C 1.546 1.105 0 N-CA-C 111.038 -0.408 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 74.76 4.12 69.94 Favored Glycine 0 N--CA 1.502 3.048 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.577 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 72.4 mmm -129.61 99.74 5.27 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.577 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 86.7 -54.59 0.06 Allowed 'General case' 0 N--CA 1.517 2.917 0 CA-C-N 119.448 1.022 . . . . 0.0 108.713 -178.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.691 HD11 ' HB2' ' A' ' 55' ' ' CYS . 36.8 mm -104.83 100.55 24.32 Favored Pre-proline 0 N--CA 1.495 1.783 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.404 ' HD3' ' CD1' ' A' ' 51' ' ' ILE . 35.6 Cg_endo -84.27 175.04 7.63 Favored 'Trans proline' 0 N--CA 1.475 0.423 0 C-N-CA 121.749 1.632 . . . . 0.0 111.511 -177.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 -84.03 142.78 30.21 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.499 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 7.3 t-20 60.12 57.95 4.41 Favored Pre-proline 0 N--CA 1.501 2.094 0 O-C-N 121.605 -0.685 . . . . 0.0 109.676 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.499 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 39.7 Cg_endo -81.41 150.24 17.11 Favored 'Trans proline' 0 N--CA 1.481 0.747 0 C-N-CA 122.219 1.946 . . . . 0.0 112.069 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 76.9 mt 51.98 42.74 30.5 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.853 177.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -66.33 -34.24 77.54 Favored 'General case' 0 N--CA 1.506 2.353 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 178.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.3 t -63.49 -26.06 68.54 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.696 ' O ' HG23 ' A' ' 24' ' ' VAL . 56.1 m -77.79 -34.76 52.05 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.678 ' HB3' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -65.94 -51.54 57.66 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.417 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.45 ' HA ' ' CE3' ' A' ' 22' ' ' TRP . 27.7 m95 -66.83 -32.43 73.7 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 119.753 -0.779 . . . . 0.0 109.682 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -64.25 -32.33 73.88 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 20' ' ' CYS . 48.2 t -70.51 -39.74 76.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 177.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 m -55.92 -40.39 73.01 Favored 'General case' 0 N--CA 1.501 2.088 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.361 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.1 m -77.19 -54.45 6.49 Favored 'General case' 0 N--CA 1.51 2.543 0 O-C-N 122.011 -0.431 . . . . 0.0 111.785 -178.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 14.3 ttm180 -60.05 -24.6 64.68 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.687 -0.633 . . . . 0.0 110.413 -178.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.531 HG23 ' O ' ' A' ' 24' ' ' VAL . 44.3 p -95.21 -66.02 0.94 Allowed 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -177.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.539 ' O ' HG23 ' A' ' 31' ' ' VAL . 3.8 m -100.35 13.27 34.96 Favored 'General case' 0 N--CA 1.51 2.556 0 O-C-N 121.247 -0.908 . . . . 0.0 111.413 -178.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 58.66 22.68 53.64 Favored Glycine 0 N--CA 1.505 3.269 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -178.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 29' ' ' CYS . 29.0 t -110.01 165.53 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.363 0 O-C-N 121.899 -0.765 . . . . 0.0 109.376 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.496 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 131.06 178.63 15.56 Favored Glycine 0 N--CA 1.499 2.896 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -65.03 176.67 2.91 Favored 'Trans proline' 0 N--CA 1.489 1.249 0 CA-C-N 119.042 1.421 . . . . 0.0 109.905 179.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.774 ' C ' HD12 ' A' ' 35' ' ' LEU . 0.3 OUTLIER -91.59 79.58 5.46 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 122.196 0.998 . . . . 0.0 109.857 -178.099 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.774 HD12 ' C ' ' A' ' 34' ' ' ARG . 9.4 mp -130.59 127.8 39.74 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.04 160.24 1.57 Allowed 'General case' 0 N--CA 1.501 2.121 0 O-C-N 122.041 -0.412 . . . . 0.0 110.12 -178.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.22 -37.93 72.02 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 122.02 -0.425 . . . . 0.0 111.206 -178.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.53 -42.77 77.99 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.881 -0.512 . . . . 0.0 110.081 -178.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -70.12 -28.17 65.17 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 2.7 tpt -70.06 -54.54 12.65 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.3 tttt -55.53 -33.9 64.22 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.505 179.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.73 -37.9 76.66 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.63 -37.83 88.81 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 13.1 m -72.23 -32.8 67.06 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.856 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.406 ' HA ' ' CB ' ' A' ' 103' ' ' CYS . 79.7 m -72.2 -29.71 64.24 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.63 -34.89 46.18 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.528 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 4.4 mm-40 -72.98 -38.15 66.79 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.911 HD11 HG12 ' A' ' 98' ' ' VAL . 1.2 tt -67.64 -59.78 3.07 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 179.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.817 ' N ' HD23 ' A' ' 48' ' ' LEU . 1.1 tm-20 -52.57 -26.9 14.63 Favored 'General case' 0 N--CA 1.504 2.245 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 47' ' ' GLN . . . -61.65 -61.31 2.61 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.561 HG23 HD13 ' A' ' 12' ' ' ILE . 45.9 mm -57.12 102.98 0.33 Allowed Pre-proline 0 N--CA 1.509 2.501 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 177.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -54.82 149.8 39.85 Favored 'Trans proline' 0 N--CA 1.486 1.044 0 C-N-CA 121.895 1.73 . . . . 0.0 112.79 -175.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -37.19 -32.1 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.427 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.415 -178.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -73.43 112.27 9.35 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 177.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.691 ' HB2' HD11 ' A' ' 12' ' ' ILE . 28.4 m 73.67 14.82 4.15 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 122.237 -0.289 . . . . 0.0 110.29 -178.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.504 ' NH1' ' O ' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -45.53 -86.52 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.919 0 O-C-N 121.083 -1.01 . . . . 0.0 109.813 -179.913 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 21.8 m -38.98 -38.55 0.45 Allowed 'General case' 0 N--CA 1.515 2.821 0 N-CA-C 113.801 1.038 . . . . 0.0 113.801 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.725 ' O ' HD12 ' A' ' 62' ' ' ILE . 0.5 OUTLIER -36.36 -43.91 0.4 Allowed 'General case' 0 N--CA 1.512 2.673 0 CA-C-N 120.294 1.406 . . . . 0.0 112.512 -179.697 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -42.55 -54.53 3.89 Favored 'General case' 0 N--CA 1.514 2.755 0 O-C-N 121.851 -0.531 . . . . 0.0 111.765 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.818 ' CG2' HD13 ' A' ' 97' ' ' LEU . 95.2 t -57.58 -42.34 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.89 -30.41 67.76 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.725 HD12 ' O ' ' A' ' 58' ' ' GLU . 1.6 mp -78.41 -30.43 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 O-C-N 121.954 -0.466 . . . . 0.0 110.469 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.678 HD21 ' HB3' ' A' ' 21' ' ' ARG . 3.8 tp -77.44 -41.72 38.71 Favored 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 119.314 -0.954 . . . . 0.0 110.282 -178.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.69 ' HA ' HD21 ' A' ' 79' ' ' LEU . 0.7 OUTLIER -78.72 -52.06 8.94 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.202 -179.821 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -81.06 -22.99 38.84 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.936 -0.478 . . . . 0.0 111.267 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.58 147.38 10.93 Favored Glycine 0 N--CA 1.498 2.823 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 -178.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.704 ' HB ' HG23 ' A' ' 62' ' ' ILE . 7.6 p -118.29 159.65 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 122.052 -0.675 . . . . 0.0 109.644 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.667 HG22 ' NE2' ' A' ' 74' ' ' HIS . 69.3 t -114.9 157.77 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 CA-C-O 121.828 0.823 . . . . 0.0 109.602 -178.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.409 ' N ' HG12 ' A' ' 68' ' ' VAL . 33.9 p -117.14 159.54 22.43 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.73 -177.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 42.6 t -63.28 -31.09 72.15 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.383 -178.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.5 p -68.32 -17.33 64.23 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.231 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.91 14.08 32.42 Favored Glycine 0 N--CA 1.498 2.795 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -102.37 156.21 17.74 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-N 118.085 0.942 . . . . 0.0 109.398 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.667 ' NE2' HG22 ' A' ' 68' ' ' VAL . 8.7 m170 -116.03 156.15 26.84 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -145.67 -174.1 4.31 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.034 0.445 . . . . 0.0 109.869 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 60.27 -148.68 43.4 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 56.11 28.32 12.8 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 122.122 -0.634 . . . . 0.0 109.679 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.452 HD23 ' NH2' ' A' ' 21' ' ' ARG . 6.4 mp -86.45 -14.37 43.43 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.716 -0.615 . . . . 0.0 111.202 -178.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.69 HD21 ' HA ' ' A' ' 64' ' ' MET . 1.0 OUTLIER -79.93 84.42 5.69 Favored 'General case' 0 N--CA 1.503 2.212 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 179.109 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -127.81 -173.13 2.84 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.464 0.649 . . . . 0.0 110.01 -178.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -50.43 102.31 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.695 0.76 . . . . 0.0 111.396 -179.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.53 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 22.2 mt -98.51 169.18 8.68 Favored Pre-proline 0 N--CA 1.497 1.916 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.53 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 28.7 Cg_endo -68.24 101.25 0.7 Allowed 'Trans proline' 0 N--CA 1.478 0.601 0 C-N-CA 121.189 1.259 . . . . 0.0 110.733 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.69 13.65 59.25 Favored Glycine 0 N--CA 1.497 2.71 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 3.7 m -143.6 91.03 6.9 Favored Pre-proline 0 N--CA 1.509 2.485 0 CA-C-N 118.637 1.219 . . . . 0.0 109.371 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -75.39 160.15 39.17 Favored 'Trans proline' 0 N--CA 1.483 0.856 0 C-N-CA 121.673 1.582 . . . . 0.0 111.464 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.0 mmt85 -49.55 -28.56 5.73 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 177.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 -57.13 -59.39 5.16 Favored 'General case' 0 N--CA 1.503 2.2 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.624 -178.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 53.6 t -61.07 -40.25 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.836 -0.54 . . . . 0.0 110.311 -178.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.734 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 0.3 OUTLIER -65.42 -26.94 68.2 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.638 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.63 -31.68 47.05 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.42 -48.99 36.89 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 122.04 -0.413 . . . . 0.0 109.902 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.464 ' HD2' HG13 ' A' ' 24' ' ' VAL . 67.2 t80 -78.46 -25.34 45.82 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 122.326 -0.234 . . . . 0.0 111.132 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.734 ' HB2' ' O ' ' A' ' 90' ' ' GLN . . . -48.98 -48.83 71.43 Favored Pre-proline 0 N--CA 1.505 2.319 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -176.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.477 ' HD3' ' HB3' ' A' ' 94' ' ' ALA . 29.3 Cg_endo -68.61 85.59 0.46 Allowed 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 121.841 1.694 . . . . 0.0 113.29 -176.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.424 ' C ' ' HD3' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -177.8 54.95 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.422 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.595 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.818 HD13 ' CG2' ' A' ' 60' ' ' VAL . 29.0 tp -86.27 -81.32 0.22 Allowed 'General case' 0 N--CA 1.507 2.388 0 O-C-N 121.218 -0.926 . . . . 0.0 111.753 -177.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.911 HG12 HD11 ' A' ' 48' ' ' LEU . 4.0 m -91.62 24.92 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.745 -0.597 . . . . 0.0 110.958 -176.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 29.9 p -93.47 168.71 10.87 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.16 -0.01 0.48 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.49 -0.756 . . . . 0.0 111.843 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.551 ' O ' HG12 ' A' ' 101' ' ' VAL . 28.0 t -97.07 0.16 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 CA-C-N 120.518 1.508 . . . . 0.0 111.249 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.409 ' HB3' ' O ' ' A' ' 97' ' ' LEU . 23.9 tp10 -140.71 -88.07 0.17 Allowed 'General case' 0 N--CA 1.504 2.245 0 CA-C-N 119.114 0.87 . . . . 0.0 111.433 -179.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.517 ' O ' HD12 ' A' ' 105' ' ' LEU . 57.3 m -143.74 45.56 1.48 Allowed 'General case' 0 N--CA 1.509 2.482 0 O-C-N 121.244 -0.91 . . . . 0.0 109.683 -179.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -40.5 -57.59 1.78 Allowed 'General case' 0 N--CA 1.504 2.263 0 O-C-N 121.192 -0.942 . . . . 0.0 113.363 -178.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.517 HD12 ' O ' ' A' ' 103' ' ' CYS . 3.6 mt 43.16 27.27 0.11 Allowed 'General case' 0 N--CA 1.515 2.777 0 CA-C-N 119.016 0.825 . . . . 0.0 111.112 -179.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 63.57 153.66 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.451 -0.781 . . . . 0.0 109.801 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.3 p -123.82 -161.18 0.96 Allowed 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.3 tp -66.99 -33.8 65.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.451 ' HB3' ' CE1' ' A' ' 113' ' ' PHE . 74.4 m-70 -70.96 -0.72 9.9 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.907 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 56.28 43.41 89.44 Favored Glycine 0 N--CA 1.501 2.984 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -172.48 170.58 43.63 Favored Glycine 0 N--CA 1.501 2.993 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -77.17 77.1 3.92 Favored 'Trans proline' 0 CA--C 1.544 1.023 0 C-N-CA 122.36 2.04 . . . . 0.0 111.513 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.451 ' CE1' ' HB3' ' A' ' 109' ' ' HIS . 33.1 p90 . . . . . 0 N--CA 1.505 2.311 0 O-C-N 121.754 -0.591 . . . . 0.0 109.827 178.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.405 ' HG3' HG21 ' A' ' 67' ' ' VAL . 30.6 Cg_endo . . . . . 0 N--CA 1.48 0.698 0 N-CA-C 111.131 -0.373 . . . . 0.0 111.131 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 62.76 16.48 56.34 Favored Glycine 0 N--CA 1.497 2.733 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.574 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 16.8 mmm -140.93 84.63 1.94 Allowed 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.882 -0.775 . . . . 0.0 109.011 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.574 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 86.73 -57.72 0.05 Allowed 'General case' 0 N--CA 1.516 2.864 0 O-C-N 121.379 -0.825 . . . . 0.0 108.84 -178.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.715 HD11 ' HB2' ' A' ' 55' ' ' CYS . 61.4 mt -92.14 104.4 10.71 Favored Pre-proline 0 N--CA 1.498 1.961 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 178.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -75.05 169.51 22.44 Favored 'Trans proline' 0 C--O 1.219 -0.433 0 C-N-CA 121.3 1.333 . . . . 0.0 111.649 -175.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 34.9 m-70 -69.28 144.62 53.54 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.489 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 5.3 t-20 65.98 55.98 1.05 Allowed Pre-proline 0 N--CA 1.506 2.357 0 O-C-N 121.358 -0.838 . . . . 0.0 110.303 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.489 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 38.6 Cg_endo -80.49 166.87 19.63 Favored 'Trans proline' 0 N--CA 1.484 0.932 0 C-N-CA 122.305 2.004 . . . . 0.0 111.923 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.6 mp 42.96 43.8 3.72 Favored 'General case' 0 N--CA 1.504 2.254 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.209 177.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -69.07 -37.68 78.63 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -63.01 -26.16 68.72 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 57.3 m -74.64 -38.78 62.42 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.584 HH22 HD23 ' A' ' 78' ' ' LEU . 3.4 ttt180 -64.13 -48.6 75.45 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 33.9 m95 -69.02 -29.07 67.17 Favored 'General case' 0 N--CA 1.502 2.149 0 C-N-CA 119.312 -0.955 . . . . 0.0 109.809 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.439 ' CD1' ' HB3' ' A' ' 40' ' ' MET . 57.1 t80 -66.5 -33.5 75.83 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.424 HG22 ' CD2' ' A' ' 93' ' ' PHE . 96.3 t -72.43 -38.96 61.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 177.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 m -56.18 -37.06 69.07 Favored 'General case' 0 N--CA 1.501 2.091 0 C-N-CA 119.946 -0.701 . . . . 0.0 109.529 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 90.9 m -77.8 -49.89 13.43 Favored 'General case' 0 N--CA 1.508 2.459 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.92 -25.29 67.82 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 121.519 -0.738 . . . . 0.0 110.544 -178.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 24' ' ' VAL . 70.4 p -93.65 -62.9 1.27 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -177.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.655 ' O ' HG23 ' A' ' 31' ' ' VAL . 3.6 m -100.43 9.23 42.92 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.384 -0.823 . . . . 0.0 111.617 -178.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 57.79 29.72 61.95 Favored Glycine 0 N--CA 1.507 3.382 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 -178.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 29' ' ' CYS . 38.5 t -120.72 164.09 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 122.155 -0.615 . . . . 0.0 109.717 -179.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.495 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 136.16 177.72 15.21 Favored Glycine 0 N--CA 1.5 2.908 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -64.43 177.33 2.18 Favored 'Trans proline' 0 N--CA 1.489 1.231 0 CA-C-N 119.196 1.498 . . . . 0.0 110.028 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.21 87.19 6.0 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 122.197 0.999 . . . . 0.0 110.412 -177.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.6 mt -141.76 127.2 18.83 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.02 152.37 2.24 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.907 -0.496 . . . . 0.0 109.81 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.1 p -59.96 -59.64 5.1 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.813 -0.555 . . . . 0.0 110.604 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -52.49 -28.79 21.82 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.818 -0.551 . . . . 0.0 111.595 -178.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -72.0 -46.89 55.56 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.816 -0.553 . . . . 0.0 109.573 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.439 ' HB3' ' CD1' ' A' ' 23' ' ' TYR . 5.5 tpt -61.97 -54.61 39.27 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -53.59 -35.75 61.2 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.34 -42.83 99.71 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.23 -41.14 96.37 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 19.8 m -65.58 -33.17 75.28 Favored 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.233 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 18.9 m -73.43 -30.16 63.03 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -178.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.27 -32.46 62.94 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -77.15 -33.47 56.62 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.785 HD22 ' O ' ' A' ' 103' ' ' CYS . 0.6 OUTLIER -73.48 -33.52 64.87 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.841 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.52 -40.38 61.79 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.25 -39.13 85.67 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.486 HG23 HG12 ' A' ' 12' ' ' ILE . 70.8 mt -82.7 105.75 5.52 Favored Pre-proline 0 N--CA 1.493 1.684 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 177.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -58.29 139.87 92.2 Favored 'Trans proline' 0 N--CA 1.48 0.712 0 C-N-CA 121.42 1.413 . . . . 0.0 110.92 -177.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.7 ' HB2' ' NH1' ' A' ' 56' ' ' ARG . . . -39.47 -29.76 0.06 Allowed 'General case' 0 N--CA 1.508 2.432 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.359 -178.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -53.16 -70.41 0.09 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.919 -0.488 . . . . 0.0 110.698 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.715 ' HB2' HD11 ' A' ' 12' ' ' ILE . 5.0 m -88.55 8.76 26.64 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 122.062 -0.399 . . . . 0.0 110.89 -179.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.7 ' NH1' ' HB2' ' A' ' 53' ' ' ALA . 5.9 mtt180 -47.58 -85.2 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.67 0 O-C-N 121.491 -0.755 . . . . 0.0 110.33 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 72.6 m -32.95 -48.85 0.22 Allowed 'General case' 0 N--CA 1.521 3.113 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -41.67 -54.34 3.3 Favored 'General case' 0 N--CA 1.512 2.668 0 CA-C-N 119.325 0.966 . . . . 0.0 111.731 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -41.82 -44.75 3.41 Favored 'General case' 0 N--CA 1.514 2.731 0 O-C-N 121.776 -0.578 . . . . 0.0 112.04 -179.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.6 t -57.22 -48.83 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -58.57 -26.83 64.01 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.957 HG23 ' HB ' ' A' ' 67' ' ' VAL . 34.8 mm -78.42 -30.76 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 O-C-N 121.985 -0.447 . . . . 0.0 110.469 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.486 HD12 ' HA ' ' A' ' 63' ' ' LEU . 14.8 tp -77.77 -43.22 31.42 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 120.11 -0.636 . . . . 0.0 109.999 -179.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.01 -50.76 10.58 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.18 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -80.6 -22.71 40.41 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 122.006 -0.434 . . . . 0.0 110.936 -178.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.73 146.89 5.7 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.957 ' HB ' HG23 ' A' ' 62' ' ' ILE . 5.5 p -118.42 161.18 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.667 HG22 ' NE2' ' A' ' 74' ' ' HIS . 56.0 t -113.34 157.85 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -179.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 42.2 p -116.67 160.07 21.28 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 121.95 0.881 . . . . 0.0 111.044 -176.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 32.9 t -64.61 -17.46 64.02 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.39 -178.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.1 p -86.49 -14.64 42.53 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 122.021 -0.424 . . . . 0.0 110.127 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.23 13.59 32.98 Favored Glycine 0 N--CA 1.499 2.892 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -105.48 158.56 16.58 Favored 'General case' 0 N--CA 1.502 2.125 0 CA-C-N 118.039 0.92 . . . . 0.0 108.834 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.667 ' NE2' HG22 ' A' ' 68' ' ' VAL . 11.3 m170 -113.72 154.95 26.46 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -179.138 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -136.89 -179.07 5.48 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 55.41 -146.94 28.82 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 108.622 -1.791 . . . . 0.0 108.622 -178.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 54.72 22.53 4.17 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 122.303 -0.528 . . . . 0.0 110.007 179.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.584 HD23 HH22 ' A' ' 21' ' ' ARG . 2.1 mp -83.1 -14.73 53.1 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.745 -0.597 . . . . 0.0 110.361 -179.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.5 mt -62.0 92.79 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -134.22 -177.21 4.48 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.719 0.771 . . . . 0.0 110.843 -178.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -48.68 130.14 17.2 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.506 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.466 ' HB2' ' HB2' ' A' ' 85' ' ' CYS . 20.6 mt -127.49 166.38 23.54 Favored Pre-proline 0 N--CA 1.496 1.87 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 29.6 Cg_endo -68.63 98.69 0.59 Allowed 'Trans proline' 0 C--N 1.328 -0.537 0 C-N-CA 120.88 1.054 . . . . 0.0 110.143 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.68 4.22 67.9 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.466 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 3.3 m -137.02 92.1 14.4 Favored Pre-proline 0 N--CA 1.508 2.47 0 CA-C-N 119.173 1.487 . . . . 0.0 110.02 -179.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -74.69 165.52 31.36 Favored 'Trans proline' 0 N--CA 1.485 1.028 0 C-N-CA 121.976 1.784 . . . . 0.0 111.328 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 23.9 mtp180 -54.09 -25.97 24.66 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.038 0.447 . . . . 0.0 110.133 178.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.58 -46.12 87.33 Favored 'General case' 0 N--CA 1.502 2.139 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.947 -177.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 42.2 t -72.46 -43.14 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.513 -0.742 . . . . 0.0 110.982 -177.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.619 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 2.2 pt20 -70.49 -27.15 63.98 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.411 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 8.7 ttt180 -78.72 -29.15 45.17 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.34 -47.34 20.2 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.999 -0.438 . . . . 0.0 110.3 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.424 ' CD2' HG22 ' A' ' 24' ' ' VAL . 90.6 t80 -79.02 -27.48 43.25 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 122.021 -0.425 . . . . 0.0 111.47 -178.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.619 ' HB2' ' O ' ' A' ' 90' ' ' GLN . . . -54.81 -46.64 99.42 Favored Pre-proline 0 N--CA 1.505 2.281 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -177.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 94' ' ' ALA . 30.1 Cg_endo -70.12 -0.22 6.89 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 122.239 1.959 . . . . 0.0 114.009 -177.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.71 23.92 12.25 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.496 -0.753 . . . . 0.0 109.838 179.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.93 -24.32 59.65 Favored 'General case' 0 N--CA 1.509 2.492 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -178.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 33.7 m -93.36 25.8 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 CA-C-N 121.0 1.727 . . . . 0.0 111.179 -178.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.406 ' C ' ' HB2' ' A' ' 104' ' ' ASN . 19.1 p -98.28 173.2 7.11 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -62.07 -1.48 0.7 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.696 -0.628 . . . . 0.0 112.25 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.584 ' O ' HG12 ' A' ' 101' ' ' VAL . 37.1 t -100.03 4.49 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 CA-C-N 120.407 1.458 . . . . 0.0 110.873 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -141.13 -89.97 0.15 Allowed 'General case' 0 N--CA 1.502 2.168 0 CA-C-N 118.99 0.814 . . . . 0.0 111.511 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.785 ' O ' HD22 ' A' ' 48' ' ' LEU . 19.5 m -143.67 43.08 1.48 Allowed 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.572 -0.705 . . . . 0.0 109.886 -178.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.409 ' ND2' ' HB3' ' A' ' 112' ' ' PRO . 57.0 t-20 -43.02 -64.81 0.56 Allowed 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.299 -0.875 . . . . 0.0 112.287 -179.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.426 ' O ' ' HB3' ' A' ' 106' ' ' ALA . 6.0 mt 45.34 29.39 0.56 Allowed 'General case' 0 N--CA 1.511 2.602 0 CA-C-O 121.066 0.46 . . . . 0.0 109.927 -178.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 105' ' ' LEU . . . 67.09 157.98 0.13 Allowed 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -178.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.6 p -128.87 -163.92 1.34 Allowed 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -179.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 18.0 tt -68.17 -33.29 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.447 ' HB3' ' CE2' ' A' ' 113' ' ' PHE . 96.9 m-70 -66.68 -4.85 9.81 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.689 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 61.45 41.51 99.56 Favored Glycine 0 N--CA 1.499 2.874 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -174.82 170.94 44.14 Favored Glycine 0 N--CA 1.5 2.966 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.409 ' HB3' ' ND2' ' A' ' 104' ' ' ASN . 32.3 Cg_endo -77.9 75.85 4.6 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 122.553 2.168 . . . . 0.0 111.387 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.447 ' CE2' ' HB3' ' A' ' 109' ' ' HIS . 36.7 p90 . . . . . 0 N--CA 1.501 2.118 0 O-C-N 121.708 -0.62 . . . . 0.0 110.447 178.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo . . . . . 0 CA--C 1.542 0.92 0 N-CA-C 110.205 -0.729 . . . . 0.0 110.205 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 109.9 -10.55 32.07 Favored Glycine 0 N--CA 1.501 2.983 0 O-C-N 121.507 -0.746 . . . . 0.0 111.255 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.571 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 6.1 mmt -128.03 111.77 13.89 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 86.17 -54.09 0.07 Allowed 'General case' 0 N--CA 1.514 2.741 0 CA-C-N 119.789 1.177 . . . . 0.0 108.708 -178.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 55.0 mt -113.38 100.74 52.44 Favored Pre-proline 0 N--CA 1.495 1.783 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 178.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -81.73 172.46 12.22 Favored 'Trans proline' 0 C--O 1.221 -0.366 0 C-N-CA 121.484 1.456 . . . . 0.0 111.524 -177.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.625 ' CE1' HG22 ' A' ' 69' ' ' THR . 44.7 m-70 -77.61 150.1 34.69 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -179.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.508 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 10.8 t-20 66.99 53.92 0.75 Allowed Pre-proline 0 N--CA 1.503 2.21 0 O-C-N 121.459 -0.775 . . . . 0.0 110.049 -178.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.508 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 39.8 Cg_endo -78.45 163.07 27.45 Favored 'Trans proline' 0 N--CA 1.484 0.937 0 C-N-CA 122.282 1.988 . . . . 0.0 111.465 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.575 ' N ' HD22 ' A' ' 17' ' ' LEU . 3.4 mm? 48.62 47.12 20.95 Favored 'General case' 0 N--CA 1.503 2.191 0 CA-C-O 121.246 0.546 . . . . 0.0 111.043 178.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -66.7 -35.43 80.1 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 121.493 -0.755 . . . . 0.0 109.078 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.18 -26.62 68.23 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 28.3 m -71.32 -45.2 63.58 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.681 ' NH2' HD23 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -59.38 -54.63 44.47 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.863 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.436 ' HA ' ' CE3' ' A' ' 22' ' ' TRP . 27.9 m95 -64.26 -27.18 68.87 Favored 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.676 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.457 ' CD2' ' HB3' ' A' ' 40' ' ' MET . 6.4 t80 -66.3 -32.5 73.95 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.692 HG22 ' CD1' ' A' ' 93' ' ' PHE . 61.1 t -70.61 -42.04 77.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 178.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 m -56.23 -44.37 79.52 Favored 'General case' 0 N--CA 1.502 2.158 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.656 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 20.9 m -76.05 -52.25 10.58 Favored 'General case' 0 N--CA 1.51 2.569 0 O-C-N 122.059 -0.401 . . . . 0.0 111.924 -178.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.7 tpm_? -61.89 -24.89 67.22 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.838 -0.539 . . . . 0.0 110.724 -178.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.531 HG23 ' O ' ' A' ' 24' ' ' VAL . 35.6 p -96.23 -64.38 1.06 Allowed 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 120.689 -0.405 . . . . 0.0 112.058 -177.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.7 m -101.32 10.89 40.16 Favored 'General case' 0 N--CA 1.511 2.613 0 CA-C-N 119.183 0.901 . . . . 0.0 111.484 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.12 18.54 57.84 Favored Glycine 0 N--CA 1.501 2.972 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -178.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.51 HG12 ' N ' ' A' ' 32' ' ' GLY . 46.2 t -102.77 164.04 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 O-C-N 121.696 -0.885 . . . . 0.0 109.112 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.51 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 130.3 179.46 16.06 Favored Glycine 0 N--CA 1.499 2.892 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -64.84 173.06 6.17 Favored 'Trans proline' 0 N--CA 1.486 1.065 0 CA-C-N 119.201 1.5 . . . . 0.0 109.879 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.432 ' O ' HD23 ' A' ' 35' ' ' LEU . 0.2 OUTLIER -92.77 84.5 4.99 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 122.026 0.917 . . . . 0.0 110.178 -177.836 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.432 HD23 ' O ' ' A' ' 34' ' ' ARG . 69.2 mt -140.79 145.1 35.88 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.582 ' HB3' ' HG3' ' A' ' 39' ' ' GLU . . . -58.29 163.11 3.16 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -179.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.23 -56.12 4.59 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.998 -0.439 . . . . 0.0 110.444 -179.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.28 -33.4 19.77 Favored 'General case' 0 N--CA 1.508 2.474 0 O-C-N 121.881 -0.512 . . . . 0.0 110.803 -178.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.582 ' HG3' ' HB3' ' A' ' 36' ' ' ALA . 3.6 mm-40 -71.35 -39.89 71.02 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 122.054 -0.404 . . . . 0.0 110.142 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.457 ' HB3' ' CD2' ' A' ' 23' ' ' TYR . 1.5 ttt -65.32 -52.79 51.6 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.432 ' HB2' ' CE2' ' A' ' 23' ' ' TYR . 6.4 tttm -53.58 -38.05 63.55 Favored 'General case' 0 N--CA 1.504 2.268 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.98 -40.92 97.27 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -60.36 -44.55 95.47 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 12.4 m -63.19 -35.95 82.0 Favored 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.635 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 69.0 m -70.52 -29.73 66.3 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.6 ttt-85 -73.8 -32.46 63.75 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -76.43 -29.48 57.02 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.844 HD11 HG12 ' A' ' 98' ' ' VAL . 0.6 OUTLIER -76.49 -36.86 57.58 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -73.41 -36.21 65.95 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.65 -53.03 60.69 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 178.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.458 HG22 ' HA ' ' A' ' 56' ' ' ARG . 42.0 mm -63.59 105.81 0.76 Allowed Pre-proline 0 N--CA 1.496 1.871 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 176.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -59.27 149.82 78.32 Favored 'Trans proline' 0 N--CA 1.479 0.651 0 C-N-CA 121.593 1.529 . . . . 0.0 110.935 -176.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -40.46 -32.08 0.18 Allowed 'General case' 0 N--CA 1.505 2.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.53 -178.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -73.49 121.73 21.03 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 178.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 15.2 m 72.9 6.41 5.34 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 122.167 -0.333 . . . . 0.0 110.23 -178.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.458 ' HA ' HG22 ' A' ' 51' ' ' ILE . 1.5 mtt180 -49.11 -87.14 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.676 0 O-C-N 121.191 -0.943 . . . . 0.0 109.691 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 82.4 m -36.39 -43.51 0.38 Allowed 'General case' 0 N--CA 1.519 3.007 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.677 ' O ' HD12 ' A' ' 62' ' ' ILE . 8.7 mt-10 -39.31 -48.36 1.84 Allowed 'General case' 0 N--CA 1.511 2.61 0 CA-C-N 119.549 1.068 . . . . 0.0 112.326 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.416 ' HB1' HD23 ' A' ' 17' ' ' LEU . . . -41.9 -50.37 4.48 Favored 'General case' 0 N--CA 1.517 2.922 0 CA-C-N 118.783 0.72 . . . . 0.0 111.522 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 1.005 HG11 HD22 ' A' ' 97' ' ' LEU . 34.9 t -58.23 -45.04 89.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.87 -27.66 65.4 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.728 HG23 ' HB ' ' A' ' 67' ' ' VAL . 1.4 mp -78.21 -30.85 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.898 -0.501 . . . . 0.0 109.852 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.514 ' CD2' HD13 ' A' ' 79' ' ' LEU . 7.3 tt -77.57 -40.73 41.38 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.469 -0.893 . . . . 0.0 110.139 -179.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 2.7 tmm? -78.4 -53.45 7.25 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.27 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -80.68 -22.83 40.07 Favored 'General case' 0 N--CA 1.502 2.154 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.157 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.97 147.63 11.79 Favored Glycine 0 N--CA 1.497 2.709 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 -178.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.728 ' HB ' HG23 ' A' ' 62' ' ' ILE . 7.6 p -118.48 160.58 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 O-C-N 122.196 -0.591 . . . . 0.0 109.782 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.692 HG22 ' NE2' ' A' ' 74' ' ' HIS . 54.7 t -114.38 157.81 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 CA-C-O 121.716 0.769 . . . . 0.0 109.292 -179.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.625 HG22 ' CE1' ' A' ' 14' ' ' HIS . 61.7 p -117.18 159.9 21.89 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.78 -177.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 35.4 t -63.3 -31.51 72.68 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.298 -178.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.2 p -69.14 -16.65 63.7 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.332 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.73 10.17 44.26 Favored Glycine 0 N--CA 1.498 2.783 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -100.18 157.56 16.49 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-N 118.04 0.92 . . . . 0.0 109.139 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.692 ' NE2' HG22 ' A' ' 68' ' ' VAL . 9.7 m170 -114.93 155.22 27.29 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -179.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -140.56 -176.44 4.64 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.122 0.487 . . . . 0.0 109.785 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.676 ' O ' HD12 ' A' ' 78' ' ' LEU . . . 56.37 -144.5 36.63 Favored Glycine 0 N--CA 1.496 2.691 0 N-CA-C 108.592 -1.803 . . . . 0.0 108.592 -178.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 56.0 21.6 5.14 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 122.224 -0.574 . . . . 0.0 110.356 179.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.681 HD23 ' NH2' ' A' ' 21' ' ' ARG . 6.7 mp -76.21 -16.76 59.77 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.744 -0.597 . . . . 0.0 110.468 -179.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.514 HD13 ' CD2' ' A' ' 63' ' ' LEU . 2.3 tp -59.34 91.64 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 41.0 mm-40 -130.81 -176.9 4.14 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.449 0.642 . . . . 0.0 109.821 -179.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.33 102.33 1.07 Allowed 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.657 0.742 . . . . 0.0 110.893 -179.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.542 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 20.5 mt -87.12 169.64 14.12 Favored Pre-proline 0 N--CA 1.496 1.856 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 177.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.542 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 29.5 Cg_endo -69.58 99.19 0.71 Allowed 'Trans proline' 0 C--N 1.328 -0.528 0 C-N-CA 121.028 1.152 . . . . 0.0 110.3 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 98.58 1.41 57.71 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.4 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 3.4 m -134.8 91.34 20.76 Favored Pre-proline 0 N--CA 1.504 2.242 0 CA-C-N 118.99 1.395 . . . . 0.0 109.274 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -72.09 161.18 45.44 Favored 'Trans proline' 0 N--CA 1.483 0.879 0 C-N-CA 121.3 1.333 . . . . 0.0 111.528 -179.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.6 mtp180 -48.15 -28.11 2.76 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.06 0.457 . . . . 0.0 109.907 178.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -60.8 -47.23 87.26 Favored 'General case' 0 N--CA 1.502 2.174 0 CA-C-N 116.325 -0.398 . . . . 0.0 112.006 -177.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 48.5 t -68.77 -39.52 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.585 -0.697 . . . . 0.0 109.837 -178.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.565 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 2.2 mp0 -66.17 -26.76 67.56 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.3 tpt180 -78.89 -35.17 44.01 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 122.085 -0.385 . . . . 0.0 109.966 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.34 -45.99 68.11 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.692 ' CD1' HG22 ' A' ' 24' ' ' VAL . 37.3 t80 -78.34 -25.52 46.42 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.7 ' HB3' ' HD3' ' A' ' 95' ' ' PRO . . . -41.56 -51.82 8.63 Favored Pre-proline 0 N--CA 1.503 2.191 0 CA-C-O 118.907 -0.568 . . . . 0.0 112.098 -177.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.7 ' HD3' ' HB3' ' A' ' 94' ' ' ALA . 29.4 Cg_endo -72.32 -171.91 0.8 Allowed 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 121.532 1.488 . . . . 0.0 109.519 179.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.46 ' HA ' HG21 ' A' ' 99' ' ' THR . 0.1 OUTLIER 66.47 18.0 10.75 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.827 -0.546 . . . . 0.0 109.827 -178.943 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 1.056 HD12 HG13 ' A' ' 98' ' ' VAL . 0.3 OUTLIER -73.3 -62.73 1.37 Allowed 'General case' 0 N--CA 1.516 2.849 0 O-C-N 121.687 -0.633 . . . . 0.0 112.134 -178.718 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 1.056 HG13 HD12 ' A' ' 97' ' ' LEU . 33.4 m -86.57 26.5 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.282 0 CA-C-N 119.621 1.101 . . . . 0.0 110.657 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.46 HG21 ' HA ' ' A' ' 96' ' ' LYS . 46.7 p -97.58 173.56 7.09 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -62.6 0.46 0.49 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.332 -0.855 . . . . 0.0 111.944 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.412 ' O ' HG12 ' A' ' 101' ' ' VAL . 5.0 t -98.57 -0.83 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 CA-C-N 120.481 1.491 . . . . 0.0 111.211 -179.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -138.46 -88.81 0.23 Allowed 'General case' 0 N--CA 1.507 2.39 0 CA-C-N 119.403 1.001 . . . . 0.0 111.918 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.757 ' O ' HD22 ' A' ' 48' ' ' LEU . 92.0 m -141.44 42.03 1.75 Allowed 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.553 -0.717 . . . . 0.0 109.734 -178.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.454 ' ND2' ' HB3' ' A' ' 112' ' ' PRO . 46.5 t-20 -38.34 -69.91 0.11 Allowed 'General case' 0 N--CA 1.506 2.339 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -178.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.7 mt 48.18 26.99 1.16 Allowed 'General case' 0 N--CA 1.51 2.534 0 O-C-N 121.912 -0.492 . . . . 0.0 110.682 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 63.91 154.66 0.06 Allowed 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.561 ' OG1' ' CE1' ' A' ' 109' ' ' HIS . 1.7 p -124.51 -151.82 0.49 Allowed 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -178.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.527 HG23 ' N ' ' A' ' 109' ' ' HIS . 0.5 OUTLIER -57.96 -39.97 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 C-N-CA 123.08 0.552 . . . . 0.0 111.279 178.509 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.587 ' CE1' ' O ' ' A' ' 113' ' ' PHE . 3.8 p80 -92.53 23.15 4.15 Favored 'General case' 0 N--CA 1.514 2.775 0 O-C-N 122.219 -0.301 . . . . 0.0 110.875 -177.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 45.47 63.57 2.68 Favored Glycine 0 N--CA 1.504 3.2 0 O-C-N 121.723 -0.61 . . . . 0.0 111.986 177.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 173.31 171.32 37.82 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 110.499 -1.041 . . . . 0.0 110.499 179.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.468 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 36.3 Cg_endo -83.3 75.35 4.38 Favored 'Trans proline' 0 CA--C 1.545 1.043 0 C-N-CA 122.711 2.274 . . . . 0.0 111.057 -179.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.587 ' O ' ' CE1' ' A' ' 109' ' ' HIS . 20.2 p90 . . . . . 0 N--CA 1.531 3.597 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo . . . . . 0 CA--C 1.541 0.835 0 N-CA-C 110.356 -0.671 . . . . 0.0 110.356 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 57.66 14.59 15.41 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.75 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 1.3 mtt -140.25 107.69 5.56 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.211 -1.17 . . . . 0.0 108.54 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.75 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 85.32 -62.22 0.07 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.843 -1.161 . . . . 0.0 108.057 -178.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.802 HD11 ' CB ' ' A' ' 55' ' ' CYS . 67.9 mt -104.05 101.17 24.22 Favored Pre-proline 0 C--N 1.304 -1.406 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 11' ' ' ALA . 33.2 Cg_endo -81.29 172.45 12.71 Favored 'Trans proline' 0 C--N 1.318 -1.073 0 C-N-CA 121.595 1.53 . . . . 0.0 111.674 -177.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.466 ' H ' ' CD2' ' A' ' 14' ' ' HIS . 29.4 m-70 -69.58 145.63 52.4 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.667 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 10.8 t-20 54.8 51.21 7.21 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 120.809 -1.182 . . . . 0.0 110.04 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.667 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 37.6 Cg_endo -78.72 166.07 24.04 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.398 2.066 . . . . 0.0 111.49 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.737 HD23 ' SG ' ' A' ' 20' ' ' CYS . 0.5 OUTLIER 48.45 48.32 19.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.741 -0.599 . . . . 0.0 111.091 178.879 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -75.08 -42.24 57.15 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.01 -1.056 . . . . 0.0 108.91 178.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.556 ' OG ' ' HE2' ' A' ' 40' ' ' MET . 0.3 OUTLIER -59.24 -25.61 64.19 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.191 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.737 ' SG ' HD23 ' A' ' 17' ' ' LEU . 71.2 m -73.78 -38.77 64.54 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.597 -0.69 . . . . 0.0 109.286 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.47 ' O ' ' HD2' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -63.51 -48.05 79.18 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.263 -0.898 . . . . 0.0 108.848 179.498 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.466 ' HA ' ' OG ' ' A' ' 25' ' ' SER . 31.0 m95 -73.08 -26.77 61.38 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.642 -1.286 . . . . 0.0 109.82 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.519 ' HB2' ' HG2' ' A' ' 40' ' ' MET . 15.2 t80 -66.17 -31.28 72.02 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.08 -1.012 . . . . 0.0 108.422 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.546 ' O ' HG23 ' A' ' 28' ' ' THR . 93.4 t -75.42 -41.52 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.466 ' OG ' ' HA ' ' A' ' 22' ' ' TRP . 0.5 OUTLIER -56.2 -42.3 76.96 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.434 -0.906 . . . . 0.0 109.986 -179.863 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 2.4 m -77.59 -55.08 5.66 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.267 -0.896 . . . . 0.0 111.256 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.87 -24.56 62.34 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 120.743 -1.223 . . . . 0.0 110.3 -178.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.546 HG23 ' O ' ' A' ' 24' ' ' VAL . 72.4 p -92.87 -67.1 0.88 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.005 -1.059 . . . . 0.0 111.351 -178.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 84' ' ' GLY . 3.6 m -99.0 16.69 21.74 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.618 -1.301 . . . . 0.0 109.843 -179.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 26' ' ' THR . . . 56.48 21.48 34.63 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.515 HG12 ' N ' ' A' ' 32' ' ' GLY . 73.6 t -105.79 161.11 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.141 -1.211 . . . . 0.0 109.615 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.515 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 138.36 179.86 17.63 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 108.849 -1.7 . . . . 0.0 108.849 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -66.19 175.8 4.52 Favored 'Trans proline' 0 N--CA 1.482 0.803 0 CA-C-N 119.127 1.464 . . . . 0.0 110.051 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 7.4 mtt-85 -91.4 82.2 5.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.847 -1.158 . . . . 0.0 110.013 -178.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.97 131.2 28.26 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -45.95 158.28 0.1 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.086 -1.009 . . . . 0.0 109.326 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -75.79 -52.34 10.62 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.973 -1.079 . . . . 0.0 110.205 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -47.12 -34.03 5.67 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.971 -1.081 . . . . 0.0 109.643 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.497 ' O ' ' HD3' ' A' ' 43' ' ' ARG . 3.0 mt-10 -69.57 -41.65 75.57 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.15 -0.969 . . . . 0.0 108.906 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.556 ' HE2' ' OG ' ' A' ' 19' ' ' SER . 2.6 tpt -61.24 -60.41 3.79 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.6 ttpm? -50.35 -40.89 50.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.745 -0.597 . . . . 0.0 109.529 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.59 -45.59 88.78 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.282 -0.886 . . . . 0.0 109.486 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.534 ' HD2' ' N ' ' A' ' 43' ' ' ARG . 1.0 OUTLIER -59.82 -48.79 80.26 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.355 -0.841 . . . . 0.0 109.851 -179.695 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.418 ' SG ' ' N ' ' A' ' 20' ' ' CYS . 14.0 m -58.03 -34.42 70.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.992 -1.068 . . . . 0.0 110.439 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 20.8 m -70.95 -30.58 66.91 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.977 -1.077 . . . . 0.0 109.091 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.63 -35.61 75.39 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.471 ' O ' ' CG1' ' A' ' 51' ' ' ILE . 3.4 mt-30 -76.95 -26.48 54.06 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.617 HD12 HD12 ' A' ' 105' ' ' LEU . 1.7 tm? -71.65 -34.83 70.07 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.491 ' HG2' HD13 ' A' ' 105' ' ' LEU . 4.2 mm-40 -77.06 -58.43 3.29 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.487 ' O ' ' HD3' ' A' ' 52' ' ' PRO . . . -46.35 -35.17 5.17 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.534 HD12 HG12 ' A' ' 12' ' ' ILE . 21.9 mm -82.01 106.62 6.62 Favored Pre-proline 0 N--CA 1.488 1.449 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.487 ' HD3' ' O ' ' A' ' 50' ' ' ALA . 25.7 Cg_endo -61.84 148.35 93.28 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 121.883 1.722 . . . . 0.0 110.886 -177.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.836 ' HB2' ' NH1' ' A' ' 56' ' ' ARG . . . -59.77 -35.05 73.84 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.665 -0.647 . . . . 0.0 111.156 -178.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.745 ' HA ' HD12 ' A' ' 108' ' ' ILE . 6.0 t80 -45.58 -27.17 0.71 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.905 -1.122 . . . . 0.0 108.137 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.802 ' CB ' HD11 ' A' ' 12' ' ' ILE . 13.3 m -116.43 -73.34 0.65 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.836 ' NH1' ' HB2' ' A' ' 53' ' ' ALA . 22.4 mtt180 31.71 -98.89 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.828 -0.545 . . . . 0.0 110.176 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.497 ' C ' ' O ' ' A' ' 56' ' ' ARG . 66.2 m -33.46 -55.89 0.43 Allowed 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.277 -0.89 . . . . 0.0 111.208 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.482 ' O ' ' C ' ' A' ' 59' ' ' ALA . 1.1 tt0 -35.74 -53.63 0.72 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.766 -1.208 . . . . 0.0 111.05 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.482 ' C ' ' O ' ' A' ' 58' ' ' GLU . . . -35.85 -52.49 0.72 Allowed 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.214 -0.928 . . . . 0.0 110.287 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.749 HG22 HD13 ' A' ' 97' ' ' LEU . 7.4 t -53.52 -50.47 49.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 121.247 -0.908 . . . . 0.0 108.784 179.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.516 ' O ' ' HB2' ' A' ' 65' ' ' ASP . 6.8 mtp85 -53.55 -29.61 37.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.403 -0.81 . . . . 0.0 109.83 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.818 HG23 ' HB ' ' A' ' 67' ' ' VAL . 17.9 mt -77.6 -30.14 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 120.957 -1.089 . . . . 0.0 110.043 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.494 ' O ' ' HA ' ' A' ' 77' ' ' ARG . 13.0 tp -77.26 -43.18 34.29 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.773 -1.205 . . . . 0.0 109.612 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 47.5 tpp -78.42 -50.96 10.76 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.18 -0.95 . . . . 0.0 109.945 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.516 ' HB2' ' O ' ' A' ' 61' ' ' ARG . 17.5 m-20 -79.68 -21.97 44.04 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.061 -1.024 . . . . 0.0 109.978 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.56 146.11 9.57 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.818 ' HB ' HG23 ' A' ' 62' ' ' ILE . 2.6 p -116.88 159.47 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.512 -0.993 . . . . 0.0 109.329 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.598 HG22 ' CD2' ' A' ' 74' ' ' HIS . 7.9 t -114.3 157.99 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 CA-C-O 121.864 0.84 . . . . 0.0 109.892 -178.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.456 ' N ' ' CG1' ' A' ' 68' ' ' VAL . 21.7 p -116.87 159.27 22.64 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.604 0.716 . . . . 0.0 109.583 -178.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.0 t -62.27 -34.17 76.03 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.588 -0.695 . . . . 0.0 110.142 -179.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.8 p -65.63 -14.93 62.18 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.525 -0.734 . . . . 0.0 109.52 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 99.97 8.09 51.65 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.674 -1.77 . . . . 0.0 108.674 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -92.1 156.81 17.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.216 -1.167 . . . . 0.0 109.5 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.598 ' CD2' HG22 ' A' ' 68' ' ' VAL . 12.5 m170 -115.8 155.88 27.06 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 120.812 -1.18 . . . . 0.0 108.675 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.436 ' HG2' ' C ' ' A' ' 74' ' ' HIS . 3.3 mt-10 -141.44 -172.89 3.62 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.088 -1.007 . . . . 0.0 110.585 -179.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 49.65 -146.07 7.73 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.494 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER 56.2 17.77 2.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -1.175 . . . . 0.0 110.1 179.64 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.421 ' O ' ' N ' ' A' ' 80' ' ' GLN . 0.1 OUTLIER -83.8 -11.96 56.33 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.983 -1.073 . . . . 0.0 110.127 -179.611 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -47.71 99.32 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.869 -1.144 . . . . 0.0 109.34 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.421 ' N ' ' O ' ' A' ' 78' ' ' LEU . 2.2 mt-30 -134.39 170.99 14.91 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.238 -0.913 . . . . 0.0 109.698 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.45 ' OD1' ' HG3' ' A' ' 87' ' ' ARG . 2.2 m-20 -65.94 107.4 1.84 Allowed 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.595 0.712 . . . . 0.0 110.82 -179.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.682 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 18.0 mt -80.0 172.06 10.81 Favored Pre-proline 0 C--N 1.301 -1.506 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 177.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.682 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 28.3 Cg_endo -68.32 100.84 0.68 Allowed 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 120.872 1.048 . . . . 0.0 109.723 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.454 ' O ' ' SG ' ' A' ' 29' ' ' CYS . . . 92.27 15.44 53.56 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 -179.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.511 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 3.4 m -148.52 90.57 4.88 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 120.802 -1.411 . . . . 0.0 108.856 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.413 ' O ' ' C ' ' A' ' 87' ' ' ARG . 30.4 Cg_endo -74.77 160.48 40.77 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.367 1.378 . . . . 0.0 111.649 -178.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.45 ' HG3' ' OD1' ' A' ' 81' ' ' ASP . 53.4 mtp180 -44.7 -29.41 0.76 Allowed 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 122.152 0.977 . . . . 0.0 108.396 178.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -54.03 -52.39 60.99 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.58 -178.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 58.8 t -65.05 -41.61 92.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 O-C-N 120.94 -1.1 . . . . 0.0 110.207 -178.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.564 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 3.6 mp0 -62.43 -27.4 69.08 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.262 -0.899 . . . . 0.0 108.705 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.498 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 0.0 OUTLIER -78.61 -33.06 47.74 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.444 -0.785 . . . . 0.0 109.957 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.502 ' O ' ' HD2' ' A' ' 95' ' ' PRO . . . -71.44 -45.6 62.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.933 -1.104 . . . . 0.0 109.499 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.574 ' O ' ' CD1' ' A' ' 93' ' ' PHE . 10.0 t80 -77.92 -25.71 48.53 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.383 -0.823 . . . . 0.0 110.102 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.782 ' HB3' ' HD3' ' A' ' 95' ' ' PRO . . . -43.55 -50.89 16.63 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.395 -0.816 . . . . 0.0 112.094 -178.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.782 ' HD3' ' HB3' ' A' ' 94' ' ' ALA . 32.9 Cg_endo -73.66 24.0 0.33 Allowed 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.64 2.227 . . . . 0.0 112.951 -178.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.411 ' O ' ' HG3' ' A' ' 102' ' ' GLU . 0.4 OUTLIER -126.8 28.69 5.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.688 -1.258 . . . . 0.0 108.898 178.612 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.749 HD13 HG22 ' A' ' 60' ' ' VAL . 0.6 OUTLIER -80.12 -77.77 0.18 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.403 -0.811 . . . . 0.0 110.403 -179.476 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 98' ' ' VAL . 2.5 m -79.81 27.89 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.906 -1.121 . . . . 0.0 110.873 -179.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.483 ' C ' ' HB2' ' A' ' 104' ' ' ASN . 5.1 p -101.27 170.98 7.88 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.909 -1.119 . . . . 0.0 108.196 179.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -60.39 1.33 0.13 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.571 -1.331 . . . . 0.0 112.179 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.404 ' HB ' ' HG2' ' A' ' 96' ' ' LYS . 2.7 t -101.02 1.69 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 119.822 -1.799 . . . . 0.0 110.972 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.508 ' HB2' ' O ' ' A' ' 97' ' ' LEU . 0.3 OUTLIER -140.17 -94.29 0.16 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.513 -1.367 . . . . 0.0 110.655 -179.714 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.468 ' O ' ' C ' ' A' ' 104' ' ' ASN . 72.8 m -131.99 38.68 3.5 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.928 -1.108 . . . . 0.0 109.004 -179.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.538 ' ND2' ' HB3' ' A' ' 112' ' ' PRO . 42.0 t-20 -29.52 -66.02 0.09 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.811 -0.556 . . . . 0.0 112.091 -179.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.617 HD12 HD12 ' A' ' 48' ' ' LEU . 11.3 mt 41.7 33.98 0.37 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.064 -1.023 . . . . 0.0 109.748 -179.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.474 ' O ' ' O ' ' A' ' 105' ' ' LEU . . . 55.23 165.6 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.032 -1.043 . . . . 0.0 108.993 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.73 ' OG1' ' CE1' ' A' ' 109' ' ' HIS . 1.7 p -133.79 -146.08 0.26 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.0 -1.063 . . . . 0.0 108.722 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.745 HD12 ' HA ' ' A' ' 54' ' ' TYR . 1.3 tt -69.05 -38.68 78.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.31 -0.869 . . . . 0.0 110.008 179.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.73 ' CE1' ' OG1' ' A' ' 107' ' ' THR . 0.6 OUTLIER -84.46 24.0 1.05 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.179 -0.951 . . . . 0.0 110.035 -179.75 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 109' ' ' HIS . . . 42.73 54.78 4.89 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -179.66 159.55 24.15 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.538 ' HB3' ' ND2' ' A' ' 104' ' ' ASN . 31.7 Cg_endo -77.04 79.58 3.09 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.722 2.281 . . . . 0.0 109.859 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.608 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.507 2.383 0 C-N-CA 118.826 -1.15 . . . . 0.0 113.073 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo . . . . . 0 CA--C 1.542 0.922 0 N-CA-C 110.999 -0.424 . . . . 0.0 110.999 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.55 -14.78 33.69 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.73 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 0.7 OUTLIER -134.87 116.68 15.04 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.18 -1.188 . . . . 0.0 108.108 179.499 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 85.61 -59.05 0.07 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.796 -1.19 . . . . 0.0 107.811 -178.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.402 HG23 HD12 ' A' ' 12' ' ' ILE . 9.9 mm -107.2 101.36 38.01 Favored Pre-proline 0 C--N 1.303 -1.434 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 178.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -81.36 175.45 9.64 Favored 'Trans proline' 0 C--N 1.318 -1.064 0 C-N-CA 121.459 1.439 . . . . 0.0 111.955 -176.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 52.8 m-70 -76.76 147.84 37.06 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.673 -0.642 . . . . 0.0 109.553 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.586 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 0.1 OUTLIER 58.22 58.03 6.54 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 120.796 -1.19 . . . . 0.0 109.93 -179.758 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.586 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 37.1 Cg_endo -79.66 168.62 19.34 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.55 2.167 . . . . 0.0 111.03 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.855 ' CD2' ' HB1' ' A' ' 59' ' ' ALA . 3.3 mm? 52.33 44.38 29.87 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.551 -0.718 . . . . 0.0 111.041 178.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.472 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 3.9 p30 -83.61 -47.29 11.43 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.867 -1.146 . . . . 0.0 109.412 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.59 -25.99 67.68 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.691 ' SG ' HD13 ' A' ' 17' ' ' LEU . 72.4 m -71.08 -50.02 38.24 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.624 -0.672 . . . . 0.0 109.62 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.561 ' CG ' ' N ' ' A' ' 22' ' ' TRP . 4.2 ptt180 -59.03 -52.09 67.24 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.132 -0.98 . . . . 0.0 109.632 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.561 ' N ' ' CG ' ' A' ' 21' ' ' ARG . 22.9 m95 -61.15 -34.32 74.83 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 118.584 -1.246 . . . . 0.0 108.943 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.538 ' HB2' ' CG ' ' A' ' 40' ' ' MET . 7.2 t80 -60.32 -30.45 69.52 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.613 ' O ' HG23 ' A' ' 28' ' ' THR . 48.0 t -72.67 -41.88 62.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 C-N-CA 118.816 -1.154 . . . . 0.0 107.94 178.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 64.8 p -55.67 -42.99 75.91 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.247 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 5.4 m -78.13 -52.98 7.9 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.158 -0.964 . . . . 0.0 111.708 -178.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.473 ' HG2' ' CE1' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -60.51 -25.76 66.35 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.703 -1.248 . . . . 0.0 110.792 -178.383 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.613 HG23 ' O ' ' A' ' 24' ' ' VAL . 21.9 p -96.83 -60.84 1.51 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.019 -1.051 . . . . 0.0 111.095 -178.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.475 ' SG ' ' O ' ' A' ' 84' ' ' GLY . 3.5 m -99.39 15.78 25.23 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.875 -1.141 . . . . 0.0 110.13 -179.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 26' ' ' THR . . . 52.44 21.02 8.02 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 -179.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.557 HG12 ' N ' ' A' ' 32' ' ' GLY . 41.7 t -109.51 165.37 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.276 -1.132 . . . . 0.0 109.62 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.557 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 130.3 178.32 15.36 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 108.58 -1.808 . . . . 0.0 108.58 -179.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -65.44 176.2 3.58 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 CA-C-N 119.188 1.494 . . . . 0.0 109.825 179.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 24.1 mtt180 -91.11 79.07 5.81 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.707 -1.246 . . . . 0.0 110.369 -177.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.465 ' O ' ' C ' ' A' ' 36' ' ' ALA . 52.1 mt -127.35 114.93 18.22 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 178.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.465 ' C ' ' O ' ' A' ' 35' ' ' LEU . . . -41.05 160.32 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.342 -0.849 . . . . 0.0 109.462 -179.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.467 HG22 ' HE1' ' A' ' 23' ' ' TYR . 0.7 OUTLIER -68.38 -59.94 2.81 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.074 -1.017 . . . . 0.0 110.377 -179.107 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -48.48 -31.55 6.54 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.074 -1.016 . . . . 0.0 110.086 -179.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -68.7 -47.01 67.51 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.192 -0.942 . . . . 0.0 108.767 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.538 ' CG ' ' HB2' ' A' ' 23' ' ' TYR . 17.6 tpp -60.04 -60.54 3.66 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.1 tppt? -47.79 -35.4 10.0 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.561 -0.712 . . . . 0.0 109.152 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.16 -43.07 92.97 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.34 -0.85 . . . . 0.0 109.383 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -63.11 -43.79 97.45 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.328 -0.857 . . . . 0.0 109.905 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.426 ' SG ' ' N ' ' A' ' 20' ' ' CYS . 19.0 m -64.57 -36.39 84.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.08 -1.012 . . . . 0.0 110.063 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 63.9 m -70.21 -29.82 66.75 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.95 -1.094 . . . . 0.0 108.976 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.448 ' NH1' ' HB2' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -73.43 -32.4 64.38 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.077 -1.014 . . . . 0.0 108.296 179.459 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -77.34 -30.99 54.18 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.368 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.039 HD11 HG12 ' A' ' 98' ' ' VAL . 8.4 tt -74.11 -38.08 63.93 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.221 -0.924 . . . . 0.0 109.089 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.447 ' O ' ' C ' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -71.17 -53.59 13.95 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.256 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.481 ' O ' ' HD3' ' A' ' 52' ' ' PRO . . . -46.54 -46.39 19.28 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 178.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 73.8 mt -67.61 106.97 1.44 Allowed Pre-proline 0 C--N 1.304 -1.387 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 176.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.529 ' O ' ' N ' ' A' ' 54' ' ' TYR . 24.5 Cg_endo -60.61 138.94 83.21 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 121.581 1.521 . . . . 0.0 111.097 -176.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.593 ' HA ' ' CG ' ' A' ' 56' ' ' ARG . . . -32.54 -33.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.198 0.523 . . . . 0.0 110.669 -178.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.529 ' N ' ' O ' ' A' ' 52' ' ' PRO . 2.0 m-85 -66.82 122.68 18.22 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.298 -0.876 . . . . 0.0 109.481 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 34.1 m 73.43 13.47 4.56 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.588 -0.695 . . . . 0.0 111.126 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.593 ' CG ' ' HA ' ' A' ' 53' ' ' ALA . 9.0 mmt85 -41.41 -87.28 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.606 -1.309 . . . . 0.0 109.362 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.521 ' C ' ' O ' ' A' ' 56' ' ' ARG . 6.5 m -24.9 -49.51 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.447 0 O-C-N 121.786 -0.571 . . . . 0.0 112.161 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.509 ' C ' ' O ' ' A' ' 57' ' ' CYS . 12.8 tt0 -25.73 -49.9 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.365 -0.834 . . . . 0.0 111.775 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.855 ' HB1' ' CD2' ' A' ' 17' ' ' LEU . . . -40.9 -60.41 1.19 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.135 -0.978 . . . . 0.0 110.013 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.981 ' CG2' HD13 ' A' ' 97' ' ' LEU . 39.8 t -52.31 -39.77 29.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 O-C-N 121.395 -0.816 . . . . 0.0 109.403 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.515 ' O ' ' HB2' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -62.01 -33.11 73.74 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.416 -0.803 . . . . 0.0 110.116 -179.677 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.771 HG23 ' HB ' ' A' ' 67' ' ' VAL . 48.5 mt -77.38 -28.47 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.926 -1.109 . . . . 0.0 110.09 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.667 HD21 HD23 ' A' ' 79' ' ' LEU . 2.3 tt -77.01 -46.72 22.83 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.779 -1.2 . . . . 0.0 109.61 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 10.2 tpt -77.19 -50.42 12.99 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.082 -1.011 . . . . 0.0 109.914 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.515 ' HB2' ' O ' ' A' ' 61' ' ' ARG . 19.9 m-20 -80.21 -21.47 42.89 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.97 -1.081 . . . . 0.0 110.076 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.429 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . 85.29 151.69 15.97 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.771 ' HB ' HG23 ' A' ' 62' ' ' ILE . 1.6 p -117.09 157.82 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.368 -1.077 . . . . 0.0 109.276 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.563 HG22 ' CD2' ' A' ' 74' ' ' HIS . 14.7 t -116.27 158.32 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.32 -0.863 . . . . 0.0 110.075 -178.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.467 ' N ' ' CG1' ' A' ' 68' ' ' VAL . 29.7 p -117.17 158.71 23.8 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.6 t -64.38 -32.98 74.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.515 -0.74 . . . . 0.0 109.791 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.2 p -64.75 -14.25 58.08 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.574 -0.704 . . . . 0.0 109.362 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 99.67 8.07 52.54 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -91.25 156.21 17.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.964 -1.315 . . . . 0.0 109.836 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.563 ' CD2' HG22 ' A' ' 68' ' ' VAL . 11.0 m170 -116.4 156.19 27.2 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.002 -1.061 . . . . 0.0 108.616 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 74' ' ' HIS . 5.2 mt-10 -142.83 -179.04 6.1 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.213 -0.93 . . . . 0.0 110.237 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 51.85 -143.11 19.87 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.438 ' HD2' ' O ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER 56.7 15.9 2.39 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.491 -1.005 . . . . 0.0 110.242 179.544 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 80' ' ' GLN . 2.4 mp -84.9 -11.04 56.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.956 -1.09 . . . . 0.0 110.244 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.788 HD21 ' HG2' ' A' ' 90' ' ' GLN . 1.1 tm? -43.03 96.22 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.008 -1.058 . . . . 0.0 109.046 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.518 ' N ' ' O ' ' A' ' 78' ' ' LEU . 83.7 mt-30 -143.53 179.39 7.15 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.198 -0.939 . . . . 0.0 110.501 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.84 112.05 4.06 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.818 0.818 . . . . 0.0 111.633 -178.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.675 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 23.2 mt -91.76 172.14 6.9 Favored Pre-proline 0 N--CA 1.488 1.463 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 177.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.675 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 28.4 Cg_endo -67.45 100.58 0.57 Allowed 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 121.1 1.2 . . . . 0.0 110.907 -179.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.475 ' O ' ' SG ' ' A' ' 29' ' ' CYS . . . 90.86 12.68 60.23 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.492 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 3.3 m -142.98 91.9 7.03 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 120.916 -1.343 . . . . 0.0 109.255 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.406 ' O ' ' C ' ' A' ' 87' ' ' ARG . 29.2 Cg_endo -73.39 159.53 46.47 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 121.272 1.315 . . . . 0.0 111.451 -179.016 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.406 ' C ' ' O ' ' A' ' 86' ' ' PRO . 6.3 mtm-85 -44.91 -27.87 0.59 Allowed 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 121.903 0.859 . . . . 0.0 108.889 178.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.95 -46.47 82.09 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.906 -0.496 . . . . 0.0 112.058 -177.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.48 HG11 ' HB ' ' A' ' 28' ' ' THR . 40.5 t -69.99 -41.66 79.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 120.689 -1.257 . . . . 0.0 110.929 -178.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.788 ' HG2' HD21 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -64.64 -30.11 71.13 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.048 -1.032 . . . . 0.0 108.807 -179.909 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.488 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 0.0 OUTLIER -78.17 -27.81 48.12 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.504 179.609 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.501 ' O ' ' HD2' ' A' ' 95' ' ' PRO . . . -73.17 -51.2 18.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.103 -0.998 . . . . 0.0 109.68 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.452 ' C ' ' HD2' ' A' ' 95' ' ' PRO . 40.9 t80 -77.78 -26.53 49.8 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.19 -0.944 . . . . 0.0 110.022 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.805 ' HB3' ' HD3' ' A' ' 95' ' ' PRO . . . -42.28 -51.96 10.38 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.383 -0.823 . . . . 0.0 111.593 -178.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.805 ' HD3' ' HB3' ' A' ' 94' ' ' ALA . 31.2 Cg_endo -72.06 80.63 1.52 Allowed 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.203 1.935 . . . . 0.0 111.628 -178.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.432 ' O ' ' HG3' ' A' ' 102' ' ' GLU . 0.0 OUTLIER 176.44 56.51 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.628 -0.67 . . . . 0.0 109.22 179.234 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.997 HD23 HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -96.27 -82.17 0.4 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.212 -0.93 . . . . 0.0 111.271 -179.075 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 1.039 HG12 HD11 ' A' ' 48' ' ' LEU . 3.6 m -81.91 28.77 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.735 -1.228 . . . . 0.0 111.197 -178.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.465 ' C ' ' HB3' ' A' ' 104' ' ' ASN . 5.3 p -97.53 170.88 8.73 Favored 'General case' 0 C--N 1.294 -1.834 0 O-C-N 120.644 -1.285 . . . . 0.0 108.449 179.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.79 -2.05 0.2 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.679 -1.263 . . . . 0.0 111.892 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.672 ' O ' HG12 ' A' ' 101' ' ' VAL . 57.4 t -100.86 6.4 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 119.844 -1.785 . . . . 0.0 110.73 -179.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.436 ' CB ' ' O ' ' A' ' 97' ' ' LEU . 0.3 OUTLIER -141.52 -91.17 0.14 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.684 -1.26 . . . . 0.0 110.386 -179.899 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.802 ' O ' HD12 ' A' ' 105' ' ' LEU . 3.6 m -142.89 38.58 1.46 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.951 -1.093 . . . . 0.0 108.861 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.493 ' O ' ' N ' ' A' ' 106' ' ' ALA . 8.3 p30 -34.87 -51.86 0.52 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.21 -0.931 . . . . 0.0 112.158 -178.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.802 HD12 ' O ' ' A' ' 103' ' ' CYS . 0.6 OUTLIER 40.55 26.94 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.953 -1.092 . . . . 0.0 109.825 -179.396 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' A' ' 104' ' ' ASN . . . 62.25 153.85 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.778 -1.202 . . . . 0.0 108.693 -178.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.4 p -128.56 -178.48 4.6 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.099 -1.001 . . . . 0.0 108.629 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.579 ' N ' ' HB1' ' A' ' 53' ' ' ALA . 7.1 tp -64.17 -33.1 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.921 -1.112 . . . . 0.0 108.83 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -62.68 -2.31 1.09 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.771 -0.581 . . . . 0.0 111.084 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 63.31 31.73 81.72 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -162.79 172.51 38.85 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.941 -1.263 . . . . 0.0 109.941 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.523 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 30.2 Cg_endo -76.87 69.46 6.91 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 123.049 2.499 . . . . 0.0 111.6 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.523 ' HB3' ' O ' ' A' ' 112' ' ' PRO . 34.9 p90 . . . . . 0 N--CA 1.497 1.904 0 O-C-N 121.397 -0.814 . . . . 0.0 110.481 178.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo . . . . . 0 N--CA 1.485 0.979 0 N-CA-C 111.203 -0.345 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 83.33 -5.69 76.02 Favored Glycine 0 N--CA 1.5 2.913 0 N-CA-C 110.696 -0.961 . . . . 0.0 110.696 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.562 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 1.6 mtp -136.81 112.24 9.25 Favored 'General case' 0 N--CA 1.501 2.121 0 CA-C-N 118.287 1.043 . . . . 0.0 108.292 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 86.39 -57.22 0.06 Allowed 'General case' 0 N--CA 1.514 2.752 0 CA-C-N 119.834 1.197 . . . . 0.0 108.171 -178.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.702 HD11 ' CB ' ' A' ' 55' ' ' CYS . 36.0 mt -106.86 100.36 31.12 Favored Pre-proline 0 N--CA 1.492 1.672 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 178.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -82.11 172.74 11.55 Favored 'Trans proline' 0 C--O 1.22 -0.388 0 C-N-CA 121.397 1.398 . . . . 0.0 111.593 -177.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 45.2 m-70 -72.44 145.19 47.79 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.412 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 4.4 t-20 65.04 64.14 1.07 Allowed Pre-proline 0 N--CA 1.505 2.285 0 O-C-N 121.521 -0.737 . . . . 0.0 109.506 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.722 ' HB2' ' HB1' ' A' ' 59' ' ' ALA . 38.2 Cg_endo -82.1 151.95 16.21 Favored 'Trans proline' 0 N--CA 1.482 0.845 0 C-N-CA 122.344 2.029 . . . . 0.0 112.047 -179.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.62 HD12 ' HB2' ' A' ' 16' ' ' PRO . 2.9 mp 46.88 35.0 2.92 Favored 'General case' 0 N--CA 1.502 2.166 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.177 177.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -66.52 -32.55 73.97 Favored 'General case' 0 N--CA 1.505 2.296 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.0 -32.32 73.98 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.476 ' O ' HG23 ' A' ' 24' ' ' VAL . 33.8 m -71.25 -33.83 70.19 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.419 ' CG ' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -60.98 -54.89 39.35 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.11 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.469 ' HA ' ' CE3' ' A' ' 22' ' ' TRP . 30.6 m95 -67.26 -27.0 66.84 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.55 -179.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.558 ' HE1' HG22 ' A' ' 37' ' ' THR . 14.5 t80 -68.4 -29.68 68.42 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.601 HG22 ' CD1' ' A' ' 93' ' ' PHE . 80.7 t -73.29 -42.61 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 177.018 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -53.24 -40.64 64.71 Favored 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 120.594 -0.442 . . . . 0.0 109.968 -179.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 31.1 m -77.19 -52.79 8.65 Favored 'General case' 0 N--CA 1.508 2.472 0 O-C-N 122.204 -0.31 . . . . 0.0 111.669 -178.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.587 ' NH1' HG21 ' A' ' 37' ' ' THR . 2.3 mmp_? -59.96 -25.06 64.9 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.859 -0.526 . . . . 0.0 110.678 -178.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 59.7 p -97.74 -65.83 0.94 Allowed 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -177.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.512 ' O ' HG23 ' A' ' 31' ' ' VAL . 57.4 m -100.88 16.04 26.5 Favored 'General case' 0 N--CA 1.51 2.546 0 O-C-N 121.298 -0.876 . . . . 0.0 111.924 -178.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 56.83 20.87 34.63 Favored Glycine 0 N--CA 1.505 3.263 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 29' ' ' CYS . 54.9 t -106.94 160.63 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 O-C-N 121.759 -0.847 . . . . 0.0 109.01 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.453 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 134.68 177.89 15.27 Favored Glycine 0 N--CA 1.499 2.851 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -66.46 172.74 8.68 Favored 'Trans proline' 0 N--CA 1.486 1.082 0 CA-C-N 119.098 1.449 . . . . 0.0 109.938 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 8.8 ttt-85 -93.27 86.33 5.29 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 122.027 0.918 . . . . 0.0 110.363 -178.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 76.4 mt -139.65 130.93 26.7 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.01 145.94 6.79 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.868 -0.52 . . . . 0.0 109.928 -178.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.587 HG21 ' NH1' ' A' ' 27' ' ' ARG . 0.8 OUTLIER -56.93 -57.87 10.62 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.705 -0.622 . . . . 0.0 111.217 -179.369 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -49.2 -36.98 21.24 Favored 'General case' 0 N--CA 1.509 2.506 0 O-C-N 121.676 -0.64 . . . . 0.0 111.246 -178.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -70.38 -38.22 74.67 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 122.042 -0.411 . . . . 0.0 110.087 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.403 ' CE ' ' HA ' ' A' ' 40' ' ' MET . 0.0 OUTLIER -64.61 -54.69 28.04 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 -179.64 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -52.71 -36.05 56.68 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.24 -43.78 97.07 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.61 -48.45 81.71 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 14.6 m -61.25 -34.0 74.43 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 122.04 -0.412 . . . . 0.0 111.338 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 17.9 m -73.8 -28.69 61.76 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 7.8 tpt85 -75.11 -34.31 61.7 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -79.08 -36.96 40.0 Favored 'General case' 0 N--CA 1.5 2.055 0 CA-C-O 121.184 0.516 . . . . 0.0 110.207 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.7 HD21 ' NH1' ' A' ' 56' ' ' ARG . 3.5 tt -70.32 -38.58 74.96 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.207 -178.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -77.72 -42.72 33.36 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.99 -37.43 63.99 Favored 'General case' 0 N--CA 1.507 2.397 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 178.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.421 ' O ' ' HD3' ' A' ' 56' ' ' ARG . 51.1 mt -86.46 105.65 8.27 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 177.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -62.87 141.59 85.2 Favored 'Trans proline' 0 N--CA 1.481 0.753 0 C-N-CA 121.517 1.478 . . . . 0.0 110.856 -177.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -43.27 -29.83 0.44 Allowed 'General case' 0 N--CA 1.503 2.189 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.286 -178.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.07 110.01 5.49 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.702 ' CB ' HD11 ' A' ' 12' ' ' ILE . 25.1 m 86.39 -15.36 0.47 Allowed 'General case' 0 N--CA 1.513 2.706 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -177.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.7 ' NH1' HD21 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -45.75 -81.94 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.357 0 O-C-N 121.737 -0.602 . . . . 0.0 110.865 -179.855 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 94.0 m -24.5 -42.88 0.01 OUTLIER 'General case' 0 N--CA 1.519 3.001 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -179.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -41.5 -57.08 2.34 Favored 'General case' 0 N--CA 1.511 2.588 0 CA-C-N 119.055 0.843 . . . . 0.0 111.429 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.722 ' HB1' ' HB2' ' A' ' 16' ' ' PRO . . . -39.43 -44.63 1.39 Allowed 'General case' 0 N--CA 1.514 2.748 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 38.7 t -58.92 -50.21 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.347 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.67 -25.05 66.07 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.917 HG23 ' HB ' ' A' ' 67' ' ' VAL . 43.1 mm -77.88 -29.13 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.906 -0.496 . . . . 0.0 109.938 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.1 tt -78.35 -41.12 34.36 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.449 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -78.08 -53.33 7.51 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.207 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -80.49 -23.56 40.06 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 122.065 -0.397 . . . . 0.0 111.591 -178.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.62 145.93 6.69 Favored Glycine 0 N--CA 1.503 3.15 0 N-CA-C 109.964 -1.255 . . . . 0.0 109.964 -179.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.917 ' HB ' HG23 ' A' ' 62' ' ' ILE . 7.2 p -118.7 159.5 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.492 0 O-C-N 122.151 -0.617 . . . . 0.0 110.209 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.704 HG22 ' NE2' ' A' ' 74' ' ' HIS . 65.7 t -115.49 157.35 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 32.0 p -117.77 159.63 22.71 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.359 -178.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.6 t -63.02 -33.91 76.43 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.076 -178.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.5 p -63.38 -18.78 64.05 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.988 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.45 13.91 34.16 Favored Glycine 0 N--CA 1.497 2.713 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -103.35 157.23 17.17 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 118.226 1.013 . . . . 0.0 109.225 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.704 ' NE2' HG22 ' A' ' 68' ' ' VAL . 8.9 m170 -115.01 155.36 27.11 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -179.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -140.32 -179.35 5.95 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 120.849 0.357 . . . . 0.0 110.122 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 51.54 -149.32 8.34 Favored Glycine 0 N--CA 1.497 2.752 0 N-CA-C 109.101 -1.6 . . . . 0.0 109.101 -179.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.8 ttp85 59.17 17.6 5.78 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 122.298 -0.531 . . . . 0.0 110.616 179.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 59.8 mt -78.34 -17.45 56.51 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.719 -0.613 . . . . 0.0 109.84 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.677 HD23 ' O ' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -51.93 98.56 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.024 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -140.1 172.56 12.58 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.106 0.479 . . . . 0.0 110.01 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -64.26 102.36 0.51 Allowed 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.672 0.749 . . . . 0.0 111.088 -179.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.647 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 23.7 mt -81.58 172.98 8.39 Favored Pre-proline 0 N--CA 1.495 1.799 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 177.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.647 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 26.3 Cg_endo -65.3 99.97 0.37 Allowed 'Trans proline' 0 N--CA 1.477 0.534 0 C-N-CA 120.971 1.114 . . . . 0.0 111.034 -179.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.68 -7.86 80.67 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 7.2 m -117.12 92.08 38.44 Favored Pre-proline 0 N--CA 1.502 2.142 0 CA-C-N 119.279 1.539 . . . . 0.0 110.3 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -71.39 164.05 37.03 Favored 'Trans proline' 0 N--CA 1.481 0.754 0 C-N-CA 121.36 1.373 . . . . 0.0 111.205 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.5 mmm-85 -48.24 -29.22 3.59 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.212 0.53 . . . . 0.0 109.571 178.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -55.69 -48.74 74.57 Favored 'General case' 0 N--CA 1.505 2.284 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.377 -178.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 80.2 t -62.55 -37.27 78.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.542 ' HB3' HD12 ' A' ' 79' ' ' LEU . 42.0 mm-40 -64.35 -30.11 71.16 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.95 -27.97 49.41 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -74.91 -46.73 33.95 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.967 -0.458 . . . . 0.0 109.874 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.601 ' CD1' HG22 ' A' ' 24' ' ' VAL . 29.3 t80 -78.17 -25.13 47.06 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 122.207 -0.308 . . . . 0.0 110.579 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.689 ' HB3' ' HD3' ' A' ' 95' ' ' PRO . . . -50.89 -52.87 53.46 Favored Pre-proline 0 N--CA 1.499 2.006 0 CA-C-O 118.842 -0.599 . . . . 0.0 111.938 -177.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.689 ' HD3' ' HB3' ' A' ' 94' ' ' ALA . 30.4 Cg_endo -71.19 -16.59 31.68 Favored 'Trans proline' 0 N--CA 1.484 0.966 0 C-N-CA 122.062 1.841 . . . . 0.0 111.159 -179.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.8 mmpt? -86.99 11.4 13.69 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.934 -0.479 . . . . 0.0 110.193 178.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.471 ' O ' ' HB3' ' A' ' 102' ' ' GLU . 0.2 OUTLIER -72.43 -60.47 2.22 Favored 'General case' 0 N--CA 1.508 2.447 0 O-C-N 121.668 -0.645 . . . . 0.0 111.33 -178.913 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.664 HG12 HD11 ' A' ' 48' ' ' LEU . 13.2 m -89.38 25.34 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 120.819 -1.176 . . . . 0.0 110.517 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 29.7 p -99.35 173.14 6.91 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.52 -0.54 0.27 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.534 -0.729 . . . . 0.0 112.07 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.535 ' O ' HG12 ' A' ' 101' ' ' VAL . 21.8 t -93.82 -0.52 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-N 120.537 1.517 . . . . 0.0 111.028 -179.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.471 ' HB3' ' O ' ' A' ' 97' ' ' LEU . 8.3 tt0 -146.95 -90.79 0.09 Allowed 'General case' 0 N--CA 1.505 2.277 0 C-N-CA 119.499 -0.88 . . . . 0.0 112.11 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.687 ' O ' HD22 ' A' ' 48' ' ' LEU . 83.8 m -137.0 45.57 2.24 Favored 'General case' 0 N--CA 1.511 2.609 0 CA-C-N 119.13 0.877 . . . . 0.0 110.609 -177.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 -43.6 -72.68 0.06 Allowed 'General case' 0 N--CA 1.508 2.469 0 O-C-N 120.924 -1.11 . . . . 0.0 112.96 -179.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.6 mp 51.25 34.48 11.54 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.966 -0.459 . . . . 0.0 110.628 -178.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 63.55 148.22 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.27 -0.894 . . . . 0.0 109.73 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.8 p -121.16 -164.41 1.12 Allowed 'General case' 0 N--CA 1.505 2.316 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -179.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.0 tt -68.26 -30.72 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.468 ' HB3' ' CE1' ' A' ' 113' ' ' PHE . 95.5 m-70 -71.48 0.66 7.87 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.644 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 60.9 36.54 92.27 Favored Glycine 0 N--CA 1.497 2.74 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -169.8 173.94 43.99 Favored Glycine 0 N--CA 1.498 2.823 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -77.88 78.53 3.53 Favored 'Trans proline' 0 N--CA 1.481 0.747 0 C-N-CA 122.65 2.234 . . . . 0.0 110.487 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.468 ' CE1' ' HB3' ' A' ' 109' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.504 2.27 0 CA-C-O 121.34 0.59 . . . . 0.0 111.399 179.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo . . . . . 0 CA--C 1.543 0.932 0 N-CA-C 110.734 -0.525 . . . . 0.0 110.734 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 69.78 6.11 54.34 Favored Glycine 0 N--CA 1.502 3.066 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.57 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 0.1 OUTLIER -140.52 107.21 5.35 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.788 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.57 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 87.04 -58.69 0.04 OUTLIER 'General case' 0 N--CA 1.516 2.829 0 CA-C-N 119.865 1.211 . . . . 0.0 108.399 -178.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.659 HD11 ' HB2' ' A' ' 55' ' ' CYS . 41.1 mt -103.57 101.38 23.48 Favored Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 178.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -81.82 172.45 12.14 Favored 'Trans proline' 0 N--CA 1.477 0.549 0 C-N-CA 121.701 1.601 . . . . 0.0 111.97 -176.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 30.6 m-70 -74.68 145.4 43.2 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.401 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 10.4 t-20 68.14 64.48 0.63 Allowed Pre-proline 0 N--CA 1.508 2.45 0 O-C-N 121.404 -0.81 . . . . 0.0 110.593 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.401 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 41.0 Cg_endo -84.34 171.42 10.06 Favored 'Trans proline' 0 N--CA 1.484 0.959 0 C-N-CA 122.51 2.14 . . . . 0.0 111.908 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 66.1 mt 43.43 46.29 5.64 Favored 'General case' 0 N--CA 1.503 2.223 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.435 177.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -73.47 -41.1 63.59 Favored 'General case' 0 N--CA 1.505 2.28 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.2 t -63.42 -25.74 68.42 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.717 ' O ' HG23 ' A' ' 24' ' ' VAL . 32.5 m -77.73 -35.38 51.98 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 110.251 -0.278 . . . . 0.0 110.251 -179.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 11.2 ttp180 -69.92 -42.96 72.63 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.418 ' HA ' ' CE3' ' A' ' 22' ' ' TRP . 31.1 m95 -73.38 -30.97 63.64 Favored 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 118.762 -1.175 . . . . 0.0 108.99 178.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.753 ' HE1' HG23 ' A' ' 37' ' ' THR . 8.2 t80 -63.96 -33.85 76.66 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.717 HG23 ' O ' ' A' ' 20' ' ' CYS . 43.6 t -70.51 -38.86 75.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 177.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.1 m -55.18 -39.18 69.27 Favored 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.887 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.9 m -77.49 -54.48 6.38 Favored 'General case' 0 N--CA 1.511 2.607 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -178.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -60.83 -24.72 66.09 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.508 -0.745 . . . . 0.0 110.6 -178.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.414 HG23 ' O ' ' A' ' 24' ' ' VAL . 44.2 p -95.93 -63.21 1.17 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 122.003 -0.435 . . . . 0.0 112.153 -177.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.683 ' O ' HG23 ' A' ' 31' ' ' VAL . 3.7 m -100.23 12.11 37.82 Favored 'General case' 0 N--CA 1.509 2.507 0 O-C-N 121.249 -0.907 . . . . 0.0 111.484 -178.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 57.26 24.13 50.35 Favored Glycine 0 N--CA 1.507 3.395 0 N-CA-C 109.434 -1.467 . . . . 0.0 109.434 -178.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 29' ' ' CYS . 27.7 t -116.48 164.83 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 O-C-N 122.053 -0.675 . . . . 0.0 109.469 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.495 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 132.09 -177.32 18.79 Favored Glycine 0 N--CA 1.499 2.871 0 N-CA-C 108.675 -1.77 . . . . 0.0 108.675 -178.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -64.01 172.22 6.4 Favored 'Trans proline' 0 N--CA 1.483 0.888 0 CA-C-N 119.485 1.643 . . . . 0.0 109.808 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -92.99 84.64 4.93 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.918 0.866 . . . . 0.0 110.518 -177.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.0 tp -140.26 132.9 28.84 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.88 159.38 0.41 Allowed 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.937 -0.477 . . . . 0.0 109.994 -179.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.753 HG23 ' HE1' ' A' ' 23' ' ' TYR . 34.5 m -74.21 -27.89 61.01 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.934 -0.479 . . . . 0.0 111.255 -178.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -74.17 -38.32 63.72 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.869 -0.519 . . . . 0.0 110.524 -178.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -72.8 -30.65 64.25 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.469 ' HA ' ' HE3' ' A' ' 40' ' ' MET . 0.5 OUTLIER -70.86 -56.09 7.04 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.665 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.74 -33.65 70.49 Favored 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.88 -34.14 74.95 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.885 -0.784 . . . . 0.0 108.885 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -66.32 -48.93 68.71 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 16.4 m -62.4 -37.71 86.82 Favored 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.332 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 89.5 m -73.88 -28.25 61.47 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -178.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -72.76 -32.27 65.52 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -77.79 -37.02 49.77 Favored 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 120.571 -0.451 . . . . 0.0 109.799 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.56 HD11 HG12 ' A' ' 98' ' ' VAL . 2.1 tt -68.65 -36.64 78.86 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -77.09 -41.64 41.35 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.74 -35.11 68.22 Favored 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.563 HG22 ' HG2' ' A' ' 56' ' ' ARG . 58.2 mt -87.0 104.73 6.51 Favored Pre-proline 0 N--CA 1.489 1.5 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 177.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -59.15 145.37 97.94 Favored 'Trans proline' 0 N--CA 1.477 0.557 0 C-N-CA 121.383 1.389 . . . . 0.0 110.305 -177.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -36.49 -32.69 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.444 0 C-N-CA 122.767 0.427 . . . . 0.0 112.049 -178.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -71.04 123.36 21.92 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.659 ' HB2' HD11 ' A' ' 12' ' ' ILE . 23.3 m 77.23 -1.04 2.82 Favored 'General case' 0 N--CA 1.509 2.497 0 C-N-CA 122.266 0.226 . . . . 0.0 110.739 -179.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.563 ' HG2' HG22 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -57.84 -91.56 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.438 -0.789 . . . . 0.0 109.762 -179.918 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 64.6 m -27.51 -42.36 0.02 OUTLIER 'General case' 0 N--CA 1.523 3.178 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -40.02 -54.24 2.26 Favored 'General case' 0 N--CA 1.513 2.703 0 CA-C-N 119.493 1.042 . . . . 0.0 111.801 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -40.4 -46.58 2.42 Favored 'General case' 0 N--CA 1.511 2.581 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 39.4 t -56.56 -49.94 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -59.32 -26.47 65.04 Favored 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.942 HG23 ' HB ' ' A' ' 67' ' ' VAL . 42.4 mm -78.42 -29.84 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 O-C-N 121.926 -0.484 . . . . 0.0 110.341 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.468 HD23 HD13 ' A' ' 79' ' ' LEU . 0.7 OUTLIER -79.0 -38.64 36.16 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.848 -0.741 . . . . 0.0 109.9 -179.48 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 2.6 ttm -78.63 -52.78 7.95 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.028 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -80.7 -24.03 39.12 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 122.007 -0.433 . . . . 0.0 111.051 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.41 144.58 5.07 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 108.839 -1.704 . . . . 0.0 108.839 -179.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.942 ' HB ' HG23 ' A' ' 62' ' ' ILE . 7.1 p -117.66 159.35 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 122.254 -0.556 . . . . 0.0 109.594 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.526 HG22 ' CD2' ' A' ' 74' ' ' HIS . 51.0 t -114.33 157.23 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.3 p -116.99 159.57 22.29 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.99 -177.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 48.3 t -62.78 -30.47 71.48 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.326 -178.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.8 p -70.1 -16.9 63.19 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.447 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.59 11.46 41.04 Favored Glycine 0 N--CA 1.498 2.8 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -98.64 157.78 16.04 Favored 'General case' 0 N--CA 1.501 2.113 0 CA-C-N 118.103 0.951 . . . . 0.0 109.227 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.526 ' CD2' HG22 ' A' ' 68' ' ' VAL . 10.8 m170 -114.93 155.68 26.44 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -140.29 -178.02 5.29 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.11 0.481 . . . . 0.0 110.194 -179.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 51.79 -144.08 17.56 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.814 -1.315 . . . . 0.0 109.814 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 55.32 22.4 4.82 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 122.394 -0.474 . . . . 0.0 110.071 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.6 mt -86.27 -13.83 45.56 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.719 -0.613 . . . . 0.0 110.93 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.468 HD13 HD23 ' A' ' 63' ' ' LEU . 1.4 tp -61.23 93.24 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -142.9 -177.44 5.33 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.545 0.688 . . . . 0.0 110.216 -178.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -54.3 138.59 38.76 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.842 0.83 . . . . 0.0 111.353 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.528 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 21.3 mt -130.61 168.26 17.74 Favored Pre-proline 0 N--CA 1.497 1.916 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 178.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.528 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 29.4 Cg_endo -68.74 99.75 0.66 Allowed 'Trans proline' 0 N--CA 1.478 0.564 0 C-N-CA 121.044 1.163 . . . . 0.0 110.386 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.8 9.91 63.65 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.466 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 3.4 m -141.95 90.88 8.3 Favored Pre-proline 0 N--CA 1.509 2.515 0 CA-C-N 118.761 1.28 . . . . 0.0 109.756 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -74.25 164.88 33.19 Favored 'Trans proline' 0 N--CA 1.487 1.097 0 C-N-CA 121.885 1.724 . . . . 0.0 111.475 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -48.94 -28.06 3.58 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.063 0.459 . . . . 0.0 110.087 178.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -60.31 -47.49 85.81 Favored 'General case' 0 N--CA 1.502 2.164 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -177.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 44.6 t -69.58 -40.94 80.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.775 -0.578 . . . . 0.0 111.518 -177.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.751 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 0.4 OUTLIER -73.3 -25.44 60.66 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.784 -179.549 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.7 tpt180 -78.93 -34.36 44.62 Favored 'General case' 0 N--CA 1.503 2.197 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.231 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.39 -43.69 31.83 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.869 -0.519 . . . . 0.0 110.003 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.548 ' CE1' HG22 ' A' ' 24' ' ' VAL . 28.4 t80 -78.53 -25.91 45.63 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 122.274 -0.267 . . . . 0.0 110.415 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.751 ' HB2' ' O ' ' A' ' 90' ' ' GLN . . . -43.41 -51.53 14.78 Favored Pre-proline 0 N--CA 1.502 2.164 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -178.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.66 ' HD3' ' HB3' ' A' ' 94' ' ' ALA . 29.2 Cg_endo -70.6 -170.24 0.43 Allowed 'Trans proline' 0 N--CA 1.481 0.784 0 C-N-CA 121.73 1.62 . . . . 0.0 111.058 -179.01 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 61.34 20.36 11.02 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 -178.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.71 -60.96 2.01 Favored 'General case' 0 N--CA 1.508 2.434 0 O-C-N 121.969 -0.457 . . . . 0.0 112.232 -178.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.56 HG12 HD11 ' A' ' 48' ' ' LEU . 19.8 m -82.94 35.06 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 O-C-N 121.112 -0.993 . . . . 0.0 111.921 -178.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.411 ' C ' ' HB2' ' A' ' 104' ' ' ASN . 24.6 p -109.1 174.99 5.62 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 178.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -59.66 -2.46 0.36 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.467 -0.771 . . . . 0.0 111.926 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.564 ' O ' HG12 ' A' ' 101' ' ' VAL . 21.9 t -95.61 1.5 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 CA-C-N 120.479 1.49 . . . . 0.0 111.321 -179.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -148.02 -91.96 0.08 Allowed 'General case' 0 N--CA 1.504 2.252 0 CA-C-N 119.011 0.823 . . . . 0.0 111.771 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 7.3 m -132.89 49.35 2.32 Favored 'General case' 0 N--CA 1.509 2.503 0 O-C-N 121.365 -0.834 . . . . 0.0 110.1 -178.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.411 ' HB2' ' C ' ' A' ' 99' ' ' THR . 38.2 t30 -42.23 -82.29 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.559 0 O-C-N 120.779 -1.201 . . . . 0.0 112.533 -179.014 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.5 ' O ' ' HB3' ' A' ' 106' ' ' ALA . 8.1 mt 51.58 24.64 2.39 Favored 'General case' 0 N--CA 1.506 2.343 0 O-C-N 121.836 -0.54 . . . . 0.0 111.922 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' A' ' 105' ' ' LEU . . . 71.07 152.27 0.11 Allowed 'General case' 0 N--CA 1.513 2.722 0 O-C-N 121.001 -1.062 . . . . 0.0 110.669 178.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.485 HG21 ' O ' ' A' ' 113' ' ' PHE . 3.9 p -127.85 -163.84 1.31 Allowed 'General case' 0 N--CA 1.51 2.536 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.418 ' CG2' ' CD2' ' A' ' 109' ' ' HIS . 10.9 tt -67.3 -37.28 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.244 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.033 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.418 ' CD2' ' CG2' ' A' ' 108' ' ' ILE . 68.3 m-70 -67.43 -2.03 5.72 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.784 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 58.57 28.6 62.74 Favored Glycine 0 N--CA 1.498 2.778 0 N-CA-C 108.744 -1.742 . . . . 0.0 108.744 -178.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -141.19 178.64 20.1 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -179.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.426 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 32.7 Cg_endo -87.87 55.36 2.63 Favored 'Trans proline' 0 N--CA 1.481 0.772 0 C-N-CA 123.358 2.705 . . . . 0.0 110.655 -179.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.485 ' O ' HG21 ' A' ' 107' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.498 1.966 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -178.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo . . . . . 0 N--CA 1.479 0.651 0 N-CA-C 110.262 -0.707 . . . . 0.0 110.262 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 71.38 4.71 57.68 Favored Glycine 0 N--CA 1.502 3.076 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.574 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 2.0 mpt? -139.91 99.85 3.79 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 118.153 0.977 . . . . 0.0 108.59 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.574 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 86.87 -57.46 0.05 OUTLIER 'General case' 0 N--CA 1.516 2.836 0 CA-C-N 119.392 0.997 . . . . 0.0 108.504 -178.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.442 ' HA ' HD12 ' A' ' 51' ' ' ILE . 17.5 mt -100.1 102.66 18.7 Favored Pre-proline 0 N--CA 1.499 1.992 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 178.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -79.76 176.37 9.56 Favored 'Trans proline' 0 C--O 1.22 -0.402 0 C-N-CA 121.458 1.439 . . . . 0.0 111.034 -177.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 41.0 m-70 -86.0 142.61 28.65 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 120.721 0.296 . . . . 0.0 111.017 -177.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.584 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 9.2 t-20 70.46 48.12 0.3 Allowed Pre-proline 0 N--CA 1.508 2.451 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 178.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.584 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 42.7 Cg_endo -86.65 175.51 5.21 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 121.79 1.66 . . . . 0.0 111.345 178.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 49.36 45.18 23.81 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 177.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -77.57 -43.16 32.71 Favored 'General case' 0 N--CA 1.509 2.482 0 O-C-N 121.219 -0.925 . . . . 0.0 108.954 178.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.94 -24.77 66.3 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 57.1 m -74.21 -34.25 63.66 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -179.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.96 -43.57 67.85 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.213 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 32.7 m95 -71.53 -26.5 62.67 Favored 'General case' 0 N--CA 1.504 2.263 0 C-N-CA 118.771 -1.172 . . . . 0.0 109.426 178.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.547 ' HB2' ' HG2' ' A' ' 40' ' ' MET . 10.9 t80 -70.24 -35.36 73.77 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.522 ' O ' HG23 ' A' ' 28' ' ' THR . 64.7 t -70.12 -38.59 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 177.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 m -57.42 -38.57 74.56 Favored 'General case' 0 N--CA 1.502 2.147 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.149 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 99.8 m -77.05 -51.75 10.53 Favored 'General case' 0 N--CA 1.511 2.578 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.2 tpt180 -62.99 -24.72 68.05 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.425 -0.797 . . . . 0.0 110.335 -178.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.522 HG23 ' O ' ' A' ' 24' ' ' VAL . 56.3 p -92.75 -66.58 0.91 Allowed 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -177.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.7 m -100.87 11.49 39.48 Favored 'General case' 0 N--CA 1.511 2.606 0 CA-C-N 119.452 1.024 . . . . 0.0 111.467 -179.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 60.49 25.58 63.25 Favored Glycine 0 N--CA 1.503 3.16 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -178.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.504 HG12 ' N ' ' A' ' 32' ' ' GLY . 47.8 t -108.32 163.73 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.317 0 O-C-N 121.911 -0.758 . . . . 0.0 109.437 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.504 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 126.04 -179.31 16.32 Favored Glycine 0 N--CA 1.499 2.849 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 -179.063 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -64.84 171.61 8.34 Favored 'Trans proline' 0 N--CA 1.486 1.033 0 CA-C-N 119.266 1.533 . . . . 0.0 109.911 179.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.759 ' O ' HD22 ' A' ' 35' ' ' LEU . 10.3 mmt-85 -93.23 84.36 4.78 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.917 0.865 . . . . 0.0 109.992 -178.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.759 HD22 ' O ' ' A' ' 34' ' ' ARG . 2.4 mm? -131.98 143.89 50.41 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.568 ' HB3' ' HG3' ' A' ' 39' ' ' GLU . . . -64.76 142.2 58.51 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -49.98 -58.7 4.93 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.506 -0.746 . . . . 0.0 111.004 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -46.82 -40.59 14.04 Favored 'General case' 0 N--CA 1.508 2.462 0 O-C-N 121.892 -0.505 . . . . 0.0 111.482 -178.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.568 ' HG3' ' HB3' ' A' ' 36' ' ' ALA . 13.5 mt-10 -62.78 -46.97 85.52 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.547 ' HG2' ' HB2' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -59.41 -57.69 11.89 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -179.585 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 39.8 tttt -51.82 -29.94 21.39 Favored 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 39' ' ' GLU . . . -65.94 -46.29 78.74 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.9 mmt-85 -58.06 -60.42 3.77 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 16.5 m -54.29 -32.82 57.27 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -178.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 21.5 m -75.43 -30.55 60.07 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -178.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.32 -34.11 70.27 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -79.05 -31.15 44.43 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.122 0.487 . . . . 0.0 109.817 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.475 ' HA ' HD22 ' A' ' 48' ' ' LEU . 1.2 tm? -67.76 -44.71 76.85 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -178.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -78.12 -28.12 48.43 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.81 -44.28 77.69 Favored 'General case' 0 N--CA 1.504 2.258 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.442 HD12 ' HA ' ' A' ' 12' ' ' ILE . 39.5 mm -79.83 106.19 4.52 Favored Pre-proline 0 N--CA 1.49 1.568 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 176.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -54.51 144.62 62.0 Favored 'Trans proline' 0 N--CA 1.481 0.766 0 C-N-CA 121.564 1.51 . . . . 0.0 111.572 -175.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.455 ' HA ' ' CG ' ' A' ' 56' ' ' ARG . . . -32.63 -32.42 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.342 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -177.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -63.19 125.27 23.53 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 14.1 m 77.56 17.15 1.47 Allowed 'General case' 0 N--CA 1.514 2.772 0 CA-C-O 119.358 -0.353 . . . . 0.0 111.898 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.455 ' CG ' ' HA ' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -48.68 -89.06 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.862 0 CA-C-N 119.851 1.205 . . . . 0.0 110.175 179.688 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 82.8 m -37.2 -44.2 0.56 Allowed 'General case' 0 N--CA 1.518 2.928 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -42.58 -51.02 5.3 Favored 'General case' 0 N--CA 1.512 2.642 0 CA-C-N 119.931 1.242 . . . . 0.0 111.735 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.616 ' HA ' HD12 ' A' ' 62' ' ' ILE . . . -41.88 -45.48 3.71 Favored 'General case' 0 N--CA 1.513 2.71 0 O-C-N 121.701 -0.625 . . . . 0.0 112.007 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.711 HG22 HD13 ' A' ' 97' ' ' LEU . 20.4 t -55.34 -48.58 76.63 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 10.1 ttp180 -58.81 -29.42 66.84 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.826 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.766 HG23 ' HB ' ' A' ' 67' ' ' VAL . 11.2 mt -77.57 -27.32 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.286 0 O-C-N 121.899 -0.501 . . . . 0.0 109.955 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.4 tp -77.63 -43.95 29.81 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 120.073 -0.651 . . . . 0.0 110.082 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.54 -50.42 11.61 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.284 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -81.09 -23.31 38.54 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.965 -0.459 . . . . 0.0 111.48 -179.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.87 149.31 8.24 Favored Glycine 0 N--CA 1.499 2.838 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -178.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.766 ' HB ' HG23 ' A' ' 62' ' ' ILE . 5.8 p -117.93 159.37 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.63 HG22 ' CE1' ' A' ' 74' ' ' HIS . 79.1 t -114.7 158.07 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-O 121.756 0.789 . . . . 0.0 109.389 -178.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.655 HG23 ' OE2' ' A' ' 75' ' ' GLU . 27.0 p -117.0 158.61 23.83 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 115.339 -0.846 . . . . 0.0 108.96 -178.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.7 t -64.26 -33.14 75.13 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.883 -178.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.6 p -62.91 -17.6 61.94 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.935 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.58 13.5 34.96 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -103.85 156.9 17.46 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-N 118.198 0.999 . . . . 0.0 109.524 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.63 ' CE1' HG22 ' A' ' 68' ' ' VAL . 9.3 m170 -115.44 155.86 26.67 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.655 ' OE2' HG23 ' A' ' 69' ' ' THR . 3.3 mp0 -142.79 -177.49 5.34 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 120.236 -0.586 . . . . 0.0 110.612 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.413 ' O ' ' CG ' ' A' ' 77' ' ' ARG . . . 59.95 -132.42 50.86 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 108.374 -1.89 . . . . 0.0 108.374 -178.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.413 ' CG ' ' O ' ' A' ' 76' ' ' GLY . 2.1 ptm180 44.18 28.61 0.29 Allowed 'General case' 0 N--CA 1.507 2.383 0 CA-C-O 120.978 0.418 . . . . 0.0 110.189 179.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.7 mt -72.81 -19.45 61.33 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 122.037 -0.415 . . . . 0.0 110.58 -178.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.644 HD13 ' CB ' ' A' ' 90' ' ' GLN . 2.5 tp -49.21 105.27 0.08 Allowed 'General case' 0 N--CA 1.503 2.183 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -139.95 170.51 15.74 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.371 0.605 . . . . 0.0 109.89 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -80.45 105.49 11.74 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 121.379 0.609 . . . . 0.0 110.342 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.598 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 15.5 mt -86.7 171.87 9.34 Favored Pre-proline 0 N--CA 1.5 2.03 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 177.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.598 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 28.9 Cg_endo -68.73 103.28 0.97 Allowed 'Trans proline' 0 C--N 1.328 -0.5 0 C-N-CA 120.865 1.043 . . . . 0.0 109.878 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.36 11.76 60.63 Favored Glycine 0 N--CA 1.498 2.813 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 3.5 m -143.07 90.37 7.46 Favored Pre-proline 0 N--CA 1.507 2.376 0 CA-C-N 118.705 1.252 . . . . 0.0 108.563 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -74.38 159.93 42.66 Favored 'Trans proline' 0 C--N 1.325 -0.673 0 C-N-CA 121.16 1.24 . . . . 0.0 111.0 -178.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.564 ' HA ' HD11 ' A' ' 79' ' ' LEU . 32.0 mtp180 -49.23 -28.64 4.79 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.389 0.614 . . . . 0.0 109.738 178.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -56.15 -49.0 75.21 Favored 'General case' 0 N--CA 1.503 2.176 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.971 -178.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.5 t -65.14 -39.43 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.667 -0.646 . . . . 0.0 109.667 -178.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.71 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 23.4 mm-40 -64.26 -29.4 70.49 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.429 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 1.7 tpt180 -78.46 -26.78 46.22 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.9 -50.14 25.5 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.869 -0.519 . . . . 0.0 109.656 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -78.88 -26.04 43.92 Favored 'General case' 0 N--CA 1.508 2.456 0 O-C-N 122.057 -0.402 . . . . 0.0 111.042 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.71 ' HB2' ' O ' ' A' ' 90' ' ' GLN . . . -48.74 -47.43 72.12 Favored Pre-proline 0 N--CA 1.505 2.278 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -177.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.519 ' HD3' ' HB3' ' A' ' 94' ' ' ALA . 33.0 Cg_endo -73.77 25.46 0.33 Allowed 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 122.371 2.047 . . . . 0.0 114.258 -178.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.501 ' HE3' HG21 ' A' ' 101' ' ' VAL . 5.1 mttp -135.61 37.81 2.88 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.711 HD13 HG22 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -74.58 -75.27 0.17 Allowed 'General case' 0 N--CA 1.503 2.208 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.992 -178.978 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 8.7 m -76.0 10.11 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 O-C-N 121.067 -1.021 . . . . 0.0 111.637 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 11.9 p -87.04 176.6 7.54 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -65.09 5.35 0.36 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.452 -0.78 . . . . 0.0 111.873 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.501 HG21 ' HE3' ' A' ' 96' ' ' LYS . 56.3 t -96.23 -5.24 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 CA-C-N 120.265 1.393 . . . . 0.0 111.009 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.509 ' HB3' ' O ' ' A' ' 97' ' ' LEU . 4.1 tp10 -142.07 -85.46 0.17 Allowed 'General case' 0 N--CA 1.513 2.71 0 C-N-CA 118.626 -1.23 . . . . 0.0 112.869 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 20.8 m -136.57 40.56 2.59 Favored 'General case' 0 N--CA 1.507 2.387 0 CA-C-N 119.601 1.091 . . . . 0.0 110.616 -177.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.408 ' O ' ' CB ' ' A' ' 105' ' ' LEU . 25.6 t30 -44.95 -95.76 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.385 -0.822 . . . . 0.0 111.946 -179.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.512 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 1.4 mt 87.19 -58.41 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.462 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -177.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.713 ' HB1' ' HA2' ' A' ' 110' ' ' GLY . . . 160.95 127.68 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.503 ' OG1' ' CE1' ' A' ' 109' ' ' HIS . 2.3 p -91.59 -146.62 0.21 Allowed 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -178.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.503 HG23 ' N ' ' A' ' 109' ' ' HIS . 6.5 tp -57.41 -39.34 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.825 -0.547 . . . . 0.0 111.059 178.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.51 ' CE1' ' O ' ' A' ' 113' ' ' PHE . 2.2 p80 -90.78 21.93 3.84 Favored 'General case' 0 N--CA 1.515 2.786 0 O-C-N 122.047 -0.408 . . . . 0.0 111.255 -177.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.713 ' HA2' ' HB1' ' A' ' 106' ' ' ALA . . . 53.18 64.89 3.77 Favored Glycine 0 N--CA 1.497 2.733 0 O-C-N 121.598 -0.688 . . . . 0.0 111.609 177.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 159.49 172.97 27.35 Favored Glycine 0 N--CA 1.498 2.822 0 CA-C-N 118.419 1.11 . . . . 0.0 111.096 178.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.476 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 36.2 Cg_endo -85.17 80.38 2.09 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.059 2.506 . . . . 0.0 111.642 -178.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.51 ' O ' ' CE1' ' A' ' 109' ' ' HIS . 8.3 p90 . . . . . 0 N--CA 1.535 3.783 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo . . . . . 0 C--O 1.215 -0.661 0 N-CA-C 110.707 -0.536 . . . . 0.0 110.707 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.72 10.2 36.62 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.744 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 0.3 OUTLIER -137.01 104.55 5.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.338 -1.095 . . . . 0.0 108.768 179.803 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.744 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 86.01 -59.68 0.06 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.749 -1.219 . . . . 0.0 108.181 -178.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 5.6 mt -102.2 101.6 20.13 Favored Pre-proline 0 C--N 1.303 -1.42 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 11' ' ' ALA . 34.3 Cg_endo -82.11 173.39 10.97 Favored 'Trans proline' 0 C--N 1.319 -0.981 0 C-N-CA 121.602 1.534 . . . . 0.0 111.945 -176.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 51.3 m-70 -74.85 149.38 39.59 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -179.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.677 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 6.4 t30 55.3 50.94 6.47 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 120.831 -1.168 . . . . 0.0 110.039 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.677 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 37.7 Cg_endo -78.99 -174.64 2.37 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 122.478 2.119 . . . . 0.0 111.122 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.611 HD21 ' HB1' ' A' ' 59' ' ' ALA . 4.3 mm? 47.12 41.79 12.02 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.716 -0.615 . . . . 0.0 111.046 178.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.444 ' CG ' ' N ' ' A' ' 19' ' ' SER . 1.9 p30 -81.91 -47.21 13.03 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.034 -1.041 . . . . 0.0 109.128 179.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.454 ' OG ' ' HD3' ' A' ' 43' ' ' ARG . 0.2 OUTLIER -60.74 -26.46 67.21 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.276 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.459 ' SG ' ' CD1' ' A' ' 17' ' ' LEU . 75.4 m -74.77 -34.73 62.52 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.526 ' HG3' ' N ' ' A' ' 22' ' ' TRP . 0.1 OUTLIER -66.95 -49.94 63.89 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.399 -0.813 . . . . 0.0 108.877 179.503 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.536 ' HB2' ' CE ' ' A' ' 40' ' ' MET . 31.6 m95 -71.44 -27.51 63.33 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.86 -1.15 . . . . 0.0 109.456 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.529 ' HB2' ' CG ' ' A' ' 40' ' ' MET . 26.4 t80 -67.03 -34.61 78.09 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.248 -0.907 . . . . 0.0 109.227 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.574 HG22 ' CD1' ' A' ' 93' ' ' PHE . 78.3 t -74.86 -40.15 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 118.59 -1.244 . . . . 0.0 108.087 178.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.467 ' OG ' ' O ' ' A' ' 22' ' ' TRP . 61.1 p -55.44 -37.66 67.99 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.114 -1.035 . . . . 0.0 109.262 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.44 ' O ' ' HA2' ' A' ' 30' ' ' GLY . 3.5 m -78.31 -55.09 5.52 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.337 -0.852 . . . . 0.0 111.476 -178.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 8.3 mmm180 -58.47 -25.1 61.91 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.792 -1.192 . . . . 0.0 110.388 -178.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.43 ' HB ' HG11 ' A' ' 89' ' ' VAL . 69.5 p -95.61 -64.44 1.06 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.175 -0.953 . . . . 0.0 111.57 -177.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.473 ' SG ' ' O ' ' A' ' 84' ' ' GLY . 3.4 m -98.89 16.15 23.3 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.816 -1.178 . . . . 0.0 109.806 -178.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' A' ' 26' ' ' THR . . . 51.78 21.94 7.97 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 -179.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.557 HG12 ' N ' ' A' ' 32' ' ' GLY . 40.7 t -102.47 165.63 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.386 -1.067 . . . . 0.0 109.335 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.557 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 129.69 176.87 14.6 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.438 -1.865 . . . . 0.0 108.438 -179.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -65.3 173.5 6.2 Favored 'Trans proline' 0 C--O 1.214 -0.693 0 CA-C-N 119.143 1.472 . . . . 0.0 109.897 179.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -92.26 82.87 4.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.872 -1.143 . . . . 0.0 110.3 -178.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.474 HD12 ' HA ' ' A' ' 35' ' ' LEU . 9.1 tp -137.29 135.5 37.19 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 35' ' ' LEU . . . -46.55 155.4 0.24 Allowed 'General case' 0 N--CA 1.487 1.375 0 O-C-N 120.923 -1.111 . . . . 0.0 109.051 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.431 ' O ' ' C ' ' A' ' 38' ' ' GLN . 0.6 OUTLIER -74.34 -55.27 6.2 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.042 -1.036 . . . . 0.0 110.002 -179.562 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.431 ' C ' ' O ' ' A' ' 37' ' ' THR . 2.2 mp0 -43.31 -34.6 1.25 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.228 -0.92 . . . . 0.0 109.691 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.607 ' O ' ' HB3' ' A' ' 42' ' ' ALA . 10.1 mm-40 -64.87 -52.1 58.41 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.109 -0.994 . . . . 0.0 108.593 179.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.536 ' CE ' ' HB2' ' A' ' 22' ' ' TRP . 0.4 OUTLIER -54.43 -60.78 2.89 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.232 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.435 ' C ' ' O ' ' A' ' 40' ' ' MET . 20.9 ttpt -44.3 -35.34 2.29 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.607 ' HB3' ' O ' ' A' ' 39' ' ' GLU . . . -63.2 -48.93 76.23 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.486 -0.759 . . . . 0.0 109.029 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.454 ' HD3' ' OG ' ' A' ' 19' ' ' SER . 7.7 mtt-85 -55.1 -52.39 63.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.373 -0.83 . . . . 0.0 109.539 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 20.9 m -55.89 -35.77 66.91 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 0.0 109.904 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 81.7 m -68.97 -28.62 66.78 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.038 -1.039 . . . . 0.0 109.148 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.72 -31.34 64.91 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.404 ' O ' HG13 ' A' ' 51' ' ' ILE . 3.4 mm-40 -76.79 -36.41 57.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.465 -0.772 . . . . 0.0 109.506 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.844 HD11 HG12 ' A' ' 98' ' ' VAL . 7.4 tt -72.21 -36.63 69.22 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.265 -0.897 . . . . 0.0 109.299 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.458 ' O ' ' C ' ' A' ' 50' ' ' ALA . 1.2 tt0 -71.64 -55.73 7.19 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.485 ' O ' ' HD3' ' A' ' 52' ' ' PRO . . . -45.92 -47.92 16.29 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 178.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.404 HG13 ' O ' ' A' ' 47' ' ' GLN . 88.9 mt -62.12 106.43 0.84 Allowed Pre-proline 0 C--N 1.303 -1.452 0 N-CA-C 107.059 -1.459 . . . . 0.0 107.059 176.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.535 ' O ' ' N ' ' A' ' 54' ' ' TYR . 25.1 Cg_endo -61.38 141.03 91.11 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 121.607 1.538 . . . . 0.0 110.925 -177.082 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.569 ' HA ' ' HG3' ' A' ' 56' ' ' ARG . . . -31.29 -35.18 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.156 0.503 . . . . 0.0 110.811 -178.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.54 ' O ' ' CB ' ' A' ' 55' ' ' CYS . 9.4 m-85 -75.0 129.14 37.14 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.138 -0.976 . . . . 0.0 109.153 179.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.54 ' CB ' ' O ' ' A' ' 54' ' ' TYR . 4.3 m 79.23 0.45 2.33 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.338 -0.851 . . . . 0.0 110.924 179.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.569 ' HG3' ' HA ' ' A' ' 53' ' ' ALA . 3.7 mmt85 -43.19 -90.24 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.704 -1.248 . . . . 0.0 109.706 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.529 ' C ' ' O ' ' A' ' 56' ' ' ARG . 3.3 m -21.47 -55.13 0.02 OUTLIER 'General case' 0 N--CA 1.514 2.755 0 O-C-N 122.069 -0.394 . . . . 0.0 111.706 -179.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.503 ' C ' ' O ' ' A' ' 57' ' ' CYS . 1.3 mm-40 -31.13 -59.41 0.22 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.596 -0.69 . . . . 0.0 110.82 -179.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.611 ' HB1' HD21 ' A' ' 17' ' ' LEU . . . -29.05 -56.38 0.14 Allowed 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 121.223 0.535 . . . . 0.0 111.07 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 1.013 ' CG2' HD22 ' A' ' 97' ' ' LEU . 32.0 t -55.17 -53.09 38.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 O-C-N 121.282 -0.886 . . . . 0.0 109.498 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.529 ' O ' ' HB2' ' A' ' 65' ' ' ASP . 17.9 mmt85 -56.49 -26.85 55.56 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.389 -0.819 . . . . 0.0 109.989 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.792 HG21 HG23 ' A' ' 67' ' ' VAL . 16.1 mm -79.09 -28.9 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.914 -1.116 . . . . 0.0 110.494 -179.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.549 ' CD1' ' HB3' ' A' ' 17' ' ' LEU . 9.1 tt -77.48 -50.03 13.52 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.91 -1.119 . . . . 0.0 108.848 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -78.12 -47.81 17.4 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.198 -0.939 . . . . 0.0 109.743 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.529 ' HB2' ' O ' ' A' ' 61' ' ' ARG . 0.7 OUTLIER -80.21 -20.02 45.64 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.117 -0.989 . . . . 0.0 109.799 -179.98 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 62' ' ' ILE . . . 102.05 162.21 26.61 Favored Glycine 0 N--CA 1.485 1.944 0 C-N-CA 119.31 -1.424 . . . . 0.0 110.749 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.792 HG23 HG21 ' A' ' 62' ' ' ILE . 3.6 p -113.85 155.54 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.527 HG22 ' NE2' ' A' ' 74' ' ' HIS . 22.3 t -120.52 156.25 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 120.893 -1.13 . . . . 0.0 110.185 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.435 ' N ' ' CG1' ' A' ' 68' ' ' VAL . 46.3 p -118.19 158.49 25.01 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.3 t -65.31 -27.9 68.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.415 -0.803 . . . . 0.0 109.681 -179.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.1 p -68.47 -14.23 62.86 Favored 'General case' 0 C--N 1.294 -1.815 0 O-C-N 121.586 -0.696 . . . . 0.0 109.238 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 99.28 8.76 52.71 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 108.827 -1.709 . . . . 0.0 108.827 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -93.02 156.41 16.91 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.106 -1.232 . . . . 0.0 109.648 -179.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.527 ' NE2' HG22 ' A' ' 68' ' ' VAL . 9.0 m170 -116.53 155.2 29.08 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 120.963 -1.086 . . . . 0.0 109.043 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.512 ' HB2' ' CG1' ' A' ' 67' ' ' VAL . 19.5 mm-40 -147.78 -169.92 3.45 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 121.563 0.696 . . . . 0.0 109.352 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 58.78 -145.61 42.92 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.93 16.9 4.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.286 -1.126 . . . . 0.0 110.069 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.521 ' O ' ' N ' ' A' ' 80' ' ' GLN . 1.0 OUTLIER -76.18 -18.51 59.05 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.985 -1.072 . . . . 0.0 109.669 -179.645 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.675 HD21 ' HB3' ' A' ' 90' ' ' GLN . 7.7 tt -47.41 94.91 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.101 -0.999 . . . . 0.0 108.706 179.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.521 ' N ' ' O ' ' A' ' 78' ' ' LEU . 23.2 mm100 -127.71 179.24 5.63 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.075 -1.016 . . . . 0.0 110.197 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.14 104.82 3.74 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.808 0.813 . . . . 0.0 110.863 -179.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.705 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 13.7 mt -82.88 173.41 7.59 Favored Pre-proline 0 C--N 1.298 -1.643 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 177.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.705 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 28.5 Cg_endo -69.15 104.86 1.29 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 120.873 1.048 . . . . 0.0 109.695 179.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.473 ' O ' ' SG ' ' A' ' 29' ' ' CYS . . . 92.04 4.75 66.63 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 -179.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.456 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 3.3 m -139.1 88.03 13.54 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 120.753 -1.44 . . . . 0.0 108.758 179.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.425 ' O ' ' C ' ' A' ' 87' ' ' ARG . 30.9 Cg_endo -76.21 159.13 37.2 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 121.638 1.558 . . . . 0.0 111.884 -178.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.425 ' C ' ' O ' ' A' ' 86' ' ' PRO . 7.1 mmm-85 -45.2 -28.24 0.74 Allowed 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.413 ' N ' ' C ' ' A' ' 86' ' ' PRO . 49.8 tt0 -54.34 -61.74 2.11 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.262 -178.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.43 HG11 ' HB ' ' A' ' 28' ' ' THR . 58.8 t -59.06 -40.64 81.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.084 -1.01 . . . . 0.0 109.952 -178.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.675 ' HB3' HD21 ' A' ' 79' ' ' LEU . 0.4 OUTLIER -62.77 -26.82 68.9 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 119.537 -0.865 . . . . 0.0 108.737 179.685 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.53 -31.22 47.41 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.434 -0.791 . . . . 0.0 109.77 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.5 ' O ' ' HD2' ' A' ' 95' ' ' PRO . . . -73.37 -42.97 61.54 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.087 -1.008 . . . . 0.0 109.47 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.574 ' CD1' HG22 ' A' ' 24' ' ' VAL . 21.5 t80 -78.03 -25.75 48.01 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.35 -0.844 . . . . 0.0 110.143 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.867 ' HB3' ' HD3' ' A' ' 95' ' ' PRO . . . -37.24 -53.36 2.16 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.597 -0.69 . . . . 0.0 110.94 -179.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.867 ' HD3' ' HB3' ' A' ' 94' ' ' ALA . 31.5 Cg_endo -73.75 -178.74 3.97 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.175 1.917 . . . . 0.0 110.305 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.447 ' HB2' ' O ' ' A' ' 95' ' ' PRO . 0.1 OUTLIER 71.36 24.66 3.66 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.248 -0.908 . . . . 0.0 108.839 -179.201 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 1.013 HD22 ' CG2' ' A' ' 60' ' ' VAL . 17.6 tp -73.01 -69.87 0.39 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.464 -0.772 . . . . 0.0 110.64 -179.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.844 HG12 HD11 ' A' ' 48' ' ' LEU . 2.4 m -79.35 26.57 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.571 -1.331 . . . . 0.0 110.906 -179.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.422 ' C ' ' HB2' ' A' ' 104' ' ' ASN . 5.2 p -103.87 174.22 5.96 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 120.617 -1.302 . . . . 0.0 108.902 179.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -58.81 -0.93 0.12 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.848 -1.157 . . . . 0.0 112.006 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.1 t -98.78 6.16 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 119.945 -1.722 . . . . 0.0 110.459 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.443 ' HB2' ' O ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -145.57 -90.49 0.1 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.741 -1.225 . . . . 0.0 110.391 -179.949 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.51 ' O ' ' CD1' ' A' ' 105' ' ' LEU . 56.0 m -145.22 40.85 1.24 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.953 -1.092 . . . . 0.0 109.195 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.555 ' O ' ' CB ' ' A' ' 105' ' ' LEU . 24.0 t30 -33.28 -89.47 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.412 -0.805 . . . . 0.0 111.983 -178.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.772 HD12 HD22 ' A' ' 48' ' ' LEU . 3.3 mt 85.3 -66.87 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -177.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.724 ' HB2' ' O ' ' A' ' 105' ' ' LEU . . . 155.97 115.1 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.639 HG21 HG21 ' A' ' 98' ' ' VAL . 2.8 p -85.55 -162.26 0.7 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.4 tp -73.38 -16.97 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 120.87 -1.144 . . . . 0.0 109.424 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.466 ' CB ' ' CE1' ' A' ' 113' ' ' PHE . 84.1 m-70 -80.06 16.27 1.27 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.432 -0.792 . . . . 0.0 110.377 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 109' ' ' HIS . . . 43.97 26.44 0.83 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 109' ' ' HIS . . . -153.6 172.72 32.4 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.45 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 33.7 Cg_endo -78.29 81.91 2.6 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 123.021 2.481 . . . . 0.0 110.938 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.589 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.064 -1.022 . . . . 0.0 110.552 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo . . . . . 0 CA--C 1.539 0.743 0 N-CA-C 110.568 -0.589 . . . . 0.0 110.568 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.4 ' C ' ' HG2' ' A' ' 10' ' ' MET . . . 54.44 17.32 8.17 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.876 -1.289 . . . . 0.0 109.876 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.747 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 1.4 mtt -139.38 108.2 5.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.29 -1.123 . . . . 0.0 108.669 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.747 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 85.35 -60.89 0.07 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.815 -1.178 . . . . 0.0 108.288 -178.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.747 HD11 ' CB ' ' A' ' 55' ' ' CYS . 1.7 mt -103.1 101.56 22.55 Favored Pre-proline 0 N--CA 1.485 1.315 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.466 ' HD3' ' O ' ' A' ' 11' ' ' ALA . 31.7 Cg_endo -80.61 174.14 11.47 Favored 'Trans proline' 0 C--N 1.317 -1.089 0 C-N-CA 121.281 1.321 . . . . 0.0 111.355 -177.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.463 ' O ' ' CG ' ' A' ' 15' ' ' ASN . 53.8 m-70 -73.75 148.27 42.74 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.769 -0.582 . . . . 0.0 109.761 -179.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.581 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 3.1 p-10 43.25 58.63 11.96 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.065 -1.022 . . . . 0.0 110.503 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.581 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 37.2 Cg_endo -81.09 166.16 18.85 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.676 2.251 . . . . 0.0 110.91 179.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.451 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 14.5 mt 55.08 45.82 25.38 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.471 -0.768 . . . . 0.0 111.179 178.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -69.74 -45.38 68.25 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.815 -1.178 . . . . 0.0 108.589 178.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.501 ' O ' ' HB2' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -62.4 -25.2 67.81 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.886 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.458 ' O ' HG23 ' A' ' 24' ' ' VAL . 73.9 m -69.55 -44.79 70.2 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.376 0.608 . . . . 0.0 109.483 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.61 -48.71 76.24 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.179 -0.951 . . . . 0.0 109.389 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.442 ' HA ' ' CE3' ' A' ' 22' ' ' TRP . 26.5 m95 -69.59 -26.25 64.37 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.443 -1.411 . . . . 0.0 109.382 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.601 ' CG ' ' HG2' ' A' ' 40' ' ' MET . 1.5 t80 -67.44 -30.11 69.75 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.865 HG13 ' HD2' ' A' ' 93' ' ' PHE . 59.1 t -75.18 -42.95 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 C-N-CA 118.758 -1.177 . . . . 0.0 107.859 178.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.7 p -56.03 -41.75 75.46 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.076 -1.05 . . . . 0.0 109.965 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.504 ' CA ' ' O ' ' A' ' 31' ' ' VAL . 3.4 m -77.83 -54.48 6.28 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.253 -0.904 . . . . 0.0 111.308 -178.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -58.7 -24.83 62.13 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 120.847 -1.158 . . . . 0.0 110.437 -178.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.421 HG23 ' O ' ' A' ' 24' ' ' VAL . 59.1 p -94.62 -65.68 0.97 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.135 -0.978 . . . . 0.0 111.232 -178.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.476 ' SG ' ' O ' ' A' ' 84' ' ' GLY . 3.5 m -99.3 16.95 21.32 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.737 -1.227 . . . . 0.0 109.914 -178.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.454 ' HA2' ' O ' ' A' ' 26' ' ' THR . . . 55.93 18.88 20.03 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 -178.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.504 ' O ' ' CA ' ' A' ' 26' ' ' THR . 30.2 t -101.6 157.3 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.312 -1.11 . . . . 0.0 109.525 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.405 ' N ' ' CG1' ' A' ' 31' ' ' VAL . . . 131.29 177.61 14.99 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.494 -1.842 . . . . 0.0 108.494 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -66.59 171.99 9.94 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 CA-C-N 119.15 1.475 . . . . 0.0 110.066 179.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -92.67 70.58 4.88 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.935 -1.103 . . . . 0.0 110.364 -178.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.451 ' O ' ' C ' ' A' ' 36' ' ' ALA . 0.8 OUTLIER -109.8 122.8 48.33 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 178.803 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.451 ' C ' ' O ' ' A' ' 35' ' ' LEU . . . -41.27 128.71 2.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.324 -0.86 . . . . 0.0 109.154 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.448 HG23 ' CE1' ' A' ' 23' ' ' TYR . 15.8 m -51.16 -38.8 54.24 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.829 -1.169 . . . . 0.0 111.377 -178.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -61.04 -36.95 80.94 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.751 -1.218 . . . . 0.0 110.194 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -72.43 -26.76 61.96 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.135 -0.978 . . . . 0.0 109.196 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.601 ' HG2' ' CG ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -72.48 -60.89 2.01 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.898 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -54.56 -36.16 64.03 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.84 -43.5 95.98 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.328 -0.857 . . . . 0.0 109.095 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.405 ' NH1' ' CG ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -60.23 -52.66 64.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.311 -0.868 . . . . 0.0 109.579 179.929 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.428 ' SG ' ' N ' ' A' ' 20' ' ' CYS . 14.7 m -56.68 -35.97 69.05 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.262 -0.899 . . . . 0.0 110.633 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 32.8 m -70.45 -30.72 67.63 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.754 -1.216 . . . . 0.0 109.043 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -68.41 -34.74 76.56 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 179.098 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.454 ' O ' HG13 ' A' ' 51' ' ' ILE . 3.1 mt-30 -77.83 -27.41 49.96 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.542 -0.724 . . . . 0.0 109.138 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.715 ' O ' HD13 ' A' ' 48' ' ' LEU . 1.6 tm? -69.55 -39.02 77.69 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.465 -0.772 . . . . 0.0 108.942 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.425 ' O ' ' C ' ' A' ' 50' ' ' ALA . 3.6 tt0 -77.41 -47.23 20.31 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.489 ' O ' ' HD3' ' A' ' 52' ' ' PRO . . . -45.53 -43.76 12.12 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 178.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.462 ' O ' ' HD2' ' A' ' 56' ' ' ARG . 49.4 mt -73.42 107.44 3.36 Favored Pre-proline 0 C--N 1.301 -1.519 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 177.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.535 ' O ' ' N ' ' A' ' 54' ' ' TYR . 25.4 Cg_endo -61.15 149.43 89.25 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 121.702 1.601 . . . . 0.0 111.224 -176.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.676 ' HA ' ' HD3' ' A' ' 56' ' ' ARG . . . -34.99 -29.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.037 0.446 . . . . 0.0 111.083 -178.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.54 ' O ' ' CB ' ' A' ' 55' ' ' CYS . 1.5 m-85 -79.88 125.87 30.28 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 120.999 -1.063 . . . . 0.0 110.017 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.747 ' CB ' HD11 ' A' ' 12' ' ' ILE . 4.5 m 81.63 -0.22 1.58 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.489 -0.757 . . . . 0.0 111.727 178.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.676 ' HD3' ' HA ' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -46.98 -89.9 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.316 -1.49 . . . . 0.0 109.328 -179.916 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.493 ' O ' ' C ' ' A' ' 58' ' ' GLU . 53.5 m -33.36 -56.81 0.42 Allowed 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.325 -0.86 . . . . 0.0 111.904 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.493 ' C ' ' O ' ' A' ' 57' ' ' CYS . 27.3 tt0 -32.34 -51.35 0.26 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.029 -1.045 . . . . 0.0 111.416 -179.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.458 ' C ' ' O ' ' A' ' 58' ' ' GLU . . . -36.17 -54.82 0.8 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.282 -0.886 . . . . 0.0 110.643 -179.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 44.0 t -54.63 -47.98 71.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 121.327 -0.858 . . . . 0.0 109.17 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.59 -27.03 62.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.217 -0.927 . . . . 0.0 109.442 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.95 HD12 ' HB ' ' A' ' 67' ' ' VAL . 3.7 mm -77.74 -30.14 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.254 -0.904 . . . . 0.0 109.747 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.527 ' O ' ' HA ' ' A' ' 77' ' ' ARG . 8.1 tt -77.88 -40.43 40.06 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.81 -1.181 . . . . 0.0 109.283 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.453 ' SD ' ' HG ' ' A' ' 79' ' ' LEU . 10.4 tpt -77.81 -53.72 7.17 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.239 -0.913 . . . . 0.0 109.985 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -79.61 -22.28 43.87 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.194 -0.941 . . . . 0.0 110.307 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.423 ' CA ' ' HB2' ' A' ' 77' ' ' ARG . . . 88.76 146.71 13.19 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.95 ' HB ' HD12 ' A' ' 62' ' ' ILE . 4.0 p -116.88 160.18 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.61 -0.935 . . . . 0.0 109.337 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.77 HG22 ' CE1' ' A' ' 74' ' ' HIS . 9.5 t -114.17 158.46 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 CA-C-O 121.9 0.857 . . . . 0.0 109.854 -178.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.459 ' N ' ' CG1' ' A' ' 68' ' ' VAL . 69.1 p -116.78 158.51 23.77 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.636 0.731 . . . . 0.0 109.728 -178.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 38.8 t -65.55 -25.63 67.51 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.418 0.628 . . . . 0.0 110.11 -178.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.2 p -71.82 -14.15 61.89 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.484 -0.76 . . . . 0.0 109.226 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.25 8.4 50.25 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 108.789 -1.725 . . . . 0.0 108.789 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -100.86 156.15 17.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.075 -1.25 . . . . 0.0 109.18 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.77 ' CE1' HG22 ' A' ' 68' ' ' VAL . 13.4 m170 -115.25 155.66 26.84 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.968 -1.083 . . . . 0.0 108.958 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.422 ' CD ' ' O ' ' A' ' 74' ' ' HIS . 22.4 mm-40 -139.51 -171.45 3.14 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.549 -0.86 . . . . 0.0 109.999 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 53.77 -147.1 20.6 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 108.366 -1.894 . . . . 0.0 108.366 -178.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.527 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 14.4 ttt85 52.94 23.13 2.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.118 -1.225 . . . . 0.0 109.577 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.18 -10.82 45.68 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.087 -1.008 . . . . 0.0 110.654 -179.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.866 HD22 ' O ' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -57.08 123.18 14.34 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.461 -1.4 . . . . 0.0 108.68 179.514 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.457 ' CG ' ' O ' ' A' ' 79' ' ' LEU . 49.6 mt-30 -156.5 -179.2 7.95 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.758 -1.214 . . . . 0.0 110.234 -178.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.19 105.57 1.12 Allowed 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.869 0.843 . . . . 0.0 110.754 -179.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.674 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 22.2 mt -89.7 171.77 8.24 Favored Pre-proline 0 C--N 1.298 -1.632 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.018 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.674 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 28.3 Cg_endo -67.29 100.39 0.55 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 121.136 1.224 . . . . 0.0 110.422 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.476 ' O ' ' SG ' ' A' ' 29' ' ' CYS . . . 91.27 14.26 57.59 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.481 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 3.3 m -144.55 91.58 6.19 Favored Pre-proline 0 N--CA 1.498 1.926 0 O-C-N 120.904 -1.35 . . . . 0.0 109.224 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.414 ' O ' ' C ' ' A' ' 87' ' ' ARG . 29.9 Cg_endo -75.2 157.09 42.11 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 121.459 1.439 . . . . 0.0 112.028 -178.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.414 ' C ' ' O ' ' A' ' 86' ' ' PRO . 8.1 mtm-85 -45.25 -28.54 0.82 Allowed 'General case' 0 N--CA 1.483 1.201 0 O-C-N 121.306 -0.872 . . . . 0.0 108.821 178.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -57.78 -62.27 1.92 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.907 -0.496 . . . . 0.0 111.456 -177.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.8 t -61.34 -39.4 82.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 120.958 -1.089 . . . . 0.0 110.137 -178.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.784 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 2.2 mp0 -63.62 -27.41 69.22 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.684 -0.806 . . . . 0.0 108.856 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.422 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 0.0 OUTLIER -78.43 -33.38 48.63 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.469 -0.77 . . . . 0.0 109.52 179.679 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.482 ' O ' ' HD2' ' A' ' 95' ' ' PRO . . . -69.98 -50.94 36.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.154 -0.966 . . . . 0.0 109.513 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.865 ' HD2' HG13 ' A' ' 24' ' ' VAL . 5.6 t80 -78.14 -25.72 47.49 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.241 -0.912 . . . . 0.0 110.239 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.843 ' HB3' ' HD3' ' A' ' 95' ' ' PRO . . . -38.55 -53.02 3.34 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.331 -0.856 . . . . 0.0 111.365 -178.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.843 ' HD3' ' HB3' ' A' ' 94' ' ' ALA . 30.0 Cg_endo -71.38 -174.68 1.29 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.025 1.817 . . . . 0.0 110.854 -179.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.496 ' CB ' ' O ' ' A' ' 95' ' ' PRO . 1.2 ttmm 74.31 32.71 0.95 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.273 -0.892 . . . . 0.0 108.857 -178.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.61 -73.08 0.25 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.475 -0.766 . . . . 0.0 111.469 -178.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.528 ' O ' ' CB ' ' A' ' 104' ' ' ASN . 2.0 m -77.62 24.69 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.737 -1.227 . . . . 0.0 111.678 -178.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 24.7 p -95.81 169.54 9.93 Favored 'General case' 0 C--N 1.294 -1.815 0 O-C-N 120.547 -1.345 . . . . 0.0 108.671 179.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.483 ' HA ' ' ND2' ' A' ' 104' ' ' ASN . 0.6 OUTLIER -59.74 -1.0 0.22 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.658 -1.276 . . . . 0.0 111.774 -179.665 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.453 ' O ' HG12 ' A' ' 101' ' ' VAL . 11.0 t -98.92 5.87 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 119.855 -1.778 . . . . 0.0 110.336 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -142.17 -91.29 0.13 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.808 -1.182 . . . . 0.0 110.117 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.535 ' O ' HD23 ' A' ' 105' ' ' LEU . 74.2 m -145.15 39.56 1.21 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.938 -1.101 . . . . 0.0 109.451 -179.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.528 ' CB ' ' O ' ' A' ' 98' ' ' VAL . 4.5 p30 -34.58 -47.9 0.34 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.355 -0.841 . . . . 0.0 111.719 -179.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.535 HD23 ' O ' ' A' ' 103' ' ' CYS . 1.3 mm? 44.44 24.75 0.1 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.695 -1.253 . . . . 0.0 110.109 -179.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.476 ' O ' ' O ' ' A' ' 105' ' ' LEU . . . 60.93 122.78 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.771 -1.205 . . . . 0.0 109.125 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.42 HG21 HG21 ' A' ' 98' ' ' VAL . 2.4 p -95.28 -172.7 2.73 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.078 -1.013 . . . . 0.0 108.624 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.2 tp -58.74 -21.43 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 120.935 -1.103 . . . . 0.0 109.21 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.498 ' HB3' ' CE1' ' A' ' 113' ' ' PHE . 79.2 m-70 -80.11 16.66 1.17 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.654 -0.654 . . . . 0.0 110.373 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 109' ' ' HIS . . . 43.93 26.89 0.9 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 109' ' ' HIS . . . -154.4 171.08 32.89 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.459 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 32.2 Cg_endo -78.67 73.57 5.86 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 123.066 2.511 . . . . 0.0 111.603 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.498 ' CE1' ' HB3' ' A' ' 109' ' ' HIS . 25.0 p90 . . . . . 0 N--CA 1.492 1.648 0 O-C-N 121.223 -0.923 . . . . 0.0 109.889 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 42.4 t . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.423 HG23 ' H ' ' A' ' 3' ' ' GLY . 0.2 OUTLIER -133.38 -90.85 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.423 ' H ' HG23 ' A' ' 2' ' ' VAL . . . -103.14 69.22 0.3 Allowed Glycine 0 N--CA 1.498 2.772 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.1 t -105.8 21.76 16.72 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 122.24 -0.565 . . . . 0.0 110.182 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 12.7 p -56.06 171.64 0.24 Allowed 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 24.3 m 64.39 118.79 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.637 HG22 ' HD2' ' A' ' 8' ' ' PRO . 0.9 OUTLIER -76.82 142.05 69.17 Favored Pre-proline 0 N--CA 1.504 2.253 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -179.911 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.637 ' HD2' HG22 ' A' ' 7' ' ' ILE . 37.8 Cg_endo -77.84 -96.03 0.01 OUTLIER 'Trans proline' 0 C--O 1.208 -0.975 0 C-N-CA 121.686 1.591 . . . . 0.0 110.247 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -38.68 -21.69 0.01 OUTLIER Glycine 0 N--CA 1.509 3.55 0 O-C-N 121.64 -0.662 . . . . 0.0 113.279 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.588 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 6.3 mtt -112.11 116.64 30.83 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 178.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.588 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 84.35 -47.59 0.1 Allowed 'General case' 0 N--CA 1.509 2.476 0 CA-C-N 120.021 1.282 . . . . 0.0 110.081 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 85.2 mt -126.27 77.28 72.3 Favored Pre-proline 0 N--CA 1.508 2.438 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -72.47 171.82 16.3 Favored 'Trans proline' 0 N--CA 1.476 0.473 0 C-N-CA 120.751 0.967 . . . . 0.0 112.5 -174.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.53 ' CE1' HG22 ' A' ' 69' ' ' THR . 29.4 m-70 -70.01 148.03 49.37 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.893 -178.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.467 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 29.0 t30 65.66 58.25 1.18 Allowed Pre-proline 0 N--CA 1.503 2.186 0 O-C-N 121.593 -0.692 . . . . 0.0 110.201 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.467 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 38.2 Cg_endo -78.85 158.4 27.68 Favored 'Trans proline' 0 N--CA 1.485 0.972 0 C-N-CA 122.376 2.051 . . . . 0.0 111.752 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.3 mt 53.74 44.25 29.89 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-O 121.074 0.464 . . . . 0.0 111.155 178.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -70.02 -40.51 75.15 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 121.584 -0.697 . . . . 0.0 109.283 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.51 -27.85 69.25 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.536 ' O ' HG23 ' A' ' 24' ' ' VAL . 44.1 m -72.9 -36.33 67.29 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.413 ' CG ' ' N ' ' A' ' 22' ' ' TRP . 0.2 OUTLIER -63.07 -54.97 29.67 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.822 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.441 ' HA ' ' CE3' ' A' ' 22' ' ' TRP . 27.8 m95 -65.64 -27.85 68.68 Favored 'General case' 0 N--CA 1.501 2.084 0 C-N-CA 119.232 -0.987 . . . . 0.0 109.671 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -67.07 -30.03 69.97 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.728 HG22 ' CD1' ' A' ' 93' ' ' PHE . 62.4 t -71.96 -41.62 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 177.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 m -56.35 -42.78 78.31 Favored 'General case' 0 N--CA 1.501 2.112 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.672 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.5 m -77.37 -50.99 11.59 Favored 'General case' 0 N--CA 1.51 2.533 0 O-C-N 122.037 -0.415 . . . . 0.0 112.104 -178.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -62.95 -24.94 68.12 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.832 -0.543 . . . . 0.0 110.733 -178.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.519 HG23 ' O ' ' A' ' 24' ' ' VAL . 34.7 p -97.05 -62.84 1.2 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 122.086 -0.384 . . . . 0.0 111.881 -177.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.6 ' O ' HG23 ' A' ' 31' ' ' VAL . 3.8 m -100.97 12.93 36.73 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 121.36 -0.838 . . . . 0.0 111.581 -178.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 57.17 21.56 39.81 Favored Glycine 0 N--CA 1.505 3.289 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -178.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 29' ' ' CYS . 45.2 t -109.49 164.24 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 O-C-N 121.87 -0.783 . . . . 0.0 109.396 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.497 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 136.14 -179.7 17.57 Favored Glycine 0 N--CA 1.5 2.928 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -63.66 173.37 4.62 Favored 'Trans proline' 0 N--CA 1.487 1.093 0 CA-C-N 119.319 1.559 . . . . 0.0 110.229 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 2.3 ptt180 -92.86 88.24 6.12 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 122.081 0.944 . . . . 0.0 110.197 -177.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.694 HD23 ' H ' ' A' ' 35' ' ' LEU . 2.1 pt? -145.53 -172.29 3.86 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 115.298 -0.865 . . . . 0.0 108.836 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -95.62 162.59 13.56 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.67 -57.33 3.62 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 122.127 -0.358 . . . . 0.0 110.182 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -51.38 -26.81 8.41 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 121.91 -0.494 . . . . 0.0 110.708 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -74.08 -44.48 53.9 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.609 ' HE3' HD11 ' A' ' 35' ' ' LEU . 2.5 ttm -63.5 -53.09 57.42 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.2 ttpp -54.24 -38.84 66.2 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.701 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.82 -38.54 91.16 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.12 -35.58 81.23 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 23.0 m -66.99 -35.57 80.26 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 120.396 -0.522 . . . . 0.0 109.616 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 18.2 m -71.76 -32.35 67.6 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.9 -35.07 74.32 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.47 ' O ' HD12 ' A' ' 51' ' ' ILE . 4.1 mt-30 -78.07 -26.3 48.14 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.804 HD11 ' NH1' ' A' ' 56' ' ' ARG . 1.6 tm? -69.72 -45.93 67.1 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -178.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -78.22 -38.82 42.23 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.62 -36.85 57.23 Favored 'General case' 0 N--CA 1.506 2.358 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.47 HD12 ' O ' ' A' ' 47' ' ' GLN . 58.0 mt -85.58 105.54 7.22 Favored Pre-proline 0 N--CA 1.488 1.446 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 176.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -62.86 148.87 92.92 Favored 'Trans proline' 0 N--CA 1.482 0.818 0 C-N-CA 121.771 1.648 . . . . 0.0 111.412 -176.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.67 ' HB1' ' N ' ' A' ' 108' ' ' ILE . . . -47.3 -27.43 1.57 Allowed 'General case' 0 N--CA 1.501 2.124 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.625 -179.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -71.1 115.04 9.77 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 12.0 m 70.54 7.94 6.41 Favored 'General case' 0 N--CA 1.507 2.384 0 O-C-N 121.998 -0.439 . . . . 0.0 110.079 -179.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.804 ' NH1' HD11 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -50.22 -93.19 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.322 -0.861 . . . . 0.0 109.507 179.848 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 88.9 m -31.63 -36.29 0.02 OUTLIER 'General case' 0 N--CA 1.521 3.108 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -41.4 -51.99 3.64 Favored 'General case' 0 N--CA 1.512 2.626 0 CA-C-N 119.762 1.164 . . . . 0.0 111.559 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -44.16 -47.06 9.06 Favored 'General case' 0 N--CA 1.511 2.581 0 O-C-N 121.765 -0.584 . . . . 0.0 112.135 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.9 t -50.73 -46.27 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.733 0 CA-C-O 122.134 0.969 . . . . 0.0 108.401 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -58.93 -50.22 74.87 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 177.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.921 HG23 ' HB ' ' A' ' 67' ' ' VAL . 28.0 mm -51.45 -26.96 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 121.673 -0.642 . . . . 0.0 110.109 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.37 -40.41 36.31 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 120.019 -0.673 . . . . 0.0 109.48 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 17.7 ttp -77.02 -55.34 5.54 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.474 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -80.95 -23.84 38.53 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.748 -0.595 . . . . 0.0 111.651 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.68 148.62 12.81 Favored Glycine 0 N--CA 1.506 3.301 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.921 ' HB ' HG23 ' A' ' 62' ' ' ILE . 8.2 p -117.73 159.91 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.559 0 O-C-N 122.185 -0.597 . . . . 0.0 110.632 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.699 HG22 ' NE2' ' A' ' 74' ' ' HIS . 54.3 t -114.97 156.92 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.53 HG22 ' CE1' ' A' ' 14' ' ' HIS . 31.1 p -117.63 160.01 21.98 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.176 -177.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.2 t -62.02 -29.67 70.43 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.642 -178.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.2 p -71.78 -16.94 62.21 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 116.618 -0.264 . . . . 0.0 110.482 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.88 14.7 30.81 Favored Glycine 0 N--CA 1.498 2.779 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.6 mm100 -103.07 156.34 17.75 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-N 118.204 1.002 . . . . 0.0 109.195 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.699 ' NE2' HG22 ' A' ' 68' ' ' VAL . 9.2 m170 -115.2 155.54 26.99 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -145.83 -175.99 4.96 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 120.995 0.426 . . . . 0.0 109.869 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 59.78 -148.51 42.09 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 108.443 -1.863 . . . . 0.0 108.443 -178.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 57.27 21.5 6.74 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 122.077 -0.661 . . . . 0.0 110.326 179.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.8 mt -81.96 -14.75 55.62 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.777 -0.577 . . . . 0.0 110.673 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.0 tt -58.72 92.48 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -130.97 177.59 7.33 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.193 0.521 . . . . 0.0 109.811 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -77.02 103.36 6.9 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.524 0.678 . . . . 0.0 110.707 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.528 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 18.1 mt -78.25 170.11 17.76 Favored Pre-proline 0 N--CA 1.497 1.875 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 177.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.528 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 29.8 Cg_endo -70.92 98.43 0.8 Allowed 'Trans proline' 0 C--N 1.327 -0.561 0 C-N-CA 120.859 1.04 . . . . 0.0 109.463 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 102.57 1.43 49.97 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 3.5 m -139.42 91.61 10.87 Favored Pre-proline 0 N--CA 1.505 2.279 0 CA-C-N 119.087 1.444 . . . . 0.0 109.191 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -72.42 163.28 39.06 Favored 'Trans proline' 0 N--CA 1.482 0.828 0 C-N-CA 121.368 1.378 . . . . 0.0 111.576 -178.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.4 mtm-85 -48.5 -28.65 3.47 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.196 0.522 . . . . 0.0 109.769 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -59.57 -46.23 89.51 Favored 'General case' 0 N--CA 1.504 2.235 0 CA-C-N 116.189 -0.46 . . . . 0.0 112.005 -177.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 49.0 t -68.88 -40.58 81.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.585 -0.697 . . . . 0.0 109.823 -178.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.489 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 1.9 mp0 -64.88 -27.39 68.83 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.35 -34.01 48.7 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 109.813 -0.439 . . . . 0.0 109.813 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.57 -45.67 68.17 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.893 -0.504 . . . . 0.0 109.808 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.728 ' CD1' HG22 ' A' ' 24' ' ' VAL . 44.3 t80 -78.57 -25.77 45.42 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 122.319 -0.238 . . . . 0.0 110.406 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.663 ' HB3' ' HD3' ' A' ' 95' ' ' PRO . . . -42.85 -51.71 12.12 Favored Pre-proline 0 N--CA 1.503 2.212 0 CA-C-O 118.87 -0.586 . . . . 0.0 112.493 -177.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.663 ' HD3' ' HB3' ' A' ' 94' ' ' ALA . 30.7 Cg_endo -72.98 -172.42 0.98 Allowed 'Trans proline' 0 N--CA 1.476 0.484 0 C-N-CA 121.697 1.598 . . . . 0.0 110.328 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.4 mttt 64.59 17.15 10.74 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -178.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.613 HD12 ' O ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -74.13 -75.89 0.15 Allowed 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.484 HG12 ' NH1' ' A' ' 56' ' ' ARG . 8.4 m -64.56 1.18 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.334 0 O-C-N 121.612 -0.68 . . . . 0.0 112.487 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 22.3 p -87.8 174.5 8.34 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -61.04 -0.1 0.28 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.424 -0.797 . . . . 0.0 111.899 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.475 ' O ' HG12 ' A' ' 101' ' ' VAL . 21.3 t -90.53 -4.04 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 CA-C-N 120.429 1.468 . . . . 0.0 111.188 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -140.25 -83.01 0.24 Allowed 'General case' 0 N--CA 1.51 2.557 0 C-N-CA 119.108 -1.037 . . . . 0.0 112.693 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 96.2 m -146.28 42.28 1.18 Allowed 'General case' 0 N--CA 1.504 2.256 0 CA-C-N 119.722 1.146 . . . . 0.0 109.258 -178.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.42 ' HA ' ' O ' ' A' ' 98' ' ' VAL . 11.2 p-10 -37.9 -60.66 0.71 Allowed 'General case' 0 N--CA 1.504 2.273 0 N-CA-C 113.553 0.945 . . . . 0.0 113.553 -178.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.402 ' O ' ' HB3' ' A' ' 106' ' ' ALA . 79.2 mt 45.92 25.06 0.27 Allowed 'General case' 0 N--CA 1.51 2.564 0 CA-C-N 119.054 0.843 . . . . 0.0 111.396 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 105' ' ' LEU . . . 64.02 141.73 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.321 -0.862 . . . . 0.0 109.674 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.2 p -112.5 -161.8 0.77 Allowed 'General case' 0 N--CA 1.506 2.348 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.67 ' N ' ' HB1' ' A' ' 53' ' ' ALA . 1.0 OUTLIER -66.13 -33.01 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.278 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -70.05 -1.25 9.35 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.189 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 57.74 30.36 62.64 Favored Glycine 0 N--CA 1.499 2.887 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -157.22 169.62 34.3 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.4 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 31.8 Cg_endo -78.22 73.85 5.6 Favored 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 122.725 2.283 . . . . 0.0 112.134 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.4 ' HB3' ' O ' ' A' ' 112' ' ' PRO . 49.2 p90 174.05 161.29 0.17 Allowed 'General case' 0 N--CA 1.507 2.407 0 O-C-N 121.827 -0.545 . . . . 0.0 110.462 177.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 16.9 p -159.1 158.65 33.36 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.9 mt 52.11 -176.88 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.678 -0.639 . . . . 0.0 109.921 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 9.0 p 46.79 24.87 0.38 Allowed 'General case' 0 N--CA 1.507 2.398 0 O-C-N 122.084 -0.385 . . . . 0.0 110.87 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.484 HD13 ' HA ' ' A' ' 117' ' ' LEU . 2.2 mm? -63.59 -155.56 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 21.8 mt -45.7 -20.46 0.08 Allowed 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.189 -0.944 . . . . 0.0 113.065 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 104.85 69.73 0.77 Allowed Glycine 0 N--CA 1.499 2.845 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 58.83 69.99 0.68 Allowed 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.765 0.793 . . . . 0.0 109.926 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -102.71 26.15 25.07 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 . . . . . 0 N--CA 1.497 1.916 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.325 -179.806 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 3.1 t . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.487 HG23 ' N ' ' A' ' 3' ' ' GLY . 26.8 m -45.87 -44.49 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.392 0 O-C-N 122.2 -0.313 . . . . 0.0 111.031 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.487 ' N ' HG23 ' A' ' 2' ' ' VAL . . . 151.61 -175.46 30.42 Favored Glycine 0 N--CA 1.5 2.907 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.1 t -151.32 52.27 0.84 Allowed 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.6 0.714 . . . . 0.0 109.296 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 84.5 p -58.38 -170.39 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.772 -0.58 . . . . 0.0 109.809 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 34.2 m -84.38 119.21 24.84 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.536 HG23 ' HB2' ' A' ' 10' ' ' MET . 3.2 tp -121.62 138.95 29.09 Favored Pre-proline 0 N--CA 1.494 1.754 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -76.2 160.22 36.35 Favored 'Trans proline' 0 N--CA 1.48 0.72 0 C-N-CA 121.65 1.567 . . . . 0.0 110.564 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.6 2.12 74.07 Favored Glycine 0 N--CA 1.501 3.017 0 N-CA-C 110.634 -0.987 . . . . 0.0 110.634 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.573 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 4.0 mmt -133.29 104.06 6.28 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 87.2 -57.11 0.04 OUTLIER 'General case' 0 N--CA 1.515 2.789 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -178.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 57.6 mt -100.53 102.36 18.61 Favored Pre-proline 0 N--CA 1.495 1.797 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 178.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -81.28 173.61 11.51 Favored 'Trans proline' 0 N--CA 1.477 0.501 0 C-N-CA 121.616 1.544 . . . . 0.0 111.879 -176.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.44 ' CE1' HG22 ' A' ' 69' ' ' THR . 32.2 m-70 -76.0 146.88 39.2 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.488 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 19.2 t-20 68.11 56.87 0.71 Allowed Pre-proline 0 N--CA 1.508 2.473 0 O-C-N 121.393 -0.817 . . . . 0.0 111.721 179.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.488 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 41.2 Cg_endo -84.56 171.1 10.0 Favored 'Trans proline' 0 N--CA 1.481 0.774 0 C-N-CA 122.139 1.893 . . . . 0.0 111.066 178.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 27.6 mt 46.2 46.45 13.19 Favored 'General case' 0 N--CA 1.502 2.167 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.096 177.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -75.49 -43.04 51.31 Favored 'General case' 0 N--CA 1.505 2.311 0 O-C-N 121.482 -0.761 . . . . 0.0 109.002 178.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -63.57 -26.33 68.64 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.715 ' O ' HG23 ' A' ' 24' ' ' VAL . 34.6 m -75.08 -34.54 61.78 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.6 ' NH1' HD23 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -68.32 -46.57 69.86 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.793 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 31.7 m95 -71.77 -29.41 64.45 Favored 'General case' 0 N--CA 1.506 2.326 0 C-N-CA 118.691 -1.203 . . . . 0.0 109.274 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -65.23 -32.41 74.07 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 20' ' ' CYS . 47.9 t -71.35 -41.05 73.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 177.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.1 m -55.5 -39.15 70.1 Favored 'General case' 0 N--CA 1.502 2.159 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.161 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 94.5 m -77.62 -51.52 10.5 Favored 'General case' 0 N--CA 1.508 2.452 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -65.14 -25.01 67.57 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.432 -0.792 . . . . 0.0 110.672 -178.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.46 HG23 ' O ' ' A' ' 24' ' ' VAL . 43.9 p -93.77 -61.09 1.61 Allowed 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -177.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.694 ' O ' HG23 ' A' ' 31' ' ' VAL . 3.8 m -100.47 7.83 43.92 Favored 'General case' 0 N--CA 1.507 2.415 0 O-C-N 121.363 -0.836 . . . . 0.0 111.784 -178.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 58.29 24.81 56.4 Favored Glycine 0 N--CA 1.506 3.302 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -178.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.694 HG23 ' O ' ' A' ' 29' ' ' CYS . 19.7 t -119.11 165.54 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 122.124 -0.633 . . . . 0.0 109.35 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.48 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 134.05 -178.89 18.01 Favored Glycine 0 N--CA 1.5 2.954 0 N-CA-C 108.394 -1.882 . . . . 0.0 108.394 -178.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.414 ' HB2' HD23 ' A' ' 35' ' ' LEU . 26.7 Cg_endo -64.62 171.67 7.96 Favored 'Trans proline' 0 N--CA 1.485 0.991 0 CA-C-N 119.63 1.715 . . . . 0.0 109.672 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.748 ' C ' HD22 ' A' ' 35' ' ' LEU . 9.6 mtp180 -92.89 80.87 4.63 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 122.066 0.936 . . . . 0.0 110.115 -177.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.748 HD22 ' C ' ' A' ' 34' ' ' ARG . 4.3 mm? -122.5 -175.67 3.2 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -99.61 140.76 33.34 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.96 -53.59 47.89 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.616 -0.677 . . . . 0.0 111.042 -179.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.6 tm0? -52.46 -46.64 66.59 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.95 -0.469 . . . . 0.0 110.888 -178.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -63.91 -32.07 73.47 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 33.1 tpp -66.94 -58.46 4.92 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 10.2 tptt -53.2 -36.99 61.57 Favored 'General case' 0 N--CA 1.501 2.076 0 CA-C-O 121.179 0.514 . . . . 0.0 109.656 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.49 -40.92 98.35 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.82 -38.74 89.27 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 20.1 m -66.5 -33.54 75.91 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 50.6 m -72.26 -31.16 65.54 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 15.3 ttt85 -73.05 -32.62 65.18 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -76.43 -32.1 58.27 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.76 HD21 HG12 ' A' ' 98' ' ' VAL . 1.1 tp -72.98 -35.94 66.98 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.486 ' OE1' HD22 ' A' ' 105' ' ' LEU . 6.0 tp10 -72.7 -37.25 67.88 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 179.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.98 -38.51 82.77 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 45.4 mt -82.38 104.7 3.64 Favored Pre-proline 0 N--CA 1.495 1.789 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 177.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -58.32 140.72 95.49 Favored 'Trans proline' 0 N--CA 1.482 0.81 0 C-N-CA 121.775 1.65 . . . . 0.0 112.208 -175.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.586 ' HB1' ' N ' ' A' ' 108' ' ' ILE . . . -48.99 -24.39 1.5 Allowed 'General case' 0 N--CA 1.5 2.075 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.201 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -45.67 -71.9 0.07 Allowed 'General case' 0 N--CA 1.505 2.319 0 O-C-N 121.969 -0.457 . . . . 0.0 111.204 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 21.1 m -110.5 23.91 13.64 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.99 -0.444 . . . . 0.0 110.86 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.2 mtt180 -40.38 -83.44 0.01 OUTLIER 'General case' 0 N--CA 1.516 2.828 0 O-C-N 121.316 -0.865 . . . . 0.0 110.863 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 75.2 m -32.28 -35.88 0.02 OUTLIER 'General case' 0 N--CA 1.52 3.035 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -46.06 -58.07 3.91 Favored 'General case' 0 N--CA 1.511 2.607 0 CA-C-N 119.933 1.242 . . . . 0.0 110.931 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -42.61 -37.94 1.85 Allowed 'General case' 0 N--CA 1.513 2.715 0 O-C-N 121.675 -0.641 . . . . 0.0 112.346 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.709 ' CG2' HD13 ' A' ' 97' ' ' LEU . 25.8 t -55.08 -49.91 67.86 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 O-C-N 121.774 -0.579 . . . . 0.0 109.556 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -58.15 -28.99 65.23 Favored 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.794 HG23 ' HB ' ' A' ' 67' ' ' VAL . 2.0 mp -77.85 -27.58 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.269 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.46 HD23 ' C ' ' A' ' 63' ' ' LEU . 10.1 tt -78.18 -40.9 36.29 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 120.117 -0.633 . . . . 0.0 109.813 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -78.85 -51.62 9.47 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.142 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -80.81 -23.91 38.89 Favored 'General case' 0 N--CA 1.502 2.135 0 C-N-CA 120.689 -0.404 . . . . 0.0 111.323 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.9 146.3 8.02 Favored Glycine 0 N--CA 1.498 2.788 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.794 ' HB ' HG23 ' A' ' 62' ' ' ILE . 14.2 p -117.45 160.12 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 O-C-N 122.347 -0.502 . . . . 0.0 109.781 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.645 HG22 ' NE2' ' A' ' 74' ' ' HIS . 55.5 t -114.2 157.54 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.44 HG22 ' CE1' ' A' ' 14' ' ' HIS . 53.3 p -117.28 159.28 22.95 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.838 -177.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 34.7 t -64.59 -28.04 69.36 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.385 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.5 p -71.4 -16.05 62.39 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.68 10.83 42.61 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -100.93 156.51 17.34 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 118.201 1.0 . . . . 0.0 109.197 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.645 ' NE2' HG22 ' A' ' 68' ' ' VAL . 11.2 m170 -115.86 155.49 27.81 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -144.44 -173.51 4.06 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.287 0.565 . . . . 0.0 110.26 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.534 ' O ' HD12 ' A' ' 78' ' ' LEU . . . 61.01 -145.01 48.56 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.722 -1.751 . . . . 0.0 108.722 -178.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.411 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 2.7 tpt180 56.44 21.61 5.71 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 122.229 -0.571 . . . . 0.0 109.486 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.6 HD23 ' NH1' ' A' ' 21' ' ' ARG . 10.1 mp -66.12 -21.6 66.35 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.484 -0.76 . . . . 0.0 109.983 -179.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.527 HD12 ' HB3' ' A' ' 90' ' ' GLN . 3.0 tt -61.04 92.9 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -141.98 176.83 8.63 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.518 0.675 . . . . 0.0 110.662 -178.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -64.2 118.38 8.51 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.857 0.837 . . . . 0.0 111.367 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.484 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 22.0 mt -112.95 166.63 10.66 Favored Pre-proline 0 N--CA 1.497 1.89 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 177.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.484 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 29.4 Cg_endo -68.6 99.81 0.65 Allowed 'Trans proline' 0 C--N 1.326 -0.632 0 C-N-CA 121.063 1.175 . . . . 0.0 110.532 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.99 8.43 64.9 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.431 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 3.4 m -141.72 91.1 8.42 Favored Pre-proline 0 N--CA 1.511 2.615 0 CA-C-N 118.869 1.335 . . . . 0.0 109.504 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -72.95 166.4 30.15 Favored 'Trans proline' 0 N--CA 1.488 1.165 0 C-N-CA 121.895 1.73 . . . . 0.0 111.754 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 72.7 mtp180 -51.13 -27.55 8.78 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.173 0.511 . . . . 0.0 109.893 178.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -61.13 -45.92 92.69 Favored 'General case' 0 N--CA 1.502 2.169 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.239 -177.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 58.6 t -69.16 -43.61 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.665 -0.647 . . . . 0.0 110.602 -178.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.65 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 31.2 mt-30 -67.49 -27.71 67.23 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.421 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 5.9 tpt180 -78.65 -26.71 45.2 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.38 -48.45 17.24 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.923 -0.486 . . . . 0.0 110.065 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -78.31 -27.64 47.28 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 122.116 -0.365 . . . . 0.0 110.999 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.65 ' HB2' ' O ' ' A' ' 90' ' ' GLN . . . -53.09 -50.86 79.81 Favored Pre-proline 0 N--CA 1.502 2.14 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.637 ' HD3' ' HB3' ' A' ' 94' ' ' ALA . 31.2 Cg_endo -71.3 82.43 1.09 Allowed 'Trans proline' 0 N--CA 1.482 0.823 0 C-N-CA 122.197 1.931 . . . . 0.0 111.978 -177.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 164.62 57.28 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.492 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.8 ' HG ' HG13 ' A' ' 98' ' ' VAL . 2.3 pt? -86.94 -56.83 3.21 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -177.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.8 HG13 ' HG ' ' A' ' 97' ' ' LEU . 13.1 m -92.48 25.14 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-N 120.833 1.651 . . . . 0.0 111.183 -178.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 30.8 p -90.74 170.47 10.1 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -62.98 -2.56 1.26 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.452 -0.78 . . . . 0.0 112.121 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.57 ' O ' HG12 ' A' ' 101' ' ' VAL . 21.6 t -100.9 2.83 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 CA-C-N 120.416 1.462 . . . . 0.0 111.269 -179.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -133.71 -90.5 0.37 Allowed 'General case' 0 N--CA 1.502 2.133 0 CA-C-N 118.822 0.737 . . . . 0.0 110.97 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.712 ' O ' HD12 ' A' ' 105' ' ' LEU . 46.8 m -143.63 37.98 1.35 Allowed 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.559 -0.713 . . . . 0.0 109.491 -178.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -33.89 -62.66 0.3 Allowed 'General case' 0 N--CA 1.509 2.516 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -178.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.712 HD12 ' O ' ' A' ' 103' ' ' CYS . 3.4 mt 50.18 20.94 0.69 Allowed 'General case' 0 N--CA 1.506 2.341 0 CA-C-N 118.944 0.793 . . . . 0.0 110.946 -179.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 63.23 124.08 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.304 -0.872 . . . . 0.0 109.769 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.8 p -89.25 -160.2 0.65 Allowed 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.586 ' N ' ' HB1' ' A' ' 53' ' ' ALA . 6.2 tt -66.58 -30.97 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.414 ' HB3' ' CE1' ' A' ' 113' ' ' PHE . 96.2 m-70 -69.35 -0.97 7.08 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.007 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 58.67 27.74 61.84 Favored Glycine 0 N--CA 1.498 2.813 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -156.74 167.79 33.72 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -78.44 75.04 5.12 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 122.722 2.281 . . . . 0.0 111.764 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.487 ' CD1' HD11 ' A' ' 117' ' ' LEU . 19.5 p90 173.99 149.75 0.08 Allowed 'General case' 0 N--CA 1.508 2.471 0 O-C-N 121.617 -0.677 . . . . 0.0 110.956 178.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 15.2 p -137.27 129.64 29.68 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 177.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.434 HD13 ' HA ' ' A' ' 115' ' ' LEU . 2.4 mm? 53.32 178.84 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.263 0 O-C-N 121.196 -0.94 . . . . 0.0 110.415 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 7.0 t 58.68 19.09 6.45 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 122.153 -0.342 . . . . 0.0 110.819 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.487 HD11 ' CD1' ' A' ' 113' ' ' PHE . 5.2 mp -62.26 -97.81 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.651 -0.655 . . . . 0.0 109.76 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.464 ' HA ' HD13 ' A' ' 118' ' ' LEU . 4.6 mm? -60.76 -14.62 22.45 Favored 'General case' 0 N--CA 1.504 2.248 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -178.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 59.33 101.54 0.01 OUTLIER Glycine 0 N--CA 1.499 2.852 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -87.02 69.27 10.22 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.724 0.773 . . . . 0.0 109.466 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -89.44 2.33 82.9 Favored Glycine 0 N--CA 1.498 2.771 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 . . . . . 0 N--CA 1.498 1.936 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.436 179.971 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 48.8 m . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.53 HG23 ' H ' ' A' ' 3' ' ' GLY . 2.5 m -54.95 -59.91 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 122.213 -0.304 . . . . 0.0 110.858 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.53 ' H ' HG23 ' A' ' 2' ' ' VAL . . . 95.35 124.03 4.24 Favored Glycine 0 N--CA 1.498 2.794 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.1 t -99.66 24.29 8.47 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 122.293 -0.534 . . . . 0.0 109.775 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.6 m -93.83 174.13 7.33 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.639 ' HB3' HD12 ' A' ' 12' ' ' ILE . 58.8 m -103.77 99.77 9.56 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.7 pt -89.24 155.72 49.02 Favored Pre-proline 0 N--CA 1.499 2.021 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -78.91 150.36 23.54 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.254 1.97 . . . . 0.0 110.503 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 79.49 -5.05 61.66 Favored Glycine 0 N--CA 1.499 2.852 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.562 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 86.8 mmm -140.82 115.23 9.39 Favored 'General case' 0 N--CA 1.501 2.105 0 CA-C-N 118.665 1.232 . . . . 0.0 108.968 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 85.72 -56.94 0.08 Allowed 'General case' 0 N--CA 1.515 2.795 0 CA-C-N 119.939 1.245 . . . . 0.0 108.434 -179.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.639 HD12 ' HB3' ' A' ' 6' ' ' CYS . 80.7 mt -110.84 100.79 47.51 Favored Pre-proline 0 N--CA 1.489 1.507 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 178.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -80.48 172.94 12.91 Favored 'Trans proline' 0 C--O 1.22 -0.413 0 C-N-CA 121.41 1.407 . . . . 0.0 111.284 -176.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 50.8 m-70 -75.79 143.33 41.99 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.454 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 2.7 m120 63.36 61.94 1.76 Allowed Pre-proline 0 N--CA 1.502 2.152 0 O-C-N 121.769 -0.582 . . . . 0.0 109.742 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.454 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 40.3 Cg_endo -83.45 167.79 13.32 Favored 'Trans proline' 0 N--CA 1.483 0.859 0 C-N-CA 122.459 2.106 . . . . 0.0 111.693 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 42.2 mt 47.64 45.89 17.91 Favored 'General case' 0 N--CA 1.504 2.233 0 CA-C-O 121.105 0.478 . . . . 0.0 111.516 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -74.13 -39.67 63.16 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.538 -0.726 . . . . 0.0 109.447 179.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.3 t -66.58 -25.95 66.88 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.533 ' O ' HG23 ' A' ' 24' ' ' VAL . 37.1 m -75.28 -41.75 56.48 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -43.75 97.03 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.434 ' HA ' ' CE3' ' A' ' 22' ' ' TRP . 38.7 m95 -74.19 -25.92 59.98 Favored 'General case' 0 N--CA 1.501 2.087 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.129 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -69.8 -28.47 65.76 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.737 HG22 ' CE1' ' A' ' 93' ' ' PHE . 52.1 t -75.61 -43.02 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 177.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.447 ' HB3' HD13 ' A' ' 82' ' ' LEU . 0.8 OUTLIER -55.78 -41.77 74.56 Favored 'General case' 0 N--CA 1.503 2.19 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.349 -179.403 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.1 m -77.67 -53.58 7.38 Favored 'General case' 0 N--CA 1.509 2.516 0 O-C-N 122.085 -0.385 . . . . 0.0 111.685 -178.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -60.5 -24.99 65.74 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.851 -0.53 . . . . 0.0 110.453 -178.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.554 HG23 ' O ' ' A' ' 24' ' ' VAL . 31.8 p -97.23 -64.11 1.07 Allowed 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -177.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.558 ' O ' HG23 ' A' ' 31' ' ' VAL . 19.6 m -101.2 14.55 31.59 Favored 'General case' 0 N--CA 1.508 2.45 0 O-C-N 121.386 -0.821 . . . . 0.0 112.0 -178.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 57.05 21.16 37.33 Favored Glycine 0 N--CA 1.505 3.255 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 29' ' ' CYS . 23.6 t -107.74 160.43 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.242 0 O-C-N 121.858 -0.79 . . . . 0.0 109.069 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.436 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 130.65 -179.39 16.97 Favored Glycine 0 N--CA 1.5 2.94 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -66.23 173.88 6.81 Favored 'Trans proline' 0 N--CA 1.486 1.076 0 CA-C-N 119.263 1.531 . . . . 0.0 109.736 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 2.9 ptt180 -92.81 82.66 4.72 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 122.086 0.945 . . . . 0.0 110.742 -177.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 24.5 mt -134.82 138.93 44.68 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.87 160.86 3.22 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -73.08 -56.49 5.05 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.963 -0.461 . . . . 0.0 111.209 -178.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -54.32 -35.65 62.9 Favored 'General case' 0 N--CA 1.506 2.364 0 O-C-N 121.913 -0.492 . . . . 0.0 110.47 -178.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -64.09 -57.65 8.98 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 5.0 ttm -53.08 -47.48 68.48 Favored 'General case' 0 N--CA 1.504 2.238 0 CA-C-O 121.6 0.714 . . . . 0.0 109.401 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 23.8 ttmt -55.95 -37.72 69.37 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.49 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.22 -35.21 79.83 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.61 -41.69 98.27 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 19.5 m -66.26 -38.65 88.32 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.552 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 84.9 m -69.76 -28.49 65.81 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -74.51 -32.23 62.43 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -74.54 -35.49 63.11 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.442 HD11 HG12 ' A' ' 98' ' ' VAL . 2.3 tt -75.68 -27.23 58.19 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.487 ' HG2' HD13 ' A' ' 105' ' ' LEU . 1.6 mm-40 -77.22 -52.16 9.71 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.57 -45.57 69.99 Favored 'General case' 0 N--CA 1.508 2.441 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.441 HD12 HG12 ' A' ' 12' ' ' ILE . 23.7 mm -67.57 106.47 1.26 Allowed Pre-proline 0 N--CA 1.49 1.528 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 175.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -58.51 151.2 63.64 Favored 'Trans proline' 0 N--CA 1.479 0.642 0 C-N-CA 121.479 1.453 . . . . 0.0 110.962 -176.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.423 ' HA ' ' HD3' ' A' ' 56' ' ' ARG . . . -40.72 -29.7 0.1 Allowed 'General case' 0 N--CA 1.507 2.377 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.686 -178.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -73.77 131.33 41.46 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 8.3 m 72.35 6.28 5.46 Favored 'General case' 0 N--CA 1.508 2.433 0 O-C-N 122.125 -0.36 . . . . 0.0 111.335 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.423 ' HD3' ' HA ' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -49.21 -85.23 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.715 0 CA-C-N 119.247 0.931 . . . . 0.0 110.038 -179.765 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 85.5 m -38.09 -45.08 0.88 Allowed 'General case' 0 N--CA 1.518 2.97 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.411 ' O ' HD12 ' A' ' 62' ' ' ILE . 25.5 tt0 -39.86 -50.7 2.45 Favored 'General case' 0 N--CA 1.511 2.586 0 CA-C-N 119.819 1.19 . . . . 0.0 112.148 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -43.86 -47.02 8.2 Favored 'General case' 0 N--CA 1.518 2.939 0 O-C-N 121.573 -0.705 . . . . 0.0 111.609 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 1.008 HG21 HD13 ' A' ' 97' ' ' LEU . 45.2 t -53.71 -45.24 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.55 -32.15 72.21 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.85 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.693 HG23 ' HB ' ' A' ' 67' ' ' VAL . 1.2 mp -70.08 -28.19 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.795 HD13 ' O ' ' A' ' 63' ' ' LEU . 0.9 OUTLIER -77.95 -39.51 42.39 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.047 -179.349 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 14.4 ttp -78.25 -54.8 5.83 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.927 -0.483 . . . . 0.0 110.374 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -80.95 -23.58 38.71 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 122.202 -0.311 . . . . 0.0 111.189 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.33 148.45 13.89 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 -178.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.693 ' HB ' HG23 ' A' ' 62' ' ' ILE . 7.7 p -118.01 159.52 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 O-C-N 122.206 -0.585 . . . . 0.0 109.661 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.647 HG22 ' NE2' ' A' ' 74' ' ' HIS . 76.2 t -115.21 157.56 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 CA-C-O 122.038 0.923 . . . . 0.0 110.368 -178.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.404 ' N ' HG12 ' A' ' 68' ' ' VAL . 23.6 p -117.23 160.65 20.73 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.569 -177.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.6 t -63.5 -34.45 77.8 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.129 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.8 p -63.82 -17.74 63.42 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.73 9.1 47.24 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -97.49 156.88 16.29 Favored 'General case' 0 N--CA 1.503 2.207 0 CA-C-N 118.278 1.039 . . . . 0.0 109.892 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.647 ' NE2' HG22 ' A' ' 68' ' ' VAL . 9.9 m170 -116.04 155.06 28.79 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -141.76 -175.96 4.58 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.009 0.433 . . . . 0.0 109.908 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 59.45 -143.76 46.13 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.3 22.06 4.56 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 122.289 -0.536 . . . . 0.0 110.167 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 55.0 mt -81.43 -15.26 55.65 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.735 -0.603 . . . . 0.0 110.739 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.707 HD21 ' HB3' ' A' ' 90' ' ' GLN . 4.7 tt -57.26 91.99 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -128.38 179.77 5.46 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.26 0.552 . . . . 0.0 109.818 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.75 106.05 7.11 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.313 0.577 . . . . 0.0 110.696 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.564 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 23.0 mt -81.33 169.63 18.34 Favored Pre-proline 0 N--CA 1.495 1.798 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 177.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.564 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 28.3 Cg_endo -66.75 99.4 0.45 Allowed 'Trans proline' 0 C--N 1.329 -0.487 0 C-N-CA 120.978 1.119 . . . . 0.0 111.201 -178.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 103.07 -14.05 55.67 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 6.1 m -123.65 92.22 48.89 Favored Pre-proline 0 N--CA 1.504 2.253 0 CA-C-N 119.323 1.561 . . . . 0.0 110.352 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -72.12 166.11 30.61 Favored 'Trans proline' 0 N--CA 1.483 0.87 0 C-N-CA 121.598 1.532 . . . . 0.0 111.04 -179.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.5 mtm180 -46.9 -28.52 1.62 Allowed 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.152 0.501 . . . . 0.0 109.754 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.8 tm0? -58.65 -52.21 66.65 Favored 'General case' 0 N--CA 1.503 2.199 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.483 -178.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 60.1 t -64.23 -41.75 93.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.746 -0.596 . . . . 0.0 109.576 -178.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.707 ' HB3' HD21 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -63.57 -25.94 68.47 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.29 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -79.0 -33.46 44.98 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.51 -47.68 63.01 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.737 ' CE1' HG22 ' A' ' 24' ' ' VAL . 42.5 t80 -78.27 -25.37 46.72 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.478 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.67 ' HB3' ' HD3' ' A' ' 95' ' ' PRO . . . -42.69 -52.17 11.18 Favored Pre-proline 0 N--CA 1.504 2.227 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -177.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.67 ' HD3' ' HB3' ' A' ' 94' ' ' ALA . 29.6 Cg_endo -70.98 -164.1 0.14 Allowed 'Trans proline' 0 C--N 1.328 -0.513 0 C-N-CA 121.689 1.593 . . . . 0.0 110.296 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 60.57 24.68 14.37 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -178.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 1.008 HD13 HG21 ' A' ' 60' ' ' VAL . 6.6 mt -73.42 -67.93 0.54 Allowed 'General case' 0 N--CA 1.505 2.276 0 O-C-N 122.034 -0.416 . . . . 0.0 111.42 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.442 HG12 HD11 ' A' ' 48' ' ' LEU . 14.7 m -85.52 22.11 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.35 -0.843 . . . . 0.0 111.085 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 30.8 p -99.44 173.31 6.81 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -59.06 -4.16 0.46 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.532 -0.73 . . . . 0.0 111.764 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.53 ' O ' HG12 ' A' ' 101' ' ' VAL . 20.0 t -91.83 -0.27 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-N 120.545 1.52 . . . . 0.0 111.403 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -140.82 -89.39 0.16 Allowed 'General case' 0 N--CA 1.504 2.261 0 CA-C-N 118.974 0.807 . . . . 0.0 111.247 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.443 ' O ' HD12 ' A' ' 105' ' ' LEU . 55.8 m -145.02 42.38 1.31 Allowed 'General case' 0 N--CA 1.508 2.471 0 O-C-N 121.432 -0.792 . . . . 0.0 109.518 -178.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -36.2 -62.5 0.44 Allowed 'General case' 0 N--CA 1.512 2.67 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -178.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.487 HD13 ' HG2' ' A' ' 49' ' ' GLU . 1.9 mt 46.3 27.76 0.62 Allowed 'General case' 0 N--CA 1.513 2.722 0 CA-C-N 118.988 0.813 . . . . 0.0 111.268 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 105' ' ' LEU . . . 70.34 150.34 0.09 Allowed 'General case' 0 N--CA 1.507 2.408 0 O-C-N 121.199 -0.938 . . . . 0.0 109.174 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.0 p -123.16 -163.78 1.14 Allowed 'General case' 0 N--CA 1.505 2.294 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.479 HG23 ' CD2' ' A' ' 109' ' ' HIS . 7.2 tp -66.12 -31.23 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.479 ' CD2' HG23 ' A' ' 108' ' ' ILE . 87.7 m-70 -75.68 5.55 6.0 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.974 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 57.96 32.29 66.28 Favored Glycine 0 N--CA 1.499 2.834 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -164.42 171.95 40.06 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 110.116 -1.193 . . . . 0.0 110.116 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -75.8 80.02 2.71 Favored 'Trans proline' 0 N--CA 1.48 0.708 0 C-N-CA 122.626 2.217 . . . . 0.0 110.855 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.461 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER 174.04 169.16 0.21 Allowed 'General case' 0 N--CA 1.502 2.163 0 CA-C-O 121.462 0.649 . . . . 0.0 111.213 179.176 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 10.3 p -178.19 137.08 0.17 Allowed 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.8 mm? 51.24 25.58 2.54 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.362 -0.836 . . . . 0.0 110.252 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 70.1 m -110.07 -65.76 1.13 Allowed 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.407 HD23 ' H ' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -49.63 -80.17 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.523 0 O-C-N 122.042 -0.411 . . . . 0.0 110.188 -179.949 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 15.7 mt -53.45 -16.47 1.46 Allowed 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -101.52 82.58 0.47 Allowed Glycine 0 N--CA 1.502 3.035 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -153.13 70.8 0.88 Allowed 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.687 0.756 . . . . 0.0 109.159 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -68.75 -16.99 70.73 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.098 0 CA-C-O 118.236 -0.887 . . . . 0.0 110.034 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 26.3 t . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.627 ' O ' HG22 ' A' ' 2' ' ' VAL . 14.5 p -90.9 31.86 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 122.256 -0.278 . . . . 0.0 110.354 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.419 ' C ' HG22 ' A' ' 4' ' ' THR . . . 135.29 -86.08 0.25 Allowed Glycine 0 N--CA 1.499 2.873 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.419 HG22 ' C ' ' A' ' 3' ' ' GLY . 9.5 t 41.28 30.72 0.13 Allowed 'General case' 0 N--CA 1.507 2.391 0 CA-C-O 121.157 0.504 . . . . 0.0 111.729 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.3 m 59.12 -159.28 0.3 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.79 -0.569 . . . . 0.0 110.028 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 34.3 m 67.64 130.6 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.164 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.653 ' N ' HD13 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -108.12 161.9 21.77 Favored Pre-proline 0 N--CA 1.503 2.197 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.488 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -78.5 153.59 27.11 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 122.126 1.884 . . . . 0.0 109.904 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 58.32 24.18 55.07 Favored Glycine 0 N--CA 1.499 2.847 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.577 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 38.7 mmm -138.07 95.08 2.96 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.98 -0.718 . . . . 0.0 109.1 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.577 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 86.77 -56.43 0.05 Allowed 'General case' 0 N--CA 1.515 2.803 0 CA-C-N 119.008 0.822 . . . . 0.0 108.796 -178.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.6 mt -104.59 101.11 26.16 Favored Pre-proline 0 N--CA 1.494 1.73 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 178.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -81.78 173.2 11.45 Favored 'Trans proline' 0 N--CA 1.476 0.457 0 C-N-CA 121.555 1.504 . . . . 0.0 111.764 -176.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 45.0 m-70 -74.52 146.15 42.9 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.519 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 0.9 OUTLIER 60.79 54.99 3.5 Favored Pre-proline 0 N--CA 1.501 2.094 0 O-C-N 121.56 -0.712 . . . . 0.0 109.955 -179.098 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.519 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 40.4 Cg_endo -81.17 166.96 18.19 Favored 'Trans proline' 0 N--CA 1.484 0.953 0 C-N-CA 122.239 1.959 . . . . 0.0 111.606 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 38.3 mt 51.09 45.08 28.3 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.921 177.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -68.09 -41.38 81.94 Favored 'General case' 0 N--CA 1.505 2.323 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.57 -26.27 68.62 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 178.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.477 ' O ' HG23 ' A' ' 24' ' ' VAL . 60.7 m -75.52 -38.65 59.25 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.717 ' HD3' HD12 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -62.43 -50.68 70.55 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.004 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.457 ' HA ' ' CE3' ' A' ' 22' ' ' TRP . 32.1 m95 -69.86 -26.46 64.21 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 119.517 -0.873 . . . . 0.0 109.853 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.432 ' O ' ' CD1' ' A' ' 23' ' ' TYR . 7.7 t80 -67.59 -30.35 69.93 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.685 HG22 ' CD1' ' A' ' 93' ' ' PHE . 59.0 t -74.43 -44.43 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 108.301 -0.999 . . . . 0.0 108.301 178.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 p -56.7 -40.96 76.55 Favored 'General case' 0 N--CA 1.505 2.277 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.38 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.3 m -77.22 -53.19 8.04 Favored 'General case' 0 N--CA 1.509 2.497 0 O-C-N 122.01 -0.432 . . . . 0.0 111.872 -178.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -61.8 -24.88 67.14 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.798 -0.563 . . . . 0.0 110.6 -178.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.542 HG23 ' O ' ' A' ' 24' ' ' VAL . 35.4 p -95.66 -63.86 1.11 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.966 -0.459 . . . . 0.0 111.956 -177.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.46 ' O ' HG23 ' A' ' 31' ' ' VAL . 3.7 m -100.93 11.91 38.68 Favored 'General case' 0 N--CA 1.509 2.491 0 O-C-N 121.315 -0.866 . . . . 0.0 111.424 -178.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 59.35 20.23 49.96 Favored Glycine 0 N--CA 1.502 3.056 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -178.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 29' ' ' CYS . 61.1 t -106.37 158.72 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 O-C-N 121.888 -0.772 . . . . 0.0 109.079 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.434 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 135.04 179.06 16.14 Favored Glycine 0 N--CA 1.497 2.761 0 N-CA-C 108.74 -1.744 . . . . 0.0 108.74 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -65.8 172.39 8.37 Favored 'Trans proline' 0 N--CA 1.483 0.904 0 CA-C-N 119.289 1.545 . . . . 0.0 109.635 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 27.8 mtt180 -92.41 74.77 5.23 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 122.155 0.978 . . . . 0.0 109.705 -178.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 35' ' ' LEU . 0.2 OUTLIER -124.05 135.87 53.87 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.084 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.57 150.84 3.51 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.977 -0.452 . . . . 0.0 110.0 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.4 m -73.74 -28.68 61.81 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.736 -0.603 . . . . 0.0 111.185 -178.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -72.74 -31.4 64.92 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.867 -0.521 . . . . 0.0 109.656 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -75.72 -32.66 60.13 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.41 ' HB3' ' CD2' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -70.29 -53.59 16.19 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.575 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 21.7 tttp -56.73 -37.41 70.95 Favored 'General case' 0 N--CA 1.506 2.374 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.19 -38.48 90.62 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.3 mpt_? -65.08 -42.65 93.92 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 17.0 m -65.21 -34.72 79.05 Favored 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.883 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 82.3 m -74.44 -29.8 61.63 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.7 ttt180 -73.63 -32.58 64.11 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -78.75 -35.89 43.95 Favored 'General case' 0 N--CA 1.502 2.17 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.112 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.1 tt -69.63 -37.42 76.78 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -75.56 -41.23 55.38 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.85 -38.01 64.24 Favored 'General case' 0 N--CA 1.509 2.48 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 177.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 59.8 mt -78.92 105.69 3.39 Favored Pre-proline 0 N--CA 1.488 1.434 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 176.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -60.01 152.05 67.72 Favored 'Trans proline' 0 N--CA 1.481 0.745 0 C-N-CA 121.712 1.608 . . . . 0.0 111.278 -176.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -41.37 -29.17 0.14 Allowed 'General case' 0 N--CA 1.507 2.415 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.376 -178.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -67.12 121.85 16.51 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 66.2 m 60.79 15.55 6.0 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 122.195 -0.316 . . . . 0.0 110.537 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.58 -91.38 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.259 -0.901 . . . . 0.0 109.876 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 54.3 m -32.28 -33.95 0.01 OUTLIER 'General case' 0 N--CA 1.521 3.112 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -40.41 -51.64 2.82 Favored 'General case' 0 N--CA 1.509 2.501 0 CA-C-N 119.759 1.163 . . . . 0.0 111.893 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.592 ' HA ' HD12 ' A' ' 62' ' ' ILE . . . -40.42 -47.88 2.66 Favored 'General case' 0 N--CA 1.514 2.746 0 O-C-N 121.897 -0.502 . . . . 0.0 112.108 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.725 HG21 HD13 ' A' ' 97' ' ' LEU . 24.4 t -58.26 -49.22 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.57 -26.27 63.43 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.871 HG23 ' HB ' ' A' ' 67' ' ' VAL . 9.3 mt -78.81 -30.76 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.996 -0.44 . . . . 0.0 110.272 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.71 ' O ' HD23 ' A' ' 63' ' ' LEU . 4.4 tt -78.03 -42.03 33.79 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 120.014 -0.675 . . . . 0.0 109.334 -178.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 6.8 tpt -78.27 -53.17 7.61 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.313 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -81.51 -21.87 38.33 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 122.147 -0.346 . . . . 0.0 111.429 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.13 149.9 14.35 Favored Glycine 0 N--CA 1.499 2.878 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -178.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.871 ' HB ' HG23 ' A' ' 62' ' ' ILE . 7.3 p -118.17 160.18 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.295 0 O-C-N 122.224 -0.574 . . . . 0.0 110.43 -179.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.735 HG22 ' NE2' ' A' ' 74' ' ' HIS . 42.3 t -114.72 157.35 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 28.2 p -117.43 160.27 21.45 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.544 0.688 . . . . 0.0 110.171 -177.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.3 t -61.65 -25.7 67.54 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.35 -178.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.2 p -80.19 -14.19 58.64 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 122.253 -0.279 . . . . 0.0 110.721 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.23 13.2 34.02 Favored Glycine 0 N--CA 1.498 2.804 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -99.15 156.92 16.71 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-N 118.103 0.951 . . . . 0.0 109.092 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.735 ' NE2' HG22 ' A' ' 68' ' ' VAL . 8.5 m170 -115.65 155.28 27.98 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -144.75 -177.14 5.36 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 120.949 0.404 . . . . 0.0 110.093 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 59.62 -141.03 47.67 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 108.876 -1.69 . . . . 0.0 108.876 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.6 ttp180 55.08 22.45 4.5 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 122.267 -0.549 . . . . 0.0 110.431 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -80.47 -15.26 57.18 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.609 -0.682 . . . . 0.0 110.657 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.717 HD12 ' HD3' ' A' ' 21' ' ' ARG . 2.1 tp -67.46 90.65 0.25 Allowed 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -126.03 177.26 6.46 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -60.81 100.69 0.12 Allowed 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 121.638 0.732 . . . . 0.0 110.535 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.559 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 19.7 mt -80.41 170.74 14.51 Favored Pre-proline 0 N--CA 1.498 1.946 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 177.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.559 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 29.2 Cg_endo -70.07 98.78 0.74 Allowed 'Trans proline' 0 C--O 1.219 -0.447 0 C-N-CA 120.709 0.939 . . . . 0.0 109.883 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 100.09 3.53 55.69 Favored Glycine 0 N--CA 1.495 2.625 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 3.5 m -138.76 91.13 12.09 Favored Pre-proline 0 N--CA 1.503 2.223 0 CA-C-N 119.114 1.457 . . . . 0.0 109.341 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -74.45 162.11 38.82 Favored 'Trans proline' 0 N--CA 1.481 0.786 0 C-N-CA 121.343 1.362 . . . . 0.0 111.2 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 3.8 mmm180 -47.92 -29.21 3.16 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -54.35 -50.46 67.41 Favored 'General case' 0 N--CA 1.508 2.432 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.809 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 63.4 t -64.63 -36.44 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.655 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 52.4 mm-40 -63.27 -26.7 68.9 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.73 -37.21 41.92 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.49 -48.76 71.51 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.685 ' CD1' HG22 ' A' ' 24' ' ' VAL . 41.3 t80 -78.51 -25.22 45.55 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 122.248 -0.282 . . . . 0.0 110.654 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.755 ' HB3' ' HD3' ' A' ' 95' ' ' PRO . . . -40.88 -52.44 6.67 Favored Pre-proline 0 N--CA 1.505 2.315 0 CA-C-O 118.978 -0.534 . . . . 0.0 112.09 -177.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.755 ' HD3' ' HB3' ' A' ' 94' ' ' ALA . 30.6 Cg_endo -74.44 -173.65 1.56 Allowed 'Trans proline' 0 C--N 1.328 -0.524 0 C-N-CA 121.708 1.606 . . . . 0.0 109.834 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 17.6 mttm 68.31 26.61 6.8 Favored 'General case' 0 N--CA 1.504 2.243 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -178.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.725 HD13 HG21 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -73.53 -69.61 0.42 Allowed 'General case' 0 N--CA 1.516 2.848 0 O-C-N 121.837 -0.539 . . . . 0.0 110.791 -179.302 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 32.8 m -88.38 26.12 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 O-C-N 121.129 -0.982 . . . . 0.0 110.385 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 27.4 p -100.1 173.51 6.6 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.77 -1.62 0.43 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.565 -0.71 . . . . 0.0 112.019 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.539 ' O ' HG12 ' A' ' 101' ' ' VAL . 20.9 t -96.77 1.29 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 CA-C-N 120.562 1.528 . . . . 0.0 111.222 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -141.09 -91.48 0.15 Allowed 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.488 -0.758 . . . . 0.0 111.318 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.536 ' O ' HD12 ' A' ' 105' ' ' LEU . 60.5 m -142.74 45.46 1.59 Allowed 'General case' 0 N--CA 1.504 2.263 0 O-C-N 121.425 -0.797 . . . . 0.0 109.577 -178.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 58.1 t-20 -40.39 -68.84 0.15 Allowed 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.297 -0.877 . . . . 0.0 113.258 -178.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.536 HD12 ' O ' ' A' ' 103' ' ' CYS . 2.1 mt 50.51 27.16 2.71 Favored 'General case' 0 N--CA 1.506 2.357 0 C-N-CA 120.329 -0.549 . . . . 0.0 110.348 -178.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 105' ' ' LEU . . . 68.52 163.26 0.22 Allowed 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.332 -0.855 . . . . 0.0 109.364 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.503 ' OG1' ' CE1' ' A' ' 109' ' ' HIS . 16.6 p -135.92 -159.94 1.01 Allowed 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 120.869 0.366 . . . . 0.0 110.439 -176.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.504 HG23 ' N ' ' A' ' 109' ' ' HIS . 0.7 OUTLIER -93.13 -47.25 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 121.9 -0.5 . . . . 0.0 111.563 -179.439 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.512 ' NE2' ' CB ' ' A' ' 114' ' ' CYS . 0.0 OUTLIER -54.28 -22.64 12.38 Favored 'General case' 0 N--CA 1.529 3.479 0 O-C-N 121.673 -0.642 . . . . 0.0 109.88 -178.838 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.34 68.81 0.79 Allowed Glycine 0 N--CA 1.499 2.898 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.698 177.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 143.57 173.19 14.91 Favored Glycine 0 N--CA 1.5 2.91 0 CA-C-N 118.809 1.305 . . . . 0.0 111.4 178.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -73.67 85.47 1.3 Allowed 'Trans proline' 0 N--CA 1.482 0.814 0 C-N-CA 122.79 2.327 . . . . 0.0 110.375 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.573 ' CG ' HD11 ' A' ' 117' ' ' LEU . 0.0 OUTLIER 176.62 -173.01 0.09 Allowed 'General case' 0 N--CA 1.515 2.78 0 C-N-CA 120.389 -0.524 . . . . 0.0 111.392 -179.823 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.512 ' CB ' ' NE2' ' A' ' 109' ' ' HIS . 28.7 p 160.6 -174.91 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.681 0 C-N-CA 123.534 0.734 . . . . 0.0 109.307 178.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 70.48 -83.73 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 O-C-N 122.223 -0.298 . . . . 0.0 110.611 178.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 15.1 m -87.59 -69.76 0.67 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.896 -0.502 . . . . 0.0 110.526 -178.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.573 HD11 ' CG ' ' A' ' 113' ' ' PHE . 0.4 OUTLIER 66.05 -87.4 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -179.415 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.8 mp -56.53 -15.84 4.99 Favored 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.04 136.18 0.35 Allowed Glycine 0 N--CA 1.5 2.918 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 60.46 72.85 0.5 Allowed 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.577 0.703 . . . . 0.0 109.909 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.55 21.4 44.77 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 . . . . . 0 N--CA 1.498 1.93 0 CA-C-O 118.061 -0.971 . . . . 0.0 109.559 180.0 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.8 m . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 48.6 t -72.16 -77.08 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 95.45 134.06 7.62 Favored Glycine 0 N--CA 1.5 2.919 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.5 t -96.13 20.92 9.51 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 122.219 -0.577 . . . . 0.0 110.105 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 60.1 p -168.77 157.4 8.32 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 34.7 m 60.3 161.87 0.05 Allowed 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -154.24 166.53 15.66 Favored Pre-proline 0 N--CA 1.507 2.416 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -76.68 143.87 24.36 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.301 2.001 . . . . 0.0 110.107 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 61.38 14.63 42.17 Favored Glycine 0 N--CA 1.501 2.969 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.573 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 5.1 mmt -141.06 108.01 5.43 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 87.04 -59.93 0.04 OUTLIER 'General case' 0 N--CA 1.514 2.767 0 CA-C-N 119.94 1.246 . . . . 0.0 108.245 -178.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.799 HD11 ' HB3' ' A' ' 55' ' ' CYS . 21.9 mt -109.82 97.54 29.29 Favored Pre-proline 0 N--CA 1.492 1.667 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 178.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -83.62 174.75 8.52 Favored 'Trans proline' 0 N--CA 1.476 0.442 0 C-N-CA 121.814 1.676 . . . . 0.0 111.503 -177.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 45.2 m-70 -71.93 142.21 49.45 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.472 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 25.8 m120 59.1 59.02 5.36 Favored Pre-proline 0 N--CA 1.5 2.058 0 O-C-N 121.436 -0.79 . . . . 0.0 109.003 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.472 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 38.2 Cg_endo -78.97 151.5 24.13 Favored 'Trans proline' 0 N--CA 1.484 0.95 0 C-N-CA 122.345 2.03 . . . . 0.0 112.264 -178.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.928 HD13 ' HB1' ' A' ' 59' ' ' ALA . 6.7 mp 43.0 42.65 3.25 Favored 'General case' 0 N--CA 1.502 2.158 0 CA-C-O 121.163 0.506 . . . . 0.0 111.825 178.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -65.37 -32.4 74.02 Favored 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.23 -25.98 67.15 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 35.1 m -76.1 -38.46 56.92 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.6 -50.28 73.21 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.42 ' HA ' ' CE3' ' A' ' 22' ' ' TRP . 36.5 m95 -70.8 -27.37 63.85 Favored 'General case' 0 N--CA 1.501 2.122 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.786 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.744 ' HE1' HG23 ' A' ' 37' ' ' THR . 7.9 t80 -68.12 -31.91 71.83 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.583 HG22 ' CD1' ' A' ' 93' ' ' PHE . 86.4 t -74.98 -40.58 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 177.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.507 ' HB3' HD13 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -55.01 -38.64 68.14 Favored 'General case' 0 N--CA 1.502 2.163 0 C-N-CA 120.095 -0.642 . . . . 0.0 109.561 -179.626 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.7 m -77.07 -51.81 10.41 Favored 'General case' 0 N--CA 1.506 2.356 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.554 -178.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -62.22 -25.21 67.68 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.795 -0.565 . . . . 0.0 111.189 -178.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 79.6 p -97.3 -63.84 1.1 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 122.233 -0.292 . . . . 0.0 111.763 -177.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.551 ' O ' HG23 ' A' ' 31' ' ' VAL . 55.8 m -101.72 14.72 31.13 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.358 -0.839 . . . . 0.0 112.129 -178.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 55.82 21.72 30.96 Favored Glycine 0 N--CA 1.505 3.254 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 29' ' ' CYS . 56.3 t -106.89 162.78 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.821 -0.811 . . . . 0.0 109.011 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.489 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 130.16 178.24 15.31 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 -179.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -66.55 174.88 5.77 Favored 'Trans proline' 0 N--CA 1.487 1.12 0 CA-C-N 119.165 1.482 . . . . 0.0 109.571 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.2 ptp85 -92.21 52.31 1.93 Allowed 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.98 0.895 . . . . 0.0 109.77 -178.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.48 127.83 41.84 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.47 148.78 4.78 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.807 -0.558 . . . . 0.0 110.171 -178.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.744 HG23 ' HE1' ' A' ' 23' ' ' TYR . 61.1 m -65.77 -40.34 91.93 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.67 -0.643 . . . . 0.0 111.947 -178.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -64.88 -44.29 90.15 Favored 'General case' 0 N--CA 1.504 2.264 0 CA-C-N 118.644 0.656 . . . . 0.0 109.72 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -66.87 -27.68 67.72 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -69.45 -59.03 3.25 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.31 -31.87 55.17 Favored 'General case' 0 N--CA 1.5 2.06 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.633 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.91 -40.79 78.93 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -64.24 -37.41 87.37 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 15.9 m -72.34 -33.45 67.31 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.922 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 21.8 m -73.69 -28.46 61.75 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 24.5 ttm180 -78.19 -35.56 48.5 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.543 ' O ' HD12 ' A' ' 51' ' ' ILE . 8.3 mt-30 -78.03 -41.92 34.13 Favored 'General case' 0 N--CA 1.502 2.157 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.494 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.549 HD22 ' O ' ' A' ' 103' ' ' CYS . 5.6 tt -64.9 -45.22 86.82 Favored 'General case' 0 C--O 1.2 -1.552 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.14 -28.66 66.64 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.497 ' HB3' ' O ' ' A' ' 47' ' ' GLN . . . -55.2 -60.34 3.53 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.543 HD12 ' O ' ' A' ' 47' ' ' GLN . 2.8 mt -58.73 103.92 0.39 Allowed Pre-proline 0 N--CA 1.51 2.572 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 178.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -50.18 144.67 22.24 Favored 'Trans proline' 0 N--CA 1.488 1.166 0 C-N-CA 121.636 1.558 . . . . 0.0 113.094 -175.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.488 ' HA ' ' CG ' ' A' ' 56' ' ' ARG . . . -22.82 -46.19 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.767 0 C-N-CA 124.28 1.032 . . . . 0.0 113.693 -177.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -62.75 138.11 58.43 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.799 ' HB3' HD11 ' A' ' 12' ' ' ILE . 20.8 m 61.68 22.82 13.25 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 122.0 -0.438 . . . . 0.0 109.819 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.488 ' CG ' ' HA ' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -44.72 -93.08 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.892 0 O-C-N 121.063 -1.023 . . . . 0.0 110.72 -179.697 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.691 ' SG ' HG21 ' A' ' 98' ' ' VAL . 76.1 m -38.94 -22.35 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.555 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 -178.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -39.07 -48.02 1.61 Allowed 'General case' 0 N--CA 1.512 2.644 0 CA-C-N 120.984 1.72 . . . . 0.0 112.249 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.928 ' HB1' HD13 ' A' ' 17' ' ' LEU . . . -44.56 -57.95 3.31 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.62 -0.675 . . . . 0.0 111.42 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.517 HG22 HD13 ' A' ' 97' ' ' LEU . 41.4 t -48.51 -41.85 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.266 0 CA-C-O 121.125 0.488 . . . . 0.0 109.686 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 22.9 mtp85 -60.09 -64.15 1.05 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.905 HD12 ' HB ' ' A' ' 67' ' ' VAL . 36.9 mm -46.13 -26.95 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.787 -0.57 . . . . 0.0 111.365 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.58 ' C ' HD13 ' A' ' 63' ' ' LEU . 3.5 tm? -77.82 -43.64 29.85 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.226 -0.989 . . . . 0.0 109.705 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -77.67 -53.38 7.62 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.6 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -79.93 -22.17 42.99 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 122.039 -0.413 . . . . 0.0 111.025 -179.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.96 154.06 15.03 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -178.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.905 ' HB ' HD12 ' A' ' 62' ' ' ILE . 2.5 p -117.46 158.94 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.341 0 CA-C-O 121.361 0.6 . . . . 0.0 109.548 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.665 HG22 ' NE2' ' A' ' 74' ' ' HIS . 54.7 t -115.69 157.05 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.6 p -117.48 159.53 22.67 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.522 -177.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.9 t -61.95 -32.73 73.19 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.23 0.538 . . . . 0.0 110.175 -178.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.2 p -65.69 -18.85 65.63 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.254 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.13 16.54 25.15 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -106.36 156.9 18.04 Favored 'General case' 0 N--CA 1.503 2.197 0 CA-C-N 118.284 1.042 . . . . 0.0 109.626 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.665 ' NE2' HG22 ' A' ' 68' ' ' VAL . 11.0 m170 -116.09 154.08 30.59 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.589 -0.695 . . . . 0.0 109.143 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -140.63 -174.99 4.12 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.044 0.449 . . . . 0.0 109.851 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 56.3 -141.29 41.33 Favored Glycine 0 N--CA 1.497 2.715 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.3 ttp180 54.39 24.8 5.44 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 122.228 -0.572 . . . . 0.0 110.54 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.4 mt -78.7 -19.03 53.39 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.698 -0.626 . . . . 0.0 110.38 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.763 HD21 ' HB3' ' A' ' 90' ' ' GLN . 6.5 tp -52.86 95.37 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.703 -0.623 . . . . 0.0 109.998 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -132.78 172.86 12.01 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -67.82 103.18 1.38 Allowed 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.497 0.665 . . . . 0.0 110.484 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.603 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 24.7 mt -78.45 171.33 12.79 Favored Pre-proline 0 N--CA 1.492 1.655 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 177.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.603 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 27.6 Cg_endo -66.61 99.21 0.43 Allowed 'Trans proline' 0 C--N 1.327 -0.579 0 C-N-CA 120.939 1.093 . . . . 0.0 110.715 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 98.18 -12.11 63.69 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 7.0 m -119.58 92.17 45.74 Favored Pre-proline 0 N--CA 1.5 2.063 0 CA-C-N 119.207 1.503 . . . . 0.0 110.101 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -73.16 164.46 35.33 Favored 'Trans proline' 0 N--CA 1.483 0.863 0 C-N-CA 121.514 1.476 . . . . 0.0 111.045 -179.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -46.32 -28.56 1.35 Allowed 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 177.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -54.47 -54.6 38.79 Favored 'General case' 0 N--CA 1.504 2.243 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.537 -178.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 64.5 t -60.84 -41.52 88.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.761 -0.587 . . . . 0.0 109.843 -178.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.763 ' HB3' HD21 ' A' ' 79' ' ' LEU . 7.1 mp0 -64.61 -26.59 68.47 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.49 -28.55 46.4 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.11 -48.68 17.11 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 122.014 -0.429 . . . . 0.0 109.876 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.583 ' CD1' HG22 ' A' ' 24' ' ' VAL . 36.1 t80 -77.72 -25.28 49.2 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 122.212 -0.305 . . . . 0.0 110.759 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.684 ' HB2' ' O ' ' A' ' 90' ' ' GLN . . . -53.15 -53.37 56.43 Favored Pre-proline 0 N--CA 1.5 2.049 0 CA-C-O 118.961 -0.542 . . . . 0.0 111.883 -177.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.682 ' HD3' ' HB3' ' A' ' 94' ' ' ALA . 30.2 Cg_endo -70.0 -11.16 29.99 Favored 'Trans proline' 0 N--CA 1.482 0.819 0 C-N-CA 121.918 1.745 . . . . 0.0 111.181 -179.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -89.47 17.19 6.53 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.727 HD21 HD23 ' A' ' 17' ' ' LEU . 0.1 OUTLIER -73.89 -71.27 0.33 Allowed 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.671 -0.643 . . . . 0.0 109.966 -179.734 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.691 HG21 ' SG ' ' A' ' 57' ' ' CYS . 13.1 m -70.58 5.6 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.36 0 O-C-N 121.176 -0.953 . . . . 0.0 112.283 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 16.3 p -92.07 174.79 7.14 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.13 -3.98 0.45 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.526 -0.734 . . . . 0.0 112.389 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.0 t -89.06 -2.2 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 CA-C-N 120.069 1.304 . . . . 0.0 111.114 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.23 -86.97 0.2 Allowed 'General case' 0 N--CA 1.508 2.456 0 C-N-CA 119.486 -0.886 . . . . 0.0 111.978 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.717 ' O ' HD12 ' A' ' 105' ' ' LEU . 95.6 m -146.7 43.83 1.18 Allowed 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.43 -0.794 . . . . 0.0 109.107 -178.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.414 ' HA ' ' O ' ' A' ' 98' ' ' VAL . 4.1 p30 -39.11 -55.4 1.62 Allowed 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.438 -0.789 . . . . 0.0 113.09 -178.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.717 HD12 ' O ' ' A' ' 103' ' ' CYS . 2.2 mt 40.8 29.84 0.08 Allowed 'General case' 0 N--CA 1.511 2.623 0 CA-C-N 118.875 0.761 . . . . 0.0 111.071 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 105' ' ' LEU . . . 65.5 155.41 0.08 Allowed 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.64 -0.662 . . . . 0.0 109.302 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.438 ' HA ' ' HD2' ' A' ' 56' ' ' ARG . 4.4 p -127.88 -160.22 1.0 Allowed 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -179.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.848 HD13 ' O ' ' A' ' 108' ' ' ILE . 0.0 OUTLIER -67.51 -34.11 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.41 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.447 ' HB3' ' CE1' ' A' ' 113' ' ' PHE . 93.1 m-70 -69.48 -2.55 11.53 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 116.234 -0.439 . . . . 0.0 112.049 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 60.25 29.92 69.78 Favored Glycine 0 N--CA 1.497 2.75 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -159.88 170.54 36.05 Favored Glycine 0 N--CA 1.496 2.653 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -78.02 76.24 4.45 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.537 2.158 . . . . 0.0 111.475 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.476 ' HD1' HD11 ' A' ' 117' ' ' LEU . 35.7 p90 173.96 163.71 0.19 Allowed 'General case' 0 N--CA 1.508 2.454 0 O-C-N 121.769 -0.582 . . . . 0.0 110.313 178.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.472 ' SG ' HG21 ' A' ' 98' ' ' VAL . 29.7 p -173.01 160.13 4.13 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 122.11 -0.369 . . . . 0.0 110.179 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 67.19 -82.91 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.261 0 O-C-N 122.133 -0.354 . . . . 0.0 111.344 178.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 40.2 t -46.08 -86.48 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.825 -0.547 . . . . 0.0 111.475 -178.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.476 HD11 ' HD1' ' A' ' 113' ' ' PHE . 0.3 OUTLIER 56.13 -95.2 0.05 Allowed 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -178.876 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.428 HD13 ' HA ' ' A' ' 118' ' ' LEU . 4.6 mm? -61.43 -11.65 11.33 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.41 -0.806 . . . . 0.0 112.794 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -54.27 114.69 4.45 Favored Glycine 0 N--CA 1.5 2.904 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -108.61 66.15 0.64 Allowed 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.935 0.874 . . . . 0.0 108.777 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -57.96 -21.68 45.92 Favored Glycine 0 N--CA 1.498 2.808 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 . . . . . 0 N--CA 1.499 2.013 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.528 -179.921 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 10.4 p . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.0 t -64.83 -71.86 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 95.7 -136.58 12.95 Favored Glycine 0 N--CA 1.497 2.749 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.593 HG23 ' O ' ' A' ' 4' ' ' THR . 5.8 t -172.64 77.29 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 61.88 171.73 0.12 Allowed 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.644 -0.66 . . . . 0.0 109.711 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 67.2 m 58.88 104.01 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 44.6 pt -94.46 156.27 38.78 Favored Pre-proline 0 N--CA 1.499 1.986 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.11 159.45 30.24 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.241 1.96 . . . . 0.0 110.358 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.45 4.71 75.5 Favored Glycine 0 N--CA 1.5 2.964 0 N-CA-C 110.839 -0.905 . . . . 0.0 110.839 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.59 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 1.5 mpt? -133.0 99.04 4.45 Favored 'General case' 0 N--CA 1.501 2.11 0 CA-C-N 118.103 0.951 . . . . 0.0 108.705 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.59 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 86.79 -56.01 0.05 Allowed 'General case' 0 N--CA 1.515 2.819 0 CA-C-N 119.355 0.98 . . . . 0.0 108.547 -178.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 9.2 mt -101.85 101.44 18.33 Favored Pre-proline 0 N--CA 1.493 1.695 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 178.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -80.58 173.37 12.35 Favored 'Trans proline' 0 N--CA 1.474 0.33 0 C-N-CA 121.536 1.491 . . . . 0.0 111.643 -176.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 46.0 m-70 -71.13 144.53 50.21 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.46 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 3.3 t-20 60.68 60.24 3.57 Favored Pre-proline 0 N--CA 1.499 1.99 0 O-C-N 121.597 -0.689 . . . . 0.0 109.198 -179.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.46 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 39.5 Cg_endo -81.43 151.28 17.45 Favored 'Trans proline' 0 N--CA 1.481 0.787 0 C-N-CA 122.318 2.012 . . . . 0.0 111.673 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.556 HD23 ' SG ' ' A' ' 20' ' ' CYS . 3.6 mp 51.57 41.26 28.52 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-O 121.048 0.451 . . . . 0.0 111.421 178.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.408 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 7.2 p-10 -65.54 -40.62 93.08 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.67 -25.99 68.42 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.556 ' SG ' HD23 ' A' ' 17' ' ' LEU . 65.4 m -73.51 -42.83 61.29 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.667 ' NH2' HD22 ' A' ' 78' ' ' LEU . 2.5 ptt-85 -60.59 -49.83 75.96 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.451 ' HA ' ' CE3' ' A' ' 22' ' ' TRP . 29.9 m95 -67.85 -26.94 66.29 Favored 'General case' 0 N--CA 1.5 2.052 0 C-N-CA 119.693 -0.803 . . . . 0.0 110.447 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.451 ' CD2' ' HB3' ' A' ' 40' ' ' MET . 5.4 t80 -66.91 -32.3 73.47 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 178.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.727 HG22 ' CE1' ' A' ' 93' ' ' PHE . 47.0 t -71.68 -43.81 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.3 m -53.91 -42.36 68.64 Favored 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.431 -179.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 16.7 m -76.96 -53.76 7.44 Favored 'General case' 0 N--CA 1.507 2.42 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -178.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.8 tpm_? -60.28 -25.53 65.79 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.78 -0.575 . . . . 0.0 110.878 -178.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 48.1 p -97.67 -63.32 1.14 Allowed 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -177.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.61 ' O ' HG23 ' A' ' 31' ' ' VAL . 45.8 m -101.26 14.69 31.16 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.451 -0.78 . . . . 0.0 112.093 -178.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 55.64 21.06 27.2 Favored Glycine 0 N--CA 1.506 3.326 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 29' ' ' CYS . 25.5 t -107.55 164.01 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 O-C-N 121.851 -0.794 . . . . 0.0 109.121 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.492 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 134.38 178.89 15.95 Favored Glycine 0 N--CA 1.498 2.817 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -66.12 175.25 4.96 Favored 'Trans proline' 0 N--CA 1.486 1.075 0 CA-C-N 119.14 1.47 . . . . 0.0 109.633 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.07 82.25 5.07 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.99 0.9 . . . . 0.0 109.941 -178.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -139.71 135.84 33.58 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.511 ' HB3' ' OE2' ' A' ' 39' ' ' GLU . . . -53.8 162.63 0.86 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 122.056 -0.402 . . . . 0.0 110.158 -179.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.89 -54.0 8.05 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 122.051 -0.406 . . . . 0.0 110.595 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -51.48 -36.51 44.73 Favored 'General case' 0 N--CA 1.507 2.398 0 O-C-N 121.742 -0.599 . . . . 0.0 111.15 -178.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.511 ' OE2' ' HB3' ' A' ' 36' ' ' ALA . 43.4 mt-10 -70.75 -36.09 72.96 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 122.052 -0.405 . . . . 0.0 110.008 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.451 ' HB3' ' CD2' ' A' ' 23' ' ' TYR . 0.8 OUTLIER -66.18 -54.25 27.61 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.856 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.0 ttpt -54.63 -36.76 64.86 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.05 -39.72 95.57 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -63.6 -40.75 97.72 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 16.4 m -67.82 -33.5 74.91 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.054 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 17.9 m -74.44 -30.44 61.89 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.22 -35.29 71.43 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 178.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -79.07 -26.85 43.01 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 120.961 0.41 . . . . 0.0 109.947 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.631 ' O ' HD13 ' A' ' 48' ' ' LEU . 1.4 tm? -71.52 -39.31 70.83 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -178.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.51 ' HG3' HD22 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -78.24 -40.45 37.2 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.454 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.41 ' O ' ' HD3' ' A' ' 52' ' ' PRO . . . -54.23 -37.61 64.81 Favored 'General case' 0 N--CA 1.505 2.294 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 178.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 80.2 mt -79.04 105.15 2.73 Favored Pre-proline 0 N--CA 1.493 1.7 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 177.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' A' ' 50' ' ' ALA . 26.7 Cg_endo -60.31 146.67 96.06 Favored 'Trans proline' 0 N--CA 1.479 0.631 0 C-N-CA 121.544 1.496 . . . . 0.0 110.997 -176.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.436 ' HB2' ' NH1' ' A' ' 56' ' ' ARG . . . -42.5 -27.99 0.19 Allowed 'General case' 0 N--CA 1.502 2.17 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.685 -178.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -67.37 119.83 12.86 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 20.8 m 62.02 17.38 8.99 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 122.383 -0.198 . . . . 0.0 110.647 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.436 ' NH1' ' HB2' ' A' ' 53' ' ' ALA . 4.6 mtt180 -44.93 -83.37 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.901 0 O-C-N 121.231 -0.918 . . . . 0.0 110.165 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.536 ' SG ' HG21 ' A' ' 98' ' ' VAL . 51.3 m -33.15 -43.62 0.11 Allowed 'General case' 0 N--CA 1.52 3.061 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -37.8 -48.07 1.07 Allowed 'General case' 0 N--CA 1.514 2.774 0 CA-C-N 119.741 1.155 . . . . 0.0 112.246 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -43.66 -53.23 5.9 Favored 'General case' 0 N--CA 1.513 2.722 0 O-C-N 121.542 -0.724 . . . . 0.0 111.582 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 38.5 t -48.69 -45.87 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.399 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.1 -54.61 45.06 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.75 HG23 ' HB ' ' A' ' 67' ' ' VAL . 34.4 mt -49.18 -27.39 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.337 0 O-C-N 121.344 -0.848 . . . . 0.0 109.965 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.431 HD12 ' HA ' ' A' ' 63' ' ' LEU . 27.5 tp -77.92 -41.85 35.11 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.491 -0.884 . . . . 0.0 109.994 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.26 -54.26 6.71 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.555 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -80.65 -22.86 40.13 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.931 -0.48 . . . . 0.0 111.224 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.65 150.49 17.07 Favored Glycine 0 N--CA 1.498 2.781 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -178.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.75 ' HB ' HG23 ' A' ' 62' ' ' ILE . 4.2 p -117.91 159.68 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.275 0 O-C-N 122.176 -0.603 . . . . 0.0 109.845 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.688 HG22 ' NE2' ' A' ' 74' ' ' HIS . 72.8 t -115.1 157.51 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 CA-C-O 121.767 0.794 . . . . 0.0 109.095 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.9 p -117.42 159.78 22.24 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.648 -177.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.3 t -62.07 -33.41 74.37 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.3 -178.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.8 p -66.2 -17.78 64.94 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.226 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.91 14.78 30.5 Favored Glycine 0 N--CA 1.498 2.798 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 67.8 mm-40 -102.58 157.06 17.2 Favored 'General case' 0 N--CA 1.503 2.221 0 CA-C-N 118.19 0.995 . . . . 0.0 109.321 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.688 ' NE2' HG22 ' A' ' 68' ' ' VAL . 9.5 m170 -115.83 155.3 28.13 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -143.48 -176.77 5.08 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.17 0.51 . . . . 0.0 110.278 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 60.09 -137.66 49.16 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 22.7 ttp180 51.42 26.07 2.96 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 122.317 -0.519 . . . . 0.0 110.301 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.667 HD22 ' NH2' ' A' ' 21' ' ' ARG . 3.4 mt -77.2 -20.47 55.29 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.719 -0.613 . . . . 0.0 110.636 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.421 HD11 HD23 ' A' ' 63' ' ' LEU . 95.8 mt -62.14 95.55 0.06 Allowed 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -143.23 177.01 8.7 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.368 0.604 . . . . 0.0 110.29 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -50.96 107.86 0.2 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.49 0.662 . . . . 0.0 111.775 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.545 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 18.3 mt -100.88 168.14 9.71 Favored Pre-proline 0 N--CA 1.495 1.797 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.545 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 26.6 Cg_endo -64.62 99.79 0.32 Allowed 'Trans proline' 0 N--CA 1.48 0.699 0 C-N-CA 121.277 1.318 . . . . 0.0 111.702 -178.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.84 -9.89 75.75 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 7.5 m -118.98 91.12 42.68 Favored Pre-proline 0 N--CA 1.503 2.217 0 CA-C-N 119.125 1.463 . . . . 0.0 110.538 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -72.02 165.44 32.59 Favored 'Trans proline' 0 N--CA 1.482 0.847 0 C-N-CA 121.712 1.608 . . . . 0.0 111.173 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.1 mmm-85 -47.59 -28.53 2.35 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -57.7 -53.42 58.36 Favored 'General case' 0 N--CA 1.502 2.159 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.048 -178.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.1 t -63.89 -38.72 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.754 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -63.19 -26.96 69.05 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.42 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.93 -35.95 42.56 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.22 -49.82 63.12 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.997 -0.439 . . . . 0.0 109.896 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.727 ' CE1' HG22 ' A' ' 24' ' ' VAL . 34.0 t80 -78.77 -25.11 44.35 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 122.12 -0.362 . . . . 0.0 110.554 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.754 ' HB2' ' O ' ' A' ' 90' ' ' GLN . . . -41.22 -51.06 8.22 Favored Pre-proline 0 N--CA 1.503 2.186 0 CA-C-O 118.773 -0.632 . . . . 0.0 112.29 -177.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.657 ' HD3' ' HB3' ' A' ' 94' ' ' ALA . 30.3 Cg_endo -72.59 -167.24 0.32 Allowed 'Trans proline' 0 C--N 1.33 -0.43 0 C-N-CA 121.505 1.47 . . . . 0.0 109.62 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 77.0 mttt 62.48 20.44 11.92 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.433 ' HA ' HD22 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -72.92 -65.45 0.8 Allowed 'General case' 0 N--CA 1.509 2.486 0 O-C-N 121.875 -0.516 . . . . 0.0 110.786 -179.132 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.536 HG21 ' SG ' ' A' ' 57' ' ' CYS . 27.1 m -84.6 20.63 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 120.963 -1.086 . . . . 0.0 111.279 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 25.2 p -98.91 174.71 6.23 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.04 -2.67 0.63 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.575 -0.703 . . . . 0.0 112.018 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.5 ' O ' HG12 ' A' ' 101' ' ' VAL . 14.4 t -94.05 -0.64 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 CA-C-N 120.591 1.541 . . . . 0.0 111.062 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -138.12 -89.65 0.23 Allowed 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.383 -0.823 . . . . 0.0 111.185 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.552 ' O ' HD12 ' A' ' 105' ' ' LEU . 54.0 m -144.92 39.5 1.23 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.374 -0.829 . . . . 0.0 109.432 -178.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -35.22 -60.84 0.46 Allowed 'General case' 0 N--CA 1.511 2.6 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -178.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.552 HD12 ' O ' ' A' ' 103' ' ' CYS . 1.1 mt 43.23 31.45 0.38 Allowed 'General case' 0 N--CA 1.511 2.617 0 CA-C-N 118.657 0.662 . . . . 0.0 110.73 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 105' ' ' LEU . . . 66.58 150.09 0.05 Allowed 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -178.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.7 p -119.58 -159.86 0.79 Allowed 'General case' 0 N--CA 1.504 2.226 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.8 tt -66.98 -32.35 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -72.92 1.73 8.21 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.9 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 57.91 33.18 67.79 Favored Glycine 0 N--CA 1.499 2.887 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -161.66 170.63 37.43 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -79.05 71.96 6.76 Favored 'Trans proline' 0 CA--C 1.545 1.047 0 C-N-CA 122.747 2.298 . . . . 0.0 111.55 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 44.8 p90 175.39 155.38 0.17 Allowed 'General case' 0 N--CA 1.505 2.311 0 O-C-N 121.816 -0.552 . . . . 0.0 110.171 178.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 20.6 p -156.31 150.33 25.19 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 56.36 -177.47 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.717 -0.614 . . . . 0.0 110.069 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 57.19 -89.97 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 55.37 -88.8 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.838 -0.539 . . . . 0.0 110.105 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 16.5 mt -50.53 -18.4 0.66 Allowed 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.6 -0.687 . . . . 0.0 112.812 -179.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -107.51 40.96 2.33 Favored Glycine 0 N--CA 1.499 2.839 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -96.16 53.5 1.36 Allowed 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.911 0.862 . . . . 0.0 109.289 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -57.34 -24.57 52.3 Favored Glycine 0 N--CA 1.499 2.876 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 . . . . . 0 N--CA 1.5 2.07 0 CA-C-O 117.85 -1.072 . . . . 0.0 110.225 179.773 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.206 0.527 . . . . 0.0 109.583 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.462 HG23 ' H ' ' A' ' 3' ' ' GLY . 0.7 OUTLIER -54.48 -99.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.353 -0.842 . . . . 0.0 109.726 -179.895 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.462 ' H ' HG23 ' A' ' 2' ' ' VAL . . . 165.47 -139.06 5.58 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.46 ' O ' ' O ' ' A' ' 5' ' ' SER . 8.5 t -116.19 20.53 14.27 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.24 -1.153 . . . . 0.0 110.092 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 4' ' ' THR . 23.2 m 42.91 -166.13 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.144 -0.973 . . . . 0.0 109.741 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.463 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 34.0 m -99.99 120.71 40.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.221 -0.924 . . . . 0.0 109.13 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.457 ' HB ' ' SD ' ' A' ' 10' ' ' MET . 1.0 OUTLIER -42.64 101.96 0.26 Allowed Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.328 -0.858 . . . . 0.0 109.81 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 6' ' ' CYS . 36.1 Cg_endo -77.86 159.0 31.25 Favored 'Trans proline' 0 C--N 1.315 -1.217 0 C-N-CA 121.87 1.713 . . . . 0.0 110.133 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 60.15 12.52 23.89 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.726 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -129.37 94.44 3.78 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.293 -1.122 . . . . 0.0 108.71 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.726 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 86.09 -58.14 0.07 Allowed 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -178.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 29.1 mt -95.69 103.25 12.29 Favored Pre-proline 0 N--CA 1.489 1.489 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.516 ' HD3' ' O ' ' A' ' 11' ' ' ALA . 34.1 Cg_endo -81.37 170.86 14.28 Favored 'Trans proline' 0 C--N 1.318 -1.038 0 C-N-CA 121.378 1.385 . . . . 0.0 111.864 -176.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.419 ' H ' ' CD2' ' A' ' 14' ' ' HIS . 29.1 m-70 -69.82 149.2 48.16 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.48 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 1.1 t-20 67.2 63.95 0.74 Allowed Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 120.623 -1.298 . . . . 0.0 110.033 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.807 ' HB2' ' HB1' ' A' ' 59' ' ' ALA . 37.3 Cg_endo -79.7 166.35 21.71 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.808 2.339 . . . . 0.0 112.151 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.53 HD23 ' SG ' ' A' ' 20' ' ' CYS . 0.2 OUTLIER 33.13 47.03 0.11 Allowed 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.581 178.789 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -74.86 -34.85 62.33 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.99 -1.069 . . . . 0.0 108.982 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.448 ' OG ' ' SG ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -62.56 -43.36 99.01 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.171 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.53 ' SG ' HD23 ' A' ' 17' ' ' LEU . 36.2 m -59.88 -40.03 87.29 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 121.352 0.596 . . . . 0.0 109.706 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.557 ' HG3' ' N ' ' A' ' 22' ' ' TRP . 0.1 OUTLIER -58.08 -51.91 67.72 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.373 -0.83 . . . . 0.0 108.915 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.557 ' N ' ' HG3' ' A' ' 21' ' ' ARG . 27.6 m95 -68.75 -26.25 65.14 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 118.591 -1.244 . . . . 0.0 110.541 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.651 ' HE1' HG22 ' A' ' 37' ' ' THR . 19.0 t80 -66.97 -32.65 74.03 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.911 -1.118 . . . . 0.0 108.593 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.558 HG22 ' CE1' ' A' ' 93' ' ' PHE . 71.3 t -72.9 -42.25 60.51 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.274 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 178.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.476 ' OG ' ' HA ' ' A' ' 22' ' ' TRP . 0.5 OUTLIER -54.84 -40.0 69.14 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.059 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.488 ' CA ' ' O ' ' A' ' 31' ' ' VAL . 3.7 m -77.28 -53.26 7.92 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.186 -0.946 . . . . 0.0 111.154 -178.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.1 ttm180 -59.56 -24.4 63.69 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.935 -1.103 . . . . 0.0 110.194 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.456 ' OG1' ' SG ' ' A' ' 85' ' ' CYS . 80.7 p -93.0 -67.53 0.85 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.186 -0.946 . . . . 0.0 111.419 -178.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.498 ' SG ' ' C ' ' A' ' 84' ' ' GLY . 93.2 m -99.51 18.07 18.79 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.496 -1.378 . . . . 0.0 110.104 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' A' ' 26' ' ' THR . . . 57.63 15.55 18.8 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.488 ' O ' ' CA ' ' A' ' 26' ' ' THR . 75.6 t -101.87 154.48 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.13 -1.218 . . . . 0.0 109.283 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.435 ' HA3' ' HG1' ' A' ' 26' ' ' THR . . . 142.66 179.23 19.3 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -66.37 177.15 3.42 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 CA-C-N 118.981 1.391 . . . . 0.0 109.875 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' ' 34' ' ' ARG . 0.1 OUTLIER -91.28 81.68 5.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.726 -1.234 . . . . 0.0 110.162 -178.125 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.461 ' CD2' ' NH1' ' A' ' 43' ' ' ARG . 25.6 tp -138.13 127.98 25.38 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.94 161.58 0.76 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.059 -1.025 . . . . 0.0 109.662 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.651 HG22 ' HE1' ' A' ' 23' ' ' TYR . 1.2 p -67.96 -61.97 1.62 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.12 -0.987 . . . . 0.0 109.987 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 37' ' ' THR . 0.8 OUTLIER -43.95 -57.22 3.44 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.017 -1.052 . . . . 0.0 109.737 -179.361 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.577 ' O ' ' HB3' ' A' ' 42' ' ' ALA . 75.5 mm-40 -49.15 -43.38 41.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.252 -0.905 . . . . 0.0 109.699 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.59 ' CE ' ' CG ' ' A' ' 23' ' ' TYR . 1.8 tmm? -59.03 -62.97 1.48 Allowed 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.493 ' HG3' ' OE1' ' A' ' 102' ' ' GLU . 19.0 tttt -40.59 -31.68 0.17 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.577 ' HB3' ' O ' ' A' ' 39' ' ' GLU . . . -68.51 -50.93 48.46 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.593 -0.692 . . . . 0.0 109.688 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.541 ' CG ' ' O ' ' A' ' 40' ' ' MET . 0.0 OUTLIER -59.14 -41.24 87.83 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.193 -1.003 . . . . 0.0 109.768 -179.597 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.448 ' SG ' ' OG ' ' A' ' 19' ' ' SER . 8.8 m -65.03 -36.09 83.25 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.89 -1.132 . . . . 0.0 110.579 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 19.1 m -69.75 -32.02 70.31 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.737 -1.227 . . . . 0.0 108.937 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.86 -32.64 67.7 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.493 ' HG3' ' O ' ' A' ' 43' ' ' ARG . 0.1 OUTLIER -77.43 -29.14 52.79 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.703 -0.623 . . . . 0.0 109.638 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.095 HD11 HG12 ' A' ' 98' ' ' VAL . 0.6 OUTLIER -75.0 -38.42 61.61 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.115 -0.991 . . . . 0.0 108.544 179.59 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.425 ' O ' ' C ' ' A' ' 50' ' ' ALA . 2.9 tt0 -69.16 -53.04 22.13 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.473 ' O ' ' HD3' ' A' ' 52' ' ' PRO . . . -47.54 -52.98 15.74 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 178.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.764 HG22 ' HG2' ' A' ' 56' ' ' ARG . 26.8 mm -58.81 106.02 0.64 Allowed Pre-proline 0 C--N 1.304 -1.393 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 177.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 50' ' ' ALA . 28.0 Cg_endo -63.77 136.25 52.55 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 121.893 1.729 . . . . 0.0 111.528 -176.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.626 ' HB1' ' N ' ' A' ' 108' ' ' ILE . . . -33.84 -36.15 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.792 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.71 ' CZ ' HD11 ' A' ' 108' ' ' ILE . 2.2 m-85 -67.63 117.14 9.16 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.01 -1.056 . . . . 0.0 108.794 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.474 ' CB ' ' O ' ' A' ' 54' ' ' TYR . 9.7 m 76.24 -2.46 2.73 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.461 -0.775 . . . . 0.0 109.784 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.764 ' HG2' HG22 ' A' ' 51' ' ' ILE . 0.4 OUTLIER -40.01 -87.44 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.199 -0.938 . . . . 0.0 109.188 -179.81 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.538 ' O ' ' C ' ' A' ' 58' ' ' GLU . 22.2 m -31.93 -58.34 0.29 Allowed 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.625 -0.672 . . . . 0.0 111.443 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.538 ' C ' ' O ' ' A' ' 57' ' ' CYS . 2.6 mm-40 -25.89 -53.5 0.05 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.55 -0.719 . . . . 0.0 111.249 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.807 ' HB1' ' HB2' ' A' ' 16' ' ' PRO . . . -37.81 -61.23 0.65 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.445 -0.785 . . . . 0.0 110.256 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.842 HG21 HD13 ' A' ' 97' ' ' LEU . 27.8 t -42.55 -51.35 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 CA-C-O 121.861 0.839 . . . . 0.0 108.904 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.485 ' O ' ' N ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -54.18 -63.66 1.08 Allowed 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.262 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.917 HD12 ' HB ' ' A' ' 67' ' ' VAL . 4.6 mm -40.06 -27.25 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.23 -0.919 . . . . 0.0 110.294 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.819 HD13 ' O ' ' A' ' 63' ' ' LEU . 0.9 OUTLIER -77.59 -46.77 21.17 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 120.704 -1.248 . . . . 0.0 109.202 -179.973 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.489 ' SD ' ' NE ' ' A' ' 91' ' ' ARG . 0.1 OUTLIER -73.62 -53.65 9.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.23 -0.919 . . . . 0.0 110.152 -179.83 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -80.2 -21.43 42.95 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.82 -1.175 . . . . 0.0 110.315 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.474 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . 84.51 151.2 12.86 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -179.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.917 ' HB ' HD12 ' A' ' 62' ' ' ILE . 7.3 p -116.64 159.39 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.414 -1.051 . . . . 0.0 109.409 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.544 ' N ' HG22 ' A' ' 67' ' ' VAL . 12.8 t -114.52 157.96 15.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-O 121.642 0.735 . . . . 0.0 109.185 -179.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.438 ' N ' ' CG1' ' A' ' 68' ' ' VAL . 27.5 p -116.83 158.94 23.12 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 121.615 0.722 . . . . 0.0 109.65 -178.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 32.1 t -62.25 -31.11 71.63 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.495 0.664 . . . . 0.0 110.13 -178.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.2 p -69.84 -14.01 62.54 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.499 -0.751 . . . . 0.0 109.6 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.3 9.24 48.29 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 108.881 -1.688 . . . . 0.0 108.881 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -91.84 157.25 16.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.088 -1.242 . . . . 0.0 109.877 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.527 ' CD2' HG22 ' A' ' 68' ' ' VAL . 10.1 m170 -115.83 156.32 26.31 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.022 -1.048 . . . . 0.0 108.739 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.406 ' HG2' ' C ' ' A' ' 74' ' ' HIS . 57.1 mm-40 -145.47 178.95 7.74 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.308 -0.87 . . . . 0.0 110.262 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 58.44 -147.13 39.8 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 2.9 ttp85 60.0 18.74 7.88 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.44 -1.035 . . . . 0.0 110.572 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.474 ' O ' ' NH2' ' A' ' 21' ' ' ARG . 1.8 mp -79.87 -19.53 48.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.837 -1.164 . . . . 0.0 109.812 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.699 HD21 ' HG2' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -64.46 89.26 0.06 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.972 -1.08 . . . . 0.0 108.691 179.484 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.42 ' O ' ' C ' ' A' ' 81' ' ' ASP . 8.3 mt-30 -136.39 178.32 7.16 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.295 -0.878 . . . . 0.0 110.201 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 80' ' ' GLN . 49.4 m-20 -39.33 129.35 1.79 Allowed 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.995 0.902 . . . . 0.0 110.93 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.609 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 22.0 mt -126.03 168.79 13.07 Favored Pre-proline 0 C--N 1.302 -1.484 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 178.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.609 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 27.4 Cg_endo -66.12 99.38 0.41 Allowed 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 121.008 1.138 . . . . 0.0 110.794 -179.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.498 ' C ' ' SG ' ' A' ' 29' ' ' CYS . . . 89.71 -7.97 80.76 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.456 ' SG ' ' OG1' ' A' ' 28' ' ' THR . 7.7 m -120.61 89.39 44.59 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 120.569 -1.547 . . . . 0.0 110.311 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.41 ' C ' ' N ' ' A' ' 88' ' ' GLN . 30.7 Cg_endo -76.44 159.01 36.4 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 C-N-CA 121.827 1.684 . . . . 0.0 111.197 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' A' ' 86' ' ' PRO . 4.3 mmt85 -44.63 -28.57 0.62 Allowed 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.41 ' N ' ' C ' ' A' ' 86' ' ' PRO . 4.5 tt0 -57.31 -60.5 3.54 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.668 -178.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 87.9 t -61.0 -42.59 93.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 O-C-N 120.793 -1.192 . . . . 0.0 110.364 -178.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.749 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -60.62 -27.53 67.83 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.182 -1.007 . . . . 0.0 108.514 179.841 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.509 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 0.0 OUTLIER -78.05 -31.16 50.17 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.43 -0.794 . . . . 0.0 109.712 179.511 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.506 ' O ' ' HD2' ' A' ' 95' ' ' PRO . . . -71.08 -50.34 34.85 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.064 -1.023 . . . . 0.0 109.522 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.558 ' CE1' HG22 ' A' ' 24' ' ' VAL . 10.4 t80 -77.67 -25.72 49.76 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.424 -0.798 . . . . 0.0 109.915 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.79 ' HB3' ' HD3' ' A' ' 95' ' ' PRO . . . -41.16 -52.46 7.22 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.308 -0.87 . . . . 0.0 111.885 -179.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.79 ' HD3' ' HB3' ' A' ' 94' ' ' ALA . 29.6 Cg_endo -70.09 97.64 0.68 Allowed 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.227 1.951 . . . . 0.0 111.47 -178.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.507 ' CB ' ' O ' ' A' ' 95' ' ' PRO . 2.1 mttt 159.55 65.35 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.842 HD13 HG21 ' A' ' 60' ' ' VAL . 1.3 mt -109.91 -89.21 0.49 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.3 -0.875 . . . . 0.0 111.589 -178.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 1.095 HG12 HD11 ' A' ' 48' ' ' LEU . 3.3 m -78.74 34.88 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 120.661 -1.275 . . . . 0.0 111.735 -178.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 12.9 p -106.83 173.32 6.37 Favored 'General case' 0 C--N 1.293 -1.882 0 O-C-N 120.706 -1.246 . . . . 0.0 108.463 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.495 ' HA ' ' OD1' ' A' ' 104' ' ' ASN . 15.3 mt-10 -60.59 1.74 0.13 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.746 -1.222 . . . . 0.0 111.874 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.7 t -99.13 0.82 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 119.888 -1.757 . . . . 0.0 110.829 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.521 ' HB3' ' O ' ' A' ' 97' ' ' LEU . 7.1 tp10 -149.93 -98.17 0.07 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.568 -1.333 . . . . 0.0 111.347 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.541 ' O ' HD22 ' A' ' 48' ' ' LEU . 78.4 m -117.39 43.65 2.3 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.93 -1.106 . . . . 0.0 109.794 -178.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.526 ' ND2' ' N ' ' A' ' 104' ' ' ASN . 0.1 OUTLIER -31.99 -92.17 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.308 -0.87 . . . . 0.0 111.806 -179.419 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.728 ' O ' ' HB3' ' A' ' 106' ' ' ALA . 1.3 mt 66.95 -1.76 1.31 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.005 -1.06 . . . . 0.0 111.822 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.728 ' HB3' ' O ' ' A' ' 105' ' ' LEU . . . 81.08 143.45 0.08 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.684 -1.26 . . . . 0.0 110.028 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.667 HG21 HG21 ' A' ' 98' ' ' VAL . 3.0 p -114.27 -162.09 0.8 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.29 -0.881 . . . . 0.0 108.723 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.71 HD11 ' CZ ' ' A' ' 54' ' ' TYR . 19.3 tt -62.09 -22.65 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.902 -1.124 . . . . 0.0 108.753 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.477 ' CE1' ' HB3' ' A' ' 117' ' ' LEU . 90.6 m-70 -80.47 14.74 1.89 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.733 -0.604 . . . . 0.0 110.486 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 109' ' ' HIS . . . 44.15 25.61 0.75 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 109' ' ' HIS . . . -150.45 169.74 30.37 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.488 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 35.1 Cg_endo -78.96 72.87 6.28 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.876 2.384 . . . . 0.0 110.989 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.488 ' HB3' ' O ' ' A' ' 112' ' ' PRO . 17.7 p90 171.77 160.99 0.1 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.37 -0.831 . . . . 0.0 109.529 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.54 ' O ' ' CB ' ' A' ' 115' ' ' LEU . 16.5 p -155.73 -155.09 0.53 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.029 -1.044 . . . . 0.0 110.021 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.54 ' CB ' ' O ' ' A' ' 114' ' ' CYS . 0.1 OUTLIER 81.58 -152.23 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.684 -0.635 . . . . 0.0 109.447 -179.685 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 115' ' ' LEU . 2.5 p -42.47 -85.52 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.213 -0.929 . . . . 0.0 109.929 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.477 ' HB3' ' CE1' ' A' ' 109' ' ' HIS . 0.3 OUTLIER 53.08 -157.04 0.16 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.226 -0.921 . . . . 0.0 109.368 -179.776 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.64 -13.2 0.61 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.829 -1.17 . . . . 0.0 112.082 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -89.57 34.13 4.13 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -172.92 78.68 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.228 -1.16 . . . . 0.0 109.573 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.09 -6.79 65.31 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.234 -1.156 . . . . 0.0 109.507 179.942 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 79.1 p . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.3 m -119.56 -111.35 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.408 ' O ' HG22 ' A' ' 4' ' ' THR . . . 94.73 -87.07 1.06 Allowed Glycine 0 N--CA 1.498 2.818 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.408 HG22 ' O ' ' A' ' 3' ' ' GLY . 8.8 t 41.44 46.8 3.03 Favored 'General case' 0 N--CA 1.51 2.539 0 CA-C-O 121.355 0.598 . . . . 0.0 111.362 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 60.6 p -120.99 -160.03 0.83 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.721 -0.612 . . . . 0.0 109.464 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 64.4 m 61.58 -160.96 0.3 Allowed 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.456 ' CG2' ' HD2' ' A' ' 8' ' ' PRO . 34.0 mt 71.76 139.79 0.07 OUTLIER Pre-proline 0 N--CA 1.506 2.355 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 -178.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.456 ' HD2' ' CG2' ' A' ' 7' ' ' ILE . 30.6 Cg_endo -71.67 165.81 31.37 Favored 'Trans proline' 0 N--CA 1.479 0.647 0 C-N-CA 121.661 1.574 . . . . 0.0 111.103 -178.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 62.84 16.32 56.48 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 -179.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.573 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 16.6 mmm -140.91 84.62 1.94 Allowed 'General case' 0 N--CA 1.5 2.051 0 CA-C-N 117.749 0.774 . . . . 0.0 108.99 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 86.82 -57.65 0.05 OUTLIER 'General case' 0 N--CA 1.515 2.824 0 O-C-N 121.368 -0.833 . . . . 0.0 108.908 -178.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.717 HD11 ' HB2' ' A' ' 55' ' ' CYS . 61.2 mt -92.21 104.5 11.04 Favored Pre-proline 0 N--CA 1.498 1.935 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -75.21 169.6 22.18 Favored 'Trans proline' 0 C--O 1.22 -0.406 0 C-N-CA 121.348 1.365 . . . . 0.0 111.547 -175.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 35.1 m-70 -69.33 144.5 53.48 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.491 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 5.3 t-20 66.08 56.01 1.03 Allowed Pre-proline 0 N--CA 1.505 2.307 0 O-C-N 121.392 -0.817 . . . . 0.0 110.282 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.491 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 39.0 Cg_endo -80.54 166.86 19.54 Favored 'Trans proline' 0 N--CA 1.483 0.908 0 C-N-CA 122.317 2.011 . . . . 0.0 111.907 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.5 mp 42.92 43.81 3.69 Favored 'General case' 0 N--CA 1.504 2.238 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.192 177.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -69.07 -37.75 78.67 Favored 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.96 -26.13 68.69 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 56.9 m -74.61 -38.68 62.51 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.585 HH22 HD23 ' A' ' 78' ' ' LEU . 3.3 ttt180 -64.31 -48.88 73.96 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 33.5 m95 -68.74 -29.31 67.69 Favored 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 119.413 -0.915 . . . . 0.0 109.686 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.44 ' CD1' ' HB3' ' A' ' 40' ' ' MET . 57.7 t80 -66.38 -33.65 76.19 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.428 HG22 ' CD2' ' A' ' 93' ' ' PHE . 92.9 t -72.25 -38.97 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 177.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 m -56.27 -37.03 69.26 Favored 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 119.951 -0.7 . . . . 0.0 109.442 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 89.7 m -77.64 -50.09 13.2 Favored 'General case' 0 N--CA 1.506 2.347 0 N-CA-C 112.208 0.448 . . . . 0.0 112.208 -178.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.77 -25.31 67.87 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.512 -0.742 . . . . 0.0 110.622 -178.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.425 HG23 ' O ' ' A' ' 24' ' ' VAL . 70.7 p -93.35 -63.38 1.22 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -177.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.65 ' O ' HG23 ' A' ' 31' ' ' VAL . 3.6 m -100.32 9.29 42.91 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.438 -0.789 . . . . 0.0 111.636 -178.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 57.78 30.05 62.37 Favored Glycine 0 N--CA 1.507 3.37 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 29' ' ' CYS . 37.9 t -121.24 164.09 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 122.192 -0.593 . . . . 0.0 109.672 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.496 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 136.19 177.82 15.29 Favored Glycine 0 N--CA 1.499 2.895 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -64.37 177.31 2.17 Favored 'Trans proline' 0 N--CA 1.489 1.254 0 CA-C-N 119.253 1.526 . . . . 0.0 110.047 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.28 87.25 5.99 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 122.17 0.986 . . . . 0.0 110.338 -177.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.5 mt -141.85 127.37 18.95 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 178.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.19 152.44 2.37 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.979 -0.45 . . . . 0.0 109.825 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.1 p -60.0 -59.66 5.07 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.789 -0.569 . . . . 0.0 110.655 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -52.56 -28.75 22.22 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.878 -0.514 . . . . 0.0 111.571 -178.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -71.97 -46.94 55.56 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.816 -0.553 . . . . 0.0 109.608 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.44 ' HB3' ' CD1' ' A' ' 23' ' ' TYR . 5.6 tpt -61.97 -54.57 39.84 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -53.61 -35.7 61.19 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.45 -42.81 99.74 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.3 -41.12 96.45 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 19.7 m -65.48 -33.22 75.43 Favored 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.244 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 18.6 m -73.47 -30.16 62.99 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.35 -32.38 62.76 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -77.02 -33.69 57.41 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.782 HD22 ' O ' ' A' ' 103' ' ' CYS . 0.6 OUTLIER -73.46 -33.53 64.91 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.49 -40.4 61.86 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.28 -39.13 85.77 Favored 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.49 HG23 HG12 ' A' ' 12' ' ' ILE . 71.7 mt -82.54 105.57 5.09 Favored Pre-proline 0 N--CA 1.493 1.684 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 177.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -58.2 139.87 92.14 Favored 'Trans proline' 0 N--CA 1.48 0.705 0 C-N-CA 121.52 1.48 . . . . 0.0 110.877 -177.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.698 ' HB2' ' NH1' ' A' ' 56' ' ' ARG . . . -39.48 -29.79 0.06 Allowed 'General case' 0 N--CA 1.507 2.387 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.356 -178.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -53.15 -70.47 0.09 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.922 -0.486 . . . . 0.0 110.623 -179.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.717 ' HB2' HD11 ' A' ' 12' ' ' ILE . 5.1 m -88.59 8.81 26.46 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.974 -0.454 . . . . 0.0 110.884 -179.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.698 ' NH1' ' HB2' ' A' ' 53' ' ' ALA . 5.9 mtt180 -47.6 -85.35 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.666 0 O-C-N 121.445 -0.784 . . . . 0.0 110.282 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 73.3 m -32.79 -48.88 0.21 Allowed 'General case' 0 N--CA 1.521 3.083 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -41.74 -54.32 3.36 Favored 'General case' 0 N--CA 1.512 2.671 0 CA-C-N 119.319 0.963 . . . . 0.0 111.755 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -41.87 -44.63 3.43 Favored 'General case' 0 N--CA 1.513 2.706 0 O-C-N 121.787 -0.57 . . . . 0.0 112.065 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.7 t -57.17 -48.9 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.4 mtt180 -58.56 -26.74 63.89 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.959 HG23 ' HB ' ' A' ' 67' ' ' VAL . 34.5 mm -78.52 -30.74 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 O-C-N 121.945 -0.472 . . . . 0.0 110.362 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.489 HD12 ' HA ' ' A' ' 63' ' ' LEU . 14.9 tp -77.87 -43.37 30.43 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 120.079 -0.649 . . . . 0.0 109.79 -179.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.79 -50.84 10.64 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.232 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -80.55 -22.74 40.52 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 122.087 -0.383 . . . . 0.0 110.88 -178.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.68 146.91 5.67 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.959 ' HB ' HG23 ' A' ' 62' ' ' ILE . 5.6 p -118.43 161.08 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.668 HG22 ' NE2' ' A' ' 74' ' ' HIS . 56.0 t -113.27 157.89 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 42.1 p -116.84 160.13 21.32 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.987 0.899 . . . . 0.0 110.969 -176.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 32.8 t -64.54 -17.53 64.01 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.431 -178.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.1 p -86.48 -14.61 42.64 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 122.05 -0.406 . . . . 0.0 110.034 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.25 13.53 33.09 Favored Glycine 0 N--CA 1.5 2.902 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -105.43 158.62 16.53 Favored 'General case' 0 N--CA 1.501 2.114 0 CA-C-N 118.142 0.971 . . . . 0.0 108.859 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.668 ' NE2' HG22 ' A' ' 68' ' ' VAL . 11.3 m170 -113.79 154.93 26.58 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -179.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -136.8 -179.02 5.45 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 55.3 -146.93 28.43 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 -178.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 54.84 22.28 4.13 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 122.253 -0.557 . . . . 0.0 109.988 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.585 HD23 HH22 ' A' ' 21' ' ' ARG . 2.1 mp -82.87 -14.61 53.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.765 -0.584 . . . . 0.0 110.388 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.5 mt -62.11 92.79 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -134.78 -177.02 4.43 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.758 0.79 . . . . 0.0 110.663 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -47.67 131.6 14.42 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.758 0.789 . . . . 0.0 111.544 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.472 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 20.6 mt -129.27 166.85 22.55 Favored Pre-proline 0 N--CA 1.497 1.918 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.472 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 29.6 Cg_endo -68.6 98.63 0.59 Allowed 'Trans proline' 0 C--N 1.327 -0.553 0 C-N-CA 120.936 1.091 . . . . 0.0 110.243 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.41 6.94 67.82 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.47 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 3.2 m -138.8 92.51 11.21 Favored Pre-proline 0 N--CA 1.508 2.425 0 CA-C-N 118.974 1.387 . . . . 0.0 110.062 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -74.79 165.45 31.45 Favored 'Trans proline' 0 N--CA 1.487 1.109 0 C-N-CA 121.924 1.749 . . . . 0.0 111.225 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 24.0 mtp180 -53.89 -25.96 22.66 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.042 0.448 . . . . 0.0 110.225 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.23 -45.86 89.65 Favored 'General case' 0 N--CA 1.503 2.213 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.008 -177.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 42.0 t -72.38 -43.37 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.596 -0.69 . . . . 0.0 111.023 -177.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.616 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 2.1 pt20 -70.37 -27.02 64.0 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.414 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 8.8 ttt180 -78.76 -29.26 45.0 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.44 -47.09 20.61 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.945 -0.472 . . . . 0.0 110.28 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.428 ' CD2' HG22 ' A' ' 24' ' ' VAL . 90.3 t80 -79.03 -27.56 43.21 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 122.088 -0.383 . . . . 0.0 111.463 -178.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.616 ' HB2' ' O ' ' A' ' 90' ' ' GLN . . . -55.09 -46.45 99.67 Favored Pre-proline 0 N--CA 1.504 2.259 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -177.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 94' ' ' ALA . 30.2 Cg_endo -70.06 -0.26 6.9 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 122.209 1.939 . . . . 0.0 114.017 -177.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.79 24.12 12.05 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.492 -0.755 . . . . 0.0 109.8 179.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.99 -24.22 59.57 Favored 'General case' 0 N--CA 1.51 2.526 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -178.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 33.7 m -93.4 25.63 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.322 0 CA-C-N 120.958 1.708 . . . . 0.0 111.182 -178.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.406 ' C ' ' HB2' ' A' ' 104' ' ' ASN . 19.0 p -98.24 173.1 7.17 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -61.94 -1.52 0.68 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.656 -0.652 . . . . 0.0 112.25 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.582 ' O ' HG12 ' A' ' 101' ' ' VAL . 36.3 t -100.04 4.4 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 CA-C-N 120.443 1.474 . . . . 0.0 110.96 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -141.07 -89.95 0.16 Allowed 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.38 -0.825 . . . . 0.0 111.488 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.782 ' O ' HD22 ' A' ' 48' ' ' LEU . 19.8 m -143.62 43.0 1.49 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.502 -0.749 . . . . 0.0 109.927 -178.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.409 ' ND2' ' HB3' ' A' ' 112' ' ' PRO . 56.9 t-20 -42.97 -64.9 0.55 Allowed 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.224 -0.923 . . . . 0.0 112.329 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.429 ' O ' ' HB3' ' A' ' 106' ' ' ALA . 6.1 mt 45.33 29.34 0.55 Allowed 'General case' 0 N--CA 1.51 2.569 0 CA-C-O 121.073 0.463 . . . . 0.0 109.995 -178.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 105' ' ' LEU . . . 67.04 157.93 0.12 Allowed 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -178.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.8 p -128.82 -163.93 1.34 Allowed 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 18.1 tt -68.14 -33.15 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 177.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.447 ' HB3' ' CE2' ' A' ' 113' ' ' PHE . 96.9 m-70 -66.67 -4.9 9.89 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.729 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 61.55 41.39 99.55 Favored Glycine 0 N--CA 1.499 2.863 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -174.87 170.95 44.15 Favored Glycine 0 N--CA 1.501 3.024 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.409 ' HB3' ' ND2' ' A' ' 104' ' ' ASN . 32.3 Cg_endo -77.86 75.84 4.6 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.54 2.16 . . . . 0.0 111.376 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.447 ' CE2' ' HB3' ' A' ' 109' ' ' HIS . 36.8 p90 178.67 156.32 0.45 Allowed 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.65 -0.656 . . . . 0.0 110.468 178.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 4.7 t 178.62 158.55 0.52 Allowed 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 55.83 22.18 5.38 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.69 -0.631 . . . . 0.0 109.879 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.74 -69.5 0.07 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.83 -0.544 . . . . 0.0 109.654 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.515 ' O ' ' HB2' ' A' ' 118' ' ' LEU . 0.4 OUTLIER 59.88 29.74 19.3 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -179.764 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.515 ' HB2' ' O ' ' A' ' 117' ' ' LEU . 20.6 mt 76.38 -18.69 0.46 Allowed 'General case' 0 N--CA 1.508 2.467 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 130.61 176.88 14.6 Favored Glycine 0 N--CA 1.5 2.91 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -97.9 43.98 1.05 Allowed 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 121.722 0.772 . . . . 0.0 109.413 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -94.3 25.29 23.19 Favored Glycine 0 N--CA 1.498 2.77 0 N-CA-C 109.886 -1.285 . . . . 0.0 109.886 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 . . . . . 0 N--CA 1.499 1.977 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.463 179.889 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 7.4 t . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.65 HG13 ' H ' ' A' ' 3' ' ' GLY . 1.9 p -44.21 -56.3 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.197 -0.939 . . . . 0.0 109.759 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.65 ' H ' HG13 ' A' ' 2' ' ' VAL . . . 102.33 149.76 22.27 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.3 t -150.62 58.65 0.94 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.262 -1.14 . . . . 0.0 109.47 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.458 ' O ' ' O ' ' A' ' 6' ' ' CYS . 0.4 OUTLIER -89.69 65.44 6.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.258 -0.901 . . . . 0.0 109.65 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.458 ' O ' ' O ' ' A' ' 5' ' ' SER . 65.3 m 60.71 139.18 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.294 -0.879 . . . . 0.0 109.774 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.876 HD13 ' H ' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -133.96 160.92 66.69 Favored Pre-proline 0 N--CA 1.491 1.602 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.363 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.524 ' HD2' ' HB ' ' A' ' 7' ' ' ILE . 34.5 Cg_endo -77.25 166.11 26.79 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.309 2.006 . . . . 0.0 110.67 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 62.46 10.85 31.61 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.727 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 2.2 mtt -140.61 95.11 2.81 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.164 -1.198 . . . . 0.0 109.317 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.727 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 86.14 -60.58 0.06 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.925 -1.11 . . . . 0.0 108.314 -179.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.484 HG13 HD12 ' A' ' 51' ' ' ILE . 1.8 mp -96.83 103.31 14.32 Favored Pre-proline 0 N--CA 1.489 1.483 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.494 ' HD3' ' O ' ' A' ' 11' ' ' ALA . 31.6 Cg_endo -79.64 166.97 21.28 Favored 'Trans proline' 0 C--N 1.32 -0.959 0 C-N-CA 121.277 1.318 . . . . 0.0 112.163 -176.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.426 ' H ' ' CD2' ' A' ' 14' ' ' HIS . 37.7 m-70 -68.65 149.0 49.62 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.496 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 0.5 OUTLIER 60.77 63.95 2.51 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 120.607 -1.308 . . . . 0.0 109.62 -179.857 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.496 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 37.2 Cg_endo -80.41 161.08 22.66 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.794 2.329 . . . . 0.0 111.372 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.449 ' CD1' ' N ' ' A' ' 17' ' ' LEU . 4.2 mp 42.07 45.61 3.45 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.526 -0.734 . . . . 0.0 110.858 178.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -76.91 -40.87 45.78 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.078 -1.014 . . . . 0.0 109.177 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.481 ' O ' ' HE3' ' A' ' 40' ' ' MET . 1.2 t -63.37 -25.96 68.53 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 58.1 m -72.26 -39.21 68.57 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.563 ' CG ' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -59.3 -53.48 57.78 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.472 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.563 ' N ' ' CG ' ' A' ' 21' ' ' ARG . 25.9 m95 -68.11 -29.48 68.41 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 118.984 -1.086 . . . . 0.0 110.429 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.459 ' HE1' HG23 ' A' ' 37' ' ' THR . 4.2 t80 -64.06 -30.62 71.68 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 120.998 -1.064 . . . . 0.0 108.346 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 1.102 HG22 ' CD2' ' A' ' 93' ' ' PHE . 74.6 t -74.93 -44.56 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 178.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.503 ' HB3' HD13 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -52.65 -41.36 63.72 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.522 -0.871 . . . . 0.0 109.633 -179.679 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.514 ' HG1' ' HA3' ' A' ' 32' ' ' GLY . 2.6 m -77.77 -56.68 4.31 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.212 -0.93 . . . . 0.0 111.689 -178.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.1 tpt85 -57.77 -24.76 58.67 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.755 -1.216 . . . . 0.0 111.0 -178.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.469 ' OG1' ' O ' ' A' ' 24' ' ' VAL . 78.3 p -97.15 -63.06 1.17 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.949 -1.094 . . . . 0.0 111.191 -178.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.565 ' O ' HG23 ' A' ' 31' ' ' VAL . 90.6 m -99.24 18.47 17.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.965 -1.084 . . . . 0.0 110.299 -178.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' A' ' 26' ' ' THR . . . 52.76 19.41 6.69 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 29' ' ' CYS . 76.0 t -107.55 149.23 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.207 -1.173 . . . . 0.0 108.782 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.514 ' HA3' ' HG1' ' A' ' 26' ' ' THR . . . 141.96 177.34 16.99 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.449 -1.86 . . . . 0.0 108.449 -179.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -66.32 172.38 9.03 Favored 'Trans proline' 0 N--CA 1.479 0.654 0 CA-C-N 118.99 1.395 . . . . 0.0 109.988 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.23 64.43 4.47 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.876 -1.14 . . . . 0.0 110.074 -178.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.679 HD11 ' NE ' ' A' ' 43' ' ' ARG . 6.6 tt -106.33 120.41 41.8 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.509 ' N ' HD23 ' A' ' 35' ' ' LEU . . . -41.56 135.32 2.15 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.345 -0.847 . . . . 0.0 109.363 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.459 HG23 ' HE1' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -52.19 -54.54 29.63 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.785 -1.197 . . . . 0.0 111.564 -178.738 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -51.93 -43.0 63.25 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.817 -1.177 . . . . 0.0 110.249 -178.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.579 ' CB ' HD21 ' A' ' 35' ' ' LEU . 27.4 mm-40 -67.12 -29.36 69.07 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.28 -0.888 . . . . 0.0 109.604 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.503 ' SD ' HD13 ' A' ' 35' ' ' LEU . 8.5 tpt -69.23 -60.78 2.11 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.123 -0.986 . . . . 0.0 108.361 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.54 -39.11 48.12 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.81 -41.42 97.74 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.347 -0.846 . . . . 0.0 109.154 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.679 ' NE ' HD11 ' A' ' 35' ' ' LEU . 21.3 mtt85 -60.08 -47.22 86.8 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.349 -0.845 . . . . 0.0 109.192 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 15.3 m -61.26 -37.05 81.72 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.19 -0.944 . . . . 0.0 110.577 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 96.9 m -71.14 -28.59 64.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.811 -1.18 . . . . 0.0 109.141 -179.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.1 tpp180 -74.35 -31.35 62.39 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.462 ' O ' HG12 ' A' ' 51' ' ' ILE . 0.7 OUTLIER -77.09 -37.13 55.02 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.952 -0.699 . . . . 0.0 109.389 179.951 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.94 HD11 HG12 ' A' ' 98' ' ' VAL . 6.2 tt -70.8 -36.57 73.06 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.297 -0.877 . . . . 0.0 108.666 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.446 ' O ' ' C ' ' A' ' 50' ' ' ALA . 13.3 tp10 -67.27 -51.4 53.35 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.514 ' O ' ' HD3' ' A' ' 52' ' ' PRO . . . -47.89 -49.68 28.97 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 178.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.484 HD12 HG13 ' A' ' 12' ' ' ILE . 33.7 mm -62.04 106.09 0.76 Allowed Pre-proline 0 C--N 1.304 -1.411 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 176.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.523 ' O ' ' N ' ' A' ' 54' ' ' TYR . 26.6 Cg_endo -63.95 141.4 77.36 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 121.631 1.554 . . . . 0.0 110.81 -177.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.535 ' HB2' ' NH2' ' A' ' 56' ' ' ARG . . . -37.15 -28.67 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.908 -0.495 . . . . 0.0 110.079 -178.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.523 ' N ' ' O ' ' A' ' 52' ' ' PRO . 0.3 OUTLIER -65.41 119.85 11.75 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.095 -1.003 . . . . 0.0 108.578 178.998 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.523 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 63.6 m 64.91 8.98 5.0 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.355 -0.841 . . . . 0.0 110.256 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.535 ' NH2' ' HB2' ' A' ' 53' ' ' ALA . 8.6 mtt180 -42.42 -87.78 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.705 -1.247 . . . . 0.0 109.471 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.501 ' O ' ' C ' ' A' ' 58' ' ' GLU . 20.9 m -28.38 -50.71 0.08 Allowed 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.512 ' HB2' ' O ' ' A' ' 55' ' ' CYS . 0.1 OUTLIER -32.22 -51.23 0.25 Allowed 'General case' 0 N--CA 1.502 2.159 0 O-C-N 120.82 -1.175 . . . . 0.0 111.432 -178.74 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.479 ' C ' ' O ' ' A' ' 58' ' ' GLU . . . -36.5 -55.39 0.84 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.313 -0.867 . . . . 0.0 110.268 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.0 t -53.18 -49.89 49.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.474 -0.766 . . . . 0.0 109.252 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.482 ' O ' ' HB2' ' A' ' 65' ' ' ASP . 2.0 ttp180 -55.34 -29.35 58.19 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.294 -0.879 . . . . 0.0 109.508 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.744 HG23 ' HB ' ' A' ' 67' ' ' VAL . 30.2 mt -77.79 -28.53 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.331 -0.856 . . . . 0.0 109.938 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.527 ' O ' ' HA ' ' A' ' 77' ' ' ARG . 26.4 tp -77.56 -44.5 28.32 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.842 -1.161 . . . . 0.0 109.486 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 30.1 ttp -78.14 -50.69 11.5 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.869 -1.144 . . . . 0.0 109.72 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.482 ' HB2' ' O ' ' A' ' 61' ' ' ARG . 15.7 m-20 -80.37 -21.26 42.54 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.017 -1.052 . . . . 0.0 110.394 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.435 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . 86.65 152.28 21.11 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.744 ' HB ' HG23 ' A' ' 62' ' ' ILE . 1.4 p -117.02 159.97 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.539 -0.977 . . . . 0.0 109.248 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.798 HG22 ' NE2' ' A' ' 74' ' ' HIS . 12.9 t -113.58 158.16 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-O 121.87 0.843 . . . . 0.0 109.384 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.468 ' N ' ' CG1' ' A' ' 68' ' ' VAL . 69.8 p -117.57 158.76 24.04 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.683 0.754 . . . . 0.0 110.088 -178.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.1 t -65.0 -25.6 67.93 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.571 0.7 . . . . 0.0 109.791 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.1 p -71.13 -15.09 62.48 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.638 -0.664 . . . . 0.0 109.388 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 99.51 10.55 47.2 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.607 -1.797 . . . . 0.0 108.607 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -103.17 157.0 17.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.269 -1.136 . . . . 0.0 109.621 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.798 ' NE2' HG22 ' A' ' 68' ' ' VAL . 11.1 m170 -115.07 155.93 26.11 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.064 -1.022 . . . . 0.0 108.821 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -142.67 -174.87 4.27 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.271 -0.893 . . . . 0.0 110.465 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 60.62 -139.47 48.11 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.527 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER 52.39 33.19 12.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.215 -1.168 . . . . 0.0 109.368 -179.884 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.479 ' O ' ' N ' ' A' ' 80' ' ' GLN . 1.3 mt -79.06 -22.23 45.64 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.976 -1.078 . . . . 0.0 109.996 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.423 ' C ' ' O ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -45.85 98.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.798 -1.189 . . . . 0.0 108.855 179.513 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.479 ' N ' ' O ' ' A' ' 78' ' ' LEU . 40.1 mt-30 -145.12 174.21 11.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.124 -0.985 . . . . 0.0 110.428 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -56.78 140.75 46.76 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 122.045 0.926 . . . . 0.0 110.701 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.663 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 17.9 mt -133.06 171.17 9.63 Favored Pre-proline 0 C--N 1.301 -1.531 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 179.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.663 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 27.5 Cg_endo -65.91 98.88 0.38 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 120.856 1.038 . . . . 0.0 110.591 -179.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.492 ' C ' ' SG ' ' A' ' 29' ' ' CYS . . . 88.3 -6.73 83.21 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.464 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 9.7 m -119.86 88.42 40.08 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 120.684 -1.48 . . . . 0.0 110.015 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 87' ' ' ARG . 30.5 Cg_endo -75.75 161.32 36.72 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 C-N-CA 122.085 1.857 . . . . 0.0 111.713 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.433 ' C ' ' O ' ' A' ' 86' ' ' PRO . 13.3 mtm-85 -43.57 -27.51 0.3 Allowed 'General case' 0 N--CA 1.482 1.136 0 CA-C-O 121.773 0.797 . . . . 0.0 108.913 178.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' A' ' 86' ' ' PRO . 32.9 tt0 -59.2 -59.84 4.81 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.753 -0.592 . . . . 0.0 111.317 -178.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 45.0 t -65.75 -40.7 88.52 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 O-C-N 120.871 -1.143 . . . . 0.0 110.531 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.909 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -63.83 -28.07 69.6 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.249 -0.98 . . . . 0.0 108.574 179.843 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.407 ' HB2' ' O ' ' A' ' 87' ' ' ARG . 0.1 OUTLIER -78.09 -29.39 49.01 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.542 -0.723 . . . . 0.0 109.592 179.556 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.479 ' O ' ' HD2' ' A' ' 95' ' ' PRO . . . -74.58 -53.52 9.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -0.909 . . . . 0.0 109.965 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 1.102 ' CD2' HG22 ' A' ' 24' ' ' VAL . 6.0 t80 -78.25 -26.6 47.32 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.042 -1.036 . . . . 0.0 110.365 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.909 ' HB2' ' O ' ' A' ' 90' ' ' GLN . . . -40.91 -52.64 6.61 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.125 -0.985 . . . . 0.0 111.34 -178.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.827 ' HD3' ' HB3' ' A' ' 94' ' ' ALA . 31.4 Cg_endo -72.27 -164.71 0.18 Allowed 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.143 1.895 . . . . 0.0 111.04 -178.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 95' ' ' PRO . 13.6 mmtm 63.73 30.41 14.71 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -178.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.507 ' HA ' HD22 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -73.77 -71.19 0.34 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.656 -0.653 . . . . 0.0 110.86 -179.157 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.94 HG12 HD11 ' A' ' 48' ' ' LEU . 2.9 m -77.45 22.9 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.623 -1.298 . . . . 0.0 111.266 -179.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.435 ' C ' ' HB3' ' A' ' 104' ' ' ASN . 7.0 p -99.22 172.68 7.21 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 120.513 -1.367 . . . . 0.0 108.898 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.465 ' HA ' ' ND2' ' A' ' 104' ' ' ASN . 40.0 mt-10 -59.63 -0.31 0.17 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.804 -1.185 . . . . 0.0 111.891 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.702 ' O ' HG12 ' A' ' 101' ' ' VAL . 97.8 t -100.28 7.39 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 119.957 -1.714 . . . . 0.0 110.33 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.506 ' HB2' ' O ' ' A' ' 97' ' ' LEU . 2.0 mm-40 -145.75 -92.71 0.09 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.758 -1.214 . . . . 0.0 110.297 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.463 ' O ' ' C ' ' A' ' 104' ' ' ASN . 33.2 m -142.13 37.86 1.58 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.945 -1.097 . . . . 0.0 109.638 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 98' ' ' VAL . 5.1 p30 -35.12 -50.96 0.53 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.244 -0.91 . . . . 0.0 111.513 -179.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 106' ' ' ALA . 12.0 mt 42.23 31.61 0.27 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.916 -1.115 . . . . 0.0 110.226 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.468 ' O ' ' O ' ' A' ' 105' ' ' LEU . . . 60.28 121.33 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.857 -1.152 . . . . 0.0 109.521 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.8 p -91.58 -165.72 1.41 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 1.035 HD13 ' O ' ' A' ' 108' ' ' ILE . 0.0 OUTLIER -61.37 -25.77 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 120.931 -1.105 . . . . 0.0 108.49 179.261 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.48 ' HB3' ' CE1' ' A' ' 113' ' ' PHE . 86.9 m-70 -76.74 14.0 0.9 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.53 -0.731 . . . . 0.0 110.717 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 50.11 25.06 7.32 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.399 -1.481 . . . . 0.0 109.399 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -156.55 172.08 34.24 Favored Glycine 0 N--CA 1.49 2.246 0 C-N-CA 119.766 -1.207 . . . . 0.0 110.085 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.474 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 33.3 Cg_endo -78.5 74.25 5.5 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 123.001 2.467 . . . . 0.0 111.195 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.48 ' CE1' ' HB3' ' A' ' 109' ' ' HIS . 32.6 p90 171.77 143.53 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.177 -0.952 . . . . 0.0 109.947 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 16.6 p -142.02 151.07 42.11 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.773 -1.204 . . . . 0.0 109.184 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.488 ' O ' ' HB2' ' A' ' 116' ' ' SER . 0.9 OUTLIER 50.88 -174.89 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.944 -1.098 . . . . 0.0 109.625 -179.903 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.488 ' HB2' ' O ' ' A' ' 115' ' ' LEU . 16.1 m 64.12 -103.46 0.11 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.497 -0.752 . . . . 0.0 110.168 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 19.6 mt 55.22 -149.9 0.44 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.022 -1.048 . . . . 0.0 109.061 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.7 mt -50.12 -15.7 0.24 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.014 -1.054 . . . . 0.0 111.738 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -63.46 -85.21 0.06 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -135.0 69.53 1.45 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.238 -1.154 . . . . 0.0 109.415 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -89.58 18.78 44.39 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.246 -1.149 . . . . 0.0 109.551 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.503 ' C ' HG23 ' A' ' 2' ' ' VAL . 79.5 p . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.503 HG23 ' C ' ' A' ' 1' ' ' SER . 5.2 t 85.29 -50.27 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.673 0 C-N-CA 122.907 0.483 . . . . 0.0 109.995 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.423 ' C ' HG22 ' A' ' 4' ' ' THR . . . 81.06 -116.55 4.24 Favored Glycine 0 N--CA 1.496 2.645 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.423 HG22 ' C ' ' A' ' 3' ' ' GLY . 9.8 t 41.43 31.28 0.17 Allowed 'General case' 0 N--CA 1.509 2.502 0 CA-C-O 121.224 0.535 . . . . 0.0 111.042 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -110.49 175.04 5.58 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.948 -0.47 . . . . 0.0 109.795 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 94.9 m -122.43 168.46 12.07 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.569 HG21 ' SD ' ' A' ' 10' ' ' MET . 17.6 mt -87.34 138.23 32.27 Favored Pre-proline 0 N--CA 1.5 2.026 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -81.24 148.73 16.84 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 121.872 1.714 . . . . 0.0 110.298 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 58.1 17.89 32.15 Favored Glycine 0 N--CA 1.499 2.866 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.583 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 84.3 mtp -140.84 108.09 5.51 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-N 117.935 0.868 . . . . 0.0 108.72 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.583 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 86.73 -58.4 0.05 OUTLIER 'General case' 0 N--CA 1.514 2.75 0 CA-C-N 119.75 1.159 . . . . 0.0 108.247 -178.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.843 HD11 ' HB3' ' A' ' 55' ' ' CYS . 44.8 mt -106.41 100.74 31.53 Favored Pre-proline 0 N--CA 1.492 1.648 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 178.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -81.01 173.47 11.89 Favored 'Trans proline' 0 N--CA 1.475 0.427 0 C-N-CA 121.471 1.447 . . . . 0.0 111.243 -177.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 59.6 m-70 -71.14 144.19 50.31 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.563 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 35.1 t-20 59.78 52.88 3.75 Favored Pre-proline 0 N--CA 1.498 1.972 0 O-C-N 121.725 -0.61 . . . . 0.0 110.05 -178.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.563 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 41.8 Cg_endo -83.05 170.27 12.39 Favored 'Trans proline' 0 N--CA 1.483 0.864 0 C-N-CA 122.043 1.829 . . . . 0.0 111.355 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.668 HD23 ' HB1' ' A' ' 59' ' ' ALA . 4.3 mm? 50.75 38.73 20.24 Favored 'General case' 0 N--CA 1.501 2.093 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.646 177.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -78.17 -43.31 28.98 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.542 -0.724 . . . . 0.0 109.484 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.18 -29.12 70.15 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 17.0 m -73.5 -40.1 64.32 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.569 ' CZ ' HD11 ' A' ' 82' ' ' LEU . 0.6 OUTLIER -61.23 -51.36 69.28 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -179.722 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.42 ' CE3' ' HA ' ' A' ' 22' ' ' TRP . 38.9 m95 -69.83 -28.15 65.46 Favored 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 119.581 -0.848 . . . . 0.0 109.743 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.589 ' HE1' HG22 ' A' ' 37' ' ' THR . 18.4 t80 -67.47 -29.63 69.14 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.547 HG22 ' CE1' ' A' ' 93' ' ' PHE . 98.9 t -75.27 -42.89 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 85.0 p -54.73 -39.02 67.83 Favored 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.939 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 77.0 m -77.45 -48.77 16.32 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 122.296 -0.252 . . . . 0.0 111.661 -178.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.6 mmm180 -64.26 -24.88 67.82 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.626 -0.671 . . . . 0.0 111.054 -178.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 82.5 p -97.0 -61.97 1.33 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 122.162 -0.336 . . . . 0.0 111.872 -177.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.654 ' O ' HG23 ' A' ' 31' ' ' VAL . 3.7 m -100.08 9.35 42.98 Favored 'General case' 0 N--CA 1.507 2.407 0 O-C-N 121.444 -0.785 . . . . 0.0 111.415 -178.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 57.43 25.93 55.8 Favored Glycine 0 N--CA 1.505 3.237 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 -178.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' ' 29' ' ' CYS . 41.0 t -115.38 164.49 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 122.105 -0.644 . . . . 0.0 109.556 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.498 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 132.61 178.28 15.43 Favored Glycine 0 N--CA 1.498 2.785 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -66.13 173.5 7.19 Favored 'Trans proline' 0 N--CA 1.486 1.058 0 CA-C-N 119.382 1.591 . . . . 0.0 109.833 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -92.24 79.99 5.04 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 122.02 0.914 . . . . 0.0 109.87 -178.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.401 ' HA ' HD22 ' A' ' 35' ' ' LEU . 0.2 OUTLIER -124.71 129.52 50.66 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.037 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.25 132.59 28.76 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.925 -0.484 . . . . 0.0 109.747 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.589 HG22 ' HE1' ' A' ' 23' ' ' TYR . 0.6 OUTLIER -52.58 -53.64 43.76 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.447 -0.783 . . . . 0.0 111.18 -179.108 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -50.12 -35.96 27.84 Favored 'General case' 0 N--CA 1.508 2.436 0 O-C-N 121.723 -0.61 . . . . 0.0 110.816 -178.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -70.93 -38.54 72.89 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 31.5 tpp -62.54 -57.55 10.74 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 41.2 tttt -55.77 -35.94 66.8 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.862 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.28 -37.09 86.25 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.74 -45.85 81.08 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 15.1 m -62.72 -35.57 80.2 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.094 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 17.7 m -75.3 -28.56 59.76 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.64 -34.95 70.22 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -78.43 -28.2 46.71 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.689 ' O ' HD13 ' A' ' 48' ' ' LEU . 1.4 tm? -72.78 -35.47 67.42 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -178.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -77.92 -51.28 10.66 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.64 -33.39 54.99 Favored 'General case' 0 N--CA 1.505 2.303 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.0 mt -87.71 104.88 7.4 Favored Pre-proline 0 N--CA 1.492 1.651 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.559 ' HD2' ' HB1' ' A' ' 11' ' ' ALA . 25.7 Cg_endo -60.56 149.22 88.08 Favored 'Trans proline' 0 N--CA 1.479 0.638 0 C-N-CA 121.826 1.684 . . . . 0.0 110.543 -177.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.1 -19.95 55.8 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.582 -177.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -49.56 -32.82 13.39 Favored 'General case' 0 N--CA 1.513 2.677 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 178.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.843 ' HB3' HD11 ' A' ' 12' ' ' ILE . 61.9 m -119.26 -69.89 0.82 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 115.336 -0.847 . . . . 0.0 108.955 178.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 35.7 mtt180 38.0 -92.96 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.696 0 C-N-CA 122.8 0.44 . . . . 0.0 111.273 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.403 ' HA ' HD13 ' A' ' 97' ' ' LEU . 86.4 m -37.96 -45.44 0.88 Allowed 'General case' 0 N--CA 1.515 2.815 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -40.21 -48.78 2.62 Favored 'General case' 0 N--CA 1.511 2.607 0 CA-C-N 119.843 1.202 . . . . 0.0 112.027 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.668 ' HB1' HD23 ' A' ' 17' ' ' LEU . . . -42.05 -49.22 4.74 Favored 'General case' 0 N--CA 1.513 2.685 0 CA-C-N 118.483 0.583 . . . . 0.0 111.905 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.921 HG21 HD22 ' A' ' 97' ' ' LEU . 57.6 t -57.94 -45.86 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -60.61 -26.83 67.29 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.795 HG23 ' HB ' ' A' ' 67' ' ' VAL . 50.6 mt -78.1 -29.31 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.881 -0.512 . . . . 0.0 109.71 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.2 tp -77.87 -41.51 36.55 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.853 -0.739 . . . . 0.0 109.954 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.707 ' SD ' HD22 ' A' ' 79' ' ' LEU . 39.4 tpp -78.56 -52.77 8.0 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.331 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -80.51 -22.94 40.43 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 122.048 -0.408 . . . . 0.0 110.981 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 85.15 147.47 9.21 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 109.196 -1.561 . . . . 0.0 109.196 -178.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.795 ' HB ' HG23 ' A' ' 62' ' ' ILE . 5.3 p -118.01 158.74 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.265 0 O-C-N 122.133 -0.628 . . . . 0.0 109.531 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.662 HG22 ' NE2' ' A' ' 74' ' ' HIS . 70.6 t -115.58 157.3 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-O 121.946 0.879 . . . . 0.0 109.463 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.6 p -117.35 159.99 21.86 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.03 -178.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 34.3 t -64.11 -33.62 76.18 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.932 -178.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.7 p -63.44 -17.8 63.07 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.69 8.13 49.52 Favored Glycine 0 N--CA 1.496 2.672 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 60.8 mt-30 -95.43 156.08 16.47 Favored 'General case' 0 N--CA 1.501 2.114 0 CA-C-N 118.158 0.979 . . . . 0.0 109.578 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.662 ' NE2' HG22 ' A' ' 68' ' ' VAL . 9.6 m170 -116.47 154.93 29.48 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -141.24 -175.49 4.36 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.106 0.479 . . . . 0.0 110.081 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 55.6 -146.1 31.03 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.9 ttp180 56.54 19.84 4.48 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 122.29 -0.535 . . . . 0.0 110.384 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.5 mt -84.03 -14.45 50.57 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.723 -0.611 . . . . 0.0 110.244 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.873 HD21 ' CB ' ' A' ' 90' ' ' GLN . 5.3 tt -61.93 92.88 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -135.31 172.8 12.49 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.255 0.55 . . . . 0.0 109.591 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -51.32 102.01 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.651 0.739 . . . . 0.0 111.384 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.569 HD11 ' CZ ' ' A' ' 21' ' ' ARG . 21.5 mt -87.2 169.99 13.18 Favored Pre-proline 0 N--CA 1.495 1.803 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 177.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.557 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 28.9 Cg_endo -68.18 100.55 0.65 Allowed 'Trans proline' 0 C--N 1.327 -0.562 0 C-N-CA 120.942 1.095 . . . . 0.0 110.609 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.17 11.99 60.6 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.416 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 3.6 m -141.91 91.33 8.17 Favored Pre-proline 0 N--CA 1.506 2.353 0 CA-C-N 118.786 1.293 . . . . 0.0 109.11 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -74.19 161.45 40.68 Favored 'Trans proline' 0 N--CA 1.482 0.825 0 C-N-CA 121.538 1.492 . . . . 0.0 111.282 -178.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.82 -28.75 2.73 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.268 0.556 . . . . 0.0 109.599 177.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -55.38 -53.49 55.57 Favored 'General case' 0 N--CA 1.503 2.199 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.654 -178.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 54.2 t -62.83 -39.91 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.709 -0.62 . . . . 0.0 109.63 -178.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.873 ' CB ' HD21 ' A' ' 79' ' ' LEU . 1.9 mp0 -64.11 -26.35 68.5 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.66 -33.99 46.68 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.29 -48.83 63.91 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.876 -0.515 . . . . 0.0 109.654 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.547 ' CE1' HG22 ' A' ' 24' ' ' VAL . 31.0 t80 -78.58 -26.25 45.49 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 122.262 -0.274 . . . . 0.0 110.55 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.695 ' HB3' ' HD3' ' A' ' 95' ' ' PRO . . . -41.25 -49.75 8.6 Favored Pre-proline 0 N--CA 1.506 2.336 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -177.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.695 ' HD3' ' HB3' ' A' ' 94' ' ' ALA . 34.5 Cg_endo -77.84 33.15 0.45 Allowed 'Trans proline' 0 CA--C 1.55 1.308 0 C-N-CA 122.206 1.937 . . . . 0.0 112.964 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 49.8 mttm -123.99 30.97 5.96 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 178.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.921 HD22 HG21 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -73.56 -71.31 0.32 Allowed 'General case' 0 N--CA 1.512 2.641 0 O-C-N 122.067 -0.396 . . . . 0.0 110.804 -179.196 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.853 HG13 HD12 ' A' ' 97' ' ' LEU . 11.0 m -94.95 28.32 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.388 -0.82 . . . . 0.0 109.855 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 27.9 p -96.96 170.05 9.42 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.414 ' HA ' ' ND2' ' A' ' 104' ' ' ASN . 0.2 OUTLIER -61.85 -2.38 0.85 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.549 -0.72 . . . . 0.0 112.015 -179.65 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.573 ' O ' HG12 ' A' ' 101' ' ' VAL . 22.0 t -98.34 4.72 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 CA-C-N 120.36 1.436 . . . . 0.0 110.894 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.429 ' HB3' ' O ' ' A' ' 97' ' ' LEU . 4.8 tp10 -142.25 -91.55 0.13 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.559 -0.713 . . . . 0.0 111.039 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.483 ' O ' HD12 ' A' ' 105' ' ' LEU . 93.6 m -143.61 42.06 1.47 Allowed 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.387 -0.821 . . . . 0.0 110.002 -178.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.414 ' ND2' ' HA ' ' A' ' 100' ' ' GLU . 3.9 p30 -39.85 -56.8 1.71 Allowed 'General case' 0 N--CA 1.508 2.456 0 N-CA-C 113.642 0.978 . . . . 0.0 113.642 -178.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.483 HD12 ' O ' ' A' ' 103' ' ' CYS . 2.0 mt 45.87 23.9 0.2 Allowed 'General case' 0 N--CA 1.508 2.432 0 CA-C-N 118.995 0.816 . . . . 0.0 111.277 -179.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 105' ' ' LEU . . . 64.76 123.79 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.317 -0.865 . . . . 0.0 109.7 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.1 p -89.89 -159.0 0.56 Allowed 'General case' 0 N--CA 1.507 2.38 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.5 tp -66.63 -31.1 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -69.77 -0.87 7.8 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.893 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 58.54 28.78 62.89 Favored Glycine 0 N--CA 1.497 2.756 0 N-CA-C 109.299 -1.521 . . . . 0.0 109.299 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -157.01 168.72 34.04 Favored Glycine 0 N--CA 1.498 2.784 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -78.68 73.96 5.69 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 122.798 2.332 . . . . 0.0 111.933 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 30.2 p90 176.29 154.01 0.2 Allowed 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.583 -0.698 . . . . 0.0 110.431 178.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 20.6 p -165.08 144.16 6.66 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 51.02 24.89 2.02 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.579 -0.7 . . . . 0.0 110.613 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 28.1 t -130.2 -89.59 0.48 Allowed 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 53.06 -88.53 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.949 -0.47 . . . . 0.0 110.412 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -51.26 -16.25 0.49 Allowed 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.11 -99.74 0.01 OUTLIER Glycine 0 N--CA 1.502 3.078 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 57.27 72.42 0.52 Allowed 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 121.648 0.737 . . . . 0.0 109.558 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -65.51 -14.5 60.19 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 . . . . . 0 N--CA 1.5 2.052 0 CA-C-O 118.113 -0.946 . . . . 0.0 109.422 -179.89 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 77.5 p . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.4 m -42.2 -37.28 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.56 0 O-C-N 122.117 -0.365 . . . . 0.0 111.629 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -67.07 96.95 0.34 Allowed Glycine 0 N--CA 1.498 2.832 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.6 t -132.55 52.5 2.07 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 121.613 0.72 . . . . 0.0 109.276 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.1 t -88.7 68.57 8.63 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 121.554 0.692 . . . . 0.0 109.574 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.1 m -140.3 -163.94 1.62 Allowed 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.681 -0.637 . . . . 0.0 109.289 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.759 HD12 ' CB ' ' A' ' 10' ' ' MET . 0.2 OUTLIER -162.53 153.56 14.74 Favored Pre-proline 0 N--CA 1.506 2.363 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -79.41 126.1 6.66 Favored 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 122.364 2.043 . . . . 0.0 111.038 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 74.76 4.12 69.94 Favored Glycine 0 N--CA 1.502 3.048 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.759 ' CB ' HD12 ' A' ' 7' ' ' ILE . 72.4 mmm -129.61 99.74 5.27 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.577 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 86.7 -54.59 0.06 Allowed 'General case' 0 N--CA 1.517 2.917 0 CA-C-N 119.448 1.022 . . . . 0.0 108.713 -178.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.691 HD11 ' HB2' ' A' ' 55' ' ' CYS . 36.8 mm -104.83 100.55 24.32 Favored Pre-proline 0 N--CA 1.495 1.783 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.404 ' HD3' ' CD1' ' A' ' 51' ' ' ILE . 35.6 Cg_endo -84.27 175.04 7.63 Favored 'Trans proline' 0 N--CA 1.475 0.423 0 C-N-CA 121.749 1.632 . . . . 0.0 111.511 -177.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 -84.03 142.78 30.21 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.499 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 7.3 t-20 60.12 57.95 4.41 Favored Pre-proline 0 N--CA 1.501 2.094 0 O-C-N 121.605 -0.685 . . . . 0.0 109.676 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.499 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 39.7 Cg_endo -81.41 150.24 17.11 Favored 'Trans proline' 0 N--CA 1.481 0.747 0 C-N-CA 122.219 1.946 . . . . 0.0 112.069 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 76.9 mt 51.98 42.74 30.5 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.853 177.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -66.33 -34.24 77.54 Favored 'General case' 0 N--CA 1.506 2.353 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 178.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.3 t -63.49 -26.06 68.54 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.696 ' O ' HG23 ' A' ' 24' ' ' VAL . 56.1 m -77.79 -34.76 52.05 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.678 ' HB3' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -65.94 -51.54 57.66 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.417 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.45 ' HA ' ' CE3' ' A' ' 22' ' ' TRP . 27.7 m95 -66.83 -32.43 73.7 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 119.753 -0.779 . . . . 0.0 109.682 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -64.25 -32.33 73.88 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 20' ' ' CYS . 48.2 t -70.51 -39.74 76.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 177.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 m -55.92 -40.39 73.01 Favored 'General case' 0 N--CA 1.501 2.088 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.361 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.1 m -77.19 -54.45 6.49 Favored 'General case' 0 N--CA 1.51 2.543 0 O-C-N 122.011 -0.431 . . . . 0.0 111.785 -178.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 14.3 ttm180 -60.05 -24.6 64.68 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.687 -0.633 . . . . 0.0 110.413 -178.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.531 HG23 ' O ' ' A' ' 24' ' ' VAL . 44.3 p -95.21 -66.02 0.94 Allowed 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -177.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.539 ' O ' HG23 ' A' ' 31' ' ' VAL . 3.8 m -100.35 13.27 34.96 Favored 'General case' 0 N--CA 1.51 2.556 0 O-C-N 121.247 -0.908 . . . . 0.0 111.413 -178.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 58.66 22.68 53.64 Favored Glycine 0 N--CA 1.505 3.269 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -178.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 29' ' ' CYS . 29.0 t -110.01 165.53 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.363 0 O-C-N 121.899 -0.765 . . . . 0.0 109.376 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.496 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 131.06 178.63 15.56 Favored Glycine 0 N--CA 1.499 2.896 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -65.03 176.67 2.91 Favored 'Trans proline' 0 N--CA 1.489 1.249 0 CA-C-N 119.042 1.421 . . . . 0.0 109.905 179.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.774 ' C ' HD12 ' A' ' 35' ' ' LEU . 0.3 OUTLIER -91.59 79.58 5.46 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 122.196 0.998 . . . . 0.0 109.857 -178.099 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.774 HD12 ' C ' ' A' ' 34' ' ' ARG . 9.4 mp -130.59 127.8 39.74 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.04 160.24 1.57 Allowed 'General case' 0 N--CA 1.501 2.121 0 O-C-N 122.041 -0.412 . . . . 0.0 110.12 -178.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.22 -37.93 72.02 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 122.02 -0.425 . . . . 0.0 111.206 -178.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.53 -42.77 77.99 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.881 -0.512 . . . . 0.0 110.081 -178.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -70.12 -28.17 65.17 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 2.7 tpt -70.06 -54.54 12.65 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.3 tttt -55.53 -33.9 64.22 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.505 179.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.73 -37.9 76.66 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.63 -37.83 88.81 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 13.1 m -72.23 -32.8 67.06 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.856 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.406 ' HA ' ' CB ' ' A' ' 103' ' ' CYS . 79.7 m -72.2 -29.71 64.24 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.63 -34.89 46.18 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.528 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 4.4 mm-40 -72.98 -38.15 66.79 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.911 HD11 HG12 ' A' ' 98' ' ' VAL . 1.2 tt -67.64 -59.78 3.07 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 179.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.817 ' N ' HD23 ' A' ' 48' ' ' LEU . 1.1 tm-20 -52.57 -26.9 14.63 Favored 'General case' 0 N--CA 1.504 2.245 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 47' ' ' GLN . . . -61.65 -61.31 2.61 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.561 HG23 HD13 ' A' ' 12' ' ' ILE . 45.9 mm -57.12 102.98 0.33 Allowed Pre-proline 0 N--CA 1.509 2.501 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 177.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -54.82 149.8 39.85 Favored 'Trans proline' 0 N--CA 1.486 1.044 0 C-N-CA 121.895 1.73 . . . . 0.0 112.79 -175.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -37.19 -32.1 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.427 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.415 -178.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -73.43 112.27 9.35 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 177.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.691 ' HB2' HD11 ' A' ' 12' ' ' ILE . 28.4 m 73.67 14.82 4.15 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 122.237 -0.289 . . . . 0.0 110.29 -178.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.504 ' NH1' ' O ' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -45.53 -86.52 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.919 0 O-C-N 121.083 -1.01 . . . . 0.0 109.813 -179.913 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 21.8 m -38.98 -38.55 0.45 Allowed 'General case' 0 N--CA 1.515 2.821 0 N-CA-C 113.801 1.038 . . . . 0.0 113.801 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.725 ' O ' HD12 ' A' ' 62' ' ' ILE . 0.5 OUTLIER -36.36 -43.91 0.4 Allowed 'General case' 0 N--CA 1.512 2.673 0 CA-C-N 120.294 1.406 . . . . 0.0 112.512 -179.697 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -42.55 -54.53 3.89 Favored 'General case' 0 N--CA 1.514 2.755 0 O-C-N 121.851 -0.531 . . . . 0.0 111.765 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.818 ' CG2' HD13 ' A' ' 97' ' ' LEU . 95.2 t -57.58 -42.34 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.89 -30.41 67.76 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.725 HD12 ' O ' ' A' ' 58' ' ' GLU . 1.6 mp -78.41 -30.43 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 O-C-N 121.954 -0.466 . . . . 0.0 110.469 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.678 HD21 ' HB3' ' A' ' 21' ' ' ARG . 3.8 tp -77.44 -41.72 38.71 Favored 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 119.314 -0.954 . . . . 0.0 110.282 -178.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.69 ' HA ' HD21 ' A' ' 79' ' ' LEU . 0.7 OUTLIER -78.72 -52.06 8.94 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.202 -179.821 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -81.06 -22.99 38.84 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.936 -0.478 . . . . 0.0 111.267 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.58 147.38 10.93 Favored Glycine 0 N--CA 1.498 2.823 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 -178.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.704 ' HB ' HG23 ' A' ' 62' ' ' ILE . 7.6 p -118.29 159.65 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 122.052 -0.675 . . . . 0.0 109.644 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.667 HG22 ' NE2' ' A' ' 74' ' ' HIS . 69.3 t -114.9 157.77 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 CA-C-O 121.828 0.823 . . . . 0.0 109.602 -178.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.409 ' N ' HG12 ' A' ' 68' ' ' VAL . 33.9 p -117.14 159.54 22.43 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.73 -177.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 42.6 t -63.28 -31.09 72.15 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.383 -178.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.5 p -68.32 -17.33 64.23 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.231 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.91 14.08 32.42 Favored Glycine 0 N--CA 1.498 2.795 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -102.37 156.21 17.74 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-N 118.085 0.942 . . . . 0.0 109.398 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.667 ' NE2' HG22 ' A' ' 68' ' ' VAL . 8.7 m170 -116.03 156.15 26.84 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -145.67 -174.1 4.31 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.034 0.445 . . . . 0.0 109.869 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 60.27 -148.68 43.4 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 56.11 28.32 12.8 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 122.122 -0.634 . . . . 0.0 109.679 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.452 HD23 ' NH2' ' A' ' 21' ' ' ARG . 6.4 mp -86.45 -14.37 43.43 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.716 -0.615 . . . . 0.0 111.202 -178.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.69 HD21 ' HA ' ' A' ' 64' ' ' MET . 1.0 OUTLIER -79.93 84.42 5.69 Favored 'General case' 0 N--CA 1.503 2.212 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 179.109 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -127.81 -173.13 2.84 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.464 0.649 . . . . 0.0 110.01 -178.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -50.43 102.31 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.695 0.76 . . . . 0.0 111.396 -179.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.53 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 22.2 mt -98.51 169.18 8.68 Favored Pre-proline 0 N--CA 1.497 1.916 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.53 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 28.7 Cg_endo -68.24 101.25 0.7 Allowed 'Trans proline' 0 N--CA 1.478 0.601 0 C-N-CA 121.189 1.259 . . . . 0.0 110.733 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.69 13.65 59.25 Favored Glycine 0 N--CA 1.497 2.71 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 3.7 m -143.6 91.03 6.9 Favored Pre-proline 0 N--CA 1.509 2.485 0 CA-C-N 118.637 1.219 . . . . 0.0 109.371 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -75.39 160.15 39.17 Favored 'Trans proline' 0 N--CA 1.483 0.856 0 C-N-CA 121.673 1.582 . . . . 0.0 111.464 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.0 mmt85 -49.55 -28.56 5.73 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 177.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 -57.13 -59.39 5.16 Favored 'General case' 0 N--CA 1.503 2.2 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.624 -178.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 53.6 t -61.07 -40.25 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.836 -0.54 . . . . 0.0 110.311 -178.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.734 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 0.3 OUTLIER -65.42 -26.94 68.2 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.638 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.63 -31.68 47.05 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.42 -48.99 36.89 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 122.04 -0.413 . . . . 0.0 109.902 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.464 ' HD2' HG13 ' A' ' 24' ' ' VAL . 67.2 t80 -78.46 -25.34 45.82 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 122.326 -0.234 . . . . 0.0 111.132 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.734 ' HB2' ' O ' ' A' ' 90' ' ' GLN . . . -48.98 -48.83 71.43 Favored Pre-proline 0 N--CA 1.505 2.319 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -176.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.477 ' HD3' ' HB3' ' A' ' 94' ' ' ALA . 29.3 Cg_endo -68.61 85.59 0.46 Allowed 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 121.841 1.694 . . . . 0.0 113.29 -176.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.424 ' C ' ' HD3' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -177.8 54.95 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.422 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.595 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.818 HD13 ' CG2' ' A' ' 60' ' ' VAL . 29.0 tp -86.27 -81.32 0.22 Allowed 'General case' 0 N--CA 1.507 2.388 0 O-C-N 121.218 -0.926 . . . . 0.0 111.753 -177.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.911 HG12 HD11 ' A' ' 48' ' ' LEU . 4.0 m -91.62 24.92 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.745 -0.597 . . . . 0.0 110.958 -176.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 29.9 p -93.47 168.71 10.87 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.16 -0.01 0.48 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.49 -0.756 . . . . 0.0 111.843 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.551 ' O ' HG12 ' A' ' 101' ' ' VAL . 28.0 t -97.07 0.16 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 CA-C-N 120.518 1.508 . . . . 0.0 111.249 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.409 ' HB3' ' O ' ' A' ' 97' ' ' LEU . 23.9 tp10 -140.71 -88.07 0.17 Allowed 'General case' 0 N--CA 1.504 2.245 0 CA-C-N 119.114 0.87 . . . . 0.0 111.433 -179.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.517 ' O ' HD12 ' A' ' 105' ' ' LEU . 57.3 m -143.74 45.56 1.48 Allowed 'General case' 0 N--CA 1.509 2.482 0 O-C-N 121.244 -0.91 . . . . 0.0 109.683 -179.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -40.5 -57.59 1.78 Allowed 'General case' 0 N--CA 1.504 2.263 0 O-C-N 121.192 -0.942 . . . . 0.0 113.363 -178.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.517 HD12 ' O ' ' A' ' 103' ' ' CYS . 3.6 mt 43.16 27.27 0.11 Allowed 'General case' 0 N--CA 1.515 2.777 0 CA-C-N 119.016 0.825 . . . . 0.0 111.112 -179.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 63.57 153.66 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.451 -0.781 . . . . 0.0 109.801 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.3 p -123.82 -161.18 0.96 Allowed 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.3 tp -66.99 -33.8 65.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.451 ' HB3' ' CE1' ' A' ' 113' ' ' PHE . 74.4 m-70 -70.96 -0.72 9.9 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.907 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 56.28 43.41 89.44 Favored Glycine 0 N--CA 1.501 2.984 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -172.48 170.58 43.63 Favored Glycine 0 N--CA 1.501 2.993 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -77.17 77.1 3.92 Favored 'Trans proline' 0 CA--C 1.544 1.023 0 C-N-CA 122.36 2.04 . . . . 0.0 111.513 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.451 ' CE1' ' HB3' ' A' ' 109' ' ' HIS . 33.1 p90 173.51 150.8 0.08 Allowed 'General case' 0 N--CA 1.505 2.311 0 O-C-N 121.754 -0.591 . . . . 0.0 109.827 178.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 20.6 p -145.49 86.62 1.76 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.756 -0.59 . . . . 0.0 110.168 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -153.58 -174.7 5.05 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.246 -0.909 . . . . 0.0 109.601 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 71.7 m -55.12 -54.76 39.06 Favored 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.495 ' O ' ' HB2' ' A' ' 118' ' ' LEU . 0.1 OUTLIER 81.1 -69.04 0.09 Allowed 'General case' 0 N--CA 1.51 2.555 0 C-N-CA 122.677 0.391 . . . . 0.0 110.707 179.223 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.495 ' HB2' ' O ' ' A' ' 117' ' ' LEU . 2.0 mp 74.09 -17.81 0.44 Allowed 'General case' 0 N--CA 1.512 2.633 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -179.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -99.05 30.07 10.55 Favored Glycine 0 N--CA 1.499 2.854 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -104.93 47.72 0.86 Allowed 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.857 0.836 . . . . 0.0 109.301 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.21 10.62 68.13 Favored Glycine 0 N--CA 1.499 2.899 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 . . . . . 0 N--CA 1.497 1.914 0 CA-C-N 118.091 0.945 . . . . 0.0 109.299 179.853 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 79.1 p . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.2 m -119.62 -111.09 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.41 ' O ' HG22 ' A' ' 4' ' ' THR . . . 94.53 -87.25 1.08 Allowed Glycine 0 N--CA 1.499 2.856 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.41 HG22 ' O ' ' A' ' 3' ' ' GLY . 8.8 t 41.54 46.6 3.1 Favored 'General case' 0 N--CA 1.509 2.522 0 CA-C-O 121.436 0.636 . . . . 0.0 111.452 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 59.9 p -120.85 -160.01 0.82 Allowed 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.728 -0.608 . . . . 0.0 109.505 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 64.0 m 61.42 -160.97 0.3 Allowed 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.456 ' CG2' ' HD2' ' A' ' 8' ' ' PRO . 33.7 mt 71.91 139.74 0.07 OUTLIER Pre-proline 0 N--CA 1.506 2.356 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 -178.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.456 ' HD2' ' CG2' ' A' ' 7' ' ' ILE . 30.6 Cg_endo -71.7 165.82 31.37 Favored 'Trans proline' 0 N--CA 1.48 0.698 0 C-N-CA 121.624 1.549 . . . . 0.0 111.131 -178.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 62.76 16.48 56.34 Favored Glycine 0 N--CA 1.497 2.733 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.574 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 16.8 mmm -140.93 84.63 1.94 Allowed 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.882 -0.775 . . . . 0.0 109.011 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.574 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 86.73 -57.72 0.05 Allowed 'General case' 0 N--CA 1.516 2.864 0 O-C-N 121.379 -0.825 . . . . 0.0 108.84 -178.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.715 HD11 ' HB2' ' A' ' 55' ' ' CYS . 61.4 mt -92.14 104.4 10.71 Favored Pre-proline 0 N--CA 1.498 1.961 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 178.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -75.05 169.51 22.44 Favored 'Trans proline' 0 C--O 1.219 -0.433 0 C-N-CA 121.3 1.333 . . . . 0.0 111.649 -175.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 34.9 m-70 -69.28 144.62 53.54 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.489 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 5.3 t-20 65.98 55.98 1.05 Allowed Pre-proline 0 N--CA 1.506 2.357 0 O-C-N 121.358 -0.838 . . . . 0.0 110.303 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.489 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 38.6 Cg_endo -80.49 166.87 19.63 Favored 'Trans proline' 0 N--CA 1.484 0.932 0 C-N-CA 122.305 2.004 . . . . 0.0 111.923 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.6 mp 42.96 43.8 3.72 Favored 'General case' 0 N--CA 1.504 2.254 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.209 177.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -69.07 -37.68 78.63 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -63.01 -26.16 68.72 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 57.3 m -74.64 -38.78 62.42 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.584 HH22 HD23 ' A' ' 78' ' ' LEU . 3.4 ttt180 -64.13 -48.6 75.45 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 33.9 m95 -69.02 -29.07 67.17 Favored 'General case' 0 N--CA 1.502 2.149 0 C-N-CA 119.312 -0.955 . . . . 0.0 109.809 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.439 ' CD1' ' HB3' ' A' ' 40' ' ' MET . 57.1 t80 -66.5 -33.5 75.83 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.424 HG22 ' CD2' ' A' ' 93' ' ' PHE . 96.3 t -72.43 -38.96 61.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 177.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 m -56.18 -37.06 69.07 Favored 'General case' 0 N--CA 1.501 2.091 0 C-N-CA 119.946 -0.701 . . . . 0.0 109.529 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 90.9 m -77.8 -49.89 13.43 Favored 'General case' 0 N--CA 1.508 2.459 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.92 -25.29 67.82 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 121.519 -0.738 . . . . 0.0 110.544 -178.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 24' ' ' VAL . 70.4 p -93.65 -62.9 1.27 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -177.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.655 ' O ' HG23 ' A' ' 31' ' ' VAL . 3.6 m -100.43 9.23 42.92 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.384 -0.823 . . . . 0.0 111.617 -178.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 57.79 29.72 61.95 Favored Glycine 0 N--CA 1.507 3.382 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 -178.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 29' ' ' CYS . 38.5 t -120.72 164.09 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 122.155 -0.615 . . . . 0.0 109.717 -179.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.495 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 136.16 177.72 15.21 Favored Glycine 0 N--CA 1.5 2.908 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -64.43 177.33 2.18 Favored 'Trans proline' 0 N--CA 1.489 1.231 0 CA-C-N 119.196 1.498 . . . . 0.0 110.028 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.21 87.19 6.0 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 122.197 0.999 . . . . 0.0 110.412 -177.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.6 mt -141.76 127.2 18.83 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.02 152.37 2.24 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.907 -0.496 . . . . 0.0 109.81 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.1 p -59.96 -59.64 5.1 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.813 -0.555 . . . . 0.0 110.604 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -52.49 -28.79 21.82 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.818 -0.551 . . . . 0.0 111.595 -178.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -72.0 -46.89 55.56 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.816 -0.553 . . . . 0.0 109.573 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.439 ' HB3' ' CD1' ' A' ' 23' ' ' TYR . 5.5 tpt -61.97 -54.61 39.27 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -53.59 -35.75 61.2 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.34 -42.83 99.71 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.23 -41.14 96.37 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 19.8 m -65.58 -33.17 75.28 Favored 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.233 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 18.9 m -73.43 -30.16 63.03 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -178.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.27 -32.46 62.94 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -77.15 -33.47 56.62 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.785 HD22 ' O ' ' A' ' 103' ' ' CYS . 0.6 OUTLIER -73.48 -33.52 64.87 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.841 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.52 -40.38 61.79 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.25 -39.13 85.67 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.486 HG23 HG12 ' A' ' 12' ' ' ILE . 70.8 mt -82.7 105.75 5.52 Favored Pre-proline 0 N--CA 1.493 1.684 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 177.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -58.29 139.87 92.2 Favored 'Trans proline' 0 N--CA 1.48 0.712 0 C-N-CA 121.42 1.413 . . . . 0.0 110.92 -177.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.7 ' HB2' ' NH1' ' A' ' 56' ' ' ARG . . . -39.47 -29.76 0.06 Allowed 'General case' 0 N--CA 1.508 2.432 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.359 -178.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -53.16 -70.41 0.09 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.919 -0.488 . . . . 0.0 110.698 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.715 ' HB2' HD11 ' A' ' 12' ' ' ILE . 5.0 m -88.55 8.76 26.64 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 122.062 -0.399 . . . . 0.0 110.89 -179.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.7 ' NH1' ' HB2' ' A' ' 53' ' ' ALA . 5.9 mtt180 -47.58 -85.2 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.67 0 O-C-N 121.491 -0.755 . . . . 0.0 110.33 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 72.6 m -32.95 -48.85 0.22 Allowed 'General case' 0 N--CA 1.521 3.113 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -41.67 -54.34 3.3 Favored 'General case' 0 N--CA 1.512 2.668 0 CA-C-N 119.325 0.966 . . . . 0.0 111.731 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -41.82 -44.75 3.41 Favored 'General case' 0 N--CA 1.514 2.731 0 O-C-N 121.776 -0.578 . . . . 0.0 112.04 -179.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.6 t -57.22 -48.83 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -58.57 -26.83 64.01 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.957 HG23 ' HB ' ' A' ' 67' ' ' VAL . 34.8 mm -78.42 -30.76 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 O-C-N 121.985 -0.447 . . . . 0.0 110.469 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.486 HD12 ' HA ' ' A' ' 63' ' ' LEU . 14.8 tp -77.77 -43.22 31.42 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 120.11 -0.636 . . . . 0.0 109.999 -179.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.01 -50.76 10.58 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.18 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -80.6 -22.71 40.41 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 122.006 -0.434 . . . . 0.0 110.936 -178.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.73 146.89 5.7 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.957 ' HB ' HG23 ' A' ' 62' ' ' ILE . 5.5 p -118.42 161.18 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.667 HG22 ' NE2' ' A' ' 74' ' ' HIS . 56.0 t -113.34 157.85 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -179.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 42.2 p -116.67 160.07 21.28 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 121.95 0.881 . . . . 0.0 111.044 -176.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 32.9 t -64.61 -17.46 64.02 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.39 -178.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.1 p -86.49 -14.64 42.53 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 122.021 -0.424 . . . . 0.0 110.127 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.23 13.59 32.98 Favored Glycine 0 N--CA 1.499 2.892 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -105.48 158.56 16.58 Favored 'General case' 0 N--CA 1.502 2.125 0 CA-C-N 118.039 0.92 . . . . 0.0 108.834 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.667 ' NE2' HG22 ' A' ' 68' ' ' VAL . 11.3 m170 -113.72 154.95 26.46 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -179.138 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -136.89 -179.07 5.48 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 55.41 -146.94 28.82 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 108.622 -1.791 . . . . 0.0 108.622 -178.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 54.72 22.53 4.17 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 122.303 -0.528 . . . . 0.0 110.007 179.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.584 HD23 HH22 ' A' ' 21' ' ' ARG . 2.1 mp -83.1 -14.73 53.1 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.745 -0.597 . . . . 0.0 110.361 -179.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.5 mt -62.0 92.79 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -134.22 -177.21 4.48 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.719 0.771 . . . . 0.0 110.843 -178.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -48.68 130.14 17.2 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.506 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.466 ' HB2' ' HB2' ' A' ' 85' ' ' CYS . 20.6 mt -127.49 166.38 23.54 Favored Pre-proline 0 N--CA 1.496 1.87 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 29.6 Cg_endo -68.63 98.69 0.59 Allowed 'Trans proline' 0 C--N 1.328 -0.537 0 C-N-CA 120.88 1.054 . . . . 0.0 110.143 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.68 4.22 67.9 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.466 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 3.3 m -137.02 92.1 14.4 Favored Pre-proline 0 N--CA 1.508 2.47 0 CA-C-N 119.173 1.487 . . . . 0.0 110.02 -179.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -74.69 165.52 31.36 Favored 'Trans proline' 0 N--CA 1.485 1.028 0 C-N-CA 121.976 1.784 . . . . 0.0 111.328 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 23.9 mtp180 -54.09 -25.97 24.66 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.038 0.447 . . . . 0.0 110.133 178.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.58 -46.12 87.33 Favored 'General case' 0 N--CA 1.502 2.139 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.947 -177.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 42.2 t -72.46 -43.14 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.513 -0.742 . . . . 0.0 110.982 -177.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.619 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 2.2 pt20 -70.49 -27.15 63.98 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.411 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 8.7 ttt180 -78.72 -29.15 45.17 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.34 -47.34 20.2 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.999 -0.438 . . . . 0.0 110.3 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.424 ' CD2' HG22 ' A' ' 24' ' ' VAL . 90.6 t80 -79.02 -27.48 43.25 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 122.021 -0.425 . . . . 0.0 111.47 -178.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.619 ' HB2' ' O ' ' A' ' 90' ' ' GLN . . . -54.81 -46.64 99.42 Favored Pre-proline 0 N--CA 1.505 2.281 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -177.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 94' ' ' ALA . 30.1 Cg_endo -70.12 -0.22 6.89 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 122.239 1.959 . . . . 0.0 114.009 -177.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.71 23.92 12.25 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.496 -0.753 . . . . 0.0 109.838 179.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.93 -24.32 59.65 Favored 'General case' 0 N--CA 1.509 2.492 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -178.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 33.7 m -93.36 25.8 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 CA-C-N 121.0 1.727 . . . . 0.0 111.179 -178.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.406 ' C ' ' HB2' ' A' ' 104' ' ' ASN . 19.1 p -98.28 173.2 7.11 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -62.07 -1.48 0.7 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.696 -0.628 . . . . 0.0 112.25 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.584 ' O ' HG12 ' A' ' 101' ' ' VAL . 37.1 t -100.03 4.49 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 CA-C-N 120.407 1.458 . . . . 0.0 110.873 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -141.13 -89.97 0.15 Allowed 'General case' 0 N--CA 1.502 2.168 0 CA-C-N 118.99 0.814 . . . . 0.0 111.511 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.785 ' O ' HD22 ' A' ' 48' ' ' LEU . 19.5 m -143.67 43.08 1.48 Allowed 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.572 -0.705 . . . . 0.0 109.886 -178.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.409 ' ND2' ' HB3' ' A' ' 112' ' ' PRO . 57.0 t-20 -43.02 -64.81 0.56 Allowed 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.299 -0.875 . . . . 0.0 112.287 -179.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.426 ' O ' ' HB3' ' A' ' 106' ' ' ALA . 6.0 mt 45.34 29.39 0.56 Allowed 'General case' 0 N--CA 1.511 2.602 0 CA-C-O 121.066 0.46 . . . . 0.0 109.927 -178.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 105' ' ' LEU . . . 67.09 157.98 0.13 Allowed 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -178.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.6 p -128.87 -163.92 1.34 Allowed 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -179.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 18.0 tt -68.17 -33.29 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.447 ' HB3' ' CE2' ' A' ' 113' ' ' PHE . 96.9 m-70 -66.68 -4.85 9.81 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.689 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 61.45 41.51 99.56 Favored Glycine 0 N--CA 1.499 2.874 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -174.82 170.94 44.14 Favored Glycine 0 N--CA 1.5 2.966 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.409 ' HB3' ' ND2' ' A' ' 104' ' ' ASN . 32.3 Cg_endo -77.9 75.85 4.6 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 122.553 2.168 . . . . 0.0 111.387 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.447 ' CE2' ' HB3' ' A' ' 109' ' ' HIS . 36.7 p90 178.72 156.3 0.45 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.708 -0.62 . . . . 0.0 110.447 178.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 4.8 t 178.61 158.61 0.52 Allowed 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 55.68 22.26 5.23 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.699 -0.626 . . . . 0.0 109.932 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.66 -69.31 0.07 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.82 -0.55 . . . . 0.0 109.694 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.516 ' O ' ' HB2' ' A' ' 118' ' ' LEU . 0.4 OUTLIER 59.68 29.73 19.31 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.718 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.516 ' HB2' ' O ' ' A' ' 117' ' ' LEU . 20.4 mt 76.31 -18.73 0.45 Allowed 'General case' 0 N--CA 1.509 2.513 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 130.69 176.92 14.61 Favored Glycine 0 N--CA 1.499 2.891 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -97.94 43.88 1.05 Allowed 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.677 0.751 . . . . 0.0 109.379 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -94.32 25.28 23.29 Favored Glycine 0 N--CA 1.498 2.814 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 . . . . . 0 N--CA 1.498 1.974 0 CA-C-O 118.003 -0.999 . . . . 0.0 109.449 179.859 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.2 m . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.056 0.455 . . . . 0.0 109.976 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.631 HG22 ' N ' ' A' ' 3' ' ' GLY . 1.2 p -108.13 -95.31 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.631 ' N ' HG22 ' A' ' 2' ' ' VAL . . . -66.92 -105.1 0.02 OUTLIER Glycine 0 N--CA 1.499 2.84 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.422 HG22 ' C ' ' A' ' 3' ' ' GLY . 4.3 t 42.87 62.99 1.6 Allowed 'General case' 0 N--CA 1.509 2.508 0 CA-C-O 121.813 0.816 . . . . 0.0 110.535 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.57 83.77 1.54 Allowed 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.668 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 39.3 m 56.52 102.98 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.549 -0.719 . . . . 0.0 110.233 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.503 HG23 ' HD2' ' A' ' 8' ' ' PRO . 94.7 mt -133.36 142.66 45.02 Favored Pre-proline 0 N--CA 1.499 2.02 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.503 ' HD2' HG23 ' A' ' 7' ' ' ILE . 35.1 Cg_endo -77.92 99.66 1.31 Allowed 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 121.849 1.699 . . . . 0.0 110.205 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 109.9 -10.55 32.07 Favored Glycine 0 N--CA 1.501 2.983 0 O-C-N 121.507 -0.746 . . . . 0.0 111.255 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.571 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 6.1 mmt -128.03 111.77 13.89 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 86.17 -54.09 0.07 Allowed 'General case' 0 N--CA 1.514 2.741 0 CA-C-N 119.789 1.177 . . . . 0.0 108.708 -178.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 55.0 mt -113.38 100.74 52.44 Favored Pre-proline 0 N--CA 1.495 1.783 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 178.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -81.73 172.46 12.22 Favored 'Trans proline' 0 C--O 1.221 -0.366 0 C-N-CA 121.484 1.456 . . . . 0.0 111.524 -177.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.625 ' CE1' HG22 ' A' ' 69' ' ' THR . 44.7 m-70 -77.61 150.1 34.69 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -179.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.508 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 10.8 t-20 66.99 53.92 0.75 Allowed Pre-proline 0 N--CA 1.503 2.21 0 O-C-N 121.459 -0.775 . . . . 0.0 110.049 -178.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.508 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 39.8 Cg_endo -78.45 163.07 27.45 Favored 'Trans proline' 0 N--CA 1.484 0.937 0 C-N-CA 122.282 1.988 . . . . 0.0 111.465 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.575 ' N ' HD22 ' A' ' 17' ' ' LEU . 3.4 mm? 48.62 47.12 20.95 Favored 'General case' 0 N--CA 1.503 2.191 0 CA-C-O 121.246 0.546 . . . . 0.0 111.043 178.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -66.7 -35.43 80.1 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 121.493 -0.755 . . . . 0.0 109.078 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.18 -26.62 68.23 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 28.3 m -71.32 -45.2 63.58 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.681 ' NH2' HD23 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -59.38 -54.63 44.47 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.863 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.436 ' HA ' ' CE3' ' A' ' 22' ' ' TRP . 27.9 m95 -64.26 -27.18 68.87 Favored 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.676 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.457 ' CD2' ' HB3' ' A' ' 40' ' ' MET . 6.4 t80 -66.3 -32.5 73.95 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.692 HG22 ' CD1' ' A' ' 93' ' ' PHE . 61.1 t -70.61 -42.04 77.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 178.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 m -56.23 -44.37 79.52 Favored 'General case' 0 N--CA 1.502 2.158 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.656 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 20.9 m -76.05 -52.25 10.58 Favored 'General case' 0 N--CA 1.51 2.569 0 O-C-N 122.059 -0.401 . . . . 0.0 111.924 -178.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.7 tpm_? -61.89 -24.89 67.22 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.838 -0.539 . . . . 0.0 110.724 -178.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.531 HG23 ' O ' ' A' ' 24' ' ' VAL . 35.6 p -96.23 -64.38 1.06 Allowed 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 120.689 -0.405 . . . . 0.0 112.058 -177.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.7 m -101.32 10.89 40.16 Favored 'General case' 0 N--CA 1.511 2.613 0 CA-C-N 119.183 0.901 . . . . 0.0 111.484 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.12 18.54 57.84 Favored Glycine 0 N--CA 1.501 2.972 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -178.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.51 HG12 ' N ' ' A' ' 32' ' ' GLY . 46.2 t -102.77 164.04 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 O-C-N 121.696 -0.885 . . . . 0.0 109.112 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.51 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 130.3 179.46 16.06 Favored Glycine 0 N--CA 1.499 2.892 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -64.84 173.06 6.17 Favored 'Trans proline' 0 N--CA 1.486 1.065 0 CA-C-N 119.201 1.5 . . . . 0.0 109.879 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.432 ' O ' HD23 ' A' ' 35' ' ' LEU . 0.2 OUTLIER -92.77 84.5 4.99 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 122.026 0.917 . . . . 0.0 110.178 -177.836 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.432 HD23 ' O ' ' A' ' 34' ' ' ARG . 69.2 mt -140.79 145.1 35.88 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.582 ' HB3' ' HG3' ' A' ' 39' ' ' GLU . . . -58.29 163.11 3.16 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -179.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.23 -56.12 4.59 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.998 -0.439 . . . . 0.0 110.444 -179.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.28 -33.4 19.77 Favored 'General case' 0 N--CA 1.508 2.474 0 O-C-N 121.881 -0.512 . . . . 0.0 110.803 -178.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.582 ' HG3' ' HB3' ' A' ' 36' ' ' ALA . 3.6 mm-40 -71.35 -39.89 71.02 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 122.054 -0.404 . . . . 0.0 110.142 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.457 ' HB3' ' CD2' ' A' ' 23' ' ' TYR . 1.5 ttt -65.32 -52.79 51.6 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.432 ' HB2' ' CE2' ' A' ' 23' ' ' TYR . 6.4 tttm -53.58 -38.05 63.55 Favored 'General case' 0 N--CA 1.504 2.268 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.98 -40.92 97.27 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -60.36 -44.55 95.47 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 12.4 m -63.19 -35.95 82.0 Favored 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.635 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 69.0 m -70.52 -29.73 66.3 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.6 ttt-85 -73.8 -32.46 63.75 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -76.43 -29.48 57.02 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.844 HD11 HG12 ' A' ' 98' ' ' VAL . 0.6 OUTLIER -76.49 -36.86 57.58 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -73.41 -36.21 65.95 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.65 -53.03 60.69 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 178.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.458 HG22 ' HA ' ' A' ' 56' ' ' ARG . 42.0 mm -63.59 105.81 0.76 Allowed Pre-proline 0 N--CA 1.496 1.871 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 176.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -59.27 149.82 78.32 Favored 'Trans proline' 0 N--CA 1.479 0.651 0 C-N-CA 121.593 1.529 . . . . 0.0 110.935 -176.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -40.46 -32.08 0.18 Allowed 'General case' 0 N--CA 1.505 2.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.53 -178.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -73.49 121.73 21.03 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 178.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 15.2 m 72.9 6.41 5.34 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 122.167 -0.333 . . . . 0.0 110.23 -178.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.458 ' HA ' HG22 ' A' ' 51' ' ' ILE . 1.5 mtt180 -49.11 -87.14 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.676 0 O-C-N 121.191 -0.943 . . . . 0.0 109.691 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 82.4 m -36.39 -43.51 0.38 Allowed 'General case' 0 N--CA 1.519 3.007 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.677 ' O ' HD12 ' A' ' 62' ' ' ILE . 8.7 mt-10 -39.31 -48.36 1.84 Allowed 'General case' 0 N--CA 1.511 2.61 0 CA-C-N 119.549 1.068 . . . . 0.0 112.326 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.416 ' HB1' HD23 ' A' ' 17' ' ' LEU . . . -41.9 -50.37 4.48 Favored 'General case' 0 N--CA 1.517 2.922 0 CA-C-N 118.783 0.72 . . . . 0.0 111.522 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 1.005 HG11 HD22 ' A' ' 97' ' ' LEU . 34.9 t -58.23 -45.04 89.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.87 -27.66 65.4 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.728 HG23 ' HB ' ' A' ' 67' ' ' VAL . 1.4 mp -78.21 -30.85 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.898 -0.501 . . . . 0.0 109.852 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.514 ' CD2' HD13 ' A' ' 79' ' ' LEU . 7.3 tt -77.57 -40.73 41.38 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.469 -0.893 . . . . 0.0 110.139 -179.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 2.7 tmm? -78.4 -53.45 7.25 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.27 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -80.68 -22.83 40.07 Favored 'General case' 0 N--CA 1.502 2.154 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.157 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.97 147.63 11.79 Favored Glycine 0 N--CA 1.497 2.709 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 -178.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.728 ' HB ' HG23 ' A' ' 62' ' ' ILE . 7.6 p -118.48 160.58 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 O-C-N 122.196 -0.591 . . . . 0.0 109.782 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.692 HG22 ' NE2' ' A' ' 74' ' ' HIS . 54.7 t -114.38 157.81 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 CA-C-O 121.716 0.769 . . . . 0.0 109.292 -179.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.625 HG22 ' CE1' ' A' ' 14' ' ' HIS . 61.7 p -117.18 159.9 21.89 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.78 -177.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 35.4 t -63.3 -31.51 72.68 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.298 -178.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.2 p -69.14 -16.65 63.7 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.332 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.73 10.17 44.26 Favored Glycine 0 N--CA 1.498 2.783 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -100.18 157.56 16.49 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-N 118.04 0.92 . . . . 0.0 109.139 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.692 ' NE2' HG22 ' A' ' 68' ' ' VAL . 9.7 m170 -114.93 155.22 27.29 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -179.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -140.56 -176.44 4.64 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.122 0.487 . . . . 0.0 109.785 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.676 ' O ' HD12 ' A' ' 78' ' ' LEU . . . 56.37 -144.5 36.63 Favored Glycine 0 N--CA 1.496 2.691 0 N-CA-C 108.592 -1.803 . . . . 0.0 108.592 -178.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 56.0 21.6 5.14 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 122.224 -0.574 . . . . 0.0 110.356 179.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.681 HD23 ' NH2' ' A' ' 21' ' ' ARG . 6.7 mp -76.21 -16.76 59.77 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.744 -0.597 . . . . 0.0 110.468 -179.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.514 HD13 ' CD2' ' A' ' 63' ' ' LEU . 2.3 tp -59.34 91.64 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 41.0 mm-40 -130.81 -176.9 4.14 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.449 0.642 . . . . 0.0 109.821 -179.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.33 102.33 1.07 Allowed 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.657 0.742 . . . . 0.0 110.893 -179.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.542 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 20.5 mt -87.12 169.64 14.12 Favored Pre-proline 0 N--CA 1.496 1.856 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 177.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.542 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 29.5 Cg_endo -69.58 99.19 0.71 Allowed 'Trans proline' 0 C--N 1.328 -0.528 0 C-N-CA 121.028 1.152 . . . . 0.0 110.3 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 98.58 1.41 57.71 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.4 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 3.4 m -134.8 91.34 20.76 Favored Pre-proline 0 N--CA 1.504 2.242 0 CA-C-N 118.99 1.395 . . . . 0.0 109.274 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -72.09 161.18 45.44 Favored 'Trans proline' 0 N--CA 1.483 0.879 0 C-N-CA 121.3 1.333 . . . . 0.0 111.528 -179.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.6 mtp180 -48.15 -28.11 2.76 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.06 0.457 . . . . 0.0 109.907 178.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -60.8 -47.23 87.26 Favored 'General case' 0 N--CA 1.502 2.174 0 CA-C-N 116.325 -0.398 . . . . 0.0 112.006 -177.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 48.5 t -68.77 -39.52 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.585 -0.697 . . . . 0.0 109.837 -178.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.565 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 2.2 mp0 -66.17 -26.76 67.56 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.3 tpt180 -78.89 -35.17 44.01 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 122.085 -0.385 . . . . 0.0 109.966 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.34 -45.99 68.11 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.692 ' CD1' HG22 ' A' ' 24' ' ' VAL . 37.3 t80 -78.34 -25.52 46.42 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.7 ' HB3' ' HD3' ' A' ' 95' ' ' PRO . . . -41.56 -51.82 8.63 Favored Pre-proline 0 N--CA 1.503 2.191 0 CA-C-O 118.907 -0.568 . . . . 0.0 112.098 -177.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.7 ' HD3' ' HB3' ' A' ' 94' ' ' ALA . 29.4 Cg_endo -72.32 -171.91 0.8 Allowed 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 121.532 1.488 . . . . 0.0 109.519 179.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.46 ' HA ' HG21 ' A' ' 99' ' ' THR . 0.1 OUTLIER 66.47 18.0 10.75 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.827 -0.546 . . . . 0.0 109.827 -178.943 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 1.056 HD12 HG13 ' A' ' 98' ' ' VAL . 0.3 OUTLIER -73.3 -62.73 1.37 Allowed 'General case' 0 N--CA 1.516 2.849 0 O-C-N 121.687 -0.633 . . . . 0.0 112.134 -178.718 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 1.056 HG13 HD12 ' A' ' 97' ' ' LEU . 33.4 m -86.57 26.5 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.282 0 CA-C-N 119.621 1.101 . . . . 0.0 110.657 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.46 HG21 ' HA ' ' A' ' 96' ' ' LYS . 46.7 p -97.58 173.56 7.09 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -62.6 0.46 0.49 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.332 -0.855 . . . . 0.0 111.944 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.412 ' O ' HG12 ' A' ' 101' ' ' VAL . 5.0 t -98.57 -0.83 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 CA-C-N 120.481 1.491 . . . . 0.0 111.211 -179.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -138.46 -88.81 0.23 Allowed 'General case' 0 N--CA 1.507 2.39 0 CA-C-N 119.403 1.001 . . . . 0.0 111.918 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.757 ' O ' HD22 ' A' ' 48' ' ' LEU . 92.0 m -141.44 42.03 1.75 Allowed 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.553 -0.717 . . . . 0.0 109.734 -178.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.454 ' ND2' ' HB3' ' A' ' 112' ' ' PRO . 46.5 t-20 -38.34 -69.91 0.11 Allowed 'General case' 0 N--CA 1.506 2.339 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -178.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.7 mt 48.18 26.99 1.16 Allowed 'General case' 0 N--CA 1.51 2.534 0 O-C-N 121.912 -0.492 . . . . 0.0 110.682 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 63.91 154.66 0.06 Allowed 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.561 ' OG1' ' CE1' ' A' ' 109' ' ' HIS . 1.7 p -124.51 -151.82 0.49 Allowed 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -178.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.527 HG23 ' N ' ' A' ' 109' ' ' HIS . 0.5 OUTLIER -57.96 -39.97 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 C-N-CA 123.08 0.552 . . . . 0.0 111.279 178.509 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.587 ' CE1' ' O ' ' A' ' 113' ' ' PHE . 3.8 p80 -92.53 23.15 4.15 Favored 'General case' 0 N--CA 1.514 2.775 0 O-C-N 122.219 -0.301 . . . . 0.0 110.875 -177.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 45.47 63.57 2.68 Favored Glycine 0 N--CA 1.504 3.2 0 O-C-N 121.723 -0.61 . . . . 0.0 111.986 177.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 173.31 171.32 37.82 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 110.499 -1.041 . . . . 0.0 110.499 179.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.468 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 36.3 Cg_endo -83.3 75.35 4.38 Favored 'Trans proline' 0 CA--C 1.545 1.043 0 C-N-CA 122.711 2.274 . . . . 0.0 111.057 -179.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.712 ' O ' HD11 ' A' ' 117' ' ' LEU . 20.2 p90 176.96 88.94 0.01 OUTLIER 'General case' 0 N--CA 1.531 3.597 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.445 ' HA ' ' NE2' ' A' ' 109' ' ' HIS . 21.9 p -118.15 170.01 9.22 Favored 'General case' 0 N--CA 1.513 2.705 0 O-C-N 119.799 -1.813 . . . . 0.0 110.702 178.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.408 ' O ' ' CB ' ' A' ' 116' ' ' SER . 0.6 OUTLIER 74.25 109.64 0.07 Allowed 'General case' 0 N--CA 1.504 2.275 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.135 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.408 ' CB ' ' O ' ' A' ' 115' ' ' LEU . 1.1 t 82.56 -69.49 0.06 Allowed 'General case' 0 N--CA 1.513 2.678 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.712 HD11 ' O ' ' A' ' 113' ' ' PHE . 1.5 mp 68.52 -156.81 0.18 Allowed 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.2 mp -46.9 -20.32 0.14 Allowed 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.453 -0.779 . . . . 0.0 113.037 -178.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 63.06 115.54 0.01 OUTLIER Glycine 0 N--CA 1.5 2.952 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -108.93 66.68 0.64 Allowed 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.843 0.83 . . . . 0.0 109.125 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -61.2 -21.88 60.08 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 . . . . . 0 N--CA 1.499 2.012 0 CA-C-O 118.412 -0.804 . . . . 0.0 110.194 -179.769 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.626 ' C ' HG12 ' A' ' 2' ' ' VAL . 86.6 p . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.314 0.578 . . . . 0.0 109.477 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.787 HG22 ' N ' ' A' ' 3' ' ' GLY . 0.2 OUTLIER 173.09 -84.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.281 -0.887 . . . . 0.0 109.207 179.892 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.787 ' N ' HG22 ' A' ' 2' ' ' VAL . . . -152.48 153.2 24.73 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 4' ' ' THR . 4.3 t -175.23 64.08 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.15 -1.206 . . . . 0.0 109.506 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.38 -152.74 0.49 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.305 -0.872 . . . . 0.0 109.316 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 79.6 m -78.23 106.86 10.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.149 -0.969 . . . . 0.0 109.469 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.794 HG22 ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -125.66 158.85 63.57 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.344 -0.848 . . . . 0.0 109.005 179.747 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.794 ' HD2' HG22 ' A' ' 7' ' ' ILE . 35.5 Cg_endo -78.75 143.9 19.01 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.469 2.112 . . . . 0.0 110.356 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 57.66 14.59 15.41 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.75 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 1.3 mtt -140.25 107.69 5.56 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.211 -1.17 . . . . 0.0 108.54 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.75 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 85.32 -62.22 0.07 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.843 -1.161 . . . . 0.0 108.057 -178.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.802 HD11 ' CB ' ' A' ' 55' ' ' CYS . 67.9 mt -104.05 101.17 24.22 Favored Pre-proline 0 C--N 1.304 -1.406 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 11' ' ' ALA . 33.2 Cg_endo -81.29 172.45 12.71 Favored 'Trans proline' 0 C--N 1.318 -1.073 0 C-N-CA 121.595 1.53 . . . . 0.0 111.674 -177.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.466 ' H ' ' CD2' ' A' ' 14' ' ' HIS . 29.4 m-70 -69.58 145.63 52.4 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.667 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 10.8 t-20 54.8 51.21 7.21 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 120.809 -1.182 . . . . 0.0 110.04 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.667 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 37.6 Cg_endo -78.72 166.07 24.04 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.398 2.066 . . . . 0.0 111.49 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.737 HD23 ' SG ' ' A' ' 20' ' ' CYS . 0.5 OUTLIER 48.45 48.32 19.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.741 -0.599 . . . . 0.0 111.091 178.879 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -75.08 -42.24 57.15 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.01 -1.056 . . . . 0.0 108.91 178.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.556 ' OG ' ' HE2' ' A' ' 40' ' ' MET . 0.3 OUTLIER -59.24 -25.61 64.19 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.191 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.737 ' SG ' HD23 ' A' ' 17' ' ' LEU . 71.2 m -73.78 -38.77 64.54 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.597 -0.69 . . . . 0.0 109.286 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.47 ' O ' ' HD2' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -63.51 -48.05 79.18 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.263 -0.898 . . . . 0.0 108.848 179.498 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.466 ' HA ' ' OG ' ' A' ' 25' ' ' SER . 31.0 m95 -73.08 -26.77 61.38 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.642 -1.286 . . . . 0.0 109.82 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.519 ' HB2' ' HG2' ' A' ' 40' ' ' MET . 15.2 t80 -66.17 -31.28 72.02 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.08 -1.012 . . . . 0.0 108.422 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.546 ' O ' HG23 ' A' ' 28' ' ' THR . 93.4 t -75.42 -41.52 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.466 ' OG ' ' HA ' ' A' ' 22' ' ' TRP . 0.5 OUTLIER -56.2 -42.3 76.96 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.434 -0.906 . . . . 0.0 109.986 -179.863 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 2.4 m -77.59 -55.08 5.66 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.267 -0.896 . . . . 0.0 111.256 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.87 -24.56 62.34 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 120.743 -1.223 . . . . 0.0 110.3 -178.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.546 HG23 ' O ' ' A' ' 24' ' ' VAL . 72.4 p -92.87 -67.1 0.88 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.005 -1.059 . . . . 0.0 111.351 -178.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 84' ' ' GLY . 3.6 m -99.0 16.69 21.74 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.618 -1.301 . . . . 0.0 109.843 -179.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 26' ' ' THR . . . 56.48 21.48 34.63 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.515 HG12 ' N ' ' A' ' 32' ' ' GLY . 73.6 t -105.79 161.11 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.141 -1.211 . . . . 0.0 109.615 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.515 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 138.36 179.86 17.63 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 108.849 -1.7 . . . . 0.0 108.849 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -66.19 175.8 4.52 Favored 'Trans proline' 0 N--CA 1.482 0.803 0 CA-C-N 119.127 1.464 . . . . 0.0 110.051 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 7.4 mtt-85 -91.4 82.2 5.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.847 -1.158 . . . . 0.0 110.013 -178.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.97 131.2 28.26 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -45.95 158.28 0.1 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.086 -1.009 . . . . 0.0 109.326 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -75.79 -52.34 10.62 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.973 -1.079 . . . . 0.0 110.205 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -47.12 -34.03 5.67 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.971 -1.081 . . . . 0.0 109.643 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.497 ' O ' ' HD3' ' A' ' 43' ' ' ARG . 3.0 mt-10 -69.57 -41.65 75.57 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.15 -0.969 . . . . 0.0 108.906 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.556 ' HE2' ' OG ' ' A' ' 19' ' ' SER . 2.6 tpt -61.24 -60.41 3.79 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.6 ttpm? -50.35 -40.89 50.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.745 -0.597 . . . . 0.0 109.529 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.59 -45.59 88.78 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.282 -0.886 . . . . 0.0 109.486 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.534 ' HD2' ' N ' ' A' ' 43' ' ' ARG . 1.0 OUTLIER -59.82 -48.79 80.26 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.355 -0.841 . . . . 0.0 109.851 -179.695 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.418 ' SG ' ' N ' ' A' ' 20' ' ' CYS . 14.0 m -58.03 -34.42 70.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.992 -1.068 . . . . 0.0 110.439 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 20.8 m -70.95 -30.58 66.91 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.977 -1.077 . . . . 0.0 109.091 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.63 -35.61 75.39 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.471 ' O ' ' CG1' ' A' ' 51' ' ' ILE . 3.4 mt-30 -76.95 -26.48 54.06 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.617 HD12 HD12 ' A' ' 105' ' ' LEU . 1.7 tm? -71.65 -34.83 70.07 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.491 ' HG2' HD13 ' A' ' 105' ' ' LEU . 4.2 mm-40 -77.06 -58.43 3.29 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.487 ' O ' ' HD3' ' A' ' 52' ' ' PRO . . . -46.35 -35.17 5.17 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.534 HD12 HG12 ' A' ' 12' ' ' ILE . 21.9 mm -82.01 106.62 6.62 Favored Pre-proline 0 N--CA 1.488 1.449 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.487 ' HD3' ' O ' ' A' ' 50' ' ' ALA . 25.7 Cg_endo -61.84 148.35 93.28 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 121.883 1.722 . . . . 0.0 110.886 -177.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.836 ' HB2' ' NH1' ' A' ' 56' ' ' ARG . . . -59.77 -35.05 73.84 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.665 -0.647 . . . . 0.0 111.156 -178.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.745 ' HA ' HD12 ' A' ' 108' ' ' ILE . 6.0 t80 -45.58 -27.17 0.71 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.905 -1.122 . . . . 0.0 108.137 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.802 ' CB ' HD11 ' A' ' 12' ' ' ILE . 13.3 m -116.43 -73.34 0.65 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.836 ' NH1' ' HB2' ' A' ' 53' ' ' ALA . 22.4 mtt180 31.71 -98.89 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.828 -0.545 . . . . 0.0 110.176 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.497 ' C ' ' O ' ' A' ' 56' ' ' ARG . 66.2 m -33.46 -55.89 0.43 Allowed 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.277 -0.89 . . . . 0.0 111.208 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.482 ' O ' ' C ' ' A' ' 59' ' ' ALA . 1.1 tt0 -35.74 -53.63 0.72 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.766 -1.208 . . . . 0.0 111.05 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.482 ' C ' ' O ' ' A' ' 58' ' ' GLU . . . -35.85 -52.49 0.72 Allowed 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.214 -0.928 . . . . 0.0 110.287 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.749 HG22 HD13 ' A' ' 97' ' ' LEU . 7.4 t -53.52 -50.47 49.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 121.247 -0.908 . . . . 0.0 108.784 179.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.516 ' O ' ' HB2' ' A' ' 65' ' ' ASP . 6.8 mtp85 -53.55 -29.61 37.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.403 -0.81 . . . . 0.0 109.83 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.818 HG23 ' HB ' ' A' ' 67' ' ' VAL . 17.9 mt -77.6 -30.14 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 120.957 -1.089 . . . . 0.0 110.043 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.494 ' O ' ' HA ' ' A' ' 77' ' ' ARG . 13.0 tp -77.26 -43.18 34.29 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.773 -1.205 . . . . 0.0 109.612 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 47.5 tpp -78.42 -50.96 10.76 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.18 -0.95 . . . . 0.0 109.945 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.516 ' HB2' ' O ' ' A' ' 61' ' ' ARG . 17.5 m-20 -79.68 -21.97 44.04 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.061 -1.024 . . . . 0.0 109.978 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.56 146.11 9.57 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.818 ' HB ' HG23 ' A' ' 62' ' ' ILE . 2.6 p -116.88 159.47 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.512 -0.993 . . . . 0.0 109.329 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.598 HG22 ' CD2' ' A' ' 74' ' ' HIS . 7.9 t -114.3 157.99 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 CA-C-O 121.864 0.84 . . . . 0.0 109.892 -178.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.456 ' N ' ' CG1' ' A' ' 68' ' ' VAL . 21.7 p -116.87 159.27 22.64 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.604 0.716 . . . . 0.0 109.583 -178.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.0 t -62.27 -34.17 76.03 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.588 -0.695 . . . . 0.0 110.142 -179.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.8 p -65.63 -14.93 62.18 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.525 -0.734 . . . . 0.0 109.52 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 99.97 8.09 51.65 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.674 -1.77 . . . . 0.0 108.674 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -92.1 156.81 17.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.216 -1.167 . . . . 0.0 109.5 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.598 ' CD2' HG22 ' A' ' 68' ' ' VAL . 12.5 m170 -115.8 155.88 27.06 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 120.812 -1.18 . . . . 0.0 108.675 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.436 ' HG2' ' C ' ' A' ' 74' ' ' HIS . 3.3 mt-10 -141.44 -172.89 3.62 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.088 -1.007 . . . . 0.0 110.585 -179.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 49.65 -146.07 7.73 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.494 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER 56.2 17.77 2.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -1.175 . . . . 0.0 110.1 179.64 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.421 ' O ' ' N ' ' A' ' 80' ' ' GLN . 0.1 OUTLIER -83.8 -11.96 56.33 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.983 -1.073 . . . . 0.0 110.127 -179.611 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -47.71 99.32 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.869 -1.144 . . . . 0.0 109.34 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.421 ' N ' ' O ' ' A' ' 78' ' ' LEU . 2.2 mt-30 -134.39 170.99 14.91 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.238 -0.913 . . . . 0.0 109.698 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.45 ' OD1' ' HG3' ' A' ' 87' ' ' ARG . 2.2 m-20 -65.94 107.4 1.84 Allowed 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.595 0.712 . . . . 0.0 110.82 -179.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.682 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 18.0 mt -80.0 172.06 10.81 Favored Pre-proline 0 C--N 1.301 -1.506 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 177.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.682 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 28.3 Cg_endo -68.32 100.84 0.68 Allowed 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 120.872 1.048 . . . . 0.0 109.723 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.454 ' O ' ' SG ' ' A' ' 29' ' ' CYS . . . 92.27 15.44 53.56 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 -179.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.511 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 3.4 m -148.52 90.57 4.88 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 120.802 -1.411 . . . . 0.0 108.856 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.413 ' O ' ' C ' ' A' ' 87' ' ' ARG . 30.4 Cg_endo -74.77 160.48 40.77 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.367 1.378 . . . . 0.0 111.649 -178.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.45 ' HG3' ' OD1' ' A' ' 81' ' ' ASP . 53.4 mtp180 -44.7 -29.41 0.76 Allowed 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 122.152 0.977 . . . . 0.0 108.396 178.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -54.03 -52.39 60.99 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.58 -178.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 58.8 t -65.05 -41.61 92.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 O-C-N 120.94 -1.1 . . . . 0.0 110.207 -178.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.564 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 3.6 mp0 -62.43 -27.4 69.08 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.262 -0.899 . . . . 0.0 108.705 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.498 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 0.0 OUTLIER -78.61 -33.06 47.74 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.444 -0.785 . . . . 0.0 109.957 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.502 ' O ' ' HD2' ' A' ' 95' ' ' PRO . . . -71.44 -45.6 62.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.933 -1.104 . . . . 0.0 109.499 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.574 ' O ' ' CD1' ' A' ' 93' ' ' PHE . 10.0 t80 -77.92 -25.71 48.53 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.383 -0.823 . . . . 0.0 110.102 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.782 ' HB3' ' HD3' ' A' ' 95' ' ' PRO . . . -43.55 -50.89 16.63 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.395 -0.816 . . . . 0.0 112.094 -178.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.782 ' HD3' ' HB3' ' A' ' 94' ' ' ALA . 32.9 Cg_endo -73.66 24.0 0.33 Allowed 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.64 2.227 . . . . 0.0 112.951 -178.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.411 ' O ' ' HG3' ' A' ' 102' ' ' GLU . 0.4 OUTLIER -126.8 28.69 5.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.688 -1.258 . . . . 0.0 108.898 178.612 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.749 HD13 HG22 ' A' ' 60' ' ' VAL . 0.6 OUTLIER -80.12 -77.77 0.18 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.403 -0.811 . . . . 0.0 110.403 -179.476 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 98' ' ' VAL . 2.5 m -79.81 27.89 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.906 -1.121 . . . . 0.0 110.873 -179.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.483 ' C ' ' HB2' ' A' ' 104' ' ' ASN . 5.1 p -101.27 170.98 7.88 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.909 -1.119 . . . . 0.0 108.196 179.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -60.39 1.33 0.13 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.571 -1.331 . . . . 0.0 112.179 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.404 ' HB ' ' HG2' ' A' ' 96' ' ' LYS . 2.7 t -101.02 1.69 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 119.822 -1.799 . . . . 0.0 110.972 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.508 ' HB2' ' O ' ' A' ' 97' ' ' LEU . 0.3 OUTLIER -140.17 -94.29 0.16 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.513 -1.367 . . . . 0.0 110.655 -179.714 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.468 ' O ' ' C ' ' A' ' 104' ' ' ASN . 72.8 m -131.99 38.68 3.5 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.928 -1.108 . . . . 0.0 109.004 -179.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.538 ' ND2' ' HB3' ' A' ' 112' ' ' PRO . 42.0 t-20 -29.52 -66.02 0.09 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.811 -0.556 . . . . 0.0 112.091 -179.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.617 HD12 HD12 ' A' ' 48' ' ' LEU . 11.3 mt 41.7 33.98 0.37 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.064 -1.023 . . . . 0.0 109.748 -179.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.474 ' O ' ' O ' ' A' ' 105' ' ' LEU . . . 55.23 165.6 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.032 -1.043 . . . . 0.0 108.993 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.73 ' OG1' ' CE1' ' A' ' 109' ' ' HIS . 1.7 p -133.79 -146.08 0.26 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.0 -1.063 . . . . 0.0 108.722 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.745 HD12 ' HA ' ' A' ' 54' ' ' TYR . 1.3 tt -69.05 -38.68 78.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.31 -0.869 . . . . 0.0 110.008 179.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.73 ' CE1' ' OG1' ' A' ' 107' ' ' THR . 0.6 OUTLIER -84.46 24.0 1.05 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.179 -0.951 . . . . 0.0 110.035 -179.75 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 109' ' ' HIS . . . 42.73 54.78 4.89 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -179.66 159.55 24.15 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.538 ' HB3' ' ND2' ' A' ' 104' ' ' ASN . 31.7 Cg_endo -77.04 79.58 3.09 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.722 2.281 . . . . 0.0 109.859 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.608 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER 173.01 96.8 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.383 0 C-N-CA 118.826 -1.15 . . . . 0.0 113.073 -179.765 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.619 ' HB3' ' NE2' ' A' ' 109' ' ' HIS . 17.3 p -124.47 173.81 8.2 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.284 -1.51 . . . . 0.0 109.561 177.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.569 ' CB ' ' O ' ' A' ' 114' ' ' CYS . 0.0 OUTLIER 84.95 -46.35 0.08 Allowed 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -179.157 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 20.0 m -72.77 -31.1 64.65 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.262 -0.899 . . . . 0.0 108.937 179.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.676 HD13 ' CD2' ' A' ' 109' ' ' HIS . 5.5 mp -59.74 -15.79 22.59 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.23 -0.919 . . . . 0.0 109.441 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.532 ' HB2' ' O ' ' A' ' 117' ' ' LEU . 20.3 mt 69.52 -15.4 0.3 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.604 -0.685 . . . . 0.0 112.466 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.26 -148.48 35.96 Favored Glycine 0 N--CA 1.491 2.327 0 O-C-N 120.342 -1.474 . . . . 0.0 109.706 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -105.08 71.4 0.95 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.335 -1.097 . . . . 0.0 109.608 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.2 -11.86 59.67 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.281 -1.129 . . . . 0.0 109.452 -179.909 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.446 ' O ' ' C ' ' A' ' 2' ' ' VAL . 76.6 p . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.446 ' C ' ' O ' ' A' ' 1' ' ' SER . 6.1 m -39.48 -45.58 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.571 -0.706 . . . . 0.0 110.144 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.536 ' O ' ' CG2' ' A' ' 4' ' ' THR . . . 146.19 -88.65 0.16 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.536 ' CG2' ' O ' ' A' ' 3' ' ' GLY . 8.5 t 40.73 29.42 0.07 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.545 -0.973 . . . . 0.0 109.826 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 3' ' ' GLY . 0.4 OUTLIER 49.66 -176.03 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.336 -0.853 . . . . 0.0 109.684 179.9 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.4 m 59.17 99.62 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.246 -0.909 . . . . 0.0 109.715 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.569 ' CG1' ' HD2' ' A' ' 8' ' ' PRO . 3.4 tt -138.88 143.41 37.25 Favored Pre-proline 0 N--CA 1.491 1.576 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.569 ' HD2' ' CG1' ' A' ' 7' ' ' ILE . 34.7 Cg_endo -77.0 140.88 20.56 Favored 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 121.739 1.626 . . . . 0.0 110.999 -179.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.55 -14.78 33.69 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.73 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 0.7 OUTLIER -134.87 116.68 15.04 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.18 -1.188 . . . . 0.0 108.108 179.499 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 85.61 -59.05 0.07 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.796 -1.19 . . . . 0.0 107.811 -178.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.402 HG23 HD12 ' A' ' 12' ' ' ILE . 9.9 mm -107.2 101.36 38.01 Favored Pre-proline 0 C--N 1.303 -1.434 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 178.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -81.36 175.45 9.64 Favored 'Trans proline' 0 C--N 1.318 -1.064 0 C-N-CA 121.459 1.439 . . . . 0.0 111.955 -176.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 52.8 m-70 -76.76 147.84 37.06 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.673 -0.642 . . . . 0.0 109.553 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.586 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 0.1 OUTLIER 58.22 58.03 6.54 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 120.796 -1.19 . . . . 0.0 109.93 -179.758 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.586 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 37.1 Cg_endo -79.66 168.62 19.34 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.55 2.167 . . . . 0.0 111.03 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.855 ' CD2' ' HB1' ' A' ' 59' ' ' ALA . 3.3 mm? 52.33 44.38 29.87 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.551 -0.718 . . . . 0.0 111.041 178.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.472 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 3.9 p30 -83.61 -47.29 11.43 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.867 -1.146 . . . . 0.0 109.412 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.59 -25.99 67.68 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.691 ' SG ' HD13 ' A' ' 17' ' ' LEU . 72.4 m -71.08 -50.02 38.24 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.624 -0.672 . . . . 0.0 109.62 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.561 ' CG ' ' N ' ' A' ' 22' ' ' TRP . 4.2 ptt180 -59.03 -52.09 67.24 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.132 -0.98 . . . . 0.0 109.632 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.561 ' N ' ' CG ' ' A' ' 21' ' ' ARG . 22.9 m95 -61.15 -34.32 74.83 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 118.584 -1.246 . . . . 0.0 108.943 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.538 ' HB2' ' CG ' ' A' ' 40' ' ' MET . 7.2 t80 -60.32 -30.45 69.52 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.613 ' O ' HG23 ' A' ' 28' ' ' THR . 48.0 t -72.67 -41.88 62.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 C-N-CA 118.816 -1.154 . . . . 0.0 107.94 178.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 64.8 p -55.67 -42.99 75.91 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.247 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 5.4 m -78.13 -52.98 7.9 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.158 -0.964 . . . . 0.0 111.708 -178.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.473 ' HG2' ' CE1' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -60.51 -25.76 66.35 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.703 -1.248 . . . . 0.0 110.792 -178.383 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.613 HG23 ' O ' ' A' ' 24' ' ' VAL . 21.9 p -96.83 -60.84 1.51 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.019 -1.051 . . . . 0.0 111.095 -178.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.475 ' SG ' ' O ' ' A' ' 84' ' ' GLY . 3.5 m -99.39 15.78 25.23 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.875 -1.141 . . . . 0.0 110.13 -179.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 26' ' ' THR . . . 52.44 21.02 8.02 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 -179.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.557 HG12 ' N ' ' A' ' 32' ' ' GLY . 41.7 t -109.51 165.37 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.276 -1.132 . . . . 0.0 109.62 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.557 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 130.3 178.32 15.36 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 108.58 -1.808 . . . . 0.0 108.58 -179.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -65.44 176.2 3.58 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 CA-C-N 119.188 1.494 . . . . 0.0 109.825 179.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 24.1 mtt180 -91.11 79.07 5.81 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.707 -1.246 . . . . 0.0 110.369 -177.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.465 ' O ' ' C ' ' A' ' 36' ' ' ALA . 52.1 mt -127.35 114.93 18.22 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 178.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.465 ' C ' ' O ' ' A' ' 35' ' ' LEU . . . -41.05 160.32 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.342 -0.849 . . . . 0.0 109.462 -179.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.467 HG22 ' HE1' ' A' ' 23' ' ' TYR . 0.7 OUTLIER -68.38 -59.94 2.81 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.074 -1.017 . . . . 0.0 110.377 -179.107 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -48.48 -31.55 6.54 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.074 -1.016 . . . . 0.0 110.086 -179.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -68.7 -47.01 67.51 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.192 -0.942 . . . . 0.0 108.767 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.538 ' CG ' ' HB2' ' A' ' 23' ' ' TYR . 17.6 tpp -60.04 -60.54 3.66 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.1 tppt? -47.79 -35.4 10.0 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.561 -0.712 . . . . 0.0 109.152 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.16 -43.07 92.97 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.34 -0.85 . . . . 0.0 109.383 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -63.11 -43.79 97.45 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.328 -0.857 . . . . 0.0 109.905 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.426 ' SG ' ' N ' ' A' ' 20' ' ' CYS . 19.0 m -64.57 -36.39 84.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.08 -1.012 . . . . 0.0 110.063 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 63.9 m -70.21 -29.82 66.75 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.95 -1.094 . . . . 0.0 108.976 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.448 ' NH1' ' HB2' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -73.43 -32.4 64.38 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.077 -1.014 . . . . 0.0 108.296 179.459 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -77.34 -30.99 54.18 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.368 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.039 HD11 HG12 ' A' ' 98' ' ' VAL . 8.4 tt -74.11 -38.08 63.93 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.221 -0.924 . . . . 0.0 109.089 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.447 ' O ' ' C ' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -71.17 -53.59 13.95 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.256 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.481 ' O ' ' HD3' ' A' ' 52' ' ' PRO . . . -46.54 -46.39 19.28 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 178.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 73.8 mt -67.61 106.97 1.44 Allowed Pre-proline 0 C--N 1.304 -1.387 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 176.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.529 ' O ' ' N ' ' A' ' 54' ' ' TYR . 24.5 Cg_endo -60.61 138.94 83.21 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 121.581 1.521 . . . . 0.0 111.097 -176.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.593 ' HA ' ' CG ' ' A' ' 56' ' ' ARG . . . -32.54 -33.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.198 0.523 . . . . 0.0 110.669 -178.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.529 ' N ' ' O ' ' A' ' 52' ' ' PRO . 2.0 m-85 -66.82 122.68 18.22 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.298 -0.876 . . . . 0.0 109.481 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 34.1 m 73.43 13.47 4.56 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.588 -0.695 . . . . 0.0 111.126 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.593 ' CG ' ' HA ' ' A' ' 53' ' ' ALA . 9.0 mmt85 -41.41 -87.28 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.606 -1.309 . . . . 0.0 109.362 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.521 ' C ' ' O ' ' A' ' 56' ' ' ARG . 6.5 m -24.9 -49.51 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.447 0 O-C-N 121.786 -0.571 . . . . 0.0 112.161 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.509 ' C ' ' O ' ' A' ' 57' ' ' CYS . 12.8 tt0 -25.73 -49.9 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.365 -0.834 . . . . 0.0 111.775 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.855 ' HB1' ' CD2' ' A' ' 17' ' ' LEU . . . -40.9 -60.41 1.19 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.135 -0.978 . . . . 0.0 110.013 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.981 ' CG2' HD13 ' A' ' 97' ' ' LEU . 39.8 t -52.31 -39.77 29.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 O-C-N 121.395 -0.816 . . . . 0.0 109.403 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.515 ' O ' ' HB2' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -62.01 -33.11 73.74 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.416 -0.803 . . . . 0.0 110.116 -179.677 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.771 HG23 ' HB ' ' A' ' 67' ' ' VAL . 48.5 mt -77.38 -28.47 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.926 -1.109 . . . . 0.0 110.09 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.667 HD21 HD23 ' A' ' 79' ' ' LEU . 2.3 tt -77.01 -46.72 22.83 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.779 -1.2 . . . . 0.0 109.61 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 10.2 tpt -77.19 -50.42 12.99 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.082 -1.011 . . . . 0.0 109.914 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.515 ' HB2' ' O ' ' A' ' 61' ' ' ARG . 19.9 m-20 -80.21 -21.47 42.89 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.97 -1.081 . . . . 0.0 110.076 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.429 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . 85.29 151.69 15.97 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.771 ' HB ' HG23 ' A' ' 62' ' ' ILE . 1.6 p -117.09 157.82 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.368 -1.077 . . . . 0.0 109.276 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.563 HG22 ' CD2' ' A' ' 74' ' ' HIS . 14.7 t -116.27 158.32 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.32 -0.863 . . . . 0.0 110.075 -178.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.467 ' N ' ' CG1' ' A' ' 68' ' ' VAL . 29.7 p -117.17 158.71 23.8 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.6 t -64.38 -32.98 74.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.515 -0.74 . . . . 0.0 109.791 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.2 p -64.75 -14.25 58.08 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.574 -0.704 . . . . 0.0 109.362 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 99.67 8.07 52.54 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -91.25 156.21 17.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.964 -1.315 . . . . 0.0 109.836 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.563 ' CD2' HG22 ' A' ' 68' ' ' VAL . 11.0 m170 -116.4 156.19 27.2 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.002 -1.061 . . . . 0.0 108.616 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 74' ' ' HIS . 5.2 mt-10 -142.83 -179.04 6.1 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.213 -0.93 . . . . 0.0 110.237 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 51.85 -143.11 19.87 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.438 ' HD2' ' O ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER 56.7 15.9 2.39 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.491 -1.005 . . . . 0.0 110.242 179.544 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 80' ' ' GLN . 2.4 mp -84.9 -11.04 56.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.956 -1.09 . . . . 0.0 110.244 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.788 HD21 ' HG2' ' A' ' 90' ' ' GLN . 1.1 tm? -43.03 96.22 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.008 -1.058 . . . . 0.0 109.046 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.518 ' N ' ' O ' ' A' ' 78' ' ' LEU . 83.7 mt-30 -143.53 179.39 7.15 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.198 -0.939 . . . . 0.0 110.501 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.84 112.05 4.06 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.818 0.818 . . . . 0.0 111.633 -178.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.675 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 23.2 mt -91.76 172.14 6.9 Favored Pre-proline 0 N--CA 1.488 1.463 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 177.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.675 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 28.4 Cg_endo -67.45 100.58 0.57 Allowed 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 121.1 1.2 . . . . 0.0 110.907 -179.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.475 ' O ' ' SG ' ' A' ' 29' ' ' CYS . . . 90.86 12.68 60.23 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.492 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 3.3 m -142.98 91.9 7.03 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 120.916 -1.343 . . . . 0.0 109.255 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.406 ' O ' ' C ' ' A' ' 87' ' ' ARG . 29.2 Cg_endo -73.39 159.53 46.47 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 121.272 1.315 . . . . 0.0 111.451 -179.016 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.406 ' C ' ' O ' ' A' ' 86' ' ' PRO . 6.3 mtm-85 -44.91 -27.87 0.59 Allowed 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 121.903 0.859 . . . . 0.0 108.889 178.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.95 -46.47 82.09 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.906 -0.496 . . . . 0.0 112.058 -177.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.48 HG11 ' HB ' ' A' ' 28' ' ' THR . 40.5 t -69.99 -41.66 79.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 120.689 -1.257 . . . . 0.0 110.929 -178.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.788 ' HG2' HD21 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -64.64 -30.11 71.13 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.048 -1.032 . . . . 0.0 108.807 -179.909 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.488 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 0.0 OUTLIER -78.17 -27.81 48.12 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.504 179.609 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.501 ' O ' ' HD2' ' A' ' 95' ' ' PRO . . . -73.17 -51.2 18.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.103 -0.998 . . . . 0.0 109.68 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.452 ' C ' ' HD2' ' A' ' 95' ' ' PRO . 40.9 t80 -77.78 -26.53 49.8 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.19 -0.944 . . . . 0.0 110.022 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.805 ' HB3' ' HD3' ' A' ' 95' ' ' PRO . . . -42.28 -51.96 10.38 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.383 -0.823 . . . . 0.0 111.593 -178.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.805 ' HD3' ' HB3' ' A' ' 94' ' ' ALA . 31.2 Cg_endo -72.06 80.63 1.52 Allowed 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.203 1.935 . . . . 0.0 111.628 -178.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.432 ' O ' ' HG3' ' A' ' 102' ' ' GLU . 0.0 OUTLIER 176.44 56.51 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.628 -0.67 . . . . 0.0 109.22 179.234 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.997 HD23 HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -96.27 -82.17 0.4 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.212 -0.93 . . . . 0.0 111.271 -179.075 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 1.039 HG12 HD11 ' A' ' 48' ' ' LEU . 3.6 m -81.91 28.77 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.735 -1.228 . . . . 0.0 111.197 -178.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.465 ' C ' ' HB3' ' A' ' 104' ' ' ASN . 5.3 p -97.53 170.88 8.73 Favored 'General case' 0 C--N 1.294 -1.834 0 O-C-N 120.644 -1.285 . . . . 0.0 108.449 179.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.79 -2.05 0.2 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.679 -1.263 . . . . 0.0 111.892 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.672 ' O ' HG12 ' A' ' 101' ' ' VAL . 57.4 t -100.86 6.4 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 119.844 -1.785 . . . . 0.0 110.73 -179.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.436 ' CB ' ' O ' ' A' ' 97' ' ' LEU . 0.3 OUTLIER -141.52 -91.17 0.14 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.684 -1.26 . . . . 0.0 110.386 -179.899 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.802 ' O ' HD12 ' A' ' 105' ' ' LEU . 3.6 m -142.89 38.58 1.46 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.951 -1.093 . . . . 0.0 108.861 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.493 ' O ' ' N ' ' A' ' 106' ' ' ALA . 8.3 p30 -34.87 -51.86 0.52 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.21 -0.931 . . . . 0.0 112.158 -178.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.802 HD12 ' O ' ' A' ' 103' ' ' CYS . 0.6 OUTLIER 40.55 26.94 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.953 -1.092 . . . . 0.0 109.825 -179.396 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' A' ' 104' ' ' ASN . . . 62.25 153.85 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.778 -1.202 . . . . 0.0 108.693 -178.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.4 p -128.56 -178.48 4.6 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.099 -1.001 . . . . 0.0 108.629 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.579 ' N ' ' HB1' ' A' ' 53' ' ' ALA . 7.1 tp -64.17 -33.1 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.921 -1.112 . . . . 0.0 108.83 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.407 ' CD2' ' HA ' ' A' ' 114' ' ' CYS . 84.9 m-70 -62.68 -2.31 1.09 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.771 -0.581 . . . . 0.0 111.084 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 63.31 31.73 81.72 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -162.79 172.51 38.85 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.941 -1.263 . . . . 0.0 109.941 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.523 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 30.2 Cg_endo -76.87 69.46 6.91 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 123.049 2.499 . . . . 0.0 111.6 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.523 ' HB3' ' O ' ' A' ' 112' ' ' PRO . 34.9 p90 173.0 159.96 0.12 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.397 -0.814 . . . . 0.0 110.481 178.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.513 ' O ' ' HB2' ' A' ' 115' ' ' LEU . 1.8 p -144.69 160.46 41.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.396 -0.815 . . . . 0.0 108.859 179.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.513 ' HB2' ' O ' ' A' ' 114' ' ' CYS . 5.5 tp 173.56 -69.73 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.131 -0.981 . . . . 0.0 109.296 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -170.91 -79.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.368 -0.833 . . . . 0.0 109.173 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.51 ' O ' ' HB2' ' A' ' 118' ' ' LEU . 5.3 mp 49.81 20.37 0.54 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.311 -0.868 . . . . 0.0 109.889 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.51 ' HB2' ' O ' ' A' ' 117' ' ' LEU . 10.4 mp 66.51 -11.77 0.22 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.251 -0.906 . . . . 0.0 112.846 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.432 ' O ' ' C ' ' A' ' 120' ' ' ALA . . . 78.12 35.84 33.22 Favored Glycine 0 N--CA 1.489 2.231 0 O-C-N 120.253 -1.529 . . . . 0.0 109.682 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 119' ' ' GLY . . . 43.22 73.01 0.15 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -1.138 . . . . 0.0 109.609 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.455 ' O ' ' CB ' ' A' ' 122' ' ' GLU . . . -63.2 -18.74 60.89 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.455 ' CB ' ' O ' ' A' ' 121' ' ' GLY . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 O-C-N 121.242 -1.152 . . . . 0.0 109.453 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 8.3 p . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.55 -88.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -109.67 89.11 0.54 Allowed Glycine 0 N--CA 1.497 2.753 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.551 HG23 ' O ' ' A' ' 4' ' ' THR . 7.3 t -177.47 69.39 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.494 0.664 . . . . 0.0 109.392 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.5 t -126.65 163.9 22.45 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.699 -0.625 . . . . 0.0 109.364 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 3.9 m 52.38 -168.97 0.04 OUTLIER 'General case' 0 N--CA 1.505 2.296 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.572 HD13 ' N ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -142.48 126.91 9.94 Favored Pre-proline 0 N--CA 1.499 2.006 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.928 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.572 ' N ' HD13 ' A' ' 7' ' ' ILE . 35.8 Cg_endo -76.27 156.42 37.39 Favored 'Trans proline' 0 N--CA 1.485 0.979 0 C-N-CA 121.859 1.706 . . . . 0.0 111.203 -178.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 83.33 -5.69 76.02 Favored Glycine 0 N--CA 1.5 2.913 0 N-CA-C 110.696 -0.961 . . . . 0.0 110.696 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.562 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 1.6 mtp -136.81 112.24 9.25 Favored 'General case' 0 N--CA 1.501 2.121 0 CA-C-N 118.287 1.043 . . . . 0.0 108.292 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 86.39 -57.22 0.06 Allowed 'General case' 0 N--CA 1.514 2.752 0 CA-C-N 119.834 1.197 . . . . 0.0 108.171 -178.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.702 HD11 ' CB ' ' A' ' 55' ' ' CYS . 36.0 mt -106.86 100.36 31.12 Favored Pre-proline 0 N--CA 1.492 1.672 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 178.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -82.11 172.74 11.55 Favored 'Trans proline' 0 C--O 1.22 -0.388 0 C-N-CA 121.397 1.398 . . . . 0.0 111.593 -177.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 45.2 m-70 -72.44 145.19 47.79 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.412 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 4.4 t-20 65.04 64.14 1.07 Allowed Pre-proline 0 N--CA 1.505 2.285 0 O-C-N 121.521 -0.737 . . . . 0.0 109.506 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.722 ' HB2' ' HB1' ' A' ' 59' ' ' ALA . 38.2 Cg_endo -82.1 151.95 16.21 Favored 'Trans proline' 0 N--CA 1.482 0.845 0 C-N-CA 122.344 2.029 . . . . 0.0 112.047 -179.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.62 HD12 ' HB2' ' A' ' 16' ' ' PRO . 2.9 mp 46.88 35.0 2.92 Favored 'General case' 0 N--CA 1.502 2.166 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.177 177.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -66.52 -32.55 73.97 Favored 'General case' 0 N--CA 1.505 2.296 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.0 -32.32 73.98 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.476 ' O ' HG23 ' A' ' 24' ' ' VAL . 33.8 m -71.25 -33.83 70.19 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.419 ' CG ' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -60.98 -54.89 39.35 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.11 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.469 ' HA ' ' CE3' ' A' ' 22' ' ' TRP . 30.6 m95 -67.26 -27.0 66.84 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.55 -179.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.558 ' HE1' HG22 ' A' ' 37' ' ' THR . 14.5 t80 -68.4 -29.68 68.42 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.601 HG22 ' CD1' ' A' ' 93' ' ' PHE . 80.7 t -73.29 -42.61 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 177.018 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -53.24 -40.64 64.71 Favored 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 120.594 -0.442 . . . . 0.0 109.968 -179.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 31.1 m -77.19 -52.79 8.65 Favored 'General case' 0 N--CA 1.508 2.472 0 O-C-N 122.204 -0.31 . . . . 0.0 111.669 -178.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.587 ' NH1' HG21 ' A' ' 37' ' ' THR . 2.3 mmp_? -59.96 -25.06 64.9 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.859 -0.526 . . . . 0.0 110.678 -178.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 59.7 p -97.74 -65.83 0.94 Allowed 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -177.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.512 ' O ' HG23 ' A' ' 31' ' ' VAL . 57.4 m -100.88 16.04 26.5 Favored 'General case' 0 N--CA 1.51 2.546 0 O-C-N 121.298 -0.876 . . . . 0.0 111.924 -178.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 56.83 20.87 34.63 Favored Glycine 0 N--CA 1.505 3.263 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 29' ' ' CYS . 54.9 t -106.94 160.63 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 O-C-N 121.759 -0.847 . . . . 0.0 109.01 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.453 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 134.68 177.89 15.27 Favored Glycine 0 N--CA 1.499 2.851 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -66.46 172.74 8.68 Favored 'Trans proline' 0 N--CA 1.486 1.082 0 CA-C-N 119.098 1.449 . . . . 0.0 109.938 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 8.8 ttt-85 -93.27 86.33 5.29 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 122.027 0.918 . . . . 0.0 110.363 -178.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 76.4 mt -139.65 130.93 26.7 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.01 145.94 6.79 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.868 -0.52 . . . . 0.0 109.928 -178.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.587 HG21 ' NH1' ' A' ' 27' ' ' ARG . 0.8 OUTLIER -56.93 -57.87 10.62 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.705 -0.622 . . . . 0.0 111.217 -179.369 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -49.2 -36.98 21.24 Favored 'General case' 0 N--CA 1.509 2.506 0 O-C-N 121.676 -0.64 . . . . 0.0 111.246 -178.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -70.38 -38.22 74.67 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 122.042 -0.411 . . . . 0.0 110.087 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.403 ' CE ' ' HA ' ' A' ' 40' ' ' MET . 0.0 OUTLIER -64.61 -54.69 28.04 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 -179.64 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -52.71 -36.05 56.68 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.24 -43.78 97.07 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.61 -48.45 81.71 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 14.6 m -61.25 -34.0 74.43 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 122.04 -0.412 . . . . 0.0 111.338 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 17.9 m -73.8 -28.69 61.76 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 7.8 tpt85 -75.11 -34.31 61.7 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -79.08 -36.96 40.0 Favored 'General case' 0 N--CA 1.5 2.055 0 CA-C-O 121.184 0.516 . . . . 0.0 110.207 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.7 HD21 ' NH1' ' A' ' 56' ' ' ARG . 3.5 tt -70.32 -38.58 74.96 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.207 -178.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -77.72 -42.72 33.36 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.99 -37.43 63.99 Favored 'General case' 0 N--CA 1.507 2.397 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 178.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.421 ' O ' ' HD3' ' A' ' 56' ' ' ARG . 51.1 mt -86.46 105.65 8.27 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 177.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -62.87 141.59 85.2 Favored 'Trans proline' 0 N--CA 1.481 0.753 0 C-N-CA 121.517 1.478 . . . . 0.0 110.856 -177.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -43.27 -29.83 0.44 Allowed 'General case' 0 N--CA 1.503 2.189 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.286 -178.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.07 110.01 5.49 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.702 ' CB ' HD11 ' A' ' 12' ' ' ILE . 25.1 m 86.39 -15.36 0.47 Allowed 'General case' 0 N--CA 1.513 2.706 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -177.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.7 ' NH1' HD21 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -45.75 -81.94 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.357 0 O-C-N 121.737 -0.602 . . . . 0.0 110.865 -179.855 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 94.0 m -24.5 -42.88 0.01 OUTLIER 'General case' 0 N--CA 1.519 3.001 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -179.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -41.5 -57.08 2.34 Favored 'General case' 0 N--CA 1.511 2.588 0 CA-C-N 119.055 0.843 . . . . 0.0 111.429 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.722 ' HB1' ' HB2' ' A' ' 16' ' ' PRO . . . -39.43 -44.63 1.39 Allowed 'General case' 0 N--CA 1.514 2.748 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 38.7 t -58.92 -50.21 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.347 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.67 -25.05 66.07 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.917 HG23 ' HB ' ' A' ' 67' ' ' VAL . 43.1 mm -77.88 -29.13 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.906 -0.496 . . . . 0.0 109.938 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.1 tt -78.35 -41.12 34.36 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.449 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -78.08 -53.33 7.51 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.207 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -80.49 -23.56 40.06 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 122.065 -0.397 . . . . 0.0 111.591 -178.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.62 145.93 6.69 Favored Glycine 0 N--CA 1.503 3.15 0 N-CA-C 109.964 -1.255 . . . . 0.0 109.964 -179.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.917 ' HB ' HG23 ' A' ' 62' ' ' ILE . 7.2 p -118.7 159.5 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.492 0 O-C-N 122.151 -0.617 . . . . 0.0 110.209 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.704 HG22 ' NE2' ' A' ' 74' ' ' HIS . 65.7 t -115.49 157.35 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 32.0 p -117.77 159.63 22.71 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.359 -178.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.6 t -63.02 -33.91 76.43 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.076 -178.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.5 p -63.38 -18.78 64.05 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.988 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.45 13.91 34.16 Favored Glycine 0 N--CA 1.497 2.713 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -103.35 157.23 17.17 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 118.226 1.013 . . . . 0.0 109.225 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.704 ' NE2' HG22 ' A' ' 68' ' ' VAL . 8.9 m170 -115.01 155.36 27.11 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -179.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -140.32 -179.35 5.95 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 120.849 0.357 . . . . 0.0 110.122 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 51.54 -149.32 8.34 Favored Glycine 0 N--CA 1.497 2.752 0 N-CA-C 109.101 -1.6 . . . . 0.0 109.101 -179.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.8 ttp85 59.17 17.6 5.78 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 122.298 -0.531 . . . . 0.0 110.616 179.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 59.8 mt -78.34 -17.45 56.51 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.719 -0.613 . . . . 0.0 109.84 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.677 HD23 ' O ' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -51.93 98.56 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.024 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -140.1 172.56 12.58 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.106 0.479 . . . . 0.0 110.01 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -64.26 102.36 0.51 Allowed 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.672 0.749 . . . . 0.0 111.088 -179.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.647 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 23.7 mt -81.58 172.98 8.39 Favored Pre-proline 0 N--CA 1.495 1.799 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 177.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.647 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 26.3 Cg_endo -65.3 99.97 0.37 Allowed 'Trans proline' 0 N--CA 1.477 0.534 0 C-N-CA 120.971 1.114 . . . . 0.0 111.034 -179.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.68 -7.86 80.67 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 7.2 m -117.12 92.08 38.44 Favored Pre-proline 0 N--CA 1.502 2.142 0 CA-C-N 119.279 1.539 . . . . 0.0 110.3 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -71.39 164.05 37.03 Favored 'Trans proline' 0 N--CA 1.481 0.754 0 C-N-CA 121.36 1.373 . . . . 0.0 111.205 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.5 mmm-85 -48.24 -29.22 3.59 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.212 0.53 . . . . 0.0 109.571 178.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -55.69 -48.74 74.57 Favored 'General case' 0 N--CA 1.505 2.284 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.377 -178.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 80.2 t -62.55 -37.27 78.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.542 ' HB3' HD12 ' A' ' 79' ' ' LEU . 42.0 mm-40 -64.35 -30.11 71.16 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.95 -27.97 49.41 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -74.91 -46.73 33.95 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.967 -0.458 . . . . 0.0 109.874 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.601 ' CD1' HG22 ' A' ' 24' ' ' VAL . 29.3 t80 -78.17 -25.13 47.06 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 122.207 -0.308 . . . . 0.0 110.579 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.689 ' HB3' ' HD3' ' A' ' 95' ' ' PRO . . . -50.89 -52.87 53.46 Favored Pre-proline 0 N--CA 1.499 2.006 0 CA-C-O 118.842 -0.599 . . . . 0.0 111.938 -177.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.689 ' HD3' ' HB3' ' A' ' 94' ' ' ALA . 30.4 Cg_endo -71.19 -16.59 31.68 Favored 'Trans proline' 0 N--CA 1.484 0.966 0 C-N-CA 122.062 1.841 . . . . 0.0 111.159 -179.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.8 mmpt? -86.99 11.4 13.69 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.934 -0.479 . . . . 0.0 110.193 178.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.471 ' O ' ' HB3' ' A' ' 102' ' ' GLU . 0.2 OUTLIER -72.43 -60.47 2.22 Favored 'General case' 0 N--CA 1.508 2.447 0 O-C-N 121.668 -0.645 . . . . 0.0 111.33 -178.913 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.664 HG12 HD11 ' A' ' 48' ' ' LEU . 13.2 m -89.38 25.34 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 120.819 -1.176 . . . . 0.0 110.517 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 29.7 p -99.35 173.14 6.91 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.52 -0.54 0.27 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.534 -0.729 . . . . 0.0 112.07 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.535 ' O ' HG12 ' A' ' 101' ' ' VAL . 21.8 t -93.82 -0.52 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-N 120.537 1.517 . . . . 0.0 111.028 -179.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.471 ' HB3' ' O ' ' A' ' 97' ' ' LEU . 8.3 tt0 -146.95 -90.79 0.09 Allowed 'General case' 0 N--CA 1.505 2.277 0 C-N-CA 119.499 -0.88 . . . . 0.0 112.11 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.687 ' O ' HD22 ' A' ' 48' ' ' LEU . 83.8 m -137.0 45.57 2.24 Favored 'General case' 0 N--CA 1.511 2.609 0 CA-C-N 119.13 0.877 . . . . 0.0 110.609 -177.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 -43.6 -72.68 0.06 Allowed 'General case' 0 N--CA 1.508 2.469 0 O-C-N 120.924 -1.11 . . . . 0.0 112.96 -179.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.6 mp 51.25 34.48 11.54 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.966 -0.459 . . . . 0.0 110.628 -178.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 63.55 148.22 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.27 -0.894 . . . . 0.0 109.73 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.8 p -121.16 -164.41 1.12 Allowed 'General case' 0 N--CA 1.505 2.316 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -179.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.0 tt -68.26 -30.72 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.468 ' HB3' ' CE1' ' A' ' 113' ' ' PHE . 95.5 m-70 -71.48 0.66 7.87 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.644 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 60.9 36.54 92.27 Favored Glycine 0 N--CA 1.497 2.74 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -169.8 173.94 43.99 Favored Glycine 0 N--CA 1.498 2.823 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -77.88 78.53 3.53 Favored 'Trans proline' 0 N--CA 1.481 0.747 0 C-N-CA 122.65 2.234 . . . . 0.0 110.487 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.468 ' CE1' ' HB3' ' A' ' 109' ' ' HIS . 0.0 OUTLIER 174.53 165.29 0.24 Allowed 'General case' 0 N--CA 1.504 2.27 0 CA-C-O 121.34 0.59 . . . . 0.0 111.399 179.353 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 3.0 t 176.03 165.55 0.4 Allowed 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 75.61 -78.36 0.04 OUTLIER 'General case' 0 N--CA 1.507 2.417 0 O-C-N 122.073 -0.392 . . . . 0.0 110.362 179.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.6 p -54.2 -89.44 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.716 -0.615 . . . . 0.0 109.764 -179.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.445 ' HG ' ' CE1' ' A' ' 109' ' ' HIS . 1.9 mm? 51.61 -88.57 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.298 0 CA-C-N 118.304 0.502 . . . . 0.0 110.585 179.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.476 ' N ' HD12 ' A' ' 118' ' ' LEU . 11.1 mp -51.84 -17.92 1.12 Allowed 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.576 -0.703 . . . . 0.0 112.654 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -109.76 153.89 16.76 Favored Glycine 0 N--CA 1.498 2.774 0 N-CA-C 109.249 -1.541 . . . . 0.0 109.249 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 56.36 68.19 0.89 Allowed 'General case' 0 N--CA 1.501 2.092 0 CA-C-O 121.769 0.795 . . . . 0.0 109.819 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -62.08 -22.13 62.36 Favored Glycine 0 N--CA 1.497 2.709 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 . . . . . 0 N--CA 1.497 1.903 0 CA-C-O 118.022 -0.99 . . . . 0.0 109.55 -179.916 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.493 ' C ' HG23 ' A' ' 2' ' ' VAL . 1.1 m . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.493 HG23 ' C ' ' A' ' 1' ' ' SER . 5.0 t 85.07 -35.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.765 0 C-N-CA 122.892 0.477 . . . . 0.0 110.948 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 97.96 152.63 28.34 Favored Glycine 0 N--CA 1.497 2.732 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.0 t -117.49 24.84 10.84 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 122.195 -0.591 . . . . 0.0 109.997 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.86 -169.03 1.55 Allowed 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 84.3 m -133.93 164.85 26.35 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.512 HG22 ' HB2' ' A' ' 10' ' ' MET . 50.7 mt -141.83 115.4 6.68 Favored Pre-proline 0 N--CA 1.5 2.049 0 CA-C-O 118.698 -0.668 . . . . 0.0 109.362 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -78.31 147.43 23.04 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 121.78 1.653 . . . . 0.0 110.734 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 69.78 6.11 54.34 Favored Glycine 0 N--CA 1.502 3.066 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.57 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 0.1 OUTLIER -140.52 107.21 5.35 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.788 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.57 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 87.04 -58.69 0.04 OUTLIER 'General case' 0 N--CA 1.516 2.829 0 CA-C-N 119.865 1.211 . . . . 0.0 108.399 -178.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.659 HD11 ' HB2' ' A' ' 55' ' ' CYS . 41.1 mt -103.57 101.38 23.48 Favored Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 178.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -81.82 172.45 12.14 Favored 'Trans proline' 0 N--CA 1.477 0.549 0 C-N-CA 121.701 1.601 . . . . 0.0 111.97 -176.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 30.6 m-70 -74.68 145.4 43.2 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.401 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 10.4 t-20 68.14 64.48 0.63 Allowed Pre-proline 0 N--CA 1.508 2.45 0 O-C-N 121.404 -0.81 . . . . 0.0 110.593 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.401 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 41.0 Cg_endo -84.34 171.42 10.06 Favored 'Trans proline' 0 N--CA 1.484 0.959 0 C-N-CA 122.51 2.14 . . . . 0.0 111.908 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 66.1 mt 43.43 46.29 5.64 Favored 'General case' 0 N--CA 1.503 2.223 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.435 177.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -73.47 -41.1 63.59 Favored 'General case' 0 N--CA 1.505 2.28 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.2 t -63.42 -25.74 68.42 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.717 ' O ' HG23 ' A' ' 24' ' ' VAL . 32.5 m -77.73 -35.38 51.98 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 110.251 -0.278 . . . . 0.0 110.251 -179.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 11.2 ttp180 -69.92 -42.96 72.63 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.418 ' HA ' ' CE3' ' A' ' 22' ' ' TRP . 31.1 m95 -73.38 -30.97 63.64 Favored 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 118.762 -1.175 . . . . 0.0 108.99 178.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.753 ' HE1' HG23 ' A' ' 37' ' ' THR . 8.2 t80 -63.96 -33.85 76.66 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.717 HG23 ' O ' ' A' ' 20' ' ' CYS . 43.6 t -70.51 -38.86 75.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 177.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.1 m -55.18 -39.18 69.27 Favored 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.887 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.9 m -77.49 -54.48 6.38 Favored 'General case' 0 N--CA 1.511 2.607 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -178.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -60.83 -24.72 66.09 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.508 -0.745 . . . . 0.0 110.6 -178.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.414 HG23 ' O ' ' A' ' 24' ' ' VAL . 44.2 p -95.93 -63.21 1.17 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 122.003 -0.435 . . . . 0.0 112.153 -177.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.683 ' O ' HG23 ' A' ' 31' ' ' VAL . 3.7 m -100.23 12.11 37.82 Favored 'General case' 0 N--CA 1.509 2.507 0 O-C-N 121.249 -0.907 . . . . 0.0 111.484 -178.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 57.26 24.13 50.35 Favored Glycine 0 N--CA 1.507 3.395 0 N-CA-C 109.434 -1.467 . . . . 0.0 109.434 -178.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 29' ' ' CYS . 27.7 t -116.48 164.83 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 O-C-N 122.053 -0.675 . . . . 0.0 109.469 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.495 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 132.09 -177.32 18.79 Favored Glycine 0 N--CA 1.499 2.871 0 N-CA-C 108.675 -1.77 . . . . 0.0 108.675 -178.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -64.01 172.22 6.4 Favored 'Trans proline' 0 N--CA 1.483 0.888 0 CA-C-N 119.485 1.643 . . . . 0.0 109.808 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -92.99 84.64 4.93 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.918 0.866 . . . . 0.0 110.518 -177.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.0 tp -140.26 132.9 28.84 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.88 159.38 0.41 Allowed 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.937 -0.477 . . . . 0.0 109.994 -179.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.753 HG23 ' HE1' ' A' ' 23' ' ' TYR . 34.5 m -74.21 -27.89 61.01 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.934 -0.479 . . . . 0.0 111.255 -178.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -74.17 -38.32 63.72 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.869 -0.519 . . . . 0.0 110.524 -178.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -72.8 -30.65 64.25 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.469 ' HA ' ' HE3' ' A' ' 40' ' ' MET . 0.5 OUTLIER -70.86 -56.09 7.04 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.665 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.74 -33.65 70.49 Favored 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.88 -34.14 74.95 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.885 -0.784 . . . . 0.0 108.885 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -66.32 -48.93 68.71 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 16.4 m -62.4 -37.71 86.82 Favored 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.332 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 89.5 m -73.88 -28.25 61.47 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -178.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -72.76 -32.27 65.52 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -77.79 -37.02 49.77 Favored 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 120.571 -0.451 . . . . 0.0 109.799 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.56 HD11 HG12 ' A' ' 98' ' ' VAL . 2.1 tt -68.65 -36.64 78.86 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -77.09 -41.64 41.35 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.74 -35.11 68.22 Favored 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.563 HG22 ' HG2' ' A' ' 56' ' ' ARG . 58.2 mt -87.0 104.73 6.51 Favored Pre-proline 0 N--CA 1.489 1.5 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 177.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -59.15 145.37 97.94 Favored 'Trans proline' 0 N--CA 1.477 0.557 0 C-N-CA 121.383 1.389 . . . . 0.0 110.305 -177.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -36.49 -32.69 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.444 0 C-N-CA 122.767 0.427 . . . . 0.0 112.049 -178.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -71.04 123.36 21.92 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.659 ' HB2' HD11 ' A' ' 12' ' ' ILE . 23.3 m 77.23 -1.04 2.82 Favored 'General case' 0 N--CA 1.509 2.497 0 C-N-CA 122.266 0.226 . . . . 0.0 110.739 -179.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.563 ' HG2' HG22 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -57.84 -91.56 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.438 -0.789 . . . . 0.0 109.762 -179.918 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 64.6 m -27.51 -42.36 0.02 OUTLIER 'General case' 0 N--CA 1.523 3.178 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -40.02 -54.24 2.26 Favored 'General case' 0 N--CA 1.513 2.703 0 CA-C-N 119.493 1.042 . . . . 0.0 111.801 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -40.4 -46.58 2.42 Favored 'General case' 0 N--CA 1.511 2.581 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 39.4 t -56.56 -49.94 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -59.32 -26.47 65.04 Favored 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.942 HG23 ' HB ' ' A' ' 67' ' ' VAL . 42.4 mm -78.42 -29.84 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 O-C-N 121.926 -0.484 . . . . 0.0 110.341 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.468 HD23 HD13 ' A' ' 79' ' ' LEU . 0.7 OUTLIER -79.0 -38.64 36.16 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.848 -0.741 . . . . 0.0 109.9 -179.48 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 2.6 ttm -78.63 -52.78 7.95 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.028 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -80.7 -24.03 39.12 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 122.007 -0.433 . . . . 0.0 111.051 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.41 144.58 5.07 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 108.839 -1.704 . . . . 0.0 108.839 -179.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.942 ' HB ' HG23 ' A' ' 62' ' ' ILE . 7.1 p -117.66 159.35 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 122.254 -0.556 . . . . 0.0 109.594 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.526 HG22 ' CD2' ' A' ' 74' ' ' HIS . 51.0 t -114.33 157.23 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.3 p -116.99 159.57 22.29 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.99 -177.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 48.3 t -62.78 -30.47 71.48 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.326 -178.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.8 p -70.1 -16.9 63.19 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.447 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.59 11.46 41.04 Favored Glycine 0 N--CA 1.498 2.8 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -98.64 157.78 16.04 Favored 'General case' 0 N--CA 1.501 2.113 0 CA-C-N 118.103 0.951 . . . . 0.0 109.227 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.526 ' CD2' HG22 ' A' ' 68' ' ' VAL . 10.8 m170 -114.93 155.68 26.44 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -140.29 -178.02 5.29 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.11 0.481 . . . . 0.0 110.194 -179.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 51.79 -144.08 17.56 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.814 -1.315 . . . . 0.0 109.814 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 55.32 22.4 4.82 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 122.394 -0.474 . . . . 0.0 110.071 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.6 mt -86.27 -13.83 45.56 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.719 -0.613 . . . . 0.0 110.93 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.468 HD13 HD23 ' A' ' 63' ' ' LEU . 1.4 tp -61.23 93.24 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -142.9 -177.44 5.33 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.545 0.688 . . . . 0.0 110.216 -178.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -54.3 138.59 38.76 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.842 0.83 . . . . 0.0 111.353 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.528 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 21.3 mt -130.61 168.26 17.74 Favored Pre-proline 0 N--CA 1.497 1.916 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 178.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.528 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 29.4 Cg_endo -68.74 99.75 0.66 Allowed 'Trans proline' 0 N--CA 1.478 0.564 0 C-N-CA 121.044 1.163 . . . . 0.0 110.386 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.8 9.91 63.65 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.466 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 3.4 m -141.95 90.88 8.3 Favored Pre-proline 0 N--CA 1.509 2.515 0 CA-C-N 118.761 1.28 . . . . 0.0 109.756 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -74.25 164.88 33.19 Favored 'Trans proline' 0 N--CA 1.487 1.097 0 C-N-CA 121.885 1.724 . . . . 0.0 111.475 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -48.94 -28.06 3.58 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.063 0.459 . . . . 0.0 110.087 178.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -60.31 -47.49 85.81 Favored 'General case' 0 N--CA 1.502 2.164 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -177.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 44.6 t -69.58 -40.94 80.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.775 -0.578 . . . . 0.0 111.518 -177.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.751 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 0.4 OUTLIER -73.3 -25.44 60.66 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.784 -179.549 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.7 tpt180 -78.93 -34.36 44.62 Favored 'General case' 0 N--CA 1.503 2.197 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.231 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.39 -43.69 31.83 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.869 -0.519 . . . . 0.0 110.003 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.548 ' CE1' HG22 ' A' ' 24' ' ' VAL . 28.4 t80 -78.53 -25.91 45.63 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 122.274 -0.267 . . . . 0.0 110.415 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.751 ' HB2' ' O ' ' A' ' 90' ' ' GLN . . . -43.41 -51.53 14.78 Favored Pre-proline 0 N--CA 1.502 2.164 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -178.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.66 ' HD3' ' HB3' ' A' ' 94' ' ' ALA . 29.2 Cg_endo -70.6 -170.24 0.43 Allowed 'Trans proline' 0 N--CA 1.481 0.784 0 C-N-CA 121.73 1.62 . . . . 0.0 111.058 -179.01 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 61.34 20.36 11.02 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 -178.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.71 -60.96 2.01 Favored 'General case' 0 N--CA 1.508 2.434 0 O-C-N 121.969 -0.457 . . . . 0.0 112.232 -178.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.56 HG12 HD11 ' A' ' 48' ' ' LEU . 19.8 m -82.94 35.06 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 O-C-N 121.112 -0.993 . . . . 0.0 111.921 -178.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.411 ' C ' ' HB2' ' A' ' 104' ' ' ASN . 24.6 p -109.1 174.99 5.62 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 178.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -59.66 -2.46 0.36 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.467 -0.771 . . . . 0.0 111.926 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.564 ' O ' HG12 ' A' ' 101' ' ' VAL . 21.9 t -95.61 1.5 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 CA-C-N 120.479 1.49 . . . . 0.0 111.321 -179.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -148.02 -91.96 0.08 Allowed 'General case' 0 N--CA 1.504 2.252 0 CA-C-N 119.011 0.823 . . . . 0.0 111.771 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 7.3 m -132.89 49.35 2.32 Favored 'General case' 0 N--CA 1.509 2.503 0 O-C-N 121.365 -0.834 . . . . 0.0 110.1 -178.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.411 ' HB2' ' C ' ' A' ' 99' ' ' THR . 38.2 t30 -42.23 -82.29 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.559 0 O-C-N 120.779 -1.201 . . . . 0.0 112.533 -179.014 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.5 ' O ' ' HB3' ' A' ' 106' ' ' ALA . 8.1 mt 51.58 24.64 2.39 Favored 'General case' 0 N--CA 1.506 2.343 0 O-C-N 121.836 -0.54 . . . . 0.0 111.922 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' A' ' 105' ' ' LEU . . . 71.07 152.27 0.11 Allowed 'General case' 0 N--CA 1.513 2.722 0 O-C-N 121.001 -1.062 . . . . 0.0 110.669 178.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.485 HG21 ' O ' ' A' ' 113' ' ' PHE . 3.9 p -127.85 -163.84 1.31 Allowed 'General case' 0 N--CA 1.51 2.536 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.418 ' CG2' ' CD2' ' A' ' 109' ' ' HIS . 10.9 tt -67.3 -37.28 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.244 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.033 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.693 ' CD2' ' HA ' ' A' ' 114' ' ' CYS . 68.3 m-70 -67.43 -2.03 5.72 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.784 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 58.57 28.6 62.74 Favored Glycine 0 N--CA 1.498 2.778 0 N-CA-C 108.744 -1.742 . . . . 0.0 108.744 -178.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -141.19 178.64 20.1 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -179.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.426 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 32.7 Cg_endo -87.87 55.36 2.63 Favored 'Trans proline' 0 N--CA 1.481 0.772 0 C-N-CA 123.358 2.705 . . . . 0.0 110.655 -179.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.567 ' CZ ' HD12 ' A' ' 115' ' ' LEU . 0.2 OUTLIER 175.68 -160.03 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -178.297 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.693 ' HA ' ' CD2' ' A' ' 109' ' ' HIS . 0.1 OUTLIER -145.71 83.11 1.64 Allowed 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 120.143 -0.623 . . . . 0.0 109.881 176.12 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.567 HD12 ' CZ ' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -37.77 179.38 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.183 0 C-N-CA 124.348 1.059 . . . . 0.0 113.702 -179.405 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.409 ' CB ' ' O ' ' A' ' 115' ' ' LEU . 2.8 t 77.72 41.83 0.13 Allowed 'General case' 0 N--CA 1.507 2.386 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 -176.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.835 HD22 ' H ' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -96.98 19.34 12.94 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.466 -0.771 . . . . 0.0 109.816 -177.548 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.8 mp -46.1 -25.26 0.55 Allowed 'General case' 0 N--CA 1.509 2.496 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -177.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 51.56 60.05 7.8 Favored Glycine 0 N--CA 1.504 3.231 0 CA-C-N 119.662 1.119 . . . . 0.0 110.531 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 59.85 71.61 0.57 Allowed 'General case' 0 N--CA 1.499 2.002 0 CA-C-O 121.771 0.796 . . . . 0.0 109.509 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -57.5 -23.29 48.51 Favored Glycine 0 N--CA 1.497 2.746 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 . . . . . 0 N--CA 1.497 1.896 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.151 179.952 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.1 m -91.4 31.91 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 122.173 -0.329 . . . . 0.0 110.491 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -88.99 87.6 1.49 Allowed Glycine 0 N--CA 1.497 2.759 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.527 HG23 ' O ' ' A' ' 4' ' ' THR . 4.3 t -176.12 78.37 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 61.3 176.81 0.11 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.526 -0.734 . . . . 0.0 109.55 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 17.5 m -115.35 162.01 17.71 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 23.5 pt -121.96 136.39 26.19 Favored Pre-proline 0 N--CA 1.499 1.983 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -179.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -81.66 160.77 19.2 Favored 'Trans proline' 0 N--CA 1.479 0.651 0 C-N-CA 122.004 1.802 . . . . 0.0 110.262 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 71.38 4.71 57.68 Favored Glycine 0 N--CA 1.502 3.076 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.574 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 2.0 mpt? -139.91 99.85 3.79 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 118.153 0.977 . . . . 0.0 108.59 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.574 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 86.87 -57.46 0.05 OUTLIER 'General case' 0 N--CA 1.516 2.836 0 CA-C-N 119.392 0.997 . . . . 0.0 108.504 -178.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.442 ' HA ' HD12 ' A' ' 51' ' ' ILE . 17.5 mt -100.1 102.66 18.7 Favored Pre-proline 0 N--CA 1.499 1.992 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 178.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -79.76 176.37 9.56 Favored 'Trans proline' 0 C--O 1.22 -0.402 0 C-N-CA 121.458 1.439 . . . . 0.0 111.034 -177.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 41.0 m-70 -86.0 142.61 28.65 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 120.721 0.296 . . . . 0.0 111.017 -177.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.584 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 9.2 t-20 70.46 48.12 0.3 Allowed Pre-proline 0 N--CA 1.508 2.451 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 178.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.584 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 42.7 Cg_endo -86.65 175.51 5.21 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 121.79 1.66 . . . . 0.0 111.345 178.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 49.36 45.18 23.81 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 177.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -77.57 -43.16 32.71 Favored 'General case' 0 N--CA 1.509 2.482 0 O-C-N 121.219 -0.925 . . . . 0.0 108.954 178.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.94 -24.77 66.3 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 57.1 m -74.21 -34.25 63.66 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -179.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.96 -43.57 67.85 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.213 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 32.7 m95 -71.53 -26.5 62.67 Favored 'General case' 0 N--CA 1.504 2.263 0 C-N-CA 118.771 -1.172 . . . . 0.0 109.426 178.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.547 ' HB2' ' HG2' ' A' ' 40' ' ' MET . 10.9 t80 -70.24 -35.36 73.77 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.522 ' O ' HG23 ' A' ' 28' ' ' THR . 64.7 t -70.12 -38.59 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 177.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 m -57.42 -38.57 74.56 Favored 'General case' 0 N--CA 1.502 2.147 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.149 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 99.8 m -77.05 -51.75 10.53 Favored 'General case' 0 N--CA 1.511 2.578 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.2 tpt180 -62.99 -24.72 68.05 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.425 -0.797 . . . . 0.0 110.335 -178.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.522 HG23 ' O ' ' A' ' 24' ' ' VAL . 56.3 p -92.75 -66.58 0.91 Allowed 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -177.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.7 m -100.87 11.49 39.48 Favored 'General case' 0 N--CA 1.511 2.606 0 CA-C-N 119.452 1.024 . . . . 0.0 111.467 -179.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 60.49 25.58 63.25 Favored Glycine 0 N--CA 1.503 3.16 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -178.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.504 HG12 ' N ' ' A' ' 32' ' ' GLY . 47.8 t -108.32 163.73 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.317 0 O-C-N 121.911 -0.758 . . . . 0.0 109.437 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.504 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 126.04 -179.31 16.32 Favored Glycine 0 N--CA 1.499 2.849 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 -179.063 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -64.84 171.61 8.34 Favored 'Trans proline' 0 N--CA 1.486 1.033 0 CA-C-N 119.266 1.533 . . . . 0.0 109.911 179.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.759 ' O ' HD22 ' A' ' 35' ' ' LEU . 10.3 mmt-85 -93.23 84.36 4.78 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.917 0.865 . . . . 0.0 109.992 -178.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.759 HD22 ' O ' ' A' ' 34' ' ' ARG . 2.4 mm? -131.98 143.89 50.41 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.568 ' HB3' ' HG3' ' A' ' 39' ' ' GLU . . . -64.76 142.2 58.51 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -49.98 -58.7 4.93 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.506 -0.746 . . . . 0.0 111.004 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -46.82 -40.59 14.04 Favored 'General case' 0 N--CA 1.508 2.462 0 O-C-N 121.892 -0.505 . . . . 0.0 111.482 -178.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.568 ' HG3' ' HB3' ' A' ' 36' ' ' ALA . 13.5 mt-10 -62.78 -46.97 85.52 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.547 ' HG2' ' HB2' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -59.41 -57.69 11.89 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -179.585 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 39.8 tttt -51.82 -29.94 21.39 Favored 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 39' ' ' GLU . . . -65.94 -46.29 78.74 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.9 mmt-85 -58.06 -60.42 3.77 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 16.5 m -54.29 -32.82 57.27 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -178.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 21.5 m -75.43 -30.55 60.07 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -178.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.32 -34.11 70.27 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -79.05 -31.15 44.43 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.122 0.487 . . . . 0.0 109.817 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.475 ' HA ' HD22 ' A' ' 48' ' ' LEU . 1.2 tm? -67.76 -44.71 76.85 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -178.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -78.12 -28.12 48.43 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.81 -44.28 77.69 Favored 'General case' 0 N--CA 1.504 2.258 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.442 HD12 ' HA ' ' A' ' 12' ' ' ILE . 39.5 mm -79.83 106.19 4.52 Favored Pre-proline 0 N--CA 1.49 1.568 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 176.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -54.51 144.62 62.0 Favored 'Trans proline' 0 N--CA 1.481 0.766 0 C-N-CA 121.564 1.51 . . . . 0.0 111.572 -175.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.455 ' HA ' ' CG ' ' A' ' 56' ' ' ARG . . . -32.63 -32.42 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.342 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -177.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -63.19 125.27 23.53 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 14.1 m 77.56 17.15 1.47 Allowed 'General case' 0 N--CA 1.514 2.772 0 CA-C-O 119.358 -0.353 . . . . 0.0 111.898 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.455 ' CG ' ' HA ' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -48.68 -89.06 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.862 0 CA-C-N 119.851 1.205 . . . . 0.0 110.175 179.688 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 82.8 m -37.2 -44.2 0.56 Allowed 'General case' 0 N--CA 1.518 2.928 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -42.58 -51.02 5.3 Favored 'General case' 0 N--CA 1.512 2.642 0 CA-C-N 119.931 1.242 . . . . 0.0 111.735 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.616 ' HA ' HD12 ' A' ' 62' ' ' ILE . . . -41.88 -45.48 3.71 Favored 'General case' 0 N--CA 1.513 2.71 0 O-C-N 121.701 -0.625 . . . . 0.0 112.007 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.711 HG22 HD13 ' A' ' 97' ' ' LEU . 20.4 t -55.34 -48.58 76.63 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 10.1 ttp180 -58.81 -29.42 66.84 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.826 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.766 HG23 ' HB ' ' A' ' 67' ' ' VAL . 11.2 mt -77.57 -27.32 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.286 0 O-C-N 121.899 -0.501 . . . . 0.0 109.955 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.4 tp -77.63 -43.95 29.81 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 120.073 -0.651 . . . . 0.0 110.082 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.54 -50.42 11.61 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.284 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -81.09 -23.31 38.54 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.965 -0.459 . . . . 0.0 111.48 -179.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.87 149.31 8.24 Favored Glycine 0 N--CA 1.499 2.838 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -178.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.766 ' HB ' HG23 ' A' ' 62' ' ' ILE . 5.8 p -117.93 159.37 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.63 HG22 ' CE1' ' A' ' 74' ' ' HIS . 79.1 t -114.7 158.07 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-O 121.756 0.789 . . . . 0.0 109.389 -178.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.655 HG23 ' OE2' ' A' ' 75' ' ' GLU . 27.0 p -117.0 158.61 23.83 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 115.339 -0.846 . . . . 0.0 108.96 -178.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.7 t -64.26 -33.14 75.13 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.883 -178.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.6 p -62.91 -17.6 61.94 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.935 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.58 13.5 34.96 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -103.85 156.9 17.46 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-N 118.198 0.999 . . . . 0.0 109.524 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.63 ' CE1' HG22 ' A' ' 68' ' ' VAL . 9.3 m170 -115.44 155.86 26.67 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.655 ' OE2' HG23 ' A' ' 69' ' ' THR . 3.3 mp0 -142.79 -177.49 5.34 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 120.236 -0.586 . . . . 0.0 110.612 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.413 ' O ' ' CG ' ' A' ' 77' ' ' ARG . . . 59.95 -132.42 50.86 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 108.374 -1.89 . . . . 0.0 108.374 -178.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.413 ' CG ' ' O ' ' A' ' 76' ' ' GLY . 2.1 ptm180 44.18 28.61 0.29 Allowed 'General case' 0 N--CA 1.507 2.383 0 CA-C-O 120.978 0.418 . . . . 0.0 110.189 179.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.7 mt -72.81 -19.45 61.33 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 122.037 -0.415 . . . . 0.0 110.58 -178.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.644 HD13 ' CB ' ' A' ' 90' ' ' GLN . 2.5 tp -49.21 105.27 0.08 Allowed 'General case' 0 N--CA 1.503 2.183 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -139.95 170.51 15.74 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.371 0.605 . . . . 0.0 109.89 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -80.45 105.49 11.74 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 121.379 0.609 . . . . 0.0 110.342 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.598 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 15.5 mt -86.7 171.87 9.34 Favored Pre-proline 0 N--CA 1.5 2.03 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 177.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.598 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 28.9 Cg_endo -68.73 103.28 0.97 Allowed 'Trans proline' 0 C--N 1.328 -0.5 0 C-N-CA 120.865 1.043 . . . . 0.0 109.878 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.36 11.76 60.63 Favored Glycine 0 N--CA 1.498 2.813 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 3.5 m -143.07 90.37 7.46 Favored Pre-proline 0 N--CA 1.507 2.376 0 CA-C-N 118.705 1.252 . . . . 0.0 108.563 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -74.38 159.93 42.66 Favored 'Trans proline' 0 C--N 1.325 -0.673 0 C-N-CA 121.16 1.24 . . . . 0.0 111.0 -178.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.564 ' HA ' HD11 ' A' ' 79' ' ' LEU . 32.0 mtp180 -49.23 -28.64 4.79 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.389 0.614 . . . . 0.0 109.738 178.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -56.15 -49.0 75.21 Favored 'General case' 0 N--CA 1.503 2.176 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.971 -178.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.5 t -65.14 -39.43 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.667 -0.646 . . . . 0.0 109.667 -178.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.71 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 23.4 mm-40 -64.26 -29.4 70.49 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.429 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 1.7 tpt180 -78.46 -26.78 46.22 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.9 -50.14 25.5 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.869 -0.519 . . . . 0.0 109.656 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -78.88 -26.04 43.92 Favored 'General case' 0 N--CA 1.508 2.456 0 O-C-N 122.057 -0.402 . . . . 0.0 111.042 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.71 ' HB2' ' O ' ' A' ' 90' ' ' GLN . . . -48.74 -47.43 72.12 Favored Pre-proline 0 N--CA 1.505 2.278 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -177.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.519 ' HD3' ' HB3' ' A' ' 94' ' ' ALA . 33.0 Cg_endo -73.77 25.46 0.33 Allowed 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 122.371 2.047 . . . . 0.0 114.258 -178.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.501 ' HE3' HG21 ' A' ' 101' ' ' VAL . 5.1 mttp -135.61 37.81 2.88 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.711 HD13 HG22 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -74.58 -75.27 0.17 Allowed 'General case' 0 N--CA 1.503 2.208 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.992 -178.978 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 8.7 m -76.0 10.11 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 O-C-N 121.067 -1.021 . . . . 0.0 111.637 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 11.9 p -87.04 176.6 7.54 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -65.09 5.35 0.36 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.452 -0.78 . . . . 0.0 111.873 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.501 HG21 ' HE3' ' A' ' 96' ' ' LYS . 56.3 t -96.23 -5.24 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 CA-C-N 120.265 1.393 . . . . 0.0 111.009 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.509 ' HB3' ' O ' ' A' ' 97' ' ' LEU . 4.1 tp10 -142.07 -85.46 0.17 Allowed 'General case' 0 N--CA 1.513 2.71 0 C-N-CA 118.626 -1.23 . . . . 0.0 112.869 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 20.8 m -136.57 40.56 2.59 Favored 'General case' 0 N--CA 1.507 2.387 0 CA-C-N 119.601 1.091 . . . . 0.0 110.616 -177.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.408 ' O ' ' CB ' ' A' ' 105' ' ' LEU . 25.6 t30 -44.95 -95.76 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.385 -0.822 . . . . 0.0 111.946 -179.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.512 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 1.4 mt 87.19 -58.41 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.462 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -177.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.713 ' HB1' ' HA2' ' A' ' 110' ' ' GLY . . . 160.95 127.68 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.503 ' OG1' ' CE1' ' A' ' 109' ' ' HIS . 2.3 p -91.59 -146.62 0.21 Allowed 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -178.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.503 HG23 ' N ' ' A' ' 109' ' ' HIS . 6.5 tp -57.41 -39.34 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.825 -0.547 . . . . 0.0 111.059 178.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.51 ' CE1' ' O ' ' A' ' 113' ' ' PHE . 2.2 p80 -90.78 21.93 3.84 Favored 'General case' 0 N--CA 1.515 2.786 0 O-C-N 122.047 -0.408 . . . . 0.0 111.255 -177.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.713 ' HA2' ' HB1' ' A' ' 106' ' ' ALA . . . 53.18 64.89 3.77 Favored Glycine 0 N--CA 1.497 2.733 0 O-C-N 121.598 -0.688 . . . . 0.0 111.609 177.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 159.49 172.97 27.35 Favored Glycine 0 N--CA 1.498 2.822 0 CA-C-N 118.419 1.11 . . . . 0.0 111.096 178.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.476 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 36.2 Cg_endo -85.17 80.38 2.09 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.059 2.506 . . . . 0.0 111.642 -178.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.597 ' CE2' HD21 ' A' ' 117' ' ' LEU . 8.3 p90 175.66 89.71 0.01 OUTLIER 'General case' 0 N--CA 1.535 3.783 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.465 ' HA ' ' NE2' ' A' ' 109' ' ' HIS . 16.9 p -113.82 -178.22 3.32 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 120.185 -1.572 . . . . 0.0 110.397 178.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.434 HD13 ' HA ' ' A' ' 115' ' ' LEU . 0.6 OUTLIER 67.56 33.22 5.2 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -178.912 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.427 ' O ' ' HB2' ' A' ' 117' ' ' LEU . 89.2 p -163.84 -135.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.597 HD21 ' CE2' ' A' ' 113' ' ' PHE . 2.4 mp 67.35 -119.52 0.23 Allowed 'General case' 0 N--CA 1.501 2.104 0 CA-C-N 119.254 0.934 . . . . 0.0 109.199 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.419 ' HB2' ' O ' ' A' ' 117' ' ' LEU . 7.0 mp 70.26 -17.02 0.28 Allowed 'General case' 0 N--CA 1.519 2.98 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -165.15 -110.26 0.23 Allowed Glycine 0 N--CA 1.499 2.879 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -129.57 -139.18 0.23 Allowed 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 52.76 22.83 12.73 Favored Glycine 0 N--CA 1.501 3.0 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 . . . . . 0 N--CA 1.499 2.016 0 CA-C-O 118.137 -0.935 . . . . 0.0 109.629 -179.774 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.691 ' C ' HG23 ' A' ' 2' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.691 HG23 ' C ' ' A' ' 1' ' ' SER . 2.8 t 83.59 -60.77 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.734 -0.604 . . . . 0.0 109.561 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 121.54 -81.18 0.34 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.5 t -89.25 38.6 0.9 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.253 -1.145 . . . . 0.0 109.492 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.5 m -46.5 164.63 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.246 -0.909 . . . . 0.0 109.438 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 84.8 m 59.19 109.82 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.125 -0.985 . . . . 0.0 109.915 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 1.005 HG22 ' HD2' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -98.41 157.81 33.71 Favored Pre-proline 0 N--CA 1.492 1.668 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.26 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 1.005 ' HD2' HG22 ' A' ' 7' ' ' ILE . 35.3 Cg_endo -78.11 156.26 29.94 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.26 1.973 . . . . 0.0 110.707 -179.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.72 10.2 36.62 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.744 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 0.3 OUTLIER -137.01 104.55 5.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.338 -1.095 . . . . 0.0 108.768 179.803 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.744 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 86.01 -59.68 0.06 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.749 -1.219 . . . . 0.0 108.181 -178.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 5.6 mt -102.2 101.6 20.13 Favored Pre-proline 0 C--N 1.303 -1.42 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 11' ' ' ALA . 34.3 Cg_endo -82.11 173.39 10.97 Favored 'Trans proline' 0 C--N 1.319 -0.981 0 C-N-CA 121.602 1.534 . . . . 0.0 111.945 -176.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 51.3 m-70 -74.85 149.38 39.59 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -179.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.677 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 6.4 t30 55.3 50.94 6.47 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 120.831 -1.168 . . . . 0.0 110.039 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.677 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 37.7 Cg_endo -78.99 -174.64 2.37 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 122.478 2.119 . . . . 0.0 111.122 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.611 HD21 ' HB1' ' A' ' 59' ' ' ALA . 4.3 mm? 47.12 41.79 12.02 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.716 -0.615 . . . . 0.0 111.046 178.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.444 ' CG ' ' N ' ' A' ' 19' ' ' SER . 1.9 p30 -81.91 -47.21 13.03 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.034 -1.041 . . . . 0.0 109.128 179.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.454 ' OG ' ' HD3' ' A' ' 43' ' ' ARG . 0.2 OUTLIER -60.74 -26.46 67.21 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.276 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.459 ' SG ' ' CD1' ' A' ' 17' ' ' LEU . 75.4 m -74.77 -34.73 62.52 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.526 ' HG3' ' N ' ' A' ' 22' ' ' TRP . 0.1 OUTLIER -66.95 -49.94 63.89 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.399 -0.813 . . . . 0.0 108.877 179.503 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.536 ' HB2' ' CE ' ' A' ' 40' ' ' MET . 31.6 m95 -71.44 -27.51 63.33 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.86 -1.15 . . . . 0.0 109.456 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.529 ' HB2' ' CG ' ' A' ' 40' ' ' MET . 26.4 t80 -67.03 -34.61 78.09 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.248 -0.907 . . . . 0.0 109.227 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.574 HG22 ' CD1' ' A' ' 93' ' ' PHE . 78.3 t -74.86 -40.15 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 118.59 -1.244 . . . . 0.0 108.087 178.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.467 ' OG ' ' O ' ' A' ' 22' ' ' TRP . 61.1 p -55.44 -37.66 67.99 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.114 -1.035 . . . . 0.0 109.262 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.44 ' O ' ' HA2' ' A' ' 30' ' ' GLY . 3.5 m -78.31 -55.09 5.52 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.337 -0.852 . . . . 0.0 111.476 -178.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 8.3 mmm180 -58.47 -25.1 61.91 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.792 -1.192 . . . . 0.0 110.388 -178.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.43 ' HB ' HG11 ' A' ' 89' ' ' VAL . 69.5 p -95.61 -64.44 1.06 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.175 -0.953 . . . . 0.0 111.57 -177.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.473 ' SG ' ' O ' ' A' ' 84' ' ' GLY . 3.4 m -98.89 16.15 23.3 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.816 -1.178 . . . . 0.0 109.806 -178.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' A' ' 26' ' ' THR . . . 51.78 21.94 7.97 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 -179.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.557 HG12 ' N ' ' A' ' 32' ' ' GLY . 40.7 t -102.47 165.63 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.386 -1.067 . . . . 0.0 109.335 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.557 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 129.69 176.87 14.6 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.438 -1.865 . . . . 0.0 108.438 -179.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -65.3 173.5 6.2 Favored 'Trans proline' 0 C--O 1.214 -0.693 0 CA-C-N 119.143 1.472 . . . . 0.0 109.897 179.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -92.26 82.87 4.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.872 -1.143 . . . . 0.0 110.3 -178.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.474 HD12 ' HA ' ' A' ' 35' ' ' LEU . 9.1 tp -137.29 135.5 37.19 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 35' ' ' LEU . . . -46.55 155.4 0.24 Allowed 'General case' 0 N--CA 1.487 1.375 0 O-C-N 120.923 -1.111 . . . . 0.0 109.051 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.431 ' O ' ' C ' ' A' ' 38' ' ' GLN . 0.6 OUTLIER -74.34 -55.27 6.2 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.042 -1.036 . . . . 0.0 110.002 -179.562 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.431 ' C ' ' O ' ' A' ' 37' ' ' THR . 2.2 mp0 -43.31 -34.6 1.25 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.228 -0.92 . . . . 0.0 109.691 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.607 ' O ' ' HB3' ' A' ' 42' ' ' ALA . 10.1 mm-40 -64.87 -52.1 58.41 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.109 -0.994 . . . . 0.0 108.593 179.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.536 ' CE ' ' HB2' ' A' ' 22' ' ' TRP . 0.4 OUTLIER -54.43 -60.78 2.89 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.232 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.435 ' C ' ' O ' ' A' ' 40' ' ' MET . 20.9 ttpt -44.3 -35.34 2.29 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.607 ' HB3' ' O ' ' A' ' 39' ' ' GLU . . . -63.2 -48.93 76.23 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.486 -0.759 . . . . 0.0 109.029 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.454 ' HD3' ' OG ' ' A' ' 19' ' ' SER . 7.7 mtt-85 -55.1 -52.39 63.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.373 -0.83 . . . . 0.0 109.539 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 20.9 m -55.89 -35.77 66.91 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 0.0 109.904 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 81.7 m -68.97 -28.62 66.78 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.038 -1.039 . . . . 0.0 109.148 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.72 -31.34 64.91 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.404 ' O ' HG13 ' A' ' 51' ' ' ILE . 3.4 mm-40 -76.79 -36.41 57.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.465 -0.772 . . . . 0.0 109.506 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.844 HD11 HG12 ' A' ' 98' ' ' VAL . 7.4 tt -72.21 -36.63 69.22 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.265 -0.897 . . . . 0.0 109.299 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.458 ' O ' ' C ' ' A' ' 50' ' ' ALA . 1.2 tt0 -71.64 -55.73 7.19 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.485 ' O ' ' HD3' ' A' ' 52' ' ' PRO . . . -45.92 -47.92 16.29 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 178.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.404 HG13 ' O ' ' A' ' 47' ' ' GLN . 88.9 mt -62.12 106.43 0.84 Allowed Pre-proline 0 C--N 1.303 -1.452 0 N-CA-C 107.059 -1.459 . . . . 0.0 107.059 176.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.535 ' O ' ' N ' ' A' ' 54' ' ' TYR . 25.1 Cg_endo -61.38 141.03 91.11 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 121.607 1.538 . . . . 0.0 110.925 -177.082 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.569 ' HA ' ' HG3' ' A' ' 56' ' ' ARG . . . -31.29 -35.18 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.156 0.503 . . . . 0.0 110.811 -178.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.54 ' O ' ' CB ' ' A' ' 55' ' ' CYS . 9.4 m-85 -75.0 129.14 37.14 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.138 -0.976 . . . . 0.0 109.153 179.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.54 ' CB ' ' O ' ' A' ' 54' ' ' TYR . 4.3 m 79.23 0.45 2.33 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.338 -0.851 . . . . 0.0 110.924 179.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.569 ' HG3' ' HA ' ' A' ' 53' ' ' ALA . 3.7 mmt85 -43.19 -90.24 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.704 -1.248 . . . . 0.0 109.706 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.529 ' C ' ' O ' ' A' ' 56' ' ' ARG . 3.3 m -21.47 -55.13 0.02 OUTLIER 'General case' 0 N--CA 1.514 2.755 0 O-C-N 122.069 -0.394 . . . . 0.0 111.706 -179.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.503 ' C ' ' O ' ' A' ' 57' ' ' CYS . 1.3 mm-40 -31.13 -59.41 0.22 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.596 -0.69 . . . . 0.0 110.82 -179.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.611 ' HB1' HD21 ' A' ' 17' ' ' LEU . . . -29.05 -56.38 0.14 Allowed 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 121.223 0.535 . . . . 0.0 111.07 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 1.013 ' CG2' HD22 ' A' ' 97' ' ' LEU . 32.0 t -55.17 -53.09 38.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 O-C-N 121.282 -0.886 . . . . 0.0 109.498 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.529 ' O ' ' HB2' ' A' ' 65' ' ' ASP . 17.9 mmt85 -56.49 -26.85 55.56 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.389 -0.819 . . . . 0.0 109.989 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.792 HG21 HG23 ' A' ' 67' ' ' VAL . 16.1 mm -79.09 -28.9 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.914 -1.116 . . . . 0.0 110.494 -179.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.549 ' CD1' ' HB3' ' A' ' 17' ' ' LEU . 9.1 tt -77.48 -50.03 13.52 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.91 -1.119 . . . . 0.0 108.848 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -78.12 -47.81 17.4 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.198 -0.939 . . . . 0.0 109.743 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.529 ' HB2' ' O ' ' A' ' 61' ' ' ARG . 0.7 OUTLIER -80.21 -20.02 45.64 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.117 -0.989 . . . . 0.0 109.799 -179.98 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 62' ' ' ILE . . . 102.05 162.21 26.61 Favored Glycine 0 N--CA 1.485 1.944 0 C-N-CA 119.31 -1.424 . . . . 0.0 110.749 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.792 HG23 HG21 ' A' ' 62' ' ' ILE . 3.6 p -113.85 155.54 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.527 HG22 ' NE2' ' A' ' 74' ' ' HIS . 22.3 t -120.52 156.25 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 120.893 -1.13 . . . . 0.0 110.185 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.435 ' N ' ' CG1' ' A' ' 68' ' ' VAL . 46.3 p -118.19 158.49 25.01 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.3 t -65.31 -27.9 68.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.415 -0.803 . . . . 0.0 109.681 -179.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.1 p -68.47 -14.23 62.86 Favored 'General case' 0 C--N 1.294 -1.815 0 O-C-N 121.586 -0.696 . . . . 0.0 109.238 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 99.28 8.76 52.71 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 108.827 -1.709 . . . . 0.0 108.827 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -93.02 156.41 16.91 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.106 -1.232 . . . . 0.0 109.648 -179.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.527 ' NE2' HG22 ' A' ' 68' ' ' VAL . 9.0 m170 -116.53 155.2 29.08 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 120.963 -1.086 . . . . 0.0 109.043 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.512 ' HB2' ' CG1' ' A' ' 67' ' ' VAL . 19.5 mm-40 -147.78 -169.92 3.45 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 121.563 0.696 . . . . 0.0 109.352 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 58.78 -145.61 42.92 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.93 16.9 4.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.286 -1.126 . . . . 0.0 110.069 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.521 ' O ' ' N ' ' A' ' 80' ' ' GLN . 1.0 OUTLIER -76.18 -18.51 59.05 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.985 -1.072 . . . . 0.0 109.669 -179.645 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.675 HD21 ' HB3' ' A' ' 90' ' ' GLN . 7.7 tt -47.41 94.91 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.101 -0.999 . . . . 0.0 108.706 179.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.521 ' N ' ' O ' ' A' ' 78' ' ' LEU . 23.2 mm100 -127.71 179.24 5.63 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.075 -1.016 . . . . 0.0 110.197 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.14 104.82 3.74 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.808 0.813 . . . . 0.0 110.863 -179.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.705 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 13.7 mt -82.88 173.41 7.59 Favored Pre-proline 0 C--N 1.298 -1.643 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 177.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.705 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 28.5 Cg_endo -69.15 104.86 1.29 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 120.873 1.048 . . . . 0.0 109.695 179.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.473 ' O ' ' SG ' ' A' ' 29' ' ' CYS . . . 92.04 4.75 66.63 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 -179.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.456 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 3.3 m -139.1 88.03 13.54 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 120.753 -1.44 . . . . 0.0 108.758 179.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.425 ' O ' ' C ' ' A' ' 87' ' ' ARG . 30.9 Cg_endo -76.21 159.13 37.2 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 121.638 1.558 . . . . 0.0 111.884 -178.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.425 ' C ' ' O ' ' A' ' 86' ' ' PRO . 7.1 mmm-85 -45.2 -28.24 0.74 Allowed 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.413 ' N ' ' C ' ' A' ' 86' ' ' PRO . 49.8 tt0 -54.34 -61.74 2.11 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.262 -178.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.43 HG11 ' HB ' ' A' ' 28' ' ' THR . 58.8 t -59.06 -40.64 81.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.084 -1.01 . . . . 0.0 109.952 -178.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.675 ' HB3' HD21 ' A' ' 79' ' ' LEU . 0.4 OUTLIER -62.77 -26.82 68.9 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 119.537 -0.865 . . . . 0.0 108.737 179.685 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.53 -31.22 47.41 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.434 -0.791 . . . . 0.0 109.77 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.5 ' O ' ' HD2' ' A' ' 95' ' ' PRO . . . -73.37 -42.97 61.54 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.087 -1.008 . . . . 0.0 109.47 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.574 ' CD1' HG22 ' A' ' 24' ' ' VAL . 21.5 t80 -78.03 -25.75 48.01 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.35 -0.844 . . . . 0.0 110.143 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.867 ' HB3' ' HD3' ' A' ' 95' ' ' PRO . . . -37.24 -53.36 2.16 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.597 -0.69 . . . . 0.0 110.94 -179.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.867 ' HD3' ' HB3' ' A' ' 94' ' ' ALA . 31.5 Cg_endo -73.75 -178.74 3.97 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.175 1.917 . . . . 0.0 110.305 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.447 ' HB2' ' O ' ' A' ' 95' ' ' PRO . 0.1 OUTLIER 71.36 24.66 3.66 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.248 -0.908 . . . . 0.0 108.839 -179.201 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 1.013 HD22 ' CG2' ' A' ' 60' ' ' VAL . 17.6 tp -73.01 -69.87 0.39 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.464 -0.772 . . . . 0.0 110.64 -179.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.844 HG12 HD11 ' A' ' 48' ' ' LEU . 2.4 m -79.35 26.57 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.571 -1.331 . . . . 0.0 110.906 -179.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.422 ' C ' ' HB2' ' A' ' 104' ' ' ASN . 5.2 p -103.87 174.22 5.96 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 120.617 -1.302 . . . . 0.0 108.902 179.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -58.81 -0.93 0.12 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.848 -1.157 . . . . 0.0 112.006 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.1 t -98.78 6.16 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 119.945 -1.722 . . . . 0.0 110.459 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.443 ' HB2' ' O ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -145.57 -90.49 0.1 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.741 -1.225 . . . . 0.0 110.391 -179.949 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.51 ' O ' ' CD1' ' A' ' 105' ' ' LEU . 56.0 m -145.22 40.85 1.24 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.953 -1.092 . . . . 0.0 109.195 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.555 ' O ' ' CB ' ' A' ' 105' ' ' LEU . 24.0 t30 -33.28 -89.47 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.412 -0.805 . . . . 0.0 111.983 -178.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.772 HD12 HD22 ' A' ' 48' ' ' LEU . 3.3 mt 85.3 -66.87 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -177.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.724 ' HB2' ' O ' ' A' ' 105' ' ' LEU . . . 155.97 115.1 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.639 HG21 HG21 ' A' ' 98' ' ' VAL . 2.8 p -85.55 -162.26 0.7 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.4 tp -73.38 -16.97 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 120.87 -1.144 . . . . 0.0 109.424 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.503 ' ND1' HD11 ' A' ' 117' ' ' LEU . 84.1 m-70 -80.06 16.27 1.27 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.432 -0.792 . . . . 0.0 110.377 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 109' ' ' HIS . . . 43.97 26.44 0.83 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 109' ' ' HIS . . . -153.6 172.72 32.4 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.45 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 33.7 Cg_endo -78.29 81.91 2.6 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 123.021 2.481 . . . . 0.0 110.938 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.589 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER 168.38 171.43 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.064 -1.022 . . . . 0.0 110.552 179.356 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.443 ' O ' ' C ' ' A' ' 115' ' ' LEU . 0.5 OUTLIER -174.54 144.66 0.89 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.234 -0.916 . . . . 0.0 109.176 179.503 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.443 ' C ' ' O ' ' A' ' 114' ' ' CYS . 71.5 mt 42.27 55.07 4.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.987 -1.07 . . . . 0.0 109.527 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.434 ' HB2' ' O ' ' A' ' 115' ' ' LEU . 13.8 t 172.34 -67.33 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.36 -0.837 . . . . 0.0 109.208 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.542 ' O ' ' HB2' ' A' ' 118' ' ' LEU . 0.2 OUTLIER 57.46 24.28 10.04 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.265 -0.897 . . . . 0.0 109.522 179.844 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.542 ' HB2' ' O ' ' A' ' 117' ' ' LEU . 1.0 OUTLIER 69.37 -14.11 0.34 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.455 -0.778 . . . . 0.0 112.269 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -174.83 176.73 47.04 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -137.0 65.69 1.49 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.092 -1.24 . . . . 0.0 109.569 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.74 -14.29 54.62 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.302 -1.117 . . . . 0.0 109.53 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 16.1 p . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.276 0.56 . . . . 0.0 109.524 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.643 HG11 ' OG ' ' A' ' 5' ' ' SER . 49.3 t -80.74 -88.82 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.17 -0.957 . . . . 0.0 109.5 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.613 ' N ' HG12 ' A' ' 2' ' ' VAL . . . 143.26 -94.14 0.18 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.2 t -89.26 39.45 0.94 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.218 -1.166 . . . . 0.0 109.258 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.643 ' OG ' HG11 ' A' ' 2' ' ' VAL . 0.1 OUTLIER -66.82 178.35 1.37 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.321 -0.862 . . . . 0.0 109.555 -179.864 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 68.2 m -135.79 178.3 7.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.336 -0.852 . . . . 0.0 109.319 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.498 ' CG2' ' HD2' ' A' ' 8' ' ' PRO . 35.2 mm -116.18 140.22 26.15 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.187 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.498 ' HD2' ' CG2' ' A' ' 7' ' ' ILE . 36.4 Cg_endo -80.35 151.07 20.06 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 122.188 1.925 . . . . 0.0 110.568 -179.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.4 ' C ' ' HG2' ' A' ' 10' ' ' MET . . . 54.44 17.32 8.17 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.876 -1.289 . . . . 0.0 109.876 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.747 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 1.4 mtt -139.38 108.2 5.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.29 -1.123 . . . . 0.0 108.669 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.747 ' HB3' ' O ' ' A' ' 10' ' ' MET . . . 85.35 -60.89 0.07 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.815 -1.178 . . . . 0.0 108.288 -178.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.747 HD11 ' CB ' ' A' ' 55' ' ' CYS . 1.7 mt -103.1 101.56 22.55 Favored Pre-proline 0 N--CA 1.485 1.315 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.466 ' HD3' ' O ' ' A' ' 11' ' ' ALA . 31.7 Cg_endo -80.61 174.14 11.47 Favored 'Trans proline' 0 C--N 1.317 -1.089 0 C-N-CA 121.281 1.321 . . . . 0.0 111.355 -177.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.463 ' O ' ' CG ' ' A' ' 15' ' ' ASN . 53.8 m-70 -73.75 148.27 42.74 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.769 -0.582 . . . . 0.0 109.761 -179.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.581 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 3.1 p-10 43.25 58.63 11.96 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.065 -1.022 . . . . 0.0 110.503 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.581 ' HD3' ' N ' ' A' ' 15' ' ' ASN . 37.2 Cg_endo -81.09 166.16 18.85 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.676 2.251 . . . . 0.0 110.91 179.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.451 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 14.5 mt 55.08 45.82 25.38 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.471 -0.768 . . . . 0.0 111.179 178.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -69.74 -45.38 68.25 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.815 -1.178 . . . . 0.0 108.589 178.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.501 ' O ' ' HB2' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -62.4 -25.2 67.81 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.886 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.458 ' O ' HG23 ' A' ' 24' ' ' VAL . 73.9 m -69.55 -44.79 70.2 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.376 0.608 . . . . 0.0 109.483 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.61 -48.71 76.24 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.179 -0.951 . . . . 0.0 109.389 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.442 ' HA ' ' CE3' ' A' ' 22' ' ' TRP . 26.5 m95 -69.59 -26.25 64.37 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.443 -1.411 . . . . 0.0 109.382 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.601 ' CG ' ' HG2' ' A' ' 40' ' ' MET . 1.5 t80 -67.44 -30.11 69.75 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.865 HG13 ' HD2' ' A' ' 93' ' ' PHE . 59.1 t -75.18 -42.95 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 C-N-CA 118.758 -1.177 . . . . 0.0 107.859 178.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.7 p -56.03 -41.75 75.46 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.076 -1.05 . . . . 0.0 109.965 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.504 ' CA ' ' O ' ' A' ' 31' ' ' VAL . 3.4 m -77.83 -54.48 6.28 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.253 -0.904 . . . . 0.0 111.308 -178.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -58.7 -24.83 62.13 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 120.847 -1.158 . . . . 0.0 110.437 -178.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.421 HG23 ' O ' ' A' ' 24' ' ' VAL . 59.1 p -94.62 -65.68 0.97 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.135 -0.978 . . . . 0.0 111.232 -178.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.476 ' SG ' ' O ' ' A' ' 84' ' ' GLY . 3.5 m -99.3 16.95 21.32 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.737 -1.227 . . . . 0.0 109.914 -178.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.454 ' HA2' ' O ' ' A' ' 26' ' ' THR . . . 55.93 18.88 20.03 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 -178.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.504 ' O ' ' CA ' ' A' ' 26' ' ' THR . 30.2 t -101.6 157.3 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.312 -1.11 . . . . 0.0 109.525 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.405 ' N ' ' CG1' ' A' ' 31' ' ' VAL . . . 131.29 177.61 14.99 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.494 -1.842 . . . . 0.0 108.494 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -66.59 171.99 9.94 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 CA-C-N 119.15 1.475 . . . . 0.0 110.066 179.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -92.67 70.58 4.88 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.935 -1.103 . . . . 0.0 110.364 -178.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.451 ' O ' ' C ' ' A' ' 36' ' ' ALA . 0.8 OUTLIER -109.8 122.8 48.33 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 178.803 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.451 ' C ' ' O ' ' A' ' 35' ' ' LEU . . . -41.27 128.71 2.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.324 -0.86 . . . . 0.0 109.154 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.448 HG23 ' CE1' ' A' ' 23' ' ' TYR . 15.8 m -51.16 -38.8 54.24 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.829 -1.169 . . . . 0.0 111.377 -178.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -61.04 -36.95 80.94 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.751 -1.218 . . . . 0.0 110.194 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -72.43 -26.76 61.96 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.135 -0.978 . . . . 0.0 109.196 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.601 ' HG2' ' CG ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -72.48 -60.89 2.01 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.898 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -54.56 -36.16 64.03 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.84 -43.5 95.98 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.328 -0.857 . . . . 0.0 109.095 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.405 ' NH1' ' CG ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -60.23 -52.66 64.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.311 -0.868 . . . . 0.0 109.579 179.929 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.428 ' SG ' ' N ' ' A' ' 20' ' ' CYS . 14.7 m -56.68 -35.97 69.05 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.262 -0.899 . . . . 0.0 110.633 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 32.8 m -70.45 -30.72 67.63 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.754 -1.216 . . . . 0.0 109.043 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -68.41 -34.74 76.56 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 179.098 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.454 ' O ' HG13 ' A' ' 51' ' ' ILE . 3.1 mt-30 -77.83 -27.41 49.96 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.542 -0.724 . . . . 0.0 109.138 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.715 ' O ' HD13 ' A' ' 48' ' ' LEU . 1.6 tm? -69.55 -39.02 77.69 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.465 -0.772 . . . . 0.0 108.942 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.425 ' O ' ' C ' ' A' ' 50' ' ' ALA . 3.6 tt0 -77.41 -47.23 20.31 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.489 ' O ' ' HD3' ' A' ' 52' ' ' PRO . . . -45.53 -43.76 12.12 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 178.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.462 ' O ' ' HD2' ' A' ' 56' ' ' ARG . 49.4 mt -73.42 107.44 3.36 Favored Pre-proline 0 C--N 1.301 -1.519 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 177.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.535 ' O ' ' N ' ' A' ' 54' ' ' TYR . 25.4 Cg_endo -61.15 149.43 89.25 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 121.702 1.601 . . . . 0.0 111.224 -176.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.676 ' HA ' ' HD3' ' A' ' 56' ' ' ARG . . . -34.99 -29.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.037 0.446 . . . . 0.0 111.083 -178.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.54 ' O ' ' CB ' ' A' ' 55' ' ' CYS . 1.5 m-85 -79.88 125.87 30.28 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 120.999 -1.063 . . . . 0.0 110.017 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.747 ' CB ' HD11 ' A' ' 12' ' ' ILE . 4.5 m 81.63 -0.22 1.58 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.489 -0.757 . . . . 0.0 111.727 178.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.676 ' HD3' ' HA ' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -46.98 -89.9 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.316 -1.49 . . . . 0.0 109.328 -179.916 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.493 ' O ' ' C ' ' A' ' 58' ' ' GLU . 53.5 m -33.36 -56.81 0.42 Allowed 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.325 -0.86 . . . . 0.0 111.904 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.493 ' C ' ' O ' ' A' ' 57' ' ' CYS . 27.3 tt0 -32.34 -51.35 0.26 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.029 -1.045 . . . . 0.0 111.416 -179.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.458 ' C ' ' O ' ' A' ' 58' ' ' GLU . . . -36.17 -54.82 0.8 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.282 -0.886 . . . . 0.0 110.643 -179.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 44.0 t -54.63 -47.98 71.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 121.327 -0.858 . . . . 0.0 109.17 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.59 -27.03 62.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.217 -0.927 . . . . 0.0 109.442 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.95 HD12 ' HB ' ' A' ' 67' ' ' VAL . 3.7 mm -77.74 -30.14 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.254 -0.904 . . . . 0.0 109.747 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.527 ' O ' ' HA ' ' A' ' 77' ' ' ARG . 8.1 tt -77.88 -40.43 40.06 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.81 -1.181 . . . . 0.0 109.283 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.453 ' SD ' ' HG ' ' A' ' 79' ' ' LEU . 10.4 tpt -77.81 -53.72 7.17 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.239 -0.913 . . . . 0.0 109.985 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -79.61 -22.28 43.87 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.194 -0.941 . . . . 0.0 110.307 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.423 ' CA ' ' HB2' ' A' ' 77' ' ' ARG . . . 88.76 146.71 13.19 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.95 ' HB ' HD12 ' A' ' 62' ' ' ILE . 4.0 p -116.88 160.18 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.61 -0.935 . . . . 0.0 109.337 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.77 HG22 ' CE1' ' A' ' 74' ' ' HIS . 9.5 t -114.17 158.46 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 CA-C-O 121.9 0.857 . . . . 0.0 109.854 -178.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.459 ' N ' ' CG1' ' A' ' 68' ' ' VAL . 69.1 p -116.78 158.51 23.77 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.636 0.731 . . . . 0.0 109.728 -178.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 38.8 t -65.55 -25.63 67.51 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.418 0.628 . . . . 0.0 110.11 -178.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.2 p -71.82 -14.15 61.89 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.484 -0.76 . . . . 0.0 109.226 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.25 8.4 50.25 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 108.789 -1.725 . . . . 0.0 108.789 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -100.86 156.15 17.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.075 -1.25 . . . . 0.0 109.18 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.77 ' CE1' HG22 ' A' ' 68' ' ' VAL . 13.4 m170 -115.25 155.66 26.84 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.968 -1.083 . . . . 0.0 108.958 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.422 ' CD ' ' O ' ' A' ' 74' ' ' HIS . 22.4 mm-40 -139.51 -171.45 3.14 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.549 -0.86 . . . . 0.0 109.999 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 53.77 -147.1 20.6 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 108.366 -1.894 . . . . 0.0 108.366 -178.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.527 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 14.4 ttt85 52.94 23.13 2.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.118 -1.225 . . . . 0.0 109.577 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.18 -10.82 45.68 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.087 -1.008 . . . . 0.0 110.654 -179.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.866 HD22 ' O ' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -57.08 123.18 14.34 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.461 -1.4 . . . . 0.0 108.68 179.514 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.457 ' CG ' ' O ' ' A' ' 79' ' ' LEU . 49.6 mt-30 -156.5 -179.2 7.95 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.758 -1.214 . . . . 0.0 110.234 -178.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.19 105.57 1.12 Allowed 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.869 0.843 . . . . 0.0 110.754 -179.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.674 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 22.2 mt -89.7 171.77 8.24 Favored Pre-proline 0 C--N 1.298 -1.632 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.018 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.674 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 28.3 Cg_endo -67.29 100.39 0.55 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 121.136 1.224 . . . . 0.0 110.422 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.476 ' O ' ' SG ' ' A' ' 29' ' ' CYS . . . 91.27 14.26 57.59 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.481 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . 3.3 m -144.55 91.58 6.19 Favored Pre-proline 0 N--CA 1.498 1.926 0 O-C-N 120.904 -1.35 . . . . 0.0 109.224 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.414 ' O ' ' C ' ' A' ' 87' ' ' ARG . 29.9 Cg_endo -75.2 157.09 42.11 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 121.459 1.439 . . . . 0.0 112.028 -178.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.414 ' C ' ' O ' ' A' ' 86' ' ' PRO . 8.1 mtm-85 -45.25 -28.54 0.82 Allowed 'General case' 0 N--CA 1.483 1.201 0 O-C-N 121.306 -0.872 . . . . 0.0 108.821 178.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -57.78 -62.27 1.92 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.907 -0.496 . . . . 0.0 111.456 -177.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.8 t -61.34 -39.4 82.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 120.958 -1.089 . . . . 0.0 110.137 -178.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.784 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 2.2 mp0 -63.62 -27.41 69.22 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.684 -0.806 . . . . 0.0 108.856 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.422 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 0.0 OUTLIER -78.43 -33.38 48.63 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.469 -0.77 . . . . 0.0 109.52 179.679 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.482 ' O ' ' HD2' ' A' ' 95' ' ' PRO . . . -69.98 -50.94 36.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.154 -0.966 . . . . 0.0 109.513 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.865 ' HD2' HG13 ' A' ' 24' ' ' VAL . 5.6 t80 -78.14 -25.72 47.49 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.241 -0.912 . . . . 0.0 110.239 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.843 ' HB3' ' HD3' ' A' ' 95' ' ' PRO . . . -38.55 -53.02 3.34 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.331 -0.856 . . . . 0.0 111.365 -178.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.843 ' HD3' ' HB3' ' A' ' 94' ' ' ALA . 30.0 Cg_endo -71.38 -174.68 1.29 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.025 1.817 . . . . 0.0 110.854 -179.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.496 ' CB ' ' O ' ' A' ' 95' ' ' PRO . 1.2 ttmm 74.31 32.71 0.95 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.273 -0.892 . . . . 0.0 108.857 -178.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.61 -73.08 0.25 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.475 -0.766 . . . . 0.0 111.469 -178.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.528 ' O ' ' CB ' ' A' ' 104' ' ' ASN . 2.0 m -77.62 24.69 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.737 -1.227 . . . . 0.0 111.678 -178.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 24.7 p -95.81 169.54 9.93 Favored 'General case' 0 C--N 1.294 -1.815 0 O-C-N 120.547 -1.345 . . . . 0.0 108.671 179.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.483 ' HA ' ' ND2' ' A' ' 104' ' ' ASN . 0.6 OUTLIER -59.74 -1.0 0.22 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.658 -1.276 . . . . 0.0 111.774 -179.665 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.453 ' O ' HG12 ' A' ' 101' ' ' VAL . 11.0 t -98.92 5.87 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 119.855 -1.778 . . . . 0.0 110.336 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -142.17 -91.29 0.13 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.808 -1.182 . . . . 0.0 110.117 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.535 ' O ' HD23 ' A' ' 105' ' ' LEU . 74.2 m -145.15 39.56 1.21 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.938 -1.101 . . . . 0.0 109.451 -179.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.528 ' CB ' ' O ' ' A' ' 98' ' ' VAL . 4.5 p30 -34.58 -47.9 0.34 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.355 -0.841 . . . . 0.0 111.719 -179.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.535 HD23 ' O ' ' A' ' 103' ' ' CYS . 1.3 mm? 44.44 24.75 0.1 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.695 -1.253 . . . . 0.0 110.109 -179.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.476 ' O ' ' O ' ' A' ' 105' ' ' LEU . . . 60.93 122.78 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.771 -1.205 . . . . 0.0 109.125 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.42 HG21 HG21 ' A' ' 98' ' ' VAL . 2.4 p -95.28 -172.7 2.73 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.078 -1.013 . . . . 0.0 108.624 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.2 tp -58.74 -21.43 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 120.935 -1.103 . . . . 0.0 109.21 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.498 ' HB3' ' CE1' ' A' ' 113' ' ' PHE . 79.2 m-70 -80.11 16.66 1.17 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.654 -0.654 . . . . 0.0 110.373 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 109' ' ' HIS . . . 43.93 26.89 0.9 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 109' ' ' HIS . . . -154.4 171.08 32.89 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.459 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 32.2 Cg_endo -78.67 73.57 5.86 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 123.066 2.511 . . . . 0.0 111.603 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.498 ' CE1' ' HB3' ' A' ' 109' ' ' HIS . 25.0 p90 172.1 149.73 0.05 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.223 -0.923 . . . . 0.0 109.889 178.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.512 ' O ' ' CB ' ' A' ' 115' ' ' LEU . 12.5 p -139.67 127.41 21.89 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.865 -1.147 . . . . 0.0 109.464 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.512 ' CB ' ' O ' ' A' ' 114' ' ' CYS . 1.3 mt 162.18 -169.14 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.705 -1.247 . . . . 0.0 109.725 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.72 21.69 3.93 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.423 -0.798 . . . . 0.0 109.089 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.828 HD22 ' C ' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -63.54 -4.22 2.71 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.201 -0.937 . . . . 0.0 110.807 -179.555 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.545 ' N ' HD13 ' A' ' 117' ' ' LEU . 0.5 OUTLIER -49.61 -22.25 1.25 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.774 -1.204 . . . . 0.0 112.691 -178.805 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -70.68 -91.12 0.08 OUTLIER Glycine 0 N--CA 1.489 2.232 0 O-C-N 120.056 -1.652 . . . . 0.0 109.479 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -131.46 -130.92 0.19 Allowed 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.236 -1.156 . . . . 0.0 108.37 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 63.44 11.29 40.29 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 . . . . . 0 N--CA 1.489 1.506 0 O-C-N 121.225 -1.162 . . . . 0.0 109.406 -179.922 . . . . . . . . 0 0 . 1 stop_ save_